PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gordon, M; El-Kalla, M; Zhao, YW; Fiteih, Y; Law, J; Volodko, N; Mohamed, A; El-Kadi, AOS; Liu, L; Odenbach, J; Thiesen, A; Onyskiw, C; Abu Ghazaleh, H; Park, J; Lee, SB; Yu, VC; Fernandez-Patron, C; Alexander, RT; Wine, E; Baksh, S				Gordon, Marilyn; El-Kalla, Mohamed; Zhao, Yuewen; Fiteih, Yahya; Law, Jennifer; Volodko, Natalia; Mohamed, Anwar; El-Kadi, Ayman O. S.; Liu, Lei; Odenbach, Jeff; Thiesen, Aducio; Onyskiw, Christina; Abu Ghazaleh, Haya; Park, Jikyoung; Lee, Sean Bong; Yu, Victor C.; Fernandez-Patron, Carlos; Alexander, R. Todd; Wine, Eytan; Baksh, Shairaz			The Tumor Suppressor Gene, RASSF1A, Is Essential for Protection against Inflammation -Induced Injury	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; STEM-CELL PROLIFERATION; NF-KAPPA-B; C-ABL; DNA METHYLTRANSFERASE-1; YAP; P53; APOPTOSIS; PROMOTES; PHOSPHORYLATION	Ras association domain family protein 1A (RASSF1A) is a tumor suppressor gene silenced in cancer. Here we report that RASSF1A is a novel regulator of intestinal inflammation as Rassf1a(+/-), Rassf1a(-/-) and an intestinal epithelial cell specific knockout mouse (Rassf1a(IEC-KO)) rapidly became sick following dextran sulphate sodium (DSS) administration, a chemical inducer of colitis. Rassf1a knockout mice displayed clinical symptoms of inflammatory bowel disease including: increased intestinal permeability, enhanced cytokine/chemokine production, elevated nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF kappa B) activity, elevated colonic cell death and epithelial cell injury. Furthermore, epithelial restitution/repair was inhibited in DSS-treated Rassf1a(-/-) mice with reduction of several makers of proliferation including Yes associated protein (YAP)-driven proliferation. Surprisingly, tyrosine phosphorylation of YAP was detected which coincided with increased nuclear p73 association, Bax-driven epithelial cell death and p53 accumulation resulting in enhanced apoptosis and poor survival of DSS-treated Rassf1a knockout mice. We can inhibit these events and promote the survival of DSS-treated Rassf1a knockout mice with intraperitoneal injection of the c-Abl and c-Abl related protein tyrosine kinase inhibitor, imatinib/gleevec. However, p53 accumulation was not inhibited by imatinib/gleevec in the Rassf1a(-/-) background which revealed the importance of p53-dependent cell death during intestinal inflammation. These observations suggest that tyrosine phosphorylation of YAP (to drive p73 association and up-regulation of pro-apoptotic genes such as Bax) and accumulation of p53 are consequences of inflammation-induced injury in DSS-treated Rassf1a(-/-) mice. Mechanistically, we can detect robust associations of RASSF1A with membrane proximal Toll-like receptor (TLR) components to suggest that RASSF1A may function to interfere and restrict TLR-driven activation of NF kappa B. Failure to restrict NF kappa B resulted in the inflammation-induced DNA damage driven tyrosine phosphorylation of YAP, subsequent p53 accumulation and loss of intestinal epithelial homeostasis.	[Gordon, Marilyn; El-Kalla, Mohamed; Fiteih, Yahya; Volodko, Natalia; Onyskiw, Christina; Abu Ghazaleh, Haya; Alexander, R. Todd; Wine, Eytan; Baksh, Shairaz] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Zhao, Yuewen; Law, Jennifer; Odenbach, Jeff; Fernandez-Patron, Carlos; Baksh, Shairaz] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Mohamed, Anwar; El-Kadi, Ayman O. S.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Liu, Lei; Wine, Eytan] Univ Alberta, Fac Med & Dent, CEGIIR, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Lab Med & Pathol, Fac Med & Dent, Edmonton, AB, Canada; [Park, Jikyoung; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA; [Yu, Victor C.] Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore 117548, Singapore; [Alexander, R. Todd] Univ Alberta, Dept Nephrol, Edmonton, AB, Canada; [Wine, Eytan; Baksh, Shairaz] Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National University of Singapore; University of Alberta; University of Alberta	Baksh, S (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	sbaksh@ualberta.ca	Alexander, R. Todd/G-1373-2012; Fiteih, Yahya/AAO-8298-2020; Yu, Victor/A-7899-2015; Baksh, Shairaz/GRX-2106-2022; Anwar-Mohamed, Anwar/J-6973-2015	Yu, Victor/0000-0003-3270-4734; Anwar-Mohamed, Anwar/0000-0001-9214-7859; Lee, Sean/0000-0001-6211-3498; Zhao, Yuewen/0000-0002-8765-1839	Canadian Institutes of Health Research; Women and Children's Health Research Institute; Canadian Breast Cancer Foundation (Prairies/NWT); Alberta Heritage Foundation for Medical Research; Canadian Foundation for Innovation/Alberta Small Equipment Grants Program; Stollery Children's Foundation/Hair Massacure Donation Fund; Alberta Innovates [201201237] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute; Canadian Breast Cancer Foundation (Prairies/NWT); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Foundation for Innovation/Alberta Small Equipment Grants Program; Stollery Children's Foundation/Hair Massacure Donation Fund; Alberta Innovates	This work was supported by grants from Canadian Institutes of Health Research, The Women and Children's Health Research Institute, the Canadian Breast Cancer Foundation (Prairies/NWT), the Alberta Heritage Foundation for Medical Research, the Canadian Foundation for Innovation/Alberta Small Equipment Grants Program and The Stollery Children's Foundation/Hair Massacure Donation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid HE, 2010, TUMOR BIOL, V32, P845; Al-Sohaily S, 2012, J GASTROEN HEPATOL, V27, P1423, DOI 10.1111/j.1440-1746.2012.07200.x; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Anwar A, 2009, J LEUKOCYTE BIOL, V86, P73, DOI [10.1189/jlb.0608334, 10.1189/JLB.0608334]; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Avruch J, 2010, BRIT J CANCER, V104, P24; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Azer SA, 2012, EUR J GASTROENTEROL; BAKSH S, 1992, PROTEIN EXPRES PURIF, V3, P322, DOI 10.1016/1046-5928(92)90008-K; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Biasi F, 2013, ANTIOXID REDOX SIGNA, V2013; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05; Dirisina R, 2011, GASTROENTEROLOGY, V141, P1036, DOI 10.1053/j.gastro.2011.05.032; Estrabaud E, 2007, CANCER RES, V67, P1054, DOI 10.1158/0008-5472.CAN-06-2530; Fausti Francesca, 2012, Mol Biol Int, V2012, P307628, DOI 10.1155/2012/307628; Fernandes MS, 2013, INT J CANCER, V132, P251, DOI 10.1002/ijc.27696; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gordon M., 2010, SMALL GTPASES, V2, P148; Goretsky T, 2012, AM J PATHOL, V181, P1306, DOI 10.1016/j.ajpath.2012.06.016; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Law Jennifer, 2012, Mol Biol Int, V2012, P536802, DOI 10.1155/2012/536802; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liao XY, 2008, INT J CANCER, V123, P296, DOI 10.1002/ijc.23494; Lin Q, 2012, BIOCHEM J, V445, P255, DOI 10.1042/BJ20111575; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Loncar MB, 2003, GUT, V52, P1297, DOI 10.1136/gut.52.9.1297; Machuy N, 2004, CELL DEATH DIFFER, V11, P290, DOI 10.1038/sj.cdd.4401336; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Park J, 2010, J BIOL CHEM, V285, P35029, DOI 10.1074/jbc.M110.165506; PRINGAULT E, 1991, P NATL ACAD SCI USA, V88, P10811, DOI 10.1073/pnas.88.23.10811; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Scrace Simon F, 2012, Mol Biol Int, V2012, P141732, DOI 10.1155/2012/141732; Song H, 2012, EMBO J, V31, P1147, DOI 10.1038/emboj.2011.480; Stamos JL, 2012, COLD SPRING HARB PER, V5; Stenson WF, 2010, CURR OPIN GASTROEN, V26, P85, DOI 10.1097/MOG.0b013e328334b417; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tommasi S, 2005, CANCER RES, V65, P92; Tommasi S, 2011, ONCOGENE, V30, P690, DOI 10.1038/onc.2010.440; Udenigwe CC, 2008, NUTR REV, V66, P445, DOI 10.1111/j.1753-4887.2008.00076.x; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van der Weyden L, 2008, ONCOGENE, V27, P4503, DOI 10.1038/onc.2008.94; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2012, CANCER RES, V72, P3817, DOI 10.1158/0008-5472.CAN-11-3343; van Limbergen J, 2011, GASTROENTEROLOGY, V141, P1566, DOI 10.1053/j.gastro.2011.09.018; Vos MD, 2005, J BIOL CHEM; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zhang HL, 2013, FASEB J, V27, P232, DOI 10.1096/fj.12-215491; Zhang H, 2011, APOPTOSIS, V16, P808, DOI 10.1007/s10495-011-0608-y; Zheng L, 2009, GASTROENTEROLOGY, V137, P2041, DOI 10.1053/j.gastro.2009.08.055; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	77	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75483	10.1371/journal.pone.0075483	http://dx.doi.org/10.1371/journal.pone.0075483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146755	gold, Green Published			2022-12-27	WOS:000326019400008
J	King, KM; West, JS; Brunner, PC; Dyer, PS; Fitt, BDL				King, Kevin M.; West, Jonathan S.; Brunner, Patrick C.; Dyer, Paul S.; Fitt, Bruce D. L.			Evolutionary Relationships between Rhynchosporium lolii sp nov and Other Rhynchosporium Species on Grasses	PLOS ONE			English	Article							RAMULARIA-COLLO-CYGNI; TAPESIA-YALLUNDAE; OILSEED RAPE; 1ST REPORT; REAL-TIME; PATHOGEN; SCALD; RESISTANCE; INFECTION; SECALIS	The fungal genus Rhynchosporium (causative agent of leaf blotch) contains several host-specialised species, including R. commune (colonising barley and brome-grass), R. agropyri (couch-grass), R. secalis (rye and triticale) and the more distantly related R. orthosporum (cocksfoot). This study used molecular fingerprinting, multilocus DNA sequence data, conidial morphology, host range tests and scanning electron microscopy to investigate the relationship between Rhynchosporium species on ryegrasses, both economically important forage grasses and common wild grasses in many cereal growing areas, and other plant species. Two different types of Rhynchosporium were found on ryegrasses in the UK. Firstly, there were isolates of R. commune that were pathogenic to both barley and Italian ryegrass. Secondly, there were isolates of a new species, here named R. lolii, that were pathogenic only to ryegrass species. R. lolii was most closely related to R. orthosporum, but exhibited clear molecular, morphological and host range differences. The species was estimated to have diverged from R. orthosporum ca. 5735 years before the present. The colonisation all the different Rhynchosporium species involved extensive hyphal growth in the sub-cuticular regions of the leaves. Finally, new species-specific PCR diagnostic tests were developed that could distinguish between these five closely related Rhynchosporium species.	[King, Kevin M.; West, Jonathan S.; Fitt, Bruce D. L.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [King, Kevin M.; Dyer, Paul S.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [West, Jonathan S.; Fitt, Bruce D. L.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England; [Brunner, Patrick C.] ETH, Plant Pathol Grp, Zurich, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nottingham; University of Hertfordshire; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitt, BDL (corresponding author), Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England.	b.fitt@herts.ac.uk	West, Jonathan S/D-6098-2011	West, Jonathan S/0000-0002-5211-2405; Dyer, Paul/0000-0003-0237-026X; King, Kevin/0000-0002-9928-1353; Bruce D. L., Fitt/0000-0003-3981-6456	Perry Foundation; University of Hertfordshire; Biotechnology and Biological Sciences Research Council; BBSRC [BBS/E/C/00005203, BB/D015200/1, BB/I017585/1, BB/I017585/2, BB/E001610/1] Funding Source: UKRI; EPSRC [TS/I000747/2, TS/I000747/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017585/2, BB/E001610/1, BBS/E/C/00004693, BB/I017585/1, BB/D015200/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [TS/I000747/1, TS/I000747/2] Funding Source: researchfish	Perry Foundation; University of Hertfordshire; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by funding from the Perry Foundation (http://www.perryfoundation.co.uk) and the University of Hertfordshire (http://www.herts.ac.uk). Rothamsted Research (http://www.rothamsted.ac.uk) receives strategic funding from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrova A, 2012, MOL PLANT PATHOL, V13, P986, DOI 10.1111/j.1364-3703.2012.00811.x; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Barrs VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064871; Boys EF, 2007, EUR J PLANT PATHOL, V118, P307, DOI 10.1007/s10658-007-9141-9; Boys EF, 2012, PLANT PATHOL, V61, P543, DOI 10.1111/j.1365-3059.2011.02529.x; BROOKS F. T., 1928, New Phytologist, V27, P215, DOI 10.1111/j.1469-8137.1928.tb06739.x; Brunner PC, 2007, J EVOLUTION BIOL, V20, P1311, DOI 10.1111/j.1420-9101.2007.01347.x; Caldwell RM, 1937, J AGRIC RES, V55, P0175; Charmet G, 1996, GENET RESOUR CROP EV, V43, P319, DOI 10.1007/BF00132951; Crouch JA, 2009, MOL ECOL, V18, P123, DOI 10.1111/j.1365-294X.2008.04008.x; DAVIS H, 1990, MYCOL RES, V94, P557, DOI 10.1016/S0953-7562(10)80023-1; Dettman JR, 2003, EVOLUTION, V57, P2721; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer PS, 2002, PLANT PATHOL, V51, P806, DOI 10.1046/j.1365-3059.2002.00774.x; FERNANDEZ JP, 1991, MYCOLOGIA, V83, P774, DOI 10.2307/3760434; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Fountaine JA, 2007, PHYTOPATHOLOGY, V97, P297, DOI 10.1094/PHYTO-97-3-0297; Gachomo EW, 2009, ANN APPL BIOL, V154, P259, DOI 10.1111/j.1744-7348.2008.00297.x; Goodwin SB, 2002, MYCOL RES, V106, P645, DOI 10.1017/S0953756202006007; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Holland SL, 2011, FUNGAL BIOL-UK, V115, P909, DOI 10.1016/j.funbio.2011.07.004; HOWLETT SG, 1987, T BRIT MYCOL SOC, V88, P547, DOI 10.1016/S0007-1536(87)80038-4; Kastelein P., 2002, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V67, P257; LANGE BJ, 1968, PHYTOPATHOLOGY, V58, P1711; LEHNACKERS H, 1990, CAN J BOT, V68, P1953, DOI 10.1139/b90-257; Lutman PJW, 2009, ASPECTS APPL BIOL, V91, P163; Murtagh GJ, 1999, LICHENOLOGIST, V31, P257; Nicholson P, 1997, PLANT PATHOL, V46, P842, DOI 10.1046/j.1365-3059.1997.d01-74.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Payne R.W., 2009, GENSTAT WINDOWS, V12nd; Preston C, 2009, WEED SCI, V57, P435, DOI 10.1614/WS-08-181.1; SHIPTON W A, 1974, Review of Plant Pathology, V53, P839; Stukenbrock EH, 2012, MYCOLOGIA, V104, P1397, DOI 10.3852/11-374; Taylor JMG, 2010, LETT APPL MICROBIOL, V50, P493, DOI 10.1111/j.1472-765X.2010.02826.x; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Taylor JW, 2006, FUNGI ENV, P313; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Walters DR, 2008, FEMS MICROBIOL LETT, V279, P1, DOI 10.1111/j.1574-6968.2007.00986.x; Welty RE, 1996, PLANT DIS, V80, P1220, DOI 10.1094/PD-80-1220; WILKINS P, 1973, PLANT PATHOL, V22, P107, DOI 10.1111/j.1365-3059.1973.tb01784.x; Zaffarano PL, 2008, EVOLUTION, V62, P1418, DOI 10.1111/j.1558-5646.2008.00390.x; Zaffarano PL, 2011, MYCOLOGIA, V103, P195, DOI 10.3852/10-119; Zaffarano PL, 2009, MOL ECOL, V18, P279, DOI 10.1111/j.1365-294X.2008.04013.x; Zhan J, 2008, PLANT PATHOL, V57, P1, DOI 10.1111/j.1365-3059.2007.01691.x	47	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e72536	10.1371/journal.pone.0072536	http://dx.doi.org/10.1371/journal.pone.0072536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146740	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400001
J	Rout, TM; McDonald-Madden, E; Martin, TG; Mitchell, NJ; Possingham, HP; Armstrong, DP				Rout, Tracy M.; McDonald-Madden, Eve; Martin, Tara G.; Mitchell, Nicola J.; Possingham, Hugh P.; Armstrong, Doug P.			How to Decide Whether to Move Species Threatened by Climate Change	PLOS ONE			English	Article							ASSISTED COLONIZATION; MANAGED RELOCATION; RISK-ASSESSMENT; BIODIVERSITY CONSERVATION; SEX DETERMINATION; HABITAT MODELS; REINTRODUCTION; ECOSYSTEMS; MIGRATION; TUATARA	Introducing species to areas outside their historical range to secure their future under climate change is a controversial strategy for preventing extinction. While the debate over the wisdom of this strategy continues, such introductions are already taking place. Previous frameworks for analysing the decision to introduce have lacked a quantifiable management objective and mathematically rigorous problem formulation. Here we develop the first rigorous quantitative framework for deciding whether or not a particular introduction should go ahead, which species to prioritize for introduction, and where and how to introduce them. It can also be used to compare introduction with alternative management actions, and to prioritise questions for future research. We apply the framework to a case study of tuatara (Sphenodon punctatus) in New Zealand. While simple and accessible, this framework can accommodate uncertainty in predictions and values. It provides essential support for the existing IUCN guidelines by presenting a quantitative process for better decision-making about conservation introductions.	[Rout, Tracy M.] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Rout, Tracy M.; McDonald-Madden, Eve; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [McDonald-Madden, Eve; Martin, Tara G.; Possingham, Hugh P.] Univ Queensland, Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [McDonald-Madden, Eve; Martin, Tara G.] CSIRO, Climate Adaptat Flagship, Brisbane, Qld, Australia; [Mitchell, Nicola J.] Univ Western Australia, Ctr Evolutionary Biol, Perth, WA 6009, Australia; [Possingham, Hugh P.] Univ Queensland, Dept Math & Phys, Brisbane, Qld, Australia; [Armstrong, Doug P.] Massey Univ, Wildlife Ecol Grp, Palmerston North, New Zealand; [Armstrong, Doug P.] Int Union Conservat Nat Species Survival Commiss, Reintro Specialist Grp, Oceania Chair, Abu Dhabi, U Arab Emirates	University of Melbourne; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Queensland; Massey University	Rout, TM (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	tmrout@unimelb.edu.au	Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Mitchell, Nicola/AAE-4132-2020; Mitchell, Nicola J/K-5277-2012; McDonald-Madden, Eve/A-5186-2012; Martin, Tara/M-1897-2016; Rout, Tracy/AGS-0555-2022	Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Mitchell, Nicola J/0000-0003-0744-984X; McDonald-Madden, Eve/0000-0001-7755-2338; Martin, Tara/0000-0001-7165-9812; Rout, Tracy/0000-0002-5976-8255	Australian Research Council through Australian Post-Doctoral Fellowships; Centre of Excellence for Environmental Decisions; Australian Government's National Environmental Research Program; Commonwealth Scientific and Industrial Research Organisation	Australian Research Council through Australian Post-Doctoral Fellowships(Australian Research Council); Centre of Excellence for Environmental Decisions; Australian Government's National Environmental Research Program(Australian Government); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by the Australian Research Council (www.arc.gov.au) through Australian Post-Doctoral Fellowships to TMR and EM-M, and the Centre of Excellence for Environmental Decisions (to HPP, TGM, and EM-M). It was also supported by the Australian Government's National Environmental Research Program (to HPP, TGM, and EM-M), and the Commonwealth Scientific and Industrial Research Organisation (through a Julius Career award to TGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; Chauvenet ALM, 2013, ANIM CONSERV, V16, P161, DOI 10.1111/j.1469-1795.2012.00589.x; DANTZIG GB, 1957, OPER RES, V5, P266, DOI 10.1287/opre.5.2.266; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Fordham DA, 2013, NATURE CLIM IN PRESS; Fox D, 2007, WORLDS COLLIDE CONSE; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hewitt N, 2011, BIOL CONSERV, V144, P2560, DOI 10.1016/j.biocon.2011.04.031; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; HOWARD RA, 1966, IEEE T SYST SCI CYB, VSSC2, P22, DOI 10.1109/TSSC.1966.300074; IUCN, 1998, IUCN GUID REINTR; IUCN, 2013, GUID REINTR OTH CONS; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Laycock H, 2009, BIOL CONSERV, V142, P3120, DOI 10.1016/j.biocon.2009.08.010; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Martin TG, 2005, ECOL APPL, V15, P266, DOI 10.1890/03-5400; McDonald-Madden E, 2011, NAT CLIM CHANGE, V1, P261, DOI 10.1038/NCLIMATE1170; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Mitchell Nicola J, 2006, Front Zool, V3, P9, DOI 10.1186/1742-9994-3-9; Mitchell NJ, 2010, GLOBAL CHANGE BIOL, V16, P60, DOI 10.1111/j.1365-2486.2009.01964.x; Pannell DJ, 2012, LAND USE POLICY, V29, P377, DOI 10.1016/j.landusepol.2011.08.002; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Seddon PJ, 2009, CONSERV BIOL, V23, P788, DOI 10.1111/j.1523-1739.2009.01200.x; Springborn M, 2011, ECOL ECON, V70, P2145, DOI 10.1016/j.ecolecon.2011.06.016; Weber J, 2009, J ENVIRON MANAGE, V90, P798, DOI 10.1016/j.jenvman.2008.01.012; Willis SG, 2009, CONSERV LETT, V2, P45, DOI 10.1111/j.1755-263X.2008.00043.x; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x	39	40	40	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75814	10.1371/journal.pone.0075814	http://dx.doi.org/10.1371/journal.pone.0075814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146778	gold, Green Published			2022-12-27	WOS:000326019400018
J	Mitter, N; Koundal, V; Williams, S; Pappu, H				Mitter, Neena; Koundal, Vikas; Williams, Sarah; Pappu, Hanu			Differential Expression of Tomato Spotted Wilt Virus-Derived Viral Small RNAs in Infected Commercial and Experimental Host Plants	PLOS ONE			English	Article							SMALL INTERFERING RNAS; DICER-LIKE PROTEINS; NICOTIANA-BENTHAMIANA; SILENCING SUPPRESSOR; THRIPS TRANSMISSION; ANTIVIRAL DEFENSE; NSM PROTEIN; TOSPOVIRUS; GENE; SEQUENCE	Background: Viral small RNAs (vsiRNAs) in the infected host can be generated from viral double-stranded RNA replicative intermediates, self-complementary regions of the viral genome or from the action of host RNA-dependent RNA polymerases on viral templates. The vsiRNA abundance and profile as well as the endogenous small RNA population can vary between different hosts infected by the same virus influencing viral pathogenicity and host response. There are no reports on the analysis of vsiRNAs of Tomato spotted wilt virus (TSWV), a segmented negative stranded RNA virus in the family Bunyaviridae, with two of its gene segments showing ambisense gene arrangement. The virus causes significant economic losses to numerous field and horticultural crops worldwide. Principal Findings: Tomato spotted wilt virus (TSWV)-specific vsiRNAs were characterized by deep sequencing in virus-infected experimental host Nicotiana benthamiana and a commercial, susceptible host tomato. The total small (s) RNA reads in TSWV-infected tomato sample showed relatively equal distribution of 21, 22 and 24 nt, whereas N. benthamiana sample was dominated by 24 nt total sRNAs. The number of vsiRNA reads detected in tomato was many a magnitude (similar to 350: 1) higher than those found in N. benthamiana, however the profile of vsiRNAs in terms of relative abundance 21, 22 and 24 nt class size was similar in both the hosts. Maximum vsiRNA reads were obtained for the M RNA segment of TSWV while the largest L RNA segment had the least number of vsiRNAs in both tomato and N. benthamiana. Only the silencing suppressor, NSs, of TSWV recorded higher antisense vsiRNA with respect to the coding frame among all the genes of TSWV. Significance: Details of the origin, distribution and abundance of TSWV vsiRNAs could be useful in designing efficient targets for exploiting RNA interference for virus resistance. It also has major implications toward our understanding of the differential processing of vsiRNAs in antiviral defense and viral pathogenicity.	[Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [Koundal, Vikas; Pappu, Hanu] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Williams, Sarah] Univ Queensland, Inst Mol Biol, St Lucia, Qld, Australia	University of Queensland; Washington State University; University of Queensland	Pappu, H (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	hrp@wsu.edu	mitter, neena/D-1862-2013	mitter, neena/0000-0001-6146-6179	Agricultural Research Center, Washington State University; USDA National Institute of Food and Agriculture Specialty Crops Research Institute	Agricultural Research Center, Washington State University; USDA National Institute of Food and Agriculture Specialty Crops Research Institute	This work was financed by Agricultural Research Center, Washington State University and USDA National Institute of Food and Agriculture Specialty Crops Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins S, 2000, MOL PLANT PATHOL, V1, P151, DOI 10.1046/j.1364-3703.2000.00022.x; Bag S, 2012, EUR J PLANT PATHOL, V134, P97, DOI 10.1007/s10658-012-0026-1; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Bucher E, 2006, J GEN VIROL, V87, P3697, DOI 10.1099/vir.0.82276-0; Chellappan P, 2005, PLANT PHYSIOL, V138, P1828, DOI 10.1104/pp.105.066563; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Garcia S, 2006, J GEN VIROL, V87, P1985, DOI 10.1099/vir.0.81827-0; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Geerts-Dimitriadou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031013; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Herr AJ, 2004, COLD SPRING HARB SYM, V69, P363, DOI 10.1101/sqb.2004.69.363; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Jan FJ, 2000, J GEN VIROL, V81, P235, DOI 10.1099/0022-1317-81-1-235; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katiyar-Agarwal S, 2007, METHOD ENZYMOL, V427, P215, DOI 10.1016/S0076-6879(07)27012-0; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewandowski DJ, 2005, VIROLOGY, V342, P26, DOI 10.1016/j.virol.2005.06.050; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Lin KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011928; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nagata T, 2000, PHYTOPATHOLOGY, V90, P454, DOI 10.1094/PHYTO.2000.90.5.454; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pang SZ, 1997, P NATL ACAD SCI USA, V94, P8261, DOI 10.1073/pnas.94.15.8261; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; PAPPU HR, 2008, ENCY VIROLOGY, V5, P133; Prabha K, 2013, INDIAN J VIROL, V24, P157, DOI 10.1007/s13337-013-0133-4; Prins M, 1996, MOL PLANT MICROBE IN, V9, P416, DOI 10.1094/MPMI-9-0416; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qiu WP, 1998, VIROLOGY, V244, P186, DOI 10.1006/viro.1998.9131; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reavy B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-18; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Silva TF, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-40; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tsompana M., 2008, ENCY VIROLOGY, V5, P157; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016928; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	84	53	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76276	10.1371/journal.pone.0076276	http://dx.doi.org/10.1371/journal.pone.0076276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143182	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100017
J	Speakman, A; Rodger, A; Phillips, AN; Gilson, R; Johnson, M; Fisher, M; Wilkins, E; Anderson, J; O'Connell, R; Lascar, M; Aderogba, K; Edwards, S; McDonnell, J; Perry, N; Sherr, L; Collins, S; Hart, G; Johnson, AM; Miners, A; Elford, J; Geretti, AM; Burman, WJ; Lampe, FC				Speakman, Andrew; Rodger, Alison; Phillips, Andrew N.; Gilson, Richard; Johnson, Margaret; Fisher, Martin; Wilkins, Ed; Anderson, Jane; O'Connell, Rebecca; Lascar, Monica; Aderogba, Kazeem; Edwards, Simon; McDonnell, Jeffrey; Perry, Nicky; Sherr, Lorraine; Collins, Simon; Hart, Graham; Johnson, Anne M.; Miners, Alec; Elford, Jonathan; Geretti, Anna-Maria; Burman, William J.; Lampe, Fiona C.			The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) Study. Design, Methods and Participant Characteristics	PLOS ONE			English	Article							HIV-INFECTION; HOMOSEXUAL-MEN; COMMUNITY SAMPLES; LIFE EXPECTANCY; VIRAL LOAD; GAY MEN; BEHAVIOR; LONDON; THERAPY; PREVENTION	Life expectancy for people diagnosed with HIV has improved dramatically however the number of new infections in the UK remains high. Understanding patterns of sexual behaviour among people living with diagnosed HIV, and the factors associated with having condom-less sex, is important for informing HIV prevention strategies and clinical care. In addition, in view of the current interest in a policy of early antiretroviral treatment (ART) for all people diagnosed with HIV in the UK, it is of particular importance to assess whether ART use is associated with increased levels of condom-less sex. In this context the ASTRA study was designed to investigate current sexual activity, and attitudes to HIV transmission risk, in a large unselected sample of HIV-infected patients under care in the UK. The study also gathered background information on demographic, socio-economic, lifestyle and disease-related characteristics, and physical and psychological symptoms, in order to identify other key factors impacting on HIV patients and the behaviours which underpin transmission. In this paper we describe the study rationale, design, methods, response rate and the demographic characteristics of the participants. People diagnosed with HIV infection attending 8 UK HIV out-patient clinics in 2011-2012 were invited to participate in the study. Those who agreed to participate completed a confidential, self-administered pen-and-paper questionnaire, and their latest CD4 count and viral load test results were recorded. During the study period, 5112 eligible patients were invited to take part in the study and 3258 completed questionnaires were obtained, representing a response rate of 64% of eligible patients. The study includes 2248 men who have sex with men (MSM), 373 heterosexual men and 637 women. Future results from ASTRA will be a key resource for understanding HIV transmission within the UK, targeting prevention efforts, and informing clinical care of individuals living with HIV.	[Speakman, Andrew; Rodger, Alison; Phillips, Andrew N.; Gilson, Richard; McDonnell, Jeffrey; Sherr, Lorraine; Hart, Graham; Johnson, Anne M.; Lampe, Fiona C.] UCL, Res Dept Infect & Populat Hlth, London, England; [Johnson, Margaret] Royal Free Hosp, Ian Charleson Day Ctr, Royal Free Ctr HIV Med, London NW3 2QG, England; [Fisher, Martin; Perry, Nicky] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Wilkins, Ed] Pennine Acute Hosp NHS Trust, Manchester, Lancs, England; [Anderson, Jane] Homerton Univ Hosp, London, England; [O'Connell, Rebecca; Lascar, Monica] Barts Hlth NHS Trust, London, England; [Aderogba, Kazeem] Eastbourne Sexual Hlth Ctr, Eastbourne, England; [Edwards, Simon] Cent & North West London Community Fdn Trust, Mortimer Market Ctr, London, England; [Collins, Simon] HIV I Base, London, England; [Miners, Alec] London Sch Hyg & Trop Med, London WC1, England; [Elford, Jonathan] City Univ London, London EC1V 0HB, England; [Geretti, Anna-Maria] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Burman, William J.] Denver Publ Hlth, Denver, CO USA	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of London; Queen Mary University London; Barts Health NHS Trust; University of London; London School of Hygiene & Tropical Medicine; City University London; University of Liverpool	Speakman, A (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	a.speakman@ucl.ac.uk	Anderson, Jane/A-1632-2012; Lampe, Fiona/I-5826-2019; Phillips, Andrew N/B-4427-2008; Collins, Simon/AAB-5123-2022	Anderson, Jane/0000-0001-5294-8707; Lampe, Fiona/0000-0001-6851-5471; Phillips, Andrew N/0000-0003-2384-4807; Sherr, Lorraine/0000-0002-5902-8011; Speakman, Andrew/0000-0003-1386-0627; Geretti, Anna Maria/0000-0002-3670-6588; Johnson, Anne/0000-0003-1330-7100; Hart, Graham/0000-0001-9676-6577; Collins, Simon/0000-0002-3537-2432	National Institute for Health Research (NIHR) [RP-PG-0608-10142]; National Institute for Health Research, through the Comprehensive Clinical Research Network; National Institute for Health Research [RP-PG-0608-10142, NF-SI-0611-10255] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The ASTRA study presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10142). The ASTRA Study Group acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, COMMUNICATION; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bernard E, 2008, NAM AIDSMAP; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Burman W, 2008, JAIDS-J ACQ IMM DEF, V49, P142, DOI 10.1097/QAI.0b013e318183a9ad; Burns FM, 2009, AIDS, V23, P262, DOI 10.1097/QAD.0b013e32831c546b; Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Das M, 2010, PLOS ONE, V5, P9; Dave SS, 2006, SEX TRANSM INFECT, V82, P117, DOI 10.1136/sti.2005.015396; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Dodds JP, 2007, SEX TRANSM INFECT, V83, P392, DOI 10.1136/sti.2006.021782; Elford J, 2004, SEX TRANSM INFECT, V80, P451, DOI 10.1136/sti.2004.010785; Elford J, 2005, AIDS, V19, P205, DOI 10.1097/00002030-200501280-00014; Elford J, 2002, AIDS, V16, P1537, DOI 10.1097/00002030-200207260-00011; Elford J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-150; Elford J, 2007, AIDS, V21, pS63, DOI 10.1097/01.aids.0000255087.62223.ff; Fenton KA, 2002, SEX TRANSM INFECT, V78, P241, DOI 10.1136/sti.78.4.241; Glass TR, 2004, AIDS, V18, P1707, DOI 10.1097/01.aids.0000131396.21963.81; Hart GJ, 2005, SEX TRANSM INFECT, V81, P367, DOI 10.1136/sti.2004.013995; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Health Protection Agency, 2012, HIV UK 2012 REP; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Kozal MJ, 2004, AIDS, V18, P2185, DOI 10.1097/00002030-200411050-00011; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; May Margaret, 2011, BMJ, V343, pd6016, DOI 10.1136/bmj.d6016; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Mercer CH, 2004, AIDS, V18, P1453, DOI 10.1097/01.aids.0000131331.36386.de; MOCROFT A, 2003, LANCET, V166, P2572; Moses SH, 2012, INT J STD AIDS, V23, P282, DOI 10.1258/ijsa.2009.009094; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neaton JD, 2008, CURR OPIN HIV AIDS, V3, P112, DOI 10.1097/COH.0b013e3282f3808b; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Rodkjaer L, 2010, HIV MED, V11, P46, DOI 10.1111/j.1468-1293.2009.00741.x; Sadler KE, 2007, SEX TRANSM INFECT, V83, P523, DOI 10.1136/sti.2007.027128; Sherr L, 2007, INT J STD AIDS, V18, P700, DOI 10.1258/095646207782193821; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stephenson JM, 2003, SEX TRANSM INFECT, V79, P7, DOI 10.1136/sti.79.1.7; Vernazza P, 2008, B MED SUISSES, V89, P165; VOGL D, 1999, SYMPTOM PREVALENCE C, P34965; Weatherburn P., 2009, WHAT DO YOU NEED 200; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williamson LM, 2008, AIDS, V22, P1063, DOI 10.1097/QAD.0b013e3282f8af9b	44	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77230	10.1371/journal.pone.0077230	http://dx.doi.org/10.1371/journal.pone.0077230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143214	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100050
J	Zhang, ZJ; Almeida, S; Lu, YB; Nishimura, AL; Peng, LT; Sun, DQ; Wu, B; Karydas, AM; Tartaglia, MC; Fong, JC; Miller, BL; Farese, RV; Moore, MJ; Shaw, CE; Gao, FB				Zhang, Zhijun; Almeida, Sandra; Lu, Yubing; Nishimura, Agnes L.; Peng, Lingtao; Sun, Danqiong; Wu, Bei; Karydas, Anna M.; Tartaglia, Maria C.; Fong, Jamie C.; Miller, Bruce L.; Farese, Robert V., Jr.; Moore, Melissa J.; Shaw, Christopher E.; Gao, Fen-Biao			Downregulation of MicroRNA-9 in iPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PLURIPOTENT STEM-CELLS; HEXANUCLEOTIDE REPEAT; RNA TARGETS; ALS; PROTEIN; DEMENTIA; DISEASE; GENE; INCLUSIONS	Transactive response DNA-binding protein 43 (TDP-43) is a major pathological protein in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). There are many disease-associated mutations in TDP-43, and several cellular and animal models with ectopic overexpression of mutant TDP-43 have been established. Here we sought to study altered molecular events in FTD and ALS by using induced pluripotent stem cell (iPSC) derived patient neurons. We generated multiple iPSC lines from an FTD/ALS patient with the TARDBP A90V mutation and from an unaffected family member who lacked the mutation. After extensive characterization, two to three iPSC lines from each subject were selected, differentiated into postmitotic neurons, and screened for relevant cell-autonomous phenotypes. Patient-derived neurons were more sensitive than control neurons to 100 nM straurosporine but not to other inducers of cellular stress. Three disease-relevant cellular phenotypes were revealed under staurosporine-induced stress. First, TDP-43 was localized in the cytoplasm of a higher percentage of patient neurons than control neurons. Second, the total TDP-43 level was lower in patient neurons with the A90V mutation. Third, the levels of microRNA-9 (miR-9) and its precursor pri-miR-9-2 decreased in patient neurons but not in control neurons. The latter is likely because of reduced TDP-43, as shRNA-mediated TDP-43 knockdown in rodent primary neurons also decreased the pri-miR-9-2 level. The reduction in miR-9 expression was confirmed in human neurons derived from iPSC lines containing the more pathogenic TARDBP M337V mutation, suggesting miR-9 downregulation might be a common pathogenic event in FTD/ALS. These results show that iPSC models of FTD/ALS are useful for revealing stress-dependent cellular defects of human patient neurons containing rare TDP-43 mutations in their native genetic contexts.	[Zhang, Zhijun; Almeida, Sandra; Lu, Yubing; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Nishimura, Agnes L.; Shaw, Christopher E.] Inst Psychiat, Dept Clin Neurosci, London, England; [Peng, Lingtao; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biol Chem & Mol Pharmacol, Worcester, MA USA; [Peng, Lingtao; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Sun, Danqiong; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Wu, Bei] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA USA; [Karydas, Anna M.; Tartaglia, Maria C.; Fong, Jamie C.; Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Massachusetts System; University of Massachusetts Worcester; University of London; King's College London; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gao, FB (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	fen-biao.gao@umassmed.edu	Nishimura, Agnes L/B-2905-2011; Lu, Yubing/G-2644-2011	Lu, Yubing/0000-0002-7715-9867; Nishimura, Agnes/0000-0001-5295-797X; Shaw, Christopher/0000-0003-0251-0146	California Institute for Regenerative Medicine [RL1-00650]; University of Massachusetts Medical School; ALS Therapy Alliance; Consortium for FTD Research; National Institutes of Health [NS066586, NS057553, AG019724, AG023501]; MRC [MC_G1000733, G0300329, G0900688] Funding Source: UKRI; Medical Research Council [G0900688, MC_G1000733, G0300329, G0500289B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS057553, R01NS066586, R01NS057553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, P01AG019724] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); University of Massachusetts Medical School; ALS Therapy Alliance; Consortium for FTD Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was initiated with a grant from the California Institute for Regenerative Medicine (RL1-00650 to FBG and RVF Jr.) and was subsequently supported by funds from the University of Massachusetts Medical School and the ALS Therapy Alliance (FBG). The work was also supported by the Consortium for FTD Research (FBG) and the National Institutes of Health (NS066586 and NS057553, FBG; AG019724 and AG023501, BLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2012, P NATL ACAD SCI USA, V109, P1913, DOI 10.1073/pnas.1117158109; Almeida S, 2012, ACTA NEUROPATHOL; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Chiang HH, 2012, J HUM GENET, V57, P316, DOI 10.1038/jhg.2012.24; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Gascon E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00048; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Iguchi Y, 2013, BRAIN, V136, P1371, DOI 10.1093/brain/awt029; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee JA, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-37; Li ZD, 2013, HUM MOL GENET, V22, P218, DOI 10.1093/hmg/dds420; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu XL, 2011, J NEUROSCI, V31, P13705, DOI 10.1523/JNEUROSCI.2827-11.2011; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019	58	51	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76055	10.1371/journal.pone.0076055	http://dx.doi.org/10.1371/journal.pone.0076055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143176	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100011
J	Breno, M; Bots, J; Van Dongen, S				Breno, Matteo; Bots, Jessica; Van Dongen, Stefan			Heritabilities of Directional Asymmetry in the Fore- and Hindlimbs of Rabbit Fetuses	PLOS ONE			English	Article							BILATERAL ASYMMETRY; DROSOPHILA-MELANOGASTER; FLUCTUATING ASYMMETRY; DEVELOPMENTAL INSTABILITY; ADAPTIVE ACCURACY; HAND DOMINANCE; SELECTION; HANDEDNESS; HUMANS; PREFERENCE	Directional asymmetry (DA), where at the population level symmetry differs from zero, has been reported in a wide range of traits and taxa, even for traits in which symmetry is expected to be the target of selection such as limbs or wings. In invertebrates, DA has been suggested to be non-adaptive. In vertebrates, there has been a wealth of research linking morphological asymmetry to behavioural lateralisation. On the other hand, the prenatal expression of DA and evidences for quantitative genetic variation for asymmetry may suggest it is not solely induced by differences in mechanic loading between sides. We estimate quantitative genetic variation of fetal limb asymmetry in a large dataset of rabbits. Our results showed a low but highly significant level of DA that is partially under genetic control for all traits, with forelimbs displaying higher levels of asymmetry. Genetic correlations were positive within limbs, but negative across bones of fore and hind limbs. Environmental correlations were positive for all, but smaller across fore and hind limbs. We discuss our results in light of the existence and maintenance of DA in locomotory traits.	[Breno, Matteo; Bots, Jessica; Van Dongen, Stefan] Univ Antwerp, Dept Biol, Evolutionary Biol Grp, B-2020 Antwerp, Belgium	University of Antwerp	Breno, M (corresponding author), Univ Antwerp, Dept Biol, Evolutionary Biol Grp, B-2020 Antwerp, Belgium.	matteo.breno@ua.ac.be	breno, matteo/ABH-4494-2020	breno, matteo/0000-0003-1559-8730	University of Antwerp [BOF-KP 4382]; Fund for Scientific Research - Flanders (FWO)	University of Antwerp; Fund for Scientific Research - Flanders (FWO)(FWO)	This work benefited from a research grant from the University of Antwerp (BOF-KP 4382). MB holds a PhD Fellowship from the Fund for Scientific Research - Flanders (FWO). JB is a postdoctoral fellow with the Fund for Scientific Reserach - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2009, SEMIN CELL DEV BIOL, V20, P479, DOI 10.1016/j.semcdb.2008.10.011; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Beardmore J, 1965, S MUT PROC PRAG CZEC; Blackburn A, 2011, AM J PHYS ANTHROPOL, V145, P639, DOI 10.1002/ajpa.21555; Breno M, 2013, BIRTH DEF B IN PRESS; Carter Ashley J R, 2009, Int J Evol Biol, V2010, P759159, DOI 10.4061/2009/759159; Cassidy KM, 1998, ANGLE ORTHOD, V68, P445; COYNE JA, 1987, J HERED, V78, P119, DOI 10.1093/oxfordjournals.jhered.a110329; Faurie C, 2004, P ROY SOC B-BIOL SCI, V271, pS43, DOI 10.1098/rsbl.2003.0092; Galatius A, 2005, MAR MAMMAL SCI, V21, P401, DOI 10.1111/j.1748-7692.2005.tb01240.x; Garland T, 2005, EVOLUTION, V59, P1851, DOI 10.1111/j.0014-3820.2005.tb01832.x; Gurnett CA, 2008, AM J HUM GENET, V83, P616, DOI 10.1016/j.ajhg.2008.10.004; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hansen TF, 2006, AM NAT, V168, P168, DOI 10.1086/505768; Hughes TE, 2007, J DENT RES, V86, P1160, DOI 10.1177/154405910708601204; Kanchan Tanuj, 2008, J Forensic Leg Med, V15, P177, DOI 10.1016/j.jflm.2007.05.009; Kharlamova AV, 2010, J MORPHOL, V271, P1501, DOI 10.1002/jmor.10890; Klingenberg Christian Peter, 2003, P427; Kraak SBM, 1997, TRENDS ECOL EVOL, V12, P230, DOI 10.1016/S0169-5347(97)86959-5; KRAHL H, 1994, AM J SPORT MED, V22, P751, DOI 10.1177/036354659402200605; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; Leamy L, 1999, J EVOLUTION BIOL, V12, P146, DOI 10.1046/j.1420-9101.1999.00023.x; Leamy L, 1997, J HERED, V88, pCP2; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; Palmer A. Richard, 2005, P359, DOI 10.1016/B978-012088777-4/50018-1; Pelabon C, 2008, EVOLUTION, V62, P2855, DOI 10.1111/j.1558-5646.2008.00495.x; Pettersson U, 2000, CALCIFIED TISSUE INT, V67, P199, DOI 10.1007/s002230001117; PLATO CC, 1980, AM J PHYS ANTHROPOL, V52, P27, DOI 10.1002/ajpa.1330520105; PURNELL DJ, 1973, HEREDITY, V31, P401, DOI 10.1038/hdy.1973.94; PURVES D, 1994, P NATL ACAD SCI USA, V91, P5030, DOI 10.1073/pnas.91.11.5030; R Development Core Team, 2011, R LANG ENV STAT COMP; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Razzetti E, 2007, ZOOMORPHOLOGY, V126, P31, DOI 10.1007/s00435-007-0028-2; Rego C, 2006, EVOLUTION, V60, P746, DOI 10.1111/j.0014-3820.2006.tb01153.x; Ribeiro AS, 2011, ANIM BEHAV, V81, P249, DOI 10.1016/j.anbehav.2010.10.014; ROY TA, 1994, AM J PHYS ANTHROPOL, V94, P203, DOI 10.1002/ajpa.1330940205; Sarringhaus LA, 2005, AM J PHYS ANTHROPOL, V128, P840, DOI 10.1002/ajpa.20190; Seligmann H, 2003, J ZOOL, V260, P129, DOI 10.1017/S0952836903003558; Seligmann H, 1998, J ZOOL, V245, P205, DOI 10.1017/S0952836998006086; Sengupta M, 2006, HUM BIOL, V78, P199, DOI 10.1353/hub.2006.0036; Sengupta M, 2007, AM J HUM BIOL, V19, P399, DOI 10.1002/ajhb.20601; Shaw CN, 2011, J HUM EVOL, V61, P480, DOI 10.1016/j.jhevol.2011.06.004; SINGH I, 1971, J ANAT, V109, P271; TUINSTRA EJ, 1990, P ROY SOC B-BIOL SCI, V241, P146, DOI 10.1098/rspb.1990.0078; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; Van Dongen S, 2009, J EVOLUTION BIOL, V22, P612, DOI 10.1111/j.1420-9101.2008.01667.x; Van Dongen S, 2010, ANIM BIOL, V60, P169, DOI 10.1163/157075610X491716; Voracek M, 2009, AM J PHYS ANTHROPOL, V140, P376, DOI 10.1002/ajpa.21105; Windig JJ, 1999, P ROY SOC B-BIOL SCI, V266, P1413, DOI 10.1098/rspb.1999.0795; Woolf CM, 1997, GENETICA, V101, P199, DOI 10.1023/A:1018366122913; Yeo RA, 2002, ELSEVIER SCI, P329	52	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76358	10.1371/journal.pone.0076358	http://dx.doi.org/10.1371/journal.pone.0076358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130770	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200035
J	He, NP; Yu, Q; Wang, RM; Zhang, YH; Gao, Y; Yu, GR				He, Nianpeng; Yu, Qiang; Wang, Ruomeng; Zhang, Yunhai; Gao, Yang; Yu, Guirui			Enhancement of Carbon Sequestration in Soil in the Temperature Grasslands of Northern China by Addition of Nitrogen and Phosphorus	PLOS ONE			English	Article							LAND-USE; DEPOSITION; STORAGE; ECOSYSTEMS; DYNAMICS; LITTER; MINERALIZATION; ACIDIFICATION; PERSPECTIVE; IMPACT	Increased nitrogen (N) deposition is common worldwide. Questions of where, how, and if reactive N-input influences soil carbon (C) sequestration in terrestrial ecosystems are of great concern. To explore the potential for soil C sequestration in steppe region under N and phosphorus (P) addition, we conducted a field experiment between 2006 and 2012 in the temperate grasslands of northern China. The experiment examined 6 levels of N (0-56 g N m(-2) yr(-1)), 6 levels of P (0-12.4 g P m(-2) yr(-1)), and a control scenario. Our results showed that addition of both N and P enhanced soil total C storage in grasslands due to significant increases of C input from litter and roots. Compared with control plots, soil organic carbon (SOC) in the 0-100 cm soil layer varied quadratically, from 156.8 to 1352.9 g C m(-2) with N addition gradient (R-2 = 0.99, P < 0.001); and logarithmically, from 293.6 to 788.6 g C m(-2) with P addition gradient (R-2 = 0.56, P = 0.087). Soil inorganic carbon (SIC) decreased quadratically with N addition. The net C sequestration on grassland (including plant, roots, SIC, and SOC) increased linearly from -128.6 to 729.0 g C m(-2) under N addition (R-2 = 0.72, P = 0.023); and increased logarithmically, from 248.5 to 698 g C m(-2) under P addition (R-2 = 0.82, P = 0.014). Our study implies that N addition has complex effects on soil carbon dynamics, and future studies of soil C sequestration on grasslands should include evaluations of both SOC and SIC under various scenarios.	[He, Nianpeng; Wang, Ruomeng; Gao, Yang; Yu, Guirui] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Yu, Qiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yu, Qiang] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Zhang, Yunhai] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Colorado State University; Chinese Academy of Sciences; Institute of Botany, CAS	He, NP (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	henp@igsnrr.ac.cn; yugr@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; Yu, Qiang/E-2097-2011; Gao, Yang/A-4128-2017; Zhang, Yunhai/F-7318-2019	于, 贵瑞/0000-0002-1859-8966; Yu, Qiang/0000-0002-5480-0623; Gao, Yang/0000-0002-2053-0418; he, nianpeng/0000-0002-0458-5953; Zhang, Yunhai/0000-0003-0613-3624	Natural Science Foundation of China [31270519]; special fund for scientific research in the public interest [201209028]; strategic program of state eco-environmental investigation and evaluation in China [STSN-02-03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund for scientific research in the public interest; strategic program of state eco-environmental investigation and evaluation in China	This work was partly funded by the Natural Science Foundation of China (31270519), by special fund for scientific research in the public interest (201209028), and by the strategic program of state eco-environmental investigation and evaluation in China (STSN-02-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann C, 2009, AGR ECOSYST ENVIRON, V133, P150, DOI 10.1016/j.agee.2009.05.006; Fornara DA, 2012, ECOLOGY, V93, P2030, DOI 10.1890/12-0292.1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gamboa AM, 2010, RESTOR ECOL, V18, P252, DOI 10.1111/j.1526-100X.2008.00432.x; Goulding KWT, 1998, AGR ECOSYST ENVIRON, V67, P135, DOI 10.1016/S0167-8809(97)00111-4; Grandy AS, 2007, ECOSYSTEMS, V10, P58, DOI 10.1007/s10021-006-9010-y; Grandy A, 2008, BIOGEOCHEMISTRY, V91, P37, DOI 10.1007/s10533-008-9257-9; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo LB, 2005, PLANT SOIL, V272, P1, DOI 10.1007/s11104-004-3611-z; Hagedorn F, 2003, SOIL BIOL BIOCHEM, V35, P1683, DOI 10.1016/j.soilbio.2003.08.015; Hagedorn F, 2012, GLOBAL CHANGE BIOL, V18, P1412, DOI 10.1111/j.1365-2486.2011.02603.x; He NP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00017.1; He NP, 2012, J GEOGR SCI, V22, P859, DOI 10.1007/s11442-012-0968-4; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Johnston CA, 2004, FRONT ECOL ENVIRON, V2, P522, DOI 10.1890/1540-9295(2004)002[0522:CCIS]2.0.CO;2; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Li LJ, 2012, PLANT SOIL ENVIRON, V58, P446, DOI 10.17221/6339-PSE; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Lu M, 2011, AGR ECOSYST ENVIRON, V140, P234, DOI 10.1016/j.agee.2010.12.010; Lu FM, 2011, BIOL FERT SOILS, V47, P187, DOI 10.1007/s00374-010-0522-4; MARION GM, 1985, SOIL SCI, V139, P468, DOI 10.1097/00010694-198505000-00014; Mi N, 2008, GLOBAL CHANGE BIOL, V14, P2380, DOI 10.1111/j.1365-2486.2008.01642.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Noble AD, 2008, GEODERMA, V144, P248, DOI 10.1016/j.geoderma.2007.11.019; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Yang YH, 2012, GLOBAL CHANGE BIOL, V18, P3672, DOI 10.1111/gcb.12025; Yang YH, 2012, GLOBAL CHANGE BIOL, V18, P2292, DOI 10.1111/j.1365-2486.2012.02694.x; Yang YH, 2011, PLANT SOIL, V343, P393, DOI 10.1007/s11104-011-0736-8; Yu QA, 2011, OECOLOGIA, V166, P1, DOI 10.1007/s00442-010-1902-z; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zeng DH, 2010, BIOGEOCHEMISTRY, V98, P185, DOI 10.1007/s10533-009-9385-x	39	17	19	14	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77241	10.1371/journal.pone.0077241	http://dx.doi.org/10.1371/journal.pone.0077241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130863	Green Submitted, gold, Green Published			2022-12-27	WOS:000325814200073
J	Herbst, S; Maucher, D; Schneider, M; Ihling, CH; Jahn, O; Sinz, A				Herbst, Sabine; Maucher, Daniel; Schneider, Marian; Ihling, Christian H.; Jahn, Olaf; Sinz, Andrea			Munc13-Like skMLCK Variants Cannot Mimic the Unique Calmodulin Binding Mode of Munc13 as Evidenced by Chemical Cross-Linking and Mass Spectrometry	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; PROTEIN-PROTEIN INTERACTIONS; SHORT-TERM PLASTICITY; PEPTIDE COMPLEX; ACTIVATION; SCATTERING; DOMAIN; MOTIF; NMR	Among the neuronal binding partners of calmodulin (CaM) are Munc13 proteins as essential presynaptic regulators that play a key role in synaptic vesicle priming and are crucial for presynaptic short-term plasticity. Recent NMR structural investigations of a CaM/Munc13-1 peptide complex have revealed an extended structure, which contrasts the compact structures of most classical CaM/target complexes. This unusual binding mode is thought to be related to the presence of an additional hydrophobic anchor residue at position 26 of the CaM binding motif of Munc13-1, resulting in a novel 1-5-8-26 motif. Here, we addressed the question whether the 1-5-8-26 CaM binding motif is a Munc13-related feature or whether it can be induced in other CaM targets by altering the motif's core residues. For this purpose, we chose skeletal muscle myosin light chain kinase (skMLCK) with a classical 1-5-8-14 CaM binding motif and constructed three skMLCK peptide variants mimicking Munc13-1, in which the hydrophobic anchor amino acid at position 14 was moved to position 26. Chemical cross-linking between CaM and skMLCK peptide variants combined with high-resolution mass spectrometry yielded insights into the peptides' binding modes. This structural comparison together with complementary binding data from surface plasmon resonance experiments revealed that skMLCK variants with an artificial 1-5-8-26 motif cannot mimic CaM binding of Munc13-1. Apparently, additional features apart from the spacing of the hydrophobic anchor residues are required to define the functional 1-5-8-26 motif of Munc13-1. We conclude that Munc13 proteins display a unique CaM binding behavior to fulfill their role as efficient presynaptic calcium sensors over broad range of Ca2+ concentrations.	[Herbst, Sabine; Maucher, Daniel; Ihling, Christian H.; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany; [Schneider, Marian] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Res Grp Artificial Binding Prot, D-06108 Halle, Saale, Germany; [Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Max Planck Society	Sinz, A (corresponding author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany.	andrea.sinz@pharmazie.uni-halle.de	Jahn, Olaf/AAD-8212-2020	Jahn, Olaf/0000-0002-3397-8924	DFG-Graduiertenkolleg 1026 "Conformational Transitions in Macromolecular Interactions'' at the Martin-Luther University Halle-Wittenberg; region of Sachsen-Anhalt; BMBF; DFG	DFG-Graduiertenkolleg 1026 "Conformational Transitions in Macromolecular Interactions'' at the Martin-Luther University Halle-Wittenberg; region of Sachsen-Anhalt; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	SH is funded by the DFG-Graduiertenkolleg 1026 "Conformational Transitions in Macromolecular Interactions'' at the Martin-Luther University Halle-Wittenberg. AS acknowledges financial support from the region of Sachsen-Anhalt, the BMBF, and the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bich C, 2010, ANAL CHEM, V82, P172, DOI 10.1021/ac901651r; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Dimova K, 2006, BBA-MOL CELL RES, V1763, P1256, DOI 10.1016/j.bbamcr.2006.09.017; Dimova K, 2009, BIOCHEMISTRY-US, V48, P5908, DOI 10.1021/bi900300r; Fabris D, 2010, J MASS SPECTROM, V45, P841, DOI 10.1002/jms.1762; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jahn O, 2004, ANAL BIOANAL CHEM, V378, P1031, DOI 10.1007/s00216-003-2353-8; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kalkhof S, 2005, ANAL CHEM, V77, P495, DOI 10.1021/ac0487294; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Krauth F, 2009, RAPID COMMUN MASS SP, V23, P2811, DOI 10.1002/rcm.4188; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P13997, DOI 10.1021/bi981311d; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P17810, DOI 10.1021/bi981656w; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipstein N, 2012, MOL CELL BIOL, V32, P4628, DOI 10.1128/MCB.00933-12; Persechini A, 2000, J BIOL CHEM, V275, P4199, DOI 10.1074/jbc.275.6.4199; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schaks S, 2011, BMMS, V2, P249; Schulz DM, 2004, BIOCHEMISTRY-US, V43, P4703, DOI 10.1021/bi036149f; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Sinz A, 2010, ANAL BIOANAL CHEM, V397, P3433, DOI 10.1007/s00216-009-3405-5; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75119	10.1371/journal.pone.0075119	http://dx.doi.org/10.1371/journal.pone.0075119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130683	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200003
J	Ruiz-Extremera, A; Munoz-Gamez, JA; Abril-Molina, A; Salmeron-Ruiz, MA; Munoz-de-Rueda, P; Pavon-Castillero, EJ; Quiles-Perez, R; Carazo, A; Gila, A; Jimenez-Ruiz, SM; Casado, J; Martin, AB; Sanjuan-Nunez, L; Ocete-Hita, E; Viota, JL; Leon, J; Salmeron, J				Ruiz-Extremera, Angeles; Antonio Munoz-Gamez, Jose; Abril-Molina, Ana; Angustias Salmeron-Ruiz, Maria; Munoz-de-Rueda, Paloma; Jose Pavon-Castillero, Esther; Quiles-Perez, Rosa; Carazo, Angel; Gila, Ana; Manuel Jimenez-Ruiz, Sergio; Casado, Jorge; Belen Martin, Ana; Sanjuan-Nunez, Laura; Ocete-Hita, Esther; Lopez Viota, Julian; Leon, Josefa; Salmeron, Javier			Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VERTICAL TRANSMISSION; NATURAL-HISTORY; LIVER FIBROSIS; INFECTION; INTERFERON; RISK; THERAPY; CHOLESTASIS; EXPRESSION	This study analyses the evolution of liver disease in women with chronic hepatitis C during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution. Of the 122 mothers recruited to this study, 89 were HCV-RNA+ve/HIV-ve and 33 were HCV-RNA-ve/HIV-ve/HCVantibody+ve and all were tested during the third trimester of pregnancy, at delivery and post-delivery. The HCV-RNA+ve mothers were categorized as either Type-A (66%), with an increase in ALT levels in the post-partum period (>40 U/L; P<0.001) or as Type-B (34%), with no variation in ALT values. The Type-A mothers also presented a significant decrease in serum HCV-RNA levels in the post-delivery period (P<0.001) and this event was concomitant with an increase in Th1 cytokine levels (INF gamma, P=0.04; IL12, P=0.01 and IL2, P=0.01). On the other hand, the Type-B mothers and the HCV-RNA-ve women presented no variations in either of these parameters. However, they did present higher Th1 cytokine levels in the partum period (INF gamma and IL2, P<0.05) than both the Type-A and the HCV-RNA-ve women. Cytokine levels at the moment of delivery do not constitute a risk factor associated with HCV vertical transmission. It is concluded that differences in the ALT and HCV-RNA values observed in HCV-RNA+ve women in the postpartum period might be due to different ratios of Th1 cytokine production. In the Type-B women, the high partum levels of Th1 cytokines and the absence of post-partum variation in ALT and HCV-RNA levels may be related to permanent Th1 cytokine stimulation.	[Ruiz-Extremera, Angeles] San Cecilio Univ Hosp, Paediat Unit, Granada, Spain; [Ruiz-Extremera, Angeles; Munoz-de-Rueda, Paloma; Quiles-Perez, Rosa; Gila, Ana; Ocete-Hita, Esther; Leon, Josefa; Salmeron, Javier] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Granada, Spain; [Ruiz-Extremera, Angeles; Ocete-Hita, Esther] Univ Granada, Paediat Unit, Granada, Spain; [Antonio Munoz-Gamez, Jose; Munoz-de-Rueda, Paloma; Jose Pavon-Castillero, Esther; Quiles-Perez, Rosa; Carazo, Angel; Gila, Ana; Manuel Jimenez-Ruiz, Sergio; Casado, Jorge; Belen Martin, Ana; Sanjuan-Nunez, Laura; Lopez Viota, Julian; Leon, Josefa; Salmeron, Javier] San Cecilio Univ Hosp, Clin Management Unit Digest Dis, Granada, Spain; [Abril-Molina, Ana; Ocete-Hita, Esther] Virgen de las Nieves Hosp, Paediat Unit, Granada, Spain; [Angustias Salmeron-Ruiz, Maria] La Paz Univ Hosp, Paediat Unit, Madrid, Spain; [Manuel Jimenez-Ruiz, Sergio; Sanjuan-Nunez, Laura; Salmeron, Javier] Univ Granada, Dept Med, Granada, Spain	Hospital Universitario San Cecilio; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada; Hospital Universitario San Cecilio; Hospital Universitario Virgen de las Nieves; Hospital Universitario La Paz; University of Granada	Munoz-Gamez, JA (corresponding author), San Cecilio Univ Hosp, Clin Management Unit Digest Dis, Granada, Spain.	jamunozgamez@gmail.com	casado, Jorge/GVT-9383-2022; Leon, Pepi/K-8972-2014	Leon, Pepi/0000-0002-0543-4823; Ruiz-Extremera, Angeles o Angela/0000-0001-7978-1708; Quiles, Rosa/0000-0001-6089-6193; Lopez-Viota, Julian/0000-0003-3112-587X	Fondo de Investigaciones Sanitarias (FIS, Instituto de Salud Carlos III) [PI080704]; Consejeria de Salud (SAS); Junta de Andalucia [SAS111213]; Ciberehd (Ciber de Enfermedades Hepaticas y Digestivas (Instituto de Salud Carlos III)	Fondo de Investigaciones Sanitarias (FIS, Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Consejeria de Salud (SAS); Junta de Andalucia(Junta de Andalucia); Ciberehd (Ciber de Enfermedades Hepaticas y Digestivas (Instituto de Salud Carlos III)	This work was supported by the Fondo de Investigaciones Sanitarias (FIS, Instituto de Salud Carlos III), [grant number PI080704]; Consejeria de Salud (SAS), Junta de Andalucia, [grant number SAS111213] and Ciberehd (Ciber de Enfermedades Hepaticas y Digestivas (Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 1998, RES VIROLOGY, V149, P229, DOI 10.1016/S0923-2516(98)80004-6; Arshad M, 2011, J VIRAL HEPATITIS, V18, P229, DOI 10.1111/j.1365-2893.2010.01413.x; Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931; Conte D, 2000, HEPATOLOGY, V31, P751, DOI 10.1002/hep.510310328; Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Fallahi P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/468107; Floreani A, 1996, BRIT J OBSTET GYNAEC, V103, P325, DOI 10.1111/j.1471-0528.1996.tb09736.x; Gervais A, 2000, J HEPATOL, V32, P293, DOI 10.1016/S0168-8278(00)80075-6; Hattori Y, 2003, J MED VIROL, V71, P205, DOI 10.1002/jmv.10471; Hayashida A, 2007, J OBSTET GYNAECOL RE, V33, P417, DOI 10.1111/j.1447-0756.2007.00582.x; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; Hurtado CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012232; Indolfi G, 2006, J MED VIROL, V78, P911, DOI 10.1002/jmv.20640; Jabeen T, 2000, QJM-INT J MED, V93, P597, DOI 10.1093/qjmed/93.9.597; Kottilil S, 2009, HEPATOLOGY, V50, P34, DOI 10.1002/hep.23055; Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390; Le Campion A, 2012, VIRUSES-BASEL, V4, P3531, DOI 10.3390/v4123531; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Lin HH, 2000, BRIT J OBSTET GYNAEC, V107, P1503, DOI 10.1111/j.1471-0528.2000.tb11675.x; Locatelli A, 1999, BRIT J OBSTET GYNAEC, V106, P498, DOI 10.1111/j.1471-0528.1999.tb08305.x; Mercalli A, 2013, IMMUNOLOGY; de Rueda PM, 2011, AM J GASTROENTEROL, V106, P1246, DOI 10.1038/ajg.2011.82; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Paternoster DM, 2008, J CLIN GASTROENTEROL, V42, P204, DOI 10.1097/01.mcg.0000247991.81591.2e; Paternoster DM, 2002, ACTA OBSTET GYN SCAN, V81, P99, DOI 10.1034/j.1600-0412.2002.810202.x; Paternoster DM, 2001, AM J GASTROENTEROL, V96, P2751, DOI 10.1111/j.1572-0241.2001.04135.x; Pergam SA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.052; Pol S, 2012, CONTRIB NEPHROL, V176, P1, DOI 10.1159/000332374; Ruiz-Extremera A, 2000, PEDIATR INFECT DIS J, V19, P511, DOI 10.1097/00006454-200006000-00004; Ruiz-Extremera A, 2005, AM J OBSTET GYNECOL, V193, P2010, DOI 10.1016/j.ajog.2005.04.045; Ruiz-Extremera A, 2011, HEPATOLOGY, V53, P1830, DOI 10.1002/hep.24298; Safir A, 2010, LIVER INT, V30, P765, DOI 10.1111/j.1478-3231.2010.02218.x; Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7; Salmeron J, 1998, REV ESP ENFERM DIG, V90, P846; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sbebl FM, 2009, J MED VIROL, V81, P1024, DOI 10.1002/jmv.21480; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416739; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Valladares G, 2010, ANN HEPATOL, V9, pS92, DOI 10.1016/S1665-2681(19)31731-4; Wan L, 2009, BIOCHEM BIOPH RES CO, V379, P855, DOI 10.1016/j.bbrc.2008.12.114	42	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75613	10.1371/journal.pone.0075613	http://dx.doi.org/10.1371/journal.pone.0075613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130726	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200018
J	Dort, J; Leblanc, N; Maltais-Giguere, J; Liaset, B; Cote, CH; Jacques, H				Dort, Junio; Leblanc, Nadine; Maltais-Giguere, Julie; Liaset, Bjorn; Cote, Claude H.; Jacques, Helene			Beneficial Effects of Cod Protein on Inflammatory Cell Accumulation in Rat Skeletal Muscle after Injury Are Driven by Its High Levels of Arginine, Glycine, Taurine and Lysine	PLOS ONE			English	Article							NITRIC-OXIDE; INSULIN-RESISTANCE; MYOGENIC CELLS; AMINO-ACID; REGENERATION; MACROPHAGES; EXPRESSION; SUPPLEMENTATION; PATHWAY; FIBERS	We have shown that feeding cod protein, which is rich in anti-inflammatory arginine, glycine, and taurine, may beneficially modulate the inflammatory response during recovery following skeletal muscle injury; however it is unknown if these amino acids are responsible for this effect. This study was designed to assess whether supplementing casein with an amino acid mixture composed of arginine, glycine, taurine and lysine, matching their respective levels in cod protein, may account for the anti-inflammatory effect of cod protein. Male Wistar rats were fed isoenergetic diets containing either casein, cod protein, or casein supplemented with L-arginine (0.45%), glycine (0.43%), L-taurine (0.17%) and L-lysine (0.44%) (casein+). After 21 days of ad libitum feeding, one tibialis anterior muscle was injured with 200 mu l bupivacaine while the saline-injected contra-lateral tibialis anterior was served as sham. Cod protein and casein+ similarly modulated the inflammation as they decreased COX-2 level at day 2 post-injury (cod protein, p=0.014; casein(+), p=0.029) and ED1(+) macrophage density at days 2 (cod protein, p=0.012; casein(+), p<0.0001), 5 (cod protein, p=0.001; casein(+), p<0.0001) and 14 (cod protein, p<0.0001; casein(+), p<0.0001) post-injury, and increased ED2(+) macrophage density at days 5 (cod protein, p<0.0001; casein(+), p=0.006), 14 (cod protein, p=0.001; casein(+), p<0.002) and 28 (cod protein, p<0.009; casein(+), p<0.005) post-injury compared with casein. Furthermore, cod protein up-regulated (p=0.037) whereas casein(+) tended to up-regulate (p=0.062) myogenin expression at day 5 post-injury compared with casein. In the cod protein-fed group, these changes resulted in greater muscle mass at days 14 (p=0.002), and 28 (p=0.001) post-injury and larger myofiber cross-sectional area at day 28 post-injury compared with casein (p=0.012). No such effects were observed with casein(+). These data indicate that anti-inflammatory actions of cod protein, contrary to its effect on muscle mass recovery, are driven by its high levels of arginine, glycine, taurine and lysine.	[Dort, Junio; Leblanc, Nadine; Maltais-Giguere, Julie; Jacques, Helene] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ, Canada; [Dort, Junio; Leblanc, Nadine; Maltais-Giguere, Julie; Jacques, Helene] Univ Laval, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Liaset, Bjorn] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Cote, Claude H.] Univ Laval, Dept Rehabil, Quebec City, PQ, Canada; [Cote, Claude H.] Univ Laval, Quebec Univ Hosp Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Jacques, H (corresponding author), Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ, Canada.	helene.jacques@fsaa.ulaval.ca		Liaset, Bjorn/0000-0002-8652-7801; Jacques, Helene/0000-0002-2755-6346	Natural Sciences and Engineering Research Council of Canada; Organization of American States	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Organization of American States	This study was supported by a grant to HJ from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), and by Summer Undergraduate Student Research Award from the Natural Sciences and Engineering Research Council of Canada to JMG. The first two years of the doctoral degree of JD was supported by an academic scholarship from the Organization of American States (http:// www.scholarships-bourses.gc.ca/scholarships-bourses/can/oas-oea.aspx?lang=fra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Aguilar FJ, 2008, EUR J PHARMACOL, V599, P152, DOI 10.1016/j.ejphar.2008.09.047; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Burns AR, 2007, AM J PHYSIOL-HEART C, V293, pH2904, DOI 10.1152/ajpheart.00871.2007; CANTINI M, 1994, BIOCHEM BIOPH RES CO, V202, P1688, DOI 10.1006/bbrc.1994.2129; Carlson Bruce M., 2008, V3, P163; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Clemmensen C, 2012, AMINO ACIDS, V43, P1265, DOI 10.1007/s00726-011-1199-1; Cote CH, 2008, MUSCLE NERVE, V37, P754, DOI 10.1002/mus.20998; Dort J, 2012, APPL PHYSIOL NUTR ME, V37, P489, DOI [10.1139/h2012-021, 10.1139/H2012-021]; El Mesallamy HO, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-46; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gauglitz GG, 2008, J BURN CARE RES, V29, P683, DOI 10.1097/BCR.0b013e31818481ce; Gilani GS, 2006, BRIT J NUTR, V95, P443, DOI 10.1079/BJN20051712; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Gregorevic P, 2004, J PHYSIOL-LONDON, V558, P549, DOI 10.1113/jphysiol.2004.066217; HALLCRAGGS ECB, 1980, BRIT J EXP PATHOL, V61, P139; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Jacques H, 2010, BRIT J NUTR, V103, P1331, DOI 10.1017/S0007114509993278; Kim C, 2009, ADV EXP MED BIOL, V643, P463, DOI 10.1007/978-0-387-75681-3_48; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kyriakides C, 1999, AM J PHYSIOL-CELL PH, V277, pC1263, DOI 10.1152/ajpcell.1999.277.6.C1263; Lapointe BM, 2002, J APPL PHYSIOL, V92, P1995, DOI 10.1152/japplphysiol.00803.2001; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Liaset B, 2008, PROCESS BIOCHEM, V43, P42, DOI 10.1016/j.procbio.2007.10.007; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Luz MAM, 2002, BRAZ J MED BIOL RES, V35, P691, DOI 10.1590/S0100-879X2002000600009; Paddon-Jones D, 2004, J CLIN ENDOCR METAB, V89, P4351, DOI 10.1210/jc.2003-032159; PALMER RM, 1983, BIOCHEM J, V214, P1011, DOI 10.1042/bj2141011; Park E, 2002, CLIN IMMUNOL, V102, P179, DOI 10.1006/clim.2001.5160; Pilon G, 2011, METABOLISM, V60, P1122, DOI 10.1016/j.metabol.2010.12.005; Pizza FX, 2005, J PHYSIOL-LONDON, V562, P899, DOI 10.1113/jphysiol.2004.073965; Politi PK, 2006, ULTRASTRUCT PATHOL, V30, P461, DOI 10.1080/01913120600854434; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ross-Inta CM, 2009, AM J PHYSIOL-GASTR L, V296, pG1130, DOI 10.1152/ajpgi.90545.2008; Rudkowska I, 2010, PHYSIOL GENOMICS, V40, P189, DOI 10.1152/physiolgenomics.00120.2009; Schaefer N, 2008, TRANSPLANTATION, V85, P1300, DOI 10.1097/TP.0b013e31816c576f; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Sheridan BC, 1998, AM J PHYSIOL-LUNG C, V274, pL337, DOI 10.1152/ajplung.1998.274.3.L337; Silva LA, 2011, CELL BIOCHEM FUNCT, V29, P43, DOI 10.1002/cbf.1716; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stoffels B, 2011, NEUROGASTROENT MOTIL, V23, P76, DOI 10.1111/j.1365-2982.2010.01603.x; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tremblay F, 2003, DIABETES, V52, P29, DOI 10.2337/diabetes.52.1.29; Vos IHC, 2001, J AM SOC NEPHROL, V12, P361, DOI 10.1681/ASN.V122361; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200	54	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77274	10.1371/journal.pone.0077274	http://dx.doi.org/10.1371/journal.pone.0077274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124612	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100169
J	Yuan, SL; Jiang, XL; Li, ZJ; He, K; Harada, M; Oshida, T; Lin, LK				Yuan, Shou-Li; Jiang, Xue-Long; Li, Zhen-Ji; He, Kai; Harada, Masashi; Oshida, Tatsuo; Lin, Liang-Kong			A Mitochondrial Phylogeny and Biogeographical Scenario for Asiatic Water Shrews of the Genus Chimarrogale: Implications for Taxonomy and Low-Latitude Migration Routes	PLOS ONE			English	Article							CYTOCHROME-B GENE; LATE-MIOCENE; TIBETAN PLATEAU; SPECIES DELIMITATION; CLIMATE-CHANGE; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENETICS; BAYESIAN ANALYSES; PLIOCENE; SEQUENCE	The six species and three subspecies in the genus Chimarrogale (Soricomorpha: Soricidae) are commonly referred to as Asiatic water shrews. The Chimarrogale are the most widely distributed group of Nectogaline shrews, extending throughout the Oriental region and Japan. Because of the limited numbers of specimens available for study, the phylogenetic relationships and biogeographical history of this genus have not been comprehensively discussed. We used mitochondrial cytochrome b gene sequences to estimate phylogenetic relationships and divergence times among four Chimarrogale species, including all three subspecies of Chimarrogale himalayica. We also conducted a species delimitation analysis and tested two alternative migration scenarios in Asia through species distribution modeling and a reconstruction of the ancestral distribution. Here, we present the first proposed hypothesis regarding the Asiatic water shrew phylogeny and reveal ten putative species within the four recognized species. Distinct phylogenetic statuses of Chimarrogale phaeura, Chimarrogale platycephala, and Chimarrogale styani were confirmed. Chimarrogale himalayica was strongly supported as paraphyletic. We suggest that three subspecies of Chimarrogale himalayica should be reconsidered as distinct species. However, these suggestions must be considered with caution because only a single locus of a mtDNA gene was used. Four additional putative species, possibly distributed in central southwestern China and Taiwan, are currently undescribed; therefore, comprehensive morphological analyses are warranted to test their taxonomic statuses. The estimated molecular divergence times indicated that rapid speciation occurred during the early Pliocene, and current distribution patterns may have been affected by global cooling during the Pliocene/Pleistocene boundary. Reconstruction of the ancestral distribution and species distribution modeling for Asiatic water shrews revealed a low-latitude migration route over which ancestral Chimarrogale migrated from Europe via Central Asia to their current distribution. Our results demonstrated that Asiatic water shrews could have evolved throughout the low-latitude migration route from Europe to East and Southeast Asia.	[Yuan, Shou-Li; Oshida, Tatsuo; Lin, Liang-Kong] Tunghai Univ, Dept Life Sci, Lab Wildlife Ecol, Taichung 40704, Taiwan; [Jiang, Xue-Long; He, Kai] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Li, Zhen-Ji] Xiamen Univ, Coll Environm & Ecol, Xiamen, Fujian, Peoples R China; [He, Kai] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Harada, Masashi] Osaka City Univ, Lab Anim Ctr, Grad Sch Med, Osaka 558, Japan	Tunghai University; Chinese Academy of Sciences; Kunming Institute of Zoology; Xiamen University; University of Manitoba; Osaka Metropolitan University	Lin, LK (corresponding author), Tunghai Univ, Dept Life Sci, Lab Wildlife Ecol, Taichung 40704, Taiwan.	lklin@thu.edu.tw	He, Kai/H-3164-2019	He, Kai/0000-0002-6234-2589				Abe H, 2003, MAMMALIAN SCI, V43, P51; Ali SS, 2012, ANN BOT-LONDON, V109, P95, DOI 10.1093/aob/mcr274; Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Billups K, 2002, PALAEOGEOGR PALAEOCL, V185, P287, DOI 10.1016/S0031-0182(02)00340-1; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Choate JR, 1998, J MAMMAL, V79, P1416; Churchfield S, 1998, BEHAV ECOLOGY RIPARI, P49; Corbet GB, 1992, MAMMALS INDO MALAYAN; Cox CB, 2000, MEM I OSWALDO CRUZ, V95, P509, DOI 10.1590/S0074-02762000000400012; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dubey S, 2006, MOL PHYLOGENET EVOL, V38, P635, DOI 10.1016/j.ympev.2005.11.005; Dubey S, 2008, MOL PHYLOGENET EVOL, V48, P953, DOI 10.1016/j.ympev.2008.07.002; Dubey S, 2007, MOL PHYLOGENET EVOL, V44, P126, DOI 10.1016/j.ympev.2006.12.002; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gorog AJ, 2004, BIOL J LINN SOC, V81, P91, DOI 10.1111/j.1095-8312.2004.00281.x; GRAY J. E., 1842, ANN MAGAZINE NATURAL, V10, P255, DOI DOI 10.1080/03745484209445232; Guo ZT, 2004, GLOBAL PLANET CHANGE, V41, P135, DOI 10.1016/j.gloplacha.2004.01.002; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Haywood AM, 2009, PHILOS T R SOC A, V367, P3, DOI 10.1098/rsta.2008.0205; He K, 2010, MOL PHYLOGENET EVOL, V56, P734, DOI 10.1016/j.ympev.2010.03.039; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HOFFMANN R S, 1987, Acta Theriologica Sinica, V7, P100; Hutterer R, 2005, MAMMAL SPECIES WORLD, P220; Iwasa MA, 2006, ACTA THERIOL, V51, P29, DOI 10.1007/BF03192652; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; JONES GS, 1971, J MAMMAL, V52, P228, DOI 10.2307/1378458; Kawamura Y., 1989, Quaternary Research (Tokyo), V28, P317; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Lewis AR, 2007, GEOL SOC AM BULL, V119, P1449, DOI 10.1130/B26134; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Lunde Darrin P., 2002, Mammal Study, V27, P137, DOI 10.3106/mammalstudy.27.137; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Marmi J, 2004, ZOOL SCR, V33, P481, DOI 10.1111/j.0300-3256.2004.00165.x; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Molnar P, 2005, PALAEONTOL ELECTRON, V8; Moss Steve J., 1998, P133; Motokawa M, 2006, ACTA THERIOL, V51, P215, DOI 10.1007/BF03192673; Ohdachi SD, 2006, J ZOOL, V270, P177, DOI 10.1111/j.1469-7998.2006.00125.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Qiu Zhuding, 2005, Scripta Geologica Special Issue, V5, P37; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Rubinoff D, 2006, CONSERV BIOL, V20, P1026, DOI 10.1111/j.1523-1739.2006.00372.x; Rzebik-Kowalska Barbara, 1998, P23; Sanders KL, 2007, BIOLOGY LETT, V3, P275, DOI 10.1098/rsbl.2007.0063; Smith Andrew T., 2008, P1; Storch Gerhard, 1998, P93; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Thomas O, 1902, ANN MAG NAT HIST SER, V10, P163, DOI DOI 10.1080/00222930208678653; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Dam JA, 2004, J PALEONTOL, V78, P741, DOI 10.1666/0022-3360(2004)078<0741:AMSFTM>2.0.CO;2; Wang L, 2006, PALAEOGEOGR PALAEOCL, V241, P118, DOI 10.1016/j.palaeo.2006.06.012; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X	77	12	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77156	10.1371/journal.pone.0077156	http://dx.doi.org/10.1371/journal.pone.0077156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124605	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100162
J	Patti, F; Morra, VB; Amato, MP; Trojano, M; Bastianello, S; Tola, MR; Cottone, S; Plant, A; Picconi, O				Patti, Francesco; Morra, Vincenzo Brescia; Amato, Maria Pia; Trojano, Maria; Bastianello, Stefano; Tola, Maria Rosalia; Cottone, Salvatore; Plant, Andrea; Picconi, Orietta		COGIMUS Study Grp	Subcutaneous Interferon beta-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study	PLOS ONE			English	Article							MILDLY DISABLED PATIENTS; DISEASE-MODIFYING DRUGS; IMMUNOMODULATORY TREATMENT; CLINICAL PREDICTORS; CORTICAL-LESIONS; GENDER; SEX; AGE; DYSFUNCTION; DECLINE	Objective: To assess the effects of subcutaneous (sc) interferon (IFN) -1a on cognition over 5 years in mildly disabled patients with relapsing-remitting multiple sclerosis (RRMS). Methods: Patients aged 18-50 years with RRMS (Expanded Disability Status Scale score <= 4.0) who had completed the 3-year COGIMUS study underwent standardized magnetic resonance imaging, neurological examination, and neuropsychological testing at years 4 and 5. Predictors of cognitive impairment at year 5 were identified using multivariate analysis. Results: Of 331 patients who completed the 3-year COGIMUS study, 265 participated in the 2-year extension study, 201 of whom (75.8%; sc IFN beta-1a three times weekly: 44 mu g, n = 108; 22 mu g, n = 93) completed 5 years' follow-up. The proportion of patients with cognitive impairment in the study population overall remained stable between baseline (18.0%) and year 5 (22.6%). The proportion of patients with cognitive impairment also remained stable in both treatment groups between baseline and year 5, and between year 3 and year 5. However, a significantly higher proportion of men than women had cognitive impairment at year 5 (26.5% vs 14.4%, p = 0.046). Treatment with the 22 versus 44 mu g dose was predictive of cognitive impairment at year 5 (hazard ratio 0.68; 95% confidence interval 0.48-0.97). Conclusions: This study suggests that sc IFN beta-1a dose-dependently stabilizes or delays cognitive impairment over a 5-year period in most patients with mild RRMS. Women seem to be more protected against developing cognitive impairment, which may indicate greater response to therapy or the inherently better prognosis associated with female sex in MS.	[Patti, Francesco] Univ Hosp, Dept Neurol, Multiple Sclerosis Ctr Sicilia Reg, Neurol Clin 1, Catania, Italy; [Morra, Vincenzo Brescia] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy; [Trojano, Maria] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy; [Bastianello, Stefano] Univ Pavia, Dept Neuroradiol, I-27100 Pavia, Italy; [Tola, Maria Rosalia] Azienda Univ Osped S Anna, UO Neurol, Dept Neurosci & Rehabil, Ferrara, Italy; [Cottone, Salvatore] Ctr Riferimento Reg Neuroimmunol, Palermo, Italy; [Plant, Andrea] Caudex Med, Oxford, England; [Picconi, Orietta] Opera CRO Srl, Genoa, Italy	University of Catania; University of Naples Federico II; University of Florence; Universita degli Studi di Bari Aldo Moro; University of Pavia; University of Ferrara; Arcispedale Sant'Anna	Patti, F (corresponding author), Univ Hosp, Dept Neurol, Multiple Sclerosis Ctr Sicilia Reg, Neurol Clin 1, Catania, Italy.	patti@unict.it	Amato, Maria Pia/AAC-5940-2022; Picconi, Orietta/L-4613-2016; Bertolotto, Antonio/K-8346-2015; Bastianello, Stefano/A-9001-2012; amato, Maria Pia/AAL-5998-2020; Lugaresi, Alessandra/C-7743-2012; Salemi, Giuseppe/D-3366-2012	Picconi, Orietta/0000-0003-3626-9952; Bertolotto, Antonio/0000-0002-7052-1907; amato, Maria Pia/0000-0003-3325-3760; Lugaresi, Alessandra/0000-0003-2902-5589; Trojano, Maria/0000-0002-6329-8946; Bastianello, Stefano/0000-0002-8414-9077; Salemi, Giuseppe/0000-0002-3756-4323; De Caro, Maria Fara/0000-0002-7520-4687; patti, francesco/0000-0002-6923-0846	Fondazione Biomedica Europea (FBE; the European Biomedical Foundation), Rome, Italy; Merck SpA (Italy), an affiliate of Merck KGaA, Darmstadt, Germany	Fondazione Biomedica Europea (FBE; the European Biomedical Foundation), Rome, Italy; Merck SpA (Italy), an affiliate of Merck KGaA, Darmstadt, Germany	This study was supported by Fondazione Biomedica Europea (FBE; the European Biomedical Foundation), Rome, Italy. The FBE covered all the study costs, from the first submission to ethics committee at Policlinico of Catania in September 2003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck SpA (Italy), an affiliate of Merck KGaA, Darmstadt, Germany, provided financial support for editorial assistance with the preparation of the manuscript, but had no role in study design, data collection and analysis or decision to publish.	Achiron A, 2005, J NEUROL NEUROSUR PS, V76, P744, DOI 10.1136/jnnp.2004.045518; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2006, J NEUROL SCI, V245, P183, DOI 10.1016/j.jns.2005.07.017; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Bagert B, 2002, CNS DRUGS, V16, P445, DOI 10.2165/00023210-200216070-00002; Barak Y, 2006, J NEUROL SCI, V245, P73, DOI 10.1016/j.jns.2005.09.015; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Caggiula M, 2006, CLIN IMMUNOL, V118, P77, DOI 10.1016/j.clim.2005.09.005; Calabrese M, 2012, MULT SCLER J, V18, P418, DOI 10.1177/1352458510394702; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Celius EG, 2000, J NEUROL SCI, V178, P132, DOI 10.1016/S0022-510X(00)00389-0; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Duque B, 2008, MULT SCLER J, V14, P947, DOI 10.1177/1352458508089686; Filippi M, 2004, LANCET, V364, P1489, DOI 10.1016/S0140-6736(04)17271-1; Francis G, 2001, NEUROLOGY, V56, P1628; Freedman MS, 2006, EXPERT OPIN PHARMACO, V7, pS1, DOI 10.1517/14656566.7.1.S1; Ghaffar O, 2007, CURR OPIN PSYCHIATR, V20, P278; Glanz BI, 2012, J NEUROL NEUROSUR PS, V83, P38, DOI 10.1136/jnnp.2010.237834; Hawkins SA, 1999, J NEUROL NEUROSUR PS, V67, P148, DOI 10.1136/jnnp.67.2.148; Hensiek AE, 2002, J NEUROL NEUROSUR PS, V72, P184, DOI 10.1136/jnnp.72.2.184; Kipp M, 2012, FRONT NEUROENDOCRIN, V33, P1, DOI 10.1016/j.yfrne.2012.01.001; Kujala P, 1997, BRAIN, V120, P289, DOI 10.1093/brain/120.2.289; Lindquist S, 2011, MULT SCLER J, V17, P851, DOI 10.1177/1352458511399797; Lynch SG, 2005, MULT SCLER J, V11, P469, DOI 10.1191/1352458505ms1182oa; Patti F, 2010, MULT SCLER, V16, P68, DOI 10.1177/1352458509350309; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Patti F, 2012, EXPERT OPIN INV DRUG, V21, P1679, DOI 10.1517/13543784.2012.716036; Pozzilli C, 2003, EUR J NEUROL, V10, P95, DOI 10.1046/j.1468-1331.2003.00519.x; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Reuter F, 2011, J NEUROL NEUROSUR PS, V82, P1157, DOI 10.1136/jnnp.2010.213744; Rogers JM, 2007, J CLIN NEUROSCI, V14, P919, DOI 10.1016/j.jocn.2007.02.006; Rudick RA, 2011, MULT SCLER J, V17, P353, DOI 10.1177/1352458510384605; Ruet A, 2013, J NEUROL, V260, P776, DOI 10.1007/s00415-012-6705-1; Tomassini V, 2005, J NEUROL NEUROSUR PS, V76, P272, DOI 10.1136/jnnp.2003.033324; Trojano M, 2009, J NEUROL SCI, V286, P109, DOI 10.1016/j.jns.2009.06.036; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; Weatherby SJM, 2000, J NEUROL, V247, P467, DOI 10.1007/s004150070179	41	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74111	10.1371/journal.pone.0074111	http://dx.doi.org/10.1371/journal.pone.0074111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24137499	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200094
J	Nunn, BL; Faux, JF; Hippmann, AA; Maldonado, MT; Harvey, HR; Goodlett, DR; Boyd, PW; Strzepek, RF				Nunn, Brook L.; Faux, Jessica F.; Hippmann, Anna A.; Maldonado, Maria T.; Harvey, H. Rodger; Goodlett, David R.; Boyd, Philip W.; Strzepek, Robert F.			Diatom Proteomics Reveals Unique Acclimation Strategies to Mitigate Fe Limitation	PLOS ONE			English	Article							SUB-ARCTIC PACIFIC; SOUTHERN-OCEAN PHYTOPLANKTON; IRON LIMITATION; MARINE DIATOM; THALASSIOSIRA-PSEUDONANA; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; BIOCHEMICAL PATHWAYS; PARTICLES TEP; CELL-SIZE	Phytoplankton growth rates are limited by the supply of iron (Fe) in approximately one third of the open ocean, with major implications for carbon dioxide sequestration and carbon (C) biogeochemistry. To date, understanding how alteration of Fe supply changes phytoplankton physiology has focused on traditional metrics such as growth rate, elemental composition, and biophysical measurements such as photosynthetic competence (F-v/F-m). Researchers have subsequently employed transcriptomics to probe relationships between changes in Fe supply and phytoplankton physiology. Recently, studies have investigated longer-term (i.e. following acclimation) responses of phytoplankton to various Fe conditions. In the present study, the coastal diatom, Thalassiosira pseudonana, was acclimated (10 generations) to either low or high Fe conditions, i.e. Fe-limiting and Fe-replete. Quantitative proteomics and a newly developed proteomic profiling technique that identifies low abundance proteins were employed to examine the full complement of expressed proteins and consequently the metabolic pathways utilized by the diatom under the two Fe conditions. A total of 1850 proteins were confidently identified, nearly tripling previous identifications made from differential expression in diatoms. Given sufficient time to acclimate to Fe limitation, T. pseudonana up-regulates proteins involved in pathways associated with intracellular protein recycling, thereby decreasing dependence on extracellular nitrogen (N), C and Fe. The relative increase in the abundance of photorespiration and pentose phosphate pathway proteins reveal novel metabolic shifts, which create substrates that could support other well-established physiological responses, such as heavily silicified frustules observed for Fe-limited diatoms. Here, we discovered that proteins and hence pathways observed to be down-regulated in short-term Fe starvation studies are constitutively expressed when T. pseudonana is acclimated (i.e., nitrate and nitrite transporters, Photosystem II and Photosystem I complexes). Acclimation of the diatom to the desired Fe conditions and the comprehensive proteomic approach provides a more robust interpretation of this dynamic proteome than previous studies.	[Nunn, Brook L.; Goodlett, David R.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Nunn, Brook L.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Faux, Jessica F.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Hippmann, Anna A.; Maldonado, Maria T.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Harvey, H. Rodger] Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA USA; [Boyd, Philip W.] Univ Otago, Dept Chem, NIWA Ctr Chem & Phys Oceanog, Dunedin, New Zealand; [Strzepek, Robert F.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Center for Environmental Science; University of British Columbia; Old Dominion University; University of Otago; Australian National University	Nunn, BL (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	brookh@uw.edu	Maldonado, Maria T/N-2877-2017; Boyd, Philip W/J-7624-2014; Strzepek, Robert Francis/A-1216-2011; Strzepek, Robert/GQH-8703-2022	Maldonado, Maria T/0000-0001-8134-9375; Boyd, Philip W/0000-0001-7850-1911; Strzepek, Robert Francis/0000-0002-6442-7121; Nunn, Brook/0000-0002-7361-4359; Hippmann, Anna/0000-0002-9495-7414	National Science Foundation [OCE1233014]; Office of Polar Programs Postdoctoral Fellowship [0444148]; National Institutes of Health [5P30ES007033-10]; Natural Sciences and Engineering Research Council of Canada; New Zealand Royal Society Marsden Fund; Ministry of Science; University of Washington's Proteomics Computer Resource Centre [UWPR95794]; Division Of Ocean Sciences [1233014] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of Polar Programs Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); University of Washington's Proteomics Computer Resource Centre; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Science Foundation grants OCE1233014 (BLN) and the Office of Polar Programs Postdoctoral Fellowship grant 0444148 (BLN). DRG was supported by National Institutes of Health 5P30ES007033-10. AH and MTM were supported by Natural Sciences and Engineering Research Council of Canada. RFS and PWB were supported by the New Zealand Royal Society Marsden Fund and the Ministry of Science. This work is supported in part by the University of Washington's Proteomics Computer Resource Centre (UWPR95794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arrigo KR, 2000, J GEOPHYS RES-OCEANS, V105, P8827, DOI 10.1029/1998JC000289; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Boyd PW, 2005, LIMNOL OCEANOGR, V50, P1872, DOI 10.4319/lo.2005.50.6.1872; Boyd PW, 1996, MAR ECOL PROG SER, V136, P179, DOI 10.3354/meps136179; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Carvalho RN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-159; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Coale KH, 2003, DEEP-SEA RES PT II, V50, P635, DOI 10.1016/S0967-0645(02)00588-X; De Nisi P, 2000, J EXP BOT, V51, P1903, DOI 10.1093/jexbot/51.352.1903; Durkin CA, 2011, J PHYCOL, V47, pS28; Durkin CA, 2012, LIMNOL OCEANOGR, V57, P1619, DOI 10.4319/lo.2012.57.6.1619; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Egleston ES, 2008, LIMNOL OCEANOGR, V53, P2462, DOI 10.4319/lo.2008.53.6.2462; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Espen L, 2000, PLANTA, V210, P985, DOI 10.1007/s004250050707; Fernie AR, 2012, PLANT PHYSIOL, V158, P1139, DOI 10.1104/pp.112.193235; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Hassler CS, 2011, P NATL ACAD SCI USA, V108, P1076, DOI 10.1073/pnas.1010963108; Hassler CS, 2009, LIMNOL OCEANOGR, V54, P987, DOI 10.4319/lo.2009.54.3.0987; Jackson GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023180; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Konopka A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00184; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; KUMA K, 1995, WATER RES, V29, P1559, DOI 10.1016/0043-1354(94)00289-J; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Kwok EY, 2006, BIOCHEMISTRY-US, V45, P6317, DOI 10.1021/bi052173c; Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v; LaRoche J, 1996, NATURE, V382, P802; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Lehninger AL, 1965, BIOENERGETICS, P258; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Leynaert A, 2004, LIMNOL OCEANOGR, V49, P1134; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Marchetti A, 2009, GEOBIOLOGY, V7, P419, DOI 10.1111/j.1472-4669.2009.00207.x; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Mari X, 2005, HARMFUL ALGAE, V4, P895, DOI 10.1016/j.hal.2004.12.014; Mari X, 2012, ESTUAR COAST SHELF S, V96, P151, DOI 10.1016/j.ecss.2011.10.028; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; Milligan AJ, 2000, J PHYCOL, V36, P78, DOI 10.1046/j.1529-8817.2000.99013.x; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Moore EK, 2012, GEOCHIM COSMOCHIM AC, V83, P324, DOI 10.1016/j.gca.2012.01.002; Muggli DL, 1996, MAR ECOL PROG SER, V132, P215, DOI 10.3354/meps132215; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Nunn BL, 2007, MAR ECOL PROG SER, V332, P281, DOI 10.3354/meps332281; Nunn BL, 2010, LIMNOL OCEANOGR, V55, P1790, DOI 10.4319/lo.2010.55.4.1790; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Ozturk M, 2004, DEEP-SEA RES PT II, V51, P2841, DOI 10.1016/j.dsr2.2000.10.001; Panchaud A, 2009, ANAL CHEM, V81, P6481, DOI 10.1021/ac900888s; Passow U, 2001, CONT SHELF RES, V21, P327, DOI 10.1016/S0278-4343(00)00101-1; PRICE N M, 1988, Biological Oceanography, V6, P443; PRICE NM, 1991, LIMNOL OCEANOGR, V36, P1071, DOI 10.4319/lo.1991.36.6.1071; PRICE NM, 1988, LIMNOL OCEANOGR, V33, P528, DOI 10.4319/lo.1988.33.4.0528; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Reinhardt I, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P371, DOI 10.1007/1-4020-4743-6_19; Rijkenberg MJA, 2005, MAR CHEM, V93, P119, DOI 10.1016/j.marchem.2004.03.021; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P3593, DOI 10.5194/bg-7-3593-2010; Scheele U, 2002, FEBS LETT, V514, P355, DOI 10.1016/S0014-5793(02)02439-0; Scherl A, 2008, ANAL CHEM, V80, P1182, DOI 10.1021/ac701680f; Steigenberger S, 2010, BIOGEOSCIENCES, V7, P109, DOI 10.5194/bg-7-109-2010; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Timmermans KR, 2004, LIMNOL OCEANOGR, V49, P2141, DOI 10.4319/lo.2004.49.6.2141; Wang YH, 2001, PLANT PHYSIOL, V127, P345, DOI 10.1104/pp.127.1.345; WESTALL JC, 1976, ABSTR PAP AM CHEM S, V172, P8; Whitney LP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00234; Wilken S, 2011, LIMNOL OCEANOGR, V56, P1399, DOI 10.4319/lo.2011.56.4.1399; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313	88	63	64	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75653	10.1371/journal.pone.0075653	http://dx.doi.org/10.1371/journal.pone.0075653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146769	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400014
J	Hill, RW; Muhich, TE; Humphries, MM				Hill, Richard W.; Muhich, Timothy E.; Humphries, Murray M.			City-Scale Expansion of Human Thermoregulatory Costs	PLOS ONE			English	Article							CRITICAL-TEMPERATURE; BODY-TEMPERATURE; METABOLIC-RATE; PEROMYSCUS; ENERGETICS; MAMMALS	The physiological maintenance of a stable internal temperature by mammals and birds - the phenomenon termed homeothermy - is well known to be energetically expensive. The annual energy requirements of free-living mammals and birds are estimated to be 15-30 times higher than those of similar-size ectothermic vertebrates like lizards. Contemporary humans also use energy to accomplish thermoregulation. They are unique, however, in having shifted thermoregulatory control from the body to the occupied environment, with most people living in cities in dwellings that are temperature-regulated by furnaces and air conditioners powered by exogenous energy sources. The energetic implications of this strategy remain poorly defined. Here we comparatively quantify energy costs in cities, dwellings, and individual human bodies. Thermoregulation persists as a major driver of energy expenditure across these three scales, resulting in energy-versus- ambient-temperature relationships remarkably similar in shape. Incredibly, despite the many and diversified uses of network-delivered energy in modern societies, the energy requirements of six North American cities are as temperature-dependent as the energy requirements of isolated, individual homeotherms. However, the annual per-person energy cost of exogenously powered thermoregulation in cities and dwellings is 9-28 times higher than the cost of endogenous, metabolic thermoregulation of the human body. Shifting the locus of thermoregulatory control from the body to the dwelling achieves climate-independent thermal comfort. However, in an era of amplifying climate change driven by the carbon footprint of humanity, we must acknowledge the energetic extravagance of contemporary, city-scale thermoregulation, which prioritizes heat production over heat conservation.	[Hill, Richard W.; Muhich, Timothy E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Humphries, Murray M.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada	Michigan State University; McGill University	Hill, RW (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	hillr@msu.edu		Muhich, Timothy/0000-0002-5642-0181				BATESON G, 1963, EVOLUTION, V17, P529, DOI 10.2307/2407104; Berry B.J.L., 2008, URBAN ECOLOGY INT PE, P25, DOI [10.1007/978-0-387-73412-5_3, DOI 10.1007/978-0-387-73412-5_3]; BONACCORSO FJ, 1992, J MAMMAL, V73, P365, DOI 10.2307/1382071; Burnside WR, 2012, BIOL REV, V87, P194, DOI 10.1111/j.1469-185X.2011.00192.x; Burton A.C., 1955, MAN COLD ENV; Bynum R. T., 2001, INSULATION HDB; DEAVERS DR, 1981, PHYSIOL ZOOL, V54, P94, DOI 10.1086/physzool.54.1.30155808; ERIKSON H, 1956, ACTA PHYSIOL SCAND, V37, P35, DOI 10.1111/j.1748-1716.1956.tb01339.x; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; FLEMING MR, 1985, AUST J ZOOL, V33, P667, DOI 10.1071/ZO9850667; Gagge AP, 1941, SCIENCE, V94, P428, DOI 10.1126/science.94.2445.428; Galloway JA, 1996, ECON HIST REV, V49, P447; GOLIGHTLY RT, 1983, J MAMMAL, V64, P624, DOI 10.2307/1380518; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Hill R., 2012, ANIMAL PHYSL, V3; HINDS DS, 1973, J MAMMAL, V54, P708, DOI 10.2307/1378969; Huang SL, 2005, ECOL MODEL, V189, P49, DOI 10.1016/j.ecolmodel.2005.03.004; Kadulski R, 1987, SOLPLAN REV, P8; Lofquist Daphne, 2012, HOUSEHOLDS FAMILIES; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1963, ECOL MONOGR, V33, P63, DOI 10.2307/1948477; MCNAB BK, 1969, COMP BIOCHEM PHYSIOL, V31, P227, DOI 10.1016/0010-406X(69)91651-X; Meehan TD, 2012, AM J HUM BIOL, V24, P713, DOI 10.1002/ajhb.22278; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; North D, 1986, J LONDONS CABIN; ODUM HT, 1971, ENV POWER SOC; PROSSER CL, 1955, BIOL REV, V30, P229, DOI 10.1111/j.1469-185X.1955.tb01208.x; Rodahl K, 1958, CI T 5 C, P177; SCHOLANDER PF, 1957, J APPL PHYSIOL, V10, P231, DOI 10.1152/jappl.1957.10.2.231; SCHOLANDER PF, 1958, J APPL PHYSIOL, V12, P1; SENDROY J, 1954, J APPL PHYSIOL, V7, P1; Shelton J, 1976, WOODBURNERS ENCY; Shurin JB, 2005, J ANIM ECOL, V74, P1029, DOI 10.1111/j.1365-2656.2005.00999.x; Speakman J.R., 1997, DOUBLY LABELLED WATE; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; WILKERSON JE, 1972, J APPL PHYSIOL, V33, P451, DOI 10.1152/jappl.1972.33.4.451; Wulsin FR, 1949, PHYSL HEAT REGULATIO, P3; Yan YY, 1996, INT J CLIMATOL, V16, P1045, DOI 10.1002/(SICI)1097-0088(199609)16:9<1045::AID-JOC73>3.0.CO;2-O	40	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76238	10.1371/journal.pone.0076238	http://dx.doi.org/10.1371/journal.pone.0076238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143181	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100016
J	Jiang, JJ; Zhang, NN; Shiba, H; Li, LY; Wang, Z				Jiang, Junjun; Zhang, Nannan; Shiba, Hiroshi; Li, Liyuan; Wang, Zhao			Spermatogenesis Associated 4 Promotes Sertoli Cell Proliferation Modulated Negatively by Regulatory Factor X1	PLOS ONE			English	Article							DNA-BINDING PROTEINS; B-VIRUS ENHANCER; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CPG ISLANDS; RFX1; EVOLUTION; CLONING; SPATA4; FAMILY	Spermatogenesis associated 4 (Spata4), a testis-specific and CpG island associated gene, is involved in regulating cell proliferation, differentiation and apoptosis. To obtain insight into the role of Spata4 in cell cycling control, we characterized the promoter region of Spata4 and investigated its transcriptional regulation mechanism. The Spata4 promoter is unidirectional transcribed and possesses multiple transcription start sites. Moreover, we present evidence that regulatory factor X1 (RFX1) could bind the typical 14-bp cis-elements of Spata4 promoter, modulate transcriptional activity and endogenous expression of Spata4, and further regulate the proliferation of Sertoli cells. Overexpression of RFX1 was shown to down-regulate both the promoter activity and mRNA expression of Spata4, whereas knockdown of RFX1 demonstrated the opposite effects. Our studies provide insight into Spata4 gene regulation and imply the potential role of RFX1 in growth of Sertoli cells. RFX1 may have negative effect on cell proliferation of Sertoli cells via modulating Spata4 expression levels by binding the conserved 14-bp cis-elements of Spata4 promoter.	[Jiang, Junjun; Zhang, Nannan; Shiba, Hiroshi; Li, Liyuan; Wang, Zhao] Tsinghua Univ, Sch Med, Dept Pharmacol, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Shiba, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioinformat, Tokyo 152, Japan	Tsinghua University; Tokyo Institute of Technology	Wang, Z (corresponding author), Tsinghua Univ, Sch Med, Dept Pharmacol, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn			National Basic Research Program (973 Project) of China [2007CB507406, 2013CB530802]; National Natural Science Foundation of China [81270425]	National Basic Research Program (973 Project) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program (973 Project) of China (Nos. 2007CB507406, 2013CB530802) and the National Natural Science Foundation of China (No. 81270425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen L, 2000, J BIOL CHEM, V275, P32227, DOI 10.1074/jbc.M002645200; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Imai-Senga Y, 2002, GENE, V289, P7, DOI 10.1016/S0378-1119(02)00542-5; Katan Y, 1997, NUCLEIC ACIDS RES, V25, P3621, DOI 10.1093/nar/25.18.3621; Kistler WS, 2009, GENE EXPR PATTERNS, V9, P515, DOI 10.1016/j.gep.2009.07.004; KOUSKOFF V, 1991, J IMMUNOL, V146, P3197; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Liu SF, 2005, J BIOCHEM MOL BIOL, V38, P739; Liu SF, 2004, BIOL PHARM BULL, V27, P1867, DOI 10.1248/bpb.27.1867; Liu SF, 2004, BIOCHEM BIOPH RES CO, V319, P32, DOI 10.1016/j.bbrc.2004.04.160; Loots Gabriela G., 2007, V395, P237; Morotami-Yano K, 2002, J BIOL CHEM, V277, P836, DOI 10.1074/jbc.M108638200; Ogi T, 2001, GENES CELLS, V6, P943, DOI 10.1046/j.1365-2443.2001.00478.x; Olesen C, 2001, MOL CELL ENDOCRINOL, V184, P25, DOI 10.1016/S0303-7207(01)00666-9; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Ray SK, 1997, J BIOL CHEM, V272, P7546, DOI 10.1074/jbc.272.11.7546; REINHOLD W, 1995, MOL CELL BIOL, V15, P3041; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Tanaka H, 2005, CELL MOL LIFE SCI, V62, P344, DOI 10.1007/s00018-004-4394-y; TSANG SY, 1990, MOL CELL BIOL, V10, P711, DOI 10.1128/MCB.10.2.711; Wang KR, 2007, J BIOL CHEM, V282, P26167, DOI 10.1074/jbc.M703448200; Wang XY, 2011, J BONE MINER RES, V26, P1964, DOI 10.1002/jbmr.394; Weitzel JM, 2003, BIOL REPROD, V68, P699, DOI 10.1095/biolreprod.102.008540	38	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75933	10.1371/journal.pone.0075933	http://dx.doi.org/10.1371/journal.pone.0075933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146794	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400027
J	Giaouris, E; Chorianopoulos, N; Doulgeraki, A; Nychas, GJ				Giaouris, Efstathios; Chorianopoulos, Nikos; Doulgeraki, Agapi; Nychas, George-John			Co-Culture with Listeria monocytogenes within a Dual-Species Biofilm Community Strongly Increases Resistance of Pseudomonas putida to Benzalkonium Chloride	PLOS ONE			English	Article							QUATERNARY AMMONIUM-COMPOUNDS; EXTRACELLULAR POLYMERIC SUBSTANCES; STAINLESS-STEEL SURFACES; ESCHERICHIA-COLI O157H7; MIXED-CULTURE BIOFILMS; DAIRY PROCESSING LINES; MULTISPECIES BIOFILMS; BACTERIAL BIOFILMS; ANTIMICROBIAL AGENTS; PATHOGENIC BACTERIA	Biofilm formation is a phenomenon occurring almost wherever microorganisms and surfaces exist in close proximity. This study aimed to evaluate the possible influence of bacterial interactions on the ability of Listeria monocytogenes and Pseudomonas putida to develop a dual-species biofilm community on stainless steel (SS), as well as on the subsequent resistance of their sessile cells to benzalkonium chloride (BC) used in inadequate (sub-lethal) concentration (50 ppm). The possible progressive adaptability of mixed-culture biofilms to BC was also investigated. To accomplish these, 3 strains per species were left to develop mixed-culture biofilms on SS coupons, incubated in daily renewable growth medium for a total period of 10 days, under either mono- or dual-species conditions. Each day, biofilm cells were exposed to disinfection treatment. Results revealed that the simultaneous presence of L. monocytogenes strongly increased the resistance of P. putida biofilm cells to BC, while culture conditions (mono-/dual-species) did not seem to significantly influence the resistance of L. monocytogenes biofilm cells. BC mainly killed L. monocytogenes cells when this was applied against the dual-species sessile community during the whole incubation period, despite the fact that from the 2nd day this community was mainly composed (>90%) of P. putida cells. No obvious adaptation to BC was observed in either L. monocytogenes or P. putida biofilm cells. Pulsed field gel electrophoresis (PFGE) analysis showed that the different strains behaved differently with regard to biofilm formation and antimicrobial resistance. Such knowledge on the physiological behavior of mixed-culture biofilms could provide the information necessary to control their formation.	[Giaouris, Efstathios; Doulgeraki, Agapi] Univ Aegean, Dept Food Sci & Nutr, Myrina, Lemnos Island, Greece; [Chorianopoulos, Nikos] Greek Agr Org Demeter, Vet Res Inst Athens, Aghia Paraskeui, Greece; [Doulgeraki, Agapi; Nychas, George-John] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece	Agricultural University of Athens	Giaouris, E (corresponding author), Univ Aegean, Dept Food Sci & Nutr, Myrina, Lemnos Island, Greece.	stagiaouris@aegean.gr	Nychas, George/B-2734-2009; Giaouris, Efstathios/J-8082-2015	Nychas, George/0000-0002-2673-6425; Giaouris, Efstathios/0000-0002-6019-5204	Action THALIS "Biological Investigation Of the Forces that Influence the Life of pathogens having as Mission to Survive in various lifestyles; BIOFILMS", which falls under the Operational Programme (OP) "Education and Lifelong Learning (EdLL)"; European Social Fund (ESF); National Resources	Action THALIS "Biological Investigation Of the Forces that Influence the Life of pathogens having as Mission to Survive in various lifestyles; BIOFILMS", which falls under the Operational Programme (OP) "Education and Lifelong Learning (EdLL)"; European Social Fund (ESF)(European Social Fund (ESF)); National Resources	This work received funding through the following sources: Action THALIS "Biological Investigation Of the Forces that Influence the Life of pathogens having as Mission to Survive in various lifestyles; BIOFILMS", which falls under the Operational Programme (OP) "Education and Lifelong Learning (EdLL)", cofinanced by the European Social Fund (ESF) and National Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase B, 2000, INT J FOOD MICROBIOL, V62, P57, DOI 10.1016/S0168-1605(00)00357-3; Antoniou K, 2005, J FOOD PROTECT, V68, P277, DOI 10.4315/0362-028X-68.2.277; Auerbach ID, 2000, J BACTERIOL, V182, P3809, DOI 10.1128/JB.182.13.3809-3815.2000; AUSTIN JW, 1995, J DAIRY RES, V62, P509, DOI 10.1017/S0022029900031204; Bagge-Ravn D, 2003, INT J FOOD MICROBIOL, V87, P239, DOI 10.1016/S0168-1605(03)00067-9; Behnke S, 2011, APPL ENVIRON MICROB, V77, P7176, DOI 10.1128/AEM.05514-11; Bourion F, 1996, SCI ALIMENT, V16, P151; Bremer PJ, 2001, J FOOD PROTECT, V64, P1369, DOI 10.4315/0362-028X-64.9.1369; Bremer PJ, 2002, LETT APPL MICROBIOL, V35, P321, DOI 10.1046/j.1472-765X.2002.01198.x; Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899; Brooks JD, 2008, INT J FOOD SCI TECH, V43, P2163, DOI 10.1111/j.1365-2621.2008.01839.x; Buffet-Bataillon S, 2012, INT J ANTIMICROB AG, V39, P381, DOI 10.1016/j.ijantimicag.2012.01.011; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Carpentier B, 2004, INT J FOOD MICROBIOL, V97, P111, DOI 10.1016/j.ijfoodmicro.2004.03.031; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Chorianopoulos NG, 2008, J APPL MICROBIOL, V104, P1586, DOI 10.1111/j.1365-2672.2007.03694.x; Chumkhunthod P, 1998, J FOOD PROTECT, V61, P1043, DOI 10.4315/0362-028X-61.8.1043; Cocolin L, 2005, INT J FOOD MICROBIOL, V103, P167, DOI 10.1016/j.ijfoodmicro.2004.12.027; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Cruz CD, 2011, FOOD MICROBIOL, V28, P1387, DOI 10.1016/j.fm.2011.06.014; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; De Jonghe V, 2011, APPL ENVIRON MICROB, V77, P460, DOI 10.1128/AEM.00521-10; Didienne R, 2012, INT J FOOD MICROBIOL, V156, P91, DOI 10.1016/j.ijfoodmicro.2012.03.007; Doulgeraki AI, 2013, FOOD MICROBIOL, V34, P62, DOI 10.1016/j.fm.2012.11.017; Dynes JJ, 2009, CAN J MICROBIOL, V55, P163, DOI [10.1139/w08-109, 10.1139/W08-109]; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Fatemi P, 1999, J FOOD PROTECT, V62, P761, DOI 10.4315/0362-028X-62.7.761; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Goller CC, 2008, CURR TOP MICROBIOL, V322, P37; Habimana O, 2011, BIOFOULING, V27, P1065, DOI 10.1080/08927014.2011.626124; Habimana O, 2010, APPL ENVIRON MICROB, V76, P4557, DOI 10.1128/AEM.02707-09; Habimana O, 2009, APPL ENVIRON MICROB, V75, P7814, DOI 10.1128/AEM.01333-09; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Hassan AN, 2004, J FOOD PROTECT, V67, P322, DOI 10.4315/0362-028X-67.2.322; Hegstad K, 2010, MICROB DRUG RESIST, V16, P91, DOI 10.1089/mdr.2009.0120; Holah JT, 2004, J APPL MICROBIOL, V97, P68, DOI 10.1111/j.1365-2672.2004.02272.x; Hood SK, 1997, J FOOD PROTECT, V60, P1135, DOI 10.4315/0362-028X-60.9.1135; Ibusquiza PS, 2012, FOOD CONTROL, V25, P202, DOI 10.1016/j.foodcont.2011.10.002; Irie Y, 2005, FEMS MICROBIOL LETT, V250, P237, DOI 10.1016/j.femsle.2005.07.012; JAMES GA, 1995, J IND MICROBIOL, V15, P257, DOI 10.1007/BF01569978; Janek T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-24; JEONG DK, 1994, FOOD SCI TECHNOL-LEB, V27, P415; Joynson JA, 2002, J APPL MICROBIOL, V93, P96, DOI 10.1046/j.1365-2672.2002.01667.x; Kalmokoff ML, 2001, J APPL MICROBIOL, V91, P725, DOI 10.1046/j.1365-2672.2001.01419.x; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Klausen M, 2006, FEMS MICROBIOL LETT, V261, P1, DOI 10.1111/j.1574-6968.2006.00280.x; Klayman BJ, 2009, ENVIRON SCI TECHNOL, V43, P2105, DOI 10.1021/es802218q; Kostaki M, 2012, APPL ENVIRON MICROB, V78, P2586, DOI 10.1128/AEM.07099-11; Kruijt M, 2009, J APPL MICROBIOL, V107, P546, DOI 10.1111/j.1365-2672.2009.04244.x; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Langsrud S, 1997, J APPL MICROBIOL, V82, P705, DOI 10.1046/j.1365-2672.1997.00186.x; Langsrud S, 2003, J APPL MICROBIOL, V95, P874, DOI 10.1046/j.1365-2672.2003.02064.x; Latorre AA, 2010, J DAIRY SCI, V93, P2792, DOI 10.3168/jds.2009-2717; Lebert I, 2007, FOOD MICROBIOL, V24, P281, DOI 10.1016/j.fm.2006.04.011; Leriche V, 2000, J APPL MICROBIOL, V88, P594, DOI 10.1046/j.1365-2672.2000.01000.x; Leriche V, 2003, ENVIRON MICROBIOL, V5, P64, DOI 10.1046/j.1462-2920.2003.00394.x; Leriche V, 1999, INT J FOOD MICROBIOL, V51, P169, DOI 10.1016/S0168-1605(99)00128-2; Licitra G, 2007, APPL ENVIRON MICROB, V73, P6980, DOI 10.1128/AEM.00835-07; Lindsay D, 2002, J APPL MICROBIOL, V92, P352, DOI 10.1046/j.1365-2672.2002.01538.x; Lourenco A, 2011, J FOOD SCI, V76, pM143, DOI 10.1111/j.1750-3841.2010.02011.x; Lunden JM, 2000, J FOOD PROTECT, V63, P1204, DOI 10.4315/0362-028X-63.9.1204; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mangalappalli-Illathu AK, 2008, ANTIMICROB AGENTS CH, V52, P3669, DOI 10.1128/AAC.00073-08; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Marouani-Gadri N, 2009, INT J FOOD MICROBIOL, V133, P62, DOI 10.1016/j.ijfoodmicro.2009.04.028; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mereghetti L, 2000, APPL ENVIRON MICROB, V66, P5083, DOI 10.1128/AEM.66.11.5083-5086.2000; Meyer B, 2006, INT J FOOD MICROBIOL, V112, P275, DOI 10.1016/j.ijfoodmicro.2006.04.012; Meylheuc T, 2006, INT J FOOD MICROBIOL, V109, P71, DOI 10.1016/j.ijfoodmicro.2006.01.013; Midelet G, 2002, APPL ENVIRON MICROB, V68, P4015, DOI 10.1128/AEM.68.8.4015-4024.2002; Minei CC, 2008, J FOOD PROTECT, V71, P634, DOI 10.4315/0362-028X-71.3.634; Moons P, 2006, APPL ENVIRON MICROB, V72, P7294, DOI 10.1128/AEM.01708-06; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Nielsen L, 2011, ENVIRON MICROBIOL, V13, P1342, DOI 10.1111/j.1462-2920.2011.02432.x; Nilsson RE, 2011, INT J FOOD MICROBIOL, V150, P14, DOI 10.1016/j.ijfoodmicro.2011.07.012; Norwood DE, 2001, LETT APPL MICROBIOL, V33, P320, DOI 10.1046/j.1472-765X.2001.01004.x; Norwood DE, 2000, J APPL MICROBIOL, V88, P512, DOI 10.1046/j.1365-2672.2000.00990.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pagedar A, 2012, J DAIRY RES, V6, P1; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Pan YW, 2009, APPL ENVIRON MICROB, V75, P5846, DOI 10.1128/AEM.00816-09; Papadopoulou OS, 2012, MEAT SCI, V90, P865, DOI 10.1016/j.meatsci.2011.11.008; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Remis JP, 2010, ISME J, V4, P1085, DOI 10.1038/ismej.2010.105; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rieu A, 2008, INT J FOOD MICROBIOL, V126, P76, DOI 10.1016/j.ijfoodmicro.2008.05.006; Russell A. D., 1996, UNDERSTANDING ANTIBA; Russell AD, 2004, J HOSP INFECT, V57, P97, DOI 10.1016/j.jhin.2004.01.004; Russell AD, 2001, AM J INFECT CONTROL, V29, P259, DOI 10.1067/mic.2001.115671; Ibusquiza PS, 2011, FOOD MICROBIOL, V28, P418, DOI 10.1016/j.fm.2010.09.014; SASAHARA KC, 1993, J FOOD PROTECT, V56, P1022, DOI 10.4315/0362-028X-56.12.1022; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Sharma M, 2002, FOOD MICROBIOL, V19, P627, DOI 10.1006/fmic.2002.0472; Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054; Sidhu MS, 2002, MICROB DRUG RESIST, V8, P393, DOI 10.1089/10766290260469679; Simoes LC, 2011, BIOFOULING, V27, P337, DOI 10.1080/08927014.2011.575935; Simoes LC, 2007, APPL ENVIRON MICROB, V73, P6192, DOI 10.1128/AEM.00837-07; Simoes M, 2009, WATER RES, V43, P229, DOI 10.1016/j.watres.2008.10.010; Simos M, 2008, INT J FOOD MICROBIOL, V128, P309, DOI 10.1016/j.ijfoodmicro.2008.09.003; Skandamis PN, 2012, APPL ENVIRON MICROB, V78, P5473, DOI 10.1128/AEM.00468-12; Soumet C, 2005, LETT APPL MICROBIOL, V41, P291, DOI 10.1111/j.1472-765X.2005.01763.x; Takahashi H, 2009, J FOOD PROTECT, V72, P1476, DOI 10.4315/0362-028X-72.7.1476; Timke M, 2005, APPL ENVIRON MICROB, V71, P6446, DOI 10.1128/AEM.71.10.6446-6452.2005; Tischer M, 2012, CHEMMEDCHEM, V7, P22, DOI 10.1002/cmdc.201100404; To MS, 2002, APPL ENVIRON MICROB, V68, P5258, DOI 10.1128/AEM.68.11.5258-5264.2002; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75; Tresse O, 2007, J FOOD PROTECT, V70, P1569, DOI 10.4315/0362-028X-70.7.1569; Tryfinopoulou P, 2002, APPL ENVIRON MICROB, V68, P65, DOI 10.1128/AEM.68.1.65-72.2002; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; Uhlich GA, 2010, FOODBORNE PATHOG DIS, V7, P935, DOI 10.1089/fpd.2009.0503; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x; Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Zhang W, 2013, FEMS MICROBIOL ECOL, V84, P344, DOI 10.1111/1574-6941.12066; Zhao T, 2004, APPL ENVIRON MICROB, V70, P3996, DOI 10.1128/AEM.70.7.3996-4003.2004; Zhao T, 2006, APPL ENVIRON MICROB, V72, P3314, DOI 10.1128/Aem.72.5.3314-3320.2006; Zhao T, 2013, J FOOD PROTECT, V76, P601, DOI 10.4315/0362-028X.JFP-12-323	127	85	89	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77276	10.1371/journal.pone.0077276	http://dx.doi.org/10.1371/journal.pone.0077276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130873	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200080
J	Grandjean, M; Sermeus, A; Branders, S; Defresne, F; Dieu, M; Dupont, P; Raes, M; De Ridder, M; Feron, O				Grandjean, Marie; Sermeus, Alexandra; Branders, Samuel; Defresne, Florence; Dieu, Marc; Dupont, Pierre; Raes, Martine; De Ridder, Mark; Feron, Olivier			Hypoxia Integration in the Serological Proteome Analysis Unmasks Tumor Antigens and Fosters the Identification of Anti-Phospho-eEF2 Antibodies as Potential Cancer Biomarkers	PLOS ONE			English	Article							AUTOANTIBODY SIGNATURES; BREAST-CANCER; ELONGATION-FACTOR-2; ANGIOGENESIS; ADAPTATION; ACTIVATION; IMPACT; MTOR	The expression by tumor cells of proteins with aberrant structure, expression or distribution accounts for the development of a humoral immune response. Autoantibodies (aAb) directed against tumor-associated antigens (TAA) may thus be particularly relevant for early detection of cancer. Serological proteome analysis (SERPA) aims to identify such circulating aAb through the immunoblotting of 2D-separated tumor cell proteins with cancer patient serum and the consecutive MS identification of proteins in reactive spots. This method has the advantage to use post-translationally modified proteins as a source of potential TAA. Here, we applied this strategy by using colorectal tumor cells pre-exposed to hypoxia in order to promote the expression of a pattern of TAA more likely to represent in vivo conditions. We used two human HCT116 and HT29 colorectal cancer cell lines exposed for 48 hours to 1% O-2. Spots positive after immunoblotting of 2D-separated lysates of hypoxic cells with the sera of tumor-bearing mice, were collected and analysed by MS for protein identification. Among the hypoxia-specific immunogenic proteins, we identified a phosphorylated form of eukaryotic translation elongation factor 2 (phospho-Thr56 eEF2). We confirmed the increased phosphorylation of this protein in hypoxic colorectal tumor cells as well as in mouse tumors. Using a specific immunoassay, we could detect the presence of corresponding anti-phospho -Thr56 eEF2 aAb in the serum of tumor-bearing mice (vs healthy mice). We further documented that the detection of these aAb preceded the detection of a palpable tumor mass in mice and validated the presence of anti-phospho-Thr56 eEF2 aAb in the serum of patients with adenomatous polyps and colorectal carcinoma. In conclusion, this study validates a phosphorylated form of eEF2 as a new TAA and more generally, provides evidence that integrating hypoxia upstream of SERPA offers a more relevant repertoire of TAA able to unmask the presence of circulating aAb.	[Grandjean, Marie; Defresne, Florence; Feron, Olivier] UCLouvain, IREC, Pole Pharmacol & Therapeut FATH, Brussels, Belgium; [Sermeus, Alexandra; De Ridder, Mark] Vrije Univ Brussel, UZ Brussel, Brussels, Belgium; [Branders, Samuel; Dupont, Pierre] UCLouvain, Inst Informat & Commun Technol Elect & Appl Math, Machine Learning Grp, Louvain, Belgium; [Dieu, Marc; Raes, Martine] UNamur, Namur Res Inst Life Sci NARILIS, Res Unit Cell Biol URBC, Namur, Belgium	Universite Catholique Louvain; Vrije Universiteit Brussel; Universite Catholique Louvain	Feron, O (corresponding author), UCLouvain, IREC, Pole Pharmacol & Therapeut FATH, Brussels, Belgium.	olivier.feron@uclouvain.be	FERON, Olivier/AAM-6395-2020; De Ridder, Mark/F-4794-2013	FERON, Olivier/0000-0001-5360-0286; De Ridder, Mark/0000-0003-4433-8807; Dieu, Marc/0000-0002-3902-542X; Sermeus, Alexandra/0000-0003-4759-5307	Fonds National de la Recherche Scientifique (F.R.S.-FNRS); Fonds de la Recherche Scientifique Medicale (FRSM); Communaute francaise de Belgique [ARC 09/14-020]; Interuniversity Attraction Pole; J. Maisin Foundation; FNRS (Brussels, Belgium)	Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Communaute francaise de Belgique(Australian Research Council); Interuniversity Attraction Pole(Belgian Federal Science Policy Office); J. Maisin Foundation; FNRS (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), the Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute francaise de Belgique (ARC 09/14-020), the Interuniversity Attraction Pole (IUAP program P7.03), and the J. Maisin Foundation. M. Grandjean is a FRIA (Fonds pour la formation a` la Recherche dans l'Industrie et dans l'Agriculture) Research Fellow. The MS facility of the URBC-NARILIS was supported by the FNRS (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Arora S, 2002, BIOCHEM BIOPH RES CO, V293, P1073, DOI 10.1016/S0006-291X(02)00324-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Daneau G, 2010, CLIN CANCER RES, V16, P410, DOI 10.1158/1078-0432.CCR-09-0583; Desmetz C, 2009, J PROTEOMICS, V72, P982, DOI 10.1016/j.jprot.2009.06.004; Desmetz C, 2009, EXPERT REV PROTEOMIC, V6, P377, DOI 10.1586/EPR.09.56; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Kobold S, 2010, HUM IMMUNOL, V71, P643, DOI 10.1016/j.humimm.2010.03.015; Lacombe J, 2013, EXPERT REV PROTEOMIC, V10, P33, DOI [10.1586/EPR.12.68, 10.1586/epr.12.68]; Ladd JJ, 2013, CANCER RES, V73, P1502, DOI 10.1158/0008-5472.CAN-12-2560; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Mariani F, 2009, CANCER LETT, V279, P221, DOI 10.1016/j.canlet.2009.02.001; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reuschenbach M, 2009, CANCER IMMUNOL IMMUN, V58, P1535, DOI 10.1007/s00262-009-0733-4; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Romero-Ruiz A, 2012, J BIOL CHEM, V287, P9651, DOI 10.1074/jbc.M111.299180; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Simiantonaki N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-320; Soussi T, 2000, CANCER RES, V60, P1777; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Tan HT, 2009, FEBS J, V276, P6880, DOI 10.1111/j.1742-4658.2009.07396.x; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vincent KA, 2002, TRENDS CARDIOVAS MED, V12, P362, DOI 10.1016/S1050-1738(02)00186-X; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	36	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76508	10.1371/journal.pone.0076508	http://dx.doi.org/10.1371/journal.pone.0076508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130777	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200041
J	Petrova, K; Wentura, D; Bermeitinger, C				Petrova, Kalina; Wentura, Dirk; Bermeitinger, Christina			What Happens during the Stimulus Onset Asynchrony in the Dot-Probe Task? Exploring the Role of Eye Movements in the Assessment of Attentional Biases	PLOS ONE			English	Article							THREATENING FACIAL EXPRESSIONS; SELECTIVE ATTENTION; VISUAL-ATTENTION; FEARFUL FACES; SACCADES; ANXIETY; RESPONSES; PARADIGM	The dot-probe paradigm is one of the most often used paradigms to investigate attentional biases towards emotional information. However, a large number of the dot-probe studies so far used a long stimulus onset asynchrony allowing for eye movements to occur, which might increase the error variance. This study aimed at addressing this methodological issue by varying the instructions with regard to the gaze behavior and calculating the reaction time (RT) bias score (i.e., RTs for targets presented at the location of the emotional compared to the neutral stimulus) separately for trials with eye movements and trials without eye movements. Results of Experiment 1 (using typical instructions, i.e., instructions that are lenient with regard to eye movements) showed an RT bias, but only in the trials without eye movements The overall RT bias (calculated "blind" for eye movements) was non-significant. In Experiment 2, stricter instructions and small changes in the procedure led to a sharp decrease in the number of eye movements, such that both the RT bias in the trials without eye movements as well as the RT bias across all trials was significant.	[Petrova, Kalina; Wentura, Dirk] Univ Saarland, Dept Psychol, D-66123 Saarbrucken, Germany; [Bermeitinger, Christina] Univ Hildesheim, Dept Psychol, D-31141 Hildesheim, Germany	Saarland University; University of Hildesheim	Petrova, K (corresponding author), Univ Saarland, Dept Psychol, D-66123 Saarbrucken, Germany.	k.petrova@mx.uni-saarland.de		Wentura, Dirk/0000-0001-9907-498X	German Research Foundation [WE 2284/8-2, IRTG 1457]	German Research Foundation(German Research Foundation (DFG))	The research reported in this article was supported by the German Research Foundation (WE 2284/8-2 and IRTG 1457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEDEKER C, 1987, VISION RES, V27, P609, DOI 10.1016/0042-6989(87)90046-0; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Egloff B, 2003, PERS INDIV DIFFER, V35, P475, DOI 10.1016/S0191-8869(02)00265-9; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; Fischer B, 1997, EXP BRAIN RES, V116, P191, DOI 10.1007/PL00005749; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Gomez C, 1998, BIOL PSYCHOL, V47, P77, DOI 10.1016/S0301-0511(97)00022-7; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; IWASAKI S, 1990, ERGONOMICS, V33, P833, DOI 10.1080/00140139008927188; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mogg K, 2007, BIOL PSYCHOL, V76, P163, DOI 10.1016/j.biopsycho.2007.07.005; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2006, NEUROIMAGE, V31, P920, DOI 10.1016/j.neuroimage.2005.12.034; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Tukey J.W., 1977, EXPLORATORY DATA ANA, P1	28	19	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76335	10.1371/journal.pone.0076335	http://dx.doi.org/10.1371/journal.pone.0076335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236QM	24130768	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200033
J	Romacho, T; Villalobos, LA; Cercas, E; Carraro, R; Sanchez-Ferrer, CF; Peiro, C				Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion			Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; EPICARDIAL ADIPOSE-TISSUE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; MMP-2/9 PRODUCTION; GENE-EXPRESSION; PLASMA VISFATIN; LIFE-SPAN; KAPPA-B; ATHEROSCLEROSIS; PROTEIN	Background: Visfatin is a multifaceted adipokine whose circulating levels are enhanced in different metabolic diseases. Extracellular visfatin can exert various deleterious effects on vascular cells, including inflammation and proliferation. Limited evidence exists, however, on the capacity of human vascular cells to synthesize and release visfatin by themselves, under basal or pro-inflammatory conditions. Methods and Results: Intracellular visfatin was detected by Western blot in non-stimulated human umbilical vein endothelial cells (HUVEC). However, exposing HUVEC for 18 h to a series of pro-inflammatory stimulus, such as interleukin (IL)-1 beta (1 to 10 ng/mL), tumor necrosis factor-alpha (1 to 10 ng/mL) or angiotensin II (10 pmol/L to 1 mu mol/L) markedly enhanced intracellular visfatin content. Using IL-1 beta (10 ng/mL; 18 h), it was determined that the increase in intracellular visfatin, which was paralleled by enhanced visfatin mRNA levels, relied on a signalling mechanism involving both nuclear factor-kappa B and poly (ADP ribose) polymerase-1 activation. Moreover, IL-1 beta modified the subcellular localization of visfatin; while in non-stimulated HUVEC immunoreactive visfatin predominantly showed an intra-nuclear granular pattern, in IL-1 beta-inflamed cells an extra-nuclear filamentous staining, co-localising with F-actin fibers and suggesting a secretory pattern, was mainly found. Indeed, IL-1 beta promoted visfatin secretion, as determined by both ELISA and immunocytochemistry. Conclusions: Human endothelial cells synthesize and release visfatin, particularly in response to inflammation. We suggest that the inflamed endothelium can be a source of visfatin, which arises as a local inflammatory mediator and a potential therapeutic target to interfere with vascular inflammation.	[Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Univ Autonoma Madrid, Dept Farmacol & Terapeut, Madrid, Spain; [Carraro, Raffaele] Hosp Univ La Princesa, Serv Endocrinol, Madrid, Spain; [Carraro, Raffaele] Univ Autonoma Madrid, Dept Med, Madrid, Spain; [Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Hosp La Princesa, Inst Invest Sanitaria, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Autonomous University of Madrid	Peiro, C (corresponding author), Univ Autonoma Madrid, Dept Farmacol & Terapeut, Madrid, Spain.	concha.peiro@uam.es	Romacho, Tania/AAB-3306-2021; Peiro, Concepcion/B-9545-2017; Romacho, Tania/B-2663-2016	Romacho, Tania/0000-0002-0962-7163; Peiro, Concepcion/0000-0002-9690-7816; Romacho, Tania/0000-0002-0962-7163; Carraro, Raffaele/0000-0002-5874-8076	Plan Nacional de I+D [SAF2011-28011, SAF2011-24648]; Sociedad Espanola de Farmacologia-Almirall; Fundacion Eugenio Rodriguez Pascual; Caja Madrid Foundation; CONACYT (Mexico)	Plan Nacional de I+D; Sociedad Espanola de Farmacologia-Almirall; Fundacion Eugenio Rodriguez Pascual; Caja Madrid Foundation; CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from Plan Nacional de I+D [SAF2011-28011, SAF2011-24648], Sociedad Espanola de Farmacologia-Almirall and Fundacion Eugenio Rodriguez Pascual. TR is the recipient of a fellowship from Caja Madrid Foundation. LV is supported by a fellowship from CONACYT (Mexico). CP and CFSF are engaged in the COST Action BM1005 ENOG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Adya R, 2008, DIABETES CARE, V31, P758, DOI 10.2337/dc07-1544; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Borradaile NM, 2010, AM J PHYSIOL-CELL PH, V298, pC66, DOI 10.1152/ajpcell.00357.2009; Borradaile NM, 2009, AGING CELL, V8, P100, DOI 10.1111/j.1474-9726.2009.00453.x; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Cheng KH, 2008, INT J OBESITY, V32, P268, DOI 10.1038/sj.ijo.0803726; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Filippatos TD, 2010, CURR VASC PHARMACOL, V8, P12, DOI 10.2174/157016110790226679; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Jeske NA, 2004, J NEUROCHEM, V90, P819, DOI 10.1111/j.1471-4159.2004.02557.x; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kadoglou NPE, 2010, EXP CLIN ENDOCR DIAB, V118, P75, DOI 10.1055/s-0029-1237360; Kato A, 2009, AM J NEPHROL, V29, P31, DOI 10.1159/000148648; Kendal CE, 2007, PLACENTA, V28, P305, DOI 10.1016/j.placenta.2006.03.011; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Liu SW, 2009, HORM METAB RES, V41, P281, DOI 10.1055/s-0028-1102914; Liu SW, 2009, CLIN ENDOCRINOL, V71, P202, DOI 10.1111/j.1365-2265.2008.03453.x; Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008; Niinaka Y, 1998, CANCER RES, V58, P2667; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Ognjanovic S, 2005, AM J OBSTET GYNECOL, V193, P273, DOI 10.1016/j.ajog.2004.11.003; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Romacho T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946427; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Stephens JM, 2006, CURR OPIN LIPIDOL, V17, P128, DOI 10.1097/01.mol.0000217893.77746.4b; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; Vallejo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027299; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P959, DOI 10.1093/ndt/gfm727	42	45	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78283	10.1371/journal.pone.0078283	http://dx.doi.org/10.1371/journal.pone.0078283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130902	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200098
J	Cheong, JLY; Anderson, PJ; Roberts, G; Burnett, AC; Lee, KJ; Thompson, DK; Molloy, C; Wilson-Ching, M; Connelly, A; Seal, ML; Wood, SJ; Doyle, LW				Cheong, Jeanie L. Y.; Anderson, Peter J.; Roberts, Gehan; Burnett, Alice C.; Lee, Katherine J.; Thompson, Deanne K.; Molloy, Carly; Wilson-Ching, Michelle; Connelly, Alan; Seal, Marc L.; Wood, Stephen J.; Doyle, Lex W.			Contribution of Brain Size to IQ and Educational Underperformance in Extremely Preterm Adolescents	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; HUMAN CEREBRAL-CORTEX; CHILDREN BORN; MATTER INJURY; AGE; SEGMENTATION; INTELLIGENCE; CHILDHOOD; OUTCOMES; VOLUMES	Objectives: Extremely preterm (EP) survivors have smaller brains, lower IQ, and worse educational achievement than their term-born peers. The contribution of smaller brain size to the IQ and educational disadvantages of EP is unknown. This study aimed (i) to compare brain volumes from multiple brain tissues and structures between EP-born (<28weeks) and term-born (>= 37weeks) control adolescents, (ii) to explore the relationships of brain tissue volumes with IQ and basic educational skills and whether this differed by group, and (iii) to explore how much total brain tissue volume explains the underperformance of EP adolescents compared with controls. Methods: Longitudinal cohort study of 148 EP and 132 term controls born in Victoria, Australia in 1991-92. At age 18, magnetic resonance imaging-determined brain volumes of multiple tissues and structures were calculated. IQ and educational skills were measured using the Wechsler Abbreviated Scale of Intelligence (WASI) and the Wide Range Achievement Test(WRAT-4), respectively. Results: Brain volumes were smaller in EP adolescents compared with controls (mean difference [95% confidence interval] of -5.9% [-8.0, -3.7%] for total brain tissue volume). The largest relative differences were noted in the thalamus and hippocampus. The EP group had lower IQs(-11.9 [-15.4, -8.5]), spelling(-8.0 [-11.5, -4.6]), math computation(-10.3 [-13.7, -6.9]) and word reading(-5.6 [-8.8, -2.4]) scores than controls; all p-values<0.001. Volumes of total brain tissue and other brain tissues and structures correlated positively with IQ and educational skills, a relationship that was similar for both the EP and controls. Total brain tissue volume explained between 20-40% of the IQ and educational outcome differences between EP and controls. Conclusions: EP adolescents had smaller brain volumes, lower IQs and poorer educational performance than controls. Brain volumes of multiple tissues and structures are related to IQ and educational outcomes. Smaller total brain tissue volume is an important contributor to the cognitive and educational underperformance of adolescents born EP.	[Cheong, Jeanie L. Y.; Doyle, Lex W.] Royal Womens Hosp, Neonatal Serv, Melbourne, Vic, Australia; [Cheong, Jeanie L. Y.; Anderson, Peter J.; Roberts, Gehan; Burnett, Alice C.; Lee, Katherine J.; Thompson, Deanne K.; Molloy, Carly; Wilson-Ching, Michelle; Seal, Marc L.; Doyle, Lex W.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cheong, Jeanie L. Y.; Doyle, Lex W.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Anderson, Peter J.; Burnett, Alice C.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Roberts, Gehan] Royal Childrens Hosp, Melbourne, Vic, Australia; [Anderson, Peter J.; Roberts, Gehan; Lee, Katherine J.; Seal, Marc L.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Thompson, Deanne K.; Connelly, Alan] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Wood, Stephen J.] Univ Birmingham, Sch Psychol, Edgbaston, W Midlands, England	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Birmingham	Cheong, JLY (corresponding author), Royal Womens Hosp, Neonatal Serv, Melbourne, Vic, Australia.	jeanie.cheong@thewomens.org.au	Tager-Flusberg, Helen B/D-5265-2009; Anderson, Peter J/B-6839-2015; Thompson, Deanne K/A-9502-2018; Thompson, Deanne/W-7177-2019; Wood, Stephen J/M-8652-2014; Doyle, Lex/AAJ-5205-2021; Lee, Katherine J/A-2519-2016; Connelly, Alan/A-9065-2013; Anderson, Peter John/O-5302-2019; Seal, Marc L/J-9290-2019; Wood, Stephen/ABF-4086-2020; Roberts, Gehan/I-6372-2015	Anderson, Peter J/0000-0001-7430-868X; Thompson, Deanne K/0000-0001-8017-5756; Thompson, Deanne/0000-0001-8017-5756; Wood, Stephen J/0000-0003-4186-5919; Doyle, Lex/0000-0002-7667-7312; Connelly, Alan/0000-0001-7159-8079; Anderson, Peter John/0000-0001-7430-868X; Seal, Marc L/0000-0002-8396-140X; Wood, Stephen/0000-0003-4186-5919; Roberts, Gehan/0000-0002-2151-1630; Cheong, Jeanie/0000-0001-5901-0455	Australian National Health and Medical Research Council [491246, 546519, 628371, 1053787, 1012236, 1053609]; Victorian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by the Australian National Health and Medical Research Council (Project Grant ID 491246 to LD, PA, SW, JC, as well as C. Robertson, S. Hope, and D. Hacking; Centre of Clinical Research Excellence Grant ID 546519; Senior Research Fellowship ID 628371 to PA; Early Career Fellowship ID 1053787 to JC; Early Career Fellowship ID 1012236 to DT; Career Development Fellowship ID 1053609 to KJL) and the Victorian Government Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy LJ, 2002, ARCH DIS CHILD, V87, P279, DOI 10.1136/adc.87.4.279; Afifi A, 2005, FUNCTIONAL NEUROANAT; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doyle LW, 2005, ARCH DIS CHILD-FETAL, V90, pF484, DOI 10.1136/adc.2004.063362; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Lawlor DA, 2006, PAEDIATR PERINAT EP, V20, P148, DOI 10.1111/j.1365-3016.2006.00704.x; Martinussen M, 2009, J PEDIATR-US, V155, P848, DOI 10.1016/j.jpeds.2009.06.015; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Northam GB, 2011, ANN NEUROL, V69, P702, DOI 10.1002/ana.22263; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Parker J, 2008, BRAIN, V131, P1344, DOI 10.1093/brain/awn062; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Robertson G, 2006, WIDE RANGE ACHIEVEME; Rotzer S, 2008, NEUROIMAGE, V39, P417, DOI 10.1016/j.neuroimage.2007.08.045; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Scott FE, 2011, NEUROPSYCHOLOGIA, V49, P2685, DOI 10.1016/j.neuropsychologia.2011.05.016; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Xie YH, 2012, J CHILD NEUROL, V27, P325, DOI 10.1177/0883073811419260	41	61	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77475	10.1371/journal.pone.0077475	http://dx.doi.org/10.1371/journal.pone.0077475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130887	gold, Green Published			2022-12-27	WOS:000325810900137
J	Minde, DP; Radli, M; Forneris, F; Maurice, MM; Rudiger, SGD				Minde, David P.; Radli, Martina; Forneris, Federico; Maurice, Madelon M.; Ruediger, Stefan G. D.			Large Extent of Disorder in Adenomatous Polyposis Coli Offers a Strategy to Guard Wnt Signalling against Point Mutations	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; BETA-CATENIN DEGRADATION; ARMADILLO REPEAT DOMAIN; CRYSTAL-STRUCTURE; INTRINSIC DISORDER; SCAFFOLD PROTEINS; STRUCTURAL BASIS; APC; AXIN; PHOSPHORYLATION	Mutations in the central region of the signalling hub Adenomatous Polyposis Coli (APC) cause colorectal tumourigenesis. The structure of this region remained unknown. Here, we characterise the Mutation Cluster Region in APC (APC-MCR) as intrinsically disordered and propose a model how this structural feature may contribute to regulation of Wnt signalling by phosphorylation. APC-MCR was susceptible to proteolysis, lacked alpha-helical secondary structure and did not display thermal unfolding transition. It displayed an extended conformation in size exclusion chromatography and was accessible for phosphorylation by CK1 epsilon in vitro. The length of disordered regions in APC increases with species complexity, from C. elegans to H. sapiens. We speculate that the large disordered region harbouring phosphorylation sites could be a successful strategy to stabilise tight regulation of Wnt signalling against single missense mutations.	[Minde, David P.; Radli, Martina; Forneris, Federico; Ruediger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Maurice, MM (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	M.M.Maurice@umcutrecht.nl; s.g.d.rudiger@uu.nl	Minde, David Paul/D-3847-2012; Forneris, Federico/AAL-5361-2020; Forneris, Federico/B-1145-2011; Rüdiger, Stefan GD/G-4906-2012	Minde, David Paul/0000-0002-2985-622X; Forneris, Federico/0000-0002-7818-1804; Forneris, Federico/0000-0002-7818-1804; Rüdiger, Stefan GD/0000-0002-1807-2972; Maurice, Madelon/0000-0001-6885-5361	European Union [MEXT-CT-2005-025651, 317371]; VIDI by the Netherlands Organization for Scientific Research (NWO) [700.55.421]; Utrecht University; European Research Council (ERC-StG) [242958]	European Union(European Commission); VIDI by the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University; European Research Council (ERC-StG)(European Research Council (ERC))	SGDR was supported by the European Union's Sixth Framework Programme (FP6) by a Marie-Curie Excellence Grant (MEXT-CT-2005-025651) and by the Seventh Framework Programme (FP7) under grant agreement ManiFold no317371, by a VIDI career development grant (700.55.421) by the Netherlands Organization for Scientific Research (NWO) and by a High Potential Grant of Utrecht University. MMM was supported by the European Research Council (ERC-StG no. 242958) and by a High Potential Grant of Utrecht University. URLs of funders: NWO: http://www.nwo.nl/; EU: http://europa.eu/index_en.htm; Utrecht University: http://www.uu.nl/; ERC: http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDRESCU AT, 1994, J MOL BIOL, V235, P587, DOI 10.1006/jmbi.1994.1015; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Balazs A, 2009, FEBS J, V276, P3744, DOI 10.1111/j.1742-4658.2009.07090.x; Bark SJ, 2001, J AM CHEM SOC, V123, P1774, DOI 10.1021/ja002909n; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bruschweiler S, 2009, J AM CHEM SOC, V131, P3063, DOI 10.1021/ja809947w; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Dahlberg CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004766; Day CL, 2000, J MOL BIOL, V301, P147, DOI 10.1006/jmbi.2000.3895; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Kurnik M, 2012, P NATL ACAD SCI USA, V109, P5705, DOI 10.1073/pnas.1118640109; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Minde DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046147; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Morishita EC, 2011, STRUCTURE, V19, P1496, DOI 10.1016/j.str.2011.07.013; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Quint S, 2010, BIOPHYS J, V99, P2541, DOI 10.1016/j.bpj.2010.08.031; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Schaefer C, 2010, BIOINFORMATICS, V26, P625, DOI 10.1093/bioinformatics/btq012; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Shibata N, 2007, ACTA CRYSTALLOGR F, V63, P529, DOI 10.1107/S1744309107022579; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tickenbrock L, 2003, J MOL BIOL, V327, P359, DOI 10.1016/S0022-2836(03)00144-X; Tickenbrock L, 2002, J BIOL CHEM, V277, P32332, DOI 10.1074/jbc.M203990200; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Xue B, 2013, FEBS LETT, V587, P1587, DOI 10.1016/j.febslet.2013.04.006; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2012, J BIOMOL STRUCT DYN, V29, P843, DOI 10.1080/073911012010525024; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yiu CPB, 2000, CHEMBIOCHEM, V1, P49, DOI 10.1002/1439-7633(20000703)1:1<49::AID-CBIC49>3.0.CO;2-A; Zhang ZY, 2012, CELL RES, V22, P372, DOI 10.1038/cr.2011.119; Zhang ZY, 2011, BIOCHEM BIOPH RES CO, V412, P732, DOI 10.1016/j.bbrc.2011.08.044	70	37	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77257	10.1371/journal.pone.0077257	http://dx.doi.org/10.1371/journal.pone.0077257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130866	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900130
J	Miyagawa, M; Nishio, S; Ikeda, T; Fukushima, K; Usami, S				Miyagawa, Maiko; Nishio, Shin-ya; Ikeda, Takuo; Fukushima, Kunihiro; Usami, Shin-ichi			Massively Parallel DNA Sequencing Successfully Identifies New Causative Mutations in Deafness Genes in Patients with Cochlear Implantation and EAS	PLOS ONE			English	Article							ELECTRIC-ACOUSTIC STIMULATION; HEARING-LOSS; TMPRSS3; PERFORMANCE; FAMILIES	Genetic factors, the most common etiology in severe to profound hearing loss, are one of the key determinants of Cochlear Implantation (CI) and Electric Acoustic Stimulation (EAS) outcomes. Satisfactory auditory performance after receiving a CI/EAS in patients with certain deafness gene mutations indicates that genetic testing would be helpful in predicting CI/EAS outcomes and deciding treatment choices. However, because of the extreme genetic heterogeneity of deafness, clinical application of genetic information still entails difficulties. Target exon sequencing using massively parallel DNA sequencing is a new powerful strategy to discover rare causative genes in Mendelian disorders such as deafness. We used massive sequencing of the exons of 58 target candidate genes to analyze 8 (4 early-onset, 4 late-onset) Japanese CI/EAS patients, who did not have mutations in commonly found genes including GJB2, SLC26A4, or mitochondrial 1555A>G or 3243A>G mutations. We successfully identified four rare causative mutations in the MYO15A, TECTA, TMPRSS3, and ACTG1 genes in four patients who showed relatively good auditory performance with CI including EAS, suggesting that genetic testing may be able to predict the performance after implantation.	[Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Ikeda, Takuo] Tsudumigaura Handicapped Childrens Hosp, Dept Otolaryngol, Shunan, Japan; [Fukushima, Kunihiro] Okayama Univ, Sch Med, Dept Otorhinolaryngol, Okayama 700, Japan	Shinshu University; Okayama University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (S. U.), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Coninx F., 2003, LITTLEARS AUDITORY Q; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Eppsteiner RW, 2012, HEARING RES, V292, P51, DOI 10.1016/j.heares.2012.08.007; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Hildebrand MS, 2011, HUM MUTAT, V32, P825, DOI 10.1002/humu.21512; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; MIYAGAWA M, 2013, PLOS ONE IN PRESS; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Usami S, 2010, AUDIOLOGICAL MED, V8, P28; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Usami S, 2012, ACTA OTO-LARYNGOL, V132, P377, DOI 10.3109/00016489.2011.649493; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Zimmerman-Phillips S., 1997, INFANT TODDLER MEANI	22	71	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75793	10.1371/journal.pone.0075793	http://dx.doi.org/10.1371/journal.pone.0075793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130743	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900058
J	Rice, RH; Bradshaw, KM; Durbin-Johnson, BP; Rocke, DM; Eigenheer, RA; Phinney, BS; Schmuth, M; Gruber, R				Rice, Robert H.; Bradshaw, Katie M.; Durbin-Johnson, Blythe P.; Rocke, David M.; Eigenheer, Richard A.; Phinney, Brett S.; Schmuth, Matthias; Gruber, Robert			Distinguishing Ichthyoses by Protein Profiling	PLOS ONE			English	Article							RECESSIVE CONGENITAL ICHTHYOSIS; LAMELLAR ICHTHYOSIS; MOLECULAR ANALYSIS; STATISTICAL-MODEL; MUTATIONS; TRANSGLUTAMINASE-1; ABNORMALITIES; DISORDERS; FILAGGRIN	To explore the usefulness of protein profiling for characterization of ichthyoses, we here determined the profile of human epidermal stratum corneum by shotgun proteomics. Samples were analyzed after collection on tape circles from six anatomic sites (forearm, palm, lower leg, forehead, abdomen, upper back), demonstrating site-specific differences in profiles. Additional samples were collected from the forearms of subjects with ichthyosis vulgaris (filaggrin (FLG) deficiency), recessive X-linked ichthyosis (steroid sulfatase (STS) deficiency) and autosomal recessive congenital ichthyosis type lamellar ichthyosis (transglutaminase 1 (TGM1) deficiency). The ichthyosis protein expression patterns were readily distinguishable from each other and from phenotypically normal epidermis. In general, the degree of departure from normal was lower from ichthyosis vulgaris than from lamellar ichthyosis, parallel to the severity of the phenotype. Analysis of samples from families with ichthyosis vulgaris and concomitant modifying gene mutations (STS deficiency, GJB2 deficiency) permitted correlation of alterations in protein profile with more complex genetic constellations.	[Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Forens Sci Grad Program, Davis, CA 95616 USA; [Durbin-Johnson, Blythe P.; Rocke, David M.] Univ Calif Davis, Div Biostat, Dept Publ Hlth Sci, Clin & Translat Sci Ctr,Biostat Core, Davis, CA 95616 USA; [Rocke, David M.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Eigenheer, Richard A.; Phinney, Brett S.] Univ Calif Davis, Prote Core Facil, Davis, CA 95616 USA; [Schmuth, Matthias; Gruber, Robert] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Medical University of Innsbruck	Gruber, R (corresponding author), Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria.	r.gruber@i-med.ac.at	Rice, Robert/AAP-7813-2021; Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302; Schmuth, Matthias/0000-0002-4064-1334	MFF Tirol [194]; National Institutes of Health (NIH) grant from the National Institute for Environmental Health Sciences [2P42 ES04699]; NIH grant from the National Center for Advancing Translational Sciences [UL1TR0000002]; EU-FP7 COST Action [BM0903]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	MFF Tirol; National Institutes of Health (NIH) grant from the National Institute for Environmental Health Sciences; NIH grant from the National Center for Advancing Translational Sciences; EU-FP7 COST Action; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by MFF Tirol grant number 194, National Institutes of Health (NIH) grant from the National Institute for Environmental Health Sciences (2P42 ES04699), NIH grant from the National Center for Advancing Translational Sciences (UL1TR0000002), and EU-FP7 COST Action BM0903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Akiyama M, 2011, DERM-ENDOCRINOL, V3, P107, DOI 10.4161/derm.3.2.15136; Aufenvenne K, 2012, J INVEST DERMATOL, V132, P1918, DOI 10.1038/jid.2012.65; Aufenvenne K, 2009, J INVEST DERMATOL, V129, P2068, DOI 10.1038/jid.2009.18; Eckl KM, 2009, J INVEST DERMATOL, V129, P1421, DOI 10.1038/jid.2008.409; Eckl KM, 2013, J INVEST DE IN PRESS; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Elias PM, 2004, J INVEST DERMATOL, V122, P314, DOI 10.1046/j.1523-1747.2003.22258.x; Elias PM, 2002, EXP DERMATOL, V11, P248, DOI 10.1034/j.1600-0625.2001.110308.x; Elmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M1111.014555, DOI 10.1074/MCP.M1111.014555]; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; Gruber R, 2010, J DERMATOL SCI, V58, P72, DOI 10.1016/j.jdermsci.2010.01.002; Herman ML, 2009, HUM MUTAT, V30, P537, DOI 10.1002/humu.20952; Hoppe T, 2012, BRIT J DERMATOL, V167, P514, DOI 10.1111/j.1365-2133.2012.10979.x; Israeli S, 2011, AM J HUM GENET, V88, P482, DOI 10.1016/j.ajhg.2011.02.011; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Lin TK, 2012, J INVEST DERMATOL, V132, P2430, DOI 10.1038/jid.2012.173; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Radner FP, 2013, PLOS GENETI IN PRESS; Ramesh R, 2011, J DERMATOL SCI, V64, P159, DOI 10.1016/j.jdermsci.2011.07.006; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Rice RH, 2005, ARCH DERMATOL RES, V297, P127, DOI 10.1007/s00403-005-0591-7; Rice RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051956; Schmuth Matthias, 2007, Adv Dermatol, V23, P231, DOI 10.1016/j.yadr.2007.07.011; Schmuth M, 2013, EUR J HUM GENET, V21, P123, DOI 10.1038/ejhg.2012.121; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	29	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75355	10.1371/journal.pone.0075355	http://dx.doi.org/10.1371/journal.pone.0075355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130705	gold, Green Published			2022-12-27	WOS:000325810900031
J	Verweij, KHW; Derks, EM				Verweij, Kim H. W.; Derks, Eske M.		Genetic Risk Outcome Psychosis Grp	The Association between Intelligence Scores and Family History of Psychiatric Disorder in Schizophrenia Patients, Their Siblings and Healthy Controls	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-RISK; BIPOLAR DISORDER; PREMORBID IQ; CHILDREN; DIAGNOSIS; RELATIVES; PEOPLE	Background: The degree of intellectual impairment in schizophrenia patients and their relatives has been suggested to be associated with the degree of familial loading for schizophrenia. Since other psychiatric disorders are also more present in relatives of schizophrenia patients, the definition of family history should be broadened. The association between family history for psychiatric disorder and intelligence scores was investigated in patients with non-affective psychosis, their unaffected siblings and controls. Methods: A sample of 712 schizophrenia proband families (696 patients and 766 siblings) and 427 healthy control families (517 subjects) participated in this study. Family history of psychiatric disorder was determined while excluding the data of the participating schizophrenia patient. A dichotomous division was made between families with no first- or second degree relative with psychiatric disorder and families with one or more affected relatives. Total intelligence scores were estimated by admission of the short form of the Wechsler Adult Intelligence Scale III. Results: A significant interaction was found between family history of psychiatric disorder and clinical status (F(2,1086.87)=4.17; p=.016). Patients with a positive family history of psychiatric disorder obtained higher intelligence scores compared to patients with no family history (mean IQ scores are 95.52 and 92.72) with an opposite effect in controls (mean IQ scores are 108.71 and 111.19). No significant difference was found between siblings of schizophrenia patients with or without a positive family history (mean IQ scores are 102.98 and 103.24). Conclusion: In patients with schizophrenia, a negative family history of psychiatric disorder was associated with relatively low IQ suggesting that the etiology in these patients may involve environmental or genetic factors which are unique to the patient and are not observed in other relatives. Possible factors include severe environmental stressors containing premature birth or brain injury and genetic factors (e.g de novo Copy Number Variants).	[Verweij, Kim H. W.; Derks, Eske M.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Derks, Eske M.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Verweij, KHW (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	k.verweij-2@umcutrecht.nl	Myin-Germeys, Inez/L-5106-2014; van Os, Jim/C-2113-2014; Derks, Eske M/A-1652-2017; krabbendam, lydia/F-9163-2010	Derks, Eske M/0000-0002-6292-6883; Bruggeman, Richard/0000-0002-3238-8471; krabbendam, lydia/0000-0003-4074-5149; Myin-Germeys, Inez/0000-0002-3731-4930	NWO [451-080-010]; Dutch Health Research Council (ZON-MW) [10-000-1001]; Lundbeck; AstraZeneca; Eli Lilly; Janssen Cilag; Amsterdam: Academic Psychiatric Centre of the Academic Medical Centre; GGZ Ingeest; Arkin; Dijk en Duin; GGZ Rivierduinen; Erasmus Medical Centre; GGZ Noord Holland Noord; Maastricht: Maastricht University Medical Centre; GGZ Eindhoven en de kempen; GGZ Breburg; GGZ Oost-Brabant; Vincent van Gogh voor Geestelijke Gezondheid; Mondriaan Zorggroep; Prins Clauscentrum Sittard; RIAGG Roermond; Universitair Centrum Sint-Jozef Kortenberg; CAPRI University of Antwerp; PC Ziekeren Sint-Truiden; PZ Sancta Maria Sint-Truiden; GGZ Overpelt; OPZ Rekem; Groningen: University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Dimence; Mediant; GGNet Warnsveld; Yulius Dordrecht; Parnassia psycho-medical centre (The Hague); Utrecht: University Medical Centre Utrecht; Altrecht; GGZ Centraal; Riagg Amersfoort; Delta	NWO(Netherlands Organization for Scientific Research (NWO)); Dutch Health Research Council (ZON-MW)(Netherlands Organization for Health Research and Development); Lundbeck(Lundbeck Corporation); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amsterdam: Academic Psychiatric Centre of the Academic Medical Centre; GGZ Ingeest; Arkin; Dijk en Duin; GGZ Rivierduinen; Erasmus Medical Centre; GGZ Noord Holland Noord; Maastricht: Maastricht University Medical Centre; GGZ Eindhoven en de kempen; GGZ Breburg; GGZ Oost-Brabant; Vincent van Gogh voor Geestelijke Gezondheid; Mondriaan Zorggroep; Prins Clauscentrum Sittard; RIAGG Roermond; Universitair Centrum Sint-Jozef Kortenberg; CAPRI University of Antwerp; PC Ziekeren Sint-Truiden; PZ Sancta Maria Sint-Truiden; GGZ Overpelt; OPZ Rekem; Groningen: University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Dimence; Mediant; GGNet Warnsveld; Yulius Dordrecht; Parnassia psycho-medical centre (The Hague); Utrecht: University Medical Centre Utrecht; Altrecht; GGZ Centraal; Riagg Amersfoort; Delta	Dr. EMD is supported by NWO (project number 451-080-010). The infrastructure for the GROUP study is funded through the Geestkracht programme of the Dutch Health Research Council (ZON-MW, grant number 10-000-1001), and matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Centre and the mental health institutions: GGZ Ingeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord Holland Noord. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGZ Eindhoven en de kempen, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh voor Geestelijke Gezondheid, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia psycho-medical centre (The Hague). Utrecht: University Medical Centre Utrecht and the mental health institutions Altrecht, GGZ Centraal, Riagg Amersfoort and Delta.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew-Blais J, 2013, COGN NEUROPSYCHIATRY, V18, P44, DOI 10.1080/13546805.2012.676309; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Bilder RM, 2006, J CLIN EXP NEUROPSYC, V28, P270, DOI 10.1080/13803390500360554; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Byrne M, 1999, PSYCHOL MED, V29, P1161, DOI 10.1017/S0033291799001002; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P379, DOI 10.1093/oxfordjournals.schbul.a033460; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Cserjesi R, 2012, PEDIATRICS, V130, pE838, DOI 10.1542/peds.2011-2079; de la Serna E, 2011, SCHIZOPHR RES, V131, P35, DOI 10.1016/j.schres.2011.06.015; Eack SM, 2010, SCHIZOPHRENIA BULL, V36, P1081, DOI 10.1093/schbul/sbp026; Faraone SV, 2000, BIOL PSYCHIAT, V48, P120, DOI 10.1016/S0006-3223(99)00263-2; Faridi K, 2009, SCHIZOPHR RES, V114, P57, DOI 10.1016/j.schres.2009.07.007; Fis NP, 2008, EUR CHILD ADOLES PSY, V17, P424, DOI 10.1007/s00787-008-0684-x; Goldstein JM, 2000, SCHIZOPHRENIA BULL, V26, P323, DOI 10.1093/oxfordjournals.schbul.a033456; Groom MJ, 2008, SCHIZOPHR RES, V99, P85, DOI 10.1016/j.schres.2007.11.008; Hughes C, 2005, ACTA PSYCHIAT SCAND, V111, P185, DOI 10.1111/j.1600-0447.2004.00392.x; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; Keshavan MS, 2011, SCHIZOPHR RES, V127, P3, DOI 10.1016/j.schres.2011.01.011; Korver N., 2012, INT J METHODS PSYCHI; Kremen WS, 1998, PSYCHIAT RES, V79, P227, DOI 10.1016/S0165-1781(98)00042-0; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maxwell M., 1992, FAMILY INTERVIEW GEN; Maziade M, 2013, SCHIZOPHR RES, V144, P9, DOI 10.1016/j.schres.2012.12.022; Maziade M, 2011, SCHIZOPHRENIA BULL, V37, P1218, DOI 10.1093/schbul/sbq026; Maziade M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019153; McIntosh AM, 2005, BRIT J PSYCHIAT, V186, P378, DOI 10.1192/bjp.186.5.378; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Mortensen PB, 2010, PSYCHOL MED, V40, P201, DOI 10.1017/S0033291709990419; Norman RMG, 2007, J NERV MENT DIS, V195, P846, DOI 10.1097/NMD.0b013e318156f8e2; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Prasad KM, 2009, SCHIZOPHR RES, V108, P163, DOI 10.1016/j.schres.2008.11.019; Ross RG, 2001, SCHIZOPHR RES, V50, P121, DOI 10.1016/S0920-9964(00)00043-8; ROY MA, 1994, ACTA PSYCHIAT SCAND, V89, P324, DOI 10.1111/j.1600-0447.1994.tb01523.x; ROY MA, 1994, AM J PSYCHIAT, V151, P805; Seidman LJ, 2006, J CLIN EXP NEUROPSYC, V28, P225, DOI 10.1080/13803390500360471; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Urfer-Parnas A, 2010, PSYCHOL MED, V40, P547, DOI 10.1017/S0033291709990754; Verweij KHW, 2011, TWIN RES HUM GENET, V14, P217, DOI 10.1375/twin.14.3.217; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wolitzky R, 2006, J CLIN EXP NEUROPSYC, V28, P167, DOI 10.1080/13803390500360315; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	46	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77215	10.1371/journal.pone.0077215	http://dx.doi.org/10.1371/journal.pone.0077215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130858	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900127
J	Hawking, MKD; Lecky, DM; Verlander, NQ; McNulty, CAM				Hawking, Meredith K. D.; Lecky, Donna M.; Verlander, Neville Q.; McNulty, Cliodna A. M.			Fun on the Farm: Evaluation of a Lesson to Teach Students about the Spread of Infection on School Farm Visits	PLOS ONE			English	Article							ESCHERICHIA-COLI O157; CAMPYLOBACTER-JEJUNI; SAFETY KNOWLEDGE; RISK-FACTORS; E-BUG; CATTLE; HYGIENE; PERSISTENCE; BEHAVIORS	Background: School visits to farms are a positive educational experience but pose risks due to the spread of zoonotic infections. A lesson plan to raise awareness about microbes on the farm and preventative behaviours was developed in response to the Griffin Investigation into the E. coli outbreak associated with Godstone Farm in 2009. This study evaluated the effectiveness of the delivery of the lesson plan in increasing knowledge about the spread of infection on the farm, amongst school students. Methods: Two hundred and twenty-five 9-11 year old students from seven junior schools in England participated. Two hundred and ten students filled in identical questionnaires covering microbes, hand hygiene, and farm hygiene before and after the lesson. Statistical analysis assessed knowledge change using difference in percentage correct answers. Results: Significant knowledge improvement was observed for all sections. In the 'Farm Hygiene' section, girls and boys demonstrated 18% (p<0.001) and 11% (p<0.001) improvement, respectively (girls vs. boys p<0.004). As girls had lower baseline knowledge the greater percentage improvement resulted in similar post intervention knowledge scores between genders (girls 80%, boys 83%). Conclusions: The lesson plan was successful at increasing awareness of microbes on the farm and infection prevention measures and should be used by teachers in preparation for a farm visit.	[Hawking, Meredith K. D.; Lecky, Donna M.; McNulty, Cliodna A. M.] Gloucestershire Royal Hosp, Dept Microbiol, Publ Hlth England, Primary Care Unit, Gloucester GL1 3NN, England; [Verlander, Neville Q.] Publ Hlth England Ctr Infect, Stat Modelling & Econ Dept, London, England	Gloucestershire Royal Hospital; Public Health England; Public Health England	Hawking, MKD (corresponding author), Gloucestershire Royal Hosp, Dept Microbiol, Publ Hlth England, Primary Care Unit, Gloucester GL1 3NN, England.	meredith.hawking@phe.gov.uk	Lecky, Donna Marie/AAB-6849-2019; Hawking, Meredith KD/E-7692-2015	Lecky, Donna Marie/0000-0002-1223-9356; Hawking, Meredith KD/0000-0003-1519-2458	Health Protection Agency, UK	Health Protection Agency, UK	This work was supported by the Health Protection Agency, UK (http://www.hpa.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belongia EA, 2003, J INFECT DIS, V187, P1460, DOI 10.1086/374622; Berry DS, 2006, J SAFETY RES, V37, P333, DOI 10.1016/j.jsr.2006.05.003; Charlett A, 2003, EPIDEMIOL INFECT, V130, P367; Crump JA, 2003, EPIDEMIOL INFECT, V131, P1055, DOI 10.1017/S0950268803001237; Ejemot-Nwadiaro R. I., 2012, COCHRANE DB SYST REV, V2, P1; Eves A, 2010, HEALTH EDUC J, V69, P21, DOI 10.1177/0017896910363313; Farming and Countryside Education, 2011, PREV CONTR ILL HLTH; Farming and Countryside Education, 2012, CONTR INF FARMS; Farming and Countryside Education, 2011, RES SCH BENCHM VIEWS; GARBER LP, 1995, J AM VET MED ASSOC, V207, P46; Goode B, 2009, ARCH PEDIAT ADOL MED, V163, P42, DOI 10.1001/archpediatrics.2008.525; Grohskopf L, 2011, AM J TRANSPLANT, V11, P2250, DOI 10.1111/j.1600-6143.2011.03793.x; Health and Safety Executive, 2007, KIDS SAF HELP CHILDR; Health Protection Agency, 2011, AV INF FARM VIS ADV; Health Protection Agency, 2010, REV MAJ OUTBR E COLI; Health Protection Agency, 2011, MAN AC BLOOD DIARRH; Health Protection Scotland, 2010, SIMPL PREC RED RISK; Heuvelink AE, 2007, EPIDEMIOL INFECT, V135, P1174, DOI 10.1017/S0950268807008072; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; Jones DL, 1999, SOIL USE MANAGE, V15, P76, DOI 10.1111/j.1475-2743.1999.tb00069.x; Lecky DM, 2010, J ANTIMICROB CHEMOTH, V65, P2674, DOI 10.1093/jac/dkq356; Lee MB, 2010, J SCH HLTH, V80, P589; LeJeune JT, 2001, APPL ENVIRON MICROB, V67, P3053, DOI 10.1128/AEM.67.7.3053-3057.2001; McMillian M, 2007, JAVMA-J AM VET MED A, V231, P1036, DOI 10.2460/javma.231.7.1036; McNulty CAM, 2011, J ANTIMICROB CHEMOTH, V66, pV3, DOI 10.1093/jac/dkr119; Nichols GL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001179; Paiba GA, 2003, VET REC, V153, P347, DOI 10.1136/vr.153.12.347; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Rahn K, 1997, EPIDEMIOL INFECT, V119, P251, DOI 10.1017/S0950268897007929; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; Stanley K, 1998, J APPL MICROBIOL, V85, P187; Thomson JA, 2005, J EXP PSYCHOL-APPL, V11, P175, DOI 10.1037/1076-898X.11.3.175; Wesley IV, 2000, APPL ENVIRON MICROB, V66, P1994, DOI 10.1128/AEM.66.5.1994-2000.2000	33	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75641	10.1371/journal.pone.0075641	http://dx.doi.org/10.1371/journal.pone.0075641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146765	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400011
J	Bicego, GT; Nkambule, R; Peterson, I; Reed, J; Donnell, D; Ginindza, H; Duong, YT; Patel, H; Bock, N; Philip, N; Mao, C; Justman, J				Bicego, George T.; Nkambule, Rejoice; Peterson, Ingrid; Reed, Jason; Donnell, Deborah; Ginindza, Henry; Duong, Yen T.; Patel, Hetal; Bock, Naomi; Philip, Neena; Mao, Cherry; Justman, Jessica			Recent Patterns in Population-Based HIV Prevalence in Swaziland	PLOS ONE			English	Article							MALE CIRCUMCISION; TRIAL	Background: The 2011 Swaziland HIV Incidence Measurement Survey (SHIMS) was conducted as part of a national study to evaluate the scale up of key HIV prevention programs. Methods: From a randomly selected sample of all Swazi households, all women and men aged 18-49 were considered eligible, and all consenting adults were enrolled and received HIV testing and counseling. In this analysis, population-based measures of HIV prevalence were produced and compared against similarly measured HIV prevalence estimates from the 2006-7 Swaziland Demographic and Health. Also, measures of HIV service utilization in both HIV infected and uninfected populations were documented and discussed. Results: HIV prevalence among adults aged 18-49 has remained unchanged between 2006-2011 at 31-32%, with substantial differences in current prevalence between women (39%) and men (24%). In both men and women, between since 2006-7 and 2011, prevalence has fallen in the young age groups and risen in the older age groups. Over a third (38%) of the HIV-infected population was unaware of their infection status, and this differed markedly between men (50%) and women (31%). Of those aware of their HIV-positive status, a higher percentage of men (63%) than women (49%) reported ART use. Conclusions: While overall HIV prevalence remains roughly constant, age-specific changes strongly suggest both improved survival of the HIV-infected and a reduction in new HIV infections. Awareness of HIV status and entry into ART services has improved in recent years but remains too low. This study identifies opportunities to improve both HIV preventive and care services in Swaziland.	[Bicego, George T.] Ctr Dis Control & Prevent CDC, Mbabane, Swaziland; [Nkambule, Rejoice; Ginindza, Henry] Minist Hlth, Mbabane, Swaziland; [Peterson, Ingrid; Ginindza, Henry] Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, Mbabane, Swaziland; [Donnell, Deborah; Mao, Cherry] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Reed, Jason; Duong, Yen T.; Patel, Hetal; Bock, Naomi] CDC Atlanta, Div Global HIV AIDS, Atlanta, GA USA; [Philip, Neena; Justman, Jessica] Columbia Univ, ICAP, New York, NY USA	Fred Hutchinson Cancer Center; Centers for Disease Control & Prevention - USA; Columbia University	Bicego, GT (corresponding author), Ctr Dis Control & Prevent CDC, Mbabane, Swaziland.	gpb4@cdc.gov	Justman, Jessica/AAA-3572-2020	Donnell, Deborah/0000-0002-0587-7480	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The CDC funded the SHIMS study and participated in the design, data analysis, and preparation of manuscript.	[Anonymous], 2009, 2007 SWAZ POP CENS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Central Statistical Office (CSO) [Swaziland] and Macro International Inc, 2008, SWAZ DEM HLTH SURV 2; Gray RH, 2007, LANCET, V369, P9562; Ministry of Health, 2012, SWAZ INC MEAS SURV S; Ministry of Health (MOH), 2011, ROUND HIV SENT SER S, P2010; Ministry of Health (MOH), 2012, ART PROGR ANN REP MB; Ministry of Health (MOH), 2012, SWAZ NAT ART PROGR E; National Emergency Response Council on HIV and AIDS (NERCHA), 2010, NAT MULTISECTORAL ST; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298	11	81	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77101	10.1371/journal.pone.0077101	http://dx.doi.org/10.1371/journal.pone.0077101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143205	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100040
J	Jern, P; Piha, J; Santtila, P				Jern, Patrick; Piha, Juhana; Santtila, Pekka			Validation of Three Early Ejaculation Diagnostic Tools: A Composite Measure Is Accurate and More Adequate for Diagnosis by Updated Diagnostic Criteria	PLOS ONE			English	Article							EVIDENCE-BASED DEFINITION; PREMATURE EJACULATION; LATENCY; POPULATION; PREVALENCE	Purpose: To validate three early ejaculation diagnostic tools, and propose a new tool for diagnosis in line with proposed changes to diagnostic criteria. Significant changes to diagnostic criteria are expected in the near future. Available screening tools do not necessarily reflect proposed changes. Materials and Methods: Data from 148 diagnosed early ejaculation patients (M-age = 42.8) and 892 controls (M-age = 33.1 years) from a population-based sample were used. Participants responded to three different questionnaires (Premature Ejaculation Profile; Premature Ejaculation Diagnostic Tool; Multiple Indicators of Premature Ejaculation). Stopwatch measured ejaculation latency times were collected from a subsample of early ejaculation patients. We used two types of responses to the questionnaires depending on the treatment status of the patients 1) responses regarding the situation before starting pharmacological treatment and 2) responses regarding current situation. Logistic regressions and Receiver Operating Characteristics were used to assess ability of both the instruments and individual items to differentiate between patients and controls. Results: All instruments had very good precision (Areas under the Curve ranging from.93-.98). A new five-item instrument (named CHecklist for Early Ejaculation Symptoms - CHEES) consisting of high-performance variables selected from the three instruments had validity (Nagelkerke R-2 range.51-. 79 for backwards/forwards logistic regression) equal to or slightly better than any individual instrument (i.e., had slightly higher validity statistics, but these differences did not achieve statistical significance). Importantly, however, this instrument was more in line with proposed changes to diagnostic criteria. Conclusions: All three screening tools had good validity. A new 5-item diagnostic tool (CHEES) based on the three instruments had equal or somewhat more favorable validity statistics compared to the other three tools, but is more in line with recently proposed diagnostic criteria.	[Jern, Patrick] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Jern, Patrick; Santtila, Pekka] Abo Akad Univ, Dept Psychol & Logoped, Turku, Finland; [Piha, Juhana] Med Ctr Mehilainen, Turku, Finland	QIMR Berghofer Medical Research Institute; Abo Akademi University	Jern, P (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	pjern@abo.fi			Academy of Finland [138291]	Academy of Finland(Academy of Finland)	This study was funded by a personal post-doctorate grant to Dr. Jern from the Academy of Finland (Grant No. 138291, web page http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althof SE, 2010, J SEX MED, V7, P2947, DOI 10.1111/j.1743-6109.2010.01975.x; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Grenier G, 1997, ARCH SEX BEHAV, V26, P27, DOI 10.1023/A:1024569319319; Jannini EA, 2005, CURR OPIN UROL, V15, P399, DOI 10.1097/01.mou.0000182327.79572.fd; Jern P, 2009, INT J IMPOT RES, V21, P62, DOI 10.1038/ijir.2008.61; Jern P., 2009, PREMATURE DELAYED EJ; Jern P, 2012, PLEASURE HLTH ED COU, P19; Langstrom N, 2005, J SEX MARITAL THER, V31, P87, DOI 10.1080/00926230590477934; Montorsi F, 2005, J SEX MED, V2, P96, DOI 10.1111/j.1743-6109.2005.20369.x; Patrick DL, 2009, BJU INT, V103, P358, DOI 10.1111/j.1464-410X.2008.08041.x; Pryor JL, 2006, LANCET, V368, P929, DOI 10.1016/S0140-6736(06)69373-2; Rosen RC, 2007, J UROLOGY, V177, P1059, DOI 10.1016/j.juro.2006.10.044; Segraves RT, 2010, J SEX MED, V7, P672, DOI 10.1111/j.1743-6109.2009.01682.x; Serefoglu EC, 2009, INT J IMPOT RES, V21, P139, DOI 10.1038/ijir.2008.58; Symonds T, 2007, EUR UROL, V52, P565, DOI 10.1016/j.eururo.2007.01.028; Waldinger MD, 2006, J SEX MED, V3, P693, DOI 10.1111/j.1743-6109.2006.00276.x; Waldinger MD, 2008, J SEX MED, V5, P492, DOI 10.1111/j.1743-6109.2007.00696.x; Waldinger MD, 2007, DRUGS, V67, P547, DOI 10.2165/00003495-200767040-00005; Waldinger MD, 2005, J SEX MED, V2, P492, DOI 10.1111/j.1743-6109.2005.00070.x; Waldinger MD, 2005, J COMP NEUROL, V493, P46, DOI 10.1002/cne.20718	20	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77676	10.1371/journal.pone.0077676	http://dx.doi.org/10.1371/journal.pone.0077676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143254	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100093
J	Stevenson, JC; Stresman, GH; Gitonga, CW; Gillig, J; Owaga, C; Marube, E; Odongo, W; Okoth, A; China, P; Oriango, R; Brooker, SJ; Bousema, T; Drakeley, C; Cox, J				Stevenson, Jennifer C.; Stresman, Gillian H.; Gitonga, Caroline W.; Gillig, Jonathan; Owaga, Chrispin; Marube, Elizabeth; Odongo, Wycliffe; Okoth, Albert; China, Pauline; Oriango, Robin; Brooker, Simon J.; Bousema, Teun; Drakeley, Chris; Cox, Jonathan			Reliability of School Surveys in Estimating Geographic Variation in Malaria Transmission in the Western Kenyan Highlands	PLOS ONE			English	Article							HIGHER-RISK; AGE; SURVEILLANCE; PREVALENCE; ANTIBODIES; INTENSITY; EXPOSURE	Background: School surveys provide an operational approach to assess malaria transmission through parasite prevalence. There is limited evidence on the comparability of prevalence estimates obtained from school and community surveys carried out at the same locality. Methods: Concurrent school and community cross-sectional surveys were conducted in 46 school/community clusters in the western Kenyan highlands and households of school children were geolocated. Malaria was assessed by rapid diagnostic test (RDT) and combined seroprevalence of antibodies to bloodstage Plasmodium falciparum antigens. Results: RDT prevalence in school and community populations was 25.7% (95% CI: 24.4-26.8) and 15.5% (95% CI: 14.4-16.7), respectively. Seroprevalence in the school and community populations was 51.9% (95% CI: 50.5-53.3) and 51.5% (95% CI: 49.5-52.9), respectively. RDT prevalence in schools could differentiate between low (<7%, 95% CI: 0-19%) and high (>39%, 95% CI: 25-49%) transmission areas in the community and, after a simple adjustment, were concordant with the community estimates. Conclusions: Estimates of malaria prevalence from school surveys were consistently higher than those from community surveys and were strongly correlated. School-based estimates can be used as a reliable indicator of malaria transmission intensity in the wider community and may provide a basis for identifying priority areas for malaria control.	[Stevenson, Jennifer C.; Gitonga, Caroline W.; Brooker, Simon J.; Cox, Jonathan] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Stresman, Gillian H.; Bousema, Teun; Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Gitonga, Caroline W.; Brooker, Simon J.] Wellcome Trust Res Programme, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya; [Gillig, Jonathan] Univ Notre Dame, Eck Inst Global Hlth, South Bend, IN USA; [Owaga, Chrispin; Marube, Elizabeth; Odongo, Wycliffe; Okoth, Albert; China, Pauline; Oriango, Robin] Ctr Dis Control & Prevent, Kenya Med Res Inst, Ctr Global Hlth Res, Kisumu, Kenya; [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; University of Notre Dame; Kenya Medical Research Institute; Radboud University Nijmegen	Cox, J (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	jonathan.cox@lshtm.ac.uk	Bousema, Teun/N-3574-2014	Bousema, Teun/0000-0003-2666-094X; Stresman, Gillian/0000-0002-6897-5459	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [45114]; Wellcome trust [091924]; Commonwealth Ph.D. scholarship; Wellcome Trust Senior Fellowship in Basic Biomedical Science [098045]; Grant Challenge Grant by the Bill and Melinda Gates Foundation [OPP1024438]	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium; Wellcome trust(Wellcome TrustEuropean Commission); Commonwealth Ph.D. scholarship; Wellcome Trust Senior Fellowship in Basic Biomedical Science(Wellcome Trust); Grant Challenge Grant by the Bill and Melinda Gates Foundation	This work was supported by the Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [grant number 45114]. CD is supported by the Wellcome trust [grant number 091924], CWG is supported by a Commonwealth Ph.D. scholarship, and SJB is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science [grant number 098045]. TB is supported by a Grant Challenge Grant by the Bill and Melinda Gates Foundation [grant number OPP1024438]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Ashton RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-25; BEADLE C, 1995, J INFECT DIS, V172, P1047, DOI 10.1093/infdis/172.4.1047; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; BRADLEY EL, 1989, AM STAT, V43, P234, DOI 10.2307/2685368; Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Cox J, 2007, TRENDS PARASITOL, V23, P142, DOI 10.1016/j.pt.2007.02.002; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Gitonga CW, 2012, AM J TROP MED HYG, V87, P1004, DOI 10.4269/ajtmh.2012.12-0215; Gitonga CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-306; Governement of Kenya, 2006, KEN INT HOUS BUDG SU; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Guyatt HL, 1999, PARASITOLOGY, V118, P257, DOI 10.1017/S0031182098003862; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Icks A, 2012, WIEN KLIN WOCHENSCHR, V124, P391, DOI 10.1007/s00508-012-0188-z; Kendjo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058686; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lucas AM, 2012, J AFR ECON, V21, P691, DOI 10.1093/jae/ejs021; Ministry of Public Health and Sanitation, 2010, NAT GUID HIV TEST CO; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sexton CJ, 2012, AIDS RES HUM RETROV, V28, P866, DOI [10.1089/aid.2011.0221, 10.1089/AID.2011.0221]; Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4; Stuckey EM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-357; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	36	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77641	10.1371/journal.pone.0077641	http://dx.doi.org/10.1371/journal.pone.0077641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143250	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100089
J	Khattar, R; Luft, O; Yavorska, N; Shalev, I; Phillips, MJ; Adeyi, O; Gao, D; Bartczak, A; Urbanellis, P; Shyu, W; Zhang, JH; Manuel, J; Levy, GA; Selzner, N				Khattar, Ramzi; Luft, Olga; Yavorska, Nataliya; Shalev, Itay; Phillips, M. James; Adeyi, Oyedele; Gao, Darrin; Bartczak, Agata; Urbanellis, Peter; Shyu, Wendy; Zhang, Jianhua; Manuel, Justin; Levy, Gary A.; Selzner, Nazia			Targeted Deletion of FGL2 Leads to Increased Early Viral Replication and Enhanced Adaptive Immunity in a Murine Model of Acute Viral Hepatitis Caused by LCMV WE	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CYTOTOXIC T-CELLS; C-VIRUS; ANTIVIRAL THERAPY; PLUS RIBAVIRIN; INFECTION; MICE; EFFECTOR; PERSISTENCE; RESPONSES	Mounting effective innate and adaptive immune responses are critical for viral clearance and the generation of long lasting immunity. It is known that production of inhibitory factors may result in the inability of the host to clear viruses, resulting in chronic viral persistence. Fibrinogen-like protein 2 (FGL2) has been identified as a novel effector molecule of CD4(+)CD25(+) Foxp3(+) regulatory T (Treg) cells that inhibits immune activity by binding to FC gamma RIIB expressed primarily on antigen presenting cells (APC). In this study, we show that infection of mice with Lymphocytic Choriomeningitis Virus WE (LCMV WE) leads to increased plasma levels of FGL2, which were detected as early as 2 days post-infection (pi) and persisted until day 50 pi. Mice deficient in FGL2 (fgl2(-/-)) had increased viral titers of LCMV WE in the liver early p.i but cleared the virus by day 12 similar to wild type mice. Dendritic cells (DC) isolated from the spleens of LCMV WE infected fgl2(-/-) had increased expression of the DC maturation markers CD80 and MHC Class II compared to wild type (fgl2(+/+)). Frequencies of CD8(+) and CD4(+) T cells producing IFN gamma in response to ex vivo peptide re-stimulation isolated from the spleen and lymph nodes were also increased in LCMV WE infected fgl2(-/-) mice. Increased frequencies of CD8(+) T cells specific for LCMV tetramers GP(33) and NP396 were detected within the liver of fgl2(-/-) mice. Plasma from fgl2(-/-) mice contained higher titers of total and neutralizing anti-LCMV antibody. Enhanced anti-viral immunity in fgl2(-/-) mice was associated with increased levels of serum alanine transaminase (ALT), hepatic necrosis and inflammation following LCMV WE infection. These data demonstrate that targeting FGL2 leads to early increased viral replication but enhanced anti-viral adaptive T & B cell responses. Targeting FGL2 may enhance the efficacy of current anti-viral therapies for hepatotropic viruses.	[Khattar, Ramzi; Luft, Olga; Yavorska, Nataliya; Shalev, Itay; Phillips, M. James; Adeyi, Oyedele; Gao, Darrin; Bartczak, Agata; Urbanellis, Peter; Shyu, Wendy; Zhang, Jianhua; Manuel, Justin; Levy, Gary A.; Selzner, Nazia] Univ Toronto, Inst Transplantat, Toronto, ON, Canada	University of Toronto	Selzner, N (corresponding author), Univ Toronto, Inst Transplantat, Toronto, ON, Canada.	nazia.selzner@uhn.ca	Selzner, Nazia/AAI-1469-2020	Selzner, Nazia/0000-0002-9435-2597; Adeyi, Oyedele/0000-0003-4272-1095				AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; ALTHAGE A, 1992, EUR J IMMUNOL, V22, P1803, DOI 10.1002/eji.1830220720; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; BATTEGAY M, 1993, J IMMUNOL, V151, P5408; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Burton JR, 2008, J HEPATOL, V49, P329, DOI 10.1016/j.jhep.2008.05.020; Chen WJ, 2006, CLIN INFECT DIS, V42, P1561, DOI 10.1086/503843; Ciurea A, 1999, P NATL ACAD SCI USA, V96, P11964, DOI 10.1073/pnas.96.21.11964; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Foerster K, 2010, J HEPATOL, V53, P608, DOI 10.1016/j.jhep.2010.04.020; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fried M, 2002, AM POETRY REV, V31, P36; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Lang PA, 2010, HEPATOLOGY, V52, P25, DOI 10.1002/hep.23640; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Muth S, 2012, P NATL ACAD SCI USA, V109, P9059, DOI 10.1073/pnas.1110620109; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; ROOST H, 1988, EUR J IMMUNOL, V18, P511, DOI 10.1002/eji.1830180404; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Shalev I, 2009, HEPATOLOGY, V49, P387, DOI 10.1002/hep.22684; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Takimoto K, 2008, EXP ANIM TOKYO, V57, P357, DOI 10.1538/expanim.57.357; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Zhu CL, 2006, HUM GENE THER, V17, P589, DOI 10.1089/hum.2006.17.589; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e72309	10.1371/journal.pone.0072309	http://dx.doi.org/10.1371/journal.pone.0072309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146739	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400001
J	Woolnough, CA; Yee, LH; Charlton, TS; Foster, LJR				Woolnough, Catherine Anne; Yee, Lachlan Hartley; Charlton, Timothy Stuart; Foster, Leslie John Ray			A Tuneable Switch for Controlling Environmental Degradation of Bioplastics: Addition of Isothiazolinone to Polyhydroxyalkanoates	PLOS ONE			English	Article							POLYMER DEGRADATION; BIODEGRADATION; FILMS; POLY(3-HYDROXYBUTYRATE); PLASTICS; COPPER; SC	Controlling the environmental degradation of polyhydroxybutyrate (PHB) and polyhydroxyvalerate (P(HB-co-HV)) bioplastics would expand the range of their potential applications. Combining PHB and P(HB-co-HV) films with the anti-fouling agent 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOI, <10% w/w) restricted microbial colonisation in soil, but did not significantly affect melting temperature or the tensile strength of films. DCOI films showed reduced biofouling and postponed the onset of weight loss by up to 100 days, a 10-fold increase compared to unmodified films where the microbial coverage was significant. In addition, the rate of PHA-DCOI weight loss, post-onset, reduced by about 150%; in contrast a recorded weight loss of only 0.05% per day for P(HB-co-HV) with a 10% DCOI loading was observed. This is in stark contrast to the unmodified PHB film, where a recorded weight loss of only 0.75% per day was made. The 'switch' that initiates film weight loss, and its subsequent reduced rate, depended on the DCOI loading to control biofouling. The control of biofouling and environmental degradation for these DCOI modified bioplastics increases their potential use in biodegradable applications.	[Woolnough, Catherine Anne; Foster, Leslie John Ray] Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia; [Woolnough, Catherine Anne; Foster, Leslie John Ray] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Sydney, NSW, Australia; [Yee, Lachlan Hartley] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Charlton, Timothy Stuart] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Southern Cross University; University of New South Wales Sydney	Yee, LH (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia.	Lachlan.yee@scu.edu.au	Yee, Lachlan H./B-6856-2008	Yee, Lachlan H./0000-0002-7258-2076; Foster, Leslie John Ray/0000-0001-5728-4479	Environmental Biotechnology Cooperative Research Centre, Australia; Australian Postgraduate Award; University of NSW Faculty	Environmental Biotechnology Cooperative Research Centre, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Postgraduate Award(Australian Government); University of NSW Faculty	An Australian Postgraduate Award supported Dr Woolnough and a University of NSW Faculty Grant to Associate Professor Foster. Dr Yee was supported by a postdoctoral fellowship from the Environmental Biotechnology Cooperative Research Centre, Australia. Glenda Scibilia provided librarian and editorial support for this study. Professors G. George and J. Vanclay provided academic discussion on the manuscript.	Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P1379, DOI 10.1163/156856205774472308; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chinga G, 2004, J PULP PAP SCI, V30, P307; Chinga G, 2007, J MICROSC-OXFORD, V227, P254, DOI 10.1111/j.1365-2818.2007.01809.x; DOI Y, 1992, POLYM DEGRAD STABIL, V36, P173, DOI 10.1016/0141-3910(92)90154-W; Foster LJR, 2006, BIOMACROMOLECULES, V7, P1344, DOI 10.1021/bm050969l; Funhoff AM, 2004, PHARM RES-DORDR, V21, P170, DOI 10.1023/B:PHAM.0000012165.68765.e6; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; Gravenmier JJ, 2005, ENVIRON TOXICOL, V20, P150, DOI 10.1002/tox.20089; Ishigaki T, 2004, CHEMOSPHERE, V54, P225, DOI 10.1016/S0045-6535(03)00750-1; JACOBSON A, 1993, ACS SYM SER, V522, P138; Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1; KUNIOKA M, 1989, APPL MICROBIOL BIOT, V30, P569, DOI 10.1007/BF00255361; LEONG K, 2002, PHOSPHATE BASED BIOD; Li X, 2005, BIOMACROMOLECULES, V6, P2740, DOI 10.1021/bm050234g; Li Z, 2004, MACROMOL BIOSCI, V4, P699, DOI 10.1002/mabi.200400009; Lu DD, 2008, EUR POLYM J, V44, P2140, DOI 10.1016/j.eurpolymj.2008.04.014; MERGAERT J, 1993, APPL ENVIRON MICROB, V59, P3233, DOI 10.1128/AEM.59.10.3233-3238.1993; Modelli A, 1999, J ENVIRON POLYM DEGR, V7, P109, DOI 10.1023/A:1021864402395; Nagai N, 2005, POLYM DEGRAD STABIL, V88, P224, DOI 10.1016/j.polymdegradstab.2004.11.001; Rasmussen K, 2010, ACS APPL MATER INTER, V2, P1879, DOI 10.1021/am100219z; Roberts DA, 2006, ENVIRON TOXICOL CHEM, V25, P2470, DOI 10.1897/05-661R.1; Sakkas VA, 2002, J CHROMATOGR A, V959, P215, DOI 10.1016/S0021-9673(02)00430-2; SCANDOLA M, 1992, MACROMOLECULES, V25, P6441, DOI 10.1021/ma00050a009; SEPPALA J, 2009, NOVEL BIODEGRADABLE, P76943; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Steen RJCA, 2004, CHEMOSPHERE, V57, P513, DOI 10.1016/j.chemosphere.2004.06.043; Thouvenin M, 2003, BIOFOULING, V19, P177, DOI 10.1080/08927014.2003.10382980; WILLINGHAM GL, 1993, P 3 AS PAC C PAINT R; Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444; Woolnough CA, 2010, POLYM INT, V59, P658, DOI 10.1002/pi.2746; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001	33	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75817	10.1371/journal.pone.0075817	http://dx.doi.org/10.1371/journal.pone.0075817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146779	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400021
J	Dalisay, DS; Williams, DE; Wang, XL; Centko, R; Chen, J; Andersen, RJ				Dalisay, Doralyn S.; Williams, David E.; Wang, Xiao Ling; Centko, Ryan; Chen, Jessie; Andersen, Raymond J.			Marine Sediment-Derived Streptomyces Bacteria from British Columbia, Canada Are a Promising Microbiota Resource for the Discovery of Antimicrobial Natural Products	PLOS ONE			English	Article							DNA GYRASE; ANTITUMOR-ACTIVITY; DRUG DEVELOPMENT; NOVOBIOCIN; ANTIMYCIN; INHIBITORS; BINDING; HSP90; MICROMONOSPORA; MICROORGANISMS	Representatives of the genus Streptomyces from terrestrial sources have been the focus of intensive research for the last four decades because of their prolific production of chemically diverse and biologically important compounds. However, metabolite research from this ecological niche had declined significantly in the past years because of the rediscovery of the same bioactive compounds and redundancy of the sample strains. More recently, a new picture has begun to emerge in which marine-derived Streptomyces bacteria have become the latest hot spot as new source for unique and biologically active compounds. Here, we investigated the marine sediments collected in the temperate cold waters from British Columbia, Canada as a valuable source for new groups of marine-derived Streptomyces with antimicrobial activities. We performed culture dependent isolation from 49 marine sediments samples and obtained 186 Streptomyces isolates, 47 of which exhibited antimicrobial activities. Phylogenetic analyses of the active isolates resulted in the identification of four different clusters of bioactive Streptomyces including a cluster with isolates that appear to represent novel species. Moreover, we explored whether these marine-derived Streptomyces produce new secondary metabolites with antimicrobial properties. Chemical analyses revealed structurally diverse secondary metabolites, including four new antibacterial novobiocin analogues. We conducted structure-activity relationships (SAR) studies of these novobiocin analogues against methicillin-resistant Staphylococcus aureus (MRSA). In this study, we revealed the importance of carbamoyl and OMe moieties at positions 3 '' and 4 '' of novobiose as well as the hydrogen substituent at position 5 of hydroxybenzoate ring for the anti-MRSA activity. Changes in the substituents at these positions dramatically impede or completely eliminate the inhibitory activity of novobiocins against MRSA.	[Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Andersen, RJ (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	raymond.andersen@ubc.ca	Dalisay, Doralyn S/I-7558-2016	Dalisay, Doralyn/0000-0003-2850-7797	National Cancer Institute-National Cooperative Drug Discovery Group [CA 67786]; NATIONAL CANCER INSTITUTE [U19CA067786] Funding Source: NIH RePORTER	National Cancer Institute-National Cooperative Drug Discovery Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute-National Cooperative Drug Discovery Group grant CA 67786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDI SL, 1988, J CHROMATOGR, V447, P65, DOI 10.1016/S0021-9673(01)91457-8; ALEXANDRE A, 1984, BIOCHIM BIOPHYS ACTA, V767, P120, DOI 10.1016/0005-2728(84)90086-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARCAMONE F. M., 1959, GIORN MICROBIOL, V7, P207; Baz JP, 1997, J ANTIBIOT, V50, P738, DOI 10.7164/antibiotics.50.738; BERGER J, 1951, J AM CHEM SOC, V73, P5295, DOI 10.1021/ja01155a084; Bernan VS, 1997, ADV APPL MICROBIOL, V43, P57, DOI 10.1016/S0065-2164(08)70223-5; Blunt JW, 2012, NAT PROD REP, V29, P144, DOI 10.1039/c2np00090c; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Calfee DP, 2012, CURR OPIN INFECT DIS, V25, P385, DOI 10.1097/QCO.0b013e3283553441; Charan RD, 2004, J NAT PROD, V67, P1431, DOI 10.1021/np040042r; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Cho KW, 2001, J NAT PROD, V64, P664, DOI 10.1021/np000599g; Crow FW, 1999, J HETEROCYCLIC CHEM, V36, P365, DOI 10.1002/jhet.5570360206; Egan S, 2001, ANTON LEEUW INT J G, V79, P127, DOI 10.1023/A:1010296220929; Erba E, 1999, BRIT J CANCER, V80, P971, DOI 10.1038/sj.bjc.6690451; Feldgarden M, 2003, MICROBIOL-SGM, V149, P3565, DOI 10.1099/mic.0.26457-0; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Fenical W, 2009, BIOORGAN MED CHEM, V17, P2175, DOI 10.1016/j.bmc.2008.10.075; FIEDLER HP, 1981, J ANTIBIOT, V34, P1107, DOI 10.7164/antibiotics.34.1107; Flatman RH, 2006, ANTIMICROB AGENTS CH, V50, P1136, DOI 10.1128/AAC.50.4.1136-1142.2006; Gourdeau H, 2008, CANCER CHEMOTH PHARM, V61, P911, DOI 10.1007/s00280-007-0544-2; GRIMMELIKHUIJZEN CJP, 1975, BIOCHIM BIOPHYS ACTA, V376, P533, DOI 10.1016/0005-2728(75)90173-5; Gulder TAM, 2010, ANGEW CHEM INT EDIT, V49, P9346, DOI 10.1002/anie.201000728; HARNED RL, 1951, ANTIBIOT CHEMOTHER, V1, P594; HAROLD FM, 1968, J BACTERIOL, V95, P816, DOI 10.1128/JB.95.3.816-823.1968; Heide L, 2009, NAT PROD REP, V26, P1241, DOI 10.1039/b808333a; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; Imhoff JF, 2011, BIOTECHNOL ADV, V29, P468, DOI 10.1016/j.biotechadv.2011.03.001; Jabes D, 2011, CURR OPIN MICROBIOL, V14, P564, DOI 10.1016/j.mib.2011.08.002; JUKES T H, 1969, P21; Kataoka M, 1997, FEMS MICROBIOL LETT, V151, P249, DOI 10.1016/S0378-1097(97)00169-9; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KLUEPFEL D, 1970, J ANTIBIOT, V23, P75, DOI 10.7164/antibiotics.23.75; Laatsch H, 2007, ANTIBASE 2007 SCIDEX; Lafitte D, 2002, BIOCHEMISTRY-US, V41, P7217, DOI 10.1021/bi0159837; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Meyers CLF, 2004, ANGEW CHEM INT EDIT, V43, P67, DOI 10.1002/anie.200352626; Meyers CLF, 2003, BIOCHEMISTRY-US, V42, P4179, DOI 10.1021/bi0340088; Mincer TJ, 2005, APPL ENVIRON MICROB, V71, P7019, DOI 10.1128/AEM.71.11.7019-7028.2005; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Mukku VJRV, 2000, J NAT PROD, V63, P1570, DOI 10.1021/np0001676; NAKAYAMA K, 1956, J ANTIBIOT, V9, P63; Pathom-aree W, 2006, EXTREMOPHILES, V10, P181, DOI 10.1007/s00792-005-0482-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHUNK CH, 1956, J AM CHEM SOC, V78, P1770, DOI 10.1021/ja01589a084; Strohl WR, 1997, BIOTECHNOLOGY ANTIBI, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOSHIMA K, 1986, TETRAHEDRON LETT, V27, P4741, DOI 10.1016/S0040-4039(00)85053-4; Westley JW, 1983, POLYETHER ANTIBIOTIC; Williams DE, 2013, ORG LETT, V15, P414, DOI 10.1021/ol303416k; Williams DE, 2011, ORG LETT, V13, P3936, DOI 10.1021/ol2014494; Yu XM, 2005, J AM CHEM SOC, V127, P12778, DOI 10.1021/ja0535864; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158; Zotchev SB, 2012, J BIOTECHNOL, V158, P168, DOI 10.1016/j.jbiotec.2011.06.002	64	45	49	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77078	10.1371/journal.pone.0077078	http://dx.doi.org/10.1371/journal.pone.0077078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130838	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200055
J	Dorrian, H; Borresen, J; Amos, M				Dorrian, Henry; Borresen, Jon; Amos, Martyn			Community Structure and Multi-Modal Oscillations in Complex Networks	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; KURAMOTO MODEL; CHIMERA STATES; SYNCHRONIZATION; DYNAMICS; MODULARITY; SYSTEMS; POPULATIONS; STABILITY	In many types of network, the relationship between structure and function is of great significance. We are particularly interested in community structures, which arise in a wide variety of domains. We apply a simple oscillator model to networks with community structures and show that waves of regular oscillation are caused by synchronised clusters of nodes. Moreover, we show that such global oscillations may arise as a direct result of network topology. We also observe that additional modes of oscillation (as detected through frequency analysis) occur in networks with additional levels of topological hierarchy and that such modes may be directly related to network structure. We apply the method in two specific domains (metabolic networks and metropolitan transport) demonstrating the robustness of our results when applied to real world systems. We conclude that (where the distribution of oscillator frequencies and the interactions between them are known to be unimodal) our observations may be applicable to the detection of underlying community structure in networks, shedding further light on the general relationship between structure and function in complex systems.	[Dorrian, Henry; Borresen, Jon; Amos, Martyn] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester M15 6BH, Lancs, England	Manchester Metropolitan University	Borresen, J (corresponding author), Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester M15 6BH, Lancs, England.	J.Borresen@mmu.ac.uk		Amos, Martyn/0000-0003-1680-5535	Dalton Research Institute	Dalton Research Institute	HD is supported by the Dalton Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.084103; Abrams DM, 2006, INT J BIFURCAT CHAOS, V16, P21, DOI 10.1142/S0218127406014551; Abrams DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.174102; Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Acebron JA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016218; Acebron JA, 1998, PHYS REV E, V57; Aldecoa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024195; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Ashwin P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026203; Ashwin P, 2005, PHYS LETT A, V347, P208, DOI 10.1016/j.physleta.2005.08.013; Ashwin P, 2010, UNDERST COMPLEX SYST, P31, DOI 10.1007/978-3-642-04629-2_3; Assenza S, 2011, SCI REPORTS, P1; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Boccaletti S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045102; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Bryden J, 2011, J R SOC INTERFACE, V8, P1031, DOI 10.1098/rsif.2010.0524; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; COLLINS JJ, 1993, BIOL CYBERN, V68, P287, DOI 10.1007/BF00201854; Dai Dai HH, 2011, VISUALCONNECTOME TOO; Dorfler F, 2012, SIAM J CONTROL OPTIM, V50, P1616, DOI 10.1137/110851584; ENRIGHT JT, 1980, SCIENCE, V209, P1542, DOI 10.1126/science.7433976; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gulbahce N, 2008, BIOESSAYS, V30, P934, DOI 10.1002/bies.20820; Hanhijarvi S, 2013, RANDOMIZATION TECHNI; HONERKAMP J, 1983, J MATH BIOL, V18, P69, DOI 10.1007/BF00275911; Hong H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054102; Hu C, 2010, PHYS LETT A; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ioannides AA, 2007, CURR OPIN NEUROBIOL, V17, P161, DOI 10.1016/j.conb.2007.03.008; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KURAMOTO Y, 1987, J STAT PHYS, V49, P569, DOI 10.1007/BF01009349; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Laing CR, 2009, PHYSICA D, V238, P1569, DOI 10.1016/j.physd.2009.04.012; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lehnertz K, 2009, J NEUROSCI METH, V183, P42, DOI 10.1016/j.jneumeth.2009.05.015; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lin YC, 2010, COMPUT CHEM ENG, V34, P821, DOI 10.1016/j.compchemeng.2009.12.004; Litvin O, 2009, P NATL ACAD SCI USA, V106, P6441, DOI 10.1073/pnas.0810208106; Lou X, 2011, CHAOS, V21; McGraw PN, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.015101; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Mirollo R, 2007, J NONLINEAR SCI, V17, P309, DOI 10.1007/s00332-006-0806-x; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Montbrio E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056125; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz S.H., 2003, SYNC EMERGING SCI SP; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Tangmunarunkit H, 2002, ACM SIGCOMM COMP COM, V32, P147, DOI 10.1145/964725.633040; Trusina A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178702; Wang XH, 2009, PHYSICA A, V388, P2975, DOI 10.1016/j.physa.2009.03.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	63	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75569	10.1371/journal.pone.0075569	http://dx.doi.org/10.1371/journal.pone.0075569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130720	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325814200016
J	Haddad, M; Walters, P; Phillips, R; Tsakok, J; Williams, P; Mann, A; Tylee, A				Haddad, Mark; Walters, Paul; Phillips, Rachel; Tsakok, Jacqueline; Williams, Paul; Mann, Anthony; Tylee, Andre			Detecting Depression in Patients with Coronary Heart Disease: a Diagnostic Evaluation of the PHQ-9 and HADS-D in Primary Care, Findings From the UPBEAT-UK Study	PLOS ONE			English	Article							HOSPITAL ANXIETY; MAJOR DEPRESSION; HEALTH QUESTIONNAIRE; GENERAL-PRACTICE; ARTERY-DISEASE; PREVALENCE; DISORDERS; SEVERITY; VALIDITY; ASSOCIATION	Objective: People with coronary heart disease (CHD) are at heightened risk of depression, and this co-occurrence of conditions is associated with poorer outcomes including raised mortality. This study compares the diagnostic accuracy of two depression case finding instruments in CHD patients relative to a diagnostic standard, the revised Clinical Interview Schedule (CIS-R). Methods: The Patient Health Questionnaire (PHQ-9), the Hospital Anxiety and Depression Scale depression subscale (HADS-D) and the CIS-R depression module were administered to 803 patients identified from the CHD registers of GP practices in Greater London. Results: Of 730 recruited patients without previously identified depression, 32 (4.4%) met ICD-10 depressive episode criteria according to the CIS-R. For the PHQ-9 and HADS-D lower cut-points than those routinely recommended were associated with improved case identifying properties. The PHQ-9 appeared the superior instrument using a cut-point of >= 8 (sensitivity=94%; specificity=84%). Using categorical scoring the PHQ-9 was 59% sensitive and 95% specific. For the HADS-D using cut-point >= 5, sensitivity was 81% and specificity was 77%. Areas under the curves (AUC) (standard error) were 0.95 (0.01) and 0.88 (0.02) for the PHQ-9 and HADS-D, and 0.91 (0.02) for PHQ-9 using the categorical algorithm. Statistically significant differences between AUCs of the PHQ-9 and the HADS-D favoured the former. Severity ratings compared across measures indicated inconsistency between recommended bandings: the PHQ-9 categorised a larger proportion of participants with mild and moderate depression. Conclusion: This is the first large-scale investigation of the accuracy of these commonly used measures within a primary care CHD population. Our results suggest that although both scales have acceptable abilities and can be used as case identification instruments for depression in patients with CHD, the PHQ-9 appeared diagnostically superior. Importantly, optimal cut-off points for depression identification in this population appear to differ from standard values, and severity ratings differ between these measures.	[Haddad, Mark] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Walters, Paul; Phillips, Rachel; Tsakok, Jacqueline; Williams, Paul; Mann, Anthony; Tylee, Andre] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England	City University London; University of London; King's College London	Tylee, A (corresponding author), Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England.	andre.tylee@kcl.ac.uk	Haddad, Mark/A-9866-2011; Williams, Paul/C-8914-2013	Haddad, Mark/0000-0002-4822-5482; Williams, Paul/0000-0001-6259-0390; Phillips, Rachel/0000-0002-3634-7845	National Institute for Health Research (NIHR) [RPPG-0606-1048]; National Institute for Health Research [RP-PG-0606-1048, MET-08-08-101] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This protocol presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RPPG-0606-1048). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Barth Jurgen, 2005, Health Qual Life Outcomes, V3, P15, DOI 10.1186/1477-7525-3-15; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blumenthal JA, 2001, AM J CARDIOL, V88, P316; Brugha T, 2009, ADULT PSYCHIAT MORBI; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Egede LE, 2007, J GEN INTERN MED, V22, P701, DOI 10.1007/s11606-007-0170-z; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Hasnain M, 2011, J PSYCHOSOM RES, V71, P6, DOI 10.1016/j.jpsychores.2010.10.009; Jordanova V, 2004, PSYCHOL MED, V34, P1013, DOI 10.1017/S0033291703001727; Kendrick T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b750; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; *MACARTHUR FDN, 2004, MACARTHUR IN DEPR PR; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Menchetti M, 2009, J PSYCHOSOM RES, V66, P335, DOI 10.1016/j.jpsychores.2008.10.008; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; *NICE, 2009, NICE NAT CLIN PRACT; *NICE, 2009, NICE NAT CLIN PRACT, V90; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Rost K, 2000, ARCH FAM MED, V9, P150, DOI 10.1001/archfami.9.2.150; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Rutledge T, 2013, PSYCHOSOM MED, V75, P335, DOI 10.1097/PSY.0b013e318291d798; Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stafford L, 2007, GEN HOSP PSYCHIAT, V29, P417, DOI 10.1016/j.genhosppsych.2007.06.005; Strik JJMH, 2001, PSYCHOSOMATICS, V42, P423, DOI 10.1176/appi.psy.42.5.423; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; Thombs BD, 2008, J GEN INTERN MED, V23, P2014, DOI 10.1007/s11606-008-0802-y; Townsend N, 2012, CORONARY HEART DIS S; Tylee A, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-38; U.S. Preventive Services Task Force, 2009, SCREEN DEPR AD REC S; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; WILKINSON MJB, 1988, J ROY COLL GEN PRACT, V38, P311; Wittkampf K, 2009, GEN HOSP PSYCHIAT, V31, P451, DOI 10.1016/j.genhosppsych.2009.06.001; World Health Organization, 2008, GLOBAL BURDEN DIS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	65	65	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78493	10.1371/journal.pone.0078493	http://dx.doi.org/10.1371/journal.pone.0078493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130903	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000325814200099
J	Ren, HB; Condit, R; Chen, B; Mi, XC; Cao, M; Ye, WH; Hao, ZQ; Ma, KP				Ren, Haibao; Condit, Richard; Chen, Bin; Mi, Xiangcheng; Cao, Min; Ye, Wanhui; Hao, Zhanqing; Ma, Keping			Geographical Range and Local Abundance of Tree Species in China	PLOS ONE			English	Article							SIZE RELATIONSHIPS; OCCUPANCY RELATIONSHIPS; SPATIAL VARIATION; BRITISH AVIFAUNA; LIFE-HISTORY; FOREST PLOT; PATTERNS; DISTRIBUTIONS; COMMUNITY; CONSERVATION	Most studies on the geographical distribution of species have utilized a few well-known taxa in Europe and North America, with little research in China and its wide range of climate and forest types. We assembled large datasets to quantify the geographic ranges of tree species in China and to test several biogeographic hypotheses: 1) whether locally abundant species tend to be geographically widespread; 2) whether species are more abundant towards their range-centers; and 3) how abundances are correlated between sites. Local abundances of 651 species were derived from four tree plots of 2025 ha where all individuals >= 1 cm in stem diameter were mapped and identified taxonomically. Range sizes of these species across China were then estimated from over 460,000 geo-referenced records; a Bayesian approach was used, allowing careful measures of error of each range estimate. The log-transformed range sizes had a bell-shaped distribution with a median of 703,000 km(2), and >90% of 651 species had ranges. 10(5) km(2). There was no relationship between local abundance and range size, and no evidence for species being more abundant towards their range-centers. Finally, species' abundances were positively correlated between sites. The widespread nature of most tree species in China suggests few are vulnerable to global extinction, and there is no indication of the double-peril that would result if rare species also had narrow ranges.	[Ren, Haibao; Chen, Bin; Mi, Xiangcheng; Ma, Keping] Chinese Acad Sci, Inst Bot, Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Condit, Richard] Smithsonian Trop Res Inst, Panama City, Panama; [Cao, Min] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Ye, Wanhui] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Hao, Zhanqing] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Smithsonian Institution; Smithsonian Tropical Research Institute; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Ma, KP (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn			NSFC Project [30670311]; China National Program for R & D Infrastructure and Facility Development [2008BAC39B02]; CTFS-SiGEO workshop series; NSF [DEB-1046113]; Direct For Biological Sciences [1354741] Funding Source: National Science Foundation	NSFC Project(National Natural Science Foundation of China (NSFC)); China National Program for R & D Infrastructure and Facility Development; CTFS-SiGEO workshop series; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by NSFC Project (30670311), China National Program for R & D Infrastructure and Facility Development (2008BAC39B02), and the CTFS-SiGEO workshop series, funded by NSF Award DEB-1046113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ADV ECOL RES; [Anonymous], 2013, ADEHABITATHR HOME RA; Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Blackburn TM, 1997, ECOGRAPHY, V20, P466, DOI 10.1111/j.1600-0587.1997.tb00414.x; Blackburn TM, 1998, ECOL LETT, V1, P47, DOI 10.1046/j.1461-0248.1998.00005.x; Blackburn TM, 2004, J BIOGEOGR, V31, P285, DOI 10.1046/j.0305-0270.2003.01018.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Condit R, 2001, BIOSCIENCE, V51, P389, DOI 10.1641/0006-3568(2001)051[0389:TSOTPC]2.0.CO;2; Condit R, 1998, TROPICAL FOREST CENS; Etherington TR, 2009, J BIOGEOGR, V36, P845, DOI 10.1111/j.1365-2699.2008.02041.x; Frost MT, 2004, ECOGRAPHY, V27, P643; Garcia-Barros E, 2010, ECOGRAPHY, V33, P392, DOI 10.1111/j.1600-0587.2010.06269.x; Gaston K.J., 1994, RARITY, P1; Gaston KJ, 1998, ECOL LETT, V1, P38, DOI 10.1046/j.1461-0248.1998.00004.x; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gaston KJ, 1997, ECOGRAPHY, V20, P569, DOI 10.1111/j.1600-0587.1997.tb00425.x; GASTON KJ, 1990, OIKOS, V58, P329, DOI 10.2307/3545224; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Gaston KJ, 1998, NATURE, V394, P229, DOI 10.1038/28288; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gaston KJ, 1996, J ANIM ECOL, V65, P701, DOI 10.2307/5669; Hao Zhan-Qing, 2008, Zhiwu Shengtai Xuebao, V32, P238, DOI 10.3773/j.issn.1005-264x.2008.02.002; HENGEVELD R, 1993, PROG PHYS GEOG, V17, P448, DOI 10.1177/030913339301700403; HENGEVELD R, 1982, J BIOGEOGR, V9, P303, DOI 10.2307/2844717; Hubbell Stephen P., 2001, V32, pi; Kenfack D, 2007, BIODIVERS CONSERV, V16, P2045, DOI 10.1007/s10531-006-9065-2; Kockemann B, 2009, J BIOGEOGR, V36, P854, DOI 10.1111/j.1365-2699.2008.02022.x; Kotze DJ, 2003, ECOGRAPHY, V26, P553, DOI 10.1034/j.1600-0587.2003.03488.x; Lan Guo-Yu, 2008, Zhiwu Shengtai Xuebao, V32, P287, DOI 10.3773/j.issn.1005-264x.2008.02.006; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Li Xi-Wen, 1994, Acta Botanica Yunnanica, V16, P221; Maurer BA, 1999, UNTANGLING ECOLOGICA; McGeoch MA, 2004, J ANIM ECOL, V73, P506, DOI 10.1111/j.0021-8790.2004.00825.x; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; Murphy HT, 2006, GLOBAL ECOL BIOGEOGR, V15, P63, DOI 10.1111/j.1466-822x.2006.00194.x; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Poulin R, 2007, ECOGRAPHY, V30, P629, DOI 10.1111/j.2007.0906-7590.05139.x; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; R Core Team, 2012, R LANG ENV STAT COMP; Reif J, 2006, J BIOGEOGR, V33, P1959, DOI 10.1111/j.1365-2699.2006.01547.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Samis KE, 2007, ECOLOGY, V88, P1747, DOI 10.1890/06-1153.1; SPITZER K, 1988, OIKOS, V53, P31, DOI 10.2307/3565659; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stevens RD, 2004, J MAMMAL, V85, P698, DOI 10.1644/BWG-128; Stevenson MD, 2012, ECOGRAPHY, V35, P704, DOI 10.1111/j.1600-0587.2011.07292.x; Symonds MRE, 2006, GLOBAL ECOL BIOGEOGR, V15, P143, DOI 10.1111/j.1466-822x.2005.00198.x; Warren M, 2010, ECOGRAPHY, V33, P148, DOI 10.1111/j.1600-0587.2009.06041.x; Williams JN, 2010, J BIOGEOGR, V37, P951, DOI 10.1111/j.1365-2699.2009.02248.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wu Z.Y., 1994, FLORA CHINA; Yang YM, 2004, BIODIVERS CONSERV, V13, P813, DOI 10.1023/B:BIOC.0000011728.46362.3c; Ye Wan-Hui, 2008, Zhiwu Shengtai Xuebao, V32, P274, DOI 10.3773/j.issn.1005-264x.2008.02.005	59	12	12	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76374	10.1371/journal.pone.0076374	http://dx.doi.org/10.1371/journal.pone.0076374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130772	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200037
J	Bautista-Lozada, A; Espinosa-Garcia, FJ				Bautista-Lozada, Alicia; Javier Espinosa-Garcia, Francisco			Odor Uniformity among Tomato Individuals in Response to Herbivore Depends on Insect Species	PLOS ONE			English	Article							JASMONATE; PLANTS; PHENOTYPES; VOLATILES; EVOLUTION; DEFENSES; ECOLOGY	Plants produce specific volatile organic compound (VOC) blends in response to herbivory. Herbivore-induced blends may prime the plant for future attack or attract carnivorous insects; these responses have been considered adaptive for plants. If herbivores differentially modify the VOC emission among individuals within a group of plants they feed upon, then plant responses to herbivores will not only produce specific blends but also variation in odor among individuals, i.e. individuals smell the same, then having a uniform odor. We investigated the VOC emission variation or uniformity among tomato individuals (Solanum lycopersicum L. cv. Castlemart) in response to moderate wounding by (1) nymphs of the psyllid Bactericera cockerelli (Sulc.) (TP); (2) Lepidoptera chewing-feeding larvae of Fall Armyworm (Spodoptera frugiperda Smith) (FAW) and (3) of Cabbage Looper (Trichoplusia ni Hubner) (CL), and (4) mechanical damage (MD). We used a ratio-based analysis to compare the fold-change in concentration from constitutive to induced VOC emission. We also used size and shape analysis to compare the emission of damaged and non-damaged individuals. Aside of finding herbivore-specific blends in line with other studies, we found patterns not described previously. We detected constitutive and induced odor variation among individuals attacked by the same herbivore, with the induced odor uniformity depending on the herbivore identity. We also showed that the fold-change of VOCs from constitutive to induced state differed among individuals independently of the uniformity of the blends before herbivore attack. We discuss our findings in the context of the ecological roles of VOCs in plant-plant and plant-carnivore insects' interactions.	[Bautista-Lozada, Alicia] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Bautista-Lozada, Alicia; Javier Espinosa-Garcia, Francisco] Univ Nacl Autonoma Mexico, Lab Ecol Quim, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Espinosa-Garcia, FJ (corresponding author), Univ Nacl Autonoma Mexico, Lab Ecol Quim, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	espinosa@cieco.unam.mx	Espinosa-García, F. J./B-4040-2016	Espinosa-García, F. J./0000-0001-9173-1957	Universidad Nacional Autonoma de Mexico [UNAM-PAPIIT IN227607]	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This study was supported by Universidad Nacional Autonoma de Mexico by the grant UNAM-PAPIIT IN227607 given to FJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Cooper WR, 2005, ENTOMOL EXP APPL, V115, P107, DOI 10.1111/j.1570-7458.2005.00289.x; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Gols R, 2007, BASIC APPL ECOL, V8, P421, DOI 10.1016/j.baae.2006.09.005; Heil M, 2012, PLANT SIGNAL BEHAV, V7, P576, DOI 10.4161/psb.19921; Heil M, 2010, BIOL LETTERS, V6, P843, DOI 10.1098/rsbl.2010.0440; Heil M, 2010, EVOL ECOL, V24, P555, DOI 10.1007/s10682-009-9348-7; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Janssen A, 2002, OIKOS, V97, P134, DOI 10.1034/j.1600-0706.2002.970114.x; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Miresmailli S, 2012, PEST MANAG SCI, V68, P101, DOI 10.1002/ps.2229; Morris WF, 2006, OIKOS, V112, P102, DOI 10.1111/j.0030-1299.2006.14253.x; Raghava T, 2010, PLANT SCI, V179, P520, DOI 10.1016/j.plantsci.2010.07.020; Rodriguez-Saona C, 2005, OECOLOGIA, V143, P566, DOI 10.1007/s00442-005-0006-7; Rodriguez-Saona CR, 2010, J CHEM ECOL, V36, P1043, DOI 10.1007/s10886-010-9854-7; Sanchez-Hernandez C, 2006, PLANT CELL ENVIRON, V29, P546, DOI 10.1111/j.1365-3040.2005.01431.x; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; SHOREY HH, 1963, J ECON ENTOMOL, V56, P536, DOI 10.1093/jee/56.4.536a; Stout MJ, 1998, OECOLOGIA, V113, P74, DOI 10.1007/s004420050355; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Torres-Gurrola G, 2011, BIOCHEM SYST ECOL, V39, P102, DOI 10.1016/j.bse.2011.01.011; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; Viswanathan DV, 2008, ECOL ENTOMOL, V33, P86, DOI 10.1111/j.1365-2311.2007.00943.x; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Yarnes CT, 2006, CAN J BOT, V84, P1233, DOI 10.1139/B06-076	31	11	11	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77199	10.1371/journal.pone.0077199	http://dx.doi.org/10.1371/journal.pone.0077199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130855	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900125
J	Kobayashi, S; Suzuki, T; Igarashi, M; Orba, Y; Ohtake, N; Nagakawa, K; Niikura, K; Kimura, T; Kasamatsu, H; Sawa, H				Kobayashi, Shintaro; Suzuki, Tadaki; Igarashi, Manabu; Orba, Yasuko; Ohtake, Noriko; Nagakawa, Keita; Niikura, Kenichi; Kimura, Takashi; Kasamatsu, Harumi; Sawa, Hirofumi			Cysteine Residues in the Major Capsid Protein, Vp1, of the JC Virus Are Important for Protein Stability and Oligomer Formation	PLOS ONE			English	Article							SIMIAN VIRUS-40; CELLS; SIMIAN-VIRUS-40; RESOLUTION; BINDING; ROLES	The capsid of the human polyomavirus JC virus (JCV) consists of 72 pentameric capsomeres of a major structural protein, Vp1. The cysteine residues of the related Vp1 of SV40 are known to contribute to Vp1 folding, pentamer formation, pentamer-pentamer contacts, and capsid stabilization. In light of the presence of a slight structural difference between JCV Vp1 and SV40 counterpart, the way the former folds could be either different from or similar to the latter. We found a difference: an important contribution of Vp1 cysteines to the formation of infectious virions, unique in JCV and absent in SV40. Having introduced amino acid substitution at each of six cysteines (C42, C80, C97, C200, C247, and C260) in JCV Vp1, we found that, when expressed in HeLa cells, the Vp1 level was decreased in C80A and C247A mutants, and remained normal in the other mutants. Additionally, the C80A and C247A Vp1-expressing cell extracts did not show the hemagglutination activity characteristic of JCV particles. The C80A and C247A mutant Vp1s were found to be less stable than the wild-type Vp1 in HeLa cells. When produced in a reconstituted in vitro protein translation system, these two mutant proteins were stable, suggesting that some cellular factors were responsible for their degradation. As determined by their sucrose gradient sedimentation profiles, in vitro translated C247A Vp1 formed pentamers, but in vitro translated C80A Vp1 was entirely monomeric. When individually incorporated into the JCV genome, the C80A and C247A mutants, but not the other Vp1 cysteine residues mutants, interfered with JCV infectivity. Furthermore, the C80A, but not the C247A, mutation prevented the nuclear localization of Vp1 in JCV genome transfected cells. These findings suggest that C80 of JCV Vp1 is required for Vp1 stability and pentamer formation, and C247 is involved in capsid assembly in the nucleus.	[Kobayashi, Shintaro; Orba, Yasuko; Kimura, Takashi; Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan; [Kobayashi, Shintaro; Sawa, Hirofumi] Hokkaido Univ, Global COE Program Zoonosis Control, Sapporo, Hokkaido, Japan; [Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Igarashi, Manabu] Hokkaido Univ, Div Bioinfomat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Ohtake, Noriko; Nagakawa, Keita] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan; [Niikura, Kenichi] Hokkaido Univ, RIES, Sapporo, Hokkaido, Japan; [Kasamatsu, Harumi] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Kasamatsu, Harumi] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); Hokkaido University; Hokkaido University; Hokkaido University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sawa, H (corresponding author), Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan.	h-sawa@czc.hokudai.ac.jp	Sawa, Hirofumi/AAW-8816-2021; Sawa, Hirofumi/F-6954-2012; Kobayashi, Shintaro/AFR-4313-2022; Igarashi, Manabu/F-6871-2012; Orba, Yasuko/F-6888-2012; Suzuki, Tadaki/ABH-2661-2020	Sawa, Hirofumi/0000-0003-2569-2755; Kobayashi, Shintaro/0000-0002-8735-5722; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Ministry of Health, Labor and Welfare, Japan; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Japan; University of California, USA	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of California, USA	This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Ministry of Health, Labor and Welfare, Japan; and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Japan; and gifts to H. K. from the University of California, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003; Chang DC, 1997, J GEN VIROL, V78, P1435, DOI 10.1099/0022-1317-78-6-1435; Chen PL, 2001, FEBS LETT, V500, P109, DOI 10.1016/S0014-5793(01)02598-4; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Gasparovic ML, 2006, J VIROL, V80, P10858, DOI 10.1128/JVI.01298-06; Gee GV, 2004, J BIOL CHEM, V279, P49172, DOI 10.1074/jbc.M409326200; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Ishizu KI, 2001, J VIROL, V75, P61, DOI 10.1128/JVI.75.1.61-72.2001; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuruma Y, 2012, BIOCHEM J, V442, P631, DOI 10.1042/BJ20111284; Li, 2002, P NATL ACAD SCI USA, V99, P1353; Li, 2009, J VIROL, V83, P37; Li, 2005, J VIROL, V79, P3859; Li, 2000, J VIROL, V74, P11388; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Okada Y, 2002, ACTA NEUROPATHOL, V104, P130, DOI 10.1007/s00401-002-0526-8; Okada Y, 2000, J BIOL CHEM, V275, P17016, DOI 10.1074/jbc.275.22.17016; Orba Y, 2008, VIROLOGY, V370, P173, DOI 10.1016/j.virol.2007.08.034; Ou WC, 1999, J GEN VIROL, V80, P39, DOI 10.1099/0022-1317-80-1-39; Ou WC, 2001, J NEUROVIROL, V7, P298; Shen PS, 2011, VIROLOGY, V411, P142, DOI 10.1016/j.virol.2010.12.005; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; Suzuki S, 2001, VIROLOGY, V286, P100, DOI 10.1006/viro.2001.0972; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; VACANTE DA, 1989, VIROLOGY, V170, P353, DOI 10.1016/0042-6822(89)90425-X	29	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76668	10.1371/journal.pone.0076668	http://dx.doi.org/10.1371/journal.pone.0076668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130786	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900080
J	Lee, H; Zhu, T; Patel, K; Zhang, YY; Truong, L; Hevener, KE; Gatuz, JL; Subramanya, G; Jeong, HY; Uprichard, SL; Johnson, ME				Lee, Hyun; Zhu, Tian; Patel, Kavankumar; Zhang, Yan-Yan; Truong, Lena; Hevener, Kirk E.; Gatuz, Joseph L.; Subramanya, Gitanjali; Jeong, Hyun-Young; Uprichard, Susan L.; Johnson, Michael E.			High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; REPLICATION; PROTEIN; INTERFERON-ALPHA-2B; RIBAVIRIN; SYSTEM; DOMAIN; CLONE	Development of drug-resistant mutations has been a major problem with all currently developed Hepatitis C Virus (HCV) NS3/4A inhibitors, including the two FDA approved drugs, significantly reducing the efficacy of these inhibitors. The high incidence of drug-resistance mutations and the limited utility of these inhibitors against only genotype 1 highlight the need for novel, broad-spectrum HCV therapies. Here we used high-throughput screening (HTS) to identify low molecular weight inhibitors against NS3/4A from multiple genotypes. A total of 40,967 compounds from four structurally diverse molecular libraries were screened by HTS using fluorescence-based enzymatic assays, followed by an orthogonal binding analysis using surface plasmon resonance (SPR) to eliminate false positives. A novel small molecule compound was identified with an IC50 value of 2.2 mu M against the NS3/4A from genotype 1b. Mode of inhibition analysis subsequently confirmed this compound to be a competitive inhibitor with respect to the substrate, indicating direct binding to the protease active site, rather than to the allosteric binding pocket that was discovered to be the binding site of a few recently discovered small molecule inhibitors. This newly discovered inhibitor also showed promising inhibitory activity against the NS3/4As from three other HCV genotypes, as well as five common drug-resistant mutants of genotype 1b NS3/4A. The inhibitor was selective for NS3 from multiple HCV genotypes over two human serine proteases, and a whole cell lysate assay confirmed inhibitory activity in the cellular environment. This compound provides a lead for further development of potentially broader spectrum inhibitors.	[Lee, Hyun; Zhu, Tian; Patel, Kavankumar; Truong, Lena; Hevener, Kirk E.; Gatuz, Joseph L.; Johnson, Michael E.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; [Lee, Hyun; Zhu, Tian; Patel, Kavankumar; Truong, Lena; Hevener, Kirk E.; Gatuz, Joseph L.; Johnson, Michael E.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Zhang, Yan-Yan; Jeong, Hyun-Young] Univ Illinois, Dept Pharm Practice, Chicago, IL USA; [Subramanya, Gitanjali; Uprichard, Susan L.] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Johnson, ME (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA.	mjohnson@uic.edu	Johnson, Michael E/F-5141-2013; Hevener, Kirk/AAC-4828-2020	Johnson, Michael E/0000-0002-8246-4081; Hevener, Kirk/0000-0002-5584-3625; Gatuz, Joseph/0000-0002-8324-5892; ZHANG, YAN-YAN/0000-0002-4229-1470; Lee, Hyun/0000-0003-2570-8120	NIDCR, UIC College of Dentistry MOST program [5T32-DE018381]; National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIDCR, UIC College of Dentistry MOST program; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.E.H. was supported during a portion of this work by NIDCR 5T32-DE018381, UIC College of Dentistry MOST program. ChemAxon, for a free academic license of their cheminformatics suite including JChem and JChem for excel, was used for HTS data analysis; and the UCSF RBVI for access to Chimera, supported by NIGMS P41-GM103311. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575. The UIC Research Open Access Article Publishing (ROAAP) Fund was used to cover the open access publishing fee for this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chaudhuri R, 2012, J CHEM INF MODEL, V52, P2245, DOI 10.1021/ci300177p; Cheng SJ, 2001, HEPATOLOGY, V33, P231, DOI 10.1053/jhep.2001.20675; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cicero DO, 1999, J MOL BIOL, V289, P385, DOI 10.1006/jmbi.1999.2746; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Jeong H, 2006, XENOBIOTICA, V36, P1, DOI 10.1080/00498250500485115; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lee H, 2012, ANAL BIOCHEM, V423, P46, DOI 10.1016/j.ab.2012.01.006; Llinas-Brunet M, 1998, BIOORG MED CHEM LETT, V8, P1713, DOI 10.1016/S0960-894X(98)00299-6; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Malancona S, 2004, BIOORG MED CHEM LETT, V14, P4575, DOI 10.1016/j.bmcl.2004.05.093; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Melnikova I, 2008, NAT REV DRUG DISCOV, V7, P799, DOI 10.1038/nrd2661; Paulson MS, 2009, ANTIVIR RES, V83, P135, DOI 10.1016/j.antiviral.2009.04.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rishton GM, 2003, DRUG DISCOV TODAY, V8, P86, DOI 10.1016/S1359644602025722; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Saalau-Bethell SM, 2012, NAT CHEM BIOL, V8, P920, DOI [10.1038/NCHEMBIO.1081, 10.1038/nchembio.1081]; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Schiering N, 2011, P NATL ACAD SCI USA, V108, P21052, DOI 10.1073/pnas.1110534108; Schrodinger, 2011, LIGPREP VERS 2 5; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Tan SL, 2006, HEPATITIS C VIRUSES; Timm J, 2007, WORLD J GASTROENTERO, V13, P4808, DOI 10.3748/wjg.v13.i36.4808; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Yang PL, 2011, CURR OPIN VIROL, V1, P607, DOI 10.1016/j.coviro.2011.10.019; Zarkesh-Esfahani SH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-69; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	37	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75144	10.1371/journal.pone.0075144	http://dx.doi.org/10.1371/journal.pone.0075144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130685	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900018
J	Luo, JF; Xiao, LH; Wu, CX; Zheng, Y; Zhao, NQ				Luo, Jianfeng; Xiao, Linhai; Wu, Chunxiao; Zheng, Ying; Zhao, Naiqing			The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004-2009	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; DUCTAL ADENOCARCINOMA; RESECTION; PANCREATICODUODENECTOMY; TRENDS; HEAD	Background: Pancreatic cancer is a devastating disease with dismal prognosis. Large population-based evidence on its survival rate and influence factors is lacking in China. Objective: This study aimed to depict the demographic factors, tumor characteristics, incidence rate and survival rate of pancreatic cancer cases in urban China. Methods: The demographic factors, tumor characteristics were collected for all the pancreatic cancer cases identified during 2004 to 2009 from the Shanghai Cancer Registry. The survival time was ascertained through linkage of the Shanghai Cancer Registry and the Shanghai Vital Statistics Registry. The deadline of death certificates was the end of December 2012. Kaplan-Meier method and Cox proportional-hazards regression model were used to explore the survival rate and influence factors. Results: 11,672 new pancreatic cancer cases were identified among Shanghai residency during 2004 to 2009. The crude incidence rate of pancreatic cancer was increasing from 12.80/100,000 in 2004 to 15.66/100,000 in 2009, while the standardized incidence rate was about 6.70/100,000 and didn't change a lot. The overall 5-year survival rate was 4.1% and the median survival time was 3.9 (95% Confidence Interval (CI) 3.8-4.0) months. Subjects had received surgical resection had improved survival (HR = 0.742, 95% CI: 0.634-0.868) than its counterparts. In adjusted multivariable Cox proportional-hazard models, factors associated with poor survival included older age at diagnosis (age >=70 years: hazard ratio (HR) = 1.827, 95% CI: 1.614-2.067), male sex (HR = 1.155, 95% CI: 1.041-1.281), distant disease at diagnosis (HR = 1.257, 95% CI: 1.061-1.488), positive lymph node (HR = 1.236, 95% CI: 1.085-1.408), tumor stage (Stage IV HR = 2.817, 95% CI: 2.029-3.909). Conclusion: The age-adjusted incidence rate was stable and overall survival rate was low among pancreatic cancer patients of Shanghai residency. Early detection and improved treatment strategies are needed to improve prognosis for this deadly disease.	[Luo, Jianfeng; Xiao, Linhai; Zhao, Naiqing] Fudan Univ, Sch Publ Hlth, Dept Hlth Stat & Social Med, Shanghai 200433, Peoples R China; [Wu, Chunxiao; Zheng, Ying] Shanghai Municipal Ctr Dis Prevent & Control, Dept Canc Control & Prevent, Shanghai, Peoples R China	Fudan University; Shanghai Center for Disease Control & Prevention	Zheng, Y (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Hlth Stat & Social Med, Shanghai 200433, Peoples R China.	yzheng@scdc.sh.cn; nqzhao@fudan.edu.cn	Luo, jian/HGE-7331-2022		National Natural Science Foundation of China [30972551, 81273187, 81102183]; 12th Five-year Major New Drug Discovery Science and Technology [2012ZX09303013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year Major New Drug Discovery Science and Technology	This research is supported by the projects 30972551, 81273187 and 81102183 from National Natural Science Foundation of China and the 12th Five-year Major New Drug Discovery Science and Technology, 2012ZX09303013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANN ICRP, V38, P1; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; Chen WQ, 2012, CHINESE J CANCER RES, V24, P1, DOI 10.1007/s11670-012-0001-6; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Distler M, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-12; DOLL R, 1967, INT J CANCER, V2, P269, DOI 10.1002/ijc.2910020310; Dong M, 1998, ANTICANCER RES, V18, P4613; Eloubeidi MA, 2006, AM J SURG, V192, P322, DOI 10.1016/j.amjsurg.2006.02.017; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Garcea G, 2008, J PANCREAS, V9, P99; Gudjonsson B, 2002, J CLIN GASTROENTEROL, V35, P180, DOI 10.1097/00004836-200208000-00011; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kuhlmann KFCD, 2004, EUR J CANCER, V40, P549, DOI 10.1016/j.ejca.2003.10.026; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Meyer W, 2000, SURG TODAY, V30, P582, DOI 10.1007/s005950070096; Ni Quan-Xing, 2002, Hepatobiliary Pancreat Dis Int, V1, P126; Ouyang HQ, 2011, PANCREAS, V40, P120, DOI 10.1097/MPA.0b013e3181e6e398; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Shaib YH, 2006, ALIMENT PHARM THER, V24, P87, DOI 10.1111/j.1365-2036.2006.02961.x; Shaib Y, 2007, AM J GASTROENTEROL, V102, P1377, DOI 10.1111/j.1572-0241.2007.01202.x; Shen CM, 2012, PANCREATOLOGY, V12, P206, DOI 10.1016/j.pan.2012.04.002; Takai S, 2003, PANCREAS, V26, P243, DOI 10.1097/00006676-200304000-00007; Zell JA, 2007, CANCER EPIDEM BIOMAR, V16, P546, DOI 10.1158/1055-9965.EPI-06-0893; Zhang Qun-hua, 2004, Zhonghua Yi Xue Za Zhi, V84, P214; Zheng S, 2003, CHINESE J HEPATOBILI, V9, P134	28	61	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76052	10.1371/journal.pone.0076052	http://dx.doi.org/10.1371/journal.pone.0076052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130758	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900067
J	Mitchell, CJ; Churchward-Venne, TA; Bellamy, L; Parise, G; Baker, SK; Phillips, SM				Mitchell, Cameron J.; Churchward-Venne, Tyler A.; Bellamy, Leeann; Parise, Gianni; Baker, Steven K.; Phillips, Stuart M.			Muscular and Systemic Correlates of Resistance Training-Induced Muscle Hypertrophy	PLOS ONE			English	Article							ANDROGEN RECEPTOR EXPRESSION; SKELETAL-MUSCLE; MYOFIBER HYPERTROPHY; CLUSTER-ANALYSIS; IGF-I; LENGTHENING CONTRACTIONS; HORMONAL ADAPTATIONS; PROTEIN-SYNTHESIS; YOUNG MEN; EXERCISE	Purpose: To determine relationships between post-exercise changes in systemic [testosterone, growth hormone (GH), insulin like grow factor 1 (IGF-1) and interleukin 6 (IL-6)], or intramuscular [skeletal muscle androgen receptor (AR) protein content and p70S6K phosphorylation status] factors in a moderately-sized cohort of young men exhibiting divergent resistance training-mediated muscle hypertrophy. Methods: Twenty three adult males completed 4 sessions.wk(-1) of resistance training for 16 wk. Muscle biopsies were obtained before and after the training period and acutely 1 and 5 h after the first training session. Serum hormones and cytokines were measured immediately, 15, 30 and 60 minutes following the first and last training sessions of the study. Results: Mean fiber area increased by 20% (range: -7 to 80%; P<0.001). Protein content of the AR was unchanged with training (fold change = 1.17 +/- 0.61; P = 0.19); however, there was a significant correlation between the changes in AR content and fiber area (r = 0.60, P = 0.023). Phosphorylation of p70S6K was elevated 5 hours following exercise, which was correlated with gains in mean fiber area (r = 0.54, P = 0.007). There was no relationship between the magnitude of the pre- or post-training exercise-induced changes in free testosterone, GH, or IGF-1 concentration and muscle fiber hypertrophy; however, the magnitude of the post exercise IL-6 response was correlated with muscle hypertrophy (r = 0.48, P = 0.019). Conclusion: Post-exercise increases in circulating hormones are not related to hypertrophy following training. Exercise-induced changes in IL-6 correlated with hypertrophy, but the mechanism for the role of IL-6 in hypertrophy is not known. Acute increases, in p70S6K phosphorylation and changes in muscle AR protein content correlated with muscle hypertrophy implicating intramuscular rather than systemic processes in mediating hypertrophy.	[Mitchell, Cameron J.; Churchward-Venne, Tyler A.; Bellamy, Leeann; Parise, Gianni; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada; [Baker, Steven K.] McMaster Univ, Sch Med, Dept Neurol, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Phillips, SM (corresponding author), McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada.	phillis@mcmaster.ca	Mitchell, Cameron/I-4423-2019; Phillips, Stuart/B-2343-2009	Mitchell, Cameron/0000-0003-3843-6806; Phillips, Stuart/0000-0002-1956-4098; Churchward-Venne, Tyler/0000-0001-6006-5461	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to SMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Ahtiainen JP, 2005, J STRENGTH COND RES, V19, P572, DOI 10.1519/00124278-200508000-00015; Ahtiainen JP, 2003, EUR J APPL PHYSIOL, V89, P555, DOI 10.1007/s00421-003-0833-3; Ahtiainen JP, 2011, STEROIDS, V76, P183, DOI 10.1016/j.steroids.2010.10.012; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Bamman MM, 2007, J APPL PHYSIOL, V102, P2232, DOI 10.1152/japplphysiol.00024.2007; Bamman MM, 2001, AM J PHYSIOL-ENDOC M, V280, pE383; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Burd NA, 2012, J PHYSIOL-LONDON, V590, P351, DOI 10.1113/jphysiol.2011.221200; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Burd NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012033; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Churchward-Venne TA, 2012, J PHYSIOL-LONDON, V590, P2751, DOI 10.1113/jphysiol.2012.228833; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; DAYNES RA, 1993, J IMMUNOL, V150, P5219; de Souza TP, 2010, J STRENGTH COND RES, V24, P1843, DOI 10.1519/JSC.0b013e3181ddae4a; Dickinson JM, 2011, J NUTR, V141, P856, DOI 10.3945/jn.111.139485; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Hartman JW, 2007, AM J CLIN NUTR, V86, P373, DOI 10.1093/ajcn/86.2.373; Kraemer WJ, 2010, CURR SPORT MED REP, V9, P242, DOI 10.1249/JSR.0b013e3181e976df; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McCall GE, 1999, CAN J APPL PHYSIOL, V24, P96, DOI 10.1139/h99-009; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Nindl BC, 2012, AM J PHYSIOL-REG I, V303, pR1080, DOI 10.1152/ajpregu.00275.2012; Orsatti FL, 2012, J STRENGTH COND RES, V26, P2130, DOI 10.1519/JSC.0b013e318239f837; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips SM, 2004, NUTRITION, V20, P689, DOI 10.1016/j.nut.2004.04.009; Phillips SM, 2000, CAN J APPL PHYSIOL, V25, P185, DOI 10.1139/h00-014; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Thalacker-Mercer AE, 2009, APPL PHYSIOL NUTR ME, V34, P632, DOI 10.1139/H09-038; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Vingren JL, 2010, SPORTS MED, V40, P1037, DOI 10.2165/11536910-000000000-00000; West DWD, 2012, EUR J APPL PHYSIOL, V112, P2693, DOI 10.1007/s00421-011-2246-z; West DWD, 2010, J APPL PHYSIOL, V108, P60, DOI 10.1152/japplphysiol.01147.2009; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P1499, DOI 10.1249/01.MSS.0000139795.83030.D1	43	115	117	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e78636	10.1371/journal.pone.0078636	http://dx.doi.org/10.1371/journal.pone.0078636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130904	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900144
J	Zdzalik, M; Kalinska, M; Wysocka, M; Stec-Niemczyk, J; Cichon, P; Stach, N; Gruba, N; Stennicke, HR; Jabaiah, A; Markiewicz, M; Kedracka-Krok, S; Wladyka, B; Daugherty, PS; Lesner, A; Rolka, K; Dubin, A; Potempa, J; Dubin, G				Zdzalik, Michal; Kalinska, Magdalena; Wysocka, Magdalena; Stec-Niemczyk, Justyna; Cichon, Przemyslaw; Stach, Natalia; Gruba, Natalia; Stennicke, Henning R.; Jabaiah, Abeer; Markiewicz, Michal; Kedracka-Krok, Sylwia; Wladyka, Benedykt; Daugherty, Patrick S.; Lesner, Adam; Rolka, Krzysztof; Dubin, Adam; Potempa, Jan; Dubin, Grzegorz			Biochemical and Structural Characterization of SplD Protease from Staphylococcus aureus	PLOS ONE			English	Article							SERINE-PROTEASE; SUBSTRATE-SPECIFICITY; EXTRACELLULAR PROTEASES; ZYMOGEN ACTIVATION; CRYSTAL-STRUCTURES; NASAL CARRIAGE; UNITED-STATES; PROTEINASES; CHYMOTRYPSIN; INFECTIONS	Staphylococcus aureus is a dangerous human pathogen. A number of the proteins secreted by this bacterium are implicated in its virulence, but many of the components of its secretome are poorly characterized. Strains of S. aureus can produce up to six homologous extracellular serine proteases grouped in a single spl operon. Although the SplA, SplB, and SplC proteases have been thoroughly characterized, the properties of the other three enzymes have not yet been investigated. Here, we describe the biochemical and structural characteristics of the SplD protease. The active enzyme was produced in an Escherichia coli recombinant system and purified to homogeneity. P1 substrate specificity was determined using a combinatorial library of synthetic peptide substrates showing exclusive preference for threonine, serine, leucine, isoleucine, alanine, and valine. To further determine the specificity of SplD, we used high-throughput synthetic peptide and cell surface protein display methods. The results not only confirmed SplD preference for a P1 residue, but also provided insight into the specificity of individual primed- and non-primed substrate-binding subsites. The analyses revealed a surprisingly narrow specificity of the protease, which recognized five consecutive residues (P4-P3-P2-P1-P1') with a consensus motif of R-(Y/W)-(P/L)-(T/L/I/V). S. To understand the molecular basis of the strict substrate specificity, we crystallized the enzyme in two different conditions, and refined the structures at resolutions of 1.56 angstrom and 2.1 angstrom. Molecular modeling and mutagenesis studies allowed us to define a consensus model of substrate binding, and illustrated the molecular mechanism of protease specificity.	[Zdzalik, Michal; Kalinska, Magdalena; Cichon, Przemyslaw; Stach, Natalia; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Wysocka, Magdalena; Gruba, Natalia; Lesner, Adam; Rolka, Krzysztof] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Wladyka, Benedykt; Dubin, Adam] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Stennicke, Henning R.] Novo Nordisk AS, Haemophilia Biol, Malov, Denmark; [Jabaiah, Abeer; Daugherty, Patrick S.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Markiewicz, Michal] Jagiellonian Univ, Dept Computat Biophys & Bioinformat, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Dept Phys Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kedracka-Krok, Sylwia; Wladyka, Benedykt] Malopolska Ctr Biotechnol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA	Jagiellonian University; Fahrenheit Universities; University of Gdansk; Jagiellonian University; Novo Nordisk; University of California System; University of California Santa Barbara; Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Louisville	Dubin, G (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	grzegorz.dubin@uj.edu.pl	Dubin, Grzegorz/J-8168-2014; Władyka, Benedykt/T-7039-2019; Potempa, Jan/AAA-6850-2021; Lesner, Adam/M-2732-2019	Dubin, Grzegorz/0000-0002-5535-5760; Władyka, Benedykt/0000-0002-9075-3529; Rolka, Krzysztof/0000-0002-4537-700X; Lesner, Adam/0000-0001-8335-3431; Potempa, Jan/0000-0002-3600-7461; Gruba, Natalia/0000-0003-3281-9945; Wysocka, Magdalena/0000-0003-2216-5597	Polish Ministry of Science and Higher Education [N N301 032834]; National Science Centre; institutional funds (DS9) from the Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University, Krakow, Poland) [UMO-2011/01/D/NZ1/01169, UMO-2011/01/N/NZ1/00208]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08];  [538-8290-1036-12]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre; institutional funds (DS9) from the Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University, Krakow, Poland); European Union(European Commission); 	This work was supported in part by grant N N301 032834 (to GD) from the Polish Ministry of Science and Higher Education; grants UMO-2011/01/D/NZ1/01169 (to GD) and UMO-2011/01/N/NZ1/00208 (to MZ) from the National Science Centre; institutional funds (DS9) from the Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University, Krakow, Poland); and a project contributed to the Development of Young Scientists and PhD students at University of Gdansk (Poland), grant 538-8290-1036-12 (to MW). The research was carried out with the equipment purchased thanks to the financial support of the European Union structural funds (grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Arvidson J, 2000, PEDIATR HEMAT ONCOL, V17, P285, DOI 10.1080/088800100276271; ARVIDSON S, 1973, BIOCHIM BIOPHYS ACTA, V302, P135, DOI 10.1016/0005-2744(73)90016-8; Avogadro, 2012, AVOGADRO OPEN SOURCE; Baron S., 1996, MED MICROBIOLOGY, V4th; Bateman KS, 2000, PROTEIN SCI, V9, P83; BERTHOLD H, 1992, BIOTECHNOL LETT, V14, P245, DOI 10.1007/BF01022318; Biedermannova L, 2008, PHYS CHEM CHEM PHYS, V10, P6350, DOI 10.1039/b805087b; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dubin G, 2012, CURR PHARM DES; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P., 1997, NEWSLETT PROTEIN CRY, V33, P22; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalinska M, 2012, BIOCHIMIE, V94, P318, DOI 10.1016/j.biochi.2011.07.020; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lesk AM, 1996, J MOL BIOL, V258, P501, DOI 10.1006/jmbi.1996.0264; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V6; Lesner A, 2001, BIOCHEM BIOPH RES CO, V285, P1350, DOI 10.1006/bbrc.2001.5339; Lesner A, 2000, BIOCHEM BIOPH RES CO, V269, P81, DOI 10.1006/bbrc.2000.2257; MacKerell A. D., 1998, ENCY COMPUTATIONAL C; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Maeda H, 1996, BIOL CHEM H-S, V377, P217; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; POTEMPA J, 1986, J BIOL CHEM, V261, P14330; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Rieneck K, 1997, BBA-GENE STRUCT EXPR, V1350, P128, DOI 10.1016/S0167-4781(96)00216-3; Rudack C, 2009, J IMMUNOL, V183, P7592, DOI 10.4049/jimmunol.0803902; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Snipas SJ, 2004, BIOL CHEM, V385, P1093, DOI 10.1515/BC.2004.142; Stec-Niemczyk J, 2009, BIOCHEM J, V419, P555, DOI 10.1042/BJ20081351; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wysocka M, 2007, COMB CHEM HIGH T SCR, V10, P171, DOI 10.2174/138620707780126714; Zdzalik M, 2012, FEMS IMMUNOL MED MIC, V66, P220, DOI 10.1111/j.1574-695X.2012.01005.x; Ziebandt AK, 2004, PROTEOMICS, V4, P3034, DOI 10.1002/pmic.200400937	66	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76812	10.1371/journal.pone.0076812	http://dx.doi.org/10.1371/journal.pone.0076812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130791	gold, Green Published			2022-12-27	WOS:000325810900086
J	Zeng, YJ; Xu, JL; Wang, Y; Zhou, CF				Zeng, Yajie; Xu, Jiliang; Wang, Yong; Zhou, Chunfa			Habitat Association and Conservation Implications Endangered Francois' Langur (Trachypithecus francoisi)	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; NATURE-RESERVE; AVAILABILITY DATA; CHINA; GUANGXI; MODEL; GUIZHOU; DECLINE; WINTER; FUSUI	Francois' langur (Trachypithecus francoisi) is an endangered primate and endemic to the limestone forests of the tropical and subtropical zone of northern Vietnam and South-west China with a population of about 2,000 individuals. Conservation efforts are hampered by limited knowledge of habitat preference in its main distribution area. We surveyed the distribution of Francois' langur and modeled the relationship between the probability of use and habitat features in Mayanghe National Nature Reserve, Guizhou, China. The main objectives of this study were to provide quantitative information on habitat preference, estimating the availability of suitable habitat, and providing management guidelines for the effective conservation of this species. By comparing 92 used locations with habitat available in the reserve, we found that Francois' langur was mainly distributed along valleys and proportionally, used bamboo forests and mixed conifer-broadleaf forests more than their availability, whereas they tended to avoid shrubby areas and coniferous forests. The langur tended to occur at sites with lower elevation, steeper slope, higher tree canopy density, and a close distance to roads and water. The habitat occupancy probability was best modeled by vegetation type, vegetation coverage, elevation, slope degree, distances to nearest water, paved road, and farmland edge. The suitable habitat in this reserve concentrated in valleys and accounted for about 25% of the total reserve area. Our results showed that Francois' langur was not only restricted at the landscapes level at the regions with karst topography, limestone cliffs, and caves, but it also showed habitat preference at the local scale. Therefore, the protection and restoration of the langur preferred habitats such as mixed conifer-broadleaf forests are important and urgent for the conservation of this declining species.	[Zeng, Yajie; Xu, Jiliang] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Wang, Yong] Alabama A&M Univ, Sch Agr & Environm Sci, Ctr Forestry Ecol & Wildlife, Normal, AL 35762 USA; [Wang, Yong; Zhou, Chunfa] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing, Peoples R China; [Wang, Yong] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China	Beijing Forestry University; Alabama A&M University; Beijing Normal University; Nanjing Forestry University	Xu, JL (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	xujiliang@bjfu.edu.cn			Forestry Commonweal Programs [200904003]; Ministry of Science & Techenology of China [2008BADB0B01]; National Key Project of Scientific and Technical Supporting Programs	Forestry Commonweal Programs; Ministry of Science & Techenology of China; National Key Project of Scientific and Technical Supporting Programs	This work was supported by the Forestry Commonweal Programs (NO. 200904003) and the National Key Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Techenology of China (NO. 2008BADB0B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BASKARAN N., 2010, J THREAT TAXA, V2, P753, DOI DOI 10.11609/J0TT.02101.753-9; Bennett Elizabeth L., 1994, P129; Bleisch William, 2004, P107; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2; Carpenter J, 2010, J WILDLIFE MANAGE, V74, P1806, DOI 10.2193/2009-368; Chen Z., 2001, GUIZHOU FOR SCI TECH, V29, P34; Cowlishaw G., 2000, PRIMATE CONSERVATION; Cramer J. S., 2003, LOGIT MODELS EC OTHE, P66; Durst P, 2000, INT C TIMB PLANT DEV; Garshelis DL, 2000, METH C CONS, P111; Guizhou Statistical Bureau, 2013, STAT YB GUIZH 2011; Guizhou Tourism Bureau, 2013, GUIZH EC CULT TOUR I; Hamer TE, 2008, J WILDLIFE MANAGE, V72, P983, DOI 10.2193/2006-565; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu CF, 2012, REPORT YANHE AUTONOM; Hu G, 2004, ORYX, V38, P48, DOI 10.1017/S0030605304000080; Hu Gang, 2011, Acta Theriologica Sinica, V31, P306; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Li Wen, 2010, Acta Theriologica Sinica, V30, P151; Li YB, 2007, ORYX, V41, P38, DOI 10.1017/S0030605307001500; Li ZY, 2004, INT J PRIMATOL, V25, P41, DOI 10.1023/B:IJOP.0000014644.36333.94; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luo Yang, 2000, Chinese Journal of Zoology, V35, P44; Luo Yang, 2007, Acta Ecologica Sinica, V27, P1715; Ministry of Environmental Protection, 2010, CHIN BIOD CONS STRAT; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Tabachnick B. G., 2013, USING MULTIVARIATE S; The Forestry Sector of Guizhou Province, 1994, REP SCI SURV RES MAY, P15; Wang DZ, 2005, PRIMATES, V46, P219, DOI 10.1007/s10329-004-0122-8; Wang S., 1998, CHINA RED DATA BOOK; Wang SL, 2011, PRIMATES, V52, P51, DOI 10.1007/s10329-010-0218-2; Wang Y, 2012, IBIS, V154, P273, DOI 10.1111/j.1474-919X.2012.01214.x; Wang YZ, 2004, J LIUPANSHUI TEACHER, V16, P1; Xu JL, 2012, ORYX, V46, P554, DOI 10.1017/S0030605311000810; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang Yongzu, 1992, Acta Theriologica Sinica, V12, P81; Zhou Qihai, 2007, Acta Theriologica Sinica, V27, P243	41	8	13	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75661	10.1371/journal.pone.0075661	http://dx.doi.org/10.1371/journal.pone.0075661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130730	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900049
J	Shimizu, H; Kubo, A; Uchibe, K; Hashimoto, M; Yokoyama, S; Takada, S; Mitsuoka, K; Asahara, H				Shimizu, Hirohito; Kubo, Atsushi; Uchibe, Kenta; Hashimoto, Megumi; Yokoyama, Shigetoshi; Takada, Shuji; Mitsuoka, Kazuhiko; Asahara, Hiroshi			The AERO System: A 3D-Like Approach for Recording Gene Expression Patterns in the Whole Mouse Embryo	PLOS ONE			English	Article							UPDATE; ATLAS; LIMB	We have recently constructed a web-based database of gene expression in the mouse whole embryo, EMBRYS (http://embrys.jp/embrys/html/MainMenu.html). To allow examination of gene expression patterns to the fullest extent possible, this database provides both photo images and annotation data. However, since embryos develop via an intricate process of morphogenesis, it would be of great value to track embryonic gene expression from a three dimensional perspective. In fact, several methods have been developed to achieve this goal, but highly laborious procedures and specific operational skills are generally required. We utilized a novel microscopic technique that enables the easy capture of rotational, 3D-like images of the whole embryo. In this method, a rotary head equipped with two mirrors that are designed to obtain an image tilted at 45 degrees to the microscope stage captures serial images at 2-degree intervals. By a simple operation, 180 images are automatically collected. These 2D images obtained at multiple angles are then used to reconstruct 3D-like images, termed AERO images. By means of this system, over 800 AERO images of 191 gene expression patterns were captured. These images can be easily rotated on the computer screen using the EMBRYS database so that researchers can view an entire embryo by a virtual viewing on a computer screen in an unbiased or non-predetermined manner. The advantages afforded by this approach make it especially useful for generating data viewed in public databases.	[Shimizu, Hirohito; Uchibe, Kenta; Hashimoto, Megumi; Yokoyama, Shigetoshi; Takada, Shuji; Mitsuoka, Kazuhiko; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Syst Biomed, Tokyo, Japan; [Kubo, Atsushi; Asahara, Hiroshi] Tokyo Med & Dent Univ, Dept Syst Biomed, Tokyo, Japan; [Uchibe, Kenta] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama 7008530, Japan	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Okayama University	Asahara, H (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Syst Biomed, Tokyo, Japan.	asahara.syst@tmd.ac.jp		Takada, Shuji/0000-0002-9406-4683	Health and Labor Sciences research grants; Genome Network Project (MEXT); MEXT; Grant of National Center for Child Health and Development; Japan Health Sciences Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23249071] Funding Source: KAKEN	Health and Labor Sciences research grants(Ministry of Health, Labour and Welfare, Japan); Genome Network Project (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant of National Center for Child Health and Development; Japan Health Sciences Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health and Labor Sciences research grants, Genome Network Project (MEXT), grants-in-aid for Scientific Research (MEXT), the Grant of National Center for Child Health and Development, Japan Health Sciences Foundation and Takeda Science Foundation. This work was performed in part under the Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Fisher ME, 2008, DEV BIOL, V317, P13, DOI 10.1016/j.ydbio.2008.01.031; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hecksher-Sorensen J, 2001, MECH DEVELOP, V100, P59, DOI 10.1016/S0925-4773(00)00508-6; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shimizu H, 2009, METHODS MOL BIOL, V577, P167, DOI 10.1007/978-1-60761-232-2_13; Smith CM, 2007, NUCLEIC ACIDS RES, V35, pD618, DOI 10.1093/nar/gkl1003; Streicher J, 2000, NAT GENET, V25, P147, DOI 10.1038/75989; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Uchibe K, 2012, DEV DYNAM, V241, P1217, DOI 10.1002/dvdy.23808; Venkataraman S, 2008, NUCLEIC ACIDS RES, V36, pD860, DOI 10.1093/nar/gkm938; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75754	10.1371/journal.pone.0075754	http://dx.doi.org/10.1371/journal.pone.0075754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146773	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400016
J	Barnaby, JY; Kim, M; Bauchan, G; Bunce, J; Reddy, V; Sicher, RC				Barnaby, Jinyoung Y.; Kim, Moon; Bauchan, Gary; Bunce, James; Reddy, Vangimalla; Sicher, Richard Charles			Drought Responses of Foliar Metabolites in Three Maize Hybrids Differing in Water Stress Tolerance	PLOS ONE			English	Article							PLANT-RESPONSES; BARLEY; GENES; EXPRESSION; ENRICHMENT; GALACTINOL; PHYSIOLOGY; LEAVES	Maize (Zea mays L.) hybrids varying in drought tolerance were treated with water stress in controlled environments. Experiments were performed during vegetative growth and water was withheld for 19 days beginning 17 days after sowing. Genotypic comparisons used measured changes of leaf water potential or results were expressed by time of treatment. Total dry matter of the drought tolerant hybrid on the final harvest was 53% less than that of the intermediate and susceptible maize hybrids when plants were water sufficient. This showed that maize hybrids selected for extreme drought tolerance possessed a dwarf phenotype that affected soil water contents and leaf water potentials. Changes of shoot and root growth, leaf water potential, net photosynthesis and stomatal conductance in response to the time of water stress treatment were diminished when comparing the drought tolerant to the intermediate or susceptible maize hybrids. Genotypic differences were observed in 26 of 40 total foliar metabolites during water stress treatments. Hierarchical clustering revealed that the tolerant maize hybrid initiated the accumulation of stress related metabolites at higher leaf water potentials than either the susceptible or intermediate hybrids. Opposite results occurred when changes of metabolites in maize leaves were expressed temporally. The above results demonstrated that genotypic differences were readily observed by comparing maize hybrids differing in drought tolerance based on either time of treatment or measured leaf water potential. Current findings provided new and potentially important insights into the mechanisms of drought tolerance in maize.	[Barnaby, Jinyoung Y.; Bunce, James; Reddy, Vangimalla; Sicher, Richard Charles] ARS, USDA, Crop Syst & Global Change Lab, Beltsville, MD 20705 USA; [Kim, Moon] ARS, USDA, Environm Microbial & Food Safety Lab, Beltsville, MD USA; [Bauchan, Gary] ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sicher, RC (corresponding author), ARS, USDA, Crop Syst & Global Change Lab, Beltsville, MD 20705 USA.	Richard.Sicher@ars.usda.gov	Bauchan, Gary/ABH-3800-2020	Bunce, James/0000-0002-6825-7510; Bauchan, Gary/0000-0003-3060-7666; Barnaby, Jinyoung/0000-0001-6507-9985				Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Araus JL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00305; Boyer JS, 2008, FUNCT PLANT BIOL, V35, P1172, DOI 10.1071/FP08157; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Harrigan GG, 2009, J AGR FOOD CHEM, V57, P9754, DOI 10.1021/jf9021515; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Pace P. F., 1999, Journal of Cotton Science, V3, P183; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; Shen B, 1997, PLANT PHYSIOL, V113, P1177, DOI 10.1104/pp.113.4.1177; Sicher RC, 2011, ADV MAIZE ESSENTIAL, V3, P373; Sicher RC, 2008, PLANT SCI, V174, P576, DOI 10.1016/j.plantsci.2008.03.001; Sicher RC, 2012, PHYSIOL PLANTARUM, V144, P238, DOI 10.1111/j.1399-3054.2011.01555.x; Silvente S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038554; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tollefson J, 2011, NATURE, V469, P144, DOI 10.1038/469144a; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Yamada M, 2005, J EXP BOT, V56, P1975, DOI 10.1093/jxb/eri195	28	20	22	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77145	10.1371/journal.pone.0077145	http://dx.doi.org/10.1371/journal.pone.0077145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143208	Green Published, gold			2022-12-27	WOS:000325894100043
J	Alzugaray, ME; Adami, ML; Diambra, LA; Hernandez-Martinez, S; Damborenea, C; Noriega, FG; Ronderos, JR				Eugenia Alzugaray, Maria; Laura Adami, Mariana; Anibal Diambra, Luis; Hernandez-Martinez, Salvador; Damborenea, Cristina; Noriega, Fernando Gabriel; Rafael Ronderos, Jorge			Allatotropin: An Ancestral Myotropic Neuropeptide Involved in Feeding	PLOS ONE			English	Article							MANDUCA-SEXTA ALLATOTROPIN; MOLECULAR CHARACTERIZATION; AEDES-AEGYPTI; NERVOUS-SYSTEM; PEPTIDE; IDENTIFICATION; EVOLUTION; ALLATOSTATIN; CNIDARIAN; RECEPTOR	Background: Cell-cell interactions are a basic principle for the organization of tissues and organs allowing them to perform integrated functions and to organize themselves spatially and temporally. Peptidic molecules secreted by neurons and epithelial cells play fundamental roles in cell-cell interactions, acting as local neuromodulators, neurohormones, as well as endocrine and paracrine messengers. Allatotropin (AT) is a neuropeptide originally described as a regulator of Juvenile Hormone synthesis, which plays multiple neural, endocrine and myoactive roles in insects and other organisms. Methods: A combination of immunohistochemistry using AT-antibodies and AT-Qdot nanocrystal conjugates was used to identify immunoreactive nerve cells containing the peptide and epithelial-muscular cells targeted by AT in Hydra plagiodesmica. Physiological assays using AT and AT-antibodies revealed that while AT stimulated the extrusion of the hypostome in a dose-response fashion in starved hydroids, the activity of hypostome in hydroids challenged with food was blocked by treatments with different doses of AT-antibodies. Conclusions: AT antibodies immunolabeled nerve cells in the stalk, pedal disc, tentacles and hypostome. AT-Qdot conjugates recognized epithelial-muscular cell in the same tissues, suggesting the existence of anatomical and functional relationships between these two cell populations. Physiological assays indicated that the AT-like peptide is facilitating food ingestion. Significance: Immunochemical, physiological and bioinformatics evidence advocates that AT is an ancestral neuropeptide involved in myoregulatory activities associated with meal ingestion and digestion.	[Eugenia Alzugaray, Maria; Laura Adami, Mariana; Rafael Ronderos, Jorge] UNLP, FCNyM, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina; [Laura Adami, Mariana; Damborenea, Cristina] UNLP, FCNyM, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina; [Anibal Diambra, Luis; Rafael Ronderos, Jorge] UNLP, CREG, La Plata, Buenos Aires, Argentina; [Hernandez-Martinez, Salvador] INSP, CISEI, Cuernavaca, Morelos, Mexico; [Noriega, Fernando Gabriel] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	National University of La Plata; National University of La Plata; National University of La Plata; State University System of Florida; Florida International University	Ronderos, JR (corresponding author), UNLP, FCNyM, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina.	jrondero@museo.fcnym.unlp.edu.ar	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; Hernandez-Martinez, Salvador/0000-0003-1276-9397	 [PICT 01287];  [FCNyM-UNLP(N673)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was financed with founds from the PICT 01287 (SECyT - Argentina) and and FCNyM-UNLP(N673) Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2003, INSECT BIOCHEM MOLEC, V33, P467, DOI 10.1016/S0965-1748(03)00005-5; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Duve H, 1999, J COMP NEUROL, V413, P405, DOI 10.1002/(SICI)1096-9861(19991025)413:3&lt;405::AID-CNE4&gt;3.0.CO;2-R; Duve H, 2000, CELL TISSUE RES, V300, P153, DOI 10.1007/s004410050056; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Grimmelikhuijzen CJP, 2002, CAN J ZOOL, V80, P1690, DOI 10.1139/Z02-137; GRIMMELIKHUIJZEN CJP, 1991, HYDROBIOLOGIA, V216, P555, DOI 10.1007/BF00026513; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Hoffmeister SAH, 1996, DEVELOPMENT, V122, P1941; Hoffmeister-Ullerich SAH, 2001, MECH DEVELOP, V106, P37, DOI 10.1016/S0925-4773(01)00401-4; Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175; Homberg U, 2003, CHRONOBIOL INT, V20, P577, DOI 10.1081/CBI-120022412; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Kass-Simon G, 2007, COMP BIOCHEM PHYS A, V146, P9, DOI 10.1016/j.cbpa.2006.09.008; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Koladich PM, 2002, PEPTIDES, V23, P645, DOI 10.1016/S0196-9781(01)00658-1; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Adami ML, 2012, ZOOMORPHOLOGY, V131, P1, DOI 10.1007/s00435-012-0146-3; Adami ML, 2011, TISSUE CELL, V43, P377, DOI 10.1016/j.tice.2011.07.005; Lee KY, 1998, J EXP BIOL, V201, P3067; LEITZ T, 1994, DEV BIOL, V163, P440, DOI 10.1006/dbio.1994.1160; LENTZ TL, 1966, J EXP ZOOL, V162, P171, DOI 10.1002/jez.1401620204; LEROITH D, 1980, P NATL ACAD SCI-BIOL, V77, P6184; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Lwalaba D, 2010, ARCH INSECT BIOCHEM, V73, P14, DOI 10.1002/arch.20332; MACKIE GO, 1968, J GEN PHYSIOL, V52, P600; Matthews HJ, 2007, J INSECT PHYSIOL, V53, P75, DOI 10.1016/j.jinsphys.2006.10.007; MCFARLANE ID, 1987, J EXP BIOL, V133, P157; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Morishita F, 2003, PEPTIDES, V24, P17, DOI 10.1016/S0196-9781(02)00272-3; Nouzova M, 2012, PEPTIDES, V34, P201, DOI 10.1016/j.peptides.2011.07.025; PAEMEN L, 1991, PEPTIDES, V12, P7, DOI 10.1016/0196-9781(91)90158-L; Park C, 2002, ZOOL SCI, V19, P287, DOI 10.2108/zsj.19.287; Petri B, 2002, J EXP BIOL, V205, P1459; Riccillo FL, 2010, TISSUE CELL, V42, P355, DOI 10.1016/j.tice.2010.07.011; Rudwall AJ, 2000, J COMP NEUROL, V428, P159, DOI 10.1002/1096-9861(20001204)428:1<159::AID-CNE11>3.0.CO;2-Y; Santini MS, 2007, J EXP BIOL, V210, P1986, DOI 10.1242/jeb.004291; Santini MS, 2009, GEN COMP ENDOCR, V160, P243, DOI 10.1016/j.ygcen.2008.12.002; SCHALLER HC, 1981, P NATL ACAD SCI-BIOL, V78, P7000, DOI 10.1073/pnas.78.11.7000; SCHUCHERT P, 1993, ACTA ZOOL-STOCKHOLM, V74, P115, DOI 10.1111/j.1463-6395.1993.tb01227.x; Sheng ZT, 2007, INSECT BIOCHEM MOLEC, V37, P90, DOI 10.1016/j.ibmb.2006.09.007; Shimizu H, 2004, J COMP PHYSIOL A, V190, P623, DOI 10.1007/s00359-004-0518-3; Santini MS, 2009, BIOL RHYTHM RES, V40, P299, DOI 10.1080/09291010802214583; Squecco R, 2011, J PHYSIOL-LONDON, V589, P5231, DOI 10.1113/jphysiol.2011.214940; Sterkel M, 2010, COMP BIOCHEM PHYS A, V155, P371, DOI 10.1016/j.cbpa.2009.12.002; Takahashi T, 2008, ACTA BIOL HUNG, V59, P227, DOI 10.1556/ABiol.59.2008.Suppl.32; Takahashi T, 2000, DEVELOPMENT, V127, P997; Takahashi T, 2003, COMP BIOCHEM PHYS B, V135, P309, DOI 10.1016/S1096-4959(03)00088-5; Takahashi T, 2009, BIOESSAYS, V31, P610, DOI 10.1002/bies.200800163; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Tortiglione C, 2007, BIOCONJUGATE CHEM, V18, P829, DOI 10.1021/bc060355t; Truesdell PF, 2000, INSECT BIOCHEM MOLEC, V30, P691, DOI 10.1016/S0965-1748(00)00040-0; Veenstra JA, 1999, PEPTIDES, V20, P1145, DOI 10.1016/S0196-9781(99)00117-5; VEENSTRA JA, 1994, J EXP BIOL, V188, P347; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Vuerinckx K, 2011, INSECT BIOCHEM MOLEC, V41, P815, DOI 10.1016/j.ibmb.2011.06.003; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weyrer Simon, 1999, Memoirs of the Queensland Museum, V44, P659; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yum S, 1998, BIOCHEM BIOPH RES CO, V248, P584, DOI 10.1006/bbrc.1998.8831; Zega G, 2007, INT J DEV BIOL, V51, P307, DOI 10.1387/ijdb.062195gz; Zhang JS, 2001, DEVELOPMENT, V128, P1607	69	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77520	10.1371/journal.pone.0077520	http://dx.doi.org/10.1371/journal.pone.0077520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143240	Green Published, gold			2022-12-27	WOS:000325894100078
J	Guziewicz, KE; Zangerl, B; Komaromy, AM; Iwabe, S; Chiodo, VA; Boye, SL; Hauswirth, WW; Beltran, WA; Aguirre, GD				Guziewicz, Karina E.; Zangerl, Barbara; Komaromy, Andras M.; Iwabe, Simone; Chiodo, Vincent A.; Boye, Sanford L.; Hauswirth, William W.; Beltran, William A.; Aguirre, Gustavo D.			Recombinant AAV-Mediated BEST1 Transfer to the Retinal Pigment Epithelium: Analysis of Serotype-Dependent Retinal Effects	PLOS ONE			English	Article							CANINE MULTIFOCAL RETINOPATHY; LEBERS CONGENITAL AMAUROSIS; MACULAR DYSTROPHY; GENE-THERAPY; SUBRETINAL INJECTION; CHILDHOOD BLINDNESS; MISSENSE MUTATIONS; RPE65 MUTATIONS; IN-VIVO; MODEL	Mutations in the BEST1 gene constitute an underlying cause of juvenile macular dystrophies, a group of retinal disorders commonly referred to as bestrophinopathies and usually diagnosed in early childhood or adolescence. The disease primarily affects macular and paramacular regions of the eye leading to major declines in central vision later in life. Currently, there is no cure or surgical management for BEST1-associated disorders. The recently characterized human disease counterpart, canine multifocal retinopathy (cmr), recapitulates a full spectrum of clinical and molecular features observed in human bestrophinopathies and offers a valuable model system for development and testing of therapeutic strategies. In this study, the specificity, efficiency and safety of rAAV-mediated transgene expression driven by the human VMD2 promoter were assessed in wild-type canine retinae. While the subretinal delivery of rAAV2/1 vector serotype was associated with cone damage in the retina when BEST1 and GFP were co-expressed, the rAAV2/2 vector serotype carrying either GFP reporter or BEST1 transgene under control of human VMD2 promoter was safe, and enabled specific transduction of the RPE cell monolayer that was stable for up to 6 months post injection. These encouraging studies with the rAAV2/2 vector lay the groundwork for development of gene augmentation therapy for human bestrophinopathies.	[Guziewicz, Karina E.; Zangerl, Barbara; Komaromy, Andras M.; Iwabe, Simone; Beltran, William A.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA; [Zangerl, Barbara] Univ New S Wales, Ctr Eye Hlth, Kensington, NSW 2033, Australia; [Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Chiodo, Vincent A.; Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	University of Pennsylvania; University of New South Wales Sydney; Michigan State University; State University System of Florida; University of Florida	Guziewicz, KE (corresponding author), Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA.	karinag@vet.upenn.edu; gda@vet.upenn.edu	Zangerl, Barbara/K-7433-2016	Zangerl, Barbara/0000-0002-7470-6298; hauswirth, william/0000-0002-3244-4947; Aguirre, Gustavo/0000-0002-5228-256X	The Foundation Fighting Blindness; Macula Vision Research Foundation; National Eye Institute/National Institutes of Health [EY06855, EY17549, EY019304, EY001583, EY021721, P30 EY001583, R24EY-022012]; NATIONAL EYE INSTITUTE [U01EY006855, R01EY006855, R01EY019304, P30EY001583, P30EY021721, R24EY022012, R01EY017549] Funding Source: NIH RePORTER	The Foundation Fighting Blindness; Macula Vision Research Foundation; National Eye Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by The Foundation Fighting Blindness, Macula Vision Research Foundation, National Eye Institute/National Institutes of Health Grants EY06855, EY17549, EY019304, EY001583, EY021721, P30 EY001583, R24EY-022012, The Van Sloun Fund for Canine Genetic Research, Hope for Vision and Research to Prevent Blindness Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre GD, 2006, COLD SPRING HARB MON, V44, P291; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beltran WA, 2010, GENE THER, V17, P1162, DOI 10.1038/gt.2010.56; Beltran WA, 2005, MOL VIS, V11, P232; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Best, 1905, Z AUGENHEILKD, V13, P199, DOI [10.1159/000290318, DOI 10.1159/000290318]; Bitner H, 2012, AM J OPHTHALMOL, V154, P403, DOI 10.1016/j.ajo.2012.02.036; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Guziewicz KE, 2012, ADV EXP MED BIOL, V723, P611, DOI 10.1007/978-1-4614-0631-0_78; Guziewicz KE, 2011, INVEST OPHTH VIS SCI, V52, P4497, DOI 10.1167/iovs.10-6385; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kiang AS, 2005, MOL THER, V12, P555, DOI 10.1016/j.ymthe.2005.03.028; Kinnick TR, 2011, RETINA-J RET VIT DIS, V31, P581, DOI 10.1097/IAE.0b013e318203ee60; Komaromy AM, 2006, CELL TRANSPLANT, V15, P511, DOI 10.3727/000000006783981701; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Milenkovic VM, 2011, J CELL SCI, V124, P2988, DOI 10.1242/jcs.085878; Milenkovic VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019364; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Mowat FM, 2008, MOL VIS, V14, P2518; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pianta MJ, 2003, EXP EYE RES, V76, P203, DOI 10.1016/S0014-4835(02)00280-4; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Zangerl B, 2010, MOL VIS, V16, P2791; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	36	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75666	10.1371/journal.pone.0075666	http://dx.doi.org/10.1371/journal.pone.0075666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143172	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100007
J	Ameni, G; Tadesse, K; Hailu, E; Deresse, Y; Medhin, G; Aseffa, A; Hewinson, G; Vordermeier, M; Berg, S				Ameni, Gobena; Tadesse, Konjit; Hailu, Elena; Deresse, Yohannes; Medhin, Girmay; Aseffa, Abraham; Hewinson, Glyn; Vordermeier, Martin; Berg, Stefan			Transmission of Mycobacterium tuberculosis between Farmers and Cattle in Central Ethiopia	PLOS ONE			English	Article							CENTRAL-EUROPEAN COUNTRIES; BOVINE TUBERCULOSIS; HUMAN-POPULATIONS; DISEASE; IDENTIFICATION; EPIDEMIOLOGY; INFECTIONS; DIAGNOSIS; PULMONARY; PATHOLOGY	Background: Transmission of Mycobacterium tuberculosis (M. tuberculosis) complex could be possible between farmers and their cattle in Ethiopia. Methodology/Principal Findings: A study was conducted in mixed type multi-purposes cattle raising region of Ethiopia on 287 households (146 households with case of pulmonary tuberculosis (TB) and 141 free of TB) and 287 herds consisting of 2,033 cattle belonging to these households to evaluate transmission of TB between cattle and farmers. Interview, bacteriological examinations and molecular typing were used for human subjects while comparative intradermal tuberculin (CIDT) test, post mortem and bacteriological examinations, and molecular typing were used for animal studies. Herd prevalence of CIDT reactors was 9.4% and was higher (p<0.01) in herds owned by households with TB than in herds owned by TB free households. Animal prevalence was 1.8% and also higher (p<0.01) in cattle owned by households with TB case than in those owned by TB free households. All mycobacteria (141) isolated from farmers were M. tuberculosis, while only five of the 16 isolates from cattle were members of the M. tuberculosis complex (MTC) while the remaining 11 were members of non-tuberculosis mycobacteria (NTM). Further speciation of the five MTC isolates showed that three of the isolates were M. bovis (strain SB1176), while the remaining two were M. tuberculosis strains (SIT149 and SIT53). Pathology scoring method described by "Vordermeier et al. (2002)" was applied and the average severity of pathology in two cattle infected with M. bovis, in 11 infected with NTM and two infected with M. tuberculosis were 5.5, 2.1 and 0.5, respectively. Conclusions/Significance: The results showed that transmission of TB from farmers to cattle by the airborne route sensitizes the cows but rarely leads to TB. Similarly, low transmission of M. bovis between farmers and their cattle was found, suggesting requirement of ingestion of contaminated milk from cows with tuberculous mastitis.	[Ameni, Gobena; Tadesse, Konjit; Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Anim Hlth & Zoonot Res Unit, Addis Ababa, Ethiopia; [Ameni, Gobena; Hailu, Elena; Deresse, Yohannes; Aseffa, Abraham] Armauer Hansen Res Inst, TB Res Team, Addis Ababa, Ethiopia; [Hewinson, Glyn; Vordermeier, Martin; Berg, Stefan] Anim Hlth & Vet Labs Agcy, TB Res Grp, Addlestone, Surrey, England	Addis Ababa University; Veterinary Laboratories Agency	Ameni, G (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Anim Hlth & Zoonot Res Unit, Addis Ababa, Ethiopia.	gobenachimidi2009@yahoo.co.uk	Hewinson, Glyn/AAA-2364-2019; Hewinson, Glyn/J-1902-2014; Aseffa, Abraham/J-3248-2016; Vordermeier, H Martin/C-6936-2011; Berg, Stefan/AAU-6463-2020; Ameni, Gobena/AAR-4201-2020	Aseffa, Abraham/0000-0002-8028-1150; Berg, Stefan/0000-0002-3470-7579; Ameni, Gobena/0000-0003-3987-0671; Medhin, Girmay/0000-0003-2146-4261; Hewinson, Glyn/0000-0002-5517-4281	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are grateful to the Wellcome Trust for financially supporting this project through the programme "Animal diseases in the developing world". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 2001, ZOONOSES COMMUNICABL, VI, P283; Agonafir M, 2010, INT J TUBERC LUNG D, V14, P1259; Alexander KA, 2002, EMERG INFECT DIS, V8, P598, DOI 10.3201/eid0806.010358; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P17; Ameni G, 2008, CLIN VACCINE IMMUNOL, V15, P1272, DOI 10.1128/CVI.00114-08; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Boulahbal F, 1978, Arch Inst Pasteur Alger, V53, P155; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bruchfeld J, 2002, J CLIN MICROBIOL, V40, P1636, DOI 10.1128/JCM.40.5.1636-1643.2002; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; GRANGE JM, 1994, VET MICROBIOL, V40, P137, DOI 10.1016/0378-1135(94)90052-3; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kazwala RR, 1998, TROP ANIM HEALTH PRO, V30, P233, DOI 10.1023/A:1005075112393; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Legesse M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-187; MAGNUS K, 1966, B WORLD HEALTH ORGAN, V35, P483; Michalak K, 1998, EMERG INFECT DIS, V4, P283, DOI 10.3201/eid0402.980217; Michel AL, 2003, J ZOO WILDLIFE MED, V34, P364, DOI 10.1638/02-063; Munyeme M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-21; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Office de International Epidemiologues (OIE), 2009, TERR MAN BOV TUB, P1; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Pavlik I, 2005, VET MED-CZECH, V50, P291, DOI 10.17221/5626-VETMED; Pavlik I, 2003, VET MED-CZECH, V48, P83, DOI 10.17221/5754-VETMED; Radostits SM, 1994, VET MED TXB DIS CATT, P748; Regassa A, 2008, VET J, V178, P119, DOI 10.1016/j.tvjl.2007.06.019; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Sternberg S, 2002, J ZOO WILDLIFE MED, V33, P378, DOI 10.1638/1042-7260(2002)033[0378:SOTTIS]2.0.CO;2; Une Y, 2007, COMP IMMUNOL MICROB, V30, P415, DOI 10.1016/j.cimid.2007.05.002; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2008, GLOBAL TUBERCULOSIS; Wilton S, 1992, PCR Methods Appl, V1, P269; World Health Organization (WHO), 2009, WHOHTMTB2009426	37	43	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76891	10.1371/journal.pone.0076891	http://dx.doi.org/10.1371/journal.pone.0076891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130804	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200044
J	Du, QC; Zhang, DZ; Chen, XJ; Gui, LS; Wu, M; Xiao, WL				Du, Qi-cui; Zhang, Dai-zun; Chen, Xiu-juan; Gui Lan-Sun; Wu, Min; Xiao, Wen-lin			The Effect of p38MAPK on Cyclic Stretch in Human Facial Hypertrophic Scar Fibroblast Differentiation	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; P38 MAP KINASE; TGF-BETA; DERMAL FIBROBLASTS; IN-VITRO; SMAD; CELLS; EXPRESSION; PROLIFERATION; ACTIVATION	Hypertrophic scars (HTS), the excessive deposition of scar tissue by fibroblasts, is one of the most common skin disorders. Fibroblasts derived from surgical scar tissue produce high levels of alpha-smooth muscle actin (alpha-SMA) and transforming growth factor-beta 1 (TGF-beta 1). However, the molecular mechanisms for this phenomenon is poorly understood. Thus, the purpose of this study was to evaluate the molecular mechanisms of HTS and their potential therapeutic implications. Fibroblasts derived from skin HTS were cultured and characterized in vitro. The fibroblasts were synchronized and randomly assigned to two groups: cyclic stretch and cyclic stretch pre-treated with SB203580 (a p38MAPK inhibitor). Cyclic stretch at 10% strain was applied at a loading frequency of 10 cycles per minute (i.e. 5 seconds of tension and 5 seconds of relaxation) for 0 h, 6 h and 12 h. Cyclic stretch on HTS fibroblasts led to an increase in the expression of alpha-SMA and TGF-beta 1 mRNA and protein and the phosphorylation of p38MAPK. SB203580 reversed these effects and caused a decrease in matrix contraction. Furthermore, HTS fibroblast growth was partially blocked by p38MAPK inhibition. Therefore, the mechanism of cyclic stretch involves p38 MAPK, and its inhibition is suggested as a novel therapeutic strategy for HTS.	[Du, Qi-cui; Chen, Xiu-juan; Gui Lan-Sun; Xiao, Wen-lin] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Stomatol, Qingdao 266071, Peoples R China; [Zhang, Dai-zun] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Paediat Dent, Qingdao 266071, Peoples R China; [Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA	Qingdao University; Qingdao University; University of North Dakota Grand Forks	Wu, M (corresponding author), Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA.	min.wu@med.und.edu; wenlinxiaocn@gmail.com		Wu, Min/0000-0003-1205-982X				Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Baryza Mary Jo, 1995, Journal of Burn Care and Rehabilitation, V16, P535, DOI 10.1097/00004630-199509000-00013; Butler PD, 2008, J AM COLL SURGEONS, V206, P731, DOI 10.1016/j.jamcollsurg.2007.12.001; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Franz M, 2009, HISTOCHEM CELL BIOL, V131, P651, DOI 10.1007/s00418-009-0559-3; GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; Guo L, 2012, MOL CELL BIOCHEM, V361, P161, DOI 10.1007/s11010-011-1100-2; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Huang C, 2004, J CELL BIOL, V164, P593, DOI 10.1083/jcb.200307081; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Ishiguro S, 2009, WOUND REPAIR REGEN, V17, P617, DOI 10.1111/j.1524-475X.2009.00511.x; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kawakita T, 2013, J CELL PHYSIOL, V228, P225, DOI 10.1002/jcp.24126; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Krane M, 2011, INT J CARDIOL, V149, P221, DOI 10.1016/j.ijcard.2010.02.003; Larjava H, 2011, J CAN DENT ASSOC, V77; Lee WL, 2012, FREE RADICAL BIO MED, V52, P1423, DOI 10.1016/j.freeradbiomed.2012.01.020; Li Zhe, 2009, Zhonghua Shao Shang Za Zhi, V25, P49; Lin ZW, 2012, BURNS, V38, P404, DOI 10.1016/j.burns.2011.08.013; Macfarlane SR, 2005, BRIT J PHARMACOL, V145, P535, DOI 10.1038/sj.bjp.0706204; Nishimura K, 2007, WOUND REPAIR REGEN, V15, P646, DOI 10.1111/j.1524-475X.2007.00295.x; Nishimura K, 2009, J SURG RES, V155, P125, DOI 10.1016/j.jss.2008.07.029; Ochicha O, 2010, INDIAN J PATHOL MICR, V53, P262, DOI 10.4103/0377-4929.64341; Omori S, 2008, KIDNEY INT, V73, P1031, DOI 10.1038/ki.2008.3; Paterno J, 2011, WOUND REPAIR REGEN, V19, P49, DOI 10.1111/j.1524-475X.2010.00643.x; Stuart K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022139; Tan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009995; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varkey M, 2011, BIOMATERIALS, V32, P7581, DOI 10.1016/j.biomaterials.2011.06.070; Viera Martha H, 2010, J Clin Aesthet Dermatol, V3, P20; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	45	18	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75635	10.1371/journal.pone.0075635	http://dx.doi.org/10.1371/journal.pone.0075635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130728	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900047
J	Hakamata, Y; Iwase, M; Kato, T; Senda, K; Inada, T				Hakamata, Yuko; Iwase, Mikio; Kato, Takashi; Senda, Kohei; Inada, Toshiya			The Neural Correlates of Mindful Awareness: A Possible Buffering Effect on Anxiety-Related Reduction in Subgenual Anterior Cingulate Cortex Activity	PLOS ONE			English	Article							CEREBRAL GLUCOSE-METABOLISM; PERSONALITY-TRAITS; FUNCTIONAL NEUROANATOMY; ORBITOFRONTAL CORTEX; SELF; METAANALYSIS; DISORDERS; HEALTH; DAMAGE; FEAR	Background: Human personality consists of two fundamental elements character and temperament. Character allays automatic and preconceptual emotional responses determined by temperament. However, the neurobiological basis of character and its interplay with temperament remain elusive. Here, we examined character-temperament interplay and explored the neural basis of character, with a particular focus on the subgenual anterior cingulate cortex extending to a ventromedial portion of the prefrontal cortex (sgACC/vmPFC). Methods: Resting brain glucose metabolism (GM) was measured using [(18) F] fluorodeoxyglucose positron emission tomography in 140 healthy adults. Personality traits were assessed using the Temperament and Character Inventory. Regions of interest (ROI) analysis and whole-brain analysis were performed to examine a combination effect of temperament and character on the sgACC/vmPFC and to explore the neural correlates of character, respectively. Results: Harm avoidance (HA), a temperament trait (i.e., depressive, anxious, vulnerable), showed a significant negative impact on the sgACC/vmPFC GM, whereas self-transcendence (ST), a character trait (i.e., intuitive, judicious, spiritual), exhibited a significant positive effect on GM in the same region (HA beta = -0.248, p = 0.003; ST: beta = 0.250, p = 0.003). In addition, when coupled with strong ST, individuals with strong HA maintained the sgACC/vmPFC GM level comparable to the level of those with low scores on both HA and ST. Furthermore, exploratory whole-brain analysis revealed a significant positive relationship between ST and sgACC/vmPFC GM (peak voxel at x = -8, y = 32, z = -8, k = 423, Z = 4.41, corrected p(FDR) = 0.030). Conclusion: The current findings indicate that the sgACC/vmPFC might play a critical role in mindful awareness to something beyond as well as in emotional regulation. Developing a sense of mindfulness may temper exaggerated emotional responses in individuals with a risk for or having anxiety and depressive disorders.	[Hakamata, Yuko] Kitasato Univ, Dept Clin Psychol, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Iwase, Mikio; Senda, Kohei] Koseikai Hosp, Diagnost Imaging Ctr, Toyohashi, Aichi, Japan; [Kato, Takashi] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Clin & Expt Neuroimaging, Obu, Aichi, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Dept Psychiat, Shinjuku Ku, Tokyo, Japan	Kitasato University; National Center for Geriatrics & Gerontology	Hakamata, Y (corresponding author), Kitasato Univ, Dept Clin Psychol, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan.	hakamata@kitasato-u.ac.jp		Hakamata, Yuko/0000-0002-5717-8091; Inada, Toshiya/0000-0002-8427-5639	Japanese Society for the Promotion of Science [24683025]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Investigators A by the Japanese Society for the Promotion of Science (to Y.H., grant number: 24683025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cloninger CR, 2006, WORLD PSYCHIATRY, V5, P71; Cloninger CR, 2011, J AFFECT DISORDERS, V128, P24, DOI 10.1016/j.jad.2010.06.012; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Deckersbach T, 2006, DEPRESS ANXIETY, V23, P133, DOI 10.1002/da.20152; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M. B., 1997, STRUCTURED CLIN INTE; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gil S, 2005, J TRAUMA STRESS, V18, P563, DOI 10.1002/jts.20065; Gil S, 2006, PSYCHOSOM MED, V68, P904, DOI 10.1097/01.psy.0000242124.21796.f8; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; Hakamata Y, 2006, NEUROSCI LETT, V396, P33, DOI 10.1016/j.neulet.2005.11.017; Hakamata Y, 2009, PSYCHIAT RES-NEUROIM, V173, P206, DOI 10.1016/j.pscychresns.2008.10.002; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Kaasinen V, 2002, NEUROSCI LETT, V332, P61, DOI 10.1016/S0304-3940(02)00929-1; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Karlsson H, 2011, MOL PSYCHIATR, V16, P282, DOI 10.1038/mp.2009.126; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kuhn S., 2011, SCHIZOPHR B; Levine B, 2004, BRAIN COGNITION, V55, P54, DOI 10.1016/s0278-2626(03)00280-x; Mielke R, 1998, J NEURAL TRANSM, V105, P821, DOI 10.1007/s007020050097; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Tijssen MJA, 2010, ACTA PSYCHIAT SCAND, V122, P255, DOI 10.1111/j.1600-0447.2010.01539.x; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030; Youn T, 2002, BIOL PSYCHOL, V60, P109, DOI 10.1016/S0301-0511(02)00047-9	50	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75526	10.1371/journal.pone.0075526	http://dx.doi.org/10.1371/journal.pone.0075526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130715	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900039
J	Honda, M; Kuwano, Y; Katsuura-Kamano, S; Kamezaki, Y; Fujita, K; Akaike, Y; Kano, S; Nishida, K; Masuda, K; Rokutan, K				Honda, Manami; Kuwano, Yuki; Katsuura-Kamano, Sakurako; Kamezaki, Yoshiko; Fujita, Kinuyo; Akaike, Yoko; Kano, Shizuka; Nishida, Kensei; Masuda, Kiyoshi; Rokutan, Kazuhito			Chronic Academic Stress Increases a Group of microRNAs in Peripheral Blood	PLOS ONE			English	Article							EXPRESSION; MIR-16; SIGNATURE; RESPONSES; STATE	MicroRNAs (miRNAs) play key roles in regulation of cellular processes in response to changes in environment. In this study, we examined alterations in miRNA profiles in peripheral blood from 25 male medical students two months and two days before the National Examination for Medical Practitioners. Blood obtained one month after the examination were used as baseline controls. Levels of seven miRNAs (miR-16, -20b, -26b, -29a, -126, -144 and -144*) were significantly elevated during the pre-examination period in association with significant down-regulation of their target mRNAs (WNT4, CCM2, MAK, and FGFR1 mRNAs) two days before the examination. State anxiety assessed two months before the examination was positively and negatively correlated with miR-16 and its target WNT4 mRNA levels, respectively. Fold changes in miR-16 levels from two days before to one month after the examination were inversely correlated with those in WNT4 mRNA levels over the same time points. We also confirmed the interaction between miR-16 and WNT4 3'UTR in HEK293T cells overexpressing FLAG-tagged WNT4 3'UTR and miR-16. Thus, a distinct group of miRNAs in periheral blood may participate in the integrated response to chronic academic stress in healthy young men.	[Honda, Manami; Kuwano, Yuki; Katsuura-Kamano, Sakurako; Kamezaki, Yoshiko; Fujita, Kinuyo; Akaike, Yoko; Kano, Shizuka; Nishida, Kensei; Masuda, Kiyoshi; Rokutan, Kazuhito] Univ Tokushima, Grad Sch, Dept Stress Sci, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University	Kuwano, Y (corresponding author), Univ Tokushima, Grad Sch, Dept Stress Sci, Inst Hlth Biosci, Tokushima 770, Japan.	kuwanoy@tokushima-u.ac.jp	Nishida, Kensei/AAF-2829-2020	Nishida, Kensei/0000-0003-2314-785X	Japan Society for the Promotion of Science [22390146, 22659142]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by grants from from Grants-in-Aid for Scientific Research B (22390146) and Grant-in-Aid for Challenging Exploratory Research (22659142) from the Japan Society for the Promotion of Science (to KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Cai ZG, 2012, CAN J PHYSIOL PHARM, V90, P37, DOI [10.1139/Y11-095, 10.1139/y11-095]; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Katsuura S, 2012, NEUROSCI LETT, V516, P79, DOI 10.1016/j.neulet.2012.03.062; Kawai T, 2007, BIOL PSYCHOL, V76, P147, DOI 10.1016/j.biopsycho.2007.07.008; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kurokawa K, 2011, STRESS, V14, P431, DOI 10.3109/10253890.2011.555930; Kuwano Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024723; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Meerson A, 2010, J MOL NEUROSCI, V40, P47, DOI 10.1007/s12031-009-9252-1; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; SPIELBER.CD, 1966, J EXP PSYCHOL, V72, P589, DOI 10.1037/h0023769; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Weigelt K, 2013, BRAIN BEHAV IMMUN, V29, P147, DOI 10.1016/j.bbi.2012.12.018; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	34	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75960	10.1371/journal.pone.0075960	http://dx.doi.org/10.1371/journal.pone.0075960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130753	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900064
J	Quester, K; Avalos-Borja, M; Vilchis-Nestor, AR; Camacho-Lopez, MA; Castro-Longoria, E				Quester, Katrin; Avalos-Borja, Miguel; Rafael Vilchis-Nestor, Alfredo; Antonio Camacho-Lopez, Marco; Castro-Longoria, Ernestina			SERS Properties of Different Sized and Shaped Gold Nanoparticles Biosynthesized under Different Environmental Conditions by Neurospora crassa Extract	PLOS ONE			English	Article							ENHANCED RAMAN-SPECTROSCOPY; SURFACE-PLASMON RESONANCE; SILVER NANOPARTICLES; METAL NANOPARTICLES; BIOLOGICAL SYNTHESIS; SCATTERING; AG; NANOWIRES; PRINCIPLE; THIONINE	Surface-enhanced Raman scattering (SERS) is a surface-sensitive technique that enhances Raman scattering by molecules adsorbed on rough metal surfaces. It is known that metal nanoparticles, especially gold and silver nanoparticles, exhibit great SERS properties, which make them very attractive for the development of biosensors and biocatalysts. On the other hand, the development of ecofriendly methods for the synthesis of metallic nanostructures has become the focus of research in several countries, and many microorganisms and plants have already been used to biosynthesize metallic nanostructures. However, the majority of these are pathogenic to plants or humans. Here, we report gold nanoparticles with good SERS properties, biosynthesized by Neurospora crassa extract under different environmental conditions, increasing Raman signals up to 40 times using methylene blue as a target molecule. Incubation of tetrachloroauric acid solution with the fungal extract at 60 degrees C and a pH value of a) 3, b) 5.5, and c) 10 resulted in the formation of gold nanoparticles of a) different shapes like triangles, hexagons, pentagons etc. in a broad size range of about 10-200 nm, b) mostly quasi-spheres with some different shapes in a main size range of 6-23 nm, and c) only quasi-spheres of 3-12 nm. Analyses included TEM, HRTEM, and EDS in order to corroborate the shape and the elemental character of the gold nanoparticles, respectively. The results presented here show that these 'green' synthesized gold nanoparticles might have potential applicability in the field of biological sensing.	[Quester, Katrin; Castro-Longoria, Ernestina] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Avalos-Borja, Miguel] UNAM, CNyN, Ensenada, Baja California, Mexico; [Rafael Vilchis-Nestor, Alfredo] UAEM UNAM, CCIQS, Toluca, Mexico; [Antonio Camacho-Lopez, Marco] UAEMex, Fac Quim, Secc Espect, Lab Invest & Desarollo Mat Avanzados, Toluca, Estado De Mexic, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Mexico	Castro-Longoria, E (corresponding author), CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	VILCHIS-NESTOR, ALFREDO R/B-6776-2016; Castro-Longoria, Ernestina/GYV-4776-2022	VILCHIS-NESTOR, ALFREDO R/0000-0001-8490-0900; CAMACHO LOPEZ, MARCO/0000-0003-0779-968X; Avalos-Borja, Miguel/0000-0003-4515-6415	SEP-CONACyT [CB2011/169154]; CONACyT	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this project was provided by a SEP-CONACyT (www.conacyt.mx) grant (CB2011/169154) to ECL. We also thank CONACyT for a grant to KQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armendariz V, 2004, J NANOPART RES, V6, P377, DOI 10.1007/s11051-004-0741-4; Basavaraja S, 2008, MATER RES BULL, V43, P1164, DOI 10.1016/j.materresbull.2007.06.020; Bfilainsa KC, 2006, COLLOID SURFACE B, V47, P160, DOI 10.1016/j.colsurfb.2005.11.026; Binupriya AR, 2010, J HAZARD MATER, V177, P539, DOI 10.1016/j.jhazmat.2009.12.066; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castro-Longoria E, 2012, J MICROBIOL BIOTECHN, V22, P1000, DOI 10.4014/jmb.1110.10085; Castro-Longoria E, 2011, Colloids Surf B Biointerfaces, V83, P42, DOI 10.1016/j.colsurfb.2010.10.035; Das P, 2012, J PHYS CHEM C, V116, P25969, DOI 10.1021/jp3103782; Fayaz AM, 2009, COLLOID SURFACE B, V74, P123, DOI 10.1016/j.colsurfb.2009.07.002; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; Govender Y, 2009, BIOTECHNOL LETT, V31, P95, DOI 10.1007/s10529-008-9825-z; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; He SY, 2008, BIOTECHNOL PROGR, V24, P476, DOI 10.1021/bp0703174; Iosin M, 2008, J OPTOELECTRON ADV M, V10, P2285; Jarvis RM, 2008, ANAL CHEM, V80, P6741, DOI 10.1021/ac800838v; Joerger R, 2000, ADV MATER, V12, P407, DOI 10.1002/(SICI)1521-4095(200003)12:6<407::AID-ADMA407>3.0.CO;2-O; Kah JCY, 2007, INT J NANOMED, V2, P785; Kamat PV, 2002, J PHYS CHEM B, V106, P7729, DOI 10.1021/jp0209289; Kathiresan K, 2010, CAN J MICROBIOL, V56, P1050, DOI 10.1139/W10-094; Kim YC, 2003, CATAL TODAY, V87, P153, DOI 10.1016/j.cattod.2003.09.012; Kottmann JP, 2001, CHEM PHYS LETT, V341, P1, DOI 10.1016/S0009-2614(01)00171-3; Kottmann JP, 2000, OPT EXPRESS, V6, P213, DOI 10.1364/OE.6.000213; Kowshik M, 2003, NANOTECHNOLOGY, V14, P95, DOI 10.1088/0957-4484/14/1/321; Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g; Liu M, 2013, ANAL BIOANAL CHEM, V405, P6131, DOI 10.1007/s00216-013-7016-9; Lu L, 2006, CHEM MATER, V18, P4894, DOI 10.1021/cm0615875; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Mukherjee P, 2002, CHEMBIOCHEM, V3, P461, DOI 10.1002/1439-7633(20020503)3:5<461::AID-CBIC461>3.0.CO;2-X; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; Pastoriza-Santos I, 2007, ADV FUNCT MATER, V17, P1443, DOI 10.1002/adfm.200601071; Philip D, 2009, SPECTROCHIM ACTA A, V73, P374, DOI 10.1016/j.saa.2009.02.037; Prusinkiewicz MA, 2012, ANALYST, V137, P4934, DOI 10.1039/c2an35620a; Rodriguez-Fernandez J, 2009, J PHYS CHEM C, V113, P18623, DOI 10.1021/jp907646d; Ruan CM, 2007, LANGMUIR, V23, P5757, DOI 10.1021/la0636356; Sanghi R., 2010, ADV MAT LETT, V1, P193, DOI [10.5185/amlett.2010.5124, DOI 10.5185/AMLETT.2010.5124]; Sau TK, 2010, ADV MATER, V22, P1805, DOI 10.1002/adma.200902557; Thomas S, 2013, SPECTROCHIM ACTA A, V112, P27, DOI 10.1016/j.saa.2013.04.047; Vigneshwaran N, 2007, LANGMUIR, V23, P7113, DOI 10.1021/la063627p; Vilchis-Nestor AR, 2008, MATER LETT, V62, P3103, DOI 10.1016/j.matlet.2008.01.138; VIRDEE HR, 1988, LASER CHEM, V9, P401, DOI 10.1155/LC.9.401; Xiao GN, 2007, CHEM PHYS LETT, V447, P305, DOI 10.1016/j.cplett.2007.09.045; Xie J, 2007, J PHYS CHEM C, V111, P16858, DOI 10.1021/jp0752668; Xie JP, 2008, ACS NANO, V2, P2473, DOI 10.1021/nn800442q; Xu W, 2004, J PHYS CHEM B, V108, P5588, DOI 10.1021/jp037994a; Yoosaf K, 2007, J PHYS CHEM C, V111, P12839, DOI 10.1021/jp073923q; Zhang J. Z., 2009, OPTICAL PROPERTIES S, P205; Zhang YX, 2011, INT J NANOMED, V6, P2899, DOI 10.2147/IJN.S24785; Zhong L, 2009, CLEO PAC RIM C	48	55	55	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77486	10.1371/journal.pone.0077486	http://dx.doi.org/10.1371/journal.pone.0077486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130891	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900140
J	De Pasquale, M; Kourteva, Y; Allos, T; D'Aquila, RT				De Pasquale, MariaPia; Kourteva, Yordanka; Allos, Tara; D'Aquila, Richard T.			Lower HIV Provirus Levels Are Associated with More APOBEC3G Protein in Blood Resting Memory CD4+T Lymphocytes of Controllers In Vivo	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL-ACTIVATION; NATURAL-KILLER-CELLS; ELITE CONTROLLERS; ANTIRETROVIRAL THERAPY; EX-VIVO; EXPRESSION; REPLICATION; INFECTION; VIF	Immunodeficiency does not progress for prolonged periods in some HLA B57- and/or B27-positive subjects with human immunodeficiency virus type 1 (HIV) infection, even in the absence of antiretroviral therapy (ART). These "controllers'' have fewer HIV provirus-containing peripheral blood mononuclear cells than "non-controller'' subjects, but lymphocytes that harbor latent proviruses were not specifically examined in studies to date. Provirus levels in resting memory cells that can serve as latent reservoirs of HIV in blood were compared here between controllers and ART-suppressed non-controllers. APOBEC3G (A3G), a cellular factor that blocks provirus formation at multiple steps if not antagonized by HIV virion infectivity factor (Vif), was also studied. HLA-linked HIV control was associated with less provirus and more A3G protein in resting CD4+ T central memory (Tcm) and effector memory (Tem) lymphocytes (provirus: p = 0.01 for Tcm and p = 0.02 for Tem; A3G: p = 0.02 for Tcm and p = 0.02 for Tem). Resting memory T cells with the highest A3G protein levels (>0.5 RLU per unit of actin) had the lowest levels of provirus (<1,000 copies of DNA per million cells) in vivo (p = 0.03, Fisher's exact test). Using two different experimental approaches, Vif-positive viruses with more A3G were found to have decreased virion infectivity ex vivo. These results raise the hypothesis that HIV control is associated with increased cellular A3G that may be packaged into Vif-positive virions to add that mode of inhibition of provirus formation to previously described adaptive immune mechanisms for HIV control.	[De Pasquale, MariaPia; Kourteva, Yordanka; Allos, Tara] Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, Nashville, TN 37212 USA; [D'Aquila, Richard T.] Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [D'Aquila, Richard T.] Northwestern Univ, Dept Med, Feinberg Sch Med, Northwestern HIV Translat Res Ctr, Chicago, IL 60611 USA	Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	D'Aquila, RT (corresponding author), Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA.	richard.daquila@northwestern.edu			National Institutes of Health (NIH) [P30 AI 54999]; Vanderbilt Meharry Center for AIDS Research via Developmental Core Awards; NIH [UL1 RR024975-01]; Merck Investigator-initiated grant; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Meharry Center for AIDS Research via Developmental Core Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Investigator-initiated grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health (NIH) P30 AI 54999, Vanderbilt Meharry Center for AIDS Research via Developmental Core Awards to MPD and YK, NIH UL1 RR024975-01 Vanderbilt Institute for Clinical and Translational Research (infrastructure support, including database) and Merck Investigator-initiated grant to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2012, CHEMMEDCHEM, V7, P1217, DOI 10.1002/cmdc.201200079; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Ananworanich J., 2013, 20 C RETR OPP INF AT; Anderson JL, 2008, VIROLOGY, V375, P1, DOI 10.1016/j.virol.2008.01.042; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Buzon MJ, 2011, J VIROL, V85, P9646, DOI 10.1128/JVI.05327-11; Carbone J, 2003, AIDS, V17, P133, DOI 10.1097/00002030-200301030-00021; Casartelli N, 2010, J EXP MED, V207, P39, DOI 10.1084/jem.20091933; Cen S, 2010, J BIOL CHEM, V285, P16546, DOI 10.1074/jbc.M109.085308; Champiat S, 2013, J VIROL, V87, P6073, DOI 10.1128/JVI.00579-12; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Chen H, 2010, INT J MOL SCI, V11, P3501, DOI 10.3390/ijms11093501; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Ejima T, 2011, INT J MOL MED, V28, P613, DOI 10.3892/ijmm.2011.737; Eyzaguirre LM, 2013, VIROLOGY, V443, P306, DOI 10.1016/j.virol.2013.05.019; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fourati S, 2010, AIDS, V24, P2313, DOI 10.1097/QAD.0b013e32833e515a; Gourraud PA, 2011, HUM IMMUNOL, V72, P207, DOI 10.1016/j.humimm.2010.12.008; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Granier C, 2013, J VIROL; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kourteva Y, 2012, VIROLOGY, V430, P1, DOI 10.1016/j.virol.2012.03.018; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; Lisovsky I, 2013, INTERVIROLOGY; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Peng J, 2013, J MOL BIOL; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Persaud D, 2013, 20 C RETR OPP INF AT; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Ruiz-Mateos E, 2010, CURR HIV RES, V8, P471, DOI 10.2174/157016210793499268; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Vetter ML, 2009, J VIROL, V83, P8646, DOI 10.1128/JVI.00020-09; Vetter ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000292; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WONG JT, 1992, HUM IMMUNOL, V35, P200, DOI 10.1016/0198-8859(92)90106-W; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414	63	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76002	10.1371/journal.pone.0076002	http://dx.doi.org/10.1371/journal.pone.0076002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146808	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400030
J	Bell, MJ; Collison, M; Lord, P				Bell, Michael J.; Collison, Matthew; Lord, Phillip			Can Inferred Provenance and Its Visualisation Be Used to Detect Erroneous Annotation? A Case Study Using UniProtKB	PLOS ONE			English	Article							GENE ONTOLOGY; SEQUENCE; RESOURCE; QUALITY; DATABASE; PERCOLATION; UPDATE; ERRORS	A constant influx of new data poses a challenge in keeping the annotation in biological databases current. Most biological databases contain significant quantities of textual annotation, which often contains the richest source of knowledge. Many databases reuse existing knowledge; during the curation process annotations are often propagated between entries. However, this is often not made explicit. Therefore, it can be hard, potentially impossible, for a reader to identify where an annotation originated from. Within this work we attempt to identify annotation provenance and track its subsequent propagation. Specifically, we exploit annotation reuse within the UniProt Knowledgebase (UniProtKB), at the level of individual sentences. We describe a visualisation approach for the provenance and propagation of sentences in UniProtKB which enables a large-scale statistical analysis. Initially levels of sentence reuse within UniProtKB were analysed, showing that reuse is heavily prevalent, which enables the tracking of provenance and propagation. By analysing sentences throughout UniProtKB, a number of interesting propagation patterns were identified, covering over 100,000 sentences. Over 8000 sentences remain in the database after they have been removed from the entries where they originally occurred. Analysing a subset of these sentences suggest that approximately 30% are erroneous, whilst 35% appear to be inconsistent. These results suggest that being able to visualise sentence propagation and provenance can aid in the determination of the accuracy and quality of textual annotation. Source code and supplementary data are available from the authors website at http://homepages.cs.ncl.ac.uk/m.j.bell1/sentence_analysis/.	[Bell, Michael J.; Lord, Phillip] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Collison, Matthew] Newcastle Univ, Sch Chem Engn & Adv Mat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Lord, P (corresponding author), Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	phillip.lord@newcastle.ac.uk			Engineering and Physical Sciences Research Council (EPSRC) [EP/G037620/1]; Engineering and Physical Sciences Research Council [980567] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MJB is funded by Engineering and Physical Sciences Research Council (EPSRC) (http://www.epsrc.ac.uk/). MC is funded by EPSRC grant (EP/G037620/1) for the Engineering Doctorate in Biopharmaceutical Process Development (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Artamonova II, 2005, BIOINFORMATICS, V21, P49, DOI 10.1093/bioinformatics/bti1206; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bell MJ, 2012, BIOINFORMATICS, V28, pI562, DOI 10.1093/bioinformatics/bts372; Bridge A, 2010, UNIRULE AUTOMATIC AN, P713, DOI [10.1038/npre.2010.5247.1, DOI 10.1038/NPRE.2010.5247.1.URL]; Buza TJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-425; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dolan ME, 2005, BIOINFORMATICS, V21, pI136, DOI 10.1093/bioinformatics/bti1019; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Eisenhaber F, 1999, BIOINFORMATICS, V15, P528, DOI 10.1093/bioinformatics/15.7.528; Fernandez-Suarez XM, 2013, NUCLEIC ACIDS RES, V41, pD1, DOI 10.1093/nar/gks1297; Galperin M Y, 1998, In Silico Biol, V1, P55; Gilks WR, 2005, MATH BIOSCI, V193, P223, DOI 10.1016/j.mbs.2004.08.001; Gilks WR, 2002, BIOINFORMATICS, V18, P1641, DOI 10.1093/bioinformatics/18.12.1641; Gross A, 2009, LECT NOTES COMPUT SC, V5647, P71, DOI 10.1007/978-3-642-02879-3_7; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Leinonen R, 2006, BIOINFORMATICS, V22, P1284, DOI 10.1093/bioinformatics/btl105; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Magrane M, 2011, DATABASE, V2011; McQuilton P, 2012, DATABASE, pbas039; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Robbins RJ, 1994, PUBLISH RES Q, V10, P3; Schnoes AM, 2013, BIASES EXPT ANNOTATI; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SPARCKJONES K, 1972, J DOC, V28, P11, DOI 10.1108/eb026526; The UniProt Consortium, 2011, UNIPROT KNOWL US MAN; The UniProt Consortium, 2011, UN REL 2011 03; Ussery DW, 2004, MICROBIOL-SGM, V150, P2015, DOI 10.1099/mic.0.27338-0; Viegas F., 2004, P 2004 C HUMAN FACTO, P575, DOI DOI 10.1145/985692.985765	35	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75541	10.1371/journal.pone.0075541	http://dx.doi.org/10.1371/journal.pone.0075541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237TP	24143170	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100005
J	Choudhury, AR; Bhattacharjee, P; Prasad, GS				Choudhury, Anirban Roy; Bhattacharjee, Paramita; Prasad, Gandham S.			Development of Suitable Solvent System for Downstream Processing of Biopolymer Pullulan Using Response Surface Methodology	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; POLYSACCHARIDE; BIOSYNTHESIS; OPTIMIZATION	Downstream processing is an important aspect of all biotechnological processes and has significant implications on quality and yield of the final product. Several solvents were examined for their efficacy on pullulan precipitation from fermentation broth. Interactions among four selected solvents and their effect on pullulan yield were studied using response surface methodology. A polynomial model was developed using D-optimal design and three contour plots were generated by performing 20 different experiments and the model was validated by performing optimization experiments. The results indicated that lower concentration of ethanol in combination with the other three solvents has resulted in higher yield of polymer from fermentation broth and the optimized solvent system was able to recover 1.44 times more pullulan as compared to the conventional ethanolic precipitation method. These observations may help in enhancing efficiency of pullulan recovery from fermentation broth and also result in reduced cost of production for the final product.	[Choudhury, Anirban Roy; Prasad, Gandham S.] CSIR, CSIR Inst Microbial Technol, Chandigarh, India; [Bhattacharjee, Paramita] Jadavpur Univ, Dept Food Technol & Biochem Engn, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Jadavpur University	Choudhury, AR (corresponding author), CSIR, CSIR Inst Microbial Technol, Chandigarh, India.	anirban@imtech.res.in		BHATTACHARJEE, PARAMITA/0000-0002-5620-1675; Prasad, Gandham S/0000-0002-8557-8789	Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to Council of Scientific and Industrial Research (CSIR), Government of India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATLEY BJ, 1980, J GEN MICROBIOL, V120, P265; Chen J, 2012, CARBOHYD POLYM, V87, P771, DOI 10.1016/j.carbpol.2011.08.062; Chi ZM, 2003, ENZYME MICROB TECH, V33, P206, DOI 10.1016/S0141-0229(03)00119-4; Choudhury AR, 2012, BIOCATAL AGRIC BIOTE, V1, P232, DOI 10.1016/j.bcab.2012.02.003; Choudhury AR, 2011, CARBOHYD POLYM, V83, P1547, DOI 10.1016/j.carbpol.2010.10.003; FINKELMAN MAJ, 1982, APPL ENVIRON MICROB, V44, P121, DOI 10.1128/AEM.44.1.121-127.1982; Forabosco A, 2006, CARBOHYD POLYM, V63, P535, DOI 10.1016/j.carbpol.2005.10.005; Israilides CJ, 1998, APPL MICROBIOL BIOT, V49, P613, DOI 10.1007/s002530051222; Jakovljevic D, 2001, J SERB CHEM SOC, V66, P377, DOI 10.2298/JSC0106377J; Kachhawa DK, 2003, CARBOHYD POLYM, V52, P25, DOI 10.1016/S0144-8617(02)00261-8; Kumar D, 2012, INT J BASIC APPL SCI, V1, P202, DOI [DOI 10.14419/IJBAS.V1I3.101, 10.14419/ijbas.v1i3.101]; Lee JH, 2001, BIOTECHNOL LETT, V23, P817, DOI 10.1023/A:1010365706691; POLLOCK TJ, 1992, APPL ENVIRON MICROB, V58, P877, DOI 10.1128/AEM.58.3.877-883.1992; Raymond HM, 1995, RESPONSE SURFACE MET; Reddy PRM, 2003, PROCESS BIOCHEM, V39, P267, DOI 10.1016/S0032-9592(03)00193-0; Rekha MR, 2007, TRENDS BIOMATER ARTI, V20; SHABTAI Y, 1995, APPL MICROBIOL BIOT, V43, P595, DOI [10.1007/s002530050457, 10.1007/BF00164760]; Sharma N, 2013, CARBOHYD POLYM, V93, P95, DOI 10.1016/j.carbpol.2012.06.059; Shingel KI, 2004, CARBOHYD RES, V339, P447, DOI 10.1016/j.carres.2003.10.034; Singh RS, 2008, CARBOHYD POLYM, V73, P515, DOI 10.1016/j.carbpol.2008.01.003; Singh RS, 2010, BRAZ ARCH BIOL TECHN, V53, P1005, DOI 10.1590/S1516-89132010000500002; Weuster-Botz D, 2000, J BIOSCI BIOENG, V90, P473, DOI 10.1263/jbb.90.473	22	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77071	10.1371/journal.pone.0077071	http://dx.doi.org/10.1371/journal.pone.0077071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143200	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100035
J	Huang, L; Zhang, T; Xie, CH; Liao, X; Yu, QQ; Feng, JP; Ma, H; Dai, J; Li, M; Chen, JG; Zang, AH; Wang, Q; Ge, SW; Qin, K; Cai, J; Yuan, XL				Huang, Liu; Zhang, Tao; Xie, Conghua; Liao, Xin; Yu, Qianqian; Feng, Jueping; Ma, Hong; Dai, Jing; Li, Min; Chen, Jigui; Zang, Aihua; Wang, Qian; Ge, Shuwang; Qin, Kai; Cai, Juan; Yuan, Xianglin			SLCO1B1 and SLC19A1 Gene Variants and Irinotecan-Induced Rapid Response and Survival: A Prospective Multicenter Pharmacogenetics Study of Metastatic Colorectal Cancer	PLOS ONE			English	Article							HIGH-DOSE LEUCOVORIN; CELL LUNG-CANCER; RANDOMIZED-TRIAL; SEVERE TOXICITIES; OATP-C; FLUOROURACIL; POLYMORPHISMS; METHOTREXATE; CHEMOTHERAPY; CARCINOMA	Background: Rapid response to chemotherapy in metastatic colorectal cancer (mCRC) patients (response within 12 weeks of chemotherapy) may increase the chance of complete resection and improved survival. Few molecular markers predict irinotecan-induced rapid response and survival. Single-nucleotide polymorphisms (SNPs) in solute carrier genes are reported to correlate with the variable pharmacokinetics of irinotecan and folate in cancer patients. This study aims to evaluate the predictive role of 3 SNPs in mCRC patients treated with irinotecan and fluoropyrimidine-containing regimens. Materials and Methods: Three SNPs were selected and genotyped in 137 mCRC patients from a Chinese prospective multicenter trial (NCT01282658). The chi-squared test, univariate and multivariable logistic regression model, and receiver operating characteristic analysis were used to evaluate correlations between the genotypes and rapid response. Kaplan-Meier survival analysis and Cox proportional hazard models were used to evaluate the associations between genotypes and survival outcomes. Benjamini and Hochberg False Discovery Rate correction was used in multiple testing Results: Genotype GA/AA of SNP rs2306283 of the gene SLCO1B1 and genotype GG of SNP rs1051266 of the gene SLC19A1 were associated with a higher rapid response rate (odds ratio [OR] =3.583 and 3.521, 95%CI =1.301-9.871 and 1.271-9.804, p=0.011 and p=0.013, respectively). The response rate was 70% in patients with both genotypes, compared with only 19.7% in the remaining patients (OR = 9.489, 95%CI = 2.191-41.093, Fisher's exact test p=0.002). Their significances were all maintained even after multiple testing (all p(c) < 0.05). The rs2306283 GA/AA genotype was also an independent prognostic factor of longer progression-free survival (PFS) (hazard ratio = 0.402, 95%CI = 0.171-0.945, p=0.037). None of the SNPs predicted overall survival. Conclusions: Polymorphisms of solute carriers' may be useful to predict rapid response to irinotecan plus fluoropyrimidine and PFS in mCRC patients.	[Huang, Liu; Liao, Xin; Yu, Qianqian; Qin, Kai; Cai, Juan; Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430074, Peoples R China; [Zhang, Tao; Ma, Hong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan 430074, Peoples R China; [Xie, Conghua; Dai, Jing] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430072, Peoples R China; [Feng, Jueping; Li, Min] Huazhong Univ Sci & Technol, Wuhan Pu Ai Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430074, Peoples R China; [Chen, Jigui; Wang, Qian] Wuhan 8th Hosp, Dept Surg, Wuhan, Peoples R China; [Zang, Aihua] Hubei Canc Hosp, Wuhan, Peoples R China; [Ge, Shuwang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol, Wuhan 430074, Peoples R China; [Cai, Juan] Yijishan Hosp, Wannan Med Coll, Dept Oncol, Wuhu, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wannan Medical College	Yuan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430074, Peoples R China.	yxl@medmail.com.cn			National Natural Science Funds [81071832, 81272492]	National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Funds No. 81071832 and No. 81272492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus HHJ, 2000, INT J CANCER, V87, P771, DOI 10.1002/1097-0215(20000915)87:6<771::AID-IJC2>3.0.CO;2-V; Carlini LE, 2005, CLIN CANCER RES, V11, P1226; Cecchin E, 2009, J CLIN ONCOL, V27, P2457, DOI 10.1200/JCO.2008.19.0314; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; DELAP RJ, 1988, YALE J BIOL MED, V61, P23; Dias MM, 2012, PHARMACOGENOMICS, V13, P889, DOI [10.2217/pgs.12.68, 10.2217/PGS.12.68]; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; ERLICHMAN C, 1988, J CLIN ONCOL, V6, P469, DOI 10.1200/JCO.1988.6.3.469; Fuchs CS, 2007, J CLIN ONCOL, V25, P4779, DOI 10.1200/JCO.2007.11.3357; Han JY, 2008, LUNG CANCER, V59, P69, DOI 10.1016/j.lungcan.2007.07.019; Han JY, 2009, LUNG CANCER, V63, P115, DOI 10.1016/j.lungcan.2007.12.003; He JK, 2011, EUR J CLIN PHARMACOL, V67, P701, DOI 10.1007/s00228-011-0994-7; Hinken M, 2011, EUR J HISTOCHEM, V55, P11, DOI 10.4081/ejh.2011.e3; Kameyama Y, 2005, PHARMACOGENET GENOM, V15, P513, DOI 10.1097/01.fpc.0000170913.73780.5f; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Liu CY, 2008, CANCER-AM CANCER SOC, V112, P1932, DOI 10.1002/cncr.23370; Lopez-Lopez E, 2011, PEDIATR BLOOD CANCER, V57, P612, DOI 10.1002/pbc.23074; Luo HY, 2011, AM J CLIN ONCOL-CANC, V34, P555, DOI 10.1097/COC.0b013e3181f47ac1; Martinez-Balibrea E, 2010, BRIT J CANCER, V103, P581, DOI 10.1038/sj.bjc.6605776; McLeod HL, 2010, J CLIN ONCOL, V28, P3227, DOI 10.1200/JCO.2009.21.7943; Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857; Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909; Pasanen MK, 2008, PHARMACOGENOMICS, V9, P19, DOI 10.2217/14622416.9.1.19; Pazdur R, 2008, ONCOLOGIST, V13, P19, DOI 10.1634/theoncologist.13-S2-19; PETRELLI N, 1987, J CLIN ONCOL, V5, P1559, DOI 10.1200/JCO.1987.5.10.1559; Pulitano C, 2011, ANN SURG ONCOL, V18, P1380, DOI 10.1245/s10434-010-1459-4; Ramsey LB, 2012, GENOME RES, V22, P1, DOI 10.1101/gr.129668.111; Sai K, 2010, CANCER CHEMOTH PHARM, V66, P95, DOI 10.1007/s00280-009-1138-y; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Takane H, 2007, THER DRUG MONIT, V29, P666, DOI 10.1097/FTD.0b013e3181357364; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; VALONE FH, 1989, J CLIN ONCOL, V7, P1427, DOI 10.1200/JCO.1989.7.10.1427; van der Bol JM, 2007, J CLIN ONCOL, V25, P2719, DOI 10.1200/JCO.2006.09.6115; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Xiang XQ, 2006, PHARMACOGENET GENOM, V16, P683, DOI 10.1097/01.fpc.0000230420.05221.71; Zhang SW, 2010, CHINA CANC, V19, P356, DOI DOI 10.1093/0CCMED/KQS01]	38	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77223	10.1371/journal.pone.0077223	http://dx.doi.org/10.1371/journal.pone.0077223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143213	Green Submitted, gold, Green Published			2022-12-27	WOS:000325894100049
J	Illa, M; Eixarch, E; Batalle, D; Arbat-Plana, A; Munoz-Moreno, E; Figueras, F; Gratacos, E				Illa, Miriam; Eixarch, Elisenda; Batalle, Dafnis; Arbat-Plana, Ariadna; Munoz-Moreno, Emma; Figueras, Francesc; Gratacos, Eduard			Long-Term Functional Outcomes and Correlation with Regional Brain Connectivity by MRI Diffusion Tractography Metrics in a Near-Term Rabbit Model of Intrauterine Growth Restriction	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; ATTENTION DEFICIT/HYPERACTIVITY DISORDER; WHITE-MATTER ABNORMALITIES; ANTERIOR CINGULATE CORTEX; OBJECT-RECOGNITION MEMORY; PREFRONTAL CORTEX; FETAL-GROWTH; BORN SMALL; STRUCTURAL CONNECTIVITY; DEVELOPMENTAL-CHANGES	Background: Intrauterine growth restriction (IUGR) affects 5-10% of all newborns and is associated with increased risk of memory, attention and anxiety problems in late childhood and adolescence. The neurostructural correlates of long-term abnormal neurodevelopment associated with IUGR are unknown. Thus, the aim of this study was to provide a comprehensive description of the long-term functional and neurostructural correlates of abnormal neurodevelopment associated with IUGR in a near-term rabbit model (delivered at 30 days of gestation) and evaluate the development of quantitative imaging biomarkers of abnormal neurodevelopment based on diffusion magnetic resonance imaging (MRI) parameters and connectivity. Methodology: At + 70 postnatal days, 10 cases and 11 controls were functionally evaluated with the Open Field Behavioral Test which evaluates anxiety and attention and the Object Recognition Task that evaluates short-term memory and attention. Subsequently, brains were collected, fixed and a high resolution MRI was performed. Differences in diffusion parameters were analyzed by means of voxel-based and connectivity analysis measuring the number of fibers reconstructed within anxiety, attention and short-term memory networks over the total fibers. Principal Findings: The results of the neurobehavioral and cognitive assessment showed a significant higher degree of anxiety, attention and memory problems in cases compared to controls in most of the variables explored. Voxel-based analysis (VBA) revealed significant differences between groups in multiple brain regions mainly in grey matter structures, whereas connectivity analysis demonstrated lower ratios of fibers within the networks in cases, reaching the statistical significance only in the left hemisphere for both networks. Finally, VBA and connectivity results were also correlated with functional outcome. Conclusions: The rabbit model used reproduced long-term functional impairments and their neurostructural correlates of abnormal neurodevelopment associated with IUGR. The description of the pattern of microstructural changes underlying functional defects may help to develop biomarkers based in diffusion MRI and connectivity analysis.	[Illa, Miriam; Eixarch, Elisenda; Figueras, Francesc; Gratacos, Eduard] Hosp Clin Barcelona, Dept Maternal Fetal Med, Inst Clin Ginecol Obstet & Neonatol ICGON, Barcelona, Spain; [Illa, Miriam; Eixarch, Elisenda; Batalle, Dafnis; Arbat-Plana, Ariadna; Munoz-Moreno, Emma; Figueras, Francesc; Gratacos, Eduard] Univ Barcelona, Fetal & Perinatal Med Res Grp, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Eixarch, Elisenda; Figueras, Francesc; Gratacos, Eduard] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gratacos, E (corresponding author), Hosp Clin Barcelona, Dept Maternal Fetal Med, Inst Clin Ginecol Obstet & Neonatol ICGON, Barcelona, Spain.	egratacos@clinic.ub.es	Batalle, Dafnis/H-7531-2019; Muñoz-Moreno, Emma/A-2363-2016; Muñoz-Moreno, Emma/ABD-6424-2021; Gratacos, Eduard/AAR-4939-2020	Batalle, Dafnis/0000-0003-2097-979X; Muñoz-Moreno, Emma/0000-0003-2104-7265; Muñoz-Moreno, Emma/0000-0003-2104-7265; Gratacos, Eduard/0000-0002-7405-7224; Arbat-Plana, Ariadna/0000-0003-0479-8323; Illa, Miriam/0000-0002-8366-830X; Eixarch, Elisenda/0000-0001-7379-9608	Fondo de Investigacion Sanitaria [PI08/0230, PI12/00851]; Rio Hortega grant [CM11/00032]; Sara Borrell grant [CD11/00048]; Instituto de Salud Carlos III; Obra Social "la Caixa"; Hospital Clinic	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Rio Hortega grant; Sara Borrell grant; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Obra Social "la Caixa"(La Caixa Foundation); Hospital Clinic	This work was supported by Fondo de Investigacion Sanitaria (PI08/0230 and PI12/00851), Rio Hortega grant (CM11/00032 to M. I.) and Sara Borrell grant (CD11/00048 to E. M.) from Instituto de Salud Carlos III; "Obra Social "la Caixa"; and Emili Letang fellowship by Hospital Clinic (to M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Alati R, 2009, INT J EPIDEMIOL, V38, P1390, DOI 10.1093/ije/dyp252; Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Balasch J, 2011, FETAL DIAGN THER, V29, P263, DOI 10.1159/000323142; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bassan H, 2000, PEDIATR NEPHROL, V15, P192, DOI 10.1007/s004670000457; Bassan H, 2011, PEDIATR NEUROL, V44, P122, DOI 10.1016/j.pediatrneurol.2010.09.012; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Battaglia FP, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00036; Berman J I, 2011, AJNR Am J Neuroradiol, V32, pE21, DOI 10.3174/ajnr.A1975; Bouet V, 2003, BEHAV BRAIN RES, V139, P97, DOI 10.1016/S0166-4328(02)00085-2; Brown MW, 2010, HIPPOCAMPUS, V20, P1228, DOI 10.1002/hipo.20858; Butler RK, 2012, EXP NEUROL, V238, P52, DOI 10.1016/j.expneurol.2012.08.002; Cowan N, 1999, CHILD DEV, V70, P1082, DOI 10.1111/1467-8624.00080; D'Arceuil H, 2008, DEV NEUROSCI-BASEL, V30, P262, DOI 10.1159/000110503; Daenen EWPM, 2001, BRAIN RES, V918, P153, DOI 10.1016/S0006-8993(01)02987-0; de Bruin N, 2006, PHARMACOL BIOCHEM BE, V85, P253, DOI 10.1016/j.pbb.2006.08.007; de Zeeuw P, 2012, HUM BRAIN MAPP, V33, P1941, DOI 10.1002/hbm.21335; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Delatour B, 2002, EUR J NEUROSCI, V15, P1400, DOI 10.1046/j.1460-9568.2002.01973.x; Delcour M, 2012, BEHAV BRAIN RES, V232, P233, DOI 10.1016/j.bbr.2012.03.029; Delcour M, 2012, BRAIN PATHOL, V22, P1, DOI 10.1111/j.1750-3639.2011.00504.x; Dere E, 2006, NEUROSCI BIOBEHAV R, V30, P1206, DOI 10.1016/j.neubiorev.2006.09.005; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Duncan GE, 1996, BRAIN RES, V713, P79, DOI 10.1016/0006-8993(95)01486-1; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Einarsson EO, 2012, LEARN MEMORY, V19, P449, DOI 10.1101/lm.027227.112; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Emond V, 2009, ENCEPHALE, V35, P107, DOI 10.1016/j.encep.2008.01.005; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Ennaceur A, 1997, BEHAV BRAIN RES, V88, P181, DOI 10.1016/S0166-4328(97)02297-3; Feldman R, 2006, PEDIATRICS, V118, pE869, DOI 10.1542/peds.2005-2040; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hall FS, 2012, PHYSIOL BEHAV, V107, P623, DOI 10.1016/j.physbeh.2012.05.014; Hardee JE, 2008, SOC COGN AFFECT NEUR, V3, P47, DOI 10.1093/scan/nsn001; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders, 2011, SEX DIFF IMPL TRANSL; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; KOOB GF, 1993, CIBA F SYMP, V172, P277; Kowalska D BP, 2008, ETH WELF 2008 9 WORL; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Larvaron P, 2007, NMR BIOMED, V20, P413, DOI 10.1002/nbm.1082; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Marsal K, 2002, CURR OPIN OBSTET GYN, V14, P127, DOI 10.1097/00001703-200204000-00005; Martin-Fernandez M, 2007, MAGN RESON IMAGING, V25, P278, DOI 10.1016/j.mri.2006.05.001; McCarton CM, 1996, PEDIATRICS, V98, P1167; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Merker B, 2007, BEHAV BRAIN SCI, V30, P63, DOI 10.1017/S0140525X07000891; Miller MM, 2012, BEHAV BRAIN RES, V229, P280, DOI 10.1016/j.bbr.2012.01.029; Modi S, 2013, BEHAV BRAIN RES, V238, P188, DOI 10.1016/j.bbr.2012.10.007; Moorman WJ, 2000, ANDROLOGIA, V32, P285, DOI 10.1046/j.1439-0272.2000.00400.x; Morsing E, 2011, PEDIATRICS, V127, pE874, DOI 10.1542/peds.2010-1821; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Munoz-Moreno E, 2009, COMPUT BIOL MED, V39, P251, DOI 10.1016/j.compbiomed.2008.12.011; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; OLTON DS, 1981, EXP BRAIN RES, V41, P380; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Ortibus E, 2012, DEV MED CHILD NEUROL, V54, P38, DOI 10.1111/j.1469-8749.2011.04147.x; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Powell HWR, 2004, NEUROIMAGE, V22, P740, DOI 10.1016/j.neuroimage.2004.01.011; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Rha DW, 2012, NEURORADIOLOGY, V54, P615, DOI 10.1007/s00234-011-0996-2; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; ROYSTON P, 1993, STAT MED, V12, P181, DOI 10.1002/sim.4780120209; Roze E, 2012, NEURORADIOLOGY, V54, P507, DOI 10.1007/s00234-011-0969-5; Salami M, 2003, P NATL ACAD SCI USA, V100, P6174, DOI 10.1073/pnas.0937380100; Sanz-Cortes M, 2013, FETAL DIAGN THER, V33, P122, DOI 10.1159/000346566; Sanz-Cortes M, 2010, ULTRASOUND OBST GYN, V36, P159, DOI 10.1002/uog.7724; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Scherjon S, 2000, PEDIATRICS, V105, P385, DOI 10.1542/peds.105.2.385; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Spampinato MV, 2009, J NEUROPSYCH CLIN N, V21, P199, DOI 10.1176/appi.neuropsych.21.2.199; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Tamm L, 2012, PSYCHIAT RES-NEUROIM, V202, P150, DOI 10.1016/j.pscychresns.2012.04.001; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tideman E, 2007, ULTRASOUND OBST GYN, V29, P614, DOI 10.1002/uog.4042; Toft PB, 1999, PEDIATR NEUROL, V21, P602, DOI 10.1016/S0887-8994(99)00046-6; Tolcos M, 2011, EXP NEUROL, V232, P53, DOI 10.1016/j.expneurol.2011.08.002; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Toussaint N., 2007, P MICCAI 07 WORKSH I; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Vasiliadis HM, 2010, DEPRESS ANXIETY, V27, P1066, DOI 10.1002/da.20739; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; WALSH RN, 1975, PSYCHOL BULL, V82, P986; Wang S, 2009, AM J NEURORADIOL, V30, P1907, DOI 10.3174/ajnr.A1697; Wang Y, 2012, PSYCHIAT RES-NEUROIM, V202, P245, DOI 10.1016/j.pscychresns.2012.01.005; Wang Y, 2012, BBA-MOL BASIS DIS, V1822, P423, DOI 10.1016/j.bbadis.2011.08.002; Watanabe Y, 2012, NEUROSCI BIOBEHAV R, V36, P134, DOI 10.1016/j.neubiorev.2011.05.003; Weible AP, 2012, J NEUROSCI, V32, P5598, DOI 10.1523/JNEUROSCI.5265-11.2012; Weible AP, 2009, J NEUROPHYSIOL, V102, P2055, DOI 10.1152/jn.00214.2009; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Yin XT, 2013, HUM BRAIN MAPP, V34, P796, DOI 10.1002/hbm.21477; Zhao P, 2005, NEUROBIOL DIS, V20, P871, DOI 10.1016/j.nbd.2005.05.024; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	127	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76453	10.1371/journal.pone.0076453	http://dx.doi.org/10.1371/journal.pone.0076453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143189	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100024
J	Spangenberg, L; Correa, A; Dallagiovanna, B; Naya, H				Spangenberg, Lucia; Correa, Alejandro; Dallagiovanna, Bruno; Naya, Hugo			Role of Alternative Polyadenylation during Adipogenic Differentiation: An In Silico Approach	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; 3' UNTRANSLATED REGIONS; MESSENGER-RNAS; EXPRESSION; MICRORNAS; MOUSE; TRANSCRIPTOME; PLURIPOTENCY; DETERMINANTS; NETWORKS	Post-transcriptional regulation of stem cell differentiation is far from being completely understood. Changes in protein levels are not fully correlated with corresponding changes in mRNAs; the observed differences might be partially explained by post-transcriptional regulation mechanisms, such as alternative polyadenylation. This would involve changes in protein binding, transcript usage, miRNAs and other non-coding RNAs. In the present work we analyzed the distribution of alternative transcripts during adipogenic differentiation and the potential role of miRNAs in post-transcriptional regulation. Our in silico analysis suggests a modest, consistent, bias in 3'UTR lengths during differentiation enabling a fine-tuned transcript regulation via small non-coding RNAs. Including these effects in the analyses partially accounts for the observed discrepancies in relative abundance of protein and mRNA.	[Spangenberg, Lucia; Naya, Hugo] Inst Pasteur Montevideo, Bioinformat Unit, Montevideo, Uruguay; [Correa, Alejandro; Dallagiovanna, Bruno] Fiocruz Parana, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Naya, Hugo] Univ Republ, Dept Prod Anim & Pasturas, Fac Agron, Curitiba, Parana, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Fundacao Oswaldo Cruz	Naya, H (corresponding author), Inst Pasteur Montevideo, Bioinformat Unit, Montevideo, Uruguay.	naya@pasteur.edu.uy	Dallagiovanna, Bruno/AAA-3603-2019	Dallagiovanna, Bruno/0000-0001-6992-7048; Naya, Hugo/0000-0001-6982-4399	Ministerio da Saude; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; FIOCRUZ-Pasteur Research Program; Fundacao Araucaria; ANII (Agencia Nacional de Investigacion e Innovacion, Uruguay)	Ministerio da Saude; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ-Pasteur Research Program; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); ANII (Agencia Nacional de Investigacion e Innovacion, Uruguay)	This work was supported by grants from Ministerio da Saude and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, FIOCRUZ-Pasteur Research Program and Fundacao Araucaria. Lucia Spangenberg received a fellowship from ANII (Agencia Nacional de Investigacion e Innovacion, Uruguay); Bruno Dallagiovanna was supported by CNPq, Hugo Naya by FIOCRUZ-Pasteur and Alejandro Correa received a fellowship from Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyle AJ, 2010, METHODS MOL BIOL, V660, P65, DOI 10.1007/978-1-60761-705-1_5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Fernandez-Tresguerres B, 2010, P NATL ACAD SCI USA, V107, P19955, DOI 10.1073/pnas.1010708107; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Fromm-Dornieden C, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-9; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gentleman R, 2012, MICRORNA DATA FUNCTI; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hu ZH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-594; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaager K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038833; Jain M, 2005, CORONARY ARTERY DIS, V16, P93, DOI 10.1097/00019501-200503000-00003; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kasashima K, 2004, BIOCHEM BIOPH RES CO, V322, P403, DOI 10.1016/j.bbrc.2004.07.130; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Kolle G, 2011, GENOME RES, V21, P2014, DOI 10.1101/gr.119321.110; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liaw HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056958; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Meenhuis A, 2011, BLOOD, V118, P916, DOI 10.1182/blood-2011-02-336487; Molina H, 2009, J PROTEOME RES, V8, P48, DOI 10.1021/pr800650r; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Rosenbaum Andrew J, 2008, Organogenesis, V4, P23; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Song L, 2006, STEM CELLS, V24, P1707, DOI 10.1634/stemcells.2005-0604; Spangenberg L, 2013, STEM CELL RES, V1, P341; Stevens SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057625; Tae SK, 2006, J CELLULAR PHYSL, V1, P341; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuller T, 2007, PLOS COMPUTATIONAL B, V3, P10; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Uccelli A, 2008, AUTOIMMUNITY, V41, P592, DOI 10.1080/08916930802200166; Zambelli F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-534; Zhang J, 2012, J BIOL CHEM; Zhang R, 2013, FRONT MED-PRC, V7, P223, DOI 10.1007/s11684-013-0252-8	50	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75578	10.1371/journal.pone.0075578	http://dx.doi.org/10.1371/journal.pone.0075578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143171	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100006
J	Bernth-Jensen, JM; Sogaard, OS				Bernth-Jensen, Jens Magnus; Sogaard, Ole Schmeltz			Polysaccharide Responsiveness Is Not Biased by Prior Pneumococcal-Conjugate Vaccination	PLOS ONE			English	Article							HIV-INFECTED ADULTS; PRIMARY IMMUNODEFICIENCY; RECURRENT INFECTIONS; IMMUNOLOGICAL MEMORY; DIAGNOSIS; RESPONSES; RELEVANCE; VACCINES; CHILDREN	Polysaccharide responsiveness is tested by measuring antibody responses to polysaccharide vaccines to diagnose for humoral immunodeficiency. A common assumption is that this responsiveness is biased by any previous exposure to the polysaccharides in the form of protein-coupled polysaccharide vaccines, such as those used in many childhood vaccination programmes. To examine this assumption, we investigated the effect of protein-coupled polysaccharide vaccination on subsequent polysaccharide responsiveness. HIV-infected adults (n = 47) were vaccinated twice with protein-coupled polysaccharides and six months later with pure polysaccharides. We measured immunoglobulin G responses against three polysaccharides present in only the polysaccharide vaccine (non-memory polysaccharides) and seven recurring polysaccharides (memory polysaccharides). Responsiveness was evaluated according to the consensus guidelines published by the American immunology societies. Impaired responsiveness to non-memory polysaccharides was more frequent than to memory polysaccharides (51% versus 28%, P = 0.015), but the individual polysaccharides did not differ in triggering sufficient responses (74% versus 77%, P = 0.53). Closer analysis revealed important shortcomings of the current evaluation guidelines. The interpreted responses number and their specificities influenced the likelihood of impaired responsiveness in a complex manor. This influence was propelled by the dichotomous approaches inherent to the American guidelines. We therefore define a novel more robust polysaccharide responsiveness measure, the Z-score, which condenses multiple, uniformly weighted responses into one continuous variable. Using the Z-score, responsiveness to non-memory polysaccharides and memory-polysaccharides were found to correlate (R-2 = 0.59, P < 0.0001). We found that polysaccharide responsiveness was not biased by prior protein-coupled polysaccharide vaccination in HIV-infected adults. Studies in additional populations are warranted.	[Bernth-Jensen, Jens Magnus] Aarhus Univ Hosp, Dept Clin Immunol, Aalborg Hosp, DK-8000 Aarhus, Denmark; [Sogaard, Ole Schmeltz] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University	Bernth-Jensen, JM (corresponding author), Aarhus Univ Hosp, Int Ctr Immunodeficiency, DK-8000 Aarhus, Denmark.	jejensen@rm.dk	Søgaard, Ole Schmeltz/AEP-7968-2022; Søgaard, Ole S/P-6058-2016; Bernth-Jensen, Jens Magnus/H-6694-2019	Søgaard, Ole Schmeltz/0000-0001-9107-2023; Bernth Jensen, Jens Magnus/0000-0002-5004-7822	University of Aarhus	University of Aarhus	OSS was a recipient of a fellowship from the University of Aarhus. JMB was employed by the public Danish hospital Aarhus University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RS, 2012, J ALLERGY CLIN IMMUN, V130, P558, DOI 10.1016/j.jaci.2012.06.013; Ballow M, 2008, CLIN REV ALLERG IMMU, V34, P129, DOI 10.1007/s12016-007-8041-2; Bernth-Jensen JM, 2011, J IMMUNOL METHODS, V373, P26, DOI 10.1016/j.jim.2011.07.017; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Borgers H, 2010, CLIN IMMUNOL, V134, P198, DOI 10.1016/j.clim.2009.10.006; de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142; de Voer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023497; Feikin DR, 2001, VACCINE, V20, P545, DOI 10.1016/S0264-410X(01)00347-4; Goldblatt D, 2009, CLIN INFECT DIS, V49, P1318, DOI 10.1086/606046; Javier FC, 2000, ANN ALLERG ASTHMA IM, V84, P25, DOI 10.1016/S1081-1206(10)62736-6; Jeurissen A, 2007, CLIN CHEM, V53, P505, DOI 10.1373/clinchem.2006.080051; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Kamchaisatian W, 2006, J ALLERGY CLIN IMMUN, V118, P1336, DOI 10.1016/j.jaci.2006.09.036; Lesprit P, 2007, AIDS, V21, P2425, DOI 10.1097/QAD.0b013e3282887e91; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Oliveira JB, 2010, J ALLERGY CLIN IMMUN, V125, pS297, DOI 10.1016/j.jaci.2009.08.043; Penaranda M, 2010, AIDS, V24, P1226, DOI 10.1097/QAD.0b013e3283389de5; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Rose MA, 2005, CLIN DIAGN LAB IMMUN, V12, P1216, DOI 10.1128/CDLI.12.10.1216-1222.2005; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112	20	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75944	10.1371/journal.pone.0075944	http://dx.doi.org/10.1371/journal.pone.0075944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146796	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400028
J	Chang, JM; Taly, JF; Erb, I; Sung, TY; Hsu, WL; Tang, CY; Notredame, C; Su, ECY				Chang, Jia-Ming; Taly, Jean-Francois; Erb, Ionas; Sung, Ting-Yi; Hsu, Wen-Lian; Tang, Chuan Yi; Notredame, Cedric; Su, Emily Chia-Yu			Efficient and Interpretable Prediction of Protein Functional Classes by Correspondence Analysis and Compact Set Relations	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION PREDICTION; MULTIPLE SEQUENCE ALIGNMENT; SUPPORT VECTOR MACHINES; CLASSIFICATION; ALGORITHM; BINDING; SIGNALP	Predicting protein functional classes such as localization sites and modifications plays a crucial role in function annotation. Given a tremendous amount of sequence data yielded from high-throughput sequencing experiments, the need of efficient and interpretable prediction strategies has been rapidly amplified. Our previous approach for subcellular localization prediction, PSLDoc, archives high overall accuracy for Gram-negative bacteria. However, PSLDoc is computational intensive due to incorporation of homology extension in feature extraction and probabilistic latent semantic analysis in feature reduction. Besides, prediction results generated by support vector machines are accurate but generally difficult to interpret. In this work, we incorporate three new techniques to improve efficiency and interpretability. First, homology extension is performed against a compact non-redundant database using a fast search model to reduce running time. Second, correspondence analysis (CA) is incorporated as an efficient feature reduction to generate a clear visual separation of different protein classes. Finally, functional classes are predicted by a combination of accurate compact set (CS) relation and interpretable one-nearest neighbor (1-NN) algorithm. Besides localization data sets, we also apply a human protein kinase set to validate generality of our proposed method. Experiment results demonstrate that our method make accurate prediction in a more efficient and interpretable manner. First, homology extension using a fast search on a compact database can greatly accelerate traditional running time up to twenty-five times faster without sacrificing prediction performance. This suggests that computational costs of many other predictors that also incorporate homology information can be largely reduced. In addition, CA can not only efficiently identify discriminative features but also provide a clear visualization of different functional classes. Moreover, predictions based on CS achieve 100% precision. When combined with 1-NN on unpredicted targets by CS, our method attains slightly better or comparable performance compared with the state-of-the-art systems.	[Chang, Jia-Ming; Erb, Ionas; Notredame, Cedric] CRG, Barcelona, Spain; [Chang, Jia-Ming; Taly, Jean-Francois; Erb, Ionas; Notredame, Cedric] UPF, Barcelona, Spain; [Taly, Jean-Francois] CRG, Bioinformat Core Facil, Barcelona, Spain; [Sung, Ting-Yi; Hsu, Wen-Lian] Acad Sinica, Inst Informat Sci, Bioinformat Lab, Taipei, Taiwan; [Tang, Chuan Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Tang, Chuan Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Su, Emily Chia-Yu] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Academia Sinica - Taiwan; National Tsing Hua University; Providence University - Taiwan; Taipei Medical University	Su, ECY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan.	emilysu@tmu.edu.tw	Sung, Ting-Yi/AAQ-5413-2021; Chang, Jia-Ming/A-5642-2008; Hsu, Wen-Lian/ABB-2851-2020; notredame, cedric/G-3868-2010	Sung, Ting-Yi/0000-0002-6028-0409; Chang, Jia-Ming/0000-0002-6711-1739; Hsu, Wen-Lian/0000-0001-7061-3513; notredame, cedric/0000-0003-1461-0988; Erb, Ionas/0000-0002-2331-9714	National Science Council [NSC101-2221-E-038-014]; "Caixa'' pre-doctoral fellowship; Centre de Regulacio Genomica (CRG); Plan Nacional [BFU2011-28575]; Ministerio de Economia y Competitividad	National Science Council(Ministry of Science and Technology, Taiwan); "Caixa'' pre-doctoral fellowship; Centre de Regulacio Genomica (CRG); Plan Nacional; Ministerio de Economia y Competitividad(Spanish Government)	The research was supported in part by National Science Council under grant NSC101-2221-E-038-014 to Emily Chia-Yu Su. Jia-Ming Chang and Cedric Notredame are funded by "a Caixa'' pre-doctoral fellowship, the Centre de Regulacio Genomica (CRG) and the Plan Nacional (BFU2011-28575) funded by the Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Chang JM, 2008, PROTEINS, V72, P693, DOI 10.1002/prot.21944; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; Chang JM, 2002, COMPACT SET NEIGHBOR; Chang JM, 2002, COMPACT SET RELATION; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Cormen Thomas H., 2009, INTRO ALGORITHMS; DEKEL E, 1992, INFORM PROCESS LETT, V44, P285, DOI 10.1016/0020-0190(92)90215-H; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fleissner R, 2005, SYST BIOL, V54, P548, DOI 10.1080/10635150590950371; Greenacre M., 2010, BIPLOTS PRACTICE; Greenacre Michael, 1984, THEORY APPL CORRES A; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hawkins J, 2007, J PROTEOME RES, V6, P1402, DOI 10.1021/pr060564n; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karypis G, 2006, PROTEINS, V64, P575, DOI 10.1002/prot.21036; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kim SK, 1996, INFORM PROCESS LETT, V57, P335, DOI 10.1016/0020-0190(96)00017-8; Korf I., 2003, BLAST OREILLY MEDIA; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lin HN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S8; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; SCHIEBER B, 1988, SIAM J COMPUT, V17, P1253, DOI 10.1137/0217079; Su ECY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-330; Su ECY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S13; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Wang JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-174; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang SL, 2012, J BIOMOL STRUCT DYN, V29, P634, DOI 10.1080/07391102.2011.672627; ZIVKOVIC D, 1991, INFORM PROCESS LETT, V38, P339, DOI 10.1016/0020-0190(91)90092-V	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75542	10.1371/journal.pone.0075542	http://dx.doi.org/10.1371/journal.pone.0075542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146760	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400011
J	Otte, JC; Keiter, S; Fassbender, C; Higley, EB; Rocha, PS; Brinkmann, M; Wahrendorf, DS; Manz, W; Wetzel, MA; Braunbeck, T; Giesy, JP; Hecker, M; Hollert, H				Otte, Jens C.; Keiter, Steffen; Fassbender, Christopher; Higley, Eric B.; Rocha, Paula Suares; Brinkmann, Markus; Wahrendorf, Dierk-Steffen; Manz, Werner; Wetzel, Markus A.; Braunbeck, Thomas; Giesy, John P.; Hecker, Markus; Hollert, Henner			Contribution of Priority PAHs and POPs to Ah Receptor-Mediated Activities in Sediment Samples from the River Elbe Estuary, Germany	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; EFFECT-DIRECTED ANALYSIS; DIBENZO-P-DIOXINS; O-DEETHYLASE INDUCTION; SUSPENDED PARTICULATE MATTER; TRACE ORGANIC CONTAMINANTS; IN-VITRO BIOASSAY; POLYCHLORINATED NAPHTHALENES; RELATIVE POTENCIES; MASAN BAY	The estuary of the River Elbe between Hamburg and the North Sea (Germany) is a sink for contaminated sediment and suspended particulate matter (SPM). One major concern is the effect of human activities on the hydrodynamics, particularly the intensive dredging activities in this area that may result in remobilization of sediment-bound pollutants. The aim of this study was to identify pollutants contributing to the toxicological risk associated with re-suspension of sediments in the Elbe Estuary by use of an effect-directed analysis that combines chemical and biological analyses in with specific fractionation techniques. Sediments were collected from sites along the Elbe Estuary and a site from a small harbor basin of the Elbe Estuary that is known to be polluted. The sixteen priority EPA-PAHs were quantified in organic extracts of sediments. In addition, dioxin equivalents of sediments were investigated by use of the 7-ethoxyresorufin O-deethylase assay with RTL-W1 cells and the Ah receptor-mediated luciferase transactivation assay with H4IIE-luc cells. Quantification of the 16 priority PAHs revealed that sediments were moderately contaminated at all of the sites in the Elbe River Estuary (<0.02-0.906 mu g/g dw). Sediments contained relatively small concentrations of dioxin equivalents (Bio-TEQ) with concentrations ranging from 15.5 to 322 pg/g dw, which were significantly correlated with dioxin equivalents calculated based on toxicity reference values and concentrations of PAH. The concentration of Bio-TEQ at the reference site exceeded 200,000 pg/g dw. In a potency balance the 16 PAHs explained between 47 and 118% of the Bio-TEQ in the luciferase assay, which can be explained by the constant input of PAHs bound to SPM from the upper course of the Elbe River into its estuary. Successful identification of a significant portion of dioxin-like activity to priority PAHs in complex environmental samples such as sediments has rarely been reported.	[Otte, Jens C.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Fassbender, Christopher; Rocha, Paula Suares; Braunbeck, Thomas] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Keiter, Steffen; Brinkmann, Markus; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res, Aachen, Germany; [Wahrendorf, Dierk-Steffen] Fed Inst Hydrol, Dept Biochem & Ecotoxicol, Koblenz, Germany; [Wetzel, Markus A.] Fed Inst Hydrol, Dept Anim Ecol, Koblenz, Germany; [Manz, Werner] Univ Koblenz Landau, Inst Integrierte Nat Wissensch, Koblenz, Germany; [Higley, Eric B.; Giesy, John P.; Hecker, Markus] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Hecker, Markus] Univ Saskatchewan, Sch,Environm & Sustainabil, Saskatoon, SK, Canada; [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Giesy, John P.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Giesy, John P.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Giesy, John P.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] City Univ Hong Kong, State Key Lab Marine Pollut, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; RWTH Aachen University; University of Koblenz & Landau; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Michigan State University; Michigan State University; City University of Hong Kong; City University of Hong Kong; University of Hong Kong	Otte, JC (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany.	Jens.Otte@kit.edu; Henner.Hollert@bio5.rwth-aachen.de	Brinkmann, Markus/L-3879-2013; Hollert, Henner/A-1027-2009	Brinkmann, Markus/0000-0002-4985-263X; Hollert, Henner/0000-0001-5776-5619; Giesy, John/0000-0003-1931-9962; Wetzel, Markus/0000-0001-6321-5269; Keiter, Steffen/0000-0002-2356-6686	Canada Foundation for Infrastructure; Canada Research Chair program	Canada Foundation for Infrastructure; Canada Research Chair program(Canada Research Chairs)	The authors wish to acknowledge the support of an instrumentation grant from the Canada Foundation for Infrastructure. Profs. Giesy and Hecker were supported by the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlf Wolfgang, 2002, Journal of Soils and Sediments, V2, P37, DOI 10.1007/BF02991249; [Anonymous], 2005, DINISO16703S; Barron MG, 2004, TOXICOL SCI, V78, P60, DOI 10.1093/toxsci/kfh051; Benedetti M, 2012, ENVIRON INT, V38, P17, DOI 10.1016/j.envint.2011.08.003; BfG, 2008, WSV SED TID STRAT PO; Birnbaum LS, 2003, ENVIRON INT, V29, P855, DOI 10.1016/S0160-4120(03)00106-5; Bittner M, 2006, ENVIRON TOXICOL, V21, P338, DOI 10.1002/tox.20185; Blahova J, 2010, ENVIRON TOXICOL CHEM, V29, P541, DOI 10.1002/etc.89; Bols NC, 1999, ECOTOX ENVIRON SAFE, V44, P118, DOI 10.1006/eesa.1999.1808; Brack W, 2000, ENVIRON TOXICOL CHEM, V19, P2493, DOI 10.1002/etc.5620191015; Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z; Brack W, 2005, ENVIRON TOXICOL CHEM, V24, P2445, DOI 10.1897/05-078R.1; Brack W, 2008, ENVIRON TOXICOL CHEM, V27, P519, DOI 10.1897/07-400.1; Brunstrom B, 1998, COMP BIOCHEM PHYS C, V121, P213, DOI 10.1016/S0742-8413(98)10042-7; Cameron P., 1990, P281; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Doostdar H, 2000, TOXICOLOGY, V144, P31, DOI 10.1016/S0300-483X(99)00215-2; Eklund B, 2010, J SOIL SEDIMENT, V10, P127, DOI 10.1007/s11368-009-0149-y; FGG-Elbe, 2012, FACH FIS FGG ELB; Fischnetz, 2004, TRAIL DECL FISH STOC; Gaumert T, 2002, HIST ZUSTAND ELBE BE; GOTZ R, 1990, CHEMOSPHERE, V20, P51, DOI 10.1016/0045-6535(90)90087-A; Gustavsson LK, 2004, ENVIRON SCI POLLUT R, V11, P379, DOI 10.1007/BF02979656; Hecker M, 2009, ENVIRON SCI POLLUT R, V16, P607, DOI 10.1007/s11356-009-0229-y; Heimann W, 2011, J SOIL SEDIMENT, V11, P1279, DOI 10.1007/s11368-011-0416-6; Heise S., 2005, STUDIE SCHADSTOFFBEL; Heise S, 2007, J ENVIRON MONITOR, V9, P943, DOI 10.1039/b704071g; Hilscherova K, 2000, ENVIRON SCI POLLUT R, V7, P159, DOI 10.1065/espr2000.02.017; Hinger G, 2011, ENVIRON SCI POLLUT R, V18, P1297, DOI 10.1007/s11356-011-0483-7; Hollert H, 2002, ECOTOXICOLOGY, V11, P323, DOI 10.1023/A:1020549103898; Huuskonen SE, 1998, CHEMOSPHERE, V36, P2921, DOI 10.1016/S0045-6535(97)10248-X; Jarosova B, 2012, ENVIRON INT, V45, P22, DOI 10.1016/j.envint.2012.04.001; Kannan K, 1998, ENVIRON SCI TECHNOL, V32, P2507, DOI 10.1021/es980167g; Keiter S, 2008, ANAL BIOANAL CHEM, V390, P2009, DOI 10.1007/s00216-007-1652-x; Keiter S, 2009, J SOIL SEDIMENT, V9, P168, DOI 10.1007/s11368-009-0087-8; Khim JS, 1999, ENVIRON SCI TECHNOL, V33, P4206, DOI 10.1021/es990449w; Khim JS, 1999, ENVIRON SCI TECHNOL, V33, P4199, DOI 10.1021/es9904484; King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027; Koh CH, 2004, ENVIRON POLLUT, V132, P489, DOI 10.1016/j.envpol.2004.05.001; LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606; LORENZEN A, 1993, ANAL BIOCHEM, V214, P346, DOI 10.1006/abio.1993.1504; Machala M, 2001, MUTAT RES-GEN TOX EN, V497, P49, DOI 10.1016/S1383-5718(01)00240-6; Murk AJ, 1996, FUND APPL TOXICOL, V33, P149, DOI 10.1006/faat.1996.0152; Olsman H, 2007, ENVIRON TOXICOL CHEM, V26, P2448, DOI 10.1897/07-004R.1; Otte JC, 2008, ENVIRON INT, V34, P1176, DOI 10.1016/j.envint.2008.05.004; Pinkney AE, 2001, ENVIRON TOXICOL CHEM, V20, P1196, DOI 10.1002/etc.5620200608; Reincke H., 2003, HOCHWASSER AUGUST 20; Rocha PS, 2010, ECOTOX ENVIRON SAFE, V73, P550, DOI 10.1016/j.ecoenv.2009.12.017; Sanderson JT, 1996, TOXICOL APPL PHARM, V137, P316, DOI 10.1006/taap.1996.0086; Schuettrumpf Holger, 2011, Environmental Sciences Europe, V23, P39, DOI 10.1186/2190-4715-23-39; Stachel B, 2006, SCI TOTAL ENVIRON, V364, P96, DOI 10.1016/j.scitotenv.2005.07.004; Stachel B, 2005, J ENVIRON SCI HEAL A, V40, P265, DOI 10.1081/ESE-200045531; Umlauf G, 2011, JRC TECHNICAL SCI RE; US-EPA, 1982, LAB TEST PROT 610; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Villeneuve DL, 2000, ARCH ENVIRON CON TOX, V39, P273; Villeneuve DL, 2002, ENVIRON TOXICOL, V17, P128, DOI 10.1002/tox.10041; Villeneuve DL, 2001, AQUAT TOXICOL, V54, P125, DOI 10.1016/S0166-445X(00)00171-5; Villeneuve DL, 2000, ENVIRON TOXICOL CHEM, V19, P2835, DOI 10.1002/etc.5620191131; Wetzel MA, 2013, SCI TOTAL ENVIRON, V449, P199, DOI 10.1016/j.scitotenv.2013.01.016; Wetzel MA, 2012, ECOL INDIC, V19, P118, DOI 10.1016/j.ecolind.2011.08.007; Willett KL, 1997, ARCH ENVIRON CON TOX, V32, P442, DOI 10.1007/s002449900211; Wolz J, 2010, SCI TOTAL ENVIRON, V408, P3327, DOI 10.1016/j.scitotenv.2010.03.029; Wolz J, 2008, ENVIRON SCI POLLUT R, V15, P536, DOI 10.1007/s11356-008-0056-6	64	32	34	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75596	10.1371/journal.pone.0075596	http://dx.doi.org/10.1371/journal.pone.0075596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146763	gold, Green Published			2022-12-27	WOS:000325819400013
J	Aronin, A; Amsili, S; Prigozhina, TB; Tzdaka, K; Rachmilewitz, J; Shani, N; Tykocinski, ML; Elhalel, MD				Aronin, Alexandra; Amsili, Shira; Prigozhina, Tatyana B.; Tzdaka, Kobi; Rachmilewitz, Jacob; Shani, Noam; Tykocinski, Mark L.; Elhalel, Michal Dranitzki			Fn14.Trail Effectively Inhibits Hepatocellular Carcinoma Growth	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; CELL-DEATH; TRAIL RECEPTORS; FUSION PROTEINS; WEAK INDUCER; TUMOR-GROWTH; TWEAK; TNF; ACTIVATION	Background: New strategies for the treatment of hepatocellular carcinoma (HCC) are needed, given that currently available chemotherapeutics are inefficient. Since tumor growth reflects the net balance between pro-proliferative and death signaling, agents shifting the equilibrium toward the latter are of considerable interest. The TWEAK: Fn14 signaling axis promotes tumor cell proliferation and tumor angiogenesis, while TRAIL: TRAIL-receptor (TRAIL-R) interactions selectively induce apoptosis in malignant cells. Fn14.TRAIL, a fusion protein bridging these two pathways, has the potential to inhibit tumor growth, by interfering with TWEAK: Fn14 signaling, while at the same time enforcing TRAIL: TRAIL-R-mediated apoptosis. Consequently, Fn14.TRAIL's capacity to inhibit HCC growth was tested. Results: Fn14.TRAIL induced robust apoptosis of multiple HCC cell lines, while sparing non-malignant hepatocyte cell lines. Differential susceptibility to this agent did not correlate with expression levels of TRAIL, TRAIL-R, TWEAK and Fn14 by these lines. Fn14.TRAIL was more potent than soluble TRAIL, soluble Fn14, or a combination of the two. The requirement of both of Fn14.TRAIL's molecular domains for function was established using blocking antibodies directed against each of them. Subcutaneous injection of Fn14.TRAIL abrogated HCC growth in a xenograft model, and was well tolerated by the mice. Conclusions: In this study, Fn14.TRAIL, a multifunctional fusion protein originally designed to treat autoimmunity, was shown to inhibit the growth of HCC, both in vitro and in vivo. The demonstration of this fusion protein's potent anti-tumor activity suggests that simultaneous targeting of two signaling axes by a single fusion can serve as a basis for highly effective anti-cancer therapies.	[Aronin, Alexandra; Prigozhina, Tatyana B.; Tzdaka, Kobi; Elhalel, Michal Dranitzki] Hadassah Hebrew Univ Med Ctr, Serv Nephrol, Jerusalem, Israel; [Aronin, Alexandra; Prigozhina, Tatyana B.; Tzdaka, Kobi; Elhalel, Michal Dranitzki] Hadassah Hebrew Univ Med Ctr, Hypertens Serv, Jerusalem, Israel; [Rachmilewitz, Jacob] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Amsili, Shira; Shani, Noam] KAHR Med LTD, Jerusalem, Israel; [Tykocinski, Mark L.] Thomas Jefferson Univ, Jefferson Med Coll, Off Dean, Philadelphia, PA 19107 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Jefferson University	Elhalel, MD (corresponding author), Hadassah Hebrew Univ Med Ctr, Serv Nephrol, Jerusalem, Israel.	michale@hadassah.org.il			KAHR Medical LTD.	KAHR Medical LTD.	This study was funded be KAHR Medical LTD. The funders had no role in study design, data collection and analysis, decision to publish or preperation of manuscript. All authors, including KAHR Medical employees saw the paper before submission.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Brown SAN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065248; Chen XP, 2003, WORLD J GASTROENTERO, V9, P2433; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Dranitzki-Elhalel M, 2007, INT IMMUNOL, V19, P355, DOI 10.1093/intimm/dxm001; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Grunert M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.154; Herr I, 2007, HEPATOLOGY, V46, P266, DOI 10.1002/hep.21740; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Kobayashi N, 2000, TRANSPL P, V32, P2368, DOI 10.1016/S0041-1345(00)01702-4; Kriegl L, 2010, CLIN CANCER RES, V16, P5529, DOI 10.1158/1078-0432.CCR-09-3403; Malhi H, 2002, J CELL SCI, V115, P2679; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Orbach A, 2010, AM J PATHOL, V177, P3159, DOI 10.2353/ajpath.2010.100301; Razmara M, 2009, AM J PATHOL, V174, P460, DOI 10.2353/ajpath.2009.080462; Rosevear HM, 2010, CURR OPIN INVEST DR, V11, P688; Schattenberg JM, 2011, J GASTROEN HEPATOL, V26, P213, DOI 10.1111/j.1440-1746.2010.06582.x; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Siegemund M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.29; Sung ES, 2009, MOL CANCER THER, V8, P2276, DOI 10.1158/1535-7163.MCT-09-0235; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wahl K, 2013, HEPATOLOGY, V57, P625, DOI 10.1002/hep.26082; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001	45	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77050	10.1371/journal.pone.0077050	http://dx.doi.org/10.1371/journal.pone.0077050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130833	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200052
J	Pan, P; Chen, XL; Li, Y; Zhang, QX; Zhao, XM; Bodombossou-Djobo, MMA; Yang, DZ				Pan, Ping; Chen, Xiaoli; Li, Yu; Zhang, Qingxue; Zhao, Xiaomiao; Bodombossou-Djobo, Madafeitom M. A.; Yang, Dongzi			Comparison of Manual and Automated Measurements of Monodominant Follicle Diameter with Different Follicle Size in Infertile Patients	PLOS ONE			English	Article							OVARIAN STIMULATION; RELIABILITY; AGREEMENT; VOLUME	This study evaluated the consistency of manual and automated measurements of monodominant follicle diameter with different follicle size in infertile patients. Transvaginal two-dimensional (2D) ultrasound and SonoAVC (Sonography-based Automated Volume Calculation) were both performed in 226 infertile patients with monodominant follicle growth. 2D diameters were separately compared with SonoAVC-generated d(V) and m-d values in different follicle category, i.e. >10 to 14 mm, >14 to 18 mm, >18 to 22 mm and >22 mm. There was moderate degree of consistency between 2D diameter and SonoAVC-generated parameters regardless of follicle size. The mean differences were 0.82 mm between 2D diameter and SonoAVC-generated d(V) value, and 0.22 mm between 2D diameter and SonoAVC-generated m-d value, respectively. The discrepancy of manual and automated measurements tended to increase as follicle size increased. Our study suggested that compared with manual measurement, SonoAVC might underestimate follicle size. The absolute size of a follicle affected the consistency of two techniques.	[Pan, Ping; Chen, Xiaoli; Li, Yu; Zhang, Qingxue; Zhao, Xiaomiao; Bodombossou-Djobo, Madafeitom M. A.; Yang, Dongzi] Sun Yat Sen Univ, Dept Obstet & Gynecol, Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Ping] Guangdong Prov Family Planning Res Inst, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China; [Bodombossou-Djobo, Madafeitom M. A.] Guangzhou Elizabeth Womens Hosp, Fertil Med Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Yang, DZ (corresponding author), Sun Yat Sen Univ, Dept Obstet & Gynecol, Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	yangdz@mail.sysu.edu.cn			Sun Yat-Sen University Clinical Research 5010 Program [2007-017]; Science Technology Research Project of Guangdong Province [2012A030400010]; Science Research Project of Population and Family Planning Committee of Guangdong Province [2012316]	Sun Yat-Sen University Clinical Research 5010 Program; Science Technology Research Project of Guangdong Province; Science Research Project of Population and Family Planning Committee of Guangdong Province	Funding for this work was provided by: Sun Yat-Sen University Clinical Research 5010 Program (Grant No. 2007-017); The Science Technology Research Project of Guangdong Province (2012A030400010); The Science Research Project of Population and Family Planning Committee of Guangdong Province (Grant No. 2012316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ata B, 2011, HUM REPROD, V26, P127, DOI 10.1093/humrep/deq320; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Deutch TD, 2009, FERTIL STERIL, V92, P1562, DOI 10.1016/j.fertnstert.2008.08.102; Duijkers IJM, 2004, EUR J OBSTET GYN R B, V117, P60, DOI 10.1016/j.ejogrb.2004.01.005; FORMAN RG, 1991, FERTIL STERIL, V56, P989; Lamazou F, 2010, FERTIL STERIL, V94, P2172, DOI 10.1016/j.fertnstert.2010.01.062; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Raine-Fenning N, 2008, ULTRASOUND OBST GYN, V31, P691, DOI 10.1002/uog.5359; Raine-Fenning N, 2007, ULTRASOUND OBST GYN, V30, P1015, DOI 10.1002/uog.5222; Raine-Fenning N, 2009, REPROD BIOMED ONLINE, V18, P658, DOI 10.1016/S1472-6483(10)60010-7; Raine-Fenning N, 2010, FERTIL STERIL, V94, P184, DOI 10.1016/j.fertnstert.2009.02.063; Raine-Fenning N, 2009, FERTIL STERIL, V91, P1469, DOI 10.1016/j.fertnstert.2008.07.1719; Rodrigue-Fuentes A, 2010, FERTIL STERIL, V93, P616, DOI 10.1016/j.fertnstert.2009.02.058; Salama S, 2010, FERTIL STERIL, V93, P2069, DOI 10.1016/j.fertnstert.2008.12.115; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Yavas Y, 2009, FERTIL STERIL, V91, P1299, DOI 10.1016/j.fertnstert.2008.01.050	16	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77095	10.1371/journal.pone.0077095	http://dx.doi.org/10.1371/journal.pone.0077095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130840	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200057
J	Carvalho, GMD; Brazil, RP; Ramos, MCDF; Meira, PCLSE; Zenobio, APLD; Botelho, HA; Sanguinette, CD; Saraiva, L; Andrade, JD				de Lima Carvalho, Gustavo Mayr; Brazil, Reginaldo Pecanha; das Neves Farah Ramos, Mariana Campos; Lamy Serra e Meira, Paula Cavalcante; Lusardo de Almeida Zenobio, Ana Paula; Botelho, Helbert Antnio; Sanguinette, Cristiani de Castilho; Saraiva, Lara; Andrade Filho, Jose Dilermando			Ecological Aspects of Phlebotomine Sandflies (Diptera: Psychodidae) from a Cave of the Speleological Province of Bambu, Brazil	PLOS ONE			English	Article							MINAS-GERAIS STATE; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; SPECIES DIPTERA; SAND FLY; VECTORS; TOCANTINS; DIVERSITY; AREAS; FOCUS	Phlebotomines are invertebrate hosts of Leishmania genus species which are etiological agents of leishmaniases in humans and other mammals. Sandflies are often collected in entomological studies of caves both in the inner area and the adjacent environments. Caves are ecotypes clearly different from the external environment. Several caves have been opened to public visitation before any studies were performed and the places do not have scientific monitoring of the fauna, flora, geological and geographical characteristics. These events can lead to the loss of geological and biological information. Considering these aspects, this study aimed to describe the sand fly fauna, including the ecological features, in a limestone cave at the Speleological Province of Bambu (Minas Gerais State, Brazil). A total of 8,354 specimens of sandflies belonging to 29 species were analyzed: Lutzomyia cavernicola (20%), Nyssomyia intermedia (15%), Martinsmyia oliveirai (13%), Evandromyia spelunca (12%), Evandromyia sallesi (11%), Migonemyia migonei (9%), Nyssomyia whitmani (9%), Sciopemyia sordellii (4%) and Lutzomyia longipalpis (2%). The others species represent 5% of the total. This manuscript presents data found on richness, diversity, evenness and seasonality, comparing the sand fly fauna trapped in the cave and its surroundings.	[de Lima Carvalho, Gustavo Mayr; das Neves Farah Ramos, Mariana Campos; Lamy Serra e Meira, Paula Cavalcante; Lusardo de Almeida Zenobio, Ana Paula; Botelho, Helbert Antnio; Sanguinette, Cristiani de Castilho; Saraiva, Lara; Andrade Filho, Jose Dilermando] Fundacao Oswaldo Cruz, Grp Estudos Leishmanioses, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [de Lima Carvalho, Gustavo Mayr; Brazil, Reginaldo Pecanha] Fundacao Oswaldo Cruz, Dept Fisiol & Bioquim Insetos, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Andrade, JD (corresponding author), Fundacao Oswaldo Cruz, Grp Estudos Leishmanioses, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	lecojandrade@hotmail.com	Andrade Filho, José Dilermando/B-7852-2013; Brazil, Reginaldo Peçanha/AAF-6777-2019	Andrade Filho, José Dilermando/0000-0002-9754-8464; 	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-0235709]; Programa Pesquisador Mineiro (FAPEMIG) [00130-12]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa Pesquisador Mineiro (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Process: APQ-0235709); Programa Pesquisador Mineiro (FAPEMIG)-00130-12; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR GM, 1984, MEM I O CRUZ, V79, P179; Aguiar GM, 2003, FLEBOTOMINEOS BRASIL; Almeida Paulo Silva de, 2010, Rev. Bras. entomol., V54, P304, DOI 10.1590/S0085-56262010000200014; Alves VR, 2008, MEM I OSWALDO CRUZ, V103, P251, DOI 10.1590/S0074-02762008005000012; Alves VR, 2011, MEM I OSWALDO CRUZ, V106, P353, DOI 10.1590/S0074-02762011000300016; Andrade Filho José Dilermando, 2004, Rev. Bras. entomol., V48, P583, DOI 10.1590/S0085-56262004000400024; Andrade JD, 2001, MEM I OSWALDO CRUZ, V96, P1085, DOI 10.1590/S0074-02762001000800010; Andrade JD, 2007, MEM I OSWALDO CRUZ, V102, P481, DOI 10.1590/S0074-02762007005000035; Auler A., 2002, B SOC VENEZ ESPELEOL, V36, P29; AZEVEDO ACR, 1991, MEM I OSWALDO CRUZ, V86, P405, DOI 10.1590/S0074-02761991000400005; Barata RA, 2008, NEOTROP ENTOMOL, V37, P226, DOI 10.1590/S1519-566X2008000200018; Barata RA, 2012, MEM I OSWALDO CRUZ, V107, P1006, DOI 10.1590/S0074-02762012000800007; Barata RA, 2012, MEM I OSWALDO CRUZ, V107, P1016, DOI 10.1590/S0074-02762012000800009; CALLISTO M., 2000, ACTA LIMNOL BRAS, V12, P55; Carvalho GML, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-158; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Culver DC, 1982, CAVE LIFE EVOLUTION; de Andrade AJ, 2010, NEOTROP ENTOMOL, V39, P115, DOI 10.1590/S1519-566X2010000100016; Carvalho GMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052254; Carvalho GMD, 2010, MEM I OSWALDO CRUZ, V105, P336, DOI 10.1590/S0074-02762010000300017; de Pita-Pereira D, 2005, T ROY SOC TROP MED H, V99, P905, DOI 10.1016/j.trstmh.2005.06.019; Deane L.M., 1965, REV BRAS BIOL, V15, P83; DEQUEIROZ RG, 1994, AM J TROP MED HYG, V50, P693, DOI 10.4269/ajtmh.1994.50.693; Elliott W. R., 1981, CAVING INT, V10, P38; FORATTINI O. P., 1973, Entomologia Medica. Vol. 4. Psychodidae. Phle-botominae. Leishmanioses. Bartonelose.; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 2006, MEM I OSWALDO CRUZ, V101, P175, DOI 10.1590/S0074-02762006000200010; Galati EAB, 1997, REV SAUDE PUBL, V31, P378, DOI 10.1590/S0034-89101997000400007; Galati Eunice A. B., 2003, Rev. Bras. entomol., V47, P283, DOI 10.1590/S0085-56262003000200017; Galati Eunice A. Bianchi, 2003, Rev. Bras. entomol., V47, P455, DOI 10.1590/S0085-56262003000300016; Galati Eunice Aparecida Bianchi, 2003, Rev. Bras. entomol., V47, P63, DOI 10.1590/S0085-56262003000100010; GOMES A D C, 1987, Memorias do Instituto Oswaldo Cruz, V82, P467, DOI 10.1590/S0074-02761987000400004; HOLSINGER JR, 1988, BRIMLEYANA, P1; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; LENG YJ, 1987, ANN TROP MED PARASIT, V81, P311, DOI 10.1080/00034983.1987.11812125; Lewis JJ, 1982, NATL CAVE MANAGEMENT, P73; LISOWSKI EA, 1981, CAVE RES FDN ANN REP, P48; Machado TO, 2012, MEM I OSWALDO CRUZ, V107, P955, DOI 10.1590/S0074-02762012000700021; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; McCarthy CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058645; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; POULSON TL, 1969, SCIENCE, V165, P971; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; RODRIGUES W. C., 2005, DIVES DIVERSIDADE ES; Saraiva L, 2008, MEM I OSWALDO CRUZ, V103, P843, DOI 10.1590/S0074-02762008000800018; Sherlok IA, 2003, FLEBOTOMINEOS BRASIL, P15; Vilela ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027721; WHO, 2010, WHO TECH REP SER, V949, P1; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	51	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77158	10.1371/journal.pone.0077158	http://dx.doi.org/10.1371/journal.pone.0077158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130847	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900123
J	MacInnis, MJ; Carter, EA; Freeman, MG; Pandit, BP; Siwakoti, A; Subedi, A; Timalsina, U; Widmer, N; Thapa, GB; Koehle, MS; Rupert, JL				MacInnis, Martin J.; Carter, Eric A.; Freeman, Michael G.; Pandit, Bidur Prasad; Siwakoti, Ashmita; Subedi, Ankita; Timalsina, Utsav; Widmer, Nadia; Thapa, Ghan Bahadur; Koehle, Michael S.; Rupert, Jim L.			A Prospective Epidemiological Study of Acute Mountain Sickness in Nepalese Pilgrims Ascending to High Altitude (4380 m)	PLOS ONE			English	Article							RISK-FACTORS; PREVENTION; ACCLIMATIZATION; ACETAZOLAMIDE; PROPHYLAXIS; POPULATION; PREVALENCE; IBUPROFEN; TOURISTS; OXIMETRY	Background: Each year, thousands of pilgrims travel to the Janai Purnima festival in Gosainkunda, Nepal (4380 m), ascending rapidly and often without the aid of pharmaceutical prophylaxis. Methods: During the 2012 Janai Purnima festival, 538 subjects were recruited in Dhunche (1950 m) before ascending to Gosainkunda. Through interviews, subjects provided demographic information, ratings of AMS symptoms (Lake Louise Scores; LLS), ascent profiles, and strategies for prophylaxis. Results: In the 491 subjects (91% follow-up rate) who were assessed upon arrival at Gosainkunda, the incidence of AMS was 34.0%. AMS was more common in females than in males (RR = 1.57; 95% CI = 1.23, 2.00), and the AMS incidence was greater in subjects > 35 years compared to subjects <= 35 years (RR = 1.63; 95% CI = 1.36, 1.95). There was a greater incidence of AMS in subjects who chose to use garlic as a prophylactic compared to those who did not (RR = 1.69; 95% CI = 1.26, 2.28). Although the LLS of brothers had a moderate correlation (intraclass correlation = 0.40, p = 0.023), sibling AMS status was a weak predictor of AMS. Conclusions: The incidence of AMS upon reaching 4380 m was 34% in a large population of Nepalese pilgrims. Sex, age, and ascent rate were significant factors in the development of AMS, and traditional Nepalese remedies were ineffective in the prevention of AMS.	[MacInnis, Martin J.; Carter, Eric A.; Koehle, Michael S.; Rupert, Jim L.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Freeman, Michael G.] Univ Glasgow, Fac Med, Glasgow, Lanark, Scotland; [Pandit, Bidur Prasad; Siwakoti, Ashmita; Subedi, Ankita; Timalsina, Utsav; Thapa, Ghan Bahadur] Tribhuvan Univ, Inst Med, Kathmandu, Nepal; [Widmer, Nadia; Koehle, Michael S.] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of Glasgow; Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of British Columbia	MacInnis, MJ (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada.	martin@alumni.ubc.ca	Koehle, Michael/C-7850-2013	Koehle, Michael/0000-0001-7026-8422; MacInnis, Martin/0000-0002-0377-5800	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC CGS Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) through Discovery grants to MS Koehle and JL Rupert. MM was funded by an NSERC CGS Scholarship (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basnyat B, 1999, AVIAT SPACE ENVIR MD, V70, P867; BASNYAT B, 1993, J WILDERNESS MED, V4, P286, DOI 10.1580/0953-9859-4.3.286; Basnyat B, 2000, WILD ENVIRON MED, V11, P89, DOI 10.1580/1080-6032(2000)011[0089:DAAPAE]2.3.CO;2; Baumgartner RW, 2007, HIGH ALT MED BIOL, V8, P108, DOI 10.1089/ham.2006.1070; Eichenberger U, 1996, AM J RESP CRIT CARE, V154, P1748, DOI 10.1164/ajrccm.154.6.8970365; Gaillard S, 2004, HIGH ALT MED BIOL, V5, P410, DOI 10.1089/ham.2004.5.410; Gertsch JH, 2012, WILD ENVIRON MED, V23, P307, DOI 10.1016/j.wem.2012.08.001; Gertsch JH, 2010, WILD ENVIRON MED, V21, P236, DOI 10.1016/j.wem.2010.06.009; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Imray C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4943; KAYSER B, 1991, J WILDERNESS MED, V2, P110, DOI 10.1580/0953-9859-2.2.110; Kayser B, 2012, HIGH ALT MED BIOL, V13, P82, DOI 10.1089/ham.2011.1084; Koehle MS, 2010, EUR J EMERG MED, V17, P119, DOI 10.1097/MEJ.0b013e32832fa099; Li XX, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-740; Litch JA, 1996, WILD ENVIRON MED, V7, P232, DOI 10.1580/1080-6032(1996)007[0232:DIHPAA]2.3.CO;2; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; MacInnis MJ, 2011, J OCCUP ENVIRON MED, V53, P159, DOI 10.1097/JOM.0b013e318206b112; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Mairer K, 2010, HIGH ALT MED BIOL, V11, P343, DOI 10.1089/ham.2010.1039; Morris DM, 2013, APPL PHYSIOL NUTR ME, V38, P363, DOI 10.1139/apnm-2012-0210; Nussbaumer-Ochsner Y, 2012, SLEEP, V35, P419, DOI 10.5665/sleep.1708; Nussbaumer-Ochsner Y, 2011, HIGH ALT MED BIOL, V12, P229, DOI 10.1089/ham.2010.1073; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; Wang SH, 2010, HIGH ALT MED BIOL, V11, P43, DOI 10.1089/ham.2009.1063; West JB, 2009, HIGH ALT MED BIOL, V10, P1, DOI 10.1089/ham.2009.10101; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Windsor JS, 2012, WILD ENVIRON MED, V23, P112, DOI 10.1016/j.wem.2012.03.001; Wu TY, 2012, THORAX, V67, P914, DOI 10.1136/thoraxjnl-2011-200623; Wu TY, 2012, CHINESE MED J-PEKING, V125, P1393, DOI 10.3760/cma.j.issn.0366-6999.2012.08.006; You HY, 2012, WILD ENVIRON MED, V23, P316, DOI 10.1016/j.wem.2012.04.001	34	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75644	10.1371/journal.pone.0075644	http://dx.doi.org/10.1371/journal.pone.0075644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130729	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900048
J	Nadalutti, CA; Korponay-Szabo, IR; Kaukinen, K; Wang, Z; Griffin, M; Maki, M; Lindfors, K				Nadalutti, Cristina Antonella; Korponay-Szabo, Ilma Rita; Kaukinen, Katri; Wang, Zhuo; Griffin, Martin; Maki, Markku; Lindfors, Katri			Thioredoxin Is Involved in Endothelial Cell Extracellular Transglutaminase 2 Activation Mediated by Celiac Disease Patient IgA	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; ENZYMATIC-ACTIVITY; AUTOANTIBODIES; EXPRESSION; IDENTIFICATION; ADHESION	Purpose: To investigate the role of thioredoxin (TRX), a novel regulator of extracellular transglutaminase 2 (TG2), in celiac patients IgA (CD IgA) mediated TG2 enzymatic activation. Methods: TG2 enzymatic activity was evaluated in endothelial cells (HUVECs) under different experimental conditions by ELISA and Western blotting. Extracellular TG2 expression was studied by ELISA and immunofluorescence. TRX was analysed by Western blotting and ELISA. Serum immunoglobulins class A from healthy subjects (H IgA) were used as controls. Extracellular TG2 enzymatic activity was inhibited by R281. PX12, a TRX inhibitor, was also employed in the present study. Results: We have found that in HUVECs CD IgA is able to induce the activation of extracellular TG2 in a dose-dependent manner. Particularly, we noted that the extracellular modulation of TG2 activity mediated by CD IgA occurred only under reducing conditions, also needed to maintain antibody binding. Furthermore, CD IgA-treated HUVECs were characterized by a slightly augmented TG2 surface expression which was independent from extracellular TG2 activation. We also observed that HUVECs cultured in the presence of CD IgA evinced decreased TRX surface expression, coupled with increased secretion of the protein into the culture medium. Intriguingly, inhibition of TRX after CD IgA treatment was able to overcome most of the CD IgA-mediated effects including the TG2 extracellular transamidase activity. Conclusions: Altogether our findings suggest that in endothelial cells CD IgA mediate the constitutive activation of extracellular TG2 by a mechanism involving the redox sensor protein TRX.	[Nadalutti, Cristina Antonella; Maki, Markku; Lindfors, Katri] Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Nadalutti, Cristina Antonella; Maki, Markku; Lindfors, Katri] Tampere Univ Hosp, Tampere, Finland; [Korponay-Szabo, Ilma Rita] Heim Palm Childrens Hosp, Celiac Dis Ctr, Budapest, Hungary; [Korponay-Szabo, Ilma Rita] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pediat, Debrecen, Hungary; [Kaukinen, Katri] Univ Tampere, Dept GastroenterologyandAlimentary Tract Surg, Tampere Univ Hosp, Sch Med, FIN-33101 Tampere, Finland; [Wang, Zhuo; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Tampere University; Tampere University; Tampere University Hospital; University of Debrecen; Tampere University; Tampere University Hospital; Aston University	Lindfors, K (corresponding author), Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	Katri.lindfors@uta.fi	Korponay-Szabó, Ilma/AAF-9048-2022; Nadalutti, Cristina/ABA-5652-2021; Korponay-Szabó, Ilma/AFK-1690-2022	Nadalutti, Cristina/0000-0002-4721-6904; Griffin, Martin/0000-0003-3824-306X; WANG, ZHUO/0000-0002-2212-8318	Academy of Finland; Tampere Graduate Program in Biomedicine and Biotechnology; Sigrid Juselius Foundation; Finnish Coeliac Society; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital [9P020, 9P033]; Pediatric Research Foundation; European Commission IAPP grant TRANSCOM [PIA-GA-2010-251506]; Hungarian scientific research grant Orszagos Tudomanyos Kutatasi (OTKA) [K101788, NK105046]	Academy of Finland(Academy of Finland); Tampere Graduate Program in Biomedicine and Biotechnology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Coeliac Society; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Pediatric Research Foundation; European Commission IAPP grant TRANSCOM; Hungarian scientific research grant Orszagos Tudomanyos Kutatasi (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The Coeliac Disease Study Group was financially supported by the Academy of Finland, the Tampere Graduate Program in Biomedicine and Biotechnology, the Sigrid Juselius Foundation, the Research Fund of the Finnish Coeliac Society, the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (grant numbers 9P020 and 9P033) and the Pediatric Research Foundation and the European Commission IAPP grant TRANSCOM (Contract number PIA-GA-2010-251506). Further, the Hungarian scientific research grant Orszagos Tudomanyos Kutatasi (OTKA) K101788, NK105046 and the Theoretical Atomic-Molecular Optical Physics (TAMOP)4.2.2.11/1/KONV-2012-0023 are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Caja S, 2010, SCAND J GASTROENTERO, V45, P421, DOI 10.3109/00365520903540822; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Dieterich W, 2003, GUT, V52, P1562, DOI 10.1136/gut.52.11.1562; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; DiRaimondo TR, 2012, J PHARMACOL EXP THER, V341, P104, DOI 10.1124/jpet.111.187385; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; FOLK JE, 1966, J BIOL CHEM, V241, P5518; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Jones RA, 1997, J CELL SCI, V110, P2461; Kiraly R, 2006, J AUTOIMMUN, V26, P278, DOI 10.1016/j.jaut.2006.03.002; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Lindfors K, 2010, AUTOIMMUN REV, V9, P744, DOI 10.1016/j.autrev.2010.06.003; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	30	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77277	10.1371/journal.pone.0077277	http://dx.doi.org/10.1371/journal.pone.0077277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130874	Green Published, gold, Green Accepted			2022-12-27	WOS:000325810900132
J	Beukers, W; Kandimalla, R; van Houwelingen, D; Kovacic, H; Chin, JFD; Lingsma, HF; Dyrskjot, L; Zwarthoff, EC				Beukers, Willemien; Kandimalla, Raju; van Houwelingen, Diandra; Kovacic, Hrvoje; Chin, Jie-Fen D.; Lingsma, Hester F.; Dyrskjot, Lars; Zwarthoff, Ellen C.			The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria	PLOS ONE			English	Article							BLADDER-CANCER; ASSAY; IMMUNOCYTOLOGY; MULTICENTER; CYTOLOGY; IMPACT	Introduction: Patients presenting with painless hematuria form a large part of the urological patient population. In many cases, especially in younger patients, the cause of hematuria is harmless. Nonetheless, hematuria could be a symptom of malignant disease and hence most patients will be subject to cystoscopy. In this study, we aimed to develop a prediction model based on methylation markers in combination with clinical variables, in order to stratify patients with high risk for bladder cancer. Material and Methods: Patients (n=169) presenting with painless hematuria were included. 54 patients were diagnosed with bladder cancer. In the remaining 115 patients, the cause of hematuria was non-malignant. Urine samples were collected prior to cystoscopy. Urine DNA was analyzed for methylation of OSR1, SIM2, OTX1, MEIS1 and ONECUT2. Methylation percentages were calculated and were combined with clinical variables into a logistic regression model. Results: Logistic regression analysis based on the five methylation markers, age, gender and type of hematuria resulted in an area under the curve (AUC) of 0.88 and an optimism corrected AUC of 0.84 after internal validation by bootstrapping. Using a cut-off value of 0.307 allowed stratification of patients in a low-risk and high-risk group, resulting in a sensitivity of 82% (44/54) and a specificity of 82% (94/115). Most aggressive tumors were found in patients in the high-risk group. The addition of cytology to the prediction model, improved the AUC from 0.88 to 0.89, with a sensitivity and specificity of 85% (39/46) and 87% (80/92), retrospectively. Conclusions: This newly developed prediction model could be a helpful tool in risk stratification of patients presenting with painless hematuria. Accurate risk prediction might result in less extensive examination of low risk patients and thereby, reducing patient burden and costs. Further validation in a large prospective patient cohort is necessary to prove the true clinical value of this model.	[Beukers, Willemien; Kandimalla, Raju; van Houwelingen, Diandra; Kovacic, Hrvoje; Chin, Jie-Fen D.; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Dyrskjot, Lars] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Aarhus University	Zwarthoff, EC (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl	Kandimalla, Raju/C-1400-2016	Kandimalla, Raju/0000-0002-0342-5229; Kovacic, Herve/0000-0001-6509-4210; Dyrskjot, Lars/0000-0001-7061-9851	Erasmus Medical Center (MRace); European Community [201663]	Erasmus Medical Center (MRace); European Community(European Commission)	This study was funded by Erasmus Medical Center (MRace 2007) and European Community Seventh Framework program FP7/2007-2012, grant agreement no 201663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogunrin F, 2012, CANCER-AM CANCER SOC, V118, P2641, DOI 10.1002/cncr.26544; Cha EK, 2012, EUR UROL, V61, P185, DOI 10.1016/j.eururo.2011.08.073; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Jocham D, 2005, J UROLOGY, V174, P862, DOI 10.1097/01.ju.0000169257.19841.2a; Kandimalla R, 2013, CLIN CANCER RES, V19, P4760, DOI 10.1158/1078-0432.CCR-12-3276; Karakiewicz PI, 2006, BJU INT, V97, P997, DOI 10.1111/j.1464-410X.2006.06036.x; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; Lotan Y, 2009, BJU INT, V103, P1368, DOI 10.1111/j.1464-410X.2009.08360.x; MARIANI AJ, 1989, J UROLOGY, V141, P350, DOI 10.1016/S0022-5347(17)40763-4; O'Sullivan P, 2012, J UROLOGY, V188, P741, DOI 10.1016/j.juro.2012.05.003; Roobol MJ, 2010, UROL ONCOL-SEMIN ORI, V28, P686, DOI 10.1016/j.urolonc.2009.12.002; Sarosdy MF, 2006, J UROLOGY, V176, P44, DOI 10.1016/S0022-5347(06)00576-3; Schmitz-Drager BJ, 2007, EUR UROL, V51, P1582, DOI 10.1016/j.eururo.2006.10.046; Shariat SF, 2010, BJU INT, V105, P300, DOI 10.1111/j.1464-410X.2009.09076.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Summerton N, 2002, BRIT J GEN PRACT, V52, P284; Witjes JA, 2007, NAT CLIN PRACT UROL, V4, P542, DOI 10.1038/ncpuro0917	17	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77657	10.1371/journal.pone.0077657	http://dx.doi.org/10.1371/journal.pone.0077657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143252	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100091
J	Gu, H; Jiang, JH; Li, JY; Zhang, YN; Dong, XS; Huang, YY; Son, XM; Lu, XY; Chen, Z				Gu, Heng; Jiang, Jian-hui; Li, Jian-ying; Zhang, Ya-nan; Dong, Xing-sheng; Huang, Yang-yu; Son, Xin-ming; Lu, Xinyan; Chen, Zheng			A Familial Cri-du-Chat/5p Deletion Syndrome Resulted from Rare Maternal Complex Chromosomal Rearrangements (CCRs) and/or Possible Chromosome 5p Chromothripsis	PLOS ONE			English	Article							DU-CHAT-SYNDROME; CAT-LIKE CRY; PRENATAL-DIAGNOSIS; MOLECULAR CHARACTERIZATION; ABNORMALITIES; PATIENT; GENES	Cri-du-Chat syndrome (MIM 123450) is a chromosomal syndrome characterized by the characteristic features, including catlike cry and chromosome 5p deletions. We report a family with five individuals showing chromosomal rearrangements involving 5p, resulting from rare maternal complex chromosomal rearrangements (CCRs), diagnosed post-and pre-natally by comprehensive molecular and cytogenetic analyses. Two probands, including a 4 1/2-year-old brother and his 2 1/2-year-old sister, showed no diagnostic cat cry during infancy, but presented with developmental delay, dysmorphic and autistic features. Both patients had an interstitial deletion del(5)(p13.3p15.33) spanning similar to 26.22 Mb. The phenotypically normal mother had de novo CCRs involving 11 breakpoints and three chromosomes: ins(11;5)(q23;p14.1p15.31),ins(21;5)(q21;p13.3p14.1),ins(21;5)(q21;p15.31p15.33),inv(7)(p22q32)dn. In addition to these two children, she had three first-trimester miscarriages, two terminations due to the identification of the 5p deletion and one delivery of a phenotypically normal daughter. The unaffected daughter had the maternal ins(11; 5) identified prenatally and an identical maternal allele haplotype of 5p. Array CGH did not detect any copy number changes in the mother, and revealed three interstitial deletions within 5p15.33-p13.3, in the unaffected daughter, likely products of the maternal insertions ins(21; 5). Chromothripsis has been recently reported as a mechanism drives germline CCRs in pediatric patients with congenital defects. We postulate that the unique CCRs in the phenotypically normal mother could resulted from chromosome 5p chromothripsis, that further resulted in the interstitial 5p deletions in the unaffected daughter. Further high resolution sequencing based analysis is needed to determine whether chromothripsis is also present as a germline structural variation in phenotypically normal individuals in this family.	[Gu, Heng; Son, Xin-ming; Chen, Zheng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Med Genet, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Jian-hui] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Jian-ying] Sun Yat Sen Univ, Affiliated Hosp 3, Child Dev Behav Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Ya-nan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infertil & Sexol, Guangzhou 510275, Guangdong, Peoples R China; [Dong, Xing-sheng] Boai Hosp, Prenatal Diag Ctr, Zhongshan, Peoples R China; [Huang, Yang-yu] Chaozhou Women & Children Hosp, Guangzhou, Guangdong, Peoples R China; [Lu, Xinyan] UT MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Gu, Heng] Family Planning Res Inst Guangdong, Guangzhou, Guangdong, Peoples R China; [Lu, Xinyan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Lu, XY (corresponding author), UT MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	xlu4@mdanderson.org; zhengchen19@hotmail.com			National Natural Science Foundation of China [30640028, 30971601]; Natural Science Foundation of Guangdong Province, China [9151008901000089]; Science and Technology Planning Project of Guangdong Province, China [2010B031600039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	This work was supported by National Natural Science Foundation of China (Grant numbers: 30640028, 30971601), Natural Science Foundation of Guangdong Province, China (9151008901000089), and by Science and Technology Planning Project of Guangdong Province, China (Grant number: 2010B031600039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astbury C, 2004, HUM GENET, V114, P448, DOI 10.1007/s00439-003-1079-1; BELL JA, 1981, AUST NZ J OBSTET GYN, V21, P207, DOI 10.1111/j.1479-828X.1981.tb00132.x; Cerruti MP, 2006, ORPHANET J RARE DIS, V1, P1; Chen CP, 2013, GENE, V524, P407, DOI 10.1016/j.gene.2013.03.003; Cornish KM, 1996, ARCH DIS CHILD, V75, P448, DOI 10.1136/adc.75.5.448; de Smith Adam J, 2010, Hugo J, V4, P1, DOI 10.1007/s11568-010-9144-z; Fang JS, 2008, CLIN GENET, V73, P585, DOI 10.1111/j.1399-0004.2008.00995.x; GENEST P, 1979, CLIN GENET, V16, P387; Gow M, 2013, J CELL MOL MED, V17, P657, DOI 10.1111/jcmm.12048; Gruchy N, 2010, AM J MED GENET A, V152A, P185, DOI 10.1002/ajmg.a.33154; Houge G, 2003, AM J MED GENET A, V118A, P235, DOI 10.1002/ajmg.a.10106; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Kondoh T, 2005, J HUM GENET, V50, P26, DOI 10.1007/s10038-004-0213-9; KORNER H, 1983, ZBL GYNAKOL, V105, P934; de Carvalho AFL, 2008, HUM GENET, V124, P387, DOI 10.1007/s00439-008-0557-x; Lee MH, 2002, PRENATAL DIAG, V22, P102, DOI 10.1002/pd.224; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Mainardi PC, 2006, EUR J MED GENET, V49, P363, DOI 10.1016/j.ejmg.2005.12.004; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Marinescu RC, 1999, AM J MED GENET, V86, P258, DOI 10.1002/(SICI)1096-8628(19990917)86:3<258::AID-AJMG12>3.0.CO;2-Q; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Patsalis PC, 2007, GENET COUNSEL, V18, P57; Pellestor F, 2011, HUM REPROD UPDATE, V17, P476, DOI 10.1093/humupd/dmr010; Roberti MC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-17; Rodriguez-Caballero A, 2010, MED ORAL PATOL ORAL, V15, pE473, DOI 10.4317/medoral.15.e473; Sreekantaiah C, 1999, AM J MED GENET, V86, P264, DOI 10.1002/(SICI)1096-8628(19990917)86:3<264::AID-AJMG13>3.0.CO;2-Y; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tsao CY, 2005, AM J MED GENET A, V134A, P198, DOI 10.1002/ajmg.a.30592; Tullu M S, 1998, J Postgrad Med, V44, P101; Vera-Carbonell A, 2009, AM J MED GENET A, V149A, P2513, DOI 10.1002/ajmg.a.33055; Wu QF, 2005, EUR J HUM GENET, V13, P475, DOI 10.1038/sj.ejhg.5201345	35	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76985	10.1371/journal.pone.0076985	http://dx.doi.org/10.1371/journal.pone.0076985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143197	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100032
J	Li, M; Gao, JP; Feng, RH; Wang, YL; Chen, XH; Sun, JY; Zhang, DQ; Zhu, ZG; Ellis, LM; Lu, M; Lee, JE; Feng, ZQ; Liu, BY				Li, Ming; Gao, Jianpeng; Feng, Runhua; Wang, Yuling; Chen, Xuehua; Sun, Jianyu; Zhang, Dongqing; Zhu, Zhenggang; Ellis, Lee M.; Lu, Mason; Lee, Jeffrey E.; Feng, Zhenqing; Liu, Bingya			Generation of Monoclonal Antibody MS17-57 Targeting Secreted Alkaline Phosphatase Ectopically Expressed on the Surface of Gastrointestinal Cancer Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ANTIGEN; INHIBITION; BIOMARKERS; ISOENZYMES; DIAGNOSIS; FEATURES; REGIONS; MARKER	Background: Therapeutic antibody development is one of the fastest growing areas of the pharmaceutical industry. Generating high-quality monoclonal antibodies against a given therapeutic target is crucial for successful drug development. However, due to immune tolerance, making it difficult to generate antibodies using conventional approaches. Methodology/Findings: Mixed four human gastric cancer (GC) cell lines were used as the immunogen in A/J mice; sixteen highly positive hybridoma colonies were selected via fluorescence-activated cell sorting-high throughput screening (FACS-HTS) using a total of 20,000 colonies in sixty-seven 96-well plates against live cells (mixed human GC cells versus human PBMC controls). MS17-57 and control commercial Alkaline Phosphatase (ALP) mAbs were used to confirm the target antigens (Ags), which were identified as ALPs expressed on the GC cell surface through a combination of western blot, immunoprecipitation and mass spectrometry (MS). MS identified the Ags recognized by MS17-57 to be two variants of a secreted ALP, PALP and IALP (Placental and intestinal ALP). These proteins belong to a hydrolase enzyme family responsible for removing phosphate groups from many types of molecules. Immunofluorescence staining using MS17-57 demonstrated higher staining of gastrointestinal (GI) cancer tissues compared to normal GI tissues (P<0.03), and confirmed binding of MS17-57 to be restricted to a functional epitope expressed on the cancer cell surface. Proliferation assays using the PALP/IALP-expressing GC cell lines demonstrated that MS17-57 inhibited cell growth by 32 +/- 8%. Transwell cell migration assays documented that MS17-57 can inhibit PALP/IALP-expressing GI cancer cell migration by 25 +/- 5%. MS17-57 mAb inhibited tumor growth in nude mice. Conclusions: Our findings indicate that PALP and IALP can be ectopically expressed on extracellular matrix of GI cancers, and that MS17-57 directed against PALP/IALP can inhibit GI cancer cells growth and migration in vitro and in vivo. This investigation provides an example of identification of cancer biomarkers representing promising therapeutic targets using mAb generated through a novel HTS technology.	[Li, Ming; Feng, Zhenqing] Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Gao, Jianpeng; Feng, Runhua; Chen, Xuehua; Zhu, Zhenggang; Liu, Bingya] Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Shanghai Inst Digest Surg, Ruijing Hosp,Sch Med, Shanghai 200030, Peoples R China; [Feng, Runhua; Wang, Yuling; Ellis, Lee M.; Lu, Mason; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Sun, Jianyu; Lu, Mason] Shanghai MabStar Inc, Shanghai, Peoples R China; [Zhang, Dongqing] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200030, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Shanghai Jiao Tong University	Feng, ZQ (corresponding author), Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China.	fengzhenqing@njmu.edu.cn; byliu@sjtu.edu.cn	Liu, Bingya/GMW-5655-2022; Gao, Jianpeng/ABA-5373-2020	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81201596, 81101847, 81172324, 91229106, 31270963]; Key Projects in the National Science & Technology Pillar Program of China [2011BA203191]; Science and Technology Commission of Shanghai Municipality [12XD1403700, 12PJ1406300]; Research Fund for the Doctoral Program of Higher Education of China [20110073110071]; Key Project of Shanghai Education Committee [12ZZ105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of Shanghai Education Committee	This work was supported by the National Natural Science Foundation of China (grant numbers 81201596, 81101847, 81172324, 91229106, 31270963); Key Projects in the National Science & Technology Pillar Program of China (2011BA203191); Science and Technology Commission of Shanghai Municipality (12XD1403700, 12PJ1406300); Research Fund for the Doctoral Program of Higher Education of China (20110073110071); Key Project of Shanghai Education Committee (12ZZ105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDPIRAK E, 1988, J NATL CANCER I, V80, P1605, DOI 10.1093/jnci/80.20.1605; Akagi M, 2003, BRIT J CANCER, V88, P796, DOI 10.1038/sj.bjc.6600811; Arvy L, 1969, Int Rev Cytol, V25, P333, DOI 10.1016/S0074-7696(08)60207-7; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Ferianec V, 2011, NEUROENDOCRINOL LETT, V32, P154; GALAM L, 2007, HIGH THROUGHPUT ASSA; Gotoh A, 2008, CLIN CHIM ACTA, V397, P13, DOI 10.1016/j.cca.2008.07.006; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Honda K, 2013, JPN J CLIN ONCOL, V43, P103, DOI 10.1093/jjco/hys200; Hong CW, 2012, CANCER RES, V72, P3715, DOI 10.1158/0008-5472.CAN-12-0063; Iqbal SJ, 2000, ANN CLIN BIOCHEM, V37, P775, DOI 10.1258/0004563001900093; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kotloff KL, 1996, VACCINE, V14, P1174; Krieg R, 2003, CELL MOL BIOL, V49, P547; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Li JJ, 2013, TRANSL ONCOL, V6, P42, DOI 10.1593/tlo.12367; Li L, 2012, ASIAN PAC J CANCER P, V13, P2069, DOI 10.7314/APJCP.2012.13.5.2069; LINDHOLM L, 1983, INT ARCH ALLER A IMM, V71, P178, DOI 10.1159/000233384; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; Mehan MR, 2013, ADV EXP MED BIOL, V735, P283, DOI 10.1007/978-1-4614-4118-2_20; Motwani M, 2003, MOL CANCER THER, V2, P549; Ofran Y, 2008, J IMMUNOL, V181, P6230, DOI 10.4049/jimmunol.181.9.6230; Ozyoruk F, 2001, CLIN DIAGN LAB IMMUN, V8, P44, DOI 10.1128/CDLI.8.1.44-51.2001; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peters E, 2013, J PHARMACOL EXP THER, V344, P2, DOI 10.1124/jpet.112.198226; Prassas I, 2008, CLIN CANCER RES, V14, P5778, DOI 10.1158/1078-0432.CCR-08-0706; RATHJEN DA, 1986, HYBRIDOMA, V5, P255, DOI 10.1089/hyb.1986.5.255; Siddique A, 2012, CLIN LIVER DIS, V16, P199, DOI 10.1016/j.cld.2012.03.012; Song JG, 2006, NEOPLASIA, V8, P995, DOI 10.1593/neo.06592; Takahashi Y, 2000, INT J CANCER, V85, P243, DOI 10.1002/(SICI)1097-0215(20000115)85:2<243::AID-IJC15>3.0.CO;2-2; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Wong HH, 2012, J GASTROINTEST ONCOL, V3, P262, DOI 10.3978/j.issn.2078-6891.2012.019; Wu HR, 1999, J MOL BIOL, V294, P151, DOI 10.1006/jmbi.1999.3141; Yang XQ, 2009, HEPATO-GASTROENTEROL, V56, P1388; Yoshinari K, 1999, CYTOTECHNOLOGY, V31, P255, DOI 10.1023/A:1008061424281	37	5	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77398	10.1371/journal.pone.0077398	http://dx.doi.org/10.1371/journal.pone.0077398			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143229	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100066
J	Provenzano, JC; Siqueira, JF; Rocas, IN; Domingues, RR; Leme, AFP; Silva, MRS				Provenzano, Jose Claudio; Siqueira, Jose F., Jr.; Rocas, Isabela N.; Domingues, Romenia R.; Paes Leme, Adriana F.; Silva, Marcia R. S.			Metaproteome Analysis of Endodontic Infections in Association with Different Clinical Conditions	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; OXIDATIVE-STRESS; ANTIBIOTIC-RESISTANCE; BACTERIA; MICROBIOTA; PROTEOMICS; PATHOGENESIS; REDUCTION; DIVERSITY; COMMUNITY	Analysis of the metaproteome of microbial communities is important to provide an insight of community physiology and pathogenicity. This study evaluated the metaproteome of endodontic infections associated with acute apical abscesses and asymptomatic apical periodontitis lesions. Proteins persisting or expressed after root canal treatment were also evaluated. Finally, human proteins associated with these infections were identified. Samples were taken from root canals of teeth with asymptomatic apical periodontitis before and after chemomechanical treatment using either NaOCl or chlorhexidine as the irrigant. Samples from abscesses were taken by aspiration of the purulent exudate. Clinical samples were processed for analysis of the exoproteome by using two complementary mass spectrometry platforms: nanoflow liquid chromatography coupled with linear ion trap quadrupole Velos Orbitrap and liquid chromatography-quadrupole time-of-flight. A total of 308 proteins of microbial origin were identified. The number of proteins in abscesses was higher than in asymptomatic cases. In canals irrigated with chlorhexidine, the number of identified proteins decreased substantially, while in the NaOCl group the number of proteins increased. The large majority of microbial proteins found in endodontic samples were related to metabolic and housekeeping processes, including protein synthesis, energy metabolism and DNA processes. Moreover, several other proteins related to pathogenicity and resistance/ survival were found, including proteins involved with adhesion, biofilm formation and antibiotic resistance, stress proteins, exotoxins, invasins, proteases and endopeptidases ( mostly in abscesses), and an archaeal protein linked to methane production. The majority of human proteins detected were related to cellular processes and metabolism, as well as immune defense. Interrogation of the metaproteome of endodontic microbial communities provides information on the physiology and pathogenicity of the community at the time of sampling. There is a growing need for expanded and more curated protein databases that permit more accurate identifications of proteins in metaproteomic studies.	[Provenzano, Jose Claudio; Silva, Marcia R. S.] Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, Rio De Janeiro, RJ, Brazil; [Provenzano, Jose Claudio; Siqueira, Jose F., Jr.; Rocas, Isabela N.] Estacio de Sa Univ, Fac Dent, Dept Endodont, Rio De Janeiro, RJ, Brazil; [Domingues, Romenia R.; Paes Leme, Adriana F.] LNBio, Brazilian Biosci Natl Lab, Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro	Provenzano, JC (corresponding author), Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, Rio De Janeiro, RJ, Brazil.	odontojcp@gmail.com	Leme, Adriana F Paes/C-9679-2012	Leme, Adriana F Paes/0000-0001-7959-147X; Soares, Marcia/0000-0001-9272-9488	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian Governmental Institutions	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Governmental Institutions	This study was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Governmental Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; [Anonymous], 2007, BIOFILM PRIMER; Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Goulhen F, 2003, CRIT REV ORAL BIOL M, V14, P399, DOI 10.1177/154411130301400603; Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Hernandez F, 2012, ANAL BIOANAL CHEM, V403, P1251, DOI 10.1007/s00216-012-5844-7; HESS HH, 1978, ANAL BIOCHEM, V85, P295, DOI 10.1016/0003-2697(78)90304-4; Huang T, 2012, BRIEF BIOINFORM, V13, P586, DOI 10.1093/bib/bbs004; Jungermann GB, 2011, J ENDODONT, V37, P1337, DOI 10.1016/j.joen.2011.06.028; Kawakami R, 2004, J BIOCHEM, V136, P541, DOI 10.1093/jb/mvh157; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Leme AFP, 2008, CARIES RES, V42, P435, DOI 10.1159/000159607; Li YF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S4; Maron PA, 2007, MICROB ECOL, V53, P486, DOI 10.1007/s00248-006-9196-8; Maruyama A, 2003, MICROBIOL-SGM, V149, P389, DOI 10.1099/mic.0.25796-0; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Munson MA, 2002, J DENT RES, V81, P761, DOI 10.1177/154405910208101108; Nandakumar R, 2009, ORAL MICROBIOL IMMUN, V24, P347, DOI 10.1111/j.1399-302X.2009.00520.x; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Ribeiro AC, 2011, J ENDODONT, V37, P922, DOI 10.1016/j.joen.2011.04.007; Ricucci D, 2010, J ENDODONT, V36, P1277, DOI 10.1016/j.joen.2010.04.007; Rocas IN, 2012, ANAEROBE, V18, P576, DOI 10.1016/j.anaerobe.2012.10.001; Rudney JD, 2010, MOL ORAL MICROBIOL, V25, P38, DOI 10.1111/j.2041-1014.2009.00558.x; Sakamoto M, 2007, ORAL MICROBIOL IMMUN, V22, P19, DOI 10.1111/j.1399-302X.2007.00315.x; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Sato I, 1996, INT ENDOD J, V29, P118, DOI 10.1111/j.1365-2591.1996.tb01172.x; Schneider T, 2010, PROTEOMICS, V10, P785, DOI 10.1002/pmic.200900450; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira Jr José F., 2007, Braz. Dent. J., V18, P267, DOI 10.1590/S0103-64402007000400001; Siqueira JF, 2013, CLIN MICROBIOL REV, V26, P255, DOI 10.1128/CMR.00082-12; Siqueira JF, 2009, ORAL SURG ORAL MED O, V107, P870, DOI 10.1016/j.tripleo.2009.01.044; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Torabinejad M, 2003, J ENDODONT, V29, P170, DOI 10.1097/00004770-200303000-00002; Vianna ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923; Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d	53	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76108	10.1371/journal.pone.0076108	http://dx.doi.org/10.1371/journal.pone.0076108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143178	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100013
J	Vokaer, BT; Charbonnier, LM; Lemaitre, PH; Spilleboudt, C; Le Moine, A				Vokaer, Benoi T.; Charbonnier, Louis-Marie; Lemaitre, Philippe H.; Spilleboudt, Chloe; Le Moine, Alain			IL-17A and IL-2-Expanded Regulatory T Cells Cooperate to Inhibit Th1-Mediated Rejection of MHC II Disparate Skin Grafts	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; TH17 CELLS; INTERLEUKIN-2; COMPLEXES; MODEL	Several evidences suggest that regulatory T cells (Treg) promote Th17 differentiation. Based on this hypothesis, we tested the effect of IL-17A neutralization in a model of skin transplantation in which long-term graft survival depends on a strong in vivo Treg expansion induced by transient exogenous IL-2 administration. As expected, IL-2 supplementation prevented rejection of MHC class II disparate skin allografts but, surprisingly, not in IL-17A-deficient recipients. We attested that IL-17A was not required for IL-2-mediated Treg expansion, intragraft recruitment or suppressive capacities. Instead, IL-17A prevented allograft rejection by inhibiting Th1 alloreactivity independently of Tregs. Indeed, T-bet expression of naive alloreactive CD4+ T cells and the subsequent Th1 immune response was significantly enhanced in IL-17A deficient mice. Our results illustrate for the first time a protective role of IL-17A in CD4+-mediated allograft rejection process.	[Vokaer, Benoi T.; Charbonnier, Louis-Marie; Lemaitre, Philippe H.; Spilleboudt, Chloe; Le Moine, Alain] Univ Libre Brussels, Inst Med Immunol, Gosselies, Belgium		Vokaer, BT (corresponding author), Univ Libre Brussels, Inst Med Immunol, Gosselies, Belgium.	bvokaer@ulb.ac.be; alemoine@ulb.ac.be		Charbonnier, Louis-Marie/0000-0002-4594-7893	Roche Organ Transplantation Research Foundation (ROTRF); Walloon Region; FNRS-Belgium; GlaxoSmithKline Biologicals	Roche Organ Transplantation Research Foundation (ROTRF); Walloon Region; FNRS-Belgium(Fonds de la Recherche Scientifique - FNRS); GlaxoSmithKline Biologicals(GlaxoSmithKline)	This work was funded by the Roche Organ Transplantation Research Foundation (ROTRF) http://www.rotrf.org/. The Institute for Medical Immunology is funded by research grants of the Walloon Region (www.wallonie.be), the FNRS-Belgium and GlaxoSmithKline Biologicals (www.gsk.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonysamy MA, 1999, J IMMUNOL, V162, P577; Auerbach MB, 2009, AM J PATHOL, V174, P2172, DOI 10.2353/ajpath.2009.080516; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burrell BE, 2008, J IMMUNOL, V181, P3906, DOI 10.4049/jimmunol.181.6.3906; Charbonnier LM, 2012, AM J TRANSPLANT, V12, P2313, DOI 10.1111/j.1600-6143.2012.04184.x; Cunnusamy K, 2011, J IMMUNOL, V186, P6737, DOI 10.4049/jimmunol.1100101; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Koga S, 1999, J IMMUNOL, V163, P4878; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Le Moine A, 2002, TRANSPLANTATION, V73, P1373, DOI 10.1097/00007890-200205150-00001; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Toh ML, 2010, ANN RHEUM DIS, V69, P1562, DOI 10.1136/ard.2009.111757; Toh ML, 2009, CYTOKINE, V48, P226, DOI 10.1016/j.cyto.2009.07.013; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Yang ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008922; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	20	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76040	10.1371/journal.pone.0076040	http://dx.doi.org/10.1371/journal.pone.0076040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146810	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400034
J	Chatterjee, R; Hoffman, M; Cliften, P; Seshan, S; Liapis, H; Jain, S				Chatterjee, Rajshekhar; Hoffman, Mary; Cliften, Paul; Seshan, Surya; Liapis, Helen; Jain, Sanjay			Targeted Exome Sequencing Integrated with Clinicopathological Information Reveals Novel and Rare Mutations in Atypical, Suspected and Unknown Cases of Alport Syndrome or Proteinuria	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BASEMENT-MEMBRANE NEPHROPATHY; GLOMERULAR-FILTRATION; NEPHROTIC SYNDROME; CHILDHOOD; HEMATURIA; REMISSION	We applied customized targeted next-generation exome sequencing (NGS) to determine if mutations in genes associated with renal malformations, Alport syndrome (AS) or nephrotic syndrome are a potential cause of renal abnormalities in patients with equivocal or atypical presentation. We first sequenced 4,041 exons representing 292 kidney disease genes in a Caucasian woman with a history of congenital vesicoureteral reflux (VUR), recurrent urinary tract infections and hydronephrosis who presented with nephrotic range proteinuria at the age of 45. Her biopsy was remarkable for focal segmental glomerulosclerosis (FSGS), a potential complication of longstanding VUR. She had no family history of renal disease. Her proteinuria improved initially, however, several years later she presented with worsening proteinuria and microhematuria. NGS analysis revealed two deleterious COL4A3 mutations, one novel and the other previously reported in AS, and a novel deleterious SALL2 mutation, a gene linked to renal malformations. Pedigree analysis confirmed that COL4A3 mutations were nonallelic and compound heterozygous. The genomic results in conjunction with subsequent abnormal electron microscopy, Collagen IV minor chain immunohistochemistry and progressive sensorineural hearing loss confirmed AS. We then modified our NGS approach to enable more efficient discovery of variants associated with AS or a subset of FSGS by multiplexing targeted exome sequencing of 19 genes associated with AS or FSGS in 14 patients. Using this approach, we found novel or known COL4A3 or COL4A5 mutations in a subset of patients with clinically diagnosed or suspected AS, APOL1 variants associated with FSGS in African Americans and novel mutations in genes associated with nephrotic syndrome. These studies demonstrate the successful application of targeted capture-based exome sequencing to simultaneously evaluate genetic variations in many genes in patients with complex renal phenotypes and provide insights into etiology of conditions with equivocal clinical and pathologic presentations.	[Chatterjee, Rajshekhar; Hoffman, Mary; Liapis, Helen; Jain, Sanjay] Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Cliften, Paul] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Liapis, Helen; Jain, Sanjay] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Seshan, Surya] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Cornell University	Jain, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA.	sjain22@wustl.edu		jain, sanjay/0000-0003-2804-127X	National Institutes of Health (NIH) George M. O'Brien Center for Kidney Disease Research [P30-DK079333]; Children Discovery Institute [MDII2009177]; renal division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health (NIH) George M. O'Brien Center for Kidney Disease Research; Children Discovery Institute; renal division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) George M. O'Brien Center for Kidney Disease Research (P30-DK079333) to Washington University, Children Discovery Institute grant MDII2009177 (SJ) and renal division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Althaus K, 2009, SEMIN THROMB HEMOST, V35, P189, DOI 10.1055/s-0029-1220327; Alves Fatima Regina Abreu, 2008, Braz J Otorhinolaryngol, V74, P807, DOI 10.1016/S1808-8694(15)30140-3; Artuso R, 2012, EUR J HUM GENET, V20, P50, DOI 10.1038/ejhg.2011.164; Boyer O, 2010, J MED GENET, V47, P445, DOI 10.1136/jmg.2009.076166; Chatterjee R, 2012, HUM GENET, V131, P1725, DOI 10.1007/s00439-012-1181-3; Choi HJ, 2008, AM J KIDNEY DIS, V51, P834, DOI 10.1053/j.ajkd.2008.01.018; Cook C, 2008, AM J KIDNEY DIS, V51, pE25, DOI 10.1053/j.ajkd.2007.09.028; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; DISCHE FE, 1985, AM J NEPHROL, V5, P103, DOI 10.1159/000166914; Gipson DS, 2006, PEDIATR NEPHROL, V21, P344, DOI 10.1007/s00467-005-2097-0; GLEESON MJ, 1984, J LARYNGOL OTOL, V98, P449, DOI 10.1017/S0022215100146894; Goldberg S, 2010, J AM SOC NEPHROL, V21, P579, DOI 10.1681/ASN.2009091004; Kashtan CE, 2004, CURR OPIN PEDIATR, V16, P177, DOI 10.1097/00008480-200404000-00011; Koziell A, 2002, HUM MOL GENET, V11, P379, DOI 10.1093/hmg/11.4.379; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liapis H, 2012, PEDIAT NEPHROL; Mitsnefes M, 2005, AM J KIDNEY DIS, V45, P309, DOI 10.1053/j.ajkd.2004.11.006; Santin S, 2009, KIDNEY INT, V76, P1268, DOI 10.1038/ki.2009.381; Savige J, 2003, KIDNEY INT, V64, P1169, DOI 10.1046/j.1523-1755.2003.00234.x; Troyanov S, 2005, J AM SOC NEPHROL, V16, P1061, DOI 10.1681/ASN.2004070593; VELOSA JA, 1983, MAYO CLIN PROC, V58, P568; Zhang Y, 2011, BLOOD, V119, P238	23	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76360	10.1371/journal.pone.0076360	http://dx.doi.org/10.1371/journal.pone.0076360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130771	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200036
J	Martin, BA; Kalata, W; Shaffer, N; Fischer, P; Luciano, M; Loth, F				Martin, Bryn A.; Kalata, Wojciech; Shaffer, Nicholas; Fischer, Paul; Luciano, Mark; Loth, Francis			Hydrodynamic and Longitudinal Impedance Analysis of Cerebrospinal Fluid Dynamics at the Craniovertebral Junction in Type I Chiari Malformation	PLOS ONE			English	Article							COMPUTATIONAL FLOW-ANALYSIS; FORAMEN MAGNUM; CSF FLOW; CRANIOCERVICAL DECOMPRESSION; MORPHOMETRIC-ANALYSIS; SYMPTOMATIC PATIENTS; OUTFLOW RESISTANCE; VEIN GRAFTS; MR; CHILDREN	Elevated or reduced velocity of cerebrospinal fluid (CSF) at the craniovertebral junction (CVJ) has been associated with type I Chiari malformation (CMI). Thus, quantification of hydrodynamic parameters that describe the CSF dynamics could help assess disease severity and surgical outcome. In this study, we describe the methodology to quantify CSF hydrodynamic parameters near the CVJ and upper cervical spine utilizing subject-specific computational fluid dynamics (CFD) simulations based on in vivo MRI measurements of flow and geometry. Hydrodynamic parameters were computed for a healthy subject and two CMI patients both pre- and post-decompression surgery to determine the differences between cases. For the first time, we present the methods to quantify longitudinal impedance (LI) to CSF motion, a subject-specific hydrodynamic parameter that may have value to help quantify the CSF flow blockage severity in CMI. In addition, the following hydrodynamic parameters were quantified for each case: maximum velocity in systole and diastole, Reynolds and Womersley number, and peak pressure drop during the CSF cardiac flow cycle. The following geometric parameters were quantified: cross-sectional area and hydraulic diameter of the spinal subarachnoid space (SAS). The mean values of the geometric parameters increased post-surgically for the CMI models, but remained smaller than the healthy volunteer. All hydrodynamic parameters, except pressure drop, decreased post-surgically for the CMI patients, but remained greater than in the healthy case. Peak pressure drop alterations were mixed. To our knowledge this study represents the first subject-specific CFD simulation of CMI decompression surgery and quantification of LI in the CSF space. Further study in a larger patient and control group is needed to determine if the presented geometric and/or hydrodynamic parameters are helpful for surgical planning.	[Martin, Bryn A.; Shaffer, Nicholas; Loth, Francis] Univ Akron, Conquer Chiari Res Ctr, Akron, OH 44325 USA; [Martin, Bryn A.; Shaffer, Nicholas; Loth, Francis] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Kalata, Wojciech] Spraying Syst Inc, Wheaton, IL USA; [Fischer, Paul] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Luciano, Mark] Cleveland Clin Fdn, Dept Neurosurg, Cleveland, OH USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; United States Department of Energy (DOE); Argonne National Laboratory; Cleveland Clinic Foundation	Martin, BA (corresponding author), Univ Akron, Conquer Chiari Res Ctr, Akron, OH 44325 USA.	director@chiari-research.org	Martin, Bryn A./N-6640-2016	Martin, Bryn A./0000-0003-1234-7880	Edward and Gayle Labuda Charitable Fund of the Vanguard Charitable Endowment Program; Conquer Chiari; Labuda Family Foundation; American Syringomyelia Alliance Project; National Institutes for Health NINDS R15 Grant [1R15NS071455-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS071455] Funding Source: NIH RePORTER	Edward and Gayle Labuda Charitable Fund of the Vanguard Charitable Endowment Program; Conquer Chiari; Labuda Family Foundation; American Syringomyelia Alliance Project; National Institutes for Health NINDS R15 Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Edward and Gayle Labuda Charitable Fund of the Vanguard Charitable Endowment Program, Conquer Chiari, the Labuda Family Foundation, the American Syringomyelia Alliance Project, and the National Institutes for Health NINDS R15 Grant No. 1R15NS071455-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 2005, J NEUROSURG, V103, P46, DOI 10.3171/jns.2005.103.1.0046; BARKOVICH AJ, 1986, AM J NEURORADIOL, V7, P795; BORGESEN SE, 1992, ACTA NEUROCHIR, V119, P12, DOI 10.1007/BF01541775; Bunck A.C, 2012, EUROPEAN RADIOLOGY; Bunck AC, 2011, EUR RADIOL, V21, P1788, DOI 10.1007/s00330-011-2105-7; Cousins J, 2009, AM J NEURORADIOL, V30, P1587, DOI 10.3174/ajnr.A1507; Curi MA, 2002, J SURG RES, V108, P191, DOI 10.1006/jsre.2002.6558; Dolar MT, 2004, AM J NEURORADIOL, V25, P142; Eklund A, 2007, MED BIOL ENG COMPUT, V45, P719, DOI 10.1007/s11517-007-0199-5; Haughton VM, 2003, AM J NEURORADIOL, V24, P169; Iskandar BJ, 2004, J NEUROSURG, V101, P169, DOI 10.3171/ped.2004.101.2.0169; Lee S, 2000, P ANN INT IEEE EMBS, V22, P719, DOI 10.1109/IEMBS.2000.900848; Linge SO, 2011, AM J NEURORADIOL, V32, P1474, DOI 10.3174/ajnr.A2496; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; McGirt MJ, 2008, CHILD NERV SYST, V24, P833, DOI 10.1007/s00381-007-0569-1; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Meyerson SL, 2000, J VASC SURG, V31, P910, DOI 10.1067/mva.2000.105957; Meyerson SL, 2000, VASC ENDOVASC SURG, V34, P10; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Moawad J, 1999, EUR J VASC ENDOVASC, V17, P517, DOI 10.1053/ejvs.1999.0819; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Sakas DE, 2005, ACTA NEUROCHIR, V147, P1223, DOI 10.1007/s00701-005-0645-9; Schwartz LB, 1997, J VASC SURG, V25, P1033, DOI 10.1016/S0741-5214(97)70127-7; Sekula RF, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-11; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Skelly CL, 2001, ANN VASC SURG, V15, P110, DOI 10.1007/BF02693810; Tubbs RS, 2010, NEUROSURGERY, V66, P385, DOI 10.1227/01.NEU.0000363407.78399.BA; Tubbs RS, 2009, CHILD NERV SYST, V25, P689, DOI 10.1007/s00381-009-0810-1; Urbizu A, 2013, J NEUROIMAGING; Vardoulis O, 2011, IMPACT AORTIC UNPUB; Yedavalli RV, 2001, J BIOMECH ENG-T ASME, V123, P372, DOI 10.1115/1.1385845; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284	34	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75335	10.1371/journal.pone.0075335	http://dx.doi.org/10.1371/journal.pone.0075335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130704	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200011
J	Durand, JD; Guinand, B; Dodson, JJ; Lecomte, F				Durand, Jean-Dominique; Guinand, Bruno; Dodson, Julian J.; Lecomte, Frederic			Pelagic Life and Depth: Coastal Physical Features in West Africa Shape the Genetic Structure of the Bonga Shad, Ethmalosa fimbriata	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; ESTUARINE FISH; CLIMATE-CHANGE; GEOGRAPHIC DISTANCE; HISTORY TRAITS; POPULATION; DISPERSAL; FISHERIES; NUCLEAR; FLOW	The bonga shad, Ethmalosa fimbriata, is a West African pelagic species still abundant in most habitats of its distribution range and thought to be only recently affected by anthropogenic pressure (habitat destruction or fishing pressure). Its presence in a wide range of coastal habitats characterised by different hydrodynamic processes, represents a case study useful for evaluating the importance of physical structure of the west African shoreline on the genetic structure of a small pelagic species. To investigate this question, the genetic diversity of E. fimbriata was assessed at both regional and species range scales, using mitochondrial (mt) and nuclear DNA markers. Whereas only three panmictic units were identified with mtDNA at the large spatial scale, nuclear genetic markers (EPIC: exon-primed intron-crossing) indicated a more complex genetic pattern at the regional scale. In the northern-most section of shad's distribution range, up to 4 distinct units were identified. Bayesian inference as well as spatial autocorrelation methods provided evidence that gene flow is impeded by the presence of deep-water areas near the coastline (restricting the width of the coastal shelf), such as the Cap Timiris and the Kayar canyons in Mauritania and Senegal, respectively. The added discriminatory power provided by the use of EPIC markers proved to be essential to detect the influence of more subtle, contemporary processes (e.g. gene flow, barriers, etc.) acting within the glacial refuges identified previously by mtDNA.	[Durand, Jean-Dominique] Univ Montpellier 2, Inst Rech Dev, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France; [Guinand, Bruno] Univ Montpellier 2, Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France; [Dodson, Julian J.] Univ Laval, Dept Biol, Laval, PQ, Canada; [Lecomte, Frederic] Minist Dev Durable Environm Faune & Parcs Quebec, Direct Expertise Faune & Ses Habitats, Direct Faune Aquat, Quebec City, PQ, Canada	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Laval University	Durand, JD (corresponding author), Univ Montpellier 2, Inst Rech Dev, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France.	Jean-Dominique.Durand@ird.fr	Durand, Jean-Dominique/G-3713-2016; Lecomte, Frederic/AAN-7766-2021	Durand, Jean-Dominique/0000-0002-0261-0377; Lecomte, Frederic/0000-0002-8845-1249; GUINAND, Bruno/0000-0002-6934-1677	IRD	IRD	IRD funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J., 2004, Journal of Environment & Development, V13, P156, DOI 10.1177/1070496504266092; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ama-Abasi D, 2004, FISH RES, V68, P225, DOI 10.1016/j.fishres.2003.12.002; Angelini R, 2011, SCI MAR, V75, P309, DOI 10.3989/scimar.2011.75n2309; Atarhouch T, 2006, MOL PHYLOGENET EVOL, V39, P373, DOI 10.1016/j.ympev.2005.08.003; Atkinson LJ, 2011, AFR J MAR SCI, V33, P157, DOI 10.2989/1814232X.2011.572378; BARRYGERARD M, 1990, RECHERCHES, P34; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2008, TECHNICAL REPORT; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Berumen ML, 2010, CORAL REEFS, V29, P883, DOI 10.1007/s00338-010-0652-z; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; BLAY J, 1982, J FISH BIOL, V21, P485, DOI 10.1111/j.1095-8649.1982.tb02854.x; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Bradbury IR, 2008, CAN J FISH AQUAT SCI, V65, P147, DOI 10.1139/F07-154; Bradbury IR, 2011, MAR ECOL PROG SER, V438, P207, DOI 10.3354/meps09286; Bradbury IR, 2007, MAR ECOL PROG SER, V340, P245, DOI 10.3354/meps340245; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; Cadrin S. X., 2005, STOCK IDENTIFICATION; Canino MF, 2010, MAR COAST FISH, V2, P375, DOI 10.1577/C09-024.1; Castric V, 2003, GENETICS, V163, P983; Charles-Dominique E, 2003, AM FISH S S, V35, P27; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Chikhi L, 1998, J FISH BIOL, V52, P861, DOI 10.1111/j.1095-8649.1998.tb00588.x; Chlaida M, 2009, ICES J MAR SCI, V66, P264, DOI 10.1093/icesjms/fsn206; Chow S, 1998, FISHERIES SCI, V64, P397, DOI 10.2331/fishsci.64.397; CHRISTENSEN V, 2004, W AFRICAN MARINE ECO, V12, P215; CROW JF, 1984, P NATL ACAD SCI-BIOL, V81, P6073, DOI 10.1073/pnas.81.19.6073; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DuBois C, 2012, MAR POLICY, V36, P1211, DOI 10.1016/j.marpol.2012.03.007; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Durand JD, 2005, MOL PHYLOGENET EVOL, V36, P277, DOI 10.1016/j.ympev.2005.01.019; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; Fogarty MJ, 2007, OCEANOGRAPHY, V20, P112, DOI 10.5670/oceanog.2007.34; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gascuel D, 2007, AFR J MAR SCI, V29, P331, DOI 10.2989/AJMS.2007.29.3.3.333; Gascuel D, 1997, AQUAT LIVING RESOUR, V10, P281, DOI 10.1051/alr:1997031; GOURENE B, 1993, J IVOIR OCEANOL LIMN, V2, P69; Gray CA, 2012, AQUAT BIOL, V16, P53, DOI 10.3354/ab00428; Guinand B, 2003, CR BIOL, V326, pS61, DOI 10.1016/S1631-0691(03)00039-8; Hassan M, 2002, MOL ECOL NOTES, V2, P334, DOI 10.1046/j.1471-8286.2002.00236.x; Hasselman DJ, 2013, MOL ECOL, V22, P1558, DOI 10.1111/mec.12197; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hauser L, 2008, FISH FISH, V9, P473, DOI 10.1111/j.1467-2979.2008.00306.x; Henriques R, 2012, AFR J MAR SCI, V34, P585, DOI 10.2989/1814232X.2012.749809; HOOGHIEMSTRA H, 1986, METEOR FORSCHUNGSE C, V0040; Hooghiemstra H, 2006, QUATERN INT, V148, P29, DOI 10.1016/j.quaint.2005.11.005; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lam VWY, 2012, AFR J MAR SCI, V34, P103, DOI 10.2989/1814232X.2012.673294; Larmuseau MHD, 2010, HEREDITY, V105, P532, DOI 10.1038/hdy.2010.9; Laurans M, 2004, AQUAT LIVING RESOUR, V17, P163, DOI 10.1051/alr:2004023; Longhurst A. R., 1960, Bull Inst franc Aft noire, V22A, P1337; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; N'goran Ya Nestor, 1991, Journal Ivoirien d'Oceanologie et de Limnologie, V1, P23; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; Panfili J, 2004, MAR ECOL PROG SER, V270, P241, DOI 10.3354/meps270241; Panfili J, 2004, AQUAT LIVING RESOUR, V17, P65, DOI 10.1051/alr:2004002; PAULY D, 2003, PERFECT OCEAN STATE, P208; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Perry RI, 2011, FISH FISH, V12, P427, DOI 10.1111/j.1467-2979.2010.00402.x; POUYAUD L, 1996, ICLARM C P, V41, P408; POUYAUD L, 1995, COMPTES RENDUS ATELI, P60; Puebla O, 2012, MOL ECOL, V21, P5675, DOI 10.1111/j.1365-294X.2012.05734.x; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sardinha MI, 2002, S AFR J MARINE SCI, V24, P49, DOI 10.2989/025776102784528303; SCHEFFERS WJ, 1976, DOC SCI PROVIS CTR R, V59, P19; SCHEFFERS WJ, 1972, DOC SCI PROVIS CTR R, V44, P21; SEVRINREYSSAC J, 1985, OCEANOGRAPHIE TROPIC, V1, P85; Simier M, 2004, ESTUAR COAST SHELF S, V59, P69, DOI 10.1016/j.ecss.2003.08.002; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sokal RR, 1995, BIOMETRY PRINCIPLES, P937; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; TORESEN R, 2002, SURVEY PELAGIC FISH; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323	94	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77483	10.1371/journal.pone.0077483	http://dx.doi.org/10.1371/journal.pone.0077483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130890	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900139
J	Freeman, HD; Sullivan, J; Hopper, LM; Talbot, CF; Holmes, AN; Schultz-Darken, N; Williams, LE; Brosnan, SF				Freeman, Hani D.; Sullivan, Jennifer; Hopper, Lydia M.; Talbot, Catherine F.; Holmes, Andrea N.; Schultz-Darken, Nancy; Williams, Lawrence E.; Brosnan, Sarah F.			Different Responses to Reward Comparisons by Three Primate Species	PLOS ONE			English	Article							OTHER-REGARDING PREFERENCES; PROSOCIAL BEHAVIOR; SAGUINUS-OEDIPUS; CAPUCHIN MONKEYS; INEQUITY; TAMARINS; COOPERATION; CHIMPANZEES	Background: Recently, much attention has been paid to the role of cooperative breeding in the evolution of behavior. In many measures, cooperative breeders are more prosocial than non-cooperatively breeding species, including being more likely to actively share food. This is hypothesized to be due to selective pressures specific to the interdependency characteristic of cooperatively breeding species. Given the high costs of finding a new mate, it has been proposed that cooperative breeders, unlike primates that cooperate in other contexts, should not respond negatively to unequal outcomes between themselves and their partner. However, in this context such pressures may extend beyond cooperative breeders to other species with pair-bonding and bi-parental care. Methods: Here we test the response of two New World primate species with different parental strategies to unequal outcomes in both individual and social contrast conditions. One species tested was a cooperative breeder (Callithrix spp.) and the second practiced bi-parental care (Aotus spp.). Additionally, to verify our procedure, we tested a third confamilial species that shows no such interdependence but does respond to individual (but not social) contrast (Saimiri spp.). We tested all three genera using an established inequity paradigm in which individuals in a pair took turns to gain rewards that sometimes differed from those of their partners. Conclusions: None of the three species tested responded negatively to inequitable outcomes in this experimental context. Importantly, the Saimiri spp responded to individual contrast, as in earlier studies, validating our procedure. When these data are considered in relation to previous studies investigating responses to inequity in primates, they indicate that one aspect of cooperative breeding, pair-bonding or bi-parental care, may influence the evolution of these behaviors. These results emphasize the need to study a variety of species to gain insight in to how decision-making may vary across social structures.	[Freeman, Hani D.; Hopper, Lydia M.; Talbot, Catherine F.; Brosnan, Sarah F.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [Freeman, Hani D.; Hopper, Lydia M.] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL USA; [Sullivan, Jennifer; Schultz-Darken, Nancy] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Hopper, Lydia M.; Holmes, Andrea N.; Williams, Lawrence E.; Brosnan, Sarah F.] UT MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Bastrop, TX USA; [Brosnan, Sarah F.] Georgia State Univ, Dept Psychol, Philosophy & Neurosci Inst, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; UTMD Anderson Cancer Center; University System of Georgia; Georgia State University	Freeman, HD (corresponding author), Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA.	hani.freeman@gmail.com	Williams, Lawrence/AAD-6685-2020	Williams, Lawrence/0000-0003-2267-9918	NSF HSD grant [SES 0729244]; NSF CAREER award [SES 0847351]; NCRR [P40 RR001542]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001254] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [0847351] Funding Source: National Science Foundation	NSF HSD grant; NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	SFB was funded by an NSF HSD grant (SES 0729244) and an NSF CAREER award (SES 0847351) which also provided support to HDF and LMH. Support for the squirrel monkey colony comes from (NCRR P40 RR001542). The authors would also like to acknowledge the Wisconsin National Primate Research Center, P51RR000167/P51OD011106 for access to their marmoset colony. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Boehm C., 1999, HIERARCHY FOREST EVO; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Brosnan SF, 2011, FOLIA PRIMATOL, V82, P56, DOI 10.1159/000328142; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Burkart JM, 2010, ANIM COGN, V13, P1, DOI 10.1007/s10071-009-0263-7; Clark M.S., 2003, HDB PSYCHOL PERSONAL, V5, P447; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; Cronin KA, 2010, P ROY SOC B-BIOL SCI, V277, P3845, DOI 10.1098/rspb.2010.0879; Cronin KA, 2009, J COMP PSYCHOL, V123, P231, DOI 10.1037/a0015094; Dindo M., 2006, AM J PRIMATOL, V69, P1; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fernandez-Duque E, 2001, AM J PRIMATOL, V53, P99, DOI 10.1002/1098-2345(200103)53:3<99::AID-AJP1>3.0.CO;2-N; Fletcher GE, 2008, AM J PRIMATOL, V70, P901, DOI 10.1002/ajp.20576; Gillis TE, 2012, AM J PRIMATOL, V74, P712, DOI 10.1002/ajp.22015; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; HOLM S, 1979, SCAND J STAT, V6, P65; Hopper L. M., 2013, J PRIMATOL, V2, P109, DOI DOI 10.4172/2167-6801.1000109; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; KOENIG A, 1995, AM J PRIMATOL, V35, P311, DOI 10.1002/ajp.1350350407; Massen JJM, 2012, AM J PRIMATOL, V74, P145, DOI 10.1002/ajp.21014; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Neiworth JJ, 2009, J COMP PSYCHOL, V123, P10, DOI 10.1037/a0012662; Pryor K., 2009, REACHING ANIMAL MIND; Raihani NJ, 2012, ANIM BEHAV, V84, P665, DOI 10.1016/j.anbehav.2012.06.023; Reynolds G. S., 1961, J EXPT ANAL BEHAV, V4, P441; Salwiczek L, PLOS ONE IN PRESS; Schaffner CM, 2005, FOLIA PRIMATOL, V76, P67, DOI 10.1159/000083614; Silberberg A, 2009, ANIM COGN, V12, P505, DOI 10.1007/s10071-009-0211-6; Stevens JR, 2010, ANIM COGN, V13, P663, DOI 10.1007/s10071-010-0309-x; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Talbot CF, 2011, BIOL LETTERS, V7, P680, DOI 10.1098/rsbl.2011.0211; Tinklepaugh OL, 1928, J COMP PSYCHOL, V8, P197, DOI 10.1037/h0075798; van Schaik CP, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P477, DOI 10.1007/978-3-642-02725-3_22; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Wascher CAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056885; Washabaugh KF, 2002, ANIM BEHAV, V63, P1163, DOI 10.1006/anbe.2002.3018; Wolovich CK, 2008, AM J PRIMATOL, V70, P211, DOI 10.1002/ajp.20477	44	23	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76297	10.1371/journal.pone.0076297	http://dx.doi.org/10.1371/journal.pone.0076297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130767	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900072
J	Martinez-Lopez, A; Garcia-Valtanen, P; Ortega-Villaizan, MD; Chico, V; Medina-Gali, RM; Perez, L; Coll, J; Estepa, A				Martinez-Lopez, Alicia; Garcia-Valtanen, Pablo; del Mar Ortega-Villaizan, Maria; Chico, Veronica; Maria Medina-Gali, Regla; Perez, Luis; Coll, Julio; Estepa, Amparo			Increasing Versatility of the DNA Vaccines through Modification of the Subcellular Location of Plasmid-Encoded Antigen Expression in the In Vivo Transfected Cells	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; RAINBOW-TROUT; RHABDOVIRUS VHSV; GLYCOPROTEIN-G; PROTEIN-G; VIRUS; FUSION; PLEUROCIDIN; VACCINATION; PEPTIDES	The route of administration of DNA vaccines can play a key role in the magnitude and quality of the immune response triggered after their administration. DNA vaccines containing the gene of the membrane-anchored glycoprotein (gpG) of the fish rhabdoviruses infectious haematopoietic necrosis virus (IHNV) or viral haematopoietic septicaemia virus (VHSV), perhaps the most effective DNA vaccines generated so far, confer maximum protection when injected intramuscularly in contrast to their low efficacy when injected intraperitoneally. In this work, taking as a model the DNA vaccine against VHSV, we focused on developing a more versatile DNA vaccine capable of inducing protective immunity regardless of the administration route used. For that, we designed two alternative constructs to gpG(1-507) (the wild type membrane-anchored gpG of VHSV) encoding either a soluble (gpG(1-462)) or a secreted soluble (gpG(LmPle20-462)) form of the VHSV-gpG. In vivo immunisation/challenge assays showed that only gpG(LmPle20-462) (the secreted soluble form) conferred protective immunity against VHSV lethal challenge via both intramuscular and intraperitoneal injection, being this the first description of a fish viral DNA vaccine that confers protection when administered intraperitoneally. Moreover, this new DNA vaccine construct also conferred protection when administered in the presence of an oil adjuvant suggesting that DNA vaccines against rhabdoviruses could be included in the formulation of current multicomponent-intaperitoneally injectable fish vaccines formulated with an oil adjuvant. On the other hand, a strong recruitment of membrane immunoglobulin expressing B cells, mainly membrane IgT, as well as t-bet expressing T cells, at early times post-immunisation, was specifically observed in the fish immunised with the secreted soluble form of the VHSV-gpG protein; this may indicate that the subcellular location of plasmid-encoded antigen expression in the in vivo transfected cells could be an important factor in determining the ways in which DNA vaccines prime the immune response.	[Martinez-Lopez, Alicia; Garcia-Valtanen, Pablo; del Mar Ortega-Villaizan, Maria; Chico, Veronica; Maria Medina-Gali, Regla; Perez, Luis; Estepa, Amparo] Miguel Hernandez Univ, IBMC, Elche, Spain; [Coll, Julio] INIA SIGT Biotecnol, Madrid, Spain; [Maria Medina-Gali, Regla] LABIOFAM Pharmaceut Labs, Havana, Cuba	Universidad Miguel Hernandez de Elche	Estepa, A (corresponding author), Miguel Hernandez Univ, IBMC, Elche, Spain.	aestepa@umh.es	Coll, julio/M-6071-2019; Del Mar Ortega-villaizan Romo, Maria/Q-9233-2018; Gali, Regla María M Medina/D-6958-2018; Coll, Julio M/G-4533-2010; del Mar Ortega-Villaizan Romo, Maria/K-3649-2014; Gali, Regla María Medina/AAH-9742-2020; Valtanen, Pablo Garcia/U-2921-2018	Coll, julio/0000-0001-8496-3493; Del Mar Ortega-villaizan Romo, Maria/0000-0003-2065-0601; Gali, Regla María M Medina/0000-0001-9401-8292; Coll, Julio M/0000-0001-8496-3493; Gali, Regla María Medina/0000-0001-9401-8292; Valtanen, Pablo Garcia/0000-0003-4382-6446; Martinez Lopez, Alicia/0000-0003-3347-0394; Perez Garcia-Estan, Luis/0000-0003-4078-8763	Spanish Ministry of Economy and Competence [AGL2011-28921-C03-01, AGL2011-28921-C03-02]; CONSOLIDER INGENIO [2010-CSD2007-00002]; Generalitat Valenciana [ISIC-2012-003 ACOMP/2013/230]	Spanish Ministry of Economy and Competence(Spanish Government); CONSOLIDER INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by Spanish Ministry of Economy and Competence grants AGL2011-28921-C03-01 and -02 and CONSOLIDER INGENIO 2010-CSD2007-00002 to AE and JC as well as by the Generalitat Valenciana grant ISIC-2012-003 ACOMP/2013/230 to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2011, FISH SHELLFISH IMMUN, V30, P815, DOI 10.1016/j.fsi.2011.01.001; Basurco B., 1989, Bulletin of the European Association of Fish Pathologists, V9, P92; Becker PD, 2008, HUM VACCINES, V4, P189, DOI 10.4161/hv.4.3.6314; Boshra H, 2004, FISH SHELLFISH IMMUN, V17, P293, DOI 10.1016/j.fsi.2004.04.002; Brocal I, 2006, APPL MICROBIOL BIOT, V72, P1217, DOI 10.1007/s00253-006-0393-7; Carlson C, 1997, VIROLOGY, V239, P198, DOI 10.1006/viro.1997.8892; Chico V, 2010, J VIROL, V84, P7140, DOI 10.1128/JVI.00023-10; Chico V, 2009, VACCINE, V27, P1938, DOI 10.1016/j.vaccine.2009.01.103; Coban C, 2011, CURR GENE THER, V11, P479, DOI 10.2174/156652311798192815; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Corbeil S, 2000, FISH SHELLFISH IMMUN, V10, P711, DOI 10.1006/fsim.2000.0286; DEKINKELIN P, 1977, CR ACAD SCI D NAT, V284, P101; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Estepa AM, 2001, J BIOL CHEM, V276, P46268, DOI 10.1074/jbc.M108682200; Falco A, 2007, ANTIVIR RES, V76, P111, DOI 10.1016/j.antiviral.2007.06.006; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Gupta PK, 2005, VET MICROBIOL, V108, P207, DOI 10.1016/j.vetmic.2005.04.007; Ingolotti M, 2010, EXPERT REV VACCINES, V9, P747, DOI 10.1586/ERV.10.57; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Lorenzo G, 1996, J VIROL METHODS, V58, P1, DOI 10.1016/0166-0934(95)01972-3; Mas V, 2004, J VIROL, V78, P1936, DOI 10.1128/JVI.78.4.1936-1944.2004; Mas V, 2002, J GEN VIROL, V83, P2671, DOI 10.1099/0022-1317-83-11-2671; McLauchlan PE, 2003, FISH SHELLFISH IMMUN, V15, P39, DOI 10.1016/S1050-4648(02)00137-7; Mitta G, 2000, J CELL SCI, V113, P2759; Nunez E, 1998, VIROLOGY, V243, P322, DOI 10.1006/viro.1998.9076; Rocha A, 2002, VET IMMUNOL IMMUNOP, V86, P89, DOI 10.1016/S0165-2427(02)00016-8; Rush C, 2002, J IMMUNOL, V169, P4951, DOI 10.4049/jimmunol.169.9.4951; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; Schijns VEJC, 2005, DEV BIOLOGICALS, V121, P127; Sunyer JO, 2005, VET IMMUNOL IMMUNOP, V108, P77, DOI 10.1016/j.vetimm.2005.07.009; Vera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024041; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; Zwollo P, 2008, DEV COMP IMMUNOL, V32, P1482, DOI 10.1016/j.dci.2008.06.008	34	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77426	10.1371/journal.pone.0077426	http://dx.doi.org/10.1371/journal.pone.0077426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130884	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900136
J	Olsson, M; Tintle, L; Kierczak, M; Perloski, M; Tonomura, N; Lundquist, A; Muren, E; Fels, M; Tengvall, K; Pielberg, G; de Citres, CD; Dorso, L; Abadie, J; Hanson, J; Thomas, A; Leegwater, P; Hedhammar, A; Lindblad-Toh, K; Meadows, JRS				Olsson, Mia; Tintle, Linda; Kierczak, Marcin; Perloski, Michele; Tonomura, Noriko; Lundquist, Andrew; Muren, Eva; Fels, Max; Tengvall, Katarina; Pielberg, Gerli; de Citres, Caroline Dufaure; Dorso, Laetitia; Abadie, Jerome; Hanson, Jeanette; Thomas, Anne; Leegwater, Peter; Hedhammar, Ake; Lindblad-Toh, Kerstin; Meadows, Jennifer R. S.			Thorough Investigation of a Canine Autoinflammatory Disease (AID) Confirms One Main Risk Locus and Suggests a Modifier Locus for Amyloidosis	PLOS ONE			English	Article							SHAR-PEI DOGS; INTERLEUKIN IL 1-BETA; RENAL AMYLOIDOSIS; HAPLOTYPE RECONSTRUCTION; CUTANEOUS MUCINOSIS; HYALURONIC-ACID; ALPHA; EXPRESSION; IL-1-BETA; INDUCTION	Autoinflammatory disease (AID) manifests from the dysregulation of the innate immune system and is characterised by systemic and persistent inflammation. Clinical heterogeneity leads to patients presenting with one or a spectrum of phenotypic signs, leading to difficult diagnoses in the absence of a clear genetic cause. We used separate genome-wide SNP analyses to investigate five signs of AID (recurrent fever, arthritis, breed specific secondary dermatitis, otitis and systemic reactive amyloidosis) in a canine comparative model, the pure bred Chinese Shar-Pei. Analysis of 255 DNA samples revealed a shared locus on chromosome 13 spanning two peaks of association. A three-marker haplotype based on the most significant SNP (p<2.6x10(-8)) from each analysis showed that one haplotypic pair (H13-11) was present in the majority of AID individuals, implicating this as a shared risk factor for all phenotypes. We also noted that a genetic signature (F-ST) distinguishing the phenotypic extremes of the breed specific Chinese Shar-Pei thick and wrinkled skin, flanked the chromosome 13 AID locus; suggesting that breed development and differentiation has played a parallel role in the genetics of breed fitness. Intriguingly, a potential modifier locus for amyloidosis was revealed on chromosome 14, and an investigation of candidate genes from both this and the chromosome 13 regions revealed significant (p<0.05) renal differential expression in four genes previously implicated in kidney or immune health (AOAH, ELMO1, HAS2 and IL6). These results illustrate that phenotypic heterogeneity need not be a reflection of genetic heterogeneity, and that genetic modifiers of disease could be masked if syndromes were not first considered as individual clinical signs and then as a sum of their component parts.	[Olsson, Mia; Muren, Eva; Tengvall, Katarina; Pielberg, Gerli; Lindblad-Toh, Kerstin; Meadows, Jennifer R. S.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Tintle, Linda] Wurtsboro Vet Clin, Wurtsboro, NY USA; [Kierczak, Marcin] Swedish Univ Agr Sci SLU, Dept Clin Sci, Computat Genet Sect, Uppsala, Sweden; [Perloski, Michele; Tonomura, Noriko; Lundquist, Andrew; Lindblad-Toh, Kerstin] Broad Inst Harvard, Cambridge, MA USA; [Perloski, Michele; Tonomura, Noriko; Lundquist, Andrew; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02139 USA; [Tonomura, Noriko] Tufts Univ, Dept Clin Sci, Cummings Sch Vet Med, North Grafton, MA USA; [Fels, Max] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Dorso, Laetitia; Abadie, Jerome] LUNAM Univ, Oniris, AMaROC Unit, F-44307 Nantes, France; [Hanson, Jeanette; Hedhammar, Ake] Swedish Univ Agr Sci SLU, Dept Clin Sci, Uppsala, Sweden; [Leegwater, Peter] Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Uppsala University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Tufts University; Yeshiva University; Albert Einstein College of Medicine; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Swedish University of Agricultural Sciences; Utrecht University	Olsson, M (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	mia.olsson@imbim.uu.se; kersli@broadinstitute.org; jennifer.meadows@imbim.uu.se	Abadie, Jérôme/ABF-5089-2020; Tengvall, Katarina/L-1933-2019; Hanson, Jeanette/Q-9283-2018	Leegwater, Peter/0000-0002-4100-015X; Meadows, Jennifer/0000-0002-0850-230X; Hanson, Jeanette/0000-0001-5596-9538; Hedhammar, Ake/0000-0001-7048-3851; Dufaure de Citres, Caroline/0000-0001-6968-3864; Kierczak, Marcin/0000-0003-2629-5655; DORSO, Laetitia/0000-0001-7790-951X	Swedish Research Council, FORMAS [221-2009-1689]; Swedish Research Council, VR [521-2012-2826]; Swedish Foundation for Strategic Research; Chinese Shar-Pei Charitable Trust; Agria och SKKs forkningsfond; European Commission [GA-201370]; European Science Foundation	Swedish Research Council, FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council, VR(Swedish Research Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Chinese Shar-Pei Charitable Trust; Agria och SKKs forkningsfond; European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by the Swedish Research Council, FORMAS (221-2009-1689); the Swedish Research Council, VR (521-2012-2826); the Swedish Foundation for Strategic Research; the Chinese Shar-Pei Charitable Trust; Agria och SKKs forkningsfond and the European Commission (FP7-LUPA, GA-201370). KL-T is the recipient of a EURYI award from the European Science Foundation. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Bjornerfeldt S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-28; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Chevrel G, 2005, ANN RHEUM DIS, V64, P1257, DOI 10.1136/ard.2004.032359; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; DIBARTOLA SP, 1990, J AM VET MED ASSOC, V197, P483; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Galeazzi M, 2006, CLIN EXP RHEUMATOL, V24, pS79; Gattorno M, 2010, CURR OPIN PEDIATR, V22, P771, DOI 10.1097/MOP.0b013e3283404598; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; Hagenfeld D, 2010, J CELL BIOCHEM, V111, P858, DOI 10.1002/jcb.22772; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Docampo MJ, 2011, VET DERMATOL, V22, P535, DOI 10.1111/j.1365-3164.2011.00986.x; Kijas JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041508; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Migita K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3849; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Ojogun N, 2009, J INFECT DIS, V200, P1685, DOI 10.1086/646616; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Ombrello MJ, 2011, NAT REV RHEUMATOL, V7, P82, DOI 10.1038/nrrheum.2010.229; Ozkurede VU, 2012, CLIN EXP IMMUNOL, V167, P382, DOI 10.1111/j.1365-2249.2011.04535.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Ramsden CA, 2000, J PEDIATR-US, V136, P62, DOI 10.1016/S0022-3476(00)90051-9; RIVAS AL, 1992, CLIN IMMUNOL IMMUNOP, V64, P36, DOI 10.1016/0090-1229(92)90057-U; SCOTT JE, 1995, J ANAT, V187, P259; Segev G, 2012, J VET INTERN MED, V26, P259, DOI 10.1111/j.1939-1676.2011.00878.x; Sen S, 2010, ARCH PATHOL LAB MED, V134, P532, DOI 10.1043/1543-2165-134.4.532; Shohat M, 2011, GENET MED, V13, P487, DOI 10.1097/GIM.0b013e3182060456; Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Uhlar CM, 1997, J IMMUNOL METHODS, V203, P123, DOI 10.1016/S0022-1759(96)00220-7; van Ham TJ, 2012, CURR BIOL, V22, P830, DOI 10.1016/j.cub.2012.03.027; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zanna G, 2008, VET DERMATOL, V19, P314, DOI 10.1111/j.1365-3164.2008.00703.x; Zanna G, 2009, VET DERMATOL, V20, P377, DOI 10.1111/j.1365-3164.2009.00799.x	46	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75242	10.1371/journal.pone.0075242	http://dx.doi.org/10.1371/journal.pone.0075242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130694	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900025
J	Rousselet, J; Imbert, CE; Dekri, A; Garcia, J; Goussard, F; Vincent, B; Denux, O; Robinet, C; Dorkeld, F; Roques, A; Rossi, JP				Rousselet, Jerome; Imbert, Charles-Edouard; Dekri, Anissa; Garcia, Jacques; Goussard, Francis; Vincent, Bruno; Denux, Olivier; Robinet, Christelle; Dorkeld, Franck; Roques, Alain; Rossi, Jean-Pierre			Assessing Species Distribution Using Google Street View: A Pilot Study with the Pine Processionary Moth	PLOS ONE			English	Article							THAUMETOPOEA-PITYOCAMPA DEN.; SCHIFF. LEP.; SAMPLE-SIZE; RANGE; PERFORMANCE; EXPANSION; POPULATIONS; IMPACTS; CLIMATE; SHIFTS	Mapping species spatial distribution using spatial inference and prediction requires a lot of data. Occurrence data are generally not easily available from the literature and are very time-consuming to collect in the field. For that reason, we designed a survey to explore to which extent large-scale databases such as Google maps and Google street view could be used to derive valid occurrence data. We worked with the Pine Processionary Moth (PPM) Thaumetopoea pityocampa because the larvae of that moth build silk nests that are easily visible. The presence of the species at one location can therefore be inferred from visual records derived from the panoramic views available from Google street view. We designed a standardized procedure allowing evaluating the presence of the PPM on a sampling grid covering the landscape under study. The outputs were compared to field data. We investigated two landscapes using grids of different extent and mesh size. Data derived from Google street view were highly similar to field data in the large-scale analysis based on a square grid with a mesh of 16 km (96% of matching records). Using a 2 km mesh size led to a strong divergence between field and Google-derived data (46% of matching records). We conclude that Google database might provide useful occurrence data for mapping the distribution of species which presence can be visually evaluated such as the PPM. However, the accuracy of the output strongly depends on the spatial scales considered and on the sampling grid used. Other factors such as the coverage of Google street view network with regards to sampling grid size and the spatial distribution of host trees with regards to road network may also be determinant.	[Dorkeld, Franck; Rossi, Jean-Pierre] Ctr Montpellier, Inst Natl Rech Agron, Unite Mixte Rech Ctr Biol Gest Populat 1062, Montpellier, France; [Rousselet, Jerome; Imbert, Charles-Edouard; Dekri, Anissa; Garcia, Jacques; Goussard, Francis; Vincent, Bruno; Denux, Olivier; Robinet, Christelle; Roques, Alain] INRA, Unite Rech Zool Forestiere 633, Ctr Orleans, Orleans, France	INRAE; INRAE	Rossi, JP (corresponding author), Ctr Montpellier, Inst Natl Rech Agron, Unite Mixte Rech Ctr Biol Gest Populat 1062, Montpellier, France.	rossi@supagro.inra.fr	Rousselet, Jérôme/AAI-9490-2020; ROUSSELET, Jérôme/H-9358-2013	Rousselet, Jérôme/0000-0001-9237-6096; ROUSSELET, Jérôme/0000-0001-9237-6096; Rossi, Jean-Pierre/0000-0002-8139-1116; Robinet, Christelle/0000-0002-4933-4656	French National Agency for Research (project URTICLIM); region Centre (project ADRIEN)	French National Agency for Research (project URTICLIM); region Centre (project ADRIEN)(Region Centre-Val de Loire)	Research was funded by the French National Agency for Research (project URTICLIM) and the region Centre (project ADRIEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguelov D, 2010, COMPUTER, V43, P32, DOI 10.1109/MC.2010.170; Arnaldo PS, 2005, FOREST ECOL MANAG, V210, P1, DOI 10.1016/j.foreco.2005.02.041; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bellehumeur C, 1997, PLANT ECOL, V130, P89, DOI 10.1023/A:1009763830908; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Chang AY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-49; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025008; Clay SA, 2011, GIS APPL AGR; DEMOLIN G, 1969, Annales des Sciences Forestieres (Paris), V26, P81; Fawcett T, 2006, PATTERN RECOGN, V27; Franklin J, 2009, MAPPING SPECIES DIST; Frome A, 2009, IEEE I CONF COMP VIS, P2373, DOI 10.1109/ICCV.2009.5459413; GERI C, 1985, ANN SCI FOREST, V42, P143, DOI 10.1051/forest:19850202; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R., 2012, RASTER GEOGRAPHIC DA; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Horn A, 2012, AGR FOREST ENTOMOL, V14, P358, DOI 10.1111/j.1461-9563.2012.00576.x; HUCHON H, 1970, Revue Forestiere Francaise (Nancy), V22, P220; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Lockwood JL, 2007, INVASION ECOLOGY; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Odgers CL, 2012, J CHILD PSYCHOL PSYC, V53, P1009, DOI 10.1111/j.1469-7610.2012.02565.x; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Carvalho LFR, 2012, PREV VET MED, V103, P74, DOI 10.1016/j.prevetmed.2011.08.006; Rey O, 2012, ECOL LETT, V15, P1266, DOI 10.1111/j.1461-0248.2012.01849.x; Robinet C, 2010, FORET WALLONNE, V108, P19; Robinet C, 2007, GLOBAL ECOL BIOGEOGR, V16, P460, DOI 10.1111/j.1466-8238.2006.00302.x; Roques L, 2011, J THEOR BIOL, V274, P43, DOI 10.1016/j.jtbi.2011.01.006; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Rundle AG, 2011, AM J PREV MED, V40, P94, DOI 10.1016/j.amepre.2010.09.034; Saumel I, 2010, LANDSCAPE URBAN PLAN, V94, P244, DOI 10.1016/j.landurbplan.2009.10.009; Samalens JC, 2007, FOREST ECOL MANAG, V253, P177, DOI 10.1016/j.foreco.2007.07.015; Samalens JC, 2011, POPUL ECOL, V53, P287, DOI 10.1007/s10144-010-0227-4; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smith RM, 2007, AGR FOREST ENTOMOL, V9, P307, DOI 10.1111/j.1461-9563.2007.00349.x; Southwood TRE, 2000, ECOLOGICAL METHODS; Thomas CD, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P19; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	44	40	40	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74918	10.1371/journal.pone.0074918	http://dx.doi.org/10.1371/journal.pone.0074918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130675	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900010
J	Spaniel, C; Honda, M; Selitsky, SR; Yamane, D; Shimakami, T; Kaneko, S; Lanford, RE; Lemon, SM				Spaniel, Carolyn; Honda, Masao; Selitsky, Sara R.; Yamane, Daisuke; Shimakami, Tetsuro; Kaneko, Shuichi; Lanford, Robert E.; Lemon, Stanley M.			microRNA-122 Abundance in Hepatocellular Carcinoma and Non-Tumor Liver Tissue from Japanese Patients with Persistent HCV versus HBV Infection	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENE-EXPRESSION; INTERFERON-ALPHA; X PROTEIN; MIR-122; RNA; GENOME; TARGET; REPLICATION; MODULATION	Mechanisms of hepatic carcinogenesis in chronic hepatitis B and hepatitis C are incompletely defined but often assumed to be similar and related to immune-mediated inflammation. Despite this, several studies hint at differences in expression of miR-122, a liver-specific microRNA with tumor suppressor properties, in hepatocellular carcinoma (HCC) associated with hepatitis B virus (HBV) versus hepatitis C virus (HCV) infection. Differences in the expression of miR-122 in these cancers would be of interest, as miR-122 is an essential host factor for HCV but not HBV replication. To determine whether the abundance of miR-122 in cancer tissue is influenced by the nature of the underlying virus infection, we measured miR-122 by qRT-PCR in paired tumor and non-tumor tissues from cohorts of HBV- and HCV-infected Japanese patients. miR-122 abundance was significantly reduced from normal in HBV-associated HCC, but not in liver cancer associated with HCV infection. This difference was independent of the degree of differentiation of the liver cancer. Surprisingly, we also found significant differences in miR-122 expression in non-tumor tissue, with miR-122 abundance reduced from normal in HCV- but not HBV-infected liver. Similar differences were observed in HCV- vs. HBV-infected chimpanzees. Among HCV-infected Japanese subjects, reductions in miR-122 abundance in non-tumor tissue were associated with a single nucleotide polymorphism near the IL28B gene that predicts poor response to interferon-based therapy (TG vs. TT genotype at rs8099917), and correlated negatively with the abundance of multiple interferon-stimulated gene transcripts. Reduced levels of miR-122 in chronic hepatitis C thus appear to be associated with endogenous interferon responses to the virus, while differences in miR-122 expression in HCV- versus HBV-associated HCC likely reflect virus-specific mechanisms contributing to carcinogenesis. The continued expression of miR-122 in HCV-associated HCC may signify an important role for HCV replication late in the progression to malignancy.	[Spaniel, Carolyn; Selitsky, Sara R.; Yamane, Daisuke; Lemon, Stanley M.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Spaniel, Carolyn; Selitsky, Sara R.; Yamane, Daisuke; Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Spaniel, Carolyn; Selitsky, Sara R.; Yamane, Daisuke; Lemon, Stanley M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Spaniel, Carolyn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Honda, Masao; Shimakami, Tetsuro; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Selitsky, Sara R.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Lanford, Robert E.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Medical Branch Galveston; Kanazawa University; University of North Carolina; University of North Carolina Chapel Hill; Texas Biomedical Research Institute	Lemon, SM (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	smlemon@med.unc.edu			National Institutes of Health [R01-AI095690, R01-CA164029]; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA164029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095690] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24790687] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by National Institutes of Health grants R01-AI095690 and R01-CA164029 and the University Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Arai E, 2009, INT J CANCER, V125, P2854, DOI 10.1002/ijc.24708; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; FERLAY JSH, 2010, ANCER INCIDENCE MORT; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; HSIA CC, 1994, J MED VIROL, V43, P216, DOI 10.1002/jmv.1890430304; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Jung JK, 2010, J GEN VIROL, V91, P493, DOI 10.1099/vir.0.015149-0; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003; Lanford RE, 2007, HEPATOLOGY, V46, P999, DOI 10.1002/hep.21776; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li Y, 2013, RNA BIOL, V10, P919, DOI 10.4161/rna.25137; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Liu WH, 2011, BBA-GENE REGUL MECH, V1809, P678, DOI 10.1016/j.bbagrm.2011.04.008; Lok AS, 2011, GASTROENTEROLOGY, V140, P840, DOI 10.1053/j.gastro.2010.11.050; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Morita K, 2011, LIVER INT, V31, P474, DOI 10.1111/j.1478-3231.2010.02433.x; Nagaoki Y, 2012, HEPATOL RES, V42, P368, DOI 10.1111/j.1872-034X.2011.00929.x; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; WANG XGJ, 2011, MOL GENETICS LIVER N, P51; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; White DL, 2011, CANCER GENET-SER, P51, DOI 10.1007/978-1-4419-6082-5_4; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Yoshizawa H, 2002, ONCOLOGY-BASEL, V62, P8, DOI 10.1159/000048270	64	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76867	10.1371/journal.pone.0076867	http://dx.doi.org/10.1371/journal.pone.0076867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130799	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900094
J	Brands, J; Kliner, D; Lipowsky, HH; Kameneva, MV; Villanueva, FS; Pacella, JJ				Brands, Judith; Kliner, Dustin; Lipowsky, Herbert H.; Kameneva, Marina V.; Villanueva, Flordeliza S.; Pacella, John J.			New Insights into the Microvascular Mechanisms of Drag Reducing Polymers: Effect on the Cell-Free Layer	PLOS ONE			English	Article							BLOOD-FLOW; SPATIOTEMPORAL VARIATIONS; ERYTHROCYTE AGGREGATION; HEMORRHAGIC-SHOCK; RAT MODEL; MODULATION; SURVIVAL; WIDTH; LEUKOCYTES; VISCOSITY	Drag-reducing polymers (DRPs) significantly increase blood flow, tissue perfusion, and tissue oxygenation in various animal models. In rectangular channel microfluidic systems, DRPs were found to significantly reduce the near-wall cell-free layer (CFL) as well as modify traffic of red blood cells (RBC) into microchannel branches. In the current study we further investigated the mechanism by which DRP enhances microvascular perfusion. We studied the effect of various concentrations of DRP on RBC distribution in more relevant round microchannels and the effect of DRP on CFL in the rat cremaster muscle in vivo. In round microchannels hematocrit was measured in parent and daughter branch at baseline and after addition of DRP. At DRP concentrations of 5 and 10 ppm, the plasma skimming effect in the daughter branch was eliminated, as parent and daughter branch hematocrit were equivalent, compared to a significantly lowered hematocrit in the daughter branch without DRPs. In anesthetized rats (N=11) CFL was measured in the cremaster muscle tissue in arterioles with a diameter of 32.6 +/- 1.7 mu m. In the control group (saline, N=6) there was a significant increase in CFL in time compared to corresponding baseline. Addition of DRP at 1 ppm (N=5) reduced CFL significantly compared to corresponding baseline and the control group. After DRP administration the CFL reduced to about 85% of baseline at 5, 15, 25 and 35 minutes after DRP infusion was complete. These in vivo and in vitro findings demonstrate that DRPs induce a reduction in CFL width and plasma skimming in the microvasculature. This may lead to an increase of RBC flux into the capillary bed, and thus explain previous observations of a DRP mediated enhancement of capillary perfusion.	[Brands, Judith; Kliner, Dustin; Villanueva, Flordeliza S.; Pacella, John J.] Univ Pittsburgh, Sch Med, Dept Med, Cardiovasc Inst, Pittsburgh, PA 15213 USA; [Lipowsky, Herbert H.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Kameneva, Marina V.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Kameneva, Marina V.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Kameneva, Marina V.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pacella, JJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Cardiovasc Inst, Pittsburgh, PA 15213 USA.	pacellajj@upmc.edu	Brands, Judith/AAG-3037-2020	Brands, Judith/0000-0002-2302-5345	American Heart Association [AHA 12POST9400001]; National Institute of Health [NIH K08 1 K08 HL086730-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL086730] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (grant AHA 12POST9400001) and National Institute of Health (grant NIH K08 1 K08 HL086730-01). (url: http://my.americanheart.org/professional/index.jsp, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Chen XH, 2011, INT J CARDIOL, V147, P112, DOI 10.1016/j.ijcard.2010.09.008; COLEMAN PB, 1987, CIRC RES, V61, P787, DOI 10.1161/01.RES.61.6.787; Cotoia A, 2009, SHOCK, V31, P258, DOI 10.1097/SHK.0b013e31817fc434; ELLIS CG, 1994, CIRC RES, V75, P357, DOI 10.1161/01.RES.75.2.357; Fahraeus R, 1929, PHYSIOL REV, V9, P241, DOI 10.1152/physrev.1929.9.2.241; FARUQUI FI, 1987, CIRCULATION, V75, P627, DOI 10.1161/01.CIR.75.3.627; FENTON BM, 1985, MICROVASC RES, V29, P103, DOI 10.1016/0026-2862(85)90010-X; Fung YC, 1993, BIOMECHANICS MECH PR, pxviii; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; GRETZ JE, 1995, MICROVASC RES, V49, P134, DOI 10.1006/mvre.1995.1011; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; HOUSE SD, 1987, AM J PHYSIOL, V252, pH211, DOI 10.1152/ajpheart.1987.252.1.H211; Johnson L, 2009, PACE, V32, P224, DOI 10.1111/j.1540-8159.2008.02206.x; JONES CJH, 1995, CARDIOVASC RES, V29, P585; Kameneva MV, 2004, BIORHEOLOGY, V41, P53; KAMENEVA MV, 1991, FLUID DYNAM, V25, P956, DOI DOI 10.1007/BF01049712; Kim S, 2006, MICROCIRCULATION, V13, P199, DOI 10.1080/10739680600556878; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kim S, 2009, BIORHEOLOGY, V46, P181, DOI 10.3233/BIR-2009-0530; KUO L, 1992, NEWS PHYSIOL SCI, V7, P5; LIPOWSKY HH, 1978, CIRC RES, V43, P738, DOI 10.1161/01.RES.43.5.738; Macias CA, 2004, SHOCK, V22, P151, DOI 10.1097/01.shk.0000131489.83194.1a; Marhefka JN, 2009, BIORHEOLOGY, V46, P281, DOI 10.3233/BIR-2009-0543; Marhefka JN, 2008, BIORHEOLOGY, V45, P599, DOI 10.3233/BIR-2008-0511; MOSTARDI RA, 1978, BIORHEOLOGY, V15, P1; Ong PK, 2011, PHYSIOL MEAS, V32, pN1, DOI 10.1088/0967-3334/32/3/N01; Ong PK, 2013, MICROCIRCULATION, V20, P440, DOI 10.1111/micc.12045; Ong PK, 2012, MICROVASC RES, V83, P118, DOI 10.1016/j.mvr.2011.11.003; Ong PK, 2010, AM J PHYSIOL-HEART C, V298, pH1870, DOI 10.1152/ajpheart.01182.2009; Pacella JJ, 2006, EUR HEART J, V27, P2362, DOI 10.1093/eurheartj/ehl165; Pacella JJ, 2012, MICROCIRCULATION, V19, P580, DOI 10.1111/j.1549-8719.2012.00190.x; Pacella JJ, 2009, BIORHEOLOGY, V46, P365, DOI 10.3233/BIR-2009-0548; Pacella JJ, 2009, BIORHEOLOGY, V46, P293, DOI 10.3233/BIR-2009-0547; Pappu V, 2007, BIORHEOLOGY, V44, P191; POLIMENI PI, 1985, J MOL CELL CARDIOL, V17, P721, DOI 10.1016/S0022-2828(85)80072-9; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; PRIES AR, 1986, AM J PHYSIOL, V251, pH1324, DOI 10.1152/ajpheart.1986.251.6.H1324; Sakai T, 2007, BRIT J ANAESTH, V98, P23, DOI 10.1093/bja/ael307; Sharan M, 2001, BIORHEOLOGY, V38, P415; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; SOUTANI M, 1995, AM J PHYSIOL-HEART C, V268, pH1959, DOI 10.1152/ajpheart.1995.268.5.H1959; Toms B., 1949, P 1 INT C RHEOL N HO, VII, P135, DOI DOI 10.1155/2011/367042; Tsai AG, 2005, AM J PHYSIOL-HEART C, V288, pH1730, DOI 10.1152/ajpheart.00998.2004; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; YAN ZY, 1991, MICROVASC RES, V42, P17, DOI 10.1016/0026-2862(91)90072-J	48	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77252	10.1371/journal.pone.0077252	http://dx.doi.org/10.1371/journal.pone.0077252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124610	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100167
J	Chen, YC; Chang, SC; Pu, C; Tang, GJ				Chen, Yu-Chun; Chang, Shih-Chieh; Pu, Christy; Tang, Gau-Jun			The Impact of Nationwide Education Program on Clinical Practice in Sepsis Care and Mortality of Severe Sepsis: A Population-Based Study in Taiwan	PLOS ONE			English	Article							GOAL-DIRECTED THERAPY; INSURANCE RESEARCH DATABASE; SURVIVING SEPSIS; RESUSCITATION BUNDLE; UNITED-STATES; SEPTIC SHOCK; MANAGEMENT; IMPLEMENTATION; GUIDELINE; TREND	Objectives: We investigated the effect of a nationwide educational program following surviving sepsis campaign (SSC) guidelines. Physicians' clinical practice in sepsis care and patient mortality rate for severe sepsis were analyzed using a nationally representative cohort. Methods: Hospitalizations for severe sepsis with organ failure from 1997 to 2008 were extracted from Taiwan's National Health Insurance Research Database (NHIRD), and trends in sepsis incidence and mortality rates were analyzed. A before-and-after study design was used to evaluate changes in the utilization rates of SSC items and changes in severe sepsis mortality rates occurred after a national education program conducted by the Joint Taiwan Critical Care Medicine Committee since 2004. A total of 39,706 hospitalizations were analyzed, which consisted of a pre-intervention cohort of 14,848 individuals (2000-2003) and a post-intervention cohort of 24,858 individuals (2005-2008). Results: The incidence rate of severe sepsis increased from 1.88 per 1,000 individuals in 1997 to 5.07 per 1,000 individuals in 2008. The cumulative mortality rate decreased slightly from 48.2% for the pre-intervention cohort to 45.9% for the post-intervention cohort. The utilization rates of almost all SSC items changed significantly between the pre-intervention and post-intervention cohorts. These changes of utilization rates were found to be associated with mild reduction in mortality rate. Conclusion: The nationwide education program through a national professional society has a significant impact on physicians' clinical practice and resulted in a slight but significant reduction of severe sepsis mortality rate.	[Chen, Yu-Chun; Tang, Gau-Jun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Yilan, Taiwan; [Chen, Yu-Chun; Pu, Christy; Tang, Gau-Jun] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chang, Shih-Chieh] Natl Yang Ming Univ Hosp, Dept Internal Med, Div Chest Med, Yilan, Taiwan; [Chang, Shih-Chieh] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tang, GJ (corresponding author), Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Yilan, Taiwan.	gaujuntang02@gmail.com	Chen, Yu Chun/K-6635-2019; Chen, Yu-Chun/B-1227-2012; Chen, YuChun/L-1052-2019	Chen, Yu-Chun/0000-0002-4124-1949; Chen, YuChun/0000-0002-4124-1949				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Coopersmith CM, 2002, CRIT CARE MED, V30, P59, DOI 10.1097/00003246-200201000-00009; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Havel C, 2011, COCHRANE DB SYST REV, V5, DOI CD003709; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kortgen A, 2006, CRIT CARE MED, V34, P943, DOI 10.1097/01.CCM.0000206112.32673.D4; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Micek ST, 2006, CRIT CARE MED, V34, P2707, DOI 10.1097/01.CCM.0000241151.25426.D7; Na S, 2012, INT J QUAL HEALTH C, V24, P452, DOI 10.1093/intqhc/mzs045; Nguyen HB, 2011, CRIT CARE, V15, DOI 10.1186/cc10469; Nguyen HM, 2012, INT J CLIN PRACT, V66, P705, DOI 10.1111/j.1742-1241.2012.02939.x; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Phua Jason, 2011, BMJ, V342, pd3245, DOI 10.1136/bmj.d3245; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; Trzeciak S, 2006, CHEST, V129, P225, DOI 10.1378/chest.129.2.225; Vasu Tajender S, 2012, J Intensive Care Med, V27, P172, DOI 10.1177/0885066610396312	28	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77414	10.1371/journal.pone.0077414	http://dx.doi.org/10.1371/journal.pone.0077414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124616	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100173
J	Knuppel, H; Metz, C; Meerpohl, JJ; Strech, D				Knueppel, Hannes; Metz, Courtney; Meerpohl, Joerg J.; Strech, Daniel			How Psychiatry Journals Support the Unbiased Translation of Clinical Research. A Cross-Sectional Study of Editorial Policies	PLOS ONE			English	Article							CONSORT STATEMENT; RANDOMIZED-TRIALS; REPORTING GUIDELINES; EMPIRICAL-EVIDENCE; MEDICAL JOURNALS; PUBLICATION; QUALITY; INSTRUCTIONS; BIAS; REGISTRATION	Introduction: Reporting guidelines (e. g. CONSORT) have been developed as tools to improve quality and reduce bias in reporting research findings. Trial registration has been recommended for countering selective publication. The International Committee of Medical Journal Editors (ICMJE) encourages the implementation of reporting guidelines and trial registration as uniform requirements (URM). For the last two decades, however, biased reporting and insufficient registration of clinical trials has been identified in several literature reviews and other investigations. No study has so far investigated the extent to which author instructions in psychiatry journals encourage following reporting guidelines and trial registration. Method: Psychiatry Journals were identified from the 2011 Journal Citation Report. Information given in the author instructions and during the submission procedure of all journals was assessed on whether major reporting guidelines, trial registration and the ICMJE's URM in general were mentioned and adherence recommended. Results: We included 123 psychiatry journals (English and German language) in our analysis. A minority recommend or require 1) following the URM (21%), 2) adherence to reporting guidelines such as CONSORT, PRISMA, STROBE (23%, 7%, 4%), or 3) registration of clinical trials (34%). The subsample of the top-10 psychiatry journals (ranked by impact factor) provided much better but still improvable rates. For example, 70% of the top-10 psychiatry journals do not ask for the specific trial registration number. Discussion: Under the assumption that better reported and better registered clinical research that does not lack substantial information will improve the understanding, credibility, and unbiased translation of clinical research findings, several stakeholders including readers (physicians, patients), authors, reviewers, and editors might benefit from improved author instructions in psychiatry journals. A first step of improvement would consist in requiring adherence to the broadly accepted reporting guidelines and to trial registration.	[Knueppel, Hannes; Metz, Courtney; Strech, Daniel] Hannover Med Sch, Inst Hist & Eth Med, CELLS, Hannover, Germany; [Metz, Courtney] Leibniz Univ Hannover, Dept Philosophy, CELLS, Hannover, Germany; [Meerpohl, Joerg J.] Univ Med Ctr Freiburg, German Cochrane Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany	Hannover Medical School; Leibniz University Hannover; University of Freiburg	Strech, D (corresponding author), Hannover Med Sch, Inst Hist & Eth Med, CELLS, Hannover, Germany.	strech.daniel@mh-hannover.de	Meerpohl, Joerg J/J-4224-2013	Meerpohl, Joerg J/0000-0002-1333-5403; Strech, Daniel/0000-0002-9153-079X; Kahrass, Hannes/0000-0003-0694-0354				Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Brody H, 2012, NEW ENGL J MED, V366, P1949, DOI 10.1056/NEJMp1203365; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cipriani A, 2007, J CLIN PSYCHOPHARM, V27, P352, DOI 10.1097/jcp.0b013e3180a9081f; Dans AL, 1998, JAMA-J AM MED ASSOC, V279, P545, DOI 10.1001/jama.279.7.545; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Demicheli V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000003.pub2; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Han C, 2009, CONTEMP CLIN TRIALS, V30, P116, DOI 10.1016/j.cct.2008.11.004; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; ICMJE, 2008, UN REQ UNPUB; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kunath F, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000430; Kunath F, 2012, UROL INT, V88, P54, DOI 10.1159/000332742; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Levin LA, 2007, ARCH INTERN MED, V167, P1576, DOI 10.1001/archinte.167.15.1576; McHenry L, 2006, J MED ETHICS, V32, P405, DOI 10.1136/jme.2005.013185; Meerpohl JJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-27; Meerpohl JJ, 2010, ARCH PEDIAT ADOL MED, V164, P268, DOI 10.1001/archpediatrics.2009.287; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Soltmann B, 2012, NERVENARZT, V83, P604, DOI 10.1007/s00115-011-3418-0; Strech D, 2012, J CLIN EPIDEMIOL, V65, P276, DOI 10.1016/j.jclinepi.2011.07.002; Strech D, 2011, J CLIN PSYCHIAT, V72, P1214, DOI 10.4088/JCP.10r06166yel; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	36	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75995	10.1371/journal.pone.0075995	http://dx.doi.org/10.1371/journal.pone.0075995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146806	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400029
J	Diekelmann, S; Wilhelm, I; Wagner, U; Born, J				Diekelmann, Susanne; Wilhelm, Ines; Wagner, Ullrich; Born, Jan			Sleep Improves Prospective Remembering by Facilitating Spontaneous-Associative Retrieval Processes	PLOS ONE			English	Article							PROSPECTIVE MEMORY RETRIEVAL; POSITRON-EMISSION-TOMOGRAPHY; DIVIDED ATTENTION; MULTIPROCESS FRAMEWORK; PREFRONTAL CORTEX; CONSOLIDATION; INTENTION; INTERFERENCE; DEMANDS; REGIONS	Memories are of the past but for the future, enabling individuals to implement intended plans and actions at the appropriate time. Prospective memory is the specific ability to remember and execute an intended behavior at some designated point in the future. Although sleep is well-known to benefit the consolidation of memories for past events, its role for prospective memory is still not well understood. Here, we show that sleep as compared to wakefulness after prospective memory instruction enhanced the successful execution of prospective memories two days later. We further show that sleep benefited both components of prospective memory, i.e. to remember that something has to be done (prospective component) and to remember what has to be done (retrospective component). Finally, sleep enhanced prospective remembering particularly when attentional resources were reduced during task execution, suggesting that subjects after sleep were able to recruit additional spontaneous-associative retrieval processes to remember intentions successfully. Our findings indicate that sleep supports the maintenance of prospective memory over time by strengthening intentional memory representations, thus favoring the spontaneous retrieval of the intended action at the appropriate time.	[Diekelmann, Susanne; Born, Jan] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Wilhelm, Ines] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Wagner, Ullrich] Charite, Dept Psychiat & Psychotherapy, Div Mind & Brain Res, D-13353 Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University Children's Hospital Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Diekelmann, S (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.	susanne.diekelmann@uni-tuebingen.de	Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248	German Research Foundation (DFG) [SFB 654]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by a grant from the German Research Foundation (DFG, SFB 654 "Plasticity and Sleep"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CC, 2008, NEUROPSYCHOLOGIA, V46, P1954, DOI 10.1016/j.neuropsychologia.2008.01.016; Anderson J.R., 1983, ARCHITECTURE COGNITI; BADDELEY A, 1984, J EXP PSYCHOL GEN, V113, P518, DOI 10.1037/0096-3445.113.4.518; BARRETT TR, 1972, J EXP PSYCHOL, V96, P321, DOI 10.1037/h0033625; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Clarke AJB, 2008, MEMORY, V16, P763, DOI 10.1080/09658210802261116; Cohen AL, 2003, CAN J EXP PSYCHOL, V57, P274, DOI 10.1037/h0087431; Cohen J. D., 1996, PROSPECTIVE MEMORY T, P267; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Diekelmann S, 2013, SLEEP, V36, P149, DOI 10.5665/sleep.2322; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Drosopoulos S, 2007, J EXP PSYCHOL GEN, V136, P169, DOI 10.1037/0096-3445.136.2.169; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fernandes MA, 2000, J EXP PSYCHOL GEN, V129, P155, DOI 10.1037/0096-3445.129.2.155; Fernandes M, 2009, CAN J EXP PSYCHOL, V63, P24, DOI 10.1037/a0012870; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Gilbert SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059852; GOSCHKE T, 1993, J EXP PSYCHOL LEARN, V19, P1211, DOI 10.1037/0278-7393.19.5.1211; Goto Y, 2008, CEREB CORTEX, V18, P1407, DOI 10.1093/cercor/bhm172; Grundgeiger T, 2014, MEMORY, V22, P679, DOI 10.1080/09658211.2013.812220; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Iidaka T, 2000, J COGNITIVE NEUROSCI, V12, P267, DOI 10.1162/089892900562093; Kennedy PJ, 2009, P NATL ACAD SCI USA, V106, P10805, DOI 10.1073/pnas.0903259106; Kliegel M., 2007, PROSPECTIVE MEMORY C; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Marsh RL, 1998, J EXP PSYCHOL LEARN, V24, P336, DOI 10.1037/0278-7393.24.2.336; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; Marsh RL, 2002, J EXP PSYCHOL LEARN, V28, P652, DOI 10.1037//0278-7393.28.4.652; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; McDaniel MA, 1998, MEM COGNITION, V26, P121, DOI 10.3758/BF03211375; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Otani H, 1997, MEMORY, V5, P343, DOI 10.1080/741941393; Paller KA, 2004, LEARN MEMORY, V11, P664, DOI 10.1101/lm.75704; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Scullin MK, 2013, COGNITIVE PSYCHOL, V67, P55, DOI 10.1016/j.cogpsych.2013.07.001; Scullin MK, 2010, PSYCHOL SCI, V21, P1028, DOI 10.1177/0956797610373373; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Skinner EI, 2009, EXP PSYCHOL, V56, P386, DOI 10.1027/1618-3169.56.6.386; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Umeda S, 2006, REV NEUROSCIENCE, V17, P267; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Zeigarnik B, 1927, PSYCHOL FORSCH, V9, P1	61	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77621	10.1371/journal.pone.0077621	http://dx.doi.org/10.1371/journal.pone.0077621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237TP	24143246	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100084
J	Kopec, KO; Lupas, AN				Kopec, Klaus O.; Lupas, Andrei N.			beta-Propeller Blades as Ancestral Peptides in Protein Evolution	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; UNFOLDED PROTEIN; DNA GYRASE; HOMOLOGY DETECTION; GALANTHUS-NIVALIS; WW DOMAINS; SEQUENCE; LECTINS; ORIGIN	Proteins of the beta-propeller fold are ubiquitous in nature and widely used as structural scaffolds for ligand binding and enzymatic activity. This fold comprises between four and twelve four-stranded beta-meanders, the so called blades that are arranged circularly around a central funnel-shaped pore. Despite the large size range of beta-propellers, their blades frequently show sequence similarity indicative of a common ancestry and it has been proposed that the majority of beta-propellers arose divergently by amplification and diversification of an ancestral blade. Given the structural versatility of beta-propellers and the hypothesis that the first folded proteins evolved from a simpler set of peptides, we investigated whether this blade may have given rise to other folds as well. Using sequence comparisons, we identified proteins of four other folds as potential homologs of beta-propellers: the luminal domain of inositol-requiring enzyme 1 (IRE1-LD), type II beta-prisms, beta-pinwheels, and WW domains. Because, with increasing evolutionary distance and decreasing sequence length, the statistical significance of sequence comparisons becomes progressively harder to distinguish from the background of convergent similarities, we complemented our analyses with a new method that evaluates possible homology based on the correlation between sequence and structure similarity. Our results indicate a homologous relationship of IRE1-LD and type II beta-prisms with beta-propellers, and an analogous one for beta-pinwheels and WW domains. Whereas IRE1-LD most likely originated by fold-changing mutations from a fully formed PQQ motif beta-propeller, type II beta-prisms originated by amplification and differentiation of a single blade, possibly also of the PQQ type. We conclude that both beta-propellers and type II beta-prisms arose by independent amplification of a blade-sized fragment, which represents a remnant of an ancient peptide world.	[Kopec, Klaus O.; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Baden Wurttembe, Germany	Max Planck Society	Lupas, AN (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Baden Wurttembe, Germany.	andrei.lupas@tuebingen.mpg.de			Max-Planck-Society	Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	This work was supported by institutional funds from the Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2008, CURR OPIN STRUC BIOL, V18, P358, DOI 10.1016/j.sbi.2008.02.006; Alva V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-17; Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Coles M, 2006, STRUCTURE, V14, P1489, DOI 10.1016/j.str.2006.08.005; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; Fetrow J S, 1998, Pac Symp Biocomput, P485; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; HOFMANN K, 1995, FEBS LETT, V358, P153, DOI 10.1016/0014-5793(94)01415-W; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoorelbeke B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-10; Hsieh TJ, 2004, J BIOL CHEM, V279, P55587, DOI 10.1074/jbc.M408934200; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Jones E., 2001, SCIPY OPEN SOURCE SC; Kalev I, 2012, BIOINFORMATICS, V28, P2996, DOI 10.1093/bioinformatics/bts538; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kramlinger VM, 2006, J BIOL CHEM, V281, P3738, DOI 10.1074/jbc.M511160200; Kurimoto E, 2007, J BIOL CHEM, V282, P33252, DOI 10.1074/jbc.C700174200; Li YH, 2009, J INSECT PHYSIOL, V55, P135, DOI 10.1016/j.jinsphys.2008.10.015; Liu W, 2005, J BIOL CHEM, V280, P14865, DOI 10.1074/jbc.M411634200; Lupas AN, 2001, J STRUCT BIOL, V134, P191, DOI 10.1006/jsbi.2001.4393; Lupas AN, 2008, COMPUTATIONAL STRUCT; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Qi Y, 2002, PROTEINS, V47, P258, DOI 10.1002/prot.10090; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell RB, 1997, J MOL BIOL, V269, P423, DOI 10.1006/jmbi.1997.1019; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sharma A, 2007, J BIOSCIENCES, V32, P1089, DOI 10.1007/s12038-007-0111-3; Shetty KN, 2012, GLYCOBIOLOGY, V22, P56, DOI 10.1093/glycob/cwr100; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Stevens TJ, 2008, PROTEINS, V70, P378, DOI 10.1002/prot.21521; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	60	57	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77074	10.1371/journal.pone.0077074	http://dx.doi.org/10.1371/journal.pone.0077074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143202	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100037
J	Ranea, LM; Marques, AD; Moller, S; Gupta, Y; Ibrahim, SM				Ranea, Laura Mellado; Marques, Andreia de Castro; Moeller, Steffen; Gupta, Yask; Ibrahim, Saleh M.			Genetic Control of Spontaneous Arthritis in a Four-Way Advanced Intercross Line	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; QUANTITATIVE TRAIT LOCI; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; MURINE MODEL; IDENTIFICATION; MICE; ALLELES; DISEASE; STRAIN	Identifying the genetic basis of complex diseases, such as rheumatoid arthritis, remains a challenge that requires experimental models to reduce the genetic and environmental variability. Numerous loci for arthritis have been identified in induced animal models; however, few spontaneous models have been genetically studied. Therefore, we generated a four-way advanced intercross line (AIL) from four inbred strains, including BXD2/TyJ which spontaneously develops autoimmune arthritis. A genome-wide scan for spontaneous arthritis was performed in a cohort of 366 mice of the fourth generation (G4) of this cross. Five loci contributing to clinical phenotypes were identified in chromosomes 3, 7, 13, 18, and X. Three of the loci found in this study, confirm previously identified loci; whereas two of them are novel loci. Interesting candidate genes for the loci are highlighted. This study provides a genetic overview of spontaneous arthritis in mice and aids to solve the genetic etiology of rheumatoid arthritis and to gain a better understanding of the disease.	[Ranea, Laura Mellado; Marques, Andreia de Castro; Moeller, Steffen; Gupta, Yask; Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany	University of Lubeck	Ibrahim, SM (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	Saleh.Ibrahim@uksh.de	Möller, Steffen/B-5368-2013; Ibrahim, Saleh/AAO-9541-2020	Möller, Steffen/0000-0002-7187-4683; Ibrahim, Saleh/0000-0001-7827-2290	DFG [DFG IB 24/6-1, DFG GRK 1727/1]; Excellence Cluster Inflammation at Interfaces [DFG EXC 306/1-2]; BMBF [IMPAM 01EC1008F]	DFG(German Research Foundation (DFG)); Excellence Cluster Inflammation at Interfaces; BMBF(Federal Ministry of Education & Research (BMBF))	This research was supported by grants from DFG (DFG IB 24/6-1, DFG GRK 1727/1), Excellence Cluster Inflammation at Interfaces (DFG EXC 306/1-2), and BMBF (IMPAM 01EC1008F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarichev VA, 2003, J IMMUNOL, V170, P2283, DOI 10.4049/jimmunol.170.5.2283; Asghari F, 2011, J MED GENET, V48, P557, DOI 10.1136/jmg.2011.089730; BAKER D, 1995, J IMMUNOL, V155, P4046; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; DARVASI A, 1995, GENETICS, V141, P1199; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33; Holmdahl R, 1998, HUMAN GENOME METHODS, P215; Huse K, 2011, EUR J IMMUNOL, V41, P3135, DOI 10.1002/eji.201141558; Imboden JB, 2009, ANNU REV PATHOL-MECH, V4, P417, DOI 10.1146/annurev.pathol.4.110807.092254; Jirholt J, 2002, INT IMMUNOL, V14, P79, DOI 10.1093/intimm/14.1.79; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; Ludwig RJ, 2012, J INVEST DERMATOL, V132, P1409, DOI 10.1038/jid.2011.466; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Merriman TR, 2001, DIABETES, V50, P184, DOI 10.2337/diabetes.50.1.184; Moller S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S5; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mountz JD, 2005, SCAND J IMMUNOL, V61, P128, DOI 10.1111/j.0300-9475.2005.01548.x; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Otto JM, 1999, ARTHRITIS RHEUM, V42, P2524, DOI 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rankin J, 2007, J IMMUNOL, V178, P4395, DOI 10.4049/jimmunol.178.7.4395; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiroiwa W, 2007, INT IMMUNOL, V19, P175, DOI 10.1093/intimm/dxl134; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Vegvari A, 2005, J IMMUNOL, V175, P2475, DOI 10.4049/jimmunol.175.4.2475; Weyand CM, 1998, SPRINGER SEMIN IMMUN, V20, P5, DOI 10.1007/BF00831996; Xie S, 2002, GENES IMMUN, V3, pS13, DOI 10.1038/sj.gene.6363886; Yang HT, 1999, J IMMUNOL, V163, P2916	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75611	10.1371/journal.pone.0075611	http://dx.doi.org/10.1371/journal.pone.0075611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146764	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400014
J	Li, ZG; Chen, YP; Zhang, SW; Chen, SL; Li, WF; Yan, LM; Shi, LG; Wu, LM; Sohr, A; Su, SK				Li, Zhiguo; Chen, Yanping; Zhang, Shaowu; Chen, Shenglu; Li, Wenfeng; Yan, Limin; Shi, Liangen; Wu, Lyman; Sohr, Alex; Su, Songkun			Viral Infection Affects Sucrose Responsiveness and Homing Ability of Forager Honey Bees, Apis mellifera L.	PLOS ONE			English	Article							ACUTE PARALYSIS VIRUS; DEFORMED-WING VIRUS; DICISTROVIRUS AFFECTING HONEYBEES; VARROA-DESTRUCTOR; RESPONSE THRESHOLDS; PROBOSCIS EXTENSION; RT-PCR; HYMENOPTERA APIDAE; 1ST DETECTION; BEHAVIOR	Honey bee health is mainly affected by Varroa destructor, viruses, Nosema spp., pesticide residues and poor nutrition. Interactions between these proposed factors may be responsible for the colony losses reported worldwide in recent years. In the present study, the effects of a honey bee virus, Israeli acute paralysis virus (IAPV), on the foraging behaviors and homing ability of European honey bees (Apis mellifera L.) were investigated based on proboscis extension response (PER) assays and radio frequency identification (RFID) systems. The pollen forager honey bees originated from colonies that had no detectable level of honey bee viruses and were manually inoculated with IAPV to induce the viral infection. The results showed that IAPV-inoculated honey bees were more responsive to low sucrose solutions compared to that of non-infected foragers. After two days of infection, around 107 copies of IAPV were detected in the heads of these honey bees. The homing ability of IAPV-infected foragers was depressed significantly in comparison to the homing ability of uninfected foragers. The data provided evidence that IAPV infection in the heads may enable the virus to disorder foraging roles of honey bees and to interfere with brain functions that are responsible for learning, navigation, and orientation in the honey bees, thus, making honey bees have a lower response threshold to sucrose and lose their way back to the hive.	[Li, Zhiguo; Zhang, Shaowu; Chen, Shenglu; Li, Wenfeng; Yan, Limin; Shi, Liangen; Su, Songkun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yanping] ARS, USDA, Bee Res Lab, Beltsville, MD USA; [Zhang, Shaowu] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Wu, Lyman; Sohr, Alex] Univ Maryland, Coll Comp Math & Nat Sci, College Pk, MD 20742 USA; [Su, Songkun] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou, Fujian, Peoples R China	Zhejiang University; United States Department of Agriculture (USDA); Australian National University; University System of Maryland; University of Maryland College Park; Fujian Agriculture & Forestry University	Su, SK (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	susongkun@zju.edu.cn		LI, WENFENG/0000-0001-8819-6009	earmarked funds for Modern Agro-industry Technology Research System [CARS-45-KXJ3]; Nature and Science Foundation Commission of Zhejiang Province [R3080306]	earmarked funds for Modern Agro-industry Technology Research System; Nature and Science Foundation Commission of Zhejiang Province	This study was supported by earmarked funds for Modern Agro-industry Technology Research System (No. CARS-45-KXJ3), Nature and Science Foundation Commission of Zhejiang Province (R3080306) to SKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abbadi AA, 2010, APPL ENTOMOL ZOOL, V45, P183, DOI 10.1303/aez.2010.183; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Bakonyi T, 2002, APIDOLOGIE, V33, P63, DOI 10.1051/apido:2001004; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Chen Y. P., 2012, VIRUS TAXONOMY, V95, P840; Chen YP, 2007, AM BEE J, V147, P1027; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Dyer FC, 1996, J EXP BIOL, V199, P147; Felsenberg J, 2011, JOVE-J VIS EXP, DOI 10.3791/2282; Frost EH, 2011, J INSECT PHYSIOL, V57, P1385, DOI 10.1016/j.jinsphys.2011.07.001; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2005, VET J, V169, P121, DOI 10.1016/j.tvjl.2004.01.004; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Pahl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019669; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2003, BEHAV ECOL SOCIOBIOL, V54, P458, DOI 10.1007/s00265-003-0640-1; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Sanpa S, 2009, J INVERTEBR PATHOL, V100, P116, DOI 10.1016/j.jip.2008.11.010; Scheiner R, 2004, J COMP PHYSIOL A, V190, P727, DOI 10.1007/s00359-004-0531-6; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Si A, 2005, PHARMACOL BIOCHEM BE, V82, P664, DOI 10.1016/j.pbb.2005.11.009; Streit S, 2003, ZOOLOGY, V106, P169, DOI 10.1078/0944-2006-00113; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thany SH, 2005, BRAIN RES, V1039, P216, DOI 10.1016/j.brainres.2005.01.056; Todd JH, 2007, APIDOLOGIE, V38, P354, DOI 10.1051/apido:2007021; Tsuruda JM, 2009, BEHAV BRAIN RES, V205, P132, DOI 10.1016/j.bbr.2009.07.022; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Yan X, 2009, SOCIOBIOLOGY, V54, P95; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0	55	39	44	1	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77354	10.1371/journal.pone.0077354	http://dx.doi.org/10.1371/journal.pone.0077354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130876	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200082
J	Yoon, D; Park, I; Schuemie, MJ; Park, MY; Kim, JH; Park, RW				Yoon, Dukyong; Park, Inwhee; Schuemie, Martijn J.; Park, Man Young; Kim, Ju Han; Park, Rae Woong			A Quantitative Method for Assessment of Prescribing Patterns Using Electronic Health Records	PLOS ONE			English	Article							DATABASE; INDICATORS; ALGORITHM; INFECTION; RISK	Background: Most available quality indicators for hospitals are represented by simple ratios or proportions, and are limited to specific events. A generalized method that can be applied to diverse clinical events has not been developed. The aim of this study was to develop a simple method of evaluating physicians' prescription patterns for diverse events and their level of awareness of clinical practice guidelines. Methods and Findings: We developed a quantitative method called Prescription pattern Around Clinical Event (PACE), which is applicable to electronic health records (EHRs). Three discrete prescription patterns (intervention, maintenance, and discontinuation) were determined based on the prescription change index (PCI), which was calculated by means of the increase or decrease in the prescription rate after a clinical event. Hyperkalemia and Clostridium difficile-associated diarrhea (CDAD) were used as example cases. We calculated the PCIs of 10 drugs related to hyperkalemia, categorized them into prescription patterns, and then compared the resulting prescription patterns with the known standards for hyperkalemia treatment. The hyperkalemia knowledge of physicians was estimated using a questionnaire and compared to the prescription pattern. Prescriptions for CDAD were also determined and compared to clinical knowledge. Clinical data of 1698, 348, and 1288 patients were collected from EHR data. The physicians prescribing behaviors for hyperkalemia and CDAD were concordant with the standard knowledge. Prescription patterns were well correlated with individual physicians' knowledge of hyperkalemia (kappa = 0.714). Prescribing behaviors according to event severity or clinical condition were plotted as a simple summary graph. Conclusion: The algorithm successfully assessed the prescribing patterns from the EHR data. The prescription patterns were well correlated with physicians' knowledge. We expect that this algorithm will enable quantification of prescribers' adherence to clinical guidelines and be used to facilitate improved prescribing practices.	[Yoon, Dukyong; Park, Man Young; Park, Rae Woong] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon 441749, South Korea; [Park, Inwhee] Ajou Univ, Sch Med, Dept Nephrol, Suwon 441749, South Korea; [Schuemie, Martijn J.] Janssen Res & Dev LLC, Titusville, NJ USA; [Kim, Ju Han] Seoul Natl Univ, Coll Med, Seoul Natl Univ Biomed Informat, Seoul, South Korea; [Park, Rae Woong] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Park, Rae Woong] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Park, Rae Woong] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiololgy Res & Training, Philadelphia, PA 19104 USA	Ajou University; Ajou University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Seoul National University (SNU); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Park, RW (corresponding author), Ajou Univ, Sch Med, Dept Biomed Informat, Suwon 441749, South Korea.	veritas@ajou.ac.kr		Schuemie, Martijn/0000-0002-0817-5361	National Research Foundation of Korea; Korean government (MSIP) [2010-0028631]; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A112022]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MSIP); Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (MSIP) (2010-0028631 to R. W. P.). The study was also supported by grants of the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A112022 to R. W. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cullen BA, 2012, SCHIZOPHRENIA B; Dillmon M, 2012, J ONCOL PRACT, V8, P350, DOI 10.1200/JOP.2012.000599; Frei CR, 2010, CLIN THER, V32, P293, DOI 10.1016/j.clinthera.2010.02.006; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Park I, 2011, J HOSP INFECT, V79, P147, DOI 10.1016/j.jhin.2011.04.011; Park I, 2012, AM J CARDIOVASC DRUG, V12, P255, DOI 10.2165/11634470-000000000-00000; Park MY, 2012, CLIN PHARMACOL THER, V92, P393, DOI 10.1038/clpt.2012.93; Park MY, 2011, HEALTHC INFORM RES, V17, P58, DOI 10.4258/hir.2011.17.1.58; Park MY, 2009, HEALTHC INFORM RES, V15, P191, DOI 10.4258/jksmi.2009.15.2.191; Park MY, 2011, PHARMACOEPIDEM DR S, V20, P598, DOI 10.1002/pds.2139; Schuemie MJ, 2011, PHARMACOEPIDEM DR S, V20, P292, DOI 10.1002/pds.2051; Sheen SS, 2008, J GEN INTERN MED, V23, P423, DOI 10.1007/s11606-007-0336-8; Shrank WH, 2007, J AM GERIATR SOC, V55, pS373, DOI 10.1111/j.1532-5415.2007.01345.x; Sittig DF, 2012, NEW ENGL J MED, V367, P1854, DOI 10.1056/NEJMsb1205420; Sood MM, 2007, MAYO CLIN PROC, V82, P1553, DOI 10.4065/82.12.1553; Viera AJ, 2005, FAM MED, V37, P360; Xiang YT, 2012, HUM PSYCHOPHARM CLIN, V27, P626, DOI 10.1002/hup.2262; Yoon D, 2012, CLIN PHARMACOL THER, V91, P467, DOI 10.1038/clpt.2011.248; Yoon D, 2012, INT J MED INFORM, V81, P196, DOI 10.1016/j.ijmedinf.2011.12.002; Zainudin BMZ, 2005, RESPIROLOGY, V10, P579, DOI 10.1111/j.1440-1843.2005.00753.x	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75214	10.1371/journal.pone.0075214	http://dx.doi.org/10.1371/journal.pone.0075214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130689	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200005
J	Azushima, K; Tamura, K; Wakui, H; Maeda, A; Ohsawa, M; Uneda, K; Kobayashi, R; Kanaoka, T; Dejima, T; Fujikawa, T; Yamashita, A; Toya, Y; Umemura, S				Azushima, Kengo; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Uneda, Kazushi; Kobayashi, Ryu; Kanaoka, Tomohiko; Dejima, Toru; Fujikawa, Tetsuya; Yamashita, Akio; Toya, Yoshiyuki; Umemura, Satoshi			Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED PROTEIN; CARDIAC-HYPERTROPHY; LIVER LIPIDS; PPAR-GAMMA; ADIPONECTIN; GHRELIN; PEPTIDE; WEIGHT; TYPE-1; SAN	Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment with a concomitant improvement in metabolic profile is important for the treatment of metabolic dysfunction with visceral obesity. Bofu-tsu-shosan (BOF) is one of oriental herbal medicine and is clinically available to treat obesity in Japan. Although BOF is a candidate as a novel therapeutic strategy to improve metabolic dysfunction with obesity, the mechanism of its beneficial effect is not fully elucidated. Here, we investigated mechanism of therapeutic effects of BOF on KKAy mice, a model of human metabolic disorders with obesity. Chronic treatment of KKAy mice with BOF persistently decreased food intake, body weight gain, low-density lipoprotein cholesterol and systolic blood pressure. In addition, both tissue weight and cell size of white adipose tissue (WAT) were decreased, with concomitant increases in the expression of adiponectin and peroxisome proliferator-activated receptors genes in WAT as well as the circulating adiponectin level by BOF treatment. Furthermore, gene expression of uncoupling protein-1, a thermogenesis factor, in brown adipose tissue and rectal temperature were both elevated by BOF. Intriguingly, plasma acylated-ghrelin, an active form of orexigenic hormone, and short-term food intake were significantly decreased by single bolus administration of BOF. These results indicate that BOF exerts a combinatorial favorable metabolic modulation including antihypertensive effect, at least partially, via its beneficial effect on adipose tissue function and its appetite-inhibitory property through suppression on the ghrelin system.	[Azushima, Kengo; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Uneda, Kazushi; Kobayashi, Ryu; Kanaoka, Tomohiko; Dejima, Toru; Fujikawa, Tetsuya; Toya, Yoshiyuki; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan; [Yamashita, Akio] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Tamura, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan.	tamukou@med.yokohama-cu.ac.jp	Fujikawa, Tetsuya/N-6520-2014	Fujikawa, Tetsuya/0000-0002-0533-3061; Azushima, Kengo/0000-0002-5136-0730	Health and Labor Sciences Research grant; Japanese Ministry of Education, Science, Sports and Culture; Salt Science Research Foundation [1134]; Yokohama Foundation for Advancement of Medical Science; Kidney Foundation, Japan [JKFB13-17]; Novartis Foundation for Gerontological Research; Grants-in-Aid for Scientific Research [25460906] Funding Source: KAKEN	Health and Labor Sciences Research grant(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Yokohama Foundation for Advancement of Medical Science; Kidney Foundation, Japan(Kidney Foundation, Japan); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Health and Labor Sciences Research grant and by grants from the Japanese Ministry of Education, Science, Sports and Culture, the Salt Science Research Foundation (number 1134), the Yokohama Foundation for Advancement of Medical Science, the Kidney Foundation, Japan (JKFB13-17) and the Novartis Foundation for Gerontological Research (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P158, DOI 10.3164/jcbn.2008023; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dietrich MO, 2012, NAT REV DRUG DISCOV, V11, P675, DOI 10.1038/nrd3739; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x; Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5; Horvath K, 2008, ARCH INTERN MED, V168, P571, DOI 10.1001/archinte.168.6.571; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Maggs Fenella G, 2012, Acute Med, V11, P107; Matsuda M, 2011, PHYSIOL GENOMICS, V43, P884, DOI 10.1152/physiolgenomics.00005.2011; Morimoto Y, 2002, YAKUGAKU ZASSHI, V122, P163, DOI 10.1248/yakushi.122.163; Morimoto Yasuo, 2001, Folia Pharmacologica Japonica, V117, P77, DOI 10.1254/fpj.117.77; Nakayama T, 2007, J ETHNOPHARMACOL, V109, P236, DOI 10.1016/j.jep.2006.07.041; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sakamoto S, 2005, IN VIVO, V19, P1029; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Takemori K, 2011, LIFE SCI, V88, P1088, DOI 10.1016/j.lfs.2011.04.002; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tsurumi Y, 2006, KIDNEY INT, V69, P488, DOI 10.1038/sj.ki.5000130; Uno K, 2012, EUR HEART J, V33, P1279, DOI 10.1093/eurheartj/ehr265; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wakui H, 2010, AM J PHYSIOL-RENAL, V299, pF991, DOI 10.1152/ajprenal.00738.2009; Wakui H, 2010, HYPERTENSION, V55, P1157, DOI 10.1161/HYPERTENSIONAHA.109.147207; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yiannikouris F, 2010, CURR OPIN NEPHROL HY, V19, P195, DOI 10.1097/MNH.0b013e3283366cd0; YOSHIDA T, 1995, INT J OBESITY, V19, P717; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024	40	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75560	10.1371/journal.pone.0075560	http://dx.doi.org/10.1371/journal.pone.0075560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130717	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900040
J	Bessonov, K; Walkey, CJ; Shelp, BJ; van Vuuren, HJJ; Chiu, D; van der Merwe, G				Bessonov, Kyrylo; Walkey, Christopher J.; Shelp, Barry J.; van Vuuren, Hennie J. J.; Chiu, David; van der Merwe, George			Functional Analyses of NSF1 in Wine Yeast Using Interconnected Correlation Clustering and Molecular Analyses	PLOS ONE			English	Article							SACCHAROMYCES GENOME DATABASE; GENE REGULATORY NETWORKS; EXPRESSION DATA; TRANSCRIPTIONAL ACTIVATION; BAYESIAN NETWORKS; CEREVISIAE; STRESS; METABOLISM; PATTERNS; PATHWAY	Analyzing time-course expression data captured in microarray datasets is a complex undertaking as the vast and complex data space is represented by a relatively low number of samples as compared to thousands of available genes. Here, we developed the Interdependent Correlation Clustering (ICC) method to analyze relationships that exist among genes conditioned on the expression of a specific target gene in microarray data. Based on Correlation Clustering, the ICC method analyzes a large set of correlation values related to gene expression profiles extracted from given microarray datasets. ICC can be applied to any microarray dataset and any target gene. We applied this method to microarray data generated from wine fermentations and selected NSF1, which encodes a C2H2 zinc finger-type transcription factor, as the target gene. The validity of the method was verified by accurate identifications of the previously known functional roles of NSF1. In addition, we identified and verified potential new functions for this gene; specifically, NSF1 is a negative regulator for the expression of sulfur metabolism genes, the nuclear localization of Nsf1 protein (Nsf1p) is controlled in a sulfur-dependent manner, and the transcription of NSF1 is regulated by Met4p, an important transcriptional activator of sulfur metabolism genes. The inter-disciplinary approach adopted here highlighted the accuracy and relevancy of the ICC method in mining for novel gene functions using complex microarray datasets with a limited number of samples.	[Bessonov, Kyrylo; van der Merwe, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Bessonov, Kyrylo; Chiu, David] Univ Guelph, Sch Comp Sci, Guelph, ON N1G 2W1, Canada; [Walkey, Christopher J.; van Vuuren, Hennie J. J.] Univ British Columbia, Wine Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Shelp, Barry J.] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph; University of British Columbia; University of Guelph	van der Merwe, G (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	gvanderm@uoguelph.ca			Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) [SR9231, 026480]; OMAFRA URL: Natural Science and Engineering Research Council (NSERC) [217271-09, 42718-2009]; Genome Canada; GvdM [151WIN]; Genome Canada URL; Ontario Graduate Scholarship	Ontario Ministry of Agriculture and Rural Affairs (OMAFRA); OMAFRA URL: Natural Science and Engineering Research Council (NSERC); Genome Canada(Genome Canada); GvdM; Genome Canada URL; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by: 1) Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grants awarded to GvdM (SR9231) and BS (026480), OMAFRA URL: http://www.omafra.gov.on.ca/english/research/index.html.2) Natural Science and Engineering Research Council (NSERC) Individual Discovery grants awarded to HJJvV (217271-09) and BJS (42718-2009), NSERC URL: http://www.nserc-crsng.gc.ca.3) Genome Canada grant awarded to HJJvV and GvdM (151WIN), Genome Canada URL: http://www.genomecanada.ca/, and an Ontario Graduate Scholarship awarded to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Bansal N, 2002, ANN IEEE SYMP FOUND, P238, DOI 10.1109/SFCS.2002.1181947; Barreto L, 2006, EUKARYOT CELL, V5, P1748, DOI 10.1128/EC.00216-06; Bhattacharya A, 2008, BIOINFORMATICS, V24, P1359, DOI 10.1093/bioinformatics/btn133; Bhattacharya A, 2010, J BIOMED INFORM, V43, P560, DOI 10.1016/j.jbi.2010.02.001; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Bulmer AG, 1979, PRINCIPLES STAT; Cheng C, 1997, YEAST, V13, P1; Cherest H, 1997, GENETICS, V145, P627; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cormier L, 2010, NUCLEIC ACIDS RES, V38, P4998, DOI 10.1093/nar/gkq257; Dojer N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-249; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Hlynialuk C, 2008, MICROBIOL-SGM, V154, P2482, DOI 10.1099/mic.0.2008/019976-0; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; MESTL T, 1995, J THEOR BIOL, V176, P291, DOI 10.1006/jtbi.1995.0199; MOUNTAIN HA, 1993, MOL MICROBIOL, V9, P221, DOI 10.1111/j.1365-2958.1993.tb01684.x; MOUNTAIN HA, 1991, YEAST, V7, P781, DOI 10.1002/yea.320070804; NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rios G, 1997, YEAST, V13, P515, DOI 10.1002/(SICI)1097-0061(199705)13:6<515::AID-YEA102>3.0.CO;2-X; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; van der Merwe GK, 2001, CURR GENET, V39, P156; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Williams-Hart T, 2002, GENETICS, V160, P1423	45	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77192	10.1371/journal.pone.0077192	http://dx.doi.org/10.1371/journal.pone.0077192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130853	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900124
J	Jiang, N; Zhu, SM; Chen, J; Niu, YJ; Zhou, LQ				Jiang, Ning; Zhu, Shimiao; Chen, Jing; Niu, Yuanjie; Zhou, Liqun			A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants	PLOS ONE			English	Article							NEEDLE-BIOPSY; BASAL-CELL; ALPHA; EXPRESSION; TISSUE; ADENOCARCINOMA; DIAGNOSIS; BIOMARKER; P504S; P63	Background: Alpha-methylacyl-CoA racemase (AMACR) is a mitochondrial and peroxisomal enzyme that is overexpressed in prostate cancer. The aim of this study was to confirm and expand the findings that the PCa risk increased in men associated with AMACR expression across various geographic regions. Methods: A systematic search of databases was carried out and other relevant articles were also identified. Then the meta-analyses were conducted according to the standard guidelines. Results: A total of 22 studies with 4,385 participants were included on the basis of inclusion criteria. AMACR by IHC was significantly associated with increased diagnosis of PCa (OR = 76.08; 95% CI, 25.53-226.68; P < 0.00001). Subgroup-analysis showed that findings didn't substantially change when only Caucasians or Asians (OR = 51.23; 95% CI, 19.41-135.24; P < 0.00001) were considered. Expression of AMACR by PCR in relation to PCa risk suggested that AMACR was associated with PCa (OR = 33.60; 95% CI, 4.67-241.77; P < 0.00001). There was also no significant publication bias observed. Conclusions: Our findings provide further evidences that the expression of AMACR contribute to PCa risk. AMACR protein overexpression was found in prostate cancers, low expression in any of the normal tissues or in benign prostatic tissue. AMACR is potentially an important prostate tumor marker.	[Jiang, Ning; Zhu, Shimiao; Chen, Jing; Niu, Yuanjie] Tianjin Med Univ, Tianjin Inst Urol, Hosp 2, Dept Urol, Tianjin, Peoples R China; [Zhou, Liqun] Peking Univ, Inst Urol, Dept Urol, Peking Univ Hosp 1, Beijing 100871, Peoples R China	Tianjin Medical University; Peking University	Niu, YJ (corresponding author), Tianjin Med Univ, Tianjin Inst Urol, Hosp 2, Dept Urol, Tianjin, Peoples R China.	jnapple@gmail.com; jnbear@126.com	Zhou, Li/GSE-4531-2022	Liqun, Zhou/0000-0003-2795-9038	Science Foundation of Tianjin [11JCZDJC19700, 2010KZ95, 09ZCZDSF04300]; National Natural Science Foundation of China [2012CB518304, 2012DFG32220]	Science Foundation of Tianjin(Natural Science Foundation of Tianjin); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Science Foundation of Tianjin (No. 11JCZDJC19700)2010KZ95 and grant number 09ZCZDSF04300; and by the National Natural Science Foundation of China, grant numbers: 2012CB518304,2012DFG32220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne TJ, 2004, HUM PATHOL, V35, P1462, DOI 10.1016/j.humpath.2004.09.009; Chen Guang-yong, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P419; Donovan MJ, 2013, CURR OPIN UROL, V23, P245, DOI 10.1097/MOU.0b013e32835f89cc; Farinola MA, 2004, HUM PATHOL, V35, P1272, DOI 10.1016/j.humpath.2004.06.015; Gupta A, 2004, AM J SURG PATHOL, V28, P1224, DOI 10.1097/01.pas.0000131544.18266.a4; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humphrey PA, 2007, J CLIN PATHOL, V60, P35, DOI 10.1136/jcp.2005.036442; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang Z, 2005, AM J CLIN PATHOL, V123, P231, DOI 10.1309/1G1NK9DBGFNB792L; Kaic G, 2009, DIAGN CYTOPATHOL, V37, P803, DOI 10.1002/dc.21103; Kristiansen G, 2008, BRIT J CANCER, V99, P939, DOI 10.1038/sj.bjc.6604614; Kuefer R, 2002, AM J PATHOL, V161, P841, DOI 10.1016/S0002-9440(10)64244-7; Kunju LP, 2005, HISTOPATHOLOGY, V47, P587, DOI 10.1111/j.1365-2559.2005.02281.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nassar A, 2005, APPL IMMUNOHISTO M M, V13, P252, DOI 10.1097/00129039-200509000-00007; Ng VWL, 2007, AM J CLIN PATHOL, V127, P248, DOI 10.1309/JCFW75KGFWQUHVQD; Osunkoya AO, 2008, AM J SURG PATHOL, V32, P461, DOI 10.1097/PAS.0b013e318157020e; Ouyang Bin, 2009, J Urol, V181, P2508, DOI 10.1016/j.juro.2009.01.110; Pertega-Gomes N, 2013, PROSTATE, V73, P763, DOI 10.1002/pros.22620; Puebla-Mora Ana Graciela, 2006, Ann Diagn Pathol, V10, P205, DOI 10.1016/j.anndiagpath.2005.09.021; Rogers CG, 2004, J UROLOGY, V172, P1501, DOI 10.1097/01.ju.0000137659.53129.14; Schostak M, 2006, CANCER DETECT PREV, V30, P449, DOI 10.1016/j.cdp.2006.07.010; Shah RB, 2013, HUM PATHOL, V44, P786, DOI 10.1016/j.humpath.2012.06.024; Shin HR, 2012, JPN J CLIN ONCOL, V42, P867, DOI 10.1093/jjco/hys077; Stewart J, 2007, J CLIN PATHOL, V60, P773, DOI 10.1136/jcp.2006.040808; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suzue K, 2005, AM J CLIN PATHOL, V123, P553, DOI 10.1309/H4JX0XEHDAC8YL3P; Thomson AH, 2008, CLIN ONCOL-UK, V20, P385, DOI 10.1016/j.clon.2008.03.009; Trpkov K, 2009, AM J CLIN PATHOL, V132, P211, DOI 10.1309/AJCPGFJP83IXZEUR; Xiao Yu, 2004, Zhonghua Yi Xue Za Zhi, V84, P1362; Yamada H, 2013, PROSTATE, V73, P54, DOI 10.1002/pros.22539; Yu Tao, 2007, Zhonghua Nan Ke Xue, V13, P222; Zha S, 2003, CANCER RES, V63, P7365; Zhou M, 2004, AM J SURG PATHOL, V28, P239, DOI 10.1097/00000478-200402000-00012; Zielie PJ, 2004, J UROLOGY, V172, P1130, DOI 10.1097/01.ju.0000133560.87118.4d	36	25	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74386	10.1371/journal.pone.0074386	http://dx.doi.org/10.1371/journal.pone.0074386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130666	gold, Green Published			2022-12-27	WOS:000325810900003
J	Mattoo, AR; Pastan, I; FitzGerald, D				Mattoo, Abid R.; Pastan, Ira; FitzGerald, David			Combination Treatments with the PKC Inhibitor, Enzastaurin, Enhance the Cytotoxicity of the Anti-Mesothelin Immunotoxin, SS1P	PLOS ONE			English	Article							PROTEIN-KINASE-C; ACUTE LYMPHOBLASTIC-LEUKEMIA; LUNG-CANCER CELLS; PSEUDOMONAS EXOTOXIN; RECOMBINANT IMMUNOTOXIN; PHASE-I; HEMATOLOGIC MALIGNANCIES; MONOCLONAL-ANTIBODIES; THERAPEUTIC TARGET; IMMUNOGENICITY	Activated protein kinase C (PKC) contributes to tumor survival and proliferation, provoking the development of inhibitory agents as potential cancer therapeutics. Immunotoxins are antibody-based recombinant proteins that employ antibody fragments for cancer targeting and bacterial toxins as the cytotoxic agent. Pseudomonas exotoxin-based immunotoxins act via the ADP-ribosylation of EF2 leading to the enzymatic inhibition of protein synthesis. Combining PKC inhibitors with the immunotoxin SS1P, targeted to surface mesothelin, was undertaken to explore possible therapeutic strategies. Enzastaurin but not two other PKC inhibitors combined with SS1P to produce synergistic cell death via apoptosis. Mechanistic insights of the synergistic killing centered on the complete loss of the prosurvival Bcl2 protein, Mcl-1, the loss of AKT and the activation of caspase 3/7. Synergy was most evident when cells exhibited resistance to the immunotoxin alone. Further, because PKC inhibition by itself was not sufficient to enhance SS1P action, enzastaurin must target other kinases that are involved in the immunotoxin pathway.	[Mattoo, Abid R.; Pastan, Ira; FitzGerald, David] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	FitzGerald, D (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	fitzgerd@helix.nih.gov	pastan, ira/P-9319-2019; MATTOO, ABID/AGI-4855-2022	pastan, ira/0000-0002-9223-0270; MATTOO, ABID/0000-0002-4947-0113	National Cancer Institute, Center for Cancer Research at the National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE [ZIABC008753] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research at the National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by funding from the Intramural Research Program, National Cancer Institute, Center for Cancer Research at the National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Andersson Y, 2004, INT J CANCER, V112, P475, DOI 10.1002/ijc.20371; Barger JF, 2013, ONCOGENE, V32, P453, DOI 10.1038/onc.2012.70; Biswas DK, 2001, P NATL ACAD SCI USA, V98, P10386, DOI 10.1073/pnas.151257998; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Du X, 2011, CLIN CANCER RES, V17, P5926, DOI 10.1158/1078-0432.CCR-11-1235; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Fitzgerald DJ, 2011, LEUKEMIA LYMPHOMA, V52, P79, DOI 10.3109/10428194.2011.569961; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Hansen JK, 2010, J IMMUNOTHER, V33, P297, DOI 10.1097/CJI.0b013e3181cd1164; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Herrera L, 2009, J PEDIAT HEMATOL ONC, V31, P936, DOI 10.1097/MPH.0b013e3181bdf211; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Kuo WL, 2010, MOL CANCER THER, V9, P2814, DOI 10.1158/1535-7163.MCT-10-0352; Liu XY, 2008, IMMUNOL REV, V222, P9, DOI 10.1111/j.1600-065X.2008.00601.x; Liu XF, 2013, CANCER RES, V73, P2281, DOI 10.1158/0008-5472.CAN-12-3436; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Mattoo AR, 2013, INT J CANCER, V132, P978, DOI 10.1002/ijc.27732; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Onda M, 2008, P NATL ACAD SCI USA, V105, P11311, DOI 10.1073/pnas.0804851105; Onda M, 2011, P NATL ACAD SCI USA, V108, P5742, DOI 10.1073/pnas.1102746108; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Pastan I, 2011, LEUKEMIA LYMPHOMA, V52, P87, DOI 10.3109/10428194.2011.573039; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; Risberg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024012; Schindler J, 2011, BRIT J HAEMATOL, V154, P471, DOI 10.1111/j.1365-2141.2011.08762.x; Steinbach D, 2007, EUR J HAEMATOL, V79, P281, DOI 10.1111/j.1600-0609.2007.00928.x; Traini R, 2010, MOL CANCER THER, V9, P2007, DOI 10.1158/1535-7163.MCT-10-0257; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x; Wu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029622; Zhang YJ, 2007, P NATL ACAD SCI USA, V104, P17099, DOI 10.1073/pnas.0708101104; Zhang YJ, 2011, CANCER RES, V71, P5915, DOI 10.1158/0008-5472.CAN-11-0466	39	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75576	10.1371/journal.pone.0075576	http://dx.doi.org/10.1371/journal.pone.0075576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130723	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900044
J	Park, MH; Park, JY; Lee, HJ; Kim, DH; Chung, KW; Park, D; Jeong, HO; Kim, HR; Park, CH; Kim, SR; Chun, P; Byun, Y; Moon, HR; Chung, HY				Park, Min Hi; Park, Ji Young; Lee, Hye Jin; Kim, Dae Hyun; Chung, Ki Wung; Park, Daeui; Jeong, Hyoung Oh; Kim, Hye Rim; Park, Chan Hum; Kim, So Ra; Chun, Pusoon; Byun, Youngjoo; Moon, Hyung Ryong; Chung, Hae Young			The Novel PPAR alpha/gamma Dual Agonist MHY 966 Modulates UVB-Induced Skin Inflammation by Inhibiting NF-kappa B Activity	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; NITRIC-OXIDE; PEROXYNITRITE; SUPEROXIDE; CHEMISTRY; APOPTOSIS; FUTURE; CELLS; MODEL	Ultraviolet B (UVB; 290 similar to 320nm) irradiation-induced lipid peroxidation induces inflammatory responses that lead to skin wrinkle formation and epidermal thickening. Peroxisome proliferator-activated receptor (PPAR) alpha/gamma dual agonists have the potential to be used as anti-wrinkle agents because they inhibit inflammatory response and lipid peroxidation. In this study, we evaluated the function of 2-bromo-4-(5-chloro-benzo[d]thiazol-2-yl) phenol (MHY 966), a novel synthetic PPAR alpha/gamma dual agonist, and investigated its anti-inflammatory and anti-lipid peroxidation effects. The action of MHY 966 as a PPAR alpha/gamma dual agonist was also determined in vitro by reporter gene assay. Additionally, 8-week-old melanin-possessing hairless mice 2 (HRM2) were exposed to 150 mJ/cm(2) UVB every other day for 17 days and MHY 966 was simultaneously pre-treated every day for 17 days to investigate the molecular mechanisms involved. MHY 966 was found to stimulate the transcriptional activities of both PPAR alpha and gamma. In HRM2 mice, we found that the skins of mice exposed to UVB showed significantly increased pro-inflammatory mediator levels (NF-kappa B, iNOS, and COX-2) and increased lipid peroxidation, whereas MHY 966 co-treatment down-regulated these effects of UVB by activating PPAR alpha and gamma. Thus, the present study shows that MHY 966 exhibits beneficial effects on inflammatory responses and lipid peroxidation by simultaneously activating PPAR alpha and gamma. The major finding of this study is that MHY 966 demonstrates potential as an agent against wrinkle formation associated with chronic UVB exposure.	[Park, Min Hi; Park, Ji Young; Lee, Hye Jin; Kim, Dae Hyun; Chung, Ki Wung; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Kim, So Ra; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan, South Korea; [Park, Min Hi; Kim, Dae Hyun; Chung, Ki Wung; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Kim, So Ra; Chung, Hae Young] Pusan Natl Univ, Biochem Lab, Busan, South Korea; [Park, Ji Young; Lee, Hye Jin; Kim, Hye Rim; Moon, Hyung Ryong] Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan, South Korea; [Chun, Pusoon] Inje Univ, Coll Pharm, Gimhae, Gyeongnam, South Korea; [Byun, Youngjoo] Korea Univ, Coll Pharm, Chungnam, South Korea	Pusan National University; Pusan National University; Pusan National University; Inje University; Korea University	Moon, HR (corresponding author), Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan, South Korea.	mhr108@pusan.ac.kr; hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020	Park, Daeui/0000-0002-9452-5849; , Youngjoo/0000-0002-0297-7734	National Research Foundation of Korea (NRF); Korea government (MEST) [2009-0083538]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, no. 2009-0083538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar Mohammad, 2002, Indian Journal of Experimental Biology, V40, P656; Bae JY, 2008, FOOD CHEM TOXICOL, V46, P1298, DOI 10.1016/j.fct.2007.09.112; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; BISSETT DL, 1987, PHOTOCHEM PHOTOBIOL, V46, P367, DOI 10.1111/j.1751-1097.1987.tb04783.x; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Cho HS, 2007, PHOTODERMATOL PHOTO, V23, P155, DOI 10.1111/j.1600-0781.2007.00298.x; Choi YJ, 2012, J DERMATOL SCI, V68, P164, DOI 10.1016/j.jdermsci.2012.09.014; Davidson SM, 2006, CELL CALCIUM, V40, P561, DOI 10.1016/j.ceca.2006.08.017; DEGRUIJL FR, 1994, HEALTH PHYS, V67, P319, DOI 10.1097/00004032-199410000-00001; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Giacomoni PU, 2004, MICRON, V35, P179, DOI 10.1016/j.micron.2003.11.004; Hanley K, 1998, J INVEST DERMATOL, V111, P440, DOI 10.1046/j.1523-1747.1998.00303.x; Hitoshi Y, 2010, INT J HEMATOL, V91, P189, DOI 10.1007/s12185-010-0531-y; Katiyar SK, 2001, TOXICOL APPL PHARM, V176, P110, DOI 10.1006/taap.2001.9276; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Olesen H, 1998, CLIN CHIM ACTA, V271, pS5, DOI 10.1016/S0009-8981(97)00214-3; Oplander C, 2007, FREE RADICAL BIO MED, V43, P818, DOI 10.1016/j.freeradbiomed.2007.05.030; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; RADI R, 1991, J BIOL CHEM, V266, P4244; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Seber S, 2006, DIABETES RES CLIN PR, V71, P52, DOI 10.1016/j.diabres.2005.05.009; Suschek CV, 2001, CELL DEATH DIFFER, V8, P515, DOI 10.1038/sj.cdd.4400839; Suschek CV, 1999, J BIOL CHEM, V274, P6130, DOI 10.1074/jbc.274.10.6130; Thuillier P, 2002, BIOCHEM J, V366, P901, DOI 10.1042/BJ20020377; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Zadelaar ASM, 2006, ARTERIOSCL THROM VAS, V26, P2560, DOI 10.1161/01.ATV.0000242904.34700.66	33	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76820	10.1371/journal.pone.0076820	http://dx.doi.org/10.1371/journal.pone.0076820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130794	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900089
J	Chaisi, ME; Janssens, ME; Vermeiren, L; Oosthuizen, MC; Collins, NE; Geysen, D				Chaisi, Mamohale E.; Janssens, Michiel E.; Vermeiren, Lieve; Oosthuizen, Marinda C.; Collins, Nicola E.; Geysen, Dirk			Evaluation of a Real-Time PCR Test for the Detection and Discrimination of Theileria Species in the African Buffalo (Syncerus caffer)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PARVA; BABESIA; PROBES; SPP.	A quantitative real-time PCR (qPCR) assay based on the cox III gene was evaluated for the simultaneous detection and discrimination of Theileria species in buffalo and cattle blood samples from South Africa and Mozambique using melting curve analysis. The results obtained were compared to those of the reverse line blot (RLB) hybridization assay for the simultaneous detection and differentiation of Theileria spp. in mixed infections, and to the 18S rRNA qPCR assay results for the specific detection of Theileria parva. Theileria parva, Theileria sp. (buffalo), Theileria taurotragi, Theileria buffeli and Theileria mutans were detected by the cox III assay. Theileria velifera was not detected from any of the samples analysed. Seventeen percent of the samples had non-species specific melting peaks and 4.5% of the samples were negative or below the detection limit of the assay. The cox III assay identified more T. parva and Theileria sp. (buffalo) positive samples than the RLB assay, and also detected more T. parva infections than the 18S assay. However, only a small number of samples were positive for the benign Theileria spp. To our knowledge T. taurotragi has never been identified from the African buffalo, its identification in some samples by the qPCR assay was unexpected. Because of these discrepancies in the results, cox III qPCR products were cloned and sequenced. Sequence analysis indicated extensive inter-and intra-species variations in the probe target regions of the cox III gene sequences of the benign Theileria spp. and therefore explains their low detection. The cox III assay is specific for the detection of T. parva infections in cattle and buffalo. Sequence data generated from this study can be used for the development of a more inclusive assay for detection and differentiation of all variants of the mildly pathogenic and benign Theileria spp. of buffalo and cattle.	[Chaisi, Mamohale E.; Oosthuizen, Marinda C.; Collins, Nicola E.] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Chaisi, Mamohale E.] Natl Univ Lesotho, Dept Biol, Roma, Lesotho; [Janssens, Michiel E.; Vermeiren, Lieve; Geysen, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Janssens, Michiel E.] Therapeut Syst Cent Europe, Ikaroslaan, Zaventm, Belgium	University of Pretoria; Institute of Tropical Medicine (ITM)	Chaisi, ME (corresponding author), Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa.	mechaisi@yahoo.co.uk	Collins, Nicola/O-6342-2014; Oosthuizen, Marinda C/N-8706-2014	Collins, Nicola/0000-0001-7296-3912; Oosthuizen, Marinda C/0000-0002-1893-0818; Chaisi, Mamohale/0000-0002-2365-1039	South African National Research Foundation [NRF ICD2006072000009]; UP Research Development Programme	South African National Research Foundation(National Research Foundation - South Africa); UP Research Development Programme	This work was part of a PhD project that was funded by the South African National Research Foundation (NRF ICD2006072000009) and UP Research Development Programme. It also falls under the Belgian Directorate General for Development Co-operation Framework agreement ITM/DGCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALLSOPP BA, 1993, PARASITOLOGY, V107, P157, DOI 10.1017/S0031182000067263; Bell AS, 2002, TRENDS PARASITOL, V18, P337, DOI 10.1016/S1471-4922(02)02331-0; Bhoora R, 2009, VET PARASITOL, V159, P112, DOI 10.1016/j.vetpar.2008.10.004; Chaisi ME, 2013, VET PARASITOL, V191, P132, DOI 10.1016/j.vetpar.2012.08.005; Chaisi ME, 2011, VET PARASITOL, V182, P150, DOI 10.1016/j.vetpar.2011.05.041; Collins Nicola E, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS217, DOI 10.1016/S0035-9203(02)90079-9; Criado-Fornelio A, 2009, VET PARASITOL, V159, P73, DOI 10.1016/j.vetpar.2008.10.012; De Vos AJ, 1984, ONDESTEPOORT J VET R, V8, P149; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FIGUEROA JV, 1995, VET PARASITOL, V57, P75, DOI 10.1016/0304-4017(94)03112-A; Gubbels JM, 1999, J CLIN MICROBIOL, V37, P1782, DOI 10.1128/JCM.37.6.1782-1789.1999; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Janssens ME, 2009, THESIS U ANWERPEN BE; Jaton K, 2006, J MED MICROBIOL, V55, P1667, DOI 10.1099/jmm.0.46675-0; KAIRO A, 1994, EMBO J, V13, P898, DOI 10.1002/j.1460-2075.1994.tb06333.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Mans BJ, 2011, PARASITOLOGY, V138, P766, DOI 10.1017/S0031182011000187; Norval R. A. I., 1992, The epidemiology of theileriosis in Africa.; Op den Buijsch RAM, 2005, PHARMACOGENOMICS J, V5, P72, DOI 10.1038/sj.tpj.6500299; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reuter M, 2005, J GENET, V84, P341, DOI 10.1007/BF02715807; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saidu S. N. A., 1981, Advances in the control of theileriosis. Proc. Internat. Conf., 9-13 Feb. 1981, Nairobi., P86; Seifert HSH, 1996, TROPICAL ANIMAL HLTH, P193; Sibeko KP, 2008, VET PARASITOL, V155, P37, DOI 10.1016/j.vetpar.2008.03.033; Staden R, 2000, Methods Mol Biol, V132, P115; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uilenberg G, 1999, TROP MED INT HEALTH, V4, pA12, DOI 10.1046/j.1365-3156.1999.00446.x; UILENBERG G., 1964, REV ELEVAGE MED VETERINAIRE PAYS TROP, V17, P655; Wang CM, 2010, VET PARASITOL, V168, P11, DOI 10.1016/j.vetpar.2009.10.015; Zarlenga DS, 2001, VET PARASITOL, V101, P215, DOI 10.1016/S0304-4017(01)00568-4; [No title captured]	34	18	19	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75827	10.1371/journal.pone.0075827	http://dx.doi.org/10.1371/journal.pone.0075827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146782	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200003
J	Ma, YQ; Vilanova, D; Atalar, K; Delfour, O; Edgeworth, J; Ostermann, M; Hernandez-Fuentes, M; Razafimahatratra, S; Michot, B; Persing, DH; Ziegler, I; Toros, B; Molling, P; Olcen, P; Beale, R; Lord, GM				Ma, Yuqian; Vilanova, David; Atalar, Kerem; Delfour, Olivier; Edgeworth, Jonathan; Ostermann, Marlies; Hernandez-Fuentes, Maria; Razafimahatratra, Sandrine; Michot, Bernard; Persing, David H.; Ziegler, Ingrid; Toros, Bianca; Molling, Paula; Olcen, Per; Beale, Richard; Lord, Graham M.			Genome-Wide Sequencing of Cellular microRNAs Identifies a Combinatorial Expression Signature Diagnostic of Sepsis	PLOS ONE			English	Article							SURVIVING SEPSIS; TRANSCRIPTOME; BIOMARKERS; DISCOVERY; MODELS	Rationale: Sepsis is a common cause of death in the intensive care unit with mortality up to 70% when accompanied by multiple organ dysfunction. Rapid diagnosis and the institution of appropriate antibiotic therapy and pressor support are therefore critical for survival. MicroRNAs are small non-coding RNAs that play an important role in the regulation of numerous cellular processes, including inflammation and immunity. Objectives: We hypothesized changes in expression of microRNAs during sepsis may be of diagnostic value in the intensive care unit (ICU). Methods: Massively parallel sequencing of microRNAs was utilised for screening microRNA candidates. Putative microRNAs were validated using quantitative real-time PCR (qRT-PCR). This study includes data from both a training cohort (UK) and an independent validation cohort (Sweden). A linear discriminant statistical model was employed to construct a diagnostic microRNA signature. Results: A panel of known and novel microRNAs were detectable in the blood of patients with sepsis. After qRT-PCR validation, microRNA miR-150 and miR-4772-5p-iso were able to discriminate between patients who have systemic inflammatory response syndrome and patients with sepsis. This finding was also validated in independent cohort with an average diagnostic accuracy of 86%. Fractionating the cellular components of blood reveals miR-4772-5p-iso is expressed differentially in monocytes. Functional experiments using primary human monocytes demonstrate that it expressed in response to TLR ligation. Conclusions: Taken together, these data provide a novel microRNA signature of sepsis that should allow rapid point-of-care diagnostic assessment of patients on ICU and also provide greater insight into the pathobiology of this severe disease.	[Ma, Yuqian; Atalar, Kerem; Hernandez-Fuentes, Maria; Lord, Graham M.] Kings Coll London, Dept Expt Immunobiol, London, England; [Beale, Richard] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England; [Ma, Yuqian; Atalar, Kerem; Edgeworth, Jonathan; Ostermann, Marlies; Hernandez-Fuentes, Maria; Beale, Richard; Lord, Graham M.] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Ma, Yuqian; Atalar, Kerem; Edgeworth, Jonathan; Ostermann, Marlies; Hernandez-Fuentes, Maria; Beale, Richard; Lord, Graham M.] Kings Coll London, London, England; [Vilanova, David; Delfour, Olivier; Razafimahatratra, Sandrine; Michot, Bernard] Cepheid Europe, R&D, Maurens Scopont, France; [Edgeworth, Jonathan; Ostermann, Marlies; Beale, Richard; Lord, Graham M.] Guys & St Thomas NHS Fdn Trust, London, England; [Persing, David H.] Cepheid, Sunnyvale, CA USA; [Ziegler, Ingrid] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Toros, Bianca; Molling, Paula; Olcen, Per] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Orebro University; Orebro University	Lord, GM (corresponding author), Kings Coll London, Dept Expt Immunobiol, London, England.	graham.lord@kcl.ac.uk	Fuentes, Maria/HGA-8617-2022; Maria, Hernandez-Fuentes/B-5011-2010; Ostermann, Marlies/AAH-8160-2021; Abraham, Sabu/E-1144-2019; Ostermann, Marlies/B-8777-2015	Maria, Hernandez-Fuentes/0000-0002-7558-9441; Abraham, Sabu/0000-0002-0916-5827; Atalar, Kerem/0000-0003-2338-8629; Stenmark, Bianca/0000-0003-4637-8626; Lord, Graham/0000-0003-2069-4743; Ostermann, Marlies/0000-0001-9500-9080	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; Guy's and St. Thomas Charity; MRC/Kidney Research UK [G0800413]; MRC [G0800413, G0600698] Funding Source: UKRI; British Heart Foundation [PG/12/36/29444] Funding Source: researchfish; Medical Research Council [G0800413, G0600698, G1000758B, MR/J006742/1, G1000758] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); Guy's and St. Thomas Charity; MRC/Kidney Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Y. Ma was funded by a graduate research fellowship from the Guy's and St. Thomas Charity. K. Atalar was funded by an MRC/Kidney Research UK Clinical Research Training Fellowship G0800413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2011, TRIZOL REAG TRIZOL L; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carrigan SD, 2004, CLIN CHEM, V50, P1301, DOI 10.1373/clinchem.2004.032144; Cid J, 2010, J INFECTION, V60, P313, DOI 10.1016/j.jinf.2010.02.013; Deitch EA, 2005, SHOCK, V24, P19, DOI 10.1097/01.shk.0000191386.18818.0a; Delfour O VD, 2007, MICROARN BIOL FUNCTI, V5, P38; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Gaieski DF, 2009, CRIT CARE MED; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Ivady B, 2011, CURR MED CHEM, V18, P3211, DOI 10.2174/092986711796391598; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Schotte D, 2011, LEUKEMIA, V25, P1389, DOI 10.1038/leu.2011.105; SIMMS HH, 1989, J CLIN INVEST, V83, P252, DOI 10.1172/JCI113867; Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Ugras S, 2011, CANCER RES, V71, P5659, DOI 10.1158/0008-5472.CAN-11-0890; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731	41	73	78	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75918	10.1371/journal.pone.0075918	http://dx.doi.org/10.1371/journal.pone.0075918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146790	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400024
J	Leinartaite, L; Johansson, AS				Leinartaite, Lina; Johansson, Ann-Sofi			Disulfide Scrambling in Superoxide Dismutase 1 Reduces Its Cytotoxic Effect in Cultured Cells and Promotes Protein Aggregation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SOD1; FAMILIAL FORM; SPINAL-CORDS; WILD-TYPE; ALS; APO; MUTATIONS; GENE; SUPEROXIDE-DISMUTASE-1	Mutations in the gene coding for superoxide dismutase 1 (SOD1) are associated with familiar forms of the neurodegenerative disease amyotrophic lateral sclerosis (ALS). These mutations are believed to result in a "gain of toxic function", leading to neuronal degeneration. The exact mechanism is still unknown, but misfolding/aggregation events are generally acknowledged as important pathological events in this process. Recently, we observed that demetallated apoSOD1, with cysteine 6 and 111 substituted for alanine, is toxic to cultured neuroblastoma cells. This toxicity depended on an intact, high affinity Zn2+ site. It was therefor contradictory to discover that wild-type apoSOD1 was not toxic, despite of its high affinity for Zn2+. This inconsistency was hypothesized to originate from erroneous disulfide formation involving C6 and C111. Using high resolution non-reducing SDS-PAGE, we have in this study demonstrated that the inability of wild-type apoSOD1 to cause cell death stems from formation of non-native intramolecular disulfides. Moreover, monomeric apoSOD1 variants capable of such disulfide scrambling aggregated into ThT positive oligomers under physiological conditions without agitation. The oligomers were stabilized by intermolecular disulfides and morphologically resembled what has in other neurodegenerative diseases been termed protofibrils. Disulfide scrambling thus appears to be an important event for misfolding and aggregation of SOD1, but may also be significant for protein function involving cysteines, e. g. mitochondrial import and copper loading.	[Leinartaite, Lina; Johansson, Ann-Sofi] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	Johansson, AS (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	ann-sofij@dbb.su.se			Swedish Research Council; Swedish Brain Foundation; Ahlen stiftelsen; Petrus och Augusta Hedlunds stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Ahlen stiftelsen; Petrus och Augusta Hedlunds stiftelse	The work was supported by the Swedish Research Council (www.vr.se), the Swedish Brain Foundation (www.hjarnfonden.se), Ahlen stiftelsen (www.ahlen-stiftelsen.se) and Petrus och Augusta Hedlunds stiftelse (www.hedlundsstiftelse.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; BIEDLER JL, 1978, CANCER RES, V38, P3751; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Brotherton T, 2011, AMYOTROPH LATERAL SC, V12, P215, DOI 10.3109/17482968.2010.531279; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Dokholyan NV, 2002, PHYSICA A, V314, P600, DOI 10.1016/S0378-4371(02)01079-8; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Johansson AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036104; Jonsson PA, 2008, ANN NEUROL, V63, P671, DOI 10.1002/ana.21356; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kohno S, 1999, NEUROSCI LETT, V276, P135, DOI 10.1016/S0304-3940(99)00803-4; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Morita M, 1996, NEUROSCI LETT, V205, P79, DOI 10.1016/0304-3940(96)12378-8; Nakamura A, 2012, AMYOTROPH LATERAL SC, V13, P479, DOI 10.3109/17482968.2011.656311; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Pires RH, 2011, J MOL RECOGNIT, V24, P467, DOI 10.1002/jmr.1112; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	44	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78060	10.1371/journal.pone.0078060	http://dx.doi.org/10.1371/journal.pone.0078060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143259	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100098
J	Macdonald, M; Campbell, K				Macdonald, Margaret; Campbell, Kenneth			Event-Related Potential Measures of a Violation of an Expected Increase and Decrease in Intensity	PLOS ONE			English	Article							MISMATCH-NEGATIVITY; ATTENTION; INFORMATION; MECHANISMS; SEQUENCES; NOVELTY; WINDOW; MMN	Unexpected physical increases in the intensity of a frequently occurring "standard" auditory stimulus are experienced as obtrusive. This could either be because of a physical change, the increase in intensity of the "deviant" stimulus, or a psychological change, the violation of the expectancy for the occurrence of the lower intensity standard stimulus. Two experiments were run in which event-related potentials (ERPs) were recorded to determine whether "psychological" increments (violation of an expectancy for a lower intensity) would be processed differently than psychological decrements (violation of an expectancy for a higher intensity). Event-related potentials (ERPs) were recorded while subjects were presented with auditory tones that alternated between low and high intensity. The subjects ignored the auditory stimuli while watching a video. Deviants were created by repeating the same stimulus. In the first experiment, pairs of stimuli alternating in intensity, were presented in separate increment (H-L...H-L...H-(H) under bar...H-L, in which H = 80 dB SPL and L = 60 dB SPL) and decrement conditions (L-H...L-H...L-(L) under bar...L-H, in which H = 90 dB SPL and L = 80 dB SPL). The paradigm employed in the second experiment consisted of an alternating intensity pattern (H-L-H-L-H-(H) under bar -H-L) or (H-L-H-L-(L) under bar -L-H-L). Importantly, the stimulus prior to the deviant (the standard) and the actual deviants in both increment and decrement conditions in both experiments were physically identical (80 dB SPL tones). The repetition of the lower intensity tone therefore acted as a psychological rather than a physical decrement (a higher intensity tone was expected) while the repetition of the higher intensity tone acted as a psychological increment (a lower intensity tone was expected). The psychological increments in both experiments elicited a larger amplitude mismatch negativity (MMN) than the decrements. Thus, regardless of whether an acoustic change signals a physical increase in intensity or violates an expected decrease in intensity, a large MMN will be elicited.	[Macdonald, Margaret; Campbell, Kenneth] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Campbell, K (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	kcampbel@uottawa.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support for this research was provided by an operating grant to K. C. by the Natural Sciences and Engineering Research Council of Canada (NSERC) and by a doctoral scholarship to MM by NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, NEUROREPORT, V6, P140, DOI 10.1097/00001756-199412300-00036; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Bregman A.S., 1990, AUDITORY SCENE ANAL; Ceponiene R, 2004, PSYCHOPHYSIOLOGY, V41, P130, DOI 10.1111/j.1469-8986.2003.00138.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Freiberg K, 2001, BRIT J DEV PSYCHOL, V19, P1, DOI 10.1348/026151001165903; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Grimm S, 2012, INT J PSYCHOPHYSIOL, V85, P88, DOI 10.1016/j.ijpsycho.2011.05.012; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; Jacobsen T, 2003, AUDIOL NEURO-OTOL, V8, P338, DOI 10.1159/000073518; Macdonald M, 2008, NEUROREPORT, V19, P309, DOI 10.1097/WNR.0b013e3282f4ede8; Macdonald M, 2011, BRAIN COGNITION, V77, P438, DOI 10.1016/j.bandc.2011.08.014; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Makeig S, 1996, ADV NEUR IN, V8, P145; Muller-Gass A, 2007, BRAIN RES, V1170, P71, DOI 10.1016/j.brainres.2007.07.023; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; NORDBY H, 1988, PSYCHOPHYSIOLOGY, V25, P262, DOI 10.1111/j.1469-8986.1988.tb01239.x; Paavilainen P, 1998, PSYCHOPHYSIOLOGY, V35, P483, DOI 10.1017/S0048577298970895; Paavilainen P, 2003, NEUROREPORT, V14, P715, DOI 10.1097/00001756-200304150-00011; Paavilainen P, 2013, INT J PSYCHOPHYSIOL, V88, P109, DOI 10.1016/j.ijpsycho.2013.03.015; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Sculthorpe LD, 2008, BRAIN RES, V1234, P78, DOI 10.1016/j.brainres.2008.07.031; Wetzel N, 2011, BIOL PSYCHOL, V86, P39, DOI 10.1016/j.biopsycho.2010.10.005; Winer BJ, 1971, STAT PRINCIPLES EXPT; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; WOESTENBURG JC, 1983, BIOL PSYCHOL, V16, P127, DOI 10.1016/0301-0511(83)90059-5; Yabe H, 1997, NEUROREPORT, V8, P1971, DOI 10.1097/00001756-199705260-00035	32	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76897	10.1371/journal.pone.0076897	http://dx.doi.org/10.1371/journal.pone.0076897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237TP	24143195	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100030
J	Mutevedzi, PC; Rodger, AJ; Kowal, P; Nyirenda, M; Newell, ML				Mutevedzi, Portia C.; Rodger, Alison J.; Kowal, Paul; Nyirenda, Makandwe; Newell, Marie-Louise			Decreased Chronic Morbidity but Elevated HIV Associated Cytokine Levels in HIV-Infected Older Adults Receiving HIV Treatment: Benefit of Enhanced Access to Care?	PLOS ONE			English	Article							SOUTH-AFRICA; INFLAMMATORY MARKERS; OBESITY; INTERLEUKIN-6; PREVALENCE; PREDICTORS; DISEASE; PEOPLE; HEALTH	Background: The association of HIV with chronic morbidity and inflammatory markers (cytokines) in older adults (50+years) is potentially relevant for clinical care, but data from African populations is scarce. Objective: To examine levels of chronic morbidity by HIV and ART status in older adults (50+years) and subsequent associations with selected pro-inflammatory cytokines and body mass index. Methods: Ordinary, ordered and generalized ordered logistic regression techniques were employed to compare chronic morbidity (heart disease (angina), arthritis, stroke, hypertension, asthma and diabetes) and cytokines (Interleukins-1 and -6, C-Reactive Protein and Tumor Necrosis Factor-alpha) by HIV and ART status on a cross-sectional random sample of 422 older adults nested within a defined rural South African population based demographic surveillance. Results: Using a composite measure of all morbidities, controlling for age, gender, BMI, smoking and wealth quintile, HIV-infected individuals on ART had 51% decreased odds (95% CI: 0.26-0.92) of current morbidity compared to HIV-uninfected. In adjusted regression, compared to HIV-uninfected, the proportional odds (aPOR) of having elevated inflammation markers of IL6 (>1.56pg/mL) was nearly doubled in HIV-infected individuals on (aPOR 1.84; 95% CI: 1.05-3.21) and not on (aPOR 1.94; 95% CI: 1.11-3.41) ART. Compared to HIV-uninfected, HIV-infected individuals on ART had >twice partial proportional odds (apPOR=2.30; p=0.004) of having non-clinically significant raised hsCRP levels(>1ug/mL); ART-naive HIV-infected individuals had >double apPOR of having hsCRP levels indicative of increased heart disease risk(>3.9ug/mL; p=0.008). Conclusions: Although HIV status was associated with increased inflammatory markers, our results highlight reduced morbidity in those receiving ART and underscore the need of pro-actively extending these services to HIV-uninfected older adults, beyond mere provision at fixed clinics. Providing health services through regular community chronic disease screening would ensure health care reaches all older adults in need.	[Mutevedzi, Portia C.; Nyirenda, Makandwe; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Mutevedzi, Portia C.; Rodger, Alison J.] UCL, Dept Infect & Populat Hlth, London, England; [Kowal, Paul] World Hlth Org Solid Act Globalizat & Environm, Geneva, Switzerland; [Kowal, Paul] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia; [Nyirenda, Makandwe] Univ Southampton, Sch Social Sci, Southampton, Hants, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, London, England	University of Kwazulu Natal; University of London; University College London; World Health Organization; University of Newcastle; University of Southampton; University of London; University College London	Mutevedzi, PC (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	pmutevedzi@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Nyirenda, Makandwe/R-4080-2018; Nyirenda, Makandwe/B-2963-2015	Newell, Marie-Louise/0000-0002-1074-7699; Nyirenda, Makandwe/0000-0002-1839-877X; Kowal, Paul/0000-0002-6314-8753	WHO's Study on global AGEing and adult health (SAGE); United States National Institute on Aging Division of Behavioral and Social Research (BSR) [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01]; Wellcome Trust United Kingdom [65377]	WHO's Study on global AGEing and adult health (SAGE); United States National Institute on Aging Division of Behavioral and Social Research (BSR); Wellcome Trust United Kingdom(Wellcome Trust)	This work was supported by WHO's Study on global AGEing and adult health (SAGE), with funding from the United States National Institute on Aging Division of Behavioral and Social Research (BSR) through an Interagency Agreement (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01). The Africa Centre core and surveillance is supported by the Wellcome Trust United Kingdom through grant number 65377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew C, 2000, LANCET, V356, P1423, DOI DOI 10.1016/S0140-6736(00)02854-3.PUBMED:11052597; [Anonymous], 2000, INT LOG REGR ALL ITS; [Anonymous], 2008, TODAYS RES AGING USE; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Cheymol G, 2000, CLIN PHARMACOKINET, V39, P215, DOI 10.2165/00003088-200039030-00004; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Dobriansky PJ, 2007, WHY POPULATION AGING; Gebo KA, 2006, DRUG AGING, V23, P897, DOI 10.2165/00002512-200623110-00005; Gebo Kelly A, 2008, Aging health, V4, P615, DOI 10.2217/1745509X.4.6.615; Goldman N, 2007, FUTURE DIRECTIONS IN; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; He W, 2012, SHADES GRAY CROSS CO; HOBER D, 1989, CLIN EXP IMMUNOL, V78, P329; Houlihan CF, 2010, INT J EPIDEMIOL, V40; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Lessells RJ, 2011, J ACQ IMMUN DEF SYND, P56; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mutevedzi PC, 2011, FUTURE VIROL, V6, P755, DOI 10.2217/FVL.11.43; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Nyirenda M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-259; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x; Puts MTE, 2005, CLIN ENDOCRINOL, V63, P403, DOI 10.1111/j.1365-2265.2005.02355.x; Rhee MS, 2008, J CLIN PHARMACOL, V48, P1212, DOI 10.1177/0091270008322177; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Targher G, 2001, DIABETES CARE, V24, P956, DOI 10.2337/diacare.24.5.956; Trayhurn P, 2005, ENDOCRINOLOGY, V146, P1003, DOI 10.1210/en.2004-1597; UCLA, STAT DAT AN EX ORD L; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wallrauch C, 2010, SAMJ, P100; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2012, WHO GLOB DAT BOD MAS; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	40	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77379	10.1371/journal.pone.0077379	http://dx.doi.org/10.1371/journal.pone.0077379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143226	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100063
J	Soeters, HM; Poole, C; Patel, MR; Van Rie, A				Soeters, Heidi M.; Poole, Charles; Patel, Monita R.; Van Rie, Annelies			The Effect of Tuberculosis Treatment at Combination Antiretroviral Therapy Initiation on Subsequent Mortality: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HIV-INFECTED PATIENTS; FOLLOW-UP; TREATMENT OUTCOMES; TREATMENT PROGRAMS; RISK-FACTORS; 1ST YEAR; ADULTS; HAART; COINFECTION; PREDICTORS	Objective: We aimed to perform a systematic review and meta-analysis examining the impact of TB treatment at the time of combination antiretroviral therapy (cART) initiation on subsequent mortality. Methods: We searched PubMed, EMBASE, and selected conference proceedings for studies that report adult mortality on cART, stratified by TB treatment status at cART initiation. Stratified random-effects and meta-regression analyses were used to examine the influence of study and population characteristics. Results: 22 eligible cohort studies reported data on 98,350 (range 74-15,225) adults, of whom 14,779 (15%) were receiving TB treatment at cART initiation. Studies of those receiving vs. not receiving TB treatment had an average mortality relative risk of 1.10 (95% confidence interval 0.87-1.40) at 1-3 months (based upon 8 estimates), 1.15 (0.94-1.41) at 6-12 months (11 estimates), and 1.33 (1.02-1.75) at 18-98 months (10 estimates) following cART initiation. However, there was a wide range of estimates and those at later time points were markedly heterogeneous. Meta-regression identified factors associated with elevated average risk estimates: lower median baseline CD4 counts and adjustment for baseline hemoglobin at 1-3 months; longer length of follow-up and women-only studies at 6-12 months; and not adjusting for BMI/weight at 18-98 months. Conclusions: Patients receiving TB treatment at cART initiation did not have a statistically significant estimated increase in short-term risk of all-cause mortality as compared to those not receiving TB treatment. TB treatment was significantly associated with increased mortality after about a year of cART, suggesting that patients with concurrent TB treatment at cART initiation may benefit from continued support after TB treatment completion.	[Soeters, Heidi M.; Poole, Charles; Patel, Monita R.; Van Rie, Annelies] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Soeters, HM (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	hsoeters@email.unc.edu	Van Rie, Annelies/C-2082-2017; Soeters, Heidi/H-3271-2019	Van Rie, Annelies/0000-0001-7666-3263; Soeters, Heidi/0000-0002-9415-9340	National Institutes of Health [2T32AI070114]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HMS and MRP were partially supported by National Institutes of Health training grant 2T32AI070114. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOB PLAN STOP TB 20; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; BASSETT IV, 2010, VIENN AUSTR 18 INT A; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bera E, 2009, SAJOG-S AFR J OBSTET, V15, P26; Bhowmik A, 2012, ASIAN PAC J TROP MED, V5, P986, DOI 10.1016/S1995-7645(12)60187-4; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Borenstein M., 2009, INTRO METAANALYSIS; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Breton G, 2012, INT J TUBERC LUNG D, V16, P1365, DOI 10.5588/ijtld.11.0693; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chu R, 2011, AM J EPIDEMIOL, V173, pS73; Curran A, 2012, AIDS REV, V14, P231; Dao CN, 2011, AIDS RES HUM RETROV, V27, P1149, DOI [10.1089/aid.2010.0345, 10.1089/AID.2010.0345]; Desilva MB, 2009, AIDS CARE, V21, P70, DOI 10.1080/09540120802017636; Dronda F, 2011, CURR HIV RES, V9, P229, DOI 10.2174/157016211796320324; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Greig J, 2012, JAIDS-J ACQ IMM DEF, V59, pE92, DOI 10.1097/QAI.0b013e31824206c7; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055824; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lartey M, 2011, CLIN INFECT DIS, V52, P547, DOI 10.1093/cid/ciq196; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Makombe SD, 2007, INT J TUBERC LUNG D, V11, P412; Manosuthi W, 2010, INT J INFECT DIS, V14, pE1013, DOI 10.1016/j.ijid.2010.06.016; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Mugusi SF, 2012, ANTIVIR THER, V17, P265, DOI 10.3851/IMP1956; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Nguyen VTT, 2011, ANTIVIR THER, V16, pA51; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Siika AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053022; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Volberding P, 2008, GLOBAL HIV AIDS MED; Walker AS, 2012, CLIN INFECT DIS, V55, P1707, DOI 10.1093/cid/cis797; Westreich D, 2012, AIDS, V26, P770, DOI 10.1097/QAD.0b013e328351f6b8; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2010, ANT THER HIV INF AD; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	59	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78073	10.1371/journal.pone.0078073	http://dx.doi.org/10.1371/journal.pone.0078073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143260	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100099
J	Cheng, L; Wang, GH; Li, J; Zhang, TJ; Xu, PG; Wang, YD				Cheng, Liang; Wang, Guohua; Li, Jie; Zhang, Tianjiao; Xu, Peigang; Wang, Yadong			SIDD: A Semantically Integrated Database towards a Global View of Human Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE; KNOWLEDGEBASE; ONTOLOGY; BIOINFORMATICS; PHENOTYPE; CYTOSCAPE; NETWORKS; PROTEINS; MICRORNA	Background: A number of databases have been developed to collect disease-related molecular, phenotypic and environmental features (DR-MPEs), such as genes, non-coding RNAs, genetic variations, drugs, phenotypes and environmental factors. However, each of current databases focused on only one or two DR-MPEs. There is an urgent demand to develop an integrated database, which can establish semantic associations among disease-related databases and link them to provide a global view of human disease at the biological level. This database, once developed, will facilitate researchers to query various DR-MPEs through disease, and investigate disease mechanisms from different types of data. Methodology: To establish an integrated disease-associated database, disease vocabularies used in different databases are mapped to Disease Ontology (DO) through semantic match. 4,284 and 4,186 disease terms from Medical Subject Headings (MeSH) and Online Mendelian Inheritance in Man (OMIM) respectively are mapped to DO. Then, the relationships between DR-MPEs and diseases are extracted and merged from different source databases for reducing the data redundancy. Conclusions: A semantically integrated disease-associated database (SIDD) is developed, which integrates 18 disease-associated databases, for researchers to browse multiple types of DR-MPEs in a view. A web interface allows easy navigation for querying information through browsing a disease ontology tree or searching a disease term. Furthermore, a network visualization tool using Cytoscape Web plugin has been implemented in SIDD. It enhances the SIDD usage when viewing the relationships between diseases and DR-MPEs. The current version of SIDD (Jul 2013) documents 4,465,131 entries relating to 139,365 DR-MPEs, and to 3,824 human diseases. The database can be freely accessed from: http://mlg.hit.edu.cn/SIDD.	[Cheng, Liang; Wang, Guohua; Li, Jie; Zhang, Tianjiao; Xu, Peigang; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China	Harbin Institute of Technology	Wang, YD (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn	Wang, Guohua/GLR-7939-2022; Zhang, Tianjiao/CVB-2759-2022; Cheng, Liang/ABY-7421-2022	Zhang, Tianjiao/0000-0001-9807-8620; Cheng, Liang/0000-0002-6665-6710	China National 863 High-Tech Program [2012AA020404, 2012AA02A602]; National Natural Science Foundation of China [60901075, 60973078, 61173085]; Natural Science Foundation of Heilongjiang Province of China [LC2009C35]; Special Research Foundation for technological Innovation Talents of Harbin [2011RFLXG011]; China National 863 High-Tech Program	China National 863 High-Tech Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Special Research Foundation for technological Innovation Talents of Harbin; China National 863 High-Tech Program(National High Technology Research and Development Program of China)	This work was supported by the China National 863 High-Tech Program (2012AA020404, 2012AA02A602); National Natural Science Foundation of China (60901075, 60973078 and 61173085); Natural Science Foundation of Heilongjiang Province of China (LC2009C35) and the Special Research Foundation for technological Innovation Talents of Harbin (2011RFLXG011). Funding for open access charge: The China National 863 High-Tech Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman RB, 2007, NAT GENET, V39, P426, DOI 10.1038/ng0407-426; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bello D. A., 2011, P INT C BIOM ONT ICB, P231; Berriz GF, 2008, BIOINFORMATICS, V24, P2272, DOI 10.1093/bioinformatics/btn424; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Boutet Emmanuel, 2007, V406, P89; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; Davis Allan Peter, 2012, DATABASE; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Furuta T, 2013, BRAIN TUMOR IN PRESS; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang HZ, 2011, BIOINFORMATICS, V27, P1190, DOI 10.1093/bioinformatics/btr101; Iragne F, 2004, BIOINFORMATICS, V20, P2331, DOI 10.1093/bioinformatics/bth241; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jonquet Clement, 2010, J Biomed Semantics, V1 Suppl 1, pS1, DOI 10.1186/2041-1480-1-S1-S1; Kong FL, 2011, NUCLEIC ACIDS RES, V39, pD895, DOI 10.1093/nar/gkq1038; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mottaz A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S3; Neveol A, 2012, LINKING MULTIPLE DIS, P767; Osborne J.D., 2007, GENERIF IS MORE COMP; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Palleja A, 2012, NUCLEIC ACIDS RES, V40, pD1036, DOI 10.1093/nar/gkr899; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Schully SD, 2011, EUR J HUM GENET, V19, P928, DOI 10.1038/ejhg.2011.53; Shah SP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-34; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Wang J, 2012, NUCLEIC ACIDS RES, V40, pD1055, DOI 10.1093/nar/gkr1171; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049686; Zhao X, 2012, NUCLEIC ACIDS RES, V40, pD1041, DOI 10.1093/nar/gkr1142	39	36	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75504	10.1371/journal.pone.0075504	http://dx.doi.org/10.1371/journal.pone.0075504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146757	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400009
J	Feng, WW; Malpica, A; Skaland, I; Gudlaugsson, E; Robboy, SJ; Dalen, I; Hua, KQ; Zhou, XR; Baak, JPA				Feng, Weiwei; Malpica, Anais; Skaland, Ivar; Gudlaugsson, Einar; Robboy, Stanley J.; Dalen, Ingvild; Hua, Keqin; Zhou, Xianrong; Baak, Jan P. A.			Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade?	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; FACTOR RECEPTOR EGFR; UTERINE SARCOMAS; PROGNOSTIC VALUE; BETA-CATENIN; CYCLIN D1; STAGES I; EXPRESSION; MANAGEMENT; TARGETS	An estimated 1500-3000 invasive Endometrial Stromal Sarcomas (ESS) cases annually occur worldwide. Before 2003, ESS was divided as low and high grade ESS based on mitotic activity. In 2003 the WHO changed the names, excluded mitoses and made nuclear atypia and necrosis the essential diagnostic criteria to distinguish ESS, Low Grade (ESS-LG, recurrence-free survival >90%) and Undifferentiated Endometrial Sarcoma (UES, poor prognosis). We have evaluated in WHO2003 defined ESS-LG whether proliferation biomarkers predict recurrence. Using survival analysis, the prognostic value of classical mitosis counts (Mitotic Activity Index, MAI) in haematoxyllin-eosin (H&E) sections, and immunohistochemical proliferation biomarkers (Ki-67 and PhosphoHistone-3 (PPH3)) were examined in 24 invasive endometrial stromal sarcomas. Three of 24 (12.5%) ESS-LG recurred. The MAI, PPH3 and Ki-67 were all prognostic (P = 0.001, 0.002 and 0.03). MAI values were >3 in the recurrent cases, but never exceeded 10 (the classical threshold for low and high grade). Non-recurrent cases had 0 <= MAI <= 3. PPH3 and Ki67 counts can be easier to perform than MAI and therefore helpful in the diagnosis of ESS, Low Grade. In conclusion, in this small study of WHO2003 defined ESS-LG, high levels of proliferation as measured by MAI, PPH3 and Ki-67 are predictive of recurrence. Larger studies are required to confirm these results.	[Feng, Weiwei; Hua, Keqin] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200433, Peoples R China; [Feng, Weiwei; Hua, Keqin] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200433, Peoples R China; [Zhou, Xianrong] Fudan Univ, Dept Pathol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Malpica, Anais] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Malpica, Anais] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Skaland, Ivar; Gudlaugsson, Einar; Baak, Jan P. A.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Dalen, Ingvild] Stavanger Univ Hosp, Dept Res, Stavanger, Norway; [Baak, Jan P. A.] Univ Bergen, Med Odontol Fac, Inst Clin, Bergen, Norway; [Robboy, Stanley J.] Duke Univ Med Ctr, Dept Pathol, Durham, NC USA; [Robboy, Stanley J.] Duke Univ Med Ctr, Dept Obstet & Gynecol, Durham, NC USA	Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Stavanger University Hospital; Stavanger University Hospital; University of Bergen; Duke University; Duke University	Feng, WW (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200433, Peoples R China.	jingsakura@gmail.com; jpabaak47@yahoo.com			Pujiang Talents Plan, Shanghai Science and Technology Committee, Shanghai, China [08PJ14026]; Norwegian Research Council; Stavanger Hospital; Stichting Bevordering Diagnostische Morfometrie, Middelburg, The Netherlands	Pujiang Talents Plan, Shanghai Science and Technology Committee, Shanghai, China; Norwegian Research Council(Research Council of NorwayEuropean Commission); Stavanger Hospital; Stichting Bevordering Diagnostische Morfometrie, Middelburg, The Netherlands(Netherlands Government)	This work was supported by the Pujiang Talents Plan, Shanghai Science and Technology Committee, (Grant No. 08PJ14026), Shanghai, China and a travel grant from the Norwegian Research Council to Dr. Feng; a sabbatical year grant of the Stavanger Hospital and grants from the Stichting Bevordering Diagnostische Morfometrie, Middelburg, The Netherlands to Prof. Baak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler VM, 2009, HISTOPATHOLOGY, V54, P355, DOI 10.1111/j.1365-2559.2009.03231.x; Amant F, 2006, GYNECOL ONCOL, V103, P1137, DOI 10.1016/j.ygyno.2006.07.013; [Anonymous], 2009, INT J GYNECOL OBSTET, V104, P179, DOI 10.1016/j.ijgo.2008.12.009; Ashraf-Ganjoei T, 2006, WORLD J SURG ONCOL, V9, P45; Capobianco G, 2012, EUR J GYNAECOL ONCOL, V33, P629; Chiang S, 2011, AM J SURG PATHOL, V35, P1364, DOI 10.1097/PAS.0b013e3182262743; Cossu-Rocca P, 2012, INT J GYNECOL PATHOL, V31, P570, DOI 10.1097/PGP.0b013e31824fe289; Croce S, 2013, MOD PATHOL; EVANS HL, 1982, CANCER-AM CANCER SOC, V50, P2170, DOI 10.1002/1097-0142(19821115)50:10<2170::AID-CNCR2820501033>3.0.CO;2-K; Feng WW, 2013, INT J GYNECOL PATHOL, V32, P299, DOI 10.1097/PGP.0b013e318229adfb; Feng WW, 2013, HISTOPATHOLOGY, V62, P675, DOI 10.1111/j.1365-2559.2011.04115.x; Feng WW, 2013, INT J GYNECOL CANCER, V23, P488, DOI 10.1097/IGC.0b013e318247aa14; Gadducci A, 1996, GYNECOL ONCOL, V63, P247, DOI 10.1006/gyno.1996.0314; Iwasaki S, 2013, ARCH GYNECOL OBSTET, V288, P385, DOI 10.1007/s00404-013-2766-3; Jakate K, 2013, MODERN PATHOL, V26, P95, DOI 10.1038/modpathol.2012.136; Kildal W, 2009, EUR J CANCER, V45, P2412, DOI 10.1016/j.ejca.2009.06.017; Kir G, 2005, INT J GYNECOL CANCER, V15, P337, DOI 10.1111/j.1525-1438.2005.15226.x; Koivisto-Korander R, 2012, MATURITAS, V72, P56, DOI 10.1016/j.maturitas.2012.01.021; Koivisto-Korander R, 2011, TUMOR BIOL, V32, P451, DOI 10.1007/s13277-010-0138-1; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Koskas M, 2009, ANTICANCER RES, V29, P4147; Kurihara S, 2008, AM J SURG PATHOL, V32, P1228, DOI 10.1097/PAS.0b013e31816a3b42; Kurihara S, 2010, MODERN PATHOL, V23, P225, DOI 10.1038/modpathol.2009.162; Lee CH, 2012, AM J SURG PATHOL, V36, P1562, DOI 10.1097/PAS.0b013e31825fa931; Lee CH, 2012, AM J SURG PATHOL, V36, P641, DOI 10.1097/PAS.0b013e31824a7b1a; Lee CH, 2012, P NATL ACAD SCI USA, V109, P929, DOI 10.1073/pnas.1115528109; Lende TH, 2011, J CLIN ONCOL, V29, P852, DOI 10.1200/JCO.2009.25.0407; Li N, 2008, GYNECOL ONCOL, V108, P306, DOI 10.1016/j.ygyno.2007.10.023; Malouf GG, 2010, ANN ONCOL, V21, P2102, DOI 10.1093/annonc/mdq064; Moinfar F, 2005, AM J SURG PATHOL, V29, P485, DOI 10.1097/01.pas.0000155149.83541.24; NORRIS HJ, 1966, CANCER, V19, P755, DOI 10.1002/1097-0142(196606)19:6<755::AID-CNCR2820190604>3.0.CO;2-U; Park JY, 2013, INT J GYNECOL CANCER, V23, P81, DOI 10.1097/IGC.0b013e3182738361; Popiolek D, 2003, GYNECOL ONCOL, V90, P353, DOI 10.1016/S0090-8258(03)00281-6; Reich O, 2000, EUR J CANCER, V36, pS93; Sardinha R, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-3; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Tavassoli FA, 2003, WHO CLASSIFICATION T	37	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75899	10.1371/journal.pone.0075899	http://dx.doi.org/10.1371/journal.pone.0075899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146786	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400024
J	do Nascimento, PRP; Martins, DRA; Monteiro, GRG; Queiroz, PV; Freire-Neto, FP; Queiroz, JW; Lima, ALM; Jeronimo, SMB				Porfirio do Nascimento, Paulo Ricardo; Arantes Martins, Daniella Regina; Gois Monteiro, Gloria Regina; Queiroz, Paula Vivianne; Freire-Neto, Francisco Paulo; Queiroz, Jose Wilton; Morais Lima, Adila Lorena; Bezerra Jeronimo, Selma Maria			Association of Pro-Inflammatory Cytokines and Iron Regulatory Protein 2 (IRP2) with Leishmania Burden in Canine Visceral Leishmaniasis	PLOS ONE			English	Article							IFN-GAMMA; INFECTION; DISEASE; BRAZIL; STEROIDOGENESIS; EPIDEMIOLOGY; REPLICATION; SUPPRESSION; INFANTUM; CHAGASI	Leishmania infantum infection in humans and dogs can evolve with a wide range of clinical presentations, varying from asymptomatic infections to visceral leishmaniasis. We hypothesized that the immune response elicited by L. infantum infection could modulate whether the host will remain asymptomatic or progress to disease. A total of 44 dogs naturally infected with L. infantum were studied. Leishmania burden was estimated in the blood and spleen by qPCR. The expression of IFN-gamma, TNF-alpha, IL-10 and Iron Regulatory Protein 2 (IRP2) were determined in the spleen by quantitative PCR. Sera cytokines were evaluated by ELISA. Dogs were grouped in quartiles according parasite burden. Increased expression of IFN-gamma and TNF-alpha was associated with reduced Leishmania burden, whereas increased IL-10 and IRP2 expressions were associated with higher Leishmania load. Increased plasma albumin and IFN-gamma expression explained 22.8% of the decrease in parasite burden in the spleen. These data confirm that lower IFN-gamma response and higher IL-10 correlated with increased parasite load and severity of the visceral leishmaniasis in dogs. The balance between the branches of immune response and the intracellular iron availability could determine, in part, the course of Leishmania infection.	[Porfirio do Nascimento, Paulo Ricardo; Freire-Neto, Francisco Paulo; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil; [Porfirio do Nascimento, Paulo Ricardo; Arantes Martins, Daniella Regina; Gois Monteiro, Gloria Regina; Freire-Neto, Francisco Paulo; Queiroz, Jose Wilton; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59072970 Natal, RN, Brazil; [Arantes Martins, Daniella Regina] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biol & Genet, BR-59072970 Natal, RN, Brazil; [Gois Monteiro, Gloria Regina; Morais Lima, Adila Lorena; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Hlth Grad Program, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil; [Queiroz, Paula Vivianne] State Univ Rio Grande Norte, Coll Med, Mossoro, RN, Brazil; [Queiroz, Jose Wilton; Bezerra Jeronimo, Selma Maria] Inst Sci & Technol Trop Dis INCT DT, Salvador, BA, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade do Estado do Rio Grande do Norte (UERN)	Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.	smbj@cb.ufrn.br	Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020	Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904	National Institutes of Health [AI030639-20]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI030639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded in part with a grant from the National Institutes of Health (AI030639-20) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; Baneth G, 2008, VET J, V175, P14, DOI 10.1016/j.tvjl.2006.11.011; Bern C, 2007, AM J TROP MED HYG, V76, P909; Boggiatto PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001019; Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344; COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003; Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005; EVANS TG, 1990, J PARASITOL, V76, P212, DOI 10.2307/3283018; EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124; Figueroa F, 2012, LIFE SCI, V90, P733, DOI 10.1016/j.lfs.2012.03.019; Gorski S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000705; HARRISON LH, 1986, REV INFECT DIS, V8, P447; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X; Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492; Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Manna L, 2009, VET J, V182, P441, DOI 10.1016/j.tvjl.2008.08.009; MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Olakanmi O, 2002, J BIOL CHEM, V277, P49727, DOI 10.1074/jbc.M209768200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707; Qian G, 1999, Pac Symp Biocomput, P314; Rose NR, 2011, J INTERF CYTOK RES, V31, P705, DOI 10.1089/jir.2011.0057; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salomon OD, 2009, MEM I OSWALDO CRUZ, V104, P801, DOI 10.1590/S0074-02762009000500024; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002; Neto RGT, 2010, VET PARASITOL, V169, P248, DOI 10.1016/j.vetpar.2010.01.023; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Wilson ME, 1996, J IMMUNOL, V156, P2231	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e73873	10.1371/journal.pone.0073873	http://dx.doi.org/10.1371/journal.pone.0073873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146743	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400002
J	Barry, KL				Barry, Katherine L.			You Are What You Eat: Food Limitation Affects Reproductive Fitness in a Sexually Cannibalistic Praying Mantid	PLOS ONE			English	Article							DEVELOPMENTAL TRADE-OFFS; RISKY MATE SEARCH; STAGMOMANTIS-LIMBATA; RESOURCE-ALLOCATION; SPERM COMPETITION; LIFE-HISTORIES; REACTION NORMS; BODY CONDITION; ALLOMETRY; SELECTION	Resource limitation during the juvenile stages frequently results in developmental delays and reduced size at maturity, and dietary restriction during adulthood can affect longevity and reproductive output. Variation in food intake can also result in alteration to the normal pattern of resource allocation among body parts or life-history stages. My primary aim in this study was to determine how varying juvenile and/or adult feeding regimes affect particular female and male traits in the sexually cannibalistic praying mantid Pseudomantis albofimbriata. Praying mantids are sit-and-wait predators whose resource intake can vary dramatically depending on environmental conditions within and across seasons, making them useful for studying the effects of feeding regime on various facets of reproductive fitness. In this study, there was a significant trend/difference in development and morphology for males and females as a result of juvenile feeding treatment, however, its effect on the fitness components measured for males was much greater than on those measured for females. Food-limited males were less likely to find a female during field enclosure experiments and smaller males were slower at finding a female in field-based experiments, providing some of the first empirical evidence of a large male size advantage for scrambling males. Only adult food limitation affected female fecundity, and the ability of a female to chemically attract males was also most notably affected by adult feeding regime (although juvenile food limitation did play a role). Furthermore, the significant difference/trend in all male traits and the lack of difference in male trait ratios between treatments suggests a proportional distribution of resources and, therefore, no trait conservation by food-limited males. This study provides evidence that males and females are under different selective pressures with respect to resource acquisition and is also one of very few to show an effect of juvenile food quantity on adult reproductive fitness in a hemimetabolous insect.	Macquarie Univ, Dept Biol Sci, Macquarie Pk, NSW, Australia	Macquarie University	Barry, KL (corresponding author), Macquarie Univ, Dept Biol Sci, Macquarie Pk, NSW, Australia.	kate.barry@mq.edu.au			The Department of Biological Sciences at Macquarie University; Linnean Society of NSW	The Department of Biological Sciences at Macquarie University; Linnean Society of NSW	The Department of Biological Sciences at Macquarie University (http://bio.mq.edu.au) and the Joyce W. Vickery Scientific Research Fund from the Linnean Society of NSW (http://linneansocietynsw.org.au/grants.html) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Allen LE, 2014, INSECT SCI, V21, P227, DOI 10.1111/1744-7917.12016; Allen LE, 2011, ANIM BEHAV, V82, P1201, DOI 10.1016/j.anbehav.2011.09.009; Andersson Malte, 1994; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Barry KL, 2010, ANIM BEHAV, V80, P405, DOI 10.1016/j.anbehav.2010.05.024; Barry KL, 2008, BEHAV ECOL, V19, P710, DOI 10.1093/beheco/arm156; Barry KL, 2011, EVOL ECOL, V25, P107, DOI 10.1007/s10682-010-9384-3; Barry KL, 2010, ANIM BEHAV, V79, P1165, DOI 10.1016/j.anbehav.2010.02.025; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; BERRIGAN D, 1994, OIKOS, V70, P474, DOI 10.2307/3545787; BIRKHEAD TR, 1988, BEHAVIOUR, V106, P112, DOI 10.1163/156853988X00115; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Brown WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035377; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; Dmitriew C, 2009, CAN J ZOOL, V87, P175, DOI 10.1139/Z09-001; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Dusse K, 1997, P ENTOMOL SOC WASH, V99, P490; Eberhard WG, 2002, CAN ENTOMOL, V134, P667, DOI 10.4039/Ent134667-5; EISENBERG RM, 1981, AM MIDL NAT, V106, P209, DOI 10.2307/2425157; Engels S, 2007, J INSECT PHYSIOL, V53, P633, DOI 10.1016/j.jinsphys.2007.05.003; Foellmer MW, 2005, J EVOLUTION BIOL, V18, P629, DOI 10.1111/j.1420-9101.2005.00868.x; Geister TL, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-10; Holwell GI, 2007, BIOL J LINN SOC, V91, P307, DOI 10.1111/j.1095-8312.2007.00788.x; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P9169, DOI 10.1073/pnas.96.16.9169; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Kaspi R, 2000, ECOL ENTOMOL, V25, P279, DOI 10.1046/j.1365-2311.2000.00266.x; Kasumovic MM, 2009, J EVOLUTION BIOL, V22, P324, DOI 10.1111/j.1420-9101.2008.01648.x; Kasumovic MM, 2007, BEHAV ECOL, V18, P189, DOI 10.1093/beheco/arl072; Kasumovic MM, 2006, CURR BIOL, V16, pR242, DOI 10.1016/j.cub.2006.03.017; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; KYNASTON SE, 1994, ANIM BEHAV, V47, P739, DOI 10.1006/anbe.1994.1103; Lelito JP, 2008, BEHAV ECOL SOCIOBIOL, V63, P313, DOI 10.1007/s00265-008-0663-8; Maxwell MR, 2010, ECOL ENTOMOL, V35, P775, DOI 10.1111/j.1365-2311.2010.01239.x; Maxwell MR, 2010, ANN ENTOMOL SOC AM, V103, P120, DOI 10.1603/008.103.0115; Maxwell MR, 1998, ENVIRON ENTOMOL, V27, P318, DOI 10.1093/ee/27.2.318; MOOK LJ, 1966, CAN ENTOMOL, V98, P913, DOI 10.4039/Ent98913-9; Moya-Larano J, 2009, J EVOLUTION BIOL, V22, P954, DOI 10.1111/j.1420-9101.2009.01707.x; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Prokop P, 2005, ETHOLOGY, V111, P836, DOI 10.1111/j.1439-0310.2005.01113.x; Shine R, 2003, BEHAV ECOL SOCIOBIOL, V54, P162, DOI 10.1007/s00265-003-0620-5; SLIFER EH, 1968, J MORPHOL, V124, P105, DOI 10.1002/jmor.1051240107; Stevens DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1049, DOI 10.1098/rspb.1999.0742; Stevens DJ, 2000, P ROY SOC B-BIOL SCI, V267, P1511, DOI 10.1098/rspb.2000.1172; Takenaka M, 2005, CAN J ZOOL, V83, P1476, DOI 10.1139/Z05-145; Thornhill R., 1983, pi; Vencl FV, 2004, INTEGR COMP BIOL, V44, P242, DOI 10.1093/icb/44.3.242	53	18	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78164	10.1371/journal.pone.0078164	http://dx.doi.org/10.1371/journal.pone.0078164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130901	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200097
J	Srinivasan, S; Spear, J; Chandran, K; Joseph, J; Kalyanaraman, B; Avadhani, NG				Srinivasan, Satish; Spear, Joseph; Chandran, Karunakaran; Joseph, Joy; Kalyanaraman, Balaraman; Avadhani, Narayan G.			Oxidative Stress Induced Mitochondrial Protein Kinase A Mediates Cytochrome C Oxidase Dysfunction	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; ENDOPLASMIC-RETICULUM; CARDIAC MITOCHONDRIA; MACROPHAGE FUNCTIONS; ELECTRON-TRANSPORT; REPERFUSION DAMAGE; COMPLEX ACTIVITY; SUBUNIT-VB; PHOSPHORYLATION; HYPOXIA	Previously we showed that Protein kinase A (PKA) activated in hypoxia and myocardial ischemia/reperfusion mediates phosphorylation of subunits I, IVi1 and Vb of cytochrome c oxidase. However, the mechanism of activation of the kinase under hypoxia remains unclear. It is also unclear if hypoxic stress activated PKA is different from the cAMP dependent mitochondrial PKA activity reported under normal physiological conditions. In this study using RAW 264.7 macrophages and in vitro perfused mouse heart system we investigated the nature of PKA activated under hypoxia. Limited protease treatment and digitonin fractionation of intact mitochondria suggests that higher mitochondrial PKA activity under hypoxia is mainly due to increased sequestration of PKA Catalytic alpha (PKA alpha) subunit in the mitochondrial matrix compartment. The increase in PKA activity is independent of mitochondrial cAMP and is not inhibited by adenylate cyclase inhibitor, KH7. Instead, activation of hypoxia-induced PKA is dependent on reactive oxygen species (ROS). H89, an inhibitor of PKA activity and the antioxidant Mito-CP prevented loss of CcO activity in macrophages under hypoxia and in mouse heart under ischemia/reperfusion injury. Substitution of wild type subunit Vb of CcO with phosphorylation resistant S40A mutant subunit attenuated the loss of CcO activity and reduced ROS production. These results provide a compelling evidence for hypoxia induced phosphorylation as a signal for CcO dysfunction. The results also describe a novel mechanism of mitochondrial PKA activation which is independent of mitochondrial cAMP, but responsive to ROS.	[Srinivasan, Satish; Spear, Joseph; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Srinivasan, Satish; Spear, Joseph; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Chandran, Karunakaran; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Chandran, Karunakaran; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Ctr Free Radical Biol, Milwaukee, WI 53226 USA	University of Pennsylvania; University of Pennsylvania; Medical College of Wisconsin; Medical College of Wisconsin	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NIBIB NIH HHS [P41 EB001980] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Agnes RS, 2010, J AM CHEM SOC, V132, P6075, DOI 10.1021/ja909652q; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; BHAT NK, 1982, BIOCHEMISTRY-US, V21, P2452, DOI 10.1021/bi00539a026; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Corso M, 2001, PLACENTA, V22, P432, DOI 10.1053/plac.2001.0672; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; DUAN JM, 1989, CAN J PHYSIOL PHARM, V67, P704, DOI 10.1139/y89-114; Eisel F, 2013, BIOCHEM PHARMACOL, V85, P101, DOI 10.1016/j.bcp.2012.10.017; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; FLAMENG W, 1991, J MOL CELL CARDIOL, V23, P1, DOI 10.1016/0022-2828(91)90034-J; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Kanamaru Y., 2012, SIGNAL TRANSDUCT, V2012; KLEITKE B, 1976, ACTA BIOL MED GER, V35, pK9; Kohr MJ, 2010, J MOL CELL CARDIOL, V48, P645, DOI 10.1016/j.yjmcc.2010.01.007; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Maggie Pui Chi, 2012, Open Biochem J, V6, P23, DOI 10.2174/1874091X01206010023; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Miura T, 2010, CARDIOVASC RES, V88, P7, DOI 10.1093/cvr/cvq206; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Papa S, 1999, FEBS LETT, V444, P245, DOI 10.1016/S0014-5793(99)00070-8; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Prieto-Martin A, 2004, NUCLEIC ACIDS RES, V32, P2059, DOI 10.1093/nar/gkh528; Riboldi E, 2013, INT IMMUNOL, V25, P67, DOI 10.1093/intimm/dxs110; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200; SCHWOCH G, 1990, BIOCHEM J, V270, P181, DOI 10.1042/bj2700181; Shaikh D, 2012, CELL SIGNAL, V24, P2396, DOI 10.1016/j.cellsig.2012.08.007; Spear JF, 2007, AM J PHYSIOL-HEART C, V292, pH2459, DOI 10.1152/ajpheart.00459.2006; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Torii S, 2009, J BIOCHEM, V146, P839, DOI 10.1093/jb/mvp129; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Zhang YL, 2010, AM J PHYSIOL-HEART C, V299, pH225, DOI 10.1152/ajpheart.01073.2009	70	43	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77129	10.1371/journal.pone.0077129	http://dx.doi.org/10.1371/journal.pone.0077129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130844	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200061
J	Xia, WX; Ye, YF; Lu, X; Wang, L; Ke, LR; Zhang, HB; Roycik, MD; Yang, J; Shi, JL; Cao, KJ; Guo, X; Xiang, YQ				Xia, Wei-Xiong; Ye, Yan-Fang; Lu, Xing; Wang, Lin; Ke, Liang-Ru; Zhang, Hai-Bo; Roycik, Mark D.; Yang, Jing; Shi, Jun-Li; Cao, Ka-Jia; Guo, Xiang; Xiang, Yan-Qun			The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; BARR-VIRUS DNA; TUMOR; SCORE; SURVIVAL; EXPRESSION; MANAGEMENT; UPDATE	Background: The aim of this study was to determine whether baseline C-reactive protein (CRP) levels and CRP kinetics predict the overall survival in metastatic nasopharyngeal carcinoma (mNPC) patients. Methods: A total of 116 mNPC patients from January 2006 to July 2011 were retrospectively reviewed. Serum CRP level was measured at baseline and thereafter at the start of each palliative chemotherapy cycle for all patients. Results: Patients with higher values of baseline CRP (>= 3.4 mg/L) had significantly worse survival than those with lower baseline CRP values (< 3.4 mg/L). Patients were divided into four groups according to baseline CRP and CRP kinetics: (1) patients whose CRP < 3.4 mg/L and never elevated during treatment; (2) patients whose CRP < 3.4 mg/L and elevated at least one time during treatment; (3) patients whose CRP >= 3.4 mg/L and normalized at least one time during treatment; and (4) patients whose CRP >= 3.4 mg/L and never normalized during treatment. The patients were further assigned to non-elevated, elevated, normalized, and non-normalized CRP groups. Overall survival rates were significantly different among the four groups, with three-year survival rates of 68%, 41%, 33%, and 0.03% for non-elevated, elevated, normalized, and non-normalized CRP groups respectively. When compared with the non-elevated group, hazard ratios of death were 1.69, 2.57, and 10.34 in the normalized, elevated, and non-normalized groups (P < 0.001). Conclusions: Baseline CRP and CRP kinetics may be useful to predict the prognosis of metastatic NPC patients treated with palliative chemotherapy and facilitate individualized treatment. A prospective study to validate this prognostic model is still needed however.	[Xia, Wei-Xiong; Ye, Yan-Fang; Lu, Xing; Wang, Lin; Ke, Liang-Ru; Zhang, Hai-Bo; Yang, Jing; Shi, Jun-Li; Cao, Ka-Jia; Guo, Xiang; Xiang, Yan-Qun] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Wei-Xiong; Ye, Yan-Fang; Lu, Xing; Wang, Lin; Ke, Liang-Ru; Zhang, Hai-Bo; Yang, Jing; Shi, Jun-Li; Cao, Ka-Jia; Guo, Xiang; Xiang, Yan-Qun] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Ye, Yan-Fang] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Roycik, Mark D.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Roycik, Mark D.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Guo, X (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China.	guoxiang@sysucc.org.cn; xiangyq@sysucc.org.cn			National Natural Science Foundation of China [81172041]; Natural Science Foundation of Guangdong Province, China [S2011010005312]; Science and Technology Planning Project of Guangdong Province, China [B031500037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	Supported by National Natural Science Foundation of China (No. 81172041), Natural Science Foundation of Guangdong Province, China (S2011010005312) and Science and Technology Planning Project of Guangdong Province, China (No. B031500037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRES RB, 1987, MOL IMMUNOL, V24, P479, DOI 10.1016/0161-5890(87)90022-8; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; An X, 2011, TUMOR BIOL, V32, P317, DOI 10.1007/s13277-010-0124-7; Bidart JM, 1999, CLIN CHEM, V45, P1695; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; FALCONER JS, 1994, ANN SURG, V219, P325, DOI 10.1097/00000658-199404000-00001; Fandi A, 2000, J CLIN ONCOL, V18, P1324, DOI 10.1200/JCO.2000.18.6.1324; Gioulbasanis I, 2012, LUNG CANCER, V77, P383, DOI 10.1016/j.lungcan.2012.04.008; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Huang YT, 1999, CANCER RES, V59, P1599; Hui EP, 2004, CANCER-AM CANCER SOC, V101, P300, DOI 10.1002/cncr.20358; Iwanicki-Caron I, 2008, J CLIN ONCOL, V26, P3681, DOI 10.1200/JCO.2007.15.0904; Jin Y, 2012, EUR J CANCER, V48, P882, DOI 10.1016/j.ejca.2011.09.004; KWONG D, 1994, INT J RADIAT ONCOL, V30, P1029, DOI 10.1016/0360-3016(94)90306-9; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lo YMD, 1999, CANCER RES, V59, P5452; Loong HH, 2008, HEMATOL ONCOL CLIN N, V22, P1267, DOI 10.1016/j.hoc.2008.08.012; Lu X, 2011, EUR J CANCER, V47, P339, DOI 10.1016/j.ejca.2010.09.025; Ma BBY, 2008, CANCER SCI, V99, P1311, DOI 10.1111/j.1349-7006.2008.00836.x; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Saito K, 2012, BJU INT, V110, P1478, DOI 10.1111/j.1464-410X.2012.11153.x; Saito K, 2009, EUR UROL, V55, P1145, DOI 10.1016/j.eururo.2008.10.012; Scott HR, 2001, LUNG CANCER, V32, P307, DOI 10.1016/S0169-5002(00)00244-0; Shimoda M, 2010, CHEMOTHERAPY, V56, P501, DOI 10.1159/000321014; Srimuninnimit Vichien, 2012, J Med Assoc Thai, V95 Suppl 2, pS199; VANDENBREKEL AJS, 1995, J CLIN ONCOL, V13, P2600, DOI 10.1200/JCO.1995.13.10.2600; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wo JY, 2009, J CLIN ONCOL, V27, P6000, DOI 10.1200/JCO.2009.23.6067; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057; Xia WX, 2013, EUR J CANC, P00188; YOUNG LS, 1988, J GEN VIROL, V69, P1051, DOI 10.1099/0022-1317-69-5-1051; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	40	22	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76958	10.1371/journal.pone.0076958	http://dx.doi.org/10.1371/journal.pone.0076958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130817	gold, Green Submitted, Green Published			2022-12-27	WOS:000325814200045
J	Dalton, P; Maute, C; Jaen, C; Wilson, T				Dalton, Pamela; Maute, Christopher; Jaen, Cristina; Wilson, Tamika			Chemosignals of Stress Influence Social Judgments	PLOS ONE			English	Article							SIGNALS; RESPONSES; BEFRIEND; ANXIETY; TEND	Human body odors have important communicative functions regarding genetic identity, immune fitness and general health, but an expanding body of research suggests they can also communicate information about an individual's emotional state. In the current study, we tested whether axillary odors obtained from women experiencing psychosocial stress could negatively influence personality judgments of warmth and competence made about other women depicted in video scenarios. 44 female donors provided three types of sweat samples: untreated exercise sweat, untreated stress sweat and treated stress sweat. After a 'washout' period, a commercial unscented anti-perspirant product was applied to the left axilla only to evaluate whether 'blocking' the stress signal would improve the social evaluations. A separate group of male and female evaluators (n = 120) rated the women in the videos while smelling one of the three types of sweat samples. Women in the video scenes were rated as being more stressed by both men and women when smelling the untreated vs. treated stress sweat. For men only, the women in the videos were rated as less confident, trustworthy and competent when smelling both the untreated stress and exercise sweat in contrast to the treated stress sweat. Women's social judgments were unaffected by sniffing the pads. The results have implications for influencing multiple types of professional and personal social interactions and impression management and extend our understanding of the social communicative function of body odors.	[Dalton, Pamela; Maute, Christopher; Jaen, Cristina; Wilson, Tamika] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Dalton, P (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	dalton@monell.org		Schopf, Veronika/0000-0003-1937-4216	PG Beauty	PG Beauty	P&G Beauty (http://pgbeautyscience.com/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2011, CHEM SENSES, V36, P19, DOI 10.1093/chemse/bjq087; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; HOLM S, 1979, SCAND J STAT, V6, P65; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; McClintock MK, 2005, CHEM SENSES, V30, pI135, DOI 10.1093/chemse/bjh151; Montagna W, 1974, STRUCTURE FUNCTION S, P332; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Rubin D, 2012, SOC COGN AFFECT NEUR, V7, P208, DOI 10.1093/scan/nsq097; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x; Wojciszke B, 1998, PERS SOC PSYCH B; Zhou W, 2008, CHEM SENSES, V33, pS175	24	29	29	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77144	10.1371/journal.pone.0077144	http://dx.doi.org/10.1371/journal.pone.0077144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130845	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900122
J	De Angelis, M; Piccolo, M; Vannini, L; Siragusa, S; De Giacomo, A; Serrazzanetti, DI; Cristofori, F; Guerzoni, ME; Gobbetti, M; Francavilla, R				De Angelis, Maria; Piccolo, Maria; Vannini, Lucia; Siragusa, Sonya; De Giacomo, Andrea; Serrazzanetti, Diana Isabella; Cristofori, Fernanda; Guerzoni, Maria Elisabetta; Gobbetti, Marco; Francavilla, Ruggiero			Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified	PLOS ONE			English	Article							GUT MICROBIOTA; SPECTRUM; BACTERIA; BEHAVIOR; HEALTH; FLORA; EPIDEMIOLOGY; MICROFLORA; SEARCH; MODEL	This study aimed at investigating the fecal microbiota and metabolome of children with Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and autism (AD) in comparison to healthy children (HC). Bacterial tag-encoded FLX-titanium amplicon pyrosequencing (bTEFAP) of the 16S rDNA and 16S rRNA analyses were carried out to determine total bacteria (16S rDNA) and metabolically active bacteria (16S rRNA), respectively. The main bacterial phyla (Firmicutes, Bacteroidetes, Fusobacteria and Verrucomicrobia) significantly (P<0.05) changed among the three groups of children. As estimated by rarefaction, Chao and Shannon diversity index, the highest microbial diversity was found in AD children. Based on 16S-rRNA and culture-dependent data, Faecalibacterium and Ruminococcus were present at the highest level in fecal samples of PDD-NOS and HC children. Caloramator, Sarcina and Clostridium genera were the highest in AD children. Compared to HC, the composition of Lachnospiraceae family also differed in PDD-NOS and, especially, AD children. Except for Eubacterium siraeum, the lowest level of Eubacteriaceae was found on fecal samples of AD children. The level of Bacteroidetes genera and some Alistipes and Akkermansia species were almost the highest in PDD-NOS or AD children as well as almost all the identified Sutterellaceae and Enterobacteriaceae were the highest in AD. Compared to HC children, Bifidobacterium species decreased in AD. As shown by Canonical Discriminant Analysis of Principal Coordinates, the levels of free amino acids and volatile organic compounds of fecal samples were markedly affected in PDD-NOS and, especially, AD children. If the gut microbiota differences among AD and PDD-NOS and HC children are one of the concomitant causes or the consequence of autism, they may have implications regarding specific diagnostic test, and/or for treatment and prevention.	[De Angelis, Maria; Piccolo, Maria; Siragusa, Sonya; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Vannini, Lucia; Serrazzanetti, Diana Isabella] Univ Cesena, Interdept Ctr Ind Agri Food Res, Cesena, Italy; [Vannini, Lucia; Guerzoni, Maria Elisabetta] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy; [De Giacomo, Andrea] Univ Bari Aldo Moro, Child Neurol & Psychiat Unit, Dept Neurol & Psychiat Sci, Bari, Italy; [Cristofori, Fernanda; Francavilla, Ruggiero] Univ Bari Aldo Moro, Dept Interdisciplinary Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Bologna; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	De Angelis, M (corresponding author), Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy.	maria.deangelis@uniba.it	De Angelis, Maria/AAA-9909-2019; FRANCAVILLA, RUGGIERO/S-1391-2019; Gobbetti, Marco/K-4138-2014	FRANCAVILLA, RUGGIERO/0000-0002-4603-974X; Vannini, Lucia/0000-0002-9417-8410; Gobbetti, Marco/0000-0003-0869-2737; De Angelis, Maria/0000-0002-2010-884X; De Giacomo, Andrea/0000-0002-3454-1679	Department of Soil, Plant and Food Science	Department of Soil, Plant and Food Science	The work was funded by the Department of Soil, Plant and Food Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; APA, 1994, DIAGN STAT MAN MENT; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Benach JL, 2012, MBIO, V3, DOI 10.1128/mBio.00019-12; Blaser MJ, 2010, P NATL ACAD SCI USA, V107, P6125, DOI 10.1073/pnas.1002112107; Bolte ER, 1998, MED HYPOTHESES, V51, P133, DOI 10.1016/S0306-9877(98)90107-4; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Giacomo A, 2009, NEUROPSYCH DIS TREAT, V5, P355; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Di Cagno R, 2009, APPL ENVIRON MICROB, V75, P3963, DOI 10.1128/AEM.02793-08; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Dietert Rodney R, 2011, Emerg Health Threats J, V4, P7111, DOI 10.3402/ehtj.v4i0.7111; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Finegold SM, 2008, MED HYPOTHESES, V70, P508, DOI 10.1016/j.mehy.2007.07.019; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Finegold SM, 2011, ANAEROBE, V17, P367, DOI 10.1016/j.anaerobe.2011.03.007; Finegold SM, 2011, MED HYPOTHESES, V77, P270, DOI 10.1016/j.mehy.2011.04.032; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Flint H. J., 2010, TOOBESJ, V2, P50; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Francavilla R, 2012, PEDIAT ALLERG IMM-UK, V23, P420, DOI 10.1111/j.1399-3038.2012.01286.x; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gondalia SV, 2012, AUTISM RES, V5, P419, DOI 10.1002/aur.1253; Gondalia SV, 2010, E J APPL PHYSIOL, V6, P24, DOI [10.7790/ejap.v6i2.213, DOI 10.7790/EJAP.V6I2.213]; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gowen CM, 2010, BIOTECHNOL J, V5, P759, DOI 10.1002/biot.201000084; Heberling CA, 2013, MED HYPOTHESES, V80, P264, DOI 10.1016/j.mehy.2012.11.044; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Louis P, 2012, DIGEST DIS SCI, V57, P1987, DOI 10.1007/s10620-012-2286-1; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Macfarlane S, 1998, FEMS MICROBIOL ECOL, V26, P231, DOI 10.1111/j.1574-6941.1998.tb00508.x; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Medina M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-19; Mulloy A, 2010, RES AUTISM SPECT DIS, V4, P328, DOI 10.1016/j.rasd.2009.10.008; Ndagijimana M, 2009, INT J FOOD MICROBIOL, V134, P147, DOI 10.1016/j.ijfoodmicro.2009.04.016; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Persico AM, 2013, NEUROTOXICOL TERATOL, V36, P82, DOI 10.1016/j.ntt.2012.09.002; Petrof EO, 2013, BENEF MICROBES, V4, P53, DOI 10.3920/BM2012.0039; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Prizant B, 1992, 11 MENTAL MEASUREMEN, P170; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Razack R, 2007, CURR OPIN GASTROEN, V23, P400, DOI 10.1097/MOG.0b013e3281ddb2a3; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594; Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08; Sandler RH, 2000, J CHILD NEUROL, V15, P429, DOI 10.1177/088307380001500701; Satokari RM, 2001, APPL ENVIRON MICROB, V67, P504, DOI 10.1128/AEM.67.2.504-513.2001; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Shannon CE, 1949, AT&T TECH J, V27, P359; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Strassburg CP, 2002, GUT, V50, P259, DOI 10.1136/gut.50.2.259; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Wall R, 2012, LIPIDS TECHNOL, V24, P10, DOI DOI 10.1002/LITE.201200232; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11; Williams BL, 2012, PLOS ONE, V6; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	77	465	488	4	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76993	10.1371/journal.pone.0076993	http://dx.doi.org/10.1371/journal.pone.0076993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130822	Green Submitted, Green Published			2022-12-27	WOS:000325810900114
J	Leong, A; Dasgupta, K; Bernatsky, S; Lacaille, D; Avina-Zubieta, A; Rahme, E				Leong, Aaron; Dasgupta, Kaberi; Bernatsky, Sasha; Lacaille, Diane; Avina-Zubieta, Antonio; Rahme, Elham			Systematic Review and Meta-Analysis of Validation Studies on a Diabetes Case Definition from Health Administrative Records	PLOS ONE			English	Article							PREDICTIVE-VALUE; HEART-DISEASE; US POPULATION; TEST ACCURACY; PRIMARY-CARE; SELF-REPORTS; PREVALENCE; PERFORMANCE; MELLITUS; QUALITY	Objectives: Health administrative data are frequently used for diabetes surveillance. We aimed to determine the sensitivity and specificity of a commonly-used diabetes case definition (two physician claims or one hospital discharge abstract record within a two-year period) and their potential effect on prevalence estimation. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched Medline (from 1950) and Embase (from 1980) databases for validation studies through August 2012 (keywords: "diabetes mellitus''; "administrative databases''; "validation studies''). Reviewers abstracted data with standardized forms and assessed quality using Quality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria. A generalized linear model approach to random-effects bivariate regression meta-analysis was used to pool sensitivity and specificity estimates. We applied correction factors derived from pooled sensitivity and specificity estimates to prevalence estimates from national surveillance reports and projected prevalence estimates over 10 years (to 2018). Results: The search strategy identified 1423 abstracts among which 11 studies were deemed relevant and reviewed; 6 of these reported sensitivity and specificity allowing pooling in a meta-analysis. Compared to surveys or medical records, sensitivity was 82.3% (95% CI 75.8, 87.4) and specificity was 97.9% (95% CI 96.5, 98.8). The diabetes case definition underestimated prevalence when it was <= 10.6% and overestimated prevalence otherwise. Conclusion: The diabetes case definition examined misses up to one fifth of diabetes cases and wrongly identifies diabetes in approximately 2% of the population. This may be sufficiently sensitive and specific for surveillance purposes, in particular monitoring prevalence trends. Applying correction factors to adjust prevalence estimates from this definition may be helpful to increase accuracy of estimates.	[Leong, Aaron; Dasgupta, Kaberi; Bernatsky, Sasha; Rahme, Elham] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Dasgupta, Kaberi; Bernatsky, Sasha; Rahme, Elham] McGill Univ, Dept Med, Montreal, PQ, Canada; [Lacaille, Diane; Avina-Zubieta, Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC V5Z 1M9, Canada	McGill University; McGill University; University of British Columbia	Rahme, E (corresponding author), McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada.	elham.rahme@mcgill.ca	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285	Canadian Arthritis Network [10-01-RIPP-04, 10-01-RIPP-02]; Canadian Institutes of Health Research [SSD-83167]	Canadian Arthritis Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Arthritis Network [10-01-RIPP-04 and 10-01-RIPP-02] and the Canadian Institutes of Health Research [SSD-83167]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2009, EC TSUN COST DIAB CA; Berger B, 1998, DIABETES CARE, V21, P546, DOI 10.2337/diacare.21.4.546; Canada S, 2012, CAN COMM HLTH SURV A; Carnahan RM, 2012, PHARMACOEPIDEM DR S, V21, P82, DOI 10.1002/pds.2321; Carral F, 2003, DIABETES RES CLIN PR, V59, P145, DOI 10.1016/S0168-8227(02)00200-0; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Chen GM, 2010, DIABETES RES CLIN PR, V89, P189, DOI 10.1016/j.diabres.2010.03.007; Clottey C, 2001, Chronic Dis Can, V22, P67; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Crowther Mark A, 2007, Hematology Am Soc Hematol Educ Program, P493; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; EGGER M, 1995, BRIT MED J, V311, P753, DOI 10.1136/bmj.311.7007.753c; Garay-Sevilla ME, 1999, DIABETIC MED, V16, P238, DOI 10.1046/j.1464-5491.1999.00033.x; Gatsonis C, 2006, AM J ROENTGENOL, V187, P271, DOI 10.2214/AJR.06.0226; German RR, 2000, EPIDEMIOLOGY, V11, P720, DOI 10.1097/00001648-200011000-00020; Glynn RJ, 1999, AM J EPIDEMIOL, V149, P541; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Harris SB, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-347; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Hjerpe P, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-23; HORNER RD, 1991, J FAM PRACTICE, V33, P593; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Johnson RL, 1997, AM J EPIDEMIOL, V146, P266; Jutte DP, 2011, ANNU REV PUBL HEALTH, V32, P91, DOI 10.1146/annurev-publhealth-031210-100700; Koleba T, 2007, CAN J DIABETES, V31, P47, DOI DOI 10.1016/S1499-2671(07)11010-8; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Ladouceur M, 2007, BIOMETRICS, V63, P272, DOI 10.1111/j.1541-0420.2006.00665.x; Littorin B, 1996, DIABETES RES CLIN PR, V33, P129, DOI 10.1016/0168-8227(96)01282-X; Lix LM, 2008, CHRONIC DIS CAN, V29, P31; Mackenbach JP, 1996, AM J PUBLIC HEALTH, V86, P706, DOI 10.2105/AJPH.86.5.706; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McEvers K, 2005, VACCINE, V23, P4128, DOI 10.1016/j.vaccine.2005.03.022; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; O'Connor PJ, 1998, AM J MANAG CARE, V4, P335; O'Connor PJ, 2006, ANN FAM MED, V4, P15, DOI 10.1370/afm.419; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Shah BR, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-142; Solberg LI, 2006, AM J MED QUAL, V21, P238, DOI 10.1177/1062860606288243; Southern DA, 2010, CAN J PUBLIC HEALTH, V101, P61, DOI 10.1007/BF03405564; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Svensen L, 2012, REPORT NATL DIABETES; Tang PC, 2007, J AM MED INFORM ASSN, V14, P10, DOI 10.1197/jamia.M2198; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wirehn ABE, 2007, SCAND J PUBLIC HEALT, V35, P424, DOI 10.1080/14034940701195230; Young TK, 2001, CAN MED ASSOC J, V164, P24	54	65	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75256	10.1371/journal.pone.0075256	http://dx.doi.org/10.1371/journal.pone.0075256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130696	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900027
J	Rios, FJO; Ferracini, M; Pecenin, M; Koga, MM; Wang, YJ; Ketelhuth, DFJ; Jancar, S				Rios, Francisco J. O.; Ferracini, Matheus; Pecenin, Mateus; Koga, Marianna M.; Wang, Yajuan; Ketelhuth, Daniel F. J.; Jancar, S.			Uptake of oxLDL and IL-10 Production by Macrophages Requires PAFR and CD36 Recruitment into the Same Lipid Rafts	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ACTIVATING-FACTOR RECEPTOR; OXIDIZED PHOSPHOLIPIDS; PPAR-GAMMA; EXPRESSION; OXIDATION; MEMBRANE; LDL; ATHEROSCLEROSIS; RECOGNITION	Macrophage interaction with oxidized low-density lipoprotein (oxLDL) leads to its differentiation into foam cells and cytokine production, contributing to atherosclerosis development. In a previous study, we showed that CD36 and the receptor for platelet-activating factor (PAFR) are required for oxLDL to activate gene transcription for cytokines and CD36. Here, we investigated the localization and physical interaction of CD36 and PAFR in macrophages stimulated with oxLDL. We found that blocking CD36 or PAFR decreases oxLDL uptake and IL-10 production. OxLDL induces IL-10 mRNA expression only in HEK293T expressing both receptors (PAFR and CD36). OxLDL does not induce IL-12 production. The lipid rafts disruption by treatment with beta CD reduces the oxLDL uptake and IL-10 production. OxLDL induces co-immunoprecipitation of PAFR and CD36 with the constitutive raft protein flotillin-1, and colocalization with the lipid raft-marker GM1-ganglioside. Finally, we found colocalization of PAFR and CD36 in macrophages from human atherosclerotic plaques. Our results show that oxLDL induces the recruitment of PAFR and CD36 into the same lipid rafts, which is important for oxLDL uptake and IL-10 production. This study provided new insights into how oxLDL interact with macrophages and contributing to atherosclerosis development.	[Rios, Francisco J. O.; Ferracini, Matheus; Pecenin, Mateus; Koga, Marianna M.; Jancar, S.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Rios, Francisco J. O.] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Wang, Yajuan; Ketelhuth, Daniel F. J.] Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden	Universidade de Sao Paulo; University of Glasgow; Karolinska Institutet	Rios, FJO (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.	fjorios@usp.br	Rios, Francisco J./C-6059-2012; Ferracini, Matheus/E-3820-2010; Jancar, Sonia/C-5153-2012; Fila Pecenin, Mateus/O-5433-2018; Ketelhuth, Daniel/F-6580-2012	Ferracini, Matheus/0000-0003-1523-6457; Jancar, Sonia/0000-0001-7983-3459; Fila Pecenin, Mateus/0000-0001-5799-012X; Ketelhuth, Daniel/0000-0002-0087-116X; Koga, Marianna/0000-0003-3244-9059; Rios, Francisco/0000-0002-8194-0787	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/03982-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant 2006/03982-5) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brocheriou I, 2000, CIRCULATION, V102, P2569; Chatterjee S, 2003, GLYCOCONJUGATE J, V20, P331, DOI 10.1023/B:GLYC.0000033629.54962.68; Davies John Q, 2005, Methods Mol Biol, V290, P91; de Oliveira SI, 2006, PROSTAG OTH LIPID M, V80, P62, DOI 10.1016/j.prostaglandins.2006.04.002; Fallahi-Sichani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006604; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Fremont L, 1999, LIFE SCI, V64, P2511, DOI 10.1016/S0024-3205(99)00209-X; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; Gaut JP, 2001, TRENDS CARDIOVAS MED, V11, P103, DOI 10.1016/S1050-1738(01)00101-3; GREENWALT DE, 1992, BLOOD, V80, P1105; Halvorsen B, 2005, J LIPID RES, V46, P211, DOI 10.1194/jlr.M400324-JLR200; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Itabe H, 1998, PROG LIPID RES, V37, P181, DOI 10.1016/S0163-7827(98)00009-5; Kazerounian S, 2011, BLOOD, V117, P4658, DOI 10.1182/blood-2010-09-305284; Ketelhuth DFJ, 2011, CIRCULATION, V124, P2433, DOI 10.1161/CIRCULATIONAHA.111.051599; Ketelhuth DFJ, 2011, THROMB HAEMOSTASIS, V106, P779, DOI 10.1160/TH11-05-0321; Kiyanagi T, 2011, ATHEROSCLEROSIS, V215, P60, DOI 10.1016/j.atherosclerosis.2010.10.019; Lemaire-Ewing S, 2012, ATHEROSCLEROSIS, V221, P303, DOI 10.1016/j.atherosclerosis.2011.10.016; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Pegorier S, 2006, ATHEROSCLEROSIS, V188, P433, DOI 10.1016/j.atherosclerosis.2005.11.015; Poisson C, 2009, J IMMUNOL, V183, P2747, DOI 10.4049/jimmunol.0802651; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Rios FJO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036632; Rios FJO, 2011, CELL PHYSIOL BIOCHEM, V27, P363, DOI 10.1159/000327962; Rios FJO, 2008, CELL PHYSIOL BIOCHEM, V22, P549, DOI 10.1159/000185539; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; SAKAI H, 1982, AM J CLIN PATHOL, V78, P58, DOI 10.1093/ajcp/78.1.58; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Shin SH, 2010, CELL PHYSIOL BIOCHEM, V26, P689, DOI 10.1159/000322336; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Carvalho MDT, 2010, J ATHEROSCLER THROMB, V17, P844, DOI 10.5551/jat.3905; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Verouti SN, 2011, ATHEROSCLEROSIS, V219, P519, DOI 10.1016/j.atherosclerosis.2011.07.123; Yuasa-Kawase M, 2012, J ATHEROSCLER THROMB, V19, P263, DOI 10.5551/jat.10603	43	30	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76893	10.1371/journal.pone.0076893	http://dx.doi.org/10.1371/journal.pone.0076893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130805	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325810900099
J	Siegert, S; Yu, ZH; Wang-Sattler, R; Illig, T; Adamski, J; Hampe, J; Nikolaus, S; Schreiber, S; Krawczak, M; Nothnagel, M; Nothlings, U				Siegert, Sabine; Yu, Zhonghao; Wang-Sattler, Rui; Illig, Thomas; Adamski, Jerzy; Hampe, Jochen; Nikolaus, Susanna; Schreiber, Stefan; Krawczak, Michael; Nothnagel, Michael; Noethlings, Ute			Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established Biomarkers	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; INDEX; EPIDEMIOLOGY; POPULATION; GENETICS; RISK; PREDICTION	Background: To date, liver biopsy is the only means of reliable diagnosis for fatty liver disease (FLD). Owing to the inevitable biopsy-associated health risks, however, the development of valid noninvasive diagnostic tools for FLD is well warranted. Aim: We evaluated a particular metabolic profile with regard to its ability to diagnose FLD and compared its performance to that of established phenotypes, conventional biomarkers and disease-associated genotypes. Methods: The study population comprised 115 patients with ultrasound-diagnosed FLD and 115 sex-and age-matched controls for whom the serum concentration was measured of 138 different metabolites, including acylcarnitines, amino acids, biogenic amines, hexose, phosphatidylcholines (PCs), lyso-PCs and sphingomyelins. Established phenotypes, biomarkers, disease-associated genotypes and metabolite data were included in diagnostic models for FLD using logistic regression and partial least-squares discriminant analysis. The discriminative power of the ensuing models was compared with respect to area under curve (AUC), integrated discrimination improvement (IDI) and by way of cross-validation (CV). Results: Use of metabolic markers for predicting FLD showed the best performance among all considered types of markers, yielding an AUC of 0.8993. Additional information on phenotypes, conventional biomarkers or genotypes did not significantly improve this performance. Phospholipids and branched-chain amino acids were most informative for predicting FLD. Conclusion: We show that the inclusion of metabolite data may substantially increase the power to diagnose FLD over that of models based solely upon phenotypes and conventional biomarkers.	[Siegert, Sabine; Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Siegert, Sabine; Noethlings, Ute] Univ Kiel, Inst Expt Med, Epidemiol Sect, Kiel, Germany; [Siegert, Sabine] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Yu, Zhonghao; Wang-Sattler, Rui; Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Adamski, Jerzy] Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Hampe, Jochen; Nikolaus, Susanna; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan; Krawczak, Michael; Noethlings, Ute] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany; [Krawczak, Michael; Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Noethlings, Ute] Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany	University of Cologne; University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Bonn	Siegert, S (corresponding author), Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany.	sabine.siegert@uni-koeln.de	Nothnagel, Michael/G-6545-2014; Krawczak, Michael/A-8964-2010; Wang-Sattler, Rui/B-5354-2014; Hampe, Jochen/A-2555-2010; Nöthlings, Ute/B-2713-2010; Nothnagel, Michael/L-7187-2019	Krawczak, Michael/0000-0003-2603-1502; Wang-Sattler, Rui/0000-0002-8794-8229; Hampe, Jochen/0000-0002-2421-6127; Nothnagel, Michael/0000-0001-8305-7114; Adamski, Jerzy/0000-0001-9259-0199	German Research Foundation (DFG) through Excellence Cluster 'Inflammation at Interfaces' [EXC 306/2]	German Research Foundation (DFG) through Excellence Cluster 'Inflammation at Interfaces'(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) through Excellence Cluster 'Inflammation at Interfaces' [EXC 306/2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2007, ANN EPIDEMIOL, V17, P863, DOI 10.1016/j.annepidem.2007.05.013; Almeda-Valdes P, 2009, ANN HEPATOL, V8, pS18, DOI 10.1016/S1665-2681(19)31822-8; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Anstee QM, 2011, SEMIN LIVER DIS, V31, P128, DOI 10.1055/s-0031-1276643; Bajaj S, 2009, INDIAN J MED RES, V129, P285; Barr J, 2010, J PROTEOME RES, V9, P4501, DOI 10.1021/pr1002593; Baumeister SE, 2008, GASTROENTEROLOGY, V134, P85, DOI 10.1053/j.gastro.2007.10.024; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2004, EUR J GASTROEN HEPAT, V16, P1087, DOI 10.1097/00042737-200411000-00002; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Bollard ME, 2005, NMR BIOMED, V18, P143, DOI 10.1002/nbm.935; Bozkurt L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032710; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356; Copas JB, 2002, BIOMETRIKA, V89, P315, DOI 10.1093/biomet/89.2.315; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Souza Mônica Rodrigues de Araújo, 2012, Arq. Gastroenterol., V49, P89, DOI 10.1590/S0004-28032012000100015; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fierbinteanu-Braticevici C, 2010, WORLD J GASTROENTERO, V16, P4784, DOI 10.3748/wjg.v16.i38.4784; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P1508, DOI 10.3748/wjg.v18.i13.1508; Hernaez R., 2011, GASTROENTEROL HEPATO, V35, P32; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Holecek M, 2010, NUTRITION, V26, P482, DOI 10.1016/j.nut.2009.06.027; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kirovski G, 2010, INT J CLIN EXP MED, V3, P202; Kotronen A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-237; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Lau K, 2010, J HYPERTENS, V28, P1829, DOI 10.1097/HJH.0b013e32833c211b; Lerchbaum E, 2011, EUR J ENDOCRINOL, V165, P935, DOI 10.1530/EJE-11-0614; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Mevik B.H., 2011, PLS PARTIAL LEAST SQ; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Myers RP, 2009, ANN HEPATOL, V8, pS25, DOI 10.1016/S1665-2681(19)31823-X; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nothlings U, 2012, BUNDESGESUNDHEITSBLA, V55, P831, DOI 10.1007/s00103-012-1487-2; Osterreicher CH, 2007, ANN HEPATOL, V6, P83; Park Young Jin, 2011, Korean J Hepatol, V17, P19, DOI 10.3350/kjhep.2011.17.1.19; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; R Development Core Team, 2012, R LANG ENV STAT COMP; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; Schafmayer C, 2007, INT J CANCER, V121, P555, DOI 10.1002/ijc.22735; Siegert S, 2012, METABOLOMICS, V2; Sorbi D, 1999, AM J GASTROENTEROL, V94, P1018; Sung KC, 2007, DIABETES CARE, V30, P2113, DOI 10.2337/dc07-0512; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wold S., 1993, 3D QSAR DRUG DESIGN; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57	65	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76813	10.1371/journal.pone.0076813	http://dx.doi.org/10.1371/journal.pone.0076813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130792	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900087
J	Zeng, R; Xiong, Y; Zhu, FM; Ma, ZF; Liao, WH; He, Y; He, JS; Li, W; Yang, J; Lu, Q; Xu, G; Yao, Y				Zeng, Rui; Xiong, Yan; Zhu, Fengming; Ma, Zufu; Liao, Wenhui; He, Yong; He, JinSeng; Li, Wei; Yang, Juan; Lu, Qian; Xu, Gang; Yao, Ying			Fenofibrate Attenuated Glucose-Induced Mesangial Cells Proliferation and Extracellular Matrix Synthesis via PI3K/AKT and ERK1/2	PLOS ONE			English	Article							PPAR-ALPHA; DIABETIC-NEPHROPATHY; ACTIVATION; ARREST	Excess mesangial extracellular matrix (ECM) and mesangial cell proliferation is the major pathologic feature of diabetic nephropathy (DN). Fenofibrate, a PPAR alpha agonist, has been shown to attenuate extracellular matrix formation in diabetic nephropathy. However, the mechanisms underlying this effect remain to be elucidated. In this study, the effect of fenofibrate on high-glucose induced cell proliferation and extracellular matrix exertion and its mechanisms were investigated in cultured rat mesangial cells by the methylthiazoletetrazolium (MTT) assay, flow cytometry and western blot. The results showed that treatment of mesangial cells (MCs) with fenofibrate repressed high-glucose induced up-regulation of extracellular matrix Collagen-IV, and inhibited entry of cell cycle into the S phase. This G1 arrest and ECM inhibition was caused by the reduction of phosphorylation and activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and AKT. On the contrary, PPAR alpha siRNA accelerated high glucose-induced cell cycle progression by ERK1/2 and AKT activation. Taken together, fenofibrate ameliorated glucose-induced mesangial cell proliferation and matrix production via its inhibition of PI3K/AKT and ERK1/2 signaling pathways. Such mechanisms may contribute to the favorable effects of treatment using fenofibrate in diabetic nephropathy.	[Zeng, Rui; Xiong, Yan; Zhu, Fengming; Ma, Zufu; He, Yong; He, JinSeng; Li, Wei; Yang, Juan; Lu, Qian; Xu, Gang; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol, Wuhan 430074, Hubei, Peoples R China; [Xiong, Yan] Wuhan 4 Hosp, Div Nephrol, Wuhan, Hubei, Peoples R China; [Liao, Wenhui] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Geriatr, Wuhan 430074, Hubei, Peoples R China; [He, Yong] Wuhan 5 Hosp, Div Nephrol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol, Wuhan 430074, Hubei, Peoples R China.	xugang@tjh.tjmu.edu.cn; yaoyingkk@126.com	Zeng, Rui/GRY-0646-2022; Yang, Juan/ABF-4433-2021	Zeng, Rui/0000-0003-1188-3198; 	National Nature Science Foundation of China (NSFC) [81170686, 81270771]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (NSFC) (numbers 81170686 and 81270771). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; COSIO FG, 1995, J AM SOC NEPHROL, V5, P1600; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Heljic Mediha, 2011, Front Biosci (Schol Ed), V3, P98, DOI 10.2741/s135; Hirasawa Y, 2011, EUR J PHARMACOL, V672, P159, DOI 10.1016/j.ejphar.2011.09.185; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Ingram AJ, 1999, KIDNEY INT, V56, P1721, DOI 10.1046/j.1523-1755.1999.00743.x; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; Kim YH, 2006, J CELL PHYSIOL, V209, P94, DOI 10.1002/jcp.20706; Kono K, 2009, AM J PHYSIOL-RENAL, V296, pF328, DOI 10.1152/ajprenal.00484.2007; Lee JJ, 2011, EUR J PHARMACOL, V650, P342, DOI 10.1016/j.ejphar.2010.10.046; Lee Sungchun, 2004, Curr Rheumatol Rep, V6, P141, DOI 10.1007/s11926-004-0059-3; Marks JB, 1998, MED CLIN N AM, V82, P877, DOI 10.1016/S0025-7125(05)70028-6; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Ohashi N, 2010, HYPERTENS RES, V33, P1174, DOI 10.1038/hr.2010.143; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Yoo KD, 2012, J PHARMACOL SCI, V118, P171, DOI 10.1254/jphs.11159FP	23	30	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76836	10.1371/journal.pone.0076836	http://dx.doi.org/10.1371/journal.pone.0076836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130796	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900091
J	Zhu, ML; Wang, MY; Shi, TY; Li, QX; Xi, P; Xia, KQ; Zheng, LZ; Wei, QY				Zhu, Mei-Ling; Wang, MengYun; Shi, Ting-Yan; Li, Qiao-Xin; Xi, Pan; Xia, Kai-Qin; Zheng, Leizhen; Wei, Qing-Yi			No Association between TGFB1 Polymorphisms and Late Radiotherapy Toxicity: A Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NORMAL TISSUE RADIOSENSITIVITY; CANCER PATIENTS; TGF-BETA-1; BREAST; FIBROSIS; XRCC1; RISK; GENE; DNA	Background: Transforming growth factor-beta 1 (TGF-beta 1) protein may be multifunctional and related to the development of fibrosis, induction of apoptosis, extracellular signaling and inhibition of proliferation in response to radiation-induced DNA damage. Several studies have investigated associations between single nucleotide polymorphisms (SNPs) in the TGFB1 gene and risk of late radiation-induced injury of normal tissue, but the conclusions remain controversial. Methods: We searched three electronic databases (i.e., MEDLINE, EMBASE and EBSCO) for eligible publications and performed a meta-analysis assessing the association of three commonly studied SNPs in TGFB1 (i.e., rs1800469, rs1800470 and rs1800471) with risk of late radiation-induced injury of normal tissue. Results: We finally included 28 case-only studies from 16 publications on aforementioned SNPs in TGFB1. However, we did not find statistical evidence of any significant association with overall risk of late radiotherapy toxicity in the pooled analysis or in further stratified analysis by cancer type, endpoint, ethnicity and sample size. Conclusions: This meta-analysis did not find statistical evidence for an association between SNPs in TGFB1 and risk of late radiation-induced injury of normal tissue, but this finding needs further confirmation by a single large study.	[Zhu, Mei-Ling; Xi, Pan; Zheng, Leizhen] Shanghai Jiao Tong Univ, Dept Oncol, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wang, MengYun; Shi, Ting-Yan; Li, Qiao-Xin; Wei, Qing-Yi] Fudan Univ, Inst Canc, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Xia, Kai-Qin] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Shanghai Jiao Tong University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Zheng, LZ (corresponding author), Shanghai Jiao Tong Univ, Dept Oncol, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China.	zhengleizhen2006@126.com; weiqingyi@yahoo.com			"China's Thousand Talents Program" Recruitment at Fudan University	"China's Thousand Talents Program" Recruitment at Fudan University	This study was supported by the funds from "China's Thousand Talents Program" Recruitment at Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1; Alsner J, 2008, SEMIN RADIAT ONCOL, V18, P126, DOI 10.1016/j.semradonc.2007.10.004; Andreassen CN, 2006, INT J RADIAT BIOL, V82, P577, DOI 10.1080/09553000600876637; Andreassen CN, 2010, RADIOTHER ONCOL, V97, P1, DOI 10.1016/j.radonc.2010.07.018; Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; ANSCHER MS, 1990, RADIAT RES, V122, P77, DOI 10.2307/3577586; Azria D, 2008, CLIN CANCER RES, V14, P6284, DOI 10.1158/1078-0432.CCR-08-0700; Barnett GC, 2012, RADIOTHER ONCOL, V105, P289, DOI 10.1016/j.radonc.2012.10.017; Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3; Barnett GC, 2010, RADIOTHER ONCOL, V97, P9, DOI 10.1016/j.radonc.2009.12.006; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; De Ruyck K, 2006, INT J RADIAT ONCOL, V65, P1240, DOI 10.1016/j.ijrobp.2006.03.047; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunning AM, 2003, CANCER RES, V63, P2610; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P517, DOI 10.1016/S1053-2498(98)00024-2; Evans ES, 2006, CYTOKINE, V35, P186, DOI 10.1016/j.cyto.2006.07.021; Ewan KB, 2002, CANCER RES, V62, P5627; Fachal L, 2012, RADIOTHER ONCOL, V103, P206, DOI 10.1016/j.radonc.2012.01.015; FINKELSTEIN JN, 1994, INT J RADIAT ONCOL, V28, P621, DOI 10.1016/0360-3016(94)90187-2; Giotopoulos G, 2007, BRIT J CANCER, V96, P1001, DOI 10.1038/sj.bjc.6603637; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Lyons AJ, 2011, OSTEORADIONECROSIS T; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Martin SI, 2010, CONTEMP HEMATOL, P15, DOI 10.1007/978-1-59745-415-5_2; Peters CA, 2008, INT J RADIAT ONCOL, V70, P752, DOI 10.1016/j.ijrobp.2007.05.023; Quarmby S, 2003, INT J RADIAT BIOL, V79, P137, DOI 10.1080/0955300021000045673; Suga T, 2008, INT J RADIAT ONCOL, V72, P808, DOI 10.1016/j.ijrobp.2008.01.029; Terrazzino S, 2012, INT J RADIAT ONCOL, V83, P504, DOI 10.1016/j.ijrobp.2011.06.2012; Thurner EM, 2012, GENETIC VARIANTS TGF; WEST CML, 1995, BRIT J RADIOL, V68, P827, DOI 10.1259/0007-1285-68-812-827; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Yuan SH, 2013, J THORAC ONCOL, V8, P208, DOI 10.1097/JTO.0b013e318274592e; Zhang G, 2010, ASS POLYMORPHISMS DN; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016	41	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76964	10.1371/journal.pone.0076964	http://dx.doi.org/10.1371/journal.pone.0076964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130819	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900112
J	Goatley, CHR; Bellwood, DR				Goatley, Christopher H. R.; Bellwood, David R.			Ecological Consequences of Sediment on High-Energy Coral Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; COMMUNITY STRUCTURE; EPILITHIC ALGAL; CLIMATE-CHANGE; HERBIVOROUS FISH; RESILIENCE; SHELF; DIVERSITY; MORTALITY; PATTERNS	Sediments are widely accepted as a threat to coral reefs but our understanding of their ecological impacts is limited. Evidence has suggested that benthic sediments bound within the epilithic algal matrix (EAM) suppress reef fish herbivory, a key ecological process maintaining reef resilience. An experimental combination of caging and sediment addition treatments were used to investigate the effects of sediment pulses on herbivory and EAMs and to determine whether sediment addition could trigger a positive-feedback loop, leading to deep, sediment-rich turfs. A 1-week pulsed sediment addition resulted in rapid increases in algal turf length with effects comparable to those seen in herbivore exclusion cages. Contrary to the hypothesised positive-feedback mechanism, benthic sediment loads returned to natural levels within 3 weeks, however, the EAM turfs remained almost 60% longer for at least 3 months. While reduced herbivore density is widely understood to be a major threat to reefs, we show that acute disturbances to reef sediments elicit similar ecological responses in the EAM. With reefs increasingly threatened by both reductions in herbivore biomass and altered sediment fluxes, the development of longer turfs may become more common on coral reefs.	[Goatley, Christopher H. R.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Goatley, CHR (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	christopher.goatley@my.jcu.edu.au	Goatley, Christopher/C-1492-2016	Goatley, Christopher/0000-0002-2930-5591	Lizard Island Reef Research Foundation; Australian Museum through a Lizard Island Doctoral Fellowship; Australian Research Council	Lizard Island Reef Research Foundation; Australian Museum through a Lizard Island Doctoral Fellowship; Australian Research Council(Australian Research Council)	This study was funded by the Lizard Island Reef Research Foundation and the Australian Museum, through a Lizard Island Doctoral Fellowship (C.H.R.G.), and the Australian Research Council (D.R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Alongi DM, 2005, MAR POLLUT BULL, V51, P239, DOI 10.1016/j.marpolbul.2004.10.033; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; CARPENTER RC, 1993, LIMNOL OCEANOGR, V38, P687, DOI 10.4319/lo.1993.38.3.0687; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P1376; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Downie RA, 2013, MAR ECOL PROG SER, V482, P217, DOI 10.3354/meps10250; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V129, P173, DOI 10.1016/0022-0981(89)90055-5; ENTSCH B, 1983, LIMNOL OCEANOGR, V28, P465, DOI 10.4319/lo.1983.28.3.0465; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Esslemont G, 2004, J MARINE SYST, V52, P51, DOI 10.1016/j.jmarsys.2004.01.005; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2007, CORAL REEFS, V26, P69, DOI 10.1007/s00338-006-0171-0; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fox RJ, 2013, CORAL REEFS, V32, P13, DOI 10.1007/s00338-012-0945-5; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; GAGAN MK, 1988, J SEDIMENT PETROL, V58, P845; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; Goatley CHR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027307; Goatley CHR, 2010, MAR ECOL PROG SER, V415, P237, DOI 10.3354/meps08761; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kench PS, 2006, J COASTAL RES, V22, P209, DOI 10.2112/05A-0016.1; Kench PS, 1998, MAR GEOL, V145, P197, DOI 10.1016/S0025-3227(97)00101-1; Kramer MJ, 2013, MAR FRESHWATER RES, V64, P687, DOI 10.1071/MF12284; Kramer MJ, 2012, CORAL REEFS, V31, P1007, DOI 10.1007/s00338-012-0924-x; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Mallela J, 2007, J FISH BIOL, V70, P523, DOI 10.1111/j.1095-8649.2007.01323.x; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Prathep A, 2003, MAR BIOL, V142, P381, DOI 10.1007/s00227-002-0940-4; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; Purcell SW, 2000, B MAR SCI, V66, P199; Purcell SW, 1996, CORAL REEFS, V15, P211, DOI 10.1007/BF01787453; SCOFFIN TP, 1992, CORAL REEFS, V11, P57, DOI 10.1007/BF00357423; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; Verges A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045543; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Vroom PS, 2011, MAR BIOL; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Wilson S, 2002, J EXP MAR BIOL ECOL, V271, P155, DOI 10.1016/S0022-0981(02)00035-7; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; WOLANSKI E, 1992, WATER ENVIRON RES, V64, P910, DOI 10.2175/WER.64.7.9	63	51	51	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77737	10.1371/journal.pone.0077737	http://dx.doi.org/10.1371/journal.pone.0077737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124619	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000325489100177
J	Dey, N; Young, B; Abramovitz, M; Bouzyk, M; Barwick, B; De, P; Leyland-Jones, B				Dey, Nandini; Young, Brandon; Abramovitz, Mark; Bouzyk, Mark; Barwick, Benjamin; De, Pradip; Leyland-Jones, Brian			Differential Activation of Wnt-beta-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-7; CELL-LINES; MOLECULAR PORTRAITS; COLORECTAL-CANCER; SIGNALING PATHWAY; CARCINOMA-CELLS; IN-VIVO; EXPRESSION; TUMORS; MATRILYSIN	Mutations of genes in tumor cells of Triple Negative subset of Breast Cancer (TNBC) deregulate pathways of signal transduction. The loss of tumor suppressor gene PTEN is the most common first event associated with basal-like subtype (Martins, De, Almendro, Gonen, and Park, 2012). Here we report for the first time that the functional upregulation of secreted-MMP7, a transcriptional target of Wnt-beta-catenin signature pathway in TNBC is associated to the loss of PTEN. We identified differential expression of mRNAs in several key-components genes, and transcriptional target genes of the Wnt-beta-catenin pathway (WP), including beta-catenin, FZD7, DVL1, MMP7, c-MYC, BIRC5, CD44, PPARD, c-MET, and NOTCH1 in FFPE tumors samples from TNBC patients of two independent cohorts. A similar differential upregulation of mRNA/protein for beta-catenin, the functional readout of WP, and for MMP7, a transcriptional target gene of beta-catenin was observed in TNBC cell line models. Genetic or pharmacological attenuation of beta-catenin by SiRNA or WP modulators (XAV939 and sulindac sulfide) and pharmacological mimicking of PTEN following LY294002 treatment downregulated MMP7 levels as well as enzymatic function of the secreted MMP7 in MMP7 positive PTEN-null TNBC cells. Patient data revealed that MMP7 mRNA was high in only a subpopulation of TNBC, and this subpopulation was characterized by a concurrent low expression of PTEN mRNA. In cell lines, a high expression of casein-zymograph-positive MMP7 was distinguished by an absence of functional PTEN. A similar inverse relationship between MMP7 and PTEN mRNA levels was observed in the PAM50 data set (a correlation coefficient of -0.54). The PAM50 subtype and outcome data revealed that the high MMP7 group had low pCR (25%) and High Rd (74%) in clinical stage T3 pathologic response in contrast to the high pCR (40%) and low residual disease (RD) (60%) of the low MMP7 group.	[Dey, Nandini; Young, Brandon; De, Pradip; Leyland-Jones, Brian] Sanford Res, Edith Sanford Breast Canc, Sioux Falls, SD USA; [Abramovitz, Mark] VM Inst Res, Montreal, PQ, Canada; [Bouzyk, Mark] Emory Univ, Atlanta, GA 30322 USA; [Barwick, Benjamin] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Young, Brandon] Scripps Res Inst Jupiter, Jupiter, FL USA; [Dey, Nandini; De, Pradip; Leyland-Jones, Brian] Univ S Dakota, Sioux Falls, SD USA	Sanford Health; Emory University; Emory University; University of South Dakota	Dey, N (corresponding author), Sanford Res, Edith Sanford Breast Canc, Sioux Falls, SD USA.	nandini.dey@sanfordhealth.org; brian.leyland-jones@sanfordhealth.org	Barwick, Benjamin/O-5185-2019	Barwick, Benjamin/0000-0001-9810-3566	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovitz M, 2011, BRIT J CANCER, V105, P1574, DOI 10.1038/bjc.2011.355; Abramovitz M, 2009, IDENTIFICATION MATRI; Abramovitz Mark, 2007, Cancer Genomics & Proteomics, V4, P135; Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Barwick BG, 2008, DIFFERENTIAL WNT PAT; Bastien RRL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-44; Beeghly-Fadiel A, 2008, CANCER RES, V68, P6453, DOI 10.1158/0008-5472.CAN-08-0636; Benhaj K, 2006, ONCOL REP, V15, P701; Bi Z, 2012, HEPATO-GASTROENTEROL, P60; Bilici A, 2012, J BUON, V17, P209; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Conlin AK, 2008, CLIN BREAST CANCER, V8, P215, DOI 10.3816/CBC.2008.n.024; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Criscitiello C, 2012, ANN ONCOL, V23, P13, DOI 10.1093/annonc/mds188; De P, 2013, CANCER CHEMOTH PHARM, V71, P867, DOI 10.1007/s00280-013-2078-0; Dey N, 2005, EXP CELL RES, V307, P1, DOI 10.1016/j.yexcr.2005.02.029; Dey N, 2013, BMC CANC IN PRESS; Dey N, 2009, CELL LINE BASED MODE; Dey N, 2007, MOL CELL BIOL, V27, P4179, DOI 10.1128/MCB.01352-06; Dreyer G, 2013, BREAST EDINBURGH SCO; Dunn BK, 2010, BREAST CANCER RES TR, V121, P281, DOI 10.1007/s10549-010-0827-x; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Ii M, 2006, EXP BIOL MED, V231, P20; Jiang WG, 2005, CLIN CANCER RES, V11, P6012, DOI 10.1158/1078-0432.CCR-05-0275; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lehmann BD, 2011, J CLIN INVESTIGATION; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Matono H, 2008, HUM PATHOL, V39, P1802, DOI 10.1016/j.humpath.2008.05.005; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Moulder SL, 2010, CLIN BREAST CANCER, V10, pS66, DOI 10.3816/CBC.2010.s.014; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pires MM, 2013, CANCER BIOL THER, V14, P246, DOI 10.4161/cbt.23297; Pradip D, 2013, AM J CANCER RES, V3, P173; PRAT A, 2010, MOL ONCOL; Preet R, 2013, CARCINOGENESIS, V34, P277, DOI 10.1093/carcin/bgs351; Rudolph-Owen LA, 1998, CANCER RES, V58, P5500; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Shiu KK, 2008, EXPERT OPIN THER TAR, V12, P1123, DOI 10.1517/14728222.12.9.1123 ; Sievers S, 2006, BIOMARKERS, V11, P270, DOI 10.1080/13547500600633954; Stambolic V, 2002, TRENDS PHARMACOL SCI, V23, P104, DOI 10.1016/S0165-6147(00)01984-2; Su JD, 2003, CANCER RES, V63, P3585; Tinsley HN, 2011, CANCER PREV RES, V4, P1275, DOI 10.1158/1940-6207.CAPR-11-0095; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Wen-hua B, 2011, HEILONGJIANG MED PHA; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Yamashita K, 1998, INT J CANCER, V79, P187; Yang L, 2011, ONCOGENE; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385; Zeng ZS, 2002, CLIN CANCER RES, V8, P144; Zheng HC, 2003, PATHOL INT, V53, P659, DOI 10.1046/j.1440-1827.2003.01542.x	75	55	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77425	10.1371/journal.pone.0077425	http://dx.doi.org/10.1371/journal.pone.0077425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143235	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100072
J	Harrison, XA; Hodgson, DJ; Inger, R; Colhoun, K; Gudmundsson, GA; McElwaine, G; Tregenza, T; Bearhop, S				Harrison, Xavier A.; Hodgson, David J.; Inger, Richard; Colhoun, Kendrew; Gudmundsson, Gudmundur A.; McElwaine, Graham; Tregenza, Tom; Bearhop, Stuart			Environmental Conditions during Breeding Modify the Strength of Mass-Dependent Carry-Over Effects in a Migratory Bird	PLOS ONE			English	Article							LONG-DISTANCE MIGRANT; NORTH-ATLANTIC OSCILLATION; BRANTA-BERNICLA; REPRODUCTIVE-PERFORMANCE; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; HABITAT QUALITY; MODEL SELECTION; CLIMATE INDEXES; SITE FIDELITY	In many animals, processes occurring in one season carry over to influence reproductive success and survival in future seasons. The strength of such carry-over effects is unlikely to be uniform across years, yet our understanding of the processes that are capable of modifying their strength remains limited. Here we show that female light-bellied Brent geese with higher body mass prior to spring migration successfully reared more offspring during breeding, but only in years where environmental conditions during breeding were favourable. In years of bad weather during breeding, all birds suffered reduced reproductive output irrespective of pre-migration mass. Our results suggest that the magnitude of reproductive benefits gained by maximising body stores to fuel breeding fluctuates markedly among years in concert with conditions during the breeding season, as does the degree to which carry-over effects are capable of driving variance in reproductive success among individuals. Therefore while carry-over effects have considerable power to drive fitness asymmetries among individuals, our ability to interpret these effects in terms of their implications for population dynamics is dependent on knowledge of fitness determinants occurring in subsequent seasons.	[Harrison, Xavier A.; Hodgson, David J.; Inger, Richard; Tregenza, Tom; Bearhop, Stuart] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Exeter, Cornwall, England; [Harrison, Xavier A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Colhoun, Kendrew] Wildfowl & Wetlands Trust, Comber, County Down, North Ireland; [Gudmundsson, Gudmundur A.] Iceland Inst Nat Hist, Reykjavik, Iceland	University of Exeter; Zoological Society of London	Harrison, XA (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Exeter, Cornwall, England.	xav.harrison@gmail.com; s.bearhop@ex.ac.uk	Inger, Richard/D-3445-2009; Bearhop, Stuart/G-3105-2012; Harrison, Xavier/F-6420-2011	Inger, Richard/0000-0003-1660-3706; Bearhop, Stuart/0000-0002-5864-0129; Harrison, Xavier/0000-0002-2004-3601; Tregenza, Thomas/0000-0003-4182-2222; Colhoun, Kendrew/0000-0003-4451-695X	NERC with a Wildfowl AMP; Wetlands Trust CASE partnership [NE/F008058/1]; RI by NERC [NE/F021690/1]; ERC [STATEMIG 310820]; NERC [NE/F021690/1] Funding Source: UKRI; Natural Environment Research Council [NE/F021690/1] Funding Source: researchfish	NERC with a Wildfowl AMP; Wetlands Trust CASE partnership; RI by NERC; ERC(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	XAH was funded by NERC grant (NE/F008058/1) with a Wildfowl & Wetlands Trust CASE partnership and RI by NERC grant (NE/F021690/1), both awarded to SB. SB is funded by an ERC Consolidator's Grant: STATEMIG 310820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barton K, 2009, UMIN MULTIMODEL INFE; Bates D, 2012, IME4 LINEAR MIXED EF; Betini GS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0110; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Bety J, 2004, BEHAV ECOL SOCIOBIOL; Dickey MH, 2008, GLOBAL CHANGE BIOL, V14, P1973, DOI 10.1111/j.1365-2486.2008.01622.x; EBBINGE BS, 1995, J AVIAN BIOL, V26, P105, DOI 10.2307/3677058; EBBINGE BS, 1989, IBIS, V131, P196, DOI 10.1111/j.1474-919X.1989.tb02762.x; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; GUDMUNDSSON GA, 1995, P ROY SOC B-BIOL SCI, V261, P73, DOI 10.1098/rspb.1995.0119; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harrison XA, 2011, MOL ECOL, V20, P4786, DOI 10.1111/j.1365-294X.2011.05283.x; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Harrison XA, 2010, MOL ECOL, V19, P5484, DOI 10.1111/j.1365-294X.2010.04852.x; Harrison XA, 2010, CONSERV GENET RESOUR, V2, P365, DOI 10.1007/s12686-010-9257-7; Inger R, 2010, J ANIM ECOL, V79, P974, DOI 10.1111/j.1365-2656.2010.01712.x; Kery M., 2010, INTRO WINBUGS ECOLOG; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Legagneux P, 2012, P ROY SOC B-BIOL SCI, V279, P876, DOI 10.1098/rspb.2011.1351; Lepage D, 2000, J ANIM ECOL, V69, P414, DOI 10.1046/j.1365-2656.2000.00404.x; Madsen J, 2007, POLAR BIOL, V30, P1363, DOI 10.1007/s00300-007-0296-9; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Norris DR, 2007, CONDOR, V109, P535; O'Briain M, 1998, ARCTIC, V51, P350; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; PROP J, 1993, ORNIS SCAND, V24, P110, DOI 10.2307/3676360; R Foundation for Statistical Computing, 2013, R LANG ENV STAT COMP; Ratikainen II, 2008, ECOL LETT, V11, P184, DOI 10.1111/j.1461-0248.2007.01122.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robson D, 2008, J ORNITHOL, V149, P473, DOI 10.1007/s10336-008-0297-7; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sedinger JS, 2011, AM NAT, V178, pE110, DOI 10.1086/662165; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Trinder MN, 2009, OIKOS, V118, P1093, DOI 10.1111/j.1600-0706.2009.17429.x; Votier SC, 2008, BIOL LETTERS, V4, P204, DOI 10.1098/rsbl.2007.0558; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	46	31	31	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77783	10.1371/journal.pone.0077783	http://dx.doi.org/10.1371/journal.pone.0077783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143258	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100097
J	Moore, P; He, KY; Tsai, B				Moore, Paul; He, Kaiyu; Tsai, Billy			Establishment of an In Vitro Transport Assay That Reveals Mechanistic Differences in Cytosolic Events Controlling Cholera Toxin and T-Cell Receptor alpha Retro-Translocation	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; HEAVY-CHAINS; P97; RETROTRANSLOCATION; ATPASE	Following retrograde trafficking to the endoplasmic reticulum (ER), cholera toxin A1 (CTA1) subunit hijacks ER-associated degradation (ERAD) machinery and retro-translocates into the cytosol to induce toxicity. We previously established a cell-based in vivo assay to identify ER components that regulate this process. However, elucidating cytosolic events that govern CTA1 retro-translocation using this assay is difficult as manipulating cytosolic factors often perturbs toxin retrograde transport to the ER. To circumvent this problem, we developed an in vitro assay in semi-permeabilized cells that directly monitors CTA1 release from the ER into the cytosol. We demonstrate CTA1 is released into the cytosol as a folded molecule in a p97- and proteasome-independent manner. Release nonetheless involves a GTP-dependent reaction. Upon extending this assay to the canonical ERAD substrate T-cell receptor alpha (TCR alpha), we found the receptor is unfolded when released into the cytosol and degraded by membrane-associated proteasome. In this reaction, p97 initially extracts TCR alpha from the ER membrane, followed by TCR alpha discharge into the cytosol that requires additional energy-dependent cytosolic activities. Our results reveal mechanistic insights into cytosolic events controlling CTA1 and TCR alpha retro-translocation, and provide a reliable tool to further probe this process.	[Moore, Paul; He, Kaiyu; Tsai, Billy] Univ Michigan Med Sch, Dept Cell & Dev Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Tsai, B (corresponding author), Univ Michigan Med Sch, Dept Cell & Dev Biol, Ann Arbor, MI USA.	btsai@umich.edu			National Institutes of Health [RO1 083252-04]; Burroughs Wellcome Fund [1006277]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health (RO1 083252-04) and the Burroughs Wellcome Fund (1006277) for support during the early part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuJarour RJ, 2005, J BIOL CHEM, V280, P15865, DOI 10.1074/jbc.M406316200; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Badizadegan K, 2004, AM J PHYSIOL-CELL PH, V287, pC1453, DOI 10.1152/ajpcell.00189.2004; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Chinnapen DJF, 2012, DEV CELL, V23, P573, DOI 10.1016/j.devcel.2012.08.002; Cho JA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00051; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Geiger R, 2013, TRAFFIC, V14, P36, DOI 10.1111/tra.12018; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Goodwin EC, 2011, MBIO, V2, DOI 10.1128/mBio.00101-11; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Inoue T, 2011, ANNU REV MICROBIOL, V65, P287, DOI 10.1146/annurev-micro-090110-102855; Inoue T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002037; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Lass A, 2007, ARCH BIOCHEM BIOPHYS, V462, P62, DOI 10.1016/j.abb.2007.04.010; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Olzmann JA, 2012, COLD SPRING HARB PER; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Sanyal S, 2012, J BIOL CHEM, V287, P23594, DOI 10.1074/jbc.M112.365312; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wolf AA, 2002, J BIOL CHEM, V277, P16249, DOI 10.1074/jbc.M109834200; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	50	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75801	10.1371/journal.pone.0075801	http://dx.doi.org/10.1371/journal.pone.0075801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146777	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400020
J	Bonner, MK; Han, BH; Skop, A				Bonner, Mary Kate; Han, Bo Hwa; Skop, Ahna			Profiling of the Mammalian Mitotic Spindle Proteome Reveals an ER Protein, OSTD-1, as Being Necessary for Cell Division and ER Morphology	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; NUCLEAR-ENVELOPE; PLASMA-MEMBRANE; FUNCTIONAL-ANALYSIS; CLEAVAGE FURROW; N-GLYCOSYLATION; VULVAL MORPHOGENESIS; CYTOKINESIS; RNAI	Cell division is important for many cellular processes including cell growth, reproduction, wound healing and stem cell renewal. Failures in cell division can often lead to tumors and birth defects. To identify factors necessary for this process, we implemented a comparative profiling strategy of the published mitotic spindle proteome from our laboratory. Of the candidate mammalian proteins, we determined that 77% had orthologs in Caenorhabditis elegans and 18% were associated with human disease. Of the C. elegans candidates (n=146), we determined that 34 genes functioned in embryonic development and 56% of these were predicted to be membrane trafficking proteins. A secondary, visual screen to detect distinct defects in cell division revealed 21 genes that were necessary for cytokinesis. One of these candidates, OSTD-1, an ER resident protein, was further characterized due to the aberrant cleavage furrow placement and failures in division. We determined that OSTD-1 plays a role in maintaining the dynamic morphology of the ER during the cell cycle. In addition, 65% of all ostd-1 RNAi-treated embryos failed to correctly position cleavage furrows, suggesting that proper ER morphology plays a necessary function during animal cell division.	[Bonner, Mary Kate; Han, Bo Hwa; Skop, Ahna] Univ Wisconsin, Lab Genet & Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Skop, A (corresponding author), Univ Wisconsin, Lab Genet & Med Genet, Madison, WI 53706 USA.	skop@wisc.edu	Skop, Ahna Renee/X-3305-2019	Skop, Ahna Renee/0000-0003-3522-4939	NSF [MCB 1158003]; NIH [K01HL092583]; Div Of Molecular and Cellular Bioscience [1158003] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092583] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NSF MCB 1158003 award and a NIH K01HL092583 award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2012, CELL, V150, P521, DOI 10.1016/j.cell.2012.05.048; AHRINGER J, 2006, EVERSE GENET WORMBOO; Ai EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019020; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Audhya A, 2007, J CELL BIOL, V178, P1309, DOI 10.1083/jcb.20070113920070911c; Austin GE, 1998, AM J CLIN PATHOL, V110, P575, DOI 10.1093/ajcp/110.5.575; Belloni G, 2012, J CELL SCI, V125, P5441, DOI 10.1242/jcs.108878; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Bonner MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020489; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; BURGE S, 2012, DATABASE-OXFORD, V2012, P1074; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Casey AK, 2012, GENETICS, V192, P441, DOI 10.1534/genetics.112.141465; Chang F, 1996, J CELL SCI, V109, P131; Donoso I, 2005, MOL GENET GENOMICS, V274, P155, DOI 10.1007/s00438-005-0005-8; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fernandez AG, 2005, GENOME RES, V15, P250, DOI 10.1101/gr.3194805; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Green RA, 2008, METHOD CELL BIOL, V85, P179, DOI 10.1016/S0091-679X(08)85009-1; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; Kurashige J, 2012, BRIT J CANCER, V107, P1233, DOI 10.1038/bjc.2012.396; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Qin C, 2013, PLANT CELL PHYSIOL, V54, P129, DOI 10.1093/pcp/pcs159; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1985, J EXP ZOOL, V234, P167, DOI 10.1002/jez.1402340120; Rojas AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031813; Rosnoblet C, 2013, GLYCOCONJUGATE J, V30, P23, DOI 10.1007/s10719-012-9389-y; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlaitz AL, 2013, DEV CELL, V26, P315, DOI 10.1016/j.devcel.2013.06.016; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stevens J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063687; Takahashi S, 2011, GENES CELLS, V16, P938, DOI 10.1111/j.1365-2443.2011.01538.x; Tang BL, 2012, CELL PHYSIOL BIOCHEM, V30, P1097, DOI 10.1159/000343301; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vleugels W, 2009, BIOCHEM BIOPH RES CO, V390, P769, DOI 10.1016/j.bbrc.2009.10.047; Wainman A, 2012, J CELL SCI, V125, P4014, DOI 10.1242/jcs.099820; Wang H, 2005, MOL BIOL CELL, V16, P4202, DOI 10.1091/mbc.E05-05-0472; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Willis DE, 2010, MOL CELL PROTEOMICS, V9, P952, DOI 10.1074/mcp.R900005-MCP200; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Zhang D, 2013, CURR OPIN CELL BIOL, V25, P142, DOI 10.1016/j.ceb.2012.09.001; Zhang D, 2010, CURR BIOL, V20, P1029, DOI 10.1016/j.cub.2010.04.017; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862; Zhou JG, 2007, CURR MICROBIOL, V55, P198, DOI 10.1007/s00284-006-0585-5	101	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77051	10.1371/journal.pone.0077051	http://dx.doi.org/10.1371/journal.pone.0077051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130834	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200053
J	Nasman, A; Andersson, E; Marklund, L; Tertipis, N; Hammarstedt-Nordenvall, L; Attner, P; Nyberg, T; Masucci, GV; Munck-Wikland, E; Ramqvist, T; Dalianis, T				Nasman, Anders; Andersson, Emilia; Marklund, Linda; Tertipis, Nikolaos; Hammarstedt-Nordenvall, Lalle; Attner, Per; Nyberg, Tommy; Masucci, Giuseppe V.; Munck-Wikland, Eva; Ramqvist, Torbjorn; Dalianis, Tina			HLA Class I and II Expression in Oropharyngeal Squamous Cell Carcinoma in Relation to Tumor HPV Status and Clinical Outcome	PLOS ONE			English	Article							MHC CLASS-I; ANTIGEN-PROCESSING MACHINERY; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; TONSILLAR CARCINOMA; CERVICAL-CANCER; DOWN-REGULATION; DR EXPRESSION; HEAD; MOLECULES	HPV-DNA positive (HPVDNA+) oropharyngeal squamous cell carcinoma (OSCC) has better clinical outcome than HPV-DNA negative (HPVDNA-) OSCC. Current treatment may be unnecessarily extensive for most HPV+ OSCC, but before de-escalation, additional markers are needed together with HPV status to better predict treatment response. Here the influence of HLA class I/HLA class II expression was explored. Pre-treatment biopsies, from 439/484 OSCC patients diagnosed 2000-2009 and treated curatively, were analyzed for HLA I and II expression, p16(INK4a) and HPV DNA. Absent/weak as compared to high HLA class I intensity correlated to a very favorable disease-free survival (DFS), disease-specific survival (DSS) and overall survival (OS) in HPVDNA+ OSCC, both in univariate and multivariate analysis, while HLA class II had no impact. Notably, HPVDNA+ OSCC with absent/weak HLA class I responded equally well when treated with induction-chemo-radiotherapy (CRT) or radiotherapy (RT) alone. In patients with HPVDNA- OSCC, high HLA class I/class II expression correlated in general to a better clinical outcome. p16(INK4a) overexpression correlated to a better clinical outcome in HPVDNA+ OSCC. Absence of HLA class I intensity in HPVDNA+ OSCC suggests a very high survival independent of treatment and could possibly be used clinically to select patients for randomized trials de-escalating therapy.	[Nasman, Anders; Andersson, Emilia; Tertipis, Nikolaos; Nyberg, Tommy; Masucci, Giuseppe V.; Ramqvist, Torbjorn; Dalianis, Tina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Marklund, Linda; Hammarstedt-Nordenvall, Lalle; Attner, Per; Munck-Wikland, Eva] Karolinska Inst, Karolinska Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Nasman, A (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	anders.nasman@ki.se	Nyberg, Tommy/AGG-2330-2022; Marklunf, Linda/L-1913-2015; Masucci, Giuseppe/A-5597-2008	Nyberg, Tommy/0000-0002-9436-0626; Masucci, Giuseppe/0000-0002-9583-2306; Hammarstedt-Nordenvall, Lalle/0000-0003-1660-9737; Dalianis, Tina/0000-0001-7022-2424; Nasman, Anders/0000-0003-4602-4297	Swedish Cancer Society; Swedish Medical Research Council; Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet; Stockholm County Council; King Gustaf V Jubilee Fund; Laryngfonden	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); King Gustaf V Jubilee Fund; Laryngfonden	This work was supported by The Swedish Cancer Society; The Swedish Medical Research Council; The Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet; the Stockholm County Council; the King Gustaf V Jubilee Fund and Laryngfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2012, CANCER IMMUNOL IMMUN, V61, P1243, DOI 10.1007/s00262-012-1201-0; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Anichini A, 2006, CANCER RES, V66, P6405, DOI 10.1158/0008-5472.CAN-06-0854; Armstrong TD, 1998, J IMMUNOL, V160, P661; Armstrong TD, 1997, P NATL ACAD SCI USA, V94, P6886, DOI 10.1073/pnas.94.13.6886; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Bottley G, 2008, ONCOGENE, V27, P1794, DOI 10.1038/sj.onc.1210798; Braakhuis BJM, 2009, ORAL ONCOL, V45, pE85, DOI 10.1016/j.oraloncology.2009.03.010; Campo MS, 2010, VIROLOGY, V407, P137, DOI 10.1016/j.virol.2010.07.044; Cancela MD, 2012, ORAL ONCOL, V48, P484, DOI 10.1016/j.oraloncology.2011.12.013; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chiriva-Internati M, 2006, IN VITRO CELL DEV-AN, V42, P89; Chung CH, 2012, OTOLARYNG CLIN N AM, V45, P795, DOI 10.1016/j.otc.2012.04.002; Dahlstrand H, 2008, ANTICANCER RES, V28, P1133; Dahlstrand HM, 2005, ANTICANCER RES, V25, P4375; ESTEBAN F, 1990, CLIN EXP METASTAS, V8, P319, DOI 10.1007/BF01810678; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; GLEW SS, 1992, CANCER RES, V52, P4009; GLEW SS, 1993, EUR J CANCER, V29A, P1963, DOI 10.1016/0959-8049(93)90453-M; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; Hutter H, 1996, CELL TISSUE RES, V286, P439, DOI 10.1007/s004410050713; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Lewis JS, 2012, HEAD NECK PATHOL, V6, pS75, DOI 10.1007/s12105-012-0369-0; Li H, 2006, BIOCHEM BIOPH RES CO, V349, P1315, DOI 10.1016/j.bbrc.2006.08.182; Lindquist D, 2007, MOL ONCOL, V1, P350, DOI 10.1016/j.molonc.2007.08.005; Madjd Z, 2005, INT J CANCER, V117, P248, DOI 10.1002/ijc.21163; Marklund L, 2012, CANCER MED-US, V1, P82, DOI 10.1002/cam4.2; Matoba K, 2005, INT J CANCER, V115, P231, DOI 10.1002/ijc.20860; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; MOMBURG F, 1987, INT J CANCER, V40, P598, DOI 10.1002/ijc.2910400504; Nasman A, 2013, INT J CANCER, V132, P72, DOI 10.1002/ijc.27635; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Ogino T, 2006, CANCER RES, V66, P9281, DOI 10.1158/0008-5472.CAN-06-0488; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Pryor DI, 2011, ASIA-PAC J CLIN ONCO, V7, P236, DOI 10.1111/j.1743-7563.2011.01420.x; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Ramqvist T, 2011, SCAND J INFECT DIS, V43, P115, DOI 10.3109/00365548.2010.526957; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; TEMPONI M, 1993, J IMMUNOL METHODS, V161, P239, DOI 10.1016/0022-1759(93)90300-V; VANDUINEN SG, 1988, CANCER RES, V48, P1019; Zehbe I, 2005, INT J CANCER, V117, P807, DOI 10.1002/ijc.21226	43	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77025	10.1371/journal.pone.0077025	http://dx.doi.org/10.1371/journal.pone.0077025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130830	gold, Green Submitted, Green Published			2022-12-27	WOS:000325814200051
J	Sena, A; Grishina, I; Thai, A; Goulart, L; Macal, M; Fenton, A; Li, J; Prindiville, T; Oliani, SM; Dandekar, S; Goulart, L; Sankaran-Walters, S				Sena, Angela; Grishina, Irina; Thai, Anne; Goulart, Larissa; Macal, Monica; Fenton, Anne; Li, Jay; Prindiville, Thomas; Oliani, Sonia Maria; Dandekar, Satya; Goulart, Luiz; Sankaran-Walters, Sumathi			Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS-INFECTION; GENE-EXPRESSION; PERIPHERAL-BLOOD; LIPOCORTIN 1; INNATE; NEUTROPHILS; MODULATION; LEUKOCYTES	Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic factors with the host immune system. Mechanisms contributing to immune dysregulation in IBD are not fully defined. Development of novel therapeutic strategies is focused on controlling aberrant immune response in IBD. Current IBD therapy utilizes a combination of immunomodulators and biologics to suppress pro-inflammatory effectors of IBD. However, the role of immunomodulatory factors such as annexin A1 (ANXA1) is not well understood. The goal of this study was to examine the association between ANXA1 and IBD, and the effects of anti-TNF-alpha, Infliximab (IFX), therapy on ANXA1 expression. Methods: ANXA1 and TNF-alpha transcript levels in PBMC were measured by RT PCR. Clinical follow up included the administration of serial ibdQs. ANXA1 expression in the gut mucosa was measured by IHC. Plasma ANXA1 levels were measured by ELISA. Results: We found that the reduction in ANXA1 protein levels in plasma coincided with a decrease in the ANXA1 mRNA expression in peripheral blood of IBD patients. ANXA1 expression is upregulated during IFX therapy in patients with a successful intervention but not in clinical non-responders. The IFX therapy also modified the cellular immune activation in the peripheral blood of IBD patients. Decreased expression of ANXA1 was detected in the colonic mucosa of IBD patients with incomplete resolution of inflammation during continuous therapy, which correlated with increased levels of TNF-alpha transcripts. Gut mucosal epithelial barrier disruption was evident by increased plasma bacterial 16S levels. Conclusion: Loss of ANXA1 expression may support inflammation during IBD and can serve as a biomarker of disease progression. Changes in ANXA1 levels may be predictive of therapeutic efficacy.	[Sena, Angela; Grishina, Irina; Goulart, Larissa; Macal, Monica; Fenton, Anne; Li, Jay; Dandekar, Satya; Goulart, Luiz; Sankaran-Walters, Sumathi] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Sena, Angela; Goulart, Luiz] Univ Fed Uberlandia, Inst Genet & Biochem, Nanobiotechnol Lab, BR-38400 Uberlandia, MG, Brazil; [Thai, Anne; Prindiville, Thomas] Univ Calif Davis, UCDHS Div Hepatol & Gastroenterol, Davis, CA 95616 USA; [Oliani, Sonia Maria] Sao Paulo State Univ, Dept Biol, UNESP, Sao Jose Do Rio Preto, SP, Brazil	University of California System; University of California Davis; Universidade Federal de Uberlandia; University of California System; University of California Davis; Universidade Estadual Paulista	Sankaran-Walters, S (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ssankara@ucdavis.edu	Goulart, Luiz R/G-7357-2012; Oliani, Sonia Maria/E-3476-2012	Goulart, Luiz R/0000-0002-1803-4861; Oliani, Sonia Maria/0000-0003-0918-2130	FAPEMIG, Brazil [APQ-02613-10]; CAPES, Brazil; National Institute of Health (NIH) [R01 DK61297, AI43274]; Building Interdisciplinary Research Careers in Women's Health award [K12 HD051958]; NICHD; ORWH; NIA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061297] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Building Interdisciplinary Research Careers in Women's Health award; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ORWH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from FAPEMIG, Brazil (APQ-02613-10), CAPES, Brazil (A.A.S. scholarship), and the National Institute of Health (NIH) R01 DK61297, AI43274). Dr. Sankaran is supported by a Building Interdisciplinary Research Careers in Women's Health award (K12 HD051958) funded by the NICHD, ORWH, and the NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Arijs I, 2010, INFLAMM BOWEL DIS, V16, P2090, DOI 10.1002/ibd.21301; Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Faria PCB, 2010, ORAL ONCOL, V46, P25, DOI 10.1016/j.oraloncology.2009.09.003; BEATTIE RM, 1995, ALIMENT PHARM THERAP, V9, P541; Beverley P C, 1992, Semin Immunol, V4, P35; Boxer Laurence A, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE17, DOI 10.1097/01.mpg.0000313830.01466.21; Caviglia R, 2008, EXPERT OPIN DRUG SAF, V7, P617, DOI 10.1517/14740338.7.5.617 ; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; CIRINO G, 1987, PROSTAGLANDINS, V34, P59, DOI 10.1016/0090-6980(87)90262-0; CIRINO G, 1987, NATURE, V328, P270, DOI 10.1038/328270a0; Clarke K, 2012, INFLAMM BOWEL DIS, V18, P174, DOI 10.1002/ibd.21792; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; D'Acquisto F, 2007, EUR J IMMUNOL, V37, P3131, DOI 10.1002/eji.200636792; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; D'Amico M, 2000, FASEB J, V14, P1867; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; de Coupade C, 2001, AM J PATHOL, V159, P1435, DOI 10.1016/S0002-9440(10)62530-8; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Kosicka A, 2013, FASEB J, V27, P368, DOI 10.1096/fj.12-213728; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Macfarlane S, 2009, CRIT REV CL LAB SCI, V46, P25, DOI [10.1080/10408360802485792, 10.1080/10408360802485792 ]; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Maurice MM, 1999, ARTHRITIS RHEUM-US, V42, P2166, DOI 10.1002/1529-0131(199910)42:10<2166::AID-ANR18>3.0.CO;2-K; MCCARTHY DA, 1991, CLIN EXP IMMUNOL, V86, P489; Meuwis MA, 2008, CLIN BIOCHEM, V41, P960, DOI 10.1016/j.clinbiochem.2008.04.021; Miehsler W, 2010, J CROHNS COLITIS, V4, P221, DOI 10.1016/j.crohns.2009.12.001; Musch MW, 2002, J CLIN INVEST, V110, P1739, DOI 10.1172/JCI200215695; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Rakoff-Nahoum S, 2010, CURR OPIN GASTROEN, V26, P572, DOI 10.1097/MOG.0b013e32833f126d; Roda G, 2010, INFLAMM BOWEL DIS, V16, P1239, DOI 10.1002/ibd.21212; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1442, DOI 10.1053/j.gastro.2008.09.053; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Sankaran-Walters S, 2011, J CLIN VIROL, V50, P31, DOI 10.1016/j.jcv.2010.09.011; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Siegmund B, 2011, WORLD J GASTROENTERO, V17, P3178, DOI 10.3748/wjg.v17.i27.3178; Stallmach A, 2010, BEST PRACT RES CL GA, V24, P167, DOI 10.1016/j.bpg.2010.01.002; STEVENS TRJ, 1993, CLIN SCI, V84, P381, DOI 10.1042/cs0840381; Vergnolle N, 2004, INFLAMM BOWEL DIS, V10, P584, DOI 10.1097/00054725-200409000-00013; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Vong L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039244; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730	53	40	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76969	10.1371/journal.pone.0076969	http://dx.doi.org/10.1371/journal.pone.0076969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130820	Green Published, gold			2022-12-27	WOS:000325814200046
J	Xia, YF; Entman, ML; Wang, YL				Xia, Yunfeng; Entman, Mark L.; Wang, Yanlin			CCR2 Regulates the Uptake of Bone Marrow-Derived Fibroblasts in Renal Fibrosis	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; TO-MESENCHYMAL TRANSITION; CIRCULATING FIBROCYTES; TUBULOINTERSTITIAL FIBROSIS; MEDIATE FIBROSIS; KIDNEY FIBROSIS; TISSUE-REPAIR; CELLS; DIFFERENTIATION; MYOFIBROBLASTS	Recent studies have shown that bone marrow-derived fibroblasts contribute significantly to the pathogenesis of renal fibrosis. However, the molecular mechanisms underlying the recruitment of bone marrow-derived fibroblasts into the kidney are incompletely understood. Bone marrow-derived fibroblasts express the chemokine receptor - CCR2. In this study, we tested the hypothesis that CCR2 participates in the recruitment of fibroblasts into the kidney during the development of renal fibrosis. Bone marrow-derived collagen-expressing GFP(+) fibroblasts were detected in the obstructed kidneys of chimeric mice transplanted with donor bone marrow from collagen alpha 1(I)-GFP reporter mice. These bone marrow-derived fibroblasts expressed PDGFR-beta and CCR2. CCR2 knockout mice accumulated significantly fewer bone marrow-derived fibroblast precursors expressing the hematopoietic marker-CD45 and the mesenchymal markers-PDGFR-beta or procollagen I in the obstructed kidneys compared with wild-type mice. Furthermore, CCR2 knockout mice displayed fewer bone marrow-derived myofibroblasts and expressed less alpha-SMA or FSP-1 in the obstructed kidneys compared with wild-type mice. Consistent with these findings, genetic deletion of CCR2 inhibited total collagen deposition and suppressed expression of collagen I and fibronectin. Moreover, genetic deletion of CCR2 inhibits MCP-1 and CXCL16 gene expression associated with a reduction of inflammatory cytokine expression and macrophage infiltration, suggesting a linear interaction between two chemokines/ligand receptors in tubular epithelial cells. Taken together, our results demonstrate that CCR2 signaling plays an important role in the pathogenesis of renal fibrosis through regulation of bone marrow-derived fibroblasts. These data suggest that inhibition of CCR2 signaling could constitute a novel therapeutic approach for fibrotic kidney disease.	[Xia, Yunfeng; Wang, Yanlin] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Xia, Yunfeng] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Med, Div Nephrol, Guangzhou, Guangdong, Peoples R China; [Entman, Mark L.] Baylor Coll Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Entman, Mark L.] Baylor Coll Med, Dept Med, DeBakey Heart Ctr, Houston, TX 77030 USA; [Entman, Mark L.] Methodist Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; The Methodist Hospital System; The Methodist Hospital - Houston	Wang, YL (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	yanlinw@bcm.edu			NIH [K08HL092958, R01DK095835, R01HL89792]; AHA [BGIA7840054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092958, R01HL089792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants - K08HL092958 and R01DK095835, an AHA grant - BGIA7840054 (to YW). MLE was supported by a NIH Grant - R01HL89792. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chen G, 2011, J AM SOC NEPHROL, V22, P1876, DOI 10.1681/ASN.2010080881; Chesney J, 1997, BIOCHEM SOC T, V25, P520, DOI 10.1042/bst0250520; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Picard N, 2008, HISTOCHEM CELL BIOL, V130, P141, DOI 10.1007/s00418-008-0433-8; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Xu J, 2011, AM J PHYSIOL-HEART C, V301, pH538, DOI 10.1152/ajpheart.01114.2010; Yang J, 2013, J AM SOC NEPHROL; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052415; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	39	37	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77493	10.1371/journal.pone.0077493	http://dx.doi.org/10.1371/journal.pone.0077493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130892	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200090
J	Xu, X; Hu, JJ; McGrath, BC; Cavener, DR				Xu, Xu; Hu, Jingjie; McGrath, Barbara C.; Cavener, Douglas R.			GCN2 in the Brain Programs PPAR gamma 2 and Triglyceride Storage in the Liver during Perinatal Development in Response to Maternal Dietary Fat	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; LEPTIN-DEFICIENT MICE; PPAR-GAMMA; EIF2-ALPHA KINASE; TRANSFER-RNA; TRANSLATIONAL CONTROL; LIPID-ACCUMULATION; HEPATIC STEATOSIS; ACID HOMEOSTASIS; GENE-EXPRESSION	The liver plays a central role in regulating lipid metabolism and facilitates efficient lipid utilization and storage. We discovered that a modest increase in maternal dietary fat in mice programs triglyceride storage in the liver of their developing offspring. The activation of this programming is not apparent, however, until several months later at the adult stage. We found that the perinatal programming of adult hepatic triglyceride storage was controlled by the eIF2 alpha kinase GCN2 (EIF2AK4) in the brain of the offspring, which stimulates epigenetic modification of the Ppar gamma 2 gene in the neonatal liver. Genetic ablation of Gcn2 in the offspring exhibited reduced hepatic triglyceride storage and repressed expression of the peroxisome proliferator-activated receptor gamma 2 (Ppar gamma 2) and two lipid droplet protein genes, Fsp27 and Cidea. Brain-specific, but not liver-specific, Gcn2 KO mice exhibit these same defects demonstrating that GCN2 in the developing brain programs hepatic triglyceride storage. GCN2 and nutrition-dependent programming of Ppar gamma 2 is correlated with trimethylation of lysine 4 of histone 3 (H3K4me3) in the Ppar gamma 2 promoter region during neonatal development. In addition to regulating hepatic triglyceride in response to modest changes in dietary fat, Gcn2 deficiency profoundly impacts the severity of the obese-diabetic phenotype of the leptin receptor mutant (db/db) mouse, by reducing hepatic steatosis and obesity but exacerbating the diabetic phenotype. We suggest that GCN2-dependent perinatal programming of hepatic triglyceride storage is an adaptation to couple early nutrition to anticipated needs for hepatic triglyceride storage in adults. However, increasing the hepatic triglyceride set point during perinatal development may predispose individuals to hepatosteatosis, while reducing circulating fatty acid levels that promote insulin resistance.	[Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu	wang, meng/GWZ-9558-2022		National Institutes of Health (NIH) [R01 DK088140, R56 GM056857]; Ajinomoto Research Foundation (3ARP) grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056857] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Research Foundation (3ARP) grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health (NIH) grants R01 DK088140 and R56 GM056857 and an Ajinomoto Research Foundation (3ARP) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bernal-Mizrachi C, 2007, CELL METAB, V5, P91, DOI 10.1016/j.cmet.2006.12.010; Bocher V, 2002, ANN NY ACAD SCI, V967, P7; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gabory A, 2011, WORLD J DIABETES, V2, P164, DOI 10.4239/wjd.v2.i10.164; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Hyatt MA, 2011, REPRODUCTION, V141, P119, DOI 10.1530/REP-10-0325; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lazarow P B, 1981, Methods Enzymol, V72, P315; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levin BE, 2009, INT J OBESITY, V33, pS53, DOI 10.1038/ijo.2009.18; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Levin BE, 2000, NUTRITION, V16, P909, DOI 10.1016/S0899-9007(00)00408-1; Levin BE, 2000, OBES RES, V8, P342, DOI 10.1038/oby.2000.41; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Matsusue K, 2010, BIOL PHARM BULL, V33, P346, DOI 10.1248/bpb.33.346; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; McMillen IC, 2004, P NUTR SOC, V63, P405, DOI 10.1079/PNS2004370; McMillen IC, 2006, REPRODUCTION, V131, P415, DOI 10.1530/rep.1.00303; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Oben JA, 2010, BIOCHEM BIOPH RES CO, V394, P24, DOI 10.1016/j.bbrc.2010.02.057; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Uno K, 2011, EUR HEART J; Uno K, 2012, EUR HEART J, V33, P1279, DOI 10.1093/eurheartj/ehr265; Viswanadha S, 2006, J LIPID RES, V47, P1859, DOI 10.1194/jlr.D600005-JLR200; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; WOLFNER M, 1975, J MOL BIOL, V96, P273, DOI 10.1016/0022-2836(75)90348-4; Yamazaki H, 2002, AM J PHYSIOL-ENDOC M, V283, pE536, DOI 10.1152/ajpendo.00094.2001; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	65	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75917	10.1371/journal.pone.0075917	http://dx.doi.org/10.1371/journal.pone.0075917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130751	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200025
J	Balsanelli, E; Tuleski, TR; de Baura, VA; Yates, MG; Chubatsu, LS; Pedrosa, FD; de Souza, EM; Monteiro, RA				Balsanelli, Eduardo; Tuleski, Thalita Regina; de Baura, Valter Antonio; Yates, Marshall Geoffrey; Chubatsu, Leda Satie; Pedrosa, Fabio de Oliveira; de Souza, Emanuel Maltempi; Monteiro, Rose Adele			Maize Root Lectins Mediate the Interaction with Herbaspirillum seropedicae via N-Acetyl Glucosamine Residues of Lipopolysaccharides	PLOS ONE			English	Article							AZOSPIRILLUM-BRASILENSE; NIF GENES; O-ANTIGEN; COLONIZATION; BIOSYNTHESIS; IDENTIFICATION; RHIZOSPHERE; INVOLVEMENT; EXPRESSION; SEQUENCES	Herbaspirillum seropedicae is a plant growth-promoting diazotrophic betaproteobacterium which associates with important crops, such as maize, wheat, rice and sugar-cane. We have previously reported that intact lipopolysaccharide (LPS) is required for H. seropedicae attachment and endophytic colonization of maize roots. In this study, we present evidence that the LPS biosynthesis gene waaL (codes for the O-antigen ligase) is induced during rhizosphere colonization by H. seropedicae. Furthermore a waaL mutant strain lacking the O-antigen portion of the LPS is severely impaired in colonization. Since N-acetyl glucosamine inhibits H. seropedicae attachment to maize roots, lectin-like proteins from maize roots (MRLs) were isolated and mass spectrometry (MS) analysis showed that MRL-1 and MRL-2 correspond to maize proteins with a jacalin-like lectin domain, while MRL-3 contains a B-chain lectin domain. These proteins showed agglutination activity against wild type H. seropedicae, but failed to agglutinate the waaL mutant strain. The agglutination reaction was severely diminished in the presence of N-acetyl glucosamine. Moreover addition of the MRL proteins as competitors in H. seropedicae attachment assays decreased 80-fold the adhesion of the wild type to maize roots. The results suggest that N-acetyl glucosamine residues of the LPS O-antigen bind to maize root lectins, an essential step for efficient bacterial attachment and colonization.	[Balsanelli, Eduardo; Tuleski, Thalita Regina; de Baura, Valter Antonio; Yates, Marshall Geoffrey; Chubatsu, Leda Satie; Pedrosa, Fabio de Oliveira; de Souza, Emanuel Maltempi; Monteiro, Rose Adele] Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana	Monteiro, RA (corresponding author), Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil.	roseadele@gmail.com	Pedrosa, Fabio 0/C-1938-2013; Chubatsu, Leda S./H-2603-2012; Balsanelli, Eduardo/O-8831-2014	Chubatsu, Leda S./0000-0002-8687-2816; Monteiro, Rose Adele/0000-0001-8226-0700	Brazilian Program of National Institutes of Science and Technology-INCT/Biological Nitrogen Fixation/Brazilian Research Council-CNPq/MCT; Fundacao Araucaria	Brazilian Program of National Institutes of Science and Technology-INCT/Biological Nitrogen Fixation/Brazilian Research Council-CNPq/MCT; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by the Brazilian Program of National Institutes of Science and Technology-INCT/Biological Nitrogen Fixation/Brazilian Research Council-CNPq/MCT and Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldani JI, 1996, INT J SYST BACTERIOL, V46, P802, DOI 10.1099/00207713-46-3-802; BALDANI VLD, 1992, SYMBIOSIS, V13, P65; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; BARANY F, 1985, P NATL ACAD SCI USA, V82, P4202, DOI 10.1073/pnas.82.12.4202; Becker A, 2005, MOL PLANT MICROBE IN, V18, P899, DOI 10.1094/MPMI-18-0899; Bhattacharya I, 2002, GLYCOCONJUGATE J, V19, P395, DOI 10.1023/B:GLYC.0000004011.54822.ea; BODDEY RM, 1995, PLANT SOIL, V174, P195, DOI 10.1007/BF00032247; Bolanos L, 2004, MOL PLANT MICROBE IN, V17, P216, DOI 10.1094/MPMI.2004.17.2.216; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burlat V, 2001, PHYTOCHEMISTRY, V57, P883, DOI 10.1016/S0031-9422(01)00117-0; Collins PM, 1995, MONOSACHARIDES THEIR, P463; Dekkers LC, 1998, MOL PLANT MICROBE IN, V11, P763, DOI 10.1094/MPMI.1998.11.8.763; DELGALLO M, 1989, J BACTERIOL, V171, P3504, DOI 10.1128/jb.171.6.3504-3510.1989; Duijff BJ, 1997, NEW PHYTOL, V135, P325, DOI 10.1046/j.1469-8137.1997.00646.x; Egener T, 1999, MOL PLANT MICROBE IN, V12, P813, DOI 10.1094/MPMI.1999.12.9.813; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470; James EK, 1997, J EXP BOT, V48, P785, DOI 10.1093/jxb/48.3.785; Jayaraman V, 1998, BBA-GEN SUBJECTS, V1381, P7, DOI 10.1016/S0304-4165(98)00031-2; Jofre E, 2004, FEMS MICROBIOL LETT, V231, P267, DOI 10.1016/S0378-1097(04)00003-5; Klassen G, 1997, CAN J MICROBIOL, V43, P887, DOI 10.1139/m97-129; KONNOVA SA, 1994, FEMS MICROBIOL LETT, V118, P93, DOI 10.1111/j.1574-6968.1994.tb06809.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; MISHKIND ML, 1983, SCIENCE, V220, P1290, DOI 10.1126/science.220.4603.1290; Olivares FL, 1997, NEW PHYTOL, V135, P723, DOI 10.1046/j.1469-8137.1997.00684.x; Ormeno-Orrillo E, 2008, ENVIRON MICROBIOL, V10, P1271, DOI 10.1111/j.1462-2920.2007.01541.x; PEDROSA FO, 1984, FEMS MICROBIOL LETT, V23, P95, DOI 10.1016/0378-1097(84)90080-6; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raval S, 2004, GLYCOBIOLOGY, V14, P1247, DOI 10.1093/glycob/cwh140; Ruan X, 2012, GLYCOBIOLOGY, V22, P288, DOI 10.1093/glycob/cwr150; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Chaves DFS, 2009, J PROTEOMICS, V73, P50, DOI 10.1016/j.jprot.2009.07.012; SERRATO RV, 2012, INT J BIOL MACROMOL, DOI [10.1016/j.ijbiomac.2012.05.034, DOI 10.1016/J.IJBI0MAC.2012.05.034]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Simons M, 1996, MOL PLANT MICROBE IN, V9, P600, DOI 10.1094/MPMI-9-0600; STINISSEN HM, 1985, PLANTA, V164, P278, DOI 10.1007/BF00396093; SUTHERLAND IW, 1985, ANNU REV MICROBIOL, V39, P243; Tellstrom V, 2007, PLANT PHYSIOL, V143, P825, DOI 10.1104/pp.106.090985; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Westermeier R, 2002, PROTEOMICS PRACTICE; Woodley P, 1996, FEMS MICROBIOL LETT, V135, P213	44	31	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77001	10.1371/journal.pone.0077001	http://dx.doi.org/10.1371/journal.pone.0077001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130823	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900115
J	Hosny, NA; Song, MY; Connelly, JT; Ameer-Beg, S; Knight, MM; Wheeler, AP				Hosny, Neveen A.; Song, Mingying; Connelly, John T.; Ameer-Beg, Simon; Knight, Martin M.; Wheeler, Ann P.			Super-Resolution Imaging Strategies for Cell Biologists Using a Spinning Disk Microscope	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENCE MICROSCOPY; DIFFRACTION BARRIER; NANOSCOPY; BREAKING; LIMIT	In this study we use a spinning disk confocal microscope (SD) to generate super-resolution images of multiple cellular features from any plane in the cell. We obtain super-resolution images by using stochastic intensity fluctuations of biological probes, combining Photoactivation Light-Microscopy (PALM)/Stochastic Optical Reconstruction Microscopy (STORM) methodologies. We compared different image analysis algorithms for processing super-resolution data to identify the most suitable for analysis of particular cell structures. SOFI was chosen for X and Y and was able to achieve a resolution of ca. 80 nm; however higher resolution was possible >30 nm, dependant on the super-resolution image analysis algorithm used. Our method uses low laser power and fluorescent probes which are available either commercially or through the scientific community, and therefore it is gentle enough for biological imaging. Through comparative studies with structured illumination microscopy (SIM) and widefield epifluorescence imaging we identified that our methodology was advantageous for imaging cellular structures which are not immediately at the cell-substrate interface, which include the nuclear architecture and mitochondria. We have shown that it was possible to obtain two coloured images, which highlights the potential this technique has for high-content screening, imaging of multiple epitopes and live cell imaging.	[Hosny, Neveen A.; Song, Mingying; Connelly, John T.; Wheeler, Ann P.] Queen Mary Univ London, Barts & Royal London Sch Med & Dent, Blizard Inst, London, England; [Ameer-Beg, Simon] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Knight, Martin M.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England	University of London; Queen Mary University London; University of London; King's College London; University of London; Queen Mary University London	Wheeler, AP (corresponding author), Queen Mary Univ London, Barts & Royal London Sch Med & Dent, Blizard Inst, London, England.	a.p.wheeler@qmul.ac.uk		Hosny, Neveen Amera/0000-0003-2224-4164; Knight, Martin/0000-0003-3755-1597; Wheeler, Ann/0000-0001-8617-827X; Ameer-Beg, Simon/0000-0001-5227-575X	Engineering and Physical Sciences Research Council/Medical Research Council; MRC [MR/K015869/1] Funding Source: UKRI; Medical Research Council [MR/K015869/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council/Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for NAH was provided by an Engineering and Physical Sciences Research Council/Medical Research Council discipline bridging grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MC, 2003, METHODS, V29, P29, DOI 10.1016/S1046-2023(02)00282-7; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cox S, 2012, NAT METHODS, V9, P195, DOI [10.1038/NMETH.1812, 10.1038/nmeth.1812]; Dedecker P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126008; Dedecker P, 2012, P NATL ACAD SCI USA, V109, P10909, DOI 10.1073/pnas.1204917109; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Erdelyi M, 2013, OPT EXPRESS, V21, P10978, DOI 10.1364/OE.21.010978; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Herbert S, 2012, MICROSC MICROANAL, V18, P1419, DOI 10.1017/S1431927612013347; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Knight MM, 2003, AM J PHYSIOL-CELL PH, V284, pC1083, DOI 10.1152/ajpcell.00276.2002; Markaki Y, 2010, COLD SH Q B, V75, P475, DOI 10.1101/sqb.2010.75.042; Mukamel EA, 2012, BIOPHYS J, V102, P2391, DOI 10.1016/j.bpj.2012.03.070; Murray JM, 2007, J MICROSC-OXFORD, V228, P390, DOI 10.1111/j.1365-2818.2007.01861.x; PETRAN M, 1986, ANN NY ACAD SCI, V483, P440, DOI 10.1111/j.1749-6632.1986.tb34554.x; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van't Hoff M, 2008, OPT EXPRESS, V16, P18495, DOI 10.1364/OE.16.018495; Wazawa T, 2005, ADV BIOCHEM ENG BIOT, V95, P77, DOI 10.1007/b102211; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	33	22	23	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74604	10.1371/journal.pone.0074604	http://dx.doi.org/10.1371/journal.pone.0074604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130668	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900004
J	Nausheen, S; Soofi, SB; Sadiq, K; Habib, A; Turab, A; Memon, Z; Khan, MI; Suhag, Z; Bhatti, Z; Ahmed, I; Bahl, R; Bhutta, S; Bhutta, ZA				Nausheen, Sidrah; Soofi, Sajid B.; Sadiq, Kamran; Habib, Atif; Turab, Ali; Memon, Zahid; Khan, M. Imran; Suhag, Zamir; Bhatti, Zaid; Ahmed, Imran; Bahl, Rajiv; Bhutta, Shireen; Bhutta, Zulfiqar A.			Validation of Verbal Autopsy Tool for Ascertaining the Causes of Stillbirth	PLOS ONE			English	Article							NEONATAL DEATHS; DIAGNOSTIC-ACCURACY; CLASSIFICATION; ALGORITHMS; RATES	Objective: To assess performance of the WHO revised verbal autopsy tool for ascertaining the causes of still birth in comparison with reference standard cause of death ascertained by standardized clinical and supportive data. Methods: All stillbirths at a tertiary hospital in Karachi, Pakistan were prospectively recruited into study from August 2006-February 2008. The reference standard cause of death was established by two senior obstetricians within 48 hours using the ICD coding system. Verbal autopsy interviews using modified WHO tool were conducted by trained health workers within 2-6 weeks of still birth and the cause of death was assigned by second panel of obstetricians. The performance was assessed in terms of sensitivity, specificity and Kappa. Results: There were 204 still births. Of these, 80.8% of antepartum and 50.5% of intrapartum deaths were correctly diagnosed by verbal autopsy. Sensitivity of verbal autopsy was highest 68.4%, (95% CI: 46-84.6) for congenital malformation followed by obstetric complication 57.6%, (95% CI: 25-84.2). The specificity for all major causes was greater than 90%. The level of agreement was high (kappa=0.72) for anomalies and moderate (k=0.4) for all major causes of still birth, except asphyxia. Conclusion: Our results suggest that verbal autopsy has reasonable validity in identifying and discriminating between causes of stillbirth in Pakistan. On the basis of these findings, we feel it has a place in resource constrained areas to inform strategic planning and mobilization of resources to attain Millennium Development Goals.	[Nausheen, Sidrah; Soofi, Sajid B.; Sadiq, Kamran; Habib, Atif; Turab, Ali; Suhag, Zamir; Bhatti, Zaid; Ahmed, Imran; Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Memon, Zahid] Res & Advocacy Fund, Maternal & Newborn Hlth Program, Islamabad, Pakistan; [Bahl, Rajiv] World Hlth Org, Dept Child & Adolescent Hlth & Dev, Geneva, Switzerland; [Khan, M. Imran] Int Vaccine Inst, Seoul, South Korea; [Bhutta, Shireen] Jinnah Postgrad Med Ctr, Dept Obstet & Gynecol, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada	Aga Khan University; University of Geneva; World Health Organization; International Vaccine Institute; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu	Memon, Zahid Ali/GRE-8118-2022	Memon, Zahid Ali/0000-0002-5321-8885	World Health Organization, Geneva;  [C6/181/502]	World Health Organization, Geneva(World Health Organization); 	This study was funded by World Health Organization, Geneva, and Award Number: C6/181/502. The funding body provided clearance for the project design but apart from field visits to review progress did not influence the field trial or the data analysis procedures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKER M, 1999, WHOCDSCSRISR994, P1; ARUN K, 2011, B WHO GENEVA, V89, P31, DOI DOI 10.2471/BLT.10.076828; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Early Breast Cancer Trialists' Collaborative Group, 2005, LANCET, V365, DOI DOI 10.1016/S0140-6736(05)66544-0; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Engmann C, 2012, J PERINATOL, V32, P585, DOI 10.1038/jp.2011.154; Engmann C, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-42; Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x; *INDEPTH NETW, 2005, INT NETW FIELD SIT C; JOY EL, 2009, BMC S1, V9, P9, DOI DOI 10.1186/1471-2210-9-S1-P9; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LAWN JE, 2005, B WORLD HEALTH ORGAN, V83, P4009; Marsh DR, 2003, PAEDIATR PERINAT EP, V17, P132, DOI 10.1046/j.1365-3016.2003.00475.x; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; PRABHAT J, 2006, PLOS MED, V3, pE18, DOI DOI 10.1371/JOURNAL.PMED.0030018; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Quigley MA, 1996, B WORLD HEALTH ORGAN, V74, P147; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; *WHO CWG, 2005, WORLD HLTH REP; *WHO JHU SNL, 2003, WHO STAND NEON VERB; Winbo IGB, 1998, INT J EPIDEMIOL, V27, P499, DOI 10.1093/ije/27.3.499; Winbo IGB, 1997, INT J EPIDEMIOL, V26, P1298, DOI 10.1093/ije/26.6.1298; World Health Organization, 2005, WHO TECHN CONS VERB; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3	26	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76933	10.1371/journal.pone.0076933	http://dx.doi.org/10.1371/journal.pone.0076933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130814	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900108
J	Pagnutti, C; Bauch, CT; Anand, M				Pagnutti, Chris; Bauch, Chris T.; Anand, Madhur			Outlook on a Worldwide Forest Transition	PLOS ONE			English	Article							DEFORESTATION; POPULATION; SCARCITY; YIELDS	It is not clear whether a worldwide "forest transition" to net reforestation will ever occur, and the need to address the main driver-agriculture-is compelling. We present a mathematical model of land use dynamics based on the world food equation that explains historical trends in global land use on the millennial scale. The model predicts that a global forest transition only occurs under a small and very specific range of parameter values (and hence seems unlikely) but if it does occur, it would have to occur within the next 70 years. In our baseline scenario, global forest cover continues to decline until it stabilizes within the next two centuries at 22% of global land cover, and wild pasture at 1.4%. Under other scenarios the model predicts unanticipated dynamics wherein a forest transition may relapse, heralding a second era of deforestation; this brings into question national-level forest transitions observed in recent decades, and suggests we need to expand our lexicon of possibilities beyond the simple "forest transition/no forest transition" dichotomy. This research also underscores that the challenge of feeding a growing population while conserving natural habitat will likely continue for decades to come.	[Pagnutti, Chris; Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Pagnutti, Chris; Bauch, Chris T.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Bauch, Chris T.; Anand, Madhur] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Guelph; University of Guelph; Princeton University	Anand, M (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	manand@uoguelph.ca			Natural Sciences and Engineering Council of Canada	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Sciences and Engineering Council of Canada (Discovery grants program) to MA and CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; [Anonymous], 1999, WORLD 6 BILL; Balk D., 2005, P INT SOC PHOT REM S, P14; CAMPBELL BMS, 1983, ECON HIST REV, V36, P26; Cavallini F., 1993, COLL MATH J, V24, P247; Chavas JP, 2005, J AGR ECON, V56, P217, DOI 10.1111/j.1477-9552.2005.00001.x; CLARK G, 1991, ECON HIST REV, V44, P445; de Fraiture C, 2007, COMPR ASSESS WAT MAN, V4, P94, DOI 10.1079/9781845932923.0094; Edelman PD, 2005, TISSUE ENG, V11, P659, DOI 10.1089/ten.2005.11.659; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; FARMER DL, 1977, ECON HIST REV, V30, P555; Goldewijk Kees Klein, 2004, ENCY LIFE SUPPORT SY, V1; Grainger A, 1995, AREA, V27, P242; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Mather AS, 1999, J RURAL STUD, V15, P65, DOI 10.1016/S0743-0167(98)00023-0; Mather AS, 2000, GEOGR J, V166, P2, DOI 10.1111/j.1475-4959.2000.tb00002.x; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Miflin B, 2000, J EXP BOT, V51, P1, DOI 10.1093/jexbot/51.342.1; Norwood B, 2004, AM J AGR ECON, V86, P1032, DOI 10.1111/j.0002-9092.2004.00651.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Satake A, 2007, ECOL APPL, V17, P2024, DOI 10.1890/07-0283.1; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Tobler W, 1995, TR956 U SANT BARB NA; Waggoner PE, 2001, POPUL DEV REV, V27, P239, DOI 10.1111/j.1728-4457.2001.00239.x; Walker AS, 1996, US GEOLOGICAL SURVEY; Wirsenius S, 2010, AGR SYST, V103, P621, DOI 10.1016/j.agsy.2010.07.005	29	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75890	10.1371/journal.pone.0075890	http://dx.doi.org/10.1371/journal.pone.0075890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130750	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900063
J	Fozouni, N; Chopp, M; Nejad-Davarani, SP; Zhang, ZG; Lehman, NL; Gu, S; Ueno, Y; Lu, M; Ding, GL; Li, L; Hu, JN; Bagher-Ebadian, H; Hearshen, D; Jiang, Q				Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Lehman, Norman L.; Gu, Steven; Ueno, Yuji; Lu, Mei; Ding, Guangliang; Li, Lian; Hu, Jiani; Bagher-Ebadian, Hassan; Hearshen, David; Jiang, Quan			Characterizing Brain Structures and Remodeling after TBI Based on Information Content, Diffusion Entropy	PLOS ONE			English	Article							WATER DIFFUSION; NERVOUS-SYSTEM; TENSOR; MRI; ANISOTROPY; COEFFICIENT; MODEL; RECOVERY; TISSUES; INDEXES	Background: To overcome the limitations of conventional diffusion tensor magnetic resonance imaging resulting from the assumption of a Gaussian diffusion model for characterizing voxels containing multiple axonal orientations, Shannon's entropy was employed to evaluate white matter structure in human brain and in brain remodeling after traumatic brain injury (TBI) in a rat. Methods: Thirteen healthy subjects were investigated using a Q-ball based DTI data sampling scheme. FA and entropy values were measured in white matter bundles, white matter fiber crossing areas, different gray matter (GM) regions and cerebrospinal fluid (CSF). Axonal densities' from the same regions of interest (ROIs) were evaluated in Bielschowsky and Luxol fast blue stained autopsy (n = 30) brain sections by light microscopy. As a case demonstration, a Wistar rat subjected to TBI and treated with bone marrow stromal cells (MSC) 1 week after TBI was employed to illustrate the superior ability of entropy over FA in detecting reorganized crossing axonal bundles as confirmed by histological analysis with Bielschowsky and Luxol fast blue staining. Results: Unlike FA, entropy was less affected by axonal orientation and more affected by axonal density. A significant agreement (r = 0.91) was detected between entropy values from in vivo human brain and histologically measured axonal density from post mortum from the same brain structures. The MSC treated TBI rat demonstrated that the entropy approach is superior to FA in detecting axonal remodeling after injury. Compared with FA, entropy detected new axonal remodeling regions with crossing axons, confirmed with immunohistological staining. Conclusions: Entropy measurement is more effective in distinguishing axonal remodeling after injury, when compared with FA. Entropy is also more sensitive to axonal density than axonal orientation, and thus may provide a more accurate reflection of axonal changes that occur in neurological injury and disease.	[Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Gu, Steven; Ueno, Yuji; Ding, Guangliang; Li, Lian; Bagher-Ebadian, Hassan; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Lehman, Norman L.] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; [Hearshen, David] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Hu, Jiani] Harper Hospita, MR Ctr, Detroit, MI USA; [Fozouni, Niloufar; Chopp, Michael; Zhang, Zheng Gang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	zhang, zheng/HCH-9684-2022; Lehman, Norman L/A-7351-2015; Ueno, Yuji/ABB-2492-2020; Nejad-Davarani, Siamak/AAH-8399-2021	Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689; Li, Lian/0000-0003-0097-1184; Lehman, Norman/0000-0001-8394-2607	National Institutes of Health [RO1 NS64134, RO1 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants RO1 NS64134, RO1 AG037506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, BIOESSAYS, V30, P1235, DOI 10.1002/bies.20851; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bastin ME, 1999, NEUROREPORT, V10, P1385, DOI 10.1097/00001756-199905140-00001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Chen Y, 2005, LECT NOTES COMPUT SC, V3565, P246; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Horsfield MA, 1998, J NEUROL NEUROSUR PS, V64, pS80; Inglis BA, 1999, AM J NEURORADIOL, V20, P713; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Jones DK, 1999, STROKE, V30, P393, DOI 10.1161/01.STR.30.2.393; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Metwalli Nader S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2260; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Shannon CE, 1997, M D COMPUT, V14, P306; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; von Bohlen und Halbach O, 1998, J NEUROSCI METH, V81, P169, DOI 10.1016/S0165-0270(98)00026-0; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wieshmann UC, 1999, NEUROIMAGE, V10, P225, DOI 10.1006/nimg.1999.0456; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zivadinov R, 2008, J NEUROL, V255, P61, DOI 10.1007/s00415-008-1009-1	54	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76343	10.1371/journal.pone.0076343	http://dx.doi.org/10.1371/journal.pone.0076343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143186	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100021
J	Shen, F; Huang, W; Qi, JH; Yuan, BF; Huang, JT; Zhou, X; Feng, YQ; Liu, YJ; Liu, SM				Shen, Fan; Huang, Wei; Qi, Jia-Hui; Yuan, Bi-Feng; Huang, Jing-Tao; Zhou, Xin; Feng, Yu-Qi; Liu, Ying-Juan; Liu, Song-Mei			Association of 5-Methylcytosine and 5-Hydroxymethylcytosine with Mitochondrial DNA Content and Clinical and Biochemical Parameters in Hepatocellular Carcinoma	PLOS ONE			English	Article							COPY NUMBER; GENOME INSTABILITY; COLORECTAL ADENOMA; TET PROTEINS; METHYLATION; CANCER; DEPLETION; HYPOMETHYLATION; RISK; PROGRESSION	Increasing epidemiological evidence has indicated that inherited variations of mitochondrial DNA (mtDNA) copy number affect the genetic susceptibility of many malignancies in a tumour-specific manner and that DNA methylation also plays an important role in controlling gene expression during the differentiation and development of hepatocellular carcinoma (HCC). Our previous study demonstrated that HCC tissues showed a lower 5-hydroxymethylcytosine (5-hmC) content when compared to tumour-adjacent tissues, but the relationship among 5-hmC, 5-methylcytosine (5-mC) and mtDNA content in HCC patients is still unknown. This study aimed to clarify the correlation among mtDNA content, 5-mC and 5-hmC by quantitative real-time PCR and liquid chromatography tandem mass spectrometry analysis. We demonstrated that 5-hmC correlated with tumour size [odds ratio (OR) 0.847, 95% confidence interval (CI) 0.746-0.962, P = 0.011], and HCC patients with a tumour size >= 5.0 cm showed a lower 5-hmC content and higher levels of fasting plasma aspartate aminotransferase, the ratio of alanine amiotransferase to aspartate aminotransferase, c-glutamyltransferase, alpha-fetoprotein than those with a tumour size <5 cm (all P<0.05). We further revealed that the mtDNA content of HCC tumour tissues was 225.97(105.42, 430.54) [median (25th Percentile, 75th Percentile)] and was negatively correlated with 5-mC content (P = 0.035), but not 5-hmC content, in genomic DNA from HCC tumour tissues.	[Shen, Fan; Qi, Jia-Hui; Huang, Jing-Tao; Zhou, Xin; Liu, Ying-Juan; Liu, Song-Mei] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Med Res Ctr, Wuhan 430072, Hubei, Peoples R China; [Huang, Wei; Yuan, Bi-Feng; Feng, Yu-Qi] Wuhan Univ, Dept Chem, Key Lab Analyt Chem Biol & Med, Minist Educ, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Liu, SM (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Med Res Ctr, Wuhan 430072, Hubei, Peoples R China.	liu_sm@126.com	Yuan, Bi-Feng/K-5803-2013; Feng, Yu-Qi/H-1479-2011	Yuan, Bi-Feng/0000-0001-5223-4659; Feng, Yu-Qi/0000-0003-1107-5385; Shen, Fan/0000-0001-7432-8891	National Basic Research Program of China (973 Program) [2012CB720600, 2012CB720601, 2012CB720605]; National Natural Science Foundation of China [81271919, 91217309, 21205091, 21228501]; Fundamental Research Funds for the Central Universities [2012303020209]; Natural Science Foundation of Hubei Province [2012FFB04405]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The work described in this paper was supported by the National Basic Research Program of China (973 Program) (2012CB720600, 2012CB720601, 2012CB720605), the National Natural Science Foundation of China (81271919, 91217309, 21205091, 21228501), the Fundamental Research Funds for the Central Universities (2012303020209) and the Natural Science Foundation of Hubei Province (2012FFB04405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral A, 2007, HUM REPROD, V22, P1585, DOI 10.1093/humrep/dem030; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bai RK, 2011, J ONCOL, V2011, DOI 10.1155/2011/496189; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6; Chang CM, 2011, LAB CHIP, V11, P2693, DOI 10.1039/c1lc20317g; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Czarnecka AM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-31; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng S, 2012, MOL MED REP, V6, P125, DOI 10.3892/mmr.2012.870; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hann HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047687; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Liao LM, 2011, CANCER EPIDEM BIOMAR, V20, P1944, DOI 10.1158/1055-9965.EPI-11-0379; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Lin CS, 2012, INT J MOL SCI, V13, P11228, DOI 10.3390/ijms130911228; Liu CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062828; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019; Navratil M, 2007, ANAL CHEM, V79, P7691, DOI 10.1021/ac0709192; Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; THOMAS GA, 1992, CARCINOGENESIS, V13, P1039, DOI 10.1093/carcin/13.6.1039; Venegas Victor, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1907s68; Villa AM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046001; Wen CP, 2012, J NATL CANCER I, V104, P1599, DOI 10.1093/jnci/djs372; WILSON MJ, 1984, BIOCHEM J, V218, P987, DOI 10.1042/bj2180987; Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002; Yamauchi A, 2005, GENETICS, V171, P1387, DOI 10.1534/genetics.104.036350; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2009, EUR J CANCER PREV, V18, P445, DOI 10.1097/CEJ.0b013e32832f9bd6; Zhao SY, 2011, CANCER SCI, V102, P1553, DOI 10.1111/j.1349-7006.2011.01968.x; Zheng SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031322; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	52	10	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76967	10.1371/journal.pone.0076967	http://dx.doi.org/10.1371/journal.pone.0076967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143196	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100031
J	Sole, M; Lenoir, M; Durfort, M; Lopez-Bejar, M; Lombarte, A; Andre, M				Sole, Marta; Lenoir, Marc; Durfort, Merce; Lopez-Bejar, Manel; Lombarte, Antoni; Andre, Michel			Ultrastructural Damage of Loligo vulgaris and Illex coindetii statocysts after Low Frequency Sound Exposure	PLOS ONE			English	Article							HIGH-INTENSITY; EVOKED-POTENTIALS; THRESHOLD SHIFTS; NOISE; FISH; HEARING; CEPHALOPODS; SONAR; EAR; INVERTEBRATE	There is a considerable lack of information concerning marine invertebrate sensitivity to sound exposure. However, recent findings on cuttlefish and octopi showed that exposure to artificial noise had a direct consequence on the functionality and physiology of the statocysts, sensory organs, which are responsible for their equilibrium and movements in the water column. Owing to a lack of available data on deep diving cephalopod species, we conducted a noise exposure comparative experiment on one Mediterranean squid, Illex coindetii, and on the European squid Loligo vulgaris. Scanning electron microscopy (SEM) revealed similar injuries in the inner structure of the statocysts, as those found in cuttlefish and octopi. In addition to the ultrastructural description of the lesions, we publish here the first images of the crista-cupula system and inner statocyst cavity of I. coindetii.	[Sole, Marta; Andre, Michel] Tech Univ Catalonia, Lab Appl Bioacoust, Barcelona, Spain; [Lenoir, Marc] Inst Neurosci Montpellier, INSERM U1051, Montpellier, France; [Durfort, Merce] Univ Barcelona, Fac Biol, Dept Cellular Biol, Barcelona, Spain; [Lopez-Bejar, Manel] Univ Autonoma Barcelona, Fac Vet Sci, Dept Anim Hlth & Anat, Bellaterra, Cerdanyola Del, Spain; [Lombarte, Antoni] Marine Sci Inst ICM CMIMA CSIC, Renewable Marine Resources Dept, Barcelona, Spain	Universitat Politecnica de Catalunya; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Andre, M (corresponding author), Tech Univ Catalonia, Lab Appl Bioacoust, Barcelona, Spain.	michel.andre@upc.edu	Lopez-Bejar, Manel A/E-8200-2012; Lopez-Bejar, Manel/S-2429-2019; Lombarte, Antoni/D-3142-2013	Lopez-Bejar, Manel A/0000-0001-9490-6126; Lopez-Bejar, Manel/0000-0001-9490-6126; Lombarte, Antoni/0000-0001-5215-4587; Andre, Michel/0000-0002-0091-7279; DURFORT, M./0000-0003-3640-9580; Sole, Marta/0000-0002-7704-5157	Spanish Ministry of the Environment [083/SDGTB/2007]	Spanish Ministry of the Environment(Spanish Government)	The Spanish Ministry of the Environment kindly funded this work (contract 083/SDGTB/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2011, FRONT ECOL ENVIRON, V9, P489, DOI 10.1890/100124; Andre M, 2009, NUCL INSTRUM METH A, V602, P262, DOI 10.1016/j.nima.2008.12.223; BIGELOW KA, 1992, MAR ECOL PROG SER, V82, P31, DOI 10.3354/meps082031; Budelmann B.U., 1990, P421; Budelmann B.-U., 1988, P757; BUDELMANN BU, 1987, PHILOS T R SOC B, V315, P305, DOI 10.1098/rstb.1987.0010; BUDELMANN BU, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P141; Budelmann BU, 1996, MICROSCOPIC ANATOMY, P119; Casper BM, 2013, COMP BIOCHEM PHYS A, V166, P352, DOI 10.1016/j.cbpa.2013.07.008; COLMERS WF, 1984, CELL TISSUE RES, V236, P505; Edren SMC, 2010, MAR MAMMAL SCI, V26, P614, DOI 10.1111/j.1748-7692.2009.00364.x; Enger P.S., 1981, HEARING SOUND COMMUN, P243, DOI DOI 10.1007/978-1-4615-7186-5_12; Fewtrell JL, 2012, MAR POLLUT BULL, V64, P984, DOI 10.1016/j.marpolbul.2012.02.009; Finneran JJ, 2007, J ACOUST SOC AM, V122, P1249, DOI 10.1121/1.2749447; Guerra A, 2004, REV RECORDS GIANT SQ, pCC 29; GUERRA A, 2004, INVESTIGACION CIENCI, V334, P35; Guerra A, 2011, BIOL CONSERV, V144, P1989, DOI 10.1016/j.biocon.2011.04.021; Guerra Angel, 1992, FAUNA IBERICA, VI; HAMERNIK RP, 1994, J ACOUST SOC AM, V95, P444, DOI 10.1121/1.408338; Hastings MC, 1996, J ACOUST SOC AM, V99, P1759, DOI 10.1121/1.414699; Hastings MC, 1995, PROCEEDINGS OF INTER-NOISE 95 - THE 1995 INTERNATIONAL CONGRESS ON NOISE CONTROL ENGINEERING, VOLS 1 AND 2, P979; Henderson Donald, 2008, V31, P195; Hu MY, 2009, COMP BIOCHEM PHYS A, V153, P278, DOI 10.1016/j.cbpa.2009.02.040; Kane AS, 2010, J FISH BIOL, V76, P1825, DOI 10.1111/j.1095-8649.2010.02626.x; LAGARDERE JP, 1982, MAR BIOL, V71, P177, DOI 10.1007/BF00394627; LOMBARTE A, 1993, HEARING RES, V64, P166, DOI 10.1016/0378-5955(93)90002-I; Lovell JM, 2006, J EXP BIOL, V209, P2480, DOI 10.1242/jeb.02211; Lovell JM, 2005, COMP BIOCHEM PHYS A, V140, P89, DOI 10.1016/j.cbpb.2004.11.003; Lucke K, 2009, J ACOUST SOC AM, V125, P4060, DOI 10.1121/1.3117443; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Nachtigall PE, 2004, MAR MAMMAL SCI, V20, P673, DOI 10.1111/j.1748-7692.2004.tb01187.x; PACKARD A, 1990, J COMP PHYSIOL A, V166, P501; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper AN, 2005, J ACOUST SOC AM, V117, P3958, DOI 10.1121/1.1904386; Popper AN, 2007, J ACOUST SOC AM, V122, P623, DOI 10.1121/1.2735115; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Puel JL, 2002, ADV OTO-RHINO-LARYNG, V59, P124; REGNAULT M, 1983, MAR ECOL PROG SER, V11, P71; Schlundt CE, 2006, J ACOUST SOC AM, V120, P3227; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Sole M, 2013, DEEP-SEA RES PT II, V95, P160, DOI 10.1016/j.dsr2.2012.10.006; STEPHENS PR, 1982, J ZOOL, V197, P241, DOI 10.1111/jzo.1982.197.2.241; Williamson R, 1995, CEPHALOPOD NEUROBIOL, P542; Williamson R, 2007, PHILOS T R SOC B, V362, P473, DOI 10.1098/rstb.2006.1975	48	27	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78825	10.1371/journal.pone.0078825	http://dx.doi.org/10.1371/journal.pone.0078825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143265	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100104
J	Thomas, MA; Song, R; Demberg, T; Vargas-Inchaustegui, DA; Venzon, D; Robert-Guroff, M				Thomas, Michael A.; Song, Rui; Demberg, Thorsten; Vargas-Inchaustegui, Diego A.; Venzon, David; Robert-Guroff, Marjorie			Effects of the Deletion of Early Region 4 (E4) Open Reading Frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on Virus-Host Cell Interaction, Transgene Expression, and Immunogenicity of Replicating Adenovirus HIV Vaccine Vectors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIGEN PRESENTATION; CYCLIN-E; DNA-REPLICATION; RHESUS MACAQUES; DENDRITIC CELLS; T-LYMPHOCYTES; GENE-PRODUCTS; RANGE MUTANT; PROTECTION	The global health burden engendered by human immunodeficiency virus (HIV)-induced acquired immunodeficiency syndrome (AIDS) is a sobering reminder of the pressing need for a preventative vaccine. In non-human primate models replicating adenovirus (Ad)-HIV/SIV recombinant vaccine vectors have been shown to stimulate potent immune responses culminating in protection against challenge exposures. Nonetheless, an increase in the transgene carrying capacity of these Ad vectors, currently limited to approximately 3000 base pairs, would greatly enhance their utility. Using a replicating, E3-deleted Ad type 5 host range mutant (Ad5 hr) encoding full-length single-chain HIV(BaL)gp120 linked to the D1 and D2 domains of rhesus macaque CD4 (rhFLSC) we systematically deleted the genes encoding early region 4 open reading frame 1 (E4orf1) through E4orf4. All the Ad-rhFLSC vectors produced similar levels of viral progeny. Cell cycle analysis of infected human and monkey cells revealed no differences in virus-host interaction. The parental and E4-deleted viruses expressed comparable levels of the transgene with kinetics similar to Ad late proteins. Similar levels of cellular immune responses and transgene-specific antibodies were elicited in vaccinated mice. However, differences in recognition of Ad proteins and induced antibody subtypes were observed, suggesting that the E4 gene products might modulate antibody responses by as yet unknown mechanisms. In short, we have improved the transgene carrying capacity by one thousand base pairs while preserving the replicability, levels of transgene expression, and immunogenicity critical to these vaccine vectors. This additional space allows for flexibility in vaccine design that could not be obtained with the current vector and as such should facilitate the goal of improving vaccine efficacy. To the best of our knowledge, this is the first report describing the effects of these E4 deletions on transgene expression and immunogenicity in a replicating Ad vector.	[Thomas, Michael A.; Song, Rui; Demberg, Thorsten; Vargas-Inchaustegui, Diego A.; Robert-Guroff, Marjorie] NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Robert-Guroff, M (corresponding author), NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD 20892 USA.	guroffm@mail.nih.gov			National Institutes of Health (NIH), National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011063] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RLP, 1967, J BIOL CHEM, V242, P1314; Alexander J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031177; Bennett EM, 1999, J IMMUNOL, V162, P5049; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; BRAITHWAITE AW, 1981, J VIROL, V39, P331, DOI 10.1128/JVI.39.2.331-340.1981; BRIDGE E, 1989, J VIROL, V63, P631, DOI 10.1128/JVI.63.2.631-638.1989; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Burgert HG, 2002, CURR TOP MICROBIOL, V269, P273; CHANDA PK, 1990, VIROLOGY, V175, P535, DOI 10.1016/0042-6822(90)90438-W; Chang SK, 2002, MOL CELLS, V14, P130; CHENG SM, 1992, J VIROL, V66, P6721, DOI 10.1128/JVI.66.11.6721-6727.1992; Cherubini G, 2006, CELL CYCLE, V5, P2244, DOI 10.4161/cc.5.19.3263; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Demberg T, 2007, J VIROL, V81, P3414, DOI 10.1128/JVI.02453-06; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; GaherySegard H, 1997, EUR J IMMUNOL, V27, P653, DOI 10.1002/eji.1830270312; Gurwith M, 2013, LANCET INFECT DIS; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hidajat R, 2010, VACCINE, V28, P3963, DOI 10.1016/j.vaccine.2010.03.046; HUANG MM, 1989, J VIROL, V63, P2605, DOI 10.1128/JVI.63.6.2605-2615.1989; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kaplan JM, 1999, J VIROL, V73, P4489, DOI 10.1128/JVI.73.5.4489-4492.1999; LEMAY P, 1984, J GEN VIROL, V65, P1419, DOI 10.1099/0022-1317-65-8-1419; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; Lusky M, 1999, J VIROL, V73, P8308, DOI 10.1128/JVI.73.10.8308-8319.1999; Malkevitch NV, 2006, VIROLOGY, V353, P83, DOI 10.1016/j.virol.2006.05.012; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Medghalchi S, 1997, VIROLOGY, V236, P8, DOI 10.1006/viro.1997.8737; MURRAY JD, 1981, J GEN VIROL, V57, P221, DOI 10.1099/0022-1317-57-1-221; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Parreno M, 2001, ONCOGENE, V20, P4793, DOI 10.1038/sj.onc.1204644; Patterson LJ, 2008, EXPERT OPIN BIOL TH, V8, P1347, DOI [10.1517/14712598.8.9.1347, 10.1517/14712598.8.9.1347 ]; Patterson LJ, 2012, CLIN VACCINE IMMUNOL, V19, P629, DOI 10.1128/CVI.00010-12; Patterson LJ, 2002, VIROLOGY, V292, P107, DOI 10.1006/viro.2001.1248; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Peng B, 2005, J VIROL, V79, P10200, DOI 10.1128/JVI.79.16.10200-10209.2005; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Querido E, 2001, J VIROL, V75, P699, DOI 10.1128/JVI.75.2.699-709.2001; Robert-Guroff M, 1998, J VIROL, V72, P10275, DOI 10.1128/JVI.72.12.10275-10280.1998; Samstag Y, 2003, ADV ENZYME REGUL, V43, P197, DOI 10.1016/S0065-2571(02)00031-6; Shen T, 2012, ANTI-CANCER AGENT ME, V12, P631, DOI 10.2174/187152012800617678; Shepard RN, 2004, J VIROL, V78, P9924, DOI 10.1128/JVI.78.18.9924-9935.2004; SHEPHERD SE, 1993, J VIROL, V67, P2944, DOI 10.1128/JVI.67.5.2944-2949.1993; Shurin GV, 2005, J IMMUNOL, V174, P3394, DOI 10.4049/jimmunol.174.6.3394; Sohn SY, 2012, J VIROL, V86, P9656, DOI 10.1128/JVI.01273-12; Song WX, 1997, INT IMMUNOL, V9, P1709, DOI 10.1093/intimm/9.11.1709; Spitkovsky D, 1996, ONCOGENE, V12, P2549; Thomas MA, 2009, J VIROL, V83, P2406, DOI 10.1128/JVI.01972-08; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zheng X, 2008, J VIROL, V82, P3415, DOI 10.1128/JVI.01708-07	54	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76344	10.1371/journal.pone.0076344	http://dx.doi.org/10.1371/journal.pone.0076344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143187	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100022
J	Warne, RW; Kardon, A; Crespi, EJ				Warne, Robin W.; Kardon, Adam; Crespi, Erica J.			Physiological, Behavioral and Maternal Factors That Contribute to Size Variation in Larval Amphibian Populations	PLOS ONE			English	Article							FROG RANA-SYLVATICA; CHEMICAL INTERFERENCE COMPETITION; WOOD FROG; LIFE-HISTORY; EGG SIZE; INDIVIDUAL-DIFFERENCES; ADAPTIVE PLASTICITY; ANIMAL PERSONALITY; STRESS HORMONES; GROWTH-RATE	Size variance among similarly aged individuals within populations is a pattern common to many organisms that is a result of interactions between intrinsic and extrinsic traits of individuals. While genetic and maternal effects, as well as physiological and behavioral traits have been shown to contribute to size variation in animal populations, teasing apart the influence of such factors on individual growth rates remain a challenge. Furthermore, tracing the effects of these interactions across life stages and in shaping adult phenotypes also requires further exploration. In this study we investigated the relationship between genetics, hatching patterns, behaviors, neuroendocrine stress axis activity and variance in growth and metamorphosis among same-aged larval amphibians. Through parallel experiments we found that in the absence of conspecific interactions, hatch time and to a lesser extent egg clutch identity (i.e. genetics and maternal effects) influenced the propensity for growth and development in individual tadpoles and determined metamorphic traits. Within experimental groups we found that variance in growth rates was associated with size-dependent foraging behaviors and responses to food restriction. We also found an inverse relationship between glucocorticoid (GC) hormone levels and body mass and developmental stage among group-reared tadpoles, which suggests that GC expression plays a role in regulating differing within-population growth trajectories in response to density-dependent conditions. Taken together these findings suggest that factors that influence hatching conditions can have long-term effects on growth and development. These results also raise compelling questions regarding the extent to which maternal and genetic factors influence physiological and behavioral profiles in amphibians.	[Warne, Robin W.; Kardon, Adam; Crespi, Erica J.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA	Vassar College	Warne, RW (corresponding author), So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA.	rwarne@siu.edu			National Science Foundation [IOS-0818212]; Vassar College Undergraduate Research Summer Institute	National Science Foundation(National Science Foundation (NSF)); Vassar College Undergraduate Research Summer Institute	This research was funded by a National Science Foundation grant IOS-0818212 and the Vassar College Undergraduate Research Summer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph EF, 1931, BIOL BULL-US, V61, P350, DOI 10.2307/1536953; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Belden LK, 2007, PHYSIOL BIOCHEM ZOOL, V80, P444, DOI 10.1086/518375; Bernardo J, 1996, AM ZOOL, V36, P216; BERVEN KA, 1982, OECOLOGIA, V52, P360, DOI 10.1007/BF00367960; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; BIESTERFELDT JM, 1993, COPEIA, P688; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; BREDEN F, 1982, ECOLOGY, V63, P1682, DOI 10.2307/1940110; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Chambers DL, 2011, COPEIA, P530, DOI 10.1643/CP-09-180; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Crespi EJ, 2005, COMP BIOCHEM PHYS A, V141, P381, DOI 10.1016/j.cbpb.2004.12.007; Crespi EJ, 2004, HORM BEHAV, V46, P399, DOI 10.1016/j.yhbeh.2004.03.011; Crespi EJ, 2013, INTEGRATIVE COMP BIO; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; CRUMP ML, 1981, OECOLOGIA, V49, P167, DOI 10.1007/BF00349184; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; Denver RJ, 2009, GEN COMP ENDOCRINOLO; Denver RJ, 2006, NEOREVIEWS, V7, pe183, DOI [DOI 10.1542/NEO.7-4-E183, 10.1542/NEO.7-4-E183]; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; Glennemeier KA, 2002, J EXP ZOOL, V292, P32, DOI 10.1002/jez.1140; Gosner K. L., 1960, Herpetologica, V16, P183; Haenel GJ, 2002, OIKOS, V96, P70, DOI 10.1034/j.1600-0706.2002.10915.x; Hayes TB, 1997, AM ZOOL, V37, P185; HOKIT DG, 1994, EVOLUTION, V48, P1383, DOI 10.1111/j.1558-5646.1994.tb05322.x; Hu F, 2008, ENDOCRINOLOGY, V149, P5470, DOI 10.1210/en.2008-0767; Huss M, 2008, OECOLOGIA, V158, P249, DOI 10.1007/s00442-008-1140-9; Huss M, 2010, OIKOS, V119, P384, DOI 10.1111/j.1600-0706.2009.17897.x; JASIENSKI M, 1988, OECOLOGIA, V77, P407, DOI 10.1007/BF00378052; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaplan RH, 1997, HERPETOLOGICA, V53, P149; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koprivnikar J, 2012, P ROY SOC B-BIOL SCI, V279, P1544, DOI 10.1098/rspb.2011.2156; Laurila A, 2002, EVOLUTION, V56, P617; Ledon-Rettig CC, 2009, J EXP BIOL, V212, P3743, DOI 10.1242/jeb.034066; McClure KV, 2009, ACTA HERPETOL, V4, P103; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Pakkasmaa S, 2003, OIKOS, V100, P55, DOI 10.1034/j.1600-0706.2003.11815.x; Peacor SD, 2006, J ANIM ECOL, V75, P990, DOI 10.1111/j.1365-2656.2006.01119.x; PETRANKA JW, 1989, COPEIA, P921, DOI 10.2307/1445978; Pfister CA, 2002, ECOLOGY, V83, P59; Reeves B., 2013, ENVIRON BEHAV, V20, P1; Relyea RA, 2002, ECOL MONOGR, V72, P523, DOI 10.1890/0012-9615(2002)072[0523:CIPITC]2.0.CO;2; Rot-Nikcevic I, 2006, BEHAV ECOL SOCIOBIOL, V60, P19, DOI 10.1007/s00265-005-0133-5; Rot-Nikcevic I, 2005, FUNCT ECOL, V19, P1008, DOI 10.1111/j.1365-2435.2005.01051.x; Saino N, 2001, J AVIAN BIOL, V32, P263, DOI 10.1111/j.0908-8857.2001.320309.x; SAS Institute, 1999, SAS STAT US GUID VER; Schmidt BR, 2012, ECOLOGY, V93, P657, DOI 10.1890/11-0892.1; SEMLITSCH RD, 1994, COPEIA, P406; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; Spear L, 1994, J ANIM ECOL, P283; TRAVIS J, 1984, ECOLOGY, V65, P1155, DOI 10.2307/1938323; UCHMANSKI J, 1985, PHILOS T ROY SOC B, V310, P1, DOI 10.1098/rstb.1985.0099; Vasconcelos D, 2004, J HERPETOL, V38, P551, DOI 10.1670/157-03A; WALDMAN B, 1984, BEHAV ECOL SOCIOBIOL, V14, P171, DOI 10.1007/BF00299616; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WERNER EE, 1992, COPEIA, P26, DOI 10.2307/1446532; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson ADM, 2012, TRENDS ECOL EVOL, V27, P529, DOI 10.1016/j.tree.2012.07.003	65	13	13	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76364	10.1371/journal.pone.0076364	http://dx.doi.org/10.1371/journal.pone.0076364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143188	gold, Green Submitted, Green Published			2022-12-27	WOS:000325894100023
J	Bot, AM; Debski, KJ; Lukasiuk, K				Bot, Anna Maria; Debski, Konrad Jozef; Lukasiuk, Katarzyna			Alterations in miRNA Levels in the Dentate Gyrus in Epileptic Rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MICROARRAY ANALYSIS; EXPRESSION PROFILE; NEURONAL-ACTIVITY; MICRORNAS; EPILEPTOGENESIS; NEUROPROTECTION; BIOINFORMATICS; PLASTICITY; CYTOKINES	The aim of this study was to characterize changes in miRNA expression in the epileptic dentate gyrus. Status epilepticus evoked by amygdala stimulation was used to induce epilepsy in rats. The dentate gyri were isolated at 7 d, 14 d, 30 d and 90 d after stimulation (n=5). Sham-operated time-matched controls were prepared for each time point (n=5). The miRNA expression was evaluated using Exiqon microarrays. Additionally, mRNA from the same animals was profiled using Affymetrix microarrays. We detected miRNA expression signatures that differentiate between control and epileptic animals. Significant changes in miRNA expression between stimulated and sham operated animals were observed at 7 and 30 d following stimulation. Moreover, we found that there are ensembles of miRNAs that change expression levels over time. Analysis of the mRNA expression from the same animals revealed that the expression of several mRNAs that are potential targets for miRNA with altered expression level is regulated in the expected direction. The functional characterization of miRNAs and their potential mRNA targets indicate that miRNA can participate in several molecular events that occur in epileptic tissue, including immune response and neuronal plasticity. This is the first report on changes in the expression of miRNA and the potential functional impact of these changes in the dentate gyrus of epileptic animals. Complex changes in the expression of miRNAs suggest an important role for miRNA in the molecular mechanisms of epilepsy.	[Bot, Anna Maria; Debski, Konrad Jozef; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Lukasiuk, K (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland.	k.lukasiuk@nencki.gov.pl	Lukasiuk, Katarzyna/F-4636-2010	Bot, Anna/0000-0003-1811-3647; Lukasiuk, Katarzyna/0000-0002-1582-0920; Debski, Konrad/0000-0001-5949-9211	National Research Centre [2011/01/M/NZ3/02139]; Ministry of Science and Education [DNP/N119/ESF-EuroEPINOMICS/2012]	National Research Centre(National Research Centre (NRC)); Ministry of Science and Education	This work was supported by National Research Centre grant 2011/01/M/NZ3/02139 and Ministry of Science and Education grant DNP/N119/ESF-EuroEPINOMICS/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zeid A, 2013, GENET TESTS MOL BIOM, V15, P807; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Banerjee P. N., 2008, EPILEPSY COMPREHENSI, P45; Banigan MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048814; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Futschik M., 2012, MFUZZ SOFT CLUSTERIN; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorter JA, 2007, EPILEPSIA, V48, P53, DOI 10.1111/j.1528-1167.2007.01290.x; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Guzik-Kornacka A, 2011, ACTA NEUROBIOL EXP, V71, P193; Hansen KF, 2013, BRAIN STRUCT FUNCT, V218, P817, DOI 10.1007/s00429-012-0431-4; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Houser CR, 2012, EPILEPSIA, V53, P67, DOI 10.1111/j.1528-1167.2012.03477.x; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Lehtimaki KA, 2003, MOL BRAIN RES, V110, P253, DOI 10.1016/S0169-328X(02)00654-X; Leite JP, 2005, EPILEPSIA, V46, P134, DOI 10.1111/j.1528-1167.2005.01021.x; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lukasiuk K, 2006, PROG BRAIN RES, V158, P223, DOI 10.1016/S0079-6123(06)58011-2; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Malan-Muller S, 2013, MOL NEUROBIOL, V47, P726, DOI 10.1007/s12035-012-8374-6; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; R Core Team, 2012, LANG ENV STAT COMP; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Sakar D., 2008, LATTICE MULTIVARIATE; Sano T, 2012, DROSOPHILA INF SERV, V3, pe287; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schouten M, 2013, NEUROSCIENCE, V241, P188, DOI 10.1016/j.neuroscience.2013.02.065; Scott HL, 2012, EUR J NEUROSCI, V36, P2941, DOI 10.1111/j.1460-9568.2012.08220.x; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sisodiya S, 2007, NAT CLIN PRACT NEURO, V3, P320, DOI 10.1038/ncpneuro0521; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Wang RY, 2013, HIPPOCAMPUS, V23, P625, DOI 10.1002/hipo.22123; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Wang Y, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/276540; Warnes GR, 2012, GPLOTS VARIOUS R PRO; Wei T, 2012, CORRPLOT VISUALIZATI; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164	66	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76051	10.1371/journal.pone.0076051	http://dx.doi.org/10.1371/journal.pone.0076051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146813	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400035
J	Goodson, JM; Tavares, M; Wang, XS; Niederman, R; Cugini, M; Hasturk, H; Barake, R; Alsmadi, O; Al-Mutawa, S; Ariga, J; Soparkar, P; Behbehani, J; Behbehani, K				Goodson, J. Max; Tavares, Mary; Wang, Xiaoshan; Niederman, Richard; Cugini, Maryann; Hasturk, Hatice; Barake, Roula; Alsmadi, Osama; Al-Mutawa, Sabiha; Ariga, Jitendra; Soparkar, Pramod; Behbehani, Jawad; Behbehani, Kazem			Obesity and Dental Decay: Inference on the Role of Dietary Sugar	PLOS ONE			English	Article							NUTRITIONAL-STATUS; KUWAITI CHILDREN; US CHILDREN; CARIES; ASSOCIATION; SCHOOLCHILDREN; ADOLESCENTS; OVERWEIGHT; RATES	Objective: To evaluate the relationship of children's obesity and dental decay. Methods: We measured parameters related to obesity and dental decay in 8,275 4th and 5th grade Kuwaiti children (average age=11.36 years) in a cross-sectional study. First to determine body weight, height, age for computation of BMI. Second, to determine numbers of teeth, numbers of fillings and numbers of untreated decayed teeth to determine extent and severity of dental disease. From these measurements, we computed measures of dental decay in children from four body weight categories; obese, overweight, normal healthy weight and underweight children. Results: The percentage of children with decayed or filled teeth varied inversely with the body weight category. The percentage of decayed or filled teeth decreased from 15.61% (n=193) in underweight children, to 13.03% (n=4,094) in normal healthy weight children, to 9.73% (n=1,786) in overweight children to 7.87% (n=2,202) in obese children. Differences between all groups were statistically significant. Male children in this population had more dental decay than female children but the reduction of tooth decay as a function of BMI was greater in male children. Conclusions: The finding of an inverse obesity-dental decay relationship contradicts the obesity-sugar and the obesity-dental decay relationship hypotheses. Sugar is well recognized as necessary and sufficient for dental decay. Sugar is also hypothesized to be a leading co-factor in obesity. If the later hypothesis is true, one would expect dental decay to increase with obesity. This was not found. The reasons for this inverse relationship are not currently clear.	[Goodson, J. Max; Tavares, Mary; Wang, Xiaoshan; Niederman, Richard; Cugini, Maryann; Hasturk, Hatice; Soparkar, Pramod] Forsyth Inst, Cambridge, MA USA; [Barake, Roula] Dasman Diabet Inst, Nutr Serv, Kuwait, Kuwait; [Alsmadi, Osama; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Al-Mutawa, Sabiha] Minist Hlth, Kuwait, Kuwait; [Ariga, Jitendra] Minist Hlth, Sch Oral Hlth Program, Kuwait, Kuwait; [Behbehani, Jawad] Kuwait Univ, Fac Dent, Kuwait, Kuwait	Harvard University; Forsyth Institute; Kuwait University	Goodson, JM (corresponding author), Forsyth Inst, Cambridge, MA USA.	mgoodson@forsyth.org	Wang, Xiaoshan/D-6292-2014	Wang, Xiaoshan/0000-0002-6760-5456; Barake, Roula/0000-0002-9461-2897; Tavares, Mary/0000-0003-4705-1238; niederman, richard/0000-0001-6674-1774	Dasman Institute, Kuwait	Dasman Institute, Kuwait	This work was funded by the Dasman Institute, Kuwait. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuZeid K, 2007, AR WAT HLTH C EG CAI; Al-Isa AN, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/459261; Al-Mutawa SA, 2006, COMMUNITY DENT HLTH, V23, P31; BAYOUMI A, 1985, INT J EPIDEMIOL, V14, P415, DOI 10.1093/ije/14.3.415; Behbehani JM, 2002, MED PRIN PRACT, V11, P36, DOI 10.1159/000057777; Burt B A, 2001, J Dent Educ, V65, P1017; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Hayden C, 2013, COMMUNITY DENT ORAL, V41, P289, DOI 10.1111/cdoe.12014; Hettmansperger TP, 2012, ROBUST NONPARAMETRIC; Hujoel P, 2009, J DENT RES, V88, P490, DOI 10.1177/0022034509337700; Jackson RT, 2011, PUBLIC HEALTH NUTR, V14, P70, DOI 10.1017/S1368980010002600; Kopycka-Kedzierawski DT, 2008, COMMUNITY DENT ORAL, V36, P157, DOI 10.1111/j.1600-0528.2007.00384.x; Macek MD, 2006, PEDIATR DENT, V28, P375; MOORE WJ, 1972, CARIES RES, V7, P139, DOI 10.1159/000259838; Narksawat K, 2009, SE ASIAN J TROP MED, V40, P338; *NRC, 1989, DIET HLTH IMPL RED C; Oliveira LB, 2008, EUR J ORAL SCI, V116, P37, DOI 10.1111/j.1600-0722.2007.00507.x; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Te Morenga L, 2013, BR MED J CLIN RES ED	20	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e74461	10.1371/journal.pone.0074461	http://dx.doi.org/10.1371/journal.pone.0074461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130667	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200001
J	Guay, C; Joly, E; Pepin, E; Barbeau, A; Hentsch, L; Pineda, M; Madiraju, SRM; Brunengraber, H; Prentki, M				Guay, Claudiane; Joly, Erik; Pepin, Emilie; Barbeau, Annie; Hentsch, Lisa; Pineda, Marco; Madiraju, S. R. Murthy; Brunengraber, Henri; Prentki, Marc			A Role for Cytosolic Isocitrate Dehydrogenase as a Negative Regulator of Glucose Signaling for Insulin Secretion in Pancreatic beta-Cells	PLOS ONE			English	Article							CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE; TRICARBOXYLIC-ACID CYCLE; ATP-CITRATE LYASE; MALIC ENZYME; PYRUVATE-CARBOXYLASE; OXIDATIVE DAMAGE; MALONYL-COA; CA2+-DEPENDENT EXOCYTOSIS; MASS-SPECTROMETRY; CELLULAR DEFENSE	Cytosolic NADPH may act as one of the signals that couple glucose metabolism to insulin secretion in the pancreatic beta-cell. NADPH levels in the cytoplasm are largely controlled by the cytosolic isoforms of malic enzyme and isocitrate dehydrogenase (IDHc). Some studies have provided evidence for a role of malic enzyme in glucose-induced insulin secretion (GIIS) via pyruvate cycling, but the role of IDHc in beta-cell signaling is unsettled. IDHc is an established component of the isocitrate/alpha-ketoglutarate shuttle that transfers reducing equivalents (NADPH) from the mitochondrion to the cytosol. This shuttle is energy consuming since it is coupled to nicotinamide nucleotide transhydrogenase that uses the mitochondrial proton gradient to produce mitochondrial NADPH and NAD(+) from NADP(+) and NADH. To determine whether flux through IDHc is positively or negatively linked to GIIS, we performed RNAi knockdown experiments in beta-cells. Reduced IDHc expression in INS 832/13 cells and isolated rat islet beta-cells resulted in enhanced GIIS. This effect was mediated at least in part via the K-ATP-independent amplification arm of GIIS. IDHc knockdown in INS 832/13 cells did not alter glucose oxidation but it reduced fatty acid oxidation and increased lipogenesis from glucose. Metabolome profiling in INS 832/13 cells showed that IDHc knockdown increased isocitrate and NADP(+) levels. It also increased the cellular contents of several metabolites linked to GIIS, in particular some Krebs cycle intermediates, acetyl-CoA, glutamate, cAMP and ATP. The results identify IDHc as a component of the emerging pathways that negatively regulate GIIS.	[Guay, Claudiane; Joly, Erik; Pepin, Emilie; Barbeau, Annie; Hentsch, Lisa; Pineda, Marco; Madiraju, S. R. Murthy; Prentki, Marc] CR CHUM, Ctr Hosp Univ Montreal, Mol Nutr Unit, Montreal, PQ, Canada; [Guay, Claudiane; Joly, Erik; Pepin, Emilie; Barbeau, Annie; Hentsch, Lisa; Pineda, Marco; Madiraju, S. R. Murthy; Prentki, Marc] CR CHUM, Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Brunengraber, Henri] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Case Western Reserve University	Guay, C (corresponding author), CR CHUM, Ctr Hosp Univ Montreal, Mol Nutr Unit, Montreal, PQ, Canada.	marc.prentki@umontreal.ca	Guay, Claudiane/AAF-5381-2019; Hentsch, Lisa/AAA-5081-2022	Hentsch, Lisa/0000-0002-3430-370X; Guay, Claudiane/0000-0002-6478-8744	Canadian Institute of Health Research; National Institutes of Health Roadmap [R33DK070291]; Fonds de Recherche en Sante du Quebec; Programmes de Biologie Moleculaire de l'Universite de Montreal; Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Programmes de Biologie Moleculaire de l'Universite de Montreal; Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Canadian Institute of Health Research (to M. Prentki) and by the National Institutes of Health Roadmap Grant R33DK070291 (to H. B.). M. Prentki is a recipient of a Canada research chair in diabetes and metabolism. C. Guay was supported by a graduate studentships from the Fonds de Recherche en Sante du Quebec and from Programmes de Biologie Moleculaire de l'Universite de Montreal. E. Pepin was supported by a graduate studentship from Programmes de Biologie Moleculaire de l'Universite de Montreal and from Diabete Quebec. A. Barbeau was supported by a graduate studentship from Diabete Quebec.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT F M, 1991, Current Opinion in Cell Biology, V3, P671, DOI 10.1016/0955-0674(91)90040-6; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fulgencio JP, 1996, DIABETES, V45, P1556, DOI 10.2337/diabetes.45.11.1556; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; HEDESKOV CJ, 1987, BIOCHEM J, V241, P161, DOI 10.1042/bj2410161; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HENQUIN JC, 1992, ENDOCRINOLOGY, V131, P127, DOI 10.1210/en.131.1.127; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Icyuz M, 2009, TRANSPLANTATION, V87, P821, DOI 10.1097/TP.0b013e318199c686; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; KHAN A, 1990, DIABETES, V39, P456, DOI 10.2337/diabetes.39.4.456; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim SY, 2007, MOL CELL BIOCHEM, V302, P27, DOI 10.1007/s11010-007-9421-x; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Lee SM, 2009, FREE RADICAL RES, V43, P165, DOI 10.1080/10715760802653661; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lorenz MA, 2013, J BIOL CHEM; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Massie B, 1998, J VIROL, V72, P2289, DOI 10.1128/JVI.72.3.2289-2296.1998; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MCGARRY JD, 1976, J LIPID RES, V17, P277; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Pepin E, 2010, J DIABETES, V2, P157, DOI 10.1111/j.1753-0407.2010.00076.x; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Qian TX, 2004, ANAL BIOCHEM, V325, P77, DOI 10.1016/j.ab.2003.10.028; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SIES H, 1977, EUR J BIOCHEM, V72, P301, DOI 10.1111/j.1432-1033.1977.tb11253.x; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; Xu J, 2008, DIABETOLOGIA, V51, P2281, DOI 10.1007/s00125-008-1155-0	80	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77097	10.1371/journal.pone.0077097	http://dx.doi.org/10.1371/journal.pone.0077097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130841	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200058
J	Wadhwa, R; Singh, R; Gao, R; Shah, N; Widodo, N; Nakamoto, T; Ishida, Y; Terao, K; Kaul, SC				Wadhwa, Renu; Singh, Rumani; Gao, Ran; Shah, Navjot; Widodo, Nashi; Nakamoto, Tomoko; Ishida, Yoshiyuki; Terao, Keiji; Kaul, Sunil C.			Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action	PLOS ONE			English	Article							SOMNIFERA ROOT EXTRACT; NF-KAPPA-B; WITHANIA-SOMNIFERA; CANCER-CELLS; WITHANOLIDE-A; LEAF EXTRACT; BALB/C MICE; WITHAFERIN; APOPTOSIS; DISEASE	Background: Cancer is a leading cause of death accounting for 15-20% of global mortality. Although advancements in diagnostic and therapeutic technologies have improved cancer survival statistics, 75% of the world population live in underdeveloped regions and have poor access to the advanced medical remedies. Natural therapies hence become an alternative choice of treatment. Ashwagandha, a tropical herb used in Indian Ayurvedic medicine, has a long history of its health promoting and therapeutic effects. In the present study, we have investigated an anticancer activity in the water extract of Ashwagandha leaves (ASH-WEX). Methodology/Principal Findings: Anticancer activity in the water extract of Ashwagandha leaves (ASH-WEX) was detected by in vitro and in vivo assays. Bioactivity-based size fractionation and NMR analysis were performed to identify the active anticancer component(s). Mechanism of anticancer activity in the extract and its purified component was investigated by biochemical assays. We report that the ASH-WEX is cytotoxic to cancer cells selectively, and causes tumor suppression in vivo. Its active anticancer component was identified as triethylene glycol (TEG). Molecular analysis revealed activation of tumor suppressor proteins p53 and pRB by ASH-WEX and TEG in cancer cells. In contrast to the hypophosphorylation of pRB, decrease in cyclin B1 and increase in cyclin D1 in ASH-WEX and TEG-treated cancer cells (undergoing growth arrest), normal cells showed increase in pRB phosphorylation and cyclin B1, and decrease in cyclin D1 (signifying their cell cycle progression). We also found that the MMP-3 and MMP-9 that regulate metastasis were down regulated in ASH-WEX and TEG-treated cancer cells; normal cells remained unaffected. Conclusion: We provide the first molecular evidence that the ASH-WEX and TEG have selective cancer cell growth arrest activity and hence may offer natural and economic resources for anticancer medicine.	[Wadhwa, Renu; Singh, Rumani; Gao, Ran; Shah, Navjot; Widodo, Nashi; Nakamoto, Tomoko; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Ishida, Yoshiyuki; Terao, Keiji] Brawijaya Univ, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia; [Widodo, Nashi] CycloChem Co Ltd, Chuo Ku, Kobe, Hyogo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Brawijaya University	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018; widodo, nashi/X-4595-2019	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; widodo, nashi/0000-0002-1126-498X; Gao, Ran/0000-0001-8712-429X	Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan; Innovation School Post-doctoral Fellowship, National Institute of Advanced Industrial Science & Technology (AIST), Japan	Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan; Innovation School Post-doctoral Fellowship, National Institute of Advanced Industrial Science & Technology (AIST), Japan	Rumani Singh was supported by the Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan. Ran Gao was supported by Innovation School Post-doctoral Fellowship, National Institute of Advanced Industrial Science & Technology (AIST), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2010, EVID-BASED COMPL ALT, V7, P177, DOI 10.1093/ecam/nem184; Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Ali NAA, 2001, J ETHNOPHARMACOL, V74, P173, DOI 10.1016/S0378-8741(00)00364-0; Bolleddula J, 2012, RAPID COMMUN MASS SP, V26, P1277, DOI 10.1002/rcm.6221; Davis L, 2001, J ETHNOPHARMACOL, V75, P165, DOI 10.1016/S0378-8741(00)00404-9; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Gupta SK, 2004, MOL CELL BIOCHEM, V260, P39; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Khan S, 2009, VACCINE, V27, P6080, DOI 10.1016/j.vaccine.2009.07.011; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni SK, 2008, INDIAN J EXP BIOL, V46, P633; Kumar P, 2009, J MED FOOD, V12, P591, DOI 10.1089/jmf.2008.0028; Kushwaha S, 2012, VACCINE, V30, P1083, DOI 10.1016/j.vaccine.2011.12.031; Lee W, 2012, TOXICOL APPL PHARM, V262, P91, DOI 10.1016/j.taap.2012.04.025; Liu JH, 2008, BIOMED PHARMACOTHER, V62, P480, DOI 10.1016/j.biopha.2007.11.003; LLanos GG, 2012, EUR J MED CHEM, V54, P499, DOI 10.1016/j.ejmech.2012.05.032; Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029; Malik F, 2009, EUR J CANCER, V45, P1494, DOI 10.1016/j.ejca.2009.01.034; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Maurya R, 2010, J PHARM PHARMACOL, V62, P153, DOI 10.1211/jpp.62.02.0001; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034277; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; NITSCHKE L, 1994, FRESEN J ANAL CHEM, V349, P451, DOI 10.1007/BF00322932; Owais M, 2005, PHYTOMEDICINE, V12, P229, DOI 10.1016/j.phymed.2003.07.012; OWEN LN, 1962, BRIT J CANCER, V16, P441, DOI 10.1038/bjc.1962.49; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Park HJ, 2008, BIOFACTORS, V33, P137, DOI 10.1002/biof.5520330206; Pawar P, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-34; RajaSankara S, 2009, NEUROSCI LETT, V454, P11, DOI 10.1016/j.neulet.2009.02.044; Rasool M, 2006, CHEM-BIOL INTERACT, V164, P174, DOI 10.1016/j.cbi.2006.09.011; Rudnick SN, 2009, AM J INFECT CONTROL, V37, P813, DOI 10.1016/j.ajic.2009.06.007; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Singh D, 2007, PHYTOTHER RES, V21, P905, DOI 10.1002/ptr.2180; Singh G, 2011, INDIAN J PHARM SCI, V73, P473, DOI 10.4103/0250-474X.95656; Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Winters M, 2006, ALTERN MED REV, V11, P269; Xu YM, 2011, PHYTOCHEMISTRY, V72, P518, DOI 10.1016/j.phytochem.2010.12.020; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Zhang X, 2012, GYNECOL ONCOL, V124, P606, DOI 10.1016/j.ygyno.2011.11.044; Zhang X, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-84	51	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77189	10.1371/journal.pone.0077189	http://dx.doi.org/10.1371/journal.pone.0077189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130852	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200067
J	Bode, NWF; Delcourt, J				Bode, Nikolai W. F.; Delcourt, Johann			Individual-to-Resource Landscape Interaction Strength Can Explain Different Collective Feeding Behaviours	PLOS ONE			English	Article							ECOLOGY	Taking in sufficient quantities of nutrients is vital for all living beings and in doing so, individuals interact with the local resource environment. Here, we focus explicitly on the interactions between feeding individuals and the resource landscape. In particular, we are interested in the emergent movement dynamics resulting from these interactions. We present an individual-based simulation model for the movement of populations in a resource landscape that allows us to vary the strength of the interactions mentioned above. The key assumption and novelty of our model is that individuals can cause the release of additional nutrients, as well as consuming them. Our model produces clear predictions. For example, we expect more tortuous individual movement paths and higher levels of aggregation in populations occupying homogeneous environments where individual movement makes more nutrients available. We also show how observed movement dynamics could change when local nutrient sources are depleted or when the population density increases. Our predictions are testable and qualitatively reproduce the different feeding behaviours observed in filter-feeding ducks, for example. We suggest that considering two-way interactions between feeding individuals and resource landscapes could help to explain fine-scale movement dynamics.	[Bode, Nikolai W. F.] Univ Essex, Dept Math Sci, Colchester CO4 3SQ, Essex, England; [Delcourt, Johann] Univ Liege, Behav Biol Unit Ethol & Anim Psychol, Lab Fish & Amphibian Ethol, Dept Environm Sci & Management,Fac Sci,Inst Zool, Liege, Belgium	University of Essex; University of Liege	Delcourt, J (corresponding author), Univ Liege, Behav Biol Unit Ethol & Anim Psychol, Lab Fish & Amphibian Ethol, Dept Environm Sci & Management,Fac Sci,Inst Zool, Liege, Belgium.	johann.delcourt@ulg.ac.be		Delcourt, Johann/0000-0001-5036-8450	AXA research fellowship; F.R.S.-FNRS (Fonds de la Recherche Scientifique, Belgium, FRFC) [2.4.617.08F]	AXA research fellowship(AXA Research Fund); F.R.S.-FNRS (Fonds de la Recherche Scientifique, Belgium, FRFC)(Fonds de la Recherche Scientifique - FNRS)	NWFB is supported by an AXA research fellowship and JD is supported by the F.R.S.-FNRS (Fonds de la Recherche Scientifique, Belgium, FRFC grant 2.4.617.08F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bazazi S, 2012, BEHAV ECOL SOCIOBIOL, V66, P879, DOI 10.1007/s00265-012-1336-1; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; BenJacob E, 1997, PHYSICA A, V238, P181, DOI 10.1016/S0378-4371(96)00457-8; Bragg AN, 1965, GNOMES NIGHT SPADEFO; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Caro Tim, 2005, pXIII; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; CROME FHJ, 1985, AUST J ZOOL, V33, P849, DOI 10.1071/ZO9850849; Czirok A, 1996, PHYS REV E, V54, P1791, DOI 10.1103/PhysRevE.54.1791; Delcourt J, 2012, REV FISH BIOL FISHER, V22, P595, DOI 10.1007/s11160-012-9260-z; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; DiGiacomo PM, 2002, J MARINE SYST, V37, P199, DOI 10.1016/S0924-7963(02)00202-6; Geroudet P, 1999, PALMIPEDES EUROPE; Gooders J, 1986, DUCKS N AM NO HEMISP; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Grossman D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023036; Guillemain M, 2000, WATERBIRDS, V23, P353, DOI 10.2307/1522173; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Johnsgard PA, 1965, HDB WATERFOWL BEHAV; KATZ LC, 1981, ANIM BEHAV, V29, P20, DOI 10.1016/S0003-3472(81)80148-0; Kils U., 1992, Advances in Limnology, V36, P83; Krause J, 2002, LIVING GROUPS; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; Mach R, 2007, B MATH BIOL, V69, P539, DOI 10.1007/s11538-006-9135-3; Obst BS, 1996, NATURE, V384, P121, DOI 10.1038/384121a0; Oom SP, 2004, ECOL COMPLEX, V1, P299, DOI 10.1016/j.ecocom.2004.06.003; PARTRIDGE BL, 1983, ENVIRON BIOL FISH, V9, P253, DOI 10.1007/BF00692374; Perna A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002592; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Rieucau G, 2008, OIKOS, V117, P501, DOI 10.1111/j.0030-1299.2008.16274.x; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Tania N, 2012, P NATL ACAD SCI USA, V109, P11228, DOI 10.1073/pnas.1201739109; THOMAS GJ, 1982, J ZOOL, V197, P131, DOI 10.1111/jzo.1982.197.1.131; Tietje WD, 1996, J WILDLIFE MANAGE, V60, P843, DOI 10.2307/3802385; Todd F, 1979, WATERFOWL DUCKS GEES; Torney CJ, 2010, P NATL ACAD SCI USA, V107, P20394, DOI 10.1073/pnas.1014316107	42	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75879	10.1371/journal.pone.0075879	http://dx.doi.org/10.1371/journal.pone.0075879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130748	gold, Green Published			2022-12-27	WOS:000325810900061
J	Hamsher, SE; LeGresley, MM; Martin, JL; Saunders, GW				Hamsher, Sarah E.; LeGresley, Murielle M.; Martin, Jennifer L.; Saunders, Gary W.			A Comparison of Morphological and Molecular-Based Surveys to Estimate the Species Richness of Chaetoceros and Thalassiosira (Bacillariophyta), in the Bay of Fundy	PLOS ONE			English	Article							BARCODING DIATOMS; DIVERSITY; RDNA; IDENTIFICATION; TAXONOMY; PRIMERS; COX1; RBCL; DNA	The goal of this study was to compare the ability of morphology and molecular-based surveys to estimate species richness for two species-rich diatom genera, Chaetoceros Ehrenb. and Thalassiosira Cleve, in the Bay of Fundy. Phytoplankton tows were collected from two sites at intervals over two years and subsampled for morphology-based surveys (2010, 2011), a culture-based DNA reference library (DRL; 2010), and a molecular-based survey (2011). The DRL and molecular-based survey utilized the 39 end of the RUBISCO large subunit (rbcL-3P) to identify genetic species groups (based on 0.1% divergence in rbcL-3P), which were subsequently identified morphologically to allow comparisons to the morphology-based survey. Comparisons were compiled for the year (2011) by site (n = 2) and by season (n = 3). Of the 34 taxa included in the comparisons, 50% of taxa were common to both methods, 35% were unique to the molecular-based survey, and 12% were unique to the morphology-based survey, while the remaining 3% of taxa were unidentified genetic species groups. The morphology-based survey excelled at identifying rare taxa in individual tow subsamples, which were occasionally missed with the molecular approach used here, while the molecular methods (the DRL and molecular-based survey), uncovered nine cryptic species pairs and four previously overlooked species. The last mentioned were typically difficult to identify and were generically assigned to Thalassiosira spp. during the morphology-based survey. Therefore, for now we suggest a combined approach encompassing routine morphology-based surveys accompanied by periodic molecular-based surveys to monitor for cryptic and difficult to identify taxa. As sequencing technologies improve, molecular-based surveys should become routine, leading to a more accurate representation of species composition and richness in monitoring programs.	[Hamsher, Sarah E.; Saunders, Gary W.] Univ New Brunswick, Fredericton, NB, Canada; [LeGresley, Murielle M.; Martin, Jennifer L.] Fisheries & Oceans Canada, St Andrews Biol Stn, St Andrews, NB, Canada	University of New Brunswick; Fisheries & Oceans Canada	Hamsher, SE (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.	sarah.hamsher@colorado.edu	Saunders, Gary W/D-8767-2014	Saunders, Gary W/0000-0003-4813-6831	Genome Canada (through the Ontario Genomics Institute); National Sciences and Engineering Research Council of Canada (NSERC); NSERC; Canada Research Chair Program; Department of Fisheries and Oceans	Genome Canada (through the Ontario Genomics Institute)(Genome Canada); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); Department of Fisheries and Oceans	This research was supported through funding to the Canadian Barcode of Life Network from Genome Canada (through the Ontario Genomics Institute), National Sciences and Engineering Research Council of Canada (NSERC), and other sponsors listed at www.BOLNET.ca. Additional funding was provided by NSERC and the Canada Research Chair Program to GWS, as well as infrastructure support from the Canada Foundation for Innovation and the New Brunswick Foundation for Innovation. Additional support was provided by the Department of Fisheries and Oceans. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; [Anonymous], OC GEN LEG OC GEN RE; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Berard-Therriault L, 1999, GUIDE IDENTIFICATION, V128; Berlyn G.P., 1976, BOT MICROTECHNIQUE C, DOI [10.2307/2418781, DOI 10.2307/2418781]; Drummond A., 2011, GENEIOUS V 5 4; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Guiry M.D., 2022, ALGAEBASE; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; HASLE GR, 1976, DEEP-SEA RES, V23, P319; Helsinki Commission (HELCOM), 2006, MAN MAR MON COMBINE; Hoppenrath M., 2009, SCHWEIZERBART SCHE V; Horner R.A, 2002, TAXONOMIC GUIDE SOME; Jensen K.G., 1998, OPERA BOT, V133, P5, DOI [10.1111/j.1756-1051.1998.tb01103.x, DOI 10.1111/J.1756-1051.1998.TB01103.X]; Kaczmarska I, 2008, BOTANY, V86, P763, DOI 10.1139/B08-046; Kraberg A.C., 2010, COASTAL PHYTOPLANKTO; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; MADDISON WP, 2003, MACCLADE VERSION 4 0; Mann DG, 2010, CRYPTOGAMIE ALGOL, V31, P557; Martin JL, 2009, J SEA RES, V61, P76, DOI 10.1016/j.seares.2008.05.011; Martin JL, 2001, CAN TECH REP FISH AQ, V2349; Martin JL, 1999, CAN TECH REP FISH AQ, V2265; Martin JL, 1995, CAN MANUSCR REP FISH, V2277; Martin JL, 2006, CAN TECH REP FISH AQ, V2629; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Poulickova A, 2010, PROTIST, V161, P353, DOI 10.1016/j.protis.2009.12.003; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Richlen ML, 2005, MOL ECOL NOTES, V5, P688, DOI 10.1111/j.1471-8286.2005.01032.x; RINES JEB, 1987, J PLANKTON RES, V9, P917, DOI 10.1093/plankt/9.5.917; Rines JEB, 1988, BIOBLIOTHECA PHYCOLO, V79; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Saunders Gary W, 2012, Methods Mol Biol, V858, P207, DOI 10.1007/978-1-61779-591-6_10; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Sherwood AR, 2008, MOL ECOL RESOUR, V8, P1011, DOI 10.1111/j.1755-0998.2008.02138.x; Sherwood AR, 2007, J PHYCOL, V43, P605, DOI 10.1111/j.1529-8817.2007.00341.x; Throndsen J., 2007, PHYTOPLANKTON NORWEG; Tomas CR, 1993, IDENTIFYING MARINE P; Trobajo R, 2010, EUR J PHYCOL, V45, P413, DOI 10.1080/09670262.2010.498586; Trobajo R, 2009, PHYCOLOGIA, V48, P443, DOI 10.2216/08-69.1; Wildish DJ, 1990, CAN TECH REP FISH AQ, V1760; Wildish DJ, 1988, CAN TECH REP FISH AQ, V1648; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	49	18	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e73521	10.1371/journal.pone.0073521	http://dx.doi.org/10.1371/journal.pone.0073521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130665	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900002
J	Hayek, LAC; Wilson, B				Hayek, Lee-Ann C.; Wilson, Brent			Quantifying Assemblage Turnover and Species Contributions at Ecologic Boundaries	PLOS ONE			English	Article							QUATERNARY BENTHIC FORAMINIFERA; SEQUENCE STRATIGRAPHY; BLAKE RIDGE; SEA-LEVEL; DIVERSITY; SLOPE; RISE; PRODUCTIVITY; PATTERNS; CHANNEL	Not all boundaries, whether stratigraphical or geographical, are marked by species-level changes in community composition. For example, paleodata for some sites do not show readily discernible glacial-interglacial contrasts. Rather, the proportional abundances of species can vary subtly between glacials and interglacials. This paper presents a simple quantitative measure of assemblage turnover (assemblage turnover index, ATI) that uses changes in species' proportional abundances to identify intervals of community change. A second, functionally-related index (conditioned-on-boundary index, CoBI) identifies species contributions to the total assemblage turnover. With these measures we examine benthonic foraminiferal assemblages to assess glacial/interglacial contrasts at abyssal depths. Our results indicate that these measures, ATI and CoBI, have potential as sequence stratigraphic tools in abyssal depth deposits. Many peaks in the set of values of ATI coincide with terminations at the end of glaciations and delineate peak-bounded ATI intervals (PATIs) separated by boundaries that approximate to glacial terminations and to transgressions at neritic depths. These measures, however, can be used to evaluate the assemblage turnover and composition at any defined ecological or paleoecological boundary. The section used is from Ocean Drilling Program (OPD) Hole 994C, drilled on the Blake Ridge, offshore SE USA.	[Hayek, Lee-Ann C.] Smithsonian Inst Math & Stat NMNH MRC 121, Washington, DC USA; [Wilson, Brent] Univ W Indies, Petr Geosci Programme, Dept Chem Engn, St Augustine, Trinidad Tobago	Smithsonian Institution; University West Indies Mona Jamaica; University West Indies Saint Augustine	Wilson, B (corresponding author), Univ W Indies, Petr Geosci Programme, Dept Chem Engn, St Augustine, Trinidad Tobago.	brent.wilson@sta.uwi.edu			U.S. National Science Foundation (NSF); Joint Oceanographic Institutions (JOI), Inc.	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Joint Oceanographic Institutions (JOI), Inc.	This research used samples provided by the Ocean Drilling Program (ODP) that is sponsored by the U.S. National Science Foundation (NSF) and participating countries under management of Joint Oceanographic Institutions (JOI), Inc. Thanks are due to two anonymous reviewers, whose suggestions improved this paper markedly.	Altenbach AV, 1999, J FORAMIN RES, V29, P173; Armentrout John M., 1996, Geological Society Special Publication, V104, P65, DOI 10.1144/GSL.SP.1996.104.01.06; Astorga G, 2011, GEOL ACTA, V9, P45, DOI 10.1344/105.000001649; Baden-Powell D. F. W., 1956, Proceedings of the Geologists' Association London, V66, P271; BANDY OL, 1960, J PALEONTOL, V34, P671; Berger W. H., 2012, MIKLANKOVITCH THEORY, P1; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; Bhaumik AK, 2007, CURR SCI INDIA, V92, P192; Bhaumik AK, 2005, CURR SCI INDIA, V88, P1969; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Bocher J, 2012, BOREAS, V41, P644, DOI 10.1111/j.1502-3885.2012.00251.x; Bolli H.M., 1985, P155; Bornmalm Lennart, 1997, Fossils and Strata, V41, P1; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; Catuneanu O., 2006, PRINCIPLES SEQUENCE, V1, DOI DOI 10.1016/C2009-0-19362-5; Catuneanu O, 2011, NEWSL STRATIGR, V44, P173, DOI 10.1127/0078-0421/2011/0011; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Cushman J. A., 1922, Bulletin United States National Museum, V104, P1; Cushman J. A., 1923, Bulletin United States National Museum, V104, P1; Cushman J. A., 1924, Bulletin United States National Museum, V104, P1; Cushman J. A., 1930, B US NAT MUS, V104, P1; Cushman J. A., 1931, US NATL MUSEUM B, V104, P1; Cushman J. A., 1920, US NATL MUSEUM B, V104, P1; Cushman J. A., 1940, US GEOLOGICAL SURV A, P35; CUSHMAN JOSEPH A., 1929, U S NATION MUS BULL, V104, P1; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; den Dulk M, 1998, MAR MICROPALEONTOL, V35, P43, DOI 10.1016/S0377-8398(98)00015-2; Dillon W. P., 1996, P ODP INIT REPTS, V164, P47; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; GABY ML, 1985, MAR GEOL, V68, P125, DOI 10.1016/0025-3227(85)90008-8; Geikie J., 1874, GREAT ICE AGE ITS RE; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Gooday AJ, 2000, DEEP-SEA RES PT II, V47, P25, DOI 10.1016/S0967-0645(99)00099-5; GUPTA AK, 1993, MICROPALEONTOLOGY, V39, P47, DOI 10.2307/1485973; Hayek LAC, 2013, J FORAMIN RES, V43, P305, DOI 10.2113/gsjfr.43.3.305; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HEEZEN BC, 1966, SCIENCE, V152, P502, DOI 10.1126/science.152.3721.502; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; KAIHO K, 1994, GEOLOGY, V22, P719, DOI 10.1130/0091-7613(1994)022<0719:BFDOIA>2.3.CO;2; Lewis FJ, 1906, SCOT GEOGR MAG, V22, P241, DOI 10.1080/14702540608554658; LINKE P, 1993, MAR MICROPALEONTOL, V20, P215, DOI 10.1016/0377-8398(93)90034-U; Luning S, 1998, J FORAMIN RES, V28, P19; Mackensen A, 1995, MICROPALEONTOLOGY, V41, P342, DOI 10.2307/1485808; Mohan K, 2011, J MICROPALAEONTOL, V30, P33, DOI 10.1144/0262-821X10-008; Murray JW, 2013, J MICROPALAEONTOL, V32, P1, DOI 10.1144/jmpaleo2012-010; MURRAY JW, 1992, J FORAMIN RES, V22, P114, DOI 10.2113/gsjfr.22.2.114; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Nagy J, 2001, J FORAMIN RES, V31, P324, DOI 10.2113/0310324; Oba T, 2000, P OCEAN DRILLING PRO; Okada Hisatake, 2000, Proceedings of the Ocean Drilling Program Scientific Results, V164, P331; Parker F. L., 1954, B MUS COMP ZOOL HARV, V111, P454; Paull CK, 1996, P OCEAN DRILLING PRO, P99; Pekar SF, 2001, J SEDIMENT RES, V71, P608, DOI 10.1306/100600710608; Pflum C.E., 1976, Special Publs Cushman Fdn, VNo. 14, P1; Phleger F. B., 1953, Report of the Swedish Deep-Sea Expedition (1947-1948), V7, P1; Phleger F. B., 1951, ECOLOGY FORAMINIFERA, V46, P1; Poag C.W., 1976, Geol Socs, V26, P185; QVALE G, 1985, MAR MICROPALEONTOL, V9, P469, DOI 10.1016/0377-8398(85)90014-3; Rai AK, 2012, OCEANOLOGIA, V54, P449, DOI 10.5697/oc.54-3.449; Schafer CT, 1978, GEOLOGICAL SURVEY CA, P1; SCHNITKER D, 1974, NATURE, V248, P385, DOI 10.1038/248385a0; Schonfeld J, 2005, MAR MICROPALEONTOL, V57, P1, DOI 10.1016/j.marmicro.2005.05.004; Schonfeld J, 2001, J FORAMIN RES, V31, P86, DOI 10.2113/0310086; SCHOTT W, 1935, RECENT MARINE SEDIME, V4, P396; SEIGLIE G A, 1968, AM ASSOC PET GEOL BULL, V52, P2231; SENGUPTA BK, 1982, MAR MICROPALEONTOL, V7, P297, DOI 10.1016/0377-8398(82)90007-X; SENGUPTA BK, 1982, GEOL SOC AM BULL, V93, P218, DOI 10.1130/0016-7606(1982)93<218:LBFOTF>2.0.CO;2; SenGupta BK, 1996, GEOLOGY, V24, P227, DOI 10.1130/0091-7613(1996)024<0227:SODICS>2.3.CO;2; Smart CW, 2006, J FORAMIN RES, V36, P34, DOI 10.2113/36.1.34; Smart CW, 2002, QUATERNARY ENVIRONMENTAL MICROPALAEONTOLOGY, P14; SMART CW, 1994, MAR MICROPALEONTOL, V23, P89, DOI 10.1016/0377-8398(94)90002-7; STREETER SS, 1982, GEOL SOC AM BULL, V93, P190, DOI 10.1130/0016-7606(1982)93<190:HALGBF>2.0.CO;2; Streeter SS, 1973, QUATERNARY RES, V3, P141; Sun HJ, 2011, CHINESE SCI BULL, V56, P2732, DOI 10.1007/s11434-011-4603-z; Taldenkova E, 2012, MAR MICROPALEONTOL, V96-97, P13, DOI 10.1016/j.marmicro.2012.06.007; THOMAS E, 1995, PALEOCEANOGRAPHY, V10, P545, DOI 10.1029/94PA03056; Torrens HS, 2002, GEOL SOC SPEC PUBL, V192, P251, DOI 10.1144/GSL.SP.2002.192.01.14; Tucholke B.E., 2002, MEMOIRS, V22, P39, DOI DOI 10.1144/GSL.MEM.2002.022.01.04; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wilson B, 2003, CARIBB J SCI, V39, P209; Wilson B., 2011, J FORAMIN RES, V41, P40; Wilson B, J FORAMINIF IN PRESS; Wilson B, 2013, J FORAMIN RES, V43, P143, DOI 10.2113/gsjfr.43.2.143; Wilson B, 2008, J MICROPALAEONTOL, V27, P177, DOI 10.1144/jm.27.2.177; WOODS J, 1993, J PLANKTON RES, V15, P1053, DOI 10.1093/plankt/15.9.1053; Wright R., 1978, Initial Reports of the Deep Sea Drilling Project, V42, P837	88	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74999	10.1371/journal.pone.0074999	http://dx.doi.org/10.1371/journal.pone.0074999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130679	Green Submitted, gold, Green Published			2022-12-27	WOS:000325810900014
J	Hertlein, E; Beckwith, KA; Lozanski, G; Chen, TL; Towns, WH; Johnson, AJ; Lehman, A; Ruppert, AS; Bolon, B; Andritsos, L; Lozanski, A; Rassenti, L; Zhao, WQ; Jarvinen, TM; Senter, L; Croce, CM; Symer, DE; de la Chapelle, A; Heerema, NA; Byrd, JC				Hertlein, Erin; Beckwith, Kyle A.; Lozanski, Gerard; Chen, Timothy L.; Towns, William H.; Johnson, Amy J.; Lehman, Amy; Ruppert, Amy S.; Bolon, Brad; Andritsos, Leslie; Lozanski, Arletta; Rassenti, Laura; Zhao, Weiqiang; Jarvinen, Tiina M.; Senter, Leigha; Croce, Carlo M.; Symer, David E.; de la Chapelle, Albert; Heerema, Nyla A.; Byrd, John C.			Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; B-CLL CELLS; CLONAL EVOLUTION; HIGH-RISK; GENE-EXPRESSION; GENOMIC ABERRATIONS; SITU HYBRIDIZATION; SURVIVAL; MUTATIONS; NUDE	Studies of chronic lymphocytic leukemia (CLL) have yielded substantial progress, however a lack of immortalized cell lines representative of the primary disease has hampered a full understanding of disease pathogenesis and development of new treatments. Here we describe a novel CLL cell line (OSU-CLL) generated by EBV transformation, which displays a similar cytogenetic and immunophenotype observed in the patient's CLL (CD5 positive with trisomy 12 and 19). A companion cell line was also generated from the same patient (OSU-NB). This cell line lacked typical CLL characteristics, and is likely derived from the patient's normal B cells. In vitro migration assays demonstrated that OSU-CLL exhibits migratory properties similar to primary CLL cells whereas OSU-NB has significantly reduced ability to migrate spontaneously or towards chemokine. Microarray analysis demonstrated distinct gene expression patterns in the two cell lines, including genes on chromosomes 12 and 19, which is consistent with the cytogenetic profile in this cell line. Finally, OSU-CLL was readily transplantable into NOG mice, producing uniform engraftment by three weeks with leukemic cells detectable in the peripheral blood spleen and bone marrow. These studies describe a new CLL cell line that extends currently available models to study gene function in this disease.	[Hertlein, Erin; Beckwith, Kyle A.; Chen, Timothy L.; Towns, William H.; Johnson, Amy J.; Ruppert, Amy S.; Andritsos, Leslie; Lozanski, Arletta; Symer, David E.; Byrd, John C.] Ohio State Univ, Dept Internal Med, Div Hematol, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lozanski, Gerard; Zhao, Weiqiang; Heerema, Nyla A.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Lehman, Amy] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Bolon, Brad] Ohio State Univ, Dept Vet Biosci & Comparat Pathol & Mouse Phenoty, Columbus, OH 43210 USA; [Rassenti, Laura] Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA; [Jarvinen, Tiina M.; Senter, Leigha; Croce, Carlo M.; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Byrd, JC (corresponding author), Ohio State Univ, Dept Internal Med, Div Hematol, Ctr Comprehens Canc, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Young, Richard A/F-6495-2012; Zhao, Weiqiang/E-4368-2011	Young, Richard A/0000-0001-8855-8647; Beckwith, Kyle/0000-0001-8025-2512	National Cancer Institute [P01 CA95426, P50CA140158]; CLL Research Consortium [P01 CA81534-02]; Leukemia and Lymphoma Society; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA151319, P50CA140158, P01CA081534] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLL Research Consortium; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (P01 CA95426 and P50CA140158); CLL Research Consortium (P01 CA81534-02), The Leukemia and Lymphoma Society (special scholar grant to EH) and The D. Warren Brown Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AvilaCarino J, 1997, INT J CANCER, V70, P1, DOI 10.1002/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO;2-1; Bazargan A, 2012, EXPERT REV ANTICANC, V12, P393, DOI [10.1586/era.12.2, 10.1586/ERA.12.2]; Berkova A, 2009, NEOPLASMA, V56, P455, DOI 10.4149/neo_2009_05_455; Bertilaccio MTS, 2010, BLOOD, V115, P1605, DOI 10.1182/blood-2009-05-223586; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Capello D, 2004, LEUKEMIA, V18, P1941, DOI 10.1038/sj.leu.2403537; Cavazzini F, 2012, LEUKEMIA LYMPHOMA, V53, P83, DOI 10.3109/10428194.2011.606384; Erdfelder F, 2010, HEMATOL REP, V2, P24, DOI 10.4081/hr.2010.e3; Ghia EM, 2008, BLOOD, V111, P5101, DOI 10.1182/blood-2007-12-130229; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Hwang KK, 2012, BLOOD, V119, pE35, DOI 10.1182/blood-2011-08-371203; Janssens A, 2012, EUR J HAEMATOL, V89, P72, DOI 10.1111/j.1600-0609.2012.01790.x; Joshi AD, 2007, CLIN CANCER RES, V13, P5295, DOI 10.1158/1078-0432.CCR-07-0283; Kardava L, 2011, INT IMMUNOL, V23, P375, DOI 10.1093/intimm/dxr027; KAWATA A, 1993, LEUKEMIA RES, V17, P883, DOI 10.1016/0145-2126(93)90154-D; Khartan-Dabaja MA, 2008, CANCER-AM CANCER SOC, V113, P897, DOI 10.1002/cncr.23671; Khinkis Leonid A, 2003, Nonlinearity Biol Toxicol Med, V1, P363, DOI 10.1080/15401420390249925; Lacerda JF, 1996, TRANSPLANTATION, V61, P492, DOI 10.1097/00007890-199602150-00030; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Langerak AW, 2011, LEUKEMIA, V25, P979, DOI 10.1038/leu.2011.49; LEE CLY, 1986, CANCER RES, V46, P2497; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Loisel S, 2005, LEUKEMIA RES, V29, P1347, DOI 10.1016/j.leukres.2005.04.017; Loscertales J, 2010, LEUKEMIA LYMPHOMA, V51, P1142, DOI 10.3109/10428191003793374; Lozanski G, 2012, LEUKEMIA LYMPHOMA, V53, P1743, DOI 10.3109/10428194.2012.668683; Mittal AK, 2007, INT J MOL MED, V20, P461; Muthusamy N, 2011, CANCER GENET-NY, V204, P77, DOI 10.1016/j.cancergen.2010.12.006; MYHRINDER AL, 2013, MOL CHARACTERIZATION, P23168; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Porpaczy E, 2009, EUR J CLIN INVEST, V39, P568, DOI 10.1111/j.1365-2362.2009.02146.x; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Rosen A, 2012, ONCOIMMUNOLOGY, V1, P18, DOI 10.4161/onci.1.1.18400; Shanafelt TD, 2008, J CLIN ONCOL, V26, pE5, DOI 10.1200/JCO.2008.16.7874; Shanafelt TD, 2006, J CLIN ONCOL, V24, P4634, DOI 10.1200/JCO.2006.06.9492; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stilgenbauer S, 2007, HAEMATOLOGICA, V92, P1242, DOI 10.3324/haematol.10720; TAKADA K, 1980, INTERVIROLOGY, V13, P223, DOI 10.1159/000149129; Villamor N, 2013, LEUKEMIA, V27, P1100, DOI 10.1038/leu.2012.357; WALLS EV, 1989, INT J CANCER, V44, P846, DOI 10.1002/ijc.2910440517; Wang J, 2004, BIOINFORMATICS, V20, P3166, DOI 10.1093/bioinformatics/bth381; WENDELHANSEN V, 1994, LEUKEMIA, V8, P476	47	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76607	10.1371/journal.pone.0076607	http://dx.doi.org/10.1371/journal.pone.0076607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130782	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900078
J	Ono, Y; Sakai, A; Otsuka, K; Uda, H; Oyama, H; Ishizuka, N; Awata, S; Ishida, Y; Iwasa, H; Kamei, Y; Motohashi, Y; Nakamura, J; Nishi, N; Watanabe, N; Yotsumoto, T; Nakagawa, A; Suzuki, Y; Tajima, M; Tanaka, E; Sakai, H; Yonemoto, N				Ono, Yutaka; Sakai, Akio; Otsuka, Kotaro; Uda, Hidenori; Oyama, Hirofumi; Ishizuka, Naoki; Awata, Shuichi; Ishida, Yasushi; Iwasa, Hiroto; Kamei, Yuichi; Motohashi, Yutaka; Nakamura, Jun; Nishi, Nobuyuki; Watanabe, Naoki; Yotsumoto, Toshihiko; Nakagawa, Atsuo; Suzuki, Yuriko; Tajima, Miyuki; Tanaka, Eriko; Sakai, Hironori; Yonemoto, Naohiro			Effectiveness of a Multimodal Community Intervention Program to Prevent Suicide and Suicide Attempts: A Quasi-Experimental Study	PLOS ONE			English	Article							DEPRESSION; STRATEGIES; TREND; RISK	Background: Multilevel and multimodal interventions have been suggested for suicide prevention. However, few studies have reported the outcomes of such interventions for suicidal behaviours. Methods: We examined the effectiveness of a community-based multimodal intervention for suicide prevention in rural areas with high suicide rates, compared with a parallel prevention-as-usual control group, covering a total of 631,133 persons. The effectiveness was also examined in highly populated areas near metropolitan cities (1,319,972 persons). The intervention started in July 2006, and continued for 3.5 years. The primary outcome was the incidence of composite outcome, consisting of completed suicides and suicide attempts requiring admission to an emergency ward for critical care. We compared the rate ratios (RRs) of the outcomes adjusted by sex, age group, region, period and interaction terms. Analyses were performed on an intention-to-treat basis and stratified by sex and age groups. Findings: In the rural areas, the overall median adherence of the intervention was significantly higher. The RR of the composite outcome in the intervention group decreased 7% compared with that of the control group. Subgroup analyses demonstrated heterogeneous effects among subpopulations: the RR of the composite outcome in the intervention group was significantly lower in males (RR = 0.77, 95% CI 0.59-0.998, p = 0.0485) and the RR of suicide attempts was significantly lower in males (RR = 0.39, 95% CI 0.22-0.68, p = 0.001) and the elderly (RR = 0.35, 95% CI 0.17-0.71, p = 0.004). The intervention had no effect on the RR of the composite outcome in the highly populated areas. Interpretation: Our findings suggest that this community-based multimodal intervention for suicide prevention could be implemented in rural areas, but not in highly populated areas. The effectiveness of the intervention was shown for males and for the elderly in rural areas.	[Ono, Yutaka; Tajima, Miyuki] Natl Ctr Neurol & Psychiat, Natl Ctr Cognit Behav Therapy & Res, Tokyo, Japan; [Sakai, Akio; Otsuka, Kotaro] Iwate Med Univ, Dept Neuropsychiat, Morioka, Iwate 020, Japan; [Otsuka, Kotaro] Iwate Med Univ, Dept Disaster & Community Psychiat, Morioka, Iwate 020, Japan; [Uda, Hidenori] Kagoshima Reg Promot Bur, Hlth Social Welf & Environm Dept, Ijuin Publ Hlth Ctr, Hioki, Kagoshima, Japan; [Oyama, Hirofumi] Aomori Univ Hlth & Welf, Fac Hlth Sci, Dept Social Welf, Aomori, Japan; [Ishizuka, Naoki] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Shinjuku Ku, Tokyo, Japan; [Awata, Shuichi] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Ishida, Yasushi] Miyazaki Univ, Fac Med, Dept Psychiat, Miyazaki, Japan; [Iwasa, Hiroto] Aomori Prefectural Ctr Mental Hlth & Welf, Aomori, Japan; [Iwasa, Hiroto] Hirosaki Univ, Div Neuropsychiat, Grad Sch Med, Hirosaki, Aomori, Japan; [Kamei, Yuichi] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Lab Med, Tokyo, Japan; [Motohashi, Yutaka] Akita Univ, Grad Sch Med, Dept Publ Hlth, Akita 010, Japan; [Nakamura, Jun] Univ Occupat & Environm Hlth, Sch Med, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan; [Nishi, Nobuyuki] Aira Isa Reg Promot Bur, Social Welf & Environm Dept, Aira Publ Hlth Ctr, Kirishima, Kagoshima, Japan; [Watanabe, Naoki] Asada Hosp, Dept Psychiat, Aki, Hiroshima, Japan; [Yotsumoto, Toshihiko] Hlth & Social Welf Dept, Hlth Promot Div, Kagoshima, Japan; [Nakagawa, Atsuo] Keio Univ, Sch Med, Clin Res Ctr, Shinjuku Ku, Tokyo, Japan; [Suzuki, Yuriko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Tokyo, Japan; [Tanaka, Eriko] Nihon Univ, Inst Humanities & Social Sci, Setagaya Ku, Tokyo, Japan; [Sakai, Hironori] Gunma Univ, Grad Sch Med, Sch Hlth Sci, Dept Basic Med Sci, Maebashi, Gunma 371, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Epidemiol & Biostat, Tokyo, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, Tokyo, Japan; [Ono, Yutaka; Sakai, Akio; Otsuka, Kotaro; Uda, Hidenori; Oyama, Hirofumi; Ishizuka, Naoki; Awata, Shuichi; Ishida, Yasushi; Iwasa, Hiroto; Kamei, Yuichi; Motohashi, Yutaka; Nakamura, Jun; Nishi, Nobuyuki; Watanabe, Naoki; Yotsumoto, Toshihiko; Nakagawa, Atsuo; Suzuki, Yuriko; Tajima, Miyuki; Tanaka, Eriko; Sakai, Hironori; Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, NOCOMIT J Grp, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Iwate Medical University; Iwate Medical University; Aomori University of Health & Welfare; National Center for Global Health & Medicine - Japan; Tokyo Metropolitan Institute of Gerontology; University of Miyazaki; Hirosaki University; National Center for Neurology & Psychiatry - Japan; Akita University; University of Occupational & Environmental Health - Japan; Keio University; National Center for Neurology & Psychiatry - Japan; Nihon University; Gunma University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Ono, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Ctr Cognit Behav Therapy & Res, Tokyo, Japan.	yutakaon@gmail.com	Nakagawa, Atsuo/AAE-2952-2020; Naohiro, Yonemoto/Y-3761-2019	Nakagawa, Atsuo/0000-0002-2294-2571; 	Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work is supported by Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong R, 2008, J PUBLIC HEALTH-UK, V30, P103, DOI 10.1093/pubmed/fdm082; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Fountoulakis KN, 2011, J AFFECT DISORDERS, V130, P10, DOI 10.1016/j.jad.2010.06.009; Fujita T., 2003, Journal of the National Institute of Public Health, V52, P295; Hegerl U, 2006, PSYCHOL MED, V36, P1225, DOI 10.1017/S003329170600780X; Knox KL, 2003, BMJ-BRIT MED J, V327, P1376, DOI 10.1136/bmj.327.7428.1376; Lonnqvist Jouko, 2009, OXFORD TXB SUICIDOLO, P794; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ono Yutaka, 2004, Keio J Med, V53, P1, DOI 10.2302/kjm.53.1; Ono Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-315; Oyama H, 2005, PSYCHIAT CLIN NEUROS, V59, P337, DOI 10.1111/j.1440-1819.2005.01379.x; Oyama H, 2008, COMMUNITY MENT HLT J, V44, P311, DOI 10.1007/s10597-008-9132-0; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; van der Feltz-Cornelis CM, 2011, CRISIS, V32, P319, DOI 10.1027/0227-5910/a000109; WHO, 2012, PUBL HLTH ACT PREV S	19	37	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74902	10.1371/journal.pone.0074902	http://dx.doi.org/10.1371/journal.pone.0074902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130673	Green Published, gold			2022-12-27	WOS:000325810900008
J	Shimato, S; Anderson, LM; Asslaber, M; Bruce, JN; Canoll, P; Anderson, DE; Anderson, RCE				Shimato, Shinji; Anderson, Lisa M.; Asslaber, Martin; Bruce, Jeffrey N.; Canoll, Peter; Anderson, David E.; Anderson, Richard C. E.			Inhibition of Caveolin-1 Restores Myeloid Cell Function in Human Glioblastoma	PLOS ONE			English	Article							GLIOMA-INFILTRATING MICROGLIA/MACROPHAGES; IMMUNOHISTOCHEMICAL ANALYSIS; MALIGNANT GLIOMAS; IN-VITRO; LYMPHOCYTES; MACROPHAGES; EXPRESSION; PHENOTYPE; TUMORS	Background: Gliomas are the most common primary brain tumor in both children and adults. The prognosis for glioblastoma (GBM), the most common type of malignant glioma, has remained dismal, with median survival a little over one year despite maximal therapy with surgery, chemotherapy, and radiation. Although immunotherapy has become increasingly successful against many systemic tumors, clinical efficacy against brain tumors has been limited. One reason for this is an incomplete understanding of the local immunologic tumor microenvironment, particularly the function of large numbers of infiltrating myeloid derived cells. Monocytes/microglia are myeloid derived immunomodulatory cells, and they represent the predominant infiltrating immune cell population in gliomas. Our group has previously demonstrated using complementary in vitro and in vivo approaches that GBM tumor cells polarize tumor-associated myeloid cells (TAMs) and suppress their immunostimulatory function. Methods and Results: To better understand the mechanisms responsible for this immunosuppression, we used gene expression profiling of stimulated monocytes in the presence or absence of GBM tumor cells. Our analysis identified caveolin-1 (CAV1), a plasma membrane molecule with pleiotropic functions, as significantly up-regulated in monocytes in the presence of GBMs. We validated these findings ex vivo by confirming up-regulation of CAV1 in TAMs isolated from GBMs immediately after surgical resection. Finally, we demonstrate that siRNA inhibition of CAV1 restores myeloid cell function, as measured by TNF-alpha secretion, in the presence of GBMs. Conclusions: Restoration of TAM function through pharmacologic blockage of CAV1 may facilitate more successful immunotherapeutic strategies directed against a variety of solid human tumors infiltrated by TAMs.	[Shimato, Shinji; Bruce, Jeffrey N.; Canoll, Peter; Anderson, Richard C. E.] Columbia Univ, Dept Neurosurg, Gabriele Bartoli Brain Tumor Res Lab, New York, NY 10027 USA; [Anderson, Lisa M.; Anderson, David E.] Erinyes Biotechnol LLC, Boston, MA USA; [Asslaber, Martin] Med Univ Graz, Dept Pathol, Graz, Austria; [Canoll, Peter] Columbia Univ, Dept Pathol, New York, NY USA	Columbia University; Medical University of Graz; Columbia University	Anderson, RCE (corresponding author), Columbia Univ, Dept Neurosurg, Gabriele Bartoli Brain Tumor Res Lab, New York, NY 10027 USA.	rca24@columbia.edu	Bruce, Jeffrey N/AAC-5307-2022		Meghan Rose Bradley Foundation; Matthew Larson Foundation	Meghan Rose Bradley Foundation; Matthew Larson Foundation	This work was supported in part by the Meghan Rose Bradley Foundation and the Matthew Larson Foundation (RCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2002, CLIN IMMUNOL, V102, P84, DOI 10.1006/clim.2001.5152; ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Anderson RCE, 2007, NEUROSURGERY, V60, P1129, DOI 10.1227/01.NEU.0000255460.91892.44; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; BROOKS WH, 1978, ANN NEUROL, V4, P219, DOI 10.1002/ana.410040305; de Almeida CJ, 2011, CELL CYCLE, V10, P2151, DOI 10.4161/cc.10.13.16234; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Filipazzi P, 2012, CANCER IMMUNOL IMMUN, V61, P255, DOI 10.1007/s00262-011-1161-9; Guruswamy S, 2009, INT J ONCOL, V35, P1037, DOI 10.3892/ijo_00000418; Harris J, 2002, IMMUNOLOGY, V105, P190, DOI 10.1046/j.1365-2567.2002.01362.x; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Held-Feindt J, 2010, EXP CELL RES, V316, P1553, DOI 10.1016/j.yexcr.2010.02.018; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Hussain SF, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-15; Hussain SF, 2005, EXPERT REV ANTICANC, V5, P777, DOI 10.1586/14737140.5.5.777; Kennedy BC, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-11; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; KUPPNER MC, 1988, CANCER RES, V48, P6926; PAINE JT, 1986, NEUROSURGERY, V18, P766, DOI 10.1227/00006123-198606000-00015; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; RIDLEY A, 1971, BRAIN, V94, P117, DOI 10.1093/brain/94.1.117; SAITO T, 1988, SURG NEUROL, V29, P435, DOI 10.1016/0090-3019(88)90137-1; Santizo RA, 2002, STROKE, V33, P613, DOI 10.1161/hs0202.102363; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Yamanaka R, 2008, TRENDS MOL MED, V14, P228, DOI 10.1016/j.molmed.2008.03.003	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77397	10.1371/journal.pone.0077397	http://dx.doi.org/10.1371/journal.pone.0077397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130882	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900135
J	Cayetano, L; Vorburger, C				Cayetano, Luis; Vorburger, Christoph			Effects of Heat Shock on Resistance to Parasitoids and on Life History Traits in an Aphid/Endosymbiont System	PLOS ONE			English	Article							FACULTATIVE BACTERIAL ENDOSYMBIONTS; SYMBIONT-CONFERRED RESISTANCE; GENETIC-VARIATION; PEA APHIDS; HOST; TEMPERATURE; SPECIFICITY; MAINTENANCE; ENVIRONMENT; VIRULENCE	Temperature variation is an important factor determining the outcomes of interspecific interactions, including those involving hosts and parasites. This can apply to variation in average temperature or to relatively short but intense bouts of extreme temperature. We investigated the effect of heat shock on the ability of aphids (Aphis fabae) harbouring protective facultative endosymbionts (Hamiltonella defensa) to resist parasitism by Hymenopteran parasitoids (Lysiphlebus fabarum). Furthermore, we investigated whether heat shocks can modify previously observed genotype-by-genotype (G x G) interactions between different endosymbiont isolates and parasitoid genotypes. Lines of genetically identical aphids possessing different isolates of H. defensa were exposed to one of two heat shock regimes (35 degrees C and 39 degrees C) or to a control temperature (20 degrees C) before exposure to three different asexual lines of the parasitoids. We observed strong G x G interactions on parasitism rates, reflecting the known genetic specificity of symbiont-conferred resistance, and we observed a significant G x G x E interaction induced by heat shocks. However, this three-way interaction was mainly driven by the more extreme heat shock (39 degrees C), which had devastating effects on aphid lifespan and reproduction. Restricting the analysis to the more realistic heat shock of 35 degrees C, the G x G x E interaction was weaker (albeit still significant), and it did not lead to any reversals of the aphid lines' susceptibility rankings to different parasitoids. Thus, under conditions feasibly encountered in the field, the relative fitness of different parasitoid genotypes on hosts protected by particular symbiont strains remains mostly uncomplicated by heat stress, which should simplify biological control programs dealing with this system.	[Cayetano, Luis; Vorburger, Christoph] ETH, Inst Integrat Biol, Zurich, Switzerland; [Cayetano, Luis; Vorburger, Christoph] Swiss Fed Inst Aquat Sci & Technol, EAWAG, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Cayetano, L (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	luis.cayetano@eawag.ch	Vorburger, Christoph/A-1650-2008	Vorburger, Christoph/0000-0002-3627-0841	Swiss National Science Foundation (SNSF Professorship) [PP00P3_123376]	Swiss National Science Foundation (SNSF Professorship)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNSF Professorship PP00P3_123376 to CV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DE, 2011, EVOL ECOL, V25, P499, DOI 10.1007/s10682-010-9413-2; Amice G, 2008, ECOL ENTOMOL, V33, P701, DOI 10.1111/j.1365-2311.2008.01019.x; Belshaw R, 2003, GENOME, V46, P170, DOI 10.1139/G02-112; Belshaw R, 1999, EVOLUTION, V53, P1189, DOI [10.2307/2640822, 10.1111/j.1558-5646.1999.tb04532.x]; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; Bryner SF, 2011, AM NAT, V177, P65, DOI 10.1086/657620; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; CARRUTHERS RI, 1992, ECOLOGY, V73, P190, DOI 10.2307/1938731; Cayetano L, 2013, J EVOLUTION IN PRESS; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Denis D, 2011, ECOL MODEL, V222, P1604, DOI 10.1016/j.ecolmodel.2011.02.023; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fels D, 2006, P ROY SOC B-BIOL SCI, V273, P1031, DOI 10.1098/rspb.2005.3404; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.2307/1165127; JAENIKE J, 1978, Evolutionary Theory, V3, P191; JUDSON OP, 1995, GENET RES, V65, P175, DOI 10.1017/S0016672300033267; Karl I, 2011, GLOBAL CHANGE BIOL, V17, P676, DOI 10.1111/j.1365-2486.2010.02277.x; Laine AL, 2008, OIKOS, V117, P1281, DOI 10.1111/j.0030-1299.2008.16563.x; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lukasik P, 2013, OECOLOGIA; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Mostowy R, 2011, P ROY SOC B-BIOL SCI, V278, P2283, DOI 10.1098/rspb.2010.2359; OHTAKA C, 1991, SYMBIOSIS, V11, P19; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Outreman Y, 2005, BEHAV PROCESS, V70, P93, DOI 10.1016/j.beproc.2005.04.004; Rouchet R, 2012, J EVOLUTION BIOL, V25, P2369, DOI 10.1111/j.1420-9101.2012.02608.x; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sandrock C, 2010, J EVOLUTION BIOL, V23, P578, DOI 10.1111/j.1420-9101.2009.01925.x; Sandrock C, 2011, MOL ECOL, V20, P4165, DOI 10.1111/j.1365-294X.2011.05242.x; Schmid M, 2012, FUNCT ECOL, V26, P207, DOI 10.1111/j.1365-2435.2011.01904.x; Stary P, 2006, APHID PARASITOIDS CZ; Tetard-Jones C, 2007, AM NAT, V170, P492, DOI 10.1086/520115; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; van Baaren J, 2005, ANIM BEHAV, V70, P153, DOI 10.1016/j.anbehav.2004.10.016; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Vorburger C, 2013, ECOL EVOL, V3, P706, DOI 10.1002/ece3.491; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004	57	14	14	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75966	10.1371/journal.pone.0075966	http://dx.doi.org/10.1371/journal.pone.0075966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143175	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100010
J	D'Souza, E; Patankar, V; Arthur, R; Alcoverro, T; Kelkar, N				D'Souza, Elrika; Patankar, Vardhan; Arthur, Rohan; Alcoverro, Teresa; Kelkar, Nachiket			Long-Term Occupancy Trends in a Data-Poor Dugong Population in the Andaman and Nicobar Archipelago	PLOS ONE			English	Article							MARINE MAMMALS; LIFE-HISTORY; SEAGRASS; CONSERVATION; LANDSCAPE; ISLANDS; QUEENSLAND; MOVEMENT; DYNAMICS; HOTSPOTS	Prioritizing efforts for conserving rare and threatened species with limited past data and lacking population estimates is predicated on robust assessments of their occupancy rates. This is particularly challenging for elusive, long-lived and wide-ranging marine mammals. In this paper we estimate trends in long-term (over 50years) occupancy, persistence and extinction of a vulnerable and data-poor dugong (Dugong dugon) population across multiple seagrass meadows in the Andaman and Nicobar archipelago (India). For this we use hierarchical Bayesian dynamic occupancy models accounting for false negatives (detection probability, 1), persistence and extinction, to two datasets: a) fragmentary long-term occurrence records from multiple sources (1959-2004, n = 40 locations), and b) systematic detection/non-detection data from current surveys (2010-2012, n = 57). Dugong occupancy across the archipelago declined by 60% (from 0.45 to 0.18) over the last 20 years and present distribution was largely restricted to sheltered bays and channels with seagrass meadows dominated by Halophila and Halodule sp. Dugongs were not found in patchy meadows with low seagrass cover. In general, seagrass habitat availability was not limiting for dugong occupancy, suggesting that anthropogenic factors such as entanglement in gillnets and direct hunting may have led to local extinction of dugongs from locations where extensive seagrass meadows still thrive. Effective management of these remnant dugong populations will require a multi-pronged approach, involving 1) protection of areas where dugongs still persist, 2) monitoring of seagrass habitats that dugongs could recolonize, 3) reducing gillnet use in areas used by dugongs, and 4) engaging with indigenous/settler communities to reduce impacts of hunting.	[D'Souza, Elrika; Patankar, Vardhan; Arthur, Rohan; Alcoverro, Teresa; Kelkar, Nachiket] Nat Conservat Fdn, Oceans & Coasts Program, Mysore, Karnataka, India; [Alcoverro, Teresa] Spanish Natl Res Council, Ctr Estudis Avancats Blanes, Blanes, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Kelkar, N (corresponding author), Nat Conservat Fdn, Oceans & Coasts Program, Mysore, Karnataka, India.	nachiket@ncf-india.org	Alcoverro, Teresa/J-9258-2012	Alcoverro, Teresa/0000-0002-3910-9594; Arthur, Rohan/0000-0003-4267-9720	Conservation Leadership Program (Future Conservationist Award); Ministry of Environment and Forests (Species Recovery Program); Mohammed Bin Zayed Species Conservation Fund; Ravi Sankaran Inlaks Small Grants Program; Nature Conservation Foundation (Oceans and Coasts program); Plan Nacional I+D+I, Spain [CTM2010-22273-C02]	Conservation Leadership Program (Future Conservationist Award); Ministry of Environment and Forests (Species Recovery Program); Mohammed Bin Zayed Species Conservation Fund; Ravi Sankaran Inlaks Small Grants Program; Nature Conservation Foundation (Oceans and Coasts program); Plan Nacional I+D+I, Spain	This research was supported and funded by the Conservation Leadership Program (Future Conservationist Award), Ministry of Environment and Forests (Species Recovery Program), Mohammed Bin Zayed Species Conservation Fund, the Ravi Sankaran Inlaks Small Grants Program and Nature Conservation Foundation (Oceans and Coasts program). TA was partially funded by the project CTM2010-22273-C02 (Plan Nacional I+D+I, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aing C, 2011, J APPL ECOL, V48, P1508, DOI 10.1111/j.1365-2664.2011.02037.x; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; [Anonymous], 1956, ANDAMAN NICOBAR ISLA; Aragones Lemnuel, 2000, Pacific Conservation Biology, V5, P277; Aragones LV, 2006, OECOLOGIA, V149, P635, DOI 10.1007/s00442-006-0477-1; Aragones Lemnuel V., 1997, Asian Marine Biology, V14, P15; Aragones Lemnuel V., 2012, P179; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Carr MH, 2003, ECOL APPL, V13, pS90; D'Souza Elrika, 2010, P443; D'souza Elrika, 2009, Journal of Threatened Taxa, V1, P49; Das H. S., 1999, Journal of the Bombay Natural History Society, V96, P195; Das HS, 1996, STATUS SEAGRASS HABI; Davidar P., 1999, P IUFRO S HELD CHIAN, P287; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; De Iongh HH, 1998, MAR ECOL-P S Z N I, V19, P179; DEIONGH HH, 1995, AQUAT BOT, V50, P1, DOI 10.1016/0304-3770(94)00438-R; Director-Census Operations, 2011, PROV POP TOT RUR URB, V2; EBERHARDT LL, 1979, WILDLIFE MONOGR, P6; Garrigue C, 2008, MAR MAMMAL SCI, V24, P81, DOI 10.1111/j.1748-7692.2007.00173.x; Grech A, 2009, THESIS; Herben T, 2006, J ECOL, V94, P131, DOI 10.1111/j.1365-2745.2005.01063.x; Hines Ellen, 2012, P58; Hines EM, 2005, MAR MAMMAL SCI, V21, P536, DOI 10.1111/j.1748-7692.2005.tb01247.x; Hodgson AJ, 2007, J EXP MAR BIOL ECOL, V340, P50, DOI 10.1016/j.jembe.2006.08.006; Issaris Y, 2012, MAR ECOL PROG SER, V453, P95, DOI 10.3354/meps09668; JAGTAP TG, 1992, INDIAN J MAR SCI, V21, P56; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Kwan D, 2006, ENVIRON CONSERV, V33, P164, DOI 10.1017/S0376892906002992; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; Marsh H, 2005, ECOL APPL, V15, P481, DOI 10.1890/04-0673; MARSH H, 1981, BIOL CONSERV, V19, P255, DOI 10.1016/0006-3207(81)90002-1; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H., 2002, DUGONG DUGONG DUGON; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; Marsh Helene, 2003, P383; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; Moore SE, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P137; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakaoka M, 1999, MAR ECOL PROG SER, V184, P97, DOI 10.3354/meps184097; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; O'Shea TJ, 2008, J MAMMAL, V89, P529, DOI 10.1644/07-MAMM-S-416R.1; Pillay R, 2011, BIOL CONSERV, V144, P1567, DOI 10.1016/j.biocon.2011.01.026; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; PREEN A, 1995, J MAMMAL, V76, P163, DOI 10.2307/1382325; Preen A, 1993, THESIS J COOK U NO Q; Preen Anthony, 2012, P91; R Development Core Team, 2012, R LANG ENV STAT COMP; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Rivadeneira MM, 2009, ECOLOGY, V90, P1291, DOI 10.1890/08-0316.1; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Royle JA, 2008, HIERARCHICAL MODELIN, P297; Sankaran R, 2005, GROUND BENEATH WAVES, VII; Saracco JF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00132.1; Sathasivam K, 2004, MARINE MAMMALS INDIA; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sheppard JK, 2007, ESTUAR COAST SHELF S, V71, P117, DOI 10.1016/j.ecss.2006.07.006; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Tun T, 2007, ASSESSMENT DUG UNPUB; van der Heide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042060	72	19	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76181	10.1371/journal.pone.0076181	http://dx.doi.org/10.1371/journal.pone.0076181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143180	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100015
J	Miller, KA; Gordon, CT; Welfare, MF; Caruana, G; Bertram, JF; Bateman, JF; Farlie, PG				Miller, Kerry A.; Gordon, Christopher T.; Welfare, Megan F.; Caruana, Georgina; Bertram, John F.; Bateman, John F.; Farlie, Peter G.			bfb, a Novel ENU-Induced blebs Mutant Resulting from a Missense Mutation in Fras1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; RENAL AGENESIS; PALATE FUSION; CLEFT-PALATE; MICE; LIMB; IDENTIFICATION; ADHESION; PROTEIN; GENES	Fras1 is an extracellular matrix associated protein with essential roles in adhesion of epithelia and mesenchyme during early embryonic development. The adhesive function of Fras1 is achieved through interaction with a group of related proteins, Frem 1-3, and a cytoplasmic adaptor protein Grip1. Mutation of each of these proteins results in characteristic epithelial blistering and have therefore become known as "blebs" proteins. Human Fraser syndrome presents with a similar phenotype and the blebs mice have been instrumental in identification of the genetic basis of Fraser syndrome. We have identified a new ENU-induced blebs allele resulting from a novel missense mutation in Fras1. The resulting mouse strain, blood filled blisters (bfb), presents with a classic blebs phenotype but does not exhibit embryonic lethality typical of other blebs mutants and in addition, we report novel palate and sternal defects. Analysis of the bfb phenotype confirms the presence of epithelial-mesenchymal adhesion defects but also supports the emerging role of blebs proteins in regulating signalling during organogenesis. The bfb strain provides new opportunities to investigate the role of Fras1 in development.	[Miller, Kerry A.; Gordon, Christopher T.; Welfare, Megan F.; Bateman, John F.; Farlie, Peter G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Mol Biol, Parkville, Vic 3052, Australia; [Caruana, Georgina; Bertram, John F.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Monash University	Farlie, PG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	peter.farlie@mcri.edu.au	Bertram, John F/I-2588-2014; Gordon, Chris/F-1267-2017	Bertram, John F/0000-0001-5863-6464; Gordon, Chris/0000-0002-9300-8399; Bateman, John/0000-0001-8542-0730	NHMRC Australia [1002660]	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by NHMRC Australia grant 1002660. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caruana G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055429; Cavalcanti DP, 2007, AM J MED GENET A, V143A, P241, DOI 10.1002/ajmg.a.31426; CHEN JM, 1953, J ANAT, V87, P130; CHEN JM, 1952, J ANAT, V86, P373; Chiotaki R, 2007, GENE EXPR PATTERNS, V7, P381, DOI 10.1016/j.modgep.2006.12.001; EIJGELAAR A, 1970, THORAX, V25, P490, DOI 10.1136/thx.25.4.490; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Hoefele J, 2013, GENE, V520, P194, DOI 10.1016/j.gene.2013.02.031; Isaac A, 2000, MECH DEVELOP, V93, P41, DOI 10.1016/S0925-4773(00)00261-6; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Kiyozumi D, 2006, P NATL ACAD SCI USA, V103, P11981, DOI 10.1073/pnas.0601011103; Kiyozumi D, 2012, J CELL BIOL, V197, P677, DOI 10.1083/jcb.201203065; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Little CaB HJ, 1923, AM J ROENTGENOL, V10, P975; Martinez-Sanz E, 2008, DIFFERENTIATION, V76, P417, DOI 10.1111/j.1432-0436.2007.00226.x; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Ng WY, 2013, CLIN GENET, V83, P162, DOI 10.1111/j.1399-0004.2012.01851.x; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; Ogur G, 2011, GENET COUNSEL, V22, P233; Petrou P, 2007, MATRIX BIOL, V26, P652, DOI 10.1016/j.matbio.2007.05.008; Pitera JE, 2012, GENESIS, V50, P892, DOI 10.1002/dvg.22045; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Saisawat P, 2012, KIDNEY INT, V81, P196, DOI 10.1038/ki.2011.315; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Smyth I, 2005, HUM MOL GENET, V14, pR269, DOI 10.1093/hmg/ddi262; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Tavares AT, 2001, INT J DEV BIOL, V45, P707; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tudela C, 2002, INT J DEV BIOL, V46, P333; van Haelst MM, 2008, AM J MED GENET A, V146A, P2252, DOI 10.1002/ajmg.a.32440; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; WALLIN J, 1994, DEVELOPMENT, V120, P1109	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76342	10.1371/journal.pone.0076342	http://dx.doi.org/10.1371/journal.pone.0076342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143185	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100020
J	Rugman-Jones, PF; Hoddle, CD; Hoddle, MS; Stouthamer, R				Rugman-Jones, Paul F.; Hoddle, Christina D.; Hoddle, Mark S.; Stouthamer, Richard			The Lesser of Two Weevils: Molecular-Genetics of Pest Palm Weevil Populations Confirm Rhynchophorus vulneratus (Panzer 1798) as a Valid Species Distinct from R. ferrugineus (Olivier 1790), and Reveal the Global Extent of Both	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE; MAXIMUM-LIKELIHOOD; DNA; EVOLUTION; SEQUENCES	The red palm weevil (RPW) is a major pest of palms. It is native to southeast Asia and Melanesia, but in recent decades has vastly expanded its range as the result of multiple accidental anthropogenic introductions into the Middle East, Mediterranean Basin, Caribbean, and U. S. A. Currently regarded as a single species, Rhynchophorus ferrugineus (Olivier), RPW displays remarkable color variation across its range, and consequently has a taxonomic history littered with new species descriptions and synonymization. We compared DNA sequences of the mitochondrial cytochrome oxidase subunit I (COI) gene from RPW populations throughout the native and invaded ranges, to investigate the specific status and invasion history of this serious economic pest, and to identify possible common routes of entry. Analyses of COI haplotype data provide conclusive support, corroborated by sequences of additional nuclear gene regions, for the existence of at least two predominantly allopatric species. The true R. ferrugineus is native only to the northern and western parts of continental southeast Asia, Sri Lanka and the Philippines, and is responsible for almost all invasive populations worldwide. In contrast, the second species, which is currently synonymized under R. ferrugineus and should be resurrected under the name R. vulneratus (Panzer), has a more southern distribution across Indonesia, and is responsible for only one invasive population; that in California, U. S. A. The distribution of COI haplotypes is used to discuss the possible existence of further cryptic species, sources and routes of entry of different invasive populations, and the implications of our findings for current control methods.	[Rugman-Jones, Paul F.; Hoddle, Christina D.; Hoddle, Mark S.; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Rugman-Jones, Paul F.; Hoddle, Christina D.; Hoddle, Mark S.; Stouthamer, Richard] Univ Calif Riverside, Ctr Invas Species Res, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Rugman-Jones, PF (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	paulrj@ucr.edu			California Department of Food and Agriculture [SCB 11061]	California Department of Food and Agriculture	This work was supported, in part, by funds from the California Department of Food and Agriculture's Specialty Crops Block Grant SCB 11061 (http://www.cdfa.ca.gov/Specialty_Crop_Competitiveness_Grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbas MST, 2010, INTEGR MANAG PLANT P, V5, P209, DOI 10.1007/978-90-481-8606-8_9; Abulyazid I., 2002, Journal of the Egyptian German Society of Zoology, V38, P1; Al-Ayied H.Y., 2006, Archives of Phytopathology and Plant Protection, V39, P303, DOI 10.1080/03235400500222461; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2008, NATION; Cox M. L., 1993, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V41, P30; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Mergawy R.A.A.M., 2011, J AGR SCI TECH-IRAN, V1, P1; El-Mergawy RAAM, 2011, J AGR, V1, P189, DOI DOI 10.1079/IJT2006113; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P631; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P227; Faleiro J. R., 2006, International Journal of Tropical Insect Science, V26, P135, DOI 10.1079/IJT2006113; Ferry M, 2002, RED PALM WEEVIL MEDI, V4; Gadelhak G. G., 2005, International Journal of Agriculture and Biology, V7, P395; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallett RH, 2004, J NAT HIST, V38, P2863, DOI 10.1080/00222930310001657874; HALLETT RH, 1993, NATURWISSENSCHAFTEN, V80, P328, DOI 10.1007/BF01141908; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hoddle M. S., 2011, Pakistan Entomologist, V33, P77; Huis A., 2013, EDIBLE INSECTS FUTUR; Kehat M, 1999, PHYTOPARASITICA, V27, P241, DOI 10.1007/BF02981465; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Molet T, 2011, CPHST PEST DATASHEET; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; NAPPO, 2010, 1 US DET RED PALM WE; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Perez AL, 1996, J CHEM ECOL, V22, P357, DOI 10.1007/BF02055104; Rugman-Jones PF, 2010, J ECON ENTOMOL, V103, P877, DOI 10.1603/EC09300; Salama H.S., 2002, Archives of Phytopathology and Plant Protection, V35, P299, DOI 10.1080/03235400216136; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang L, 2013, INSECT SCI, V20, P689, DOI 10.1111/j.1744-7917.2012.01561.x; Wattanapongsiri A., 1966, Sci Bull Dep Agric Bangkok, V1, P1; Woodruff DS, 1993, J BIOGEOGR, V30, P551	39	73	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78379	10.1371/journal.pone.0078379	http://dx.doi.org/10.1371/journal.pone.0078379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143263	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100102
J	Schrunder, S; Schnack-Schiel, SB; Auel, H; Sartoris, FJ				Schruender, Sabine; Schnack-Schiel, Sigrid B.; Auel, Holger; Sartoris, Franz Josef			Control of Diapause by Acidic pH and Ammonium Accumulation in the Hemolymph of Antarctic Copepods	PLOS ONE			English	Article							INVERTEBRATE SIPUNCULUS-NUDUS; CALANUS-PROPINQUUS COPEPODA; LIFE-CYCLE STRATEGIES; MARGINAL ICE-ZONE; CALANOIDES-ACUTUS; WEDDELL-SEA; METABOLIC DEPRESSION; BUOYANCY MECHANISM; MARINE ZOOPLANKTON; RHINCALANUS-GIGAS	Life-cycles of polar herbivorous copepods are characterised by seasonal/ontogenetic vertical migrations and diapause to survive periods of food shortage during the long winter season. However, the triggers of vertical migration and diapause are still far from being understood. In this study, we test the hypothesis that acidic pH and the accumulation of ammonium (NH4+) in the hemolymph contribute to the control of diapause in certain Antarctic copepod species. In a recent study, it was already hypothesized that the replacement of heavy ions by ammonium is necessary for diapausing copepods to achieve neutral buoyancy at overwintering depth. The current article extends the hypothesis of ammonium-aided buoyancy by highlighting recent findings of low pH values in the hemolymph of diapausing copepods with elevated ammonium concentrations. Since ammonia (NH3) is toxic to most organisms, a low hemolymph pH is required to maintain ammonium in the less toxic ionized form (NH4+). Recognizing that low pH values are a relevant factor reducing metabolic rate in other marine invertebrates, the low pH values found in overwintering copepods might not only be a precondition for ammonium accumulation, but in addition, it may insure metabolic depression throughout diapause.	[Schruender, Sabine; Auel, Holger] Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany; [Schnack-Schiel, Sigrid B.; Sartoris, Franz Josef] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Schrunder, S (corresponding author), Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany.	sabines@uni-bremen.de		Sartoris, Franz-Josef/0000-0001-7228-3220	Deutsche Forschungsgemeinschaft (DFG) [AU 175/6, SA 1713/3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of the priority programme 'Antarctic Research with comparative investigations in Arctic ice areas' (grant numbers AU 175/6 and SA 1713/3). http://www.spp-antarktisforschung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON A, 1991, MAR BIOL, V109, P79, DOI 10.1007/BF01320234; Atkinson A, 1998, J MARINE SYST, V15, P289, DOI 10.1016/S0924-7963(97)00081-X; Auel H, 2005, DEEP-SEA RES PT I, V52, P1272, DOI 10.1016/j.dsr.2005.01.005; Ben-Yaakov S, 1970, LIMNOL OCEANOGR, P326; Bocher P, 2002, J PLANKTON RES, V24, P1317, DOI 10.1093/plankt/24.12.1317; BOWER CE, 1978, J FISH RES BOARD CAN, V35, P1012, DOI 10.1139/f78-165; Boyd CM, 2002, MAR BIOL, V141, P605, DOI 10.1007/s00227-002-0872-z; BUSA WB, 1983, SCIENCE, V221, P366, DOI 10.1126/science.221.4608.366; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; CHEN JC, 1992, AQUACULTURE, V104, P249, DOI 10.1016/0044-8486(92)90207-2; CLARKE A, 1991, POLAR RES, V10, P355, DOI 10.1111/j.1751-8369.1991.tb00659.x; CLARKE MR, 1979, J MAR BIOL ASSOC UK, V59, P259, DOI 10.1017/S0025315400042570; Conover R.J., 1991, Journal of Marine Systems, V2, P1, DOI 10.1016/0924-7963(91)90011-I; DENTON EJ, 1974, PROC R SOC SER B-BIO, V185, P273, DOI 10.1098/rspb.1974.0020; DENTON EJ, 1969, PROC R SOC SER B-BIO, V174, P271, DOI 10.1098/rspb.1969.0093; DONNELLY J, 1994, POLAR BIOL, V14, P171; Fofonoff N.P., 1983, UNESCO TECH PAP MAR, V36, P17; Hagen W, 2001, ZOOL-ANAL COMPLEX SY, V104, P313, DOI 10.1078/0944-2006-00037; HAGEN W, 1996, RES PAP, V43, P139; HAND SC, 1988, SCIENCE, V239, P1425, DOI 10.1126/science.239.4846.1425; Heath MR, 2004, ICES J MAR SCI, V61, P698, DOI 10.1016/j.icesjms.2004.03.013; HOPKINS TL, 1989, DEEP-SEA RES, V36, P543, DOI 10.1016/0198-0149(89)90005-8; HOPKINS TL, 1993, DEEP-SEA RES PT I, V40, P81, DOI 10.1016/0967-0637(93)90054-7; Irigoien X, 2004, J PLANKTON RES, V26, P259, DOI 10.1093/plankt/fbh030; Langenbuch M, 2002, J EXP BIOL, V205, P1153; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Lin YC, 2001, J EXP MAR BIOL ECOL, V259, P109, DOI 10.1016/S0022-0981(01)00227-1; MARIN VH, 1993, POLAR BIOL, V13, P35; Metz C, 1995, MAR ECOL PROG SER, V129, P71, DOI 10.3354/meps129071; OSTRENSKY A, 1995, AQUACULTURE, V132, P339, DOI 10.1016/0044-8486(94)00343-M; Pasternak AF, 2001, HYDROBIOLOGIA, V453, P25, DOI 10.1023/A:1013147413136; Pond DW, 2012, J PLANKTON RES, V34, P443, DOI 10.1093/plankt/fbs027; Pond DW, 2012, DEEP-SEA RES PT II, V59, P93, DOI 10.1016/j.dsr2.2011.05.009; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; Portner HO, 2000, J EXP BIOL, V203, P2417; Prosser, 1973, COMP ANIMAL PHYSL, P966; Randall DJ, 2002, MAR POLLUT BULL, V45, P17, DOI 10.1016/S0025-326X(02)00227-8; REES BB, 1990, J EXP BIOL, V152, P77; Reipschlager A, 1996, J EXP BIOL, V199, P1801; SANDERS NK, 1988, J EXP BIOL, V138, P333; Sartoris FJ, 2010, LIMNOL OCEANOGR, V55, P1860, DOI 10.4319/lo.2010.55.5.1860; Schnack-Schiel SB, 2001, HYDROBIOLOGIA, V453, P9, DOI 10.1023/A:1013195329066; SCHNACKSCHIEL SB, 1991, MAR ECOL PROG SER, V70, P17, DOI 10.3354/meps070017; SCHNACKSCHIEL SB, 1995, ICES J MAR SCI, V52, P541, DOI 10.1016/1054-3139(95)80068-9; Seibel BA, 2004, J EXP MAR BIOL ECOL, V313, P375, DOI 10.1016/j.jembe.2004.08.015; SWIFT DJ, 1981, J FISH BIOL, V19, P45, DOI 10.1111/j.1095-8649.1981.tb05810.x; Visser Andre W., 1999, Fisheries Oceanography, V8, P100, DOI 10.1046/j.1365-2419.1999.00001.x; Voight JR, 1994, MAR FRESHW BEHAV PHY, V25, P193, DOI 10.1080/10236249409378917; Voronina N. M., 1970, P162; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Yamada Yuichiro, 1999, Plankton Biology and Ecology, V46, P62	51	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77498	10.1371/journal.pone.0077498	http://dx.doi.org/10.1371/journal.pone.0077498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143238	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100076
J	Dameron, O; Bettembourg, C; Le Meur, N				Dameron, Olivier; Bettembourg, Charles; Le Meur, Nolwenn			Measuring the Evolution of Ontology Complexity: The Gene Ontology Case Study	PLOS ONE			English	Article							SEMANTIC SIMILARITY; TERMS; OWL	Ontologies support automatic sharing, combination and analysis of life sciences data. They undergo regular curation and enrichment. We studied the impact of an ontology evolution on its structural complexity. As a case study we used the sixty monthly releases between January 2008 and December 2012 of the Gene Ontology and its three independent branches, i.e. biological processes (BP), cellular components (CC) and molecular functions (MF). For each case, we measured complexity by computing metrics related to the size, the nodes connectivity and the hierarchical structure. The number of classes and relations increased monotonously for each branch, with different growth rates. BP and CC had similar connectivity, superior to that of MF. Connectivity increased monotonously for BP, decreased for CC and remained stable for MF, with a marked increase for the three branches in November and December 2012. Hierarchy-related measures showed that CC and MF had similar proportions of leaves, average depths and average heights. BP had a lower proportion of leaves, and a higher average depth and average height. For BP and MF, the late 2012 increase of connectivity resulted in an increase of the average depth and average height and a decrease of the proportion of leaves, indicating that a major enrichment effort of the intermediate-level hierarchy occurred. The variation of the number of classes and relations in an ontology does not provide enough information about the evolution of its complexity. However, connectivity and hierarchy-related metrics revealed different patterns of values as well as of evolution for the three branches of the Gene Ontology. CC was similar to BP in terms of connectivity, and similar to MF in terms of hierarchy. Overall, BP complexity increased, CC was refined with the addition of leaves providing a finer level of annotations but decreasing slightly its complexity, and MF complexity remained stable.	[Dameron, Olivier; Bettembourg, Charles; Le Meur, Nolwenn] Univ Rennes, Rennes, France; [Dameron, Olivier; Bettembourg, Charles] Inst Rech Informat & Syst Aleatoires, Rennes, France; [Bettembourg, Charles] UMR1348 PEGASE Inst Natl Rech Agron, Rennes, France; [Le Meur, Nolwenn] Ecole Hautes Etud Sante Publ, Rennes, France	Universite de Rennes; Universite de Rennes; INRAE	Dameron, O (corresponding author), Univ Rennes, Rennes, France.	olivier.dameron@univ-rennes1.fr	Le Meur, Nolwenn/M-3039-2013	Le Meur, Nolwenn/0000-0001-8451-4014; Dameron, Olivier/0000-0001-8959-7189				Alterovitz G, 2010, NAT BIOTECHNOL, V28, P128, DOI 10.1038/nbt0210-128; [Anonymous], 2012, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKS1050; Aranguren ME, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-57; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bada Michael., 2004, J WEB SEMANT, V1, P235, DOI [10.1016/j.websem.2003.12.003, DOI 10.1016/J.WEBSEM.2003.12.003]; Baorto D, 2009, J BIOMED INFORM, V42, P494, DOI 10.1016/j.jbi.2009.03.005; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Ceusters W, 2009, J BIOMED INFORM, V42, P518, DOI 10.1016/j.jbi.2008.12.008; Cimino JJ, 2009, J BIOMED INFORM, V42, P571, DOI 10.1016/j.jbi.2008.12.003; Cimino JJ, 1998, J AM MED INFORM ASSN, V5, P41, DOI 10.1136/jamia.1998.0050041; de Coronado S, 2009, J BIOMED INFORM, V42, P530, DOI 10.1016/j.jbi.2009.01.003; Faria D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040519; Gillis J, 2013, BIOINFORMATICS; Golbreich C, 2007, LECT NOTES COMPUT SC, V4825, P169; Gross A, 2012, BIOINFORMATICS, V28, P2671, DOI 10.1093/bioinformatics/bts498; Gu HY, 2009, J BIOMED INFORM, V42, P550, DOI 10.1016/j.jbi.2009.01.001; Guarino N, 2002, COMMUN ACM, V45, P61, DOI 10.1145/503124.503150; Hartung M, 2008, LNCS, V5109; Hartung M, 2012, BIOINFORMATICS, V28, P895, DOI 10.1093/bioinformatics/bts029; Hartung M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-250; Hoehndorf R., 2012, BRIEFINGS BIOINFORMA; Jin B, 2010, BIOINFORMATICS, V26, P2445, DOI 10.1093/bioinformatics/btq449; Jupp Simon, 2012, J Biomed Semantics, V3 Suppl 1, pS3, DOI 10.1186/2041-1480-3-S1-S3; Kirsten T, 2011, J BIOMED SEMANT, V2, DOI 10.1186/2041-1480-2-6; Kohler S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-418; Kohler J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-212; Leonelli S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-325; Li HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057809, 10.1371/journal.pone.0066745]; Loguercio S., 2012, 2012 IEEE Second International Conference on Healthcare Informatics, Imaging and Systems Biology (HISB), DOI 10.1109/HISB.2012.69; Malone J, 2013, J BIOMED INFORM, V46, P5, DOI 10.1016/j.jbi.2012.04.002; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; Park JS, 2008, KOREAN J RADIOL, V9, pS7, DOI 10.3348/kjr.2008.9.s.s7; Park YR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S40; Pesquita C, 2011, INT C BIOM ONT ICBO; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Rector AL, 2011, J AM MED INFORM ASSN, V18, P432, DOI 10.1136/amiajnl-2010-000045; Shchekotykhin K, 2012, J WEB SEMANT, V12-13, P88, DOI 10.1016/j.websem.2011.12.006; Stevens R, 2007, INT J HUM-COMPUT ST, V65, P583, DOI 10.1016/j.ijhcs.2007.03.006; Verspoor K, 2009, BIOINFORMATICS, V25, pI77, DOI 10.1093/bioinformatics/btp195; Yang HX, 2012, BIOINFORMATICS, V28, P1383, DOI 10.1093/bioinformatics/bts129; Yao LX, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001055	44	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75993	10.1371/journal.pone.0075993	http://dx.doi.org/10.1371/journal.pone.0075993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146805	Green Published, gold			2022-12-27	WOS:000325819400033
J	Mortimer, D; French, SD; McKenzie, JE; OConnor, DA; Green, SE				Mortimer, Duncan; French, Simon D.; McKenzie, Joanne E.; OConnor, Denise A.; Green, Sally E.			Economic Evaluation of Active Implementation versus Guideline Dissemination for Evidence-Based Care of Acute Low-Back Pain in a General Practice Setting	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PATIENT OUTCOMES; PRACTITIONERS; MANAGEMENT; FEEDBACK	Introduction: The development and publication of clinical practice guidelines for acute low-back pain has resulted in evidence-based recommendations that have the potential to improve the quality and safety of care for acute low-back pain. Development and dissemination of guidelines may not, however, be sufficient to produce improvements in clinical practice; further investment in active implementation of guideline recommendations may be required. Further research is required to quantify the trade-off between the additional upfront cost of active implementation of guideline recommendations for low-back pain and any resulting improvements in clinical practice. Methods: Cost-effectiveness analysis alongside the IMPLEMENT trial from a health sector perspective to compare active implementation of guideline recommendations via the IMPLEMENT intervention (plus standard dissemination) against standard dissemination alone. Results: The base-case analysis suggests that delivery of the IMPLEMENT intervention dominates standard dissemination (less costly and more effective), yielding savings of $135 per x-ray referral avoided (-$462.93/3.43). However, confidence intervals around point estimates for the primary outcome suggest that - irrespective of willingness to pay (WTP) - we cannot be at least 95% confident that the IMPLEMENT intervention differs in value from standard dissemination. Conclusions: Our findings demonstrate that moving beyond development and dissemination to active implementation entails a significant additional upfront investment that may not be offset by health gains and/or reductions in health service utilization of sufficient magnitude to render active implementation cost-effective.	[Mortimer, Duncan] Monash Univ, Ctr Hlth Econ, Clayton, Vic, Australia; [French, Simon D.; McKenzie, Joanne E.; OConnor, Denise A.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [French, Simon D.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia	Monash University; Monash University; University of Melbourne	Mortimer, D (corresponding author), Monash Univ, Ctr Hlth Econ, Clayton, Vic, Australia.	duncan.mortimer@monash.edu	McKenzie, Joanne E/I-2925-2014; O'Connor, Denise/ABC-6655-2020	McKenzie, Joanne E/0000-0003-3534-1641; O'Connor, Denise/0000-0002-6836-122X; Mortimer, Duncan Stuart/0000-0002-7211-6454; French, Simon/0000-0002-7061-7706; Green, Sally Elizabeth/0000-0002-9564-9050	Australian National Health and Medical Research Council [334060]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors received a Primary Health Care Project Grant (334060) in the amount of AUD$426,000 from the Australian National Health and Medical Research Council (www.nhmrc.gov.au) to undertake the research reported here and the associated clinical trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2008, SECT 8 2 HLTH WORKF; Australian Acute Musculoskeletal Pain Guidelines Group (AAMPGG), 2003, EV BAS MAN AC MUSC P; Becker A, 2003, DEGAM GUIDELINE LOW; Becker A, 2008, SPINE, V33, P473, DOI 10.1097/BRS.0b013e3181657e0d; Becker A, 2012, SPINE, V37, P701, DOI 10.1097/BRS.0b013e31822b01bd; Bekkering GE, 2005, PHYS THER, V85, P544, DOI 10.1093/ptj/85.6.544; Bekkering GE., 2003, PHYS THER, V89, P82, DOI DOI 10.1016/S0031-9406(05)60579-2; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Dey P, 2004, BRIT J GEN PRACT, V54, P33; Eccles M, 2001, LANCET, V357, P1406, DOI 10.1016/S0140-6736(00)04564-5; Engers AJ, 2005, SPINE, V30, P595; Freeborn DK, 1997, J GEN INTERN MED, V12, P619, DOI 10.1046/j.1525-1497.1997.07122.x; French SD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006094.pub2; French SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065471; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Glick H, 2007, EC EVALUATION CLIN T; Grimshaw JM, 2001, MED CARE, V39, pII2; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Hoeijenbos M, 2005, HEALTH POLICY, V75, P85, DOI 10.1016/j.healthpol.2005.02.008; McKenzie JE, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-11; National Health & Medical Research Council, 2003, EV BAS MAN AC MUSC P; Page MJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-35; Rossignol M, 2000, SPINE, V25, P251, DOI 10.1097/00007632-200001150-00018; Schectman JM, 2003, J GEN INTERN MED, V18, P773, DOI 10.1046/j.1525-1497.2003.10205.x; Stevenson K, 2006, J EVAL CLIN PRACT, V12, P365, DOI 10.1111/j.1365-2753.2006.00565.x; Vale L, 2007, EUR J HEALTH ECON, V8, P111, DOI 10.1007/s10198-007-0043-8	28	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75647	10.1371/journal.pone.0075647	http://dx.doi.org/10.1371/journal.pone.0075647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146767	Green Published, gold			2022-12-27	WOS:000325819400015
J	Hou, AH; Toh, LX; Gan, KH; Lee, KJR; Manser, E; Tong, L				Hou, Aihua; Toh, Li Xian; Gan, Kah Hui; Lee, Khee Jin Ryan; Manser, Edward; Tong, Louis			Rho GTPases and Regulation of Cell Migration and Polarization in Human Corneal Epithelial Cells	PLOS ONE			English	Article							BINDING PROTEIN-RHO; FAMILY GTPASES; CDC42 CONTROLS; INTEGRIN ALPHA-V-BETA-5; KINASE; EXPRESSION; ADHESION; CYTOSKELETON; ACTIVATION; LIMBAL	Purpose: Epithelial cell migration is required for regeneration of tissues and can be defective in a number of ocular surface diseases. This study aimed to determine the expression pattern of Rho family small G-proteins in human corneal epithelial cells to test their requirement in directional cell migration. Methods: Rho family small G-protein expression was assessed by reverse transcription-polymerase chain reaction. Dominant-inhibitory constructs encoding Rho proteins or Rho protein targeting small interfering RNA were transfected into human corneal epithelial large T antigen cells, and wound closure rate were evaluated by scratch wounding assay, and a complementary non-traumatic cell migration assay. Immunofluorescence staining was performed to study cell polarization and to assess Cdc42 downstream effector. Results: Cdc42, Chp, Rac1, RhoA, TC10 and TCL were expressed in human corneal epithelial cells. Among them, Cdc42 and TCL were found to significantly affect cell migration in monolayer scratch assays. These results were confirmed through the use of validated siRNAs directed to Cdc42 and TCL. Scramble siRNA transfected cells had high percentage of polarized cells than Cdc42 or TCL siRNA transfected cells at the wound edge. We showed that the Cdc42-specific effector p21-activated kinase 4 localized predominantly to cell-cell junctions in cell monolayers, but failed to translocate to the leading edge in Cdc42 siRNA transfected cells after monolayer wounding. Conclusion: Rho proteins expressed in cultured human corneal epithelial cells, and Cdc42, TCL facilitate two-dimensional cell migration in-vitro. Although silencing of Cdc42 and TCL did not noticeably affect the appearance of cell adhesions at the leading edge, the slower migration of these cells indicates both GTP-binding proteins play important roles in promoting cell movement of human corneal epithelial cells.	[Hou, Aihua; Gan, Kah Hui; Lee, Khee Jin Ryan; Tong, Louis] Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore, Singapore; [Toh, Li Xian; Manser, Edward] ASTAR, Inst Med Biol, RGS Grp, Singapore, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore; [Tong, Louis] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	National University of Singapore; Singapore National Eye Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Singapore National Eye Center; National University of Singapore; National University of Singapore	Tong, L (corresponding author), Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore, Singapore.	Louis.tong.h.t@snec.com.sg	Manser, Edward/ABD-2301-2020	Tong, Louis/0000-0002-3986-6552	Singapore National Research Foundation [NMRC/1206/2009, NMRC/CSA/013/2009, NMRC/TCR/002-SERI/2008]	Singapore National Research Foundation(National Research Foundation, Singapore)	This research is supported by the Singapore National Research Foundation under its NMRC/1206/2009, NMRC/CSA/013/2009, NMRC/TCR/002-SERI/2008 and administered by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Anderson SC, 2001, INVEST OPHTH VIS SCI, V42, P933; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Edelhauser HF, 2006, INVEST OPHTH VIS SCI, V47, P1755, DOI 10.1167/iovs.05-1139; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Faure Sandrine, 2011, Small GTPases, V2, P310; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Inaki M, 2012, P NATL ACAD SCI USA, V109, P2027, DOI 10.1073/pnas.1115260109; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; KAUR S, 2011, CHARACTERISATION EXP; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kimura K, 2011, INVEST OPHTH VIS SCI, V52, P3181, DOI 10.1167/iovs.10-5684; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Li J, 2011, MOL VIS, V17, P2263; Li ZL, 2010, MOL BIOL CELL, V21, P3317, DOI 10.1091/mbc.E10-03-0245; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P941; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; POTHULA S, 2013, INVEST OPHTHALMOL VI; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Ridley AJ, 2012, METHODS MOL BIOL, V827, P3, DOI 10.1007/978-1-61779-442-1_1; Saito J, 2004, JPN J OPHTHALMOL, V48, P199, DOI 10.1007/s10384-003-0059-2; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Siak JJK, 2011, INVEST OPHTH VIS SCI, V52, P230, DOI 10.1167/iovs.10-5735; Streichan SJ, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045004; SundarRaj N, 1998, INVEST OPHTH VIS SCI, V39, P1266; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Vadodaria KC, 2013, J NEUROSCI, V33, P1179, DOI 10.1523/JNEUROSCI.2103-12.2013; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; Weber KSC, 1998, EUR J IMMUNOL, V28, P2245, DOI 10.1002/(SICI)1521-4141(199807)28:07<2245::AID-IMMU2245>3.0.CO;2-V; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Wherlock M, 2002, J CELL SCI, V115, P239; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; WU RL, 1994, DIFFERENTIATION, V55, P137, DOI 10.1046/j.1432-0436.1994.5520137.x; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Yin J, 2008, INVEST OPHTH VIS SCI, V49, P900, DOI 10.1167/iovs.07-1122; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	66	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77107	10.1371/journal.pone.0077107	http://dx.doi.org/10.1371/journal.pone.0077107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130842	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200059
J	Kim, HJ; Kim, J; Cho, H; Ye, BS; Yoon, CW; Noh, Y; Kim, GH; Lee, JH; Kim, JS; Choe, YS; Lee, KH; Kim, CH; Seo, SW; Weiner, MW; Na, DL; Seong, JK				Kim, Hee Jin; Kim, Jeonghun; Cho, Hanna; Ye, Byoung Seok; Yoon, Cindy W.; Noh, Young; Kim, Geon Ha; Lee, Jae Hong; Kim, Jae Seung; Choe, Yearn Seong; Lee, Kyung-Han; Kim, Chang-Hun; Seo, Sang Won; Weiner, Michael W.; Na, Duk L.; Seong, Joon-Kyung			Individual Subject Classification of Mixed Dementia from Pure Subcortical Vascular Dementia Based on Subcortical Shape Analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PERMUTATION TESTS; HIPPOCAMPAL; AMYGDALA; ATROPHY; VOLUME; MRI; AD	Subcortical vascular dementia (SVaD), one of common causes of dementia, has concomitant Alzheimer's disease (AD) pathology in over 30%, termed "mixed dementia''. Identifying mixed dementia from SVaD is important because potential amyloid-targeted therapies may be effective for treatment in mixed dementia. The purpose of this study was to discriminate mixed dementia from pure SVaD using magnetic resonance imaging (MRI). We measured brain amyloid deposition using the 11C-Pittsburgh compound B positron emission tomography (PiB-PET) in 68 patients with SVaD. A PiB retention ratio greater than 1.5 was considered PiB(+). Hippocampal and amygdalar shape were used in the incremental learning method to discriminate mixed dementia from pure SVaD because these structures are known to be prominently involved by AD pathologies. Among 68 patients, 23 (33.8%) patients were positive for PiB binding. With use of hippocampal shape analysis alone, PiB(+) SVaD could be discriminated from PiB(-) SVaD with 77.9% accuracy (95.7% sensitivity and 68.9% specificity). With use of amygdalar shape, the discrimination accuracy was 75.0% (87.0% sensitivity and 68.9% specificity). When hippocampal and amygdalar shape were analyzed together, accuracy increased to 82.4% (95.7% sensitivity and 75.6% specificity). An incremental learning method using hippocampal and amygdalar shape distinguishes mixed dementia from pure SVaD. Furthermore, our results suggest that amyloid pathology and vascular pathology have different effects on the shape of the hippocampus and amygdala.	[Kim, Hee Jin; Cho, Hanna; Ye, Byoung Seok; Seo, Sang Won; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Jeonghun; Kim, Chang-Hun] Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea; [Yoon, Cindy W.] Inha Univ, Coll Med, Dept Neurol, Inchon, South Korea; [Noh, Young] Gachon Univ, Gil Med Ctr, Dept Neurol, Inchon, South Korea; [Kim, Geon Ha] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Neurol, Seoul, South Korea; [Lee, Jae Hong] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Jae Seung] Univ Ulsan, Coll Med, Dept Nucl Med, Seoul, South Korea; [Choe, Yearn Seong; Lee, Kyung-Han] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea; [Weiner, Michael W.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Weiner, Michael W.] Dept Vet Affairs Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA; [Seong, Joon-Kyung] Korea Univ, Dept Biomed Engn, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Inha University; Gachon University; Ewha Womans University; University of Ulsan; Asan Medical Center; University of Ulsan; Sungkyunkwan University (SKKU); Samsung Medical Center; University of California System; University of California San Francisco; Korea University	Seo, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	sangwonseo@empal.com; jkseong@korea.ac.kr	Na, Duk Lyul/C-9598-2011; Yoon, Cindy/HCJ-0079-2022	Yoon, Cindy/0000-0002-4697-6610	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065, A120798]; Samsung Medical Center Clinical Research Development Program grant [CRL-108011, CRS 110-14-1]; Converging Research Center Program through the Ministry of Education, Science and Technology [2010K001054]; National Research Foundation of Korea (NRF); Korea government (MEST) [2013-00009999]; NRF; Korea government (MSIP) [2010-0028631]; Basic Science Research Program through the NRF; Ministry of Education [2012-004157]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Samsung Medical Center Clinical Research Development Program grant(Samsung); Converging Research Center Program through the Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NRF; Korea government (MSIP); Basic Science Research Program through the NRF; Ministry of Education	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (No. A102065, A120798), a Samsung Medical Center Clinical Research Development Program grant (CRL-108011 and CRS 110-14-1), the Converging Research Center Program through the Ministry of Education, Science and Technology (2010K001054), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013-00009999), the NRF grant funded by the Korea government (MSIP) (No. 2010-0028631), and Basic Science Research Program through the NRF funded by the Ministry of Education (No. 2012-004157). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso M, 2006, PSYCHIAT RES-NEUROIM, V146, P251, DOI 10.1016/j.pscychresns.2006.01.007; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cavedo E, 2011, NEUROLOGY, V76, P727, DOI 10.1212/WNL.0b013e31820d62d9; Cho Y, 2012, NEUROIMAGE, V59, P2217, DOI 10.1016/j.neuroimage.2011.09.085; Cho Y, 2011, NEUROIMAGE, V57, P1376, DOI 10.1016/j.neuroimage.2011.05.066; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; de Leeuw FE, 2006, STROKE, V37, P2248, DOI 10.1161/01.STR.0000236555.87674.e1; Du AT, 2002, NEUROLOGY, V58, P1635, DOI 10.1212/WNL.58.11.1635; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Hinrichs C, 2009, NEUROIMAGE, V48, P138, DOI 10.1016/j.neuroimage.2009.05.056; Horinek D, 2007, CURR OPIN PSYCHIATR, V20, P273; Jae-il Kim, 2012, Journal of Computing Science and Engineering, V6, P219, DOI 10.5626/JCSE.2012.6.3.219; Jagust WJ, 2008, ANN NEUROL, V63, P72, DOI 10.1002/ana.21296; Kim GH, 2012, ALZHEIMERS DEMENT S, V8, pP158; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kohannim O, 2010, NEUROBIOL AGING, V31, P1429, DOI 10.1016/j.neurobiolaging.2010.04.022; Lee JH, 2011, NEUROLOGY, V77, P18, DOI 10.1212/WNL.0b013e318221acee; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Liu CJ, 2000, IEEE T IMAGE PROCESS, V9, P132, DOI 10.1109/83.817604; Marrocco C, 2008, PATTERN RECOGN, V41, P1961, DOI 10.1016/j.patcog.2007.11.017; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Pieper S, 2006, P ISBI NAN MACR; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Seo SW, 2007, NEUROIMAGE, V36, P289, DOI 10.1016/j.neuroimage.2007.02.042; Shi J, 2013, NEUROIMAGE, V78, P111, DOI 10.1016/j.neuroimage.2013.04.018; Sorkine O, 2006, COMPUT GRAPH FORUM, V25, P789, DOI 10.1111/j.1467-8659.2006.00999.x; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; van de Pol L, 2011, NEURODEGENER DIS, V8, P465, DOI 10.1159/000326695; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Yu H, 2001, PATTERN RECOGN, V34, P2067, DOI 10.1016/S0031-3203(00)00162-X; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	38	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75602	10.1371/journal.pone.0075602	http://dx.doi.org/10.1371/journal.pone.0075602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130724	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200017
J	Knight, EJ; Klepac, KM; Kralik, JD				Knight, Emily J.; Klepac, Kristen M.; Kralik, Jerald D.			Too Good to Be True: Rhesus Monkeys React Negatively to Better-than-Expected Offers	PLOS ONE			English	Article							LEARNED HELPLESSNESS; COGNITIVE-DISSONANCE; EMOTIONAL RESPONSES; GREAT APES; DECISION; QUANTITY; CORTEX; REINFORCEMENT; CONSEQUENCES; FOUNDATIONS	To succeed in a dynamically changing world, animals need to predict their environments. Humans, in fact, exhibit such a strong desire for consistency that one of the most well-established findings in social psychology is the effort people make to maintain consistency among their beliefs, attitudes, and behavior. However, displeasure with unpredictability leads to a potential paradox, because a positive outcome that exceeds one's expectations often leads to increased subjective value and positive affect, not the opposite. We tested the hypothesis that two evolutionarily-conserved evaluation processes underlie goal-directed behavior: (1) consistency, concerned with prediction errors, and (2) valuation, concerned with outcome utility. Rhesus monkeys (Macaca mulatta) viewed a food item and then were offered an identical, better, or worse food, which they could accept or reject. The monkeys ultimately accepted all offers, attesting to the influence of the valuation process. However, they were slower to accept the unexpected offers, and they exhibited aversive reactions, especially to the better-than-expected offers, repeatedly turning their heads and looking away before accepting the food item. Our findings (a) provide evidence for two separable evaluation processes in primates, consistency and value assessment, (b) reveal a direct relationship between consistency assessment and emotional processes, and (c) show that our wariness with events that are much better than expected is shared with other social primates.	[Knight, Emily J.; Klepac, Kristen M.; Kralik, Jerald D.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Kralik, JD (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	Jerald.D.Kralik@Dartmouth.edu		Knight, Emily/0000-0002-6971-1148	NIMH [1 K22 MH071756-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [K22MH071756] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by NIMH 1 K22 MH071756-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson R.P., 1968, THEORIES COGNITIVE C; ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; AMSEL A, 1994, PSYCHON B REV, V1, P280, DOI 10.3758/BF03213968; ARONSON E, 1968, ADV EXPT SOCIAL PSYC, P1; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; BUSH LK, 1993, PSYCHOL BULL, V113, P566, DOI 10.1037/0033-2909.113.3.566; CARLSMITH JM, 1963, J ABNORM PSYCHOL, V66, P151, DOI 10.1037/h0042692; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Chen MK, 2009, J EXP SOC PSYCHOL, V45, P425, DOI 10.1016/j.jesp.2008.08.026; Chen YH, 2009, J AUTISM DEV DISORD, V39, P635, DOI 10.1007/s10803-008-0663-6; Chu S, 2007, PERS INDIV DIFFER, V42, P1291, DOI 10.1016/j.paid.2006.10.007; Cooper J, 2007, COGNITIVE DISSONANCE; Cosmides L., 2005, HDB EVOLUTIONARY PSY, P584; Coughlan R, 2001, ORGAN BEHAV HUM DEC, V85, P211, DOI 10.1006/obhd.2000.2939; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P267, DOI 10.1111/j.1749-6632.1990.tb48900.x; Dickinson A., 1994, ANIMAL LEARNING COGN; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014; Eilam D, 2006, NEUROSCI BIOBEHAV R, V30, P456, DOI 10.1016/j.neubiorev.2005.08.003; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Gazzaniga M. S., 2008, COGNITIVE NEUROSCIEN; Goswami U., 2008, COGNITIVE DEV; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; HALL G, 1979, J EXP PSYCHOL ANIM B, V5, P31, DOI 10.1037/0097-7403.5.1.31; Harmon-Jones E., 1999, COGNITIVE DISSONANCE; Hassin R. R., 2010, SELF CONTROL SOC MIN; Hastie R., 2001, RATIONAL CHOICE UNCE; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; HOGG RV, 1974, J AM STAT ASSOC, V69, P909, DOI 10.2307/2286160; Hsee CK, 2010, PERSPECT PSYCHOL SCI, V5, P343, DOI 10.1177/1745691610374586; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 1982, JUDGEMENT UNCERTAINT; KANNER L, 1968, ACTA PAEDOPSYCHIATR, V35, P100; Kobayashi R, 1998, PSYCHIAT CLIN NEUROS, V52, P383, DOI 10.1046/j.1440-1819.1998.00415.x; Kralik JD, 2005, J COMP PSYCHOL, V119, P78, DOI 10.1037/0735-7036.119.1.78; KRALIK JD, 2011, BEHAV CONTROL PRIMAT; KRALIK JD, PUBLIC LIB IN PRESS; Kralik JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046240; Kralik JD, 2012, BEHAV PROCESS, V89, P197, DOI 10.1016/j.beproc.2011.09.010; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Mahajan N, 2011, J PERS SOC PSYCHOL, V100, P387, DOI 10.1037/a0022459; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Marticorena DCW, 2011, DEVELOPMENTAL SCI, V14, P1406, DOI 10.1111/j.1467-7687.2011.01085.x; Mazur JE, 2005, LEARNING BEHAV; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Meunier M, 1999, EUR J NEUROSCI, V11, P4403, DOI 10.1046/j.1460-9568.1999.00854.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MINEKA S, 1978, J ABNORM PSYCHOL, V87, P256, DOI 10.1037/0021-843X.87.2.256; Murray EA, 2005, ANIM BEHAV, V69, P991, DOI 10.1016/j.anbehav.2004.06.034; O'Reilly RC, 2010, CURR OPIN NEUROBIOL, V20, P257, DOI 10.1016/j.conb.2010.01.008; Passingham REP, 2012, NEUROBIOLOGY PREFRON; Pearce J. M., 2008, ANIMAL LEARNING COGN, V3rd; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Platt M. L., 2010, PRIMATE NEUROETHOLOG; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rescorla R. A., 1972, CLASSICAL CONDITIONI; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P57, DOI 10.1901/jeab.1961.4-57; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shepperd JA, 2002, PSYCHOL SCI, V13, P85, DOI 10.1111/1467-9280.00416; Shifferman EM, 2009, ANIM COGN, V12, P547, DOI 10.1007/s10071-009-0215-2; Silberberg A, 1998, J EXP PSYCHOL ANIM B, V24, P215, DOI 10.1037/0097-7403.24.2.215; Silberberg A, 2009, ANIM COGN, V12, P505, DOI 10.1007/s10071-009-0211-6; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; STADDON JER, 1970, LEARN MOTIV, V1, P227, DOI 10.1016/0023-9690(70)90148-7; Stout SC, 2003, LEARN MOTIV, V34, P437, DOI 10.1016/S0023-9690(03)00038-9; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Teigen KH, 2003, COGNITION, V87, P55, DOI 10.1016/S0010-0277(02)00201-9; Thierry B., 2004, MACAQUE SOC MODEL ST; Thorsteinson TJ, 2004, J BUS PSYCHOL, V19, P125, DOI 10.1023/B:JOBU.0000040276.75748.b9; Tinklepaugh OL, 1928, J COMP PSYCHOL, V8, P197, DOI 10.1037/h0075798; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; WEISS JM, 1970, PSYCHOSOM MED, V32, P397, DOI 10.1097/00006842-197007000-00008; Williams BA, 2002, ANIM LEARN BEHAV, V30, P1, DOI 10.3758/BF03192905; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Winer B.J., 1991, STAT PRINCIPLES EXPT; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Zentall TR, 2007, J EXP ANAL BEHAV, V88, P131, DOI 10.1901/jeab.2007.27-06	109	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75768	10.1371/journal.pone.0075768	http://dx.doi.org/10.1371/journal.pone.0075768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130742	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900057
J	Ryan, M; Suaya, JA; Chapman, JD; Stason, WB; Shepard, DS; Thomas, CP				Ryan, Marian; Suaya, Jose A.; Chapman, John D.; Stason, William B.; Shepard, Donald S.; Thomas, Cindy Parks			Incidence and Cost of Pneumonia in Older Adults with COPD in the United States	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; HEART-FAILURE; INHALED CORTICOSTEROIDS; ECONOMIC BURDEN; RISK; HOSPITALIZATION; PREVALENCE; PROGNOSIS; DIAGNOSIS	Objectives: To estimate the incidence of pneumonia by COPD status and the excess cost of inpatient primary pneumonia in elders with COPD. Study Design: A retrospective, longitudinal study using claims linked to eligibility/demographic data for a 5% sample of fee-for-service Medicare beneficiaries from 2005 through 2007. Methods: Incidence rates of pneumonia were calculated for elders with and without COPD and for elders with COPD and coexistent congestive heart failure (CHF). Propensity-score matching with multivariate generalized linear regression was used to estimate the excess direct medical cost of inpatient primary pneumonia in elders with COPD as compared with elders with COPD but without a pneumonia hospitalization. Results: Elders with COPD had nearly six-times the incidence of pneumonia compared with elders without COPD (167.6/1000 person-years versus 29.5/1000 person-years; RR=5.7, p <0. 01); RR increased to 8.1 for elders with COPD and CHF compared with elders without COPD. The incidence of inpatient primary pneumonia among elders with COPD was 54.2/1000 person-years compared with 7/1000 person-years for elders without COPD; RR=7.7, p<0.01); RR increased to 11.0 for elders with COPD and CHF compared with elders without COPD. The one-year excess direct medical cost of inpatient pneumonia in COPD patients was $ 22,697 ($ 45,456 in cases vs. $ 22,759 in controls (p <0.01)); 70.2% of this cost was accrued during the quarter of the index hospitalization. During months 13 through 24 following the index hospitalization, the excess direct medical cost was $ 5,941 ($ 23,215 in cases vs. $ 17,274 in controls, p<0.01). Conclusions: Pneumonia occurs more frequently in elders with COPD than without COPD. The excess direct medical cost in elders with inpatient pneumonia extends up to 24 months following the index hospitalization and represents $ 28,638 in 2010 dollars.	[Ryan, Marian; Chapman, John D.; Stason, William B.; Shepard, Donald S.; Thomas, Cindy Parks] Brandeis Univ, Heller Sch, Schneider Inst Healthcare Syst, Waltham, MA 02254 USA; [Suaya, Jose A.] GlaxoSmithKline Vaccines, Philadelphia, PA USA	Brandeis University; GlaxoSmithKline	Ryan, M (corresponding author), Brandeis Univ, Heller Sch, Schneider Inst Healthcare Syst, Waltham, MA 02254 USA.	mryan@brandeis.edu	Thomas, Cindy Parks/L-3204-2015	Thomas, Cindy Parks/0000-0001-5855-1196	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This research has been funded by GlaxoSmithKline. Decisions on study design, data collection and analysis, decision where to publish, and preparation of the manuscript were done solely and collectively by the authors. Authors adhere to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2011, AM J RESP CRIT CARE, V184, P507, DOI 10.1164/rccm.201103-0405PP; Akazawa M, 2008, CLIN THER, V30, P1003, DOI 10.1016/j.clinthera.2008.05.020; Andersson F, 2002, RESP MED, V96, P700, DOI 10.1053/rmed.2002.1334; *ATS, 2005, AM J RESP CRIT CARE, V171, P1143; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Benfield T, 2008, CHEST, V134, P46, DOI 10.1378/chest.07-2933; Blanchette CM, 2008, J MANAGE CARE PHARM, V14, P176, DOI 10.18553/jmcp.2008.14.2.176; Bohannon Richard W, 2003, Conn Med, V67, P599; Boudestein LCM, 2009, EUR J HEART FAIL, V11, P1182, DOI 10.1093/eurjhf/hfp148; BRANCATI FL, 1993, LANCET, V342, P30, DOI 10.1016/0140-6736(93)91887-R; Bratzler Dale W, 2004, J Okla State Med Assoc, V97, P227; Briggs Dick D Jr, 2004, J Manag Care Pharm, V10, pS3; *BUCC, 2009, HRON COND WAR US MAN, P23; BURGE S, 2003, EUR RESPIR J, V41, P46, DOI DOI 10.1183/09031936.03.00078002; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Crespo A, 2013, EUR RESPIR J, V42; Dodd S, 2006, J EVAL CLIN PRACT, V12, P76, DOI 10.1111/j.1365-2753.2006.00610.x; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Faulkner Michele A, 2002, Expert Opin Pharmacother, V3, P219; Franciosi LG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-74; Fromer L, 2008, INT J CLIN PRACT, V62, P1219, DOI 10.1111/j.1742-1241.2008.01807.x; Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784; *IN GLOB CHRON OBS, 2011, LOB STRAT DIAGN MAN; *IN GLOB CHRON OBS, 2010, LOB STRAT DIAGN MAN; Joo MJ, 2010, RESP MED, V104, P246, DOI 10.1016/j.rmed.2009.10.002; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kaysar M, 2008, GERIATR GERONTOL INT, V8, P227, DOI 10.1111/j.1447-0594.2008.00480.x; Koivula I, 1999, ARCH INTERN MED, V159, P1550, DOI 10.1001/archinte.159.14.1550; Krumholz HM., 2008, HOSP 30 DAY PNEUMONI; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Macchia A, 2012, EUR RESPIR J, V39, P51, DOI 10.1183/09031936.00044411; Mannino DM, 2009, RESP MED, V103, P224, DOI 10.1016/j.rmed.2008.09.005; *MED, 2006, FED REGISTER, V71, P65883; *MEDPAC, 2008, MED PAYM POL; Menzin J, 2008, RESP MED, V102, P1248, DOI 10.1016/j.rmed.2008.04.009; Minkoff NB., 2005, J MANAG CARE PHAR SA, V11, pS20; Mor A, 2013, EUR J INTERN MED, V24, P349, DOI 10.1016/j.ejim.2013.02.013; Moran JL, 2007, J EVAL CLIN PRACT, V13, P381, DOI 10.1111/j.1365-2753.2006.00711.x; *NHLBI, 2007, MORB MORT 2007 CHART; Omachi TA, 2008, COPD, V5, P339, DOI 10.1080/15412550802522700; Padeletti M, 2008, INT J CARDIOL, V125, P209, DOI 10.1016/j.ijcard.2007.12.001; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Ruchlin HS, 2001, PHARMACOECONOMICS, V19, P623, DOI 10.2165/00019053-200119060-00002; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P923, DOI 10.1164/ajrccm.160.3.9901107; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Seemungal Terence A R, 2009, Int J Chron Obstruct Pulmon Dis, V4, P203; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Thomas CP, 2012, CHEST, V142, P973, DOI 10.1378/chest.11-1160; Tinkelman D, 2003, AM J MANAG CARE, V9, P767; Tinkelman David G, 2007, Prim Care Respir J, V16, P41, DOI 10.3132/pcrj.2007.00009; Vestbo J, 2006, THORAX, V61, P86, DOI 10.1136/thx.2005.046227; Ward MM, 2000, RESP MED, V94, P1123, DOI 10.1053/rmed.2000.0933; Zeng QJ, 2012, J THORAC DIS, V4, P310, DOI 10.3978/j.issn.2072-1439.2012.01.09	59	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75887	10.1371/journal.pone.0075887	http://dx.doi.org/10.1371/journal.pone.0075887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130749	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900062
J	Traber, PG; Chou, H; Zomer, E; Hong, F; Klyosov, A; Fiel, MI; Friedman, SL				Traber, Peter G.; Chou, Hsin; Zomer, Eliezer; Hong, Feng; Klyosov, Anatole; Fiel, Maria-Isabel; Friedman, Scott L.			Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; BINDING; INFLAMMATION; EXPRESSION; ANTIGEN; DOMAIN; CELLS	Galectin-3 protein is critical to the development of liver fibrosis because galectin-3 null mice have attenuated fibrosis after liver injury. Therefore, we examined the ability of novel complex carbohydrate galectin inhibitors to treat toxin-induced fibrosis and cirrhosis. Fibrosis was induced in rats by intraperitoneal injections with thioacetamide (TAA) and groups were treated with vehicle, GR-MD-02 (galactoarabino-rhamnogalaturonan) or GM-CT-01 (galactomannan). In initial experiments, 4 weeks of treatment with GR-MD-02 following completion of 8 weeks of TAA significantly reduced collagen content by almost 50% based on Sirius red staining. Rats were then exposed to more intense and longer TAA treatment, which included either GR-MD-02 or GM-CT-01 during weeks 8 through 11. TAA rats treated with vehicle developed extensive fibrosis and pathological stage 6 Ishak fibrosis, or cirrhosis. Treatment with either GR-MD-02 (90 mg/kg ip) or GM-CT-01 (180 mg/kg ip) given once weekly during weeks 8-11 led to marked reduction in fibrosis with reduction in portal and septal galectin-3 positive macrophages and reduction in portal pressure. Vehicle-treated animals had cirrhosis whereas in the treated animals the fibrosis stage was significantly reduced, with evidence of resolved or resolving cirrhosis and reduced portal inflammation and ballooning. In this model of toxin-induced liver fibrosis, treatment with two galectin protein inhibitors with different chemical compositions significantly reduced fibrosis, reversed cirrhosis, reduced galectin-3 expressing portal and septal macrophages, and reduced portal pressure. These findings suggest a potential role of these drugs in human liver fibrosis and cirrhosis.	[Traber, Peter G.; Zomer, Eliezer; Klyosov, Anatole] Galectin Therapeut Inc, Norcross, GA USA; [Traber, Peter G.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Chou, Hsin; Hong, Feng; Friedman, Scott L.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY USA; [Fiel, Maria-Isabel] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA	Emory University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Traber, PG (corresponding author), Galectin Therapeut Inc, Norcross, GA USA.	traber@galectintherapeutics.com			Galectin Therapeutics	Galectin Therapeutics	Three of the authors (PGT, EZ, AK), including the corresponding author (PGT) were employees of Galectin Therapeutics, which funded the studies. Hence, employees of the funder had a direct role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Bonis PAL, 2001, NEW ENGL J MED, V344, P452, DOI 10.1056/NEJM200102083440610; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Colnot C, 1998, IMMUNOLOGY, V94, P290, DOI 10.1046/j.1365-2567.1998.00517.x; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Forsman H, 2011, ARTHRITIS RHEUM-US, V63, P445, DOI 10.1002/art.30118; Friedman SL, 2007, HEPATOLOGY, V45, P242, DOI 10.1002/hep.21459; FRIEDMAN SL, 1992, HEPATOLOGY, V15, P234, DOI 10.1002/hep.1840150211; Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803; Haudek KC, 2010, BBA-GEN SUBJECTS, V1800, P181, DOI 10.1016/j.bbagen.2009.07.005; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HO MK, 1982, J IMMUNOL, V128, P2281; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Jiang JX, 2012, AM J PHYSIOL-GASTR L, V302, pG439, DOI 10.1152/ajpgi.00257.2011; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lippert E, 2008, CLIN EXP IMMUNOL, V152, P285, DOI 10.1111/j.1365-2249.2008.03618.x; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Maeda N, 2003, J BIOL CHEM, V278, P18938, DOI 10.1074/jbc.M209673200; Maeda Naoto, 2004, Comp Hepatol, V3 Suppl 1, pS10, DOI 10.1186/1476-5926-2-S1-S10; Miller MC, 2012, GLYCOBIOLOGY, V22, P543, DOI 10.1093/glycob/cwr173; Miller MC, 2011, GLYCOBIOLOGY, V21, P1627, DOI 10.1093/glycob/cwr083; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265; Oberg CT, 2011, CHIMIA, V65, P18, DOI 10.2533/chimia.2011.18; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Papaspyridonos M, 2008, ARTERIOSCL THROM VAS, V28, P433, DOI 10.1161/ATVBAHA.107.159160; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; SATO S, 1992, J GEN MICROBIOL, V138, P1992, DOI 10.1099/00221287-138-9-1992; Schuppan D, 2010, LIVER INT, V30, P795, DOI 10.1111/j.1478-3231.2010.02264.x; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719	43	134	140	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75361	10.1371/journal.pone.0075361	http://dx.doi.org/10.1371/journal.pone.0075361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130706	Green Published, gold			2022-12-27	WOS:000325810900032
J	Huehnchen, P; Boehmerle, W; Endres, M				Huehnchen, Petra; Boehmerle, Wolfgang; Endres, Matthias			Assessment of Paclitaxel Induced Sensory Polyneuropathy with "Catwalk" Automated Gait Analysis in Mice	PLOS ONE			English	Article							CHANNEL ALPHA(2)DELTA-1 SUBUNIT; PAINFUL PERIPHERAL NEUROPATHY; SCIATIC-NERVE INJURY; MECHANICAL ALLODYNIA; UP-REGULATION; RAT; MODELS; GABAPENTIN; EXPRESSION; NOCICEPTION	Neuropathic pain as a symptom of sensory nerve damage is a frequent side effect of chemotherapy. The most common behavioral observation in animal models of chemotherapy induced polyneuropathy is the development of mechanical allodynia, which is quantified with von Frey filaments. The data from one study, however, cannot be easily compared with other studies owing to influences of environmental factors, inter-rater variability and differences in test paradigms. To overcome these limitations, automated quantitative gait analysis was proposed as an alternative, but its usefulness for assessing animals suffering from polyneuropathy has remained unclear. In the present study, we used a novel mouse model of paclitaxel induced polyneuropathy to compare results from electrophysiology and the von Frey method to gait alterations measured with the Catwalk test. To mimic recently improved clinical treatment strategies of gynecological malignancies, we established a mouse model of dose-dense paclitaxel therapy on the common C57Bl/6 background. In this model paclitaxel treated animals developed mechanical allodynia as well as reduced caudal sensory nerve action potential amplitudes indicative of a sensory polyneuropathy. Gait analysis with the Catwalk method detected distinct alterations of gait parameters in animals suffering from sensory neuropathy, revealing a minimized contact of the hind paws with the floor. Treatment of mechanical allodynia with gabapentin improved altered dynamic gait parameters. This study establishes a novel mouse model for investigating the side effects of dose-dense paclitaxel therapy and underlines the usefulness of automated gait analysis as an additional easy-to-use objective test for evaluating painful sensory polyneuropathy.	[Huehnchen, Petra; Boehmerle, Wolfgang; Endres, Matthias] Charite, Klin & Hsch Ambulanz Neurol, D-13353 Berlin, Germany; [Huehnchen, Petra; Boehmerle, Wolfgang; Endres, Matthias] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Endres, Matthias] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Boehmerle, W (corresponding author), Charite, Klin & Hsch Ambulanz Neurol, D-13353 Berlin, Germany.	wolfgang.boehmerle@charite.de	Huehnchen, Petra/ABA-5685-2020	Huehnchen, Petra/0000-0002-6825-7270; Endres, Matthias/0000-0001-6520-3720; Boehmerle, Wolfgang/0000-0001-7195-3894	federal ministry of education and research via the grant center for stroke research Berlin [01 EO 0801]; Volkswagen foundation; Deutsche Forschungsgemeinschaft DFG (NeuroCure)	federal ministry of education and research via the grant center for stroke research Berlin; Volkswagen foundation(Volkswagen); Deutsche Forschungsgemeinschaft DFG (NeuroCure)	The research leading to these results has received funding for the procurement of equipment and consumables from the federal ministry of education and research via the grant center for stroke research Berlin (01 EO 0801), the Volkswagen foundation (Lichtenberg program to Matthias Endres), and Deutsche Forschungsgemeinschaft DFG (NeuroCure). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmet A, 2006, INT J PEDIATR OTORHI, V70, P779, DOI 10.1016/j.ijporl.2005.11.011; Authier N, 2009, NEUROTHERAPEUTICS, V6, P620, DOI 10.1016/j.nurt.2009.07.003; Boroujerdi A, 2008, PAIN, V139, P358, DOI 10.1016/j.pain.2008.05.004; Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; Cendelin J, 2010, BEHAV BRAIN RES, V210, P8, DOI 10.1016/j.bbr.2010.01.035; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Ferland CE, 2011, PHARMACOL BIOCHEM BE, V97, P603, DOI 10.1016/j.pbb.2010.11.003; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Gauchan P, 2009, BIOL PHARM BULL, V32, P732, DOI 10.1248/bpb.32.732; Hess V, 2003, ANN ONCOL, V14, P638, DOI 10.1093/annonc/mdg176; Katsumata N, 2011, ANN ONCOL S8, V22, pviii29; Kim KJ, 1997, EXP BRAIN RES, V113, P200, DOI 10.1007/BF02450318; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Leandri M, 2012, J NEUROSCI METH, V209, P403, DOI 10.1016/j.jneumeth.2012.07.005; Lindenlaub T, 2000, BRAIN RES, V866, P15, DOI 10.1016/S0006-8993(00)02190-9; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Matsumoto M, 2006, J PHARMACOL EXP THER, V318, P735, DOI 10.1124/jpet.106.103614; Mo M, 2012, FASEB J; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; OCHOA JL, 1994, CURR OPIN NEUROL, V7, P407, DOI 10.1097/00019052-199410000-00008; Piesla MJ, 2009, BRAIN RES, V1295, P89, DOI 10.1016/j.brainres.2009.07.091; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sato J, 1999, NEUROSCI LETT, V266, P21, DOI 10.1016/S0304-3940(99)00260-8; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wang MS, 2002, ANN NEUROL, V52, P442, DOI 10.1002/ana.10300; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044	39	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76772	10.1371/journal.pone.0076772	http://dx.doi.org/10.1371/journal.pone.0076772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143194	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100029
J	Mowry, EM; Carey, RF; Blasco, MR; Pelletier, J; Duquette, P; Villoslada, P; Malikova, I; Roger, E; Kinkel, RP; McDonald, J; Bacchetti, P; Waubant, E				Mowry, Ellen M.; Carey, Robert F.; Blasco, Maria R.; Pelletier, Jean; Duquette, Pierre; Villoslada, Pablo; Malikova, Irina; Roger, Elaine; Kinkel, R. Phillip; McDonald, Jamie; Bacchetti, Peter; Waubant, Emmanuelle			Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS	PLOS ONE			English	Article							INTERFERON BETA-1A; CONTROLLED-TRIAL; CD4(+) T; REPLICATION; RECEPTOR; RISK; CD58; CD6	Objective: The anatomic location of subsequent relapses in early multiple sclerosis (MS) appears to be predicted by the first attack location. We sought to determine if genetic polymorphisms associated with MS susceptibility are associated with attack location. Methods: 17 genome-wide association study-identified MS susceptibility polymorphisms were genotyped in 503 white, non-Hispanic patients seen within a year of MS onset. Their association with the CNS location of the first two MS attacks was assessed in multivariate repeated measures analyses (generalized estimating equations with robust standard errors). Results: The IL12A polymorphism was independently associated with increased odds of attacks involving the spinal cord (OR = 1.52, 95% CI 1.11, 2.07, p = 0.009), as was the IRF8 polymorphism (OR = 2.40, 95% CI [1.04, 5.50], p = 0.040). The IL7R polymorphism was associated with reduced odds of attacks involving the brainstem/cerebellum (OR = 0.46, 95% CI 0.22, 0.97, p = 0.041), as were the TNFRSF1A and IL12A polymorphisms. The CD6 polymorphism conferred reduced odds of optic neuritis as an attack location (OR = 0.69, 95% CI [0.49, 0.97], p = 0.034). Several other genes showed trends for association with attack location. Conclusions: Some of the MS susceptibility genes may be associated with MS attack location. The IL12A polymorphism is of particular interest given that interferon beta therapy appears to influence IL12 levels. These findings may lead to improved understanding of MS pathogenesis and treatment.	[Mowry, Ellen M.] Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA; [Carey, Robert F.; McDonald, Jamie; Waubant, Emmanuelle] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA; [Blasco, Maria R.] Hosp Univ Puerta Hierro, Dept Neurol, Madrid, Spain; [Pelletier, Jean; Malikova, Irina] Aix Marseille Univ, Ctr Hosp Univ Timone, Ctr Resonance Magnet Biol & Med, Pole Neurosci Clin,Serv Neurol, Marseille, France; [Duquette, Pierre; Roger, Elaine] Univ Montreal, Ctr Hosp, Multiple Sclerosis Clin, Montreal, PQ, Canada; [Villoslada, Pablo] Inst Biomed Res August Pi Sunyer, Hosp Clin, Ctr Neuroimmunol, Barcelona, Spain; [Kinkel, R. Phillip] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Johns Hopkins University; University of California System; University of California San Francisco; Hospital Puerta de Hierro-Majadahonda; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montreal; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Francisco	Mowry, EM (corresponding author), Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA.	emowry1@jhmi.edu	Villoslada, Pablo/AAF-9547-2019	Mowry, Ellen/0000-0003-0623-5188; Blasco Quilez, Maria Rosario/0000-0003-2719-4629; Villoslada, Pablo/0000-0002-8735-6119	National Multiple Sclerosis Society [RG-3692A]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was supported by a National Multiple Sclerosis Society research grant (www.nmss.org; RG-3692A; PI E. Waubant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Beck RW, 2002, ANN NEUROL, V51, P481, DOI 10.1002/ana.10148; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; CONFAVREUX C, 1994, ANN NEUROL, V36, pS136, DOI 10.1002/ana.410360733; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Deen S, 2008, J NEUROL NEUROSUR PS, V79, P1190, DOI 10.1136/jnnp.2007.136440; Esposito F, 2010, GENES IMMUN, V11, P397, DOI 10.1038/gene.2010.28; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hoppenbrouwers IA, 2009, J HUM GENET, V54, P676, DOI 10.1038/jhg.2009.96; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Kress-Bennett JM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-155; Marcus JF, 2010, MULT SCLER J, V16, P1004; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Mowry EM, 2009, J NEUROL NEUROSUR PS, V80, P400, DOI 10.1136/jnnp.2008.157305; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Waubant E, 2012, NEUROLOGY, V78, P1171, DOI 10.1212/WNL.0b013e31824f7fdd	27	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75565	10.1371/journal.pone.0075565	http://dx.doi.org/10.1371/journal.pone.0075565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130718	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200015
J	Ricotti, L; Rigosa, J; Niosi, A; Menciassi, A				Ricotti, Leonardo; Rigosa, Jacopo; Niosi, Alberto; Menciassi, Arianna			Analysis of Balance, Rapidity, Force and Reaction Times of Soccer Players at Different Levels of Competition	PLOS ONE			English	Article							MULTIDIMENSIONAL PERFORMANCE-CHARACTERISTICS; FEMALE COLLEGIATE SOCCER; POSTURAL CONTROL; LOWER-EXTREMITIES; STANDING BALANCE; DYNAMIC BALANCE; VERTICAL JUMP; INJURIES; STRENGTH; POWER	In the present study we analyzed 12 physical parameters, namely force, static and dynamic balance (both quantified by means of 4 parameters each), rapidity, visual reaction times and acoustic reaction times, over 185 subjects. 170 of them played soccer in teams enrolled in all the ten different Italian soccer leagues. Results show that 6 parameters (out of the 12 analyzed) permit to identify and discriminate top-level players, among those showing the same training frequency. The other parameters are strictly related to training frequency or do not discriminate among players or control subjects (non-athletes), such as visual and acoustic reaction times. Principal component analysis permits to identify 4 clusters of subjects with similar performances, thus representing a useful instrument to characterize the overall ability of players in terms of athletic characteristics, on the basis of their location on the principal component parameters plane.	[Ricotti, Leonardo; Rigosa, Jacopo; Niosi, Alberto; Menciassi, Arianna] Scuola Super Sant Anna, BioRobot Inst, Pisa, Italy	Scuola Superiore Sant'Anna	Ricotti, L (corresponding author), Scuola Super Sant Anna, BioRobot Inst, Pisa, Italy.	l.ricotti@sssup.it	Ricotti, Leonardo/GXF-0124-2022	Ricotti, Leonardo/0000-0001-8797-3742				Ben Moussa AZ, 2012, SCI SPORT, V27, P54, DOI 10.1016/j.scispo.2011.03.006; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Biec E, 2010, EUR J APPL PHYSIOL, V110, P703, DOI 10.1007/s00421-010-1551-2; Bird SP, 2012, STRENGTH COND J, V34, P73, DOI 10.1519/SSC.0b013e31824f175e; Bressel E, 2007, J ATHL TRAINING, V42, P42; Cometti G, 2001, INT J SPORTS MED, V22, P45, DOI 10.1055/s-2001-11331; Dunning E., 1999, SPORTS MATTERS SOCIO; Elferink-Gemser MT, 2007, J SPORT SCI, V25, P481, DOI 10.1080/02640410600719945; FIFA, 2007, FIFA MAGAZINE, P10; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; Gerbino PG, 2007, GAIT POSTURE, V26, P501, DOI 10.1016/j.gaitpost.2006.11.205; Gioftsidou A, 2006, EUR J APPL PHYSIOL, V96, P659, DOI 10.1007/s00421-005-0123-3; Gioftsidou A, 2012, J HUM SPORT EXERC, V7, P639, DOI 10.4100/jhse.2012.73.04; Gissis Ioannis, 2006, Res Sports Med, V14, P205, DOI 10.1080/15438620600854769; Gribble PA, 2007, J ATHL TRAINING, V42, P35; Grigg P., 1994, J SPORT REHABIL, V3, P2, DOI [10.1123/jsr.3.1.2, DOI 10.1123/JSR.3.1.2]; Gstottner M, 2009, MOTOR CONTROL, V13, P218, DOI 10.1123/mcj.13.2.218; HAMSHER KDS, 1977, CORTEX, V13, P306; Hrysomallis C, 2007, SPORTS MED, V37, P547, DOI 10.2165/00007256-200737060-00007; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Jakobsen MD, 2011, EUR J APPL PHYSIOL, V111, P521, DOI 10.1007/s00421-010-1669-2; Jovanovic M, 2011, J STRENGTH COND RES, V25, P1285, DOI 10.1519/JSC.0b013e3181d67c65; Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0; Kraemer R, 2009, AM J SPORT MED, V37, P1384, DOI 10.1177/0363546509333012; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Lopez-Segovia M, 2011, J HUM KINET, V30, P135, DOI 10.2478/v10078-011-0081-2; Malliou P, 2004, J BACK MUSCULOSKELET, V17, P101, DOI 10.3233/BMR-2004-173-403; Matsuda S, 2010, PERCEPT MOTOR SKILL, V111, P167, DOI 10.2466/05.23.26.27.PMS.111.4.167-177; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Morasso PG, 1999, HUM MOVEMENT SCI, V18, P759, DOI 10.1016/S0167-9457(99)00039-1; NASHNER LM, 1982, J NEUROSCI, V2, P536; Paillard T, 2006, SCAND J MED SCI SPOR, V16, P345, DOI 10.1111/j.1600-0838.2005.00502.x; Paillard T, 2006, J ATHL TRAINING, V41, P172; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Papaevangelou E., 2012, J PHYS ED SPORT, V12, P362, DOI [10.7752/jpes.2012.03054, DOI 10.7752/JPES.2012.03054]; Requena B, 2009, J STRENGTH COND RES, V23, P1391, DOI 10.1519/JSC.0b013e3181a4e88e; Rey E, 2012, J ELECTROMYOGR KINES, V22, P866, DOI 10.1016/j.jelekin.2012.06.003; Ricotti L, 2011, J HUM SPORT EXERC, V6, P616, DOI 10.4100/jhse.2011.64.05; Ricotti L, 2011, GAIT POSTURE, V33, P462, DOI 10.1016/j.gaitpost.2010.12.026; Rikberg A, 2011, PEDIATR EXERC SCI, V23, P537, DOI 10.1123/pes.23.4.537; Ruschel C., 2011, Motri., V7, P73; RYUSHI T, 1988, Scandinavian Journal of Sports Sciences, V10, P7; Soderman K, 2000, KNEE SURG SPORT TR A, V8, P356, DOI 10.1007/s001670000147; Spierer DK, 2011, J STRENGTH COND RES, V25, P1134, DOI 10.1519/JSC.0b013e3181d09e4c; Stray-Pedersen JI, 2006, MED SCI SPORT EXER, V38, pS243, DOI 10.1249/00005768-200605001-01072; Swanenburg J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-162; Teixeira LA, 2011, RES Q EXERCISE SPORT, V82, P21, DOI 10.1080/02701367.2011.10599718; Thorpe JL, 2008, J STRENGTH COND RES, V22, P1429, DOI 10.1519/JSC.0b013e31818202db; Tillin NA, 2010, MED SCI SPORT EXER, V42, P781, DOI 10.1249/MSS.0b013e3181be9c7e; WEINECK J, 2004, OPTIMALES TRAINING; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Wilson G, 1995, Aust J Sci Med Sport, V27, P20; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wisloff U, 2004, BRIT J SPORT MED, V38, P285, DOI 10.1136/bjsm.2002.002071; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wong DP, 2012, INT J SPORTS MED, V33, P647, DOI 10.1055/s-0032-1304588; Yap CW, 2000, STRENGTH COND J, V22, P9, DOI 10.1519/00126548-200002000-00002	57	26	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77264	10.1371/journal.pone.0077264	http://dx.doi.org/10.1371/journal.pone.0077264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130870	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200077
J	Beygo, J; Ammerpohl, O; Gritzan, D; Heitmann, M; Rademacher, K; Richter, J; Caliebe, A; Siebert, R; Horsthemke, B; Buiting, K				Beygo, Jasmin; Ammerpohl, Ole; Gritzan, Daniela; Heitmann, Melanie; Rademacher, Katrin; Richter, Julia; Caliebe, Almuth; Siebert, Reiner; Horsthemke, Bernhard; Buiting, Karin			Deep Bisulfite Sequencing of Aberrantly Methylated Loci in a Patient with Multiple Methylation Defects	PLOS ONE			English	Article							RECURRENT HYDATIDIFORM MOLE; DNA METHYLATION; CPG ISLANDS; REPRODUCTIVE WASTAGE; MUTATIONS; NLRP7; PHENOTYPE; GENE; IDENTIFICATION; GENOTYPE	NLRP7 is a maternal effect gene as maternal mutations in this gene cause recurrent hydatidiform moles, spontaneous abortions and stillbirths, whereas live births are very rare. We have studied a patient with multiple anomalies born to a mother with a heterozygous NLRP7 mutation. By array-based CpG methylation analysis of blood DNA from the patient, his parents and 18 normal controls on Illumina Infinium HumanMethylation27 BeadChips we found that the patient had methylation changes (delta beta >= 0.3) at many imprinted loci as well as at 87 CpGs associated with 85 genes of unknown imprinting status. Using a pseudoproband (permutation) approach, we found methylation changes at only 7-24 CpGs (mean 15; standard deviation 4.84) in the controls. Thus, the number of abberantly methylated CpGs in the patient is more than 14 standard deviations higher. In order to identify novel imprinted genes among the 85 conspicuous genes in the patient, we selected 19 (mainly hypomethylated) genes for deep bisulfite amplicon sequencing on the ROCHE/454 Genome Sequencer in the patient and at least two additional controls. These controls had not been included in the array analysis and were heterozygous for a single nucleotide polymorphism at the test locus, so that allele-specific DNA methylation patterns could be determined. Apart from FAM50B, which we proved to be imprinted in blood, we did not observe allele-specific DNA methylation at the other 18 loci. We conclude that the patient does not only have methylation defects at imprinted loci but (at least in blood) also an excess of methylation changes at apparently non-imprinted loci.	[Beygo, Jasmin; Gritzan, Daniela; Heitmann, Melanie; Rademacher, Katrin; Horsthemke, Bernhard; Buiting, Karin] Univ Duisburg Essen, Inst Humangenet, Univ Klinikum Essen, Essen, Germany; [Ammerpohl, Ole; Richter, Julia; Caliebe, Almuth; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Ammerpohl, Ole; Richter, Julia; Caliebe, Almuth; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany	University of Duisburg Essen; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Horsthemke, B (corresponding author), Univ Duisburg Essen, Inst Humangenet, Univ Klinikum Essen, Essen, Germany.	bernhard.horsthemke@uni-due.de	Caliebe, Almuth/G-1248-2018; Siebert, Reiner/A-8049-2010; Ammerpohl, Ole/G-2691-2010	Caliebe, Almuth/0000-0003-2157-425X; 	Bundesministerium fur Bildung und Forschung (Network imprinting diseases) [01GM1114]	Bundesministerium fur Bildung und Forschung (Network imprinting diseases)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (Network imprinting diseases, 01GM1114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz LK, 2012, CURR OPIN GENET DEV, V22, P72, DOI 10.1016/j.gde.2011.12.001; Beygo J, 2011, MOL SYNDROMOL, V2, P53, DOI 10.1159/000335545; Beygo J, 2013, HUM MOL GENET, V22, P544, DOI 10.1093/hmg/dds465; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Davison AC, 1997, BOOTSTRAP METHODS TH, Vx, P582; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dixon PH, 2012, J MED GENET, V49, P206, DOI 10.1136/jmedgenet-2011-100602; Djuric U, 2006, HUM GENET, V120, P390, DOI 10.1007/s00439-006-0192-3; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Fallahian M, 2013, HUM MUTAT, V34, P301, DOI 10.1002/humu.22228; Fisher RA, 2004, J REPROD MED, V49, P595; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Hayward BE, 2009, HUM MUTAT, V30, pE629, DOI 10.1002/humu.20993; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035789; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Martin-Trujillo A, 2011, EPIGENETICS-US, V6, P1236, DOI 10.4161/epi.6.10.17654; Messaed C, 2011, J MED GENET, V48, P540, DOI 10.1136/jmg.2011.089144; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Nakabayashi K, 2011, HUM MOL GENET, V20, P3188, DOI 10.1093/hmg/ddr224; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Prickett AR, 2012, MOL GENET GENOMICS, V287, P621, DOI 10.1007/s00438-012-0708-6; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Turan N, 2010, EPIGENETICS-US, V5, P16, DOI 10.4161/epi.5.1.10557; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Williams D, 2010, EUR J OBSTET GYN R B, V150, P3, DOI 10.1016/j.ejogrb.2010.01.003; Zeschnigk M, 2009, HUM MOL GENET, V18, P1439, DOI 10.1093/hmg/ddp054; Zhang AP, 2011, NUCLEIC ACIDS RES, V39, P5388, DOI 10.1093/nar/gkr108; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	50	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76953	10.1371/journal.pone.0076953	http://dx.doi.org/10.1371/journal.pone.0076953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130816	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900110
J	Fuentes, CT; Runa, C; Blanco, XA; Orvalho, V; Haggard, P				Fuentes, Christina T.; Runa, Catarina; Blanco, Xenxo Alvarez; Orvalho, Veronica; Haggard, Patrick			Does My Face FIT?: A Face Image Task Reveals Structure and Distortions of Facial Feature Representation	PLOS ONE			English	Article							SELF-FACE; OWN FACE; BODY; PERCEPTION; HEAD; RECOGNITION; HEMISPHERE; BRAIN; SIZE	Despite extensive research on face perception, few studies have investigated individuals' knowledge about the physical features of their own face. In this study, 50 participants indicated the location of key features of their own face, relative to an anchor point corresponding to the tip of the nose, and the results were compared to the true location of the same individual's features from a standardised photograph. Horizontal and vertical errors were analysed separately. An overall bias to underestimate vertical distances revealed a distorted face representation, with reduced face height. Factor analyses were used to identify separable subconfigurations of facial features with correlated localisation errors. Independent representations of upper and lower facial features emerged from the data pattern. The major source of variation across individuals was in representation of face shape, with a spectrum from tall/thin to short/wide representation. Visual identification of one's own face is excellent, and facial features are routinely used for establishing personal identity. However, our results show that spatial knowledge of one's own face is remarkably poor, suggesting that face representation may not contribute strongly to self-awareness.	[Fuentes, Christina T.; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Runa, Catarina; Blanco, Xenxo Alvarez; Orvalho, Veronica] Univ Porto, Inst Telecomunicacoes, Porto Interact Ctr, P-4100 Porto, Portugal	University of London; University College London; Instituto de Telecomunicacoes; Universidade do Porto	Haggard, P (corresponding author), UCL, Inst Cognit Neurosci, London, England.	haggard@ucl.ac.uk		Haggard, Patrick/0000-0001-7798-793X; Runa Miranda, Catarina/0000-0002-6018-1160; orvalho, veronica/0000-0002-7150-6098	EU FP7 project [VERE 257696]; ESRC	EU FP7 project(European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by EU FP7 project VERE 257696, work package 1. PH was further supported by an ESRC Professorial Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY GC, 1969, J EXP PSYCHOL, V81, P376, DOI 10.1037/h0027737; Bianchi I, 2008, BRIT J PSYCHOL, V99, P513, DOI 10.1348/000712608X304469; Brady N, 2005, BRAIN COGNITION, V58, P334, DOI 10.1016/j.bandc.2005.01.001; Brady N, 2004, NEUROPSYCHOLOGIA, V42, P1156, DOI 10.1016/j.neuropsychologia.2004.02.007; Bredart S, 2003, PERCEPTION, V32, P805, DOI 10.1068/p3354; Casey SJ, 2005, EXP BRAIN RES, V166, P583, DOI 10.1007/s00221-005-2398-3; Chamberlain R, 2013, Q J EXP PSYCHOL, V66, P1448, DOI 10.1080/17470218.2012.750678; Collishaw SM, 2005, PERCEPTION, V34, P163, DOI 10.1068/p5216; Corradi-Dell'Acqua C, 2008, CEREB CORTEX, V18, P2879, DOI 10.1093/cercor/bhn046; Costa M, 2001, J NONVERBAL BEHAV, V25, P63, DOI 10.1023/A:1006737224617; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Greenberg SN, 2009, J EXP PSYCHOL LEARN, V35, P499, DOI 10.1037/a0014640; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keyes H, 2010, Q J EXP PSYCHOL, V63, P840, DOI 10.1080/17470211003611264; Little AC, 2007, BIOL PSYCHOL, V76, P209, DOI 10.1016/j.biopsycho.2007.08.003; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Metzinger T., 2004, BEING NO ONE SELF MO; Mundfrom DJ, 2005, INT J TEST, V5, P159, DOI 10.1207/s15327574ijt0502_4; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Ramon M, 2012, BRAIN COGNITION, V78, P7, DOI 10.1016/j.bandc.2011.10.009; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rooney B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00066; SAVARDI U, 2006, DIPAV QUADERNI, V15, P59; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; TANAKA JW, 2011, OXFORD HDB FACE PERC; Thomas R, 2006, ACTA PSYCHOL, V121, P317, DOI 10.1016/j.actpsy.2005.08.002; TVERSKY B, 1981, COGNITIVE PSYCHOL, V13, P407, DOI 10.1016/0010-0285(81)90016-5; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Zhou GM, 2012, PSYCHON B REV, V19, P157, DOI 10.3758/s13423-011-0174-x	36	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76805	10.1371/journal.pone.0076805	http://dx.doi.org/10.1371/journal.pone.0076805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130790	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900085
J	Hsing, CH; Kwok, FA; Cheng, HC; Li, CF; Chang, MS				Hsing, Chung-Hsi; Kwok, Franky Antonius; Cheng, Hung-Chi; Li, Chien-Feng; Chang, Ming-Shi			Inhibiting Interleukin-19 Activity Ameliorates Esophageal Squamous Cell Carcinoma Progression	PLOS ONE			English	Article							CANCER-PATIENTS; TH2 CYTOKINES; MESSENGER-RNA; TUMOR-CELL; IL-19; EXPRESSION; METASTASIS; RECEPTORS; FAMILY; CXCR4	Background: IL-19 is expressed in esophageal squamous cell carcinoma (SCC), but its biological effect on esophageal cancer remains unclear. We determined the correlation between IL-19 expression levels and clinicopathological variables and explored the effects of IL-19 on the esophageal SCC in vivo and in vitro. Methodology/Principal Findings: We determined the expression levels of esophageal SCC tissues from 60 patients using immunohistochemistry. We examined the effects of IL-19 on intracellular signaling, cytokines production as well as proliferation, colonization, and migration in the human esophageal SCC cell line CE81T. Monoclonal antibodies (mAbs) against IL-19 (1BB1) and its receptor IL-20R1 (51D) were used to antagonize the effects of IL-19. We injected SCID mice with CE81T cells and then treated them with anti-IL-19 mAb or control IgG every 3 days and determined tumor growth for 32 days. Of the 60 esophageal SCC patients, 36 patients (60%) were IL-19 strongly stained, which was associated with advanced tumor stage. CE81T cells expressed IL-19 and its receptors. IL-19 induced phosphorylation of STAT3, P38, JNK, ERK1/2, Akt, and NF-kappa B in CE81T cells. IL-19 promoted the proliferation, colonization, and migration of CE81T cells, which were antagonized by 1BB1 and 51D. IL-19 also induced expression of the transcripts of TGF-beta, cyclin B1, CXCR4, and MMP-1 in CE81T cells. In CE81T tumor-bearing mice, 1BB1 reduced tumor growth and downregulated TGF-beta, cyclin B1, MMP-1, and CXCR4 expression in tumors. Conclusions/Significance: IL-19 affects the pathogenesis of esophageal cancer. IL-19 mAb (1BB1) is potentially a potent drug for esophageal cancer therapy.	[Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Hsing, Chung-Hsi] Taipei Med Univ, Dept Anesthesiol, Coll Med, Taipei, Taiwan; [Kwok, Franky Antonius; Cheng, Hung-Chi; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Inst Biochem & Mol Biol, Tainan 70101, Taiwan; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan	Chi Mei Hospital; Taipei Medical University; National Cheng Kung University; Chi Mei Hospital	Chang, MS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Biochem & Mol Biol, Tainan 70101, Taiwan.	mschang@mail.ncku.edu.tw		Li, Chien-Feng/0000-0002-9527-7576	National Science Council, Taiwan [NSC 101-2314-B-384-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 101-2314-B-384-003-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2009, CURR OPIN PHARMACOL, V9, P396, DOI 10.1016/j.coph.2009.06.010; Alanara T, 2010, SCAND J RHEUMATOL, V39, P118, DOI 10.3109/03009740903170823; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Department of Health (DOH) RoCR, 2007, HLTH STAT; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2007, NEPHROL DIAL TRANSPL, V22, P2230, DOI 10.1093/ndt/gfm179; Hsing CH, 2006, CYTOKINE, V35, P44, DOI 10.1016/j.cyto.2006.07.006; Hsing CH, 2006, ANN THORAC SURG, V81, P2196, DOI 10.1016/j.athoracsur.2006.01.092; Hsing CH, 2012, CLIN CANCER RES, V18, P713, DOI 10.1158/1078-0432.CCR-11-1532; Hsing CH, 2008, CYTOKINE, V44, P221, DOI 10.1016/j.cyto.2008.06.007; Hsu YH, 2006, ARTHRITIS RHEUM-US, V54, P2722, DOI 10.1002/art.22039; HU CP, 1984, J NATL CANCER I, V72, P577; Jaiswal K, 2006, AM J PHYSIOL-GASTR L, V290, pG335, DOI 10.1152/ajpgi.00167.2005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; Kan T, 2001, BIOCHEM BIOPH RES CO, V286, P792, DOI 10.1006/bbrc.2001.5400; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.biochem.55.1.1037; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; MCCLELLAND RA, 1990, CANCER RES, V50, P3545; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; NICOLSON GL, 1988, BIOCHIM BIOPHYS ACTA, V948, P175, DOI 10.1016/0304-419X(88)90010-8; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Paduch R, 2005, CELL BIOL INT, V29, P497, DOI 10.1016/j.cellbi.2005.01.007; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Ries LAG, SEER CANC STAT REV 1; Rikiishi H, 1993, Hum Cell, V6, P21; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sabbioni MEE, 2000, BREAST CANCER RES TR, V59, P279, DOI 10.1023/A:1006379925343; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Sasaki K, 2008, J SURG ONCOL, V97, P433, DOI 10.1002/jso.20976; Sigmundsdottir H, 2001, CLIN EXP IMMUNOL, V126, P365, DOI 10.1046/j.1365-2249.2001.01688.x; SWAIN SL, 1991, CURR OPIN IMMUNOL, V3, P304, DOI 10.1016/0952-7915(91)90028-Y; Takahashi S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-103; Wang JS, 2008, WORLD J GASTROENTERO, V14, P3982, DOI 10.3748/wjg.14.3982; Wei L, 2010, INT J CANC; Wu MT, 2001, BRIT J CANCER, V85, P658, DOI 10.1054/bjoc.2001.1927; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	54	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75254	10.1371/journal.pone.0075254	http://dx.doi.org/10.1371/journal.pone.0075254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130695	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900026
J	Liu, HL; Wang, TT; Wang, JK; Quan, FS; Zhang, Y				Liu, Hongliang; Wang, Tingting; Wang, Jinke; Quan, Fusheng; Zhang, Yong			Characterization of Liaoning Cashmere Goat Transcriptome: Sequencing, De Novo Assembly, Functional Annotation and Comparative Analysis	PLOS ONE			English	Article							DISCOVERY; SANGER; GENOME; MODEL	Background: Liaoning cashmere goat is a famous goat breed for cashmere wool. In order to increase the transcriptome data and accelerate genetic improvement for this breed, we performed de novo transcriptome sequencing to generate the first expressed sequence tag dataset for the Liaoning cashmere goat, using next-generation sequencing technology. Results: Transcriptome sequencing of Liaoning cashmere goat on a Roche 454 platform yielded 804,601 high-quality reads. Clustering and assembly of these reads produced a non-redundant set of 117,854 unigenes, comprising 13,194 isotigs and 104,660 singletons. Based on similarity searches with known proteins, 17,356 unigenes were assigned to 6,700 GO categories, and the terms were summarized into three main GO categories and 59 sub-categories. 3,548 and 46,778 unigenes had significant similarity to existing sequences in the KEGG and COG databases, respectively. Comparative analysis revealed that 42,254 unigenes were aligned to 17,532 different sequences in NCBI non-redundant nucleotide databases. 97,236 (82.51%) unigenes were mapped to the 30 goat chromosomes. 35,551 (30.17%) unigenes were matched to 11,438 reported goat protein-coding genes. The remaining non-matched unigenes were further compared with cattle and human reference genes, 67 putative new goat genes were discovered. Additionally, 2,781 potential simple sequence repeats were initially identified from all unigenes. Conclusion: The transcriptome of Liaoning cashmere goat was deep sequenced, de novo assembled, and annotated, providing abundant data to better understand the Liaoning cashmere goat transcriptome. The potential simple sequence repeats provide a material basis for future genetic linkage and quantitative trait loci analyses.	[Liu, Hongliang; Quan, Fusheng; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China; [Wang, Tingting; Wang, Jinke] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Southeast University - China	Quan, FS (corresponding author), Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	quanfusheng@nwsuaf.edu.cn; zhangyong1956@nwsuaf.edu.cn	wang, tingting/AAK-2640-2020; Wang, Jinke/AAT-7832-2021; Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071	National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This research was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WL, 2012, BIOCH GENET, V50, P1; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Guo D, 2010, CHINA ANIMAL HUSBAND, V12, P030; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; Hornshoj H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-30; Huh JW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-163; Jin M, 2011, MOL BIOL REP, V38, P3023, DOI 10.1007/s11033-010-9968-6; Jin Mei, 2006, Acta Genetica Sinica, V33, P230, DOI 10.1016/S0379-4172(06)60045-0; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Nyberg KG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-287; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Peterson MP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-305; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sato S, 2009, CURR GENET, V55, P273, DOI 10.1007/s00294-009-0243-0; Schmid J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-329; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; Torales SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-291; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang BA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120054; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	40	18	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77062	10.1371/journal.pone.0077062	http://dx.doi.org/10.1371/journal.pone.0077062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130835	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900120
J	Rodder, D; Lawing, AM; Flecks, M; Ahmadzadeh, F; Dambach, J; Engler, JO; Habel, JC; Hartmann, T; Hornes, D; Ihlow, F; Schidelko, K; Stiels, D; Polly, PD				Roedder, Dennis; Lawing, A. Michelle; Flecks, Morris; Ahmadzadeh, Faraham; Dambach, Johannes; Engler, Jan O.; Habel, Jan Christian; Hartmann, Timo; Hoernes, David; Ihlow, Flora; Schidelko, Kathrin; Stiels, Darius; Polly, P. David			Evaluating the Significance of Paleophylogeographic Species Distribution Models in Reconstructing Quaternary Range-Shifts of Nearctic Chelonians	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; TURTLE GLYPTEMYS-INSCULPTA; CLIMATE-CHANGE; CONSERVATION GENETICS; MITOCHONDRIAL-DNA; MOLECULAR PHYLOGEOGRAPHY; SLIDER TURTLES; HYBRID ZONES; SAMPLE-SIZE; FRESH-WATER	The climatic cycles of the Quaternary, during which global mean annual temperatures have regularly changed by 5-10 degrees C, provide a special opportunity for studying the rate, magnitude, and effects of geographic responses to changing climates. During the Quaternary, high- and mid-latitude species were extirpated from regions that were covered by ice or otherwise became unsuitable, persisting in refugial retreats where the environment was compatible with their tolerances. In this study we combine modern geographic range data, phylogeny, Pleistocene paleoclimatic models, and isotopic records of changes in global mean annual temperature, to produce a temporally continuous model of geographic changes in potential habitat for 59 species of North American turtles over the past 320 Ka (three full glacial-interglacial cycles). These paleophylogeographic models indicate the areas where past climates were compatible with the modern ranges of the species and serve as hypotheses for how their geographic ranges would have changed in response to Quaternary climate cycles. We test these hypotheses against physiological, genetic, taxonomic and fossil evidence, and we then use them to measure the effects of Quaternary climate cycles on species distributions. Patterns of range expansion, contraction, and fragmentation in the models are strongly congruent with (i) phylogeographic differentiation; (ii) morphological variation; (iii) physiological tolerances; and (iv) intraspecific genetic variability. Modern species with significant interspecific differentiation have geographic ranges that strongly fluctuated and repeatedly fragmented throughout the Quaternary. Modern species with low genetic diversity have geographic distributions that were highly variable and at times exceedingly small in the past. Our results reveal the potential for paleophylogeographic models to (i) reconstruct past geographic range modifications, (ii) identify geographic processes that result in genetic bottlenecks; and (iii) predict threats due to anthropogenic climate change in the future.	[Roedder, Dennis; Flecks, Morris; Ahmadzadeh, Faraham; Dambach, Johannes; Engler, Jan O.; Hartmann, Timo; Hoernes, David; Ihlow, Flora; Schidelko, Kathrin; Stiels, Darius] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Lawing, A. Michelle] Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA; [Engler, Jan O.; Habel, Jan Christian] Univ Trier, Dept Biogeog, Trier, Germany; [Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Tennessee System; University of Tennessee Knoxville; Universitat Trier; Indiana University System; Indiana University Bloomington	Rodder, D (corresponding author), Zool Forsch Museum Alexander Koenig, Bonn, Germany.	d.roedder.zfmk@uni-bonn.de	Engler, Jan O/C-3432-2009; Ahmadzadeh, Faraham/AAB-1283-2021; Polly, P. David/ABC-6597-2020; Rödder, Dennis/AAT-8644-2021; Lawing, Michelle/F-7453-2019; Habel, Jan Christian/H-2112-2019	Ahmadzadeh, Faraham/0000-0001-7152-8484; Polly, P. David/0000-0001-7338-8526; Rödder, Dennis/0000-0002-6108-1639; Lawing, Michelle/0000-0003-4041-6177; Ihlow, Flora/0000-0002-0460-4210; Habel, Jan Christian/0000-0003-1378-9381; Stiels, Darius/0000-0001-7679-9689	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through National Science Foundation (NSF) [EF-0832858]; University of Tennessee, Knoxville; National Science Foundation [EAR-0843935]; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through National Science Foundation (NSF); University of Tennessee, Knoxville; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD; PostDoc fellowship JCH), through a postdoctoral fellowship to AML at the National Institute for Mathematical and Biological Synthesis (NIMBioS), which is sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through National Science Foundation (NSF) Award #EF-0832858, with additional support from The University of Tennessee, Knoxville, and through a National Science Foundation Grant EAR-0843935 to PDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato ML, 2008, MOL ECOL, V17, P570, DOI 10.1111/j.1365-294X.2007.03580.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bailey LA, 2008, SOUTHWEST NAT, V53, P406, DOI 10.1894/GC-179.1; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bourque JR, 2012, J VERTEBR PALEONTOL, V32, P836, DOI 10.1080/02724634.2012.670179; Bowman A., 2010, R PACKAGE SM NONPARA; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Bury R.B., 1972, THESIS U CALIFORNIA; Butler JM, 2011, BIOL J LINN SOC, V102, P889, DOI 10.1111/j.1095-8312.2011.01625.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CREWS D, 1994, DEV GENET, V15, P297, DOI 10.1002/dvg.1020150310; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; Darwin C, 1859, ORIGIN SPECIES MEANS; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Dodd Jr. K. C., 2002, N AM BOX TURTLES NAT; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Echelle AA, 2010, CONSERV GENET, V11, P1375, DOI 10.1007/s10592-009-9966-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ennen JR, 2010, CHELONIAN CONSERV BI, V9, P98, DOI 10.2744/CCB-0835.1; Ernst CH, 2009, TURTLES US CANADA; Escobedo-Galvan AH, 2012, CRETACEOUS RES, V36, P116, DOI 10.1016/j.cretres.2012.02.016; Espindola A, 2012, ECOL LETT, V15, P649, DOI 10.1111/j.1461-0248.2012.01779.x; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; FOLKERTS GW, 1969, COPEIA, P677; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Fritz U, 2012, J ZOOL SYST EVOL RES, V50, P125, DOI 10.1111/j.1439-0469.2011.00647.x; Godsoe W, 2010, OIKOS, V119, P53, DOI 10.1111/j.1600-0706.2009.17630.x; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Graham RW, 1996, SCIENCE, V272, P1601; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Habel JC, 2005, J BIOGEOGR, V32, P1489, DOI 10.1111/j.1365-2699.2005.01273.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hardy CR, 2005, SYST BIOL, V54, P299, DOI 10.1080/10635150590923317; Harris Arthur H., 1993, Bulletin of the New Mexico Museum of Natural History and Science, V2, P179; Hauswaldt JS, 2005, MOL ECOL, V14, P723, DOI 10.1111/j.1365-294X.2005.02451.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hewitt Godfrey M., 2011, P123; HIBBARD CLAUDE W., 1960, CONTR MUS PALEONTOL UNIV MICHIGAN, V16, P1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holman J. A., 1971, Contr Mus Paleont Univ Mich, V23, P349; HOLMAN J A, 1987, Contributions from the Museum of Paleontology University of Michigan, V27, P129; Holman J.A., 1995, PLEISTOCENE AMPHIBIA; Holman J. Alan, 2001, Zoologische Abhandlungen (Dresden), V51, P331; Howeth JG, 2008, MOL ECOL, V17, P4209, DOI 10.1111/j.1365-294X.2008.03904.x; Hulin V, 2009, OECOLOGIA, V160, P493, DOI 10.1007/s00442-009-1313-1; Hutchinson G. E., 1965, ECOLOGICAL THEATER E; HUTCHISON VICTOR H., 1966, HERPETOLOGIA, V22, P32; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Iverson J.B., 1992, Smithsonian Herpetological Information Service, P1; Iverson John B., 2007, Chelonian Research Monographs, V4, P85; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; LAMB T, 1992, J HERED, V83, P262, DOI 10.1093/oxfordjournals.jhered.a111211; Lawing AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028554; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maguire KC, 2009, PALEOBIOLOGY, V35, P587, DOI 10.1666/0094-8373-35.4.587; MAHMOUD I Y, 1969, Southwestern Naturalist, V14, P31, DOI 10.2307/3669247; Makarieva AM, 2005, P ROY SOC B-BIOL SCI, V272, P2325, DOI 10.1098/rspb.2005.3223; McCord WP, 2010, REPTILIA, V71, P39; McGaugh SE, 2008, ZOOL SCR, V37, P289, DOI 10.1111/j.1463-6409.2008.00329.x; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mockford SW, 2007, CONSERV GENET, V8, P209, DOI 10.1007/s10592-006-9163-4; Mockford SW, 2005, BIOL CONSERV, V123, P373, DOI 10.1016/j.biocon.2004.11.021; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips CA, 1996, CONSERV BIOL, V10, P397, DOI 10.1046/j.1523-1739.1996.10020397.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Poelchau MF, 2013, J BIOGEOGR, V40, P662, DOI 10.1111/j.1365-2699.2011.02648.x; Polly PD, 2011, DEV QUATER SCI, V14, P279; Preston RE, 1979, LATE PLEISTOCENE COL; Pritchard P. C. H., 1968, International Turtle and Tortoise Society Journal, V2, P20; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Reinig WF, 1938, ELIMINATION SELEKTIO; RHODIN A., 2010, CHELONIAN RES MONOGR, V5, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V3.2010; Riddle BR, 1998, ECOGRAPHY, V21, P437, DOI 10.1111/j.1600-0587.1998.tb00409.x; Roberts DR, 2012, GLOBAL ECOL BIOGEOGR, V21, P121, DOI 10.1111/j.1466-8238.2011.00657.x; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Roman J, 1999, CONSERV BIOL, V13, P135, DOI 10.1046/j.1523-1739.1999.98007.x; Rosenbaum PA, 2007, CONSERV GENET, V8, P331, DOI 10.1007/s10592-006-9172-3; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; SCHWARTZ ALBERT, 1956, FIELDIANA ZOOL, V34, P461; Seidel ME, 2002, J HERPETOL, V36, P285; Serb JM, 2001, MOL PHYLOGENET EVOL, V18, P149, DOI 10.1006/mpev.2000.0858; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Silber S, 2011, BIOL LETTERS, V7, P295, DOI 10.1098/rsbl.2010.0882; Smith AD, 2008, THESIS OHIO U; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sommer RS, 2009, J BIOGEOGR, V36, P2013, DOI 10.1111/j.1365-2699.2009.02187.x; Spinks PQ, 2005, MOL ECOL, V14, P2047, DOI 10.1111/j.1365-294X.2005.02564.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starkey DE, 2003, EVOLUTION, V57, P119; Stephens PR, 2009, MOL ECOL, V18, P4664, DOI 10.1111/j.1365-294X.2009.04378.x; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2008, QUATERNARY SCI REV, V27, P2499, DOI 10.1016/j.quascirev.2008.08.003; Stigall AL, 2006, J BIOGEOGR, V33, P2051, DOI 10.1111/j.1365-2699.2006.01585.x; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Tessier N, 2005, CAN J ZOOL, V83, P765, DOI 10.1139/Z05-065; Thomson RC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-19; Valenzuela N, 2004, REPTILIAN INCUBATION, P1; Valenzuela N, 2011, EVOLUTION, V65, P1808, DOI 10.1111/j.1558-5646.2011.01258.x; van Dijk PP., 2011, CHELONIAN RES MONOGR, V5, P165, DOI [10.3854/crm.5.000.checklist.v4.2011, DOI 10.3854/CRM.5.000.CHECKLIST.V4.2011]; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; Venables WN., 2002, MODERN APPL STAT S 4; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106; Walker D, 1997, COPEIA, P16, DOI 10.2307/1447835; Walker D, 1998, ANNU REV ECOL SYST, V29, P23, DOI 10.1146/annurev.ecolsys.29.1.23; WALKER D, 1995, MOL ECOL, V4, P365, DOI 10.1111/j.1365-294X.1995.tb00229.x; Walker D, 1998, HERPETOLOGICA, V54, P174; Walker D, 1998, ANIM CONSERV, V1, P55, DOI 10.1111/j.1469-1795.1998.tb00226.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Weisrock DW, 2000, MOL PHYLOGENET EVOL, V14, P152, DOI 10.1006/mpev.1999.0689; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Woodburne M. O., 2004, LATE CRETACEOUS CENO; Wright S, 1943, GENETICS, V28, P114; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570	155	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e72855	10.1371/journal.pone.0072855	http://dx.doi.org/10.1371/journal.pone.0072855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130664	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900001
J	Xiang, YX; Chen, L; Liu, HQ; Liu, XQ; Wei, XB; Sun, BZ; Wang, T; Zhang, XM				Xiang, Yanxiao; Chen, Lin; Liu, Huiqing; Liu, Xiaoqian; Wei, Xinbing; Sun, Baozhu; Wang, Tian; Zhang, Xiumei			Inhibition of sPLA(2)-IIA Prevents LPS-Induced Neuroinflammation by Suppressing ERK1/2-cPLA(2)alpha Pathway in Mice Cerebral Cortex	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ARACHIDONIC-ACID RELEASE; CENTRAL-NERVOUS-SYSTEM; CPLA(2) PHOSPHORYLATION; CEREBROSPINAL-FLUID; PROSTAGLANDIN E-2; BRAIN; IIA; ASTROCYTES; LIPOPOLYSACCHARIDE	Neuroinflammation is involved in various central nervous system (CNS) disorders, including brain infections, ischemia, trauma, stroke, and degenerative CNS diseases. In the CNS inflammation, secretory phospholipase A(2)-IIA (sPLA(2)-IIA) acts as a mediator, resulting in the generation of the precursors of pro-inflammatory lipid mediators, such as prostaglandins (PGs) and leukotrienes (LTs). However, the role of sPLA(2)-IIA in neuroinflammation is more complicated and remains unclear yet. In the present study, we investigated the effect of sPLA(2)-IIA inhibition by specific inhibitor SC-215 on the inflammation in LPS-induced mice cerebral cortex and primary astrocytes. Our results showed that the inhibition of sPLA(2)-IIA alleviated the release of PGE(2) by suppressing the activation of ERK1/2, cPLA2 alpha, COX-2 and mPGES-1. These findings demonstrated that sPLA(2)-IIA showed the potential to regulate the neuroinflammation in vivo and in vitro, indicating that sPLA(2)-IIA might be a novel target for the treatment of acute neuroinflammation.	[Xiang, Yanxiao; Chen, Lin; Liu, Huiqing; Liu, Xiaoqian; Wei, Xinbing; Zhang, Xiumei] Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Sun, Baozhu] Shandong Univ, Dept Anesthesiol, Qilu Hosp, Jinan 250100, Peoples R China; [Wang, Tian] Yantai Univ, Sch Pharm, Dept Pharmacol, Yantai, Shandong, Peoples R China	Shandong University; Shandong University; Yantai University	Zhang, XM (corresponding author), Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China.	zhangxm@sdu.edu.cn			Natural Science Foundation of Shandong Province, China [ZR2010HM132, ZR2010HM082]; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU [21300072613091]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Graduate Independent Innovation Foundation of Shandong University, GIIFSDU	This work was supported by the Natural Science Foundation of Shandong Province, China (Nos. ZR2010HM132 and ZR2010HM082) and the Graduate Independent Innovation Foundation of Shandong University, GIIFSDU (No 21300072613091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; Blom M, 1998, BLOOD, V91, P3037; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bosetti F, 2003, J NEUROCHEM, V87, P1471, DOI 10.1046/j.1471-4159.2003.02118.x; Cannon TR, 1998, BRIT J PHARMACOL, V123, P637, DOI 10.1038/sj.bjp.0701650; CARASSO RL, 1977, J NEUROL NEUROSUR PS, V40, P967, DOI 10.1136/jnnp.40.10.967; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Chalbot S, 2009, CLIN CHEM, V55, P2171, DOI 10.1373/clinchem.2009.130286; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Dieter P, 2002, CELL SIGNAL, V14, P199, DOI 10.1016/S0898-6568(01)00243-1; DiSanto E, 1996, BRAIN RES, V740, P239, DOI 10.1016/S0006-8993(96)00865-7; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fonteh AN, 2000, J IMMUNOL, V165, P2773, DOI 10.4049/jimmunol.165.5.2773; Gao W, 2009, J PHYSIOL PHARMACOL, V60, P145; Guo JT, 2002, J NEUROSCI, V22, P5900; Hansford KA, 2003, CHEMBIOCHEM, V4, P181, DOI 10.1002/cbic.200390029; Ibeas E, 2009, CARDIOVASC RES, V81, P54, DOI 10.1093/cvr/cvn234; Jaulmes A, 2005, ARTERIOSCL THROM VAS, V25, P1161, DOI 10.1161/01.ATV.0000164310.67356.a9; Johann S, 2008, J MOL NEUROSCI, V34, P177, DOI 10.1007/s12031-007-9028-4; Johnson RW, 1997, BRAIN RES, V752, P219, DOI 10.1016/S0006-8993(96)01454-0; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Kwiatkoski M, 2013, EXP NEUROL, V240, P88, DOI 10.1016/j.expneurol.2012.11.008; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Saito O, 2010, BRIT J PHARMACOL, V160, P1754, DOI 10.1111/j.1476-5381.2010.00811.x; SEILHAMER JJ, 1989, J BIOCHEM, V106, P38, DOI 10.1093/oxfordjournals.jbchem.a122815; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Strokin M, 2007, J NEUROCHEM, V102, P1771, DOI 10.1111/j.1471-4159.2007.04663.x; TAKAKUWA T, 1994, RES COMMUN CHEM PATH, V84, P283; Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332; Tian W, 2008, J BIOL CHEM, V283, P3960, DOI 10.1074/jbc.M707345200; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103	46	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77909	10.1371/journal.pone.0077909	http://dx.doi.org/10.1371/journal.pone.0077909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130900	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900143
J	Iglesias, JM; Beloqui, I; Garcia-Garcia, F; Leis, O; Vazquez-Martin, A; Eguiara, A; Cufi, S; Pavon, A; Menendez, JA; Dopazo, J; Martin, AG				Manuel Iglesias, Juan; Beloqui, Izaskun; Garcia-Garcia, Francisco; Leis, Olatz; Vazquez-Martin, Alejandro; Eguiara, Arrate; Cufi, Silvia; Pavon, Andres; Menendez, Javier A.; Dopazo, Joaquin; Martin, Angel G.			Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin	PLOS ONE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO PROPAGATION; FALSE DISCOVERY RATE; SOLID TUMORS; IDENTIFICATION; ASSAY	Tumors are heterogeneous at the cellular level where the ability to maintain tumor growth resides in discrete cell populations. Floating sphere-forming assays are broadly used to test stem cell activity in tissues, tumors and cell lines. Spheroids are originated from a small population of cells with stem cell features able to grow in suspension culture and behaving as tumorigenic in mice. We tested the ability of eleven common breast cancer cell lines representing the major breast cancer subtypes to grow as mammospheres, measuring the ability to maintain cell viability upon serial non-adherent passage. Only MCF7, T47D, BT474, MDA-MB-436 and JIMT1 were successfully propagated as long-term mammosphere cultures, measured as the increase in the number of viable cells upon serial non-adherent passages. Other cell lines tested (SKBR3, MDA-MB-231, MDA-MB-468 and MDA-MB-435) formed cell clumps that can be disaggregated mechanically, but cell viability drops dramatically on their second passage. HCC1937 and HCC1569 cells formed typical mammospheres, although they could not be propagated as long-term mammosphere cultures. All the sphere forming lines but MDA-MB-436 express E-cadherin on their surface. Knock down of E-cadherin expression in MCF-7 cells abrogated its ability to grow as mammospheres, while re-expression of E-cadherin in SKBR3 cells allow them to form mammospheres. Therefore, the mammosphere assay is suitable to reveal stem like features in breast cancer cell lines that express E-cadherin.	[Manuel Iglesias, Juan; Beloqui, Izaskun; Leis, Olatz; Eguiara, Arrate; Pavon, Andres; Martin, Angel G.] Fdn Inbiomed, Regulat Cell Growth Lab, San Sebastian, Gipuzkoa, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, Computat Genom Inst, Valencia, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, INB, Valencia, Spain; [Vazquez-Martin, Alejandro; Cufi, Silvia; Menendez, Javier A.] ICO, Translat Res Lab, Girona, Spain; [Vazquez-Martin, Alejandro; Cufi, Silvia; Menendez, Javier A.] Girona Biomed Res Inst IDIBGi, Girona, Spain; [Dopazo, Joaquin] CIBERER, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martin, AG (corresponding author), Fdn Inbiomed, Regulat Cell Growth Lab, San Sebastian, Gipuzkoa, Spain.	kelfox@me.com	García-García, Francisco/N-2263-2019; MENENDEZ, JAVIER A/C-6148-2016; García-García, Francisco/B-1929-2014; Dopazo, Joaquin/A-9270-2014	García-García, Francisco/0000-0001-8354-5636; MENENDEZ, JAVIER A/0000-0001-8733-4561; García-García, Francisco/0000-0001-8354-5636; Dopazo, Joaquin/0000-0003-3318-120X; Garcia Martin, Angel/0000-0002-3831-2769; Cufi, Silvia/0000-0002-2476-748X	Obra Social Kutxa; Fundacion Medica Mutua Madrilena; Gobierno Vasco (Saiotek program); Gobierno Vasco (Consejeria de Educacion) [PI2010-25]; Instituto de Salud Carlos III Accion Estrategica en Salud [PI2010-01035]; MICINN; GVA-FEDER [PROMETEO/2010/001]; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria [FIS], Spain [CD08/00283]; Ministerio de Ciencia e Innovacion (MICINN, Spain) [SAF2009-11579];  [BIO2011-27069]	Obra Social Kutxa; Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III); Gobierno Vasco (Saiotek program); Gobierno Vasco (Consejeria de Educacion); Instituto de Salud Carlos III Accion Estrategica en Salud; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); GVA-FEDER; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria [FIS], Spain(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	The Regulation of Cell Growth Laboratory is supported by grants from Obra Social Kutxa, Fundacion Medica Mutua Madrilena, Gobierno Vasco (Saiotek program and Consejeria de Educacion PI2010-25) and Instituto de Salud Carlos III Accion Estrategica en Salud (PI2010-01035). This work is partly supported by grant BIO2011-27069, MICINN and PROMETEO/2010/001 from the GVA-FEDER to J. Dopazo. Alejandro Vazquez-Martin received the Sara Borrell post-doctoral contract (CD08/00283, Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria [FIS], Spain). Silvia Cufi received a Research Fellowship (Formacion de Personal Investigador [FPI]; SAF2009-11579) from the Ministerio de Ciencia e Innovacion (MICINN, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borgna S, 2012, CELL CYCLE, V11, P4242, DOI 10.4161/cc.22543; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Diaz-Guerra E, 2012, FASEB J, V26, P3844, DOI 10.1096/fj.11-200782; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hiraguri S, 1998, CANCER RES, V58, P1972; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Lehmann C, 2012, INT J ONCOL, V41, P1932, DOI 10.3892/ijo.2012.1654; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Piggott L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2945; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricardo S, 2011, J CLIN PATHOL, V51, P1659; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Serrano M, 2000, CARCINOGENESIS, V21, P865, DOI 10.1093/carcin/21.5.865; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499	44	130	131	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77281	10.1371/journal.pone.0077281	http://dx.doi.org/10.1371/journal.pone.0077281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124614	gold, Green Published, Green Submitted			2022-12-27	WOS:000325489100171
J	Tsugita, M; Yamada, N; Noguchi, S; Yamada, K; Moritake, H; Shimizu, K; Akao, Y; Ohno, T				Tsugita, Masanori; Yamada, Nami; Noguchi, Shunsuke; Yamada, Kazunari; Moritake, Hiroshi; Shimizu, Katsuji; Akao, Yukihiro; Ohno, Takatoshi			Ewing Sarcoma Cells Secrete EWS/Fli-1 Fusion mRNA via Microvesicles	PLOS ONE			English	Article							MALIGNANT-MELANOMA; PROSTATE-CANCER; DOWN-REGULATION; SOFT PARTS; PROTEIN; GROWTH; EWS-FLI1; TUMORS; INHIBITION; EXPRESSION	Tumours defined as Ewing sarcoma (ES) constitute a group of highly malignant neoplasms that most often affect children and young adults in the first 2 decades of life. The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24;12), is detected in 95% of ES patients. Recently, it was validated that cells emit a heterogeneous mixture of vesicular, organelle-like structures (microvesicles, MVs) into their surroundings including blood and body fluids, and that these MVs contain a selected set of tumor-related proteins and high levels of mRNAs and miRNAs. In this present study, we detected the Ewing sarcoma-specific EWS/Fli-1 mRNA in MVs from the culture medium of ES cell lines carrying t(11;22) (q24;12). Also, we detected this fusion gene in approximately 40% of the blood samples from mice inoculated with xenografts of TC135 or A673 cells. These findings indicate the EWS/Fli-1 mRNA in MVs might be a new non-invasive diagnostic marker for specific cases of Ewing sarcoma.	[Tsugita, Masanori; Yamada, Kazunari; Shimizu, Katsuji; Ohno, Takatoshi] Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu, Japan; [Tsugita, Masanori; Yamada, Nami; Noguchi, Shunsuke; Akao, Yukihiro] United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Yamada, Nami] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Moritake, Hiroshi] Miyazaki Univ, Fac Med, Dept Reprod & Dev Med, Div Pediat, Miyazaki, Japan	Gifu University; Gifu University; University of Miyazaki	Ohno, T (corresponding author), Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu, Japan.	takaohno@gifu-u.ac.jp		Yamada, Nami/0000-0002-1220-0814	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Camussi G, 2011, AM J CANCER RES, V1, P98; Dohjima T, 2003, MOL THER, V7, P811, DOI 10.1016/S1525-0016(03)00101-1; Dohjima T, 2000, BRIT J CANCER, V82, P16, DOI 10.1054/bjoc.1998.0870; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Itoh T, 2012, J MOL HISTOL, V43, P509, DOI 10.1007/s10735-012-9415-1; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Lin PP, 1999, CANCER RES, V59, P1428; Matsuhashi A, 2012, CURR CANCER DRUG TAR, V12, P625, DOI 10.2174/156800912801784839; Miller IV, 2013, BIOL CELL, V105, P289, DOI 10.1111/boc.201200086; Moritake H, 2002, CANCER GENET CYTOGEN, V135, P48, DOI 10.1016/S0165-4608(01)00641-0; Nagano A, 2010, INT J CANCER, V126, P2790, DOI 10.1002/ijc.24781; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Noerholm M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-22; Nozawa S, 2005, J BIOL CHEM, V280, P27544, DOI 10.1074/jbc.M411626200; OHNO T, 1994, ONCOGENE, V9, P3087; OHNO T, 1993, CANCER RES, V53, P5859; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; Takigami I, 2011, INT J CANCER, V128, P216, DOI 10.1002/ijc.25564; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; van Maldegem AM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-7; Wakahara K, 2008, MOL CANCER RES, V6, P1937, DOI 10.1158/1541-7786.MCR-08-0054; Yamamoto T, 2009, J CANCER RES CLIN, V135, P1125, DOI 10.1007/s00432-009-0554-z; Zhang JS, 2004, CANCER RES, V64, P6026, DOI 10.1158/0008-5472.CAN-03-2594	28	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77416	10.1371/journal.pone.0077416	http://dx.doi.org/10.1371/journal.pone.0077416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124617	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100174
J	Monaco, G; Decrock, E; Nuyts, K; Wagner, LE; Luyten, T; Strelkov, SV; Missiaen, L; De Borggraeve, WM; Leybaert, L; Yule, DI; De Smedt, H; Parys, JB; Bultynck, G				Monaco, Giovanni; Decrock, Elke; Nuyts, Koen; Wagner, Larry E., II; Luyten, Tomas; Strelkov, Sergei V.; Missiaen, Ludwig; De Borggraeve, Wim M.; Leybaert, Luc; Yule, David I.; De Smedt, Humbert; Parys, Jan B.; Bultynck, Geert			Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP3 Receptor	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; ENDOPLASMIC-RETICULUM; BCL-2 FAMILY; BH4 DOMAIN; CALCIUM-RELEASE; BETA-SHEET; APOPTOSIS; BINDING	The anti-apoptotic Bcl-2 protein is the founding member and namesake of the Bcl-2-protein family. It has recently been demonstrated that Bcl-2, apart from its anti-apoptotic role at mitochondrial membranes, can also directly interact with the inositol 1,4,5-trisphosphate receptor (IP3R), the primary Ca2+-release channel in the endoplasmic reticulum (ER). Bcl-2 can thereby reduce pro-apoptotic IP3R-mediated Ca2+ release from the ER. Moreover, the Bcl-2 homology domain 4 (Bcl-2-BH4) has been identified as essential and sufficient for this IP3R-mediated anti-apoptotic activity. In the present study, we investigated whether the reported inhibitory effect of a Bcl-2-BH4 peptide on the IP (3)R1 was related to the distinctive alpha-helical conformation of the BH4 domain peptide. We therefore designed a peptide with two glycine "hinges" replacing residues I14 and V15, of the wild-type Bcl-2-BH4 domain (Bcl-2-BH4-IV/GG). By comparing the structural and functional properties of the Bcl-2-BH4-IV/GG peptide with its native counterpart, we found that the variant contained reduced alpha-helicity, neither bound nor inhibited the IP (3)R1 channel, and in turn lost its anti-apoptotic effect. Similar results were obtained with other substitutions in Bcl-2-BH4 that destabilized the alpha-helix with concomitant loss of IP3R inhibition. These results provide new insights for the further development of Bcl-2-BH4-derived peptides as specific inhibitors of the IP3R with significant pharmacological implications.	[Monaco, Giovanni; Luyten, Tomas; Missiaen, Ludwig; De Smedt, Humbert; Parys, Jan B.; Bultynck, Geert] Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Louvain, Belgium; [Decrock, Elke; Leybaert, Luc] Univ Ghent, Dept Basic Med Sci, Physiol Grp, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Nuyts, Koen; De Borggraeve, Wim M.] Dept Chem, Sect Mol Design & Synth, Heverlee, Belgium; [Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Strelkov, Sergei V.] Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, Louvain, Belgium	Ghent University; University of Rochester	Monaco, G (corresponding author), Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Louvain, Belgium.	Giovanni.Monaco@med.kuleuven.be; Geert.Bultynck@med.kuleuven.be	Nuyts, Koen/L-9930-2017; Strelkov, Sergei V/G-7425-2014; Monaco, Giovanni/J-2957-2019; Leybaert, Luc/F-4079-2015; De Borggraeve, Wim/AGE-5612-2022	Nuyts, Koen/0000-0003-0387-9965; Strelkov, Sergei V/0000-0001-7189-4652; Monaco, Giovanni/0000-0001-5209-4326; Leybaert, Luc/0000-0001-6452-6982; De Borggraeve, Wim/0000-0001-7813-6192; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Research Council KU Leuven [OT/STRT1/10/044]; Research Foundation - Flanders (F.W.O.) [G.0788.11, G.0571.12, G.0819.13]; Interuniversity Attraction Poles Program (Belgian Science Policy) [IAP/P7]; Royal Flemish Academy of Belgium for Science and the Arts (Research Award from the Octaaf Dupont Foundation); Research Foundation - Flanders	Research Council KU Leuven(KU Leuven); Research Foundation - Flanders (F.W.O.)(FWO); Interuniversity Attraction Poles Program (Belgian Science Policy)(Belgian Federal Science Policy Office); Royal Flemish Academy of Belgium for Science and the Arts (Research Award from the Octaaf Dupont Foundation); Research Foundation - Flanders(FWO)	This work has been supported by grants from the Research Council KU Leuven (OT/STRT1/10/044 to GB) [http://www.kuleuven.be/research/funding/bof/]; Research Foundation - Flanders (F.W.O.; grant numbers G.0788.11 to GB and SS, G.0571.12 to GB and JBP and G.0819.13 to GB and HDS) [http://www.fwo.be/]; The Interuniversity Attraction Poles Program (Belgian Science Policy IAP/P7 to GB, HDS, JBP, LM) [http://www.belspo.be/belspo/iap/index_en.stm]; and The Royal Flemish Academy of Belgium for Science and the Arts (Research Award from the Octaaf Dupont Foundation 2010 to GB) [http://www.kvab.be]. GM and ED are supported by the Research Foundation - Flanders through a doctoral and postdoctoral fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl H, 2013, BBA-REV CANCER, V1835, P180, DOI 10.1016/j.bbcan.2012.12.001; Bender T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011106; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; BOND SL, 1994, CELL GROWTH DIFFER, V5, P179; Cantara S, 2004, J VASC RES, V41, P202, DOI 10.1159/000077408; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; De Vuyst E, 2008, BIOPHYS J, V94, P469, DOI 10.1529/biophysj.107.109470; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DECROCK E, 2013, COLD SPRING IN PRESS; Dremina ES, 2012, BIOCHEM J, V444, P127, DOI 10.1042/BJ20111114; Dremina ES, 2004, BIOCHEM J, V383, P361, DOI 10.1042/BJ20040187; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Hunter JJ, 1996, MOL CELL BIOL, V16, P877; Jochim AL, 2009, MOL BIOSYST, V5, P924, DOI 10.1039/b903202a; JOHANNING GL, 2012, CHEMOTHERAPY, V1, P1, DOI DOI 10.4236/MC.2012.11001; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Kawamoto SA, 2012, J MED CHEM, V55, P1137, DOI 10.1021/jm201125d; Khemtemourian L, 2006, J PEPT SCI, V12, P58, DOI 10.1002/psc.686; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Lama D, 2010, BIOCHEMISTRY-US, V49, P2574, DOI 10.1021/bi100029k; Lee LC, 1996, J BIOL CHEM, V271, P23284, DOI 10.1074/jbc.271.38.23284; LYU PCC, 1991, J AM CHEM SOC, V113, P3568, DOI 10.1021/ja00009a052; McDunn JE, 2009, BIOCHEM BIOPH RES CO, V382, P657, DOI 10.1016/j.bbrc.2009.03.080; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Monaco G, 2013, CELL MOL LIFE SCI, V70, P1171, DOI 10.1007/s00018-012-1118-y; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Reed JC, 1996, ADV EXP MED BIOL, V406, P99; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sani MA, 2008, FEBS J, V275, P561, DOI 10.1111/j.1742-4658.2007.06222.x; Sani MA, 2007, J PEPT SCI, V13, P100, DOI 10.1002/psc.803; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; STEHNOBITTEL L, 1995, NEURON, V14, P163, DOI 10.1016/0896-6273(95)90250-3; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Wang KR, 2008, PEPTIDES, V29, P963, DOI 10.1016/j.peptides.2008.01.015; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	54	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73386	10.1371/journal.pone.0073386	http://dx.doi.org/10.1371/journal.pone.0073386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24137498	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200074
J	Edros, RZ; McDonnell, S; Al-Rubeai, M				Edros, Raihana Z.; McDonnell, Susan; Al-Rubeai, Mohamed			Using Molecular Markers to Characterize Productivity in Chinese Hamster Ovary Cell Lines	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY PRODUCTION; PROTEIN DISULFIDE-ISOMERASE; RECOMBINANT CHO-CELLS; MESSENGER-RNA LEVELS; BIOPHARMACEUTICAL BENCHMARKS; GENE AMPLIFICATION; SECRETION RATES; COPY NUMBERS; IMMUNOGLOBULIN; EXPRESSION	Selection of high producing cell lines to produce maximum product concentration is a challenging and time consuming task for the biopharmaceutical industry. The identification of early markers to predict high productivity will significantly reduce the time required for new cell line development. This study identifies candidate determinants of high productivity by profiling the molecular and morphological characteristics of a panel of six Chinese Hamster Ovary (CHO) stable cell lines with varying recombinant monoclonal antibody productivity levels ranging between 2 and 50 pg/cell/day. We examined the correlation between molecular parameters and specific productivity (q(p)) throughout the growth phase of batch cultures. Results were statistically analyzed using Pearson correlation coefficient. Our study revealed that, overall, heavy chain (HC) mRNA had the strongest association with q(p) followed by light chain (LC) mRNA, HC intracellular polypeptides, and intracellular antibodies. A significant correlation was also obtained between qp and the following molecular markers: growth rate, biomass, endoplasmic reticulum, and LC polypeptides. However, in these cases, the correlation was not observed at all-time points throughout the growth phase. The repeated sampling throughout culture duration had enabled more accurate predictions of productivity in comparison to performing a single-point measurement. Since the correlation varied from day to day during batch cultivation, single-point measurement was of limited use in making a reliable prediction.	[Al-Rubeai, Mohamed] Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 2, Ireland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Al-Rubeai, M (corresponding author), Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 2, Ireland.	m.al-rubeai@ucd.ie		Edros, Raihana/0000-0001-9315-8605	University Malaysia Pahang	University Malaysia Pahang	RRZE is funded by University Malaysia Pahang. The fund is to cover registration and bench fees and maintenance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	ALRUBEAI M, 1990, J BIOTECHNOL, V16, P67, DOI 10.1016/0168-1656(90)90066-K; Barnes LM, 2004, BIOTECHNOL BIOENG, V85, P115, DOI 10.1002/bit.10893; Barnes LM, 2006, BIOTECHNOL BIOENG, V94, P530, DOI 10.1002/bit.20856; Becker E, 2008, J BIOTECHNOL, V135, P217, DOI 10.1016/j.jbiotec.2008.03.008; Becker E, 2010, J BIOTECHNOL, V146, P198, DOI 10.1016/j.jbiotec.2009.11.018; BERGMAN LW, 1979, J BIOL CHEM, V254, P5690; BERGMAN LW, 1981, J BIOL CHEM, V256, P701; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Borth N, 2005, BIOTECHNOL PROGR, V21, P106, DOI 10.1021/bp0498241; Borth N, 1999, J BIOTECHNOL, V67, P57, DOI 10.1016/S0168-1656(98)00162-X; Cain K, 2013, BIOTECHNOLOGY PROGR; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Davis R, 2000, BIOTECHNOL PROGR, V16, P736, DOI 10.1021/bp000107q; Derouazi M, 2006, BIOCHEM BIOPH RES CO, V340, P1069, DOI 10.1016/j.bbrc.2005.12.111; Dorai H, 2006, HYBRIDOMA, V25, P1, DOI 10.1089/hyb.2006.25.1; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Fann CH, 1999, BIOTECHNOL BIOENG, V63, P464, DOI 10.1002/(SICI)1097-0290(19990520)63:4<464::AID-BIT10>3.0.CO;2-H; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Gomez N, 2012, BIOTECHNOL BIOENG, V109, P125, DOI 10.1002/bit.23288; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Gu MB, 1995, CYTOTECHNOLOGY, V18, P159, DOI 10.1007/BF00767763; HAYWARD BE, 1986, NUCLEIC ACIDS RES, V14, P999, DOI 10.1093/nar/14.2.999; Jun SC, 2006, BIOTECHNOL PROGR, V22, P770, DOI 10.1021/bp060004t; Kalwy S, 2006, MOL BIOTECHNOL, V34, P151, DOI 10.1385/MB:34:2:151; Khoo SHG, 2009, BIOTECHNOL BIOENG, V102, P188, DOI 10.1002/bit.22041; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; Kim SJ, 1999, BIOTECHNOL BIOENG, V64, P741, DOI 10.1002/(SICI)1097-0290(19990920)64:6<741::AID-BIT14>3.0.CO;2-X; Kingston RE, 2001, AMPLIFICATION USING; Krampe B, 2011, BIOTECHNOL BIOENG, V108, P1603, DOI 10.1002/bit.23100; Ku SCY, 2010, BIOTECHNOL PROGR, V26, P517, DOI 10.1002/btpr.322; LASKOV R, 1971, J MOL BIOL, V56, P327, DOI 10.1016/0022-2836(71)90468-2; Lattenmayer C, 2007, J BIOTECHNOL, V128, P716, DOI 10.1016/j.jbiotec.2006.12.016; Lee CJ, 2009, BIOTECHNOL BIOENG, V102, P1107, DOI 10.1002/bit.22126; Lee MS, 2000, BIOTECHNOL BIOENG, V68, P260, DOI 10.1002/(SICI)1097-0290(20000505)68:3<260::AID-BIT4>3.0.CO;2-M; LENNY N, 1991, J BIOL CHEM, V266, P20532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd DR, 1999, CYTOTECHNOLOGY, V30, P49, DOI 10.1023/A:1008093404237; Lloyd DR, 2000, CYTOTECHNOLOGY, V34, P59, DOI 10.1023/A:1008103730027; McNeeley KM, 2005, CYTOTECHNOLOGY, V48, P15, DOI 10.1007/s10616-005-2926-9; Mohan C, 2007, BIOTECHNOL BIOENG, V98, P611, DOI 10.1002/bit.21453; O'Callaghan PM, 2010, BIOTECHNOL BIOENG, V106, P938, DOI 10.1002/bit.22769; Ohya T, 2008, BIOTECHNOL BIOENG, V100, P317, DOI 10.1002/bit.21758; Osterlehner A, 2011, BIOTECHNOL BIOENG, V108, P2670, DOI 10.1002/bit.23216; PENDSE GJ, 1992, BIOTECHNOL BIOENG, V40, P119, DOI 10.1002/bit.260400117; Peng RW, 2011, BIOTECHNOL BIOENG, V108, P611, DOI 10.1002/bit.22986; Peng RW, 2010, METAB ENG, V12, P18, DOI 10.1016/j.ymben.2009.08.007; RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P839, DOI 10.1002/bit.260360814; Reisinger H, 2008, APPL MICROBIOL BIOT, V81, P701, DOI 10.1007/s00253-008-1701-1; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Walsh G, 2003, NAT BIOTECHNOL, V21, P865, DOI 10.1038/nbt0803-865; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yang YS, 2010, J BIOTECHNOL, V147, P180, DOI 10.1016/j.jbiotec.2010.04.004	61	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75935	10.1371/journal.pone.0075935	http://dx.doi.org/10.1371/journal.pone.0075935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146795	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200005
J	He, J; Xi, B; Ruiter, R; Shi, TY; Zhu, ML; Wang, MY; Li, QX; Zhou, XY; Qiu, LX; Wei, QY				He, Jing; Xi, Bo; Ruiter, Rikje; Shi, Ting-Yan; Zhu, Mei-Ling; Wang, Meng-Yun; Li, Qiao-Xin; Zhou, Xiao-Yan; Qiu, Li-Xin; Wei, Qing-Yi			Association of LEP G2548A and LEPR Q223R Polymorphisms with Cancer Susceptibility: Evidence from a Meta-Analysis	PLOS ONE			English	Article							RECEPTOR GENE POLYMORPHISMS; OBESITY-RELATED GENES; BODY-MASS INDEX; BREAST-CANCER; PROSTATE-CANCER; SERUM LEPTIN; COLORECTAL-CANCER; ADIPOKINE GENES; PROMOTER REGION; GASTRIC-CANCER	Background: Numerous epidemiological studies have examined associations of genetic variations in LEP (G2548A, -2548 nucleotide upstream of the ATG start site) and LEPR (Q223R, nonsynonymous SNP in exon 6) with cancer susceptibility; however, the findings are inconsistent. Therefore, we performed a meta-analysis to comprehensively evaluate such associations. Methods: We searched published literature from MEDLINE, EMBASE, Web of Science and CBM for eligible publications. We also assessed genotype-based mRNA expression data from HapMap for rs7799039 (G2548A) and rs1137101 (Q223R) in normal cell lines derived from 270 subjects with different ethnicities. Results: The final analysis included 16 published studies of 6569 cases and 8405 controls for the LEP G2548A and 19 studies of 7504 cases and 9581 controls for the LEPR Q223R. Overall, LEP G2548A was statistically significantly associated with an increased risk of overall cancer (AA vs. GG: OR=1.27, 95% CI=1.05-1.54; recessive model: OR=1.19, 95% CI=1.00-1.41). Further stratifications by cancer type showed an increased risk for prostate cancer (recessive model: OR=1.26, 95% CI=1.05-1.51) but not for other cancers. For LEPR Q223R, no statistical evidence for an association with risk of cancer was found for all; however, further stratification by ethnicity showed an increased risk for Africans but not for other ethnicities. No significantly differences in LEP and LEPR mRNA expression were found among genotypes or by ethnicity. Conclusions: Despite some limitations, this meta-analysis found some statistical evidence for an association between the LEP 2548AA genotype and overall risk of cancer, particularly for prostate cancer, but given this variant did not have an effect on mRNA expression, this association warrants additional validation in large and well-designed studies.	[He, Jing; Shi, Ting-Yan; Zhu, Mei-Ling; Wang, Meng-Yun; Li, Qiao-Xin; Qiu, Li-Xin; Wei, Qing-Yi] Fudan Univ Shanghai Canc Ctr, Inst Canc, Shanghai, Peoples R China; [He, Jing; Shi, Ting-Yan; Zhu, Mei-Ling; Wang, Meng-Yun; Li, Qiao-Xin; Zhou, Xiao-Yan; Qiu, Li-Xin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Xi, Bo] Shandong Univ, Sch Publ Hlth, Inst Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Ruiter, Rikje] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Zhou, Xiao-Yan] Fudan Univ Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Qiu, Li-Xin] Fudan Univ Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Shandong University; Erasmus University Rotterdam; Erasmus MC; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Qiu, LX (corresponding author), Fudan Univ Shanghai Canc Ctr, Inst Canc, Shanghai, Peoples R China.	mdqiulixin@hotmail.com; weiqingyi@yahoo.com	He, Jing/M-5774-2015	He, Jing/0000-0002-1954-2892	China's Thousand Talents Program recruitment at Fudan University; National Natural Science Foundation of China [81101808]	China's Thousand Talents Program recruitment at Fudan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the China's Thousand Talents Program recruitment at Fudan University and the National Natural Science Foundation of China(81101808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Chia VM, 2007, CANCER EPIDEM BIOMAR, V16, P2697, DOI 10.1158/1055-9965.EPI-07-0467; Chovanec J, 2009, Klin Onkol, V22, P223; Cleveland RJ, 2010, BREAST CANCER RES TR, V120, P745, DOI 10.1007/s10549-009-0503-1; Cohen SS, 2012, ANN NUTR METAB, V60, P90, DOI 10.1159/000336180; Dai K, 2010, CHIN J GASTROENTEROL, V19, P722; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doecke JD, 2008, CANCER EPIDEM BIOMAR, V17, P1007, DOI 10.1158/1055-9965.EPI-08-0023; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gallicchio L, 2007, CANCER DETECT PREV, V31, P95, DOI 10.1016/j.cdp.2007.02.004; Han Cun-zhi, 2011, Zhonghua Zhong Liu Za Zhi, V33, P207; Han Cun-zhi, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P136; Han CZ, 2008, BIOL TRACE ELEM RES, V126, P38, DOI 10.1007/s12011-008-8182-z; He BS, 2012, MOL BIOL REP, V39, P3117, DOI 10.1007/s11033-011-1076-8; He J, 2013, INT J CANCER, V133, P1765, DOI 10.1002/ijc.28089; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Hoffstedt J, 2002, HORM METAB RES, V34, P355, DOI 10.1055/s-2002-33466; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim EY, 2012, J KOREAN SURG SOC, V83, P7, DOI 10.4174/jkss.2012.83.1.7; Kim KZ, 2012, HUM REPROD, V27, P2193, DOI 10.1093/humrep/des147; Kote-Jarai Z, 2003, BJU INT, V92, P109, DOI 10.1046/j.1464-410X.2003.04272.x; Lakka HM, 2000, J INTERN MED, V248, P77, DOI 10.1046/j.1365-2796.2000.00696.x; Li YL, 2012, J CANCER RES CLIN, V138, P311, DOI 10.1007/s00432-011-1098-6; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu CL, 2007, ONCOLOGY-BASEL, V72, P75, DOI 10.1159/000111097; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mantzoros CS, 1998, CLIN ENDOCRINOL, V49, P551, DOI 10.1046/j.1365-2265.1998.00571.x; Moore SC, 2009, INT J CANCER, V124, P869, DOI 10.1002/ijc.24043; Nyante SJ, 2011, BREAST CANCER RES TR, V129, P593, DOI 10.1007/s10549-011-1517-z; Okobia MN, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-338; Partida-Perez M, 2010, CANCER BIOMARK, V7, P117, DOI 10.3233/CBM-2010-0154; Pechlivanis S, 2009, EUR J ENDOCRINOL, V160, P933, DOI 10.1530/EJE-09-0039; Ribeiro R, 2004, PROSTATE, V59, P268, DOI 10.1002/pros.20004; Ribeiro R, 2006, EUR J CANCER, V42, P1188, DOI 10.1016/j.ejca.2006.02.004; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Slattery ML, 2008, INT J CANCER, V122, P1611, DOI 10.1002/ijc.23135; Snoussi K, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-38; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Teras LR, 2009, CANCER EPIDEM BIOMAR, V18, P2553, DOI 10.1158/1055-9965.EPI-09-0542; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Ulybina Iu M, 2008, Mol Biol (Mosk), V42, P947; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Vasku A, 2009, INT J COLORECTAL DIS, V24, P289, DOI 10.1007/s00384-008-0553-6; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Willett EV, 2005, BRIT J CANCER, V93, P811, DOI 10.1038/sj.bjc.6602762; Woo HY, 2006, CANCER LETT, V237, P137, DOI 10.1016/j.canlet.2005.05.041; Yapijakis C, 2009, J CANCER RES CLIN, V135, P603, DOI 10.1007/s00432-008-0494-z; Yiannakouris N, 2001, J CLIN ENDOCR METAB, V86, P4434, DOI 10.1210/jc.86.9.4434	52	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75135	10.1371/journal.pone.0075135	http://dx.doi.org/10.1371/journal.pone.0075135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146750	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200002
J	Chou, TW; Feng, JH; Huang, CC; Cheng, YW; Chien, SC; Wang, SY; Shyur, LF				Chou, Tsui-Wei; Feng, Jia-Hua; Huang, Chi-Chang; Cheng, Ya-Wen; Chien, Shih-Chang; Wang, Sheng-Yang; Shyur, Lie-Fen			A Plant Kavalactone Desmethoxyyangonin Prevents Inflammation and Fulminant Hepatitis in Mice	PLOS ONE			English	Article							NF-KAPPA-B; ALPINIA-PRICEI HAYATA; SIGNAL-TRANSDUCTION; LIVER; LIPOPOLYSACCHARIDE; METABOLOMICS; CELL; ACID; ACTIVATION; FAILURE	Alpinia pricei Hayata is a Formosan plant which has been popularly used as nutraceutical or folk medicine for inflammation and various disorders. An active compound of the plant rhizomes, desmethoxyyangonin (DMY), was identified in this study for its novel effect against endotoxin lipopolysaccharide (LPS)-stimulated inflammation in murine macrophages and LPS/D-galactosamine (LPS/D-GalN)-induced fulminant hepatitis in mice. DMY was observed to significantly inhibit proliferation and activation of T cells ex vivo and the activity of several pro-inflammatory mediators in vitro. DMY also protected LPS/D-GalN-induced acute hepatic damages in mice through inhibiting aminotransferases activities and infiltrations of inflammatory macrophages, neutrophils and pathogenic T cells into the liver tissues. In addition, pretreatment with DMY significantly improved the survival rate of LPS/D-GalN -treated mice to 90% (9/10), compared to LPS/D-GalN-treated group (40%, 4/10). UPLC/MS platform-based comparative metabolomics approach was used to explore the serum metabolic profile in fulminant hepatic failure (FHF) mice with or without the DMY pretreatment. The results showed that LPS/D-GalN-induced hepatic damage is likely through perturbing amino acid metabolism, which leads to decreased pyruvate formation via catalysis of aminotransferases, and DMY treatment can prevent to a certain degree of these alterations in metabolic network in mouse caused by LPS/D-GalN. Mechanistic investigation demonstrated that DMY protects LPS or LPS/D-GalN -induced damages in cell or liver tissues mainly through de-regulating IKK/NF.B and Jak2/STAT3 signaling pathways. This report provides evidence-based knowledge to support the rationale for the use of A. pricei root extract in anti-inflammation and also its new function as hepatoprotetive agent against fulminant hepatitis.	[Chou, Tsui-Wei] Taoyuan Innovat Inst Technol, Dept Culinary Arts, Chungli, Taoyuan County, Taiwan; [Feng, Jia-Hua; Cheng, Ya-Wen; Shyur, Lie-Fen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Feng, Jia-Hua] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Huang, Chi-Chang] Natl Taiwan Sport Univ, Grad Inst Sports Sci, Guishan Township, Taoyuan County, Taiwan; [Chien, Shih-Chang] Natl Chung Hsing Univ, Expt Forest Management Off, Taichung 40227, Taiwan; [Wang, Sheng-Yang] Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan; [Shyur, Lie-Fen] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Chung Hsing University; National Chung Hsing University; Taipei Medical University	Wang, SY (corresponding author), Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan.	taiwanfir@dragon.nchu.edu.tw; lfshyur@ccvax.sinica.edu.tw	Wang, Sheng-Yang/M-9656-2019	Wang, Sheng-Yang/0000-0002-8579-3569; Huang, Chi-Chang/0000-0003-1446-6787	NSTP/AB; Academia Sinica, Taiwan, R.O.C	NSTP/AB; Academia Sinica, Taiwan, R.O.C(Academia Sinica - Taiwan)	This study was supported by a grant from the NSTP/AB and an institutional grant from Academia Sinica, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201; Chang NW, 2010, FOOD CHEM TOXICOL, V48, P2350, DOI 10.1016/j.fct.2010.05.070; Chiang YM, 2005, BRIT J PHARMACOL, V146, P352, DOI 10.1038/sj.bjp.0706343; Chou YC, 2009, PHYTOTHER RES, V23, P558, DOI 10.1002/ptr.2691; Dharmaratne HRW, 2002, PHYTOCHEMISTRY, V59, P429; Feng B, 2008, LIVER TRANSPLANT, V14, P1620, DOI 10.1002/lt.21578; Gao JJ, 1998, J IMMUNOL, V161, P4803; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; GUAN KL, 1994, CELL SIGNAL, V6, P581, DOI 10.1016/0898-6568(94)90041-8; Hou CC, 2010, J NUTR BIOCHEM, V21, P1045, DOI 10.1016/j.jnutbio.2009.08.010; Hseu YC, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep142; Huang CC, 2013, J NUTR BIOCHEM, V24, P516, DOI 10.1016/j.jnutbio.2012.01.013; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kao ES, 2009, BIOSCI BIOTECH BIOCH, V73, P385, DOI 10.1271/bbb.80639; Katayama K, 2004, HEPATOL RES, V30, pS71, DOI 10.1016/j.hepres.2004.08.013; Kosai K, 1999, HEPATOLOGY, V30, P151, DOI 10.1002/hep.510300102; Kuo YF, 2010, FREE RADICAL BIO MED, V49, P214, DOI 10.1016/j.freeradbiomed.2010.04.005; Lee C, 2006, MOL PHARMACOL, V69, P1041, DOI 10.1124/mol.105.018481; Manna SK, 2011, J PROTEOME RES, V10, P4120, DOI 10.1021/pr200310s; Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rockey DC, 1996, AM J PHYSIOL-GASTR L, V271, pG260, DOI 10.1152/ajpgi.1996.271.2.G260; Russo FP, 2011, CYTOTHERAPY, V13, P135, DOI 10.3109/14653249.2010.545386; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Shyur LF, 2008, CURR OPIN CHEM BIOL, V12, P66, DOI 10.1016/j.cbpa.2008.01.032; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Wang XY, 2011, METABOLOMICS, V7, P226, DOI 10.1007/s11306-010-0244-5; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Yang YX, 2007, MOL IMMUNOL, V44, P984, DOI 10.1016/j.molimm.2006.03.013; ZIMMERMANN C, 1989, HEPATOLOGY, V9, P594, DOI 10.1002/hep.1840090414	31	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77626	10.1371/journal.pone.0077626	http://dx.doi.org/10.1371/journal.pone.0077626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143247	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100085
J	Hoppe, T				Hoppe, Travis			Singular Value Decomposition of the Radial Distribution Function for Hard Sphere and Square Well Potentials	PLOS ONE			English	Article							DISCRETE MOLECULAR-DYNAMICS; MONTE-CARLO-SIMULATION; INTEGRAL-EQUATION; PHASE COEXISTENCE; FLUIDS; SHOULDER; BEHAVIOR; PROTEIN; MODEL; EQUILIBRIA	We compute the singular value decomposition of the radial distribution function g(r) for hard sphere, and square well solutions. We find that g(r) decomposes into a small set of basis vectors allowing for an extremely accurate representation at all interpolated densities and potential strengths. In addition, we find that the coefficient vectors describing the magnitude of each basis vector are well described by a low-order polynomial. We provide a program to calculate g(r) in this compact representation for the investigated parameter range.	NIDDK, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hoppe, T (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	hoppeta@mail.nih.gov		Hoppe, Travis/0000-0002-4694-3050	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherie N, 1996, PHYS REV LETT, V77, P4832, DOI 10.1103/PhysRevLett.77.4832; Born M., 2000, PRINCIPLES OPTICS EL; Chang BH, 2003, BIOMACROMOLECULES, V4, P1713, DOI 10.1021/bm0300406; di Dio PJ, 2011, J CHEM THEORY COMPUT, V7, P3035, DOI 10.1021/ct2003385; di Dio PJ, 2013, J MOL LIQUIDS NULL; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Elliott JR, 1999, J CHEM PHYS, V110, P3043, DOI 10.1063/1.477899; Guillen-Escamilla I, 2011, PHYSICA A, V390, P3637, DOI 10.1016/j.physa.2011.05.031; Hoppe T, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803099; KOFKE DA, 1993, J CHEM PHYS, V98, P4149, DOI 10.1063/1.465023; Lang A, 1999, J PHYS-CONDENS MAT, V11, P10143, DOI 10.1088/0953-8984/11/50/308; Liu HJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2085051; Lomakin A, 1996, J CHEM PHYS, V104, P1646, DOI 10.1063/1.470751; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Mulero A, 2001, PHYS CHEM CHEM PHYS, V3, P4991, DOI 10.1039/b104049a; Mulero A., 2008, **DROPPED REF**, DOI DOI 10.1007/978-3-540-78767-9; Pagan DL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1890925; PANAGIOTOPOULOS AZ, 1987, MOL PHYS, V61, P813, DOI 10.1080/00268978700101491; Piasecki J, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4801329; ROGERS FJ, 1980, J CHEM PHYS, V73, P6272, DOI 10.1063/1.440124; ROGERS FJ, 1984, PHYS REV A, V30, P999, DOI 10.1103/PhysRevA.30.999; Valadez-Perez NE, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747193; VEGA L, 1992, J CHEM PHYS, V96, P2296, DOI 10.1063/1.462080; WEHNER MF, 1986, J STAT PHYS, V42, P493, DOI 10.1007/BF01127723; Wentzel N, 2007, J PHYS CHEM B, V111, P1478, DOI 10.1021/jp065062b; Yuste SB, 2011, MOL PHYS, V109, P987, DOI 10.1080/00268976.2011.562472; Zernike V. F., 1934, PHYSICA, V1, P689; Zhou SQ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3265984	29	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75792	10.1371/journal.pone.0075792	http://dx.doi.org/10.1371/journal.pone.0075792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143174	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100009
J	Xu, X; Tan, C; Li, PP; Zhang, SS; Pang, XW; Liu, HJ; Li, L; Sun, XY; Zhang, Y; Wu, HN; Chen, XP; Ge, Q				Xu, Xi; Tan, Cheng; Li, Pingping; Zhang, Shusong; Pang, Xuewen; Liu, Hongju; Li, Li; Sun, Xiuyuan; Zhang, Yu; Wu, Hounan; Chen, Xiaoping; Ge, Qing			Changes of Cytokines during a Spaceflight Analog - a 45-Day Head-Down Bed Rest	PLOS ONE			English	Article							LONG-DURATION SPACEFLIGHT; MEMORY B-CELLS; AMPHIBIAN PLEURODELES-WALTL; RHODIOLA-IMBRICATA RHIZOME; SHORT-TERM SPACEFLIGHT; EPSTEIN-BARR-VIRUS; CD4(+) T-CELLS; SPACE-FLIGHT; IMMUNE-RESPONSES; GENE-EXPRESSION	Spaceflight is associated with deregulation in the immune system. Head-down bed rest (HDBR) at -6 degrees is believed to be the most practical model for examining multi-system responses to microgravity in humans during spaceflight. In the present study, a 45-day HDBR was performed to investigate the alterations in human immune cell distributions and their functions in response to various stimuli. The effect of countermeasure, Rhodiola rosea (RR) treatment, was also examined. A significant decrease of interferon-gamma (IFN-gamma) and interleukin-17 (IL-17) productions by activated T cells, increase of IL-1 beta and IL-18 by activated B and myeloid cells were observed during HDBR. The upregulation of serum cortisol was correlated with the changes of IL-1 family cytokines. In addition, a significant increase of memory T and B cell and regulatory T cells (Treg) were also detected. The uptake of RR further decreased IFN-gamma level and slowed down the upregulation of IL-1 family cytokines. These data suggest that for prolonged HDBR and spaceflight, the decreased protective T cell immunity and enhanced proinflammatory cytokines should be closely monitored. The treatment with RR may play an important role in suppressing proinflammatory cytokines but not in boosting protective T cell immunity.	[Xu, Xi; Li, Pingping; Zhang, Shusong; Pang, Xuewen; Sun, Xiuyuan; Zhang, Yu; Ge, Qing] Peking Univ, Key Lab Med Immunol, Minist Hlth, Dept Immunol,Sch Basic Med Sci,Hlth Sci Ctr, Beijing 100871, Peoples R China; [Tan, Cheng; Liu, Hongju; Li, Li; Chen, Xiaoping] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Wu, Hounan] Peking Univ, Med & Hlth Analyt Ctr, Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University; Peking University	Wu, HN (corresponding author), Peking Univ, Med & Hlth Analyt Ctr, Hlth Sci Ctr, Beijing 100871, Peoples R China.	wuhounan@bjmu.edu.cn; xpchen2009@yahoo.com; qingge@bjmu.edu.cn	Li, Ping/GYV-4914-2022		Natural Basic Research Program of China [2011CB711000, 2010CB945300]; National Natural Science Foundation of China [31070787, 31270935, 31171144, 30871222]; opening foundation of the State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center [SMFA12K08]; Program for New Century Excellent Talents in University [NCET-10-0175/BMU20100005]; Research Fund for the Doctoral Program of Higher Education [20100001110049]	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); opening foundation of the State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from the Natural Basic Research Program of China (2011CB711000, 2010CB945300, Q.G.), the National Natural Science Foundation of China (31070787 and 31270935, Q.G., 31171144 and 30871222, X.C.), the opening foundation of the State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA12K08, Q.G.), Program for New Century Excellent Talents in University (NCET-10-0175/BMU20100005, Q.G.), the Research Fund for the Doctoral Program of Higher Education (20100001110049, Q.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BRAIN BEHAV IMMUN, V19, P547; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; BERKENBOSCH F, 1987, SCIENCE, V238, P524, DOI 10.1126/science.2443979; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Buravkova LB., 2004, J GRAVIT PHYSL, V11, P177; Caillot-Augusseau A, 1998, CLIN CHEM, V44, P578; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; CHAPES SK, 1994, ADV SPACE RES, V14, P5, DOI 10.1016/0273-1177(94)90380-8; Chouker A, 2001, J APPL PHYSIOL, V90, P1736, DOI 10.1152/jappl.2001.90.5.1736; Cogoli Augusto, 1993, Environmental Medicine (Nagoya), V37, P107; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Crucian BE, 2009, AVIAT SPACE ENVIR MD, V80, pA37, DOI 10.3357/ASEM.BR05.2009; Enoksson SL, 2011, P NATL ACAD SCI USA, V108, pE1399, DOI 10.1073/pnas.1107830108; Frank MG, 2012, BRAIN BEHAV IMMUN, V26, P337, DOI 10.1016/j.bbi.2011.10.005; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; GMUNDER FK, 1992, ACTA PHYSIOL SCAND, V144, P131; GMUNDER FK, 1994, AVIAT SPACE ENVIR MD, V65, P419; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Guan S, 2011, IMMUNOPHARM IMMUNOT, V33, P738, DOI 10.3109/08923973.2011.567988; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Hsieh CH, 2010, NEUROSCIENCE, V165, P1191, DOI 10.1016/j.neuroscience.2009.12.003; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; Ishaque S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-70; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kaur I, 2008, CLIN VACCINE IMMUNOL, V15, P1523, DOI 10.1128/CVI.00065-08; Kelsen J, 2012, CYTOKINE, V59, P403, DOI 10.1016/j.cyto.2012.04.032; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Konstantinova IV, 1995, ACTA ASTRONAUT, V36, P713, DOI 10.1016/0094-5765(95)00161-1; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Li HX, 2009, J ETHNOPHARMACOL, V123, P257, DOI 10.1016/j.jep.2009.03.009; Lind SM, 2009, EUR J IMMUNOL, V39, P2293, DOI 10.1002/eji.200839195; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; MAES M, 1993, AM J PSYCHIAT, V150, P1189; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; MEEHAN RT, 1992, IMMUNOLOGY, V76, P491; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Meshkov D, 1995, ACTA ASTRONAUT, V36, P719, DOI 10.1016/0094-5765(95)00162-X; Mills PJ, 2001, PSYCHOSOM MED, V63, P886, DOI 10.1097/00006842-200111000-00006; Mishra KP, 2006, IMMUNOPHARM IMMUNOT, V28, P201, DOI 10.1080/08923970600815139; Mishra KP, 2010, IMMUNOPHARM IMMUNOT, V32, P141, DOI [10.3109/08923970903218874, 10.3109/08923970903503668]; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Morbach H, 2011, ARTHRITIS RHEUM-US, V63, P3458, DOI 10.1002/art.30569; Moynihan JA, 2003, BRAIN BEHAV IMMUN, V17, pS11; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Schmitt DA, 2000, PFLUG ARCH EUR J PHY, V441, pR79, DOI 10.1007/s004240000349; Schmitt DA, 1996, J INTERF CYTOK RES, V16, P151, DOI 10.1089/jir.1996.16.151; Shearer WT, 2009, J ALLERGY CLIN IMMUN, V123, P900, DOI 10.1016/j.jaci.2008.12.016; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; Stein TP, 1999, AM J PHYSIOL-ENDOC M, V276, pE1014; Stowe RP, 2011, AVIAT SPACE ENVIR MD, V82, P627, DOI 10.3357/ASEM.2980.2011; Stowe RP, 2000, NEUROIMMUNOMODULAT, V8, P51, DOI 10.1159/000026453; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tanaka T, 2001, INT ARCH ALLERGY IMM, V125, P236, DOI 10.1159/000053821; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; Uchakin P N, 1998, J Gravit Physiol, V5, pP171; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Wang HB, 2009, PHYTOMEDICINE, V16, P146, DOI 10.1016/j.phymed.2008.07.013; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811	75	26	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77401	10.1371/journal.pone.0077401	http://dx.doi.org/10.1371/journal.pone.0077401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143230	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100067
J	Li, WWY; Lam, WWT; Shun, SC; Lai, YH; Law, WL; Poon, J; Fielding, R				Li, Wylie Wai Yee; Lam, Wendy Wing Tak; Shun, Shiow-Ching; Lai, Yeur-Hur; Law, Wai-Lun; Poon, Jensen; Fielding, Richard			Psychometric Assessment of the Chinese Version of the Supportive Care Needs Survey Short-Form (SCNS-SF34-C) among Hong Kong and Taiwanese Chinese Colorectal Cancer Patients	PLOS ONE			English	Article							SATISFACTION QUESTIONNAIRE CHPSQ-9; CONFIRMATORY FACTOR-ANALYSIS; QUALITY-OF-LIFE; BREAST-CANCER; RECTAL-CANCER; LUNG-CANCER; VALIDATION; SCALE; INSTRUMENT; CARCINOMA	Background: Accurate assessment of unmet supportive care needs is essential for optimal cancer patient care. This study used confirmatory factor analysis (CFA) to test the known factor structures of the short form of Supportive Care Need Survey (SCNS-34) in Hong Kong and Taiwan Chinese patients diagnosed with colorectal cancer (CRC). Methods: 360 Hong Kong and 263 Taiwanese Chinese CRC patients completed the Chinese version of SCNS-SF34. Comparative measures (patient satisfaction, anxiety, depression, and symptom distress) tested convergent validity while known group differences were examined to test discriminant validity. Results: The original 5-factor and recent 4-factor models of the SCNS demonstrated poor data fit using CFA in both Hong Kong and Taiwan samples. Subsequently a modified five-factor model with correlated residuals demonstrated acceptable fit in both samples. Correlations demonstrated convergent and divergent validity and known group differences were observed. Conclusions: While the five-factor model demonstrated a better fit for data from Chinese colorectal cancer patients, some of the items within its domain overlapped, suggesting item redundancy. The five-factor model showed good psychometric properties in these samples but also suggests conceptualization of unmet supportive care needs are currently inadequate.	[Li, Wylie Wai Yee; Lam, Wendy Wing Tak; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Div Behav Hlth, Ctr Psychooncol Res & Training, Hong Kong, Hong Kong, Peoples R China; [Shun, Shiow-Ching; Lai, Yeur-Hur] Natl Taiwan Univ, Dept Nursing, Taipei 10764, Taiwan; [Poon, Jensen] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National Taiwan University; University of Hong Kong	Lam, WWT (corresponding author), Univ Hong Kong, Sch Publ Hlth, Div Behav Hlth, Ctr Psychooncol Res & Training, Hong Kong, Hong Kong, Peoples R China.	wwtlam@hku.hk	; Lam, Wendy Wing Tak/C-4319-2009	SHUN, SHIOW-CHING/0000-0002-9883-4446; LAI, YEUR-HUR/0000-0003-0313-2634; Lam, Wendy Wing Tak/0000-0003-2383-0149	Health Services Research Fund, Food and Health Bureau, The Government of Hong Kong, SAR [08090921]	Health Services Research Fund, Food and Health Bureau, The Government of Hong Kong, SAR	This work was supported by a grant from Health Services Research Fund (Grant No. 08090921), Food and Health Bureau, The Government of Hong Kong, SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge L, 2009, PSYCHOONCOLOGY S2, V18, pS117; Au A, 2011, PSYCHO-ONCOLOGY, V20, P1292, DOI 10.1002/pon.1851; Beesley V, 2008, PSYCHO-ONCOLOGY, V17, P392, DOI 10.1002/pon.1249; Black J.T, 1992, MULTIVARIATE DATA AN; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Boyes A, 2009, J EVAL CLIN PRACT, V15, P602, DOI 10.1111/j.1365-2753.2008.01057.x; Bredart A, 2012, EUR J CANCER CARE, V21, P450, DOI 10.1111/j.1365-2354.2012.01356.x; Butler LD, 1995, QUALITY PATIENTS PER; Byrne B. M., 2006, STRUCTURAL EQUATION, V2nd; Chan YF, 2010, QUAL LIFE RES, V19, P865, DOI 10.1007/s11136-010-9645-1; Chorost MI, 2000, AM J SURG, V179, P271, DOI 10.1016/S0002-9610(00)00327-5; Cossich T, 2004, QUAL LIFE RES, V13, P1225, DOI 10.1023/B:QURE.0000037496.94640.d9; Fielding R, 2004, CANCER-AM CANCER SOC, V100, P2500, DOI 10.1002/cncr.20303; Fielding R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065099; Girgis A, 2012, PSYCHO-ONCOLOGY, V21, P827, DOI 10.1002/pon.1973; Hong Kong Cancer Registry, 2009, LEAD CANC SIT HONG K; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jorgensen ML, 2012, SUPPORT CARE CANCER, V20, P1275, DOI 10.1007/s00520-011-1214-9; Kline R.B., 2011, PRINCIPLES PRACTICE; Lai YH., 1998, J NURS RES, V6, P279, DOI [10.7081/NR.199808.0279, DOI 10.7081/NR.199808.0279]; Lam WWT, 2011, BREAST CANCER RES TR, V130, P531, DOI 10.1007/s10549-011-1592-1; Larn WWT, 2008, J PAIN SYMPTOM MANAG, V36, P584, DOI 10.1016/j.jpainsymman.2007.12.008; Lehmann C, 2012, SUPPORT CARE CANCER, V20, P2415, DOI 10.1007/s00520-011-1351-1; Li WWY, 2012, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3068, DOI 10.1002/P0N.3068]; Liao MN, 2012, ONCOL NURS FORUM, V39, pE380, DOI 10.1188/12.ONF.E380-E389; McCorkle R, 1978, Cancer Nurs, V1, P373; McDowell ME, 2010, PSYCHO-ONCOLOGY, V19, P508, DOI 10.1002/pon.1604; Muthen L.K., 2009, MPLUS USERS GUIDE; Okuyama T, 2009, PSYCHO-ONCOL, V18, P1003, DOI 10.1002/pon.1482; Patel D, 2011, J AFFECT DISORDERS, V131, P412, DOI 10.1016/j.jad.2010.11.014; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Sanders SL, 2010, PSYCHO-ONCOLOGY, V19, P480, DOI 10.1002/pon.1577; Schofield P, 2012, PSYCHO-ONCOLOGY, V21, P1107, DOI 10.1002/pon.2016; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sharpe L, 2011, J PSYCHOSOM RES, V70, P395, DOI 10.1016/j.jpsychores.2010.11.003; SPRANGERS MAG, 1995, DIS COLON RECTUM, V38, P361, DOI 10.1007/BF02054222; Uchida M, 2011, JPN J CLIN ONCOL, V41, P530, DOI 10.1093/jjco/hyq230; Wang J., 2020, STRUCTURAL EQUATION, DOI [DOI 10.1002/, DOI 10.1002/9781118356258]; Ware J. E., 1997, MAP R WINDOWS MULTIT; Wilson TR, 2006, DIS COLON RECTUM, V49, P1692, DOI 10.1007/s10350-006-0709-9; Wong WS, 2008, PSYCHO-ONCOL, V17, P292, DOI 10.1002/pon.1247; Wong WS, 2009, VALUE HEALTH, V12, P597, DOI 10.1111/j.1524-4733.2008.00480.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	19	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75755	10.1371/journal.pone.0075755	http://dx.doi.org/10.1371/journal.pone.0075755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24146774	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400018
J	Endo, H; Shiroki, T; Nakagawa, T; Yokoyama, M; Tamai, K; Yamanami, H; Fujiya, T; Sato, I; Yamaguchi, K; Tanaka, N; Iijima, K; Shimosegawa, T; Sugamura, K; Satoh, K				Endo, Hiroyuki; Shiroki, Takeharu; Nakagawa, Takayuki; Yokoyama, Misa; Tamai, Keiichi; Yamanami, Hideaki; Fujiya, Tsuneaki; Sato, Ikuro; Yamaguchi, Kazunori; Tanaka, Nobuyuki; Iijima, Katsunori; Shimosegawa, Tooru; Sugamura, Kazuo; Satoh, Kennichi			Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer	PLOS ONE			English	Article							CARCINOMA PROGRESSION; SURVIVAL; ELEMENTS; PROJECT	The long non-coding RNA HOTAIR has been reported to be a poor prognostic biomarker in a variety of malignant tumors. However, little is known about the association of HOTAIR with gastric cancer. We examined the expression of HOTAIR in 68 gastric cancer samples using quantitative real-time RT-PCR and analyzed its correlation with the clinical parameters. The functional role of HOTAIR was examined by generating human gastric cancer cell lines with increased or suppressed HOTAIR expression. The anchorage -independent growth was assessed by soft agar assay. The increased or suppressed HOTAIR expressing gastric cancer cells were injected into the tail vein or peritoneal cavity of immunodeficient mice to examine the effect of this molecule on metastasis and peritoneal dissemination. The expression of HOTAIR was significantly higher in cancer lesions than in adjacent non-cancerous tissues in human gastric cancers. In the diffuse type of gastric cancer, the High-HOTAIR group (HOTAIR/GAPDH > 1) showed significantly more venous invasion, frequent lymph node metastases and a lower overall survival rate compared to the Low-HOTAIR group (HOTAIR/GAPDH < 1). Colony formation on the soft agar was enhanced in a HOTAIR-dependent manner. HOTAIR-expressing MKN74 formed more liver metastasis compared to control when they were injected into the tail vein of mice. In addition, reduced expression of HOTAIR in KATO III suppressed peritoneal dissemination. These results suggest that HOTAIR plays a pivotal role in the development of gastric cancer.	[Endo, Hiroyuki; Shiroki, Takeharu; Nakagawa, Takayuki; Yokoyama, Misa; Satoh, Kennichi] Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, Natori, Miyagi 9811293, Japan; [Tamai, Keiichi; Yamaguchi, Kazunori; Tanaka, Nobuyuki; Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Yamanami, Hideaki; Fujiya, Tsuneaki] Miyagi Canc Ctr, Dept Surg, Natori, Miyagi 9811293, Japan; [Sato, Ikuro] Miyagi Canc Ctr, Dept Pathol, Natori, Miyagi 9811293, Japan; [Endo, Hiroyuki; Shiroki, Takeharu; Iijima, Katsunori; Shimosegawa, Tooru] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Sendai, Miyagi 980, Japan	Miyagi Cancer Center; Miyagi Cancer Center; Miyagi Cancer Center; Miyagi Cancer Center; Tohoku University	Satoh, K (corresponding author), Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, 47-1 Aza Nodayama, Natori, Miyagi 9811293, Japan.	ksatoh-gi@umin.ac.jp	Tamai, Keiichi/AAW-8261-2021	Tamai, Keiichi/0000-0003-0813-5885	JSPS KAKENHI [24791480, 24591022]; HIROMI Medical Research Foundation; Daiwa Securities Health Foundation; Grants-in-Aid for Scientific Research [23592521, 24591022, 25860572] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); HIROMI Medical Research Foundation; Daiwa Securities Health Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 24791480 and 24591022 (http://www.jsps.go.jp/j-grantsinaid/index.html), and grant-in-aid from HIROMI Medical Research Foundation (http://www.smtb.jp/personal/entrustment/management/public/example/pdf/natural-06a.pdf) and Daiwa Securities Health Foundation (http://www.daiwa-grp.jp/dsh/grant/outline.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boku N, 2013, GASTRIC CAN IN PRESS; Boku N, 2011, JPN J CLIN ONCOL, V41, P1315, DOI 10.1093/jjco/hyr129; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Geng YJ, 2011, J INT MED RES, V39, P2119, DOI 10.1177/147323001103900608; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hajjari M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0670-0; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; NAKATANI H, 1990, JPN J CANCER RES, V81, P707, DOI 10.1111/j.1349-7006.1990.tb02631.x; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Yagi K, 2012, DIAGN THER ENDOSC; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y	20	210	225	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77070	10.1371/journal.pone.0077070	http://dx.doi.org/10.1371/journal.pone.0077070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130837	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200054
J	Flenniken, ML; Andino, R				Flenniken, Michelle L.; Andino, Raul			Non-Specific dsRNA-Mediated Antiviral Response in the Honey Bee	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; COLONY COLLAPSE DISORDER; DEFORMED WING VIRUS; COMPLETE GENOME SEQUENCE; ACUTE PARALYSIS VIRUS; PICORNA-LIKE VIRUS; QUEEN-CELL-VIRUS; APIS-MELLIFERA; IMMUNE-RESPONSES; GENE-EXPRESSION	Honey bees are essential pollinators of numerous agricultural crops. Since 2006, honey bee populations have suffered considerable annual losses that are partially attributed to Colony Collapse Disorder (CCD). CCD is an unexplained phenomenon that correlates with elevated incidence of pathogens, including RNA viruses. Honey bees are eusocial insects that live in colonies of genetically related individuals that work in concert to gather and store nutrients. Their social organization provides numerous benefits, but also facilitates pathogen transmission between individuals. To investigate honey bee antiviral defense mechanisms, we developed an RNA virus infection model and discovered that administration of dsRNA, regardless of sequence, reduced virus infection. Our results suggest that dsRNA, a viral pathogen associated molecular pattern (PAMP), triggers an antiviral response that controls virus infection in honey bees.	[Flenniken, Michelle L.; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Flenniken, Michelle L.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	University of California System; University of California San Francisco; Montana State University System; Montana State University Bozeman	Flenniken, ML (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	michelle.flenniken@montana.edu; raul.andino@ucsf.edu			A. P. Giannini Foundation; Honey Bee Biology Postdoctoral Fellowship; UC-Davis and Haagen Dazs; National Science Foundation EPSCoR Cooperative Agreement [EPS-110134]; Project Apis m.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040085] Funding Source: NIH RePORTER; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	A. P. Giannini Foundation; Honey Bee Biology Postdoctoral Fellowship; UC-Davis and Haagen Dazs; National Science Foundation EPSCoR Cooperative Agreement(National Science Foundation (NSF)); Project Apis m.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by postdoctoral fellowships awarded to Dr. Michelle L. Flenniken by the A. P. Giannini Foundation and by a Honey Bee Biology Postdoctoral Fellowship co-sponsored by UC-Davis and Haagen Dazs, and current support from the National Science Foundation EPSCoR Cooperative Agreement #EPS-110134 and Project Apis m. (projectapism.org), and funding support awarded to Dr. Raul Andino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; Asgari S, 2010, INSECT VIROLOGY, V1, P54; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attasart P, 2010, ARCH VIROL, V155, P825, DOI 10.1007/s00705-010-0649-5; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; Bartholomay LC, 2012, J INVERTEBR PATHOL, V110, P261, DOI 10.1016/j.jip.2012.03.002; Benjeddou M, 2002, J GEN VIROL, V83, P3139, DOI 10.1099/0022-1317-83-12-3139; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Cash AC, 2005, GENES BRAIN BEHAV, V4, P267, DOI 10.1111/j.1601-183X.2005.00131.x; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen Y, 2004, APIDOLOGIE; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Desai SD, 2012, INSECT MOL BIOL, V21, P446, DOI 10.1111/j.1365-2583.2012.01150.x; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans JD, 2009, J APICULT RES, V48, P300, DOI 10.3896/IBRA.1.48.4.13; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Evans J, 2010, PARLIAMENT AFF, V63, P1, DOI 10.1093/pa/gsp042; Fischman BJ, 2011, P NATL ACAD SCI USA, V108, P10847, DOI 10.1073/pnas.1100301108; Flenniken ML, 2010, INSECT VIROLOGY, P367; Nunes FMF, 2009, INSECT BIOCHEM MOLEC, V39, P157, DOI 10.1016/j.ibmb.2008.10.011; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hirai M, 2004, INSECT MOL BIOL, V13, P399, DOI 10.1111/j.0962-1075.2004.00497.x; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Jefferson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054097; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Kingsolver MB, 2012, P NATL ACAD SCI USA, V109, P18639, DOI 10.1073/pnas.1216736109; Labreuche Y, 2010, DEV COMP IMMUNOL, V34, P1209, DOI 10.1016/j.dci.2010.06.017; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Liu JS, 2013, J INSECT PHYSIOL, V59, P646, DOI 10.1016/j.jinsphys.2013.03.013; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Lozano J, 2012, DEV GENES EVOL, V222, P229, DOI 10.1007/s00427-012-0404-x; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Naug D, 2007, P ROY SOC B-BIOL SCI, V274, P61, DOI 10.1098/rspb.2006.3695; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810; Nilsen KA, 2011, J EXP BIOL, V214, P1488, DOI 10.1242/jeb.050393; Nunes Francis M.F., 2013, Insects, V4, P90, DOI 10.3390/insects4010090; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109; Pitaluga AN, 2008, DEV COMP IMMUNOL, V32, P191, DOI 10.1016/j.dci.2007.06.008; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Robalino J, 2004, J VIROL, V78, P10442, DOI 10.1128/JVI.78.19.10442-10448.2004; Robalino J, 2007, DEV COMP IMMUNOL, V31, P539, DOI 10.1016/j.dci.2006.08.011; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Sheffield JB, 2007, MICROSC MICROANAL, V13, P200, DOI 10.1017/S1431927607076611; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang Y, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000896, DOI 10.1371/J0URNAL.PGEN.1000896]; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhang Y, 2010, J INSECT PHYSIOL, V56, P1207, DOI 10.1016/j.jinsphys.2010.03.019	113	87	90	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77263	10.1371/journal.pone.0077263	http://dx.doi.org/10.1371/journal.pone.0077263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130869	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200076
J	Korrodi-Gregorio, L; Lopes, AM; Esteves, SLC; Afonso, S; de Matos, AL; Lissovsky, AA; Silva, OABDE; Silva, EFDE; Esteves, PJ; Fardilha, M				Korrodi-Gregorio, Luis; Lopes, Ana Margarida; Esteves, Sara L. C.; Afonso, Sandra; de Matos, Ana Lemos; Lissovsky, Andrey A.; da Cruz e Silva, Odete A. B.; da Cruz e Silva, Edgar F.; Esteves, Pedro Jose; Fardilha, Margarida			An Intriguing Shift Occurs in the Novel Protein Phosphatase 1 Binding Partner, TCTEX1D4: Evidence of Positive Selection in a Pika Model	PLOS ONE			English	Article							STRUCTURAL BASIS; CYTOPLASMIC DYNEIN; CATALYTIC SUBUNIT; DOCKING MOTIF; OCHOTONA; IDENTIFICATION; GLYCOSYLATION; GENE; PROTEIN-PHOSPHATASE-1; DIVERSIFICATION	T-complex testis expressed protein 1 domain containing 4 (TCTEX1D4) contains the canonical phosphoprotein phosphatase 1 (PPP1) binding motif, composed by the amino acid sequence RVSF. We identified and validated the binding of TCTEX1D4 to PPP1 and demonstrated that indeed this protein is a novel PPP1 interacting protein. Analyses of twenty-one mammalian species available in public databases and seven Lagomorpha sequences obtained in this work showed that the PPP1 binding motif 90RVSF93 is present in all of them and is flanked by a palindromic sequence, PLGS, except in three species of pikas (Ochotona princeps, O. dauurica and O. pusilla). Furthermore, for the Ochotona species an extra glycosylation site, motif 96NLS98, and the loss of the palindromic sequence were observed. Comparison with other lagomorphs suggests that this event happened before the Ochotona radiation. The d(N)/d(S) for the sequence region comprising the PPP1 binding motif and the flanking palindrome highly supports the hypothesis that for Ochotona species this region has been evolving under positive selection. In addition, mutational screening shows that the ability of pikas TCTEX1D4 to bind to PPP1 is maintained, although the PPP1 binding motif is disrupted, and the N- and C-terminal surrounding residues are also abrogated. These observations suggest pika as an ideal model to study novel PPP1 complexes regulatory mechanisms.	[Korrodi-Gregorio, Luis; Esteves, Sara L. C.; da Cruz e Silva, Edgar F.; Fardilha, Margarida] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Lab Signal Transduct, P-3800 Aveiro, Portugal; [Korrodi-Gregorio, Luis; Esteves, Sara L. C.; da Cruz e Silva, Odete A. B.; da Cruz e Silva, Edgar F.; Fardilha, Margarida] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Lopes, Ana Margarida; Afonso, Sandra; de Matos, Ana Lemos; Esteves, Pedro Jose] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, CIBIO UP,InBio, Vairao, Portugal; [Lopes, Ana Margarida] Univ Porto, Fac Ciencias, Dept Zool & Antropol, P-4100 Oporto, Portugal; [Lopes, Ana Margarida] Univ Nantes, INSERM, U892, Nantes, France; [de Matos, Ana Lemos] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Lissovsky, Andrey A.] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [da Cruz e Silva, Odete A. B.] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Neurosci Lab, P-3800 Aveiro, Portugal; [Esteves, Pedro Jose] Inst Invest & Formacao Avancada Ciencias & Tecnol, CESPU, Gandra Prd, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto; Universidade do Porto; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Loyola University Chicago; Lomonosov Moscow State University; Universidade de Aveiro	Esteves, PJ (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, CIBIO UP,InBio, Vairao, Portugal.	pjesteves@cibio.up.pt; mfardilha@ua.pt	Esteves, Pedro J/A-7537-2010; Lissovsky, Andrey A/B-1965-2012; afonso, sandra/M-5702-2013; da Cruz e Silva, Odete A B/F-4072-2010; Afonso, Sandra/AAV-9350-2021; Fardilha, Margarida/G-3182-2010; Korrodi-Gregório, Luís/N-6796-2013; Lopes, Ana/M-3285-2013; Esteves, Sara/L-9001-2013	Esteves, Pedro J/0000-0002-6055-8298; Lissovsky, Andrey A/0000-0003-0525-0327; afonso, sandra/0000-0001-7212-991X; da Cruz e Silva, Odete A B/0000-0003-3718-9874; Afonso, Sandra/0000-0001-7212-991X; Fardilha, Margarida/0000-0001-7459-9173; Korrodi-Gregório, Luís/0000-0002-2811-8081; Lopes, Ana/0000-0002-7176-0969; Esteves, Sara/0000-0002-1658-3816	FCT (Portuguese Foundation for Science and Technology) [SFRH/BD/41751/2007, SFRH/BD/78738/2011, SFRH/BD/42334/2007, SFRH/BD/48566/2008, SPRH/BPD/27021/2006]; FCT project [PTDC/BIABEC/103158/2008]; project "Genomics Applied to Genetic Resources"; North Portugal Regional Operational Programme under the National Strategic Reference Framework, through the European Regional Development Fund [ON.2-O Novo Norte]	FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); FCT project(Portuguese Foundation for Science and Technology); project "Genomics Applied to Genetic Resources"; North Portugal Regional Operational Programme under the National Strategic Reference Framework, through the European Regional Development Fund	FCT (Portuguese Foundation for Science and Technology) supported the doctoral fellowship of Luis Korrodi-Gregorio (SFRH/BD/41751/2007), Ana Margarida Lopes (SFRH/BD/78738/2011), Sara Luisa de Castro Esteves (SFRH/BD/42334/2007) and Ana Lemos de Matos (SFRH/BD/48566/2008) and post-doctoral fellowship of Pedro Jose Esteves (SPRH/BPD/27021/2006). This work was also supported by a FCT project (PTDC/BIABEC/103158/2008) and by the project "Genomics Applied to Genetic Resources," cofinanced by North Portugal Regional Operational Programme 2007/2013 (ON.2-O Novo Norte), under the National Strategic Reference Framework, through the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2009, CONSERV GENET, P1; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Browne GJ, 2007, BIOCHEM J, V402, P187, DOI 10.1042/BJ20060600; Carmo CR, 2006, IMMUNOGENETICS, V58, P494, DOI 10.1007/s00251-006-0095-4; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chang JS, 2002, J BIOL CHEM, V277, P48002, DOI 10.1074/jbc.M208471200; Cohen PTW, 2002, J CELL SCI, V115, P241; Cohen PTW, 2003, METHOD ENZYMOL, V366, P135; Corbet G, 1983, ACTA ZOOL FENN, P1; Dawson M, 1981, P WORLD LAG C; de Matos AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-294; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Esteves PJ, 2005, IMMUNOGENETICS, V57, P874, DOI 10.1007/s00251-005-0022-0; Fardilha M, 2004, ANN NY ACAD SCI, V1030, P468, DOI 10.1196/annals.1329.059; Fardilha M, 2010, CURRENT MED CHEM, V17; Fardilha M, 2004, CHARACTERIZATION PP1; Fardilha M, 2011, BIOCHEM PHARMACOL, V82, P1403, DOI 10.1016/j.bcp.2011.02.018; Gibbons JA, 2005, J BIOL CHEM, V280, P15903, DOI 10.1074/jbc.M500871200; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hoffman R, 2005, MAMMAL SPECIES WORLD, P185; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Korrodi-Gregorio L, 2013, BIOL OPEN; Lanier HC, 2009, MOL PHYLOGENET EVOL, V53, P1, DOI 10.1016/j.ympev.2009.05.035; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lissovsky AA, 2007, J MAMMAL, V88, P1195, DOI 10.1644/06-MAMM-A-363R.1; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; Marques F, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-135; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; McKenna Malcolm C., 1997, pi; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Niu YD, 2004, FOLIA ZOOL, V53, P141; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Pinheiro A, 2013, IMMUNOGENETICS; Pinheiro A, 2011, IMMUNOGENETICS, V63, P397, DOI 10.1007/s00251-011-0533-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rose KD, 2008, P ROY SOC B-BIOL SCI, V275, P1203, DOI 10.1098/rspb.2007.1661; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TAJIMA F, 1991, J MOL EVOL, V33, P470, DOI 10.1007/BF02103140; Takemiya A, 2009, PLANT PHYSIOL, V150, P144, DOI 10.1104/pp.109.135335; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; van der Loo W, 2009, J VIROL, V83, P2386, DOI 10.1128/JVI.01116-08; van der Loo W, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-72; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wakula P, 2006, BIOCHEM J, V400, P377, DOI 10.1042/BJ20060758; Wu WJ, 2007, J BIOL CHEM, V282, P26431, DOI 10.1074/jbc.M704969200; Yu N, 2000, MOL PHYLOGENET EVOL, V16, P85, DOI 10.1006/mpev.2000.0776; Zwickl D. J, 2006, GENETIC ALGORITHM AP	66	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77236	10.1371/journal.pone.0077236	http://dx.doi.org/10.1371/journal.pone.0077236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130861	Green Submitted, gold, Green Published			2022-12-27	WOS:000325814200071
J	Langhammer, PF; Lips, KR; Burrowes, PA; Tunstall, T; Palmer, CM; Collins, JP				Langhammer, Penny F.; Lips, Karen R.; Burrowes, Patricia A.; Tunstall, Tate; Palmer, Crystal M.; Collins, James P.			A Fungal Pathogen of Amphibians, Batrachochytrium dendrobatidis, Attenuates in Pathogenicity with In Vitro Passages	PLOS ONE			English	Article							POPULATION DECLINES; CHYTRIDIOMYCOSIS; DISEASE; HISTORY; TRANSMISSION; TEMPERATURE; EXTINCTION; DYNAMICS	Laboratory investigations into the amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), have accelerated recently, given the pathogen's role in causing the global decline and extinction of amphibians. Studies in which host animals were exposed to Bd have largely assumed that lab-maintained pathogen cultures retained the infective and pathogenic properties of wild isolates. Attenuated pathogenicity is common in artificially maintained cultures of other pathogenic fungi, but to date, it is unknown whether, and to what degree, Bd might change in culture. We compared zoospore production over time in two samples of a single Bd isolate having different passage histories: one maintained in artificial media for more than six years (JEL427-P39), and one recently thawed from cryopreserved stock (JEL427-P9). In a common garden experiment, we then exposed two different amphibian species, Eleutherodactylus coqui and Atelopus zeteki, to both cultures to test whether Bd attenuates in pathogenicity with in vitro passages. The culture with the shorter passage history, JEL427-P9, had significantly greater zoospore densities over time compared to JEL427-P39. This difference in zoospore production was associated with a difference in pathogenicity for a susceptible amphibian species, indicating that fecundity may be an important virulence factor for Bd. In the 130-day experiment, Atelopus zeteki frogs exposed to the JEL427-P9 culture experienced higher average infection intensity and 100% mortality, compared with 60% mortality for frogs exposed to JEL427-P39. This effect was not observed with Eleutherodactylus coqui, which was able to clear infection. We hypothesize that the differences in phenotypic performance observed with Atelopus zeteki are rooted in changes of the Bd genome. Future investigations enabled by this study will focus on the underlying mechanisms of Bd pathogenicity.	[Langhammer, Penny F.; Palmer, Crystal M.; Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Lips, Karen R.; Tunstall, Tate] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Burrowes, Patricia A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA	Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland College Park; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Langhammer, PF (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	penny.langhammer@asu.edu		Lips, Karen/0000-0002-2719-1551	EPA STAR Graduate Fellowship; P.E.O Scholar Award	EPA STAR Graduate Fellowship(United States Environmental Protection Agency); P.E.O Scholar Award	This study was funded by an EPA STAR Graduate Fellowship and a P.E.O Scholar Award to Penny Langhammer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bishop PJ, 2009, DIS AQUAT ORGAN, V84, P9, DOI 10.3354/dao02028; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Brem FMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061260; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burrowes PA, 2004, HERPETOLOGICA, V60, P141, DOI 10.1655/03-50; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Butt TM, 2006, ECOLOGICAL AND SOCIETAL APPROACH TO BIOLOGICAL CONTROL, P213; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Collins J.P., 2009, EXTINCTION OUR TIMES; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Greenspan SE, 2012, J WILDLIFE DIS, V48, P575, DOI 10.7589/0090-3558-48.3.575; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Hyman OJ, 2012, DIS AQUAT ORGAN, V97, P185, DOI 10.3354/dao02423; IUCN, 2012, IUCN RED LIST THREAT; Joneson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002338; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longo AV, 2013, J WILDLIFE DIS, V49, P197, DOI 10.7589/2012-05-129; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; LORD JC, 1986, J INVERTEBR PATHOL, V48, P355, DOI 10.1016/0022-2011(86)90064-9; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Myers JM, 2012, J CHEM ECOL, V38, P958, DOI 10.1007/s10886-012-0170-2; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Core Development Team, 2008, R LANG ENV STAT COMP; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Safavi SA, 2012, BIOLOGIA, V67, P1062, DOI 10.2478/s11756-012-0120-z; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Voyles J, 2009, THESIS J COOK U; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Voyles J, 2011, FUNGAL ECOL, V4, P196, DOI [10.1016/j.funeco.2010.12.003, 10.1016/j.funeco.2010.12.00]; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	45	42	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77630	10.1371/journal.pone.0077630	http://dx.doi.org/10.1371/journal.pone.0077630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130895	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200092
J	Nishijima, T; Hamada, Y; Watanabe, K; Komatsu, H; Kinai, E; Tsukada, K; Teruya, K; Gatanaga, H; Kikuchi, Y; Oka, S				Nishijima, Takeshi; Hamada, Yohei; Watanabe, Koji; Komatsu, Hirokazu; Kinai, Ei; Tsukada, Kunihisa; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi			Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; PROTEASE INHIBITORS; RENAL STONES; COMBINATION; EFAVIRENZ; NAIVE; LOPINAVIR/RITONAVIR; UROLITHIASIS; PREVALENCE	Background: Although ritonavir-boosted atazanavir (ATV/r) is known to be associated with nephrolithiasis, little is known about the incidence of nephrolithiasis in patients treated with ritonavir-boosted Darunavir (DRV/r), the other preferred protease inhibitor. Methods: In a single-center cohort, the incidence of nephrolithiasis was compared between HIV-infected patients who commenced DRV/r-containing antiretroviral therapy and those on ATV/r. The effects of ATV/r use over DRV/r were estimated by univariate and multivariate Cox hazards models. Results: Renal stones were diagnosed in only one patient (0.86 per 1000 person-years) of the DRV/r group (n=540) and 37 (20.2 per 1000 person-years) of the ATV/r group (n=517). The median [interquartile (IQR)] observation period in the DRV/r group was 27.1 months (IQR 18.1-38.4 months), and 40.6 months (IQR 17.5-42.7) for the ATV/r group. The total observation period was 1,163.6 person-years and 1,829.6 person-years for the DRV/r group and for the ATV/r group, respectively. In the 37 patients on ATV/r who developed nephrolithiasis, the median time from commencement of ATV/r to diagnosis was 28.1 months (IQR 18.4-42.7), whereas nephrolithiasis in the single patient of the DRV/r group occurred 11.2 month after the introduction of DRV/r. ATV/r use over DRV/r was significantly associated with nephrolithiasis by uni- and multivariate analyses (HR=26.01; 95% CI, 3.541-191.0; p=0.001) (adjusted HR=21.47; 95% CI, 2.879-160.2; p=0.003). Conclusion: The incidence of nephrolithiasis was substantially lower in patients on DRV/r than those on ATV/r. The results suggest that DRV/r should be selected for treatment of HIV-infected patients at risk of chronic kidney disease.	[Nishijima, Takeshi; Hamada, Yohei; Watanabe, Koji; Kinai, Ei; Tsukada, Kunihisa; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Komatsu, Hirokazu] Saku Cent Hosp, Dept Community Care, Nagano, Japan; [Nishijima, Takeshi; Watanabe, Koji; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167; Hamada, Yohhei/0000-0002-9845-4267	Ministry of Health, Labor, and Welfare, Japan [H22-AIDS-001]; Global Center of Excellence Program, Ministry of Education, Science, Sports and Culture of Japan	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program, Ministry of Education, Science, Sports and Culture of Japan	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labor, and Welfare, Japan (H22-AIDS-001), and the Global Center of Excellence Program, the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini L, 2012, JAIDS-J ACQ IMM DEF, V59, P18, DOI 10.1097/QAI.0b013e31823a6124; Alexander RT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5287; Anderson PL, 2007, AIDS, V21, P1060, DOI 10.1097/QAD.0b013e3280c56ae1; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Chang HR, 2006, NEW ENGL J MED, V355, P2158, DOI 10.1056/NEJMc061892; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Couzigou C, 2007, CLIN INFECT DIS, V45, pE105, DOI 10.1086/521930; de Lastours V, 2013, J ANTIMICROB CHEMOTH, V68, P1850, DOI 10.1093/jac/dkt125; Deeks SG, 1997, JAMA-J AM MED ASSOC, V277, P145, DOI 10.1001/jama.277.2.145; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Hirano A, 2010, BIOL PHARM BULL, V33, P1426, DOI 10.1248/bpb.33.1426; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Keddis MT, 2013, CURR OPIN NEPHROL HY, V22, P390, DOI 10.1097/MNH.0b013e32836214b9; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Parmar MS, 2004, BMJ-BRIT MED J, V328, P1420, DOI 10.1136/bmj.328.7453.1420; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003; Takahashi M, 2005, BIOL PHARM BULL, V28, P1286, DOI 10.1248/bpb.28.1286; Tattevin P, 2013, CLIN INFECT DIS, V56, P1186, DOI 10.1093/cid/cis1211; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77268	10.1371/journal.pone.0077268	http://dx.doi.org/10.1371/journal.pone.0077268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130871	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200078
J	Silambarasan, S; Abraham, J				Silambarasan, Sivagnanam; Abraham, Jayanthi			Mycoremediation of Endosulfan and Its Metabolites in Aqueous Medium and Soil by Botryosphaeria laricina JAS6 and Aspergillus tamarii JAS9	PLOS ONE			English	Article							TOXIC METABOLITE; BETA-ENDOSULFAN; ALPHA-ENDOSULFAN; VERATRYL ALCOHOL; DEGRADATION; BIODEGRADATION; ENRICHMENT; BIOREMEDIATION; INSECTICIDE; ASCOMYCETE	Microbial degradation offers an efficient and ecofriendly approach to remove toxicants from the contaminated environments. Botryosphaeria laricina JAS6 and Aspergillus tamarii JAS9 were capable of degrading endosulfan and their metabolites which were isolated through enrichment technique. Both the strains were able to withstand an exposure of 1300 mg/L and showed luxuriant growth at 1000 mg/L of endosulfan. The change in pH in the culture broth was from 6.8 to 3.4 and 3.8 during growth kinetic studies of JAS6 and JAS9 strains, respectively upon biological degradation of endosulfan. The degradation of endosulfan by JAS6 and JAS9 strains were examined by HPLC. The biodegradation rate constant (k) and the initial concentration were reduced by 50% (DT50) which was determined by first and pseudo first order kinetic models. In the present investigation it has been revealed that Botryosphaeria laricina JAS6 and Aspergillus tamarii JAS9 possessing endosulfan degrading capability are being reported for the first time. These findings confirm the degradation of endosulfan by JAS6 and JAS9 strains which were accompanied by significant reduction in the toxicity and could be used as remedial measure in contaminated environments.	[Silambarasan, Sivagnanam; Abraham, Jayanthi] VIT Univ, Microbial Biotechnol Lab, Sch Biosci & Technol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Abraham, J (corresponding author), VIT Univ, Microbial Biotechnol Lab, Sch Biosci & Technol, Vellore, Tamil Nadu, India.	jayanthi.abraham@gmail.com	Abraham, Jayanthi/Q-6651-2018	Abraham, Jayanthi/0000-0001-5005-3088				Awasthi N, 2003, APPL MICROBIOL BIOT, V62, P279, DOI 10.1007/s00253-003-1241-7; Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; Barbosa AM, 1996, LETT APPL MICROBIOL, V23, P93, DOI 10.1111/j.1472-765X.1996.tb00038.x; Bhalerao TS, 2007, INT BIODETER BIODEGR, V59, P315, DOI 10.1016/j.ibiod.2006.09.002; Dekker RFH, 2001, ENZYME MICROB TECH, V28, P81, DOI 10.1016/S0141-0229(00)00274-X; Frisvad JC, 2000, STUD MYCOL, P201; GOEBEL H, 1982, RESIDUE REV, V83, P1; Goswami S, 2009, BIODEGRADATION, V20, P199, DOI 10.1007/s10532-008-9213-3; Goto T, 1996, APPL ENVIRON MICROB, V62, P4036, DOI 10.1128/AEM.62.11.4036-4038.1996; Goveas SW, 2011, EURASIA J BIOSCI, V5, P48, DOI DOI 10.5053/EJ0BI0S.2011.5.0.6; Guerin T.F., 2005, INT J ENVIRON STUD, V62, P235, DOI 10.1080/0020723042000257745; Guha A., 2000, INDIAN J ENV HLTH, V42, P9; Horn BW, 1996, MYCOLOGIA, V88, P574, DOI 10.2307/3761151; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Hussain S, 2007, BIODEGRADATION, V18, P731, DOI 10.1007/s10532-007-9102-1; Hussain S, 2007, WORLD J MICROB BIOT, V23, P939, DOI 10.1007/s11274-006-9317-z; JANARDHANAN KK, 1984, CAN J MICROBIOL, V30, P247, DOI 10.1139/m84-036; KATAYAMA A, 1993, ENVIRON TOXICOL CHEM, V12, P1059, DOI 10.1002/etc.5620120612; Kullman SW, 1996, APPL ENVIRON MICROB, V62, P593, DOI 10.1128/AEM.62.2.593-600.1996; Kumar K, 2007, CHEMOSPHERE, V68, P317, DOI 10.1016/j.chemosphere.2006.12.076; Kwon GS, 2005, APPL MICROBIOL BIOT, V67, P845, DOI 10.1007/s00253-004-1879-9; Kwon GS, 2002, FEMS MICROBIOL LETT, V215, P255, DOI 10.1111/j.1574-6968.2002.tb11399.x; Li W, 2009, J HAZARD MATER, V167, P209, DOI 10.1016/j.jhazmat.2008.12.111; MARTENS R, 1976, APPL ENVIRON MICROB, V31, P853, DOI 10.1128/AEM.31.6.853-858.1976; Martin AR, 2007, INT BIODETER BIODEGR, V60, P35, DOI DOI 10.1016/J.IBI0D.2006.10.008; Mukherjee I, 2005, B ENVIRON CONTAM TOX, V75, P1034, DOI 10.1007/s00128-005-0853-2; Mukherjee I., 1994, TOXICOL ENVIRON CHEM, V46, P217, DOI DOI 10.1080/02772249409358115; Paul V, 1997, ENVIRON TOXICOL PHAR, V18, P571; Pino N, 2011, INT BIODETER BIODEGR, V65, P827, DOI 10.1016/j.ibiod.2011.06.001; Rivero A, 2012, J CHROMATOGR B, V907, P168, DOI 10.1016/j.jchromb.2012.09.010; Shetty PK, 2000, CURR SCI INDIA, V79, P1381; Shivaramaiah HM, 2005, J ENVIRON SCI HEAL B, V40, P711, DOI 10.1080/03601230500189311; Siddique T, 2003, J AGR FOOD CHEM, V51, P8015, DOI 10.1021/jf030503z; Siddique T, 2003, J ENVIRON QUAL, V32, P47, DOI 10.2134/jeq2003.0047; Silambarasan S, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1369-0; Singh NS, 2011, BIODEGRADATION, V22, P845, DOI 10.1007/s10532-010-9442-0; Sutherland TD, 2002, J APPL MICROBIOL, V92, P541, DOI 10.1046/j.1365-2672.2002.01559.x; Sutherland TD, 2000, APPL ENVIRON MICROB, V66, P2822, DOI 10.1128/AEM.66.7.2822-2828.2000; Wan MT, 2005, ENVIRON TOXICOL CHEM, V24, P1146, DOI 10.1897/04-300R1.1	39	17	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77170	10.1371/journal.pone.0077170	http://dx.doi.org/10.1371/journal.pone.0077170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130848	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200063
J	Zhao, BB; Zheng, SJ; Gong, LL; Wang, Y; Chen, CF; Jin, WJ; Zhang, D; Yuan, XH; Guo, J; Duan, ZP; He, YW				Zhao, Bin-Bin; Zheng, Su-Jun; Gong, Lu-Lu; Wang, Yu; Chen, Cai-Feng; Jin, Wen-Jing; Zhang, Ding; Yuan, Xiao-Hui; Guo, Jian; Duan, Zhong-Ping; He, You-Wen			T Lymphocytes from Chronic HCV-Infected Patients Are Primed for Activation-Induced Apoptosis and Express Unique Pro-Apoptotic Gene Signature	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; CELLS; LIVER; IL-9; DYSFUNCTION; RESPONSES; GAMMA; IMMUNOBIOLOGY; MECHANISMS; HISTORY	Although extensive studies have demonstrated the functional impairment of antigen-specific CD4(+) and CD8(+) T-cells during chronic hepatitis C virus (HCV) infection, the functional status of global CD4(+) and CD8(+) T-cells remains unclear. In this report, we recruited 42 long-term (similar to 20 years) treatment-naive chronic HCV (CHC) patients and 15 healthy donors (HDs) to investigate differences in global CD4(+) and CD8(+) T-cells function. We show that CD4(+) and CD8(+) T-cells from CHC patients underwent increased apoptosis after TCR stimulation. Furthermore, IFN-gamma, IL-9 and IP-10 were elevated in CHC patients' plasma and promoted activation-induced T-cells death. Global CD4(+) and CD8(+) T-cells also showed unique transcriptional profiles in the expression of apoptosis-related genes. We identified BCL2, PMAIP1, and CASP1 in CD4(+) T-cells and IER3 and BCL2A1 in CD8(+) T-cells from CHC patients as HCV-specific gene signatures. Importantly, the gene expression patterns of CD4(+) and CD8(+) T-cells from CHC patients differ from those in CD4(+) and CD8(+) T-cells from human immunodeficiency virus type 1 (HIV-1) or hepatitis B virus (HBV) infected individuals. Our results indicate that chronic HCV infection causes a systemic change in cytokine levels that primes T-cells for activation-induced apoptosis. Furthermore, HCV infection programs unique apoptosis-related gene expression profiles in CD4(+) and CD8(+) T-cells, leading to their enhanced activation-induced apoptosis. These results provide novel insights to the pathogenesis of chronic HCV infection.	[Zhao, Bin-Bin; Gong, Lu-Lu; Chen, Cai-Feng; Jin, Wen-Jing; Zhang, Ding; Yuan, Xiao-Hui; He, You-Wen] Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhao, Bin-Bin; Gong, Lu-Lu; Chen, Cai-Feng; Jin, Wen-Jing; Zhang, Ding; Yuan, Xiao-Hui; He, You-Wen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zheng, Su-Jun; Duan, Zhong-Ping] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China; [Wang, Yu; Guo, Jian; He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Duke University	Duan, ZP (corresponding author), Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China.	duan2517@163.com; youwen.he@duke.edu		Wang, Yu/0000-0001-7935-9902	Ministry of Health of China [2012ZX10002-006, 2013ZX10004-601, 2013ZX10002002-006, 2012ZX10002004-006]; Beijing Municipal Bureau of Health [2011-2018-04]; Institute of Pathogen Biology [2009IPB108]; Chinese Academy of Medical Science & Peking Union Medical College	Ministry of Health of China; Beijing Municipal Bureau of Health; Institute of Pathogen Biology; Chinese Academy of Medical Science & Peking Union Medical College	This study is supported by the National Grand Program on Key Infectious Diseases (No. 2012ZX10002-006, No. 2013ZX10004-601, No. 2013ZX10002002-006; No. 2012ZX10002004-006) from the Ministry of Health of China, the Capital Health Development Research Project (No. 2011-2018-04) from Beijing Municipal Bureau of Health and the Institute of Pathogen Biology (No. 2009IPB108), Chinese Academy of Medical Science & Peking Union Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Cappuzzello C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-28; Chuang YT, 2008, J IMMUNOL, V180, P3238, DOI 10.4049/jimmunol.180.5.3238; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Das A, 2008, J EXP MED, V205, P2111, DOI 10.1084/jem.20072076; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Dunkle A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.95; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Epperly MW, 2002, RADIAT RES, V157, P568, DOI 10.1667/0033-7587(2002)157[0568:MSDSIR]2.0.CO;2; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Guzman-Fulgencio M, 2012, J ANTIMICROB CHEMOTH, V67, P1238, DOI 10.1093/jac/dkr595; He YW, 1998, CRIT REV IMMUNOL, V18, P503, DOI 10.1615/CritRevImmunol.v18.i6.20; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Jin WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033356; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Li HM, 2011, EUR J IMMUNOL, V41, P2197, DOI 10.1002/eji.201041125; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sidahmed AME, 2012, CYTOKINE, V59, P433, DOI 10.1016/j.cyto.2012.05.002; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; ZHANG ZN, 2013, CLIN CHEM	44	13	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77008	10.1371/journal.pone.0077008	http://dx.doi.org/10.1371/journal.pone.0077008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130824	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200047
J	Bagheri, M; Rezakhani, A; Nystrom, S; Turkina, MV; Roghani, M; Hammarstrom, P; Mohseni, S				Bagheri, Maryam; Rezakhani, Arjang; Nystrom, Sofie; Turkina, Maria V.; Roghani, Mehrdad; Hammarstrom, Per; Mohseni, Simin			Amyloid Beta(1-40)-Induced Astrogliosis and the Effect of Genistein Treatment in Rat: A Three-Dimensional Confocal Morphometric and Proteomic Study	PLOS ONE			English	Article							KAPPA-B ACTIVATION; TYROSINE KINASE INHIBITOR; CEREBRAL-CORTEX; ASTROCYTE MORPHOLOGY; ALZHEIMERS-DISEASE; RENAL INFLAMMATION; SANFILIPPO DISEASE; GENE-EXPRESSION; BRAIN; HIPPOCAMPUS	Astrocytes are highly involved in regulation and homeostasis of the extracellular environment in the healthy brain. In pathological conditions, these cells play a major role in the inflammatory response seen in CNS tissues, which is called reactive astrogliosis and includes hypertrophy and proliferation of astrocytes. Here, we performed 3D confocal microscopy to evaluate the morphological response of reactive astrocytes positive for glial fibrillary acidic protein (GFAP) in rats, to the presence of A beta(1-40) in the rat brain before and after treatment with genistein. In 50 astrocytes per animal, we measured the volume and surface area for the nucleus, cell body, the entire cell, the tissue covered by single astrocytes and quantified the number and length of branches, the density of the astrocytes and the intensity of GFAP immunoreactivity. Injecting A beta(1-40) into the brain of rats caused astrogliosis indicated by increased values for all measured parameters. Mass spectrometric analysis of hippocampal tissue in A beta(1-40)-injected brain showed decreased amounts of tubulins, enolases and myelin basic protein, and increased amounts of dihydropyrimidinase-related protein 2. In A beta(1-40)-injected rats pretreated with genistein, GFAP intensity was decreased to the sham-operated group level, and A beta(1-40)-induced astrogliosis was significantly ameliorated.	[Bagheri, Maryam] Ilam Univ Med Sci, Fac Med, Dept Physiol, Ilam, Iran; [Rezakhani, Arjang; Turkina, Maria V.; Mohseni, Simin] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Nystrom, Sofie; Hammarstrom, Per] Linkoping Univ, IFM Dept Chem, Linkoping, Sweden; [Roghani, Mehrdad] Shahed Univ, Neurophysiol Res Grp, Dept Physiol, Tehran, Iran	Linkoping University; Linkoping University; Shahed University	Mohseni, S (corresponding author), Ilam Univ Med Sci, Fac Med, Dept Physiol, Ilam, Iran.	Simin.Mohseni@liu.se	bagheri, Maryam/F-6865-2017	bagheri, Maryam/0000-0002-4188-6288; Nystrom, Sofie/0000-0002-4303-4783; Roghani, Mehrdad/0000-0002-9209-8484	County Council of Ostergotland (Sweden); Linkoping University; Cellular and Molecular Research Center; Tehran University of Medical Sciences (Tehran, Iran)	County Council of Ostergotland (Sweden); Linkoping University; Cellular and Molecular Research Center; Tehran University of Medical Sciences (Tehran, Iran)(Tehran University of Medical Sciences)	This project was supported by grants from the County Council of Ostergotland (Sweden), Linkoping University, and the Cellular and Molecular Research Center affiliated with Tehran University of Medical Sciences (Tehran, Iran). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Bagheri M, 2012, BRAIN RES, V1429, P145, DOI 10.1016/j.brainres.2011.10.020; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Caccamo D, 2005, NEUROTOXICOLOGY, V26, P915, DOI 10.1016/j.neuro.2005.01.010; Cashion AB, 2003, ENDOCRINOLOGY, V144, P274, DOI 10.1210/en.2002-220711; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; de Ruijter J, 2012, ANN NEUROL, V71, P110, DOI 10.1002/ana.22643; Duan W, 2003, AM J RESP CRIT CARE, V167, P185, DOI 10.1164/rccm.200205-420OC; Elmarakby AA, 2011, VASC PHARMACOL, V55, P149, DOI 10.1016/j.vph.2011.07.007; GARWOOD CJ, 2011, DROSOPHILA INF SERV, V2, pE167; Garwood Claire J, 2010, Front Psychiatry, V1, P136, DOI 10.3389/fpsyt.2010.00136; Girardi E, 2004, NEUROCHEM RES, V29, P371, DOI 10.1023/B:NERE.0000013739.15160.a8; Guerreiro N, 2008, J ALZHEIMERS DIS, V13, P17; Hama K, 2004, J NEUROCYTOL, V33, P277, DOI 10.1023/B:NEUR.0000044189.08240.a2; Hamalainen M, 2011, PLANTA MED, V77, P1504, DOI 10.1055/s-0030-1270762; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Ibrahim AS, 2010, MOL VIS, V16, P2033; JATURAPATPORN D, 2012, SPIRIN STEROIDAL NON, V2, P6378; Ji GY, 2011, INT IMMUNOPHARMACOL, V11, P762, DOI 10.1016/j.intimp.2011.01.036; Kim DJ, 2009, TOXICOL MECH METHOD, V19, P251, DOI 10.1080/15376510802563330; Kim JM, 2011, BIOGERONTOLOGY, V12, P537, DOI 10.1007/s10522-011-9345-4; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Little AR, 2001, NEUROTOXICOLOGY, V22, P607, DOI 10.1016/S0161-813X(01)00032-8; Lu H, 2009, J NEUROL SCI, V278, P91, DOI 10.1016/j.jns.2008.12.007; Malinova V, 2012, JIMD REP, V5, P21, DOI 10.1007/8904_2011_87; Moran J, 2013, EXP GERONTOL, V48, P414, DOI 10.1016/j.exger.2013.02.010; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; Palanisamy N, 2011, EUR J PHARMACOL, V667, P355, DOI 10.1016/j.ejphar.2011.06.011; Parachikova A, 2010, J ALZHEIMERS DIS, V21, P527, DOI 10.3233/JAD-2010-100204; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Persichini T, 2010, NEUROSCI LETT, V484, P133, DOI 10.1016/j.neulet.2010.08.034; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sadowska-Krowicka H, 1998, P SOC EXP BIOL MED, V217, P351; Safavi-Abbasi S, 2001, GLIA, V36, P102, DOI 10.1002/glia.1099; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sullivan SM, 2010, GLIA, V58, P181, DOI 10.1002/glia.20911; Torres-Platas SG, 2011, NEUROPSYCHOPHARMACOL, V36, P2650, DOI 10.1038/npp.2011.154; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; Vanzani MC, 2005, MEDICINA-BUENOS AIRE, V65, P213; Verdrengh M, 2003, INFLAMM RES, V52, P341, DOI 10.1007/s00011-003-1182-8; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; WEIS S, 1993, NEUROPATH APPL NEURO, V19, P329, DOI 10.1111/j.1365-2990.1993.tb00448.x; Zhang YJ, 2012, INFLAMMATION, V35, P377, DOI 10.1007/s10753-011-9365-x	56	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76526	10.1371/journal.pone.0076526	http://dx.doi.org/10.1371/journal.pone.0076526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130779	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900075
J	Kang, TH; Park, Y; Bader, JS; Friedmann, T				Kang, Tae Hyuk; Park, Yongjin; Bader, Joel S.; Friedmann, Theodore			The Housekeeping Gene Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Regulates Multiple Developmental and Metabolic Pathways of Murine Embryonic Stem Cell Neuronal Differentiation	PLOS ONE			English	Article							LESCH-NYHAN-DISEASE; DOPAMINERGIC-NEURONS; MICROGLIAL ACTIVATION; TYROSINE-PHOSPHATASE; BASAL GANGLIA; KNOCKOUT MICE; RNA-SEQ; EXPRESSION; SOX2; INHIBITION	The mechanisms by which mutations of the purinergic housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT) cause the severe neurodevelopmental Lesch Nyhan Disease (LND) are poorly understood. The best recognized neural consequences of HPRT deficiency are defective basal ganglia expression of the neurotransmitter dopamine (DA) and aberrant DA neuronal function. We have reported that HPRT deficiency leads to dysregulated expression of multiple DA-related developmental functions and cellular signaling defects in a variety of HPRT-deficient cells, including human induced pluripotent stem (iPS) cells. We now describe results of gene expression studies during neuronal differentiation of HPRT-deficient murine ESD3 embryonic stem cells and report that HPRT knockdown causes a marked switch from neuronal to glial gene expression and dysregulates expression of Sox2 and its regulator, genes vital for stem cell pluripotency and for the neuronal/glial cell fate decision. In addition, HPRT deficiency dysregulates many cellular functions controlling cell cycle and proliferation mechanisms, RNA metabolism, DNA replication and repair, replication stress, lysosome function, membrane trafficking, signaling pathway for platelet activation (SPPA) multiple neurotransmission systems and sphingolipid, sulfur and glycan metabolism. We propose that the neural aberrations of HPRT deficiency result from combinatorial effects of these multi-system metabolic errors. Since some of these aberrations are also found in forms of Alzheimer's and Huntington's disease, we predict that some of these systems defects play similar neuropathogenic roles in diverse neurodevelopmental and neurodegenerative diseases in common and may therefore provide new experimental opportunities for clarifying pathogenesis and for devising new potential therapeutic targets in developmental and genetic disease.	[Kang, Tae Hyuk; Friedmann, Theodore] UCSD Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Kang, Tae Hyuk; Friedmann, Theodore] UCSD Sch Med, Rady Childrens Hosp San Diego, La Jolla, CA USA; [Park, Yongjin; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, High Throughput Biol Ctr, Baltimore, MD USA; [Park, Yongjin; Bader, Joel S.] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University	Friedmann, T (corresponding author), UCSD Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	tfriedmann@ucsd.edu			National Institutes of Health [DK082840]; Lesch Nyhan Disease Children's Research Foundation; UCSD Department of Pediatrics; UCSD Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lesch Nyhan Disease Children's Research Foundation; UCSD Department of Pediatrics; UCSD Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants from the National Institutes of Health (DK082840), the Lesch Nyhan Disease Children's Research Foundation, the UCSD Department of Pediatrics and the UCSD Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bertelli M, 2006, CLIN CHIM ACTA, V373, P104, DOI 10.1016/j.cca.2006.05.013; Bertelli M, 2009, J CLIN NEUROSCI, V16, P1061, DOI 10.1016/j.jocn.2008.12.011; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Ceballos-Picot I, 2009, HUM MOL GENET, V18, P2317, DOI 10.1093/hmg/ddp164; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; Deutsch SI, 2005, CLIN NEUROPHARMACOL, V28, P28, DOI 10.1097/01.wnf.0000152043.36198.25; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egami K, 2007, NEUROBIOL DIS, V26, P396, DOI 10.1016/j.nbd.2007.01.010; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Esposito G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028668; Evsen L, 2013, J NEUROSCI, V33, P3879, DOI 10.1523/JNEUROSCI.4030-12.2013; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Garcia MG, 2012, J INHERIT METAB DIS, V35, P1129, DOI 10.1007/s10545-012-9470-5; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guibinga GH, 2012, HUM MOL GENET, V21, P609, DOI 10.1093/hmg/ddr495; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; JINNAH HA, 1994, J NEUROSCI, V14, P1164; Jinnah HA, 2000, LESCH NYHAN DIS ITS, P2537; Kang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016572; Krady JK, 2002, GLIA, V40, P11, DOI 10.1002/glia.10101; Laszlo A, 2009, IDEGGYOGY SZEMLE, V62, P413; Li HL, 2009, NAT NEUROSCI, V12, P815, DOI 10.1038/nn0709-815; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Makoukji J, 2011, J NEUROSCI, V31, P9620, DOI 10.1523/JNEUROSCI.0761-11.2011; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pinto CS, 2006, J NEUROCHEM, V96, P454, DOI 10.1111/j.1471-4159.2005.03570.x; Pinto CS, 2005, J NEUROCHEM, V93, P1579, DOI 10.1111/j.1471-4159.2005.03151.x; Sadeghian M, 2012, J NEUROIMMUNOL, V246, P69, DOI 10.1016/j.jneuroim.2012.03.010; Saito Y, 2000, BRAIN DEV-JPN, V22, pS122; Sandhoff K, 1998, ACTA BIOCHIM POL, V45, P373, DOI 10.18388/abp.1998_4232; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schebesta M, 2009, DEV DYNAM, V238, P887, DOI 10.1002/dvdy.21909; Smith DW, 2000, MOL THER, V1, P486, DOI 10.1006/mthe.2000.0057; Suh HS, 2005, J IMMUNOL, V174, P2712, DOI 10.4049/jimmunol.174.5.2712; Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Yeh J, 1998, J NEUROSCI RES, V53, P78, DOI 10.1002/(SICI)1097-4547(19980701)53:1<78::AID-JNR8>3.0.CO;2-G	54	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74967	10.1371/journal.pone.0074967	http://dx.doi.org/10.1371/journal.pone.0074967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130677	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900012
J	Scheepens, JF; Frei, ES; Stocklin, J				Scheepens, J. F.; Frei, Eva S.; Stoecklin, Juerg			Glacial History Affected Phenotypic Differentiation in the Alpine Plant, Campanula thyrsoides	PLOS ONE			English	Article							LATITUDINAL POPULATION DIFFERENTIATION; GENETIC DIFFERENTIATION; F-ST; DIVERGENCE; GROWTH; Q(ST); CONSEQUENCES; DISPERSAL; PHENOLOGY; TIME	Numerous widespread Alpine plant species show molecular differentiation among populations from distinct regions. This has been explained as the result of genetic drift during glacial survival in isolated refugia along the border of the European Alps. Since genetic drift may affect molecular markers and phenotypic traits alike, we asked whether phenotypic differentiation mirrors molecular patterns among Alpine plant populations from different regions. Phenotypic traits can be under selection, so we additionally investigated whether part of the phenotypic differentiation can be explained by past selection and/or current adaptation. Using the monocarpic Campanula thyrsoides as our study species, a common garden experiment with plants from 21 populations from four phylogeographic groups located in regions across the Alps and the Jura Mountains was performed to test for differentiation in morphological and phenological traits. Past selection was investigated by comparing phenotypic differentiation among and within regions with molecular differentiation among and within regions. The common garden results indicated regional differentiation among populations for all investigated phenotypic traits, particularly in phenology. Delayed flowering in plants from the South-eastern Alps suggested adaptation to long sub-mediterranean summers and contrasted with earlier flowering of plants experiencing shorter growing seasons in regions with higher elevation to the West. Comparisons between molecular and phenotypic differentiation revealed diversifying selection among regions in height and biomass, which is consistent with adaptation to environmental conditions in glacial refugia. Within regions, past selection acted against strong diversification for most phenotypic traits, causing restricted postglacial adaptation. Evidence consistent with post-glacial adaptation was also given by negative correlation coefficients between several phenotypic traits and elevation of the population's origin. In conclusion, our study suggests that, irrespective of adaptation of plants to their current environment, glacial history can have a strong and long-lasting influence on the phenotypic evolution of Alpine plants.	[Scheepens, J. F.; Frei, Eva S.; Stoecklin, Juerg] Univ Basel, Inst Bot, Sect Plant Ecol, CH-4056 Basel, Switzerland	University of Basel	Scheepens, JF (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	jofrsc@utu.fi	Scheepens, J.F./AAF-7440-2021	Scheepens, J.F./0000-0003-1650-2008	Swiss National Science Foundation [3100AO-116785]; Freiwillige Akademische Gesellschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Freiwillige Akademische Gesellschaft	This study has been supported financially by the Swiss National Science Foundation (http://www.snf.ch), project no. 3100AO-116785 to J.S., and with a grant from the Freiwillige Akademische Gesellschaft (http://www.fag-basel.ch/) to J.F.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2007, FLORA, V202, P218, DOI 10.1016/j.flora.2006.06.003; AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; Aeschimann D., 2005, FLORA ALPINA; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Crawley M.J., 2007, R BOOK; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Frei ES, 2012, ALPINE BOT, V122, P23, DOI 10.1007/s00035-012-0103-2; Frei ES, 2012, PLANT ECOL, V213, P395, DOI 10.1007/s11258-011-9984-1; Frei ES, 2012, J ECOL, V100, P297, DOI 10.1111/j.1365-2745.2011.01909.x; GALEN C, 1991, EVOLUTION, V45, P1218, DOI 10.1111/j.1558-5646.1991.tb04388.x; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Hautier Y, 2009, J PLANT ECOL, V2, P125, DOI 10.1093/jpe/rtp011; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jager EJ., 2000, BER BAYR BOT GES, V69, P93; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klekowski EJ, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P227; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Kuss P, 2011, PERSPECT PLANT ECOL, V13, P101, DOI 10.1016/j.ppees.2011.02.003; Kuss P, 2008, J ECOL, V96, P821, DOI 10.1111/j.1365-2745.2008.01374.x; Kuss P, 2007, PERSPECT PLANT ECOL, V9, P37, DOI 10.1016/j.ppees.2007.06.001; Lamy JB, 2012, MOL ECOL, V21, P5646, DOI 10.1111/mec.12017; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Merxmuller H, 1954, JB VEREINS SCHUTZE A, V19, P97; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; OUBORG NJ, 1991, OECOLOGIA, V86, P359, DOI 10.1007/BF00317601; Ozenda P., 1988, VEGETATION ALPEN EUR; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; R Core Team, 2020, R LANG ENV STAT COMP; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Sandring S, 2007, J EVOLUTION BIOL, V20, P558, DOI 10.1111/j.1420-9101.2006.01260.x; Scheepens JF, 2012, ANN BOT-LONDON, V110, P1479, DOI 10.1093/aob/mcs131; Scheepens JF, 2011, PLANT ECOL DIVERS, V4, P403, DOI 10.1080/17550874.2011.636077; Scheepens JF, 2011, ALPINE BOT, V121, P37, DOI 10.1007/s00035-011-0087-3; Scheepens JF, 2010, OECOLOGIA, V164, P141, DOI 10.1007/s00442-010-1650-0; SCHMID B, 1994, EVOLUTION, V48, P1525, DOI 10.1111/j.1558-5646.1994.tb02194.x; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Sokal RR, 1995, BIOMETRY; SPITZE K, 1993, GENETICS, V135, P367; Thiel-Egenter C, 2011, J BIOGEOGR, V38, P772, DOI 10.1111/j.1365-2699.2010.02441.x; Thiel-Egenter C, 2009, MOL ECOL, V18, P4495, DOI 10.1111/j.1365-294X.2009.04360.x; Vitasse Y, 2009, CAN J FOREST RES, V39, P1259, DOI 10.1139/X09-054; Volis S, 2005, HEREDITY, V95, P466, DOI 10.1038/sj.hdy.6800745; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344	53	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e73854	10.1371/journal.pone.0073854	http://dx.doi.org/10.1371/journal.pone.0073854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146742	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000326019400002
J	Cowan, FM; Mtetwa, S; Davey, C; Fearon, E; Dirawo, J; Wong-Gruenwald, R; Ndikudze, T; Chidiya, S; Benedikt, C; Busza, J; Hargreaves, JR				Cowan, Frances M.; Mtetwa, Sibongile; Davey, Calum; Fearon, Elizabeth; Dirawo, Jeffrey; Wong-Gruenwald, Ramona; Ndikudze, Theresa; Chidiya, Samson; Benedikt, Clemens; Busza, Joanna; Hargreaves, James R.			Engagement with HIV Prevention Treatment and Care among Female Sex Workers in Zimbabwe: a Respondent Driven Sampling Survey	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CONDOM USE; BARRIERS; BEHAVIOR; WOMEN; RISK; INTERVENTIONS; INFECTIONS; PREVALENCE; PROSTITUTES	Objective(S): To determine the HIV prevalence and extent of engagement with HIV prevention and care among a representative sample of Zimbabwean sex workers working in Victoria Falls, Hwange and Mutare. Design: Respondent driven sampling (RDS) surveys conducted at each site. Methods: Sex workers were recruited using respondent driven sampling with each respondent limited to recruiting 2 peers. Participants completed an interviewer-administered questionnaire and provided a finger prick blood sample for HIV antibody testing. Statistical analysis took account of sampling method. Results: 870 women were recruited from the three sites. HIV prevalence was between 50 and 70%. Around half of those confirmed HIV positive were aware of their HIV status and of those 50-70% reported being enrolled in HIV care programmes. Overall only 25-35% of those with laboratory-confirmed HIV were accessing antiretroviral therapy. Among those reporting they were HIV negative, 21-28% reported having an HIV test in the last 6 months. Of those tested HIV negative, most (65-82%) were unaware of their status. Around two-thirds of sex workers reported consistent condom use with their clients. As in other settings, sex workers reported high rates of gender based violence and police harassment. Conclusions: This survey suggests that prevalence of HIV is high among sex workers in Zimbabwe and that their engagement with prevention, treatment and care is sub-optimal. Intensifying prevention and care interventions for sex workers has the potential to markedly reduce HIV and social risks for sex workers, their clients and the general population in Zimbabwe and elsewhere in the region.	[Cowan, Frances M.] UCL, London, England; [Cowan, Frances M.; Mtetwa, Sibongile; Dirawo, Jeffrey] Zimbabwe AIDS Prevent Project Trust, Harare, Zimbabwe; [Cowan, Frances M.; Mtetwa, Sibongile; Dirawo, Jeffrey] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR Zimbabwe, Harare, Zimbabwe; [Davey, Calum; Fearon, Elizabeth; Busza, Joanna; Hargreaves, James R.] London Sch Hyg & Trop Med, London WC1, England; [Wong-Gruenwald, Ramona; Ndikudze, Theresa] Deutsch Gesell Int Zusammenarbeit GmbH, Bonn, Germany; [Chidiya, Samson; Benedikt, Clemens] United Nations Populat Fund UNFPA, Harare, Zimbabwe	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; United Nations Population Fund	Cowan, FM (corresponding author), UCL, London, England.	f.cowan@ucl.ac.uk		Fearon, Elizabeth/0000-0001-5574-251X; Cowan, Frances/0000-0003-3087-4422; Rutsito, Sibongile/0000-0002-9155-840X; Busza, Joanna/0000-0001-6334-0318; Hargreaves, James/0000-0002-3509-3572	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH; German Federal Ministry for Economic Cooperation and Development (BMZ)	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH; German Federal Ministry for Economic Cooperation and Development (BMZ)	The study was funded by Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ). Two members of GIZ's team acted as co-investigators. In addition, Stefan Weinmann and Sabine Flessenkamper commented on the manuscript.	Arnott J, 2009, RIGHTS NOT RESCUE RE; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; *COUNC NA, 2006, ZIMB NAT BEH CHANG S; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V38, P202, DOI 10.1097/00126334-200502010-00012; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; Cwikel JG, 2008, SEX HEALTH, V5, P9, DOI 10.1071/SH07024; Deering KN, 2009, AIDS PATIENT CARE ST, V23, P603, DOI 10.1089/apc.2009.0022; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; Kachroo S, 2006, B WORLD HEALTH ORGAN, V84, P999, DOI 10.2471/BLT.06.032656; Kayembe PK, 2008, SEX TRANSM INFECT, V84, P202, DOI 10.1136/sti.2007.028324; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; Kriitmaa K, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000386735.87177.2a; Langhaug L, 2012, TROP MED INT HEALTH, V17, P827, DOI 10.1111/j.1365-3156.2012.02999.x; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mavhu W, 2008, CULT HEALTH SEX, V10, P563, DOI 10.1080/13691050801948102; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; MUNOZ J, 2010, SAHARA J-J SOC ASP H, V7, P51, DOI DOI 10.1080/17290376.2010.9724969; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; *NAT AIDS COUNC MO, 2006, ZIMB NAT HIV AIDS ST, P2006; Pauw I, 2003, CULT HEALTH SEX, V5, P465, DOI 10.1080/136910501185198; PIOT P, 1988, SOZ PRAVENTIV MED, V33, P336, DOI 10.1007/BF02084300; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Scorgie F., 2011, I EXPECT BE ABUSED I; Szwarcwald CL, 2011, JAIDS-J ACQ IMM DEF, V57, pS129, DOI 10.1097/QAI.0b013e31821e9a36; UNAIDS, 2012, REP GLOB AIDS EP; *US NAT COMM CLIN, 1997, STAND BLOOD COLL FIL; Valdiserri RO, 2003, NAT MED, V9, P881, DOI 10.1038/nm0703-881; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; White RG, 2012, SEX TRANSM INFECT, V88, P397, DOI 10.1136/sextrans-2012-050703; WHO, 2011, PREV HIV SEX WORK SE; *WHO UNAIDS NSWP, 2012, PREV TREATM HIV OTH; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; *WORLD HLTH ORG DO, 2005, TOOLK TARG HIV AIDS; *ZIMB CENTR STAT A, 2011, ZIMB DEM HLTH SURV 2	46	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77080	10.1371/journal.pone.0077080	http://dx.doi.org/10.1371/journal.pone.0077080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237TP	24143203	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000325894100038
J	Parravicini, V; Micheli, F; Montefalcone, M; Morri, C; Villa, E; Castellano, M; Povero, P; Bianchi, CN				Parravicini, Valeriano; Micheli, Fiorenza; Montefalcone, Monica; Morri, Carla; Villa, Elisa; Castellano, Michela; Povero, Paolo; Bianchi, Carlo Nike			Conserving Biodiversity in a Human-Dominated World: Degradation of Marine Sessile Communities within a Protected Area with Conflicting Human Uses	PLOS ONE			English	Article							MASS-MORTALITY; FACILITATION; DISTURBANCE; HABITATS; CASCADES; IMPACTS; MEADOWS; REEF	Conservation research aims at understanding whether present protection schemes are adequate for the maintenance of ecosystems structure and function across time. We evaluated long-term variation in rocky reef communities by comparing sites surveyed in 1993 and again in 2008. This research took place in Tigullio Gulf, an emblematic case study where various conservation measures, including a marine protected area, have been implemented to manage multiple human uses. Contrary to our prediction that protection should have favored ecosystem stability, we found that communities subjected to conservation measures (especially within the marine protected area) exhibited the greatest variation toward architectural complexity loss. Between 1993 and 2008, chronic anthropogenic pressures (especially organic load) that had already altered unprotected sites in 1993 expanded their influence into protected areas. This expansion of human pressure likely explains our observed changes in the benthic communities. Our results suggest that adaptive ecosystem-based management (EBM), that is management taking into account human interactions, informed by continuous monitoring, is needed in order to attempt reversing the current trend towards less architecturally complex communities. Protected areas are not sufficient to stop ecosystem alteration by pressures coming from outside. Monitoring, and consequent management actions, should therefore extend to cover the relevant scales of those pressures.	[Parravicini, Valeriano] CESAB FRB, Aix En Provence, France; [Parravicini, Valeriano] IRD UR Coreus Lab Arago 227, Banyuls Sur Mer, France; [Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Montefalcone, Monica; Morri, Carla; Villa, Elisa; Castellano, Michela; Povero, Paolo; Bianchi, Carlo Nike] Univ Genoa, DiSTAV, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy	Institut de Recherche pour le Developpement (IRD); Stanford University; University of Genoa	Parravicini, V (corresponding author), CESAB FRB, Immeuble Henri Poincare Domaine Petit Arbois, Aix En Provence, France.	valeriano.parravicini@ird.fr	Parravicini, Valeriano/A-8539-2011	Castellano, Michela/0000-0001-6101-0112; Morri, Carla/0000-0003-4520-2741; Micheli, Fiorenza/0000-0002-6865-1438; Parravicini, Valeriano/0000-0002-3408-1625; Bianchi, Carlo Nike/0000-0003-1071-3285	Italian Ministry of the Environment; Pew Fellowship in Marine Conservation	Italian Ministry of the Environment; Pew Fellowship in Marine Conservation	The present work is done under the aegis of the project 'The impacts of biological invasions and climate change on the biodiversity of the Mediterranean Sea' (Italy-Israel co-operation) funded by the Italian Ministry of the Environment. FM was partly supported by a Pew Fellowship in Marine Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Alvarez-Filip L, 2011, CORAL REEFS, V30, P1051, DOI 10.1007/s00338-011-0795-6; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Asnaghi V, 2009, MAR ECOL-EVOL PERSP, V30, P505, DOI 10.1111/j.1439-0485.2009.00346.x; Bianchi C.N., 2004, BIOL MAR MEDITERR, V11, P185; Bianchi C. N., 1994, B MUS I BIOL U GEN, V58-59, P181; Bianchi C. N., 1994, BENTHOS GOLFO TIGULL; Bulleri F, 2008, MAR ECOL PROG SER, V364, P77, DOI 10.3354/meps07484; Bussotti S., 1996, Doriana, V6, P1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Danovaro R, 1997, ESTUAR COAST SHELF S, V44, P723, DOI 10.1006/ecss.1996.0135; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Duarte L, 2013, ACTA OECOL, V51, P1, DOI 10.1016/j.actao.2013.05.002; Fukami T, 2001, OIKOS, V92, P215, DOI 10.1034/j.1600-0706.2001.920203.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gorley C.K., 2006, GETTING STARTED PRIM; Greco S, 2004, AQUAT CONSERV, V14, pS119, DOI 10.1002/aqc.656; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Royo CLY, 2009, J ENVIRON MANAGE, V90, P1494, DOI 10.1016/j.jenvman.2008.10.007; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mardia K.V, 1980, MULTIVARIATE ANAL; Marti R, 2005, ESTUAR COAST SHELF S, V64, P613, DOI 10.1016/j.ecss.2005.04.009; McLeod KL, COMMUNICATION PARTNE; Melegari GE, 1973, PORTOFINO SUBGUIDA C; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; Misic C, 2008, CONT SHELF RES, V28, P2725, DOI 10.1016/j.csr.2008.09.006; Montefalcone M, 2010, AQUAT CONSERV, V20, P507, DOI 10.1002/aqc.1128; Montefalcone M, 2009, MAR POLLUT BULL, V58, P515, DOI 10.1016/j.marpolbul.2008.12.001; Morri C, 1988, B MUS I BIOL U GEN S, V52, P213; Nike Bianchi Carlo, 2003, Biogeographia, V24, P319; Olsson P, 2008, P NATL ACAD SCI USA, V105, P9489, DOI 10.1073/pnas.0706905105; Orfanidis S., 2001, MEDITERRANEAN MARINE, V2, P45, DOI [DOI 10.12681/MMS.266, 10.12681/mms.266]; Parravicini V, 2010, BIOL CONSERV, V143, P2435, DOI 10.1016/j.biocon.2010.06.006; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Pisano E., 1980, Memorie di Biologia Marina e di Oceanografia, V10, P269; Pisano E., 1982, ATT CONV UN OP AFF S, P93; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sano M, 2010, COAST MANAGE, V38, P76, DOI 10.1080/08920750903411734; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Thomsen MS, 2010, INTEGR COMP BIOL, V50, P158, DOI 10.1093/icb/icq042; Tortonese E., 1962, Pubblicazioni della Stazione Zoologica di Napoli, V32, P99; Tortonese E., 1961, Archivio di Oceanografia e Limnologia Roma, V12, P163; Tortonese E., 1958, Archivio di Oceanografia e Limnologia, V11, P167; Vietti RC, 2010, CHEM ECOL, V26, P319, DOI 10.1080/02757541003689845; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P264, DOI 10.1016/j.jembe.2011.02.017	58	52	52	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75767	10.1371/journal.pone.0075767	http://dx.doi.org/10.1371/journal.pone.0075767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143173	Green Published, gold			2022-12-27	WOS:000325894100008
J	Rousalova, I; Banerjee, S; Sangwan, V; Evenson, K; McCauley, JA; Kratzke, R; Vickers, SM; Saluja, A; D'Cunha, J				Rousalova, Ilona; Banerjee, Sulagna; Sangwan, Veena; Evenson, Kristen; McCauley, Joel A.; Kratzke, Robert; Vickers, Selwyn M.; Saluja, Ashok; D'Cunha, Jonathan			Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PANCREATIC-CANCER; RADIATION SENSITIZATION; PRECLINICAL MODELS; MET AMPLIFICATION; INDUCE APOPTOSIS; TRIPTOLIDE; EXPRESSION; ACTIVATION	Background: Minnelide, a pro-drug of triptolide, has recently emerged as a potent anticancer agent. The precise mechanisms of its cytotoxic effects remain unclear. Methods: Cell viability was studied using CCK8 assay. Cell proliferation was measured real-time on cultured cells using Electric Cell Substrate Impedence Sensing (ECIS). Apoptosis was assayed by Caspase activity on cultured lung cancer cells and TUNEL staining on tissue sections. Expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA, APAF-1) was estimated by qRTPCR. Effect of Minnelide on proliferative cells in the tissue was estimated by Ki-67 staining of animal tissue sections. Results: In this study, we investigated in vitro and in vivo antitumor effects of triptolide/Minnelide in non-small cell lung carcinoma (NSCLC). Triptolide/Minnelide exhibited anti-proliferative effects and induced apoptosis in NSCLC cell lines and NSCLC mouse models. Triptolide/Minnelide significantly down-regulated the expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA) and up-regulated pro-apoptotic APAF-1 gene, in part, via attenuating the NF-kappa B signaling activity. Conclusion: In conclusion, our results provide supporting mechanistic evidence for Minnelide as a potential in NSCLC.	[Rousalova, Ilona; Banerjee, Sulagna; Sangwan, Veena; Evenson, Kristen; McCauley, Joel A.; Vickers, Selwyn M.; Saluja, Ashok] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Kratzke, Robert] Univ Minnesota, Minneapolis, MN 55455 USA; [D'Cunha, Jonathan] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Saluja, A (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, Box 242 UMHC, Minneapolis, MN 55455 USA.	asaluja@umn.edu	Rousalova, Ilona/O-4425-2017	Rousalova, Ilona/0000-0002-6736-1287	Norgren/MacMillan Lung Cancer Research Fund; Herbert Schwieters Family Lung Cancer Research Fund; University of Minnesota, Department of Surgery; NIH [R01-CA170946, CA124723]; Proshek-Fulbright Fellowship; NATIONAL CANCER INSTITUTE [R01CA170946, R01CA124723] Funding Source: NIH RePORTER	Norgren/MacMillan Lung Cancer Research Fund; Herbert Schwieters Family Lung Cancer Research Fund; University of Minnesota, Department of Surgery(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Proshek-Fulbright Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Norgren/MacMillan Lung Cancer Research Fund, Herbert Schwieters Family Lung Cancer Research Fund, and intramural funding from the University of Minnesota, Department of Surgery. Part of the study was supported by NIH grants R01-CA170946 and CA124723 to AKS. IR was supported by Proshek-Fulbright Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; American Cancer Society, 2013, ANC FACTS FIG 2013; Antonoff MB, 2010, J SURG RES, V163, P72, DOI 10.1016/j.jss.2010.04.047; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Baby J, 2007, CANCER LETT, V255, P85, DOI 10.1016/j.canlet.2007.03.024; Banerjee S, 2013, CANCER LETT, V335, P412, DOI 10.1016/j.canlet.2013.02.050; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Batra S, 2011, ARCH IMMUNOL THER EX, V59, P335, DOI 10.1007/s00005-011-0136-z; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Borja-Cacho D, 2010, J GASTROINTEST SURG, V14, P252, DOI 10.1007/s11605-009-1065-6; Breathnach OS, 2001, J CLIN ONCOL, V19, P1734, DOI 10.1200/JCO.2001.19.6.1734; Burikhanov R, 2013, CANCER RES, V73, P1011, DOI 10.1158/0008-5472.CAN-12-3212; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; Chen YW, 2010, ANTI-CANCER DRUG, V21, P502, DOI 10.1097/CAD.0b013e328337337c; Chugh R, 2012, SCI TRANSL MED, V4; Corvaro M, 2007, CANCER BIOL THER, V6, P209, DOI 10.4161/cbt.6.2.3622; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Denlinger Chadrick E, 2004, Semin Thorac Cardiovasc Surg, V16, P28, DOI 10.1053/j.semtcvs.2003.12.004; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fischer B, 2003, BIOCHEM BIOPH RES CO, V306, P516, DOI 10.1016/S0006-291X(03)01004-0; Frese S, 2003, ONCOGENE, V22, P5427, DOI 10.1038/sj.onc.1206842; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Gomyo Y, 2004, ONCOGENE, V23, P6779, DOI 10.1038/sj.onc.1207381; Hoffarth S, 2008, CELL DEATH DIFFER, V15, P161, DOI 10.1038/sj.cdd.4402256; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Hu YP, 2003, CLIN CANCER RES, V9, P2826; Huang LN, 2013, MOL BIOL REP, V40, P917, DOI 10.1007/s11033-012-2132-8; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jones DR, 2002, J THORAC CARDIOV SUR, V123, P310, DOI 10.1067/mtc.2002.118684; Jones DR, 2000, ANN THORAC SURG, V70, P930, DOI 10.1016/S0003-4975(00)01635-0; Kim SM, 2013, J BIOCHEM, V153, P93, DOI 10.1093/jb/mvs119; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krepela E, 2004, BIOL CHEM, V385, P153, DOI 10.1515/BC.2004.034; Krosch TCK, 2013, AM J SURG, V205, P387, DOI 10.1016/j.amjsurg.2013.01.008; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lee KY, 2002, EXP MOL MED, V34, P462, DOI 10.1038/emm.2002.64; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liu JR, 2002, CANCER RES, V62, P924; Liu L, 2009, FEBS J, V276, P1459, DOI 10.1111/j.1742-4658.2009.06888.x; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mujumdar N, 2010, AUTOPHAGY, V6, P997, DOI 10.4161/auto.6.7.13334; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; MUKHOPADHYAY T, 1995, ONCOGENE, V11, P999; Nam HT, 2010, J BIOCHEM, V148, P573, DOI 10.1093/jb/mvq089; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; Ries L, 2013, ANCER STAT REV 1975; Sakai T, 2004, J BIOL CHEM, V279, P41131, DOI 10.1074/jbc.M402902200; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Shinoura N, 2001, INT J CANCER, V93, P252, DOI 10.1002/ijc.1327; Shinoura N, 2001, JPN J CANCER RES, V92, P467, DOI 10.1111/j.1349-7006.2001.tb01117.x; Sun H, 2012, ANTI-CANCER DRUG, V23, P1039, DOI 10.1097/CAD.0b013e32835679b8; Sun LX, 2011, BIOCHEM BIOPH RES CO, V416, P99, DOI 10.1016/j.bbrc.2011.11.004; Sun Y, 2005, BLOOD, V105, P4070, DOI 10.1182/blood-2004-10-4075; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tang XY, 2007, POSTGRAD MED J, V83, P338, DOI 10.1136/pgmj.2006.055426; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; WEI YS, 1991, ACTA PHARM SINIC, V12, P406; Westfall SD, 2008, CHEMOTHERAPY, V54, P67, DOI 10.1159/000112419; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; Xu B, 2010, CANCER LETT, V291, P200, DOI 10.1016/j.canlet.2009.10.013; Yang H, 2008, J INT MED RES, V36, P734, DOI 10.1177/147323000803600416; Yang HJ, 2013, J BIOL CHEM, V288, P2965, DOI 10.1074/jbc.M112.385989; Yang M, 2008, INT J MOL MED, V22, P489, DOI 10.3892/ijmm_00000047; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zhang ZF, 2006, ANN THORAC SURG, V82, P243, DOI 10.1016/j.athoracsur.2006.01.049; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	93	36	37	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77411	10.1371/journal.pone.0077411	http://dx.doi.org/10.1371/journal.pone.0077411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143232	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100069
J	Sokhi, UK; Bacolod, MD; Dasgupta, S; Emdad, L; Das, SK; Dumur, CI; Miles, MF; Sarkar, D; Fisher, PB				Sokhi, Upneet K.; Bacolod, Manny D.; Dasgupta, Santanu; Emdad, Luni; Das, Swadesh K.; Dumur, Catherine I.; Miles, Michael F.; Sarkar, Devanand; Fisher, Paul B.			Identification of Genes Potentially Regulated by Human Polynucleotide Phosphorylase (hPNPase(old-35)) Using Melanoma as a Model	PLOS ONE			English	Article							TERMINAL DIFFERENTIATION; INTERMEMBRANE SPACE; RNA DEGRADATION; DOWN-REGULATION; KI-67 PROTEIN; CENP-E; CELLS; GROWTH; PROGRESSION; EXPRESSION	Human Polynucleotide Phosphorylase (hPNPase(old)-35 or PNPT1) is an evolutionarily conserved 3'-> 5' exoribonuclease implicated in the regulation of numerous physiological processes including maintenance of mitochondrial homeostasis, mtRNA import and aging-associated inflammation. From an RNase perspective, little is known about the RNA or miRNA species it targets for degradation or whose expression it regulates; except for c-myc and miR-221. To further elucidate the functional implications of hPNPase(old-35) in cellular physiology, we knocked-down and overexpressed hPNPase(old-35) in human melanoma cells and performed gene expression analyses to identify differentially expressed transcripts. Ingenuity Pathway Analysis indicated that knockdown of hPNPase(old-35) resulted in significant gene expression changes associated with mitochondrial dysfunction and cholesterol biosynthesis; whereas overexpression of hPNPase(old-35) caused global changes in cell-cycle related functions. Additionally, comparative gene expression analyses between our hPNPase(old-35) knockdown and overexpression datasets allowed us to identify 77 potential "direct" and 61 potential "indirect" targets of hPNPaseo(ld-35) which formed correlated networks enriched for cell-cycle and wound healing functional association, respectively. These results provide a comprehensive database of genes responsive to hPNPase(old-35) expression levels; along with the identification new potential candidate genes offering fresh insight into cellular pathways regulated by PNPT1 and which may be used in the future for possible therapeutic intervention in mitochondrial-or inflammation-associated disease phenotypes.	[Sokhi, Upneet K.; Bacolod, Manny D.; Dasgupta, Santanu; Emdad, Luni; Das, Swadesh K.; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Bacolod, Manny D.; Dasgupta, Santanu; Emdad, Luni; Das, Swadesh K.; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA USA; [Emdad, Luni; Miles, Michael F.; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Richmond, VA USA; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Fisher, PB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	pbfisher@vcu.edu	Miculescu, Florin/A-4524-2011; Dumur, Catherine/AAH-9489-2020; Duta, Liviu Marian/AAF-9375-2019; Duta, Liviu Marian/G-3417-2011	Miculescu, Florin/0000-0001-6757-5616; Duta, Liviu Marian/0000-0002-6408-6056; Duta, Liviu Marian/0000-0002-6408-6056; SOKHI, UPNEET/0000-0001-5907-5646; Bacolod, Manny/0000-0002-2085-4877	National Institutes of Health [R01 CA097318]; Samuel Waxman Cancer Research Foundation; VCU Massey Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; VCU Massey Cancer Center	The present study was supported in part by National Institutes of Health, NCI grant R01 CA097318, the Samuel Waxman Cancer Research Foundation and the VCU Massey Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BALABAN G, 1984, CANCER GENET CYTOGEN, V11, P429, DOI 10.1016/0165-4608(84)90024-4; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Chan I, 2008, J CELL PHYSIOL, V215, P401, DOI 10.1002/jcp.21320; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Das SK, 2011, ONCOGENE, V30, P1733, DOI 10.1038/onc.2010.572; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; Deutscher MP, 2001, PROG NUCLEIC ACID RE, V66, P67; DEUTSCHER MP, 1993, J BIOL CHEM, V268, P13011; Dumur CI, 2009, LARYNGOSCOPE, V119, P91, DOI 10.1002/lary.20005; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; FISHER PB, 1985, J INTERFERON RES, V5, P11, DOI 10.1089/jir.1985.5.11; Gatta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015965; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIOVANELLA BC, 1974, JNCI-J NATL CANCER I, V52, P921, DOI 10.1093/jnci/52.3.921; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; HERLYN M, 1985, CANCER RES, V45, P5670; HUBERMAN E, 1979, CANCER RES, V39, P2618; Huynh KM, 2009, GENE, V433, P32, DOI 10.1016/j.gene.2008.11.013; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; JIANG HP, 1995, ONCOGENE, V10, P1855; Leszczyniecka M, 2003, GENE, V316, P143, DOI 10.1016/S0378-1119(03)00752-2; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Leszczyniecka M, 2002, P NATL ACAD SCI USA, V99, P16636, DOI 10.1073/pnas.252643699; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Rahmanzadeh R, 2007, CELL PROLIFERAT, V40, P422, DOI 10.1111/j.1365-2184.2007.00433.x; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Redmond LC, 2008, DEV DYNAM, V237, P436, DOI 10.1002/dvdy.21426; Rizzi R, 2008, NEUROSCI LETT, V441, P129, DOI 10.1016/j.neulet.2008.06.018; Sarkar D, 2004, CANCER RES, V64, P7473, DOI 10.1158/0008-5472.CAN-04-1772; Sarkar D, 2006, CELL DEATH DIFFER, V13, P1541, DOI 10.1038/sj.cdd.4401829; Sarkar D, 2003, J BIOL CHEM, V278, P24542, DOI 10.1074/jbc.M302421200; Sarkar D, 2007, CANCER RES, V67, P7948, DOI 10.1158/0008-5472.CAN-07-0872; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Sarkar D, 2006, CELL CYCLE, V5, P1080, DOI 10.4161/cc.5.10.2741; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Sokhi UK, 2013, ADV CANC RE IN PRESS, P119; Staudt MR, 2009, J CELL PHYSIOL, V218, P304, DOI 10.1002/jcp.21602; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Van Maerken T, 2009, J CELL PHYSIOL, V219, P707, DOI 10.1002/jcp.21719; Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001; Wang G., 2011, BIOCHIM BIOPHYS ACTA, V1819, P998; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077	58	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76284	10.1371/journal.pone.0076284	http://dx.doi.org/10.1371/journal.pone.0076284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143183	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100018
J	Togao, O; Kessinger, CW; Huang, G; Soesbe, TC; Sagiyama, K; Dimitrov, I; Sherry, AD; Gao, JM; Takahashi, M				Togao, Osamu; Kessinger, Chase W.; Huang, Gang; Soesbe, Todd C.; Sagiyama, Koji; Dimitrov, Ivan; Sherry, A. Dean; Gao, Jinming; Takahashi, Masaya			Characterization of Lung Cancer by Amide Proton Transfer (APT) Imaging: An In-Vivo Study in an Orthotopic Mouse Model	PLOS ONE			English	Article							HUMAN BRAIN-TUMORS; MAGNETIZATION-TRANSFER; SCREENING EXPERIENCE; COMPUTED-TOMOGRAPHY; PULMONARY NODULES; WATER SATURATION; CHEST CT; RESONANCE; EXCHANGE; MRI	Amide proton transfer (APT) imaging is one of the chemical exchange saturation transfer (CEST) imaging methods which images the exchange between protons of free tissue water and the amide groups (-NH) of endogenous mobile proteins and peptides. Previous work suggested the ability of APT imaging for characterization of the tumoral grade in the brain tumor. In this study, we tested the feasibility of in-vivo APT imaging of lung tumor and investigated whether the method could differentiate the tumoral types on orthotopic tumor xenografts from two malignant lung cancer cell lines. The results revealed that APT imaging is feasible to quantify lung tumors in the moving lung. The measured APT effect was higher in the tumor which exhibited more active proliferation than the other. The present study demonstrates that APT imaging has the potential to provide a characterization test to differentiate types or grade of lung cancer noninvasively, which may eventually reduce the need invasive needle biopsy or resection for lung cancer.	[Togao, Osamu; Soesbe, Todd C.; Sagiyama, Koji; Dimitrov, Ivan; Sherry, A. Dean; Takahashi, Masaya] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Adv Imaging Res Ctr, Dallas, TX 75235 USA; [Kessinger, Chase W.; Huang, Gang; Gao, Jinming] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, M (corresponding author), UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Adv Imaging Res Ctr, Dallas, TX 75235 USA.	masaya.takahashi@utsouthwestern.edu	Togao, Osamu/AAE-4702-2022; Sherry, Dean/P-2348-2018	Sagiyama, Koji/0000-0001-7253-0703; Sherry, Dean/0000-0001-7150-8301	Cancer Prevention & Research Institution of Texas [RP101243-P04]; National Institutes of Health [RO1CA129011]; NATIONAL CANCER INSTITUTE [R01CA129011, R01CA115531] Funding Source: NIH RePORTER	Cancer Prevention & Research Institution of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Cancer Prevention & Research Institution of Texas (RP101243-P04) and the National Institutes of Health (RO1CA129011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco E, 2010, CANCER RES, V70, P3896, DOI 10.1158/0008-5472.CAN-09-3995; Diederich S, 2000, CANCER, V89, P2483, DOI 10.1002/1097-0142(20001201)89:11+<2483::AID-CNCR27>3.0.CO;2-1; Dimitrov I., 2012, P 20 ANN M EXH INT S; Hansell DM, 1999, CLIN CHEST MED, V20, P739, DOI 10.1016/S0272-5231(05)70253-7; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Imbalzano KM, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-7; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Kangasniemi K, 2012, P 20 ANN M EXH INT S; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Kino A, 2007, EUR J RADIOL, V64, P397, DOI 10.1016/j.ejrad.2007.08.014; Kiryu S, 2006, MAGN RESON IMAGING, V24, P1325, DOI 10.1016/j.mri.2006.08.009; Kubo S, 2006, MAGN RESON MED, V56, P698, DOI 10.1002/mrm.21006; Kubo T, 2008, AM J ROENTGENOL, V190, P335, DOI 10.2214/AJR.07.2556; Lindell RM, 2009, CHEST, V136, P1586, DOI 10.1378/chest.09-0915; Lindell RM, 2005, AM J ROENTGENOL, V185, P126, DOI 10.2214/ajr.185.1.01850126; Madero-Visbal RA, 2010, SURG ONCOL; Mani T, 2009, CONTRAST MEDIA MOL I, V4, P183, DOI 10.1002/cmmi.279; Matsuoka S, 2008, MAGN RESON IMAGING C, V16, P275, DOI 10.1016/j.mric.2008.03.006; Pastorino U, 2010, BRIT J CANCER, V102, P1681, DOI 10.1038/sj.bjc.6605660; Pekar J, 1996, MAGNET RESON MED, V35, P70, DOI 10.1002/mrm.1910350110; Ren JM, 2008, MAGN RESON MED, V60, P1047, DOI 10.1002/mrm.21722; Revel MP, 2004, RADIOLOGY, V231, P453, DOI 10.1148/radiol.2312030167; Salhotra A, 2008, NMR BIOMED, V21, P489, DOI 10.1002/nbm.1216; Scheidegger R, 2011, MAGN RESON MED, V66, P1275, DOI 10.1002/mrm.22912; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Soesbe TC, 2012, MAGN RESON MED, V68, P816, DOI 10.1002/mrm.23302; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Takahashi M, 2007, EUR J RADIOL, V64, P367, DOI 10.1016/j.ejrad.2007.08.011; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Togao O, 2010, MAGN RESON MED, V64, P1491, DOI 10.1002/mrm.22521; van Zijl PCM, 2003, MAGNET RESON MED, V49, P440, DOI 10.1002/mrm.10398; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; Varma G, 2012, MAGN RESON MED, V68, P1228, DOI 10.1002/mrm.23310; Zhao XN, 2013, MOL IMAGING BIOL, V15, P114, DOI 10.1007/s11307-012-0563-1; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	41	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77019	10.1371/journal.pone.0077019	http://dx.doi.org/10.1371/journal.pone.0077019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143199	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100034
J	Yu, X; Bi, YC; Han, ZZ; Law, SP				Yu, Xi; Bi, Yanchao; Han, Zaizhu; Law, Sam-Po			An fMRI Study of Grammatical Morpheme Processing Associated with Nouns and Verbs in Chinese	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; SENTENCE COMPREHENSION; FRONTAL-CORTEX; NAMING ACTIONS; BROCAS AREA; BRAIN; LANGUAGE; REPRESENTATIONS; CLASSIFIERS; COMPLEXITY	This study examined whether the degree of complexity of a grammatical component in a language would impact on its representation in the brain through identifying the neural correlates of grammatical morpheme processing associated with nouns and verbs in Chinese. In particular, the processing of Chinese nominal classifiers and verbal aspect markers were investigated in a sentence completion task and a grammaticality judgment task to look for converging evidence. The Chinese language constitutes a special case because it has no inflectional morphology per se and a larger classifier than aspect marker inventory, contrary to the pattern of greater verbal than nominal paradigmatic complexity in most European languages. The functional imaging results showed BA47 and left supplementary motor area and superior medial frontal gyrus more strongly activated for classifier processing, and the left posterior middle temporal gyrus more responsive to aspect marker processing. We attributed the activation in the left prefrontal cortex to greater processing complexity during classifier selection, analogous to the accounts put forth for European languages, and the left posterior middle temporal gyrus to more demanding verb semantic processing. The overall findings significantly contribute to cross-linguistic observations of neural substrates underlying processing of grammatical morphemes from an analytic and a classifier language, and thereby deepen our understanding of neurobiology of human language.	[Yu, Xi; Law, Sam-Po] Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China; [Bi, Yanchao; Han, Zaizhu] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	University of Hong Kong; Beijing Normal University	Law, SP (corresponding author), Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China.	splaw@hku.hk		Yu, Xi/0000-0003-0818-1451	Research Grant Council of Hong Kong [HKU 746608H]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	study was supported by a General Research Fund from the Research Grant Council of Hong Kong (HKU 746608H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN K, 1977, LANGUAGE, V53, P285, DOI 10.2307/413103; BADECKER W, 1987, BRAIN LANG, V32, P278, DOI 10.1016/0093-934X(87)90129-5; Berlingeri M, 2008, COGN NEUROPSYCHOL, V25, P528, DOI 10.1080/02643290701674943; Bi YC, 2010, COGNITION, V116, P101, DOI 10.1016/j.cognition.2010.04.004; Bick A, 2008, J COGNITIVE NEUROSCI, V20, P406, DOI 10.1162/jocn.2008.20.3.406; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bozic M, 2010, LANG LINGUIST COMPAS, V4, P1063, DOI 10.1111/j.1749-818x.2010.00254.x; Cappelletti M, 2008, J COGNITIVE NEUROSCI, V20, P707, DOI 10.1162/jocn.2008.20045; Chan AHD, 2008, ANN NY ACAD SCI, V1145, P30, DOI 10.1196/annals.1416.000; Chao Y.R., 1979, GRAMMAR SPOKEN CHINE; Chien YC, 2003, J EAST ASIAN LINGUIS, V12, P91, DOI 10.1023/A:1022401006521; Chou TL, 2006, HUM BRAIN MAPP, V27, P915, DOI 10.1002/hbm.20231; Chou TL, 2012, NEUROPSYCHOLOGIA, V50, P1408, DOI 10.1016/j.neuropsychologia.2012.02.025; Chou TL, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.027.2009; Chou TL, 2009, EXP BRAIN RES, V198, P465, DOI 10.1007/s00221-009-1942-y; Chou TL, 2006, NEUROIMAGE, V29, P1141, DOI 10.1016/j.neuroimage.2005.09.064; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Cooke A, 2002, HUM BRAIN MAPP, V15, P80, DOI 10.1002/hbm.10006; Damasio H, 2001, NEUROIMAGE, V13, P1053, DOI 10.1006/nimg.2001.0775; Davis MH, 2004, BRAIN LANG, V89, P439, DOI 10.1016/S0093-934X(03)00471-1; DEMB JB, 1995, J NEUROSCI, V15, P5870; Deng Y, 2008, NEUROPSYCHOLOGIA, V46, P1864, DOI 10.1016/j.neuropsychologia.2007.09.010; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gao MY, 2009, LANG COGNITIVE PROC, V24, P1124, DOI 10.1080/01690960802018323; Grindrod CM, 2008, BRAIN RES, V1229, P167, DOI 10.1016/j.brainres.2008.07.017; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Han ZH, 2010, SECOND LANG ACQUIS, P1; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Hong Z, 2007, J EAST ASIAN LINGUIS, V16, P43, DOI 10.1007/s10831-006-9006-9; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Killingley S.-Y., 1983, CANTONESE CLASSIFIER; Li CharlesN., 1981, MANDARIN CHINESE FUN; Li P, 2004, NEUROIMAGE, V21, P1533, DOI 10.1016/j.neuroimage.2003.10.044; Li P, 2010, J EAST ASIAN LINGUIS, V19, P207, DOI 10.1007/s10831-010-9060-1; Liljestrom M, 2008, NEUROIMAGE, V41, P1132, DOI 10.1016/j.neuroimage.2008.03.016; Liu CL, 2006, NEUROREPORT, V17, P1397, DOI 10.1097/01.wnr.0000233090.00463.35; Longe O, 2007, CEREB CORTEX, V17, P1812, DOI 10.1093/cercor/bhl099; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Marangolo P, 2006, CORTEX, V42, P1093, DOI 10.1016/S0010-9452(08)70221-1; Marslen-Wilson W, 1998, TRENDS COGN SCI, V2, P428, DOI 10.1016/S1364-6613(98)01239-X; Meinzer M, 2009, NEUROPSYCHOLOGIA, V47, P1964, DOI 10.1016/j.neuropsychologia.2009.03.008; MICELI G, 1988, BRAIN LANG, V35, P24, DOI 10.1016/0093-934X(88)90100-9; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palti D, 2007, HUM BRAIN MAPP, V28, P303, DOI 10.1002/hbm.20280; Righi G, 2010, J COGNITIVE NEUROSCI, V22, P213, DOI 10.1162/jocn.2009.21200; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Roskies AL, 2001, J COGNITIVE NEUROSCI, V13, P829, DOI 10.1162/08989290152541485; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Sahin NT, 2006, CORTEX, V42, P540, DOI 10.1016/S0010-9452(08)70394-0; Shapiro K, 2003, NEUROPSYCHOLOGIA, V41, P1189, DOI 10.1016/S0028-3932(03)00037-X; Shapiro K, 2000, COGNITIVE NEUROPSYCH, V17, P665, DOI 10.1080/026432900750038281; Shapiro KA, 2005, NEUROIMAGE, V24, P1058, DOI 10.1016/j.neuroimage.2004.10.015; Shapiro KA, 2006, P NATL ACAD SCI USA, V103, P1644, DOI 10.1073/pnas.0504142103; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Shapiro KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00026; Siri S, 2008, CEREB CORTEX, V18, P171, DOI 10.1093/cercor/bhm043; Slobin D. I., 1985, CROSSLINGUISTIC STUD, V2; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tranel D, 2005, BRAIN LANG, V92, P288, DOI 10.1016/j.bandl.2004.01.011; Tsapkini K, 2002, J NEUROLINGUIST, V15, P265, DOI 10.1016/S0911-6044(01)00039-2; Tyler LK, 2008, J COGNITIVE NEUROSCI, V20, P1381, DOI 10.1162/jocn.2008.20095; Tyler LK, 2008, PHILOS T R SOC B, V363, P1037, DOI 10.1098/rstb.2007.2158; TZENG OJL, 1991, BRAIN LANG, V41, P184, DOI 10.1016/0093-934X(91)90152-Q; Vannest J, 2005, COGN AFFECT BEHAV NE, V5, P67, DOI 10.3758/CABN.5.1.67; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Wang SP, 2008, NEUROPSYCHOLOGIA, V46, P1371, DOI 10.1016/j.neuropsychologia.2007.12.020; WANG WSY, 1973, SCI AM, V228, P50, DOI 10.1038/scientificamerican0273-50; Wilson SM, 2004, J COGNITIVE NEUROSCI, V16, P238, DOI 10.1162/089892904322984535; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Yang J, 2011, J NEUROLINGUIST, V24, P674, DOI 10.1016/j.jneuroling.2011.07.002; Yu X, 2012, BRAIN LANG, V122, P126, DOI 10.1016/j.bandl.2012.05.002; Yu X, 2011, NEUROIMAGE, V58, P912, DOI 10.1016/j.neuroimage.2011.06.039; Zhang JX, 2004, NEUROIMAGE, V23, P975, DOI 10.1016/j.neuroimage.2004.07.008; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	80	7	7	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e74952	10.1371/journal.pone.0074952	http://dx.doi.org/10.1371/journal.pone.0074952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	236SL	24146745	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400004
J	de Araujo, RF; Souza, TO; de Moura, LM; Torres, KP; de Souza, LB; Alves, MDCF; Rocha, HO; de Araujo, AA				de Araujo Junior, Raimundo Fernandes; Souza, Tatiana Oliveira; de Moura, Ligia Moreno; Torres, Kerginaldo Paulo; de Souza, Lelia Batista; Costa Feitosa Alves, Maria do Socorro; Rocha, Hugo Oliveira; de Araujo, Aurigena Antunes			Atorvastatin Decreases Bone Loss, Inflammation and Oxidative Stress in Experimental Periodontitis	PLOS ONE			English	Article							OSTEOPROTEGERIN; TISSUE; RATS	The aim of this study is to determine the effects of Atorvastatin treatment, an inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase, in periodontal disease. Male Wistar albino rats were randomly divided into five groups of ten rats each: (1) non-ligated treatment (NL), (2) ligature only (L), (3) ligature plus 1 mg/kg Atorvastatin daily for 10 days, (4) ligature plus 5 mg/kg Atorvastatin daily for 10 days, and (5) ligature plus 10 mg/kg Atorvastatin daily for 10 days. Following the treatment course, the periodontal tissue of the animals was analyzed by Measurement of alveolar bone loss, Histopathology and immunohistochemistry to determine of the expression of COX-2, MMP-2, MMP9, and RANKL/RANK/OPG. ELISA assay was used to quantitate the levels of IL-1 beta, IL-10, TNF-alpha, myeloperoxidase, malondialdehyde, and glutathione. The periodontal group treated with 10 mg/kg of Atorvastatin (3.9 +/- 0.9 mm; p<0.05) showed reverse the alveolar bone loss caused Experimental Periodontal Disease compared to (L) (7.02 +/- 0.17 mm). The periodontal group treated with 10 mg/kg of Atorvastatin showed a significant reduction in MPO and MDA (p<0.05) compared to ligature only group (L). Similarly in this group, the levels of the proinflammatory cytokines IL-1 beta and TNF-alpha were significantly decreased (p<0.05). Furthermore, MMP-2, MMP-9, RANKL/RANK, and COX-2 were all downregulated by Atorvastatin treatment, while OPG expression was increased. The findings support a role of Atorvastatin for reducing the bone loss, inflammatory response, oxidative stress, and expression of extracellular matrix proteins, while reducing RANK/RANKL and increase OPG in periodontal disease.	[de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Hlth Sci, Postgrad Program Funct & Struct Biol, Natal, RN, Brazil; [Souza, Tatiana Oliveira] Univ Fed Rio Grande do Norte, Postgrad Program Hlth Sci, Natal, RN, Brazil; [de Moura, Ligia Moreno] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, UNP, Dept Dent, Natal, RN, Brazil; [Torres, Kerginaldo Paulo] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil; [de Souza, Lelia Batista] Univ Fed Rio Grande do Norte, Postgrad Program Oral Pathol, Natal, RN, Brazil; [Costa Feitosa Alves, Maria do Socorro] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, Postgrad Program Hlth Sci, Natal, RN, Brazil; [Rocha, Hugo Oliveira] Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Postgrad Program Pharmaceut Sci, Postgrad Program Publ Hlth, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Potiguar; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, AA (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program Pharmaceut Sci, Postgrad Program Publ Hlth, Natal, RN, Brazil.	aurigena@ufrnet.br	de Araujo, Aurigena/ABI-8455-2020	Araujo, Aurigena/0000-0001-9264-4695				Araujo AA, 2013, NAUNYN SCHMIEDEBERGS; ARAUJO RFD, 2013, PLOS ONE, V0008; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005; Bellosta S, 2000, ANN MED, V32, P164, DOI 10.3109/07853890008998823; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Carvalho RD, 2013, ARCH ORAL BIOL, V58, P50, DOI 10.1016/j.archoralbio.2012.04.020; Chang BC, 2011, PHARMAZIE, V66, P535, DOI 10.1691/ph.2011.0826; Corotti MV, 2009, ARCH ORAL BIOL, V54, P764, DOI 10.1016/j.archoralbio.2009.04.013; Cui JJ, 2012, CELL BIOCHEM BIOPHYS, V62, P87, DOI 10.1007/s12013-011-9264-7; Dalcico R, 2012, J PERIODONTOL; Deng Ping, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P1018; Deo V, 2010, DENT TODAY, V29, P64; Deo V, 2010, DENT TODAY, V29, P68; Deo Vikas, 2010, Dent Today, V29, P60; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Hernandez C, 2011, DIABETES METAB, V37, P124, DOI 10.1016/j.diabet.2010.08.006; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kim JY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4018; Kirkwood KL, 2007, PERIODONTOL 2000, V43, P294, DOI 10.1111/j.1600-0757.2006.00166.x; Leitao RFC, 2005, J PERIODONTOL, V76, P956, DOI 10.1902/jop.2005.76.6.956; Medeiros CACX, 2011, CANCER CHEMOTH PHARM, V67, P1085, DOI 10.1007/s00280-010-1409-7; Otenio CC, 2012, GENET MOL RES, V11; Pozo P, 2005, J PERIODONTAL RES, V40, P199, DOI 10.1111/j.1600-0765.2005.00786.x; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Shirakabe A, 2012, J CARDIOL, V59, P374, DOI 10.1016/j.jjcc.2012.01.009; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; WAHL SM, 1993, J PERIODONTOL, V64, P450; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606; Yen CA, 2008, J PERIODONTOL, V79, P104, DOI [10.1902/jop.2008.070271, 10.1902/jop.2008.070271 ]	32	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75322	10.1371/journal.pone.0075322	http://dx.doi.org/10.1371/journal.pone.0075322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130702	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200010
J	Gu, GM; Wang, TT; Yang, Y; Xu, XH; Wang, JK				Gu, Guangming; Wang, Tingting; Yang, Yang; Xu, Xinhui; Wang, Jinke			An Improved SELEX-Seq Strategy for Characterizing DNA-Binding Specificity of Transcription Factor: NF-kappa B as an Example	PLOS ONE			English	Article							IN-VIVO; CHROMATIN IMMUNOPRECIPITATION; ONLINE DATABASE; MICROARRAY DATA; PROTEIN; SEQUENCE; GENOME; CELLS; EXPRESSION; MOLECULES	SELEX-Seq is now the optimal high-throughput technique for characterizing DNA-binding specificities of transcription factors. In this study, we introduced an improved EMSA-based SELEX-Seq strategy with several advantages. The improvements of this strategy included: (1) using a FAM-labeled probe to track protein-DNA complex in polyacrylamide gel for rapidly recovering the protein-bound dsDNA without relying on traditional radioactive labeling or ethidium bromide staining; (2) monitoring the specificity of SELEX selection by detecting a positive and negative sequence doped into the input DNAs used in each round with PCR amplification; (3) using nested PCR to ensure the specificity of PCR amplification of the selected DNAs after each round; (4) using the nucleotides added at the 59 end of the nested PCR primers as the split barcode to code DNAs from various rounds for multiplexing sequencing samples. The split barcode minimized selection times and thus greatly simplified the current SELEX-Seq procedure. The reliability of the strategy was demonstrated by performing a successful SELEX-Seq of a well-known transcription factor, NF-kappa B. Therefore, this study provided a useful SELEX-Seq strategy for characterizing DNA-binding specificities of transcription factors.	[Gu, Guangming; Wang, Tingting; Yang, Yang; Xu, Xinhui; Wang, Jinke] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Wang, JK (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	wangjinke@seu.edu.cn	wang, tingting/AAK-2640-2020; Wang, Jinke/AAT-7832-2021		National Natural Science Foundation of China [61171030]; Technology Support Program of Jiangsu [BE2012741]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Support Program of Jiangsu	This work was supported by the National Natural Science Foundation of China (61171030) and Technology Support Program of Jiangsu (BE2012741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanova D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-225; ALEX R, 1992, NUCLEIC ACIDS RES, V20, P2257, DOI 10.1093/nar/20.9.2257; Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Celedon A, 2010, J PHYS CHEM B, V114, P16929, DOI 10.1021/jp107541q; Collas P, 2008, FRONT BIOSCI-LANDMRK, V13, P929, DOI 10.2741/2733; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ferraris L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1213; Gao J, 2011, LETT BIOTECHNOL CHIN, V22, P71; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hallikas O, 2006, NAT PROTOC, V1, P215, DOI 10.1038/nprot.2006.33; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-441; Liu JJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni139; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ohmori K, 2005, EUR J CARDIO-THORAC, V27, P23, DOI 10.1016/j.ejcts.2004.09.016; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; PAPOULAS O, 1992, J BIOL CHEM, V267, P10470; Puckett JW, 2007, J AM CHEM SOC, V129, P12310, DOI 10.1021/ja0744899; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Sooter LJ, 2004, J ASS LAB AUTOM, V9, P277; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Tantin D, 2008, GENOME RES, V18, P631, DOI 10.1101/gr.072942.107; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JK, 2003, ANAL BIOCHEM, V316, P192, DOI 10.1016/S0003-2697(03)00049-6; Wang XL, 2009, J CLIN IMMUNOL, V29, P387, DOI 10.1007/s10875-009-9274-z; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	51	23	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76109	10.1371/journal.pone.0076109	http://dx.doi.org/10.1371/journal.pone.0076109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130762	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200031
J	Oettler, J; Dijkstra, MB; Heinze, J				Oettler, Jan; Dijkstra, Michiel B.; Heinze, Juergen			Egg-Laying "Intermorphs'' in the Ant Crematogaster smithi neither Affect Sexual Production nor Male Parentage	PLOS ONE			English	Article							FLORIDA HARVESTER ANT; WORKER REPRODUCTION; ALLOCATION RATIOS; RESOURCE AVAILABILITY; INVESTMENT RATIOS; UNFERTILIZED EGGS; INSECT SOCIETIES; QUEEN CONTROL; EVOLUTION; CASTE	We study male parentage and between-colony variation in sex allocation and sexual production in the desert ant Crematogaster smithi, which usually has only one singly-mated queen per nest. Colonies of this species are known to temporarily store nutrients in the large fat body of intermorphs, a specialized female caste intermediate in morphology between queens and workers. Intermorphs repackage at least part of this fat into consumable but viable male-destined eggs. If these eggs sometimes develop instead of being eaten, intermorphs will be reproductive competitors of the queen but-due to relatedness asymmetries-allies of their sister worker. Using genetic markers we found a considerable proportion of non-queen sons in some, but not all, colonies. Even though intermorphs produce similar to 1.7 x more eggs than workers, their share in the parentage of adult males is estimated to be negligible due to their small number compared to workers. Furthermore, neither colony-level sex allocation nor overall sexual production was correlated with intermorph occurrence or number. We conclude that intermorph-laid eggs typically do not survive and that the storage of nutrients and their redistribution as eggs by intermorphs is effectively altruistic.	[Oettler, Jan; Heinze, Juergen] Univ Regensburg, D-93053 Regensburg, Germany; [Dijkstra, Michiel B.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Regensburg; University of Lausanne	Oettler, J (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	jan.oettler@biologie.uni-regensburg.de; michiel.b.dijkstra@gmail.com		Dijkstra, Michiel/0000-0003-1519-4656	German Academic Exchange Service (DAAD); Marie Curie grant [41343-INVICTA2]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie grant(European Commission)	This study was supported by two grants to JO from the German Academic Exchange Service (DAAD) and a Marie Curie grant 41343-INVICTA2 to MBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron S, 2001, J ANIM ECOL, V70, P831, DOI 10.1046/j.0021-8790.2001.00545.x; BARTZ SH, 1982, BEHAV ECOL SOCIOBIOL, V10, P137, DOI 10.1007/BF00300174; Beekman M, 2003, TRENDS ECOL EVOL, V18, P277, DOI 10.1016/S0169-5347(03)00068-5; Blaimer BB, 2012, ZOOKEYS, P23, DOI 10.3897/zookeys.199.2631; Bono JM, 2003, P ROY SOC B-BIOL SCI, V270, P811, DOI 10.1098/rspb.2002.2287; Bono JM, 2002, INSECT SOC, V49, P320, DOI 10.1007/PL00012655; BOOMSMA JJ, 1989, AM NAT, V133, P517, DOI 10.1086/284933; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; BOOMSMA JJ, 1995, FUNCT ECOL, V9, P743, DOI 10.2307/2390247; Boomsma JJ, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P93, DOI 10.1017/CBO9780511542053.005; Borgesen LW, 2000, INSECT SOC, V47, P141, DOI 10.1007/PL00001692; Bosch J, 2008, ANIM BEHAV, V75, P809, DOI 10.1016/j.anbehav.2007.06.018; Bourke Andrew F.G., 2005, P1, DOI 10.1079/9780851998121.0001; Brown WD, 2006, BEHAV ECOL SOCIOBIOL, V60, P612, DOI 10.1007/s00265-006-0204-2; Buschmann AH, 2002, AMEISENSCHUTZ AKTUEL, V16, P1; Cahan S, 1999, BEHAV ECOL, V10, P585, DOI 10.1093/beheco/10.5.585; Chapuisat M, 1997, P ROY SOC B-BIOL SCI, V264, P1255, DOI 10.1098/rspb.1997.0173; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Crozier R.H., 1996, EVOLUTION SOCIAL INS; de Menten L, 2005, ANIM BEHAV, V69, P1031, DOI 10.1016/j.anbehav.2004.09.005; Desfor KB, 2007, IBIS, V149, P98; DESLIPPE RJ, 1995, ECOLOGY, V76, P375, DOI 10.2307/1941196; Dijkstra MB, 2007, ANIM BEHAV, V74, P519, DOI 10.1016/j.anbehav.2006.11.020; Dijkstra MB, 2008, OIKOS, V117, P1892, DOI 10.1111/j.1600-0706.2008.16822.x; Foitzik S, 2004, BEHAV ECOL SOCIOBIOL, V55, P484, DOI 10.1007/s00265-003-0718-9; Foster KR, 2000, MOL ECOL, V9, P735, DOI 10.1046/j.1365-294x.2000.00920.x; Foster KR, 2001, AM NAT, V158, P615, DOI 10.1086/323588; FRANK SA, 1987, BEHAV ECOL SOCIOBIOL, V20, P195, DOI 10.1007/BF00299733; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; HEINZE J, 1993, P NATL ACAD SCI USA, V90, P8412, DOI 10.1073/pnas.90.18.8412; Heinze J, 1999, NATURWISSENSCHAFTEN, V86, P93, DOI 10.1007/s001140050579; Heinze J., 1997, Psyche (Cambridge), V102, P173, DOI 10.1155/1995/65249; Heinze J, 1998, INSECT SOC, V45, P113, DOI 10.1007/s000400050073; Heinze J, 2000, INSECT SOC, V47, P299, DOI 10.1007/PL00001719; Heinze J, 2001, BEHAV ECOL SOCIOBIOL, V50, P270, DOI 10.1007/s002650100353; Helantera H, 2009, BIOL LETTERS, V5, P700, DOI 10.1098/rsbl.2009.0501; HERBERS JM, 1990, AM NAT, V136, P178, DOI 10.1086/285091; HERBERS JM, 1979, AM NAT, V114, P818, DOI 10.1086/283531; Holldobler B., 1990, pi; KASPARI M, 1995, BEHAV ECOL SOCIOBIOL, V37, P255, DOI 10.1007/s002650050189; Khila A, 2008, P NATL ACAD SCI USA, V105, P17884, DOI 10.1073/pnas.0807351105; Kim JY, 1999, BEHAV ECOL, V10, P552, DOI 10.1093/beheco/10.5.552; Kummerli R, 2009, BIOL LETTERS, V5, P713, DOI 10.1098/rsbl.2009.0295; Longino John T., 2003, Zootaxa, V151, P1; Mehdiabadi NJ, 2003, TRENDS ECOL EVOL, V18, P88, DOI 10.1016/S0169-5347(02)00056-3; Meunier J, 2008, BEHAV ECOL, V19, P382, DOI 10.1093/beheco/arm143; Moilanen A, 2004, MOL ECOL NOTES, V4, P795, DOI 10.1111/j.1471-8286.2004.00779.x; NONACS P, 1986, Q REV BIOL, V61, P1, DOI 10.1086/414723; PAMILO P, 1991, AM NAT, V137, P83, DOI 10.1086/285147; PAMILO P, 1993, HEREDITY, V70, P472, DOI 10.1038/hdy.1993.69; Passera L, 2001, SCIENCE, V293, P1308, DOI 10.1126/science.1062076; Peeters C, 2013, ARTHROPOD STRUCT DEV, V42, P257, DOI 10.1016/j.asd.2013.02.003; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Rosenheim JA, 1996, AM NAT, V148, P501, DOI 10.1086/285937; Rosset H, 2006, CURR BIOL, V16, P328, DOI 10.1016/j.cub.2005.12.036; SCHMIDHEMPEL P, 1992, J EVOLUTION BIOL, V5, P1, DOI 10.1046/j.1420-9101.1992.5010001.x; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Schrempf A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002592; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Smith CR, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_32.1; Smith CR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1479, DOI 10.1007/s00265-007-0380-8; Strohm E, 1997, P ROY SOC B-BIOL SCI, V264, P423, DOI 10.1098/rspb.1997.0060; Suefuji M, 2008, BIOL LETTERS, V4, P670, DOI 10.1098/rsbl.2008.0355; SUNDSTROM L, 1994, NATURE, V367, P266, DOI 10.1038/367266a0; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tsuneoka Y, 2013, ENTOMOL SCI, V16, P259, DOI 10.1111/ens.12001; Wenseleers T, 2005, BIOL LETT-UK, V1, P125, DOI 10.1098/rsbl.2004.0281; Wenseleers T, 2004, J EVOLUTION BIOL, V17, P1035, DOI 10.1111/j.1420-9101.2004.00751.x; Wenseleers T, 2006, AM NAT, V168, pE163, DOI 10.1086/508619; Yamauchi K, 2006, CURR BIOL, V16, P2424, DOI 10.1016/j.cub.2006.10.007; Yang AS, 2004, CURR BIOL, V14, P514, DOI 10.1016/j.cub.2004.03.005	73	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75278	10.1371/journal.pone.0075278	http://dx.doi.org/10.1371/journal.pone.0075278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130699	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200007
J	Birke, K; Lipo, E; Birke, MT; Kumar-Singh, R				Birke, Kerstin; Lipo, Erion; Birke, Marco T.; Kumar-Singh, Rajendra			Topical Application of PPADS Inhibits Complement Activation and Choroidal Neovascularization in a Model of Age-Related Macular Degeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MEMBRANE-ATTACK-COMPLEX; FACTOR-H POLYMORPHISM; RECEPTOR; VEGF; IMMUNOLOGY; EXPRESSION; PAZOPANIB; DISEASE; RETINA	Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly. AMD patients have elevated levels of membrane attack complex (MAC) in their choroidal blood vessels and retinal pigment epithelium (RPE). MAC forms pores in cell membranes. Low levels of MAC result in an elevation of cytokine release such as vascular endothelial growth factor (VEGF) that promotes the formation of choroidal neovascularization (CNV). High levels of MAC result in cell lysis and RPE degeneration is a hallmark of advanced AMD. The current standard of care for CNV associated with wet AMD is intravitreal injection of anti-VEGF molecules every 4 to 12 weeks. Such injections have significant side effects. Recently, it has been found that membrane pore-forming proteins such as a-haemolysin can mediate their toxic effects through auto-and paracrine signaling and that complement-induced lysis is amplified through ATP release followed by P2X receptor activation. We hypothesized that attenuation of P2X receptor activation may lead to a reduction in MAC deposition and consequent formation of CNV. Hence, in this study we investigated topical application of the purinergic P2X antagonist Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) as a potential treatment for AMD. We found that 4.17 mu M PPADS inhibited formation of HUVEC master junctions and master segments by 74.7%. In a human complement mediated cell lysis assay, 104 mM PPADS enabled almost complete protection of Hepa1c1c7 cells from 1% normal human serum mediated cell lysis. Daily topical application of 4.17 mM PPADS for 3 days attenuated the progression of laser induced CNV in mice by 41.8% and attenuated the deposition of MAC at the site of the laser injury by 19.7%. Our data have implications for the future treatment of AMD and potentially other ocular disorders involving CNV such as angioid streaks, choroidal rupture and high myopia.	[Birke, Kerstin; Lipo, Erion; Birke, Marco T.; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Kumar-Singh, R (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	Rajendra.Kumar-Singh@tufts.edu		Lipo, Erion/0000-0002-3179-0688; Kumar-Singh, Rajendra/0000-0002-7754-0713	Ellison Foundation; Virginia B Smith Trust; National Institute of Health/National Eye Institute [EY021805, EY013837]; Department of Defense/Telemedicine and Advanced Technology Research Center; Lions Eye Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY013837, R01EY021805] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Virginia B Smith Trust; National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Defense/Telemedicine and Advanced Technology Research Center(United States Department of Defense); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants to R. K. S. from The Ellison Foundation, The Virginia B Smith Trust, The National Institute of Health/National Eye Institute (EY021805 and EY013837), The Department of Defense/Telemedicine and Advanced Technology Research Center and grants to the Department of Ophthalmology at Tufts University School of Medicine from the Lions Eye Foundation and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Ament CS, 2006, ARCH OPHTHALMOL-CHIC, V124, P957, DOI 10.1001/archopht.124.7.957; Bee YS, 2010, MOL VIS, V16, P756; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Brand CS, 2012, EYE, V26, pS1, DOI 10.1038/eye.2012.32; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; Casten RJ, 2013, CURR OPIN OPHTHALMOL, V24, P239, DOI 10.1097/ICU.0b013e32835f8e55; Cloutier F, 2012, INVEST OPHTH VIS SCI, V53, P1195, DOI 10.1167/iovs.11-9064; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Coddou C, 2009, J NEUROSCI, V29, P12284, DOI 10.1523/JNEUROSCI.2096-09.2009; DAVIES A, 1993, IMMUNOL RES, V12, P258, DOI 10.1007/BF02918257; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Ford KM, 2011, INVEST OPHTH VIS SCI, V52, P9478, DOI 10.1167/iovs.11-8353; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Georgalas Ilias, 2009, Ther Clin Risk Manag, V5, P81; Goldstein JE, 2012, ARCH OPHTHALMOL-CHIC, V130, P1028, DOI 10.1001/archophthalmol.2012.1197; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Hejl JL, 2013, PFLUG ARCH EUR J PHY, V465, P529, DOI 10.1007/s00424-012-1174-z; Iwase T, 2013, INVEST OPHTH VIS SCI, V54, P503, DOI 10.1167/iovs.12-10473; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Keane PA, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/483034; Kiuchi K, 2008, INVEST OPHTH VIS SCI, V49, P1705, DOI 10.1167/iovs.07-0089; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kunchithapautham K, 2012, ADV EXP MED BIOL, V723, P23, DOI 10.1007/978-1-4614-0631-0_4; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Larsen CK, 2011, J MEMBRANE BIOL, V244, P131, DOI 10.1007/s00232-011-9406-2; Lazarus Alon, 2011, Proc Am Thorac Soc, V8, P508, DOI 10.1513/pats.201102-021MW; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Montero JA, 2010, CURR DRUG TARGETS, V11, P630; Mullins RF, 2011, EXP EYE RES, V93, P565, DOI 10.1016/j.exer.2011.06.015; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Nishiguchi KM, 2012, INVEST OPHTH VIS SCI, V53, P508, DOI 10.1167/iovs.11-8425; Robbie SJ, 2013, INVEST OPHTH VIS SCI, V54, P1490, DOI 10.1167/iovs.12-10169; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sarman S, 2008, CURR EYE RES, V33, P285, DOI 10.1080/02713680701885470; Sheu SJ, 2009, MOL VIS, V15, P1897; Shima C, 2008, ACTA OPHTHALMOL, V86, P372, DOI 10.1111/j.1600-0420.2007.01067.x; Skals M, 2011, PFLUG ARCH EUR J PHY, V462, P669, DOI 10.1007/s00424-011-1010-x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wu L, 2008, GRAEF ARCH CLIN EXP, V246, P81, DOI 10.1007/s00417-007-0660-z; Wu T, 2011, AM J PHYSIOL-HEART C, V301, pH69, DOI 10.1152/ajpheart.01035.2010; Yafai Y, 2011, EUR J PHARMACOL, V666, P12, DOI 10.1016/j.ejphar.2011.05.016	50	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76766	10.1371/journal.pone.0076766	http://dx.doi.org/10.1371/journal.pone.0076766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130789	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900083
J	Castoria, G; Giovannelli, P; Di Donato, M; Hayashi, R; Arra, C; Appella, E; Auricchio, F; Migliaccio, A				Castoria, Gabriella; Giovannelli, Pia; Di Donato, Marzia; Hayashi, Ryo; Arra, Claudio; Appella, Ettore; Auricchio, Ferdinando; Migliaccio, Antimo			Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells	PLOS ONE			English	Article							DEPENDENT NUCLEAR EXPORT; SOFT-TISSUE SARCOMAS; BREAST-CANCER CELLS; ESTRADIOL-RECEPTOR; MATRIX METALLOPROTEINASES; DNA-SYNTHESIS; STEROID-RECEPTORS; GROWTH; SRC; PEPTIDE	Background: Hormones and growth factors influence the proliferation and invasiveness of human mesenchymal tumors. The highly aggressive human fibrosarcoma HT1080 cell line harbors classical androgen receptor (AR) that responds to androgens triggering cell migration in the absence of significant mitogenesis. As occurs in many human cancer cells, HT1080 cells also express epidermal growth factor receptor (EGFR). Experimental: Findings: We report that the pure anti-androgen Casodex inhibits the growth of HT1080 cell xenografts in immune-depressed mice, revealing a novel role of AR in fibrosarcoma progression. In HT1080 cultured cells EGF, but not androgens, robustly increases DNA synthesis. Casodex abolishes the EGF mitogenic effect, implying a crosstalk between EGFR and AR. The mechanism underlying this crosstalk has been analyzed using an AR-derived small peptide, S1, which prevents AR/Src tyrosine kinase association and androgen-dependent Src activation. Present findings show that in HT1080 cells EGF induces AR/Src Association, and the S1 peptide abolishes both the assembly of this complex and Src activation. The S1 peptide inhibits EGF-stimulated DNA synthesis, cell matrix metalloproteinase-9 (MMP-9) secretion and invasiveness of HT1080 cells. Both Casodex and S1 peptide also prevent DNA synthesis and migration triggered by EGF in various human cancer-derived cells (prostate, breast, colon and pancreas) that express AR. Conclusion: This study shows that targeting the AR domain involved in AR/ Src association impairs EGF signaling in human fibrosarcoma HT1080 cells. The EGF-elicited processes inhibited by the peptide (DNA synthesis, MMP-9 secretion and invasiveness) cooperate in increasing the aggressive phenotype of HT1080 cells. Therefore, AR represents a new potential therapeutic target in human fibrosarcoma, as supported by Casodex inhibition of HT1080 cell xenografts. The extension of these findings in various human cancer-derived cell lines highlights the conservation of this process across divergent cancer cells and identifies new potential targets in the therapeutic approach to human cancers.	[Castoria, Gabriella; Giovannelli, Pia; Di Donato, Marzia; Auricchio, Ferdinando; Migliaccio, Antimo] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Arra, Claudio] Ist Diag & Cura Tumori Fdn G Pascale, Naples, Italy; [Hayashi, Ryo; Appella, Ettore] NCI, Cell Biol Lab, Bethesda, MD 20892 USA	Universita della Campania Vanvitelli; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Migliaccio, A (corresponding author), Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	antimo.migliaccio@unina2.it	Giovannelli, Pia/J-7931-2019; Migliaccio, Antimo/AAB-3376-2019; Castoria, Gabriella/I-3349-2019; Di Donato, Marzia/M-3114-2018	Castoria, Gabriella/0000-0002-0576-4494; Arra, Claudio/0000-0003-3162-2091; Di Donato, Marzia/0000-0001-7207-826X; Giovannelli, Pia/0000-0002-2488-917X; Migliaccio, Antimo/0000-0002-4197-2055	Italian Association for Cancer Research (A.I.R.C.) [IG 11520]; Italian Ministry for University and Scientific Research (P.R.I.N) [2010NFEB9L_002]; A.I.R.C.	Italian Association for Cancer Research (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for University and Scientific Research (P.R.I.N)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); A.I.R.C.(Fondazione AIRC per la ricerca sul cancro)	The Italian Association for Cancer Research (A.I.R.C.; grant number IG 11520 to AM), and the Italian Ministry for University and Scientific Research (P.R.I.N 2010-2011; grant number 2010NFEB9L_002 to GC) funded this work. Pia Giovannelli is supported by a fellowship from A.I.R.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogush TA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1421, DOI 10.1134/S0006297910120011; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Castoria G, 2004, STEROIDS, V69, P517, DOI 10.1016/j.steroids.2004.05.001; Castoria G, 2012, ONCOGENE, V31, P4868, DOI 10.1038/onc.2011.642; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHAUDHURI PK, 1980, CANCER RES, V40, P861; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; DiDomenico M, 1996, CANCER RES, V56, P4516; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; GUSTERSON B, 1985, INT J CANCER, V36, P689; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 2011, METHODS MOL BIOL, V776, P361, DOI 10.1007/978-1-61779-243-4_21; Migliaccio A, 2010, MOL CELL ENDOCRINOL, V327, P19, DOI 10.1016/j.mce.2010.06.014; Okitsu Kohichiroh, 2010, Genes Cancer, V1, P859, DOI 10.1177/1947601910383417; Partridge JJ, 2007, J BIOL CHEM, V282, P35964, DOI 10.1074/jbc.M705993200; Ren WH, 2008, CLIN CANCER RES, V14, P2785, DOI 10.1158/1078-0432.CCR-07-4471; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Stabile LP, 2002, CANCER RES, V62, P2141; Vanderschueren D, 2008, CURR OPIN ENDOCRINOL, V15, P250, DOI 10.1097/MED.0b013e3282fe6ca9; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298	28	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76899	10.1371/journal.pone.0076899	http://dx.doi.org/10.1371/journal.pone.0076899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130806	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900100
J	Elster, JD; McGuire, TF; Lu, J; Prochownik, EV				Elster, Jennifer D.; McGuire, Terence F.; Lu, Jie; Prochownik, Edward V.			Rapid In Vitro Derivation of Endothelium Directly From Human Cancer Cells	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; PROGENITOR CELLS; BREAST-CANCER; GROWTH-FACTOR; BEVACIZUMAB; EXPRESSION; MICROENVIRONMENT	The development of an independent blood supply by a tumor is essential for maintaining growth beyond a certain limited size and for providing a portal for metastatic dissemination. Host-derived endothelial cells (ECs) residing in and compromising the tumor vasculature originate via distinct processes known as sprouting angiogenesis and vasculogenesis. More recently ECs originating directly from the tumor cells themselves have been described although the basis for this phenomenon remains poorly understood. Here we describe in vitro conditions that allow lung and ovarian cancer cells to undergo a rapid and efficient transition into ECs that are indistinguishable from those obtained in vivo. A variety of methods were used to establish that the acquired phenotypes and behaviors of these tumor-derived ECs (TDECs) closely resemble those of authentic ECs. Xenografts arising from co-inoculated in vitro-derived TDECs and tumor cells were also more highly vascularized than control tumors; moreover, their blood vessels were on average larger and frequently contained admixtures of host-derived ECs and TDECs derived from the initial inoculum. These results demonstrate that cancer cells can be manipulated under well-defined in vitro conditions to initiate a tumor cell-to-EC transition that is largely cell-autonomous, highly efficient and closely mimics the in vivo process. These studies provide a suitable means by which to identify and perhaps modify the earliest steps in TDEC generation.	[Elster, Jennifer D.; McGuire, Terence F.; Lu, Jie; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA.	procev@chp.edu			NIH [RO1 CA140624]; St. Baldrick's post-doctoral fellowship award; NATIONAL CANCER INSTITUTE [R01CA140624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's post-doctoral fellowship award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant RO1 CA140624 to E.V.P. and by a St. Baldrick's post-doctoral fellowship award to J.D.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Amini A, 2012, CURR CANCER DRUG TAR, V12, P23, DOI 10.2174/156800912798888956; Beaudry P, 2008, MOL CANCER THER, V7, P418, DOI 10.1158/1535-7163.MCT-07-0568; Birner P, 2003, BRAIN PATHOL, V13, P133, DOI 10.1111/j.1750-3639.2003.tb00013.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Folkman J, 2003, CANCER BIOL THER, V2, pS127; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Le Bourhis X, 2010, BREAST CANCER RES TR, V120, P17, DOI 10.1007/s10549-009-0686-5; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Mackey JR, 2012, CANCER TREAT REV, V38, P673, DOI 10.1016/j.ctrv.2011.12.002; McGuire TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037138; Moserle L, 2009, CURR MOL MED, V9, P935, DOI 10.2174/156652409789712800; Naumov GN, 2009, CLIN EXP METASTAS, V26, P51, DOI 10.1007/s10585-008-9176-0; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rigolin GM, 2006, BLOOD, V107, P2531, DOI 10.1182/blood-2005-04-1768; Rini BI, 2004, CLIN CANCER RES, V10, P2584, DOI 10.1158/1078-0432.CCR-03-0605; Sajithlal GB, 2010, INT J CANCER, V127, P2268, DOI 10.1002/ijc.25251; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; SIMONSEN CC, 1983, P NATL ACAD SCI-BIOL, V80, P2495, DOI 10.1073/pnas.80.9.2495; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77675	10.1371/journal.pone.0077675	http://dx.doi.org/10.1371/journal.pone.0077675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130897	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900142
J	Phipps, WL; Wolter, K; Michael, MD; MacTavish, LM; Yarnell, RW				Phipps, W. Louis; Wolter, Kerri; Michael, Michael D.; MacTavish, Lynne M.; Yarnell, Richard W.			Do Power Lines and Protected Areas Present a Catch-22 Situation for Cape Vultures (Gyps coprotheres)?	PLOS ONE			English	Article							LAND-USE; RANGING BEHAVIOR; BREEDING STATUS; WIND-FARMS; MORTALITY; FULVUS; AFRICANUS; POPULATION; DECLINE	Cape vulture Gyps coprotheres populations have declined across their range due to multiple anthropogenic threats. Their susceptibility to fatal collisions with the expanding power line network and the prevalence of carcasses contaminated with illegal poisons and other threats outside protected areas are thought to be the primary drivers of declines in southern Africa. We used GPS-GSM units to track the movements and delineate the home ranges of five adult (mean +/- SD minimum convex polygon area = 121,655 +/- 90,845 km(2)) and four immature (mean +/- SD minimum convex polygon area = 492,300 +/- 259,427 km(2)) Cape vultures to investigate the influence of power lines and their use of protected areas. The vultures travelled more than 1,000 km from the capture site and collectively entered five different countries in southern Africa. Their movement patterns and core foraging ranges were closely associated with the spatial distribution of transmission power lines and we present evidence that the construction of power lines has allowed the species to extend its range to areas previously devoid of suitable perches. The distribution of locations of known Cape vulture mortalities caused by interactions with power lines corresponded to the core ranges of the tracked vultures. Although some of the vultures regularly roosted at breeding colonies located inside protected areas the majority of foraging activity took place on unprotected farmland. Their ability to travel vast distances very quickly and the high proportion of time they spend in the vicinity of power lines and outside protected areas make Cape vultures especially vulnerable to negative interactions with the expanding power line network and the full range of threats across the region. Co-ordinated cross-border conservation strategies beyond the protected area network will therefore be necessary to ensure the future survival of threatened vultures in Africa.	[Phipps, W. Louis; Yarnell, Richard W.] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, Notts, England; [Wolter, Kerri] VulPro, Rietfontein, North West Prov, South Africa; [Michael, Michael D.] Eskom Holdings Ltd, Res Testing & Dev, Johannesburg, Gauteng Provinc, South Africa; [MacTavish, Lynne M.] Mankwe Wildlife Reserve, Mogwase, North West Prov, South Africa	Nottingham Trent University	Phipps, WL (corresponding author), Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, Notts, England.	louis.phipps@ntu.ac.uk	Yarnell, Richard W/C-3531-2014; Phipps, Louis/I-2935-2019	Phipps, Louis/0000-0003-0400-2014; Yarnell, Richard/0000-0001-6584-7374	Mazda Wildlife; Rand Merchant Bank and Computer Facilities; Eskom Holdings Ltd through VulPro; Mankwe Wildlife Reserve; Leverhulme Trust; WLP; Nottingham Trent University	Mazda Wildlife; Rand Merchant Bank and Computer Facilities; Eskom Holdings Ltd through VulPro; Mankwe Wildlife Reserve; Leverhulme Trust(Leverhulme Trust); WLP; Nottingham Trent University	The Mazda Wildlife Fund provided KW and VulPro with a research vehicle. Rand Merchant Bank and Computer Facilities provided additional funding to VulPro. Eskom Holdings Ltd funded the tracking units through VulPro. Mankwe Wildlife Reserve provided additional funding for fieldwork. The Leverhulme Trust funded fieldwork and WLP with a Study Abroad Studentship. WLP received a Vice Chancellor's bursary from Nottingham Trent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M. D., 2008, VULTURE NEWS, V57, P45; Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; Bamford AJ, 2009, IBIS, V151, P51, DOI 10.1111/j.1474-919X.2008.00878.x; Barrientos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032569; Benson PC, 2004, OSTRICH, V75, P118, DOI 10.2989/00306520409485423; BENSON PC, 1990, OSTRICH, V61, P134, DOI 10.1080/00306525.1990.9634162; Beyer H. L, 2012, GEOSPATIAL MODELLING; BirdLife International, 2012, IUCN 2012 IUCN RED L; BirdLife International, 2008, IUCN RED LIST THREAT; Borello WD, 2002, BIRD CONSERV INT, V12, P79, DOI 10.1017/S0959270902002058; Bose M, 2007, ORYX, V41, P503, DOI 10.1017/S0030605307000312; Boshoff AF, 2011, BIRD CONSERV INT, V21, P311, DOI 10.1017/S095927091100013X; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Diekmann M., 2004, VULTURE NEWS, V51, P34; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Duriez O, 2012, BIRD STUDY, V59, P193, DOI 10.1080/00063657.2012.658640; Duriez Olivier, 2011, Ringing & Migration, V26, P24; Eskom-EWT, 2012, CENTR INC REG HELD C; ESRI, 2008, ARCMAP 8 3; Garcia-Fernandez AJ, 2005, ENVIRON TOXICOL, V20, P459, DOI 10.1002/tox.20132; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Guil F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028212; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Herremans M, 2000, BIOL CONSERV, V94, P31, DOI 10.1016/S0006-3207(99)00166-4; HOUSTON DC, 1974, J ZOOL, V172, P35; *IUCN, 2003, WORLD DAT PROT AR; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Janss GFE, 2000, BIOL CONSERV, V95, P353, DOI 10.1016/S0006-3207(00)00021-5; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Kendall CJ, 2012, J RAPTOR RES, V46, P135, DOI 10.3356/JRR-10-87.1; Kruger R, 2001, AVIAN INTERACTIONS U, P229; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2012, SCIENCE, V338, P192, DOI 10.1126/science.338.6104.192-a; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; MERETSKY VJ, 1992, CONDOR, V94, P313, DOI 10.2307/1369205; Monadjem A, 2005, BIODIVERS CONSERV, V14, P2079, DOI 10.1007/s10531-004-4358-9; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Mundy P., 1992, VULTURES AFRICA; Mundy P.J., 1997, ATLAS SO AFRICAN BIR, V1, P158; Murn C, 2008, OSTRICH, V79, P191, DOI 10.2989/OSTRICH.2008.79.2.9.583; Naidoo V, 2011, J S AFR VET ASSOC, V82, P24; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; Phipps WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052813; Rodgers A.R., 2007, HOME RANGE TOOLS HRT; Shaw JM, 2010, IBIS, V152, P590, DOI 10.1111/j.1474-919X.2010.01039.x; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Thiollay JM, 2006, BIRD CONSERV INT, V16, P353, DOI 10.1017/S0959270906000487; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Whittington-Jones C, 2011, VULTURE NEWS, V60, P6; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	62	20	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76794	10.1371/journal.pone.0076794	http://dx.doi.org/10.1371/journal.pone.0076794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24137496	gold, Green Published			2022-12-27	WOS:000325810900084
J	Tompkins, VS; Han, SS; Olivier, A; Syrbu, S; Bair, T; Button, A; Jacobus, L; Wang, ZB; Lifton, S; Raychaudhuri, P; Morse, HC; Weiner, G; Link, B; Smith, BJ; Janz, S				Tompkins, Van S.; Han, Seong-Su; Olivier, Alicia; Syrbu, Sergei; Bair, Thomas; Button, Anna; Jacobus, Laura; Wang, Zebin; Lifton, Samuel; Raychaudhuri, Pradip; Morse, Herbert C., III; Weiner, George; Link, Brian; Smith, Brian J.; Janz, Siegfried			Identification of Candidate B-Lymphoma Genes by Cross-Species Gene Expression Profiling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXM1; PLASMA-CELL NEOPLASMS; C-MYC; BURKITTS-LYMPHOMA; TUMOR-SUPPRESSOR; CANCER; TARGET; PROGRESSION; CYCLE; RESISTANCE	Comparative genome-wide expression profiling of malignant tumor counterparts across the human-mouse species barrier has a successful track record as a gene discovery tool in liver, breast, lung, prostate and other cancers, but has been largely neglected in studies on neoplasms of mature B-lymphocytes such as diffuse large B cell lymphoma (DLBCL) and Burkitt lymphoma (BL). We used global gene expression profiles of DLBCL-like tumors that arose spontaneously in Myc-transgenic C57BL/6 mice as a phylogenetically conserved filter for analyzing the human DLBCL transcriptome. The human and mouse lymphomas were found to have 60 concordantly deregulated genes in common, including 8 genes that Cox hazard regression analysis associated with overall survival in a published landmark dataset of DLBCL. Genetic network analysis of the 60 genes followed by biological validation studies indicate FOXM1 as a candidate DLBCL and BL gene, supporting a number of studies contending that FOXM1 is a therapeutic target in mature B cell tumors. Our findings demonstrate the value of the "mouse filter" for genomic studies of human B-lineage neoplasms for which a vast knowledge base already exists.	[Tompkins, Van S.; Han, Seong-Su; Olivier, Alicia; Syrbu, Sergei; Lifton, Samuel; Janz, Siegfried] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Bair, Thomas] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Button, Anna; Smith, Brian J.] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA; [Jacobus, Laura; Weiner, George; Link, Brian] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Syrbu, Sergei; Jacobus, Laura; Weiner, George; Link, Brian; Smith, Brian J.; Janz, Siegfried] Univ Iowa, Holden Comprehens Canc Ctr, Carver Coll Med, Iowa City, IA 52242 USA; [Wang, Zebin; Raychaudhuri, Pradip] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL USA; [Lifton, Samuel] Univ Iowa, Dept Stat & Actuarial Sci, Coll Liberal Arts & Sci, Iowa City, IA 52242 USA; [Morse, Herbert C., III] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Janz, S (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA.	siegfried-janz@uiowa.edu	Tompkins, Van/A-5757-2018	Tompkins, Van/0000-0003-1279-8075; weiner, george/0000-0003-3427-0562; Link, Brian/0000-0001-5084-0698; Button, Anna/0000-0002-8540-6047; Morse, Herbert/0000-0002-9331-3705; Han, Seong-Su/0000-0001-9824-6751; Syrbu, Sergei/0000-0003-4620-7923	UI/MC Lymphoma SPORE [5 P50 CA097274]; American Cancer Society [PF0818001L2B]; NIH [T32 HL07734]; Multiple Myeloma Research and International Waldenstrom's Macroglobulinemia Foundations; NCI [R01CA151354]; NIH, National institute of Allergy and Infectious Diseases (HCM); NATIONAL CANCER INSTITUTE [R01CA151354, P50CA097274] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER	UI/MC Lymphoma SPORE; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research and International Waldenstrom's Macroglobulinemia Foundations; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National institute of Allergy and Infectious Diseases (HCM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Developmental Research Award of the UI/MC Lymphoma SPORE 5 P50 CA097274 to SJ. VST was supported by Postdoctoral Fellowship PF0818001L2B from the American Cancer Society and NIH T32 HL07734. This work was also supported, in part, by research awards from the Multiple Myeloma Research and International Waldenstrom's Macroglobulinemia Foundations (SJ) and R01CA151354 from the NCI (SJ), as well as the Intramural Research Program of the NIH, National institute of Allergy and Infectious Diseases (HCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek N, 2010, HUM PATHOL, V41, P1448, DOI 10.1016/j.humpath.2010.04.001; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andreasson U, 2009, AM J HEMATOL, V84, P803, DOI 10.1002/ajh.21549; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475; Chan MM, 2005, CARCINOGENESIS, V26, P1343, DOI 10.1093/carcin/bgi100; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dai YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-77; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frontini M, 2012, DEV CELL, V23, P356, DOI 10.1016/j.devcel.2012.06.018; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Green MR, 2011, GENE CHROMOSOME CANC, V50, P313, DOI 10.1002/gcc.20856; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hsu PL, 1998, CANCER RES, V58, P5507; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Janz Siegfried, 2008, P179, DOI 10.1007/978-0-387-69132-9_8; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kass DJ, 2011, CYTOKINE, V55, P325, DOI 10.1016/j.cyto.2011.05.021; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kramer MHH, 1996, J CLIN ONCOL, V14, P2131, DOI 10.1200/JCO.1996.14.7.2131; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lossos IS, 2002, P NATL ACAD SCI USA, V99, P8886, DOI 10.1073/pnas.132253599; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mancina RM, 2013, DIABETES-METAB RES, V29, P413, DOI 10.1002/dmrr.2408; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nadler-Holly M, 2012, P NATL ACAD SCI USA, V109, P18833, DOI 10.1073/pnas.1209277109; OFFIT K, 1991, GENE CHROMOSOME CANC, V3, P189, DOI 10.1002/gcc.2870030304; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Rhodes DR, 2004, ANN NY ACAD SCI, V1020, P32, DOI 10.1196/annals.1310.005; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sethi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Uddin S, 2012, HAEMATOL-HEMATOL J, V97, P1092, DOI 10.3324/haematol.2011.053421; Voehringer DW, 2000, P NATL ACAD SCI USA, V97, P2680, DOI 10.1073/pnas.97.6.2680; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2006, FEBS J, V273, P4645, DOI 10.1111/j.1742-4658.2006.05468.x; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Zhao L, 2003, MOL CANCER RES, V1, P195	66	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76889	10.1371/journal.pone.0076889	http://dx.doi.org/10.1371/journal.pone.0076889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130802	Green Published, gold			2022-12-27	WOS:000325810900097
J	Miyaji, Y; Otsuka, N; Toyoizumi-Ajisaka, H; Shibayama, K; Kamachi, K				Miyaji, Yusuke; Otsuka, Nao; Toyoizumi-Ajisaka, Hiromi; Shibayama, Keigo; Kamachi, Kazunari			Genetic Analysis of Bordetella pertussis Isolates from the 2008-2010 Pertussis Epidemic in Japan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; TEMPORAL TRENDS; WHOOPING-COUGH; UNITED-STATES; VACCINE; STRAINS; DIVERSITY; PERTACTIN; FIM3; AGGLUTINATION	A large pertussis epidemic occurred between 2008 and 2010 in Japan. To investigate epidemic strains, we analyzed 33 Bordetella pertussis isolates from the epidemic period by sequencing virulence-associated genes (fim3, ptxP, ptxA, and prn) and performing multilocus variable-number tandem repeat analysis (MLVA), and compared these results with those of 101 isolates from non-epidemic, earlier and later time periods. DNA sequencing of the fim3 allele revealed that the frequency of fim3B was 4.3%, 12.8%, 30.3%, and 5.1% within isolates in 2002-2004, 2005-2007, 2008-2010, and 2011-2012, respectively. The isolation rate of the fim3B strain therefore temporarily increased during the epidemic period 2008-2010. In contrast, the frequencies of the virulence-associated allelic variants, ptxP3, ptxA1, and prn2, increased with time during overall study period, indicating that these variants were not directly involved in the occurrence of the 2008-2010 epidemic. MLVA genotyping in combination with analysis of allele types showed that the prevalence of an MT27d strain temporarily increased in the epidemic period, and that this strain carried virulence-associated allelic variants (fim3B, ptxP3, ptxA1, and prn2) also identified in recent epidemic strains of Australia, Europe, and the US. Phenotypic analyses revealed that the serotype Fim3 strain was predominant (>= 87%) during all the periods studied, and that the frequency of adhesion pertactin (Prn) non-expressing B. pertussis decreased by half in the epidemic period. All MT27d strains expressed Prn and Fim3 proteins, suggesting that B. pertussis MT27d strains expressing Prn and Fim3B have the potential to cause large epidemics worldwide.	[Miyaji, Yusuke; Otsuka, Nao; Toyoizumi-Ajisaka, Hiromi; Shibayama, Keigo; Kamachi, Kazunari] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Miyaji, Yusuke] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan	National Institute of Infectious Diseases (NIID); Saint Marianna University	Kamachi, K (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	kamachi@nih.go.jp		Kamachi, Kazunari/0000-0001-5259-1744	Ministry of Health, Labor and Welfare of Japan [24170201]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by a grant (24170201) for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Alexander F, 2012, CLIN VACCINE IMMUNOL, V19, P1776, DOI 10.1128/CVI.00355-12; AOYAMA T, 1986, J CLIN MICROBIOL, V23, P1046, DOI 10.1128/JCM.23.6.1046-1048.1986; Barkoff AM, 2012, CLIN VACCINE IMMUNOL, V19, P1703, DOI 10.1128/CVI.00367-12; Bisgard KM, 2001, J INFECT DIS, V183, P1360, DOI 10.1086/319858; Campbell P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035874; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Fisman DN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-694; Geuijen CAW, 1997, INFECT IMMUN, V65, P4222, DOI 10.1128/IAI.65.10.4222-4228.1997; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Han HJ, 2008, VACCINE, V26, P1530, DOI 10.1016/j.vaccine.2008.01.020; Hegerle N, 2012, CLIN MICROBIOL INFEC, V18, pE340, DOI 10.1111/j.1469-0691.2012.03925.x; Heikkinen E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-162; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kurniawan J, 2010, EMERG INFECT DIS, V16, P297, DOI 10.3201/eid1602.081707; LAIRD WJ, 1980, J CLIN MICROBIOL, V11, P430, DOI 10.1128/JCM.11.4.430-432.1980; Lin YC, 2006, MICROBES INFECT, V8, P2082, DOI 10.1016/j.micinf.2006.03.019; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nakamura Y, 2011, CLIN MICROBIOL INFEC, V17, P365, DOI 10.1111/j.1469-0691.2010.03255.x; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Okada K, 2010, VACCINE, V28, P7626, DOI 10.1016/j.vaccine.2010.09.050; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Petersen RF, 2012, EMERG INFECT DIS, V18, P767, DOI 10.3201/eid1805.110812; Poolman JT, 2007, EXPERT REV VACCINES, V6, P47, DOI 10.1586/14760584.6.1.47; Queenan AM, 2013, NEW ENGL J MED, V368, P583, DOI 10.1056/NEJMc1209369; Schmidtke AJ, 2012, EMERG INFECT DIS, V18, P1248, DOI 10.3201/eid1808.120082; Shuel M, 2013, INT J INFECT DIS, V17, pE413, DOI 10.1016/j.ijid.2012.12.015; Spokes Paula J, 2010, N S W Public Health Bull, V21, P167, DOI 10.1071/NB10031; Tsang RSW, 2005, J CLIN MICROBIOL, V43, P2449, DOI 10.1128/JCM.43.5.2449-2451.2005; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; van Gent M, 2009, VACCINE, V27, P1898, DOI 10.1016/j.vaccine.2009.01.111; van Loo IHM, 2002, J CLIN MICROBIOL, V40, P1994, DOI 10.1128/JCM.40.6.1994-2001.2002; Williamson P, 1996, FEMS IMMUNOL MED MIC, V13, P169, DOI 10.1016/0928-8244(95)00123-9; Zhang L, 2010, EMERG INFECT DIS, V16, P1695, DOI 10.3201/eid1611.100401; Zhang SM, 2011, J BACTERIOL, V193, P4017, DOI 10.1128/JB.05184-11	48	59	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77165	10.1371/journal.pone.0077165	http://dx.doi.org/10.1371/journal.pone.0077165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124606	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100163
J	De, A; De, A; Papasian, C; Hentges, S; Banerjee, S; Haque, I; Banerjee, SK				De, Alok; De, Archana; Papasian, Chris; Hentges, Shane; Banerjee, Snigdha; Haque, Inamul; Banerjee, Sushanta K.			Emblica officinalis Extract Induces Autophagy and Inhibits Human Ovarian Cancer Cell Proliferation, Angiogenesis, Growth of Mouse Xenograft Tumors	PLOS ONE			English	Article							BETA-ENDORPHIN RELEASE; HYPOTHALAMIC NEURONS; UP-REGULATION; IN-VITRO; APOPTOSIS; HYPOXIA; EXPRESSION; INDUCTION; BCL-2; MODULATION	Patients with ovarian cancer (OC) may be treated with surgery, chemotherapy and/or radiation therapy, although none of these strategies are very effective. Several plant-based natural products/dietary supplements, including extracts from Emblica officinalis (Amla), have demonstrated potent anti-neoplastic properties. In this study we determined that Amla extract (AE) has anti-proliferative effects on OC cells under both in vitro and in vivo conditions. We also determined the anti-proliferative effects one of the components of AE, quercetin, on OC cells under in vitro conditions. AE did not induce apoptotic cell death, but did significantly increase the expression of the autophagic proteins beclin1 and LC3B-II under in vitro conditions. Quercetin also increased the expression of the autophagic proteins beclin1 and LC3B-II under in vitro conditions. AE also significantly reduced the expression of several angiogenic genes, including hypoxia-inducible factor 1 alpha (HIF-1 alpha) in OVCAR3 cells. AE acted synergistically with cisplatin to reduce cell proliferation and increase expression of the autophagic proteins beclin1 and LC3B-II under in vitro conditions. AE also had anti-proliferative effects and induced the expression of the autophagic proteins beclin1 and LC3B-II in mouse xenograft tumors. Additionally, AE reduced endothelial cell antigen - CD31 positive blood vessels and HIF-1 alpha expression in mouse xenograft tumors. Together, these studies indicate that AE inhibits OC cell growth both in vitro and in vivo possibly via inhibition of angiogenesis and activation of autophagy in OC. Thus AE may prove useful as an alternative or adjunct therapeutic approach in helping to fight OC.	[De, Alok] Univ Missouri, Sch Med, Dept OB GYN, Kansas City, MO 64108 USA; [De, Archana; Banerjee, Snigdha; Haque, Inamul; Banerjee, Sushanta K.] VA Med Ctr, Canc Res Unit, Kansas City, MO USA; [Papasian, Chris] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Hentges, Shane] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Banerjee, Snigdha; Haque, Inamul; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Med, Div Hematol & Oncol, Kansas City, KS 66103 USA; [Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Colorado State University; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	De, A (corresponding author), Univ Missouri, Sch Med, Dept OB GYN, Kansas City, MO 64108 USA.	dea@umkc.edu	Haque, Inamul/I-2482-2019; Hentges, Shane T/B-9747-2012	Haque, Inamul/0000-0002-1307-9446; Banerjee, Sushanta/0000-0002-7698-0717	UMKC; VA Merit Award Grant	UMKC; VA Merit Award Grant(US Department of Veterans Affairs)	This study was supported by a UMKC intramural fund and a VA Merit Award Grant (SKB, SB). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish or participation of the manuscript.	Baliga MS, 2011, EUR J CANCER PREV, V20, P225, DOI 10.1097/CEJ.0b013e32834473f4; Banerjee S, 2008, BIOCHEMISTRY-US, V47, P3345, DOI 10.1021/bi8000352; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; *BOARD, 2011, SURV RAT OV CANC; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chopra RN, 1958, INDIGENOUS DRUGS IND; Conte C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003078; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DE A, 1994, J BIOL CHEM, V269, P26697; De A, 2002, ALCOHOL CLIN EXP RES, V26, P1420, DOI 10.1097/01.ALC.0000030621.35354.E0; De A, 1999, ALCOHOL CLIN EXP RES, V23, P850, DOI 10.1097/00000374-199905000-00013; De A, 2002, J PHARMACOL EXP THER, V301, P119, DOI 10.1124/jpet.301.1.119; DE A, 1995, INT J ONCOL, V7, P643; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fernando NT, 2008, CLIN CANCER RES, V14, P1529, DOI 10.1158/1078-0432.CCR-07-4126; Folkman J, 1974, Adv Cancer Res, V19, P331, DOI 10.1016/S0065-230X(08)60058-5; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Haddad JJ, 2002, EUR CYTOKINE NETW, V13, P250; HAWKINS CJ, 1994, IMMUNOL REV, V142, P127, DOI 10.1111/j.1600-065X.1994.tb00886.x; Hirsch K, 2000, NUTR CANCER, V38, P245, DOI 10.1207/S15327914NC382_14; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Ishikawa K, 2010, INVEST OPHTH VIS SCI, V51, P4307, DOI 10.1167/iovs.09-4605; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jose JK, 2001, J ETHNOPHARMACOL, V75, P65, DOI 10.1016/S0378-8741(00)00378-0; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; KUWABARA K, 1995, P NATL ACAD SCI USA, V92, P4606, DOI 10.1073/pnas.92.10.4606; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Liu WK, 2008, J NAT PROD, V71, P842, DOI 10.1021/np8001223; Lu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043934; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; NEWCOMB EW, 2009, HIF 1 REGULATION CHE; Ngamkitidechakul C, 2010, PHYTOTHER RES, V24, P1405, DOI 10.1002/ptr.3127; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Penolazzi L, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-59; PEVERALI FA, 1994, J CELL PHYSIOL, V161, P1, DOI 10.1002/jcp.1041610102; Plouzek CA, 1999, EUR J CANCER, V35, P1541, DOI 10.1016/S0959-8049(99)00180-X; Ricciardi A, 2008, MOL CANCER RES, V6, P175, DOI 10.1158/1541-7786.MCR-07-0391; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sen S, 2010, INT J PHARM SCI RES, V1, P32, DOI 10.13040/IJPSR.0975-8232.1(11).32-44; Shi YH, 2007, PATHOLOGY, V39, P396, DOI 10.1080/00313020701444549; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slager EH, 2006, BLOOD, V107, P4954, DOI 10.1182/blood-2005-09-3883; Tan ML, 2005, J ETHNOPHARMACOL, V96, P287, DOI 10.1016/j.jep.2004.09.025; TSUJIMOTO Y, 1989, ONCOGENE, V4, P1331; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wang XM, 1997, J MED MICROBIOL, V46, P705, DOI 10.1099/00222615-46-8-705; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yoshida D, 2006, J NEURO-ONCOL, V76, P13, DOI 10.1007/s11060-005-3279-0; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang Lan-zhen, 2003, Zhongguo Zhongyao Zazhi, V28, P940; Zhao Y, 1997, CANCER LETT, V121, P163, DOI 10.1016/S0304-3835(97)00348-0; Zhu YM, 2006, BRIT J CANCER, V94, P1936, DOI 10.1038/sj.bjc.6603177	58	50	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72748	10.1371/journal.pone.0072748	http://dx.doi.org/10.1371/journal.pone.0072748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24133573	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000112
J	Binder, ZA; Siu, IM; Eberhart, CG; ap Rhys, C; Bai, RY; Staedtke, V; Zhang, H; Smoll, NR; Piantadosi, S; Piccirillo, SG; DiMeco, F; Weingart, JD; Vescovi, A; Olivi, A; Riggins, GJ; Gallia, GL				Binder, Zev A.; Siu, I-Mei; Eberhart, Charles G.; ap Rhys, Colette; Bai, Ren-Yuan; Staedtke, Verena; Zhang, Hao; Smoll, Nicolas R.; Piantadosi, Steven; Piccirillo, Sara G.; DiMeco, Francesco; Weingart, Jon D.; Vescovi, Angelo; Olivi, Alessandro; Riggins, Gregory J.; Gallia, Gary L.			Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome	PLOS ONE			English	Article							GENE-EXPRESSION; EMBRYONAL CARCINOMA; MAJOR SIALOPROTEIN; PROSTATE-CANCER; SELF-RENEWAL; MOUSE-BRAIN; IDENTIFICATION; TUMORS; BREAST; MARKER	Glioblastoma multiforme (GBM) is the most common primary malignant adult brain tumor and is associated with poor survival. Recently, stem-like cell populations have been identified in numerous malignancies including GBM. To identify genes whose expression is changed with differentiation, we compared transcript profiles from a GBM oncosphere line before and after differentiation. Bioinformatic analysis of the gene expression profiles identified podocalyxin-like protein (PODXL), a protein highly expressed in human embryonic stem cells, as a potential marker of undifferentiated GBM stem-like cells. The loss of PODXL expression upon differentiation of GBM stem-like cell lines was confirmed by quantitative real-time PCR and flow cytometry. Analytical flow cytometry of numerous GBM oncosphere lines demonstrated PODXL expression in all lines examined. Knockdown studies and flow cytometric cell sorting experiments demonstrated that PODXL is involved in GBM stem-like cell proliferation and oncosphere formation. Compared to PODXL-negative cells, PODXL-positive cells had increased expression of the progenitor/stem cell markers Musashi1, SOX2, and BMI1. Finally, PODXL expression directly correlated with increasing glioma grade and was a marker for poor outcome in patients with GBM. In summary, we have demonstrated that PODXL is expressed in GBM stem-like cells and is involved in cell proliferation and oncosphere formation. Moreover, high PODXL expression correlates with increasing glioma grade and decreased overall survival in patients with GBM.	[Binder, Zev A.; Siu, I-Mei; ap Rhys, Colette; Bai, Ren-Yuan; DiMeco, Francesco; Weingart, Jon D.; Olivi, Alessandro; Riggins, Gregory J.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Binder, Zev A.] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Binder, Zev A.] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Staedtke, Verena] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Zhang, Hao] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Smoll, Nicolas R.] Monash Univ, Gippsland Med Sch, Churchill, Vic, Australia; [Piantadosi, Steven] Johns Hopkins Univ, Sch Med, Dept Oncol Biostat, Baltimore, MD USA; [Piccirillo, Sara G.] StemGen, Milan, Italy; [DiMeco, Francesco] Ist Nazl Neurol Carlo Besta, Dept Neurosurg, Milan, Italy; [Weingart, Jon D.; Olivi, Alessandro; Riggins, Gregory J.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Vescovi, Angelo] Univ Milano Biocca, Dept Biotechnol & Biosci, Milan, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Federation University Australia; Monash University; Johns Hopkins University; IRCCS Istituto Neurologico Besta; Johns Hopkins University; University of Milano-Bicocca	Gallia, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	ggallia1@jhmi.edu	Vescovi, Angelo Luigi/A-4919-2015; Olivi, Alessandro/K-6531-2016; DiMeco, Francesco/Z-5431-2019; DiMeco, Francesco/Q-3785-2016; Smoll, Nicolas/D-3322-2013	Vescovi, Angelo Luigi/0000-0002-1742-4112; Olivi, Alessandro/0000-0002-4489-7564; DiMeco, Francesco/0000-0001-6213-5793; Piccirillo, Sara Grazia Maria/0000-0003-4109-1992; Smoll, Nicolas/0000-0002-6923-9701	Brain Tumor Funding Collaborative; Virginia and D.K. Ludwig Fund for Cancer Research; National Institutes of Health [T32CA130840]; NATIONAL CANCER INSTITUTE [T32CA130840] Funding Source: NIH RePORTER	Brain Tumor Funding Collaborative; Virginia and D.K. Ludwig Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Brain Tumor Funding Collaborative (GJR), the Virginia and D.K. Ludwig Fund for Cancer Research (GJR), and the Postdoctoral Training Program in Nanotechnology for Cancer Medicine supported by National Institutes of Health grant T32CA130840 (ZAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Cai JL, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-26; Cancer Genome Anatomy Project, 2002, SAGE GEN; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Cerutti JM, 2004, J CLIN INVEST, V113, P1234, DOI 10.1172/JCI200419617; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014; Hayatsu N, 2008, BIOCHEM BIOPH RES CO, V374, P394, DOI 10.1016/j.bbrc.2008.07.049; He JT, 2010, J PROTEOME RES, V9, P2565, DOI 10.1021/pr100012p; Heukamp LC, 2006, HISTOPATHOLOGY, V49, P242, DOI 10.1111/j.1365-2559.2006.02489.x; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kelley TW, 2005, AM J CLIN PATHOL, V124, P134, DOI 10.1309/7BHLAHHU0N4MHT7Q; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerosuo L, 2004, BRIT J HAEMATOL, V124, P809, DOI 10.1111/j.1365-2141.2004.04840.x; Koch LK, 2008, HUM PATHOL, V39, P1597, DOI 10.1016/j.humpath.2008.03.008; Larrucea S, 2007, CELL MOL LIFE SCI, V64, P2965, DOI 10.1007/s00018-007-7374-6; Larrucea S, 2008, EXP CELL RES, V314, P2004, DOI 10.1016/j.yexcr.2008.03.009; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Loilome W, 2009, J NEURO-ONCOL, V94, P359, DOI 10.1007/s11060-009-9885-5; Mao XG, 2009, TRANSL ONCOL, V2, P247, DOI 10.1593/tlo.09136; Ney JT, 2007, HUM PATHOL, V38, P359, DOI 10.1016/j.humpath.2006.08.025; Nicolis SK, 2007, NEUROBIOL DIS, V25, P217, DOI 10.1016/j.nbd.2006.08.022; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Nowakowski A, 2010, MOL CELL NEUROSCI, V43, P90, DOI 10.1016/j.mcn.2009.09.011; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Platet N, 2007, FEBS LETT, V581, P1435, DOI 10.1016/j.febslet.2007.02.071; Porter DA, 2001, CANCER RES, V61, P5697; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Shen G, 2008, IN VITRO CELL DEV-AN, V44, P280, DOI 10.1007/s11626-008-9115-z; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Siu IM, 2010, J NEUROSURG-PEDIATR, V6, P92, DOI 10.3171/2010.3.PEDS09366; Siu IM, 1997, AM J PATHOL, V150, P1805; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Stanhope-Baker P, 2004, J BIOL CHEM, V279, P33575, DOI 10.1074/jbc.M404787200; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vitureira N, 2005, GENE EXPR PATTERNS, V5, P349, DOI 10.1016/j.modgep.2004.10.002; Vitureira N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012003; Wu H, 2013, EXP THER MED, V5, P1025, DOI 10.3892/etm.2013.957; Yasuoka H, 2008, J CLIN PATHOL, V61, P1228, DOI 10.1136/jcp.2008.059956; Yasuoka H, 2012, J CLIN PATHOL, V65, P399, DOI 10.1136/jclinpath-2011-200359; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269	68	32	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75945	10.1371/journal.pone.0075945	http://dx.doi.org/10.1371/journal.pone.0075945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146797	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400026
J	Cucinotta, FA; Kim, MHY; Chappell, LJ; Huff, JL				Cucinotta, Francis A.; Kim, Myung-Hee Y.; Chappell, Lori J.; Huff, Janice L.			How Safe Is Safe Enough? Radiation Risk for a Human Mission to Mars	PLOS ONE			English	Article							CIRCULATORY DISEASE; IONIZING-RADIATION; SPACE RADIATION; EXPOSURE; IRRADIATION; CANCER; DEPENDENCE; MORTALITY; RAYS	Astronauts on a mission to Mars would be exposed for up to 3 years to galactic cosmic rays (GCR) - made up of high-energy protons and high charge (Z) and energy (E) (HZE) nuclei. GCR exposure rate increases about three times as spacecraft venture out of Earth orbit into deep space where protection of the Earth's magnetosphere and solid body are lost. NASA's radiation standard limits astronaut exposures to a 3% risk of exposure induced death (REID) at the upper 95% confidence interval (CI) of the risk estimate. Fatal cancer risk has been considered the dominant risk for GCR, however recent epidemiological analysis of radiation risks for circulatory diseases allow for predictions of REID for circulatory diseases to be included with cancer risk predictions for space missions. Using NASA's models of risks and uncertainties, we predicted that central estimates for radiation induced mortality and morbidity could exceed 5% and 10% with upper 95% CI near 10% and 20%, respectively for a Mars mission. Additional risks to the central nervous system (CNS) and qualitative differences in the biological effects of GCR compared to terrestrial radiation may significantly increase these estimates, and will require new knowledge to evaluate.	[Cucinotta, Francis A.] NASA, Lyndon B Johnson Space Ctr, Space Radiat Program, Houston, TX 77058 USA; [Cucinotta, Francis A.] Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA; [Kim, Myung-Hee Y.; Chappell, Lori J.; Huff, Janice L.] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Universities Space Research Association (USRA)	Cucinotta, FA (corresponding author), NASA, Lyndon B Johnson Space Ctr, Space Radiat Program, Houston, TX 77058 USA.	francis.cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020	Huff, Janice/0000-0003-4236-7698; Kim, Myung-Hee/0000-0001-5575-6858	NASA Space Radiation Risk Project; University of Nevada Las Vegas	NASA Space Radiation Risk Project; University of Nevada Las Vegas	This work was supported by the NASA Space Radiation Risk Project, and the University of Nevada Las Vegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerospace Safety Advisory Panel, 2010, ANN REP 2010; Alpen E.L., 1993, RADIAT RES, V88, P132, DOI DOI 10.2307/3575758; Alwood JS, 2010, BONE, V47, P248, DOI 10.1016/j.bone.2010.05.004; [Anonymous], 2009, 2009502 NASA SP; Badhwar GD, 2000, RADIAT RES, V153, P1, DOI 10.1667/0033-7587(2000)153[0001:ACODDO]2.0.CO;2; Badhwar GD, 1992, RADIAT MEAS, V20, P403; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Chylack LT, 2012, RADIAT RES, V178, P25, DOI 10.1667/RR2876.1; Committee for Evaluation of Space Radiation Cancer Risk Model National Research Council, 2012, TECHN EV NASA MOD CA; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2013, 2013217375 NASA TP; Cucinotta FA, 2008, RADIAT RES, V170, P127, DOI 10.1667/RR1330.1; Cucinotta FA, 2007, RADIAT ENVIRON BIOPH, V46, P101, DOI 10.1007/s00411-007-0099-y; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Datta K, 2013, PLOS ONE, V8; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Durante M, 2011, REV MOD PHYS, V83, P1245, DOI 10.1103/RevModPhys.83.1245; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; GRAHN D, 1992, RADIAT RES, V129, P19, DOI 10.2307/3577899; Haley GE, 2013, RADIAT RES, V179, P590, DOI 10.1667/RR2946.1; International Commission on Radiation Protection, 2003, ICRP PUBL, V103; JOSEPH JA, 1992, RADIAT RES, V130, P88, DOI 10.2307/3578484; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Kim MHY, 2009, ADV SPACE RES, V44, P1428, DOI 10.1016/j.asr.2009.07.028; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; *NAT RES COUNC, 1996, RAD HAZ CREWS INT MI; National Academy of Sciences Committee on the Biological Effects of Radiation, 2006, HLTH RISKS EXP LOW L; National Aeronautics and Space Administration, 2013, ASTR FACT BOOK; National Aeronautics and Space Administration, 2007, STD3001 NASA; National Council on Radiation Protection and Measurements, 2000, 132 NCRP; National Council on Radiation Protection and Measurements, 1997, 126 NCRP; National Council on Radiation Protection and Measurements, 2011, 167 NCRP; National Council on Radiation Protection and Measurements, 2006, 153 NAT COUNC RAD PR; O'Neill PM, 2010, IEEE T NUCL SCI, V57, P3148, DOI 10.1109/TNS.2010.2083688; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, UNSCEAR 2008 REP GEN; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1; WILSON JW, 1994, ADV SPACE RES, V14, P841, DOI 10.1016/0273-1177(94)90549-5; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989	45	113	117	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e74988	10.1371/journal.pone.0074988	http://dx.doi.org/10.1371/journal.pone.0074988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146746	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400003
J	Wang, J; Song, SJ; Shi, L; Zhu, Q; Ma, CC; Tan, XQ; Ding, Y; Niu, ZY				Wang, Jing; Song, Shujun; Shi, Liang; Zhu, Qiang; Ma, Chuanchuan; Tan, Xiaoqing; Ding, Yin; Niu, Zhongying			Temporal Expression of Pelp1 during Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; ER-ALPHA; GENE-EXPRESSION; OSTEOBLASTS; PROTEIN; BETA; MNAR; ACTIVATION; RESISTANCE	Background: Osteogenic induction and bone formation are heavily affected by environmental factors, including estrogen, estrogen receptors, and coregulatory proteins, such as the recently reported proline-, glutamic acid-, and leucine-rich protein 1(Pelp1). Objective: To investigate Pelp1 expression in rat bone mesenchymal stem cells (rBMSCs) during cell proliferation and osteogenic differentiation. Methods: rBMSCs were cultured in routine and osteogenic differentiation media. Cell proliferation was assessed at days 1, 3, 5, 7, 9, 11, 14, and 21. Pelp1 protein expression in the nucleus and cytoplasm were detected by immunocytochemical analysis. Real-time RT-PCR and western blot were used to detect mRNA and protein expressions of Pelp1, osteocalcin (OCN), and alkaline phosphatase (ALP). Results: Over 21 days, rBMSCs in routine culture exhibited a 1-2 day lag phase and exponential growth from day 3 to 9, plateauing at day 9, and correlated with temporal mRNA expression of Pelp1, which almost reached baseline levels at day 21. In osteogenic induction cultures, Pelp1 mRNA levels rose at day 9 and steadily increased until day 21, reaching 6.8-fold greater value compared with day 1. Interestingly, Pelp1 mRNA expression in osteogenic cultures exhibited a trend similar to that of OCN expression. Pelp1 knockdown by siRNA transfection inhibited undifferentiated rBMSC proliferation, and bone markers OCN and ALP expressions in rBMSCs cultured in routine and osteogenic differentiation media. Conclusions: Pelp1 may be a key player in BMSCs proliferation and osteogenic differentiation, meriting further consideration as a target for development of therapies for pathological bone loss conditions, such as menopausal bone loss.	[Wang, Jing; Ding, Yin] Forth Mil Med Univ, Coll Stomatol, Dept Orthodont, Xian, Peoples R China; [Song, Shujun; Tan, Xiaoqing] 306 Hosp PLA, Dept Pathol & Expt Med, Beijing, Peoples R China; [Shi, Liang; Ma, Chuanchuan; Niu, Zhongying] 306 Hosp PLA, Dept Stomatol, Beijing, Peoples R China; [Zhu, Qiang] Gen Hosp Peoples Liberat Army, Dept Urol, Beijing, Peoples R China	Air Force Military Medical University	Ding, Y (corresponding author), Forth Mil Med Univ, Coll Stomatol, Dept Orthodont, Xian, Peoples R China.	dingyin.fmmu@gmail.com; zhongying.niu@gmail.com		Shi, Liang/0000-0002-4325-2879	306th Hospital of the People's Liberation Army (PLA)	306th Hospital of the People's Liberation Army (PLA)	The authors gratefully acknowledge the support of the 306th Hospital of the People's Liberation Army (PLA). We thank the staff in the Center of Pathology and Experimental Medicine of the 306th Hospital of PLA for their skills, knowledge, and advice.	Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Bennani-Baiti IM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3249; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Bowring C E, 2011, Menopause Int, V17, P63, DOI 10.1258/mi.2011.011012; Brann DW, 2008, MOL CELL ENDOCRINOL, V290, P2, DOI 10.1016/j.mce.2008.04.019; Brennan O, 2012, HORM METAB RES, V44, P47, DOI 10.1055/s-0031-1291358; Centrella M, 2012, STEROIDS, V77, P174, DOI 10.1016/j.steroids.2011.10.016; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; Chimutengwende-Gordon M, 2012, CURR STEM CELL RES T, V7, P122, DOI 10.2174/157488812799219036; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Grivas PD, 2009, CELL ONCOL, V31, P235, DOI 10.3233/CLO-2009-0467; Hongo Hiromi, 2011, Clin Calcium, V21, P63, DOI CliCa111116471654; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; Mishra SK, 2004, GENE, V330, P115, DOI 10.1016/j.gene.2004.01.011; Pawlak J, 2005, CELL TISSUE RES, V320, P545, DOI 10.1007/s00441-005-1090-z; Shi H, 2010, ANAL CHEM, V82, P2213, DOI 10.1021/ac902417s; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P59, DOI 10.1016/j.mce.2008.07.020; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Toran-Allerand CD, 2004, EXP GERONTOL, V39, P1579, DOI 10.1016/j.exger.2004.05.006; Vadlamudi RK, 2005, HUM PATHOL, V36, P670, DOI 10.1016/j.humpath.2005.03.016; Vadlamudi RK, 2007, NUCL RECEPT SIGNAL, V5; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Xiao Y, 2010, INT J ORAL SCI, V2, P127, DOI 10.4248/IJOS10045; Yildirim M, 2011, BRAIN RES, V1379, P98, DOI 10.1016/j.brainres.2010.07.053; Zilli M, 2009, BBA-REV CANCER, V1795, P62, DOI 10.1016/j.bbcan.2008.08.003	29	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75477	10.1371/journal.pone.0075477	http://dx.doi.org/10.1371/journal.pone.0075477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146754	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400007
J	Crawford, TQ; Hecht, FM; Pilcher, CD; Ndhlovu, LC; Barbour, JD				Crawford, Timothy Q.; Hecht, Fredrick M.; Pilcher, Christopher D.; Ndhlovu, Lishomwa C.; Barbour, Jason D.			Activation Associated ERK1/2 Signaling Impairments in CD8(+) T Cells Co-Localize with Blunted Polyclonal and HIV-1 Specific Effector Functions in Early Untreated HIV-1 Infection	PLOS ONE			English	Article							MAP-KINASE; IMMUNE ACTIVATION; PERFORIN EXPRESSION; MEMORY; RESPONSES; PHOSPHORYLATION; PROLIFERATION; AP-1; TRANSCRIPTION; EXHAUSTION	We recently observed that a large proportion of activated (CD38(+)HLA-DR+) CD8(+) T cells from recently HIV-1-infected adults are refractory to phosphorylation of ERK1/2 kinases (p-ERK1/2-refractory). Given that the ERK1/2 pathway mediates intracellular signaling critical for multiple T cell functions, including key effector functions, the loss of ERK1/2 responsiveness may have broad consequences for CD8(+) T cell function. In the current study, we hypothesized that the p-ERK1/2-refractory population, localized largely within the activated CD38(+)HLA-DR+ CD8(+) T cell population, would display impairments in CD8(+) T cell effector functions, such as cytokine production and degranulation, compared to CD8(+) p-ERK1/2-responsive cells. We further hypothesized that the p-ERK1/2-refractory phenotype is persistent over time during untreated infection, and would correlate with poorer virologic control, in a manner independent of CD8(+) T cell activation level. We performed single-cell resolution, flow cytometric assays of phospho-kinase responses paired to intracellular cytokine staining in one assay to examine IFN-gamma, perforin and CD107 alpha responses in CD8(+) T cells by ERK1/2 signaling profile. On a per cell basis, p-ERK1/2-refractory cells, which fall predominantly within the activated CD8(+) T cell compartment, produced less IFN-gamma in response to polyclonal or HIV-1 antigen-specific stimulation, and expressed lower levels of perforin and CD107 alpha. The p-ERK1/2 refractory cell population displayed minimal overlap with the PD-1 and Tim-3 inhibitory exhaustion markers and predicted high viral load independent of activation, suggesting that ERK1/2 may be a unique marker and point of intervention for improving CD8(+) T cell function. Blunted effector functions, secondary to ERK1/2 signaling deficits concentrated within activated CD8(+) T cells, may contribute to immunodeficiency and underlie the predictive capacity of CD8(+) T cell activation on HIV-1 disease progression. (270/300).	[Crawford, Timothy Q.; Ndhlovu, Lishomwa C.; Barbour, Jason D.] Univ Hawaii Manoa, Hawaii Ctr HIV AIDS, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Hecht, Fredrick M.; Pilcher, Christopher D.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA USA	University of Hawaii System; University of Hawaii Manoa; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Barbour, JD (corresponding author), Univ Hawaii Manoa, Hawaii Ctr HIV AIDS, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	jbarbour@hawaii.edu	n, l/AAX-3992-2020	Hecht, Frederick/0000-0002-5782-1171; Ndhlovu, Lishomwa/0000-0001-5427-4187	National Institutes of Health [R21 AI076014, R56 AI083112, P01 AI071713, K24 AT007827]; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076014, P01AI071713, P30AI027763, R56AI083112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was supported by the following grants from the National Institutes of Health: R21 AI076014 (Barbour), R56 AI083112 (Ndhlovu), P01 AI071713 (Hecht) and K24 AT007827 (Hecht). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Betts MR, 2001, IMMUNOL LETT, V79, P117, DOI 10.1016/S0165-2478(01)00273-5; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Card CM, 2012, JAIDS-J ACQ IMM DEF, V59, P427, DOI 10.1097/QAI.0b013e3182454fcd; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Crawford TQ, 2011, J VIROL, V85, P12343, DOI 10.1128/JVI.05682-11; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Egerton M, 1998, INT IMMUNOL, V10, P223, DOI 10.1093/intimm/10.2.223; Egerton M, 1996, EUR J IMMUNOL, V26, P2279, DOI 10.1002/eji.1830261002; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Freer G., 2013, METHODS; Furler RL, 2010, IMMUNOL RES; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2012, CURR HIV AIDS REP; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Lazarevic V, 2002, AM J RESP CRIT CARE, V166, P1116, DOI 10.1164/rccm.2204027; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Ndongala ML, 2009, CLIN IMMUNOL, V131, P277, DOI 10.1016/j.clim.2008.11.006; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Park WR, 2004, INT IMMUNOL, V16, P295, DOI 10.1093/intimm/dxh034; Pasquinelli V, 2013, J INFECT DIS, V207, P340, DOI 10.1093/infdis/jis672; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Samten B, 2008, J IMMUNOL, V181, P2056, DOI 10.4049/jimmunol.181.3.2056; Schulz Kenneth R, 2012, Curr Protoc Immunol, VChapter 8, DOI 10.1002/0471142735.im0817s96; Sharma A, 2012, J IMMUNOL, V188, P3859, DOI 10.4049/jimmunol.1103729; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Teixeiro E, 2010, FEBS J, V277, P30, DOI 10.1111/j.1742-4658.2009.07368.x; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tzelepis F, 2013, J IMMUNOL, V190, P1066, DOI 10.4049/jimmunol.1200639; van Baarle D, 2005, IMMUNOL LETT, V97, P19, DOI 10.1016/j.imlet.2004.10.003; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	64	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77412	10.1371/journal.pone.0077412	http://dx.doi.org/10.1371/journal.pone.0077412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143233	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100070
J	Henner, A; Ventura, PB; Jiang, Y; Zong, H				Henner, Astra; Ventura, P. Britten; Jiang, Ying; Zong, Hui			MADM-ML, a Mouse Genetic Mosaic System with Increased Clonal Efficiency	PLOS ONE			English	Article							DOUBLE MARKERS; CELL; MEDULLOBLASTOMA; MICE; ORIGIN	Mosaic Analysis with Double Markers (MADM) is a mouse genetic system that allows simultaneous gene knockout and fluorescent labeling of sparse, clonally-related cells within an otherwise normal mouse, thereby circumventing embryonic lethality problems and providing single-cell resolution for phenotypic analysis in vivo. The clonal efficiency of MADM is intrinsically low because it relies on Cre/loxP-mediated mitotic recombination between two homologous chromosomes rather than within the same chromosome, as in the case of conditional knockout (CKO). Although sparse labeling enhances in vivo resolution, the original MADM labels too few or even no cells when a low-expressing Cre transgene is used or a small population of cells is studied. Recently, we described the usage of a new system, MADM-ML, which contains three mutually exclusive, self-recognizing loxP variant sites as opposed to a single loxP site present in the original MADM system (referred to as MADM-SL in this paper). Here we carefully compared the recombination efficiency between MADM-SL and MADM-ML using the same Cre transgene, and found that the new system labels significantly more cells than the original system does. When we established mouse medulloblastoma models with both the original and the new MADM systems, we found that, while the MADM-SL model suffered from varied tumor progression and incomplete penetrance, the MADM-ML model had consistent tumor progression and full penetrance of tumor formation. Therefore MADM-ML, with its higher recombination efficiency, will broaden the applicability of MADM for studying many biological questions including normal development and disease modeling at cellular resolution in vivo.	[Henner, Astra; Ventura, P. Britten; Jiang, Ying; Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Zong, H (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Ctr Cell Signaling, Ctr Brain Immunol & Glia, Charlottesville, VA 22903 USA.	hz9s@virginia.edu			NIH/NCI [R01-CA136495]; NIH/NINDS [7F31NS076313]; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [R01CA136495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076313] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is partially supported by NIH/NCI grant (R01-CA136495). P Britten Ventura is supported by NIH/NINDS pre-doctoral fellowship (7F31NS076313). Hui Zong is a Pew Scholar in Biomedical Sciences, supported by the Pew Charitable Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; EVANS DGR, 1991, BRIT J CANCER, V64, P959, DOI 10.1038/bjc.1991.435; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hippenmeyer S, 2013, CELL REP, V3, P960, DOI 10.1016/j.celrep.2013.02.002; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Kim HS, 2013, CELL, V152, P387, DOI 10.1016/j.cell.2013.01.027; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Lo Muzio L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-32; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Tasic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033332; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wetmore C, 2001, CANCER RES, V61, P513; Yang SB, 2012, J PHYSIOL-LONDON, V590, P2645, DOI 10.1113/jphysiol.2012.228486; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	28	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77672	10.1371/journal.pone.0077672	http://dx.doi.org/10.1371/journal.pone.0077672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143253	gold, Green Submitted, Green Published			2022-12-27	WOS:000325894100092
J	Huang, YN; Wu, H; Xue, RY; Liu, TT; Dong, L; Yao, J; Zhang, Y; Shen, XZ				Huang, Yingnan; Wu, Hao; Xue, Ruyi; Liu, Taotao; Dong, Ling; Yao, Jun; Zhang, Yang; Shen, Xizhong			Identification of N-Glycosylation in Hepatocellular Carcinoma Patients' Serum with a Comparative Proteomic Approach	PLOS ONE			English	Article							ALPHA-TRYPSIN INHIBITOR; CLUSTERIN ISOFORMS; MASS-SPECTROMETRY; CELL-INTERACTIONS; HEPATITIS-B; FACTOR-H; CANCER; EXPRESSION; BIOMARKERS; PROTEINS	Aim: This study is to explore the different expressions of serum N-glycoproteins and glycosylation sites between hepatocellular carcinoma (HCC) patients and healthy controls. Method: We combined high abundant proteins depletion and hydrophilic affinity method to enrich the glycoproteins. Through liquid chromatography-tandem mass spectrometry (LC-MS/MS), we extensively surveyed different expressions of glycosylation sites and glycoproteins between the two groups. Result: This approach identified 152 glycosylation sites and 54 glycoproteins expressed differently between HCC patients and healthy controls. With the absolute values of Pearson coefficients of at least 0.8, eight proteins were identified significantly up or down regulated in HCC serum. Those proteins are supposed to be involved in several biological processes, cellular components and molecular functions of hepatocarcinogenesis. Several of them had been reported abnormally regulated in several kinds of malignant tumors, and may be promising biomarkers of HCC. Conclusion: Our work provides a systematic and quantitative method of glycoproteomics and demonstrates some key changes in clinical HCC serum. These proteomic signatures may help to unveil the underlying mechanisms of hepatocarcinogenesis and may be useful for the exploration of candidate biomarkers.	[Huang, Yingnan; Wu, Hao; Xue, Ruyi; Liu, Taotao; Dong, Ling; Shen, Xizhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Yao, Jun; Zhang, Yang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yao, Jun] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Shen, XZ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	shen.xizhong@zs-hospital.sh.cn	liu, taotao/GSI-7460-2022	Xue, Ruyi/0000-0002-5710-0091	Shanghai Science and Technology Commission [10410709400, 10411950100]; National Nature Science Foundation of China [81000968, 81101540, 81101637, 81172273, 81272388]; Doctoral Fund of Ministry of Education of China [20120071110058]; National Clinical Key Special Subject of China	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); National Clinical Key Special Subject of China	This study was supported by Shanghai Science and Technology Commission (http://www.stcsm.gov.cn/) (10410709400 and 10411950100) and National Nature Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm) (No. 81000968, No. 81101540, No. 81101637, No. 81172273, No. 81272388) Doctoral Fund of Ministry of Education of China (http://www.moe.gov.cn/) (20120071110058), and The National Clinical Key Special Subject of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Cao J, 2009, J PROTEOME RES, V8, P662, DOI 10.1021/pr800826u; Cheng ZZ, 2005, CLIN CHEM, V51, P856, DOI 10.1373/clinchem.2004.042192; Cochrane DR, 2007, J BIOL CHEM, V282, P2278, DOI 10.1074/jbc.M608162200; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Fu Bin-sheng, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1775; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; Heo SH, 2007, PROTEOMICS, V7, P4292, DOI 10.1002/pmic.200700433; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Liang Cynthia, 2012, Methods Mol Biol, V854, P181, DOI 10.1007/978-1-61779-573-2_13; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Malaguarnera G, 2010, DIGEST DIS SCI, V55, P2744, DOI 10.1007/s10620-010-1184-7; Mao YL, 2010, GUT, V59, P1687, DOI 10.1136/gut.2010.214916; Matsubara M, 2012, J GASTROEN HEPATOL, V27, P1602, DOI 10.1111/j.1440-1746.2012.07173.x; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Penno MAS, 2012, J PROTEOMICS, V77, P40, DOI 10.1016/j.jprot.2012.07.002; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Pucci S, 2009, ADV CANCER RES, V104, P25, DOI 10.1016/S0065-230X(09)04003-2; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Rodriguez-Pineiro AM, 2006, MOL CELL PROTEOMICS, V5, P1647, DOI 10.1074/mcp.M600143-MCP200; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sterling RK, 2012, AM J GASTROENTEROL, V107, P64, DOI 10.1038/ajg.2011.312; Sun BY, 2007, MOL CELL PROTEOMICS, V6, P141, DOI 10.1074/mcp.T600046-MCP200; Tajiri M, 2005, GLYCOBIOLOGY, V15, P1332, DOI 10.1093/glycob/cwj019; Thulasiraman V, 2005, ELECTROPHORESIS, V26, P3561, DOI 10.1002/elps.200500147; Tousi F, 2012, J CHROMATOGR A, V1256, P121, DOI 10.1016/j.chroma.2012.07.066; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wang YS, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-15; Yang HH, 2013, J BIOMED MATER RES A, V101, P1935, DOI 10.1002/jbm.a.34491; Yen TY, 2012, J PROTEOME RES, V11, P656, DOI 10.1021/pr201041j; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	37	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77161	10.1371/journal.pone.0077161	http://dx.doi.org/10.1371/journal.pone.0077161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143209	Green Submitted, gold, Green Published			2022-12-27	WOS:000325894100044
J	Kochhan, E; Lenard, A; Ellertsdottir, E; Herwig, L; Affolter, M; Belting, HG; Siekmann, AF				Kochhan, Eva; Lenard, Anna; Ellertsdottir, Elin; Herwig, Lukas; Affolter, Markus; Belting, Heinz-Georg; Siekmann, Arndt F.			Blood Flow Changes Coincide with Cellular Rearrangements during Blood Vessel Pruning in Zebrafish Embryos	PLOS ONE			English	Article							PROGRAMMED CAPILLARY REGRESSION; IN-VIVO; TRANSGENIC ZEBRAFISH; APOPTOSIS; ANGIOGENESIS; LYMPHANGIOGENESIS; MACROPHAGES; NETWORK; PATHWAY; DEATH	After the initial formation of a highly branched vascular plexus, blood vessel pruning generates a hierarchically structured network with improved flow characteristics. We report here on the cellular events that occur during the pruning of a defined blood vessel in the eye of developing zebrafish embryos. Time-lapse imaging reveals that the connection of a new blood vessel sprout with a previously perfused multicellular endothelial tube leads to the formation of a branched, Y-shaped structure. Subsequently, endothelial cells in parts of the previously perfused branch rearrange from a multicellular into a unicellular tube, followed by blood vessel detachment. This process is accompanied by endothelial cell death. Finally, we show that differences in blood flow between neighboring vessels are important for the completion of the pruning process. Our data suggest that flow induced changes in tubular architecture ensure proper blood vessel pruning.	[Kochhan, Eva; Siekmann, Arndt F.] Max Planck Inst Mol Biomed, Lab Cardiovasc Patterning, Munster, Germany; [Lenard, Anna; Ellertsdottir, Elin; Herwig, Lukas; Affolter, Markus; Belting, Heinz-Georg] Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland	Max Planck Society; University of Basel	Siekmann, AF (corresponding author), Max Planck Inst Mol Biomed, Lab Cardiovasc Patterning, Munster, Germany.	arndt.siekmann@mpi-muenster.mpg.de	Siekmann, Arndt/AAE-4769-2021	Affolter, Markus/0000-0002-5171-0016; Siekmann, Arndt/0000-0001-6972-2173; Belting, Heinz-Georg/0000-0002-1538-4364	Max Planck Society; Deutsche Forschungsgemeinschaft [DFG SI-1374/3-1]; European Research Council [260794-ZebrafishAngio]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was funded by the Max Planck Society (www.mpg.de; AFS), the Deutsche Forschungsgemeinschaft (DFG SI-1374/3-1; www.dfg.de; AFS) and an European Research Council starting grant (260794-ZebrafishAngio; erc.europa.eu; AFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Baluk P, 2004, AM J PATHOL, V165, P1071, DOI 10.1016/S0002-9440(10)63369-X; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Fujita M, 2011, DEVELOPMENT, V138, P1705, DOI 10.1242/dev.058776; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LANG R, 1994, DEVELOPMENT, V120, P3395; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lobov IB, 2011, BLOOD, V117, P6728, DOI 10.1182/blood-2010-08-302067; Meeson A, 1996, DEVELOPMENT, V122, P3929; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Taniguchi H, 1999, ANN ANAT, V181, P555, DOI 10.1016/S0940-9602(99)80061-2; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Westerfield M, 1993, ZEBRAFISH BOOK; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Zanella C, 2010, IEEE T IMAGE PROCESS, V19, P770, DOI 10.1109/TIP.2009.2033629	36	77	77	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75060	10.1371/journal.pone.0075060	http://dx.doi.org/10.1371/journal.pone.0075060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146748	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400006
J	Burford, BJ; Welch, V; Waters, E; Tugwell, P; Moher, D; O'Neill, J; Koehlmoos, T; Petticrew, M				Burford, Belinda J.; Welch, Vivian; Waters, Elizabeth; Tugwell, Peter; Moher, David; O'Neill, Jennifer; Koehlmoos, Tracey; Petticrew, Mark			Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors	PLOS ONE			English	Article								Reporting guidelines can be used to encourage standardised and comprehensive reporting of health research. In light of the global commitment to health equity, we have previously developed and published a reporting guideline for equity-focused systematic reviews (PRISMA-E 2012). The objectives of this study were to explore the utility of the equity extension items included in PRISMA-E 2012 from a systematic review author perspective, including facilitators and barriers to its use. This will assist in designing dissemination and knowledge translation strategies. We conducted a survey of systematic review authors to expose them to the new items in PRISMA-E 2012, establish the extent to which they had historically addressed those items in their own reviews, and gather feedback on the usefulness of the new items. Data were analysed using Microsoft Excel 2008 and Stata (version 11.2 for Mac). Of 151 respondents completing the survey, 18.5% (95% CI: 12.7% to 25.7%) had not heard of the PRISMA statement before, although 83.4% (95% CI: 77.5% to 89.3%) indicated that they plan to use PRISMA-E 2012 in the future, depending on the focus of their review. Most (68.9%; 95% CI: 60.8% to 76.2%) thought that using PRISMA-E 2012 would lead them to conduct their reviews differently. Important facilitators to using PRISMA-E 2012 identified by respondents were journal endorsement and incorporation of the elements of the guideline into systematic review software. Barriers identified were lack of time, word limits and the availability of equity data in primary research. This study has been the first to 'road-test' the new PRISMA-E 2012 reporting guideline and the findings are encouraging. They confirm the acceptability and potential utility of the guideline to assist review authors in reporting on equity in their reviews. The uptake and impact of PRISMA-E 2012 over time on design, conduct and reporting of primary research and systematic reviews should continue to be examined.	[Burford, Belinda J.; Waters, Elizabeth] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Cochrane Publ Hlth Grp, Melbourne, Vic, Australia; [Burford, Belinda J.; Waters, Elizabeth] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Jack Brockhoff Child Hlth & Wellbeing Program, Melbourne, Vic, Australia; [Welch, Vivian; Tugwell, Peter; O'Neill, Jennifer] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Welch, Vivian] Univ Ottawa, Elizabeth Bruyere Res Inst, Ottawa, ON, Canada; [Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Koehlmoos, Tracey] Int Ctr Diarrhoeal Dis Res ICDDRB, Ctr Equ & Hlth Syst, Dhaka, Bangladesh; [Petticrew, Mark] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England	University of Melbourne; University of Melbourne; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; International Centre for Diarrhoeal Disease Research (ICDDR); University of London; London School of Hygiene & Tropical Medicine	Burford, BJ (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Cochrane Publ Hlth Grp, Melbourne, Vic, Australia.	belinda@burford.co	Tugwell, Peter/AFD-8076-2022; Moher, David/I-3408-2019; Welch, Vivian Andrea/AAD-9338-2020; Petticrew, Mark/AAY-6274-2021	Tugwell, Peter/0000-0001-5062-0556; Moher, David/0000-0003-2434-4206; Welch, Vivian Andrea/0000-0002-5238-7097; 	Australian National Health and Medical Research Council (NHMRC); Victorian Health Promotion Foundation (VicHealth); Canadian Institutes of Health Research [Planning Grant - Knowledge Translation Branch of CIHR] [KPE - 114370, 248168]; Rockefeller Foundation; Jack Brockhoff Foundation; University Research Chair	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Health Promotion Foundation (VicHealth); Canadian Institutes of Health Research [Planning Grant - Knowledge Translation Branch of CIHR](Canadian Institutes of Health Research (CIHR)); Rockefeller Foundation; Jack Brockhoff Foundation; University Research Chair	Belinda Burford as part of the Cochrane Public Health Group received funding support from the Australian National Health and Medical Research Council (NHMRC) and the Victorian Health Promotion Foundation (VicHealth). Vivian Welch, Mark Petticrew, Peter Tugwell and Jennifer O'Neill received funding from the Canadian Institutes of Health Research (www.cihr.ca) [Planning Grant - Knowledge Translation Branch of CIHR, CIHR Funding Reference # KPE - 114370, Application Number # 248168, Amount $25,000 CDN] to hold a meeting for the development of the PRISMA-Equity 2012 reporting guidelines, and conference facilities and travel funds were provided by the Rockefeller Foundation to hold the meeting at the Bellagio Centre in Italy. Elizabeth Waters is funded by a philanthropic donation from the Jack Brockhoff Foundation. David Moher is funded through a University Research Chair. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript. None of the individuals were contracted by funders or employed by funders.	Bosch-Capblanch X, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001185; Coren E., 2013, COCHRANE DB SYST REV, V2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Simera I, 2008, PLOS MED, V5, P869, DOI 10.1371/journal.pmed.0050139; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Turley R, 2013, COCHRANE DB SYST REV, V1; Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60; Welch V, 2010, COCHRANE DB SYST REV, V12; Welch V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001333; White H, 2012, WORKING PAPER; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; WHO, 2011, P WORLD C SOC DET HL	14	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75122	10.1371/journal.pone.0075122	http://dx.doi.org/10.1371/journal.pone.0075122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130684	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000325814200004
J	Rix, U; Colinge, J; Blatt, K; Gridling, M; Rix, LLR; Parapatics, K; Cerny-Reiterer, S; Burkard, TR; Jager, U; Melo, JV; Bennett, KL; Valent, P; Superti-Furga, G				Rix, Uwe; Colinge, Jacques; Blatt, Katharina; Gridling, Manuela; Rix, Lily L. Remsing; Parapatics, Katja; Cerny-Reiterer, Sabine; Burkard, Thomas R.; Jaeger, Ulrich; Melo, Junia V.; Bennett, Keiryn L.; Valent, Peter; Superti-Furga, Giulio			A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph plus ALL	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; CHROMOSOME-POSITIVE LEUKEMIAS; TYROSINE KINASE INHIBITORS; B-CELL RECEPTOR; CHEMICAL PROTEOMICS; DOMAIN MUTATIONS; SMALL MOLECULES; CHRONIC-PHASE; IMATINIB	Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is in part driven by the tyrosine kinase bcr-abl, but imatinib does not produce long-term remission. Therefore, second-generation ABL inhibitors are currently in clinical investigation. Considering different target specificities and the pronounced genetic heterogeneity of Ph+ ALL, which contributes to the aggressiveness of the disease, drug candidates should be evaluated with regard to their effects on the entire Ph+ ALL-specific signaling network. Here, we applied an integrated experimental and computational approach that allowed us to estimate the differential impact of the bcr-abl inhibitors nilotinib, dasatinib, Bosutinib and Bafetinib. First, we determined drug-protein interactions in Ph+ ALL cell lines by chemical proteomics. We then mapped those interactions along with known genetic lesions onto public protein-protein interactions. Computation of global scores through correlation of target affinity, network topology, and distance to disease-relevant nodes assigned the highest impact to dasatinib, which was subsequently confirmed by proliferation assays. In future, combination of patient-specific genomic information with detailed drug target knowledge and network-based computational analysis should allow for an accurate and individualized prediction of therapy.	[Rix, Uwe; Colinge, Jacques; Gridling, Manuela; Rix, Lily L. Remsing; Parapatics, Katja; Burkard, Thomas R.; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr, A-1010 Vienna, Austria; [Blatt, Katharina; Cerny-Reiterer, Sabine; Jaeger, Ulrich; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Cerny-Reiterer, Sabine; Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Melo, Junia V.] Ctr Canc Biol, Dept Haematol, Adelaide, SA, Australia; [Melo, Junia V.] Univ London Imperial Coll Sci Technol & Med, London, England	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Ludwig Boltzmann Institute; Centre for Cancer Biology; Imperial College London	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015; Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019; Test, Test/Y-7921-2019; Test, PV/U-9451-2019; Colinge, Jacques/D-1578-2017; Colinge, Jacques/Z-2613-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Colinge, Jacques/0000-0003-2466-4824; Colinge, Jacques/0000-0003-2466-4824; Bennett, Keiryn L./0000-0001-9356-7708; Burkard, Thomas/0000-0002-0884-2929	Austrian federal ministry for science and research bmwf under the GEN-AU program project PLACEBO [GZ BMWF-70.081/0018-II/1a/2008]; Austrian federal ministry for science and research bmwf under the GEN-AU program project BIN III [GZ BMWF-70.081/0018-II/1a/2008]; Austrian federal ministry for science and research bmwf (FFG) [820961, 820962]; Austrian Science Fund (FWF) [P18737-B11]; NIHR Biomedical Research Centre Funding Scheme, UK; Austrian Academy of Sciences (OAW)	Austrian federal ministry for science and research bmwf under the GEN-AU program project PLACEBO; Austrian federal ministry for science and research bmwf under the GEN-AU program project BIN III; Austrian federal ministry for science and research bmwf (FFG); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIHR Biomedical Research Centre Funding Scheme, UK; Austrian Academy of Sciences (OAW)	This study was supported by the Austrian federal ministry for science and research bmwf under the GEN-AU program projects PLACEBO and BIN III (GZ BMWF-70.081/0018-II/1a/2008, FFG project numbers 820961 and 820962), the Austrian Science Fund (FWF; P18737-B11) and the NIHR Biomedical Research Centre Funding Scheme, UK. CeMM is supported by the Austrian Academy of Sciences (OAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Berger SI, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000723; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; BREHME M, 2009, P NATL ACAD SCI USA, P80743; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Colinge J, 2010, LECT NOTES OPER RES, V13, P305; Colinge J, 2012, PROTEOM CLIN APPL, V6, P102, DOI 10.1002/prca.201100077; Daub H, 2005, BBA-PROTEINS PROTEOM, V1754, P183, DOI 10.1016/j.bbapap.2005.07.028; Deguchi Y, 2008, LEUKEMIA RES, V32, P980, DOI 10.1016/j.leukres.2007.11.008; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2006, NEW ENGL J MED, V354, P2594, DOI 10.1056/NEJMe068073; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Fernbach NV, 2009, J PROTEOME RES, V8, P4753, DOI 10.1021/pr900455x; Fullmer A, 2011, LEUKEMIA LYMPHOMA, V52, P81, DOI 10.3109/10428194.2010.546917; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Gruber F, 2009, BRIT J HAEMATOL, V145, P581, DOI 10.1111/j.1365-2141.2009.07666.x; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Horio T, 2007, BIOORG MED CHEM LETT, V17, P2712, DOI 10.1016/j.bmcl.2007.03.002; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian H, 2010, CANCER-AM CANCER SOC, V116, P2665, DOI 10.1002/cncr.25079; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Martinelli G, 2009, J CLIN ONCOL, V27, P5202, DOI 10.1200/JCO.2008.21.6408; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ottmann O, 2007, BLOOD, V110, P2309, DOI 10.1182/blood-2007-02-073528; Pfeifer H, 2007, BLOOD, V110, P727, DOI 10.1182/blood-2006-11-052373; Piccaluga PP, 2007, CANCER-AM CANCER SOC, V110, P1178, DOI 10.1002/cncr.22881; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Rix U, 2010, LEUKEMIA, V24, P44, DOI 10.1038/leu.2009.228; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wetzler M, 2004, BRIT J HAEMATOL, V124, P275, DOI 10.1046/j.1365-2141.2003.04736.x	52	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77155	10.1371/journal.pone.0077155	http://dx.doi.org/10.1371/journal.pone.0077155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130846	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200062
J	Archer, E; Hand, GA; Blair, SN				Archer, Edward; Hand, Gregory A.; Blair, Steven N.			Validity of US Nutritional Surveillance: National Health and Nutrition Examination Survey Caloric Energy Intake Data, 1971-2010	PLOS ONE			English	Article							RESTING METABOLIC-RATE; HABITUAL FOOD-INTAKE; DIETARY-INTAKE; SELF-REPORT; FUNDAMENTAL PRINCIPLES; NUTRIENT; OBESE; FAT; EXPENDITURE; PHYSIOLOGY	Importance: Methodological limitations compromise the validity of U.S. nutritional surveillance data and the empirical foundation for formulating dietary guidelines and public health policies. Objectives: Evaluate the validity of the National Health and Nutrition Examination Survey (NHANES) caloric intake data throughout its history, and examine trends in the validity of caloric intake estimates as the NHANES dietary measurement protocols evolved. Design: Validity of data from 28,993 men and 34,369 women, aged 20 to 74 years from NHANES I (1971-1974) through NHANES 2009-2010 was assessed by: calculating physiologically credible energy intake values as the ratio of reported energy intake (rEI) to estimated basal metabolic rate (BMR), and subtracting estimated total energy expenditure (TEE) from NHANES rEI to create 'disparity values'. Main Outcome Measures: 1) Physiologically credible values expressed as the ratio rEI/BMR and 2) disparity values (rEI-TEE). Results: The historical rEI/BMR values for men and women were 1.31 and 1.19, (95% CI: 1.30-1.32 and 1.18-1.20), respectively. The historical disparity values for men and women were -281 and -365 kilocalorie-per-day, (95% CI: -299, -264 and -378, -351), respectively. These results are indicative of significant under-reporting. The greatest mean disparity values were -716 kcal/day and -856 kcal/day for obese (i.e., >= 30 kg/m2) men and women, respectively. Conclusions: Across the 39-year history of the NHANES, EI data on the majority of respondents (67.3% of women and 58.7% of men) were not physiologically plausible. Improvements in measurement protocols after NHANES II led to small decreases in underreporting, artifactual increases in rEI, but only trivial increases in validity in subsequent surveys. The confluence of these results and other methodological limitations suggest that the ability to estimate population trends in caloric intake and generate empirically supported public policy relevant to diet-health relationships from U. S. nutritional surveillance is extremely limited.	[Archer, Edward; Hand, Gregory A.; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Archer, E (corresponding author), Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.	archerec@email.sc.edu	Archer, Edward/J-9567-2017	Archer, Edward/0000-0002-9339-6918	Coca-Cola Company	Coca-Cola Company	This study was funded via an unrestricted research grant from The Coca-Cola Company. The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Ahuja JKC, 2008, J FOOD COMPOS ANAL, V21, pS119, DOI 10.1016/j.jfca.2007.05.005; Ahuja JKC, 2009, J FOOD COMPOS ANAL, V22, pS63, DOI 10.1016/j.jfca.2009.02.005; Ahuja JKC, 2006, J FOOD COMPOS ANAL, V19, pS7, DOI 10.1016/j.jfca.2005.12.007; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Becker W, 1999, BRIT J NUTR, V81, pS127, DOI 10.1017/S0007114599000975; BLACK AE, 1991, EUR J CLIN NUTR, V45, P583; Black AE, 2001, J AM DIET ASSOC, V101, P70, DOI 10.1016/S0002-8223(01)00018-9; Blair D, 1992, Vital Health Stat 4, P43; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Briefel RR, 1997, AM J CLIN NUTR, V65, P1203; CDC Ce nter of Disease Control and Prevention, 2012, NAT HLTH EX SURV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Dwyer J, 2003, J NUTR, V133, p590S; FAO, 2001, FOOD BAL SHEETS HDB; FAO/WHO/UNU, 2004, HUM EN REQ REP JOINT; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Ford ES, 2013, AM J CLIN NUTR; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Freedman LS, 2004, J NUTR, V134, P1836, DOI 10.1093/jn/134.7.1836; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Goris AHC, 1999, J NUTR, V129, P878, DOI 10.1093/jn/129.4.878; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; GUENTHER PM, 1994, J AM DIET ASSOC, V94, P270, DOI 10.1016/0002-8223(94)90367-0; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hebert JR, 2002, ANN EPIDEMIOL, V12, P577, DOI 10.1016/S1047-2797(01)00297-6; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Heerstrass DW, 1998, INT J EPIDEMIOL, V27, P186, DOI 10.1093/ije/27.2.186; Heitmann BL, 2005, PUBLIC HEALTH NUTR, V8, P1322, DOI 10.1079/PHN2005750; Heitmann BL, 2000, INT J OBESITY, V24, P435, DOI 10.1038/sj.ijo.0801176; Huang TTK, 2005, OBES RES, V13, P1205, DOI 10.1038/oby.2005.143; IOM, 2005, REP PAN MACR DIET RE; IOM, 2003, DIET REF INT APPL DI, P248; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Kelly A, 1991, WHO Reg Publ Eur Ser, V34, P39; Kelly A, 1991, WHO Reg Publ Eur Ser, V34, P15; Kohlmeier L, 1991, WHO Reg Publ Eur Ser, V34, P73; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Lissner L, 2000, BRIT J NUTR, V83, pS21; Livingstone MBE, 2003, MARKERS VALIDITY REP, p895S; McCrory MA, 2002, PUBLIC HEALTH NUTR, V5, P873, DOI 10.1079/PHN2002387; McDowell M, 1994, DIETARY COLLECTION S; McDowell MA, 1994, UPDATE 3 NATL HLTH N; McGowan MJ, 2001, PUBLIC HEALTH NUTR, V4, P1043, DOI 10.1079/PHN2001185; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Muth M. K., 2011, USDA EC RES SERV TEC, V1927; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; O'Neil CE, 2011, MEAT SCI, V87, P250, DOI 10.1016/j.meatsci.2010.10.020; Okubo H, 2004, PUBLIC HEALTH NUTR, V7, P911, DOI 10.1079/PHN2004635; Perloff B, 1998, Public Health Rev, V26, P43; Phillips KM, 2006, ANAL BIOANAL CHEM, V384, P1341, DOI 10.1007/s00216-005-0294-0; RACETTE SB, 1995, AM J CLIN NUTR, V62, P345, DOI 10.1093/ajcn/62.2.345; Scagliusi FB, 2003, J AM DIET ASSOC, V103, P1306, DOI 10.1016/S0002-8223(03)01074-5; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Shiely F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054386; Skinner AC, 2012, PEDIATRICS, V130, pE936, DOI 10.1542/peds.2012-0605; Slining MM, 2013, AM J PREV MED, V44, P174, DOI 10.1016/j.amepre.2012.09.064; Smith AM, 2011, MEAT SCI, V89, P228, DOI 10.1016/j.meatsci.2011.04.027; Stewart H, 2004, FOOD POLICY, V29, P643, DOI 10.1016/j.foodpol.2004.10.003; Stewart H, 2012, ELECT REPORT EC RES; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Taber DR, 2009, ANN EPIDEMIOL, V19, P316, DOI 10.1016/j.annepidem.2009.01.001; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Trabulsi J, 2001, AM J PHYSIOL-ENDOC M, V281, pE891, DOI 10.1152/ajpendo.2001.281.5.E891; Urban LE, 2011, JAMA-J AM MED ASSOC, V306, P287, DOI 10.1001/jama.2011.993; USDA, 2011, NUTR DAT SET RET BEE; USDA, 2012, NAT AGR LIB NAT NUTR; Weihrauch JL, 1992, PROBLEMS ENERGY CALC; Yanetz R, 2008, J AM DIET ASSOC, V108, P455, DOI 10.1016/j.jada.2007.12.004	74	243	245	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76632	10.1371/journal.pone.0076632	http://dx.doi.org/10.1371/journal.pone.0076632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130784	Green Published, gold			2022-12-27	WOS:000325810900079
J	Chen, H; Zhou, B; Brecher, M; Banavali, N; Jones, SA; Li, Z; Zhang, J; Nag, D; Kramer, LD; Ghosh, AK; Li, HM				Chen, Hui; Zhou, Bing; Brecher, Matthew; Banavali, Nilesh; Jones, Susan A.; Li, Zhong; Zhang, Jing; Nag, Dilip; Kramer, Laura D.; Ghosh, Arun K.; Li, Hongmin			S-Adenosyl-Homocysteine Is a Weakly Bound Inhibitor for a Flaviviral Methyltransferase	PLOS ONE			English	Article							NILE-VIRUS METHYLTRANSFERASE; GENERAL FORCE-FIELD; RNA CAP; NS5; DENGUE; ADENOSYLHOMOCYSTEINE; CHARMM; MOLECULES; DYNAMICS; ADENOSYLMETHIONINE	The methyltransferase enzyme (MTase), which catalyzes the transfer of a methyl group from S-adenosyl-methionine (AdoMet) to viral RNA, and generates S-adenosyl-homocysteine (AdoHcy) as a by-product, is essential for the life cycle of many significant human pathogen flaviviruses. Here we investigated inhibition of the flavivirus MTase by several AdoHcy-derivatives. Unexpectedly we found that AdoHcy itself barely inhibits the flavivirus MTase activities, even at high concentrations. AdoHcy was also shown to not inhibit virus growth in cell-culture. Binding studies confirmed that AdoHcy has a much lower binding affinity for the MTase than either the AdoMet co-factor, or the natural AdoMet analog inhibitor sinefungin (SIN). While AdoMet is a positively charged molecule, SIN is similar to AdoHcy in being uncharged, and only has an additional amine group that can make extra electrostatic contacts with the MTase. Molecular Mechanics Poisson-Boltzmann Sovation Area analysis on AdoHcy and SIN binding to the MTase suggests that the stronger binding of SIN may not be directly due to interactions of this amine group, but due to distributed differences in SIN binding resulting from its presence. The results suggest that better MTase inhibitors could be designed by using SIN as a scaffold rather than AdoHcy.	[Chen, Hui; Brecher, Matthew; Banavali, Nilesh; Jones, Susan A.; Li, Zhong; Zhang, Jing; Nag, Dilip; Kramer, Laura D.; Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Zhou, Bing; Ghosh, Arun K.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Zhou, Bing; Ghosh, Arun K.] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA; [Banavali, Nilesh; Kramer, Laura D.; Li, Hongmin] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Li, HM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	lih@wadsworth.org	Zhou, Bing/J-3281-2015; Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Li, Zhong/0000-0002-1039-7000; Banavali, Nilesh/0000-0003-2206-7049; Brecher, Matthew/0000-0003-1151-2290	National Institute of Health (NIH) [AI 09433501]; NIAID training grant [1T32AI055429]; National Science Foundation [OCI-1053575]; Computational Center for Nanotechnology Innovations (CCNI) resources housed at the Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094335, T32AI055429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID training grant; National Science Foundation(National Science Foundation (NSF)); Computational Center for Nanotechnology Innovations (CCNI) resources housed at the Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants (AI 09433501 to LDK, AKG, HL) from the National Institute of Health (NIH). MB was supported by funding from a NIAID training grant (1T32AI055429). The authors would also like to acknowledge computing resources provided by the Wadsworth Center, New York State Department of Health and the Wadsworth Center Tissue Culture Core facility for providing cells and media. This work also used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575, and the Computational Center for Nanotechnology Innovations (CCNI) resources housed at the Rensselaer Polytechnic Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200; Bhattacharya D, 2008, VIROLOGY, V380, P276, DOI 10.1016/j.virol.2008.07.013; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS JB, 1983, J CHROMATOGR, V276, P279, DOI 10.1016/S0378-4347(00)85094-X; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012; Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642; Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Li SH, 2013, J VIROL IN PRESS; Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; Liu Lihui, 2010, Front Biol (Beijing), V5, P286; Loehrer FMT, 1997, J PHARMACOL EXP THER, V282, P845; Luzhkov VB, 2007, BIOORGAN MED CHEM, V15, P7795, DOI 10.1016/j.bmc.2007.08.049; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001; PERNA AF, 1993, J CLIN INVEST, V91, P2497; Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m; Poirier LA, 2001, CANCER EPIDEM BIOMAR, V10, P649; Puig-Basagoiti F, 2009, ANTIVIR RES, V83, P71, DOI 10.1016/j.antiviral.2009.03.005; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0; Stabler SP, 2006, AM J CLIN NUTR, V84, P1422, DOI 10.1093/ajcn/84.6.1422; TERUELLOPEZ E, 1991, INVEST CLIN, V32, P201; Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang PY, 2000, J AM CHEM SOC, V122, P12422, DOI 10.1021/ja001989s; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	51	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76900	10.1371/journal.pone.0076900	http://dx.doi.org/10.1371/journal.pone.0076900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130807	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900101
J	Han, XJ; Wang, YD; Chen, YC; Lin, LY; Wu, QK				Han, Xiao-Jiao; Wang, Yang-Dong; Chen, Yi-Cun; Lin, Li-Yuan; Wu, Qing-Ke			Transcriptome Sequencing and Expression Analysis of Terpenoid Biosynthesis Genes in Litsea cubeba	PLOS ONE			English	Article							ESSENTIAL OILS; CHEMICAL-COMPOSITION; GENOME SEQUENCE; MEDICINAL-PLANT; FAMILY; IDENTIFICATION; ANNOTATION; METABOLISM; GENERATION; TOXICITY	Background: Aromatic essential oils extracted from fresh fruits of Litsea cubeba (Lour.) Pers., have diverse medical and economic values. The dominant components in these essential oils are monoterpenes and sesquiterpenes. Understanding the molecular mechanisms of terpenoid biosynthesis is essential for improving the yield and quality of terpenes. However, the 40 available L. cubeba nucleotide sequences in the public databases are insufficient for studying the molecular mechanisms. Thus, high-throughput transcriptome sequencing of L. cubeba is necessary to generate large quantities of transcript sequences for the purpose of gene discovery, especially terpenoid biosynthesis related genes. Results: Using Illumina paired-end sequencing, approximately 23.5 million high-quality reads were generated. De novo assembly yielded 68,648 unigenes with an average length of 834 bp. A total of 38,439 (56%) unigenes were annotated for their functions, and 35,732 and 25,806 unigenes could be aligned to the GO and COG database, respectively. By searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG), 16,130 unigenes were assigned to 297 KEGG pathways, and 61 unigenes, which contained the mevalonate and 2-C-methyl-D-erythritol 4-phosphate pathways, could be related to terpenoid backbone biosynthesis. Of the 12,963 unigenes, 285 were annotated to the terpenoid pathways using the PlantCyc database. Additionally, 14 terpene synthase genes were identified from the transcriptome. The expression patterns of the 16 genes related to terpenoid biosynthesis were analyzed by RT-qPCR to explore their putative functions. Conclusion: RNA sequencing was effective in identifying a large quantity of sequence information. To our knowledge, this study is the first exploration of the L. cubeba transcriptome, and the substantial amount of transcripts obtained will accelerate the understanding of the molecular mechanisms of essential oils biosynthesis. The results may help improve future genetic and genomics studies on the molecular mechanisms behind the chemical composition of essential oils in L. cubeba fruits.	[Han, Xiao-Jiao; Wang, Yang-Dong; Chen, Yi-Cun; Lin, Li-Yuan; Wu, Qing-Ke] Chinese Acad Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China; [Han, Xiao-Jiao; Wang, Yang-Dong; Chen, Yi-Cun; Lin, Li-Yuan; Wu, Qing-Ke] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Peoples R China	Chinese Academy of Forestry; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Wang, YD (corresponding author), Chinese Acad Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China.	wyd11111@126.com		Han, Xiaojiao/0000-0001-6082-7569	Zhejiang Science and Technology Hall [2011R50030]; Basic Scientific Research Project of Nonprofit Central Research Institutions of Chinese Academy of Forestry [61254]	Zhejiang Science and Technology Hall; Basic Scientific Research Project of Nonprofit Central Research Institutions of Chinese Academy of Forestry	The work presented here was supported by Zhejiang Science and Technology Hall (No. 2011R50030) and Basic Scientific Research Project of Nonprofit Central Research Institutions of Chinese Academy of Forestry (No. 61254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Annadurai RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056217; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chang YT, 2011, TREE GENET GENOMES, V7, P835, DOI 10.1007/s11295-011-0377-3; Chen CJ, 2012, J WOOD SCI, V58, P538, DOI 10.1007/s10086-012-1277-3; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Cheng AX, 2007, J INTEGR PLANT BIOL, V49, P179, DOI 10.1111/j.1744-7909.2007.00395.x; Choi EM, 2004, FITOTERAPIA, V75, P141, DOI 10.1016/j.fitote.2003.11.003; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Drew DP, 2013, INT J MOL SCI, V14, P9080, DOI 10.3390/ijms14059080; Falara V, 2011, PLANT PHYSIOL, V157, P770, DOI 10.1104/pp.111.179648; Foster AJ, 2013, PLANT PHYSIOL, V161, P1993, DOI 10.1104/pp.112.206383; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Ho CL, 2010, NAT PROD COMMUN, V5, P617; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Hwang JK, 2005, FITOTERAPIA, V76, P684, DOI 10.1016/j.fitote.2005.05.007; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang ZL, 2009, J AGR FOOD CHEM, V57, P4833, DOI 10.1021/jf900274r; Julsing MK, 2006, BIOMOL ENG, V23, P265, DOI 10.1016/j.bioeng.2006.08.001; Kamal KJ, 2006, MED AROMATIC PLANTS, P166; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu TT, 2012, INT J FOOD MICROBIOL, V156, P68, DOI 10.1016/j.ijfoodmicro.2012.03.005; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Luo M, 2005, J FOOD PROTECT, V68, P581, DOI 10.4315/0362-028X-68.3.581; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagegowda D.A., 2007, MED PLANTS BIOTECHNO, V2, P469; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Nieuwenhuizen NJ, 2013, PLANT PHYSIOL, V161, P787, DOI 10.1104/pp.112.208249; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sapir-Mir M, 2008, PLANT PHYSIOL, V148, P1219, DOI 10.1104/pp.108.127951; Seo SM, 2009, J AGR FOOD CHEM, V57, P6596, DOI 10.1021/jf9015416; Si LL, 2012, MOLECULES, V17, P7057, DOI 10.3390/molecules17067057; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang HW, 2010, CHEM BIODIVERS, V7, P229, DOI 10.1002/cbdv.200800349; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wouters J, 2003, J AM CHEM SOC, V125, P3198, DOI 10.1021/ja029171p; Wullschleger SD, 2013, TREE PHYSIOL, V33, P357, DOI 10.1093/treephys/tps081; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	58	50	55	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76890	10.1371/journal.pone.0076890	http://dx.doi.org/10.1371/journal.pone.0076890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130803	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900098
J	Leutheuser, H; Schuldhaus, D; Eskofier, BM				Leutheuser, Heike; Schuldhaus, Dominik; Eskofier, Bjoern M.			Hierarchical, Multi-Sensor Based Classification of Daily Life Activities: Comparison with State-of-the-Art Algorithms Using a Benchmark Dataset	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY RECOGNITION; WALKING; PREVENTION; PATTERNS; SENSOR; SPORTS; HEALTH	Insufficient physical activity is the 4th leading risk factor for mortality. Methods for assessing the individual daily life activity (DLA) are of major interest in order to monitor the current health status and to provide feedback about the individual quality of life. The conventional assessment of DLAs with self-reports induces problems like reliability, validity, and sensitivity. The assessment of DLAs with small and light-weight wearable sensors (e. g. inertial measurement units) provides a reliable and objective method. State-of-the-art human physical activity classification systems differ in e. g. the number and kind of sensors, the performed activities, and the sampling rate. Hence, it is difficult to compare newly proposed classification algorithms to existing approaches in literature and no commonly used dataset exists. We generated a publicly available benchmark dataset for the classification of DLAs. Inertial data were recorded with four sensor nodes, each consisting of a triaxial accelerometer and a triaxial gyroscope, placed on wrist, hip, chest, and ankle. Further, we developed a novel, hierarchical, multi-sensor based classification system for the distinction of a large set of DLAs. Our hierarchical classification system reached an overall mean classification rate of 89.6% and was diligently compared to existing state-of-the-art algorithms using our benchmark dataset. For future research, the dataset can be used in the evaluation process of new classification algorithms and could speed up the process of getting the best performing and most appropriate DLA classification system.	[Leutheuser, Heike; Schuldhaus, Dominik; Eskofier, Bjoern M.] Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, Dept Comp Sci, Nurnberg, Germany	University of Erlangen Nuremberg	Leutheuser, H (corresponding author), Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, Dept Comp Sci, Nurnberg, Germany.	heike.leutheuser@cs.fau.de; dominik.schuldhaus@cs.fau.de	Eskofier, Bjoern/ABF-1284-2021; Leutheuser, Heike/GYJ-1186-2022	Eskofier, Bjoern/0000-0002-0417-0336; 	Bavarian Ministry for Economic Affairs, Infrastructure, Transport, and Technology; European fund for regional development [IUK-1103-0012//IUK383/001]; adidas AG; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-University Erlangen-Nuremberg	Bavarian Ministry for Economic Affairs, Infrastructure, Transport, and Technology; European fund for regional development(European Commission); adidas AG; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nuremberg	This work was supported by the Bavarian Ministry for Economic Affairs, Infrastructure, Transport, and Technology and the European fund for regional development (grant number: IUK-1103-0012//IUK383/001; http://www.stmwivt.bayern.de/themen/). Financial and technical support of the study were provided by adidas AG. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-University Erlangen-Nuremberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 1999, CAN FAM PHYSICIAN, V45, P992; Agostini G, 2003, EURASIP J APPL SIG P, V2003, P5, DOI 10.1155/S1110865703210118; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Altun K, 2010, LECT NOTES COMPUT SC, V6219, P38, DOI 10.1007/978-3-642-14715-9_5; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Burns A, 2010, IEEE SENS J, V10, P1527, DOI 10.1109/JSEN.2010.2045498; Duda R.O., 2000, PATTERN CLASSIFICATI; Ermes M, 2008, IEEE T INF TECHNOL B, V12, P20, DOI 10.1109/TITB.2007.899496; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Koskimaki H, 2009, MED C CONTR AUTOMAT, P401, DOI 10.1109/MED.2009.5164574; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Liu SP, 2012, IEEE T BIO-MED ENG, V59, P687, DOI 10.1109/TBME.2011.2178070; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Nyan MN, 2006, J BIOMECH, V39, P2647, DOI 10.1016/j.jbiomech.2005.08.014; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Oguma Y, 2002, BRIT J SPORT MED, V36, P162, DOI 10.1136/bjsm.36.3.162; Parkka J, 2006, IEEE T INF TECHNOL B, V10, P119, DOI 10.1109/TITB.2005.856863; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Preece SJ, 2009, IEEE T BIO-MED ENG, V56, P871, DOI 10.1109/TBME.2008.2006190; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Schuldhaus D, 2012, INT C PATT RECOG, P2258; Sekine M, 2000, MED ENG PHYS, V22, P285, DOI 10.1016/S1350-4533(00)00041-2; Sekine M, 2002, IEEE T NEUR SYS REH, V10, P188, DOI 10.1109/TNSRE.2002.802879; Seon-Woo Lee, 2002, IEEE Pervasive Computing, V1, P24, DOI 10.1109/MPRV.2002.1037719; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Tamura T, 1997, METHOD INFORM MED, V36, P356; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Wang N, 2007, P ANN INT IEEE EMBS, P4899, DOI 10.1109/IEMBS.2007.4353438; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010; Witten IH, 2011, MOR KAUF D, P1	43	107	109	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75196	10.1371/journal.pone.0075196	http://dx.doi.org/10.1371/journal.pone.0075196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130686	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900019
J	Ording, AG; Garne, JP; Nystrom, PMW; Froslev, T; Sorensen, HT; Lash, TL				Ording, Anne Gulbech; Garne, Jens Peter; Nystrom, Petra Mariann Witt; Froslev, Trine; Sorensen, Henrik Toft; Lash, Timothy L.			Comorbid Diseases Interact with Breast Cancer to Affect Mortality in the First Year after Diagnosis-A Danish Nationwide Matched Cohort Study	PLOS ONE			English	Article							OLDER PATIENTS; SURVIVAL; REGISTRY; RECURRENCE; QUALITY; COLON; DEATH; CARE; AGE	Background: Survival of breast cancer patients with comorbidity, compared to those without comorbidity, has been well characterized. The interaction between comorbid diseases and breast cancer, however, has not been well-studied. Methods: From Danish nationwide medical registries, we identified all breast cancer patients between 45 and 85 years of age diagnosed from 1994 to 2008. Women without breast cancer were matched to the breast cancer patients on specific comorbid diseases included in the Charlson comorbidity Index (CCI). Interaction contrasts were calculated as a measure of synergistic effect on mortality between comorbidity and breast cancer. Results: The study included 47,904 breast cancer patients and 237,938 matched comparison women. In the first year, the strongest interaction between comorbidity and breast cancer was observed in breast cancer patients with a CCI score of >= 4, which accounted for 29 deaths per 1000 person-years. Among individual comorbidities, dementia interacted strongly with breast cancer and accounted for 148 deaths per 1000 person-years within one year of follow-up. There was little interaction between comorbidity and breast cancer during one to five years of follow-up. Conclusions: There was substantial interaction between comorbid diseases and breast cancer, affecting mortality. Successful treatment of the comorbid diseases or the breast cancer can delay mortality caused by this interaction in breast cancer patients.	[Ording, Anne Gulbech; Froslev, Trine; Sorensen, Henrik Toft; Lash, Timothy L.] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Garne, Jens Peter] Aalborg Univ Hosp, Aalborg Hosp, Breast Clin, Aalborg, Denmark; [Nystrom, Petra Mariann Witt] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden; [Lash, Timothy L.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Aarhus University; Aalborg University; Aalborg University Hospital; Uppsala University; Uppsala University Hospital; Emory University; Rollins School Public Health	Ording, AG (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	ao@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040	Danish Agency for Science, Technology and Innovation; Karen Elise Jensen Foundation; Clinical Epidemiology Research Foundation; Aarhus University; Aalborg Sygehus; Region North Denmark; Arkitekt Holger Hjortenberg og hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	Danish Agency for Science, Technology and Innovation; Karen Elise Jensen Foundation; Clinical Epidemiology Research Foundation; Aarhus University; Aalborg Sygehus; Region North Denmark; Arkitekt Holger Hjortenberg og hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	This study was supported by the Danish Agency for Science, Technology and Innovation, Karen Elise Jensen Foundation, the Clinical Epidemiology Research Foundation, Aarhus University, Aalborg Sygehus, Region North Denmark, Arkitekt Holger Hjortenberg og hustru Dagmar Hjortenbergs Foundation, and Inge og Jorgen Larsens Mindelegat Foundation. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Baade PD, 2006, CANCER CAUSE CONTROL, V17, P287, DOI 10.1007/s10552-005-0530-0; Bush D, 2011, BREAST CANCER RES TR, V127, P243, DOI 10.1007/s10549-010-1186-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cronin-Fenton DP, 2007, BRIT J CANCER, V96, P1462, DOI 10.1038/sj.bjc.6603717; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gonzalez EC, 2001, SOUTHERN MED J, V94, P913; Gorin SS, 2005, J AM GERIATR SOC, V53, P1897, DOI 10.1111/j.1532-5415.2005.00467.x; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Greenland S., 2008, MODERN EPIDEMIOLOGY; Gupta SK, 2004, J AM GERIATR SOC, V52, P1681, DOI 10.1111/j.1532-5415.2004.52461.x; Jensen AR, 2002, EUR J CANCER PREV, V11, P359, DOI 10.1097/00008469-200208000-00007; Land LH, 2012, BREAST CANCER RES TR, V131, P1013, DOI 10.1007/s10549-011-1819-1; Lash TL, 2000, CANCER-AM CANCER SOC, V89, P1739, DOI 10.1002/1097-0142(20001015)89:8<1739::AID-CNCR14>3.0.CO;2-F; Launay-Vacher V, 2007, CANCER-AM CANCER SOC, V110, P1376, DOI 10.1002/cncr.22904; Newschaffer CJ, 1998, J GERONTOL A-BIOL, V53, pM372, DOI 10.1093/gerona/53A.5.M372; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Pedersen CB, 2006, DAN MED BULL, V53, P441; Raji MA, 2008, ARCH INTERN MED, V168, P2033, DOI 10.1001/archinte.168.18.2033; Riihimaki M, 2012, ANN ONCOL, V23, P604, DOI 10.1093/annonc/mdr160; Ring A, 2011, J CLIN ONCOL, V29, P4266, DOI 10.1200/JCO.2011.35.5545; Schonberg MA, 2010, J CLIN ONCOL, V28, P2038, DOI 10.1200/JCO.2009.25.9796; Snyder CF, 2013, J CLIN ONCOL, V31, P1140, DOI 10.1200/JCO.2012.43.0272; Storm HH, 1997, DAN MED BULL, V44, P535; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	28	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76013	10.1371/journal.pone.0076013	http://dx.doi.org/10.1371/journal.pone.0076013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130755	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900065
J	Savage, N; Yang, TJW; Chen, CY; Lin, KL; Monk, NAM; Schmidt, W				Savage, Natasha; Yang, Thomas J. W.; Chen, Chung Ying; Lin, Kai-Lan; Monk, Nicholas A. M.; Schmidt, Wolfgang			Positional Signaling and Expression of ENHANCER OF TRY AND CPC1 Are Tuned to Increase Root Hair Density in Response Phosphate Deficiency in Arabidopsis thaliana	PLOS ONE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; RECEPTOR-LIKE KINASE; CAPRICE TRANSCRIPTION; FATE SPECIFICATION; ELONGATION; PATTERN; PROTEIN; ORGANIZATION; WEREWOLF; DIVISION	Phosphate (Pi) deficiency induces a multitude of responses aimed at improving the acquisition of Pi, including an increased density of root hairs. To understand the mechanisms involved in Pi deficiency-induced alterations of the root hair phenotype in Arabidopsis (Arabidopsis thaliana), we analyzed the patterning and length of root epidermal cells under control and Pi-deficient conditions in wild-type plants and in four mutants defective in the expression of master regulators of cell fate, CAPRICE (CPC), ENHANCER OF TRY AND CPC 1 (ETC1), WEREWOLF (WER) and SCRAMBLED (SCM). From this analysis we deduced that the longitudinal cell length of root epidermal cells is dependent on the correct perception of a positional signal ('cortical bias') in both control and Pi-deficient plants; mutants defective in the receptor of the signal, SCM, produced short cells characteristic of root hair-forming cells (trichoblasts). Simulating the effect of cortical bias on the time-evolving probability of cell fate supports a scenario in which a compromised positional signal delays the time point at which non-hair cells opt out the default trichoblast pathway, resulting in short, trichoblast-like non-hair cells. Collectively, our data show that Pi-deficient plants increase root hair density by the formation of shorter cells, resulting in a higher frequency of hairs per unit root length, and additional trichoblast cell fate assignment via increased expression of ETC1.	[Savage, Natasha] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Yang, Thomas J. W.; Chen, Chung Ying; Lin, Kai-Lan; Schmidt, Wolfgang] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Monk, Nicholas A. M.] Univ Nottingham, Div Appl Math, Sch Math Sci, Nottingham NG7 2RD, England; [Monk, Nicholas A. M.] Univ Nottingham, Ctr Plant Integrat Biol, Sch Biosci, Loughborough, Leics, England; [Schmidt, Wolfgang] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Schmidt, Wolfgang] Natl Taiwan Univ, Coll Life Sci, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan	University of Liverpool; Academia Sinica - Taiwan; University of Nottingham; University of Nottingham; National Chung Hsing University; National Taiwan University	Schmidt, W (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	wosh@gate.sinica.edu.tw	Schmidt, Wolfgang/AAA-2807-2022; Schmidt, Wolfgang/A-3234-2014	Schmidt, Wolfgang/0000-0002-7850-6832; Monk, Nick/0000-0002-5465-4857	Royal Society UK; National Science Council Taiwan; Royal Society; Wellcome Trust	Royal Society UK(Royal Society of London); National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	This work was supported by a bilateral grant from the Royal Society UK and the National Science Council Taiwan to NAMM and WS. NS was funded by the Royal Society and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Chandrika NNP, 2013, NEW PHYTOL, V198, P709, DOI 10.1111/nph.12194; Clowes FAL, 2000, NEW PHYTOL, V146, P83, DOI 10.1046/j.1469-8137.2000.00614.x; Costa S, 2000, CURR OPIN GENET DEV, V10, P405, DOI 10.1016/S0959-437X(00)00104-0; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; DOLAN L, 1993, DEVELOPMENT, V119, P71; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Grierson C, 2002, ARABIDOPSIS BOOK, V1, pe0060; Kang YH, 2009, PLANT CELL, V21, P1080, DOI 10.1105/tpc.108.063180; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Kuppusamy KT, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0811633106; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Leavitt RG, 1904, TRICHOMES ROOT VASCU; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Li WF, 2010, MOL PLANT, V3, P212, DOI 10.1093/mp/ssp086; Lin WD, 2011, PLANT PHYSIOL, V155, P1383, DOI 10.1104/pp.110.166520; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; Masucci JD, 1996, PLANT CELL, V8, P1505, DOI 10.1105/tpc.8.9.1505; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Ryu KH, 2005, DEVELOPMENT, V132, P4765, DOI 10.1242/dev.02055; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Savage NS, 2008, PLOS BIOL, V6, P1899, DOI 10.1371/journal.pbio.0060235; Schiefelbein J, 2009, J EXP BOT, V60, P1515, DOI 10.1093/jxb/ern339; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562	36	36	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75452	10.1371/journal.pone.0075452	http://dx.doi.org/10.1371/journal.pone.0075452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130712	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325810900037
J	Wang, M; Zhu, XY; Wang, L; Lin, Y				Wang, Ming; Zhu, Xiao-Yang; Wang, Liang; Lin, Yu			The-607C/A Polymorphisms in Interleukin-18 Gene Promoter Contributes to Cancer Risk: Evidence from A Meta-Analysis of 22 Case-Control Studies	PLOS ONE			English	Article							SERUM INTERLEUKIN-18; IL-18 PROMOTER; CARCINOMA; SUSCEPTIBILITY; ASSOCIATION; MARKER; LEVEL	Background: Several observational studies have investigated the association between -607 C/A polymorphism of IL-18 gene and cancer risk; however, the results were inconsistent. Therefore, we performed a meta-analysis to derive a more precise estimation of the association to help us better understand the relationship between -607 C/A polymorphism of IL-18 gene promoter and risk of cancer. Methods: A literature search was carried out using PubMed, EMBASE, and China National Knowledge Infrastructure (CNKI) database between January 1966 and February 2013. Fixed-effect and random-effect models were used to estimate the pooled odds ratio (OR) and the corresponding 95% confidence intervals (CIs). Results: A total of 22 case-control studies including 4100 cancer cases and 4327 controls contributed to the analysis. Significant association between -607C/A polymorphism in IL-18 gene promoter and cancer risk was observed (CA vs CC: OR = 1.221, 95% CI: 1.096, 1.360; P-heterogeneity=0.219; AA/CA vs. CC: OR = 1.203, 95% CI: 1.057, 1.369; P-heterogeneity=0.064). In the subgroup analysis by ethnicity, -607C/A polymorphism significantly increased risk of cancer among Asian population (AA/CA vs. CC: OR = 1.197, 95% CI: 1.023,1.401; P-heterogeneity=0.088); however, no significant association was found in Caucasian or African population. The -607C/A polymorphism was associated with a significantly increased risk of nasopharyngeal carcinoma (CA vs CC: OR = 1.330, 95% CI: 1.029,1.719; P-heterogeneity=0.704; AA/CA vs. CC: OR = 1.323, 95% CI: 1.037,1.687; P-heterogeneity=0.823) and esophageal cancer (AA/CA vs. CC: OR = 1.289, 95% CI: 1.002,1.658; P-heterogeneity=0.700). Conclusions: The present meta-analysis suggests that the -607C/A polymorphisms in IL-18 gene promoter is associated with a significantly increased risk of cancer, especially for nasopharyngeal carcinoma and esophageal cancer and in Asian population. More studies with larger sample size, well controlled confounding factors are warranted to validate this association.	[Wang, Ming] Cangzhou Cent Hosp, Dept Radiat Therapy, Cangzhou, Hebei Province, Peoples R China; [Zhu, Xiao-Yang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Radiat Therapy, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Liang] Cangzhou Cent Hosp, Dept Endoscop Profess, Cangzhou, Hebei Province, Peoples R China; [Lin, Yu] Inner Mongolia Med Univ, Dept Radiat Therapy, Affiliated Hosp, Hohhot, Neimenggu Provi, Peoples R China	Zhejiang University; Inner Mongolia Medical University	Wang, M (corresponding author), Cangzhou Cent Hosp, Dept Radiat Therapy, Cangzhou, Hebei Province, Peoples R China.	mwangm@yeah.net						Asefi V, 2009, J LARYNGOL OTOL, V123, P444, DOI 10.1017/S0022215108003733; Babar M, 2012, AM J GASTROENTEROL, V107, P1331, DOI 10.1038/ajg.2012.134; Baxevanis CN, 2003, J IMMUNOL, V171, P2953, DOI 10.4049/jimmunol.171.6.2953; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bushley AW, 2004, GYNECOL ONCOL, V95, P672, DOI 10.1016/j.ygyno.2004.08.024; Dehaghani AS, 2009, MOL BIOL REP, V36, P2393, DOI 10.1007/s11033-009-9469-7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; Du B, 2012, MED J W CHINA, V25, P1683; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farhat K, 2008, CYTOKINE, V43, P132, DOI 10.1016/j.cyto.2008.05.004; Farjadfar A, 2009, ACTA ONCOL, V48, P971, DOI 10.1080/02841860902878145; Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0; Gunel N, 2002, CANCER-AM CANCER SOC, V95, P663, DOI 10.1002/cncr.10705; Guo Jun-yu, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P400; Haghshenas MR, 2009, J GASTROEN HEPATOL, V24, P1119, DOI 10.1111/j.1440-1746.2009.05791.x; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Jaiswal PK, 2013, GENE, V519, P128, DOI 10.1016/j.gene.2013.01.025; Kashef MA, 2008, J REPROD MED, V53, P855; Kawabata T, 2001, CANCER, V92, P2050, DOI 10.1002/1097-0142(20011015)92:8<2050::AID-CNCR1544>3.0.CO;2-5; Khalili-Azad T, 2009, NEOPLASMA, V56, P22, DOI 10.4149/neo_2009_01_22; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lebel-Binay S, 2000, EUR CYTOKINE NETW, V11, P15; Liu JM, 2013, GENET MOL RES, V12, P820, DOI 10.4238/2013.March.15.2; Liu YU, 2007, DNA CELL BIOL, V26, P613, DOI 10.1089/dna.2007.0600; Nikiteas N, 2007, ANTICANCER RES, V27, P3849; Nong LG, 2009, DNA CELL BIOL, V28, P507, DOI 10.1089/dna.2009.0912; Pratesi C, 2006, CANCER IMMUNOL IMMUN, V55, P23, DOI 10.1007/s00262-005-0688-z; Qi Tao, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P754; Saenz-Lopez P, 2010, HUM IMMUNOL, V71, P309, DOI 10.1016/j.humimm.2009.11.010; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Taheri M, 2012, Prague Med Rep, V113, P217; Thong-Ngam D, 2006, WORLD J GASTROENTERO, V12, P4473, DOI 10.3748/wjg.v12.i28.4473; Tschoeke SK, 2006, CRIT CARE MED, V34, P1225, DOI 10.1097/01.CCM.0000208356.05575.16; Tsuboi K, 2004, CANCER LETT, V205, P207, DOI 10.1016/j.canlet.2003.10.010; Vairaktaris E, 2007, ANTICANCER RES, V27, P4011; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Wei YS, 2007, ACTA ONCOL, V46, P1090, DOI 10.1080/02841860701373595; Yang Hong-ling, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1006	42	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76915	10.1371/journal.pone.0076915	http://dx.doi.org/10.1371/journal.pone.0076915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130810	Green Submitted, gold, Green Published			2022-12-27	WOS:000325810900104
J	Chen, DL; Jiang, BH; Xing, JD; Liu, MX; Cui, M; Liu, YQ; Wang, ZZ; Chen, L; Yang, H; Zhang, CH; Yao, ZD; Zhang, N; Ji, JF; Qu, H; Su, XQ				Chen, Donglai; Jiang, Beihai; Xing, Jiadi; Liu, Maoxing; Cui, Ming; Liu, Yiqiang; Wang, Zaozao; Chen, Lei; Yang, Hong; Zhang, Chenghai; Yao, Zhendan; Zhang, Nan; Ji, Jiafu; Qu, Hong; Su, Xiangqian			Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Disease-Specific Survival after R0 Resection in a Chinese Gastric Cancer Population	PLOS ONE			English	Article							US-DERIVED NOMOGRAM; PROGNOSTIC NOMOGRAM; INDIVIDUAL SURVIVAL; UNITED-STATES; RECURRENCE; CARCINOMA; SURGERY; KOREA	Background: Prediction of disease-specific survival (DSS) for individual patient with gastric cancer after R0 resection remains a clinical concern. Since the clinicopathologic characteristics of gastric cancer vary widely between China and western countries, this study is to evaluate a nomogram from Memorial Sloan-Kettering Cancer Center (MSKCC) for predicting the probability of DSS in patients with gastric cancer from a Chinese cohort. Methods: From 1998 to 2007, clinical data of 979 patients with gastric cancer who underwent R0 resection were retrospectively collected from Peking University Cancer Hospital & Institute and used for external validation. The performance of the MSKCC nomogram in our population was assessed using concordance index (C-index) and calibration plot. Results: The C-index for the MSKCC predictive nomogram was 0.74 in the Chinese cohort, compared with 0.69 for American Joint Committee on Cancer (AJCC) staging system (P<0.0001). This suggests that the discriminating value of MSKCC nomogram is superior to AJCC staging system for prognostic prediction in the Chinese population. Calibration plots showed that the actual survival of Chinese patients corresponded closely to the MSKCC nonogram-predicted survival probabilities. Moreover, MSKCC nomogram predictions demonstrated the heterogeneity of survival in stage IIA/IIB/IIIA/IIIB disease of the Chinese patients. Conclusion: In this study, we externally validated MSKCC nomogram for predicting the probability of 5- and 9-year DSS after R0 resection for gastric cancer in a Chinese population. The MSKCC nomogram performed well with good discrimination and calibration. The MSKCC nomogram improved individualized predictions of survival, and may assist Chinese clinicians and patients in individual follow-up scheduling, and decision making with regard to various treatment options.	[Chen, Donglai; Qu, Hong] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China; [Jiang, Beihai; Xing, Jiadi; Liu, Maoxing; Cui, Ming; Wang, Zaozao; Chen, Lei; Yang, Hong; Zhang, Chenghai; Yao, Zhendan; Zhang, Nan; Su, Xiangqian] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Dept Minimally Invas Gastrointestinal Surg, Beijing, Peoples R China; [Liu, Yiqiang] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Dept Pathol, Beijing, Peoples R China; [Ji, Jiafu] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Dept Surg, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University	Qu, H (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China.	quh@mail.cbi.pku.edu.cn; suxiangqian@bjmu.edu.cn		JI, JIAFU/0000-0001-6878-5543; Jiang, Beihai/0000-0002-3665-9291	National Natural Science Foundation of China [81272766, 31171270, 81071658]; Capital Medical Development and Research Foundation [2009-2093]; Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission) [Z121107001012130]; Beijing Natural Science Foundation [7132054]; New Star of Science and Technology Program of Beijing (Beijing Municipal Science & Technology Commission) [2011060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical Development and Research Foundation; Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); New Star of Science and Technology Program of Beijing (Beijing Municipal Science & Technology Commission)	This study was supported by the grants from the National Natural Science Foundation of China (No. 81272766, No. 31171270, and No. 81071658), Capital Medical Development and Research Foundation (No. 2009-2093), Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission No. Z121107001012130), Beijing Natural Science Foundation (No. 7132054), New Star of Science and Technology Program of Beijing (Beijing Municipal Science & Technology Commission No. 2011060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedei A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/437348; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dikken JL, 2013, ANN SURG ONCOL, V20, P1623, DOI 10.1245/s10434-012-2723-6; Dikken JL, 2012, THER ADV GASTROENTER, V5, P49, DOI 10.1177/1756283X11410771; Gold JS, 2007, ANN SURG ONCOL, V14, P3159, DOI 10.1245/s10434-007-9542-1; Graesslin O, 2010, J CLIN ONCOL, V28, P2032, DOI 10.1200/JCO.2009.24.6314; Gronchi A, 2013, J CLIN ONCOL, V31, P1649, DOI 10.1200/JCO.2012.44.3747; Han DS, 2012, J CLIN ONCOL, V30, P3834, DOI 10.1200/JCO.2012.41.8343; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kattan MW, 2003, J CLIN ONCOL, V21, P3647, DOI 10.1200/JCO.2003.01.240; Koc M, 2009, LANGENBECK ARCH SURG, V394, P755, DOI 10.1007/s00423-008-0426-z; Lai JF, 2009, ANN SURG ONCOL, V16, P1896, DOI 10.1245/s10434-009-0473-x; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Novotny AR, 2006, ANN SURG, V243, P74, DOI 10.1097/01.sla.0000194088.81126.85; Peeters KCMJ, 2005, CANCER-AM CANCER SOC, V103, P702, DOI 10.1002/cncr.20783; Rudloff U, 2010, J CLIN ONCOL, V28, P3762, DOI 10.1200/JCO.2009.26.8847; Song KY, 2014, GASTRIC CANCER, V17, P287, DOI 10.1007/s10120-013-0270-x; Strong VE, 2013, J SURG ONCOL, V107, P634, DOI 10.1002/jso.23288; Strong VE, 2010, ANN SURG, V251, P640, DOI 10.1097/SLA.0b013e3181d3d29b; Takahashi Tsunehiro, 2013, Cancers (Basel), V5, P48, DOI 10.3390/cancers5010048; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Weiser MR, 2008, J CLIN ONCOL, V26, P380, DOI 10.1200/JCO.2007.14.1291; Zhu XD, 2010, ONCOL LETT, V1, P407, DOI 10.3892/ol_00000071	23	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76041	10.1371/journal.pone.0076041	http://dx.doi.org/10.1371/journal.pone.0076041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146811	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200008
J	Delye, C; Deulvot, C; Chauvel, B				Delye, Christophe; Deulvot, Chrystel; Chauvel, Bruno			DNA Analysis of Herbarium Specimens of the Grass Weed Alopecurus myosuroides Reveals Herbicide Resistance Pre-Dated Herbicides	PLOS ONE			English	Article							A CARBOXYLASE INHIBITORS; ACETYL-COA CARBOXYLASE; COENZYME; EVOLUTION; AMPLIFICATION; MUTATIONS; FITNESS; COSTS	Acetyl-CoA carboxylase (ACCase) alleles carrying one point mutation that confers resistance to herbicides have been identified in arable grass weed populations where resistance has evolved under the selective pressure of herbicides. In an effort to determine whether herbicide resistance evolves from newly arisen mutations or from standing genetic variation in weed populations, we used herbarium specimens of the grass weed Alopecurus myosuroides to seek mutant ACCase alleles carrying an isoleucine-to-leucine substitution at codon 1781 that endows herbicide resistance. These specimens had been collected between 1788 and 1975, i.e., prior to the commercial release of herbicides inhibiting ACCase. Among the 734 specimens investigated, 685 yielded DNA suitable for PCR. Genotyping the ACCase locus using the derived Cleaved Amplified Polymorphic Sequence (dCAPS) technique identified one heterozygous mutant specimen that had been collected in 1888. Occurrence of a mutant codon encoding a leucine residue at codon 1781 at the heterozygous state was confirmed in this specimen by sequencing, clearly demonstrating that resistance to herbicides can pre-date herbicides in weeds. We conclude that point mutations endowing resistance to herbicides without having associated deleterious pleiotropic effects can be present in weed populations as part of their standing genetic variation, in frequencies higher than the mutation frequency, thereby facilitating their subsequent selection by herbicide applications.	[Delye, Christophe; Deulvot, Chrystel; Chauvel, Bruno] INRA, Agroecol UMR1347, F-21034 Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Delye, C (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	delye@dijon.inra.fr			Bayer CropScience SA (Lyon, France)	Bayer CropScience SA (Lyon, France)	The authors are grateful to Bayer CropScience SA (Lyon, France) for supporting this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Chauvel B, 2012, CROP PROT, V42, P320, DOI 10.1016/j.cropro.2012.07.011; Cozzolino S, 2007, CONSERV GENET, V8, P629, DOI 10.1007/s10592-006-9209-7; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Delye C, 2007, WEED RES, V47, P95, DOI 10.1111/j.1365-3180.2007.00544.x; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, WEED RES, V45, P323, DOI 10.1111/j.1365-3180.2005.00467.x; Delye C, 2004, MOL BIOL EVOL, V21, P884, DOI 10.1093/molbev/msh095; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; DELYE C, 2013, TRENDS GENET, DOI DOI 10.1016/J.TIG.2013.06.001.PUBMED:23830583; Delye C, 2010, BASIC APPL ECOL, V11, P504, DOI 10.1016/j.baae.2010.06.008; Delye C, 2013, ANN BOT-LONDON, V111, P681, DOI 10.1093/aob/mct018; Delye C, 2013, PEST MANAG SCI, V69, P176, DOI 10.1002/ps.3318; Delye C, 2010, NEW PHYTOL, V186, P1005, DOI 10.1111/j.1469-8137.2010.03233.x; Ffrench-Constant RH, 2007, TRENDS GENET, V23, P1, DOI 10.1016/j.tig.2006.11.006; Gressel J, 2006, P NATL ACAD SCI USA, V103, P12215, DOI 10.1073/pnas.0603666103; Gugerli F, 2005, NEW PHYTOL, V166, P409, DOI 10.1111/j.1469-8137.2005.01360.x; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Jasieniuk M, 1996, WEED SCI, V44, P176, DOI 10.1017/S0043174500093747; Johnsson H, 1944, HEREDITAS, V30, P469; Menchari Y, 2008, J APPL ECOL, V45, P939, DOI 10.1111/j.1365-2664.2008.01462.x; Moss SR, 2007, WEED TECHNOL, V21, P300, DOI 10.1614/WT-06-087.1; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; RENDINA AR, 1988, PLANT PHYSIOL, V86, P983, DOI 10.1104/pp.86.4.983; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; SAVOLAINEN V, 1995, PLANT SYST EVOL, V197, P87, DOI 10.1007/BF00984634; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Sundar D.R, 2009, BINOM BINOMIAL CONFI; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; VANHIMME M, 1975, P EUR WEED RES SOC S, P23; Vila-Aiub MM, 2011, HEREDITY, V107, P386, DOI 10.1038/hdy.2011.29; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Wang T, 2010, HEREDITY, V105, P394, DOI 10.1038/hdy.2009.183	35	27	30	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75117	10.1371/journal.pone.0075117	http://dx.doi.org/10.1371/journal.pone.0075117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146749	Green Published, gold			2022-12-27	WOS:000326019400004
J	Smrz, J; Kovac, L; Mikes, J; Lukesova, A				Smrz, Jaroslav; Kovac, Lubomir; Mikes, Jaromir; Lukesova, Alena			Microwhip Scorpions (Palpigradi) Feed on Heterotrophic Cyanobacteria in Slovak Caves - A Curiosity among Arachnida	PLOS ONE			English	Article							FINE-STRUCTURE; ACARI; HEMOCYTES	To date, only morphological and anatomical descriptions of microwhip scorpions (Arachnida: Palpigradi) have been published. This very rare group is enigmatic not only in its relationships to other arachnids, but especially due to the fact that these animals dwell only underground (in caves, soil, and interstitial spaces). We observed the curious feeding habit of the microwhip scorpion Eukoenenia spelaea over the course of one year in Ardovska Cave, located in Slovakia's Karst region. We chose histology as our methodology in studying 17 specimens and based it upon Masson's triple staining, fluorescent light and confocal microscopy. Single-celled cyanobacteria (blue-green algae) were conspicuously predominant in the gut of all studied palpigrades. Digestibility of the consumed cyanobacteria was supported by the presence of guanine crystals, glycogen deposits and haemocytes inside the palpigrade body. Cyanobacteria, the oldest cellular organisms on Earth, are very resistant to severe conditions in caves, including even darkness. Therefore, the cyanobacteria are able to survive in dark caves as nearly heterotrophic organisms and are consumed by cave palpigrades. Such feeding habit is extraordinary within the almost wholly predacious orders of the class Arachnida, and particularly so due to the type of food observed.	[Smrz, Jaroslav] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Kovac, Lubomir; Mikes, Jaromir] Safarik Univ, Inst Biol & Ecol, Fac Sci, Kosice, Slovakia; [Lukesova, Alena] Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	Charles University Prague; University of Pavol Jozef Safarik Kosice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Smrz, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	smrz@cesnet.cz	Kováč, Ľubomír/J-5954-2015; Lukešová, Alena/G-1451-2014; Mikes, Jaromir/X-3588-2019	Kováč, Ľubomír/0000-0001-8194-2128; Mikes, Jaromir/0000-0002-9941-7855	Slovak Research and Development Agency [VVCE-0001-07]; NEXO (Network of Excellence in Oncology) [007/20092.1/OPVaV]; Ministry of Education of the Czech Republic [MSM 0021620828]	Slovak Research and Development Agency(Slovak Research and Development Agency); NEXO (Network of Excellence in Oncology); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The study was supported by the Slovak Research and Development Agency under contract no. VVCE-0001-07 and the NEXO (Network of Excellence in Oncology) under contract no. 007/20092.1/OPVaV and by grant MSM 0021620828 from the Ministry of Education of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullin SR, 2009, RUSS J ECOL+, V40, P301, DOI 10.1134/S1067413609040122; ALBERTI G, 1979, ZOOMORPHOLOGIE, V94, P111, DOI 10.1007/BF00994060; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; BRINTON LP, 1971, J PARASITOL, V57, P1110, DOI 10.2307/3277874; Bronn, 1943, KLASSEN ORDNUNGEN TI, V5, P1; CASTENHOLZ RW, 1992, J PHYCOL, V28, P737, DOI 10.1111/j.0022-3646.1992.00737.x; Christian Erhard, 1998, Senckenbergiana Biologica, V77, P241; FAY P, 1965, J GEN MICROBIOL, V39, P11, DOI 10.1099/00221287-39-1-11; Flechtner V. R., 1999, ENIGMATIC MICROORGAN, P231; Hammen L. van der, 1969, Zoologische Mededeelingen Leiden, V44, P41; Imms AD, 1973, GEN TXB ENTOMOLOGY; Kalina T., 2005, CYANOBACTERIA ALGAE; Kova L., 2002, STUDIES SOIL FAUNA C, P93; Kovac L'ubomir, 1999, P157; Krantz G., 2009, MANUAL ACAROLOGY; Lamprinou V, 2009, FOTTEA, V9, P155, DOI 10.5507/fot.2009.014; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; Martinez A, 2010, J CAVE KARST STUD, V72, P11, DOI 10.4311/jcks2009lsc0082; Millot J., 1943, REV FRANC ENT, V9, P127; Millot J., 1942, REV FRANC ENT, V9, P33; Monniot F., 1966, Rev Ecol Biol Sci, V3, P41; Novakova A, 2005, CONTRIBUTIONS SOIL Z, P107; Roewer CF, 1943, BRONNS KLASSEN ORDNU, V5, P640; ROWLAND JM, 1980, J ARACHNOL, V8, P69; Ruckeb Augusta, 1903, Zoologische Jahrbuecher (Systematik), Vxviii, P401; SMRZ J, 1989, J MORPHOL, V200, P215, DOI 10.1002/jmor.1052000210; Smrz J, 2000, PEDOBIOLOGIA, V44, P175, DOI 10.1078/S0031-4056(04)70036-0; Smrz J, 2002, EUR J SOIL BIOL, V38, P35, DOI 10.1016/S1164-5563(01)01120-7; Smrz J, 2006, EUR J ENTOMOL, V103, P679, DOI 10.14411/eje.2006.088; Sustr V, 2005, EUR J SOIL BIOL, V41, P69, DOI 10.1016/j.ejsobi.2005.09.008; Symonova R, 2009, J CRUSTACEAN BIOL, V29, P18, DOI 10.1651/08-3003.1; Taylor T.N., 1996, PALYNOLOGY PRINCIPLE, P427; van der Hammen L., 1982, ZOOL VERH, V196, P1; Vandel A., 1965, BIOSPELEOLOGY BIOL C; Vinogradova ON, 2000, ALGAE, V2, P41	35	17	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75989	10.1371/journal.pone.0075989	http://dx.doi.org/10.1371/journal.pone.0075989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146804	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400028
J	Alqudah, MAY; Agarwal, S; Al-Keilani, MS; Sibenaller, ZA; Ryken, TC; Assem, M				Alqudah, Mohammad A. Y.; Agarwal, Supreet; Al-Keilani, Maha S.; Sibenaller, Zita A.; Ryken, Timothy C.; Assem, Mahfoud			NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN D1; GLIOBLASTOMA; PATHWAY; GROWTH; CANCER; PROGRESSION; INHIBITION; RECEPTOR	Using a GWA analysis of a comprehensive glioma specimen population, we identified whole gain of chromosome 19 as one of the major chromosomal aberrations that correlates to patients' outcomes. Our analysis of significant loci revealed for the first time NOTCH3 as one of the most significant amplification. NOTCH3 amplification is associated with worse outcome compared to tumors with non-amplified locus. NOTCH receptors (NOTCH1-4) are key positive regulators of cell-cell interactions, angiogenesis, cell adhesion and stem cell niche development which have been shown to play critical roles in several human cancers. Our objective is to determine the molecular roles of NOTCH3 in glioma pathogenesis and aggressiveness. Here we show for the first time that NOTCH3 plays a major role in glioma cell proliferation, cell migration, invasion and apoptosis. Therefore, our study uncovers the prognostic value and the oncogenic function of NOTCH3 in gliomagenesis and supports NOTCH3 as a promising target of therapy in high grade glioma. Our studies allowed the identification of a subset of population that may benefit from GSI- or anti-NOTCH3- based therapies. This may lead to the design of novel strategies to improve therapeutic outcome of patients with glioma by establishing medical and scientific basis for personalized chemotherapies.	[Alqudah, Mohammad A. Y.; Agarwal, Supreet; Al-Keilani, Maha S.; Assem, Mahfoud] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Sibenaller, Zita A.; Ryken, Timothy C.] Univ Iowa, Dept Neurosurg & Radiat Oncol, Iowa City, IA 52242 USA; [Ryken, Timothy C.] Iowa Spine & Brain Inst, Dept Neurosurg, Waterloo, IA USA	University of Iowa; University of Iowa	Assem, M (corresponding author), Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA.	mahfoud-assem@uiowa.edu	agarwal, supreet/AAI-7296-2021	Alqudah, Mohammad/0000-0001-7210-7964	Institute of Clinical and Translational Science at the University of Iowa; National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH) [UL1RR024979]; American Cancer Society [IRG-77-004-34]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER	Institute of Clinical and Translational Science at the University of Iowa; National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Institute of Clinical and Translational Science at the University of Iowa award. This publication was made possible by Grant Number UL1RR024979 from the National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CTSA or NIH. This research was also supported through the Institutional Research Grant Number IRG-77-004-34 from the American Cancer Society, administered through The Holden Comprehensive Cancer Center at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062852; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Assem M, 2012, OMICS, V16, P113, DOI 10.1089/omi.2011.0031; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bellavia D, 2007, CELL CYCLE, V6, P2730, DOI 10.4161/cc.6.22.4894; Burton EC, 2002, CANCER RES, V62, P6205; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Dang L, 2006, DEV NEUROSCI-BASEL, V28, P58, DOI 10.1159/000090753; Dang TP, 2012, ADV EXP MED BIOL, V727, P199, DOI 10.1007/978-1-4614-0899-4_15; Deorah Sundeep, 2006, Neurosurg Focus, V20, pE1, DOI 10.3171/foc.2006.20.4.E1; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fassl A, 2012, ONCOGENE, V31, P4698, DOI 10.1038/onc.2011.615; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Huhn SL, 1999, CLIN CANCER RES, V5, P1435; Lin J, 2010, ARCH MED RES, V41, P519, DOI 10.1016/j.arcmed.2010.10.006; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Man CH, 2012, J PATHOL, V226, P471, DOI 10.1002/path.2997; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Reardon DA, 2012, BRIT J CANCER, V107, P1481, DOI 10.1038/bjc.2012.415; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Tchorz JS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.65; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Xiang J, 2012, CL LYMPH MYELOM LEUK, V12, P59, DOI 10.1016/j.clml.2011.07.005; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yao J, 2010, MED ONCOL, V27, P1017, DOI 10.1007/s12032-009-9326-5; Zhang XH, 2012, CANCER SCI, V103, P181, DOI 10.1111/j.1349-7006.2011.02154.x	38	36	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77299	10.1371/journal.pone.0077299	http://dx.doi.org/10.1371/journal.pone.0077299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143218	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100055
J	Ikotun, OF; Marquez, BV; Huang, CF; Masuko, K; Daiji, M; Masuko, T; McConathy, J; Lapi, SE				Ikotun, Oluwatayo F.; Marquez, Bernadette V.; Huang, Chaofeng; Masuko, Kazue; Daiji, Miyamoto; Masuko, Takashi; McConathy, Jonathan; Lapi, Suzanne E.			Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MONOCLONAL-ANTIBODIES; HEAVY-CHAIN; IN-VIVO; PET; EXPRESSION; CANCER; TUMORS; F-18-FDG; PROTEIN	The L-type amino acid transporter-1 (LAT1, SLC7A5) is upregulated in a wide range of human cancers, positively correlated with the biological aggressiveness of tumors, and a promising target for both imaging and therapy. Radiolabeled amino acids such as O-(2-[F-18]fluoroethyl)-L-tyrosine (FET) that are transport substrates for system L amino acid transporters including LAT1 have met limited success for oncologic imaging outside of the brain, and thus new strategies are needed for imaging LAT1 in systemic cancers. Here, we describe the development and biological evaluation of a novel zirconium-89 labeled antibody, [Zr-89]DFO-Ab2, targeting the extracellular domain of LAT1 in a preclinical model of colorectal cancer. This tracer demonstrated specificity for LAT1 in vitro and in vivo with excellent tumor imaging properties in mice with xenograft tumors. PET imaging studies showed high tumor uptake, with optimal tumor-to-non target contrast achieved at 7 days post administration. Biodistribution studies demonstrated tumor uptake of 10.5 +/- 1.8 percent injected dose per gram (%ID/g) at 7 days with a tumor to muscle ratio of 13 to 1. In contrast, the peak tumor uptake of the radiolabeled amino acid [F-18]FET was 4.4 +/- 0.5 % ID/g at 30 min after injection with a tumor to muscle ratio of 1.4 to 1. Blocking studies with unlabeled anti-LAT1 antibody demonstrated a 55% reduction of [Zr-89] DFO-Ab2 accumulation in the tumor at 7 days. These results are the first report of direct PET imaging of LAT1 and demonstrate the potential of immunoPET agents for imaging specific amino acid transporters.	[Ikotun, Oluwatayo F.; Marquez, Bernadette V.; Huang, Chaofeng; McConathy, Jonathan; Lapi, Suzanne E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Masuko, Kazue; Daiji, Miyamoto; Masuko, Takashi] Kinki Univ, Sch Pharm, Cell Biol Lab, Dept Pharmaceut Sci, Osaka, Japan	Washington University (WUSTL); Kindai University (Kinki University)	Lapi, SE (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	lapis@mir.wustl.edu		marquez-nostra, bernadette/0000-0001-9024-0750	American Cancer Society [PFTED-10-208-01-SIED]; National Cancer Institute [K08CA154790]; Mallinckrodt Institute of Radiology; NATIONAL CANCER INSTITUTE [P30CA091842, K08CA154790] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mallinckrodt Institute of Radiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	O. F. Ikotun is supported by the American Cancer Society (PFTED-10-208-01-SIED). Dr. McConathy is supported by the National Cancer Institute (K08CA154790) and the Mallinckrodt Institute of Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou DS, 2011, NUCL MED BIOL, V38, P675, DOI 10.1016/j.nucmedbio.2010.12.011; Boado RJ, 2007, BIOTECHNOL BIOENG, V97, P1376, DOI 10.1002/bit.21369; Chang AJ, 2013, MOL IMAGING, V12, P1, DOI 10.2310/7290.2012.00016; Chen W, 2006, J NUCL MED, V47, P904; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Dijkers ECF, 2009, J NUCL MED, V50, P974, DOI 10.2967/jnumed.108.060392; Fan XT, 2010, BIOCHEM PHARMACOL, V80, P811, DOI 10.1016/j.bcp.2010.05.021; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Grosu AL, 2011, INT J RADIAT ONCOL, V81, P1049, DOI 10.1016/j.ijrobp.2010.07.002; Haase C, 2007, J NUCL MED, V48, P2063, DOI 10.2967/jnumed.107.043620; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Jager PL, 2001, J NUCL MED, V42, P432; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kaira K, 2009, CANCER SCI, V100, P249, DOI 10.1111/j.1349-7006.2008.01029.x; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Lahoutte T, 2004, J NUCL MED, V45, P1591; Lee TS, 2009, NUCL MED BIOL, V36, P681, DOI 10.1016/j.nucmedbio.2009.03.009; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Masuko T, 2011, CANCER SCI, V102, P25, DOI 10.1111/j.1349-7006.2010.01741.x; Mishra V, 2006, J DRUG TARGET, V14, P45, DOI 10.1080/10611860600612953; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Nayak TK, 2012, J NUCL MED, V53, P113, DOI 10.2967/jnumed.111.094169; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ohkawa M, 2011, BIOCHEM BIOPH RES CO, V406, P649, DOI 10.1016/j.bbrc.2011.02.135; Ohno Y, 2008, CANCER SCI, V99, P1000, DOI 10.1111/j.1349-7006.2008.00770.x; Pauleit D, 2004, J NUCL MED, V45, P374; Pauleit D, 2009, NUCL MED BIOL, V36, P779, DOI 10.1016/j.nucmedbio.2009.05.005; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Sai KKS, 2013, J NUCL MED, V54, P1120, DOI 10.2967/jnumed.112.113217; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Spaeth N, 2004, J NUCL MED, V45, P1931; TEIXEIRA S, 1987, J BIOL CHEM, V262, P9574; Vosjan MJWD, 2010, NAT PROTOC, V5, P739, DOI 10.1038/nprot.2010.13; Watanabe H, 2000, EUR J NUCL MED, V27, P1509, DOI 10.1007/s002590000344; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Youland RS, 2013, J NEURO-ONCOL, V111, P11, DOI 10.1007/s11060-012-0986-1; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zuhayra M, 2009, BIOORGAN MED CHEM, V17, P7441, DOI 10.1016/j.bmc.2009.09.029	41	29	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77476	10.1371/journal.pone.0077476	http://dx.doi.org/10.1371/journal.pone.0077476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143237	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100074
J	Izikki, M; Mercier, O; Lecerf, F; Guin, LL; Hoang, E; Dorfmuller, P; Perros, F; Humbert, M; Simonneau, G; Dartevelle, P; Fadel, E; Eddahibi, S				Izikki, Mohamed; Mercier, Olaf; Lecerf, Florence; Guin, Lauriane Lubert; Hoang, Eric; Dorfmueller, Peter; Perros, Frederic; Humbert, Marc; Simonneau, Gerald; Dartevelle, Philippe; Fadel, Elie; Eddahibi, Saadia			The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats	PLOS ONE			English	Article							MUSCLE-CELL APOPTOSIS; GROWTH-FACTOR; ORGAN-CULTURE; DNA-SYNTHESIS; INHIBITION; PROLIFERATION; CARCINOMA; ARTERIES; BINDING	Background: Pulmonary hypertension (PH) is a progressive disorder characterized by an increase in pulmonary artery pressure and structural changes in the pulmonary vasculature. Several observations indicate that growth factors play a key role in PH by modulating pulmonary artery smooth muscle cell (PA-SMC) function. In rats, established monocrotaline-induced PH (MCT-PH) can be reversed by blocking platelet-derived growth factor receptors (PDGF-R), epidermal growth factor receptors (EGF-R), or fibroblast growth factor receptors (FGF-R). All these receptors belong to the receptor tyrosine kinase (RTK) family. Methods and Results: We evaluated whether RTK blockade by the nonspecific growth factor inhibitor, suramin, reversed advanced MCT-PH in rats via its effects on growth-factor signaling pathways. We found that suramin inhibited RTK and ERK1/2 phosphorylation in cultured human PA-SMCs. Suramin inhibited PA-SMC proliferation induced by serum, PDGF, FGF2, or EGF in vitro and ex vivo. Treatment with suramin from day 1 to day 21 after monocrotaline injection attenuated PH development, as shown by lower values for pulmonary artery pressure, right ventricular hypertrophy, and distal vessel muscularization on day 21 compared to control rats. Treatment with suramin from day 21 to day 42 after monocrotaline injection reversed established PH, thereby normalizing the pulmonary artery pressure values and vessel structure. Suramin treatment suppressed PA-SMC proliferation and attenuated both the inflammatory response and the deposition of collagen. Conclusions: RTK blockade by suramin can prevent MCT-PH and reverse established MCT-PH in rats. This study suggests that an anti-RTK strategy that targets multiple RTKs could be useful in the treatment of pulmonary hypertension.	[Izikki, Mohamed; Lecerf, Florence; Guin, Lauriane Lubert; Hoang, Eric; Dorfmueller, Peter; Perros, Frederic; Humbert, Marc; Simonneau, Gerald; Fadel, Elie; Eddahibi, Saadia] INSERM, U999, Le Plessis Robinson, France; [Mercier, Olaf; Lecerf, Florence; Dorfmueller, Peter; Dartevelle, Philippe; Fadel, Elie; Eddahibi, Saadia] Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue	Eddahibi, S (corresponding author), INSERM, U999, Le Plessis Robinson, France.	saadia.eddahibi@inserm.fr	Humbert, Marc/ABD-5112-2021; Perros, Frédéric/N-6921-2017; Simonneau, Gerald/ABE-6614-2020; Humbert, Marc/AAC-8459-2019	Perros, Frédéric/0000-0001-7730-2427; Humbert, Marc/0000-0003-0703-2892; Mercier, Olaf/0000-0002-4760-6267; Dorfmuller, Peter/0000-0003-2499-6829	INSERM; Agence National de la Recherche [ANR-08-GENOPAT-004]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR))	This study was supported by grants from the INSERM, and the Agence National de la Recherche (ANR-08-GENOPAT-004 to S. E., A. L-V and M. H.). This article reflects only the authors' views and under no circumstances is the European Community liable for any use that may be made of the information it contains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan YS, 2003, J APPL PHYSIOL, V95, P771, DOI 10.1152/japplphysiol.00915.2002; Cowan KN, 1999, CIRC RES, V84, P1223, DOI 10.1161/01.RES.84.10.1223; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Ghofrani HA, 2010, AM J RESP CRIT CARE, V182, P1171, DOI 10.1164/rccm.201001-0123OC; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X; HOSANG M, 1985, J CELL BIOCHEM, V29, P265, DOI 10.1002/jcb.240290310; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Karam Gholamreza Asadi, 2005, Pak J Pharm Sci, V18, P46; LESCHEY KH, 1991, INVEST OPHTH VIS SCI, V32, P1770; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Mekontso-Dessap A, 2006, J THORAC CARDIOV SUR, V131, P651, DOI 10.1016/j.jtcvs.2005.08.048; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; MOTZER RJ, 1992, CANCER RES, V52, P5775; MYERS C, 1992, J CLIN ONCOL, V10, P881, DOI 10.1200/JCO.1992.10.6.881; RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818, DOI 10.1152/ajpheart.1979.236.6.H818; Raj P A, 1998, Angiogenesis, V2, P183, DOI 10.1023/A:1009244623717; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Shi WB, 1997, J APPL PHYSIOL, V83, P1476, DOI 10.1152/jappl.1997.83.5.1476; SJOLUND M, 1989, CELL TISSUE RES, V256, P35; Souza R, 2006, THORAX, V61, P736, DOI 10.1136/thx.2006.064097; TAKANO S, 1994, CANCER RES, V54, P2654; WALTHER MM, 1994, J UROLOGY, V152, P1599, DOI 10.1016/S0022-5347(17)32486-2; WILLIAMS LT, 1984, J BIOL CHEM, V259, P5287; Zanghi JA, 2000, BIOTECHNOL PROGR, V16, P319, DOI 10.1021/bp0000353; Zhang YL, 2001, J PHARMACOL EXP THER, V299, P426	27	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77073	10.1371/journal.pone.0077073	http://dx.doi.org/10.1371/journal.pone.0077073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143201	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100036
J	Kolanowska, M				Kolanowska, Marta			Niche Conservatism and the Future Potential Range of Epipactis helleborine (Orchidaceae)	PLOS ONE			English	Article							DISTRIBUTIONS; MODELS	The aim of the present study was to evaluate the current distribution of suitable niches for the invasive orchid species, Epipactis helleborine, and to estimate the possibility of its further expansion. Moreover, niche modeling tools were used to explain its rapid expansion in North America and to test the niche conservatism of the species. The maximum entropy method was used to create models of the suitable niche distribution. A database of E. helleborine localities was prepared based on the examination of herbarium specimens, information from electronic databases as well as data gathered during field works. The differences between the niches occupied by native and invasive populations were evaluated using the niche overlap and niche identity test indexes. Moreover, the coverage of the most suitable habitats for the species was measured for three future scenarios as well as for the present time model. Populations of E. helleborine occupy North American west coast habitats very similar to those preferred by native, Eurasian populations, while the expansion in the east coast is related to the niche shift. The created models of suitable niche distribution indicate that the species does not realize its potential niche in the native range. The total surface of the habitats potentially available for E. helleborine will decrease in all climate change scenarios created for 2080.	Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk	Kolanowska, M (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland.	martakolanowska@wp.pl	Kolanowska, Marta/AAR-3107-2020	Kolanowska, Marta/0000-0001-5347-5403				Ackerman J., 2007, LANKESTERIANA, V7, P19, DOI [10.15517/lank.v7i1-2.18386, DOI 10.15517/LANK.V7I1-2.18386]; Adamowski Wojciech, 1995, Wiadomosci Botaniczne, V39, P105; Brenan J. P. M., 1983, WATSONIA, V14, P237; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Defrieri RL, 2011, J SOIL SCI PLANT NUT, V11, P111, DOI 10.4067/S0718-95162011000300009; Delforge P, 2005, GUIDE ORCHIDEES EURO; Dickson J. H., 1990, URBAN ECOL, P245; Dorn R. D., 1984, VASCULAR PLANTS MONT; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Goodenough AE, 2010, COMMUNITY ECOL, V11, P13, DOI 10.1556/ComEc.11.2010.1.3; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 1999, GENET RESOUR CROP EV, V46, P291, DOI 10.1023/A:1008628005016; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Kolanowska M, 2013, PLANT BIOSY IN PRESS; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P47, DOI 10.1111/j.1472-4642.2011.00849.x; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Palaoro AV, 2013, FRESHWATER BIOL, V58, P1379, DOI 10.1111/fwb.12134; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prochazka F, 1983, ORCHIDEJE NASI PRIRO; Ramirez J, 2008, HIGH RESOLUTION STAT; Rebele F, 1998, LANDSCHAFT STADT, V20, P49; Recart W, 2013, BIOL INVASIONS, V15, P283, DOI 10.1007/s10530-012-0283-0; Rodriguez-Robles JA, 2010, MOL ECOL, V19, P1860, DOI 10.1111/j.1365-294X.2010.04616.x; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Squirrell J, 2001, AM J BOT, V88, P1409, DOI 10.2307/3558447; Swiercz A, 2004, PRZEGLAD PRZYRODNICZ, V15, P117; Thiers B., INDEX HERBARIORUM GL; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weber W. A., 1996, COLORADO FLORA E SLO; Zenkert CA, 1949, HOBBIES, V29, P93; [No title captured]	45	33	36	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77352	10.1371/journal.pone.0077352	http://dx.doi.org/10.1371/journal.pone.0077352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143222	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100059
J	Mohr, AM; Bailey, JM; Lewallen, ME; Liu, X; Radhakrishnan, P; Yu, F; Tapprich, W; Hollingsworth, MA				Mohr, Ashley M.; Bailey, Jennifer M.; Lewallen, Michelle E.; Liu, Xiang; Radhakrishnan, Prakash; Yu, Fang; Tapprich, William; Hollingsworth, Michael A.			MUC1 Regulates Expression of Multiple microRNAs Involved in Pancreatic Tumor Progression, Including the miR-200c/141 Cluster	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; BETA-CATENIN; E-CADHERIN; DOWN-REGULATION; TARGETING ZEB1; C-SRC; TRANSCRIPTION; GROWTH; CARCINOMA	MUC1 is a transmembrane glycoprotein that modulates transcription via its cytoplasmic domain. We evaluated the capacity of MUC1 to regulate the global transcription of microRNAs in pancreatic cancer cells expressing MUC1. Results indicated that MUC1 regulated expression of at least 103 microRNAs. We evaluated further regulation of the microRNA transcript cluster miR-200c/141, which was among the most highly regulated microRNAs. We found that MUC1 directly interacted with ZEB1, a known transcriptional repressor of the miR-200c/141 cluster, at the promoter of miR-200c/141, and further reduced transcript production. These data indicate that signaling through MUC1 influences cancer progression by regulating transcription of microRNAs that are associated with the process of metastasis.	[Mohr, Ashley M.; Liu, Xiang; Radhakrishnan, Prakash; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Bailey, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Surg, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Lewallen, Michelle E.] Stowers Inst Med Res, Kansas City, MO USA; [Yu, Fang] Univ Nebraska Med Ctr, Coll Publ Hlth Biostat, Omaha, NE USA; [Tapprich, William] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; Johns Hopkins University; Stowers Institute for Medical Research; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System	Hollingsworth, MA (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	mahollin@unmc.edu		Bailey-Lundberg, Jennifer/0000-0002-4750-106X	NIH [R01CA57362, P50 CA127297-02, U01 CA111294, U54 CA163120]; NCI Cancer Center [P30 CA036727-2452]; Alliance of Glycobiologists for Detection of Cancer and Cancer Risk [NIH U01 CA128437]; Tumor Microenvironment Network; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA057362, P50CA127297, U01CA111294, U54CA163120, U01CA128437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alliance of Glycobiologists for Detection of Cancer and Cancer Risk; Tumor Microenvironment Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH R01CA57362, NIH P50 CA127297-02, NCI Cancer Center Support Grant P30 CA036727-2452, NIH U01 CA111294 Early Detection Research Network, NIH U01 CA128437 Alliance of Glycobiologists for Detection of Cancer and Cancer Risk, NIH U54 CA163120 Tumor Microenvironment Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Chiang YP, 2012, PATHOL ONCOL RES, V18, P585, DOI 10.1007/s12253-011-9480-x; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Fu GD, 2013, HYPERTENSION, V61, P864, DOI 10.1161/HYPERTENSIONAHA.111.203489; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Mohr AM, 2012, P 103 ANN M AM ASS C; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Rajabi H, 2013, ONCOGENE; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Tian Z, 2012, BLOOD; Wang XC, 2010, AM J MED SCI, V340, P385, DOI 10.1097/MAJ.0b013e3181e892a0; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Yang L, 2007, CANCER RES, V67, P5587, DOI 10.1158/0008-5472.CAN-06-2287; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Zhao JL, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-23	37	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e73306	10.1371/journal.pone.0073306	http://dx.doi.org/10.1371/journal.pone.0073306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143167	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100002
J	Stelter, M; Acajjaoui, S; McSweeney, S; Timmins, J				Stelter, Meike; Acajjaoui, Samira; McSweeney, Sean; Timmins, Joanna			Structural and Mechanistic Insight into DNA Unwinding by Deinococcus radiodurans UvrD	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; E. COLI UVRD; ESCHERICHIA-COLI; PCRA HELICASE; REP HELICASE; CRYSTAL-STRUCTURES; PROTEIN; PURIFICATION; REPLICATION; GENE	DNA helicases are responsible for unwinding the duplex DNA, a key step in many biological processes. UvrD is a DNA helicase involved in several DNA repair pathways. We report here crystal structures of Deinococcus radiodurans UvrD (drUvrD) in complex with DNA in different nucleotide-free and bound states. These structures provide us with three distinct snapshots of drUvrD in action and for the first time trap a DNA helicase undergoing a large-scale spiral movement around duplexed DNA. Our structural data also improve our understanding of the molecular mechanisms that regulate DNA unwinding by Superfamily 1A (SF1A) helicases. Our biochemical data reveal that drUvrD is a DNA-stimulated ATPase, can translocate along ssDNA in the 3'-5' direction and shows ATP-dependent 3'-5', and surprisingly also, 5'-3' helicase activity. Interestingly, we find that these translocase and helicase activities of drUvrD are modulated by the ssDNA binding protein. Analysis of drUvrD mutants indicate that the conserved beta-hairpin structure of drUvrD that functions as a separation pin is critical for both drUvrD's 3'-5' and 5'-3' helicase activities, whereas the GIG motif of drUvrD involved in binding to the DNA duplex is essential for the 5'-3' helicase activity only. These special features of drUvrD may reflect its involvement in a wide range of DNA repair processes in vivo.	[Stelter, Meike; Acajjaoui, Samira; McSweeney, Sean; Timmins, Joanna] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Stelter, Meike; Timmins, Joanna] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Stelter, Meike; Timmins, Joanna] CNRS, Inst Biol Struct, Grenoble, France; [Stelter, Meike; Timmins, Joanna] Commissariat Energie Atom & Energies Alternat, Dept Sci Vivant, Inst Biol Struct, Grenoble, France	European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Timmins, J (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, BP 220, F-38043 Grenoble, France.	joanna.timmins@ibs.fr	TIMMINS, Joanna/P-5486-2019	TIMMINS, Joanna/0000-0002-9066-9095	ESRF; CNRS via an ATIP-AVENIR; Ligue contre le Cancer	ESRF; CNRS via an ATIP-AVENIR; Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was funded by the inhouse research program of the ESRF. MS and JT are funded by the CNRS via an ATIP-AVENIR grant and by the Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine P. V., 2005, CCP4 NEWSLETTER, P42; AMARATUNGA M, 1993, BIOCHEMISTRY-US, V32, P6815, DOI 10.1021/bi00078a003; An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200; Anand SP, 2004, NUCLEIC ACIDS RES, V32, P3190, DOI 10.1093/nar/gkh641; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Cao Z, 2009, DNA REPAIR, V8, P612, DOI 10.1016/j.dnarep.2008.12.011; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; Chang TL, 2002, J BIOL CHEM, V277, P45880, DOI 10.1074/jbc.M207383200; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Collins R, 2003, EXTREMOPHILES, V7, P35, DOI 10.1007/s00792-002-0293-4; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kumar S, 2001, IBM J RES DEV, V45, P499, DOI 10.1147/rd.453.0499; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; LiCata VJ, 2008, METHOD CELL BIOL, V84, P243, DOI 10.1016/S009l-679X(07)84009-X; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1987, J BIOL CHEM, V262, P2066; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris PD, 2001, METHODS, V23, P149, DOI 10.1006/meth.2000.1116; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naqvi A, 2003, J BACTERIOL, V185, P6633, DOI 10.1128/JB.185.22.6633-6639.2003; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; PANUSKA JR, 1980, J BIOL CHEM, V255, P5208; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sabarinathan R, 2011, J BIOSCIENCES, V36, P253, DOI 10.1007/s12038-011-9067-4; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Suhasini AN, 2010, CELL CYCLE, V9, P2317, DOI 10.4161/cc.9.12.11902; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Sun B, 2008, EMBO J, V27, P3279, DOI 10.1038/emboj.2008.240; Tomko EJ, 2012, J MOL BIOL, V418, P32, DOI 10.1016/j.jmb.2012.02.013; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Unciuleac MC, 2010, J BIOL CHEM, V285, P34319, DOI 10.1074/jbc.M110.162925; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu YL, 2010, METHODS, V51, P303, DOI 10.1016/j.ymeth.2010.02.021; Yang W, 2010, ANNU REV BIOPHYS, V39, P367, DOI 10.1146/annurev.biophys.093008.131415; Yokota H, 2013, BIOPHYS J, V104, P924, DOI 10.1016/j.bpj.2013.01.014; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998; Zhang WK, 2007, J MOL BIOL, V371, P336, DOI 10.1016/j.jmb.2007.05.050	60	19	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77364	10.1371/journal.pone.0077364	http://dx.doi.org/10.1371/journal.pone.0077364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143224	Green Published, gold			2022-12-27	WOS:000325894100061
J	Zabetakis, D; Anderson, GP; Bayya, N; Goldman, ER				Zabetakis, Dan; Anderson, George P.; Bayya, Nikhil; Goldman, Ellen R.			Contributions of the Complementarity Determining Regions to the Thermal Stability of a Single-Domain Antibody	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; AFFINITY TRANSFER; ANTIGEN RECEPTOR; ENTEROTOXIN-B; FRAGMENTS; IDENTIFICATION; FRAMEWORK; SCAFFOLD; PROTEIN; SHARKS	Single domain antibodies (sdAbs) are the recombinantly-expressed variable domain from camelid (or shark) heavy chain only antibodies and provide rugged recognition elements. Many sdAbs possess excellent affinity and specificity; most refold and are able to bind antigen after thermal denaturation. The sdAb A3, specific for the toxin Staphylococcal enterotoxin B (SEB), shows both sub-nanomolar affinity for its cognate antigen (0.14 nM) and an unusually high melting point of 85 degrees C. Understanding the source of sdAb A3' s high melting temperature could provide a route for engineering improved melting temperatures into other sdAbs. The goal of this work was to determine how much of sdAb A3' s stability is derived from its complementarity determining regions (CDRs) versus its framework. Towards answering this question we constructed a series of CDR swap mutants in which the CDRs from unrelated sdAbs were integrated into A3' s framework and where A3' s CDRs were integrated into the framework of the other sdAbs. All three CDRs from A3 were moved to the frameworks of sdAb D1 (a ricin binder that melts at 50 C) and the anti-ricin sdAb C8 (melting point of 60 degrees C). Similarly, the CDRs from sdAb D1 and sdAb C8 were moved to the sdAb A3 framework. In addition individual CDRs of sdAb A3 and sdAb D1 were swapped. Melting temperature and binding ability were assessed for each of the CDR-exchange mutants. This work showed that CDR2 plays a critical role in sdAb A3' s binding and stability. Overall, results from the CDR swaps indicate CDR interactions play a major role in the protein stability.	[Zabetakis, Dan; Anderson, George P.; Goldman, Ellen R.] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA; [Bayya, Nikhil] Amer Soc Engn Educ, Sci & Engn Apprenticeship Program, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Goldman, ER (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA.	ellen.goldman@nrl.navy.mil	Anderson, George P/D-2461-2011	Anderson, George P/0000-0001-7545-9893	Defense Threat Reduction Agency (DTRA) [CBCALL12-LS6-2-0036]; Naval Research Laboratory base 6.1 funds	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Naval Research Laboratory base 6.1 funds	This work was supported by Defense Threat Reduction Agency (DTRA) project number CBCALL12-LS6-2-0036, and Naval Research Laboratory base 6.1 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Anderson GP, 2012, ANAL CHEM, V84, P5198, DOI 10.1021/ac300864j; Anderson GP, 2010, ANAL CHEM, V82, P7202, DOI 10.1021/ac100961x; Anderson GP, 2008, ANAL CHEM, V80, P9604, DOI 10.1021/ac8019398; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Glaven RH, 2012, BIOSENSORS-BASEL, V2, P43, DOI 10.3390/bios2010043; Goldman ER, 2011, TOXINS, V3, P1405, DOI 10.3390/toxins3111405; Graef RR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-86; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Inoue H, 2011, PROTEIN SCI, V20, P1971, DOI 10.1002/pro.734; McConnell AD, 2013, PROTEIN ENG DES SEL, V26, P151, DOI 10.1093/protein/gzs090; Nicaise M, 2004, PROTEIN SCI, V13, P1882, DOI 10.1110/ps.03540504; Nuttall SD, 2001, MOL IMMUNOL, V38, P313, DOI 10.1016/S0161-5890(01)00057-8; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Walper SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032801	24	28	42	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77678	10.1371/journal.pone.0077678	http://dx.doi.org/10.1371/journal.pone.0077678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143255	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100094
J	Thu, HNT; Tien, SFH; Loh, SL; Yan, JSB; Korzh, V				Hang Nguyen Thi Thu; Tien, Steven Fong Haw; Loh, Siau Lin; Yan, Jimmy So Bok; Korzh, Vladimir			tbx2a Is Required for Specification of Endodermal Pouches during Development of the Pharyngeal Arches	PLOS ONE			English	Article							T-BOX GENES; TRANSCRIPTION FACTOR TBX2; NEURAL CREST; CRANIOFACIAL DEVELOPMENT; THYROID-HORMONE; EXPRESSION; ZEBRAFISH; HEART; EVOLUTION; IDENTIFICATION	Tbx2 is a member of the T-box family of transcription factors essential for embryo-and organogenesis. A deficiency in the zebrafish paralogue tbx2a causes abnormalities of the pharyngeal arches in a p53-independent manner. The pharyngeal arches are formed by derivatives of all three embryonic germ layers: endodermal pouches, mesenchymal condensations and neural crest cells. While tbx2a expression is restricted to the endodermal pouches, its function is required for the normal morphogenesis of the entire pharyngeal arches. Given the similar function of Tbx1 in craniofacial development, we explored the possibility of an interaction between Tbx1 and Tbx2a. The use of bimolecular fluorescence complementation revealed the interaction between Tbx2a and Tbx1, thus providing support for the idea that functional interaction between different, co-expressed Tbx proteins could be a common theme across developmental processes in cell lineages and tissues. Together, this work provides mechanistic insight into the role of TBX2 in human disorders affecting the face and neck.	[Hang Nguyen Thi Thu; Tien, Steven Fong Haw; Loh, Siau Lin; Korzh, Vladimir] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Hang Nguyen Thi Thu; Korzh, Vladimir] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Hang Nguyen Thi Thu; Yan, Jimmy So Bok] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; National University of Singapore	Korzh, V (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	vlad@imcb.a-star.edu.sg	Korzh, Vladimir P/H-1596-2011	Korzh, Vladimir P/0000-0002-6580-7986; So, Jimmy, Bok-Yan/0000-0002-9772-7905	Agency for Science, Technology and Resaerch of Singapore	Agency for Science, Technology and Resaerch of Singapore	Agency for Science, Technology and Resaerch of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Ballif BC, 2010, AM J HUM GENET, V86, P454, DOI 10.1016/j.ajhg.2010.01.038; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; Bohnsack BL, 2013, DEV BIOL, V373, P300, DOI 10.1016/j.ydbio.2012.11.005; Borke JL, 2003, ANN PLAS SURG, V51, P499, DOI 10.1097/01.SAP.0000067964.14122.3E; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Cerny R, 2004, DEV BIOL, V266, P252, DOI 10.1016/j.ydbio.2003.09.039; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Cheah FSH, 2010, MECH DEVELOP, V127, P329, DOI 10.1016/j.mod.2010.04.003; Chen JR, 2004, CALCIFIED TISSUE INT, V74, P561, DOI 10.1007/s00223-003-0106-5; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; COULY GF, 1993, DEVELOPMENT, V117, P409; Dheen T, 1999, DEVELOPMENT, V126, P2703; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Gibson-Brown JJ, 1998, MECH DEVELOP, V74, P165, DOI 10.1016/S0925-4773(98)00056-2; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; GonzalezManchon C, 1997, DNA CELL BIOL, V16, P533, DOI 10.1089/dna.1997.16.533; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Graham A, 2005, J ANAT, V207, P479, DOI 10.1111/j.1469-7580.2005.00472.x; Graham A, 2001, J ANAT, V199, P133, DOI 10.1017/S0021878201008159; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hatcher CJ, 2001, NAT MED, V7, P1185, DOI 10.1038/nm1101-1185; Hayata T, 1999, DEV GENES EVOL, V209, P625, DOI 10.1007/s004270050297; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; KARDONG K, 2002, VERTEBRATES COMP ANA, P762; Khattab M, 2011, AM J MED GENET A, V155A, P3082, DOI 10.1002/ajmg.a.34307; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; King M, 2006, AM J MED GENET A, V140A, P1407, DOI 10.1002/ajmg.a.31250; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Kusch T, 2002, GENE DEV, V16, P518, DOI 10.1101/gad.213002; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee KH, 1996, DEV BIOL, V180, P722, DOI 10.1006/dbio.1996.0341; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Mesbah K, 2012, HUM MOL GENET, V21, P1217, DOI 10.1093/hmg/ddr553; Minguillon Carolina, 2003, Briefings in Functional Genomics & Proteomics, V2, P224, DOI 10.1093/bfgp/2.3.224; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Paxton C, 2002, GENE, V283, P117, DOI 10.1016/S0378-1119(01)00878-2; Peyrieras N, 1998, CURR BIOL, V8, P783, DOI 10.1016/S0960-9822(98)70303-3; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Plageman TF, 2005, DEV DYNAM, V232, P11, DOI 10.1002/dvdy.20201; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Prince VE, 1998, DEVELOPMENT, V125, P393; Quinlan R, 2004, DEVELOPMENT, V131, P593, DOI 10.1242/dev.00950; Radio FC, 2010, AM J MED GENET A, V152A, P2061, DOI 10.1002/ajmg.a.33506; Renucci A, 1996, DEVELOPMENT, V122, P3735; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Ruvinsky I, 2000, DEV GENES EVOL, V210, P82, DOI 10.1007/s004270050014; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schoenwolf GC., 2009, LARSENS HUMAN EMBRYO; Showell C, 2006, DEV DYNAM, V235, P1623, DOI 10.1002/dvdy.20714; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Stoller JZ, 2005, HUM MOL GENET, V14, P885, DOI 10.1093/hmg/ddi081; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; Vaccari E, 2010, DEV BIOL, V343, P94, DOI 10.1016/j.ydbio.2010.04.016; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402	72	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77171	10.1371/journal.pone.0077171	http://dx.doi.org/10.1371/journal.pone.0077171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130849	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200064
J	Yeh, CH; Schmitt, B; Le Bihan, D; Li-Schlittgen, JR; Lin, CP; Poupon, C				Yeh, Chun-Hung; Schmitt, Benoit; Le Bihan, Denis; Li-Schlittgen, Jing-Rebecca; Lin, Ching-Po; Poupon, Cyril			Diffusion Microscopist Simulator: A General Monte Carlo Simulation System for Diffusion Magnetic Resonance Imaging	PLOS ONE			English	Article							RELAXATION-TIME NMR; BRAIN WHITE-MATTER; HIGH B-VALUE; SPIN-ECHO; SELF-DIFFUSION; WATER DIFFUSION; FIBER-TRACKING; FIELD-GRADIENT; MULTICOMPARTMENT SYSTEMS; RESTRICTED DIFFUSION	This article describes the development and application of an integrated, generalized, and efficient Monte Carlo simulation system for diffusion magnetic resonance imaging (dMRI), named Diffusion Microscopist Simulator (DMS). DMS comprises a random walk Monte Carlo simulator and an MR image synthesizer. The former has the capacity to perform large-scale simulations of Brownian dynamics in the virtual environments of neural tissues at various levels of complexity, and the latter is flexible enough to synthesize dMRI datasets from a variety of simulated MRI pulse sequences. The aims of DMS are to give insights into the link between the fundamental diffusion process in biological tissues and the features observed in dMRI, as well as to provide appropriate ground-truth information for the development, optimization, and validation of dMRI acquisition schemes for different applications. The validity, efficiency, and potential applications of DMS are evaluated through four benchmark experiments, including the simulated dMRI of white matter fibers, the multiple scattering diffusion imaging, the biophysical modeling of polar cell membranes, and the high angular resolution diffusion imaging and fiber tractography of complex fiber configurations. We expect that this novel software tool would be substantially advantageous to clarify the interrelationship between dMRI and the microscopic characteristics of brain tissues, and to advance the biophysical modeling and the dMRI methodologies.	[Yeh, Chun-Hung; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Yeh, Chun-Hung; Schmitt, Benoit; Le Bihan, Denis; Poupon, Cyril] Commissariat Energie Atom & Energies Alternat CEA, NeuroSpin, Gif Sur Yvette, France; [Yeh, Chun-Hung; Schmitt, Benoit; Le Bihan, Denis; Poupon, Cyril] Inst Federatif Rech 49, Gif Sur Yvette, France; [Li-Schlittgen, Jing-Rebecca] Inst Natl Rech Informat & Automat INRIA Saclay, Determinat Formes & Identificat Equipe DEFI, Palaiseau, France	National Yang Ming Chiao Tung University; CEA	Poupon, C (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, NeuroSpin, Gif Sur Yvette, France.	cyril.poupon@gmail.com	Yeh, Chun-Hung/ABE-7568-2020	Yeh, Chun-Hung/0000-0001-5727-9346	National Science Council of Taiwan; Partenariat Huber Currier Orchid project; DFMRI; SimuDMRI projects; French National Research Agency; European CONNECT project; French Institute in Taipei; CEA NeuroSpin Centre; National Yang-Ming University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Partenariat Huber Currier Orchid project; DFMRI; SimuDMRI projects; French National Research Agency(French National Research Agency (ANR)); European CONNECT project; French Institute in Taipei; CEA NeuroSpin Centre; National Yang-Ming University	This research is partly supported by the National Science Council of Taiwan, the Partenariat Huber Currier Orchid project, the DFMRI and SimuDMRI projects approved by the French National Research Agency, and the European CONNECT project. CHY is grateful to the "Programme Joseph Fourier (2008-2010)" scholarship co-financed by the French Institute in Taipei, the CEA NeuroSpin Centre, and National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Balls GT, 2009, MAGN RESON MED, V62, P771, DOI 10.1002/mrm.22033; Barzykin AV, 1998, PHYS REV B, V58, P14171, DOI 10.1103/PhysRevB.58.14171; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Callaghan, 1993, PRINCIPLES NUCL MAGN; Callaghan PT, 2002, MAGN RESON CHEM, V40, pS15, DOI 10.1002/mrc.1122; Chen KC, 2000, P NATL ACAD SCI USA, V97, P8306, DOI 10.1073/pnas.150338197; Chin CL, 2004, MAGN RESON MED, V52, P733, DOI 10.1002/mrm.20223; Cho KH, 2008, NEUROIMAGE, V42, P262, DOI 10.1016/j.neuroimage.2008.03.053; Close TG, 2009, NEUROIMAGE, V47, P1288, DOI 10.1016/j.neuroimage.2009.03.077; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; COOPER RL, 1974, BIOPHYS J, V14, P161, DOI 10.1016/S0006-3495(74)85904-7; Cory DG, 1990, POLYM PREPR, V31, P149; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Does MD, 2003, MAGN RESON MED, V49, P206, DOI 10.1002/mrm.10385; Fieremans E, 2008, PHYS MED BIOL, V53, P5405, DOI 10.1088/0031-9155/53/19/009; Fieremans E, 2008, J MAGN RESON, V190, P189, DOI 10.1016/j.jmr.2007.10.014; Flint J, 2009, NEUROIMAGE, V46, P411, DOI 10.1016/j.neuroimage.2009.02.003; Frank LR, 2006, C P IEEE ENG MED BIO, V1, P2243; Hall MG, 2009, IEEE T MED IMAGING, V28, P1354, DOI 10.1109/TMI.2009.2015756; HAZLEWOOD CF, 1991, MAGNET RESON MED, V19, P214; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Karger J., 1988, ADV MAGNETIC OPTICAL, P1; KARLICEK RF, 1980, J MAGN RESON, V37, P75, DOI 10.1016/0022-2364(80)90095-5; Kroenke CD, 2004, NEUROCHEM INT, V45, P561, DOI 10.1016/j.neuint.2003.11.020; Landman BA, 2010, NMR BIOMED, V23, P152, DOI 10.1002/nbm.1437; LATOUR LL, 1994, P NATL ACAD SCI USA, V91, P1229, DOI 10.1073/pnas.91.4.1229; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lin CP, 2001, NEUROIMAGE, V14, P1035, DOI 10.1006/nimg.2001.0882; MERBOLDT KD, 1989, MAGNET RESON MED, V9, P423, DOI 10.1002/mrm.1910090316; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Novikov EG, 1998, J MAGN RESON, V135, P522, DOI 10.1006/jmre.1998.1597; Ozarslan E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2905765; Panagiotaki E, 2010, LECT NOTES COMPUT SC, V6362, P404; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Perrin M, 2005, LECT NOTES COMPUT SC, V3565, P52; Perrin M, 2005, PHILOS T R SOC B, V360, P881, DOI 10.1098/rstb.2005.1650; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Poupon C, 2008, MAGN RESON MED, V60, P1276, DOI 10.1002/mrm.21789; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Regan DG, 2002, BIOPHYS J, V83, P161, DOI 10.1016/S0006-3495(02)75158-8; Schmitt B, 2010, THESIS ECOLE NATL SU; Schwarcz A, 2004, MAGNET RESON MED, V51, P278, DOI 10.1002/mrm.10702; Shemesh N, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454131; Shemesh N, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3285299; Shemesh N, 2009, J MAGN RESON, V200, P214, DOI 10.1016/j.jmr.2009.07.005; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STEPISNIK J, 1993, PHYSICA B, V183, P343, DOI 10.1016/0921-4526(93)90124-O; TANNER JE, 1970, J CHEM PHYS, V52, P2523, DOI 10.1063/1.1673336; TAYLOR DG, 1985, PHYS MED BIOL, V30, P345, DOI 10.1088/0031-9155/30/4/009; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van der Weerd L, 2002, J MAGN RESON, V156, P213, DOI 10.1006/jmre.2002.2550; Waudby CA, 2011, J MAGN RESON, V211, P67, DOI 10.1016/j.jmr.2011.04.004; Yablonskiy DA, 2003, MAGNET RESON MED, V50, P664, DOI 10.1002/mrm.10578; Yeh CH, 2008, IEEE T MED IMAGING, V27, P1415, DOI 10.1109/TMI.2008.922189; Yeh CH, 2010, NEUROIMAGE, V51, P743, DOI 10.1016/j.neuroimage.2010.02.041	77	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76626	10.1371/journal.pone.0076626	http://dx.doi.org/10.1371/journal.pone.0076626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130783	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200042
J	Lind, U; Rosenblad, MA; Wrange, AL; Sundell, KS; Jonsson, PR; Andre, C; Havenhand, J; Blomberg, A				Lind, Ulrika; Rosenblad, Magnus Alm; Wrange, Anna-Lisa; Sundell, Kristina S.; Jonsson, Per R.; Andre, Carl; Havenhand, Jonathan; Blomberg, Anders			Molecular Characterization of the alpha-Subunit of Na+/K+ ATPase from the Euryhaline Barnacle Balanus improvisus Reveals Multiple Genes and Differential Expression of Alternative Splice Variants	PLOS ONE			English	Article							TROPONIN-T GENE; H+-ATPASE; SALINITY TOLERANCE; NA++K+-ATPASE; GILLS; NA,K-ATPASE; CRAB; OSMOREGULATION; NA+,K+-ATPASE; MEMBRANE	The euryhaline bay barnacle Balanus improvisus has one of the broadest salinity tolerances of any barnacle species. It is able to complete its life cycle in salinities close to freshwater (3 PSU) up to fully marine conditions (35 PSU) and is regarded as one of few truly brackish-water species. Na+/K+ ATPase (NAK) has been shown to be important for osmoregulation when marine organisms are challenged by changing salinities, and we therefore cloned and examined the expression of different NAKs from B. improvisus. We found two main gene variants, NAK1 and NAK2, which were approximately 70% identical at the protein level. The NAK1 mRNA existed in a long and short variant with the encoded proteins differing only by 27 N-terminal amino acids. This N-terminal stretch was coded for by a separate exon, and the two variants of NAK1 mRNAs appeared to be created by alternative splicing. We furthermore showed that the two NAK1 isoforms were differentially expressed in different life stages and in various tissues of adult barnacle, i.e the long isoform was predominant in cyprids and in adult cirri. In barnacle cyprid larvae that were exposed to a combination of different salinities and pCO(2) levels, the expression of the long NAK1 mRNA increased relative to the short in low salinities. We suggest that the alternatively spliced long variant of the Nak1 protein might be of importance for osmoregulation in B. improvisus in low salinity conditions.	[Lind, Ulrika; Rosenblad, Magnus Alm; Blomberg, Anders] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Wrange, Anna-Lisa; Sundell, Kristina S.; Jonsson, Per R.; Andre, Carl; Havenhand, Jonathan] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Blomberg, A (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	anders.blomberg@cmb.gu.se	Sundell, Kristina/F-8884-2016; Andre, Carl/B-4237-2010; Havenhand, Jon N/F-5435-2013; Sundell, Kristina/E-5606-2014; Jonsson, Per R/E-6707-2013	Sundell, Kristina/0000-0002-7643-2083; Andre, Carl/0000-0003-4404-7292; Havenhand, Jon N/0000-0003-0253-3428; Jonsson, Per/0000-0002-1793-5473; Havenhand, Jonathan/0000-0001-6721-7763; Blomberg, Anders/0000-0002-1260-3920	Swedish Research Councils, VR; FORMAS; BILS	Swedish Research Councils, VR(Swedish Research Council); FORMAS(Swedish Research Council Formas); BILS	This work was performed within Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se) which is supported by a Linnaeus-grant from the Swedish Research Councils, VR (www.vr.se) and FORMAS (www.formas.se). MAR was partly funded by BILS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; AUSTIN AP, 1958, Q J MICROSC SCI, V99, P497; Babakov AV, 2000, PLANTA, V211, P446, DOI 10.1007/s004250000347; BAXTERLOWE LA, 1989, FEBS LETT, V257, P181, DOI 10.1016/0014-5793(89)81816-2; Benoist P, 1998, J BIOL CHEM, V273, P7538, DOI 10.1074/jbc.273.13.7538; Berntsson KM, 2000, J EXP MAR BIOL ECOL, V251, P59, DOI 10.1016/S0022-0981(00)00210-0; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boxshall Geoff A., 2009, Arthropod Systematics & Phylogeny, V67, P229; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Chan PM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005157; CHARMANTIER G, 1988, BIOL BULL-US, V175, P102, DOI 10.2307/1541897; Charmantier G, 2001, J EXP BIOL, V204, P967; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Cieluch U, 2007, MAR ECOL PROG SER, V329, P169, DOI 10.3354/meps329169; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; DAVENPORT J, 1976, J MAR BIOL ASSOC UK, V56, P889, DOI 10.1017/S0025315400020932; De Gregoris TB, 2011, BIOFOULING, V27, P367, DOI 10.1080/08927014.2011.577211; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DINEEN JF, 1992, J EXP MAR BIOL ECOL, V156, P239, DOI 10.1016/0022-0981(92)90249-A; Efendiev R, 2005, J BIOL CHEM, V280, P16272, DOI 10.1074/jbc.M500486200; Fehsenfeld S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-488; FOSTER BA, 1970, PHILOS T ROY SOC B, V256, P377, DOI 10.1098/rstb.1970.0001; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; FYHN HJ, 1976, COMP BIOCHEM PHYS A, V53, P19, DOI 10.1016/S0300-9629(76)80004-7; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Gohad NV, 2009, J EXP MAR BIOL ECOL, V380, P88, DOI 10.1016/j.jembe.2009.09.008; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; Havird JC, 2013, COMP BIOCHEM PHYS D, V8, P131, DOI 10.1016/j.cbd.2013.01.003; Hu MY, 2011, AM J PHYSIOL-REG I, V300, pR1100, DOI 10.1152/ajpregu.00653.2010; IPCC, 2007, CLIM CHANG PHYS SCI; Jayasundara N, 2007, J EXP BIOL, V210, P2070, DOI 10.1242/jeb.004309; Jimenez T, 2010, REPRODUCTION, V139, P835, DOI 10.1530/REP-09-0495; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Jorgensen PL, 2008, J MEMBRANE BIOL, V221, P39, DOI 10.1007/s00232-007-9083-3; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaeodee M, 2011, COMP BIOCHEM PHYS B, V159, P244, DOI 10.1016/j.cbpb.2011.05.004; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kerkeb L, 2002, PHYSIOL PLANTARUM, V116, P37, DOI 10.1034/j.1399-3054.2002.1160105.x; Kultz D, 2001, J EXP BIOL, V204, P2975; Lind U, 2010, MOL PHARMACOL, V78, P237, DOI 10.1124/mol.110.063594; Lucu C, 2003, COMP BIOCHEM PHYS A, V135, P195; Lucu C, 2000, J EXP MAR BIOL ECOL, V246, P163, DOI 10.1016/S0022-0981(99)00179-3; MACIAS MT, 1991, GENE, V105, P197, DOI 10.1016/0378-1119(91)90151-Z; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Magee JA, 2003, CAN J FISH AQUAT SCI, V60, P214, DOI 10.1139/F03-015; Marden JH, 2001, J EXP BIOL, V204, P3457; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; McCormick SD, 2009, J EXP BIOL, V212, P3994, DOI 10.1242/jeb.037275; NASROLAHI A, 2012, THESIS KIEL; Nasrolahi A, 2012, MAR BIOL, V159, P331, DOI 10.1007/s00227-011-1811-7; Nilsen TO, 2007, J EXP BIOL, V210, P2885, DOI 10.1242/jeb.002873; Nongthomba U, 2007, GENETICS, V177, P295, DOI 10.1534/genetics.106.056812; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Perry SF, 2006, RESP PHYSIOL NEUROBI, V154, P199, DOI 10.1016/j.resp.2006.04.010; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pham D, 2012, AQUACULTURE, V362, P10, DOI 10.1016/j.aquaculture.2012.07.026; PRESSLEY TA, 1992, AM J PHYSIOL, V262, pC743, DOI 10.1152/ajpcell.1992.262.3.C743; Price NT, 2010, J BIOL CHEM, V285, P7857, DOI 10.1074/jbc.M109.072892; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; Richards JG, 2003, J EXP BIOL, V206, P4475, DOI 10.1242/jeb.00701; Saez AG, 2009, GENETICA, V136, P479, DOI 10.1007/s10709-009-9356-0; Segall L, 2002, J BIOL CHEM, V277, P35202, DOI 10.1074/jbc.M206115200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; TAKEYASU K, 1990, AM J PHYSIOL, V259, pC619, DOI 10.1152/ajpcell.1990.259.4.C619; Towle DW, 2001, J EXP BIOL, V204, P4005; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Turpayeva YP, 1961, T I OCEANOL, V49, P205; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WALLEY LJ, 1969, PHILOS T ROY SOC B, V256, P237, DOI 10.1098/rstb.1969.0042; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zhen Y, 2012, SCIENCE, V337, P1634, DOI 10.1126/science.1226630	78	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77069	10.1371/journal.pone.0077069	http://dx.doi.org/10.1371/journal.pone.0077069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130836	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900121
J	Rasmussen, G; Monecke, S; Ehricht, R; Soderquist, B				Rasmussen, Gunlog; Monecke, Stefan; Ehricht, Ralf; Soderquist, Bo			Prevalence of Clonal Complexes and Virulence Genes among Commensal and Invasive Staphylococcus aureus Isolates in Sweden	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; METHICILLIN-RESISTANT; EXPERIMENTAL ENDOCARDITIS; CAPSULAR POLYSACCHARIDES; INFECTIVE ENDOCARDITIS; BIOFILM FORMATION; CLUMPING FACTOR; STRAINS; EXPRESSION; ADHERENCE	Staphylococcus aureus encodes a remarkable number of virulence factors which may contribute to its pathogenicity and ability to cause invasive disease. The main objective of this study was to evaluate the association between S. aureus invasiveness and bacterial genotype, in terms of the presence of virulence genes and affiliation to clonal complexes. Also, the significance of different virulence genes, mainly adhesins, for the development of infective endocarditis was investigated. DNA microarray technology was used to analyze 134 S. aureus isolates, all methicillin-susceptible, derived from three groups of clinically well-characterized patients: nasal carriers (n=46), bacteremia (n=55), and bacteremia with infective endocarditis (n=33). Invasive isolates were dominant in four of the major clonal complexes: 5, 8, 15, and 25. Of the 170 virulence genes examined, those encoding accessory gene regulator group II (agr II), capsule polysaccharide serotype 5 (cap5), and adhesins such as S. aureus surface protein G (sasG) and fibronectin-binding protein B (fnbB) were found to be associated with invasive disease. The same was shown for the leukocidin genes lukD/lukE, as well as the genes encoding serine protease A and B (splA/splB), staphylococcal complement inhibitor (scn) and the staphylococcal exotoxin-like protein (setC or selX). In addition, there was a trend of higher prevalence of certain genes or gene clusters (sasG, agr II, cap5) among isolates causing infective endocarditis compared to other invasive isolates. In most cases, the presence of virulence genes was linked to clonal complex affiliation. In conclusion, certain S. aureus clonal lineages harboring specific sets of virulence genes seem to be more successful in causing invasive disease.	[Rasmussen, Gunlog; Soderquist, Bo] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Soderquist, Bo] Orebro Univ Hosp Sweden, Orebro, Sweden; [Rasmussen, Gunlog; Soderquist, Bo] Univ Orebro, Fac Med & Hlth, Orebro, Sweden	Orebro University; Alere; Technische Universitat Dresden; Orebro University	Rasmussen, G (corresponding author), Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden.	gunlog.rasmussen@orebroll.se		Soderquist, Bo/0000-0001-5939-2932	Research Comitte of the County Council of Orebro University Hospital	Research Comitte of the County Council of Orebro University Hospital	Funding for this study was provided by grants from the Research Comitte of the County Council of Orebro University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; Chi Chia-Yu, 2010, J Clin Microbiol, V48, P292, DOI 10.1128/JCM.01788-09; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Ferry Tristan, 2005, Curr Infect Dis Rep, V7, P420, DOI 10.1007/s11908-005-0043-8; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Gill SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018673; Gillaspy AF, 1998, INFECT IMMUN, V66, P3170, DOI 10.1128/IAI.66.7.3170-3178.1998; Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914; Hogevik H, 1998, APMIS, V106, P901, DOI 10.1111/j.1699-0463.1998.tb00237.x; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Que YA, 2001, INFECT IMMUN, V69, P6296, DOI 10.1128/IAI.69.10.6296-6302.2001; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Soderquist Bo, 1998, Clin Microbiol Infect, V4, P366, DOI 10.1111/j.1469-0691.1998.tb00080.x; Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279; Werbick C, 2007, J INFECT DIS, V195, P1678, DOI 10.1086/517517; Xiong YQ, 2009, J INFECT DIS, V199, P201, DOI 10.1086/595738	37	59	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77477	10.1371/journal.pone.0077477	http://dx.doi.org/10.1371/journal.pone.0077477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130888	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900138
J	Yoneda, Y; Ito, S; Kunisada, T; Morimoto, Y; Kanzaki, H; Yoshida, A; Shimizu, K; Ozaki, T; Ouchida, M				Yoneda, Yasushi; Ito, Sachio; Kunisada, Toshiyuki; Morimoto, Yuki; Kanzaki, Hirotaka; Yoshida, Aki; Shimizu, Kenji; Ozaki, Toshifumi; Ouchida, Mamoru			Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein	PLOS ONE			English	Article							ONCOPROTEIN SYT-SSX1; NUCLEAR-LOCALIZATION; SYT INTERACTS; GENE; EXPRESSION; TRANSLOCATION; COMPLEXES; POLYCOMB; GROWTH; IDENTIFICATION	Synovial sarcoma is a relatively rare high-grade soft tissue sarcoma that often develops in the limbs of young people and induces the lung and the lymph node metastasis resulting in poor prognosis. In patients with synovial sarcoma, specific chromosomal translocation of t(X; 18) (p11.2; q11.2) is observed, and SS18-SSX fusion protein expressed by this translocation is reported to be associated with pathogenesis. However, role of the fusion protein in the pathogenesis of synovial sarcoma has not yet been completely clarified. In this study, we focused on the localization patterns of SS18-SSX fusion protein. We constructed expression plasmids coding for the full length SS18-SSX, the truncated SS18 moiety (tSS18) and the truncated SSX moiety (tSSX) of SS18-SSX, tagged with fluorescent proteins. These plasmids were transfected in synovial sarcoma SYO-1 cells and we observed the expression of these proteins using a fluorescence microscope. The SS18-SSX fusion protein showed a characteristic speckle pattern in the nucleus. However, when SS18-SSX was co-expressed with tSSX, localization of SS18-SSX changed from speckle patterns to the diffused pattern similar to the localization pattern of tSSX and SSX. Furthermore, cell proliferation and colony formation of synovial sarcoma SYO-1 and YaFuSS cells were suppressed by exogenous tSSX expression. Our results suggest that the characteristic speckle localization pattern of SS18-SSX is strongly involved in the tumorigenesis through the SSX moiety of the SS18-SSX fusion protein. These findings could be applied to further understand the pathogenic mechanisms, and towards the development of molecular targeting approach for synovial sarcoma.	[Yoneda, Yasushi; Morimoto, Yuki; Yoshida, Aki; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthoped Surg, Okayama 7008530, Japan; [Yoneda, Yasushi; Ito, Sachio; Kanzaki, Hirotaka; Shimizu, Kenji; Ouchida, Mamoru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan; [Kunisada, Toshiyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med Mat Musculoskeletal Reconstruct, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Ouchida, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan.	ouchidam@md.okayama-u.ac.jp						Al-Hussaini H., 2011, Sarcoma, V2011, P231789, DOI 10.1155/2011/231789; Barco R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005060; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Brodin B, 2001, GENE, V268, P173, DOI 10.1016/S0378-1119(01)00412-7; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; de Bruijn DRH, 2007, GENE CHROMOSOME CANC, V46, P107, DOI 10.1002/gcc.20399; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; de Bruijn DRH, 2002, GENE CHROMOSOME CANC, V34, P285, DOI 10.1002/gcc.10073; de Bruijn DRH, 2001, ONCOGENE, V20, P3281, DOI 10.1038/sj.onc.1204419; dos Santos NR, 2000, EXP CELL RES, V256, P192, DOI 10.1006/excr.2000.4813; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Fernebro J, 2006, INT J CANCER, V118, P1165, DOI 10.1002/ijc.21475; Garcia CB, 2012, ONCOGENE, V31, P2323, DOI 10.1038/onc.2011.418; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Gure AO, 1997, INT J CANCER, V72, P965, DOI 10.1002/(SICI)1097-0215(19970917)72:6<965::AID-IJC8>3.0.CO;2-N; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Horvai AE, 2006, ARCH PATHOL LAB MED, V130, P792; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Ishida M, 2004, GENES CELLS, V9, P419, DOI 10.1111/j.1356-9597.2004.00737.x; Ishida M, 2007, MOL CELL BIOL, V27, P1348, DOI 10.1128/MCB.00658-06; Ito T, 2005, CANCER LETT, V224, P311, DOI 10.1016/j.canlet.2004.10.030; Ito T, 2004, LAB INVEST, V84, P1484, DOI 10.1038/labinvest.3700174; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Morimoto Y, 2003, CANCER LETT, V199, P35, DOI 10.1016/S0304-3835(03)00314-8; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Naka N, 2005, J MOL DIAGN, V7, P187, DOI 10.1016/S1525-1578(10)60545-4; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Palmerini E, 2009, CANCER, V115, P2988, DOI 10.1002/cncr.24370; Paulino AC, 2004, AM J CLIN ONCOL-CANC, V27, P122, DOI 10.1097/01.coc.0000047130.91699.DC; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Przybyl Joanna, 2012, Sarcoma, V2012, P249219, DOI 10.1155/2012/249219; Saito T, 2006, CANCER RES, V66, P6919, DOI 10.1158/0008-5472.CAN-05-3697; Shi WY, 2013, AM J CLIN ONCOL-CANC, V36, P83, DOI 10.1097/COC.0b013e31823fe450; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; Smith HA, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/150591; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Sun Y, 2006, ONCOGENE, V25, P1042, DOI 10.1038/sj.onc.1209143; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Tornkvist M, 2008, BIOCHEM BIOPH RES CO, V368, P793, DOI 10.1016/j.bbrc.2008.01.162; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P93, DOI 10.1016/0165-4608(86)90153-6; Tureci O, 1996, CANCER RES, V56, P4766; Tureci O, 1998, INT J CANCER, V77, P19, DOI 10.1002/(SICI)1097-0215(19980703)77:1<19::AID-IJC4>3.0.CO;2-2; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xie YT, 2003, ONCOGENE, V22, P7628, DOI 10.1038/sj.onc.1207153	53	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77564	10.1371/journal.pone.0077564	http://dx.doi.org/10.1371/journal.pone.0077564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130893	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900141
J	Zheng, XQ; Xia, T; Yang, X; Yuan, T; Hu, YC				Zheng, Xinqi; Xia, Tian; Yang, Xin; Yuan, Tao; Hu, Yecui			The Land Gini Coefficient and Its Application for Land Use Structure Analysis in China	PLOS ONE			English	Article							INEQUALITY; SIZE	We introduce the Gini coefficient to assess the rationality of land use structure. The rapid transformation of land use in China provides a typical case for land use structure analysis. In this study, a land Gini coefficient (LGC) analysis tool was developed. The land use structure rationality was analyzed and evaluated based on statistical data for China between 1996 and 2008. The results show: (1) The LGC of three major land use types-farmland, built-up land and unused land-was smaller when the four economic districts were considered as assessment units instead of the provinces. Therefore, the LGC is spatially dependent; if the calculation unit expands, then the LGC decreases, and this relationship does not change with time. Additionally, land use activities in different provinces of a single district differed greatly. (2) At the national level, the LGC of the three main land use types indicated that during the 13 years analyzed, the farmland and unused land were evenly distributed across China. However, the built-up land distribution was relatively or absolutely unequal and highlights the rapid urbanization in China. (3) Trends in the distribution of the three major land use types are very different. At the national level, when using a district as the calculation unit, the LGC of the three main land use types increased, and their distribution became increasingly concentrated. However, when a province was used as the calculation unit, the LGC of the farmland increased, while the LGC of the built-up and unused land decreased. These findings indicate that the distribution of the farmland became increasingly concentrated, while the built-up land and unused land became increasingly uniform. (4) The LGC analysis method of land use structure based on geographic information systems (GIS) is flexible and convenient.	[Zheng, Xinqi; Xia, Tian; Yuan, Tao; Hu, Yecui] China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China; [Yang, Xin] Chinese Acad Sci, Res Ctr Operat & Dev Beijing, Inst Policy & Management, Beijing, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; CAS Institutes of Science & Development	Zheng, XQ (corresponding author), China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China.	zxqsd@126.com			National Public Benefit (Land) Research Foundation of China [201111014]	National Public Benefit (Land) Research Foundation of China	This study was supported by the following grant: the National Public Benefit (Land) Research Foundation of China (No. 201111014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024707; Chuai XW, 2013, ENVIRON SCI POLICY, V25, P50, DOI 10.1016/j.envsci.2012.05.005; Fang LN, 2009, ECOLOGICAL EC, V2, P329; He ZX, 2005, ANN BOT-LONDON, V95, P287, DOI 10.1093/aob/mci024; Herold M., 2005, Computers, Environment and Urban Systems, V29, P369, DOI 10.1016/j.compenvurbsys.2003.12.001; [扈传荣 HU Chuan-rong], 2009, [中国土地科学, China Land Science], V23, P44; JURIK TW, 1991, OECOLOGIA, V87, P539, DOI 10.1007/BF00320418; Kamanga P, 2009, ECOL ECON, V68, P613, DOI 10.1016/j.ecolecon.2008.08.018; Lee WC, 1996, INT J EPIDEMIOL, V25, P426, DOI 10.1093/ije/25.2.426; Li J, 2011, P NATL ACAD SCI USA, V108, P7721, DOI 10.1073/pnas.1101018108; Liu Y., 2004, STAT DECIS MAK, V9, P15; [鲁春阳 Lu Chunyang], 2010, [地理科学进展, Progress in Geography], V29, P861; MARTINEZ E, 1992, J PHYCOL, V28, P259, DOI 10.1111/j.0022-3646.1992.00259.x; Matsumoto M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-12; McDonald RI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009509; Miao ZH, 2011, LECT NOTES ARTIF INT, V7002, P671, DOI 10.1007/978-3-642-23881-9_85; Ministry of Public Security Administration, 1997, DEM DAT COUNT CHIN; Nanning Municipal Bureau of Land and Resources, 2007, LAND US CLASS NAT LA; Norheim OF, 2010, PUBLIC HEALTH ETH-UK, V3, P282, DOI 10.1093/phe/phq017; [潘竟虎 Pan Jinghu], 2010, [山地学报, Journal of Mountain Science], V28, P407; Steinberger JK, 2010, ECOL ECON, V69, P1148, DOI 10.1016/j.ecolecon.2009.12.009; Sun T, 2010, RESOUR CONSERV RECY, V54, P601, DOI 10.1016/j.resconrec.2009.10.017; Sun YJ, 2011, AREAL RES DEV, V30, p[93, 117]; [谭永忠 Tan Yongzhong], 2003, [自然资源学报, Journal of Natural Resources], V18, P112; The Central People's Government of the People's Republic of China, 2011, 2 STRAT CONST STRAT; Thinh N.X., 2002, ENVIRON IMPACT ASSES, V22, p475?492, DOI [10.1016/S0195-9255(02)00023-9, DOI 10.1016/S0195-9255(02)00023-9]; Wang J, 2011, INT S WAT RES ENV PR, P798; Wang ML, 2011, INT S WAT RES ENV PR, P992; Wang R, 2006, STUDY OPTIMIZATION L; [王涛 Wang Tao], 2010, [山西大学学报. 自然科学版, Journal of Shanxi University], V33, P473; White TJ, 2007, ECOL ECON, V64, P402, DOI 10.1016/j.ecolecon.2007.07.024; Xu XQ, 1997, URBAN GEOGRAPHY; Yang X, 2008, DYNAMIC CALCULATION; YITZHAKI S, 1979, Q J ECON, V93, P321, DOI 10.2307/1883197; [郑新奇 ZHENG Xinqi], 2008, [中国土地科学, China Land Science], V22, P4	35	18	21	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76165	10.1371/journal.pone.0076165	http://dx.doi.org/10.1371/journal.pone.0076165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130764	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900070
J	Pal, HC; Sharma, S; Strickland, LR; Agarwal, J; Athar, M; Elmets, CA; Afaq, F				Pal, Harish Chandra; Sharma, Samriti; Strickland, Leah Ray; Agarwal, Jyoti; Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh			Delphinidin Reduces Cell Proliferation and Induces Apoptosis of Non-Small-Cell Lung Cancer Cells by Targeting EGFR/VEGFR2 Signaling Pathways	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; NECK-CANCER; EGFR; INHIBITION; ACTIVATION; PHOSPHORYLATION; CHEMOTHERAPY; RESISTANCE; THERAPY	Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor 2 (VEGFR2) have emerged as two effective clinical targets for non-small-cell lung cancer (NSCLC). In the present study, we found that delphinidin, an anthocyanidin, present in pigmented fruits and vegetables, is a potent inhibitor of both EGFR and VEGFR2 in NSCLC cells that overexpress EGFR/VEGFR2. Using these cells, we next determined the effects of delphinidin on cell growth and apoptosis in vitro and on tumor growth and angiogenesis in vivo. Delphinidin (5-60 mu M) treatment of NSCLC cells inhibited the activation of PI3K, and phosphorylation of AKT and MAPKs. Additionally, treatment of NSCLC cells with delphinidin resulted in inhibition of cell growth without having significant toxic effects on normal human bronchial epithelial cells. Specifically, treatment of NCI-H441 and SK-MES-1 cells with delphindin (5-60 mu M) resulted in (i) cleavage of PARP protein, (ii) activation of caspase-3 and -9, (iii) downregulation of anti-apoptotic proteins (Bcl2, Bcl-xL and Mcl-1), (iv) upregulation of pro-apoptotic proteins (Bax and Bak), and (v) decreased expression of PCNA and cyclin D1. Furthermore, in athymic nude mice subcutaneously implanted with human NSCLC cells, delphinidin treatment caused a (i) significant inhibition of tumor growth, (ii) decrease in the expression of markers for cell proliferation (Ki67 and PCNA) and angiogenesis (CD31 and VEGF), and (iii) induction of apoptosis, when compared with control mice. Based on these observations, we suggest that delphinidin, alone or as an adjuvant to current therapies, could be used for the management of NSCLC, especially those that overexpress EGFR and VEGFR2.	[Pal, Harish Chandra; Sharma, Samriti; Strickland, Leah Ray; Agarwal, Jyoti; Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Afaq, F (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	fafaq@uab.edu	Pal, Harish C./AAH-9604-2020	Pal, Harish C./0000-0003-3079-7439	NIH [AT004966]; National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program [CA13148-39]; NATIONAL CANCER INSTITUTE [R01CA138998, P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004966] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by NIH Grant AT004966 and the National Cancer Institute CA13148-39 UAB Comprehensive Cancer Center Junior Faculty Development Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2008, INT J CANCER, V123, P1508, DOI 10.1002/ijc.23675; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Bin Hafeez B, 2008, CANCER RES, V68, P8564, DOI 10.1158/0008-5472.CAN-08-2232; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Ciardiello F, 2006, ANN ONCOL, V17, pVII109, DOI 10.1093/annonc/mdl962; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Earnshaw WC, 2006, ANNU REV BIOCHEM, V68, P383; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrero JM, 2001, ANN ONCOL, V12, P841, DOI 10.1023/A:1011183421477; Gazdar AF, 2010, CANCER METAST REV, V29, P37, DOI 10.1007/s10555-010-9201-z; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Haseeb A, 2013, RHEUMATOLOGY, V52, P998, DOI 10.1093/rheumatology/kes363; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hirsch FR, 2009, ONCOGENE, V28, pS32, DOI 10.1038/onc.2009.199; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Jimeno A, 2006, BBA-REV CANCER, V1766, P217, DOI 10.1016/j.bbcan.2006.08.008; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; MAZZA G, 1995, CRIT REV FOOD SCI, V35, P341, DOI 10.1080/10408399509527704; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mueller KL, 2010, TRANSL ONCOLOGY, V5, P327; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Noda Y, 2002, J AGR FOOD CHEM, V50, P166, DOI 10.1021/jf0108765; Pennell NA, 2009, ONCOLOGIST, V14, P399, DOI 10.1634/theoncologist.2008-0276; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Seong AR, 2011, BIOCHEM BIOPH RES CO, V410, P581, DOI 10.1016/j.bbrc.2011.06.029; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2009, EXP CELL RES, V315, P557, DOI 10.1016/j.yexcr.2008.07.026; Siegel R., 2013, CANC FACTS FIGURES 2; Silva SR, 2011, INT J CANCER, V128, P1045, DOI 10.1002/ijc.25441; Syed DN, 2008, TOXICOL APPL PHARM, V231, P52, DOI 10.1016/j.taap.2008.03.023; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yang F, 2011, CANCER RES, V71, P5512, DOI 10.1158/0008-5472.CAN-10-2614; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040178	51	70	72	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77270	10.1371/journal.pone.0077270	http://dx.doi.org/10.1371/journal.pone.0077270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124611	Green Submitted, gold, Green Published			2022-12-27	WOS:000325489100168
J	Roberts, BJ; Reddy, R; Wahl, JK				Roberts, Brett J.; Reddy, Roopa; Wahl, James K., III			Stratifin (14-3-3 sigma) Limits Plakophilin-3 Exchange with the Desmosomal Plaque	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-CELLS; E-CADHERIN; IDENTIFICATION; DESMOPLAKIN; DESMOGLEIN; BINDING; PLAKOGLOBIN; PROTEINS; ASSOCIATION	Desmosomes are prominent cell-cell adhesive junctions in stratified squamous epithelia and disruption of desmosomal adhesion has been shown to have dramatic effects on the function and integrity of these tissues. During normal physiologic processes, such as tissue development and wound healing, intercellular adhesion must be modified locally to allow coordinated cell movements. The mechanisms that control junction integrity and adhesive strength under these conditions are poorly understood. We utilized a proteomics approach to identify plakophilin-3 associated proteins and identified the 14-3-3 family member stratifin. Stratifin interacts specifically with plakophilin-3 and not with other plakophilin isoforms and mutation analysis demonstrated the binding site includes serine 285 in the amino terminal head domain of plakophilin-3. Stratifin interacts with a cytoplasmic pool of plakophilin-3 and is not associated with the desmosome in cultured cells. FRAP analysis revealed that decreased stratifin expression leads to an increase in the exchange rate of cytoplasmic plakophilin-3/GFP with the pool of plakophilin-3/GFP in the desmosome resulting in decreased desmosomal adhesion and increased cell migration. We propose a model by which stratifin plays a role in regulating plakophilin-3 incorporation into the desmosomal plaque by forming a plakophilin-3 stratifin complex in the cytosol and thereby affecting desmosome dynamics in squamous epithelial cells.	[Roberts, Brett J.; Reddy, Roopa; Wahl, James K., III] Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Wahl, JK (corresponding author), Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE USA.	jwahl@unmc.edu			National Institute of General Medical Sciences from the National Institutes of Health [P20GM103489]; Nebraska Department of Health and Human Services; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Nebraska Department of Health and Human Services; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Institute of General Medical Sciences (P20GM103489) from the National Institutes of Health and the Nebraska Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Bornslaeger EA, 2001, J CELL SCI, V114, P727; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Cabral RM, 2012, J CELL SCI, V125, P2853, DOI 10.1242/jcs.084152; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; HAMMOND NL, 2012, J INVEST DERMATOL; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; Lai SJ, 2011, J BIOL CHEM, V286, P34606, DOI 10.1074/jbc.M111.238527; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Muller J, 2003, EMBO J, V22, P4431, DOI 10.1093/emboj/cdg426; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Petrof G, 2012, BRIT J DERMATOL, V166, P36, DOI 10.1111/j.1365-2133.2011.10640.x; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Sobolik-Delmaire T, 2007, CELL COMMUN ADHES, V14, P99, DOI 10.1080/15419060701463082; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Sobolik-Delmaire T, 2010, J INVEST DERMATOL, V130, P2638, DOI 10.1038/jid.2010.191; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; THOMASON HA, 2012, J PATHOL; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Wahl JK, 2000, J CELL SCI, V113, P1737; Wahl JK, 2002, HYBRIDOMA HYBRIDOM, V21, P37, DOI 10.1089/15368590252917629; Wahl JK, 1996, J CELL SCI, V109, P1143; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Xin Y, 2010, J INVEST DERMATOL, V130, P1934, DOI 10.1038/jid.2010.56; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029554	44	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77012	10.1371/journal.pone.0077012	http://dx.doi.org/10.1371/journal.pone.0077012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124604	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100161
J	Felmy, B; Songhet, P; Slack, EMC; Muller, AJ; Kremer, M; Van Maele, L; Cayet, D; Heikenwalder, M; Sirard, JC; Hardt, WD				Felmy, Boas; Songhet, Pascal; Slack, Emma Marie Caroline; Mueller, Andreas J.; Kremer, Marcus; Van Maele, Laurye; Cayet, Delphine; Heikenwalder, Mathias; Sirard, Jean-Claude; Hardt, Wolf-Dietrich			NADPH Oxidase Deficient Mice Develop Colitis and Bacteremia upon Infection with Normally Avirulent, TTSS-1-and TTSS-2-Deficient Salmonella Typhimurium	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ENTERICA SEROVAR TYPHIMURIUM; TOLL-LIKE RECEPTORS; NITRIC-OXIDE; HOST-DEFENSE; DENDRITIC CELLS; REACTIVE OXYGEN; PATHOGENICITY ISLAND-2; PHAGOCYTE OXIDASE; MOUSE MODEL	Infections, microbe sampling and occasional leakage of commensal microbiota and their products across the intestinal epithelial cell layer represent a permanent challenge to the intestinal immune system. The production of reactive oxygen species by NADPH oxidase is thought to be a key element of defense. Patients suffering from chronic granulomatous disease are deficient in one of the subunits of NADPH oxidase. They display a high incidence of Crohn's disease-like intestinal inflammation and are hyper-susceptible to infection with fungi and bacteria, including a 10-fold increased risk of Salmonellosis. It is not completely understood which steps of the infection process are affected by the NADPH oxidase deficiency. We employed a mouse model for Salmonella diarrhea to study how NADPH oxidase deficiency (Cybb(-/-)) affects microbe handling by the large intestinal mucosa. In this animal model, wild type S. Typhimurium causes pronounced enteropathy in wild type mice. In contrast, an avirulent S. Typhimurium mutant (S.Tm-avir; invGsseD), which lacks virulence factors boosting trans-epithelial penetration and growth in the lamina propria, cannot cause enteropathy in wild type mice. We found that Cybb(-/-) mice are efficiently infected by S.Tm-avir and develop enteropathy by day 4 post infection. Cell depletion experiments and infections in Cybb(-/-) Myd88(-/-) mice indicated that the S.Tm-avir-inflicted disease in Cybb(-/-) mice hinges on CD11c(+)CX(3)CR1(+) monocytic phagocytes mediating colonization of the cecal lamina propria and on Myd88-dependent proinflammatory immune responses. Interestingly, in mixed bone marrow chimeras a partial reconstitution of Cybb-proficiency in the bone marrow derived compartment was sufficient to ameliorate disease severity. Our data indicate that NADPH oxidase expression is of key importance for restricting the growth of S.Tm-avir in the mucosal lamina propria. This provides important insights into microbe handling by the large intestinal mucosa and the role of NADPH oxidase in maintaining microbe-host mutualism at this exposed body surface.	[Felmy, Boas; Songhet, Pascal; Slack, Emma Marie Caroline; Mueller, Andreas J.; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, D BIOL, CH-8092 Zurich, Switzerland; [Kremer, Marcus] Tech Univ Munich, Inst Allgemeine Pathol & Pathol Anat, D-80290 Munich, Germany; [Van Maele, Laurye; Cayet, Delphine; Sirard, Jean-Claude] Univ Lille Nord France, Inst Natl Sante & Rech Med, Ctr Infect & Immun Lille, Inst Pasteur Lille,CNRS,UMR 8204, Lille, France; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, D-80290 Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hardt, WD (corresponding author), ETH, Inst Microbiol, D BIOL, CH-8092 Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Van Maele, Laurye/ABD-3375-2020; Slack, Emma/AAD-5837-2019; Sirard, Jean-Claude/B-5932-2011; Van Maele, Laurye/P-2882-2017; Slack, Emma/B-1612-2016; Heikenwalder, Mathias/AAA-2269-2020	Van Maele, Laurye/0000-0001-9495-5403; Slack, Emma/0000-0002-2473-1145; Sirard, Jean-Claude/0000-0001-9854-4652; Van Maele, Laurye/0000-0001-9495-5403; Slack, Emma/0000-0002-2473-1145; Muller, Andreas/0000-0002-0281-6383; Hardt, Wolf-Dietrich/0000-0002-9892-6420; CAYET, Delphine/0000-0003-1720-0845	Swiss National Science Foundation [310000-113623/1, 310030-132997/1]; European Union [SavinMucoPath INCO-CT-2006-032296]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	This work was supported by grants to WDH from the Swiss National Science Foundation (310000-113623/1 and 310030-132997/1) and from the European Union (SavinMucoPath INCO-CT-2006-032296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alam MS, 2008, MICROBIOL IMMUNOL, V52, P197, DOI 10.1111/j.1348-0421.2008.00030.x; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bispham J, 2001, INFECT IMMUN, V69, P367, DOI 10.1128/IAI.69.1.367-377.2001; Bjorgvinsdottir H, 1997, BLOOD, V89, P41, DOI 10.1182/blood.V89.1.41.41_41_48; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Conlan JW, 1996, INFECT IMMUN, V64, P1043, DOI 10.1128/IAI.64.3.1043-1047.1996; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Dinauer MC, 2001, BLOOD, V97, P3738, DOI 10.1182/blood.V97.12.3738; Elsen S, 2004, J CELL SCI, V117, P2215, DOI 10.1242/jcs.01085; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Grez M, 2011, MOL THER, V19, P28, DOI 10.1038/mt.2010.232; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Harrington L, 2007, FEMS IMMUNOL MED MIC, V51, P372, DOI 10.1111/j.1574-695X.2007.00313.x; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kappeli R, 2011, INT J MED MICROBIOL, V301, P117, DOI 10.1016/j.ijmm.2010.08.017; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Muller AJ, 2012, CELL HOST MICROBE, V11, P19, DOI 10.1016/j.chom.2011.11.013; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Mutunga M, 2004, VACCINE, V22, P4124, DOI 10.1016/j.vaccine.2003.10.053; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; OHNO Y, 1985, J BIOL CHEM, V260, P8438; Pizzolla A, 2012, J IMMUNOL, V188, P5003, DOI 10.4049/jimmunol.1103430; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; REX JH, 1990, J INFECT DIS, V162, P523, DOI 10.1093/infdis/162.2.523; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Silva-Herzog E, 2008, CELL MICROBIOL, V10, P2151, DOI 10.1111/j.1462-5822.2008.01192.x; Simonsen J, 2009, STAT MED, V28, P1882, DOI 10.1002/sim.3592; Soler-Palacin P, 2007, ALLERGOL IMMUNOPATH, V35, P83, DOI 10.1157/13106774; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; Talbot S, 2009, IMMUNOLOGY, V128, P472, DOI 10.1111/j.1365-2567.2009.03146.x; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vallance BA, 2002, INFECT IMMUN, V70, P6424, DOI 10.1128/IAI.70.11.6424-6435.2002; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546	66	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77204	10.1371/journal.pone.0077204	http://dx.doi.org/10.1371/journal.pone.0077204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143212	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100047
J	Vincent-Salomon, A; Benhamo, V; Gravier, E; Rigaill, G; Gruel, N; Robin, S; de Rycke, Y; Mariani, O; Pierron, G; Gentien, D; Reyal, F; Cottu, P; Fourquet, A; Rouzier, R; Sastre-Garau, X; Delattre, O				Vincent-Salomon, Anne; Benhamo, Vanessa; Gravier, Eleonore; Rigaill, Guillem; Gruel, Nadege; Robin, Stephane; de Rycke, Yann; Mariani, Odette; Pierron, Gaelle; Gentien, David; Reyal, Fabien; Cottu, Paul; Fourquet, Alain; Rouzier, Roman; Sastre-Garau, Xavier; Delattre, Olivier			Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; ADJUVANT CHEMOTHERAPY; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; RECURRENCE SCORE; CANCER; SURVIVAL; SIGNATURE; HYBRIDIZATION; EXPERIENCE	Background: The accurate prognosis definition to tailor treatment for early luminal invasive breast carcinoma patients remains challenging. Materials and Methods: Two hundred fourteen early luminal breast carcinomas were genotyped with single nucleotide polymorphisms (SNPs) array to determine the number of chromosomal breakpoints as a marker of genomic instability. Proliferation was assessed by KI67 (immunohistochemistry) and genomic grade index (transcriptomic analysis). IHC3 (IHC4 score for HER2 negative tumors) was also determined. Results: In the training set (109 cases), the optimal cut-off was 34 breakpoints with a specificity of 0.94 and a sensitivity of 0.57 (Area under the curve (AUC): 0.81[0.71; 0.91]). In the validation set (105 cases), the outcome of patients with > 34 breakpoints (11 events / 22 patients) was poorer (logrank test p < 0.001; Relative Risk (RR): 3.7 [1.73; 7.92]), than that of patients with < 34 breakpoints (19 events / 83 patients). Whereas genomic grade and KI67 had a significant prognostic value in univariate analysis in contrast to IHC3 that failed to have a statistical significant prognostic value in this series, the number of breakpoints remained the only significant parameter predictive of outcome (RR: 3.47, Confidence Interval (CI [1.29; 9.31], p = 0.014)) in multivariate analysis. Conclusion: Genomic instability, defined herein as a high number of chromosomal breakpoints, in early stage luminal breast carcinoma is a stronger prognostic marker than proliferation.	[Vincent-Salomon, Anne; Mariani, Odette; Pierron, Gaelle; Sastre-Garau, Xavier] Inst Curie, Dept Tumor Biol, Paris, France; [Vincent-Salomon, Anne; Benhamo, Vanessa; Gruel, Nadege; Delattre, Olivier] Inst Curie, INSERM, U830, Paris, France; [Benhamo, Vanessa; Gravier, Eleonore; Rigaill, Guillem; Gruel, Nadege; Gentien, David] Inst Curie, Dept Translat Res, Paris, France; [Gravier, Eleonore; de Rycke, Yann] Inst Curie, Dept Biostat, Paris, France; [Gravier, Eleonore] Inst Curie, INSERM, U900, Paris, France; [Gravier, Eleonore] Ecole Mines Paris, Paris, France; [Rigaill, Guillem; Robin, Stephane] AgroParisTech, UMR518, Paris, France; [Reyal, Fabien; Rouzier, Roman] Inst Curie, Dept Surg, Paris, France; [Cottu, Paul] Inst Curie, Dept Med Oncol, Paris, France; [Fourquet, Alain] Inst Curie, Dept Radiat Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Vincent-Salomon, A (corresponding author), Inst Curie, Dept Tumor Biol, Paris, France.	anne.salomon@curie.net	Gentien, David/O-9356-2019; Cottu, Paul/ABC-8595-2020; Gentien, David/L-7757-2017; Rouzier, Roman/G-2953-2018	Gentien, David/0000-0001-8317-5188; Sastre-Garau, Xavier/0000-0001-5992-2083; Rigaill, Guillem/0000-0002-7176-7511; delattre, olivier/0000-0002-8730-2276; Rouzier, Roman/0000-0002-8167-6808				Arnedos M, 2012, EUR J CANCER, V48, P2293, DOI 10.1016/j.ejca.2012.06.014; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barton S, 2012, BRIT J CANCER, V106, P1760, DOI 10.1038/bjc.2012.166; Bedard PL, 2011, NAT REV CLIN ONCOL, V8, P272, DOI 10.1038/nrclinonc.2011.19; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Blamey RW, 2010, EUR J CANCER, V46, P56, DOI 10.1016/j.ejca.2009.09.009; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELLIS IO, 1992, HISTOPATHOLOGY, V20, P479; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gravier E, 2010, GENE CHROMOSOME CANC, V49, P1125, DOI 10.1002/gcc.20820; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Habermann JK, 2009, INT J CANCER, V124, P1552, DOI 10.1002/ijc.24017; Ignatiadis M, 2012, NAT REV CLIN ONCOL, V9, P12, DOI 10.1038/nrclinonc.2011.188; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krijgsman O, 2012, GENE CHROMOSOME CANC, V51, P344, DOI 10.1002/gcc.21920; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Picard F, 2011, BIOSTATISTICS, V12, P413, DOI 10.1093/biostatistics/kxq076; Piccart-Gebhart MJ, 2007, ANN ONCOL, V18, P2, DOI 10.1093/annonc/mdm532; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Reyal F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035184; RIGAILL G, 2010, ARXIV10040887V1, P40887; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Smid M, 2011, BREAST CANCER RES TR, V128, P23, DOI 10.1007/s10549-010-1026-5; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Zhang NR, 2007, BIOMETRICS, V63, P22, DOI 10.1111/j.1541-0420.2006.00662.x	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76496	10.1371/journal.pone.0076496	http://dx.doi.org/10.1371/journal.pone.0076496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143191	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100026
J	Wu, T; Tang, Q; Gao, ZC; Yu, ZP; Song, HZ; Zheng, XD; Chen, W				Wu, Tao; Tang, Qiong; Gao, Zichun; Yu, Zhuoping; Song, Haizhao; Zheng, Xiaodong; Chen, Wei			Blueberry and Mulberry Juice Prevent Obesity Development in C57BL/6 Mice	PLOS ONE			English	Article							BERRY ANTHOCYANINS; INSULIN-RESISTANCE; WHOLE BERRIES; WEIGHT; ANTIOXIDANT; PARAMETERS; LEPTIN; MODEL	Objectives: To establish whether blueberry (Vaccinium ashei) and mulberry (Morus australis Poir) juice, anthocyanin rich fruit juice, may help counteract obesity. Design: And Methods: Four-week-old C57BL/6 mice were fed a high-fat diet (HFD) with or without blueberry and mulberry juice for 12 weeks. Body weight, serum and hepatic lipids, liver and adipose tissues morphology, insulin and leptin were assessed. Results: Mice fed HFD exhibited increased body weight, insulin resistance, serum and hepatic lipids. In comparison, blueberry and mulberry juice inhibited body weight gain, decreased the serum cholesterol, reduced the resistance to insulin, attenuated lipid accumulation and decreased the leptin secretin. Conclusion: These results indicate that blueberry and mulberry juice may help counteract obesity.	[Wu, Tao; Tang, Qiong; Gao, Zichun; Yu, Zhuoping; Song, Haizhao; Zheng, Xiaodong; Chen, Wei] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Tao; Zheng, Xiaodong; Chen, Wei] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, XD (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xdzheng@zju.edu.cn; zjuchenwei@zju.edu.cn	Wu, Tao/E-7769-2011	Wu, Tao/0000-0002-0629-8421	National Key Technology R&D Program of China [2012BAD33B08]; National Natural Science Foundation of China [31000775]; Zhejiang Innovation Program for Graduates [YK2011008]; Fundamental Research Funds for the Central Universities [2013QNA6012]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Innovation Program for Graduates; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Key Technology R&D Program of China (Grant No. 2012BAD33B08), the National Natural Science Foundation of China (Grant No. 31000775), Zhejiang Innovation Program for Graduates (Grant No. YK2011008) and the Fundamental Research Funds for the Central Universities (2013QNA6012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003; Arcari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158; Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Dennison BA, 1999, J AM COLL NUTR, V18, P346, DOI 10.1080/07315724.1999.10718874; Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Finer N, 2013, ENCY HUMAN NUTR, P404; FOLCH J, 1957, J BIOL CHEM, V226, P497; GILBERT CA, 2013, ANNU REV MED, V64, P1, DOI DOI 10.1146/ANNUREV-MED-121211-091605.PUBMED:23020876; Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Kaume L, 2012, J FUNCT FOODS, V4, P480, DOI 10.1016/j.jff.2012.02.008; Kim KH, 2011, ANNU REV FOOD SCI T, V2, P237, DOI 10.1146/annurev-food-022510-133656; LIST EO, 2012, INT J OBESITY, V11, P1; Liu LK, 2009, J AGR FOOD CHEM, V57, P7605, DOI 10.1021/jf9014697; Maratos-Flier E, 2008, NAT MED, V14, P604, DOI 10.1038/nm0608-604; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nicklas TA, 2008, ARCH PEDIAT ADOL MED, V162, P557, DOI 10.1001/archpedi.162.6.557; Prieur X, 2008, ENDOCRINOLOGY, V149, P5432, DOI 10.1210/en.2008-0498; Prior RL, 2008, J AGR FOOD CHEM, V56, P647, DOI 10.1021/jf071993o; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.3862; SAMUELWU YH, 2013, J FUNCT FOODS, V5, P923, DOI DOI 10.1016/J.JFF.2013.02.002; Siegrist M, 2013, NUTRITION, V29, P851, DOI 10.1016/j.nut.2012.12.011; Sancho RAS, 2012, FOOD RES INT, V46, P378, DOI 10.1016/j.foodres.2011.11.021; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Titta L, 2010, INT J OBESITY, V34, P578, DOI 10.1038/ijo.2009.266; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011	36	81	86	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77585	10.1371/journal.pone.0077585	http://dx.doi.org/10.1371/journal.pone.0077585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143244	Green Published, gold			2022-12-27	WOS:000325894100082
J	Masquelier, T; Deco, G				Masquelier, Timothee; Deco, Gustavo			Network Bursting Dynamics in Excitatory Cortical Neuron Cultures Results from the Combination of Different Adaptive Mechanism	PLOS ONE			English	Article							AVALANCHES; SYNCHRONIZATION; TRANSMISSION; PLASTICITY; MEMORY; TIME	In the brain, synchronization among cells of an assembly is a common phenomenon, and thought to be functionally relevant. Here we used an in vitro experimental model of cell assemblies, cortical cultures, combined with numerical simulations of a spiking neural network (SNN) to investigate how and why spontaneous synchronization occurs. In order to deal with excitation only, we pharmacologically blocked GABA(A)ergic transmission using bicuculline. Synchronous events in cortical cultures tend to involve almost every cell and to display relatively constant durations. We have thus named these "network spikes'' (NS). The inter-NS-intervals (INSIs) proved to be a more interesting phenomenon. In most cortical cultures NSs typically come in series or bursts ("bursts of NSs'', BNS), with short (similar to 1 s) INSIs and separated by long silent intervals (tens of s), which leads to bimodal INSI distributions. This suggests that a facilitating mechanism is at work, presumably short-term synaptic facilitation, as well as two fatigue mechanisms: one with a short timescale, presumably short-term synaptic depression, and another one with a longer timescale, presumably cellular adaptation. We thus incorporated these three mechanisms into the SNN, which, indeed, produced realistic BNSs. Next, we systematically varied the recurrent excitation for various adaptation timescales. Strong excitability led to frequent, quasi-periodic BNSs (CV similar to 0), and weak excitability led to rare BNSs, approaching a Poisson process (CV similar to 1). Experimental cultures appear to operate within an intermediate weakly-synchronized regime (CV similar to 0.5), with an adaptation timescale in the 2-8 s range, and well described by a Poisson-with-refractory-period model. Taken together, our results demonstrate that the INSI statistics are indeed informative: they allowed us to infer the mechanisms at work, and many parameters that we cannot access experimentally.	[Masquelier, Timothee; Deco, Gustavo] Univ Pompeu Fabra, Dept Informat & Commun Technol, Unit Brain & Cognit, Barcelona, Spain; [Masquelier, Timothee] CNRS, Lab Neurobiol Adapt Proc, UMR 7102, Paris, France; [Masquelier, Timothee] Univ Paris 06, Paris, France; [Deco, Gustavo] Univ Pompeu Fabra, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; ICREA; Pompeu Fabra University	Masquelier, T (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Unit Brain & Cognit, Barcelona, Spain.	timothee.masquelier@alum.mit.edu	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Masquelier, Timothee/F-1159-2010; DECO, GUSTAVO/A-6341-2008	Masquelier, Timothee/0000-0001-8629-9506; DECO, GUSTAVO/0000-0002-8995-7583	European Union [269459]; ERC [295129]; Spanish Research Project [SAF2010-16085]; CONSOLIDER-INGENIO Program [CSD2007-00012]; ICREA Funding Source: Custom	European Union(European Commission); ERC(European Research Council (ERC)European Commission); Spanish Research Project(Spanish Government); CONSOLIDER-INGENIO Program(Spanish Government); ICREA(ICREA)	This work was funded by the European Union Seventh Framework Program (FP7/2007-2013) under grant agreements no. 269459 (Coronet). GD was also supported by the ERC Advanced Grant: DYSTRUCTURE (n. 295129), by the Spanish Research Project SAF2010-16085, and by the CONSOLIDER-INGENIO 2010 Program CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Baltz T, 2011, J NEUROPHYSIOL, V106, P1500, DOI 10.1152/jn.00889.2010; Beggs JM, 2003, J NEUROSCI, V23, P11167; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Corner MA, 2002, NEUROSCI BIOBEHAV R, V26, P127, DOI 10.1016/S0149-7634(01)00062-8; Eytan D, 2003, J NEUROSCI, V23, P9349; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; FRERE RC, 1982, BRAIN RES, V244, P145, DOI 10.1016/0006-8993(82)90912-X; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gerstner W, 2002, SPIKING NEURON MODEL; Gigante G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.148101; Gilson M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002231; Giugliano M, 2004, J NEUROPHYSIOL, V92, P977, DOI 10.1152/jn.00067.2004; Goodman Dan, 2008, Front Neuroinform, V2, P5, DOI 10.3389/neuro.11.005.2008; Gritsun T, 2011, BIOL CYBERN, V105, P197, DOI 10.1007/s00422-011-0457-3; Gritsun TA, 2010, BIOL CYBERN, V102, P293, DOI 10.1007/s00422-010-0366-x; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nakanishi K, 1998, BRAIN RES, V795, P137, DOI 10.1016/S0006-8993(98)00283-2; Park I, 2006, IEEE IJCNN, P581; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Thivierge JP, 2008, J NEUROSCI, V28, P7968, DOI 10.1523/JNEUROSCI.0870-08.2008; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; Tsodyks M, 2000, J NEUROSCI, V20; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wiedemann UA, 2003, J NEUROPHYSIOL, V90, P3902, DOI 10.1152/jn.00284.2003; Zrenner C, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00173; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	49	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75824	10.1371/journal.pone.0075824	http://dx.doi.org/10.1371/journal.pone.0075824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146781	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400022
J	Wang, L; Jiang, Q; Chu, J; Lin, L; Li, XG; Chai, GS; Wang, Q; Wang, JZ; Tian, Q				Wang, Lu; Jiang, Qian; Chu, Jiang; Lin, Li; Li, Xiao-Guang; Chai, Gao-Shang; Wang, Qun; Wang, Jian-Zhi; Tian, Qing			Expression of Tau40 Induces Activation of Cultured Rat Microglial Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PAIRED HELICAL FILAMENTS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; PROTEIN-TAU; PHOSPHORYLATED-TAU; TRANSGENIC MICE; NEUROFIBRILLARY PATHOLOGY; CEREBRAL-CORTEX	Accumulation of microtubule-associated protein tau has been observed in the brain of aging and tauopathies. Tau was observed in microglia, but its role is not illustrated. By immunofluorescence staining and the fractal dimension value assay in the present study, we observed that microglia were activated in the brains of rats and mice during aging, simultaneously, the immunoreactivities of total tau and the phosphorylated tau were significantly enhanced in the activated microglia. Furtherly by transient transfection of tau40 (human 2N/4R tau) into the cultured rat microglia, we demonstrated that expression of tau40 increased the level of Iba1, indicating activation of microglia. Moreover, expression of tau40 significantly enhanced the membranous localization of the phosphorylated tau at Ser396 in microglia possibly by a mechanism involving protein phosphatase 2A, extracellular signal-regulated kinase and glycogen synthase kinase-3 beta. It was also found that expression of tau40 promoted microglial migration and phagocytosis, but not proliferation. And we observed increased secretion of several cytokines, including interleukin (IL)-1 beta, IL-6, IL-10, tumor necrosis factor-a and nitric oxide after the expression of tau40. These data suggest a novel role of human 2N/4R tau in microglial activation.	[Wang, Lu; Jiang, Qian; Chu, Jiang; Lin, Li; Li, Xiao-Guang; Chai, Gao-Shang; Wang, Qun; Wang, Jian-Zhi; Tian, Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Dis, Dept Pathophysiol,Key Lab, Wuhan 430074, Peoples R China; [Wang, Lu] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Peoples R China	Huazhong University of Science & Technology; Xinxiang Medical University	Wang, JZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Dis, Dept Pathophysiol,Key Lab, Wuhan 430074, Peoples R China.	wangjz@mails.tjmu.edu.cn; tianq@hust.edu.cn			Natural Science Foundation of China [30971204, 81271404]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the Natural Science Foundation of China (grant number: 30971204, 81271404)(http://www.nsfc.gov.cn/Portal0/default152.htm). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arrasate M, 2000, NEUROCHEM RES, V25, P43, DOI 10.1023/A:1007583214722; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bashir A, 2011, EUR REV MED PHARMACO, V15, P1282; Becher B, 2000, GLIA, V29, P293; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Cakman I, 1996, MECH AGEING DEV, V87, P197, DOI 10.1016/0047-6374(96)01708-3; Carlson NG, 1999, J IMMUNOL, V163, P3963; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Chung HS, 2013, NEUROCHEM RES; Crespo-Biel N, 2007, NEUROCHEM INT, V50, P435, DOI 10.1016/j.neuint.2006.10.002; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; GOEDERT M, 1995, NEUROBIOL AGING, V16, P325, DOI 10.1016/0197-4580(95)00017-9; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Iseki E, 2006, NEUROSCI LETT, V405, P29, DOI 10.1016/j.neulet.2006.06.036; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee Sangmook, 2012, Int J Alzheimers Dis, V2012, P172837, DOI 10.1155/2012/172837; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Mitchell TW, 2002, ANN NEUROL, V51, P182, DOI 10.1002/ana.10086; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; ODAWARA T, 1995, NEUROSCI LETT, V192, P145, DOI 10.1016/0304-3940(95)11595-N; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; SHIN RW, 1989, AM J PATHOL, V134, P1365; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Sjogren M, 2001, CLIN CHEM, V47, P1776; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Sloane JA, 1999, NEUROBIOL AGING, V20, P395, DOI 10.1016/S0197-4580(99)00066-4; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Song XY, 2004, J LEUKOCYTE BIOL, V75, P1147, DOI 10.1189/jlb.0403128; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tapiola T, 1997, NEUROREPORT, V8, P3961, DOI 10.1097/00001756-199712220-00022; Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; TODARO GJ, 1965, J CELL COMPAR PHYSL, V66, P325, DOI 10.1002/jcp.1030660310; Uchihara T, 2000, NEUROSCI LETT, V286, P99, DOI 10.1016/S0304-3940(00)01103-4; VAUGHAN DW, 1974, J NEUROCYTOL, V3, P405, DOI 10.1007/BF01098730; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; Weindruch R, 2002, MECH AGEING DEV, V123, P177, DOI 10.1016/S0047-6374(01)00344-X; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4	91	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76057	10.1371/journal.pone.0076057	http://dx.doi.org/10.1371/journal.pone.0076057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146816	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400037
J	Ager-Wick, E; Dirks, RP; Burgerhout, E; Nourizadeh-Lillabadi, R; de Wijze, DL; Spaink, HP; van den Thillart, GEEJM; Tsukamoto, K; Dufour, S; Weltzien, FA; Henkel, CV				Ager-Wick, Eirill; Dirks, Ron P.; Burgerhout, Erik; Nourizadeh-Lillabadi, Rasoul; de Wijze, Danielle L.; Spaink, Herman P.; van den Thillart, Guido E. E. J. M.; Tsukamoto, Katsumi; Dufour, Sylvie; Weltzien, Finn-Arne; Henkel, Christiaan V.			The Pituitary Gland of the European Eel Reveals Massive Expression of Genes Involved in the Melanocortin System	PLOS ONE			English	Article							GONADOTROPIN-BETA-SUBUNIT; FRESH-WATER EELS; ANGUILLA-ANGUILLA; CARBOXYPEPTIDASE-E; SECRETOGRANIN-II; DIFFERENTIAL EXPRESSION; SORTING RECEPTOR; JAPANESE EEL; PROOPIOMELANOCORTIN; SEQUENCE	Hormones secreted from the pituitary gland regulate important processes such as development, growth and metabolism, reproduction, water balance, and body pigmentation. Synthesis and secretion of pituitary hormones are regulated by different factors from the hypothalamus, but also through feedback mechanisms from peripheral organs, and from the pituitary itself. In the European eel extensive attention has been directed towards understanding the different components of the brain-pituitary-gonad axis, but little is known about the regulation of upstream processes in the pituitary gland. In order to gain a broader mechanistic understanding of the eel pituitary gland, we have performed RNA-seq transcriptome profiling of the pituitary of prepubertal female silver eels. RNA-seq reads generated on the Illumina platform were mapped to the recently assembled European eel genome. The most abundant transcript in the eel pituitary codes for pro-opiomelanocortin, the precursor for hormones of the melanocortin system. Several genes putatively involved in downstream processing of pro-opiomelanocortin were manually annotated, and were found to be highly expressed, both by RNA-seq and by qPCR. The melanocortin system, which affects skin color, energy homeostasis and in other teleosts interacts with the reproductive system, has so far received limited attention in eels. However, since up to one third of the silver eel pituitary's mRNA pool encodes pro-opiomelanocortin, our results indicate that control of the melanocortin system is a major function of the eel pituitary.	[Ager-Wick, Eirill; Nourizadeh-Lillabadi, Rasoul; Weltzien, Finn-Arne; Henkel, Christiaan V.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Dirks, Ron P.; Burgerhout, Erik; de Wijze, Danielle L.; van den Thillart, Guido E. E. J. M.; Henkel, Christiaan V.] ZF Screens BV, Leiden, Netherlands; [Burgerhout, Erik; de Wijze, Danielle L.; Spaink, Herman P.; van den Thillart, Guido E. E. J. M.; Henkel, Christiaan V.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Tsukamoto, Katsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan; [Dufour, Sylvie] Museum Natl Hist Nat, Res Unit BOREA, CNRS 7208, F-75231 Paris, France	Norwegian University of Life Sciences; Leiden University; Leiden University - Excl LUMC; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Henkel, CV (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	c.v.henkel@biology.leidenuniv.nl	Burgerhout, Erik/AAI-4527-2020; Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Ager-Wick, Eirill/0000-0001-8368-2008; Henkel, Christiaan/0000-0001-9838-8215; weltzien, finn-arne/0000-0002-5111-1558	Norwegian School of Veterinary Science; Research Council of Norway [184851]; Centre National de la Recherche Scientifique; L'Agence Nationale de la Recherche [08-BLAN-0173]	Norwegian School of Veterinary Science; Research Council of Norway(Research Council of Norway); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); L'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Norwegian School of Veterinary Science and the Research Council of Norway (184851), by Centre National de la Recherche Scientifique and L'Agence Nationale de la Recherche (08-BLAN-0173), and by private resources from ZF-screens B.V., Leiden University and The University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrubaian J, 2003, GEN COMP ENDOCR, V132, P384, DOI 10.1016/S0016-6480(03)00119-9; Anders S, 2012, HTSEQ VERSION 0 5 3P; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ardehali MB, 2009, NAT STRUCT MOL BIOL, V16, P1123, DOI 10.1038/nsmb1109-1123; Aroua S, 2007, GEN COMP ENDOCR, V153, P333, DOI 10.1016/j.ygcen.2007.02.027; ARVAN P, 1991, J BIOL CHEM, V266, P14171; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burgerhout E, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-16; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Coll AP, 2009, MOL CELL ENDOCRINOL, V300, P147, DOI 10.1016/j.mce.2008.09.007; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cool DR, 1998, MOL CELL ENDOCRINOL, V139, P7, DOI 10.1016/S0303-7207(98)00081-1; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; DUFOUR S, 1988, GEN COMP ENDOCR, V70, P20, DOI 10.1016/0016-6480(88)90090-1; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; FISCHERCOLBRIE R, 1995, PROG NEUROBIOL, V46, P49, DOI 10.1016/0301-0082(94)00060-U; Freyhof J., 2010, IUCN RED LIST THREAT; Han YS, 2003, AQUACULTURE, V219, P783, DOI 10.1016/S0044-8486(02)00578-1; Heinsbroek LTN, 2007, AQUACULTURE, V267, P175, DOI 10.1016/j.aquaculture.2007.03.028; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Holthuis JCM, 1996, J NEUROCHEM, V66, P2248; Holthuis JCM, 1996, J BIOL CHEM, V271, P17755, DOI 10.1074/jbc.271.30.17755; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Huang YS, 1999, ENDOCRINOLOGY, V140, P1228, DOI 10.1210/en.140.3.1228; Kanda S, 2011, GEN COMP ENDOCR, V173, P253, DOI 10.1016/j.ygcen.2011.05.015; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Lee J, 1999, PEPTIDES, V20, P1391, DOI 10.1016/S0196-9781(99)00148-5; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Metz JR, 2006, GEN COMP ENDOCR, V148, P150, DOI 10.1016/j.ygcen.2006.03.001; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Mizusawa K, 2011, GEN COMP ENDOCR, V171, P75, DOI 10.1016/j.ygcen.2010.12.008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; NOZAKI M, 1990, GEN COMP ENDOCR, V77, P348, DOI 10.1016/0016-6480(90)90224-A; Palstra Arjan, 2009, V30, P229; PANKHURST NW, 1982, J FISH BIOL, V21, P127, DOI 10.1111/j.1095-8649.1982.tb03994.x; PANKHURST NW, 1984, CAN J ZOOL, V62, P1143, DOI 10.1139/z84-165; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Rousseau Karine, 2009, V30, P39; Sbaihi M, 2001, J FISH BIOL, V59, P302, DOI 10.1006/jfbi.2001.1642; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Takahashi A, 2006, GEN COMP ENDOCR, V148, P85, DOI 10.1016/j.ygcen.2005.09.020; Tanaka S, 2003, ZOOL SCI, V20, P1183, DOI 10.2108/zsj.20.1183; Tesch F-W., 2003, EEL; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Van Ginneken V, 2007, ANIM BIOL, V57, P63, DOI 10.1163/157075607780002014; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Weltzien FA, 2005, GEN COMP ENDOCR, V142, P134, DOI 10.1016/j.ygcen.2004.12.019; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Weltzien FA, 2003, GEN COMP ENDOCR, V131, P87, DOI 10.1016/S0016-6480(02)00606-8; Yada T, 2002, GEN COMP ENDOCR, V128, P36, DOI 10.1016/S0016-6480(02)00047-3; Yasuda A, 2011, PEPTIDES, V32, P2127, DOI 10.1016/j.peptides.2011.08.016; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014; Zhao E, 2006, NEUROPEPTIDES, V40, P275, DOI 10.1016/j.npep.2006.05.002	67	11	12	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77396	10.1371/journal.pone.0077396	http://dx.doi.org/10.1371/journal.pone.0077396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130881	gold, Green Published			2022-12-27	WOS:000325814200085
J	Hirsch, BT; Prange, S; Hauver, SA; Gehrt, SD				Hirsch, Ben T.; Prange, Suzanne; Hauver, Stephanie A.; Gehrt, Stanley D.			Raccoon Social Networks and the Potential for Disease Transmission	PLOS ONE			English	Article							PROCYON-LOTOR; CANINE-DISTEMPER; GENETIC RELATEDNESS; SEROLOGIC SURVEY; CONTACT RATES; UNITED-STATES; NEW-JERSEY; RABIES; ONTARIO; USA	Raccoons are an important vector of rabies and other pathogens. The degree to which these pathogens can spread through a raccoon population should be closely linked to association rates between individual raccoons. Most studies of raccoon sociality have found patterns consistent with low levels of social connectivity within populations, thus the likelihood of direct pathogen transmission between raccoons is theoretically low. We used proximity detecting collars and social network metrics to calculate the degree of social connectivity in an urban raccoon population for purposes of estimating potential pathogen spread. In contrast to previous assumptions, raccoon social association networks were highly connected, and all individuals were connected to one large social network during 15 out of 18 months of study. However, these metrics may overestimate the potential for a pathogen to spread through a population, as many of the social connections were based on relatively short contact periods. To more closely reflect varying probabilities of pathogen spread, we censored the raccoon social networks based on the total amount of time spent in close proximity between two individuals per month. As this time criteria for censoring the social networks increased from one to thirty minutes, corresponding measures of network connectivity declined. These findings demonstrate that raccoon populations are much more tightly connected than would have been predicted based on previous studies, but also point out that additional research is needed to calculate more precise transmission probabilities by infected individuals, and determine how disease infection changes normal social behaviors.	[Hirsch, Ben T.; Gehrt, Stanley D.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Hirsch, Ben T.] Smithsonian Trop Res Inst, Balboa, Panama; [Prange, Suzanne] Ohio Div Wildlife, Athens, OH USA; SUNY Binghamton, Sch Educ, Binghamton, NY USA	University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Hirsch, BT (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	hirschb@si.edu	Prange, Suzanne/GSE-3990-2022	hirsch, ben/0000-0003-0142-7340	National Science Foundation [0425203]; Cook County Animal and Rabies Control; Max McGraw Wildlife Foundation	National Science Foundation(National Science Foundation (NSF)); Cook County Animal and Rabies Control; Max McGraw Wildlife Foundation	This project was funded in part by the National Science Foundation (ID-0425203), Cook County Animal and Rabies Control and the Max McGraw Wildlife Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARASH DP, 1974, SCIENCE, V185, P794, DOI 10.1126/science.185.4153.794; Beasley JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058982; BIGLER WJ, 1973, AM J EPIDEMIOL, V98, P326, DOI 10.1093/oxfordjournals.aje.a121562; Blanton JD, 2011, JAVMA-J AM VET MED A, V239, P773, DOI 10.2460/javma.239.6.773; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Chamberlain MJ, 2002, AM MIDL NAT, V148, P297, DOI 10.1674/0003-0031(2002)148[0297:STRAAR]2.0.CO;2; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; CRANFIELD MR, 1984, CAN VET J, V25, P63; Cullingham CI, 2008, MOL ECOL, V17, P4874, DOI 10.1111/j.1365-294X.2008.03956.x; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Dharmarajan G, 2012, BASIC APPL ECOL, V13, P560, DOI 10.1016/j.baae.2012.08.010; Ewer, 1998, CARNIVORES; Gehrt S.D., 2003, WILD MAMMALS N AM BI, V2nd, P611; Gehrt SD, 2001, WILDLIFE SOC B, V29, P833; Gehrt SD, 1998, ANIM BEHAV, V55, P1211, DOI 10.1006/anbe.1997.0657; Gehrt SD, 2004, SOUTHWEST NAT, V49, P116, DOI 10.1894/0038-4909(2004)049<0116:SPADIA>2.0.CO;2; Gompper ME, 2005, J ZOOL, V266, P215, DOI 10.1017/S0952836905006813; Grant JWA, 2002, ANIM BEHAV, V63, P323, DOI 10.1006/anbe.2001.1891; GRAU GA, 1970, J WILDLIFE MANAGE, V34, P364, DOI 10.2307/3799023; Greene GE, 1990, INFECT DIS DOG CAT, P226; Hamede R, 2012, J APPL ECOL, V49, P447, DOI 10.1111/j.1365-2664.2011.02103.x; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hanlon C.A., 2007, RABIES, P201, DOI DOI 10.1016/B978-012369366-2/50007-5; Hauver S, 2013, ETHOLOGY, V119, P769, DOI 10.1111/eth.12118; Hirsch BT, 2007, Q REV BIOL, V82, P9, DOI 10.1086/511657; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; HOFF G L, 1974, Journal of Wildlife Diseases, V10, P423; HUBBARD DR, 1985, J WILDLIFE DIS, V21, P105, DOI 10.7589/0090-3558-21.2.105; JENKINS SR, 1988, REV INFECT DIS, V10, pS620; JENKINS SR, 1987, AM J EPIDEMIOL, V126, P429, DOI 10.1093/oxfordjournals.aje.a114674; KAPPUS K D, 1970, Journal of Wildlife Diseases, V6, P507; Kaufmann J.H., 1982, P567; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; McLean R.G., 1975, P53; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P365, DOI 10.2165/00019053-199814040-00004; Mitchell MA, 1999, J WILDLIFE DIS, V35, P347, DOI 10.7589/0090-3558-35.2.347; Moore DA, 1999, PREV VET MED, V40, P19, DOI 10.1016/S0167-5877(99)00005-7; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; NETTLES VF, 1979, AM J PUBLIC HEALTH, V69, P601, DOI 10.2105/AJPH.69.6.601; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pitt JA, 2008, J MAMMAL, V89, P646, DOI 10.1644/07-MAMM-A-224R.1; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Prange S, 2004, J MAMMAL, V85, P483, DOI 10.1644/BOS-121; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Prange S, 2011, J MAMMAL, V92, P1331, DOI 10.1644/10-MAMM-A-416.1; Raizman EA, 2009, J WILDLIFE DIS, V45, P531, DOI 10.7589/0090-3558-45.2.531; Recuenco S, 2008, PREV VET MED, V86, P30, DOI 10.1016/j.prevetmed.2008.03.001; Robert K, 2012, J WILDLIFE MANAGE, V76, P1670, DOI 10.1002/jwmg.435; Rosatte RC, 2009, J WILDLIFE DIS, V45, P772, DOI 10.7589/0090-3558-45.3.772; Rosatte R, 2006, J WILDLIFE DIS, V42, P589, DOI 10.7589/0090-3558-42.3.589; Roscoe DE, 1998, J WILDLIFE DIS, V34, P752, DOI 10.7589/0090-3558-34.4.752; ROSCOE DE, 1993, J WILDLIFE DIS, V29, P390, DOI 10.7589/0090-3558-29.3.390; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Ryder TB, 2012, BIOL LETTERS, V8, P917, DOI 10.1098/rsbl.2012.0536; Sandell M., 1989, P164; SEIDENSTICKER J, 1988, NATL GEOGR RES, V4, P359; SMITH JS, 1990, J WILDLIFE DIS, V26, P473, DOI 10.7589/0090-3558-26.4.473; Tinline R, 2002, PREV VET MED, V56, P89, DOI 10.1016/S0167-5877(02)00126-5; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; Wilson E.O., 1975, P1; Wilson ML, 1997, AM J TROP MED HYG, V57, P457, DOI 10.4269/ajtmh.1997.57.457; Winkler W.G., 1991, P325; Wright AN, 2005, OECOLOGIA, V144, P148, DOI 10.1007/s00442-005-0018-3	65	35	35	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75830	10.1371/journal.pone.0075830	http://dx.doi.org/10.1371/journal.pone.0075830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130746	Green Published, Green Accepted, gold			2022-12-27	WOS:000325814200024
J	Kabyemela, E; Goncalves, BP; Prevots, DR; Morrison, R; Harrington, W; Gwamaka, M; Kurtis, JD; Fried, M; Duffy, PE				Kabyemela, Edward; Goncalves, Bronner P.; Prevots, D. Rebecca; Morrison, Robert; Harrington, Whitney; Gwamaka, Moses; Kurtis, Jonathan D.; Fried, Michal; Duffy, Patrick E.			Cytokine Profiles at Birth Predict Malaria Severity during Infancy	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM-FALCIPARUM MALARIA; FACTOR-ALPHA; GAMMA-INTERFERON; IMMUNE-RESPONSES; IN-VITRO; CHILDREN; ANEMIA; RISK; SUSCEPTIBILITY	Background: Severe malaria risk varies between individuals, and most of this variation remains unexplained. Here, we examined the hypothesis that cytokine profiles at birth reflect inter-individual differences that persist and influence malaria parasite density and disease severity throughout early childhood. Methods and Findings: Cytokine levels (TNF-alpha, IFN-gamma, IL-1 beta, IL-4, IL-5, IL-6 and IL-10) were measured at birth (cord blood; N=783) and during subsequent routine follow-up visits (peripheral blood) for children enrolled between 2002 and 2006 into a birth cohort in Muheza, Tanzania. Children underwent blood smear and clinical assessments every 2-4 weeks, and at the time of any illness. Cord blood levels of all cytokines were positively correlated with each other (Spearman's rank correlation). Cord levels of IL-1 beta and TNF-alpha (but not other cytokines) correlated with levels of the same cytokine measured at routine visits during early life (P < 0.05). Higher cord levels of IL-1 beta but not TNF-alpha were associated with lower parasite densities during infancy (P=0.003; Generalized Estimating Equation (GEE) method), with an average similar to 40% reduction versus children with low cord IL-1 beta levels, and with decreased risk of severe malaria during follow-up (Cox regression): adjusted hazard ratio (95% CI) 0.60 (0.39-0.92), P = 0.02. Conclusion: IL-1 beta levels at birth are related to future IL-1 beta levels as well as the risk of severe malaria in early life. The effect on severe malaria risk may be due in part to the effect of inflammatory cytokines to control parasite density.	[Kabyemela, Edward; Morrison, Robert; Gwamaka, Moses; Fried, Michal; Duffy, Patrick E.] Seattle Biomed Res Inst, MOMS Project, Seattle, WA 98109 USA; [Kabyemela, Edward; Morrison, Robert; Gwamaka, Moses; Fried, Michal; Duffy, Patrick E.] Muheza Designated Dist Hosp, Muheza, Tanzania; [Goncalves, Bronner P.; Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Goncalves, Bronner P.; Prevots, D. Rebecca] NIAID, Lab Clin Infect Dis, Epidemiol Unit, NIH, Bethesda, MD 20892 USA; [Harrington, Whitney] Seattle Childrens Hosp, Seattle, WA USA; [Harrington, Whitney] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Kurtis, Jonathan D.] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI USA; [Kurtis, Jonathan D.] Brown Univ, Sch Med, Dept Pathol & Lab Med, Providence, RI 02912 USA	Center for Infectious Disease Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Seattle Children's Hospital; University of Washington; University of Washington Seattle; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Duffy, PE (corresponding author), Seattle Biomed Res Inst, MOMS Project, 4 Nickerson St, Seattle, WA 98109 USA.	patrick.duffy@nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Division of Intramural Research (DIR) of NIAID, NIH; NIAID, NIH [R01AI52059]; Bill & Melinda Gates Foundation [29202]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative [1364]; US National Institutes of Health Fogarty International Center (FIC) [D43 TW005509]; FOGARTY INTERNATIONAL CENTER [D43TW005509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001153, R01AI052059, ZIAAI001178] Funding Source: NIH RePORTER	Division of Intramural Research (DIR) of NIAID, NIH; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research (DIR) and the extramural program (grant R01AI52059) of NIAID, NIH; the Bill & Melinda Gates Foundation (grant 29202); the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (grant 1364); the US National Institutes of Health Fogarty International Center (FIC) (grant D43 TW005509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taiar A, 2009, T ROY SOC TROP MED H, V103, P72, DOI 10.1016/j.trstmh.2008.09.010; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Chong SS, 2000, BLOOD, V95, P360; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; CURFS JHAJ, 1990, J EXP MED, V172, P1287, DOI 10.1084/jem.172.5.1287; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Fievet N, 1996, PARASITE IMMUNOL, V18, P483, DOI 10.1046/j.1365-3024.1996.d01-19.x; Fortin A, 2002, HUM MOL GENET, V11, P2469, DOI 10.1093/hmg/11.20.2469; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Hensmann M, 2001, INFECT IMMUN, V69, P2364, DOI 10.1128/IAI.69.4.2364-2371.2001; Hugosson E, 2004, PARASITE IMMUNOL, V26, P111, DOI 10.1111/j.0141-9838.2004.00678.x; Jacobs P, 1996, INFECT IMMUN, V64, P44, DOI 10.1128/IAI.64.1.44-49.1996; Kabyemela ER, 2008, INFECT IMMUN, V76, P1527, DOI 10.1128/IAI.00964-07; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; King CL, 2002, J IMMUNOL, V168, P356, DOI 10.4049/jimmunol.168.1.356; KREMSNER PG, 1995, AM J TROP MED HYG, V53, P532, DOI 10.4269/ajtmh.1995.53.532; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Ly NP, 2007, PEDIATRICS, V119, pE171, DOI 10.1542/peds.2006-0524; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mordmuller BG, 1997, EUR CYTOKINE NETW, V8, P29; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Ouma C, 2008, J INFECT DIS, V198, P1219, DOI 10.1086/592055; PIED S, 1992, J IMMUNOL, V148, P197; Ramharter M, 2004, EUR CYTOKINE NETW, V15, P189; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; ROCKETT KA, 1992, INFECT IMMUN, V60, P3725, DOI 10.1128/IAI.60.9.3725-3730.1992; ROCKETT KA, 1994, AM J TROP MED HYG, V50, P735, DOI 10.4269/ajtmh.1994.50.735; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Thuma PE, 2011, J INFECT DIS, V203, P211, DOI 10.1093/infdis/jiq041; WENISCH C, 1995, CLIN IMMUNOL IMMUNOP, V74, P115, DOI 10.1006/clin.1995.1017; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	43	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77214	10.1371/journal.pone.0077214	http://dx.doi.org/10.1371/journal.pone.0077214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130857	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200069
J	Phillips, C; Hoenigman, R; Higbee, B; Reed, T				Phillips, Caleb; Hoenigman, Rhonda; Higbee, Becky; Reed, Tom			Understanding the Sustainability of Retail Food Recovery	PLOS ONE			English	Article								In this paper we study the simultaneous problems of food waste and hunger in the context of food (waste) rescue and redistribution as a means for mitigating hunger. To this end, we develop an empirical model that can be used in Monte Carlo simulations to study the dynamics of the underlying problem. Our model's parameters are derived from a data set provided by a large food bank and food rescue organization in north central Colorado. We find that food supply is a non-parametric heavy-tailed process that is well modeled with an extreme value peaks over threshold model. Although the underlying process is stochastic, the basic approach of food rescue and redistribution to meet hunger demand appears to be feasible. The ultimate sustainability of this model is intimately tied to the rate at which food expires and hence the ability to preserve and quickly transport and redistribute food. The cost of the redistribution is related to the number and density of participating suppliers. The results show that costs can be reduced (and supply increased) simply by recruiting additional donors to participate. With sufficient funding and manpower, a significant amount of food can be rescued from the waste stream and used to feed the hungry.	[Phillips, Caleb; Hoenigman, Rhonda] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Higbee, Becky] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Reed, Tom] Community Food Share Inc, Niwot, CO USA	University of Colorado System; University of Colorado Boulder; Stanford University	Phillips, C (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	caleb.phillips@colorado.edu						Bloom J., 2010, AM WASTELAND AM THRO; Bureau UC, 2011, 2007 EC CENS SECT 72; Department of Labor: Bureau of Labor Statistics USD, 2011, CAR GUID IND; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Harvest C, 2011, RESCUING FOOD NEW YO; Inc MPR, 2010, TECHNICAL REPORT; Inc SG, 2010, HELP FEED HUNGR 34 Y; Jones TW, 2005, BIOCYCLE, P2; Kantor L. S., 1997, FoodReview, V20, P2; Nord M, 2009, TECHNICAL REPORT; of Agriculture: Economic Research Service USD, 2010, LOSS ADJ FOOD AV; of Agriculture USD, 2011, FOOD SEC US DEF HUNG; Philabundance, 2011, DRIV HUNG OUR COMM	13	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75530	10.1371/journal.pone.0075530	http://dx.doi.org/10.1371/journal.pone.0075530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130716	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200014
J	Zhang, ZF; Cogswell, ME; Gillespie, C; Fang, J; Loustalot, F; Dai, SF; Carriquiry, AL; Kuklina, EV; Hong, YL; Merritt, R; Yang, QH				Zhang, Zefeng; Cogswell, Mary E.; Gillespie, Cathleen; Fang, Jing; Loustalot, Fleetwood; Dai, Shifan; Carriquiry, Alicia L.; Kuklina, Elena V.; Hong, Yuling; Merritt, Robert; Yang, Quanhe			Association between Usual Sodium and Potassium Intake and Blood Pressure and Hypertension among US Adults: NHANES 2005-2010	PLOS ONE			English	Article							DIETARY-SODIUM; NUTRITIONAL FACTORS; RANDOMIZED-TRIALS; SALT INTAKE; CALCIUM; DISEASE; METAANALYSIS; COLLECTION; REDUCTION; EXCRETION	Objectives: Studies indicate high sodium and low potassium intake can increase blood pressure suggesting the ratio of sodium-to-potassium may be informative. Yet, limited studies examine the association of the sodium-to-potassium ratio with blood pressure and hypertension. Methods: We analyzed data on 10,563 participants aged >= 20 years in the 2005-2010 National Health and Nutrition Examination Survey who were neither taking anti-hypertensive medication nor on a low sodium diet. We used measurement error models to estimate usual intakes, multivariable linear regression to assess their associations with blood pressure, and logistic regression to assess their associations with hypertension. Results: The average usual intakes of sodium, potassium and sodium-to-potassium ratio were 3,569 mg/d, 2,745 mg/d, and 1.41, respectively. All three measures were significantly associated with systolic blood pressure, with an increase of 1.04 mmHg (95% CI, 0.27-1.82) and a decrease of 1.24 mmHg (95% CI, 0.31-2.70) per 1,000 mg/d increase in sodium or potassium intake, respectively, and an increase of 1.05 mmHg (95% CI, 0.12-1.98) per 0.5 unit increase in sodium-to-potassium ratio. The adjusted odds ratios for hypertension were 1.40 (95% CI, 1.07-1.83), 0.72 (95% CI, 0.53-0.97) and 1.30 (95% CI, 1.05-1.61), respectively, comparing the highest and lowest quartiles of usual intake of sodium, potassium or sodium-to-potassium ratio. Conclusions: Our results provide population-based evidence that concurrent higher sodium and lower potassium consumption are associated with hypertension.	[Zhang, Zefeng; Cogswell, Mary E.; Gillespie, Cathleen; Fang, Jing; Loustalot, Fleetwood; Dai, Shifan; Kuklina, Elena V.; Hong, Yuling; Merritt, Robert; Yang, Quanhe] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA; [Carriquiry, Alicia L.] Iowa State Univ, Dept Stat, Ames, IA USA	Centers for Disease Control & Prevention - USA; Iowa State University	Zhang, ZF (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA.	zzhang3@cdc.gov	Kuklina, Elena/AAF-3532-2020	Kuklina, Elena/0000-0002-9686-6495; Gillespie, Cathleen/0000-0003-1878-1055	Office of Dietary Supplements, National Institutes of Health [3R01HL091024-02S1]; NSF-PGRP from the National Science Foundation [114139]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091024] Funding Source: NIH RePORTER	Office of Dietary Supplements, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-PGRP from the National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Carriquiry is currently receiving a grant (#3R01HL091024-02S1) from the Office of Dietary Supplements, National Institutes of Health and A GRANT (NSF-PGRP#114139) from the National Science Foundation. For the remaining authors, no funding was declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto Nancy J, 2013, BMJ, V346, pf1378, DOI 10.1136/bmj.f1378; Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; *AM HEART ASS, 2010, HEART DIS STROK STAT, pE19; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; CUTLER JA, 1991, HYPERTENSION, V17, pI27, DOI 10.1161/01.HYP.17.1_Suppl.I27; ELLIOTT P, 1988, BRIT MED J, V297, P319; ELLIOTT P, 1991, HYPERTENSION S1, V17, P3; Elliott P, 2007, CIRCULATION, V116, P1563, DOI 10.1161/CIRCULATIONAHA.106.675579; Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996; Geleijnse JM, 1996, J HYPERTENS, V14, P737, DOI 10.1097/00004872-199606000-00009; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; GRUCHOW HW, 1988, AM J CLIN NUTR, V48, P1463, DOI 10.1093/ajcn/48.6.1463; Guenther PM, 2013, AM J CLIN NUTR, V97, P842, DOI 10.3945/ajcn.112.047779; Guenther PM, 1997, J NUTR, V127, P1106, DOI 10.1093/jn/127.6.1106; Hajjar IM, 2001, ARCH INTERN MED, V161, P589, DOI 10.1001/archinte.161.4.589; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Hedayati SS, 2012, CLIN J AM SOC NEPHRO, V7, P315, DOI 10.2215/CJN.02060311; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huggins CE, 2011, BRIT J NUTR, V105, P248, DOI 10.1017/S0007114510003223; *I MED, 2005, DIET REF INT WAT POT, P546; Joseph ML, 2010, J NUTR, V140, p2094S, DOI 10.3945/jn.110.123588; KESTELOOT H, 1988, HYPERTENSION, V12, P594, DOI 10.1161/01.HYP.12.6.594; KHAW KT, 1988, CIRCULATION, V77, P53, DOI 10.1161/01.CIR.77.1.53; KOK FJ, 1986, AM J EPIDEMIOL, V123, P1043, DOI 10.1093/oxfordjournals.aje.a114332; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu LJ, 2000, HYPERTENS RES, V23, P151, DOI 10.1291/hypres.23.151; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Svetkey LP, 1999, ARCH INTERN MED, V159, P285, DOI 10.1001/archinte.159.3.285; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Tunstall-Pedoe H, 1999, SEMIN NEPHROL, V19, P500; WITTEMAN JCM, 1989, CIRCULATION, V80, P1320, DOI 10.1161/01.CIR.80.5.1320	39	89	92	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75289	10.1371/journal.pone.0075289	http://dx.doi.org/10.1371/journal.pone.0075289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130700	Green Submitted, gold, Green Published			2022-12-27	WOS:000325814200008
J	Aushev, VN; Zborovskaya, IB; Laktionov, KK; Girard, N; Cros, MP; Herceg, Z; Krutovskikh, V				Aushev, Vasily N.; Zborovskaya, Irina B.; Laktionov, Konstantin K.; Girard, Nicolas; Cros, Marie-Pierre; Herceg, Zdenko; Krutovskikh, Vladimir			Comparisons of microRNA Patterns in Plasma before and after Tumor Removal Reveal New Biomarkers of Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CANCER; SERUM; EXPRESSION; PROGNOSIS; IDENTIFICATION; SIGNATURES; ONCOMIRS; SURVIVAL; MIR-205	Lung cancer is the major human malignancy, accounting for 30% of all cancer-related deaths worldwide. Poor survival of lung cancer patients, together with late diagnosis and resistance to classic chemotherapy, highlights the need for identification of new biomarkers for early detection. Among different cancer biomarkers, small non-coding RNAs called microRNAs (miRNAs) are considered the most promising, owing to their remarkable stability, their cancer-type specificity, and their presence in body fluids. However, results of multiple previous attempts to identify circulating miRNAs specific for lung cancer are inconsistent, likely due to two main reasons: prominent variability in blood miRNA content among individuals and difficulties in distinguishing tumor-relevant miRNAs in the blood from their non-tumor counterparts. To overcome these impediments, we compared circulating miRNA profiles in patients with lung squamous cell carcinoma (SCC) before and after tumor removal, assuming that the levels of all tumor-relevant miRNAs would drop after the surgery. Our results revealed a specific panel of the miRNAs (miR-205, -19a, -19b, -30b, and -20a) whose levels decreased strikingly in the blood of patients after lung SCC surgery. Interestingly, miRNA profiling of plasma fractions of lung SCC patients revealed high levels of these miRNA species in tumor-specific exosomes; additionally, some of these miRNAs were also found to be selectively secreted to the medium by cultivated lung cancer cells. These results strengthen the notion that tumor cells secrete miRNA-containing exosomes into circulation, and that miRNA profiling of the exosomal plasma fraction may reveal powerful cancer biomarkers.	[Aushev, Vasily N.; Cros, Marie-Pierre; Herceg, Zdenko; Krutovskikh, Vladimir] Int Agcy Res Canc, Epigenet Unit, F-69372 Lyon, France; [Aushev, Vasily N.; Zborovskaya, Irina B.; Laktionov, Konstantin K.] Russian Acad Med Sci, Carcinogenesis Inst, NN Blokhin Russian Canc Res Ctr, Moscow, Russia; [Girard, Nicolas] Hosp Civils Lyon, Dept Resp Med, Natl Expert Ctr Thym Malignancies, Reference Ctr Orphan Pulm Dis,Louis Pradel Hosp, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; CHU Lyon	Krutovskikh, V (corresponding author), Int Agcy Res Canc, Epigenet Unit, 150 Cours Albert Thomas, F-69372 Lyon, France.	vkrutovskikh@gmail.com	Aushev, Vasily N./A-7209-2008; Girard, Nicolas/ABE-3618-2021; Laktionov, Konstantin K/G-1431-2019	Aushev, Vasily N./0000-0001-8003-358X; Girard, Nicolas/0000-0001-9909-2299; Laktionov, Konstantin K/0000-0003-4469-502X	Russian Foundation for Basic Research [11-04-12097-ofi-m-2011, 12-04-31491]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	VA was supported by Russian Foundation for Basic Research grants (11-04-12097-ofi-m-2011 and 12-04-31491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Cortez Maria Angelica, 2012, Recent Results Cancer Res, V195, P151, DOI 10.1007/978-3-642-28160-0_13; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FAIRBANKS VF, 1992, CLIN CHEM, V38, P132; Hamamoto J, 2013, MOL MED REP, V8, P456, DOI 10.3892/mmr.2013.1517; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jiang M, 2013, MOL CELL BIOCH; Kelly BD, 2013, BJU INT, V111, P17, DOI 10.1111/j.1464-410X.2012.11244.x; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Krutovskikh VA, 2010, BIOESSAYS, V32, P894, DOI 10.1002/bies.201000040; Le HB, 2012, MED ONCOL, V29, P3190, DOI 10.1007/s12032-012-0303-z; Li CL, 2013, P NATL ACAD SCI USA, V110, pE1112, DOI 10.1073/pnas.1302184110; Lin QY, 2013, J SURG ONCOL, V107, P767, DOI 10.1002/jso.23312; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; Ma RM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-38; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qin AY, 2013, EUR J CELL BIOL, V92, P54, DOI 10.1016/j.ejcb.2012.11.002; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Shao CY, 2012, ARCH ORAL BIOL, V57, P1012, DOI 10.1016/j.archoralbio.2012.04.002; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Yao B, 2012, EMBO REP, V13, P1102, DOI 10.1038/embor.2012.160; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575	49	96	102	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e78649	10.1371/journal.pone.0078649	http://dx.doi.org/10.1371/journal.pone.0078649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130905	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900145
J	Balachandran, YL; Girija, S; Selvakumar, R; Tongpim, S; Gutleb, AC; Suriyanarayanan, S				Balachandran, Yekkuni L.; Girija, Shanmugam; Selvakumar, Rajendran; Tongpim, Saowanit; Gutleb, Arno C.; Suriyanarayanan, Sarvajeyakesavalu			Differently Environment Stable Bio-Silver Nanoparticles: Study on Their Optical Enhancing and Antibacterial Properties	PLOS ONE			English	Article							SURFACE-CHARGE; ESCHERICHIA-COLI; GREEN SYNTHESIS; OUTER-MEMBRANE; TOXICITY; STABILITY; RAMAN; SIZE; AGGREGATION; CHEMISTRY	Generally, limited research is extended in studying stability and applicational properties of silver nanoparticles (Ag NPs) synthesized by adopting 'green chemistry' protocol. In this work, we report on the synthesis of stable Ag NPs using plant-derived materials such as leaf extract of Neem (Azadirachta indica) and biopolymer pectin from apple peel. In addition, the applicational properties of Ag NPs such as surface-enhanced Raman scattering (SERS) and antibacterial efficiencies were also investigated. As-synthesized nanoparticles (NPs) were characterized using various instrumentation techniques. Both the plant materials (leaf extract and biopolymer) favored the synthesis of well-defined NPs capped with biomaterials. The NPs were spherical in shape with an average particle size between 14-27 nm. These bio-NPs exhibited colloidal stability in most of the suspended solutions such as water, electrolyte solutions (NaCl; NaNO3), biological solution (bovine serum albumin), and in different pH solutions (pH 7; 9) for a reasonable time period of 120 hrs. Both the bio-NPs were observed to be SERS active through displaying intrinsic SERS signals of the Raman probe molecule (Nile blue A). The NPs were effective against the Escherichia coli bacterium when tested in nutrient broth and agar medium. Scanning and high-resolution transmission electron microscopy (SEM and HRTEM) images confirmed cellular membrane damage of nanoparticle treated E. coli cells. These environmental friendly template Ag NPs can be used as an antimicrobial agent and also for SERS based analytical applications.	[Balachandran, Yekkuni L.; Girija, Shanmugam] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Selvakumar, Rajendran] PSG Inst Adv Studies, Dept Nanobiotechnolgy, Coimbatore, Tamil Nadu, India; [Tongpim, Saowanit] Khon Kaen Univ, Dept Microbiol, Khon Kaen, Thailand; [Gutleb, Arno C.] Ctr Rech Publ Gabriel Lippmann, Dept Environm & Agrobiotechnol, Belvaux, Luxembourg; [Suriyanarayanan, Sarvajeyakesavalu] JSS Univ, Dept Water & Hlth, Mysore, Karnataka, India	Bharathiar University; Khon Kaen University; Luxembourg Institute of Science & Technology; JSS Academy of Higher Education & Research	Suriyanarayanan, S (corresponding author), JSS Univ, Dept Water & Hlth, Mysore, Karnataka, India.	sunsjk@jssuni.edu.in	Gutleb, Arno C./AAK-9182-2021; Sarvajayakesavalu, Suriyanarayanan/W-3608-2019; sarvajayakesavalu, suriyanarayanan/GPF-9996-2022; Yekkuni, Balachandran L/L-3461-2013	Gutleb, Arno C./0000-0001-9725-9112; Sarvajayakesavalu, Suriyanarayanan/0000-0003-3607-8304; Yekkuni, Balachandran L/0000-0003-0050-0999				Alvarez-Puebla RA, 2005, J PHYS CHEM B, V109, P3787, DOI 10.1021/jp045015o; Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x; Auffan M, 2009, ENVIRON POLLUT, V157, P1127, DOI 10.1016/j.envpol.2008.10.002; Chen KL, 2006, LANGMUIR, V22, P10994, DOI 10.1021/la062072v; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L; dos Santos DS, 2005, J MATER CHEM, V15, P3045, DOI 10.1039/b506218g; Doty RC, 2005, CHEM MATER, V17, P4630, DOI 10.1021/cm0508017; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P9004, DOI 10.1021/es901706j; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jacob JA, 2008, LANGMUIR, V24, P528, DOI 10.1021/la702073r; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p; Kong JM, 2008, SYNTH REACT INORG M, V38, P186, DOI 10.1080/15533170801926218; Kumar V, 2009, J CHEM TECHNOL BIOT, V84, P151, DOI 10.1002/jctb.2023; LAWLESS MK, 1992, J CHEM PHYS, V96, P8037, DOI 10.1063/1.462355; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g; Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8617, DOI 10.1021/es8026314; MacCuspie RI, 2011, J ENVIRON MONITOR, V13, P1212, DOI 10.1039/c1em10024f; MAY CD, 1990, CARBOHYD POLYM, V12, P79, DOI 10.1016/0144-8617(90)90105-2; Mukhiddinov ZK, 2000, TALANTA, V53, P171, DOI 10.1016/S0039-9140(00)00456-2; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Parashar UK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/41/415104; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Selvakumar R, 2014, J EXP NANOSCI, V9, P1075, DOI 10.1080/17458080.2013.778425; Shukla R, 2008, SMALL, V4, P1425, DOI 10.1002/smll.200800525; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sriamornsak P., 2003, SILPAKORN U SCI INT, V3, P206, DOI DOI 10.5458/JAG.54.211; Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374; Sutton A, 2009, J POLYM SCI POL CHEM, V47, P4482, DOI 10.1002/pola.23501; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Tielemans M, 2006, PROG ORG COAT, V55, P128, DOI 10.1016/j.porgcoat.2005.08.010; Verwey E.J., 1948, THEORY STABILITY LYO; Zamiri R, 2012, B MATER SCI, V35, P727, DOI 10.1007/s12034-012-0360-0; Zhang W, 2011, ENVIRON SCI TECHNOL, V45, P4422, DOI 10.1021/es104205a	41	35	36	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77043	10.1371/journal.pone.0077043	http://dx.doi.org/10.1371/journal.pone.0077043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130832	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900119
J	Baran, B; Daniels, D; Spencer, RMC				Baran, Bengi; Daniels, Dasha; Spencer, Rebecca M. C.			Sleep-Dependent Consolidation of Value-Based Learning	PLOS ONE			English	Article							MEMORY REACTIVATION; STRATEGIC CONTROL; OLDER-ADULTS; ATTENTION; CHILDREN	It has been suggested that sleep selectively enhances memories with future relevance. Given that sleep's benefits can vary by item within a learning context, the present study investigated whether the amount of sleep-dependent consolidation may vary across items based on the value of the to-be-learned material. For this purpose, we used a value-based learning paradigm in which participants studied words paired with point values. There were two groups; participants either studied the words in the evening and were tested after a 12 hr interval containing a full night of sleep, or studied the words in the morning and were tested after 12 hr of continuous daytime wake. Free recall (F(1,36) = 19.35, p < .001) and recognition accuracy (F(1,36) = 7.59, p = .01) for words were better following sleep relative to wake. However there was no difference in the linear increase in the probability of delayed recall with increasing word value for sleep and wake groups (p = .74). Thus, while encoding may vary with the value of the to-be-learned item, sleep-dependent consolidation does not.	[Baran, Bengi; Spencer, Rebecca M. C.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Daniels, Dasha; Spencer, Rebecca M. C.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Baran, B (corresponding author), Univ Massachusetts, Dept Psychol, Tobin Hall, Amherst, MA 01003 USA.	bbaran@psych.umass.edu		Spencer, Rebecca/0000-0002-8674-2384	Commonwealth College Honors Research Grant; National Institutes of Health [R01 AG040133]; NATIONAL INSTITUTE ON AGING [R01AG040133] Funding Source: NIH RePORTER	Commonwealth College Honors Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by a Commonwealth College Honors Research Grant awarded to D.D. at University of Massachusetts, Amherst. R.M.C.S. and B.B. were supported by National Institutes of Health R01 AG040133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castel AD, 2007, MEM COGNITION, V35, P689, DOI 10.3758/BF03193307; Castel AD, 2011, NEUROPSYCHOLOGY, V25, P15, DOI 10.1037/a0020298; Castel AD, 2009, NEUROPSYCHOLOGY, V23, P297, DOI 10.1037/a0014888; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Davies M., 2010, FREQUENCY DICT CONT; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Oudiette D, 2013, J NEUROSCI, V33, P6672, DOI 10.1523/JNEUROSCI.5497-12.2013; Oudiette D, 2013, TRENDS COGN SCI, V17, P142, DOI 10.1016/j.tics.2013.01.006; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; R Development Core Team, 2011, R LANG ENV STAT COMP; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Spencer R.M.C., 2013, ISRN PHYSL, V71, P233, DOI [10.1155/2013/619319, DOI 10.1155/2013/619319]; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	26	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75326	10.1371/journal.pone.0075326	http://dx.doi.org/10.1371/journal.pone.0075326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130703	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900030
J	Bernardi, C; Soffientini, U; Piacente, F; Tonetti, MG				Bernardi, Cinzia; Soffientini, Ugo; Piacente, Francesco; Tonetti, Michela G.			Effects of MicroRNAs on Fucosyltransferase 8 (FUT8) Expression in Hepatocarcinoma Cells	PLOS ONE			English	Article							CORE FUCOSYLATION; GROWTH; CARCINOMA	Fucosyltransferase 8 (FUT8) catalyzes the transfer of alpha 1,6-linked fucose to the first N-acetylglucosamine in N-linked glycans (core fucosylation). Increased core fucosylation has been reported during hepatocarcinogenesis, in both cell-associated and secreted proteins. Accordingly, increased core fucosylation of alpha-fetoprotein and alpha 1-antitrypsin is currently used as a diagnostic and prognostic indicator. The present study provides new evidences that FUT8 can be regulated also through miRNA-mediated mechanisms. Using microRNA/target prediction programs, we identified miR-122 and miR-34a seed regions in the 3' untranslated region (3'UTR) of FUT8. Then we used human and rodents hepatocarcinoma cell lines to evaluate the impact of transfection of miR-122 and miR-34a mimics on FUT8 mRNA and protein levels. This study demonstrated that forced expression of these miRNAs is able to induce a decrease of FUT8 levels and also to affect core fucosylation of secreted proteins. The ability of miR-122 and miR-34a to specifically interact with and regulate the 3'UTR of FUT8 was demonstrated via a luciferase reporter assay. Since miR-122 and miR-34a downregulation is a common feature in spontaneous human hepatocarcinoma, our finding that these miRNAs are able to target FUT8 3'UTR suggests that, together with transcriptional and other post-transcriptional systems, a miRNA-mediated mechanism could also be involved in the increased core fucosylation observed in liver tumors. Moreover, these findings also point out that miRNAs may be widely involved in the regulation of glycosylation machinery.	[Tonetti, Michela G.] Univ Genoa, Dept Expt Med, Genoa, Italy; Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy	University of Genoa; University of Genoa	Tonetti, MG (corresponding author), Univ Genoa, Dept Expt Med, Genoa, Italy.	tonetti@unige.it	Tonetti, Michela/F-3039-2018; Bernardi, Cinzia/K-3416-2018; TONETTI, MICHELA/AAF-3404-2021; Piacente, Francesco/J-8295-2016	Bernardi, Cinzia/0000-0001-9342-5929; TONETTI, MICHELA/0000-0002-8829-7173; Piacente, Francesco/0000-0001-5470-5987; Soffientini, Ugo/0000-0001-9676-4803	Regione Liguria [Progetto di Ricerca Sanitaria Regionale]; Regione Liguria [P.O. C.R.O. FSE, Asse IV Capitale umano]	Regione Liguria [Progetto di Ricerca Sanitaria Regionale]; Regione Liguria [P.O. C.R.O. FSE, Asse IV Capitale umano]	This work was supported in part by Regione Liguria [Progetto di Ricerca Sanitaria Regionale 2009]. C. B. was supported by a PhD fellowship from Regione Liguria [P.O. C.R.O. FSE 2007-2013, Asse IV Capitale umano]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Cheng J, 2010, PROTEOMICS, V10, P1557, DOI 10.1002/pmic.200900646; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Ito Y, 2003, CANCER LETT, V200, P167, DOI 10.1016/S0304-3835(03)00383-5; Jansson MD, 2010, MOL ONCOL, V30, P1; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Matsumoto K, 2008, CANCER SCI, V99, P1611, DOI 10.1111/j.1349-7006.2008.00847.x; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Sturla L, 2005, GLYCOBIOLOGY, V15, P924, DOI 10.1093/glycob/cwi081; Takahashi M, 1999, CARBOHYD RES, V344, P1387; Takahashi T, 2000, INT J CANCER, V88, P914, DOI 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200	22	53	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76540	10.1371/journal.pone.0076540	http://dx.doi.org/10.1371/journal.pone.0076540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130780	Green Submitted, gold, Green Published			2022-12-27	WOS:000325810900076
J	Cangi, N; Horak, IG; Apanaskevich, DA; Matthee, S; das Neves, LCBG; Estrada-Pena, A; Matthee, CA				Cangi, Nidia; Horak, Ivan G.; Apanaskevich, Dmitry A.; Matthee, Sonja; das Neves, Luis C. B. G.; Estrada-Pena, Agustin; Matthee, Conrad A.			The Influence of Interspecific Competition and Host Preference on the Phylogeography of Two African Ixodid Tick Species	PLOS ONE			English	Article							GENUS HYALOMMA KOCH; SOUTH-AFRICA; WILD ANIMALS; AMBLYOMMA-HEBRAEUM; LIFE-CYCLE; RICKETTSIA-AFRICAE; POPULATION-GROWTH; GENETIC DIVERSITY; EASTERN TRANSVAAL; ACARI IXODIDAE	A comparative phylogeographic study on two economically important African tick species, Amblyomma hebraeum and Hyalomma rufipes was performed to test the influence of host specificity and host movement on dispersion. Pairwise AMOVA analyses of 277 mtDNA COI sequences supported significant population differentiation among the majority of sampling sites. The geographic mitochondrial structure was not supported by nuclear ITS-2 sequencing, probably attributed to a recent divergence. The three-host generalist, A. hebraeum, showed less mtDNA geographic structure, and a lower level of genetic diversity, while the more host-specific H. rufipes displayed higher levels of population differentiation and two distinct mtDNA assemblages (one predominantly confined to South Africa/Namibia and the other to Mozambique and East Africa). A zone of overlap is present in southern Mozambique. A mechanistic climate model suggests that climate alone cannot be responsible for the disruption in female gene flow. Our findings furthermore suggest that female gene dispersal of ticks is more dependent on the presence of juvenile hosts in the environment than on the ability of adult hosts to disperse across the landscape. Documented interspecific competition between the juvenile stages of H. rufipes and H. truncatum is implicated as a contributing factor towards disrupting gene flow between the two southern African H. rufipes genetic assemblages.	[Cangi, Nidia; Matthee, Conrad A.] Univ Stellenbosch, Evolutionary Genom Grp, Dept Bot & Zool, Matieland, South Africa; [Horak, Ivan G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Apanaskevich, Dmitry A.] Georgia So Univ, US Natl Tick Collect, James H Oliver Jr Inst Coastal Plain Sci, Statesboro, GA 30460 USA; [Matthee, Sonja] Univ Stellenbosch, Dept Conservat Ecol & Entomol, Matieland, South Africa; [das Neves, Luis C. B. G.] Eduardo Mondlane Univ, Ctr Biotecnol UEM, Maputo, Mozambique; [das Neves, Luis C. B. G.] Eduardo Mondlane Univ, Fac Vet, Maputo, Mozambique; [Estrada-Pena, Agustin] Fac Vet, Dept Parasitol, Zaragoza, Zaragoza, Spain	Stellenbosch University; University of Pretoria; University System of Georgia; Georgia Southern University; Stellenbosch University; Eduardo Mondlane University; Eduardo Mondlane University	Matthee, CA (corresponding author), Univ Stellenbosch, Evolutionary Genom Grp, Dept Bot & Zool, Matieland, South Africa.	cam@sun.ac.za	Matthee, Conrad A./B-1620-2012	Matthee, Conrad A./0000-0002-6836-069X; Matthee, Sonja/0000-0001-7289-6262; Neves, Luis/0000-0002-5435-5996; Estrada Pena, Agustin/0000-0001-7483-046X	National Research Foundation (NRF); South African Biosystematics Initiative (SABI); Stellenbosch University; South African National Research Foundation	National Research Foundation (NRF); South African Biosystematics Initiative (SABI); Stellenbosch University; South African National Research Foundation(National Research Foundation - South Africa)	The National Research Foundation (NRF), South African Biosystematics Initiative (SABI) and Stellenbosch University are thanked for financial support. There was a South African National Research Foundation grant to Conrad Matthee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; ANDREW HR, 1989, VET PARASITOL, V34, P261, DOI 10.1016/0304-4017(89)90056-3; [Anonymous], GUIDE IDENTIFICATION; Apanaskevich DA, 2006, ONDERSTEPOORT J VET, V73, P1; Apanaskevich DA, 2008, INT J ACAROL, V34, P13, DOI 10.1080/01647950808683704; Barker SC, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P1, DOI 10.1017/CBO9780511551802.002; Barker SC, 2002, EXP APPL ACAROL, V28, P55, DOI 10.1023/A:1025333830086; Berkvens DL, 1998, MED VET ENTOMOL, V12, P234, DOI 10.1046/j.1365-2915.1998.00106.x; BOOMKER J, 1992, ONDERSTEPOORT J VET, V59, P175; BROWN SJ, 1988, VET PARASITOL, V28, P245, DOI 10.1016/0304-4017(88)90112-4; Chen Z, 2012, EXP APPL ACAROL, V56, P85, DOI 10.1007/s10493-011-9490-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cumming GS, 1999, B ENTOMOL RES, V89, P303, DOI 10.1017/S0007485399000450; Cumming GS, 2002, ECOLOGY, V83, P255, DOI 10.1890/0012-9658(2002)083[0255:CCAVAL]2.0.CO;2; de Meeus T, 2002, TRENDS PARASITOL, V18, P247, DOI 10.1016/S1471-4922(02)02269-9; Deem SL, 1998, J ZOO WILDLIFE MED, V29, P109; DEVOS AJ, 1981, ONDERSTEPOORT J VET, V48, P1; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Estrada-Pena A, 2008, VET PARASITOL, V151, P256, DOI 10.1016/j.vetpar.2007.11.014; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fielden LJ, 1996, EXP APPL ACAROL, V20, P625, DOI 10.1007/BF00053326; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FOURIE LJ, 1991, J S AFR VET ASSOC, V62, P104; Fu YX, 1997, GENETICS, V147, P915; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Gylfe A, 2001, HEREDITAS, V134, P195, DOI 10.1111/j.1601-5223.2001.00195.x; Hall TA, 2005, BIOEDIT V7 0 5; Hasle G, 2009, ONDERSTEPOORT J VET, V76, P167; Horak IG, 2007, ONDERSTEPOORT J VET, V74, P231; HORAK IG, 1992, ONDERSTEPOORT J VET, V59, P259; HORAK IG, 1991, ONDERSTEPOORT J VET, V58, P125; HORAK IG, 1991, ONDERSTEPOORT J VET, V58, P261; HORAK IG, 1982, ONDERSTEPOORT J VET, V49, P85; Horak IG, 2002, EXP APPL ACAROL, V27, P113, DOI 10.1023/A:1021587001198; HORAK IG, 1987, J S AFR VET ASSOC, V58, P15; HORAK IG, 1995, ONDERSTEPOORT J VET, V62, P123; HORAK IG, 1993, ONDERSTEPOORT J VET, V60, P163; Kain DE, 1999, HEREDITY, V83, P378, DOI 10.1038/sj.hdy.6886110; Kelly PJ, 1996, INT J SYST BACTERIOL, V46, P611, DOI 10.1099/00207713-46-2-611; Kelly PJ, 2001, J S AFR VET ASSOC, V72, P182; Kempf F, 2010, INFECT GENET EVOL, V10, P989, DOI 10.1016/j.meegid.2010.06.003; Kempf F, 2009, MOL ECOL, V18, P4450, DOI 10.1111/j.1365-294X.2009.04356.x; Krakowetz CN, 2010, J VECTOR ECOL, V35, P163, DOI 10.1111/j.1948-7134.2010.00043.x; KUHNERT F, 1995, INT J PARASITOL, V25, P887, DOI 10.1016/0020-7519(95)00009-Q; Labruna MB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-46; LAWRENCE JA, 1979, J S AFR VET ASSOC, V50, P311; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohman DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-301; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Matthee CA, 2002, MOL ECOL, V11, P465, DOI 10.1046/j.0962-1083.2001.01458.x; McCoy KD, 2003, EVOLUTION, V57, P288, DOI 10.1111/j.0014-3820.2003.tb00263.x; Mitchell M, 1996, TROP ANIM HEALTH PRO, V28, pS53, DOI 10.1007/BF02310700; Mixson Tonya R., 2004, Acta Zoologica Sinica, V50, P176; Mixson TR, 2006, J VECTOR ECOL, V31, P181, DOI 10.3376/1081-1710(2006)31[181:ITPSAD]2.0.CO;2; Morand S., 2010, BIOGEOGRAPHY HOST PA; Mtshali MS, 2007, ZOONOSES PUBLIC HLTH, V54, P23, DOI 10.1111/j.1863-2378.2007.00998.x; Needham G.R., 1986, P100; Norval R. A. I., 2004, Infectious diseases of livestock, Volume One, P3; Norval RAI, 1983, VET J, V23, P1; Norval RAI, 1984, ACAROLOGY; Noureddine R, 2011, INT J PARASITOL, V41, P183, DOI 10.1016/j.ijpara.2010.08.010; Parola P, 2001, EMERG INFECT DIS, V7, P1014, DOI 10.3201/eid0706.010616; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Porretta D, 2013, MOL ECOL, V22, P1666, DOI 10.1111/mec.12203; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Qiu WG, 2002, GENETICS, V160, P833; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; RAHMAN MH, 1984, FOLIA PARASIT, V31, P63; RECHAV Y, 1987, J MED ENTOMOL, V24, P575, DOI 10.1093/jmedent/24.5.575; RECHAV Y, 1987, EXP APPL ACAROL, V3, P219, DOI 10.1007/BF01270458; RECHAV Y, 1990, ONDERSTEPOORT J VET, V57, P7; Rees DJ, 2003, MOL PHYLOGENET EVOL, V27, P131, DOI 10.1016/S1055-7903(02)00374-3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Song S, 2011, INT J PARASITOL, V41, P871, DOI 10.1016/j.ijpara.2011.03.008; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; Uys AC, 2005, ONDERSTEPOORT J VET, V72, P339; Van Niekerk DJ, 2006, ONDERSTEPOORT J VET, V73, P123; WALKER JB, 1984, ONDERSTEPOORT J VET, V51, P171	88	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76930	10.1371/journal.pone.0076930	http://dx.doi.org/10.1371/journal.pone.0076930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130813	Green Published, gold			2022-12-27	WOS:000325810900107
J	Dean, AS; Fournie, G; Kulo, AE; Boukaya, GA; Schelling, E; Bonfoh, B				Dean, Anna S.; Fournie, Guillaume; Kulo, Abalo E.; Boukaya, G. Aboudou; Schelling, Esther; Bonfoh, Bassirou			Potential Risk of Regional Disease Spread in West Africa through Cross-Border Cattle Trade	PLOS ONE			English	Article							TRANSMISSION; RINDERPEST; MOVEMENTS; DYNAMICS; PATTERNS; NETWORK; MODEL	Background: Transboundary animal movements facilitate the spread of pathogens across large distances. Cross-border cattle trade is of economic and cultural importance in West Africa. This study explores the potential disease risk resulting from large-scale, cross-border cattle trade between Togo, Burkina Faso, Ghana, Benin, and Nigeria for the first time. Methods and Principal Findings: A questionnaire-based survey of livestock movements of 226 cattle traders was conducted in the 9 biggest cattle markets of northern Togo in February-March 2012. More than half of the traders (53.5%) operated in at least one other country. Animal flows were stochastically simulated based on reported movements and the risk of regional disease spread assessed. More than three quarters (79.2%, range: 78.1-80.0%) of cattle flowing into the market system originated from other countries. Through the cattle market system of northern Togo, non-neighbouring countries were connected via potential routes for disease spread. Even for diseases with low transmissibility and low prevalence in a given country, there was a high risk of disease introduction into other countries. Conclusions: By stochastically simulating data collected by interviewing cattle traders in northern Togo, this study identifies potential risks for regional disease spread in West Africa through cross-border cattle trade. The findings highlight that surveillance for emerging infectious diseases as well as control activities targeting endemic diseases in West Africa are likely to be ineffective if only conducted at a national level. A regional approach to disease surveillance, prevention and control is essential.	[Dean, Anna S.; Schelling, Esther] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Dean, Anna S.; Schelling, Esther] Univ Basel, Basel, Switzerland; [Fournie, Guillaume] Univ London, Royal Vet Coll, Dept Vet Clin Sci, London WC1E 7HU, England; [Kulo, Abalo E.] Univ Lome, Ecole Super Agron, Lome, Togo; [Boukaya, G. Aboudou] Minist Agr Elevage & Peche, Direct Elevage, Lome, Togo; [Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; University of London Royal Veterinary College	Schelling, E (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	esther.schelling@unibas.ch	Schelling, Esther/K-7990-2015	Schelling, Esther/0000-0001-6444-0898; Fournie, Guillaume/0000-0002-6998-1201; Dean, Anna/0000-0002-9539-7164	National Center of Competence in Research North-South (NCCR North-South) in Switzerland	National Center of Competence in Research North-South (NCCR North-South) in Switzerland	This study was funded by the National Center of Competence in Research North-South (NCCR North-South) in Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; de Haan L, 1999, AFR STUD CTR RES SER, V15, P205; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; FAO/OIE, 2012, GLOB FOOT MOUTH DIS; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Fournie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037986; Hutchinson OC, 2003, LANCET INFECT DIS, V3, P42, DOI 10.1016/S1473-3099(03)00488-2; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kerr J, 2010, WORKING TRADERS UNDE, P59; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kulo A, 2011, B ANIMAL HLTH PRODUC, V59; Ly I, 2007, SEMINAIRE FORMATION; Mariner JC, 2006, PREV VET MED, V73, P55, DOI 10.1016/j.prevetmed.2005.09.001; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Perry BD, 2013, P NATL ACAD SCI USA, V110, P20871, DOI 10.1073/pnas.1012953108; R Development Core Team, 2012, R LANG ENV STAT COMP; Schwarzer G., 2012, META METAANALYSIS R; Tempia S, 2010, REV SCI TECH OIE, V29, P497, DOI 10.20506/rst.29.3.1996; The Pirbright Institute, 2012, FOOT AND MOUTH DIS; Tounkara K, 2012, FAO OIE GLOB C FOOT; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Williams T.O., 2006, IMPROVING LIVESTOCK	24	35	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75570	10.1371/journal.pone.0075570	http://dx.doi.org/10.1371/journal.pone.0075570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130721	Green Published, Green Accepted, gold			2022-12-27	WOS:000325810900042
J	Lee, CW; Cheng, TM; Lin, CP; Pan, JP				Lee, Chin-Wei; Cheng, Tsai-Mu; Lin, Chih-Pei; Pan, Ju-Pin			Plasma Haptoglobin Concentrations Are Elevated in Patients with Coronary Artery Disease	PLOS ONE			English	Article							HEART-DISEASE; RISK FACTOR; POLYMORPHISM; INFLAMMATION; PHENOTYPE; GENOTYPE; PURIFICATION; INDIVIDUALS; DETERMINANT; MORTALITY	Inflammation underlies the development and progression of coronary artery plaques. Haptoglobin (Hp) is an acute phase protein, the synthesis of which is increased during inflammation. The aim of this study was to investigate plasma Hp concentrations and phenotype in patients with coronary artery disease (CAD). We recruited 359 patients with fixed luminal stenosis >= 50% in at least one coronary artery (CAD group) and 83 patients with luminal stenosis <= 40%, normal ejection fraction, and normal regional wall motion (control group). Plasma Hp concentrations were measured using a phenotype-specific enzyme-linked immunosorbent assay. Hp phenotype was determined by native polyacrylamide gel electrophoresis. Plasma lipid concentrations were measured. Plasma Hp concentrations were significantly higher in the CAD compared with the control group (262.4 +/- 144.2 vs 176.0 +/- 86.7 ng/mL, P<0.001); however, there was no between group difference in the distribution of Hp phenotype (1-1 = 7.5% vs 7.2%; 2-1 = 40.4% vs 42.2%; 2-2 = 52.1% vs 50.6%). Stepwise multivariate logistic regression revealed that high Hp concentrations (odds ratio [OR] = 5.865), male sex (OR = 3.689), hypertension (OR = 2.632), diabetes mellitus (OR = 3.300), and low-density lipoprotein concentrations (OR = 1.480) were independently associated with CAD (all P<0.05). Hp phenotype was not associated with CAD. Plasma Hp concentrations were significantly correlated with the severity of luminal stenosis (r = 0.236, P<0.001). Our findings suggest that plasma Hp concentrations may be elevated in patients with CAD. There does not appear to be any relationship between Hp phenotype and CAD.	[Lee, Chin-Wei] Taipei Vet Gen Hosp, Tao Yuan Branch, Dept Med, Div Cardiol, Tao Yuan, Taiwan; [Cheng, Tsai-Mu] Taipei Med Univ, Coll Med & Technol, Grad Inst Translat Med, Taipei, Taiwan; [Lin, Chih-Pei] Taipei Vet Gen Hosp, Biochem Sect, Dept Pathol & Lab Med, Taipei, Taiwan; [Lin, Chih-Pei] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Pan, Ju-Pin] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Pan, Ju-Pin] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Pan, JP (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.	jppan@vghtpe.gov.tw			Taipei Veterans General Hospital Taiwan, ROC [VGH92-356, VGH94-210]	Taipei Veterans General Hospital Taiwan, ROC(Taipei Veterans General Hospital)	This study was supported by grants from the Taipei Veterans General Hospital (VGH92-356 and VGH94-210, [J.P.P]) Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Austen W G, 1975, Circulation, V51, P5; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Cheng TM, 2007, CLIN BIOCHEM, V40, P1045, DOI 10.1016/j.clinbiochem.2007.04.018; De Bacquer D, 2001, ATHEROSCLEROSIS, V157, P161, DOI 10.1016/S0021-9150(00)00690-0; Delanghe J, 1999, ATHEROSCLEROSIS, V145, P287, DOI 10.1016/S0021-9150(99)00079-9; Delanghe JR, 2011, ATHEROSCLEROSIS, V217, P80, DOI 10.1016/j.atherosclerosis.2011.03.031; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hamirani YS, 2008, ATHEROSCLEROSIS, V201, P1, DOI 10.1016/j.atherosclerosis.2008.04.045; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Holme I, 2009, ANN MED, V41, P522, DOI 10.1080/07853890903089453; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois MR, 1996, CLIN CHEM, V42, P1589; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Levy AP, 2000, NEW ENGL J MED, V343, P969, DOI 10.1056/NEJM200009283431313; Levy AP, 2004, ATHEROSCLEROSIS, V172, P361, DOI 10.1016/j.atherosclerosis.2003.10.014; Levy AP, 2002, J AM COLL CARDIOL, V40, P1984, DOI 10.1016/S0735-1097(02)02534-2; Liau CY, 2003, J CHROMATOGR B, V790, P209, DOI 10.1016/S1570-0232(03)00128-4; McPherson R, 2012, CAN J CARDIOL, V28, P662, DOI 10.1016/j.cjca.2012.05.014; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Moreno PR, 2008, J AM COLL CARDIOL, V52, P1049, DOI 10.1016/j.jacc.2008.06.029; MORIMATSU M, 1991, J BIOL CHEM, V266, P11833; Pan JP, 2011, J VASC SURG, V53, P1189, DOI 10.1016/j.jvs.2010.10.122; Roguin A, 2003, DIABETES CARE, V26, P2628, DOI 10.2337/diacare.26.9.2628; Staals J, 2008, CURR NEUROVASC RES, V5, P153, DOI 10.2174/156720208785425675; Suleiman M, 2005, DIABETES, V54, P2802, DOI 10.2337/diabetes.54.9.2802; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; Tseng CF, 2004, PROTEIN EXPRES PURIF, V33, P265, DOI 10.1016/j.pep.2003.09.006; Wilson PWF, 2008, AM J MED, V121, P15, DOI 10.1016/j.amjmed.2008.06.012	30	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76817	10.1371/journal.pone.0076817	http://dx.doi.org/10.1371/journal.pone.0076817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130793	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900088
J	Lemak, A; Yee, A; Wu, H; Yap, D; Zeng, H; Dombrovski, L; Houliston, S; Aparicio, S; Arrowsmith, CH				Lemak, Alexander; Yee, Adelinda; Wu, Hong; Yap, Damian; Zeng, Hong; Dombrovski, Ludmila; Houliston, Scott; Aparicio, Samuel; Arrowsmith, Cheryl H.			Solution NMR Structure and Histone Binding of the PHD Domain of Human MLL5	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; LINEAGE LEUKEMIA 5; AUTOIMMUNE REGULATOR; PROTEIN STRUCTURES; GENE-EXPRESSION; FINGER; METHYLATION; RECOGNITION; CONTRIBUTES; HOMOLOG	Mixed Lineage Leukemia 5 (MLL5) is a histone methyltransferase that plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. In addition to its catalytic domain, MLL5 contains a PHD finger domain, a protein module that is often involved in binding to the N-terminus of histone H3. Here we report the NMR solution structure of the MLL5 PHD domain showing a variant of the canonical PHD fold that combines conserved H3 binding features from several classes of other PHD domains (including an aromatic cage) along with a novel C-terminal alpha-helix, not previously seen. We further demonstrate that the PHD domain binds with similar affinity to histone H3 tail peptides di- and tri-methylated at lysine 4 (H3K4me2 and H3K4me3), the former being the putative product of the MLL5 catalytic reaction. This work establishes the PHD domain of MLL5 as a bone fide 'reader' domain of H3K4 methyl marks suggesting that it may guide the spreading or further methylation of this site on chromatin.	[Lemak, Alexander; Yee, Adelinda; Houliston, Scott] Northeast Struct Genom Consortium, Toronto, ON, Canada; [Lemak, Alexander; Yee, Adelinda; Houliston, Scott] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Wu, Hong; Zeng, Hong; Dombrovski, Ludmila] Univ Toronto, Struct Genom Consortium, Toronto, ON M5S 1A1, Canada; [Yap, Damian; Aparicio, Samuel] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Inst Canc, Toronto, ON M5S 1A1, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Structural Genomics Consortium; British Columbia Cancer Agency; University of Toronto; University of Toronto		carrow@uhnres.utoronto.ca		Yap, Damian/0000-0002-5370-4592; Aparicio, Samuel/0000-0002-0487-9599; Arrowsmith, Cheryl/0000-0002-4971-3250	National Institutes of Health through Northeast Structural Genomics Consortium [U54 GM094597]; Natural Sciences and Engineering Research Council of Canada; Structural Genomics Consortium which is a registered charity [1097737]; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research (CIHR); Genome Canada through the Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health through Northeast Structural Genomics Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Structural Genomics Consortium which is a registered charity; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health through Northeast Structural Genomics Consortium (U54 GM094597), the Natural Sciences and Engineering Research Council of Canada, and the Structural Genomics Consortium which is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, Canada Foundation for Innovation, the Canadian Institutes for Health Research (CIHR), Genome Canada through the Ontario Genomics Institute [OGI-055], GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; Cheng F, 2011, ONCOGENE, V30, P3599, DOI 10.1038/onc.2011.71; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; GODDARD TD, 2003, SPARKY NMR ASSIGNMEN; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu J, 2012, J CELL SCI, V125, P4676, DOI 10.1242/jcs.110411; Liu J, 2010, J BIOL CHEM, V285, P20904, DOI 10.1074/jbc.M109.098558; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhou PP, 2013, J BIOL CHEM, V288, P17532, DOI 10.1074/jbc.M112.439729	47	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77020	10.1371/journal.pone.0077020	http://dx.doi.org/10.1371/journal.pone.0077020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130829	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900117
J	Sisay, S; Pryce, G; Jackson, SJ; Tanner, C; Ross, RA; Michael, GJ; Selwood, DL; Giovannoni, G; Baker, D				Sisay, Sofia; Pryce, Gareth; Jackson, Samuel J.; Tanner, Carolyn; Ross, Ruth A.; Michael, Gregory J.; Selwood, David L.; Giovannoni, Gavin; Baker, David			Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; ACID-AMIDE-HYDROLASE; CANNABINOID RECEPTOR; C57BL/6 MICE; BIOZZI ABH; TNF-ALPHA; 17 CELLS; T-CELLS; SUSCEPTIBILITY	Endocannabinoids and some phytocannabinoids bind to CB1 and CB2 cannabinoid receptors, transient receptor potential vanilloid one (TRPV1) receptor and the orphan G protein receptor fifty-five (GPR55). Studies using C57BL/10 and C57BL/6 (Cnr2(tm1Zim)) CB2 cannabinoid receptor knockout mice have demonstrated an immune-augmenting effect in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis. However, other EAE studies in Biozzi ABH mice often failed to show any treatment effect of either CB2 receptor agonism or antagonism on inhibition of T cell autoimmunity. The influence of genetic background on the induction of EAE in endocannabinoid system-related gene knockout mice was examined. It was found that C57BL/6. GPR55 knockout mice developed less severe disease, notably in female mice, following active induction with myelin oligodendrocyte glycoprotein 35-55 peptide. In contrast C57BL/6. CB2 (Cnr2(Dgen)) receptor knockout mice developed augmented severity of disease consistent with the genetically and pharmacologically-distinct, Cnr2(tm1Zim) mice. However, when the knockout gene was bred into the ABH mouse background and EAE induced with spinal cord autoantigens the immune-enhancing effect of CB2 receptor deletion was lost. Likewise CB1 receptor and transient receptor potential vanilloid one knockout mice on the ABH background demonstrated no alteration in immune-susceptibility, in terms of disease incidence and severity of EAE, in contrast to that reported in some C57BL/6 mouse studies. Furthermore the immune-modulating influence of GPR55 was marginal on the ABH mouse background. Whilst sedative doses of tetrahydrocannabinol could induce immunosuppression, this was associated with a CB1 receptor rather than a CB2 receptor-mediated effect. These data support the fact that non-psychoactive doses of medicinal cannabis have a marginal influence on the immune response in MS. Importantly, it adds a note of caution for the translational value of some transgenic/gene knockout and other studies on low-EAE susceptibility backgrounds with inconsistent disease course and susceptibility.	[Sisay, Sofia; Pryce, Gareth; Jackson, Samuel J.; Michael, Gregory J.; Giovannoni, Gavin; Baker, David] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Tanner, Carolyn; Ross, Ruth A.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland; [Ross, Ruth A.] Univ Toronto, Toronto, ON, Canada; [Selwood, David L.] UCL, Wolfson Inst Biomed Res, London, England	University of London; Queen Mary University London; University of Aberdeen; University of Toronto; University of London; University College London	Baker, D (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England.	david.baker@qmul.ac.uk	Ross, R./AAG-7468-2019	Selwood, David/0000-0002-6817-5064	Multiple Sclerosis Society of Great Britain and Northern Ireland; Wellcome Trust; MRC [MC_PC_13037] Funding Source: UKRI	Multiple Sclerosis Society of Great Britain and Northern Ireland; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Multiple Sclerosis Society of Great Britain and Northern Ireland and The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; ALLEN SJ, 1993, CELL IMMUNOL, V146, P335, DOI 10.1006/cimm.1993.1031; AMOR S, 1994, J IMMUNOL, V153, P4349; Amor S, 2005, J NEUROIMMUNOL, V165, P1, DOI 10.1016/j.jneuroim.2005.04.010; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; BAKER D, 1995, J IMMUNOL, V155, P4046; Baker D, 2012, MULT SCLER RELAT DIS, V1, P64, DOI 10.1016/j.msard.2011.11.001; Baker D, 2012, J NEUROIMMUNOL, V242, P78, DOI 10.1016/j.jneuroim.2011.11.003; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; BOLTON C, 2013, INFLAMM RES, P3993; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Croxford JL, 1997, J NEUROIMMUNOL, V74, P205, DOI 10.1016/S0165-5728(96)00219-6; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de Lago E, 2012, NEUROPHARMACOLOGY, V62, P2299, DOI 10.1016/j.neuropharm.2012.01.030; Delarasse C, 2003, GLIA, P67; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; Disanto G, 2012, HUM MOL GENET, V21, P3575, DOI 10.1093/hmg/dds189; Docagne F, 2007, MOL CELL NEUROSCI, V34, P551, DOI 10.1016/j.mcn.2006.12.005; Encinas JA, 1996, J IMMUNOL, V157, P2186; FESTING MFW, 1993, J EXP ANIM SCI, V35, P210; Fillmore PD, 2004, AM J PATHOL, V164, P167, DOI 10.1016/S0002-9440(10)63107-0; Graves RS, 2011, MULT SCLER J, V17, pS431; Hoi PM, 2007, BRIT J PHARMACOL, V152, P751, DOI 10.1038/sj.bjp.0707470; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Karlsson J, 2003, J IMMUNOL, V170, P1019, DOI 10.4049/jimmunol.170.2.1019; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Katona S, 2005, CLIN EXP IMMUNOL, V140, P580, DOI 10.1111/j.1365-2249.2005.02803.x; Kozela E, 2011, BRIT J PHARMACOL, V163, P1507, DOI 10.1111/j.1476-5381.2011.01379.x; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; LEVINE S, 1973, J IMMUNOL, V110, P139; Li K, 2013, PANCREAS, V42, P123, DOI 10.1097/MPA.0b013e318259f6f0; Lou ZY, 2011, MOL IMMUNOL, V49, P453, DOI 10.1016/j.molimm.2011.09.016; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; McHugh Douglas, 2012, J Mol Signal, V7, P10, DOI 10.1186/1750-2187-7-10; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Montero E, 2004, J AUTOIMMUN, V23, P1, DOI 10.1016/j.jaut.2004.05.001; Musumeci G, 2011, NEUROBIOL DIS, V43, P669, DOI 10.1016/j.nbd.2011.05.018; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Okuda Y, 2002, IMMUNOL LETT, V81, P25, DOI 10.1016/S0165-2478(01)00339-X; Olsson LM, 2012, EUR J IMMUNOL, V42, P1969, DOI 10.1002/eji.201242601; ONEILL JK, 1993, J NEUROIMMUNOL, V45, P1, DOI 10.1016/0165-5728(93)90157-T; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; PALTSER G, 2013, MOL MED, DOI DOI 10.2119/M0LMED.2012.00329.PUBMED:23689362; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P1242, DOI 10.1016/j.bbi.2011.03.017; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Shetty A, 2012, NEUROLOGY, V78; Slingsby JH, 1996, IMMUNOGENETICS, V43, P72; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Spach KM, 2009, J IMMUNOL, V182, P1789, DOI 10.4049/jimmunol.0803200; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; TEUSCHER C, 1987, CELL IMMUNOL, V110, P294, DOI 10.1016/0008-8749(87)90124-9; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Webb M, 2008, NEUROSCI LETT, V439, P106, DOI 10.1016/j.neulet.2008.04.090; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Wotherspoon G, 2005, NEUROSCIENCE, V135, P235, DOI 10.1016/j.neuroscience.2005.06.009; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Wu FL, 2010, HISTOCHEM CELL BIOL, V133, P313, DOI 10.1007/s00418-009-0673-2; Zajicek JP, 2012, J NEUROL NEUROSUR PS, V83, P1125, DOI 10.1136/jnnp-2012-302468; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zurita E, 2011, TRANSGENIC RES, V20, P481, DOI 10.1007/s11248-010-9403-8	81	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76907	10.1371/journal.pone.0076907	http://dx.doi.org/10.1371/journal.pone.0076907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130809	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900103
J	Gong, XP; Liu, J; Dong, P; Zhang, PD; Li, N; Zhao, XQ; Wang, YJ				Gong, Xiping; Liu, Jia; Dong, Pei; Zhang, Pandeng; Li, Na; Zhao, Xingquan; Wang, Yongjun			Assessment of Dynamic Cerebral Autoregulation in Patients with Basilar Artery Stenosis	PLOS ONE			English	Article							IMPAIRED CEREBROVASCULAR AUTOREGULATION; BLOOD-PRESSURE; TRANSCRANIAL DOPPLER; CAROTID STENOSIS; OCCLUSION; HUMANS; CORTEX; STROKE; RISK	Background and Aims: Previous studies have shown impaired cerebral autoregulation (CA) in carotid and middle cerebral artery (MCA) stenosis/occlusion. Little is known about CA in patients with basilar artery (BA) stenosis. We therefore investigated dynamic CA patterns in BA stenosis using transfer function analysis (TFA). Methods: We measured spontaneous oscillations of blood flow velocity (CBFV) in the right posterior cerebral artery (PCA), and left MCA and mean arterial pressure (ABP) continuously in 25 patients with BA stenosis (moderate n=16 with 50-69% occlusion and severe n=9 with >= 70% occlusion) and 22 healthy volunteers in supine position during 6 circles per minute deep breath. Analysis was based on the 'black-box' model of transfer function deriving phase and gain in both PCA and MCA. Results: Though changes of phase shift and gain between the patients and healthy controls were observed in MCA, the differences are however not significant. Phase shift in PCA was significantly decreased in severe stenosis when comparing with healthy controls and moderate stenosis (4.2 +/- 34.2 degrees VS 41.1 +/- 40.4 degrees, 4.2 +/- 34.2 degrees VS 34.2 +/- 27.2 degrees, both p<0.05), whilst the gain in PCA is increased for moderate BA stenosis and decreased for severe BA stenosis. Furthermore, we found that phase shift were almost abolished in patients with ischemic stroke who developed unfavorable clinical outcome (mRs>2) on the 90 days after stroke onset. Conclusion: Dynamic CA in PCA reduces in patients with severe BA stenosis and those with ischemic stroke who present poor outcome in 90 days after stroke onset. Phase shift might be a sensitive index prompting impaired CA in posterior circulation.	[Gong, Xiping; Dong, Pei; Li, Na; Zhao, Xingquan; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Liu, Jia; Zhang, Pandeng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Liu, J (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	Jia.liu@siat.ac.cn; yongjunwang1962@gmail.com			Beijing Municipal Science & Technology Commission [D111107003111007]; National Natural Science Foundation of China [81000644]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by Beijing Municipal Science & Technology Commission (No. D111107003111007) and Dr. Jia Liu's work is supported by National Natural Science Foundation of China (No. 81000644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Blaser T, 2002, STROKE, V33, P1057, DOI 10.1161/01.STR.0000013671.70986.39; BrantZawadzki M, 1997, AM J NEURORADIOL, V18, P1820; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Dohmen C, 2007, STROKE, V38, P56, DOI 10.1161/01.STR.0000251642.18522.b6; Endo A, 2012, PEDIATR EMERG CARE, V28, P153, DOI 10.1097/PEC.0b013e3182442fe8; Haubrich C, 2004, STROKE, V35, P848, DOI 10.1161/01.STR.0000120729.99039.B6; Haubrich C, 2003, STROKE, V34, P1881, DOI 10.1161/01.STR.0000080936.36601.34; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Marquardt L, 2009, BRAIN, V132, P982, DOI 10.1093/brain/awp026; Nakagawa K, 2009, STROKE, V40, P2062, DOI 10.1161/STROKEAHA.108.545285; Oehm E, 2006, CEREBROVASC DIS, V22, P204, DOI 10.1159/000093810; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Reinhard M, 2001, NEUROL RES, V23, P55, DOI 10.1179/016164101101198299; Rosengarten B, 2002, CEREBROVASC DIS, V13, P21, DOI 10.1159/000047741; Tang SC, 2008, J VASC SURG, V48, P88, DOI 10.1016/j.jvs.2008.02.025; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	25	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77802	10.1371/journal.pone.0077802	http://dx.doi.org/10.1371/journal.pone.0077802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124620	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100178
J	Nakamura, T; Otsuka, S; Ichii, O; Sakata, Y; Nagasaki, KI; Hashimoto, Y; Kon, Y				Nakamura, Teppei; Otsuka, Saori; Ichii, Osamu; Sakata, Yuko; Nagasaki, Ken-Ichi; Hashimoto, Yoshiharu; Kon, Yasuhiro			Relationship between Numerous Mast Cells and Early Follicular Development in Neonatal MRL/MpJ Mouse Ovaries	PLOS ONE			English	Article							METAPHASE-SPECIFIC APOPTOSIS; MURINE MODEL; MRL; TISSUE; DEATH; MICE; TNF; EXPRESSION; SPERMATOCYTES; ANGIOGENESIS	In the neonatal mouse ovary, clusters of oocytes called nests break into smaller cysts and subsequently form individual follicles. During this period, we found numerous mast cells in the ovary of MRL/MpJ mice and investigated their appearance and morphology with follicular development. The ovarian mast cells, which were already present at postnatal day 0, tended to localize adjacent to the surface epithelium. Among 11 different mouse strains, MRL/MpJ mice possessed the greatest number of ovarian mast cells. Ovarian mast cells were also found in DBA/1, BALB/c, NZW, and DBA/2 mice but rarely in C57BL/6, NZB, AKR, C3H/He, CBA, and ICR mice. The ovarian mast cells expressed connective tissue mast cell markers, although mast cells around the surface epithelium also expressed a mucosal mast cell marker in MRL/MpJ mice. Some ovarian mast cells migrated into the oocyte nests and directly contacted the compressed and degenerated oocytes. In MRL/MpJ mice, the number of oocytes in the nest was significantly lower than in the other strains, and the number of oocytes showed a positive correlation with the number of ovarian mast cells. The gene expression of a mast cell marker also correlated with the expression of an oocyte nest marker, suggesting a link between the appearance of ovarian ? 4mast cells and early follicular development. Furthermore, the expression of follicle developmental markers was significantly higher in MRL/MpJ mice than in C57BL/6 mice. These results indicate that the appearance of ovarian mast cells is a unique phenotype of neonatal MRL/MpJ mice, and that ovarian mast cells participate in early follicular development, especially nest breakdown.	[Nakamura, Teppei; Otsuka, Saori; Ichii, Osamu; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan; [Nakamura, Teppei; Sakata, Yuko; Nagasaki, Ken-Ichi] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Japan; [Hashimoto, Yoshiharu] Hokkaido Univ, Off Fac Dev & Teaching Enriched Vet Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kon, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan.	y-kon@vetmed.hokudai.ac.jp		Kon, Yasuhiro/0000-0002-8859-6122; NAKAMURA, Teppei/0000-0003-3204-0245	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380156]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	These studies were supported by a Grant-in-Aid for Scientific Research B (No. 24380156) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANNSTROM M, 1993, BIOL REPROD, V48, P277, DOI 10.1095/biolreprod48.2.277; CAVENDER JL, 1988, BIOL REPROD, V39, P989, DOI 10.1095/biolreprod39.4.989; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; COUCOUVANIS EC, 1993, EXP CELL RES, V209, P238, DOI 10.1006/excr.1993.1307; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; De Felici M, 2008, AUTOPHAGY, V4, P240, DOI 10.4161/auto.5410; De Pol A, 1997, HUM REPROD, V12, P2235, DOI 10.1093/humrep/12.10.2235; EPIFANO O, 1995, DEVELOPMENT, V121, P1947; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; GAYTAN F, 1991, BIOL REPROD, V45, P27, DOI 10.1095/biolreprod45.1.27; Greenfeld CR, 2007, BIOL REPROD, V76, P224, DOI 10.1095/biolreprod.106.055509; Gurish MF, 1997, BLOOD, V90, P382; Heikkilae HM, 2008, ARTERIOSCL THROM VAS, V28, P309, DOI 10.1161/ATVBAHA.107.151340; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kerr JB, 2006, REPRODUCTION, V132, P95, DOI 10.1530/rep.1.01128; Kon Y, 1999, CELL TISSUE RES, V296, P359, DOI 10.1007/s004410051296; Kon Y, 2000, ANAT HISTOL EMBRYOL, V29, P313, DOI 10.1046/j.1439-0264.2000.00279.x; Kon Y, 2007, ANAT HISTOL EMBRYOL, V36, P172, DOI 10.1111/j.1439-0264.2006.00728.x; Kon Y, 2001, MOL REPROD DEV, V58, P216, DOI 10.1002/1098-2795(200102)58:2&lt;216::AID-MRD11&gt;3.0.CO;2-C; KRISHNA A, 1989, J ENDOCRINOL, V120, P363, DOI 10.1677/joe.0.1200363; Latti S, 2003, J CELL PHYSIOL, V195, P130, DOI 10.1002/jcp.10235; Lee S, 2010, MAMM GENOME, V21, P162, DOI 10.1007/s00335-010-9254-x; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lobascio AM, 2007, REPRODUCTION, V134, P241, DOI 10.1530/REP-07-0141; Marcinkiewicz JL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1997, DOI 10.2741/marcin; Namiki Y, 2005, MAMM GENOME, V16, P96, DOI 10.1007/s00335-004-2424-y; Namiki Y, 2003, MOL REPROD DEV, V64, P179, DOI 10.1002/mrd.10208; NORMAN RJ, 1994, J ENDOCRINOL, V140, P333, DOI 10.1677/joe.0.1400333; Nose M, 2000, INT J CARDIOL, V75, pS53, DOI 10.1016/S0167-5273(00)00191-1; Otsuka S, 2008, JPN J VET RES, V56, P129; Otsuka S, 2008, BIOL REPROD, V79, P9, DOI 10.1095/biolreprod.107.064519; Otsuka S, 2012, MAMM GENOME, V23, P741, DOI 10.1007/s00335-012-9405-3; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Ramirez RA, 2012, DEV DYNAM, V241, P890, DOI 10.1002/dvdy.23778; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; Rudolph MI, 2004, BIOCELL, V28, P1; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SKALKO RG, 1968, ANAT REC, V161, P459, DOI 10.1002/ar.1091610407; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; Takayama T, 2005, BIOL REPROD, V72, P1315, DOI 10.1095/biolreprod.104.038810; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Wulff BC, 2012, J INVEST DERMATOL, V132, P458, DOI 10.1038/jid.2011.324; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Yu HR, 2005, MAMM GENOME, V16, P918, DOI 10.1007/s00335-005-0077-0	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77246	10.1371/journal.pone.0077246	http://dx.doi.org/10.1371/journal.pone.0077246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124609	gold, Green Published			2022-12-27	WOS:000325489100166
J	Costa, A; Candeo, A; Fieramonti, L; Valentini, G; Bassi, A				Costa, Alex; Candeo, Alessia; Fieramonti, Luca; Valentini, Gianluca; Bassi, Andrea			Calcium Dynamics in Root Cells of Arabidopsis thaliana Visualized with Selective Plane Illumination Microscopy	PLOS ONE			English	Article							CA2+ DYNAMICS; REVEALS; OSCILLATIONS; RESOLUTION; CAMELEON; GROWTH; INFORMATION; SIGNATURES; SIGNALS; RANGE	Selective Plane Illumination Microscopy (SPIM) is an imaging technique particularly suited for long term in-vivo analysis of transparent specimens, able to visualize small organs or entire organisms, at cellular and eventually even subcellular resolution. Here we report the application of SPIM in Calcium imaging based on Forster Resonance Energy Transfer (FRET). Transgenic Arabidopsis plants expressing the genetically encoded-FRET-based Ca2+ probe Cameleon, in the cytosol or nucleus, were used to demonstrate that SPIM enables ratiometric fluorescence imaging at high spatial and temporal resolution, both at tissue and single cell level. The SPIM-FRET technique enabled us to follow nuclear and cytosolic Ca2+ dynamics in Arabidopsis root tip cells, deep inside the organ, in response to different stimuli. A relevant physiological phenomenon, namely Ca2+ signal percolation, predicted in previous studies, has been directly visualized.	[Costa, Alex] Univ Milan, Dipartimento Biosci, Milan, Italy; [Candeo, Alessia; Fieramonti, Luca; Valentini, Gianluca; Bassi, Andrea] Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy	University of Milan; Polytechnic University of Milan	Costa, A (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	alex.costa@unimi.it	Candeo, Alessia/AAC-7138-2021; Costa, Alex/I-5172-2015; Bassi, Andrea/I-4542-2012; Valentini, Gianluca/G-4594-2011	Candeo, Alessia/0000-0001-9597-3056; Costa, Alex/0000-0002-2628-1176; Bassi, Andrea/0000-0002-5017-0775; Valentini, Gianluca/0000-0002-6340-3021	Futuro in Ricerca [2010 RBFR10S1LJ_001]	Futuro in Ricerca	This work was partially supported by Futuro in Ricerca 2010 RBFR10S1LJ_001 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding were received for this study.	Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Behera S, 2013, COLD SPRING HARB PRO, V1, P2013; Costa A, 2010, PLANT J, V62, P760, DOI 10.1111/j.1365-313X.2010.04190.x; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Grossmann G, 2011, PLANT CELL, V23, P4234, DOI 10.1105/tpc.111.092577; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Krebs M, 2012, PLANT J, V69, P181, DOI 10.1111/j.1365-313X.2011.04780.x; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Loro G, 2013, J MICROSC-OXFORD, V249, P8, DOI 10.1111/j.1365-2818.2012.03683.x; Loro G, 2012, PLANT J, V71, P1, DOI 10.1111/j.1365-313X.2012.04968.x; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; Maizel A, 2011, PLANT J, V68, P377, DOI 10.1111/j.1365-313X.2011.04692.x; Mazars C, 2011, BIOCHIMIE, V93, P2068, DOI 10.1016/j.biochi.2011.05.039; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Plieth C, 2010, PLANT SIGNAL BEHAV, V5, P379, DOI 10.4161/psb.5.4.10717; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Rincon-Zachary M, 2010, PLANT PHYSIOL, V152, P1442, DOI 10.1104/pp.109.147256; Sena G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021303; Short EF, 2012, PLANT J, V71, P948, DOI 10.1111/j.1365-313X.2012.05043.x; Sieberer BJ, 2009, PLANT PHYSIOL, V151, P1197, DOI 10.1104/pp.109.142851; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; Swoger J, 2007, OPT EXPRESS, V15, P8029, DOI 10.1364/OE.15.008029; Tanaka K, 2010, PLANT PHYSIOL, V154, P705, DOI 10.1104/pp.110.162503; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Whalley HJ, 2013, NEW PHYTOL, V197, P690, DOI 10.1111/nph.12087; Whalley HJ, 2011, PLANT CELL, V23, P4079, DOI 10.1105/tpc.111.090480; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhu XH, 2013, MOL PLANT, V6, P444, DOI 10.1093/mp/sst013	42	55	56	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75646	10.1371/journal.pone.0075646	http://dx.doi.org/10.1371/journal.pone.0075646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146766	Green Published, gold			2022-12-27	WOS:000326019400012
J	Robin, MH; Colbach, N; Lucas, P; Montfort, F; Cholez, C; Debaeke, P; Aubertot, JN				Robin, Marie-Helene; Colbach, Nathalie; Lucas, Philippe; Montfort, Francoise; Cholez, Celia; Debaeke, Philippe; Aubertot, Jean-Noel			Injury Profile SIMulator, a Qualitative Aggregative Modelling Framework to Predict Injury Profile as a Function of Cropping Practices, and Abiotic and Biotic Environment. II. Proof of Concept: Design of IPSIM-Wheat-Eyespot	PLOS ONE			English	Article							WINTER-WHEAT; PSEUDOCERCOSPORELLA-HERPOTRICHOIDES; OCULIMACULA-YALLUNDAE; MULTIATTRIBUTE MODEL; DISEASE DEVELOPMENT; TAPESIA ACUFORMIS; CAUSAL AGENT; SOIL TILLAGE; YIELD LOSS; SYSTEMS	IPSIM (Injury Profile SIMulator) is a generic modelling framework presented in a companion paper. It aims at predicting a crop injury profile as a function of cropping practices and abiotic and biotic environment. IPSIM's modelling approach consists of designing a model with an aggregative hierarchical tree of attributes. In order to provide a proof of concept, a model, named IPSIM-Wheat-Eyespot, has been developed with the software DEXi according to the conceptual framework of IPSIM to represent final incidence of eyespot on wheat. This paper briefly presents the pathosystem, the method used to develop IPSIM-Wheat-Eyespot using IPSIM's modelling framework, simulation examples, an evaluation of the predictive quality of the model with a large dataset (526 observed site-years) and a discussion on the benefits and limitations of the approach. IPSIM-Wheat-Eyespot proved to successfully represent the annual variability of the disease, as well as the effects of cropping practices (Efficiency = 0.51, Root Mean Square Error of Prediction = 24%; bias = 5.0%). IPSIM-Wheat-Eyespot does not aim to precisely predict the incidence of eyespot on wheat. It rather aims to rank cropping systems with regard to the risk of eyespot on wheat in a given production situation through ex ante evaluations. IPSIM-Wheat-Eyespot can also help perform diagnoses of commercial fields. Its structure is simple and permits to combine available knowledge in the scientific literature (data, models) and expertise. IPSIM-Wheat-Eyespot is now available to help design cropping systems with a low risk of eyespot on wheat in a wide range of production situations, and can help perform diagnoses of commercial fields. In addition, it provides a proof of concept with regard to the modelling approach of IPSIM. IPSIM-Wheat-Eyespot will be a sub-model of IPSIM-Wheat, a model that will predict injury profile on wheat as a function of cropping practices and the production situation.	[Robin, Marie-Helene; Cholez, Celia; Debaeke, Philippe; Aubertot, Jean-Noel] INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France; [Robin, Marie-Helene; Cholez, Celia] Univ Toulouse, Inst Natl Polytech Toulouse, Ecole Ingn Purpan, Toulouse, France; [Colbach, Nathalie] INRA, Unite Mixte Rech Agroecol 1347, F-21034 Dijon, France; [Debaeke, Philippe; Aubertot, Jean-Noel] Univ Toulouse, Inst Natl Polytech Toulouse, Unite Mixte Rech Agrosyst & Agri Gest Ressources, Castanet Tolosan, France	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Aubertot, JN (corresponding author), INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France.	Jean-Noel.Aubertot@toulouse.inra.fr	Colbach, Nathalie/C-6677-2014	Colbach, Nathalie/0000-0002-3791-037X; ROBIN, Marie-Helene/0000-0002-3108-3908	INRA; INPT EI Purpan; project MICMAC design [ANR-09-STRA-06]; French National Agency for Research; Programme "Assessing and reducing environmental risks from plant protection products (pesticides)"; French Ministry in charge of Ecology and Sustainable Development (project "ASPIB")	INRA; INPT EI Purpan; project MICMAC design; French National Agency for Research(French National Research Agency (ANR)); Programme "Assessing and reducing environmental risks from plant protection products (pesticides)"; French Ministry in charge of Ecology and Sustainable Development (project "ASPIB")	This study was carried out within a PhD project co-funded by INRA and INPT EI Purpan, by the project MICMAC design (ANR-09-STRA-06) supported by the French National Agency for Research, and by the Programme "Assessing and reducing environmental risks from plant protection products (pesticides)", funded by the French Ministry in charge of Ecology and Sustainable Development (project "ASPIB"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Anken T, 2004, SOIL TILL RES, V78, P171, DOI 10.1016/j.still.2004.02.005; Aubertot J. N., 2005, P 9 INT WORKSH PLANT; Aubertot JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073202; Bailey KL, 2001, CAN J PLANT SCI, V81, P789, DOI 10.4141/P00-152; Bell EM, 2006, J AGRIC SAF HEALTH, V12, P101, DOI 10.13031/2013.20385; Bergez JE, 2010, EUR J AGRON, V32, P3, DOI 10.1016/j.eja.2009.06.001; Birch ANE, 2011, J EXP BOT, V62, P3251, DOI 10.1093/jxb/err064; Bohanec M, 2003, SPRING INT SER ENG C, V745, P23; Bohanec M, 2009, DEXI PROGRAM MULTIAT; Bohanec M, 2008, ECOL MODEL, V215, P247, DOI 10.1016/j.ecolmodel.2008.02.016; Bohanec M, 2007, PEDOBIOLOGIA, V51, P239, DOI 10.1016/j.pedobi.2007.03.006; BREMAN H, 1983, SCIENCE, V221, P1341, DOI 10.1126/science.221.4618.1341; Burnett F.J., 2004, DEV RISK ASSESSMENT; Cavelier A., 1998, Brighton Crop Protection Conference: Pests & Diseases - 1998: Volume 3: Proceedings of an International Conference, Brighton, UK, 16-19 November 1998., P1023; CLARKSON JDS, 1981, PLANT PATHOL, V30, P125, DOI 10.1111/j.1365-3059.1981.tb01243.x; CLARKSON JP, 1993, PLANT PATHOL, V42, P543, DOI 10.1111/j.1365-3059.1993.tb01534.x; COLBACH N, 1994, AGRONOMIE, V14, P525, DOI 10.1051/agro:19940805; COLBACH N, 1995, EUR J AGRON, V4, P217, DOI 10.1016/S1161-0301(14)80048-8; Colbach N, 1998, EUR J PLANT PATHOL, V104, P37, DOI 10.1023/A:1008673925979; Colbach N, 1999, CROP PROT, V18, P451, DOI 10.1016/S0261-2194(99)00044-7; COLBACH N, 1995, EUR J PLANT PATHOL, V101, P601, DOI 10.1007/BF01874864; Colbach N, 1995, MODELISATION INFLUEN; COX JUDITH, 1962, PLANT PATHOL, V11, P65, DOI 10.1111/j.1365-3059.1962.tb00168.x; Crous PW, 2003, EUR J PLANT PATHOL, V109, P841, DOI 10.1023/A:1026111030426; Datnoff LE., 2007, MINERAL NUTR PLANT D; Delos M., 1995, Phytoma, P26; Dore T, 2008, AGRON SUSTAIN DEV, V28, P151, DOI 10.1051/agro:2007031; DOUSSINAULT G, 1983, NATURE, V303, P698, DOI 10.1038/303698a0; Dyer PS, 1996, MYCOL RES, V100, P1219, DOI 10.1016/S0953-7562(96)80184-5; Epstein L, 2003, ANNU REV PHYTOPATHOL, V41, P351, DOI 10.1146/annurev.phyto.41.052002.095612; FITT BDL, 1988, PLANT PATHOL, V37, P311, DOI 10.1111/j.1365-3059.1988.tb02081.x; FITT BDL, 1990, ANN APPL BIOL, V117, P473, DOI 10.1111/j.1744-7348.1990.tb04235.x; Griffiths BS, 2010, APPL SOIL ECOL, V46, P43, DOI 10.1016/j.apsoil.2010.06.012; HERRMAN T, 1985, PLANT DIS, V69, P948; Jalaluddin M, 1996, PLANT PATHOL, V45, P1052, DOI 10.1046/j.1365-3059.1996.d01-194.x; Jenkyn JF, 2010, ANN APPL BIOL, V156, P387, DOI 10.1111/j.1744-7348.2010.00396.x; Jenkyn JF, 2001, J AGR SCI, V136, P1, DOI 10.1017/S0021859600008558; Kropff MJ, 1995, AGR SYST, V49, P413, DOI 10.1016/0308-521X(95)00034-3; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Leroux P., 2006, 8eme Conference Internationale sur les Maladies des Plantes, Tours, France,  5 et 6 Decembre, 2006, P574; Leroux P, 1997, PESTIC SCI, V51, P321, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;321::AID-PS639&gt;3.0.CO;2-U; Loyce C, 2008, CROP PROT, V27, P1131, DOI 10.1016/j.cropro.2008.02.001; Lucas JA, 2000, ADV BOT RES, V33, P225, DOI 10.1016/S0065-2296(00)33044-0; Matusinsky P, 2009, J PLANT PATHOL, V91, P93; Meynard JM, 2003, CR BIOL, V326, P37, DOI 10.1016/S1631-0691(03)00006-4; Montanari A, 2006, J PLANT PATHOL, V88, P149; MUNDT CC, 1995, CROP PROT, V14, P509, DOI 10.1016/0261-2194(95)00035-K; MURRAY TD, 1994, PLANT BREEDING, V113, P281, DOI 10.1111/j.1439-0523.1994.tb00737.x; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Paillotin G, 2008, ECOPHYTO2018 CHANTIE; Parnell S, 2008, PLANT PATHOL, V57, P509, DOI 10.1111/j.1365-3059.2007.01786.x; Payen D, 1979, CR HEBD ACAD SCI, V7, P473; Pelzer E, 2012, ECOL INDIC, V18, P171, DOI 10.1016/j.ecolind.2011.11.019; PREW RD, 1995, J AGR SCI, V124, P173, DOI 10.1017/S0021859600072853; Ray RV, 2006, J EXP BOT, V57, P2249, DOI 10.1093/jxb/erj192; Ray RV, 2004, CROP PROT, V23, P1199, DOI 10.1016/j.cropro.2004.05.003; Russell PE, 2005, J AGR SCI-CAMBRIDGE, V143, P11, DOI 10.1017/S0021859605004971; Sadok W, 2009, AGRON SUSTAIN DEV, V29, P447, DOI 10.1051/agro/2009006; Saur L, 1997, AGRONOMIE, V17, P113, DOI 10.1051/agro:19970204; Savary S, 2000, PLANT DIS, V84, P341, DOI 10.1094/PDIS.2000.84.3.341; Savary S, 2006, EUR J PLANT PATHOL, V115, P123, DOI 10.1007/s10658-005-0651-z; SCOTT PR, 1974, ANN APPL BIOL, V78, P269, DOI 10.1111/j.1744-7348.1974.tb01506.x; Smiley RW, 1996, PLANT DIS, V80, P813, DOI 10.1094/PD-80-0813; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Toderi G., 2000, ATTI GIORNATE FITOPA, V2, P241; Vanova M, 2011, PLANT SOIL ENVIRON, V57, P245, DOI 10.17221/334/2010-PSE; VILICHMELLER V, 1992, BIOL AGRIC HORTIC, V8, P299, DOI 10.1080/01448765.1992.9754607; Wallach D., 2006, WORKING DYNAMIC CROP, Vfirst; Wei L, 2011, J PHYTOPATHOL, V159, P457, DOI 10.1111/j.1439-0434.2011.01795.x; Wiese M.V., 1987, COMPENDIUM WHEAT DIS; Willocquet L, 2008, FIELD CROP RES, V107, P12, DOI 10.1016/j.fcr.2007.12.013; Zhang XY, 2006, CROP PROT, V25, P1013, DOI 10.1016/j.cropro.2006.01.013	73	8	8	6	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75829	10.1371/journal.pone.0075829	http://dx.doi.org/10.1371/journal.pone.0075829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146783	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400020
J	Girerd, N; Scridon, A; Bessiere, F; Chauveau, S; Geloen, A; Boussel, L; Morel, E; Chevalier, P				Girerd, Nicolas; Scridon, Alina; Bessiere, Francis; Chauveau, Samuel; Geloen, Alain; Boussel, Loic; Morel, Elodie; Chevalier, Philippe			Periatrial Epicardial Fat Is Associated with Markers of Endothelial Dysfunction in Patients with Atrial Fibrillation	PLOS ONE			English	Article							WILLEBRAND-FACTOR LEVELS; ADIPOSE-TISSUE; PERICARDIAL FAT; RISK-FACTOR; FOLLOW-UP; OBESITY; PREDICTORS; EXPRESSION; RHYTHM	Background: Epicardial adipose tissue (EAT) is associated to atrial fibrillation (AF) burden and outcome after AF ablation. We intended to determine whether global or local EAT is associated with systemic and/or left atrial (LA) inflammation and markers of endothelial dysfunction in AF patients. Methods and Results: Total, atrial, and ventricular EAT volume (EATtotal, EATatrial, EATventricular) were measured by multislice cardiac CT in 49 patients with paroxysmal (PAF, n=25) or persistent AF (PeF, n=24). Periatrial epicardial fat thickness at the esophagus (LA-ESO) and thoracic aorta (LA-ThA) were also measured. Vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), soluble intercellular adhesion molecule 1 (sICAM-1), transforming growth factor-beta 1 (TGF-beta 1), and von Willebrand Factor (vWF) levels were measured in peripheral and LA blood samples obtained during catheterization during AF ablation. Patients with PeF had higher EATatrial (P<0.05) and LA-ESO (P=0.04) than patients with PAF. VEGF, IL-8, and TGF-beta 1 were not associated with EAT. In contrast, after adjusting for LA volume and body mass index, higher LA-ThA was significantly associated with higher sICAM-1 and vWF levels, both in peripheral blood (P<0.05) and in LA (P<0.05). Similar results were found with LA-ESO. Body mass index, EATtotal and EATventricular were not associated with sICAM-1 and vWF. Conclusions: Periatrial epicardial fat showed a significant positive association with increased levels of sICAM-1 and vWF, which are biomarkers of endothelial dysfunction. No such associations were found when considering body mass index or EATtotal. These results suggest that local EAT rather than regional or total adiposity may modulate endothelial dysfunction in patients with AF.	[Girerd, Nicolas; Bessiere, Francis; Chauveau, Samuel; Chevalier, Philippe] Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Dept, Bron, France; [Scridon, Alina] Univ Med & Pharm Targu Mures, Dept Physiol, Targu Mures, Romania; [Geloen, Alain] INSA, INSERM, U870, INRA 1235, Villeurbanne, France; [Boussel, Loic] Hosp Civils Lyon, Croix Rousse Hosp, Dept Radiol, Lyon, France; [Morel, Elodie; Chevalier, Philippe] Louis Pradel Cardiovasc Hosp, Lyon Reference Ctr Inherited Arrhythmias, Lyon, France	CHU Lyon; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CHU Lyon; CHU Lyon	Chevalier, P (corresponding author), Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Dept, Bron, France.	philippe.chevalier@chu-lyon.fr	Boussel, Loic/H-7184-2014; GIRERD, Nicolas/D-5493-2011	Girerd, Nicolas/0000-0002-3278-2057; Scridon, Alina/0000-0002-9763-4266; GELOEN, Alain/0000-0001-7921-1254				Acevedo M, 2012, J THROMB THROMBOLYS, V33, P383, DOI 10.1007/s11239-012-0690-1; Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Aydin H, 2010, METAB SYNDR RELAT D, V8, P229, DOI 10.1089/met.2009.0080; Batal O, 2010, CIRC-ARRHYTHMIA ELEC, V3, P230, DOI 10.1161/CIRCEP.110.957241; Bosanska L, 2010, PHYSIOL RES, V59, P79, DOI 10.33549/physiolres.931705; Chen PS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P618, DOI 10.1161/CIRCEP.112.974956; Chevalier P, 2005, HEART RHYTHM, V2, P518, DOI 10.1016/j.hrthm.2005.01.022; Hanzu FA, 2011, J THROMB HAEMOST, V9, P1236, DOI 10.1111/j.1538-7836.2011.04285.x; Kamiyama N, 1998, JPN CIRC J, V62, P837, DOI 10.1253/jcj.62.837; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lin YK, 2013, INT J CARDIOL, V167, P1979, DOI 10.1016/j.ijcard.2012.05.009; Lin YK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0293-1; Lin YK, 2010, MED HYPOTHESES, V74, P1026, DOI 10.1016/j.mehy.2010.01.004; Lip GYH, 2006, STROKE, V37, P2294, DOI 10.1161/01.STR.0000236840.00467.84; Liu T, 2011, J AM COLL CARDIOL, V57, P1249, DOI 10.1016/j.jacc.2010.09.068; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mizia-Stec Katarzyna, 2006, Pharmacol Rep, V58 Suppl, P21; Nagashima K, 2012, CIRC-ARRHYTHMIA ELEC, V5, P676, DOI 10.1161/CIRCEP.112.971200; Nagashima K, 2011, CIRC J, V75, P2559, DOI 10.1253/circj.CJ-11-0554; Parikh NI, 2009, OBESITY, V17, P2054, DOI 10.1038/oby.2009.60; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pinto A, 2009, CLIN SCI, V116, P781, DOI 10.1042/CS20080372; Roldan V, 2011, J AM COLL CARDIOL, V57, P2496, DOI 10.1016/j.jacc.2010.12.033; Scridon A, 2012, EUROPACE, V14, P948, DOI 10.1093/europace/eur418; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P376, DOI 10.1111/j.1540-8167.2010.01919.x; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Thijssen DHJ, 2006, AM J PHYSIOL-HEART C, V291, pH3122, DOI 10.1152/ajpheart.00240.2006; Tsang TSM, 2008, EUR HEART J, V29, P2227, DOI 10.1093/eurheartj/ehn324; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	34	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77167	10.1371/journal.pone.0077167	http://dx.doi.org/10.1371/journal.pone.0077167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143210	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100045
J	Gunawardana, M; Mullen, M; Moss, JA; Pyles, RB; Nusbaum, RJ; Patel, J; Vincent, KL; Wang, C; Guo, C; Yuan, YC; Warden, CD; Baum, MM				Gunawardana, Manjula; Mullen, Madeline; Moss, John A.; Pyles, Richard B.; Nusbaum, Rebecca J.; Patel, Jignesh; Vincent, Kathleen L.; Wang, Charles; Guo, Chao; Yuan, Yate-Ching; Warden, Charles D.; Baum, Marc M.			Global Expression of Molecular Transporters in the Human Vaginal Tract: Implications for HIV Chemoprophylaxis	PLOS ONE			English	Article							PROTEASE INHIBITOR SAQUINAVIR; ANTIRETROVIRAL PROPHYLAXIS; DRUG-INTERACTIONS; ANTIVIRAL AGENTS; GENE-EXPRESSION; PREVENTION; PHARMACOKINETICS; INFECTION; TENOFOVIR; REPRODUCIBILITY	Background: Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap. Methodology/Principal Findings: Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43%) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83%) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types. Conclusions/Significance: Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over-or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP.	[Gunawardana, Manjula; Mullen, Madeline; Moss, John A.; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Pasadena, CA USA; [Pyles, Richard B.; Patel, Jignesh] UTMB, Dept Pediat, Galveston, TX USA; [Pyles, Richard B.; Patel, Jignesh] UTMB, Dept Microbiol & Immunol, Galveston, TX USA; [Nusbaum, Rebecca J.] UTMB, Human Pathophysiol & Translat Med Grad Program, Galveston, TX USA; [Vincent, Kathleen L.] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Wang, Charles; Guo, Chao] City Hope Comprehens Canc Ctr, Beckman Res Inst, Funct Genom Core, Duarte, CA USA; [Yuan, Yate-Ching; Warden, Charles D.] City Hope Natl Med Ctr, Dept Mol Med, Bioinformat Core, Duarte, CA 91010 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Baum, MM (corresponding author), Oak Crest Inst Sci, Dept Chem, Pasadena, CA USA.	m.baum@oak-crest.org	Guo, Chao/B-2647-2010	Guo, Chao/0000-0002-6673-0933; Warden, Charles/0000-0002-1827-4486; Moss, John/0000-0001-8091-3245; Nusbaum, Rebecca/0000-0002-8378-8037; Baum, Marc/0000-0003-1558-5649; Vincent, Kathleen/0000-0003-3051-9551	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI100744]; National Center for Research Resources, National Institutes of Health [1UL1RR029876-01]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100744] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI100744. Funding support under Award Number 1UL1RR029876-01 from the National Center for Research Resources, National Institutes of Health, also is acknowledged. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand BS, 2004, CURR EYE RES, V29, P153, DOI 10.1080/02713680490504614; Anand BS, 2003, INVEST OPHTH VIS SCI, V44, P2529, DOI 10.1167/iovs.02-1251; Anderle P, 2004, EUR J PHARM SCI, V21, P17, DOI 10.1016/S0928-0987(03)00169-6; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown KC, 2009, CLIN PHARMACOKINET, V48, P211, DOI 10.2165/00003088-200948040-00001; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2012, AIDS, V26, P1585, DOI 10.1097/QAD.0b013e3283543e83; Dickinson L, 2010, ANTIVIR RES, V85, P176, DOI 10.1016/j.antiviral.2009.07.017; Ford J, 2004, J ANTIMICROB CHEMOTH, V54, P982, DOI 10.1093/jac/dkh487; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Jain R, 2005, INT J PHARMACEUT, V303, P8, DOI 10.1016/j.ijpharm.2005.06.017; Janoria KG, 2010, J OCUL PHARMACOL TH, V26, P265, DOI 10.1089/jop.2009.0123; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kim Richard B, 2003, Top HIV Med, V11, P136; Kis O, 2010, TRENDS PHARMACOL SCI, V31, P22, DOI 10.1016/j.tips.2009.10.001; Kuchiiwa T, 2011, HISTOCHEM CELL BIOL, V135, P351, DOI 10.1007/s00418-011-0794-2; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Maffeo A, 2004, MICROBIOLOGICA, V27, P119; Mao Shihong, 2009, Journal of Bioinformatics and Computational Biology, V7, P157, DOI 10.1142/S0219720009004011; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Shattock RJ, 2011, SCIENCE, V333, P42, DOI 10.1126/science.1206399; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; [No title captured]; [No title captured]	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77340	10.1371/journal.pone.0077340	http://dx.doi.org/10.1371/journal.pone.0077340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143220	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100057
J	Inoue, K; Wada, J; Eguchi, J; Nakatsuka, A; Teshigawara, S; Murakami, K; Ogawa, D; Terami, T; Katayama, A; Tone, A; Iseda, I; Hida, K; Yamada, M; Ogawa, T; Makino, H				Inoue, Kentaro; Wada, Jun; Eguchi, Jun; Nakatsuka, Atsuko; Teshigawara, Sanae; Murakami, Kazutoshi; Ogawa, Daisuke; Terami, Takahiro; Katayama, Akihiro; Tone, Atsuhito; Iseda, Izumi; Hida, Kazuyuki; Yamada, Masao; Ogawa, Tomohisa; Makino, Hirofumi			Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray	PLOS ONE			English	Article							OROSOMUCOID EXCRETION; KIDNEY; ALBUMINURIA; DISEASE; ALPHA(1)-MICROGLOBULIN; GLYCOSYLATION; ADIPONECTIN; BIOMARKERS; PROTEOMICS; MORTALITY	We analyzed the urine samples of patients with type 2 diabetes at various stages of diabetic nephropathy by lectin microarray to identify a biomarker to predict the progression of diabetic nephropathy. Japanese patients with type 2 diabetes at various stages of nephropathy were enrolled and we performed lectin microarray analyses (n = 17) and measured urinary excretion of fetuin-A (n = 85). The increased signals of urine samples were observed in Sia alpha 2-6Gal/GalNAc-binding lectins (SNA, SSA, TJA-I) during the progression of diabetic nephropathy. We next isolated sialylated glycoproteins by using SSA-lectin affinity chromatography and identified fetuin-A by liquid chromatography-tandem mass spectrometer. Urinary excretion of fetuin-A significantly increased during the progression of albuminuria (A1, 0.40 +/- 0.43; A2, 0.60 +/- 0.53; A3 1.57 +/- 1.13 ng/gCr; p = 7.29x10(-8)) and of GFR stages (G1, 0.39 +/- 0.39; G2, 0.49 +/- 0.45; G3, 1.25 +/- 1.18; G4, 1.34 +/- 0.80 ng/gCr; p = 3.89x10(-4)). Multivariate logistic regression analysis was employed to assess fetuin-A as a risk for diabetic nephropathy with microalbuminuria or GFR<60 mL/min. Fetuin-A is demonstrated as a risk factor for both microalbuminuria and reduction of GFR in diabetic nephropathy with the odds ratio of 4.721 (1.881-11.844) and 3.739 (1.785-7.841), respectively. Collectively, the glycan profiling analysis is useful method to identify the urine biomarkers and fetuin-A is a candidate to predict the progression of diabetic nephropathy.	[Inoue, Kentaro; Wada, Jun; Eguchi, Jun; Nakatsuka, Atsuko; Teshigawara, Sanae; Murakami, Kazutoshi; Ogawa, Daisuke; Terami, Takahiro; Katayama, Akihiro; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, Okayama 7008530, Japan; [Nakatsuka, Atsuko; Ogawa, Daisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Diabet Nephropathy, Kita Ku, Okayama 7008530, Japan; [Murakami, Kazutoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008530, Japan; [Tone, Atsuhito; Iseda, Izumi; Hida, Kazuyuki] Natl Hosp Org, Okayama Med Ctr, Dept Diabet & Metab, Kita Ku, Okayama, Japan; [Yamada, Masao] GlycoTechnica Ltd, Aoba Ku, Yokohama, Kanagawa, Japan; [Ogawa, Tomohisa] GP BioSci Co Ltd, Aoba Ku, Yokohama, Kanagawa, Japan	Okayama University; Okayama University; Okayama University	Wada, J (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, Okayama 7008530, Japan.	junwada@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011; Nakatsuka, Atsuko/L-2765-2017; Murakami, Kazutoshi/AAV-1940-2020	WADA, Jun/0000-0003-1468-5170; Murakami, Kazutoshi/0000-0002-6042-8960; Ogawa, Tomohisa/0000-0001-8700-6330	JSPS [23390241, 25126716]; Health Labor Sciences Research Grant, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grant, Japan	This work was supported by JSPS Grant-in-Aid for Scientific Research, Grant numbers (23390241, 25126716) and Health Labor Sciences Research Grant, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JM, 2010, PROTEOM CLIN APPL, V4, P644, DOI 10.1002/prca.200900196; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; BIERHUIZEN MFA, 1988, EUR J BIOCHEM, V175, P387, DOI 10.1111/j.1432-1033.1988.tb14208.x; BRATT T, 1993, BIOCHIM BIOPHYS ACTA, V1157, P147, DOI 10.1016/0304-4165(93)90058-G; Christiansen MS, 2010, DIABETES RES CLIN PR, V89, P16, DOI 10.1016/j.diabres.2010.03.018; Christiansen MS, 2009, SCAND J CLIN LAB INV, V69, P272, DOI 10.1080/00365510802531100; Christiansen MS, 2002, DIABETOLOGIA, V45, P115, DOI 10.1007/s125-002-8251-3; Emoto M, 2010, METABOLISM, V59, P873, DOI 10.1016/j.metabol.2009.10.005; Epaso LH, 2010, DIABETES CARE, V33, P408, DOI 10.2337/dc09-1541; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Galanti LM, 1996, DIABETES METAB, V22, P324; Gu W, 2008, PROTEOM CLIN APPL, V2, P744, DOI 10.1002/prca.200780083; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hong CY, 2003, DIABETES CARE, V26, P338, DOI 10.2337/diacare.26.2.338; Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z; ITO S, 1989, ACTA ENDOCRINOL-COP, V120, P584, DOI 10.1530/acta.0.1200584; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Jiang HJ, 2009, NEPHROLOGY, V14, P332, DOI 10.1111/j.1440-1797.2008.01053.x; Jung CH, 2013, DIAB VASC DIS RES; KIDO T, 1985, TOXICOL LETT, V24, P195; Koluman BU, 2013, CLIN NEPHROL, V80, P9, DOI 10.5414/CN107920; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Lee CL, 2011, DIABETES, V60, P909, DOI 10.2337/db10-1186; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; Matsui I, 2013, AM J PHYSIOL-RENAL, V304, pF751, DOI 10.1152/ajprenal.00329.2012; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Narita T, 2004, DIABETES CARE, V27, P1176, DOI 10.2337/diacare.27.5.1176; Nedic O, 2012, J CHROMATOGR B, V904, P93, DOI 10.1016/j.jchromb.2012.07.028; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Pal D., 2012, NAT MED; Penders J, 2004, CLIN CHIM ACTA, V346, P107, DOI 10.1016/j.cccn.2004.03.037; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; PFLEIDERER S, 1993, CLIN INVESTIGATOR, V71, P972; Raimondo F, 2013, MOL BIOSYST, V9, P1139, DOI 10.1039/c2mb25396h; Rao PV, 2007, DIABETES CARE, V30, P629, DOI 10.2337/dc06-2056; Roos M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-48; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Saroha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046374; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Thanabalasingham G, 2013, DIABETES, V62, P1329, DOI 10.2337/db12-0880; WATERS PJ, 1995, DIABETIC MED, V12, P670, DOI 10.1111/j.1464-5491.1995.tb00567.x; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874; Zurbig P, 2012, DIABETES, V61, P3304, DOI 10.2337/db12-0348	45	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77118	10.1371/journal.pone.0077118	http://dx.doi.org/10.1371/journal.pone.0077118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143207	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100042
J	Caillon, L; Killian, JA; Lequin, O; Khemtemourian, L				Caillon, Lucie; Killian, J. Antoinette; Lequin, Olivier; Khemtemourian, Lucie			Biophysical Investigation of the Membrane-Disrupting Mechanism of the Antimicrobial and Amyloid-Like Peptide Dermaseptin S9	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; BIOLOGICAL-MEMBRANES; MAGNETIC-RESONANCE; LIPID INTERACTIONS; NMR-SPECTROSCOPY; MODEL MEMBRANES; BILAYERS; POLYPEPTIDE; BINDING; PHOSPHOLIPIDS	Dermaseptin S9 (Drs S9) is an atypical cationic antimicrobial peptide with a long hydrophobic core and with a propensity to form amyloid-like fibrils. Here we investigated its membrane interaction using a variety of biophysical techniques. Rather surprisingly, we found that Drs S9 induces efficient permeabilisation in zwitterionic phosphatidylcholine (PC) vesicles, but not in anionic phosphatidylglycerol (PG) vesicles. We also found that the peptide inserts more efficiently in PC than in PG monolayers. Therefore, electrostatic interactions between the cationic Drs S9 and anionic membranes cannot explain the selectivity of the peptide towards bacterial membranes. CD spectroscopy, electron microscopy and ThT fluorescence experiments showed that the peptide adopts slightly more beta-sheet and has a higher tendency to form amyloid-like fibrils in the presence of PC membranes as compared to PG membranes. Thus, induction of leakage may be related to peptide aggregation. The use of a pre-incorporation protocol to reduce peptide/peptide interactions characteristic of aggregates in solution resulted in more alpha-helix formation and a more pronounced effect on the cooperativity of the gel-fluid lipid phase transition in all lipid systems tested. Calorimetric data together with H-2-and P-31-NMR experiments indicated that the peptide has a significant impact on the dynamic organization of lipid bilayers, albeit slightly less for zwitterionic than for anionic membranes. Taken together, our data suggest that in particular in membranes of zwitterionic lipids the peptide binds in an aggregated state resulting in membrane leakage. We propose that also the antimicrobial activity of Drs S9 may be a result of binding of the peptide in an aggregated state, but that specific binding and aggregation to bacterial membranes is regulated not by anionic lipids but by as yet unknown factors.	[Caillon, Lucie; Lequin, Olivier; Khemtemourian, Lucie] Univ Paris 06, UMR CNRS UPMC ENS 7203, Lab Biomol, Paris, France; [Killian, J. Antoinette] Univ Utrecht, Bijvoet Ctr, Res Grp Membrane Biochem & Biophys, NL-3508 TB Utrecht, Netherlands; [Killian, J. Antoinette] Univ Utrecht, Inst Biomembranes, Utrecht, Netherlands	UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Utrecht University	Lequin, O (corresponding author), Univ Paris 06, UMR CNRS UPMC ENS 7203, Lab Biomol, Paris, France.	olivier.lequin@upmc.fr; lucie.khemtemourian@upmc.fr	Killian, J. Antoinette/I-3001-2016	Killian, J. Antoinette/0000-0001-8010-3816; LEQUIN, Olivier/0000-0001-5307-3068; khemtemourian, lucie/0000-0001-6754-5724	TGIR-RMN-THC [Fr3050]	TGIR-RMN-THC	Financial support from the TGIR-RMN-THC Fr3050 for conducting the NMR experiments is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; Ambroggio EE, 2004, BBA-BIOMEMBRANES, V1664, P31, DOI 10.1016/j.bbamem.2004.03.013; Auvynet C, 2008, FEBS J, V275, P4134, DOI 10.1111/j.1742-4658.2008.06554.x; BLOOM M, 1981, CHEM PHYS LETT, V80, P198, DOI 10.1016/0009-2614(81)80089-9; Bonev B, 2001, PHYS CHEM CHEM PHYS, V3, P2904, DOI 10.1039/b103352m; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Buchoux S, 2008, BIOPHYS J, V95, P3840, DOI 10.1529/biophysj.107.128322; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Byrne C, 2012, STEROIDS, V77, P979, DOI 10.1016/j.steroids.2012.02.022; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; Castano S, 2000, BBA-BIOMEMBRANES, V1463, P65, DOI 10.1016/S0005-2736(99)00175-3; Castano S, 1999, BBA-BIOMEMBRANES, V1416, P176, DOI 10.1016/S0005-2736(98)00220-X; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; DUFOURC EJ, 1990, EUR J BIOCHEM, V187, P581, DOI 10.1111/j.1432-1033.1990.tb15340.x; DUFOURC EJ, 1986, BIOCHEMISTRY-US, V25, P6448, DOI 10.1021/bi00369a016; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fernandez DI, 2011, AUST J CHEM, V64, P798, DOI 10.1071/CH11062; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Heimburg T, 1996, BIOPHYS J, V70, P84, DOI 10.1016/S0006-3495(96)79551-6; Ivanova VP, 2003, BIOPHYS J, V84, P2427, DOI 10.1016/S0006-3495(03)75047-4; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Joanne P, 2009, BBA-BIOMEMBRANES, V1788, P1772, DOI 10.1016/j.bbamem.2009.05.001; Khemtemourian L, 2007, EUR BIOPHYS J BIOPHY, V36, P107, DOI 10.1007/s00249-006-0111-5; Khemtemourian L, 2011, J AM CHEM SOC, V133, P15598, DOI 10.1021/ja205007j; Khemtemourian L, 2010, BBA-BIOMEMBRANES, V1798, P1805, DOI 10.1016/j.bbamem.2010.05.022; Khemtemourian L, 2010, EUR BIOPHYS J BIOPHY, V39, P1359, DOI 10.1007/s00249-009-0572-4; Khemtemourian L, 2009, BIOCHEMISTRY-US, V48, P10918, DOI 10.1021/bi901076d; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Lee DK, 2013, BIOCHEMISTRY; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; Mason AJ, 2007, BIOCHEMISTRY-US, V46, P15175, DOI 10.1021/bi701344m; Mason AJ, 2006, MOL MEMBR BIOL, V23, P185, DOI 10.1080/09687860500485303; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ramamoorthy A, 2006, BBA-BIOMEMBRANES, V1758, P154, DOI 10.1016/j.bbamem.2006.02.014; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Salnikov ES, 2009, BIOCHIMIE, V91, P734, DOI 10.1016/j.biochi.2009.01.002; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Sood R, 2007, J FLUORESC, V17, P223, DOI 10.1007/S10895-007-0161-9; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Walrant A, 2011, BBA-BIOMEMBRANES, V1808, P382, DOI 10.1016/j.bbamem.2010.09.009; Zhao H, 2006, BBA-BIOMEMBRANES, V1758, P1461, DOI 10.1016/j.bbamem.2006.03.037; Zhao HX, 2005, BIOCHEMISTRY-US, V44, P2857, DOI 10.1021/bi048510j	56	36	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75528	10.1371/journal.pone.0075528	http://dx.doi.org/10.1371/journal.pone.0075528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146759	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400010
J	Bonnan, MF; Wilhite, DR; Masters, SL; Yates, AM; Gardner, CK; Aguiar, A				Bonnan, Matthew F.; Wilhite, D. Ray; Masters, Simon L.; Yates, Adam M.; Gardner, Christine K.; Aguiar, Adam			What Lies Beneath: Sub-Articular Long Bone Shape Scaling in Eutherian Mammals and Saurischian Dinosaurs Suggests Different Locomotor Adaptations for Gigantism	PLOS ONE			English	Article							KNEE-JOINT; ALLIGATOR-MISSISSIPPIENSIS; GEOMETRIC MORPHOMETRICS; SAUROPOD DINOSAURS; SEXUAL-DIMORPHISM; ANIMAL JOINTS; BODY-SIZE; CARTILAGE; EVOLUTION; THICKNESS	Eutherian mammals and saurischian dinosaurs both evolved lineages of huge terrestrial herbivores. Although significantly more saurischian dinosaurs were giants than eutherians, the long bones of both taxa scale similarly and suggest that locomotion was dynamically similar. However, articular cartilage is thin in eutherian mammals but thick in saurischian dinosaurs, differences that could have contributed to, or limited, how frequently gigantism evolved. Therefore, we tested the hypothesis that sub-articular bone, which supports the articular cartilage, changes shape in different ways between terrestrial mammals and dinosaurs with increasing size. Our sample consisted of giant mammal and reptile taxa (i.e., elephants, rhinos, sauropods) plus erect and non-erect outgroups with thin and thick articular cartilage. Our results show that eutherian mammal sub-articular shape becomes narrow with well-defined surface features as size increases. In contrast, this region in saurischian dinosaurs expands and remains gently convex with increasing size. Similar trends were observed in non-erect outgroup taxa (monotremes, alligators), showing that the trends we report are posture-independent. These differences support our hypothesis that sub-articular shape scales differently between eutherian mammals and saurischian dinosaurs. Our results show that articular cartilage thickness and sub-articular shape are correlated. In mammals, joints become ever more congruent and thinner with increasing size, whereas archosaur joints remained both congruent and thick, especially in sauropods. We suggest that gigantism occurs less frequently in mammals, in part, because joints composed of thin articular cartilage can only become so congruent before stress cannot be effectively alleviated. In contrast, frequent gigantism in saurischian dinosaurs may be explained, in part, by joints with thick articular cartilage that can deform across large areas with increasing load.	[Bonnan, Matthew F.; Aguiar, Adam] Richard Stockton Coll New Jersey, Biol Program, Galloway, NJ USA; [Wilhite, D. Ray] Auburn Univ, Sch Vet Med, Auburn, AL 36849 USA; [Masters, Simon L.] Beaumont Sch, Cleveland Hts, OH USA; [Yates, Adam M.] Museum Cent Australia, Alice Springs, NT, Australia; [Gardner, Christine K.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA	Auburn University System; Auburn University; Western Illinois University	Bonnan, MF (corresponding author), Richard Stockton Coll New Jersey, Biol Program, Galloway, NJ USA.	Matthew.Bonnan@stockton.edu			College of New Jersey	College of New Jersey	We thank the many institutions and individuals that provided us with access to specimens for this study. Much of the archosaur data was collected for previous studies [14,15,26,31] and the heartfelt thanks and appreciation expressed in those references continues more strongly than ever here. For the present study, we wish to thank the following institutions and staff: AMNH: N. B. Simmons and staff (Mammalogy), J. Meng, J. Galkin, and staff (Fossil Mammals); FMNH: W. Stanley and staff (Mammalogy), K. D. Angielczyk, W. Simpson, and staff (Fossil Mammals); UNMH: R. Irmis, M. Getty, and staff; CLQ: M. Leschin; SAM: A. Chinsamy-Turan and staff; BPI: B. Rubidge and staff. We thank K. Schuenman at WIU for collecting data on felids used in this study. Feedback from G. S. Paul, H. Tsai, and S. Gatesy at the 2012 Society of Vertebrate Paleontology meeting further improved our manuscript. Discussions with J. Shulman at the Richard Stockton College of New Jersey on static physics were helpful. D. Henderson and an anonymous reviewer provided useful comments, critiques, and suggestions on a first draft of this manuscript. We also thank PLoS One editor P. Dodson for shepherding our manuscript through the PLoS system, and his feedback, comments, and suggestions. Finally, we thank the Richard Stockton College of New Jersey for support with publication charges.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Birch JM, 1997, J MAMMAL, V78, P1187, DOI 10.2307/1383062; Bonnan MF, 2008, J VERTEBR PALEONTOL, V28, P422, DOI 10.1671/0272-4634(2008)28[422:ULAGMT]2.0.CO;2; Bonnan MF, 2007, ANAT REC, V290, P1089, DOI 10.1002/ar.20578; Bonnan MF, 2010, ANAT REC, V293, P2044, DOI 10.1002/ar.21266; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Carrano MT, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P229; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; Carter DR, 1998, ZOOL J LINN SOC-LOND, V123, P163, DOI 10.1006/zjls.1997.0108; Carter DR, 2001, SKELETAL FUNCTION FO; Castaneda S, 2011, BIOCHEM PHARMACOL, V83, P315, DOI DOI 10.1016/J.BCP.2011.09.018; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Christiansen Per, 1997, Gaia, V14, P45; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V149, P423; Dilkes DW, 2012, COMPLETE DINOSAUR, V27, P151; Doube M, 2011, P ROY SOC B-BIOL SCI, V278, P3067, DOI 10.1098/rspb.2011.0069; Egger GF, 2008, J MORPHOL, V269, P118, DOI 10.1002/jmor.10600; Farlow J, 1995, ECOLOGY EVOLUTION, V193, P44, DOI [10.1126/science.193.4247.44, DOI 10.1126/SCIENCE.193.4247.44]; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Fortelius M., 2008, ZOOLOGICAL J LINNEAN, V108, P85, DOI [DOI 10.1111/J.1096-3642.1993.TB02560.X, 10.1111/j.1096-3642.1993.tb02560.x.]; Fujiwara S, 2010, J MORPHOL, V271, P883, DOI 10.1002/jmor.10846; FUSS FK, 1994, ANAT REC, V238, P297, DOI 10.1002/ar.1092380303; Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GRAF J, 1993, INT ORTHOP, V17, P113; Haines RW, 1942, J ANAT, V76, P270; Hassell EMA, 2012, ECOL EVOL, V2, P1738, DOI 10.1002/ece3.278; Hildebrand M., 1995, ANAL VERTEBRATE STRU; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; HOSHINO A, 1987, J BONE JOINT SURG BR, V69, P807, DOI 10.1302/0301-620X.69B5.3680348; JENKINS FA, 1973, AM J ANAT, V137, P281, DOI 10.1002/aja.1001370304; Ji YN, 2011, ACTA GEOL SIN-ENGL, V85, P58, DOI 10.1111/j.1755-6724.2011.00378.x; Kovachev Dimitar, 2006, Geologica Balcanica, V35, P5; Liem KF., 2001, FUNCTIONAL ANATOMY V; Malda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057683; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Neraudeau D, 2012, CRETACEOUS RES, V37, P1, DOI 10.1016/j.cretres.2012.01.006; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Petermann H, 2013, J ANAT, V222, P419, DOI 10.1111/joa.12028; Prothero D. R., 2002, HORNS TUSKS FLIPPERS; Prothero D. R., 2013, RHINOCEROS GIANTS PA; PROTHERO DR, 1982, PALEOBIOLOGY, V8, P16, DOI 10.1017/S0094837300004322; Rohlf J, 2012, THIN PLATE SPLINES P; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Shoshani Jeheskel, 1996, P9; SIMON WH, 1973, J BONE JOINT SURG AM, VA 55, P1614, DOI 10.2106/00004623-197355080-00004; SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305; SIMON WH, 1971, ARTHRITIS RHEUM, V14, P493, DOI 10.1002/art.1780140409; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Snover M.L., 2007, BIOL TURTLES, P17; Tidwell V, 2005, LIFE O PAST, P187; Tsai HP, 2012, J VERTEBR PALEONTOL, V32, P184; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vogel S., 2003, COMP BIOMECHANICS LI; Von Huene F, 1929, ANALES MUSEO PLATA, V2, P1; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	66	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75216	10.1371/journal.pone.0075216	http://dx.doi.org/10.1371/journal.pone.0075216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130690	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900022
J	Martinez-Estevez, L; Balvanera, P; Pacheco, J; Ceballos, G				Martinez-Estevez, Lourdes; Balvanera, Patricia; Pacheco, Jesus; Ceballos, Gerardo			Prairie Dog Decline Reduces the Supply of Ecosystem Services and Leads to Desertification of Semiarid Grasslands	PLOS ONE			English	Article							CYNOMYS-LUDOVICIANUS; HABITAT; HETEROGENEITY; DEGRADATION; SYSTEM	Anthropogenic impacts on North American grasslands, a highly endangered ecosystem, have led to declines of prairie dogs, a keystone species, over 98% of their historical range. While impacts of this loss on maintenance of grassland biodiversity have been widely documented, much less is known about the consequences on the supply of ecosystem services. Here we assessed the effect of prairie dogs in the supply of five ecosystem services by comparing grasslands currently occupied by prairie dogs, grasslands devoid of prairie dogs, and areas that used to be occupied by prairie dogs that are currently dominated by mesquite scrub. Groundwater recharge, regulation of soil erosion, regulation of soil productive potential, soil carbon storage and forage availability were consistently quantitatively or qualitatively higher in prairie dog grasslands relative to grasslands or mesquite scrub. Our findings indicate a severe loss of ecosystem services associated to the absence of prairie dogs. These findings suggest that contrary to a much publicize perception, especially in the US, prairie dogs are fundamental in maintaining grasslands and their decline have strong negative impacts in human well - being through the loss of ecosystem services.	[Martinez-Estevez, Lourdes; Pacheco, Jesus; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Balvanera, Patricia] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Mexico City 04510, DF, Mexico; [Balvanera, Patricia] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Balvanera, Patricia] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Stanford University; Columbia University	Martinez-Estevez, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	mariadelourdes_martinez@yahoo.com.mx		Ceballos, Gerardo/0000-0001-8374-2656	National Council of Science and Technology (CONACyT) [83773]; J.M. Kaplan Fund; Whitley Fund for Nature; Fundacion Slim; International and Borderlands Program of the Arizona Game and Fish Department; National Council of Science and Technology (CONACyT)	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); J.M. Kaplan Fund; Whitley Fund for Nature; Fundacion Slim; International and Borderlands Program of the Arizona Game and Fish Department; National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors' work in the Janos region has been supported by many institutions. They are particularly grateful to the National Council of Science and Technology (CONACyT) through the project 83773, the J.M. Kaplan Fund, the Whitley Fund for Nature, the Fundacion Slim, and the International and Borderlands Program of the Arizona Game and Fish Department. LME was supported by a scholarship by the National Council of Science and Technology (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2006, J TORREY BOT SOC, V133, P626, DOI 10.3159/1095-5674(2006)133[626:EAOOTC]2.0.CO;2; [Anonymous], 1996, PRAIRIE CONSERVATION; Archer S., 2000, GLOBAL BIOGEOCHEMICA, P1; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Avila-Flores R., 2009, THESIS U ALBERTA EDM; Bagchi S, 2006, BIOL CONSERV, V127, P438, DOI 10.1016/j.biocon.2005.09.003; BONHAM CD, 1976, J RANGE MANAGE, V29, P221, DOI 10.2307/3897280; Brady N.C., 2004, ELEMENTS NATURE PROP, Vsecond; Cartron J.-L., 2005, BIODIVERSITY ECOSYST; Ceballos G, 1999, J ARID ENVIRON, V41, P161, DOI 10.1006/jare.1998.0479; CEBALLOS G, 1993, BIOL CONSERV, V63, P105, DOI 10.1016/0006-3207(93)90497-O; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Davidson AD, 2008, J ARID ENVIRON, V72, P2142, DOI 10.1016/j.jaridenv.2008.07.006; Davidson AD, 2008, J ARID ENVIRON, V72, P1133, DOI 10.1016/j.jaridenv.2007.12.015; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food and Agriculture Organization of the United Nations, 2010, INTEGRATED CROP MANA, V9; Fredrickson EL, 2006, J ARID ENVIRON, V65, P285, DOI 10.1016/j.jaridenv.2005.10.019; Garcia E, 1981, MODIFICACIONES SISTE, V3rd; Havstad Kris M., 2006, P3; Herrick J. E., 2005, MONITORING MANUAL GR, VI; Herrick J. E, 2005, MONITORING MANUAL GR, VII; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Huber-Sannwald E, 2006, HYDROL PROCESS, V20, P3395, DOI 10.1002/hyp.6337; Kay S, 2010, STRAIGHT FURROW; Kotliar Natasha B., 2006, P53; Kotliar NB, 1999, ENVIRON MANAGE, V24, P177, DOI 10.1007/s002679900225; KRUEGER K, 1986, ECOLOGY, V67, P760, DOI 10.2307/1937699; Letey J., 1985, Advances in soil science. Volume I, P277; List R, 2010, INT J WILDERNESS, V16, P35; Mc Ginty A, 2005, BRUSH BUSTERS AVOID; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller B, 2000, CONSERV BIOL, V14, P318, DOI 10.1046/j.1523-1739.2000.99201.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; Murray S., 2000, PILOT ANAL GLOBAL EC; Ortega-Ochoa C., 2008, RANGELANDS, V30, P2, DOI 10.2111/1551-501X-30.6.2; PELLANT M, 2005, INTERPRETING INDICAT, P1734; Peters DPC, 2006, BIOSCIENCE, V56, P491, DOI 10.1641/0006-3568(2006)56[491:DCLNII]2.0.CO;2; Proctor Jonathan, 2006, P232; Risser P, 2003, BIODIVERSITY, P176; Royo Marquez M. H., 2001, Tecnica Pecuaria en Mexico, V39, P89; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Siebe C., 2006, MANUAL DESCRIPCION E; Snyman HA, 2005, J ARID ENVIRON, V60, P457, DOI 10.1016/j.jaridenv.2004.06.006; Soil Survey Staff, 2010, KEYS SOIL TAX; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; WHICKER AD, 1988, BIOSCIENCE, V38, P778, DOI 10.2307/1310787; WRIGHT JP, 2006, BIOSCIENCE, P56	53	36	37	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75229	10.1371/journal.pone.0075229	http://dx.doi.org/10.1371/journal.pone.0075229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130691	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900023
J	Takata, H; Hanafusa, T; Mori, T; Shimura, M; Iida, Y; Ishikawa, K; Yoshikawa, K; Yoshikawa, Y; Maeshima, K				Takata, Hideaki; Hanafusa, Tomo; Mori, Toshiaki; Shimura, Mari; Iida, Yutaka; Ishikawa, Kenichi; Yoshikawa, Kenichi; Yoshikawa, Yuko; Maeshima, Kazuhiro			Chromatin Compaction Protects Genomic DNA from Radiation Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SINGLE-MOLECULE OBSERVATION; CHROMOSOME TERRITORIES; MITOTIC CHROMOSOMES; MAMMALIAN-CELLS; NUCLEAR ARCHITECTURE; IONIZING-RADIATION; ANTICANCER DRUGS; GAMMA-RADIATION; LIVING CELLS	Genomic DNA is organized three-dimensionally in the nucleus, and is thought to form compact chromatin domains. Although chromatin compaction is known to be essential for mitosis, whether it confers other advantages, particularly in interphase cells, remains unknown. Here, we report that chromatin compaction protects genomic DNA from radiation damage. Using a newly developed solid-phase system, we found that the frequency of double-strand breaks (DSBs) in compact chromatin after ionizing irradiation was 5-50-fold lower than in decondensed chromatin. Since radical scavengers inhibited DSB induction in decondensed chromatin, condensed chromatin had a lower level of reactive radical generation after ionizing irradiation. We also found that chromatin compaction protects DNA from attack by chemical agents. Our findings suggest that genomic DNA compaction plays an important role in maintaining genomic integrity.	[Takata, Hideaki; Hanafusa, Tomo; Maeshima, Kazuhiro] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan; [Takata, Hideaki] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan; [Mori, Toshiaki] Osaka Prefecture Univ, Ctr Radiat Res, Sakai, Osaka 591, Japan; [Shimura, Mari] Natl Ctr Global Hlth & Med, Dept Intractable Dis, Res Inst, Shinjuku Ku, Tokyo, Japan; [Iida, Yutaka] Toray Res Ctr Ltd, Inorgan Anal Labs, Otsu, Shiga, Japan; [Ishikawa, Kenichi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Adv Radiat Biol Res Program, Inage Ku, Chiba 260, Japan; [Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan; [Yoshikawa, Yuko] Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Shiga, Japan; [Maeshima, Kazuhiro] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Genet, Mishima, Shizuoka, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Osaka University; Osaka Metropolitan University; National Center for Global Health & Medicine - Japan; Toray Research Center, Inc.; National Institutes for Quantum Science & Technology; Kyoto University; Ritsumeikan University; Graduate University for Advanced Studies - Japan	Takata, H (corresponding author), Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan.	htakata@wakate.frc.eng.osaka-u.ac.jp; kmaeshim@lab.nig.ac.jp	Takata, Hideaki/L-6914-2018; Yoshikawa, Kenichi/N-1867-2019	Takata, Hideaki/0000-0001-9436-1517; Yoshikawa, Kenichi/0000-0002-2751-7136; Maeshima, Kazuhiro/0000-0003-3909-0341	JST CREST grant; NIG Collaborative Research (A); Naitoh Science Foundation	JST CREST grant; NIG Collaborative Research (A); Naitoh Science Foundation	JST CREST grant, NIG Collaborative Research (A), Naitoh Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2008, EPIGENETICS-US, V3, P300, DOI 10.4161/epi.3.6.7273; Aker T, 1977, OVARY, V3, P1; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Berezney R, 2005, ADV ENZYME REGUL, V45, P17, DOI 10.1016/j.advenzreg.2005.02.013; Bryant JM, 2012, MOL CELL BIOL, V32, P2771, DOI 10.1128/MCB.00282-12; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cole A., 1967, THEORETICAL BIOPHYSI, V1, P305; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179; De Schutter H, 2009, ANTICANCER AGENTS ME, V9, P99; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Douki T, 2000, RADIAT RES, V153, P29, DOI 10.1667/0033-7587(2000)153[0029:PARIDO]2.0.CO;2; ELIA MC, 1992, CANCER RES, V52, P1580; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Gan L, 2013, CHROMOSOMA; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hable V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041943; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Hancock R, 2007, SEMIN CELL DEV BIOL, V18, P668, DOI 10.1016/j.semcdb.2007.08.006; Hansen JC, 2012, EMBO J, V31, P1621, DOI 10.1038/emboj.2012.66; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Karagiannis TC, 2007, ONCOGENE, V26, P3963, DOI 10.1038/sj.onc.1210174; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kim MS, 2003, CANCER RES, V63, P7291; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; KRISCH RE, 1991, RADIAT RES, V126, P251, DOI 10.2307/3577826; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Ma H, 1998, J CELL BIOL, V143, P1415, DOI 10.1083/jcb.143.6.1415; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maeshima K, 2008, J BIOCHEM, V143, P145, DOI 10.1093/jb/mvm214; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; MILLIGAN JR, 1993, RADIAT RES, V133, P151, DOI 10.2307/3578350; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nozaki T, 2013, NUCLEUS-PHILA, V4, P349, DOI 10.4161/nucl.26053; NYGREN J, 1995, INT J RADIAT BIOL, V68, P11, DOI 10.1080/09553009514550861; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Quenet D, 2012, EMBO REP, V13, P943, DOI 10.1038/embor.2012.143; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Sadler TW., 2010, LANGMANS MED EMBRYOL, V11th; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SPOTHEIMMAURIZOT M, 1995, INT J RADIAT BIOL, V68, P571, DOI 10.1080/09553009514551561; Suzuki M, 2000, INT J RADIAT ONCOL, V48, P241, DOI 10.1016/S0360-3016(00)00568-X; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; Valota A, 2003, INT J RADIAT BIOL, V79, P643, DOI 10.1080/09553000310001596977; Vasireddy RS, 2010, CELL MOL LIFE SCI, V67, P291, DOI 10.1007/s00018-009-0181-5; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Ward JF, 1997, FACTORS CONTROLLING; WARTERS RL, 1992, RADIAT RES, V130, P309, DOI 10.2307/3578376; Warters RL, 1999, RADIAT RES, V151, P354, DOI 10.2307/3579948; WOODCOCK CLF, 1976, EXP CELL RES, V97, P101, DOI 10.1016/0014-4827(76)90659-5; Yoshikawa Y, 2006, BIOPHYS J, V90, P993, DOI 10.1529/biophysj.105.069963; Yoshikawa Y, 2008, CHEM PHYS LETT, V456, P80, DOI 10.1016/j.cplett.2008.03.009; Zhang F, 2009, CANCER BIOL THER, V8, P823, DOI 10.4161/cbt.8.9.8143; Zink D, 1999, EXP CELL RES, V247, P176, DOI 10.1006/excr.1998.4311	70	130	132	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75622	10.1371/journal.pone.0075622	http://dx.doi.org/10.1371/journal.pone.0075622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130727	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900046
J	Ullah, S; Ahmed, F; Badshah, A; Altaf, AA; Raza, R; Lal, B; Hussain, R				Ullah, Shafiq; Ahmed, Fiaz; Badshah, Amin; Altaf, Ataf Ali; Raza, Ramsha; Lal, Bhajan; Hussain, Rizwan			Solvothermal Preparation of ZnO Nanorods as Anode Material for Improved Cycle Life Zn/AgO Batteries	PLOS ONE			English	Article							ZINC ELECTRODES; SILVER-ZINC; NANOSTRUCTURES; MICROPARTICLES; ADDITIVES; POWDER; OXIDE	Nano materials with high surface area increase the kinetics and extent of the redox reactions, thus resulting in high power and energy densities. In this study high surface area zinc oxide nanorods have been synthesized by surfactant free ethylene glycol assisted solvothermal method. The nanorods thus prepared have diameters in the submicron range (300 similar to 500 nm) with high aspect ratio. They have uniform geometry and well aligned direction. These nanorods are characterized by XRD, SEM, Specific Surface Area Analysis, solubility in alkaline medium, EDX analysis and galvanostatic charge/discharge studies in Zn/AgO batteries. The prepared zinc oxide nanorods have low solubility in alkaline medium with higher structural stability, which imparts the improved cycle life stability to Zn/AgO cells.	[Ullah, Shafiq; Badshah, Amin; Lal, Bhajan] Quaid I Azam Univ, Dept Chem, Islamabad, Pakistan; [Ahmed, Fiaz; Raza, Ramsha; Hussain, Rizwan] Natl Engn & Sci Commiss, Islamabad, Pakistan; [Altaf, Ataf Ali] Bahauddin Zakariya Univ, Dept Chem, Sahiwal, Pakistan	Quaid I Azam University; National Engineering & Scientific Commission - Pakistan; Bahauddin Zakariya University	Badshah, A (corresponding author), Quaid I Azam Univ, Dept Chem, Islamabad, Pakistan.	aminbadshah@yahoo.com	Badshah, Amin/H-9397-2015; Altaf, Ataf Ali/A-5258-2013	Altaf, Ataf Ali/0000-0001-8018-5890	Quaid-i-Azam University	Quaid-i-Azam University	Funding from Quaid-i-Azam University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, J MATER CHEM, V21, P7723, DOI 10.1039/c1jm10720h; Baruah S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/013001; Braam KT, 2012, J POWER SOURCES, V199, P367, DOI 10.1016/j.jpowsour.2011.09.076; Cao Z, 2011, APPL SURF SCI, V257, P4151, DOI 10.1016/j.apsusc.2010.11.188; Coleman VA, 2006, ZINC OXIDE BULK, THIN FILMS AND NANOSTRUCTURES: PROCESSING, PROPERTIES AND APPLICATIONS, P1, DOI 10.1016/B978-008044722-3/50001-4; El Abedin SZ, 2012, AUST J CHEM, V65, P1529, DOI 10.1071/CH12330; Jothi N. S. N., 2012, ARCH APPL SCI RES, V4, P1698; Kalpana R., 2012, ARCH APPL SCI RES, V4, P1996; Karpinski AP, 1999, J POWER SOURCES, V80, P53, DOI 10.1016/S0378-7753(99)00164-0; Kiani MA, 2011, INT J ELECTROCHEM SC, V6, P2581; Kong JZ, 2010, J SOLID STATE CHEM, V183, P1359, DOI 10.1016/j.jssc.2010.04.005; Lee JH, 2011, APPL PHYS A-MATER, V102, P545, DOI 10.1007/s00339-010-6097-y; Lewis H, 2001, J POWER SOURCES, V96, P128, DOI 10.1016/S0378-7753(01)00489-X; Linden D., 2002, HDB BATTERIES, P18; Liu JP, 2009, J PHYS CHEM C, V113, P5336, DOI 10.1021/jp900427c; Park I, 2011, ORG ELECTRON, V12, P424, DOI 10.1016/j.orgel.2010.12.002; Ramimoghadam D, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-71; Salkind AJ, 1996, ELECTROCHEM SOC P, V95, P101; Shivkumar R, 1998, J POWER SOURCES, V75, P90, DOI 10.1016/S0378-7753(98)00096-2; SHIVKUMAR R, 1995, J POWER SOURCES, V55, P53, DOI 10.1016/0378-7753(94)02170-8; Skelton J, 1997, J POWER SOURCES, V80, P53; Smith DF, 1999, J POWER SOURCES, V80, P66, DOI 10.1016/S0378-7753(98)00251-1; Suryakala K, 2006, INT J ELECTROCHEM SC, V1, P372; Takahashi S, 2008, MATER LETT, V62, P3407, DOI 10.1016/j.matlet.2008.03.018; Ullah S, 2011, INT J ELECTROCHEM SC, V6, P3801; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Xiang Q, 2010, SENSOR ACTUAT B-CHEM, V143, P635, DOI 10.1016/j.snb.2009.10.007; Zhang H, 2009, J RARE EARTH, V27, P980, DOI 10.1016/S1002-0721(08)60374-9; Zhu LQ, 2009, J PHYS CHEM SOLIDS, V70, P45, DOI 10.1016/j.jpcs.2008.09.005	29	12	12	6	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75999	10.1371/journal.pone.0075999	http://dx.doi.org/10.1371/journal.pone.0075999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146807	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200007
J	Mukolo, A; Blevins, M; Victor, B; Vaz, LME; Sidat, M; Vergara, A				Mukolo, Abraham; Blevins, Meridith; Victor, Bart; Vaz, Lara M. E.; Sidat, Mohsin; Vergara, Alfredo			Correlates of Social Exclusion and Negative Labeling and Devaluation of People Living with HIV/AIDS in Rural Settings: Evidence from a General Household Survey in Zambezia Province, Mozambique	PLOS ONE			English	Article							HIV-RELATED STIGMA; SOUTH-AFRICAN WOMEN; DISCRIMINATORY ATTITUDES; AIDS STIGMA; CARE; SERVICES; INTERVENTIONS; PREVALENCE; PREDICTORS; KNOWLEDGE	Background: Increased HIV/AIDS knowledge and access to antiretroviral treatment (ART) have been hypothesized to decrease HIV stigma. However, stigma persists as a barrier to HIV services uptake. We studied the relationship between stigma, knowledge and attitudes towards HIV and its treatment, and confidence in the legal system (legal rights certitude). Methods: We analyzed data from a household survey of 3749 randomly sampled female heads of households in 259 enumeration areas across 14 districts of Zambezia Province, Mozambique. The questionnaire included questions about beliefs, attitudes and behavior towards PLWHA, HIV transmission knowledge, treatment-related beliefs, and legal rights certitude. Factor analysis distinguished two stigma constructs: Negative labeling and devaluation (NLD) and social exclusion (SoE). Multivariable linear regression was used to determine the association between stigma, knowledge of HIV/AIDS, treatment-related beliefs, and legal rights certitude, while controlling for variance in socio-demographics. Results: A 4-point increase in knowledge about HIV transmission was associated with more than a 3 unit decrease in NLD and SoE stigma scores (p<0.001). Given HIV transmission knowledge, a 25-point increase in legal rights certitude was associated with a 4.62 unit drop in NLD stigma (p<0.001); we did not detect an association between legal rights certitude and SoE stigma. Knowing at least one HIV positive person was associated with lower SoE (-3.17, 95% CI: -5.78, -0.56); no association with NLD (p = 0.1) was detected. ART efficacy belief was associated with higher NLD and lower SoE (2.90 increase and 6.94 decrease, respectively; p <= 0.001). Conclusion: Increasing knowledge about HIV transmission and access to ART are likely to reduce stigma, but neither of the two is a panacea. Raising community awareness of the legal rights of PLWHA might improve the efficacy of stigma reduction efforts. Strategies that focus on specific domains of stigma might be more effective than generic stigma reduction strategies.	[Mukolo, Abraham; Blevins, Meridith; Vaz, Lara M. E.; Vergara, Alfredo] Vanderbilt Univ Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN USA; [Mukolo, Abraham; Vaz, Lara M. E.; Vergara, Alfredo] Vanderbilt Univ Sch Med, Dept Prevent Med, Nashville, TN USA; [Blevins, Meridith] Vanderbilt Univ Sch Med, Dept Biostat, Nashville, TN USA; [Vaz, Lara M. E.] Friends Global Hlth, Maputo, Mozambique; [Sidat, Mohsin] Univ Eduardo Mondlane, Sch Med, Maputo, Mozambique; [Victor, Bart] Vanderbilt Univ, Owen Grad Sch Management, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Eduardo Mondlane University; Vanderbilt University	Mukolo, A (corresponding author), Vanderbilt Univ Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN USA.	abraham.mukolo@vanderbilt.edu		Blevins, Meridith/0000-0002-3861-9859; Sidat, Mohsin/0000-0002-8378-2014	United States Agency for International Development (USAID)-Mozambique through World Vision, Inc. [656-A-00-09-00141-00]; Vanderbilt University through the endowment of the Amos Christie Chair in Global Health	United States Agency for International Development (USAID)-Mozambique through World Vision, Inc.(United States Agency for International Development (USAID)); Vanderbilt University through the endowment of the Amos Christie Chair in Global Health	The Ogumaniha-SCIP baseline survey was supported by the United States Agency for International Development (USAID)-Mozambique (Award No. 656-A-00-09-00141-00) through a sub-grant from World Vision, Inc. Funding support for the secondary data analysis is from Vanderbilt University through the endowment of the Amos Christie Chair in Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2004, SCHIZOPHRENIA BULL, V30, P1049, DOI 10.1093/oxfordjournals.schbul.a007120; [Anonymous], 2008, HORIZONS OR TOOLKIT; [Anonymous], 1990, HUMAN DEV REPORT; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Campbell C, 2007, J HEALTH PSYCHOL, V12, P403, DOI 10.1177/1359105307076229; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; de Wit JBF, 2008, HIV MED, V9, P20, DOI 10.1111/j.1468-1293.2008.00586.x; Dlamini PS, 2007, PUBLIC HEALTH NURS, V24, P389, DOI 10.1111/j.1525-1446.2007.00649.x; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Ekstrand ML, 2012, AIDS BEHAV, V16, P700, DOI 10.1007/s10461-011-9888-z; Esses VM, 2004, PREJUDICE DISCRIMINA, P101; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Greeff M, 2010, INT J NURS STUD, V47, P475, DOI 10.1016/j.ijnurstu.2009.09.008; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Harrell FE, 2001, REGRESSION MODELING; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Holzemer W L, 2004, SAHARA J, V1, P165; Instituto Nacional de Saude (INS), 2009, MOZ NAT SURV PREV BE; Jorm AF, 2009, AUST NZ J PSYCHIAT, V43, P183, DOI 10.1080/00048670802653349; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kalofonos IA, 2010, MED ANTHROPOL Q, V24, P363, DOI 10.1111/j.1548-1387.2010.01109.x; Kohi TW, 2010, J ASSOC NURSE AIDS C, V21, P134, DOI 10.1016/j.jana.2009.09.004; Kohi TW, 2006, NURS ETHICS, V13, P404, DOI 10.1191/0969733006ne865oa; Kuppin S, 2006, AM J PUBLIC HEALTH, V96, P1766, DOI 10.2105/AJPH.2004.060855; Lau J, 2003, DISABIL REHABIL, V25, P1354, DOI 10.1080/09638280310001616349; Lau JTF, 2005, SEX TRANSM INFECT, V81, P113, DOI 10.1136/sti.2004.011767; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Little R. J. A., 1987, STAT ANAL MISSING DA; Luseno WK, 2010, AIDS PATIENT CARE ST, V24, P257, DOI 10.1089/apc.2009.0213; Luseno WK, 2009, AIDS CARE, V21, P178, DOI 10.1080/09540120802017594; MacPherson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026814; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Mall S, 2013, AIDS CARE, V25, P194, DOI 10.1080/09540121.2012.689810; Maman S, 2009, SOC SCI MED, V68, P2271, DOI 10.1016/j.socscimed.2009.04.002; Maughan-Brown B, 2010, SOC SCI MED, V70, P368, DOI 10.1016/j.socscimed.2009.09.041; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Monjok Emmanuel, 2009, Afr J Reprod Health, V13, P21; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Mukolo A, 2013, AIDS BEHAV, V17, P5, DOI 10.1007/s10461-011-0097-6; Mukolo A, 2010, J AM ACAD CHILD PSY, V49, P92, DOI 10.1016/j.jaac.2009.12.003; MULDER M, 1973, J PERS SOC PSYCHOL, V26, P151, DOI 10.1037/h0034468; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nthomang K, 2009, HEALTH CARE WOMEN IN, V30, P233, DOI 10.1080/07399330802662077; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Pearson CR, 2009, AIDS BEHAV, V13, P1189, DOI 10.1007/s10461-009-9596-0; Pescosolido BA, 2007, PSYCHIAT SERV, V58, P619, DOI 10.1176/appi.ps.58.5.619; Petros G, 2006, CULT HEALTH SEX, V8, P67, DOI 10.1080/13691050500391489; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Pulerwitz J, 2008, AIDS CARE, V20, P764, DOI 10.1080/09540120701506796; Pulerwitz J, 2010, PUBLIC HEALTH REP, V125, P272, DOI 10.1177/003335491012500218; Riessman CK, 2009, SOCIOL HEALTH ILL, V31, P300, DOI 10.1111/j.1467-9566.2008.1154_1.x; Roura M, 2009, SEX TRANSM INFECT, V85, P308, DOI 10.1136/sti.2008.033183; Roura M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-22; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Smith RA, 2012, AIDS BEHAV, V16, P525, DOI 10.1007/s10461-012-0154-9; Surkan PJ, 2010, AIDS CARE, V22, P803, DOI 10.1080/09540120903443392; Tee Y, 2009, SAHARA J-J SOC ASP H, V6, P179, DOI 10.1080/17290376.2009.9724946; Turan JM, 2010, AIDS BEHAV; UNAIDS/RST-ESA, 2012, MOZ KEY EL NAT RESP; UNAIDS/RST-ESA, 2008, HUM RIGHTS STIGM DIS; Uys L, 2009, AIDS PATIENT CARE ST, V23, P1059, DOI 10.1089/apc.2009.0085; Vergara AE, 2011, BASELINE SURVEY REPO; Visser MJ, 2009, AIDS CARE, V21, P197, DOI 10.1080/09540120801932157; Zuch M, 2012, AIDS BEHAV, V16, P564, DOI 10.1007/s10461-011-0089-6	72	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75744	10.1371/journal.pone.0075744	http://dx.doi.org/10.1371/journal.pone.0075744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24146771	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400016
J	Voet, A; Berenger, F; Zhang, KYJ				Voet, Arnout; Berenger, Francois; Zhang, Kam Y. J.			Electrostatic Similarities between Protein and Small Molecule Ligands Facilitate the Design of Protein-Protein Interaction Inhibitors	PLOS ONE			English	Article							DISCOVERY; SHAPE; IDENTIFICATION; BENCHMARKING; RECOGNITION; POTENTIALS; INTERFACES; LESSONS; DOCKING; BINDING	One of the underlying principles in drug discovery is that a biologically active compound is complimentary in shape and molecular recognition features to its receptor. This principle infers that molecules binding to the same receptor may share some common features. Here, we have investigated whether the electrostatic similarity can be used for the discovery of small molecule protein-protein interaction inhibitors (SMPPIIs). We have developed a method that can be used to evaluate the similarity of electrostatic potentials between small molecules and known protein ligands. This method was implemented in a software called EleKit. Analyses of all available (at the time of research) SMPPII structures indicate that SMPPIIs bear some similarities of electrostatic potential with the ligand proteins of the same receptor. This is especially true for the more polar SMPPIIs. Retrospective analysis of several successful SMPPIIs has shown the applicability of EleKit in the design of new SMPPIIs.	[Voet, Arnout; Berenger, Francois; Zhang, Kam Y. J.] RIKEN, Inst Labs, Zhang Initiat Res Unit, Wako, Saitama, Japan	RIKEN	Zhang, KYJ (corresponding author), RIKEN, Inst Labs, Zhang Initiat Res Unit, Wako, Saitama, Japan.	kamzhang@riken.jp	Zhang, Kam Y. J./B-3552-2012; Berenger, Francois/ABH-8997-2020; voet, arnout/O-5248-2014	Zhang, Kam Y. J./0000-0002-9282-8045; Berenger, Francois/0000-0003-1377-944X; voet, arnout/0000-0002-3329-2703	JSPS; Initiative Research Unit program from RIKEN, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Initiative Research Unit program from RIKEN, Japan	This work was supported by the JSPS and the Initiative Research Unit program from RIKEN, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Armstrong MS, 2010, J COMPUT AID MOL DES, V24, P789, DOI 10.1007/s10822-010-9374-0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blomberg N, 1999, PROTEINS, V37, P379, DOI 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K; CARBO R, 1980, INT J QUANTUM CHEM, V17, P1185, DOI 10.1002/qua.560170612; Cavalluzzo C, 2012, RSC ADV, V2, P974, DOI 10.1039/c1ra00582k; Chau PL, 1994, J COMPUT AID MOL DES, V8, P51325; Chemical Computing Group Inc, 2011, MOL OP ENV MOE; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Danelutto M, 2012, PROCEDIA COMPUT SCI, V9, P1837, DOI 10.1016/j.procs.2012.04.202; Dias R, 2008, CURR DRUG TARGETS, V9, P1040, DOI 10.2174/138945008786949432; Dlugosz M, 2012, J PHYS CHEM B, V116, P5437, DOI 10.1021/jp301265y; Dlugosz M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2948414; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fry DC, 2008, CURR PROTEIN PEPT SC, V9, P240, DOI 10.2174/138920308784533989; Fry DC, 2012, CURR PHARM DESIGN, V18, P4679; Gorham RD, 2011, ANN BIOMED ENG, V39, P1252, DOI 10.1007/s10439-010-0226-9; Hartman G, 1992, J MED CHEM, V35, P46402; HODGKIN EE, 1987, INT J QUANTUM CHEM, V14, P105; Horvath D, 2011, METHODS MOL BIOL, V672, P261, DOI 10.1007/978-1-60761-839-3_11; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Kieslich CA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002840; Kieslich CA, 2011, BIOTECHNOL PROGR, V27, P316, DOI 10.1002/btpr.541; Leroy X, 2011, OCAML SYSTEM RELEASE; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Muchmore SW, 2006, CHEM BIOL DRUG DES, V67, P174, DOI 10.1111/j.1747-0285.2006.00341.x; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Neudert G, 2011, BIOINFORMATICS, V27, P1021, DOI 10.1093/bioinformatics/btr055; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nray-Szab G, 1993, J MOL RECOGNIT, V6, P205; OpenEye Scientific Software Inc, 2010, OECHEM 1 7 4; PETKE JD, 1993, J COMPUT CHEM, V14, P928, DOI 10.1002/jcc.540140808; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Ullmann GM, 1997, BIOCHEMISTRY-US, V36, P16187, DOI 10.1021/bi971241v; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Villoutreix BO, 2012, CURR PHARM DESIGN, V18, P4648; Voet A, 2013, CURR TOP MED CHEM, V13, P989, DOI 10.2174/1568026611313090003; Voet A, 2012, CURR PHARM DESIGN, V18, P4586, DOI 10.2174/138161212802651616; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	49	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75762	10.1371/journal.pone.0075762	http://dx.doi.org/10.1371/journal.pone.0075762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130741	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200022
J	Weiser, K; Barton, M; Gershoony, D; DasGupta, R; Cardozo, T				Weiser, Keren; Barton, Meredith; Gershoony, Dafna; DasGupta, Ramanuj; Cardozo, Timothy			HIV's Nef Interacts with beta-Catenin of the Wnt Signaling Pathway in HEK293 Cells	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; CD4(+) T-CELLS; CLATHRIN-COATED VESICLES; CRYSTAL-STRUCTURE; DOWN-REGULATION; STRUCTURE PREDICTION; DILEUCINE MOTIF; SURFACE CD4; SUBUNIT-H; V-ATPASE	The Wnt signaling pathway is implicated in major physiologic cellular functions, such as proliferation, migration, cell fate specification, maintenance of pluripotency and induction of tumorigenicity. Proliferation and migration are important responses of T-cells, which are major cellular targets of HIV infection. Using an informatics screen, we identified a previously unsuspected interaction between HIV's Nef protein and beta-catenin, a key component of the Wnt pathway. A segment in Nef contains identical amino acids at key positions and structurally mimics the beta-catenin binding sites on endogenous beta-catenin ligands. The interaction between Nef and beta-catenin was confirmed in vitro and in a co-immunoprecipitation from HEK293 cells. Moreover, the introduction of Nef into HEK293 cells specifically inhibited a Wnt pathway reporter.	[Weiser, Keren; Barton, Meredith; Gershoony, Dafna; DasGupta, Ramanuj; Cardozo, Timothy] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA	New York University	Cardozo, T (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	Timothy.Cardozo@nyumc.org		Dasgupta, Ramanuj/0000-0001-9015-3729	National Institutes of Health [DP2 OD004631, P30AI027742]; NATIONAL CANCER INSTITUTE [R01CA155125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027742] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by: National Institutes of Health (http://www.nih.gov), Grant numbers: DP2 OD004631 and P30AI027742 (CFAR Developmental Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R, 1997, COMP SIM BIOMOL SYST, V3, P32; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P731, DOI 10.1007/s11481-012-9411-y; Allers K, 2010, J VIROL, V84, P3259, DOI 10.1128/JVI.01715-09; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Bucher P, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P53; Carroll-Anzinger D, 2007, J VIROL, V81, P5864, DOI 10.1128/JVI.02234-06; Churchill MJ, 2006, J VIROL, V80, P1047, DOI 10.1128/JVI.80.2.1047-1052.2006; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Djordjevic JT, 2004, AIDS RES HUM RETROV, V20, P547, DOI 10.1089/088922204323087804; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; Gail R, 2005, J BIOL CHEM, V280, P7107, DOI 10.1074/jbc.M410215200; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Henderson LJ, 2012, J NEUROSCI, V32, P16306, DOI 10.1523/JNEUROSCI.3145-12.2012; Hossain MZ, 2008, INT IMMUNOL, V20, P925, DOI 10.1093/intimm/dxn051; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIM SY, 1989, P NATL ACAD SCI USA, V86, P9544, DOI 10.1073/pnas.86.23.9544; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; KOHLEISEN B, 1992, AIDS, V6, P1427, DOI 10.1097/00002030-199212000-00002; Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Mandic R, 2001, MOL BIOL CELL, V12, P463, DOI 10.1091/mbc.12.2.463; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; MARIANI R, 1993, P NATL ACAD SCI USA, V90, P5549, DOI 10.1073/pnas.90.12.5549; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Narasipura SD, 2012, J VIROL, V86, P1911, DOI 10.1128/JVI.06266-11; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; OVOD V, 1992, AIDS, V6, P25, DOI 10.1097/00002030-199201000-00003; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sawai ET, 2000, J VIROL, V74, P2038, DOI 10.1128/JVI.74.4.2038-2045.2000; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; Sreenath K, 2010, VIROLOGY, V400, P76, DOI 10.1016/j.virol.2010.01.017; Stolp B, 2010, J VIROL, V84, P3935, DOI 10.1128/JVI.02467-09; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Sun J, 2011, J MOL BIOL, V405, P519, DOI 10.1016/j.jmb.2010.11.010; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Williams M, 2002, J VIROL, V76, P12173, DOI 10.1128/JVI.76.23.12173-12184.2002; Wortman B, 2002, J VIROL, V76, P11159, DOI 10.1128/JVI.76.21.11159-11165.2002; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108; Zsak L, 2001, J VIROL, V75, P3066, DOI 10.1128/JVI.75.7.3066-3076.2001	87	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77865	10.1371/journal.pone.0077865	http://dx.doi.org/10.1371/journal.pone.0077865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130899	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200095
J	Yang, J; Liu, DM; Jing, WX; Dahms, HU; Wang, L				Yang, Jian; Liu, Dongmei; Jing, Weixin; Dahms, Hans-Uwe; Wang, Lan			Effects of Cadmium on Lipid Storage and Metabolism in the Freshwater Crab Sinopotamon henanense	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; YANGTZE-RIVER; HEAVY-METALS; YELLOW-RIVER; ACCUMULATION; TOXICITY; METALLOTHIONEIN; HEPATOPANCREAS; PEROXIDATION; HEPATOCYTES	Since environmental effects of molecular traits are often questioned we analyze here the molecular effects of cadmium (Cd) on lipid pathways and their effects on tissues development. Lipids are an important energy source for the developing embryo, and accumulate in the ovary and hepatopancreas of decapod crustaceans. The extend of Cd affecting lipid storage and metabolism, is studied here with the freshwater crabs Sinopotamon henanense. Crabs were exposed to water-born Cd at 1.45, 2.9, 5.8 mg/l for 10, 15, and 20 days. With significantly increased Cd accumulation in exposed crabs, lipid content in hepatopancreas and ovary showed a time-dependent and concentration-dependent reduction, being at least one of the reasons for a lower ovarian index (OI) and hepatopancreatic index (HI). After 10-day exposure increased triglyceride (TG) level in hemolymph and up-regulation of pancreatic lipase (PL) activity in the hepatopancreas suggested an increased nutritional lipid uptake. However, two processes led to lower lipid levels upon Cd exposure: an increased utilization of lipids and a down-regulated lipoprotein lipase (LPL) led to insufficient lipid transport. 10-day Cd exposure also triggered the production of beta-nicotinamide adenine dinucleotide 2'-phosphate reduced tetrasodium salt hydrate (NADPH), as well as to the synthesis of adenosine triphosphate (ATP) and fatty acids. With increasing exposure time, the crabs at 15 and 20-day exposure contained less lipid and TG, suggesting that more energy was consumed during the exposure time. Meanwhile, the level of NADPH, ATP and the activity of PL, LPL, fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC) activity was down-regulated suggesting an impairment of the crab metabolism by Cd in addition to causing a lower lipid level.	[Yang, Jian; Liu, Dongmei; Jing, Weixin; Wang, Lan] Shanxi Univ, Sch Life Sci, Lab Bioeffect & Mol Mech Class Environm Pollutant, Taiyuan, Shanxi Province, Peoples R China; [Dahms, Hans-Uwe] Sangmyung Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea	Shanxi University; Sang Myung University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Lab Bioeffect & Mol Mech Class Environm Pollutant, Taiyuan, Shanxi Province, Peoples R China.	lanwang@sxu.edu.cn			National Science Foundation of China [30870267, 30970361]; Shanxi Province Nature Science Foundation [2008011069]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Province Nature Science Foundation	This research was supported by a grant from the National Science Foundation of China (30870267 and 30970361) and Shanxi Province Nature Science Foundation (2008011069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAVA VR, 1993, NIPPON SUICAN GAKKAI, V59, P345, DOI DOI 10.2331/SUISAN.59.345; ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; Andre JM, 2007, COMP BIOCHEM PHYS A, V148, P899, DOI 10.1016/j.cbpa.2007.09.006; ANGER K, 1986, MAR BIOL, V90, P261, DOI 10.1007/BF00569137; Bai JH, 2012, J HYDROL, V450, P244, DOI 10.1016/j.jhydrol.2012.05.006; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calhoa CF, 2012, ECOTOXICOLOGY, V21, P48, DOI 10.1007/s10646-011-0762-6; CAREY C, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432406; Chen Yao-wu, 2007, Journal of China University of Petroleum, V31, P74; Cheng Yong-Xu, 1998, Acta Zoologica Sinica, V44, P420; CHINNI S, 2004, J APPL AQUACULT, V14, P47, DOI DOI 10.1300/J028V14N03_; Corticeiro SC, 2006, ENZYME MICROB TECH, V40, P132, DOI 10.1016/j.enzmictec.2005.10.053; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; ENGEL DW, 1979, ENVIRON HEALTH PERSP, V28, P81, DOI 10.2307/3428908; Feng JL, 2010, SCI CHINA CHEM, V53, P1217, DOI 10.1007/s11426-010-0089-9; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Firat O, 2010, FISH PHYSIOL BIOCHEM, V36, P647, DOI 10.1007/s10695-009-9337-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Goldberg IJ, 1996, J LIPID RES, V37, P693; Han Tuo, 2008, Sichuan Journal of Zoology, V27, P804; HAVEL RJ, 1987, AM J PHYSIOL, V253, pE1, DOI 10.1152/ajpendo.1987.253.1.E1; KANG X, 2012, TOXIC DRUGS TEST, V4, P221; Larregle EV, 2008, FOOD CHEM TOXICOL, V46, P1786, DOI 10.1016/j.fct.2008.01.018; LAUTIER J, 1988, BIOCHEM SYST ECOL, V16, P203, DOI 10.1016/0305-1978(88)90098-1; Li Yong-Quan, 2008, Acta Hydrobiologica Sinica, V32, P373; Lin S, 2002, CHEM GEOL, V182, P377, DOI 10.1016/S0009-2541(01)00331-X; Liu DM, 2011, AQUAT TOXICOL, V105, P394, DOI 10.1016/j.aquatox.2011.07.013; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Lubzens E, 1995, ISR J AQUACULT-BAMID, V47, P185; Lucia M, 2010, ECOTOXICOLOGY, V19, P163, DOI 10.1007/s10646-009-0401-7; MA W, 2007, ENVIRON TOXICOL, V23, P393; Mendez L, 2001, MAR BIOL, V138, P687, DOI 10.1007/s002270000508; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; MOURENTE G, 1994, MAR BIOL, V121, P187, DOI 10.1007/BF00349488; Pacyna JM, 2009, ATMOS ENVIRON, V43, P117, DOI 10.1016/j.atmosenv.2008.09.066; Pan LQ, 2006, COMP BIOCHEM PHYS C, V144, P67, DOI 10.1016/j.cbpc.2006.06.001; Pierron F, 2007, AQUAT TOXICOL, V81, P304, DOI 10.1016/j.aquatox.2006.12.014; Pirrone N., 2010, ATMOSPHERIC CHEM PHY, V10, P4719, DOI DOI 10.5194/ACPD-10-4719-2010; Revathi P, 2011, ECOTOX ENVIRON SAFE, V74, P623, DOI 10.1016/j.ecoenv.2010.08.027; ROMERO MJM, 1991, TOXICOL APPL PHARM, V111, P485, DOI 10.1016/0041-008X(91)90252-A; SAMYAL A, 2011, J FOOD SCI TECHNOL, V3, P160; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; TESHIMA S, 1983, B JPN SOC SCI FISH, V49, P957; TORREBLANCA A, 1991, B ENVIRON CONTAM TOX, V47, P933, DOI 10.1007/BF01689526; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Venugopal NBRK, 1997, B ENVIRON CONTAM TOX, V59, P132, DOI 10.1007/s001289900455; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WANG J, 2007, BIOCHEMISTRY; Wang L, 2008, CHEMOSPHERE, V74, P51, DOI 10.1016/j.chemosphere.2008.09.025; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024405; Weinstock PH, 1997, P NATL ACAD SCI USA, V94, P10261, DOI 10.1073/pnas.94.19.10261; Wen XB, 2001, COMP BIOCHEM PHYS B, V130, P95, DOI 10.1016/S1096-4959(01)00411-0; Winzer K, 2001, J HISTOCHEM CYTOCHEM, V49, P1025, DOI 10.1177/002215540104900810; WRIGHT DA, 1977, J EXP BIOL, V67, P163; Wu JP, 2005, COMP BIOCHEM PHYS C, V140, P383, DOI 10.1016/j.cca.2005.03.006; XUAN R, 2013, GUANGDONG AGR SCI, V7, P123; Xuan RJ, 2011, COMP BIOCHEM PHYS C, V154, P268, DOI 10.1016/j.cbpc.2011.06.005; Xue L.Z., 1987, J E CHINA NORMAL U N, V3, P88; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701; Zhao S, 2012, MAR POLLUT BULL, V64, P1163, DOI 10.1016/j.marpolbul.2012.03.023; Zhou LB, 2012, APPL MECH MATER, V209-211, P1116, DOI 10.4028/www.scientific.net/AMM.209-211.1116	64	32	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77569	10.1371/journal.pone.0077569	http://dx.doi.org/10.1371/journal.pone.0077569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130894	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200091
J	Perry, C; Pick, M; Bdolach, N; Hazan-Halevi, I; Kay, S; Berr, I; Reches, A; Harishanu, Y; Grisaru, D				Perry, Chava; Pick, Marjorie; Bdolach, Nir; Hazan-Halevi, Inbal; Kay, Sigi; Berr, Idit; Reches, Adi; Harishanu, Yair; Grisaru, Dan			Endurance Exercise Diverts the Balance between Th17 Cells and Regulatory T Cells	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TGF-BETA; IMMUNE FUNCTION; PHYSICAL-ACTIVITY; ASTHMA; INFLAMMATION; MECHANISMS; CYTOKINE; RESPONSES; MARATHON	Endurance, marathon-type exertion is known to induce adverse changes in the immune system. Increased airway hyper-responsiveness and airway inflammation are well documented in endurance athletes and endurance exercise is considered a major risk factor for asthma in elite athletes. Yet, the mechanisms underlying this phenomenon are still to be deduced. We studied the effect of strenuous endurance exercise (marathon and half-ironman triathlon) on CD4+ lymphocyte sub-populations and on the balance between effector and regulatory CD4+ lymphocytes in the peripheral blood of trained athletes, Endurance exercise induced a significant increase in Th17 cells and a sustained decrease in peripheral blood regulatory T cells (Tregs). While interleukin (IL)-2 levels remained undetectable, post-race serum IL-6 and transforming growth factor (TGF) beta levels were significantly elevated. Treg levels in sedentary controls' decreased in vitro after incubation with athletes' post-exercise serum, an effect that was attenuated by supplements of IL-2 or anti IL-6 neutralizing antibodies. Our data suggest that exercise-induced changes in serum cytokine levels promote alterations in Tregs and Th17 cell populations, which may divert the subtle balance in the immune system towards inflammation. This may explain allergic and autoimmune phenomena previously reported in endurance athletes and contribute to our understanding of exercise-related asthma.	[Perry, Chava; Hazan-Halevi, Inbal; Kay, Sigi; Berr, Idit; Harishanu, Yair] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-69978 Tel Aviv, Israel; [Pick, Marjorie] Hebrew Univ Jerusalem, Dept Hematol, Hadassah Univ Hosp, Jerusalem, Israel; [Bdolach, Nir; Reches, Adi; Grisaru, Dan] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Obstet & Gynecol, Gynecol Oncol Unit,Lis Matern Hosp, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Perry, C (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-69978 Tel Aviv, Israel.	chavap@tlvmc.gov.il			Department of Hematology, Tel Aviv Medical Center	Department of Hematology, Tel Aviv Medical Center	The work was funded by Department of Hematology, Tel Aviv Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaranta A, 2004, MED SCI SPORT EXER, V36, P919, DOI 10.1249/01.MSS.0000128250.17793.47; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Balen S, 2008, COLLEGIUM ANTROPOL, V32, P285; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Das UN, 2004, NUTRITION, V20, P323, DOI 10.1016/j.nut.2003.11.017; Das UN, 2006, EUR HEART J, V27, P1385, DOI 10.1093/eurheartj/ehi867; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Haahtela T, 2008, ALLERGY, V63, P685, DOI 10.1111/j.1398-9995.2008.01686.x; Helenius I, 2002, J ALLERGY CLIN IMMUN, V109, P962, DOI 10.1067/mai.2002.124769; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; Neubauer O, 2008, EUR J APPL PHYSIOL, V104, P417, DOI 10.1007/s00421-008-0787-6; Nicklas BJ, 2008, J AM GERIATR SOC, V56, P2045, DOI 10.1111/j.1532-5415.2008.01994.x; Nieman DC, 1999, SPORTS MED, V27, P73, DOI 10.2165/00007256-199927020-00001; NIEMAN DC, 1990, J SPORT MED PHYS FIT, V30, P316; Nystad W, 2000, MED SCI SPORT EXER, V32, P266, DOI 10.1097/00005768-200002000-00003; Robson-Ansley P, 2012, MED SCI SPORT EXER, V44, P999, DOI 10.1249/MSS.0b013e318243253d; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wang J, 2012, SCAND J MED SCI SPOR, V22, P643, DOI 10.1111/j.1600-0838.2010.01288.x; Wang RF, 2006, SEMIN CANCER BIOL, V16, P106, DOI 10.1016/j.semcancer.2005.11.004; Xu QY, 2007, J IMMUNOL, V178, P3983, DOI 10.4049/jimmunol.178.6.3983; Yegutkin GG, 2007, J PHYSIOL-LONDON, V579, P553, DOI 10.1113/jphysiol.2006.119453; Yeh SH, 2006, BRIT J SPORT MED, V40, P239, DOI 10.1136/bjsm.2005.022095; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	37	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74722	10.1371/journal.pone.0074722	http://dx.doi.org/10.1371/journal.pone.0074722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130669	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900005
J	Salih, MA; Mundwiller, E; Khan, AO; AlDrees, A; Elmalik, SA; Hassan, HH; Al-Owain, M; Alkhalidi, HMS; Katona, I; Kabiraj, MM; Chrast, R; Kentab, AY; Alzaidan, H; Rodenburg, RJ; Bosley, TM; Weis, J; Koenig, M; Stevanin, G; Azzedine, H				Salih, Mustafa A.; Mundwiller, Emeline; Khan, Arif O.; AlDrees, Abdulmajeed; Elmalik, Salah A.; Hassan, Hamdy H.; Al-Owain, Mohammed; Alkhalidi, Hisham M. S.; Katona, Istvan; Kabiraj, Mohammad M.; Chrast, Roman; Kentab, Amal Y.; Alzaidan, Hamad; Rodenburg, Richard J.; Bosley, Thomas M.; Weis, Joachim; Koenig, Michel; Stevanin, Giovanni; Azzedine, Hamid			New Findings in a Global Approach to Dissect the Whole Phenotype of PLA2G6 Gene Mutations	PLOS ONE			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; PHOSPHOLIPASE A(2); PARKINSONISM; DEFICIENCY; SPECTRUM	Mutations in PLA2G6 gene have variable phenotypic outcome including infantile neuroaxonal dystrophy, atypical neuroaxonal dystrophy, idiopathic neurodegeneration with brain iron accumulation and Karak syndrome. The cause of this phenotypic variation is so far unknown which impairs both genetic diagnosis and appropriate family counseling. We report detailed clinical, electrophysiological, neuroimaging, histologic, biochemical and genetic characterization of 11 patients, from 6 consanguineous families, who were followed for a period of up to 17 years. Cerebellar atrophy was constant and the earliest feature of the disease preceding brain iron accumulation, leading to the provisional diagnosis of a recessive progressive ataxia in these patients. Ultrastructural characterization of patients' muscle biopsies revealed focal accumulation of granular and membranous material possibly resulting from defective membrane homeostasis caused by disrupted PLA2G6 function. Enzyme studies in one of these muscle biopsies provided evidence for a relatively low mitochondrial content, which is compatible with the structural mitochondrial alterations seen by electron microscopy. Genetic characterization of 11 patients led to the identification of six underlying PLA2G6 gene mutations, five of which are novel. Importantly, by combining clinical and genetic data we have observed that while the phenotype of neurodegeneration associated with PLA2G6 mutations is variable in this cohort of patients belonging to the same ethnic background, it is partially influenced by the genotype, considering the age at onset and the functional disability criteria. Molecular testing for PLA2G6 mutations is, therefore, indicated in childhood-onset ataxia syndromes, if neuroimaging shows cerebellar atrophy with or without evidence of iron accumulation.	[Salih, Mustafa A.; Kentab, Amal Y.] King Saud Univ, Coll Med, Div Pediat Neurol, Riyadh 11461, Saudi Arabia; [Mundwiller, Emeline; Stevanin, Giovanni] Grp Hosp Pitie Salpetriere, Genotyping & Sequencing Facil, Inst Cerveau & Moelle Epiniere ICM, F-75634 Paris, France; [Khan, Arif O.] King Khalid Eye Specialist Hosp, Div Paediat Ophthalmol, Riyadh, Saudi Arabia; [AlDrees, Abdulmajeed; Elmalik, Salah A.] King Saud Univ, Coll Med, Dept Physiol, Riyadh 11461, Saudi Arabia; [Hassan, Hamdy H.] King Saud Univ, Coll Med, Dept Radiol, Riyadh 11461, Saudi Arabia; [Al-Owain, Mohammed; Alzaidan, Hamad] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia; [Alkhalidi, Hisham M. S.] King Saud Univ, Coll Med, Dept Pathol, Riyadh 11461, Saudi Arabia; [Katona, Istvan; Weis, Joachim] Univ Klinikum RWTH, Inst Neuropathol, Aachen, Germany; [Kabiraj, Mohammad M.] Armed Forces Hosp, Dept Neurosci, Riyadh, Saudi Arabia; [Chrast, Roman; Azzedine, Hamid] Univ Lausanne, Dept Med Genet, Fac Biol & Med, Lausanne, Switzerland; [Rodenburg, Richard J.] Radboud Univ Nijmegen, Lab Genet Endocrine & Metab disorders LGEM 774, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat,Dept Lab Med,Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Bosley, Thomas M.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Bosley, Thomas M.] Cooper Univ Hosp, Div Neurol, Camden, NJ USA; [Koenig, Michel] Univ Strasbourg, INSERM, CNRS, IGBMC, Illkirch Graffenstaden, France; [Koenig, Michel] Coll France, Illkirch Graffenstaden, France; [Stevanin, Giovanni] EPHE, F-75006 Paris, France; [Stevanin, Giovanni] INSERM, U975, Paris, France; [Stevanin, Giovanni] CNRS, UMR 7225, Paris, France; [Stevanin, Giovanni] Univ Paris 06, UMR S 975, Ctr Rech, Inst Cerveau & Moelle Epiniere,GHPS, Paris, France; [Stevanin, Giovanni] GPHS, AP HP, Dept Genet & Cytogenet, Paris, France	King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; King Khaled Eye Specialist Hospital; King Saud University; King Saud University; King Faisal Specialist Hospital & Research Center; King Saud University; RWTH Aachen University; RWTH Aachen University Hospital; Prince Sultan Military Medical City; University of Lausanne; Radboud University Nijmegen; King Saud University; Cooper University Hospital; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP)	Azzedine, H (corresponding author), Univ Lausanne, Dept Med Genet, Fac Biol & Med, Lausanne, Switzerland.	Hamid.Azzeddine@yahoo.fr	Stevanin, Giovanni/E-5038-2016; AL-DREES, ABDULMAJEED A/N-9534-2016; Rodenburg, Richard/N-3579-2014; Salih, Mustafa/C-1222-2014; Katona, Istvan/I-6704-2016; Weis, Joachim/G-1984-2014	Stevanin, Giovanni/0000-0001-9368-8657; AL-DREES, ABDULMAJEED A/0000-0002-3125-050X; Rodenburg, Richard/0000-0001-5227-3527; Salih, Mustafa/0000-0002-4379-2111; Katona, Istvan/0000-0002-0955-8911; Weis, Joachim/0000-0003-3280-6773; Chrast, Roman/0000-0003-4189-3514; Kentab, Amal/0000-0002-3627-4973	King Saud University, Riyadh, Saudi Arabia [RGP-VPP]; Gebert Ruf Foundation [GRS-046/09]; French National Agency for Research(ANR); Association Contre les Syndromes Cerebelleux, France; Verum Foundation; European Union (Omics call, "Neuromics"); Fondation Roger de Spoelberch; program "Investissements d'avenir" [ANR-10-IAIHU-06]; Association Francaise contre les Myopathies (AFM), France	King Saud University, Riyadh, Saudi Arabia(King Saud University); Gebert Ruf Foundation; French National Agency for Research(ANR)(French National Research Agency (ANR)); Association Contre les Syndromes Cerebelleux, France; Verum Foundation; European Union (Omics call, "Neuromics"); Fondation Roger de Spoelberch; program "Investissements d'avenir"(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM), France(Association Francaise contre les Myopathies)	MAM and co-authors are thankful to the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia, for supporting the work through the research group project number RGP-VPP. RC was supported by the Gebert Ruf Foundation (grant number GRS-046/09). GS was supported by the French National Agency for Research(ANR), Association Contre les Syndromes Cerebelleux, France, The Verum Foundation, the European Union (Omics call, "Neuromics"), The Fondation Roger de Spoelberch and the program "Investissements d'avenir" ANR-10-IAIHU-06 (to the Brain and Spine Institute). HA was supported by Association Francaise contre les Myopathies (AFM), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoum M, 2013, CEREBELLUM; Assoum M, 2010, BRAIN, V133, P2439, DOI 10.1093/brain/awq181; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Biancheri R, 2007, EUR J PAEDIATR NEURO, V11, P175, DOI 10.1016/j.ejpn.2006.11.013; Bower MA, 2011, MOVEMENT DISORD, V26, P1768, DOI 10.1002/mds.23617; Carrilho I, 2008, EUR J PAEDIATR NEURO, V12, P491, DOI 10.1016/j.ejpn.2008.01.005; FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735; Garcia A, 2000, CLIN NEUROPHYSIOL, V111, P513, DOI 10.1016/S1388-2457(99)00279-5; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Grosser HR, 2007, EUR RESPIR J, V1, P73; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kimura J, 2001, ELECTRODIAGNOSIS DIS, P109; Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lu CS, 2012, AM J MED GENET B, V159B, P183, DOI 10.1002/ajmg.b.32012; Mehler MF, 2009, BRAIN RES REV, V59, P388, DOI 10.1016/j.brainresrev.2008.11.001; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Mubaidin A, 2003, J MED GENET, V40, P543, DOI 10.1136/jmg.40.7.543; Oh SJ, 2003, CLIN ELECTROMYOGRAPH, V3rd; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Preston DC, 2005, ELECTROMYOGRAPHY NEU, P628; SALIH MAM, 1990, J CHILD NEUROL, V5, P321, DOI 10.1177/088307389000500410; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P254, DOI 10.2174/157015908785777193; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sina F, 2009, EUR J NEUROL, V16, P101, DOI 10.1111/j.1468-1331.2008.02356.x; SPERL W, 1990, EUR J PEDIATR, V149, P487, DOI 10.1007/BF01959401; Tonelli A, 2010, CLIN GENET, V78, P432, DOI 10.1111/j.1399-0004.2010.01417.x; WEIS J, 1995, MUSCLE NERVE, V18, P175, DOI 10.1002/mus.880180205; Wu Y, 2009, EUR J NEUROL, V16, P240, DOI 10.1111/j.1468-1331.2008.02397.x; Yoshino H, 2010, NEUROLOGY, V75, P1356, DOI 10.1212/WNL.0b013e3181f73649; Zhao ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026991; Zhao ZS, 2011, ENDOCRINOLOGY, V152, P336; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	36	31	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76831	10.1371/journal.pone.0076831	http://dx.doi.org/10.1371/journal.pone.0076831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130795	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900090
J	Smith, HC; Pollock, K; Waples, K; Bradley, S; Bejder, L				Smith, Holly C.; Pollock, Ken; Waples, Kelly; Bradley, Stuart; Bejder, Lars			Use of the Robust Design to Estimate Seasonal Abundance and Demographic Parameters of a Coastal Bottlenose Dolphin (Tursiops aduncus) Population	PLOS ONE			English	Article							CAPTURE-RECAPTURE; TEMPORARY EMIGRATION; PHOTOGRAPHIC IDENTIFICATION; SITE FIDELITY; GROUP-SIZE; SHARK BAY; TRUNCATUS; PATTERNS; SURVIVAL; HABITAT	As delphinid populations become increasingly exposed to human activities we rely on our capacity to produce accurate abundance estimates upon which to base management decisions. This study applied mark-recapture methods following the Robust Design to estimate abundance, demographic parameters, and temporary emigration rates of an Indo-Pacific bottlenose dolphin (Tursiops aduncus) population off Bunbury, Western Australia. Boat-based photo-identification surveys were conducted year-round over three consecutive years along pre-determined transect lines to create a consistent sampling effort throughout the study period and area. The best fitting capture-recapture model showed a population with a seasonal Markovian temporary emigration with time varying survival and capture probabilities. Abundance estimates were seasonally dependent with consistently lower numbers obtained during winter and higher during summer and autumn across the three-year study period. Specifically, abundance estimates for all adults and juveniles (combined) varied from a low of 63 (95% CI 59 to 73) in winter of 2007 to a high of 139 (95% CI 134 to148) in autumn of 2009. Temporary emigration rates (gamma') for animals absent in the previous period ranged from 0.34 to 0.97 (mean = 0.54; +/- SE 0.11) with a peak during spring. Temporary emigration rates for animals present during the previous period (gamma '') were lower, ranging from 0.00 to 0.29, with a mean of 0.16 (+/- SE 0.04). This model yielded a mean apparent survival estimate for juveniles and adults (combined) of 0.95 (+/- SE 0.02) and a capture probability from 0.07 to 0.51 with a mean of 0.30 (+/- SE 0.04). This study demonstrates the importance of incorporating temporary emigration to accurately estimate abundance of coastal delphinids. Temporary emigration rates were high in this study, despite the large area surveyed, indicating the challenges of sampling highly mobile animals which range over large spatial areas.	[Smith, Holly C.; Pollock, Ken; Waples, Kelly; Bradley, Stuart; Bejder, Lars] Murdoch Univ, Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Sch Vet & Life Sci, Perth, WA, Australia; [Smith, Holly C.; Waples, Kelly] Dept Environm & Conservat, Nat Conservat Div, Marine Sci Program, Perth, WA, Australia; [Pollock, Ken] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	Murdoch University; University of North Carolina; North Carolina State University	Smith, HC (corresponding author), Murdoch Univ, Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Sch Vet & Life Sci, Perth, WA, Australia.	h.smith@murdoch.edu.au	Bejder, Lars/D-1772-2017	Bejder, Lars/0000-0001-8138-8606; Raudino, Holly/0000-0002-2661-6431	South West Marine Research Program; Bemax Cable Sands; BHP Billiton Worsley Alumina Pty Ltd; Bunbury Dolphin Discovery Centre; Bunbury Port Authority; City of Bunbury; Cristal Global; Department of Environment and Conservation; Iluka; Millard Marine; Naturaliste Charters; Newmont Boddington Gold; South West Development Commission; WA Plantation Resources; Murdoch University	South West Marine Research Program; Bemax Cable Sands; BHP Billiton Worsley Alumina Pty Ltd; Bunbury Dolphin Discovery Centre; Bunbury Port Authority; City of Bunbury; Cristal Global; Department of Environment and Conservation; Iluka; Millard Marine; Naturaliste Charters; Newmont Boddington Gold; South West Development Commission; WA Plantation Resources; Murdoch University	This project was financially and logistically supported by the partners of the South West Marine Research Program. These include Bemax Cable Sands, BHP Billiton Worsley Alumina Pty Ltd, Bunbury Dolphin Discovery Centre, Bunbury Port Authority, the City of Bunbury, Cristal Global, Department of Environment and Conservation, Iluka, Millard Marine, Naturaliste Charters, Newmont Boddington Gold, South West Development Commission and WA Plantation Resources. HS was supported by a Murdoch University scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Bearzi G, 2008, AQUAT CONSERV, V18, P130, DOI 10.1002/aqc.843; Beasley I, 2013, MAR MAMMAL SCI, V29, pE226, DOI 10.1111/j.1748-7692.2012.00614.x; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; Currey RJC, 2008, NEW ZEAL J MAR FRESH, V42, P439, DOI 10.1080/00288330809509972; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; Donaldson R, 2012, ANIM CONSERV, V15, P427, DOI 10.1111/j.1469-1795.2012.00548.x; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fury CA, 2008, MAR FRESHWATER RES, V59, P1015, DOI 10.1071/MF08109; Genov Tilen, 2008, Annales Series Historia Naturalis, V18, P227; Gowans S, 2001, MAR MAMMAL SCI, V17, P76, DOI 10.1111/j.1748-7692.2001.tb00981.x; Gubbins C, 2002, J MAMMAL, V83, P178, DOI 10.1644/1545-1542(2002)083<0178:UOHRBR>2.0.CO;2; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kendall W. L., 2004, Animal Biodiversity and Conservation, V27, P97; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Krebs, 2001, ECOLOGY; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Reynolds J. R. I., 2000, BOTTLENOSE DOLPHIN B; Rosel PE, 2011, NMFSSEFSC621 NOAA, P38; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Straley JM, 2009, J BIOGEOGR, V36, P427, DOI 10.1111/j.1365-2699.2008.01906.x; Toth JL, 2012, MAR MAMMAL SCI, V28, P461, DOI 10.1111/j.1748-7692.2011.00497.x; Urian K., 1999, 425 NMFSSEFSC NAT OC, P22; Urian KW, 2009, MAR MAMMAL SCI, V25, P619, DOI 10.1111/j.1748-7692.2009.00284.x; Verborgh P, 2009, MAR MAMMAL SCI, V25, P523, DOI 10.1111/j.1748-7692.2008.00280.x; Vermeulen Els, 2009, Aquatic Mammals, V35, P378, DOI 10.1578/AM.35.3.2009.378; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Watson-Capps JJ, 2005, BIOL CONSERV, V124, P519, DOI 10.1016/j.biocon.2005.03.001; Wells R.S., 1991, P199; Wells RS, 2008, MAR MAMMAL SCI, V24, P774, DOI 10.1111/j.1748-7692.2008.00212.x; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams K. B., 2002, ANAL MANAGEMENT ANIM, P3; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1	53	67	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76574	10.1371/journal.pone.0076574	http://dx.doi.org/10.1371/journal.pone.0076574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130781	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900077
J	Watanabe, M; Nakano, K; Matsunari, H; Matsuda, T; Maehara, M; Kanai, T; Kobayashi, M; Matsumura, Y; Sakai, R; Kuramoto, M; Hayashida, G; Asano, Y; Takayanagi, S; Arai, Y; Umeyama, K; Nagaya, M; Hanazono, Y; Nagashima, H				Watanabe, Masahito; Nakano, Kazuaki; Matsunari, Hitomi; Matsuda, Taisuke; Maehara, Miki; Kanai, Takahiro; Kobayashi, Mirina; Matsumura, Yukina; Sakai, Rieko; Kuramoto, Momoko; Hayashida, Gota; Asano, Yoshinori; Takayanagi, Shuko; Arai, Yoshikazu; Umeyama, Kazuhiro; Nagaya, Masaki; Hanazono, Yutaka; Nagashima, Hiroshi			Generation of Interleukin-2 Receptor Gamma Gene Knockout Pigs from Somatic Cells Genetically Modified by Zinc Finger Nuclease-Encoding mRNA	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; EMBRYO MICROINJECTION; LYMPHOID DEVELOPMENT; CLONED PIGS; MICE; DISRUPTION; CLONING; MODEL; CHAIN; RATS	Zinc finger nuclease (ZFN) is a powerful tool for genome editing. ZFN-encoding plasmid DNA expression systems have been recently employed for the generation of gene knockout (KO) pigs, although one major limitation of this technology is the use of potentially harmful genome-integrating plasmid DNAs. Here we describe a simple, non-integrating strategy for generating KO pigs using ZFN-encoding mRNA. The interleukin-2 receptor gamma (IL2RG) gene was knocked out in porcine fetal fibroblasts using ZFN-encoding mRNAs, and IL2RG KO pigs were subsequently generated using these KO cells through somatic cell nuclear transfer (SCNT). The resulting IL2RG KO pigs completely lacked a thymus and were deficient in T and NK cells, similar to human X-linked SCID patients. Our findings demonstrate that the combination of ZFN-encoding mRNAs and SCNT provides a simple robust method for producing KO pigs without genomic integration.	[Watanabe, Masahito; Nakano, Kazuaki; Matsunari, Hitomi; Matsuda, Taisuke; Maehara, Miki; Kanai, Takahiro; Kobayashi, Mirina; Matsumura, Yukina; Sakai, Rieko; Kuramoto, Momoko; Hayashida, Gota; Asano, Yoshinori; Takayanagi, Shuko; Arai, Yoshikazu; Umeyama, Kazuhiro; Nagashima, Hiroshi] Meiji Univ, Lab Dev Engn, Dept Life Sci, Sch Agr, Kawasaki, Kanagawa, Japan; [Watanabe, Masahito; Matsunari, Hitomi; Umeyama, Kazuhiro; Nagaya, Masaki; Nagashima, Hiroshi] MUIIBR, Kawasaki, Kanagawa, Japan; [Hanazono, Yutaka] Jichi Med Univ, Div Regenerat Med, Ctr Mol Med, Shimotsuke, Tochigi, Japan; [Hanazono, Yutaka; Nagashima, Hiroshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Meiji University; Jichi Medical University; Japan Science & Technology Agency (JST)	Nagashima, H (corresponding author), Meiji Univ, Lab Dev Engn, Dept Life Sci, Sch Agr, Kawasaki, Kanagawa, Japan.	hnagas@isc.meiji.ac.jp		Nagashima, Hiroshi/0000-0001-9940-8783	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency; Meiji University International Institute for Bio-Resource Research (MUIIBR)	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Meiji University International Institute for Bio-Resource Research (MUIIBR)	This work was supported by the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency and by the Meiji University International Institute for Bio-Resource Research (MUIIBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Forsberg EJ, 2002, BIOL REPROD, V67, P327, DOI 10.1095/biolreprod67.1.327; Fujimura T, 2008, J REPROD DEVELOP, V54, P58, DOI 10.1262/jrd.19110; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Honma D, 2003, J INTERF CYTOK RES, V23, P101, DOI 10.1089/107999003321455499; Iguma LT, 2005, GENET MOL RES, V4, P55; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li P, 2013, J SURG RES, V181, pE39, DOI 10.1016/j.jss.2012.06.035; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; MATSUNARI H, 2012, XENOTRANSPLANTATION, P37; Matsunari H, 2008, CLONING STEM CELLS, V10, P313, DOI 10.1089/clo.2008.0024; Matsunari H, 2009, J REPROD DEVELOP, V55, P225, DOI 10.1262/jrd.20164; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; PORTER ACG, 1993, EUR J BIOCHEM, V218, P273, DOI 10.1111/j.1432-1033.1993.tb18375.x; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; Vajta G, 2006, ANIM REPROD SCI, V92, P211, DOI 10.1016/j.anireprosci.2005.12.001; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Whyte JJ, 2012, J ANIM SCI, V90, P1111, DOI 10.2527/jas.2011-4546; Whyte JJ, 2011, MOL REPROD DEV, V78, P2, DOI 10.1002/mrd.21271; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Zakhartchenko V, 2001, MOL REPROD DEV, V60, P362, DOI 10.1002/mrd.1098	47	64	73	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76478	10.1371/journal.pone.0076478	http://dx.doi.org/10.1371/journal.pone.0076478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130776	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900073
J	Irvine, MA; Worbe, Y; Bolton, S; Harrison, NA; Bullmore, ET; Voon, V				Irvine, Michael A.; Worbe, Yulia; Bolton, Sorcha; Harrison, Neil A.; Bullmore, Edward T.; Voon, Valerie			Impaired Decisional Impulsivity in Pathological Videogamers	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE SCALE; HIGHER DISCOUNT RATES; VIDEO-GAME USE; DELAYED REWARDS; COMPUTER GAMES; INHIBITION; ADDICTION; VALIDATION; DEPRESSION; HEROIN	Background: Pathological gaming is an emerging and poorly understood problem. Impulsivity is commonly impaired in disorders of behavioural and substance addiction, hence we sought to systematically investigate the different subtypes of decisional and motor impulsivity in a well-defined pathological gaming cohort. Methods: Fifty-two pathological gaming subjects and age-, gender-and IQ-matched healthy volunteers were tested on decisional impulsivity (Information Sampling Task testing reflection impulsivity and delay discounting questionnaire testing impulsive choice), and motor impulsivity (Stop Signal Task testing motor response inhibition, and the premature responding task). We used stringent diagnostic criteria highlighting functional impairment. Results: In the Information Sampling Task, pathological gaming participants sampled less evidence prior to making a decision and scored fewer points compared with healthy volunteers. Gaming severity was also negatively correlated with evidence gathered and positively correlated with sampling error and points acquired. In the delay discounting task, pathological gamers made more impulsive choices, preferring smaller immediate over larger delayed rewards. Pathological gamers made more premature responses related to comorbid nicotine use. Greater number of hours played also correlated with a Motivational Index. Greater frequency of role playing games was associated with impaired motor response inhibition and strategy games with faster Go reaction time. Conclusions: We show that pathological gaming is associated with impaired decisional impulsivity with negative consequences in task performance. Decisional impulsivity may be a potential target in therapeutic management.	[Irvine, Michael A.; Bolton, Sorcha; Bullmore, Edward T.; Voon, Valerie] Univ Cambridge, Dept Psychiat, Cambridge, England; [Worbe, Yulia; Bullmore, Edward T.; Voon, Valerie] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Bullmore, Edward T.; Voon, Valerie] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Harrison, Neil A.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of Cambridge; University of Cambridge; University of Brighton; University of Sussex	Voon, V (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	vv247@cam.ac.uk	Worbe, Yulia/GYV-3751-2022; Bullmore, Ed/C-1706-2012; Voon, Valerie/O-7038-2017	Bullmore, Ed/0000-0002-8955-8283; Voon, Valerie/0000-0001-6790-1776; Worbe, Yulia/0000-0001-5903-9370; Harrison, Neil/0000-0002-9584-3769; Bolton, Sorcha/0000-0001-5857-6748	Wellcome Trust [WT093705MA]; Medical Research Council [G0001354B, G1000183B, G0001354] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by a fellowship grant from the Wellcome Trust (WT093705MA; wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Charlton JP, 2007, COMPUT HUM BEHAV, V23, P1531, DOI 10.1016/j.chb.2005.07.002; Choo H, 2010, ANN ACAD MED SINGAP, V39, P822; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Diergaarde L, 2008, BIOL PSYCHIAT, V63, P301, DOI 10.1016/j.biopsych.2007.07.011; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Ferguson CJ, 2011, J PSYCHIATR RES, V45, P1573, DOI 10.1016/j.jpsychires.2011.09.005; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; Gentile DA, 2011, PEDIATRICS, V127, pE319, DOI 10.1542/peds.2010-1353; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Griffiths MD, 1998, PSYCHOL REP, V82, P475, DOI 10.2466/PR0.82.2.475-480; Han DH, 2012, J PSYCHIATR RES, V46, P507, DOI 10.1016/j.jpsychires.2012.01.004; Han DH, 2010, CYBERPSYCH BEH SOC N, V13, P655, DOI 10.1089/cyber.2009.0327; Johansson A, 2004, PSYCHOL REP, V95, P641, DOI 10.2466/pr0.95.2.641-650; King DL, 2013, CLIN PSYCHOL REV, V33, P331, DOI 10.1016/j.cpr.2013.01.002; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Ko CH, 2010, PSYCHIAT RES, V175, P121, DOI 10.1016/j.psychres.2008.10.004; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kuhn S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.53; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; Lemmens JS, 2006, CYBERPSYCHOL BEHAV, V9, P638, DOI 10.1089/cpb.2006.9.638; Lemmens JS, 2009, MEDIA PSYCHOL, V12, P77, DOI 10.1080/15213260802669458; Li DD, 2011, CYBERPSYCH BEH SOC N, V14, P535, DOI 10.1089/cyber.2010.0463; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Littel M, 2012, ADDICT BIOL, V17, P934, DOI 10.1111/j.1369-1600.2012.00467.x; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Lorenz RC, 2013, ADDICT BIOL, V18, P134, DOI 10.1111/j.1369-1600.2012.00491.x; Nelson HE, 1982, NAT ADULT READING TE; Pallanti S, 2005, J GAMBL STUD, V21, P431, DOI 10.1007/s10899-005-5557-3; Park HS, 2010, CNS SPECTRUMS, V15, P159, DOI 10.1017/S1092852900027437; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Petry NM, 2001, DRUG ALCOHOL DEPEN, V63, P29, DOI 10.1016/S0376-8716(00)00188-5; Porter G, 2010, AUST NZ J PSYCHIAT, V44, P120, DOI 10.3109/00048670903279812; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Salguero RAT, 2002, ADDICTION, V97, P1601; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Topor DR, 2011, J CLIN PSYCHIAT, V72, P1611, DOI 10.4088/JCP.11m07040; van Holst RJ, 2012, J ADOLESCENT HEALTH, V50, P541, DOI 10.1016/j.jadohealth.2011.07.006; Voon V, 2013, BIOL PSYCHI IN PRESS; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048961	47	42	42	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75914	10.1371/journal.pone.0075914	http://dx.doi.org/10.1371/journal.pone.0075914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146789	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326019400023
J	Kimball, BA; Yamazaki, K; Kohler, D; Bowen, RA; Muth, JP; Opiekun, M; Beauchamp, GK				Kimball, Bruce A.; Yamazaki, Kunio; Kohler, Dennis; Bowen, Richard A.; Muth, Jack P.; Opiekun, Maryanne; Beauchamp, Gary K.			Avian Influenza Infection Alters Fecal Odor in Mallards	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; PARASITIZED MALES; VIRUS-INFECTION; RECOGNITION; AVOIDANCE; SCENT; ODORTYPES; RESPONSES	Changes in body odor are known to be a consequence of many diseases. Much of the published work on disease-related and body odor changes has involved parasites and certain cancers. Much less studied have been viral diseases, possibly due to an absence of good animal model systems. Here we studied possible alteration of fecal odors in animals infected with avian influenza viruses (AIV). In a behavioral study, inbred C57BL/6 mice were trained in a standard Y-maze to discriminate odors emanating from feces collected from mallard ducks (Anas platyrhynchos) infected with low-pathogenic avian influenza virus compared to fecal odors from non-infected controls. Mice could discriminate odors from non-infected compared to infected individual ducks on the basis of fecal odors when feces from post-infection periods were paired with feces from pre-infection periods. Prompted by this indication of odor change, fecal samples were subjected to dynamic headspace and solvent extraction analyses employing gas chromatography/mass spectrometry to identify chemical markers indicative of AIV infection. Chemical analyses indicated that AIV infection was associated with a marked increase of acetoin (3-hydroxy-2-butanone) in feces. These experiments demonstrate that information regarding viral infection exists via volatile metabolites present in feces. Further, they suggest that odor changes following virus infection could play a role in regulating behavior of conspecifics exposed to infected individuals.	[Kimball, Bruce A.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Philadelphia, PA USA; [Yamazaki, Kunio; Opiekun, Maryanne; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Kohler, Dennis] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Muth, Jack P.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Monell Chemical Senses Center; United States Department of Agriculture (USDA); Colorado State University; Colorado State University	Kimball, BA (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Philadelphia, PA USA.	bruce.a.kimball@aphis.usda.gov			United States Department of Agriculture- Animal and Plant Health Inspection Service (USDA-APHIS)-National Wildlife Disease Program	United States Department of Agriculture- Animal and Plant Health Inspection Service (USDA-APHIS)-National Wildlife Disease Program	Funding was provided to Monell by the United States Department of Agriculture- Animal and Plant Health Inspection Service (USDA-APHIS)-National Wildlife Disease Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albone ES, 1984, MAMALIAN SEMIOCHEMIS; Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; BEAUCHAMP GK, 1994, IMMUNOGENETICS, V39, P109, DOI 10.1007/BF00188613; BEAUCHAMP GK, 1995, P NATL ACAD SCI USA, V92, P2617, DOI 10.1073/pnas.92.7.2617; Carriere KC, 2001, COMMUN STAT-SIMUL C, V30, P327, DOI 10.1081/SAC-100002370; DISTELHEIM I H, 1973, International Journal of Dermatology, V12, P241, DOI 10.1111/j.1365-4362.1973.tb00043.x; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Hutchings MR, 1998, ANIM SCI, V67, P97, DOI 10.1017/S1357729800009838; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Kavaliers M, 2005, ANIM BEHAV, V70, P693, DOI 10.1016/j.anbehav.2004.12.016; Kavaliers M, 2005, TRENDS PARASITOL, V21, P423, DOI 10.1016/j.pt.2005.07.008; KAVALIERS M, 1995, ANIM BEHAV, V50, P1161, DOI 10.1016/0003-3472(95)80032-8; Kavaliers M, 2003, ANIM BEHAV, V65, P59, DOI 10.1006/anbe.2002.2043; Kwak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003591; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; LIDDELL K, 1976, POSTGRAD MED J, V52, P136, DOI 10.1136/pgmj.52.605.136; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; Moser E, 2010, J VET BEHAV, V5, P145, DOI 10.1016/j.jveb.2010.01.002; Murphy J, 2005, J APPL MICROBIOL, V99, P301, DOI 10.1111/j.1365-2672.2005.02590.x; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Penn D, 1998, ETHOLOGY, V104, P685, DOI 10.1111/j.1439-0310.1998.tb00102.x; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Rajchard J, 2008, VET MED-CZECH, V53, P412, DOI 10.17221/1926-VETMED; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; SPIZIZEN J, 1957, BIOCHIM BIOPHYS ACTA, V23, P333, DOI 10.1016/0006-3002(57)90336-0; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Xiao ZJ, 2010, AFR J MICROBIOL RES, V4, P1997; Yamazaki K, 2002, P NATL ACAD SCI USA, V99, P5612, DOI 10.1073/pnas.082093099	31	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75411	10.1371/journal.pone.0075411	http://dx.doi.org/10.1371/journal.pone.0075411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146753	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400006
J	Koblin, BA; Egan, JE; Rundle, A; Quinn, J; Tieu, HV; Cerda, M; Ompad, DC; Greene, E; Hoover, DR; Frye, V				Koblin, Beryl A.; Egan, James E.; Rundle, Andrew; Quinn, James; Hong-Van Tieu; Cerda, Magdalena; Ompad, Danielle C.; Greene, Emily; Hoover, Donald R.; Frye, Victoria			Methods to Measure the Impact of Home, Social, and Sexual Neighborhoods of Urban Gay, Bisexual, and Other Men Who Have Sex with Men	PLOS ONE			English	Article							DISPARITIES GEOCODING PROJECT; COLLECTIVE EFFICACY; UNITED-STATES; TRANSMITTED INFECTIONS; SOCIOECONOMIC MEASURES; BUILT ENVIRONMENT; HEALTH OUTCOMES; RISK BEHAVIOR; HIV; PREVENTION	Men who have sex with men (MSM) accounted for 61% of new HIV diagnoses in the United States in 2010. Recent analyses indicate that socio-structural factors are important correlates of HIV infection. NYCM2M was a cross-sectional study designed to identify neighborhood-level characteristics within the urban environment that influence sexual risk behaviors, substance use and depression among MSM living in New York City. The sample was recruited using a modified venue-based time-space sampling methodology and through select websites and mobile applications. This paper describes novel methodological approaches used to improve the quality of data collected for analysis of the impact of neighborhoods on MSM health. Previous research has focused predominately on residential neighborhoods and used pre-determined administrative boundaries (e. g., census tracts) that often do not reflect authentic and meaningful neighborhoods. This study included the definition and assessment of multiple neighborhoods of influence including where men live (home neighborhood), socialize (social neighborhood) and have sex (sexual neighborhood). Furthermore, making use of technological advances in mapping, we collected geo-points of reference for each type of neighborhood and identified and constructed self-identified neighborhood boundary definitions. Finally, this study collected both perceived neighborhood characteristics and objective neighborhood conditions to create a comprehensive, flexible and rich neighborhood-level set of covariates. This research revealed that men perceived their home, social and sexual neighborhoods in different ways. Few men (15%) had the same home, social and sexual neighborhoods; for 31%, none of the neighborhoods was the same. Of the three types of neighborhoods, the number of unique social neighborhoods was the lowest; the size of sexual neighborhoods was the smallest. The resultant dataset offers the opportunity to conduct analyses that will yield context-specific and nuanced understandings of the relations among neighborhood space, and the well-being and health of urban MSM.	[Koblin, Beryl A.; Hong-Van Tieu] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Egan, James E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Rundle, Andrew; Quinn, James; Cerda, Magdalena; Greene, Emily] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Hong-Van Tieu] Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA; [Ompad, Danielle C.] NYU, CHIBPS, New York, NY USA; [Ompad, Danielle C.] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Nutr Food Studies & Publ Hlth, New York, NY USA; [Greene, Emily; Frye, Victoria] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Social & Behav Sci, New York, NY 10021 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Frye, Victoria] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA	New York Blood Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Columbia University; New York University; New York University; New York Blood Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University	Koblin, BA (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA.	bkoblin@nybloodcenter.org	Rundle, Andrew G/A-5282-2009; Ompad, Danielle/F-3163-2013	Rundle, Andrew G/0000-0003-0211-7707; Ompad, Danielle/0000-0003-0240-0393; Greene, Emily/0000-0001-6321-7088; Frye, Victoria/0000-0003-3239-7201; Egan, James Erin/0000-0003-3888-7148; Cerda, Magdalena/0000-0001-8441-7046	National Institute of Child Health and Human Development (NICHD) [R01 HD059729]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035, K01DA030449, T32DA031099] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by a grant from National Institute of Child Health and Human Development (NICHD) R01 HD059729 http://www.nichd.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2009, DRUG ALCOHOL DEPEN, V100, P138, DOI 10.1016/j.drugalcdep.2008.09.012; Bolton SL, 2011, CAN J PSYCHIAT, V56, P35, DOI 10.1177/070674371105600107; Browning CR, 2004, DEMOGRAPHY, V41, P697, DOI 10.1353/dem.2004.0029; Browning CR, 2003, J MARRIAGE FAM, V65, P730, DOI 10.1111/j.1741-3737.2003.00730.x; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; Buttram ME, 2013, AM J MENS HEALTH, V7, P110, DOI 10.1177/1557988312458793; Cameron JE, 2004, SELF IDENTITY, V3, P239, DOI 10.1080/13576500444000047; Carpiano RM, 2011, J HEALTH SOC BEHAV, V52, P74, DOI 10.1177/0022146510395026; Centers for Disease Control and Prevention (CDC), 2012, HIV SURV REP, V22; Choi KH, 2002, AIDS EDUC PREV, V14, P472, DOI 10.1521/aeap.14.8.472.24114; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Cohen D, 2000, AM J PUBLIC HEALTH, V90, P230, DOI 10.2105/AJPH.90.2.230; Drabble L, 2005, J STUD ALCOHOL, V66, P111, DOI 10.15288/jsa.2005.66.111; Egan JE, 2011, AIDS BEHAV, V15, pS35, DOI 10.1007/s10461-011-9902-5; Egan JE, 2011, 139 ANN M AM PUBL HL; Frye V, 2006, J URBAN HEALTH, V83, P308, DOI 10.1007/s11524-006-9033-x; Frye V, 2011, 139 ANN M AM PUBL HL; Frye V, 2008, AM J PUBLIC HEALTH, V98, P1473, DOI 10.2105/AJPH.2007.112813; Frye V, 2010, AIDS BEHAV, V14, P974, DOI 10.1007/s10461-008-9438-5; Galea S, 2005, SOC SCI MED, V60, P1017, DOI 10.1016/j.socscimed.2004.06.036; Gates G., 2011, US CENSUS SNAPSHOT 2; Google Inc, 2009, GOOGL EARTH VERS 5 1; Jones K. T., 2012, 19 INT AIDS C WASH D; KELLY JA, 1992, J CONSULT CLIN PSYCH, V60, P576, DOI 10.1037/0022-006X.60.4.576; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Kelly JA, 2004, AIDS CARE, V16, P139, DOI 10.1080/09540120410001640986; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E; Krieger N, 2003, PUBLIC HEALTH REP, V118, P240, DOI 10.1093/phr/118.3.240; Krieger Nancy, 2003, American Journal of Public Health, V93, P1655, DOI 10.2105/AJPH.93.10.1655; LALLI M, 1992, J ENVIRON PSYCHOL, V12, P285, DOI 10.1016/S0272-4944(05)80078-7; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; McCabe SE, 2010, AM J PUBLIC HEALTH, V100, P1946, DOI 10.2105/AJPH.2009.163147; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mills TC, 2004, AM J PSYCHIAT, V161, P278, DOI 10.1176/appi.ajp.161.2.278; Mills TC, 2001, AM J PUBLIC HEALTH, V91, P980, DOI 10.2105/AJPH.91.6.980; New York City Department of Planning, 2010, BYT BIG APPL; New York City Mayor's Office of Operations, 2013, MAYORS MAN REP; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Perkins D, 1990, AM J COMMUN PSYCHOL, V19, P83; Purciel M, 2009, J ENVIRON PSYCHOL, V29, P457, DOI 10.1016/j.jenvp.2009.03.004; Root ED, 2012, ANN ASSOC AM GEOGR, V102, P986, DOI 10.1080/00045608.2012.659621; Ross CE, 1999, URBAN AFF REV, V34, P412, DOI 10.1177/107808749903400304; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; SAMPSON RJ, 1989, AM J SOCIOL, V94, P774, DOI 10.1086/229068; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sampson RJ, 1997, NEIGHBORHOOD POVERTY, V2, P1; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P473; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tarrant M, 2001, J ADOLESCENCE, V24, P597, DOI 10.1006/jado.2000.0392; U. S. Census Bureau, 2011, NEW YORK CIT HOUS VA; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; WRIGHT D, 2002, DHHS PUBLICATION; Yen IH, 2009, AM J PREV MED, V37, P455, DOI 10.1016/j.amepre.2009.06.022	60	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75878	10.1371/journal.pone.0075878	http://dx.doi.org/10.1371/journal.pone.0075878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146785	Green Published, gold			2022-12-27	WOS:000326019400021
J	Chen, MY; Zhang, XM; Liu, JN; Storey, KB				Chen, Muyan; Zhang, Xiumei; Liu, Jianning; Storey, Kenneth B.			High-Throughput Sequencing Reveals Differential Expression of miRNAs in Intestine from Sea Cucumber during Aestivation	PLOS ONE			English	Article							APOSTICHOPUS-JAPONICUS SELENKA; MICRORNA REGULATION; WATER TEMPERATURE; EMERGING ROLES; BIOGENESIS; RESPONSES; CLUSTER; GROWTH; GENE	The regulatory role of miRNA in gene expression is an emerging hot new topic in the control of hypometabolism. Sea cucumber aestivation is a complicated physiological process that includes obvious hypometabolism as evidenced by a decrease in the rates of oxygen consumption and ammonia nitrogen excretion, as well as a serious degeneration of the intestine into a very tiny filament. To determine whether miRNAs play regulatory roles in this process, the present study analyzed profiles of miRNA expression in the intestine of the sea cucumber (Apostichopus japonicus), using Solexa deep sequencing technology. We identified 308 sea cucumber miRNAs, including 18 novel miRNAs specific to sea cucumber. Animals sampled during deep aestivation (DA) after at least 15 days of continuous torpor, were compared with animals from a non-aestivation (NA) state (animals that had passed through aestivation and returned to the active state). We identified 42 differentially expressed miRNAs [RPM (reads per million)> 10, |FC| (|fold change|) >= 1, FDR (false discoveryrate) <0.01] during aestivation, which were validated by two other miRNA profiling methods: miRNA microarray and real-time PCR. Among the most prominent miRNA species, miR-200-3p, miR-2004, miR-2010, miR-22, miR-252a, miR-252a-3p and miR92 were significantly over-expressed during deep aestivation compared with non-aestivation animals. Preliminary analyses of their putative target genes and GO analysis suggest that these miRNAs could play important roles in global transcriptional depression and cell differentiation during aestivation. High-throughput sequencing data and microarray data have been submitted to GEO database.	[Chen, Muyan; Zhang, Xiumei] Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China; [Liu, Jianning] LC BIO CO LTD, Hangzhou, Zhejiang, Peoples R China; [Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	Ocean University of China; Carleton University	Chen, MY (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China.	chenmuyan@gmail.com	Liu, Jian Ning/GZA-6919-2022	Liu, Jian Ning/0000-0002-8932-054X	National Natural Science Foundation [31201972]; Research Fund of young scholars for the Doctoral Program of Higher Education of China [20120132120009]; Research fund for talented scholars Ocean University of China [1400841212003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund of young scholars for the Doctoral Program of Higher Education of China; Research fund for talented scholars Ocean University of China	This work was supported by the National Natural Science Foundation (No. 31201972), Research Fund of young scholars for the Doctoral Program of Higher Education of China (No. 20120132120009) and Research fund for talented scholars Ocean University of China (No. 1400841212003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnous K, 2008, BBA-GEN SUBJECTS, V1780, P185, DOI 10.1016/j.bbagen.2007.10.009; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biggar Kyle K., 2012, Genomics Proteomics & Bioinformatics, V10, P302, DOI 10.1016/j.gpb.2012.09.002; Biggar KK, 2012, CELL CYCLE, V11, P1705, DOI 10.4161/cc.19790; Biggar KK, 2011, J MOL CELL BIOL, V3, P167, DOI 10.1093/jmcb/mjq045; Biggar KK, 2009, CRYOBIOLOGY, V59, P317, DOI 10.1016/j.cryobiol.2009.08.009; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Du HX, 2011, PLOS ONE, V7; Friedman LM, 2009, MAMM GENOME, V20, P581, DOI 10.1007/s00335-009-9230-5; Gao F, 2009, CHIN J OCEANOL LIMN, V27, P714, DOI 10.1007/s00343-009-9202-3; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Huang YC, 2013, DEVELOPMENT, V140, P897, DOI 10.1242/dev.080192; Ji TT, 2008, AQUACULTURE, V283, P180, DOI 10.1016/j.aquaculture.2008.07.006; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Kadri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029217; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li F., 1996, FISH CHINA, V3, P49, DOI DOI 10.1152/AJPCELL.1998.275.1.C1; Liu LH, 2010, TOXICOL IN VITRO, V24, P1168, DOI 10.1016/j.tiv.2010.02.016; Liu YT, 2010, PHYSIOL GENOMICS, V42A, P39, DOI 10.1152/physiolgenomics.00054.2010; Loomis SH, 2010, PROG MOL SUBCELL BIO, V49, P231, DOI 10.1007/978-3-642-02421-4_11; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morin PJ, 2008, BBA-GENE REGUL MECH, V1779, P628, DOI 10.1016/j.bbagrm.2008.07.011; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Storey KB, 2007, J EXP BIOL, V210, P1700, DOI 10.1242/jeb.02716; Storey KB, 2012, J EXP BIOL, V215, P1425, DOI 10.1242/jeb.054403; Tazawa H, 2011, EXPERT OPIN BIOL TH, V11, P145, DOI 10.1517/14712598.2011.542749; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Withers PC, 2010, MOL PHYSL ASPECTS; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiong J, 2012, CURR MOL MED, V12, P247, DOI 10.2174/156652412799218886; Yang HS, 2006, J EXP MAR BIOL ECOL, V330, P505, DOI 10.1016/j.jembe.2005.09.010; Yang HS, 2005, AQUAC RES, V36, P1085, DOI 10.1111/j.1365-2109.2005.01325.x	39	50	53	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76120	10.1371/journal.pone.0076120	http://dx.doi.org/10.1371/journal.pone.0076120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143179	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100014
J	Chen, YT; Chen, FYT; Vijmasi, T; Stephens, DN; Gallup, M; McNamara, NA				Chen, Ying Ting; Chen, Feeling Y. T.; Vijmasi, Trinka; Stephens, Denise N.; Gallup, Marianne; McNamara, Nancy A.			Pax6 Downregulation Mediates Abnormal Lineage Commitment of the Ocular Surface Epithelium in Aqueous-Deficient Dry Eye Disease	PLOS ONE			English	Article							SQUAMOUS METAPLASIA; SJOGRENS-SYNDROME; STEM-CELLS; CORNEAL EPITHELIUM; EXPRESSION; PROTEIN; TRANSDIFFERENTIATION; DIFFERENTIATION; MOUSE; GENE	Keratinizing squamous metaplasia (SQM) of the ocular surface is a blinding consequence of systemic autoimmune disease and there is no cure. Ocular SQM is traditionally viewed as an adaptive tissue response during chronic keratoconjunctivitis sicca (KCS) that provokes pathological keratinization of the corneal epithelium and fibrosis of the corneal stroma. Recently, we established the autoimmune regulator-knockout (Aire KO) mouse as a model of autoimmune KCS and identified an essential role for autoreactive CD4+ T cells in SQM pathogenesis. In subsequent studies, we noted the down-regulation of paired box gene 6 (Pax6) in both human patients with chronic KCS associated with Sjgren's syndrome and Aire KO mice. Pax6 encodes a pleiotropic transcription factor guiding eye morphogenesis during development. While the postnatal function of Pax6 is largely unknown, we hypothesized that its role in maintaining ocular surface homeostasis was disrupted in the inflamed eye and that loss of Pax6 played a functional role in the initiation and progression of SQM. Adoptive transfer of autoreactive T cells from Aire KO mice to immunodeficient recipients confirmed CD4+ T cells as the principal downstream effectors promoting Pax6 downregulation in Aire KO mice. CD4+ T cells required local signaling via Interleukin-1 receptor (IL-1R1) to provoke Pax6 loss, which prompted a switch from corneal-specific cytokeratin, CK12, to epidermal-specific CK10. The functional role of Pax6 loss in SQM pathogenesis was indicated by the reversal of SQM and restoration of ocular surface homeostasis following forced expression of Pax6 in corneal epithelial cells using adenovirus. Thus, tissue-restricted restoration of Pax6 prevented aberrant epidermal-lineage commitment suggesting adjuvant Pax6 gene therapy may represent a novel therapeutic approach to prevent SQM in patients with chronic inflammatory diseases of the ocular surface.	[Chen, Ying Ting; Chen, Feeling Y. T.; Vijmasi, Trinka; Stephens, Denise N.; Gallup, Marianne; McNamara, Nancy A.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [McNamara, Nancy A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [McNamara, Nancy A.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [McNamara, Nancy A.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [McNamara, Nancy A.] Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McNamara, NA (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.	nancy.mcnamara@ucsf.edu		Chen, Ying-Ting/0000-0002-8606-2418	NEI [EY016203, EY02162]; NATIONAL EYE INSTITUTE [P30EY002162, R01EY016203] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NEI EY016203 (NAM) and EY02162 (UCSF Ophthalmology Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bian F, 2010, STEM CELLS, V28, P2172, DOI 10.1002/stem.539; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Chen YT, 2010, AM J PATHOL, V177, P1333, DOI 10.2353/ajpath.2010.100227; Chen YT, 2009, MOL VIS, V15, P563; Chen YT, 2012, LAB INVEST J TECH ME; Chin-Chance CVT, 2006, J INVEST MED, V54, P132, DOI 10.2310/6650.2006.05035; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; COOPER KD, 1985, J INVEST DERMATOL, V85, P546, DOI 10.1111/1523-1747.ep12277391; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; DeVoss JJ, 2010, J IMMUNOL, V184, P4236, DOI 10.4049/jimmunol.0902434; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Li W, 2008, INVEST OPHTH VIS SCI, V49, P154, DOI 10.1167/iovs.07-0883; MOLL R, 1983, DIFFERENTIATION, V23, P256; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shiraishi A, 1998, INVEST OPHTH VIS SCI, V39, P2554; Sivak JM, 2004, MOL CELL BIOL, V24, P245, DOI 10.1128/MCB.24.1.245-257.2004; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; TSENG SCG, 1985, OPHTHALMOLOGY, V92, P728; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Zhou DL, 2012, AM J PATHOL, V181, P753, DOI 10.1016/j.ajpath.2012.05.014	34	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77286	10.1371/journal.pone.0077286	http://dx.doi.org/10.1371/journal.pone.0077286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143217	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100054
J	Garg, M; Potter, JA; Abrahams, VM				Garg, Manish; Potter, Julie A.; Abrahams, Vikki M.			Identification of microRNAs That Regulate TLR2-Mediated Trophoblast Apoptosis and Inhibition of IL-6 mRNA	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED REGULATION; HTR-8/SVNEO CELLS; HUMAN PLACENTAS; EXPRESSION; ACTIVATION; RECEPTOR; LET-7; PREGNANCY; TOLL-LIKE-RECEPTOR-2	While infection-induced placental inflammation is a common mechanism of adverse pregnancy outcome, some pathogens can also trigger placental apoptosis, and Toll-like receptors (TLRs) mediate this response. Treatment of human first trimester trophoblast cells with bacterial peptidoglycan (PDG) reduces their constitutive secretion of IL-6 protein and induces apoptosis. This apoptotic response is dependent upon the cell's expression of TLR1, TLR2 and TLR10, and their lack of TLR6, such that ectopic expression of TLR6 prevents PDG-induced apoptosis and restores IL-6 production. In this current study we have identified three microRNAs (miRs) that regulate TLR2-mediated responses in the human trophoblast. Herein we report that miR-329 plays a pivotal role in mediating PDG-induced trophoblast apoptosis and inhibition of IL-6 mRNA expression by targeting the NF-kappa B subunit, p65. TLR2 activation by PDG upregulates miR-329 expression and inhibits NF-kappa B p65 and IL-6 mRNA, and this is reversed by the presence of TLR6. Moreover, inhibition of miR-329 prevents PDG-induced inhibition of NF-kappa B p65 and IL-6 mRNA expression, and restores cell survival. In addition, we have found miR-23a and let-7c to directly regulate PDG-mediated inhibition of IL-6 mRNA. TLR2 activation by PDG upregulates miR23a and let-7c expression and this is reversed by the presence of TLR6. Furthermore, inhibition of both miR23a and let-7c prevents PDG-inhibition of trophoblast IL-6 mRNA expression. Together, our findings suggest that multiple miRs are involved in the molecular regulation of TLR2-mediated responses in the trophoblast towards gram-positive bacterial components.	[Abrahams, Vikki M.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Div Maternal Fetal Med, New Haven, CT USA	Yale University; Yale University	Abrahams, VM (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, New Haven, CT 06520 USA.	vikki.abrahams@yale.edu			NICHD, NIH [HD049446]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049446] Funding Source: NIH RePORTER	NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant HD049446 from the NICHD, NIH (to VMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, J IMMUNOL, V180, P6035, DOI 10.4049/jimmunol.180.9.6035; Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Aravalli RN, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-11; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Balkundi DR, 2003, BIOL REPROD, V69, P718, DOI 10.1095/biolreprod.102.013102; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellas RE, 1997, AM J PATHOL, V151, P891; Dai Y, 2012, PLACENTA, V33, P824, DOI 10.1016/j.placenta.2012.07.012; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Equils O, 2006, J IMMUNOL, V177, P1257, DOI 10.4049/jimmunol.177.2.1257; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Herschkowitz JI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002182; Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Keane MM, 2000, BREAST CANCER RES TR, V64, P211, DOI 10.1023/A:1006458407515; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Ma Y, 2007, PLACENTA, V28, P1024, DOI 10.1016/j.placenta.2007.05.003; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Montenegro D, 2009, J PATHOL, V217, P113, DOI 10.1002/path.2463; Morales-Prieto DM, 2011, AM J REPROD IMMUNOL, V66, P57, DOI 10.1111/j.1600-0897.2011.01037.x; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Mulla MJ, 2013, AM J REPROD IMMUNOL, V69, P449, DOI 10.1111/aji.12065; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Qiu SW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-10; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	56	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77249	10.1371/journal.pone.0077249	http://dx.doi.org/10.1371/journal.pone.0077249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143215	gold, Green Submitted, Green Published			2022-12-27	WOS:000325894100051
J	Gehre, F; Antonio, M; Faihun, F; Odoun, M; Uwizeye, C; de Rijk, P; de Jong, BC; Affolabi, D				Gehre, Florian; Antonio, Martin; Faihun, Frank; Odoun, Mathieu; Uwizeye, Cecile; de Rijk, Pim; de Jong, Bouke C.; Affolabi, Dissou			The First Phylogeographic Population Structure and Analysis of Transmission Dynamics of M. africanum West African 1-Combining Molecular Data from Benin, Nigeria and Sierra Leone	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; GENETIC DIVERSITY; MIRU-VNTRPLUS; STRAINS; IDENTIFICATION; EPIDEMIOLOGY; BACTERIA; CAMEROON; LINEAGE; BACILLI	Mycobacterium africanum is an important cause of tuberculosis (TB) in West Africa. So far, two lineages called M. africanum West African 1 (MAF1) and M. africanum West African 2 (MAF2) have been defined. Although several molecular studies on MAF2 have been conducted to date, little is known about MAF1. As MAF1 is mainly present in countries around the Gulf of Guinea we aimed to estimate its prevalence in Cotonou, the biggest city in Benin. Between 2005-06 we collected strains in Cotonou/Benin and genotyped them using spoligo- and 12-loci-MIRU-VNTR-typing. Analyzing 194 isolates, we found that 31% and 6% were MAF1 and MAF2, respectively. Therefore Benin is one of the countries with the highest prevalence (37%) of M. africanum in general and MAF1 in particular. Moreover, we combined our data from Benin with publicly available genotyping information from Nigeria and Sierra Leone, and determined the phylogeographic population structure and genotypic clustering of MAF1. Within the MAF1 lineage, we identified an unexpected great genetic variability with the presence of at least 10 sub-lineages. Interestingly, 8 out of 10 of the discovered sub-lineages not only clustered genetically but also geographically. Besides showing a remarkable local restriction to certain regions in Benin and Nigeria, the sub-lineages differed dramatically in their capacity to transmit within the human host population. While identifying Benin as one of the countries with the highest overall prevalence of M. africanum, this study also contains the first detailed description of the transmission dynamics and phylogenetic composition of the MAF1 lineage.	[Gehre, Florian; Antonio, Martin; de Jong, Bouke C.] MRC Unit, Fajara, Gambia; [Gehre, Florian; Uwizeye, Cecile; de Rijk, Pim; de Jong, Bouke C.] Inst Trop Med, B-2000 Antwerp, Belgium; [de Jong, Bouke C.] NYU, New York, NY USA; [Faihun, Frank; Odoun, Mathieu; Affolabi, Dissou] Lab Reference Mycobacteries, Cotonou, Benin	University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); New York University	Gehre, F (corresponding author), MRC Unit, Fajara, Gambia.	fgehre@mrc.gm	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675	Belgian Directorate-Generale for Development Co-orporation (DGDC) as part of the "Strategic Network TB 3.14"; project "Study on M. africanum population structure in Benin and The Gambia"; European Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council [MC_U190071468, MC_UP_A900_1122] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_U190071468] Funding Source: UKRI	Belgian Directorate-Generale for Development Co-orporation (DGDC) as part of the "Strategic Network TB 3.14"; project "Study on M. africanum population structure in Benin and The Gambia"; European Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by a grant from the Belgian Directorate-Generale for Development Co-orporation (DGDC) as part of the "Strategic Network TB 3.14" and the project "Study on M. africanum population structure in Benin and The Gambia" as well as by the European Developing Countries Clinical Trials Partnership (EDCTP) - funded "West African Node of Excellence for Tuberculosis and Malaria" (WANETAM-plus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2005, AIDS, V19, P1714, DOI 10.1097/01.aids.0000185991.54595.41; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103; HUET M, 1971, Revue de Tuberculose et de Pneumologie, V35, P413; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Lawson L, 2012, PLOS ONE, V7; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	23	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77000	10.1371/journal.pone.0077000	http://dx.doi.org/10.1371/journal.pone.0077000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143198	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100033
J	Kohn, CG; Kluger, J; Azeem, M; Coleman, CI				Kohn, Christine G.; Kluger, Jeffrey; Azeem, Meena; Coleman, Craig I.			Short-Term Consequences of Angiographically-Confirmed Coronary Stent Thrombosis	PLOS ONE			English	Article							ROUTINE CLINICAL-PRACTICE; DRUG-ELUTING STENTS; BARE-METAL; MYOCARDIAL-INFARCTION; OUTCOMES; INTERVENTION; PREDICTORS; ASPIRATION; REGISTRY; TRIALS	Objectives: To conduct a meta-analysis to quantify the real-world incidence of in-hospital or 30-day death or myocardial infarction (MI), and angiographically-confirmed ST-related treatment costs. Background: The short-term clinical and economic consequences of coronary stent thrombosis (ST) are thought to be significant. Methods: We searched MEDLINE, Embase and Scopus from January 2000-July 2012 to identify observational/registry studies that evaluated a cohort of >= 25 patients experiencing angiographically-confirmed thrombosis of a drug-eluting or bare-metal stent, required the use of dual-antiplatelet therapy for guideline-recommended durations, and reported incidences of in-hospital or 30-day death or MI and/or ST-related treatment costs. Incidences and costs from each study were pooled using random-effects meta-analysis. Results: Twenty-three studies were included. Of the 13 studies reporting in-hospital outcomes, 12 (N=8,832 STs) reported mortality data, with the pooled incidence rate estimated to be 7.9%, 95% CI=5.4%-11.3%, I-2=86%. Ten studies (N=1,294 STs) reported 30-day death, with a pooled incidence of 11.6%, 95% CI=8.8%-15.1%, I-2=55%. Patients experiencing early ST (within 30-days of implant) had higher in-hospital and 30-day mortality than those experiencing very-late ST (interaction p<0.04 for both). Stent type had no significant effect on in-hospital or 30-day mortality. In the 5 studies (N=542 STs) and 3 studies (N=180 STs) reporting in-hospital and 30-day MI, respectively, the pooled incidence rates were 6.1%, 95% CI=2.1%-16.2%, I-2=88% and 9.5%, 95% CI=3.8%-22.0%, I-2=65%. One study reported costs associated with ST, estimating the median/patient cost of hospitalization to treat early ST at $11,134 (in 2000US$). Conclusions: Regardless of stent type used, the short-term consequences of coronary ST appear significant.	[Kohn, Christine G.; Coleman, Craig I.] Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT 06260 USA; [Kohn, Christine G.; Azeem, Meena; Coleman, Craig I.] Hartford Hosp, Evidence Based Practice Ctr, Hartford, CT 06115 USA; [Kluger, Jeffrey] Hartford Hosp, Dept Cardiol, Hartford, CT 06115 USA	University of Connecticut; Hartford Hospital; Hartford Hospital	Coleman, CI (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT 06260 USA.	ccolema@harthosp.org		Coleman, Craig/0000-0003-4868-7158	Janssen Pharmaceuticals, Raritan, NJ	Janssen Pharmaceuticals, Raritan, NJ	This research was supported by a grant from Janssen Pharmaceuticals, Raritan, NJ. Janssen Pharmaceuticals reviewed the final report prior to submission. The authors of this report are entirely responsible for its content. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2012, JACC-CARDIOVASC INTE, V5, P131, DOI 10.1016/j.jcin.2011.10.013; Becker D, 2009, MED SCI MONITOR, V15, pCR236; Brar SS, 2009, J AM COLL CARDIOL, V53, P1677, DOI 10.1016/j.jacc.2009.03.013; Burzotta F, 2008, EUR HEART J, V29, P3011, DOI 10.1093/eurheartj/ehn479; Chechi T, 2008, J AM COLL CARDIOL, V51, P2396, DOI 10.1016/j.jacc.2008.01.070; Cheneau E, 2003, CIRCULATION, V108, P43, DOI 10.1161/01.CIR.0000078636.71728.40; Cutlip DE, 2001, CIRCULATION, V103, P1967; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Danenberg HD, 2009, ISR MED ASSOC J, V11, P529; de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057; Del Pace S, 2010, INTERN EMERG MED, V5, P121, DOI 10.1007/s11739-010-0350-4; Ergelen M, 2010, AM HEART J, V159, P672, DOI 10.1016/j.ahj.2009.12.032; Hesstermans AACM, 2010, J THROMB HAEMOST, V8, P2385, DOI 10.1111/j.1538-7836.2010.04046.x; Honda Y, 2003, CIRCULATION, V108, P2, DOI 10.1161/01.CIR.0000075929.79964.D8; Kimura T, 2010, CIRCULATION, V122, P52, DOI 10.1161/CIRCULATIONAHA.109.903955; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Le Feuvre C, 2008, ARCH CARDIOVASC DIS, V101, P220, DOI 10.1016/S1875-2136(08)73696-9; Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077; Lemesle G, 2009, J INVASIVE CARDIOL, V21, P210; Mahmoud KD, 2011, AM J CARDIOL, V108, P1721, DOI 10.1016/j.amjcard.2011.07.044; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Reynolds Matthew R, 2002, J Invasive Cardiol, V14, P364; Slottow TLP, 2008, AM J CARDIOL, V102, P298, DOI 10.1016/j.amjcard.2008.03.055; van Werkum JW, 2009, CIRCULATION, V119, P828, DOI 10.1161/CIRCULATIONAHA.108.799403; Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi135; Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006; Windecker S, 2007, CIRCULATION, V116, P1952, DOI 10.1161/CIRCULATIONAHA.106.683995; Yeo KK, 2012, CATHETER CARDIO INTE, V79, P550, DOI 10.1002/ccd.23011	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77330	10.1371/journal.pone.0077330	http://dx.doi.org/10.1371/journal.pone.0077330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143219	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100056
J	Low, SK; Takahashi, A; Ashikawa, K; Inazawa, J; Miki, Y; Kubo, M; Nakamura, Y; Katagiri, T				Low, Siew-Kee; Takahashi, Atsushi; Ashikawa, Kyota; Inazawa, Johji; Miki, Yoshio; Kubo, Michiaki; Nakamura, Yusuke; Katagiri, Toyomasa			Genome-Wide Association Study of Breast Cancer in the Japanese Population	PLOS ONE			English	Article							ORAL-CONTRACEPTIVE USE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; CONFER SUSCEPTIBILITY; MAMMOGRAPHIC DENSITY; RISK; GENE; ESTROGEN; WOMEN; MUTATIONS	Breast cancer is the most common malignancy among women in worldwide including Japan. Several studies have identified common genetic variants to be associated with the risk of breast cancer. Due to the complex linkage disequilibrium structure and various environmental exposures in different populations, it is essential to identify variants associated with breast cancer in each population, which subsequently facilitate the better understanding of mammary carcinogenesis. In this study, we conducted a genome-wide association study (GWAS) as well as whole-genome imputation with 2,642 cases and 2,099 unaffected female controls. We further examined 13 suggestive loci (P<1.0x10(-5)) using an independent sample set of 2,885 cases and 3,395 controls and successfully validated two previously-reported loci, rs2981578 (combined P-value of 1.31610 212, OR = 1.23; 95% CI = 1.16-.30) on chromosome 10q26 (FGFR2), rs3803662 (combined P-value of 2.79610 211, OR = 1.21; 95% CI = 1.15-. 28) and rs12922061 (combined P-value of 3.97610 210, OR = 1.23; 95% CI = 1.15-. 31) on chromosome 16q12 (TOX3-LOC643714). Weighted genetic risk score on the basis of three significantly associated variants and two previously reported breast cancer associated loci in East Asian population revealed that individuals who carry the most risk alleles in category 5 have 2.2 times higher risk of developing breast cancer in the Japanese population than those who carry the least risk alleles in reference category 1. Although we could not identify additional loci associated with breast cancer, our study utilized one of the largest sample sizes reported to date, and provided genetic status that represent the Japanese population. Further local and international collaborative study is essential to identify additional genetic variants that could lead to a better, accurate prediction for breast cancer.	[Low, Siew-Kee; Takahashi, Atsushi] Inst Phys & Chem Res RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Low, Siew-Kee; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Ashikawa, Kyota; Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Lab Genotyping Dev, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Miki, Yoshio] Japanese Fdn Canc Res, Inst Canc, Dept Genet Iagnosis, Tokyo 170, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med & Surg, Chicago, IL 60637 USA; [Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima, Japan	RIKEN; University of Tokyo; RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japanese Foundation for Cancer Research; University of Chicago; Tokushima University	Low, SK (corresponding author), Inst Phys & Chem Res RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.	amanda.sklow@src.riken.jp	Kubo, Michiaki/N-7947-2015	Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Sciences and Technology; Japanese Government	Ministry of Education, Culture, Sports, Sciences and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government	This work was conducted as a part of Biobank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bates CM, 2007, PEDIATR NEPHROL, V22, P343, DOI 10.1007/s00467-006-0239-7; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; COLES C, 1992, CANCER RES, V52, P5291; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elgazzar S, 2012, J HUM GENET, V57, P766, DOI 10.1038/jhg.2012.108; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iodice S, 2010, EUR J CANCER, V46, P2275, DOI 10.1016/j.ejca.2010.04.018; Islam T, 2012, EUR J CANC PREV; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Liang J, 2008, CARCINOGENESIS, V29, P2341, DOI 10.1093/carcin/bgn235; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; McTiernan A, 2003, ONCOLOGIST, V8, P326, DOI 10.1634/theoncologist.8-4-326; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Phipps AI, 2011, JNCI-J NATL CANCER I, V103, P470, DOI 10.1093/jnci/djr030; Raskin L, 2008, CANCER EPIDEM BIOMAR, V17, P1060, DOI 10.1158/1055-9965.EPI-08-0018; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhu XG, 2009, MOL ENDOCRINOL, V23, P1397, DOI 10.1210/me.2009-0071	45	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76463	10.1371/journal.pone.0076463	http://dx.doi.org/10.1371/journal.pone.0076463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143190	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100025
J	Liu, ZF; Ye, FH; Zhang, HY; Gao, Y; Tan, AH; Zhang, SJ; Xiao, Q; Zhang, B; Huang, LL; Ye, BB; Qin, X; Wu, CL; Lu, Z; Zhang, YJ; Liao, M; Yang, XB; Mo, ZN				Liu, Zhenfang; Ye, Fanghui; Zhang, Haiying; Gao, Yong; Tan, Aihua; Zhang, Shijun; Xiao, Qiang; Zhang, Bing; Huang, Lulu; Ye, Bingbing; Qin, Xue; Wu, Chunlei; Lu, Zheng; Zhang, Youjie; Liao, Ming; Yang, Xiaobo; Mo, Zengnan			The Association between the Levels of Serum Ferritin and Sex Hormones in a Large Scale of Chinese Male Population	PLOS ONE			English	Article							TESTOSTERONE LEVELS; RISK-FACTORS; TRANSCRIPTIONAL REGULATION; RESPONSIVE ELEMENT; METABOLIC SYNDROME; PROSTATE-CANCER; IRON-DEFICIENCY; MEN; ANDROGEN; HEPCIDIN	Background: The ferritin is an important participant of iron-storage but its regulation and related factors were not well defined. The present objective was to explore the potential association between serum ferritin levels and sex hormones. Methods: 1999 Chinese men in the Fangchenggang Area Male Health and Examination Survey (FAMHES) were recruited in this cross-sectional study. Levels of serum ferritin, total testosterone (free testosterone was calculated from the total one), estradiol and sex hormone-binding protein were detected in venous blood samples. The effects of age, BMI, smoking as well as alcohol consumption were analyzed on ferritin levels, respectively, and then the Pearson's correlation analysis was used to evaluate the association between ferritin levels and sex hormones adjusting for the above factors. Results: The age, BMI and alcohol consumption significantly affected serum ferritin levels, but there was no significant difference between smokers and nonsmokers. Ferritin levels were significantly and negatively associated with total testosterone (R = -0.205, P<0.001), sex hormone-binding protein (R = -0.161, P<0.001) and free testosterone (R = -0.097, P<0.001). After age and alcohol consumption were adjusted, the above associations were still significant (R = -0.200, -0.181 and -0.083, respectively, all P<0.001). However, there was only borderline negative association between ferritin levels and estradiol (adjusted R = -0.039, P = 0.083). Conclusion: The large scale of epidemic results showed the significantly negative associations between serum ferritin levels and sex hormones, which may provide more clues to explore the potential regulation and biological mechanism of ferritin.	[Liu, Zhenfang] Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Guangxi, Peoples R China; [Ye, Fanghui; Zhang, Haiying; Gao, Yong; Tan, Aihua; Zhang, Shijun; Xiao, Qiang; Zhang, Bing; Huang, Lulu; Ye, Bingbing; Wu, Chunlei; Lu, Zheng; Zhang, Youjie; Liao, Ming; Yang, Xiaobo; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China; [Zhang, Haiying; Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Wu, Chunlei; Lu, Zheng; Zhang, Youjie; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Yang, XB (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China.	yxbo21021@163.com; zengnanmo@hotmail.com	Zhang, Youjie/F-7346-2016; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138	Guangxi Science Fund for Distinguished Young Scholars [2012jjFA40011]; National Key Basic Research Program grant 973 [2012CB518300, 2012CB518303]; National Natural Science Foundation of China [81160072, 81060234]; Guangxi Natural Science Foundation [2010GXNSFB013064]	Guangxi Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Key Basic Research Program grant 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	The study was supported by grants from the Guangxi Science Fund for Distinguished Young Scholars (2012jjFA40011), National Key Basic Research Program grant 973 (2012CB518300 and 2012CB518303), National Natural Science Foundation of China (81160072, 81060234), and Guangxi Natural Science Foundation (2010GXNSFB013064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051379; Assia N, 2010, MOL VIS, V16, P2487; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; BERGE LN, 1994, ARTERIOSCLER THROMB, V14, P857, DOI 10.1161/01.ATV.14.6.857; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BEVILACQUA MA, 1994, GENE, V141, P287, DOI 10.1016/0378-1119(94)90587-8; Brockenbrough AT, 2006, AM J KIDNEY DIS, V47, P251, DOI 10.1053/j.ajkd.2005.10.022; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052255; Chen JX, 2012, BBA-GEN SUBJECTS, V1820, P256, DOI 10.1016/j.bbagen.2011.07.015; Choi Hyoung Soo, 2012, Korean J Hematol, V47, P286, DOI 10.5045/kjh.2012.47.4.286; Coviello AD, 2008, J CLIN ENDOCR METAB, V93, P914, DOI 10.1210/jc.2007-1692; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Eguchi A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/239476; Enea C, 2008, STEROIDS, V73, P1203, DOI 10.1016/j.steroids.2008.06.009; Garcia-Cruz E, 2012, BJU INT, V110, pE199, DOI 10.1111/j.1464-410X.2011.10876.x; Garcia-Cruz E, 2012, BJU INT, V110, pE541, DOI 10.1111/j.1464-410X.2012.11232.x; Gautier A, 2011, EUR J ENDOCRINOL, V165, P339, DOI 10.1530/EJE-11-0215; Gonzales GF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1319, DOI 10.1152/ajpendo.90940.2008; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; Hong D, 2013, MATURITAS, V74, P148, DOI 10.1016/j.maturitas.2012.10.016; Huhtaniemi IT, 2010, J CLIN ENDOCR METAB, V95, P1898, DOI 10.1210/jc.2009-2071; INTRAGUMTORNCHAI T, 1988, AM J CLIN NUTR, V48, P641, DOI 10.1093/ajcn/48.3.641; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; JONES BM, 1980, CLIN CHIM ACTA, V106, P203, DOI 10.1016/0009-8981(80)90173-4; Kelly DM, 2013, J ENDOCRINOL, V217, pR47, DOI 10.1530/JOE-12-0582; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kuvibidila SR, 2004, J NATL MED ASSOC, V96, P641; Laaksonen DE, 2003, EUR J ENDOCRINOL, V149, P601, DOI 10.1530/eje.0.1490601; Leedman PJ, 1996, J BIOL CHEM, V271, P12017, DOI 10.1074/jbc.271.20.12017; Li S, 2011, CLIN BIOCHEM, V44, P1325, DOI 10.1016/j.clinbiochem.2011.08.1137; Liao MZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034085, 10.1371/journal.pone.0039234]; Mohr BA, 2006, EUR J ENDOCRINOL, V155, P443, DOI 10.1530/eje.1.02241; Moilanen AM, 2007, CARCINOGENESIS, V28, P916, DOI 10.1093/carcin/bgl222; Przybyszewska J, 2013, POL ARCH MED WEWN, V123, P105, DOI 10.20452/pamw.1623; Ratledge C, 2007, FOOD NUTR BULL, V28, pS515, DOI 10.1177/15648265070284S405; Rushton DH, 2010, CRIT REV ONCOL HEMAT, V73, P1, DOI 10.1016/j.critrevonc.2009.03.010; SANTAMBROGIO P, 1987, BRIT J HAEMATOL, V65, P235, DOI 10.1111/j.1365-2141.1987.tb02271.x; Shahani S, 2009, J ENDOCRINOL INVEST, V32, P704, DOI 10.1007/BF03345745; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Tan TCH, 2012, LIVER INT, V32, P1391, DOI 10.1111/j.1478-3231.2012.02828.x; Tivesten A, 2009, J CLIN ENDOCR METAB, V94, P2482, DOI 10.1210/jc.2008-2650; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vaarala MH, 2008, INT J CANCER, V122, P2511, DOI 10.1002/ijc.23425; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Waalen J, 2011, EUR J HAEMATOL, V87, P107, DOI 10.1111/j.1600-0609.2011.01631.x; Walker NM, 2010, HEPATOLOGY, V51, P1683, DOI 10.1002/hep.23537; WORWOOD M, 1975, CLIN SCI MOL MED, V48, P441, DOI 10.1042/cs0480441; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; Wu IC, 2010, MATURITAS, V67, P348, DOI 10.1016/j.maturitas.2010.07.010; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; YOKOMORI N, 1991, ENDOCRINOLOGY, V128, P1474, DOI 10.1210/endo-128-3-1474; Yoo KD, 2012, CLIN ENDOCRINOL, V77, P233, DOI 10.1111/j.1365-2265.2011.04248.x; Zandman-Goddard G, 2008, ISR MED ASSOC J, V10, P83	54	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75908	10.1371/journal.pone.0075908	http://dx.doi.org/10.1371/journal.pone.0075908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146788	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400025
J	Tu, LH; Hu, TX; Zhang, J; Huang, LH; Xiao, YL; Chen, G; Hu, HL; Liu, L; Zheng, JK; Xu, ZF; Chen, LH				Tu, Li-hua; Hu, Ting-xing; Zhang, Jian; Huang, Li-hua; Xiao, Yin-long; Chen, Gang; Hu, Hong-ling; Liu, Li; Zheng, Jiang-kun; Xu, Zhen-feng; Chen, Liang-hua			Nitrogen Distribution and Cycling through Water Flows in a Subtropical Bamboo Forest under High Level of Atmospheric Deposition	PLOS ONE			English	Article							PLEIOBLASTUS-AMARUS PLANTATION; ORGANIC NITROGEN; RAINY AREA; SOIL RESPIRATION; N DEPOSITION; THROUGHFALL; STEMFLOW; PRECIPITATION; RAINFALL; SULFUR	Background: The hydrological cycle is an important way of transportation and reallocation of reactive nitrogen (N) in forest ecosystems. However, under a high level of atmospheric N deposition, the N distribution and cycling through water flows in forest ecosystems especially in bamboo ecosystems are not well understood. Methodology/Principal Findings: In order to investigate N fluxes through water flows in a Pleioblastus amarus bamboo forest, event rainfall/snowfall (precipitation, PP), throughfall (TF), stemflow (SF), surface runoff (SR), forest floor leachate (FFL), soil water at the depth of 40 cm (SW1) and 100 cm (SW2) were collected and measured through the whole year of 2009. Nitrogen distribution in different pools in this ecosystem was also measured. Mean N pools in vegetation and soil (0-1 m) were 351.7 and 7752.8 kg ha(-1). Open field nitrogen deposition at the study site was 113.8 kg N ha(-1) yr(-1), which was one of the highest in the world. N-NH4+, N-NO3- and dissolved organic N (DON) accounted for 54%, 22% and 24% of total wet N deposition. Net canopy accumulated of N occurred with N-NO3- and DON but not N-NH4+. The flux of total dissolved N (TDN) to the forest floor was greater than that in open field precipitation by 17.7 kg N ha(-1) yr(-1), due to capture of dry and cloudwater deposition net of canopy uptake. There were significant negative exponential relationships between monthly water flow depths and monthly mean TDN concentrations in PP, TF, SR, FFL and SW1. Conclusions/Significance: The open field nitrogen deposition through precipitation is very high over the world, which is the main way of reactive N input in this bamboo ecosystem. The water exchange and N consume mainly occurred in the litter floor layer and topsoil layer, where most of fine roots of bamboo distributed.	[Tu, Li-hua; Hu, Ting-xing; Zhang, Jian; Huang, Li-hua; Xiao, Yin-long; Chen, Gang; Hu, Hong-ling; Zheng, Jiang-kun] Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China; [Zhang, Jian; Xu, Zhen-feng; Chen, Liang-hua] Sichuan Agr Univ, Coll Forestry, Inst Ecol Forestry, Chengdu, Peoples R China; [Liu, Li] Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China; [Liu, Li] Sichuan Agr Univ, Personnel Dept, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Hu, TX (corresponding author), Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China.	hutx001@163.com			Specialized Research Fund for the Doctoral Program of Higher Education of China [20125103120018]; Scientific Research Fund of Sichuan Provincial Education Department [12ZA118]; National Key Technology R&D Program of China [2011BAC09B05]; Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Fund of Sichuan Provincial Education Department; National Key Technology R&D Program of China(National Key Technology R&D Program); Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	This study was funded by Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20125103120018), Scientific Research Fund of Sichuan Provincial Education Department (No. 12ZA118), National Key Technology R&D Program of China (No. 2011BAC09B05), and Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Aber JD, 1995, WATER AIR SOIL POLL, V85, P1665, DOI 10.1007/BF00477219; AGREN GI, 1988, ENVIRON POLLUT, V54, P185, DOI 10.1016/0269-7491(88)90111-X; Boyce RL, 1996, CAN J FOREST RES, V26, P1539, DOI 10.1139/x26-173; Brookshire ENJ, 2007, ECOSYSTEMS, V10, P252, DOI 10.1007/s10021-007-9019-x; BUTLER TJ, 1995, ATMOS ENVIRON, V29, P1253, DOI 10.1016/1352-2310(94)00339-M; Chaves J, 2009, ECOSYSTEMS, V12, P961, DOI 10.1007/s10021-009-9270-4; Chen XY, 2007, SCI TOTAL ENVIRON, V378, P317, DOI 10.1016/j.scitotenv.2007.02.028; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Chuyong GB, 2004, BIOGEOCHEMISTRY, V67, P73, DOI 10.1023/B:BIOG.0000015316.90198.cf; Cornell SE, 2011, ENVIRON POLLUT, V159, P2214, DOI 10.1016/j.envpol.2010.11.014; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Dezi S, 2010, GLOBAL CHANGE BIOL, V16, P1470, DOI 10.1111/j.1365-2486.2009.02102.x; Dezzeo N, 2006, FOREST ECOL MANAG, V234, P218, DOI 10.1016/j.foreco.2006.07.003; Draaijers GPJ, 1995, WATER AIR SOIL POLL, V85, P2253, DOI 10.1007/BF01186169; Draaijers GPJ, 1996, ATMOS ENVIRON, V30, P3349, DOI 10.1016/1352-2310(96)00030-1; Fang YT, 2011, J FOREST RES-JPN, V16, P341, DOI 10.1007/s10310-011-0267-4; Fang YT, 2009, ECOSYSTEMS, V12, P33, DOI 10.1007/s10021-008-9203-7; FAO, 2010, GLOBAL FOREST RESOUR; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; GALLOWAY JN, 1982, J GEOPHYS RES-OCEANS, V87, P8771, DOI 10.1029/JC087iC11p08771; Goller R, 2006, BIOGEOCHEMISTRY, V77, P57, DOI 10.1007/s10533-005-1061-1; Grimshaw H.M., 1989, CHEM ANAL ECOLOGICAL, V2nd, P81; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Hagedorn F, 2000, BIOGEOCHEMISTRY, V50, P137, DOI 10.1023/A:1006398105953; Hogberg P, 2007, NATURE, V447, P781, DOI 10.1038/447781a; Hu ZY, 2007, PEDOSPHERE, V17, P360, DOI 10.1016/S1002-0160(07)60043-5; Jia GD, 2010, ATMOS ENVIRON, V44, P2309, DOI 10.1016/j.atmosenv.2010.03.041; JORDAN CF, 1978, OIKOS, V31, P257, DOI 10.2307/3543571; KRUG FJ, 1979, ANALYST, V104, P47, DOI 10.1039/an9790400047; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lehmann CMB, 2005, ENVIRON POLLUT, V135, P347, DOI 10.1016/j.envpol.2004.11.016; Lin XinChun, 2004, Journal of Zhejiang Forestry College, V21, P168; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; LLOYD CR, 1988, AGR FOREST METEOROL, V42, P63, DOI 10.1016/0168-1923(88)90067-6; Mitchell MJ, 2001, HYDROL PROCESS, V15, P3305, DOI 10.1002/hyp.503; Neff JC, 2002, BIOGEOCHEMISTRY, V57, P99, DOI 10.1023/A:1015791622742; Onozawa Y, 2009, J FOREST RES-JPN, V14, P111, DOI 10.1007/s10310-008-0108-2; SCHULZE ED, 1989, SCIENCE, V244, P776, DOI 10.1126/science.244.4906.776; SFAPRC, 2010, STAT FOR RES CHIN 20; Sleutel S, 2009, BIOGEOSCIENCES, V6, P2743, DOI 10.5194/bg-6-2743-2009; Ti CP, 2012, BIOGEOCHEMISTRY, V108, P381, DOI 10.1007/s10533-011-9606-y; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Tu LH, 2011, PEDOSPHERE, V21, P685, DOI 10.1016/S1002-0160(11)60171-9; Tu Li-Hua, 2011, Chinese Journal of Plant Ecology, V35, P125, DOI 10.3724/SP.J.1258.2011.00125; Tu LH, 2011, PLANT SOIL, V340, P383, DOI 10.1007/s11104-010-0610-0; Tu Li-hua, 2010, Yingyong Shengtai Xuebao, V21, P2472; Tu Li-hua, 2009, Yingyong Shengtai Xuebao, V20, P2943; van Leeuwen EP, 1995, 722108006 RIVM; Violaki K, 2010, MAR CHEM, V120, P179, DOI 10.1016/j.marchem.2009.08.004; Vries W. de, 2009, Forest Ecology and Management, V258, P1814, DOI 10.1016/j.foreco.2009.02.034; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Zhang Y, 2008, ATMOS ENVIRON, V42, P1436, DOI 10.1016/j.atmosenv.2007.11.002; Zhang Y, 2012, ATMOS ENVIRON, V46, P195, DOI 10.1016/j.atmosenv.2011.09.080; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; ZHU PF, 1989, FOREST SOIL SICHUAN; Zhuang Ping, 2002, Shengwu Duoyangxing, V10, P339	58	10	16	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75862	10.1371/journal.pone.0075862	http://dx.doi.org/10.1371/journal.pone.0075862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146784	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400023
J	Ji, FH; Li, ZM; Young, JN; Yeranossian, A; Liu, H				Ji, Fuhai; Li, Zhongmin; Young, J. Nilas; Yeranossian, Artin; Liu, Hong			Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; RECEPTOR AGONISTS; RENAL-FUNCTION; RISK; ACTIVATION; RELEASE; ALPHA-2	Background: And Objectives: The aim of this retrospective investigation was to study the relationships among chronic kidney disease, acute kidney injury (AKI), and potential benefits by post-bypass dexmedetomidine use in patients undergoing cardiac surgery. Methods: The patient data were reviewed from the institutional Society of Thoracic Surgeons National Adult Cardiac Surgery Database after IRB approval. 1,133 patients were identified and divided into two groups: those who received dexmedetomidine or those who did not during the post-bypass period. The postoperative outcomes include the incidence of AKI, any complication and all cause of mortality. Results: Post-bypass dexmedetomidine use was associated with significantly reduced the incidence of total AKI (26.1% vs. 33.75%; adjusted OR, 0.7033; 95% CI, 0.540 to 0.916; p=0.0089). In addition, post-bypass dexmedetomidine use was more likely to reduce the incidence of AKI in these patients with preoperative normal kidney function (Stage1; 32.8% to 22.8%; p=0.0233) and mild CKD (Stage 2; 32.8% to 24.7; p=0.0003) after cardiac surgery. Post-bypass infusion of dexmedetomidine was associated with significantly reduced incidence of any complication and 30-day mortalities. Conclusions: Post-bypass dexmedetomidine use is associated with a significant reduction in the incidence of AKI, especially mild AKI in patients with preoperative normal renal function and mild CKD undergoing cardiac surgery.	[Ji, Fuhai] Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Jiangsu, Peoples R China; [Ji, Fuhai; Yeranossian, Artin; Liu, Hong] Univ Calif Davis Hlth Syst, Dept Anesthesiol & Pain Med, Sacramento, CA USA; [Li, Zhongmin] Univ Calif Davis Hlth Syst, Dept Internal Med, Sacramento, CA USA; [Young, J. Nilas] Univ Calif Davis Hlth Syst, Div Cardiothorac Surg, Sacramento, CA USA	Soochow University - China; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Liu, H (corresponding author), Univ Calif Davis Hlth Syst, Dept Anesthesiol & Pain Med, Sacramento, CA USA.	hualiu@ucdavis.edu		Liu, Hong/0000-0003-3611-7131	Department of Anesthesiology and Pain Medicine; Department of Anesthesiology and Pain Medicine, of University of California Davis Health System; Department of Surgery of University of California Davis Health System; Department of Internal Medicine of University of California Davis Health System; NIH [UL1 TR000002]; Jiangsu Province's by Key Provincial Talents Program, China; Jiangsu province's six major peak talents program, China; Suzhou science and Technology Bureau's program, China [SYS201111]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER	Department of Anesthesiology and Pain Medicine; Department of Anesthesiology and Pain Medicine, of University of California Davis Health System; Department of Surgery of University of California Davis Health System; Department of Internal Medicine of University of California Davis Health System; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jiangsu Province's by Key Provincial Talents Program, China; Jiangsu province's six major peak talents program, China; Suzhou science and Technology Bureau's program, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was partially supported by the Department of Anesthesiology and Pain Medicine, Department of Surgery and Department of Internal Medicine of University of California Davis Health System and NIH grant UL1 TR000002. This study was supported by grant from Jiangsu Province's by Key Provincial Talents Program, China (FJ), by Jiangsu province's six major peak talents program, China (FJ) and by Suzhou science and Technology Bureau's program No. SYS201111 (FJ) from, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2008, INT J ARTIF ORGANS, V31, P166, DOI 10.1177/039139880803100210; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Borthwick E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3365; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; CHERTOW GM, 1995, ARCH INTERN MED, V155, P1505, DOI 10.1001/archinte.155.14.1505; CHOU SY, 1990, KIDNEY INT, V37, P1, DOI 10.1038/ki.1990.1; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; Englberger L, 2011, J THORAC CARDIOV SUR, V141, P552, DOI 10.1016/j.jtcvs.2010.02.045; Frumento RJ, 2006, J CLIN ANESTH, V18, P422, DOI 10.1016/j.jclinane.2006.02.005; GELLAI M, 1987, J PHARMACOL EXP THER, V240, P723; Gu JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10283; HARADA T, 1993, J UROLOGY, V149, P159, DOI 10.1016/S0022-5347(17)36030-5; HELBOHANSEN S, 1986, ACTA ANAESTH SCAND, V30, P235, DOI 10.1111/j.1399-6576.1986.tb02404.x; Hsing CH, 2012, AM J PHYSIOL-RENAL, V303, pF1443, DOI 10.1152/ajprenal.00143.2012; Jalonen J, 1997, ANESTHESIOLOGY, V86, P331; Jarnberg Per-Olof, 2004, Best Pract Res Clin Anaesthesiol, V18, P645; Joris JL, 1998, J AM COLL CARDIOL, V32, P1389, DOI 10.1016/S0735-1097(98)00406-9; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Khan ZP, 1999, ANAESTHESIA, V54, P146, DOI 10.1046/j.1365-2044.1999.00659.x; Kulka PJ, 1996, CRIT CARE MED, V24, P947, DOI 10.1097/00003246-199606000-00012; Leino K, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-9; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Menon DV, 2007, J AM COLL CARDIOL, V50, P626, DOI 10.1016/j.jacc.2007.03.060; Okada H, 2007, RESUSCITATION, V74, P538, DOI 10.1016/j.resuscitation.2007.01.032; REVES JG, 1984, AM J CARDIOL, V53, P722, DOI 10.1016/0002-9149(84)90393-X; Rosner Mitchell H, 2008, J Intensive Care Med, V23, P3, DOI 10.1177/0885066607309998; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Shirasaka T, 2007, ANESTHESIOLOGY, V107, P605, DOI 10.1097/01.anes.0000281916.65365.4e; Stafford-Smith M, 2009, CURR OPIN CRIT CARE, V15, P498, DOI 10.1097/MCC.0b013e328332f753; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Taoda M, 2001, NEUROCHEM INT, V38, P317, DOI 10.1016/S0197-0186(00)00096-6; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Weatherby KE, 2003, INFECT IMMUN, V71, P22, DOI 10.1128/IAI.71.1.22-29.2003; Yang CL, 2011, J SURG RES, V167, pE273, DOI 10.1016/j.jss.2010.02.020; Zhang XY, 2012, ANESTHESIOLOGY, V116, P1035, DOI 10.1097/ALN.0b013e3182503964	36	46	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77446	10.1371/journal.pone.0077446	http://dx.doi.org/10.1371/journal.pone.0077446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130886	gold, Green Published			2022-12-27	WOS:000325814200088
J	Liu, Y; Luo, DJ; Zhao, H; Zhu, ZY; Hu, W; Cheng, CHK				Liu, Yun; Luo, Daji; Zhao, Hui; Zhu, Zuoyan; Hu, Wei; Cheng, Christopher H. K.			Inheritable and Precise Large Genomic Deletions of Non-Coding RNA Genes in Zebrafish Using TALENs	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; CHROMOSOMAL DELETIONS; EFFECTOR NUCLEASES; EMBRYONIC-DEVELOPMENT; MICRORNA EXPRESSION; TRANSCRIPTION; CELLS; KNOCKOUT; ORGANIZATION; RECOGNITION	Transcription activator-like effector nucleases (TALENs) have so far been applied to disrupt protein-coding genes which constitute only 2-3% of the genome in animals. The majority (70-90%) of the animal genome is actually transcribed as non-coding RNAs (ncRNAs), yet the lack of efficient tools to knockout ncRNA genes hinders studies on their in vivo functions. Here we have developed novel strategies using TALENs to achieve precise and inheritable large genomic deletions and knockout of ncRNA genes in zebrafish. We have demonstrated that individual miRNA genes could be disrupted using one pair of TALENs, whereas large microRNA (miRNA) gene clusters and long non-coding RNA (lncRNA) genes could be precisely deleted using two pairs of TALENs. We have generated large genomic deletions of two miRNA clusters (the 1.2 kb miR-17-92 cluster and the 79.8 kb miR-430 cluster) and one long non-coding RNA (lncRNA) gene (the 9.0 kb malat1), and the deletions are transmitted through the germline. Taken together, our results establish TALENs as a robust tool to engineer large genomic deletions and knockout of ncRNA genes, thus opening up new avenues in the application of TALENs to study the genome in vivo.	[Liu, Yun; Zhao, Hui; Cheng, Christopher H. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Luo, Daji; Zhu, Zuoyan; Hu, Wei] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Luo, Daji] Wuhan Univ, Sch Basic Med Sci, Dept Genet, Wuhan 430072, Peoples R China; [Liu, Yun; Zhao, Hui; Cheng, Christopher H. K.] Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci, Core Lab, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Wuhan University; Chinese University of Hong Kong, Shenzhen	Hu, W (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	huwei@ihb.ac.cn; chkcheng@cuhk.edu.hk	Luo, Daji/AAQ-3065-2021; Zhao, Hui/B-8429-2016; CHENG, Ki Christopher/R-9641-2018	Zhao, Hui/0000-0001-8160-6415; CHENG, Ki Christopher/0000-0001-8970-9048	Research Grant Council of Hong Kong [462312]; National Natural Science Foundation of China [31172394, 30900853, 30930069]; Chinese Academy of Sciences [KSCX2-EW-N-004]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Research Grant Council of Hong Kong (462312 to CHKC), the National Natural Science Foundation of China (31172394 to CHKC, 30900853 to DL and 30930069 to WH) and the Chinese Academy of Sciences (KSCX2-EW-N-004 to WH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Ansai S, 2013, GENETICS IN PRESS; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Huarte M, 2013, CELL RES, V23, P449, DOI 10.1038/cr.2012.169; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koprunner M, 2001, GENE DEV, V15, P2877; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lim SM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r69; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464	50	13	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76387	10.1371/journal.pone.0076387	http://dx.doi.org/10.1371/journal.pone.0076387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130773	Green Submitted, gold, Green Published			2022-12-27	WOS:000325814200038
J	Wan, H; Hu, JP; Li, KS; Tian, XH; Chang, S				Wan, Hua; Hu, Jian-ping; Li, Kang-shun; Tian, Xu-hong; Chang, Shan			Molecular Dynamics Simulations of DNA-Free and DNA-Bound TAL Effectors	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; BINDING SPECIFICITY; CRYSTAL-STRUCTURE; III EFFECTORS; RECOGNITION; PROTEIN; COMPLEXES; PATHOGEN; RICE; GENE	TAL (transcriptional activator-like) effectors (TALEs) are DNA-binding proteins, containing a modular central domain that recognizes specific DNA sequences. Recently, the crystallographic studies of TALEs revealed the structure of DNA-recognition domain. In this article, molecular dynamics (MD) simulations are employed to study two crystal structures of an 11.5-repeat TALE, in the presence and absence of DNA, respectively. The simulated results indicate that the specific binding of RVDs (repeat-variable diresidues) with DNA leads to the markedly reduced fluctuations of tandem repeats, especially at the two ends. In the DNA-bound TALE system, the base-specific interaction is formed mainly by the residue at position 13 within a TAL repeat. Tandem repeats with weak RVDs are unfavorable for the TALE-DNA binding. These observations are consistent with experimental studies. By using principal component analysis (PCA), the dominant motions are open-close movements between the two ends of the superhelical structure in both DNA-free and DNA-bound TALE systems. The open-close movements are found to be critical for the recognition and binding of TALE-DNA based on the analysis of free energy landscape (FEL). The conformational analysis of DNA indicates that the 59 end of DNA target sequence has more remarkable structural deformability than the other sites. Meanwhile, the conformational change of DNA is likely associated with the specific interaction of TALE-DNA. We further suggest that the arrangement of N-terminal repeats with strong RVDs may help in the design of efficient TALEs. This study provides some new insights into the understanding of the TALE-DNA recognition mechanism.	[Wan, Hua; Li, Kang-shun; Tian, Xu-hong; Chang, Shan] South China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China; [Hu, Jian-ping] Leshan Normal Univ, Coll Chem, Leshan, Peoples R China	South China Agricultural University; Leshan Normal University	Chang, S (corresponding author), South China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China.	schang@scau.edu.cn		Chang, Shan/0000-0001-7169-9398	National Natural Science Foundation of China [31200990, 31372116, 11247018, 31071837, 70971043]; Guangdong Province Science and Technology Plan Project [2012B010100029, 2010B080701070]; key Project of Chinese Ministry of Education [211159]; Science and Technology Bureau Foundation of Sichuan Province [2011JYZ007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Plan Project; key Project of Chinese Ministry of Education(Ministry of Education, China); Science and Technology Bureau Foundation of Sichuan Province	This work was supported by the National Natural Science Foundation of China (31200990, 31372116, 11247018, 31071837, 70971043), Guangdong Province Science and Technology Plan Project (2012B010100029, 2010B080701070), the key Project of Chinese Ministry of Education (211159) and the Science and Technology Bureau Foundation of Sichuan Province (2011JYZ007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT METHODS, V9, P23, DOI 10.1038/nmeth.1807; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bradley P, 2012, PROTEIN SCI, V21, P471, DOI 10.1002/pro.2034; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Hatano T, 2001, PHYS REV LETT, V86, P3463, DOI 10.1103/PhysRevLett.86.3463; Hu JP, 2008, ACTA PHYS-CHIM SIN, V24, P1803, DOI 10.3866/PKU.WHXB20081012; Hu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054929; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jalili S, 2012, EUR BIOPHYS J BIOPHY, V41, P329, DOI 10.1007/s00249-012-0790-z; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Maisuradze GG, 2010, J CHEM THEORY COMPUT, V6, P583, DOI 10.1021/ct9005745; Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Negureanu L, 2012, J BIOMOL STRUCT DYN, V29, P757, DOI 10.1080/07391102.2012.10507412; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prabakaran P, 2006, STRUCTURE, V14, P1355, DOI 10.1016/j.str.2006.06.018; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wan H, 2013, PHYS CHEM CHEM PHYS, V15, P1241, DOI 10.1039/c2cp41388d; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Yin P, 2012, CELL REP, V2, P707, DOI 10.1016/j.celrep.2012.09.001; YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	59	37	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76045	10.1371/journal.pone.0076045	http://dx.doi.org/10.1371/journal.pone.0076045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130757	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200028
J	Cohen-Or, I; Katz, C; Ron, EZ				Cohen-Or, Ifat; Katz, Chen; Ron, Eliora Z.			Metabolism of AGEs - Bacterial AGEs Are Degraded by Metallo-Proteases	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INVOLVEMENT; DEGRADATION; INHIBITION; COMPLICATIONS; PATHOGENESIS; MECHANISM; PROTEINS	Advanced Glycation End Products (AGEs) are the final products of non-enzymatic protein glycation that results in loss of protein structure and function. We have previously shown that in E. coli AGEs are continually formed as high-molecular weight protein complexes. Moreover, we showed that AGEs are removed from the cells by an active, ATP-dependent secretion and that these secreted molecules have low molecular weight. Taken together, these results indicate that E. coli contains a fraction of low molecular weight AGEs, in addition to the high-molecular weight AGEs. Here we show that the low-molecular weight AGEs originate from high-molecular weight AGEs by proteolytic degradation. Results of in-vitro and in vivo experiments indicated that this degradation is carried out not by the major ATP-dependent proteases that are responsible for the main part of bacterial protein quality control but by an alternative metal-dependent proteolysis. This proteolytic reaction is essential for the further secretion of AGEs from the cells. As the biochemical reactions involving AGEs are not yet understood, the implication of a metalloprotease in breakdown of high molecular weight AGEs and their secretion constitutes an important step in the understanding of AGEs metabolism.	[Cohen-Or, Ifat; Ron, Eliora Z.] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Katz, Chen] MIGAL Galilee Res Ctr, Kiriat Shmone, Israel	Tel Aviv University	Ron, EZ (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	eliora@post.tau.ac.il						Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baynes J W, 1989, Prog Clin Biol Res, V304, P43; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Cohen-Or I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017974; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Kankova K, 2008, P NUTR SOC, V67, P60, DOI 10.1017/S0029665108006034; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; MAZUS B, 1986, BIOCHEMISTRY-US, V25, P2941, DOI 10.1021/bi00358a031; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; Petrillo TM, 2000, NEW ENGL J MED, V342, P1250, DOI 10.1056/NEJM200004273421704; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Stolzing A, 2006, FREE RADICAL BIO MED, V40, P1017, DOI 10.1016/j.freeradbiomed.2005.10.061; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Takeuchi M, 2009, J ALZHEIMERS DIS, V16, P845, DOI 10.3233/JAD-2009-0974; TAYLOR ES, 1947, J GEN MICROBIOL, V1, P86, DOI 10.1099/00221287-1-1-86; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Turlin E, 1996, BIOCHIMIE, V78, P822, DOI 10.1016/S0300-9084(97)84334-9; Van Nguyen C, 2006, MOL NUTR FOOD RES, V50, P1140, DOI 10.1002/mnfr.200600144; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Zhu BZ, 2000, CHEM-BIOL INTERACT, V129, P249, DOI 10.1016/S0009-2797(00)00208-8	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74970	10.1371/journal.pone.0074970	http://dx.doi.org/10.1371/journal.pone.0074970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130678	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900013
J	Ebsen, H; Schroder, A; Kabelitz, D; Janssen, O				Ebsen, Henriette; Schroeder, Alexandra; Kabelitz, Dieter; Janssen, Ottmar			Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; REGULATED INTRAMEMBRANE PROTEOLYSIS; TRANS-GOLGI NETWORK; SECRETORY LYSOSOMES; TNF-ALPHA; INTRACELLULAR DOMAIN; PRECURSOR PROTEIN; GAMMA-SECRETASE; CALCIUM INFLUX	A disintegrin and metalloproteases (ADAMs) have been implicated in many processes controlling organismic development and integrity. Important substrates of ADAM proteases include growth factors, cytokines and their receptors and adhesion proteins. The inducible but irreversible cleavage of their substrates alters cell-cell communication and signaling. The crucial role of ADAM proteases (e. g. ADAM10 and 17) for mammalian development became evident from respective knockout mice, that displayed pre- or perinatal lethality with severe defects in many organs and tissues. Although many substrates for these two ADAM proteases were identified over the last decade, the regulation of their surface appearance, their enzymatic activity and their substrate specificity are still not well understood. We therefore analyzed the constitutive and inducible surface expression of ADAM10 and ADAM17 on a variety of human T cell and tumor cell lines. We demonstrate that ADAM10 is constitutively present at comparably high levels on the majority of the tested cell types. Stimulation with phorbol ester and calcium ionophore does not significantly alter the amount of surface ADAM10, except for a slight down-regulation from T cell blasts. Using FasL shedding as a readout for ADAM10 activity, we show that PKC activation and calcium mobilization are both prerequisite for activation of ADAM10 resulting in a production of soluble FasL. In contrast to ADAM10, the close relative ADAM17 is detected at only low levels on unstimulated cells. ADAM17 surface expression on T cell blasts is rapidly induced by stimulation. Since this inducible mobilization of ADAM17 is sensitive to inhibitors of actin filament formation, we propose that ADAM17 but not ADAM10 is prestored in a subcellular compartment that is transported to the cell surface in an activation-and actin-dependent manner.	[Ebsen, Henriette; Schroeder, Alexandra; Kabelitz, Dieter; Janssen, Ottmar] Univ Kiel, Inst Immunol, Univ Hosp Schleswig Holstein Campus Kiel, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Janssen, O (corresponding author), Univ Kiel, Inst Immunol, Univ Hosp Schleswig Holstein Campus Kiel, Kiel, Germany.	ojanssen@email.uni-kiel.de	Kabelitz, Dieter/A-2757-2010; Janssen, Ottmar/E-9735-2010; Kabelitz, Dieter/AAB-4199-2021; Janssen, Ottmar/N-8769-2019; Ebsen, Henriette/B-1886-2015	Janssen, Ottmar/0000-0002-9612-8900; Janssen, Ottmar/0000-0002-9612-8900; 	Deutsche Forschungsgemeinschaft Bonn, Germany (DFG) [SFB877]	Deutsche Forschungsgemeinschaft Bonn, Germany (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft Bonn, Germany (SFB877, projects B4, A7) (DFG: http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Annaert WG, 2009, SEMIN CELL DEV BIOL, V20, P125, DOI 10.1016/j.semcdb.2009.03.005; Bell HL, 2010, AM J MED SCI, V339, P105, DOI 10.1097/MAJ.0b013e3181cb4487; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Gutierrez-Lopez MD, 2011, CELL MOL LIFE SCI, V68, P3275, DOI 10.1007/s00018-011-0639-0; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Guo Sha, 2012, Chinese Medical Sciences Journal, V27, P73; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Holback S, 2008, BIOCHEM BIOPH RES CO, V365, P298, DOI 10.1016/j.bbrc.2007.10.167; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Lettau M, 2006, P NATL ACAD SCI USA, V103, P5911, DOI 10.1073/pnas.0508562103; LETTAU M, 2004, SIGNAL TRANSDUCT, V4, P206, DOI DOI 10.1002/SITA.200400037; Lettau M, 2007, IMMUNOL LETT, V108, P10, DOI 10.1016/j.imlet.2006.10.001; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 2011, J BIOL CHEM, V286, P40443, DOI 10.1074/jbc.M111.280495; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Parr-Sturgess CA, 2010, BIOCHEM J, V432, P283, DOI 10.1042/BJ20100321; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schmidt H, 2008, PROTEOMICS, V8, P2911, DOI 10.1002/pmic.200800170; Schmidt H, 2011, J PROTEOME RES, V10, P1603, DOI 10.1021/pr100967v; Schmidt H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-4; Schmidt H, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-41; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Trad A, 2011, J IMMUNOL METHODS, V371, P91, DOI 10.1016/j.jim.2011.06.015; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Voss Matthias, 2008, Cell Commun Signal, V6, P11, DOI 10.1186/1478-811X-6-11; Walev I, 1996, P NATL ACAD SCI USA, V93, P7882, DOI 10.1073/pnas.93.15.7882; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zhang C, 2010, DEV DYNAM, V239, P2594, DOI 10.1002/dvdy.22391	70	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76853	10.1371/journal.pone.0076853	http://dx.doi.org/10.1371/journal.pone.0076853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130797	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900092
J	Shukla, KK; Kwon, WS; Rahman, MS; Park, YJ; You, YA; Pang, MG				Shukla, Kamla Kant; Kwon, Woo-Sung; Rahman, Md Saidur; Park, Yoo-Jin; You, Young-Ah; Pang, Myung-Geol			Nutlin-3a Decreases Male Fertility via UQCRC2	PLOS ONE			English	Article							HUMAN SPERM FUNCTION; TYROSINE PHOSPHORYLATION; MOUSE SPERM; HUMAN-SPERMATOZOA; IN-VITRO; PROTEIN; P53; CAPACITATION; MDM2; DEGRADATION	Ubiquinol-cytochrome-c reductase core protein 2 (UQCRC2) is a component of ubiquinol-cytochrome c reductase complex that is known to correlate with male fertility via spermatogenesis. Simultaneously, nutlin-3a is a small molecule antagonist of mouse double minute 2 repressor (MDM2), activate p53 and induce apoptosis responsible for spermatogenesis. To date, however there are no known effects of nutlin-3a on reproduction. Therefore, present study was designed to investigate the effect of nutlin-3a on male fertility via UQCRC2. In this in vitro trial with mice spermatozoa, we utilized CASA, CTC staining, ATP assay, western blotting, and IVF to measure the main study outcome. The short-term exposure of spermatozoa in nutlin-3a decreases sperm motion kinematics, intracellular ATP production, capacitation, the acrosome reaction, UQCRC2, and tyrosine phosphorylation (TYP) of sperm proteins in a dose-dependent manner. Notably, the decreased UQCRC2 and TYP were associated with reduced sperm kinematics, ATP production, and capacitation, which ultimately led to adverse effects on male fertility such as poor fertilization rates and embryo development. Thus, nutlin-3a may be considered as a potential male contraceptive agent due to its ability to decrease fertility secondary to changes in overall sperm physiology and embryonic development. However, the results of this preliminary study have to be confirmed by additional independent trial.	[Shukla, Kamla Kant; Kwon, Woo-Sung; Rahman, Md Saidur; Park, Yoo-Jin; You, Young-Ah; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea	Chung Ang University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Rahman, Md Saidur/AAT-2972-2020; Rahman, Saidur/J-7855-2012; Pang, Myung-Geol/AAV-2014-2021; Kwon, Woo-Sung/J-6731-2019; Rahman, Mohammad Saifur/GZM-5483-2022; Shukla, Kamla Kant/AAO-1256-2020; Rahman, Mohammad Sohelur/AAJ-7376-2020	Rahman, Saidur/0000-0003-4583-8731; Pang, Myung-Geol/0000-0003-2019-3789; Kwon, Woo-Sung/0000-0002-0848-7189; Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Mohammad Sohelur/0000-0002-4489-2202; You, Younag-Ah/0000-0001-6714-7144; Shukla, Kamla Kant/0000-0001-6086-2938	Rural Development Administration, Republic of Korea [PJ008415]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by the Rural Development Administration, Republic of Korea, through a project entitled the "Cooperative Research Program for Agriculture Science & Technology Development" (Project No. PJ008415), which is currently being implemented in the Department of Animal Science and Technology, Chung-Ang University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1995, J CELL SCI, V108, P2017; Edwards SE, 2007, REPROD SCI, V14, P655, DOI 10.1177/1933719107306227; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hong S, 2011, CURR PHARM DESIGN, V17, P560, DOI [10.2174/138161211795222603, DOI 10.2174/138161211795222603.PUBMED:21391906]; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Kwon WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054192; Kwon WS, 2013, FERTIL STERIL, V99, P354, DOI 10.1016/j.fertnstert.2012.09.021; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Marin-Briggiler CI, 2003, FERTIL STERIL, V79, P1396, DOI 10.1016/S0015-0282(03)00267-X; Marty MS, 1999, MUTAT RES-FUND MOL M, V427, P39, DOI 10.1016/S0027-5107(99)00083-4; Maxwell WMC, 1999, THERIOGENOLOGY, V52, P1353, DOI 10.1016/S0093-691X(99)00222-8; Megumi T, 2009, J RADIAT RES, V50, P11, DOI [10.1269/jrr.08099, DOI 10.1269/JRR.08099.PUBMED:19218778]; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211; Park YJ, 2012, J PROTEOME RES, V11, P4162, DOI 10.1021/pr300248s; Perez LJ, 1996, THERIOGENOLOGY, V45, P1037, DOI 10.1016/0093-691X(96)00031-3; QUINN P, 1982, J REPROD FERTIL, V66, P161; Seligman J, 2004, BIOL REPROD, V71, P1009, DOI 10.1095/biolreprod.104.028035; Shukla KK, 2012, J ANDROL, V33, P777, DOI 10.2164/jandrol.111.015552; Shukla KK, 2011, REPROD BIOMED ONLINE, V22, P421, DOI 10.1016/j.rbmo.2011.01.010; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Suryawanshi AR, 2011, J ANDROL, V32, P240, DOI 10.2164/jandrol.110.010967; Sutovsky P, 2004, HUM REPROD, V19, P628, DOI 10.1093/humrep/deh131; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WISHART GJ, 1986, BRIT POULTRY SCI, V27, P97, DOI 10.1080/00071668608416859	31	26	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76959	10.1371/journal.pone.0076959	http://dx.doi.org/10.1371/journal.pone.0076959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130818	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900111
J	Wu, MQ; Huang, F; Jiang, XM; Fan, ZP; Zhou, HS; Liu, C; Jiang, QL; Zhang, Y; Zhao, K; Xuan, L; Zhai, X; Zhang, FH; Yin, CX; Sun, J; Feng, R; Liu, QF				Wu, Meiqing; Huang, Fen; Jiang, Xinmiao; Fan, Zhiping; Zhou, Hongsheng; Liu, Can; Jiang, Qianli; Zhang, Yu; Zhao, Ke; Xuan, Li; Zhai, Xiao; Zhang, Fuhua; Yin, Changxin; Sun, Jing; Feng, Ru; Liu, Qifa			Herpesvirus-Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SOLID-ORGAN TRANSPLANTATION; VIRAL ENCEPHALITIS; LYMPHOPROLIFERATIVE DISORDERS; HEMATOLOGICAL MALIGNANCIES; INFECTIONS; GUIDELINES; MANAGEMENT; ADULTS; CNS	Herpesvirus infections of the central nervous system (CNS) are associated with encephalitis/myelitis and lymphoproliferative diseases in immunocompromised individuals. As of now, data of herpesvirus-associated CNS diseases in transplant recipients is limited. Hence, in this prospective study, we investigated the incidence of herpesvirus-associated CNS diseases and explored the diagnosis of these diseases in 281 allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Herpesvirus-DNA and cerebrospinal fluid (CSF) cells were sampled from 58 recipients with herpesvirus-associated diseases or with unexplainable CNS manifestations. Results showed that 23 patients were diagnosed as herpesvirus-associated CNS diseases, including 15 Epstein-Barr virus (EBV)-associated diseases (4 encephalitis and 11 lymphoproliferative diseases), 5 herpes simplex virus type 1 encephalitis, 2 cytomegalovirus encephalitis/myelitis and 1 varicella zoster virus encephalitis. The median time of diseases onset was 65 (range 22-542) days post-transplantation. The 3-year cumulative incidence of herpesvirus-associated encephalitis/myelitis and post-transplant lymphoproliferative disorder (PTLD) was 6.3% +/- 1.9% and 4.1% +/- 1.2%, respectively. Of the evaluable cases, CSF cells mainly consisted of CD19(+)CD20(+) B cells (7/11) and had clonal rearrangement of immunoglobulin genes (3/11) in patients with CNS-PTLD. On the contrary, in patients with encephalitis/myelitis, CSF cells were comprised of different cell populations and none of the gene rearrangement was detected. Herpesvirus-associated CNS diseases are common in the early stages of allo-HSCT, wherein EBV is the most frequent causative virus. The immunophenotypic and clonal analysis of CSF cells might be helpful in the differential diagnosis between encephalitis and lymphoproliferative diseases.	[Wu, Meiqing; Huang, Fen; Jiang, Xinmiao; Fan, Zhiping; Zhou, Hongsheng; Liu, Can; Jiang, Qianli; Zhang, Yu; Zhao, Ke; Xuan, Li; Zhai, Xiao; Zhang, Fuhua; Yin, Changxin; Sun, Jing; Feng, Ru; Liu, Qifa] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Liu, QF (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	liuqifa628@163.com			National Natural Science Foundation of China [81000231, 30971300, 81270647]; National Public Health Grand Research Foundation [201202017]; Research Fund for the Doctoral Program of Higher Education of China [20104433110003]; Science and Technology Project of Guangdong Province of China [2009A030200007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Project of Guangdong Province of China	This work was supported by the National Natural Science Foundation of China (Grant No. 81000231, No. 30971300, No. 81270647); the National Public Health Grand Research Foundation (Grant No. 201202017); the Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20104433110003); and the Science and Technology Project of Guangdong Province of China (Grant No. 2009A030200007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-13; Anduze-Faris BM, 2000, AIDS, V14, P517, DOI 10.1097/00002030-200003310-00007; Boivin Guy, 2004, Herpes, V11 Suppl 2, p48A; Borchers S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050248; Brion A, 1995, NOUV REV FR HEMATOL, V37, P289; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; De Broucker T, 2012, CLIN MICROBIOL INFEC, V18, P808, DOI 10.1111/j.1469-0691.2011.03705.x; Denes E, 2004, EMERG INFECT DIS, V10, P729, DOI 10.3201/eid1004.030587; Evens AM, 2010, J CLIN ONCOL, V28, P1038, DOI 10.1200/JCO.2009.25.4961; Jagadeesh D, 2012, CURR TREAT OPTION ON, V13, P122, DOI 10.1007/s11864-011-0177-x; Kalita J, 2011, NEUROL INDIA, V59, P116, DOI 10.4103/0028-3886.84347; Kittan NA, 2011, TRANSPL INFECT DIS, V13, P524, DOI 10.1111/j.1399-3062.2011.00621.x; Korfel A, 2013, HAEMATOLOGICA, V98, P364, DOI 10.3324/haematol.2012.077917; Koskiniemi M, 2001, J NEUROVIROL, V7, P400, DOI 10.1080/135502801753170255; Liu QF, 2010, TRANSPL INFECT DIS, V12, P284, DOI 10.1111/j.1399-3062.2010.00502.x; Maecker B, 2007, J CLIN ONCOL, V25, P4902, DOI 10.1200/JCO.2006.10.2392; Martelius T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-281; Reddy N, 2011, BIOL BLOOD MARROW TR, V17, P591, DOI 10.1016/j.bbmt.2010.08.007; Sawada A, 2011, PEDIATR INT, V53, P1010, DOI 10.1111/j.1442-200X.2011.03437.x; Schmidt-Hieber M, 2011, HAEMATOL-HEMATOL J, V96, P142, DOI 10.3324/haematol.2010.029876; Shimizu H, 2011, INT J HEMATOL, V94, P495, DOI 10.1007/s12185-011-0951-3; Stahl JP, 2011, MED MALADIES INFECT, V41, P453, DOI 10.1016/j.medmal.2011.05.015; Steiner I, 2005, EUR J NEUROL, V12, P331, DOI 10.1111/j.1468-1331.2005.01126.x; Studahl M, 1998, SCAND J INFECT DIS, V30, P215, DOI 10.1080/00365549850160828; Styczynski J, 2009, BONE MARROW TRANSPL, V43, P757, DOI 10.1038/bmt.2008.386; Swerdlow SH, 2008, WHO CLASSIFICATION T, P343; Tsao SY, 2011, ANN HEMATOL, V90, P113, DOI 10.1007/s00277-010-0947-8; Weinberg A, 2002, ANN NEUROL, V52, P543, DOI 10.1002/ana.10321; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Xu B, 1999, J 1 MILITARY MED U, V19; Xuan L, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-46	31	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77805	10.1371/journal.pone.0077805	http://dx.doi.org/10.1371/journal.pone.0077805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124621	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100179
J	Nichols, E; Uriarte, M; Peres, CA; Louzada, J; Braga, RF; Schiffler, G; Endo, W; Spector, SH				Nichols, Elizabeth; Uriarte, Maria; Peres, Carlos A.; Louzada, Julio; Braga, Rodrigo Fagundes; Schiffler, Gustavo; Endo, Whaldener; Spector, Sacha H.			Human-Induced Trophic Cascades along the Fecal Detritus Pathway	PLOS ONE			English	Article							DUNG BEETLE COMMUNITIES; POPULATION-DENSITIES; INTERACTION STRENGTH; ASSEMBLAGE STRUCTURE; ECOSYSTEM FUNCTION; TROPICAL FORESTS; SEED DISPERSAL; TOP-DOWN; DIVERSITY; MAMMALS	Human presence and activity in tropical forest is thought to exert top-down regulation over the various 'green-world' pathways of plant-based foodwebs. However, these effects have never been explored for the 'brown-world' pathways of fecal-detritus webs. The strong effects of humans on tropical game mammals are likely to indirectly influence fecal detritivores (including Scarabaeine dung beetles), with subsequent indirect impacts on detrivore-mediated and plant-facilitating detrital processes. Across a 380-km gradient of human influence in the western Brazilian Amazon, we conducted the first landscape-level assessment of human-induced cascade effects on the fecal detritus pathway, by coupling data on human impact, game mammal and detritivore community structure, and rate measurements of a key detritus process (i.e. dung beetle-mediated secondary seed dispersal). We found evidence that human impact indirectly influences both the diversity and biomass of fecal detritivores, but not detritivore-mediated processes. Cascade strength varied across detritivore groups defined by species' traits. We found smaller-bodied dung beetles were at higher risk of local decline in areas of human presence, and that body size was a better predictor of cascade structure than fecal resource manipulation strategy. Cascade strength was also stronger in upland, unflooded forests, than in seasonally flooded forests. Our results suggest that the impact of human activity in tropical forest on fecal-detritus food web structure is mediated by both species' traits and habitat type. Further research will be required to determine the conditions under which these cascade effects influence fecal-detritus web function.	[Nichols, Elizabeth; Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Nichols, Elizabeth] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Louzada, Julio; Braga, Rodrigo Fagundes] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Louzada, Julio] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Schiffler, Gustavo] Univ Estadual Campinas, Dept Biol, Sao Paulo, Brazil; [Endo, Whaldener] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Spector, Sacha H.] Scen Hudson, Dept Conservat Sci, Poughkeepsie, NY USA	Columbia University; American Museum of Natural History (AMNH); University of East Anglia; Universidade Federal de Lavras; Lancaster University; Universidade Estadual de Campinas; Norwegian University of Life Sciences	Nichols, E (corresponding author), Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil.	lizsnichols@gmail.com	Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020; Endo, Whaldener/D-1726-2012; Louzada, Julio/F-1265-2010; Uriarte, Maria/L-8944-2013; Nichols, Elizabeth/L-7484-2013; Peres, Carlos A./B-1276-2013	Peres, Carlos A./0000-0002-1588-8765; Endo, Whaldener/0000-0002-7305-4398; Louzada, Julio/0000-0002-1481-3112; Nichols, Elizabeth/0000-0002-4960-6842; Peres, Carlos A./0000-0002-1588-8765	Brazilian Conselho Nacional Desenvolvimento Cientifico e Tecnologico [CNPq - 480645/2008-6]; United States National Science Foundation Research Coordination Network (NSF) [DEB-0043443]; DEFRA/UK Darwin Initiative grant [16-001]; Department of Ecology, Evolution and Environmental Biology at Columbia University; Columbia University Faculty Fellowship; Yeh Family Foundation; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Brazilian Conselho Nacional Desenvolvimento Cientifico e Tecnologico; United States National Science Foundation Research Coordination Network (NSF); DEFRA/UK Darwin Initiative grant; Department of Ecology, Evolution and Environmental Biology at Columbia University; Columbia University Faculty Fellowship; Yeh Family Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support for this study came from a Brazilian Conselho Nacional Desenvolvimento Cientifico e Tecnologico grant to EN, SS and JL (CNPq - 480645/2008-6; http://www.cnpq.br/), a United States National Science Foundation Research Coordination Network grant to SS (NSF Grant No. DEB-0043443; http://www.nsf.gov/), a DEFRA/UK Darwin Initiative grant to CAP (Ref. 16-001;http://www.defra.gov.uk/) and a pre-dissertation travel award from the Department of Ecology, Evolution and Environmental Biology at Columbia University to EN. EN also acknowledges funding from a Columbia University Faculty Fellowship and the Yeh Family Foundation. No individuals employed or contracted by any of these funders other than the named authors played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen E, 2007, BIOTROPICA, V39, P141, DOI 10.1111/j.1744-7429.2006.00239.x; Andresen Ellen, 2005, P331, DOI 10.1079/9780851998060.0331; [Anonymous], 2002, CAUSE CORRELATION BI; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bates D. M., 2010, IME4 MIXED EFFECTS M; Bayley PB, 1989, CAN SPEC PUBL FISH A, V106, P385; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Braga RF, 2012, ECOSYSTEMS, V15, P1173, DOI 10.1007/s10021-012-9576-5; BURGER BV, 1991, Z NATURFORSCH C, V46, P1073; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Chame M, 2003, MEM I OSWALDO CRUZ, V98, P71, DOI 10.1590/S0074-02762003000900014; Clayton L, 1997, ECOL APPL, V7, P642, DOI 10.1890/1051-0761(1997)007[0642:BHTBAS]2.0.CO;2; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; Derickx J, 1992, NO CORACAO AMAZONA J; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Esterci Neide, 2010, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V5, P59; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Halffter G., 1982, NESTING BEHAV DUNG B; Haugaasen T, 2005, AM J PRIMATOL, V67, P243, DOI 10.1002/ajp.20180; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Hawes JE, 2012, FOREST ECOL MANAG, V281, P163, DOI 10.1016/j.foreco.2012.06.023; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Horgan FG, 2005, FOREST ECOL MANAG, V216, P117, DOI 10.1016/j.foreco.2005.05.049; HOWDEN H F, 1975, Biotropica, V7, P77, DOI 10.2307/2989750; [Instituto Brasileiro de Geografia e Estatstica (IBGE) The Brazilian Institute of Geography and Statistics], 2010, CENS POP 2010; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Maron JL, 2011, ECOL LETT, V14, P661, DOI 10.1111/j.1461-0248.2011.01633.x; Martin-Piera F., 1996, Miscellania Zoologica (Barcelona), V19, P13; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; MEB, 2003, MOV ED BAS DEP CAR M; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Naranjo EJ, 2007, BIOL CONSERV, V138, P412, DOI 10.1016/j.biocon.2007.05.010; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1106, DOI 10.1046/j.1523-1739.2003.02045.x; Newton P, 2012, ENVIRON CONSERV, V39, P97, DOI 10.1017/S0376892911000580; Newton P, 2012, GLOBAL ENVIRON CHANG, V22, P127, DOI 10.1016/j.gloenvcha.2011.10.006; Newton P, 2011, FOREST ECOL MANAG, V261, P255, DOI 10.1016/j.foreco.2010.10.014; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Nichols E, 2011, DUNG BEETLE ECOLOGY; Nichols E, 2013, ECOLOGY, V94, P180, DOI 10.1890/12-0251.1; Otto SB, 2008, ECOLOGY, V89, P134, DOI 10.1890/07-0066.1; Palacois E, 2005, FOLIA PRIMATOL, V76, P135, DOI 10.1159/000084376; Parry L, 2009, BIOL CONSERV, V142, P1777, DOI 10.1016/j.biocon.2009.03.018; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2000, BIOL RESOURCE MANAGE, P31; Peres CA, 1997, FOLIA PRIMATOL, V68, P199, DOI 10.1159/000157247; PERES CA, 1999, MAMMALS NEOTROPICS C, P564; Peres CA, 2011, CENSO MONITORAMENTO; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Persson L, 1999, OIKOS, V85, P385, DOI 10.2307/3546688; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Poulsen JR, 2011, ECOL APPL, V21, P1819, DOI 10.1890/10-1083.1; Puertas PE, 2004, PEOPLE NATURE WILDLI, P122; R Core Team, 2016, R FDN STAT COMP; Refisch J, 2005, BIOTROPICA, V37, P136, DOI 10.1111/j.1744-7429.2005.03174.x; Rist J, 2008, BIOL CONSERV, V141, P2086, DOI 10.1016/j.biocon.2008.06.005; ROBINSON JG, 1986, OECOLOGIA, V68, P516, DOI 10.1007/BF00378765; Roslin T, 2001, OECOLOGIA, V127, P69, DOI 10.1007/s004420000565; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Silvius KM, 2002, J TROP ECOL, V18, P707, DOI 10.1017/S0266467402002468; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J., 2010, TROPHIC CASCADES PRE; Terborgh J., 2006, EMERGING THREATS TRO, P241; Tribe G.D., 2011, P87; Urquiza-Haas T, 2011, ANIM CONSERV, V14, P271, DOI 10.1111/j.1469-1795.2010.00426.x; Vaz-de-Mello FZ, 2011, ZOOTAXA, P1; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Wardle DA, 2004, FRONT ECOL ENVIRON, V2, P145, DOI 10.1890/1540-9295(2004)002[0145:HCILHM]2.0.CO;2; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; Wu XW, 2011, ECOL MONOGR, V81, P313, DOI 10.1890/10-0808.1; Zhao C, 2013, J ANIM ECOL, V82, P749, DOI 10.1111/1365-2656.12058	96	25	25	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75819	10.1371/journal.pone.0075819	http://dx.doi.org/10.1371/journal.pone.0075819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146780	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400019
J	Ha, B; Lv, ZY; Bian, Z; Zhang, XG; Mishra, A; Liu, Y				Ha, Binh; Lv, Zhiyuan; Bian, Zhen; Zhang, Xiugen; Mishra, Aarti; Liu, Yuan			'Clustering' SIRP alpha into the Plasma Membrane Lipid Microdomains Is Required for Activated Monocytes and Macrophages to Mediate Effective Cell Surface Interactions with CD47	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL-REGULATORY PROTEIN; NEUTROPHIL TRANSMIGRATION; COMPLEX-FORMATION; GROWTH-FACTOR; SHP-2; SUBSTRATE-1; RECEPTOR; SHPS-1; RAFTS	SIRP alpha, an ITIMs-containing signaling receptor, negatively regulates leukocyte responses through extracellular interactions with CD47. However, the dynamics of SIRP alpha-CD47 interactions on the cell surface and the governing mechanisms remain unclear. Here we report that while the purified SIRPa binds to CD47 and that SIRPa is expressed on monocytes and monocytic THP-1 or U937, these SIRPa are ineffective to mediate cell binding to immobilized CD47. However, cell binding to CD47 is significantly enhanced when monocytes transmigrating across endothelia, or being differentiated into macrophages. Cell surface labeling reveals SIRP alpha to be diffused on naive monocytes but highly clustered on transmigrated monocytes and macrophages. Protein crosslink and equilibrium centrifugation confirm that SIRP alpha in the latter cells forms oligomerized complexes resulting in increased avidity for CD47 binding. Furthermore, formation of SIRPa complexes/clusters requires the plasma membrane 'lipid rafts' and the activity of Src family kinase during macrophage differentiation. These results together suggest that 'clustering' SIRP alpha into plasma membrane microdomains is essential for activated monocytes and macrophages to effectively interact with CD47 and initiate intracellular signaling.	[Ha, Binh; Lv, Zhiyuan; Bian, Zhen; Zhang, Xiugen; Mishra, Aarti; Liu, Yuan] Georgia State Univ, Program Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Lv, Zhiyuan; Bian, Zhen] Nanjing Univ, Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China	University System of Georgia; Georgia State University; Nanjing University	Liu, Y (corresponding author), Georgia State Univ, Program Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	yliu@gsu.edu	Mishra, Aarti/AAI-4038-2021	Mishra, Aarti/0000-0002-7845-6759	American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106839] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Research Scholar Grant from the American Cancer Society (YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Ikeda H, 2006, J IMMUNOL, V177, P3123, DOI 10.4049/jimmunol.177.5.3123; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kinchen JM, 2008, CURR BIOL, V18, pR521, DOI 10.1016/j.cub.2008.04.058; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; Mamtani M, 2007, MED HYPOTHESES, V68, P1065, DOI 10.1016/j.mehy.2006.09.044; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Ochi F, 1997, BIOCHEM BIOPH RES CO, V239, P483, DOI 10.1006/bbrc.1997.7489; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Okajo J, 2007, J IMMUNOL, V178, P6164, DOI 10.4049/jimmunol.178.10.6164; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Olsson M, 2007, BIOCHEM BIOPH RES CO, V352, P193, DOI 10.1016/j.bbrc.2006.11.002; Patschan S, 2006, AM J PHYSIOL-HEART C, V290, pH2210, DOI 10.1152/ajpheart.01112.2005; Riff JD, 2005, INFECT IMMUN, V73, P7113, DOI 10.1128/IAI.73.11.7113-7125.2005; ROUSSEL MF, 1989, P NATL ACAD SCI USA, V86, P7924, DOI 10.1073/pnas.86.20.7924; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Takada T, 1998, J BIOL CHEM, V273, P9234, DOI 10.1074/jbc.273.15.9234; Takizawa H, 2007, NAT IMMUNOL, V8, P1287, DOI 10.1038/ni1207-1287; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109	40	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77615	10.1371/journal.pone.0077615	http://dx.doi.org/10.1371/journal.pone.0077615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143245	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100083
J	Xu, DM; Liu, G; Cheng, L; Lu, XH; Chen, WQ; Deng, ZX				Xu, Dongmei; Liu, Guang; Cheng, Lin; Lu, Xinhua; Chen, Wenqing; Deng, Zixin			Identification of Mur34 as the Novel Negative Regulator Responsible for the Biosynthesis of Muraymycin in Streptomyces sp NRRL30471	PLOS ONE			English	Article							AUTOREGULATOR RECEPTOR PROTEIN; PHOR-PHOP SYSTEM; PEPTIDOGLYCAN BIOSYNTHESIS; SECONDARY METABOLISM; LAVENDULAE FRI-5; GENE-CLUSTER; TRANSCRIPTIONAL REGULATOR; 2-COMPONENT SYSTEM; FARA ACTS; A-FACTOR	Background: Muraymycin, a potent translocase I (MraY) inhibitor, is produced by Streptomyces sp. NRRL30471. The muraymycin gene cluster (mur) was recently cloned, and bioinformatic analysis of mur34 revealed its encoding product exhibits high homology to a large family of proteins, including KanI and RacI in individual biosynthetic pathway of kanamycin and ribostamycin. However, the precise role of these proteins remains unknown. Principal Findings: Here we report the identification of Mur34 as the novel negative regulator involved in muraymycin biosynthesis. Independent disruption of mur34 on chromosome and cosmid directly resulted in significant improvement of muraymycin production by at least 10 folds, thereof confirming the negative function of Mur34 during muraymycin biosynthesis and realizing the engineered production of muraymycin in heterologous host. Gene expression analysis indicated that the transcription level of the mur genes in mur34 mutant (DM-5) was dramatically enhanced by ca. 30 folds. Electrophoretic mobility shift assay (EMSA) showed that Mur34 specifically bound to the promoter region of mur33. Further experiments showed that a 28-bp region downstream of the transcription start point (TSP) was protected by His(6)Mur34, and the 210 region is essential for the activity of mur33 promoter. Conclusions: Mur34 plays an unambiguously negative role in muraymycin biosynthesis via binding to the upstream of mur33. More importantly, Mur34 represents a novel family of regulators acting in negative manner to regulate the secondary metabolites biosynthesis in bacteria.	[Xu, Dongmei; Liu, Guang; Chen, Wenqing; Deng, Zixin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Dongmei; Liu, Guang; Chen, Wenqing; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Cheng, Lin; Chen, Wenqing; Deng, Zixin] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan 430072, Peoples R China; [Cheng, Lin; Chen, Wenqing; Deng, Zixin] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China; [Xu, Dongmei; Lu, Xinhua] NCPC New Drug Res & Dev Co Ltd, North China Pharmaceut Grp Corp, Shijiazhuang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wuhan University; Wuhan University	Chen, WQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	wenqingchen2010@gmail.com; zxdeng@sjtu.edu.cn		Chen, Wenqing/0000-0003-2557-8960	Ministry of Science and Technology [973, 863]; National Science Foundation of China,; Open Fund of State Key Laboratory of Bio-organic and Natural Products Chemistry; Ministry of Education, the Science and Technology Commission of Shanghai Municipality; Shanghai Leading Academic Discipline [B203]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China,(National Natural Science Foundation of China (NSFC)); Open Fund of State Key Laboratory of Bio-organic and Natural Products Chemistry; Ministry of Education, the Science and Technology Commission of Shanghai Municipality; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	This work was supported by Grants 973 and 863 from the Ministry of Science and Technology, the National Science Foundation of China, Open Fund of State Key Laboratory of Bio-organic and Natural Products Chemistry, the Ministry of Education, the Science and Technology Commission of Shanghai Municipality, and Shanghai Leading Academic Discipline Project B203. (http://www.most.gov.cn/; http://www.nsfc.gov.cn/Portal0/default152.htm; http://211.166.12.38/V1/Program1/Default. aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TB, 2001, MOL MICROBIOL, V39, P553, DOI 10.1046/j.1365-2958.2001.02240.x; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; HORINOUCHI S, 1992, ANNU REV MICROBIOL, V46, P377, DOI 10.1146/annurev.micro.46.1.377; INGRAM C, 1989, J BACTERIOL, V171, P6617, DOI 10.1128/jb.171.12.6617-6624.1989; Kang JG, 1997, NUCLEIC ACIDS RES, V25, P2566, DOI 10.1093/nar/25.13.2566; Kato JY, 2004, J BACTERIOL, V186, P2206, DOI 10.1128/JB.186.7.2206-2211.2004; Kaysser L, 2011, CHEMBIOCHEM, V12, P477, DOI 10.1002/cbic.201000460; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kimura K, 1998, J ANTIBIOT, V51, P1099, DOI 10.7164/antibiotics.51.1099; Kinoshita H, 1997, J BACTERIOL, V179, P6986, DOI 10.1128/jb.179.22.6986-6993.1997; Kitani S, 1999, J BACTERIOL, V181, P5081, DOI 10.1128/JB.181.16.5081-5084.1999; Kitani S, 2001, J BACTERIOL, V183, P4357, DOI 10.1128/JB.183.14.4357-4363.2001; Kitani S, 2008, GENE, V425, P9, DOI 10.1016/j.gene.2008.07.043; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Li Q, 2013, J BACTERIOL; Lin YI, 2002, BIOORG MED CHEM LETT, V12, P2341, DOI 10.1016/S0960-894X(02)00469-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDonald LA, 2003, ANAL CHEM, V75, P2730, DOI 10.1021/ac0264731; McKenzie NL, 2007, J BACTERIOL, V189, P5284, DOI 10.1128/JB.00305-07; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Paradkar A, 2003, CRIT REV BIOTECHNOL, V23, P1, DOI 10.1080/713609296; Rodriguez-Garcia A, 2009, NUCLEIC ACIDS RES, V37, P3230, DOI 10.1093/nar/gkp162; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SALATREP.JM, 1971, EUR J BIOCHEM, V20, P400, DOI 10.1111/j.1432-1033.1971.tb01406.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheeler NL, 2005, J BACTERIOL, V187, P687, DOI 10.1128/JB.187.2.687-696.2005; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Tanino T, 2011, J MED CHEM, V54, P8421, DOI 10.1021/jm200906r; Tanino T, 2010, J ORG CHEM, V75, P1366, DOI 10.1021/jo9027193; Yamashita A, 2003, BIOORG MED CHEM LETT, V13, P3345, DOI 10.1016/S0960-894X(03)00671-1; Zhang WJ, 2010, P NATL ACAD SCI USA, V107, P16828, DOI 10.1073/pnas.1011557107; ZUKOWSKI MM, 1983, P NATL ACAD SCI-BIOL, V80, P1101, DOI 10.1073/pnas.80.4.1101	43	10	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76068	10.1371/journal.pone.0076068	http://dx.doi.org/10.1371/journal.pone.0076068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143177	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100012
J	Donini, LM; Poggiogalle, E; Mosca, V; Pinto, A; Brunani, A; Capodaglio, P				Donini, Lorenzo Maria; Poggiogalle, Eleonora; Mosca, Veronica; Pinto, Alessandro; Brunani, Amelia; Capodaglio, Paolo			Disability Affects the 6-Minute Walking Distance in Obese Subjects (BMI > 40 kg/m(2))	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; REFERENCE EQUATIONS; REFERENCE VALUES; ELDERLY ADULTS; EXERCISE; WORK; INDIVIDUALS; COPD	ntroduction: In obese subjects, the relative reduction of the skeletal muscle strength, the reduced cardio-pulmonary capacity and tolerance to effort, the higher metabolic costs and, therefore, the increased inefficiency of gait together with the increased prevalence of co-morbid conditions might interfere with walking. Performance tests, such as the six-minute walking test (6MWT), can unveil the limitations in cardio-respiratory and motor functions underlying the obesity-related disability. Therefore the aims of the present study were: to explore the determinants of the 6-minute walking distance (6MWD) and to investigate the predictors of interruption of the walk test in obese subjects. Methods: Obese patients [body mass index (BMI)>40 kg/m(2)] were recruited from January 2009 to December 2011. Anthropometry, body composition, specific questionnaire for Obesity-related Disabilities (TSD-OC test), fitness status and 6MWT data were evaluated. The correlation between the 6MWD and the potential independent variables (anthropometric parameters, body composition, muscle strength, flexibility and disability) were analysed. The variables which were singularly correlated with the response variable were included in a multivariated regression model. Finally, the correlation between nutritional and functional parameters and test interruption was investigated. Results: 354 subjects (87 males, mean age 48.5 +/- 14 years, 267 females, mean age 49.8 +/- 15 years) were enrolled in the study. Age, weight, height, BMI, fat mass and fat free mass indexes, handgrip strength and disability were significantly correlated with the 6MWD and considered in the multivariate analysis. The determination coefficient of the regression analysis ranged from 0.21 to 0.47 for the different models. Body weight, BMI, waist circumference, TSD-OC test score and flexibility were found to be predictors of the 6MWT interruption. Discussion: The present study demonstrated the impact of disability in obese subjects, together with age, anthropometric data, body composition and strength, on the 6-minute walking distance.	[Donini, Lorenzo Maria; Poggiogalle, Eleonora; Mosca, Veronica; Pinto, Alessandro] Univ Roma La Sapienza, Food Sci & Endocrinol Sect, Dept Expt Med Med Physiopathol, I-00185 Rome, Italy; [Brunani, Amelia; Capodaglio, Paolo] Ist Auxol Italiano IRCCS, Rehabil Unit, Oggebbio, Verbania, Italy; [Brunani, Amelia; Capodaglio, Paolo] Ist Auxol Italiano IRCCS, Res Lab Biomech & Rehabil, Oggebbio, Verbania, Italy	Sapienza University Rome; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Donini, LM (corresponding author), Univ Roma La Sapienza, Food Sci & Endocrinol Sect, Dept Expt Med Med Physiopathol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	lorenzomaria.donini@uniroma1.it	Paolo, Capodaglio/AAB-7795-2019; Poggiogalle, Eleonora/AAB-9338-2019; Donini, Lorenzo/AAS-3873-2020	Paolo, Capodaglio/0000-0003-3719-8789; Donini, Lorenzo/0000-0003-4692-4754; Amelia, Brunani/0000-0003-3059-544X; Poggiogalle, Eleonora/0000-0003-0862-5892; Pinto, Alessandro/0000-0002-4864-2294				Alameri H, 2009, RESP MED, V103, P1041, DOI 10.1016/j.rmed.2009.01.012; Andrews AW, 1996, PHYS THER, V76, P248, DOI 10.1093/ptj/76.3.248; Beriault K, 2009, INT J SPORTS MED, V30, P725, DOI 10.1055/s-0029-1231043; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Camarri B, 2006, RESP MED, V100, P658, DOI 10.1016/j.rmed.2005.08.003; Capodaglio P, 2013, J ENDOCRINOL INVEST, V19; Capodaglio P, 2013, DISABIL REHABIL, V35, P1199, DOI 10.3109/09638288.2012.726313; Capodaglio P, 2010, INT J OCCUP SAF ERGO, V16, P507, DOI 10.1080/10803548.2010.11076863; Capodaglio P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-47; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Donini LM, 2011, DISABIL REHABIL, V33, P2509, DOI 10.3109/09638288.2011.575529; Dourado Victor Zuniga, 2011, Arq. Bras. Cardiol., V96, pe128; Dourado VZ, 2006, CHEST, V129, P551, DOI 10.1378/chest.129.3.551; Enright Paul L, 2003, Respir Care, V48, P783; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Gibbons W J, 2001, J Cardiopulm Rehabil, V21, P87, DOI 10.1097/00008483-200103000-00005; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Hulens M, 2003, SCAND J MED SCI SPOR, V13, P98, DOI 10.1034/j.1600-0838.2003.10273.x; Jenkins KR, 2004, GERONTOLOGIST, V44, P206, DOI 10.1093/geront/44.2.206; Jenkins Sue, 2009, Physiotherapy Theory and Practice, V25, P516, DOI [10.1080/09593980802664711, 10.3109/09593980802664711]; KUSHNER RF, 1992, J AM COLL NUTR, V11, P199; Larsson UE, 2008, PHYSIOTHER RES INT, V13, P84, DOI 10.1002/pri.398; Launois C, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-61; Li AM, 2007, AM J RESP CRIT CARE, V176, P174, DOI 10.1164/rccm.200607-883OC; Lohman TG, 1988, ANTHROPOMETRIC STAND, P183; Malatesta D, 2009, MED SCI SPORT EXER, V41, P426, DOI 10.1249/MSS.0b013e31818606e7; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Poh H, 2006, RESPIROLOGY, V11, P211, DOI 10.1111/j.1440-1843.2006.00820.x; Precilios H, 2013, J ENDOCRINOL INVEST, V36, P72, DOI 10.3275/8240; Saad HB, 2009, RESP MED, V103, P74, DOI 10.1016/j.rmed.2008.07.023; Salvadori A, 1999, RESPIRATION, V66, P25, DOI 10.1159/000029333; SALVADORI A, 1992, CHEST, V101, P674, DOI 10.1378/chest.101.3.674; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Wearing SC, 2006, OBES REV, V7, P239, DOI 10.1111/j.1467-789X.2006.00251.x; Wearing SC, 2006, OBES REV, V7, P13, DOI 10.1111/j.1467-789X.2006.00215.x	38	28	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75491	10.1371/journal.pone.0075491	http://dx.doi.org/10.1371/journal.pone.0075491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146756	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400008
J	Rooker, JR; Kitchens, LL; Dance, MA; Wells, RJD; Falterman, B; Cornic, M				Rooker, Jay R.; Kitchens, Larissa L.; Dance, Michael A.; Wells, R. J. David; Falterman, Brett; Cornic, Maelle			Spatial, Temporal, and Habitat-Related Variation in Abundance of Pelagic Fishes in the Gulf of Mexico: Potential Implications of the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							CRUDE-OIL; ENVIRONMENTAL-CONTROL; IMPROVING LIGHT; LARVAL; RECRUITMENT; PACIFIC; IMPACTS; IDENTIFICATION; GEOLOCATION; TOXICITY	Time-series data collected over a four-year period were used to characterize patterns of abundance for pelagic fishes in the northern Gulf of Mexico (GoM) before (2007-2009) and after (2010) the Deepwater Horizon oil spill. Four numerically dominant pelagic species (blackfin tuna, blue marlin, dolphinfish, and sailfish) were included in our assessment, and larval density of each species was lower in 2010 than any of the three years prior to the oil spill, although larval abundance in 2010 was often statistically similar to other years surveyed. To assess potential overlap between suitable habitat of pelagic fish larvae and surface oil, generalized additive models (GAMs) were developed to evaluate the influence of ocean conditions on the abundance of larvae from 2007-2009. Explanatory variables from GAMs were then linked to environmental data from 2010 to predict the probability of occurrence for each species. The spatial extent of surface oil overlapped with early life habitat of each species, possibly indicating that the availability of high quality habitat was affected by the DH oil spill. Shifts in the distribution of spawning adults is another factor known to influence the abundance of larvae, and the spatial occurrence of a model pelagic predator (blue marlin) was characterized over the same four-year period using electronic tags. The spatial extent of oil coincided with areas used by adult blue marlin from 2007-2009, and the occurrence of blue marlin in areas impacted by the DH oil spill was lower in 2010 relative to pre-spill years.	[Rooker, Jay R.; Kitchens, Larissa L.; Dance, Michael A.; Wells, R. J. David; Cornic, Maelle] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Rooker, Jay R.; Kitchens, Larissa L.; Dance, Michael A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Falterman, Brett] McDaniel Charitable Fdn, Texas City, TX USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station	Rooker, JR (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	rookerj@tamug.edu	Rooker, Jay/M-3197-2013	Rooker, Jay/0000-0002-5934-7688	National Marine Fisheries Service (Southeast Fisheries Science Center); McDaniel Charitable Foundation	National Marine Fisheries Service (Southeast Fisheries Science Center); McDaniel Charitable Foundation	This work was supported by the National Marine Fisheries Service (Southeast Fisheries Science Center) and the McDaniel Charitable Foundation. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019735; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Carr JP, 2009, BIOL CONSERV, V142, P477, DOI 10.1016/j.biocon.2008.10.004; Couillard CM, 2005, ENVIRON TOXICOL CHEM, V24, P1496, DOI 10.1897/04-267R.1; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; de Soysa TY, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-40; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; Hemmer MJ, 2011, ENVIRON TOXICOL CHEM, V30, P2244, DOI 10.1002/etc.619; Hernandez FJ, 2010, FISH B-NOAA, V108, P193; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Kraus RT, 2011, MAR BIOL, V158, P699, DOI 10.1007/s00227-010-1593-3; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Le Henaff M, 2012, ENVIRON SCI TECHNOL, V46, P7267, DOI 10.1021/es301570w; Lindo-Atichati D, 2012, MAR ECOL PROG SER, V463, P245, DOI 10.3354/meps09860; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Machu E, 2009, FISH OCEANOGR, V18, P287, DOI 10.1111/j.1365-2419.2009.00511.x; Muhling BA, 2012, MAR ECOL PROG SER, V450, P37, DOI 10.3354/meps09540; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Nunn AD, 2012, REV FISH BIOL FISHER, V22, P377, DOI 10.1007/s11160-011-9240-8; Olney J.E., 2006, EARLY STAGES ATLANTI, P1019; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Polovina JJ, 2009, FISH B-NOAA, V107, P523; R Development Core Team, 2010, R LANG ENV STAT COMP; Rocha-Olivares A, 2008, ICHTHYOL RES, V55, P389, DOI 10.1007/s10228-008-0040-7; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Sandman A, 2008, J MARINE SYST, V74, pS86, DOI 10.1016/j.jmarsys.2008.03.028; Schwemmer P, 2011, ECOL APPL, V21, P1851, DOI 10.1890/10-0615.1; Smith BL, 2010, MOL ECOL RESOUR, V10, P193, DOI 10.1111/j.1755-0998.2009.02726.x; Smultea Mari Ann, 1995, Aquatic Mammals, V21, P171; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Velando A, 2011, BIOL CONSERV, V144, P1167, DOI 10.1016/j.biocon.2011.01.004; Villamor B, 2011, FISH OCEANOGR, V20, P397, DOI 10.1111/j.1365-2419.2011.00592.x; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; WEISS J, 1991, PHYSICA D, V48, P273, DOI 10.1016/0167-2789(91)90088-Q; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	50	81	82	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76080	10.1371/journal.pone.0076080	http://dx.doi.org/10.1371/journal.pone.0076080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130759	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200029
J	Yabuki, C; Komatsu, H; Tsujihata, Y; Maeda, R; Ito, R; Matsuda-Nagasumi, K; Sakuma, K; Miyawaki, K; Kikuchi, N; Takeuchi, K; Habata, Y; Mori, M				Yabuki, Chiori; Komatsu, Hidetoshi; Tsujihata, Yoshiyuki; Maeda, Risa; Ito, Ryo; Matsuda-Nagasumi, Kae; Sakuma, Kensuke; Miyawaki, Kazumasa; Kikuchi, Naoya; Takeuchi, Koji; Habata, Yugo; Mori, Masaaki			A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1	PLOS ONE			English	Article							FREE FATTY-ACID; STIMULATED INSULIN-SECRETION; PANCREATIC BETA-CELLS; RECEPTOR 1 AGONIST; GPR40 AGONIST; DOUBLE-BLIND; GLUCOSE; TAK-875; IDENTIFICATION; DISCOVERY	Selective free fatty acid receptor 1 (FFAR1)/GPR40 agonist fasiglifam (TAK-875), an antidiabetic drug under phase 3 development, potentiates insulin secretion in a glucose-dependent manner by activating FFAR1 expressed in pancreatic b cells. Although fasiglifam significantly improved glycemic control in type 2 diabetes patients with a minimum risk of hypoglycemia in a phase 2 study, the precise mechanisms of its potent pharmacological effects are not fully understood. Here we demonstrate that fasiglifam acts as an ago-allosteric modulator with a partial agonistic activity for FFAR1. In both Ca2+ influx and insulin secretion assays using cell lines and mouse islets, fasiglifam showed positive cooperativity with the FFAR1 ligand c-linolenic acid (gamma-LA). Augmentation of glucose-induced insulin secretion by fasiglifam, gamma-LA, or their combination was completely abolished in pancreatic islets of FFAR1-knockout mice. In diabetic rats, the insulinotropic effect of fasiglifam was suppressed by pharmacological reduction of plasma free fatty acid (FFA) levels using a lipolysis inhibitor, suggesting that fasiglifam potentiates insulin release in conjunction with plasma FFAs in vivo. Point mutations of FFAR1 differentially affected Ca2+ influx activities of fasiglifam and c-LA, further indicating that these agonists may bind to distinct binding sites. Our results strongly suggest that fasiglifam is an ago-allosteric modulator of FFAR1 that exerts its effects by acting cooperatively with endogenous plasma FFAs in human patients as well as diabetic animals. These findings contribute to our understanding of fasiglifam as an attractive antidiabetic drug with a novel mechanism of action.	[Yabuki, Chiori; Tsujihata, Yoshiyuki; Ito, Ryo; Matsuda-Nagasumi, Kae; Sakuma, Kensuke; Miyawaki, Kazumasa; Takeuchi, Koji; Habata, Yugo; Mori, Masaaki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Komatsu, Hidetoshi; Maeda, Risa; Kikuchi, Naoya] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Yabuki, C (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	chiori.yabuki@takeda.com		Komatsu, Hidetoshi/0000-0003-1630-0537	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. Employees of Takeda played roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Dobbins RL, 1998, DIABETES, V47, P1613, DOI 10.2337/diabetes.47.10.1613; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; HOYER D, 1993, TRENDS PHARMACOL SCI, V14, P270, DOI 10.1016/0165-6147(93)90129-8; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kaku K, 2013, DIABETES CARE, V36, P245, DOI 10.2337/dc12-0872; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Leifke E, 2012, CLIN PHARMACOL THER, V92, P29, DOI 10.1038/clpt.2012.43; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Lin DCH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027270; Lu SY, 2010, J MOL GRAPH MODEL, V28, P766, DOI 10.1016/j.jmgm.2010.02.001; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Matsuda-Nagasumi K, 2013, DIABETES OBES METAB, V15, P538, DOI 10.1111/dom.12065; Meijssen S, 2001, J CLIN ENDOCR METAB, V86, P4193, DOI 10.1210/jc.86.9.4193; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan NG, 2009, CURR OPIN CLIN NUTR, V12, P117, DOI 10.1097/MCO.0b013e328321e423; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Naik H, 2012, J CLIN PHARMACOL, V52, P1007, DOI 10.1177/0091270011409230; Negoro N, 2012, J MED CHEM, V55, P3960, DOI 10.1021/jm300170m; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Sasaki S, 2011, J MED CHEM, V54, P1365, DOI 10.1021/jm101405t; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Takeuchi M, 2012, BRIT J PHARMACOL, V168, P1570; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; VAAG A, 1991, J CLIN INVEST, V88, P1282, DOI 10.1172/JCI115432; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708	43	72	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76280	10.1371/journal.pone.0076280	http://dx.doi.org/10.1371/journal.pone.0076280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130766	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200032
J	Lee, EJ; Kang, G; Kang, SW; Jang, KT; Lee, J; Park, JO; Park, CK; Sohn, TS; Kim, S; Kim, KM				Lee, Eui Jin; Kang, Guhyun; Kang, Shin Woo; Jang, Kee-Taek; Lee, Jeeyun; Park, Joon Oh; Park, Cheol Keun; Sohn, Tae Sung; Kim, Sung; Kim, Kyoung-Mee			GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; GENE-EXPRESSION SIGNATURES; WILD-TYPE; KIT; MUTATIONS; ABERRATIONS	Oncogenic mutations in gastrointestinal stromal tumors (GISTs) predict prognosis and therapeutic responses to imatinib. In wild-type GISTs, the tumor-initiating events are still unknown, and wild-type GISTs are resistant to imatinib therapy. We performed an association study between copy number alterations (CNAs) identified from array CGH and gene expression analyses results for four wild-type GISTs and an imatinib-resistant PDGFRA D842V mutant GIST, and compared the results to those obtained from 27 GISTs with KIT mutations. All wild-type GISTs had multiple CNAs, and CNAs in 1p and 22q that harbor the SDHB and GSTT1 genes, respectively, correlated well with expression levels of these genes. mRNA expression levels of all SDH gene subunits were significantly lower (P=0.041), whereas mRNA expression levels of VEGF (P=0.025), IGF1R (P=0.026), and ZNFs (P<0.05) were significantly higher in GISTs with wild-type/PDGFRA D842V mutations than GISTs with KIT mutations. qRT-PCR validation of the GSTT1 results in this cohort and 11 additional malignant GISTs showed a significant increase in the frequency of GSTT1 CN gain and increased mRNA expression of GSTT1 in wild-type/PDGFRA D842V GISTs than KIT-mutant GISTs (P=0.033). Surprisingly, all four malignant GISTs with KIT exon 11 deletion mutations with primary resistance to imatinib had an increased GSTT1 CN and mRNA expression level of GSTT1. Increased mRNA expression of GSTT1 and ZNF could be predictors of a poor response to imatinib. Our integrative approach reveals that for patients with wild-type (or imatinib-resistant) GISTs, attempts to target VEGFRs and IGF1R may be reasonable options.	[Lee, Eui Jin; Kang, Guhyun; Kang, Shin Woo; Jang, Kee-Taek; Park, Cheol Keun; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Jeeyun; Park, Joon Oh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Sohn, Tae Sung; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Kang, Guhyun] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pathol, Seoul, South Korea; [Kang, Shin Woo] Korea Univ, Dept Math, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Korea University	Kim, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	kkmkys@skku.ed	Lee, Jee Yun/C-9646-2011; Kim, Sung/G-4114-2014; Lee, Jeeyun/I-7171-2015		National Research Foundation of Korea [S-2010-0503-000-1]; Samsung Biomedical Research Institute [C-A9-203-1]	National Research Foundation of Korea(National Research Foundation of Korea); Samsung Biomedical Research Institute(Samsung)	This study was supported by grants from the National Research Foundation of Korea (http://www.nrf.re.kr)(S-2010-0503-000-1) and Samsung Biomedical Research Institute (http://www.sbri.or.kr)(C-A9-203-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaram NP, 2008, CLIN CANCER RES, V14, P3204, DOI 10.1158/1078-0432.CCR-07-1984; Antonescu CR, 2004, CLIN CANCER RES, V10, P3282, DOI 10.1158/1078-0432.CCR-03-0715; Assamaki R, 2007, GENE CHROMOSOME CANC, V46, P564, DOI 10.1002/gcc.20439; Astolfi A, 2010, LAB INVEST, V90, P1285, DOI 10.1038/labinvest.2010.110; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Belinsky MG, 2008, CELL CYCLE, V7, P2949, DOI 10.4161/cc.7.19.6760; Belinsky MG, 2009, GENE CHROMOSOME CANC, V48, P886, DOI 10.1002/gcc.20689; Chen Y, 2004, J BIOMED SCI, V11, P65, DOI 10.1159/000075290; Chung YJ, 2006, LEUKEMIA, V20, P1542, DOI 10.1038/sj.leu.2404310; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gold JS, 2009, LANCET ONCOL, V10, P1045, DOI 10.1016/S1470-2045(09)70242-6; Gunawan B, 2007, J PATHOL, V211, P463, DOI 10.1002/path.2128; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Janeway KA, 2007, CANCER RES, V67, P9084, DOI 10.1158/0008-5472.CAN-07-1938; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Janeway KA, 2009, PEDIATR BLOOD CANCER, V52, P767, DOI 10.1002/pbc.21909; Kang DY, 2007, AM J SURG PATHOL, V31, P224, DOI 10.1097/01.pas.0000213318.66800.94; Kang HJ, 2006, PROTEOMICS, V6, P1151, DOI 10.1002/pmic.200500372; Koh Y, 2010, CANCER GENET CYTOGEN, V203, P215, DOI 10.1016/j.cancergencyto.2010.08.022; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Pierotti MA, 2011, NAT REV CLIN ONCOL, V8, P161, DOI 10.1038/nrclinonc.2011.3; Rink L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054477; Rink L, 2009, MOL CANCER THER, V8, P2172, DOI 10.1158/1535-7163.MCT-09-0193; Rouveirol C, 2006, BIOINFORMATICS, V22, P849, DOI 10.1093/bioinformatics/btl004; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Wardelmann E, 2007, VIRCHOWS ARCH, V451, P743, DOI 10.1007/s00428-007-0473-9; Wozniak A, 2007, GENE CHROMOSOME CANC, V46, P261, DOI 10.1002/gcc.20408; Yang JL, 2008, CANCER, V113, P1532, DOI 10.1002/cncr.23778	35	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77219	10.1371/journal.pone.0077219	http://dx.doi.org/10.1371/journal.pone.0077219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124608	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100165
J	Bergelson, E; Shvartsman, M; Idsardi, WJ				Bergelson, Elika; Shvartsman, Michael; Idsardi, William J.			Differences in Mismatch Responses to Vowels and Musical Intervals: MEG Evidence	PLOS ONE			English	Article							AUDITORY-CORTEX; CONSONANCE THEORY; SPEECH; PERCEPTION; SOUNDS	We investigated the electrophysiological response to matched two-formant vowels and two-note musical intervals, with the goal of examining whether music is processed differently from language in early cortical responses. Using magnetoencephalography (MEG), we compared the mismatch-response (MMN/MMF, an early, pre-attentive difference-detector occurring approximately 200 ms post-onset) to musical intervals and vowels composed of matched frequencies. Participants heard blocks of two stimuli in a passive oddball paradigm in one of three conditions: sine waves, piano tones and vowels. In each condition, participants heard two-formant vowels or musical intervals whose frequencies were 11, 12, or 24 semitones apart. In music, 12 semitones and 24 semitones are perceived as highly similar intervals (one and two octaves, respectively), while in speech 12 semitones and 11 semitones formant separations are perceived as highly similar (both variants of the vowel in 'cut'). Our results indicate that the MMN response mirrors the perceptual one: larger MMNs were elicited for the 12-11 pairing in the music conditions than in the language condition; conversely, larger MMNs were elicited to the 12-24 pairing in the language condition that in the music conditions, suggesting that within 250 ms of hearing complex auditory stimuli, the neural computation of similarity, just as the behavioral one, differs significantly depending on whether the context is music or speech.	[Bergelson, Elika] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Shvartsman, Michael] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Bergelson, Elika; Shvartsman, Michael; Idsardi, William J.] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA	University of Pennsylvania; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park	Bergelson, E (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	elikab@psych.upenn.edu		Bergelson, Elika/0000-0003-2742-4797; Idsardi, William/0000-0003-4461-2685	NSF-GRFP grant; NSF-IGERT grant; NIH [7R01DC005660-07]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	NSF-GRFP grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF-IGERT grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by NSF-GRFP and NSF-IGERT grants to EB, and NIH grant 7R01DC005660-07 to WJI.	Cousineau M, 2012, P NATL ACAD SCI USA, V109, P19858, DOI 10.1073/pnas.1207989109; de Cheveigne A, 2008, J NEUROSCI METH, V171, P331, DOI 10.1016/j.jneumeth.2008.03.015; Delattre P, 1952, WORD, V8, P195, DOI 10.1080/00437956.1952.11659431; Elmer S, 2011, CEREB CORTEX, V21, P1; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; HILLENBRAND J, 1990, J ACOUST SOC AM, V88, P655, DOI 10.1121/1.399768; HURON D, 1991, MUSIC PERCEPT, V9, P135; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1460, DOI 10.1121/1.1911624; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1451, DOI 10.1121/1.1911623; Krumhansl Carol L, 2001, COGNITIVE FDN MUSICA; KUHL PK, 1991, PERCEPT PSYCHOPHYS, V50, P93, DOI 10.3758/BF03212211; LEVELT WJM, 1966, BRIT J MATH STAT PSY, V19, P163, DOI 10.1111/j.2044-8317.1966.tb00366.x; McLachlan N, 2010, PSYCHOL REV, V117, P175, DOI 10.1037/a0018063; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; POLS LCW, 1969, J ACOUST SOC AM, V46, P458, DOI 10.1121/1.1911711; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Schwartz DA, 2003, J NEUROSCI, V23, P7160, DOI 10.1523/JNEUROSCI.23-18-07160.2003; Tervaniemi M, 1999, NEUROIMAGE, V9, P330, DOI 10.1006/nimg.1999.0405; Vanzella P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015449; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	23	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76758	10.1371/journal.pone.0076758	http://dx.doi.org/10.1371/journal.pone.0076758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237TP	24143193	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100028
J	Zhan, YY; Wang, L; Liu, J; Ma, KL; Liu, CP; Zhang, Y; Zou, W				Zhan, Yaoyao; Wang, Liang; Liu, Jing; Ma, Keli; Liu, Cuiping; Zhang, Yuan; Zou, Wei			Choline Plasmalogens Isolated from Swine Liver Inhibit Hepatoma Cell Proliferation Associated with Caveolin-1/Akt Signaling	PLOS ONE			English	Article							PI3K/AKT/MTOR PATHWAY; EXPRESSION; CHOLESTEROL; PURIFICATION; INVOLVEMENT; DEFICIENCY; CAVEOLAE; HEALTH; BCL-2; PEMT2	Plasmalogens play multiple roles in the structures of biological membranes, cell membrane lipid homeostasis and human diseases. We report the isolation and identification of choline plasmalogens (ChoPlas) from swine liver by high performance thin layer chromatography (HPTLC) and high performance liquid chromatography (HPLC)/MS. The growth and viability of hepatoma cells (CBRH7919, HepG2 and SMMC7721) was determined following ChoPlas treatment comparing with that of human normal immortal cell lines (HL7702). Result indicated that ChoPlas inhibited hepatoma cell proliferation with an optimal concentration and time of 25 mu mol/L and 24 h. To better understand the mechanism of the ChoPlas-induced inhibition of hepatoma cell proliferation, Caveolin-1 and PI3K/Akt pathway signals, including total Akt, phospho-Akt(pAkt) and Bcl-2 expression in CBRH7919 cells, were determined by western blot. ChoPlas treatment increased Caveolin-1 expression and reduced the expression of phospho-Akt (pAkt) and Bcl-2, downstream targets of the PI3K/Akt pathway. Further cell cycle analysis showed that ChoPlas treatment induced G1 and G1/S phase transition cell cycle arrest. The expression of essential cell cycle regulatory proteins involved in the G1 and G1/S phase transitions, cyclin D, CDK4, cyclin E and CDK2, were also analyzed by western blot. ChoPlas reduced CDK4, cyclin E and CDK2 expression. Taken together, the results indicate that swine liver-derived natural ChoPlas inhibits hepatoma cell proliferation associated with Caveolin-1 and PI3K/Akt signals.	[Zhan, Yaoyao; Wang, Liang; Liu, Cuiping; Zhang, Yuan; Zou, Wei] Liaoning Normal Univ, Coll Life Sci, Dalian, Liaoning, Peoples R China; [Liu, Jing] Dalian Med Univ, Affiliated Hosp 1, Regenerat Med Ctr, Dalian, Liaoning, Peoples R China; [Zhan, Yaoyao] Dalian Ocean Univ, Coll Fisheries & Life Sci, Dalian, Liaoning, Peoples R China; [Ma, Keli] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Liaoning, Peoples R China; [Zhang, Yuan] Jilin Univ, Key Lab Mol Enzymol, Ministrat Educ, Changchun 130023, Jilin, Peoples R China	Liaoning Normal University; Dalian Medical University; Dalian Ocean University; Dalian Medical University; Jilin University	Zou, W (corresponding author), Liaoning Normal Univ, Coll Life Sci, Dalian, Liaoning, Peoples R China.	weizou60@hotmail.com	Wang, Liang/O-8394-2019	Wang, Liang/0000-0003-1952-3525	key laboratory project of Department of Education of Liaoning Province [LS2010095]; National Natural Science Foundation of China [30570225, 30970353]; International S&T Coorperation Project of the Ministry of ST China [2010DFR30850]	key laboratory project of Department of Education of Liaoning Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Coorperation Project of the Ministry of ST China	This work was supported by the key laboratory project of Department of Education of Liaoning Province (LS2010095), National Natural Science Foundation of China (numbers 30570225, 30970353), International S&T Coorperation Project of the Ministry of S&T China (number 2010DFR30850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Braverman NE, 2012, BIOCHIM BIOPHYS ACTA, V1822, P1422; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Burgermeister E, 2007, CANCER RES, V67, P8519, DOI 10.1158/0008-5472.CAN-07-1125; Chen Wong L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P575, DOI 10.2174/156801105774574649; CUI Z, 1993, J BIOL CHEM, V268, P16655; Demou ZN, 2010, ANN BIOMED ENG, V38, P3509, DOI 10.1007/s10439-010-0097-0; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Eymin B, 2010, CELL ADHES MIGR, V4, P114, DOI 10.4161/cam.4.1.10977; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Farooqui AA, 1997, NEUROCHEM RES, V22, P523, DOI 10.1023/A:1027380331807; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frank PG, 2007, CELL CYCLE, V6, P115, DOI 10.4161/cc.6.2.3722; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Ghayad SE, 2010, RECENT PAT ANTI-CANC, V5, P29, DOI 10.2174/157489210789702208; Guruswamy S, 2009, INT J ONCOL, V35, P1037, DOI 10.3892/ijo_00000418; HEYMANS HSA, 1983, NATURE, V306, P69, DOI 10.1038/306069a0; Igarashi M, 2011, J ALZHEIMERS DIS, V24, P507, DOI 10.3233/JAD-2011-101608; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P299, DOI 10.1007/BF00710270; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Li YL, 2009, IUBMB LIFE, V61, P846, DOI 10.1002/iub.222; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu J, 2001, AM J PHYSIOL-CELL PH, V280, pC823, DOI 10.1152/ajpcell.2001.280.4.C823; Liu PS, 1999, NAT CELL BIOL, V1, P369, DOI 10.1038/14067; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Mandel H, 1998, BIOCHEM BIOPH RES CO, V250, P369, DOI 10.1006/bbrc.1998.9321; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Nadler Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1998; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; RAPPORT MM, 1984, J LIPID RES, V25, P1522; Ren Gang, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P379; SCHAEFER EJ, 1995, J LIPID RES, V36, P1427; Schedin S, 1997, J BIOL CHEM, V272, P6245, DOI 10.1074/jbc.272.10.6245; Shack S, 2003, MOL CELL BIOL, V23, P2407, DOI 10.1128/MCB.23.7.2407-2414.2003; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Straten PT, 2010, ONCOTARGET, V1, P239; VANCE JE, 1990, BIOCHIM BIOPHYS ACTA, V1045, P128, DOI 10.1016/0005-2760(90)90141-J; Liang W, 2006, CHIN J CHROMATOGR, V24, P271; Wang X, 2011, MOL BIOL REP, V38, P761, DOI 10.1007/s11033-010-0164-5; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-182; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-214; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001; Zou W, 2002, BBA-MOL CELL BIOL L, V1581, P49, DOI 10.1016/S1388-1981(02)00120-8; Zundel W, 2000, MOL CELL BIOL, V20, P1507, DOI 10.1128/MCB.20.5.1507-1514.2000	55	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77387	10.1371/journal.pone.0077387	http://dx.doi.org/10.1371/journal.pone.0077387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143228	Green Submitted, gold, Green Published			2022-12-27	WOS:000325894100065
J	Wakai, T; Yamamoto, N				Wakai, Taketo; Yamamoto, Naoyuki			A Novel Branched Chain Amino Acids Responsive Transcriptional Regulator, BCARR, Negatively Acts on the Proteolytic System in Lactobacillus helveticus	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS; ANTIHYPERTENSIVE PEPTIDES; BINDING DOMAIN; FERMENTED MILK; CBS DOMAIN; SOUR MILK; CODY; PROTEINS	Transcriptional negative regulation of the proteolytic system of Lactobacillus helveticus CM4 in response to amino acids seems to be very important for the control of antihypertensive peptide production; however, it remains poorly understood. A 26-kDa protein with N-terminal cystathionine beta-synthase domains (CBS domain protein), which seems to be involved in the regulatory system, was purified by using a DNA-sepharose bound 300-bp DNA fragment corresponding to the upstream regions of the six proteolytic genes that are down-regulated by amino acids. The CBS domain protein bound to a DNA fragment corresponding to the region upstream of the pepV gene in response to branched chain amino acids (BCAAs). The expression of the pepV gene in Escherichia coli grown in BCAA-enriched medium was repressed when the CBS domain protein was co-expressed. These results reveal that the CBS domain protein acts as a novel type of BCAA-responsive transcriptional regulator (BCARR) in L. helveticus. From comparative analysis of the promoter regions of the six proteolysis genes, a palindromic AT-rich motif, 5'-AAAAANNCTWTTATT-3', was predicted as the consensus DNA motif for the BCARR protein binding. Footprint analysis using the pepV promotor region and gel shift analyses with the corresponding short DNA fragments strongly suggested that the BCARR protein binds adjacent to the pepV promoter region and affects the transcription level of the pepV gene in the presence of BCAAs. Homology search analysis of the C-terminal region of the BCARR protein suggested the existence of a unique beta alpha beta beta alpha beta fold structure that has been reported in a variety of ACT (aspartate kinase-chorismate mutase-tyrA) domain proteins for sensing amino acids. These results also suggest that the sensing of BCAAs by the ACT domain might promote the binding of the BCARR to DNA sequences upstream of proteolysis genes, which affects the gene expression of the proteolytic system in L. helveticus.	[Wakai, Taketo] Calpis Co Ltd, Microbiol & Fermentat Lab, Sagamihara, Kanagawa, Japan; [Yamamoto, Naoyuki] Calpis Co Ltd, Res & Dev Planning Dept, Sagamihara, Kanagawa, Japan		Yamamoto, N (corresponding author), Calpis Co Ltd, Res & Dev Planning Dept, Sagamihara, Kanagawa, Japan.	naoyuki.yamamoto@calpis.co.jp						Aguado-Llera D, 2010, FEBS LETT, V584, P4485, DOI 10.1016/j.febslet.2010.10.006; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bailey TL, 1994, FITTING MIXTURE MODE; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Belitsky BR, 2011, J BACTERIOL, V193, P473, DOI 10.1128/JB.01151-10; Blagova EV, 2003, ACTA CRYSTALLOGR D, V59, P155, DOI 10.1107/S0907444902018358; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; De Man J., 1972, J APPL BACTERIOL, V23, P130, DOI DOI 10.1111/J.1365-2672.1960.TB00188.X; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; den Hengst CD, 2005, J BACTERIOL, V187, P512, DOI 10.1128/JB.187.2.512-521.2005; Ettema TJG, 2002, J BIOL CHEM, V277, P37464, DOI 10.1074/jbc.M206063200; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Gatti M, 2004, APPL ENVIRON MICROB, V70, P182, DOI 10.1128/AEM.70.1.182-190.2004; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Joseph P, 2005, J BACTERIOL, V187, P4127, DOI 10.1128/JB.187.12.4127-4139.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEENHOUTS KJ, 1990, APPL ENVIRON MICROB, V56, P2726, DOI 10.1128/AEM.56.9.2726-2735.1990; Lemos JA, 2008, J BACTERIOL, V190, P5291, DOI 10.1128/JB.00288-08; Liu F, 2009, FEMS MICROBIOL LETT, V297, P164, DOI 10.1111/j.1574-6968.2009.01672.x; Liu ST, 1998, ANAL BIOCHEM, V255, P158, DOI 10.1006/abio.1997.2457; NAKAMURA Y, 1995, J DAIRY SCI, V78, P1253, DOI 10.3168/jds.S0022-0302(95)76745-5; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004; Petranovic D, 2004, MOL MICROBIOL, V53, P613, DOI 10.1111/j.1365-2958.2004.04136.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Ritt JF, 2009, J APPL MICROBIOL, V106, P801, DOI 10.1111/j.1365-2672.2008.04032.x; Sadat-Mekmene L, 2011, INT J FOOD MICROBIOL, V146, P1, DOI 10.1016/j.ijfoodmicro.2011.01.039; Sambrook J., 1989, MOL CLONING; Slattery L, 2010, J DAIRY SCI, V93, P4435, DOI 10.3168/jds.2010-3327; Sneath PHA, 1986, BERGEYS MANUAL SYSTE, V2; Wakai T, 2013, J BIOSCI BIOENG, V115, P246, DOI 10.1016/j.jbiosc.2012.09.020; Wakai T, 2012, J BIOSCI BIOENG, V114, P133, DOI 10.1016/j.jbiosc.2012.03.015; YAMAMOTO N, 1994, BIOSCI BIOTECH BIOCH, V58, P776, DOI 10.1271/bbb.58.776; YAMAMOTO N, 1995, APPL ENVIRON MICROB, V61, P698, DOI 10.1128/AEM.61.2.698-701.1995; Yamamoto N, 2011, LACTIC ACID BACTERIA AND BIFIDOBACTERIA: CURRENT PROGRESS IN ADVANCED RESEARCH, P223; Yin J, 2011, ACTA CRYSTALLOGR F, V67, P933, DOI 10.1107/S1744309111021105	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75976	10.1371/journal.pone.0075976	http://dx.doi.org/10.1371/journal.pone.0075976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146802	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400032
J	Yeh, FC; Tseng, WYI				Yeh, Fang-Cheng; Tseng, Wen-Yih Isaac			Sparse Solution of Fiber Orientation Distribution Function by Diffusion Decomposition	PLOS ONE			English	Article							SPHERICAL DECONVOLUTION; CROSSING FIBERS; LEAST ANGLE; MRI; REGRESSION; TRACTOGRAPHY; RESOLUTION	Fiber orientation is the key information in diffusion tractography. Several deconvolution methods have been proposed to obtain fiber orientations by estimating a fiber orientation distribution function (ODF). However, the L-2 regularization used in deconvolution often leads to false fibers that compromise the specificity of the results. To address this problem, we propose a method called diffusion decomposition, which obtains a sparse solution of fiber ODF by decomposing the diffusion ODF obtained from q-ball imaging (QBI), diffusion spectrum imaging (DSI), or generalized q-sampling imaging (GQI). A simulation study, a phantom study, and an in-vivo study were conducted to examine the performance of diffusion decomposition. The simulation study showed that diffusion decomposition was more accurate than both constrained spherical deconvolution and ball-and-sticks model. The phantom study showed that the angular error of diffusion decomposition was significantly lower than those of constrained spherical deconvolution at 30 degrees crossing and ball-and-sticks model at 60 degrees crossing. The in-vivo study showed that diffusion decomposition can be applied to QBI, DSI, or GQI, and the resolved fiber orientations were consistent regardless of the diffusion sampling schemes and diffusion reconstruction methods. The performance of diffusion decomposition was further demonstrated by resolving crossing fibers on a 30-direction QBI dataset and a 40-direction DSI dataset. In conclusion, diffusion decomposition can improve angular resolution and resolve crossing fibers in datasets with low SNR and substantially reduced number of diffusion encoding directions. These advantages may be valuable for human connectome studies and clinical research.	[Yeh, Fang-Cheng] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ Coll Med, Ctr Optoelectron Med, Taipei, Taiwan; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	Carnegie Mellon University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tseng, WYI (corresponding author), Natl Taiwan Univ Coll Med, Ctr Optoelectron Med, Taipei, Taiwan.	wytseng@ntu.edu.tw	Yeh, Fang-Cheng/E-9698-2012	Yeh, Fang-Cheng/0000-0002-7946-2173; Tseng, Wen-Yih Isaac/0000-0002-2314-6868	National Science Council, Taiwan [NSC100-3112-B-002-016, NSC100-2321-B-002-015]; National Health Research Institute, Taiwan [NHRI-EX101-10145NI]; National Institutes of Health/National Institute of Mental Health, USA [U01MH093765]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Institutes of Health/National Institute of Mental Health, USA	This work was supported in part by the National Science Council, Taiwan (NSC100-3112-B-002-016, NSC100-2321-B-002-015), National Health Research Institute, Taiwan (NHRI-EX101-10145NI) and National Institutes of Health/National Institute of Mental Health, USA (U01MH093765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil H, 2011, SCIENCE, V331, P708, DOI 10.1126/science.1199305; Alexander DC, 2005, LECT NOTES COMPUT SC, V3565, P76; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Dell'Acqua F, 2010, NEUROIMAGE, V49, P1446, DOI 10.1016/j.neuroimage.2009.09.033; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hastie T, 2007, ELECTRON J STAT, V1, P1, DOI 10.1214/07-EJS004; Hesterberg T, 2008, STAT SURV, V2, P61, DOI 10.1214/08-SS035; Jeurissen B, 2012, HUM BRAIN MAPP; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaden E, 2012, MED IMAGE ANAL, V16, P876, DOI 10.1016/j.media.2012.01.004; Kezele I, 2010, MED IMAGE ANAL, V14, P332, DOI 10.1016/j.media.2010.01.002; Kuo LW, 2008, NEUROIMAGE, V41, P7, DOI 10.1016/j.neuroimage.2008.02.016; Landman BA, 2012, NEUROIMAGE, V59, P2175, DOI 10.1016/j.neuroimage.2011.10.011; Parker GD, 2013, NEUROIMAGE, V65, P433, DOI 10.1016/j.neuroimage.2012.10.022; Patel V, 2010, NEUROIMAGE, V51, P1071, DOI 10.1016/j.neuroimage.2010.02.060; Ramirez-Manzanares A, 2007, IEEE T MED IMAGING, V26, P1091, DOI 10.1109/TMI.2007.900461; Schultz T, 2010, LECT NOTES COMPUT SC, V6361, P674; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Yeh FC, 2011, NEUROIMAGE, V55, P1054, DOI 10.1016/j.neuroimage.2010.11.087; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126	31	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75747	10.1371/journal.pone.0075747	http://dx.doi.org/10.1371/journal.pone.0075747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146772	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400017
J	Slater, J; Tierney, A; Kraus, N				Slater, Jessica; Tierney, Adam; Kraus, Nina			At-Risk Elementary School Children with One Year of Classroom Music Instruction Are Better at Keeping a Beat	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; DEVELOPMENTAL DYSLEXIA; COGNITIVE-DEVELOPMENT; RHYTHM PERCEPTION; TEMPORAL CONTROL; LIFE-SPAN; SKILLS; BRAIN; ENTRAINMENT; METER	Temporal processing underlies both music and language skills. There is increasing evidence that rhythm abilities track with reading performance and that language disorders such as dyslexia are associated with poor rhythm abilities. However, little is known about how basic time-keeping skills can be shaped by musical training, particularly during critical literacy development years. This study was carried out in collaboration with Harmony Project, a non-profit organization providing free music education to children in the gang reduction zones of Los Angeles. Our findings reveal that elementary school children with just one year of classroom music instruction perform more accurately in a basic finger-tapping task than their untrained peers, providing important evidence that fundamental time-keeping skills may be strengthened by short-term music training. This sets the stage for further examination of how music programs may be used to support the development of basic skills underlying learning and literacy, particularly in at-risk populations which may benefit the most.	[Slater, Jessica; Tierney, Adam; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Slater, Jessica; Tierney, Adam; Kraus, Nina] Northwestern Univ, Dept Commun Sci, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Kraus, N (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	nkraus@northwestern.edu	Slater, Jessica/AAS-4515-2020	Slater, Jessica/0000-0001-7281-5231; Tierney, Adam/0000-0002-7624-6918	Knowles Hearing Center, NIH [T32 DC009399-02]; National Association of Music Merchants; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009399] Funding Source: NIH RePORTER	Knowles Hearing Center, NIH; National Association of Music Merchants; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Knowles Hearing Center, NIH T32 DC009399-02, and the National Association of Music Merchants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Ben-Pazi H, 2003, DEV MED CHILD NEUROL, V45, P743, DOI 10.1017/S0012162203001385; Ben-Pazi H, 2007, J CHILD NEUROL, V22, P543, DOI 10.1177/0883073807302610; Bugaj K, 2011, B COUN RES MUSIC ED, P89; Buzsaki G., 2009, RHYTHMS BRAIN, DOI [10.1093/acprof:oso/9780195301069.001.0001, DOI 10.1093/ACPROF:OSO/9780195301069.001.0001]; Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; DAUER RM, 1983, J PHONETICS, V11, P51, DOI 10.1016/S0095-4470(19)30776-4; Dellatolas G, 2009, ARCH CLIN NEUROPSYCH, V24, P555, DOI 10.1093/arclin/acp044; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Drake C, 2000, COGNITION, V74, P1, DOI 10.1016/S0010-0277(99)00061-X; Drewing K, 2006, INT J BEHAV DEV, V30, P280, DOI 10.1177/0165025406066764; Ellis RJ, 2013, NEUROIMAGE, V75, P97, DOI 10.1016/j.neuroimage.2013.02.045; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gooding L., 2011, UPDATE APPL RES MUSI, V30, P32, DOI [DOI 10.1177/8755123311418481, 10.1177/8755123311418481]; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grieshaber K., 1987, B COUNCIL RES MUSIC, V90, P73; Gromko JE, 2005, J RES MUSIC EDUC, V53, P199, DOI 10.2307/3598679; Hamalainen JA, 2012, NEUROIMAGE, V59, P2952, DOI 10.1016/j.neuroimage.2011.09.075; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, COGNITIVE PSYCHOL, V50, P354, DOI 10.1016/j.cogpsych.2004.09.003; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Levitin DJ., 2009, MUSIC MED, V1, P9, DOI [10.1177/1943862109338604, DOI 10.1177/1943862109338604]; Lipscomb S. D., 2008, 2008 INT C MUS PERC; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; Nozaradan S, 2012, J NEUROSCI, V32, P17572, DOI 10.1523/JNEUROSCI.3203-12.2012; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; Reifinger J, 2006, UPDATE U S C DEP MUS, V25, P15; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2007, MUSIC PERCEPT, V24, P367, DOI 10.1525/MP.2007.24.4.367; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2010, HUM MOVEMENT SCI, V29, P200, DOI 10.1016/j.humov.2009.08.002; Schlaug G, 2005, ANN NY ACAD SCI, V1060, P219, DOI 10.1196/annals.1360.015; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Skoe E, 2012, J NEUROSCI, V32, P11507, DOI 10.1523/JNEUROSCI.1949-12.2012; Standley JM, 2008, UPDATE APPL RES MUS, V27, P17, DOI DOI 10.1177/8755123308322270; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Tierney A, 2013, J NEUROSCI; Tierney AT, 2013, BRAIN LANG, V124, P225, DOI 10.1016/j.bandl.2012.12.014; Trainor LJ, 2009, ANN NY ACAD SCI, V1169, P133, DOI 10.1111/j.1749-6632.2009.04589.x; Woerner C, 1999, WECHSLER ABBREVIATED	54	34	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77250	10.1371/journal.pone.0077250	http://dx.doi.org/10.1371/journal.pone.0077250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236QM	24130865	Green Published, gold, Green Accepted			2022-12-27	WOS:000325814200074
J	Alati, R; Smith, GD; Lewis, SJ; Sayal, K; Draper, ES; Golding, J; Fraser, R; Gray, R				Alati, Rosa; Smith, George Davey; Lewis, Sarah J.; Sayal, Kapil; Draper, Elizabeth S.; Golding, Jean; Fraser, Robert; Gray, Ron			Effect of Prenatal Alcohol Exposure on Childhood Academic Outcomes: Contrasting Maternal and Paternal Associations in the ALSPAC Study	PLOS ONE			English	Article							LIGHT DRINKING; SPECTRUM DISORDERS; COGNITIVE DEFICITS; PREGNANCY; RISK; CHILDREN; HEALTH; CONSUMPTION; PARENTS; BRAIN	Background: The impact of low-to-moderate levels of alcohol consumption during pregnancy on child cognitive outcomes has been of recent concern. This study has tested the hypothesis that low-to-moderate maternal alcohol use in pregnancy is associated with lower school test scores at age 11 in the offspring via intrauterine mechanisms. Methods: We used data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a birth cohort study based in the South West of England. Analyses were conducted on 7062 participants who had complete data on: maternal and paternal patterns of alcohol use in the first trimester and at 18 weeks' gestation, child's academic outcomes measured at age 11, gender, maternal age, parity, marital status, ethnicity, household crowding, home ownership status and parental education. We contrasted the association of mother's alcohol consumption during pregnancy with child's National Curriculum Key Stage 2 (KS2) test scores with the association for father's alcohol consumption (during the time the mother was pregnant) with child's National Curriculum Key Stage 2 (KS2) test scores. We used multivariate linear regression to estimate mean differences and 95% confidence intervals [CI] in KS2 scores across the exposure categories and computed f statistics to compare maternal and paternal associations. Findings and conclusions: Drinking up to 1 unit of alcohol a day during pregnancy was not associated with lower test scores. However, frequent prenatal consumption of 4 units (equivalent to 32 grams of alcohol) on each single drinking occasion was associated with reduced educational attainment [Mean change in offspring KS2 score was -0.68 (-1.03, -0.33) for maternal alcohol categories compared to 0.27 (0.07, 0.46) for paternal alcohol categories]. Frequent consumption of 4 units of alcohol during pregnancy may adversely affect childhood academic outcomes via intrauterine mechanisms.	[Alati, Rosa] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Alati, Rosa] Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld, Australia; [Smith, George Davey; Lewis, Sarah J.; Golding, Jean] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Smith, George Davey] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Sayal, Kapil] Univ Nottingham, Nottingham NG7 2RD, England; [Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Fraser, Robert] Univ Sheffield, Sheffield, S Yorkshire, England; [Gray, Ron] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England	University of Queensland; University of Queensland; University of Bristol; University of Bristol; University of Nottingham; University of Leicester; University of Sheffield; University of Oxford	Alati, R (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	r.alati@sph.uq.edu.au	Alati, Rosa/G-2523-2010; Draper, Elizabeth S/I-6304-2018; Davey Smith, George/A-7407-2013; Alati, Rosa/A-2335-2014; Draper, Elizabeth/S-6874-2019	Draper, Elizabeth S/0000-0001-9340-8176; Davey Smith, George/0000-0002-1407-8314; Alati, Rosa/0000-0002-9240-3450; Draper, Elizabeth/0000-0001-9340-8176; Golding, Jean/0000-0003-2826-3307; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lewis, Sarah/0000-0003-4311-6890; Sayal, Kapil/0000-0002-2050-4316; s, hema/0000-0002-3440-9475	Wellcome Trust [083506]; Australian National Health & Medical Research Council [519721]; MRC [MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1, G9815508] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was specifically funded by the Wellcome Trust Project Grant titled 'Effects of prenatal alcohol consumption and alcohol metabolising genes on child growth and neurodevelopment in the ALSPAC study' (Grant Number: 083506). RA had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. RA is funded by an Australian National Health & Medical Research Council Career Development Award in Population Health (ID 519721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alati R, 2008, PEDIATR RES, V64, P659, DOI 10.1203/PDR.0b013e318187cc31; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brion MJA, 2007, HYPERTENSION, V49, P1422, DOI 10.1161/HYPERTENSIONAHA.106.085316; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Burden MJ, 2005, ALCOHOL CLIN EXP RES, V29, P443, DOI 10.1097/01.ALC.0000156125.50577.EC; D'Onofrio BM, 2007, ARCH GEN PSYCHIAT, V64, P1296, DOI 10.1001/archpsyc.64.11.1296; D'Onofrio BM, 2009, ADDICTION, V104, P1278, DOI 10.1111/j.1360-0443.2009.02631.x; Davey Smith G, 2009, EARLY NUTR PROGRAMMI; Gmel G, 2011, ADDICTION, V106, P1037, DOI 10.1111/j.1360-0443.2010.03167.x; Gray R, 2013, BJOG-INT J OBSTET GY, V120, P1039, DOI 10.1111/1471-0528.12211; Gray R, 2009, ADDICTION, V104, P1279; Henderson J, 2007, BJOG-INT J OBSTET GY, V114, P243, DOI 10.1111/j.1471-0528.2006.01163.x; Henderson J, 2007, J EPIDEMIOL COMMUN H, V61, P1069, DOI 10.1136/jech.2006.054213; Jacobson JL, 2002, ALCOHOL RES HEALTH, V26, P282; Kelly Y, 2013, BJOG; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Kelly YJ, 2012, J EPIDEMIOL COMMUN H, V66, P41, DOI 10.1136/jech.2009.103002; Lahey BB, 2009, J CHILD PSYCHOL PSYC, V50, P53, DOI 10.1111/j.1469-7610.2008.01980.x; Lewis SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049407; Mattson SN, 2001, ALCOHOL RES HEALTH, V25, P185; Mukherjee RAS, 2006, J ROY SOC MED, V99, P298, DOI 10.1258/jrsm.99.6.298; Mumford SE, 1999, ARCH DIS CHILD-FETAL, V81, pF146, DOI 10.1136/fn.81.2.F146; National Health Service (NHS), 2012, WHAT LEV DRINK RED H; National Institute on Alcohol Abuse and Alcoholism (NHAAA), 2012, ALC HLTH MOD BING DR; Nordstrom B, 2003, AM J OBSTET GYNECOL, V189, pS129; Norman AL, 2009, DEV DISABIL RES REV, V15, P209, DOI 10.1002/ddrr.72; O'Leary CM, 2004, J PAEDIATR CHILD H, V40, P2, DOI 10.1111/j.1440-1754.2004.00280.x; O'Leary CM, 2012, DRUG ALCOHOL REV, V31, P170, DOI 10.1111/j.1465-3362.2011.00331.x; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Robinson M, 2010, BJOG-INT J OBSTET GY, V117, P1139, DOI 10.1111/j.1471-0528.2010.02596.x; Sayal K, 2013, ARCH DIS CHILD, V98, P107, DOI 10.1136/archdischild-2012-302436; Sayal K, 2009, INT J EPIDEMIOL, V38, P140, DOI 10.1093/ije/dyn370; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; Smith GD, 2009, INT J EPIDEMIOL, V38, P1, DOI 10.1093/ije/dyp002; StataCorp, 2011, STAT STAT SOFTW REL, P173; Streissguth A, 2007, J CLIN PSYCHOL MED S, V14, P81, DOI 10.1007/s10880-007-9067-6; Willford JA, 2006, ALCOHOL CLIN EXP RES, V30, P1051, DOI 10.1111/j.1530-0277.2006.00119.x	40	35	35	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74844	10.1371/journal.pone.0074844	http://dx.doi.org/10.1371/journal.pone.0074844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130672	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900007
J	Borthakur, A; Bhattacharyya, S; Kumar, A; Anbazhagan, AN; Tobacman, JK; Dudeja, PK				Borthakur, Alip; Bhattacharyya, Sumit; Kumar, Anoop; Anbazhagan, Arivarasu Natarajan; Tobacman, Joanne K.; Dudeja, Pradeep K.			Lactobacillus acidophilus Alleviates Platelet-Activating Factor-Induced Inflammatory Responses in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECROTIZING ENTEROCOLITIS; CROHNS-DISEASE; COLONIC-MUCOSA; PROBIOTICS; EXPRESSION; MICROBIOTA; PATHWAY; PHOSPHORYLATION; INTERLEUKIN-8	Probiotics have been used as alternative prevention and therapy modalities in intestinal inflammatory disorders including inflammatory bowel diseases (IBD) and necrotizing enterocolitis (NEC). Pathophysiology of IBD and NEC includes the production of diverse lipid mediators, including platelet-activating factor (PAF) that mediate inflammatory responses in the disease. PAF is known to activate NF-kappa B, however, the mechanisms of PAF-induced inflammation are not fully defined. We have recently described a novel PAF-triggered pathway of NF-kappa B activation and IL-8 production in intestinal epithelial cells (IECs), requiring the pivotal role of the adaptor protein Bcl10 and its interactions with CARMA3 and MALT1. The current studies examined the potential role of the probiotic Lactobacillus acidophilus in reversing the PAF-induced, Bcl10-dependent NF-kappa B activation and IL-8 production in IECs. PAF treatment (5 mu Mx24 h) of NCM460 and Caco-2 cells significantly increased nuclear p65 NF-kappa B levels and IL-8 secretion (2-3-fold, P < 0.05), compared to control, which were blocked by pretreatment of the cells for 6 h with L. acidophilus (LA) or its culture supernatant (CS), followed by continued treatments with PAF for 24 h. LA-CS also attenuated PAF-induced increase in Bcl10 mRNA and protein levels and Bcl10 promoter activity. LA-CS did not alter PAF-induced interaction of Bcl10 with CARMA3, but attenuated Bcl10 interaction with MALT1 and also PAF-induced ubiquitination of IKK gamma. Efficacy of bacteria-free CS of LA in counteracting PAF-induced inflammatory cascade suggests that soluble factor(s) in the CS of LA mediate these effects. These results define a novel mechanism by which probiotics counteract PAF-induced inflammation in IECs.	[Borthakur, Alip; Bhattacharyya, Sumit; Kumar, Anoop; Anbazhagan, Arivarasu Natarajan; Tobacman, Joanne K.; Dudeja, Pradeep K.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA; [Dudeja, Pradeep K.] Jesse Brown VA Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Borthakur, A (corresponding author), Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA.	alipb@uic.edu			National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) [DK-54016, DK-81858, DK-92441]; Bill & Melinda Gates Foundation [OPP1058288]; Department of Veteran Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092441, R01DK054016, R01DK081858] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK): DK-54016 (PKD), DK-81858 (PKD), DK-92441 (PKD); Bill & Melinda Gates Foundation: OPP1058288 (AB) and Department of Veteran Affairs (PKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2010, J BIOL CHEM, V285, P522, DOI 10.1074/jbc.M109.050815; Borman RA, 1998, BRIT J PHARMACOL, V123, P231, DOI 10.1038/sj.bjp.0701602; Borthakur A, 2008, J NUTR, V138, P1355, DOI 10.1093/jn/138.7.1355; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Carlisle EM, 2013, CURR OPIN PEDIATR, V25, P382, DOI 10.1097/MOP.0b013e3283600e91; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; CHAO W, 1992, J BIOL CHEM, V267, P6725; Choi JH, 2001, J IMMUNOL, V166, P5139, DOI 10.4049/jimmunol.166.8.5139; Claud EC, 2008, AM J PHYSIOL-GASTR L, V294, pG1191, DOI 10.1152/ajpgi.00318.2007; Dai C, 2013, MOL CELL BIOCHEM, V374, P1, DOI 10.1007/s11010-012-1488-3; De Plaen IG, 1998, BBA-LIPID LIPID MET, V1392, P185, DOI 10.1016/S0005-2760(98)00024-1; Egea L, 2008, BBA-MOL CELL BIOL L, V1781, P270, DOI 10.1016/j.bbalip.2008.03.009; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; Frost BL, 2013, SEMIN PEDIATR SURG, V22, P88, DOI 10.1053/j.sempedsurg.2013.01.005; Ganguli K, 2012, GASTROENTEROL CLIN N, V41, P733, DOI 10.1016/j.gtc.2012.08.004; Gautheron J, 2010, CELL MOL LIFE SCI, V67, P3101, DOI 10.1007/s00018-010-0404-9; Grishin A, 2013, SEMIN PEDIATR SURG, V22, P69, DOI 10.1053/j.sempedsurg.2013.01.002; Han SJ, 1999, EUR J IMMUNOL, V29, P1334, DOI 10.1002/(SICI)1521-4141(199904)29:04<1334::AID-IMMU1334>3.0.CO;2-0; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Howarth GS, 2013, NUTRIENTS, V5, P58, DOI 10.3390/nu5010058; HSUEH W, 1994, ACTA PAEDIATR, V83, P11, DOI 10.1111/j.1651-2227.1994.tb13234.x; Im SY, 1997, EUR J IMMUNOL, V27, P2800, DOI 10.1002/eji.1830271109; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jonkers D, 2012, DRUGS, V72, P803, DOI 10.2165/11632710-000000000-00000; KALD B, 1990, DIGESTION, V46, P199, DOI 10.1159/000200346; Kaur N, 2011, GUT MICROBES, V2, P211, DOI 10.4161/gmic.2.4.17863; Lu J, 2008, AM J PHYSIOL-GASTR L, V294, pG1181, DOI 10.1152/ajpgi.00343.2007; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Magrone T, 2013, CURR PHARM DESIGN, V19, P1329; Merendino N, 1999, AM J PHYSIOL-GASTR L, V277, pG810, DOI 10.1152/ajpgi.1999.277.4.G810; Nasu K, 1999, MOL HUM REPROD, V5, P548, DOI 10.1093/molehr/5.6.548; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Rosebeck S, 2011, CELL CYCLE, V10, P2485, DOI 10.4161/cc.10.15.16923; Roth M, 1996, J EXP MED, V184, P191, DOI 10.1084/jem.184.1.191; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Singh V, 2012, AM J PHYSIOL-GASTR L, V303, pG1393, DOI 10.1152/ajpgi.00345.2012; SOBHANI I, 1992, GUT, V33, P1220, DOI 10.1136/gut.33.9.1220; Sun Jiyuan, 2010, World J Biol Chem, V1, P353, DOI 10.4331/wjbc.v1.i12.353; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Veerappan Ganesh R, 2012, Curr Gastroenterol Rep, V14, P324, DOI 10.1007/s11894-012-0265-5; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Whelan K, 2013, CURR OPIN GASTROEN, V29, P184, DOI 10.1097/MOG.0b013e32835d7bba; Wu GD, 2013, ANAEROBE; Xu LF, 2012, INFLAMMATION, V35, P308, DOI 10.1007/s10753-011-9320-x; Yang YJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-38; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	50	34	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75664	10.1371/journal.pone.0075664	http://dx.doi.org/10.1371/journal.pone.0075664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130731	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900050
J	Wiens, GD; Vallejo, RL; Leeds, TD; Palti, Y; Hadidi, S; Liu, SX; Evenhuis, JP; Welch, TJ; Rexroad, CE				Wiens, Gregory D.; Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Hadidi, Sima; Liu, Sixin; Evenhuis, Jason P.; Welch, Timothy J.; Rexroad, Caird E., III			Assessment of Genetic Correlation between Bacterial Cold Water Disease Resistance and Spleen Index in a Domesticated Population of Rainbow Trout: Identification of QTL on Chromosome Omy19	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; QUANTITATIVE TRAIT LOCI; SALMON SALMO-SALAR; AMEBIC GILL DISEASE; ATLANTIC SALMON; FLAVOBACTERIUM-PSYCHROPHILUM; INCREASE RESISTANCE; INTEGRATED MAP; MAJOR QTL; MYKISS	Selective breeding of animals for increased disease resistance is an effective strategy to reduce mortality in aquaculture. However, implementation of selective breeding programs is limited by an incomplete understanding of host resistance traits. We previously reported results of a rainbow trout selection program that demonstrated increased survival following challenge with Flavobacterium psychrophilum, the causative agent of bacterial cold water disease (BCWD). Mechanistic study of disease resistance identified a positive phenotypic correlation between post-challenge survival and spleen somatic-index (SI). Herein, we investigated the hypothesis of a genetic correlation between the two traits influenced by colocalizing QTL. We evaluated the inheritance and calculated the genetic correlation in five year-classes of odd-and even-year breeding lines. A total of 322 pedigreed families (n = 25,369 fish) were measured for disease resistance, and 251 families (n = 5,645 fish) were evaluated for SI. Spleen index was moderately heritable in both even-year (h(2) = 0.56 +/- 0.18) and odd-year (h(2) = 0.60 +/- 0.15) lines. A significant genetic correlation between SI and BCWD resistance was observed in the even-year line (r(g) = 0.45 +/- 0.20, P = 0.03) but not in the odd-year line (r(g) = 0.16 +/- 0.12, P = 0.19). Complex segregation analyses of the even-year line provided evidence of genes with major effect on SI, and a genome scan of a single family, 2008132, detected three significant QTL on chromosomes Omy19, 16 and 5, in addition to ten suggestive QTL. A separate chromosome scan for disease resistance in family 2008132 identified a significant BCWD QTL on Omy19 that was associated with time to death and percent survival. In family 2008132, Omy19 microsatellite alleles that associated with higher disease resistance also associated with increased spleen size raising the hypothesis that closely linked QTL contribute to the correlation between these traits. To our knowledge, this is the first estimation of spleen size heritability and evidence for genetic linkage with specific disease resistance in a teleost fish.	[Wiens, Gregory D.; Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Hadidi, Sima; Liu, Sixin; Evenhuis, Jason P.; Welch, Timothy J.; Rexroad, Caird E., III] ARS, Natl Ctr Cool & Cold Water Aquaculture, USDA, Kearneysville, WV USA	United States Department of Agriculture (USDA)	Wiens, GD (corresponding author), ARS, Natl Ctr Cool & Cold Water Aquaculture, USDA, Kearneysville, WV USA.	greg.wiens@ars.usda.gov	Vallejo, Roger/AAE-7591-2020	Vallejo, Roger/0000-0002-5399-3531; Wiens, Gregory/0000-0002-5478-7780; Welch, Tim/0000-0003-1096-3006; Leeds, Timothy/0000-0002-9872-1134	Agricultural Research Service CRIS project [1930-32000-005]	Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by Agricultural Research Service CRIS project 1930-32000-005 "Integrated Approaches for Improving Aquatic Animal Health in Cool and Cold Water Aquaculture". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, GENETICS ANAL QUANTI; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Barnes M. E., 2011, The Open Fish Science Journal, V4, P40, DOI 10.2174/1874401X01104010040; BOLDMAN KG, 1995, MANUAL USE IN PRESS; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Brown LL, 1997, DIS AQUAT ORGAN, V29, P213, DOI 10.3354/dao029213; Cipriano RC, 2005, J AQUAT ANIM HEALTH, V17, P275, DOI 10.1577/H05-003.1; Crump EM, 2001, APPL ENVIRON MICROB, V67, P750, DOI 10.1128/AEM.67.2.750-759.2001; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Falconer D. S., 1996, INTRO QUANTITATIVE G; FANGE R, 1985, EXPERIENTIA, V41, P152, DOI 10.1007/BF02002607; Fawcett GL, 2008, OBESITY, V16, P1861, DOI 10.1038/oby.2008.300; Figenschou L, 2012, BEHAV ECOL, P1; Groff Joseph M., 2000, Journal of Applied Aquaculture, V10, P17, DOI 10.1300/J028v10n04_02; Hadidi S, 2008, J IMMUNOL, V180, P4156, DOI 10.4049/jimmunol.180.6.4156; Henryon M, 2005, AQUACULTURE, V250, P621, DOI 10.1016/j.aquaculture.2004.12.022; Houston RD, 2010, HEREDITY, V105, P318, DOI 10.1038/hdy.2009.171; Houston RD, 2008, DEV BIOLOGICALS, V132, P199, DOI 10.1159/000317160; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; JANSS LLG, 2008, IBAY MANUAL VERSION; Kenney-Hunt JP, 2006, MAMM GENOME, V17, P526, DOI 10.1007/s00335-005-0160-6; Kjoglum S, 2008, AQUAC RES, V39, P498, DOI 10.1111/j.1365-2109.2008.01904.x; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Kube PD, 2012, AQUACULTURE, V364, P165, DOI 10.1016/j.aquaculture.2012.08.026; LaFrentz BR, 2004, DIS AQUAT ORGAN, V59, P17, DOI 10.3354/dao059017; LaFrentz BR, 2003, J FISH DIS, V26, P377, DOI 10.1046/j.1365-2761.2003.00468.x; Langevin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039126; Leach RJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-107; Leeds TD, 2010, J ANIM SCI, V88, P1936, DOI 10.2527/jas.2009-2538; Moen T, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-53; Moen T, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P166, DOI 10.1079/9781845935559.0166; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Palti Y, 2006, ANIM GENET, V37, P597, DOI 10.1111/j.1365-2052.2006.01527.x; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Phillips RB, 2013, ANIM GENET, V44, P107, DOI 10.1111/j.1365-2052.2011.02314.x; Phillips RB, 2003, IMMUNOGENETICS, V55, P561, DOI 10.1007/s00251-003-0615-4; Quillet E, 2007, DIS AQUAT ORGAN, V76, P7, DOI 10.3354/dao076007; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; SAS Institute Inc, 2007, SAS 9 1 3 HELP DOC; Seaton G, 2006, GRIDQTL GRID PORTAL; Silverstein JT, 2009, J ANIM SCI, V87, P860, DOI 10.2527/jas.2008-1157; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Stear M.J., 2012, CAB REV PERSPECTIVES, V7; Taylor RS, 2009, AQUACULTURE, V294, P172, DOI 10.1016/j.aquaculture.2009.06.007; Vallejo RL, 2010, J ANIM SCI, V88, P3814, DOI 10.2527/jas.2010-2951; Vallejo RL, 2009, J ANIM SCI, V87, P3490, DOI 10.2527/jas.2008-1616; VANMUISWINKEL WB, 1991, RES IMMUNOL, V142, P362, DOI 10.1016/0923-2494(91)90093-X; Vatsos IN, 2006, J FISH DIS, V29, P441, DOI 10.1111/j.1365-2761.2006.00735.x; Verrier ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055302; Verrier ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033935; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wiens GD, 2013, AQUACULTURE, V388, P128, DOI 10.1016/j.aquaculture.2013.01.018; Wiens GD, 2010, FISH SHELLFISH IMMUN, V29, P639, DOI 10.1016/j.fsi.2010.06.010; Wringe BF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-63	60	47	49	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75749	10.1371/journal.pone.0075749	http://dx.doi.org/10.1371/journal.pone.0075749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130739	gold, Green Published			2022-12-27	WOS:000325810900056
J	Stead, M; Moodie, C; Angus, K; Bauld, L; McNeill, A; Thomas, J; Hastings, G; Hinds, K; O'Mara-Eves, A; Kwan, I; Purves, RI; Bryce, SL				Stead, Martine; Moodie, Crawford; Angus, Kathryn; Bauld, Linda; McNeill, Ann; Thomas, James; Hastings, Gerard; Hinds, Kate; O'Mara-Eves, Alison; Kwan, Irene; Purves, Richard I.; Bryce, Stuart L.			Is Consumer Response to Plain/Standardised Tobacco Packaging Consistent with Framework Convention on Tobacco Control Guidelines? A Systematic Review of Quantitative Studies	PLOS ONE			English	Review							CIGARETTE PACK DESIGN; ADULT SMOKERS PERCEPTIONS; HEALTH WARNINGS; BRAND IMAGE; IMPACT; PRODUCTS; RISK; CHILDREN; FOOD	Background and Objectives: Standardised or 'plain' tobacco packaging was introduced in Australia in December 2012 and is currently being considered in other countries. The primary objective of this systematic review was to locate, assess and synthesise published and grey literature relating to the potential impacts of standardised tobacco packaging as proposed by the guidelines for the international Framework Convention on Tobacco Control: reduced appeal, increased salience and effectiveness of health warnings, and more accurate perceptions of product strength and harm. Methods: Electronic databases were searched and researchers in the field were contacted to identify studies. Eligible studies were published or unpublished primary research of any design, issued since 1980 and concerning tobacco packaging. Twenty-five quantitative studies reported relevant outcomes and met the inclusion criteria. A narrative synthesis was conducted. Results: Studies that explored the impact of package design on appeal consistently found that standardised packaging reduced the appeal of cigarettes and smoking, and was associated with perceived lower quality, poorer taste and less desirable smoker identities. Although findings were mixed, standardised packs tended to increase the salience and effectiveness of health warnings in terms of recall, attention, believability and seriousness, with effects being mediated by the warning size, type and position on pack. Pack colour was found to influence perceptions of product harm and strength, with darker coloured standardised packs generally perceived as containing stronger tasting and more harmful cigarettes than fully branded packs; lighter coloured standardised packs suggested weaker and less harmful cigarettes. Findings were largely consistent, irrespective of location and sample. Conclusions: The evidence strongly suggests that standardised packaging will reduce the appeal of packaging and of smoking in general; that it will go some way to reduce consumer misperceptions regarding product harm based upon package design; and will help make the legally required on-pack health warnings more salient.	[Stead, Martine; Moodie, Crawford; Angus, Kathryn; Bauld, Linda; Hastings, Gerard; Purves, Richard I.; Bryce, Stuart L.] Univ Stirling, Inst Social Mkt & Canc Res, United Kingdom Ctr Tobacco Control Res, Stirling FK9 4LA, Scotland; [Stead, Martine; Moodie, Crawford; Angus, Kathryn; Bauld, Linda; Hastings, Gerard; Purves, Richard I.; Bryce, Stuart L.] Univ Stirling, United Kingdom Ctr Tobacco & Alcohol Studies, Stirling FK9 4LA, Scotland; [McNeill, Ann] Kings Coll London, Addict Dept, Inst Psychiat, United Kingdom Ctr Tobacco & Alcohol Studies, London, England; [Thomas, James; Hinds, Kate; O'Mara-Eves, Alison; Kwan, Irene] W London Inst Higher Educ, Evidence Policy & Practice Informat & Coordinatin, Social Sci Res Unit, London, England	University of Stirling; University of Stirling; University of London; King's College London; Brunel University; University of London; University College London	Stead, M (corresponding author), Univ Stirling, Inst Social Mkt & Canc Res, United Kingdom Ctr Tobacco Control Res, Stirling FK9 4LA, Scotland.	martine.stead@stir.ac.uk		McNeill, Ann/0000-0002-6223-4000; Moodie, Crawford/0000-0002-1805-2509; Thomas, James/0000-0003-4805-4190; Stead, Martine/0000-0002-3066-4604; O'Mara-Eves, Alison/0000-0002-0359-6423	Department of Health through the Public Health Research Consortium (PHRC); British Heart Foundation; Cancer Research United Kingdom; Economic and Social Research Council; Medical Research Council; National Institute of Health Research under United Kingdom Clinical Research Collaboration; Cancer Research UK [15192] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	Department of Health through the Public Health Research Consortium (PHRC); British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research under United Kingdom Clinical Research Collaboration; Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This review was funded by the Department of Health through the Public Health Research Consortium (PHRC). The views expressed are those of the authors and not necessarily those of the Department of Health. Information about the wider programme of the PHRC is available from http://www.phrc.lshtm.ac.uk. The University of Stirling and King's College London authors are members of the United Kingdom Centre for Tobacco Control Studies (http://www.ukctcs.org). Funding from the British Heart Foundation, Cancer Research United Kingdom, the Economic and Social Research Council, the Medical Research Council and the National Institute of Health Research, under the auspices of the United Kingdom Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Finco FDBA, 2010, J INT FOOD AGRIBUS M, V22, P125, DOI 10.1080/08974430903372963; [Anonymous], 2009, SYSTEMATIC REV CRDS; [Anonymous], 2008, EL GUID IMPL ART 13; Bansal-Travers M, 2011, AM J PREV MED, V40, P674, DOI 10.1016/j.amepre.2011.01.021; Beede P, 1990, PROMOTIONAL IMPACT C; Bondy SJ, 1996, TECHNICAL REPORT, P153; Borenstein M, 2009, INTRO META ANAL; Canadian Cancer Society, 2012, CIGR PACK HLTH WARN; Cavalcante TM., 2003, LABELLING PACKAGING; COOPER HM, 1980, PSYCHOL BULL, V87, P442, DOI 10.1037/0033-2909.87.3.442; *CTR HLTH PROM, 1993, EFF PLAIN PACK IM TO; Devinney TM, 2010, ANAL CONSUMER RES EV; Donovan RJ, 1993, SMOKERS NONSMOKERS R; Doxey J, 2011, TOB CONTROL, V20, P353, DOI 10.1136/tc.2010.038315; Elliott CD, 2009, CAN J COMMUN, V34, P359, DOI 10.22230/cjc.2009v34n3a2220; Environics Research Group, 2008, CONS RES SIZ HLTH WA; Eriksen M, 2012, TOBACCO ATLAS; European Commission, 2012, EX SUMM IMP ASS ACC; Ford A, 2012, ADDICT RES THEORY, V20, P339, DOI 10.3109/16066359.2011.632700; Freeman B, 2008, ADDICTION, V103, P580, DOI 10.1111/j.1360-0443.2008.02145.x; Gallopel-Morvan K, 2010, ACT C INT AFM ASS FR, P17; Gallopel-Morvan K, 2012, TOB CONTROL, V21, P502, DOI 10.1136/tobaccocontrol-2011-050079; Gartner C, 2011, ADDICTION, V106, P1555, DOI 10.1111/j.1360-0443.2011.03478.x; Germain D, 2010, J ADOLESCENT HEALTH, V46, P385, DOI 10.1016/j.jadohealth.2009.08.009; Goldberg M, 1995, PACKAGES CANT SPEAK; Grossman G, 2006, ADMAP, V41, P38; Hammond D, 2013, J ADOLESCENT HEALTH, V52, P151, DOI 10.1016/j.jadohealth.2012.06.003; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Hammond D, 2011, NICOTINE TOB RES, V13, P579, DOI 10.1093/ntr/ntr045; Hammond D, 2010, SALUD PUBLICA MEXICO, V52, pS226, DOI 10.1590/S0036-36342010000800018; Hammond D, 2009, EUR J PUBLIC HEALTH, V19, P631, DOI 10.1093/eurpub/ckp122; Harden A, 2004, J EPIDEMIOL COMMUN H, V58, P794, DOI 10.1136/jech.2003.014829; Hoek J, 2009, AM MARK ASS 20 ANN M; Hoek J, 2011, TOB CONTROL, V20, P183, DOI 10.1136/tc.2010.037861; International Union Against Lung and Tuberculosis Disease, 2009, TOB PACK LAB TECHN G; Jarvis MJ, 2001, JNCI-J NATL CANCER I, V93, P134, DOI 10.1093/jnci/93.2.134; Klimchuk MR., 2012, PACKAGING DESIGN SUC, V2; Kotnowski K, 2013, ADDICTION, V108, P1658, DOI 10.1111/add.12183; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Meyers H., 1998, MARKETERS GUIDE SUCC; Mitreva M, 2011, TOB REPORTER     JUL, P78; Moodie C, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2012-050681, DOI 10.1136/T0BACC0C0NTR0L-2012-050681]; Moodie C, 2011, PROTOCOL PLAIN TOBAC; Moodie C, 2012, PLAIN TOBACCO PACKAG; Moodie C, 2012, NICOTINE TOB RES, V14, P98, DOI 10.1093/ntr/ntr136; Moodie C, 2011, TOB CONTROL, V20, P367, DOI 10.1136/tc.2011.042911; Moodie C, 2010, TOB CONTROL, V19, P168, DOI 10.1136/tc.2009.033449; Morris Philip, 1990, MARKETING NEW PRODUC, V2044762173-2364; Munafo MR, 2011, ADDICTION, V106, P1505, DOI 10.1111/j.1360-0443.2011.03430.x; Neman, 2011, JAP TOB INT JSC GROD; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Ogba IE, 2010, YOUNG CONSUM, V11, P77, DOI 10.1108/17473611011026037; Padilla J, 2010, CRITICAL REV LIT GEN; PEERSMAN G, 1997, REV GUIDELINES DATA; Pollay R., 2001, SMOKING TOBACCO CONT, P199; Quit Victoria, 2011, PLAIN PACKAGING TOBA; Rootman I, 1995, STUDY YOUTH SMOKING; Sara R, 1990, INT J PHYS DISTRIB, V20, P29, DOI [DOI 10.1108/EUM0000000000372, 10.1108/EUM0000000000372]; Shepherd J, 2003, 11 COCHR C BARC 26 3; Simms C, 2010, MARKETING THEOR, V10, P397, DOI 10.1177/1470593110382826; Swanson M, 1997, THESIS U W AUSTR PER; The Research Business, 1996, QUAL RES UK POT MARL; Thomas J., 2012, INTRO SYSTEMATIC REV, P179; Thomas J., 2010, EPPI REVIEWER 40 SOF; Thrasher JF, 2011, HEALTH POLICY, V102, P41, DOI 10.1016/j.healthpol.2011.06.003; Wakefield M, 2002, TOB CONTROL, V11, pI73, DOI 10.1136/tc.11.suppl_1.i73; Wakefield MA, 2008, TOB CONTROL, V17, P416, DOI 10.1136/tc.2008.026732; White C, 2011, THESIS U WATERLOO WA; Wilkenfeld J, 2000, JNCI-J NATL CANCER I, V92, P90, DOI 10.1093/jnci/92.2.90; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2004, WHO FRAM CONV TOB CO; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization, 2009, HIST WHO FRAM CONV T; World Health Organization, 2012, WHO GLOB REP MORT AT	76	63	63	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75919	10.1371/journal.pone.0075919	http://dx.doi.org/10.1371/journal.pone.0075919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146791	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400025
J	Hsu, DC; Kerr, SJ; Iampornsin, T; Pett, SL; Avihingsanon, A; Thongpaeng, P; Zaunders, JJ; Ubolyam, S; Ananworanich, J; Kelleher, AD; Cooper, DA				Hsu, Denise C.; Kerr, Stephen J.; Iampornsin, Thatri; Pett, Sarah L.; Avihingsanon, Anchalee; Thongpaeng, Parawee; Zaunders, John J.; Ubolyam, Sasiwimol; Ananworanich, Jintanat; Kelleher, Anthony D.; Cooper, David A.			Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; CYTOMEGALOVIRUS-SPECIFIC CD4(+); ACTIVE ANTIRETROVIRAL THERAPY; ALLOGENEIC BONE-MARROW; CHRONIC IMMUNE ACTIVATION; NATURAL-HISTORY; HIV-1-INFECTED INDIVIDUALS; 1-INFECTED PATIENTS; PROTEASE INHIBITOR; EFFECTOR MEMORY	Objectives: Restoration of Cytomegalovirus-specific-CD4 T cell (CMV-Sp-CD4) responses partly accounts for the reduction of CMV-disease with antiretroviral-therapy (ART), but CMV-Sp-CD4 may also drive immune activation and immunosenescence. This study characterized the dynamics of CMV-Sp-CD4 after ART initiation and explored associations with CD4 T cell recovery as well as frequency of naive CD4 T cells at week 96. Methods: Fifty HIV-infected, ART-naive Thai adults with CD4 T cell count <= 350cells/mu L and starting ART were evaluated over 96 weeks (ClinicalTrials.gov identifier NCT01296373). CMV-Sp-CD4 was detected by co-expression of CD25/CD134 by flow cytometry after CMV-antigen stimulation. Results: All subjects were CMV sero-positive, 4 had quantifiable CMV-DNA (range 2.3-3.9 log(10) copies/mL) at baseline but none had clinically apparent CMV-disease. Baseline CMV-Sp-CD4 response was positive in 40 subjects. Those with CD4 T cell count <100cells/mu L were less likely to have positive baseline CMV-Sp-CD4 response (P=0.003). Positive baseline CMV-Sp-CD4 response was associated with reduced odds of quantifiable CMV-DNA (P=0.022). Mean CD4 T cell increase at week 96 was 213 cells/mu L. This was associated positively with baseline HIV-VL (P=0.001) and negatively with age (P=0.003). The frequency of CMV-Sp-CD4 increased at week 4 (P=0.008), then declined. Those with lower baseline CMV-Sp-CD4 (P=0.009) or CDC category C (P<0.001) had greater increases in CMV-Sp-CD4 at week 4. At week 96, CD4 T cell count was positively (P<0.001) and the frequency of CMV-Sp-CD4 was negatively (P=0.001) associated with the percentage of naive CD4 T cells. Conclusions: Increases in CMV-Sp-CD4 with ART occurred early and were greater in those with more advanced immunodeficiency. The frequency of CMV-Sp-CD4 was associated with reduced naive CD4 T cells, a marker associated with immunosenescence.	[Hsu, Denise C.; Kerr, Stephen J.; Pett, Sarah L.; Zaunders, John J.; Kelleher, Anthony D.; Cooper, David A.] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Hsu, Denise C.; Kerr, Stephen J.; Iampornsin, Thatri; Avihingsanon, Anchalee; Thongpaeng, Parawee; Ubolyam, Sasiwimol; Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Pett, Sarah L.; Zaunders, John J.; Kelleher, Anthony D.; Cooper, David A.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; Thai Red Cross Society	Hsu, DC (corresponding author), Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.	d.hsu@amr.org.au	Zaunders, John/J-6553-2012; Kerr, Stephen/J-6126-2012; Ananworanich, Jintanat/AAC-6348-2021	Zaunders, John/0000-0002-5912-5989; Kerr, Stephen/0000-0002-1919-4525; Ananworanich, Jintanat/0000-0003-1369-3224	Australian Government Department of Health and Ageing; National Health and Medical Research Council (NHMRC) [510448]	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the following sources: the Australian Government Department of Health and Ageing; the National Health and Medical Research Council (NHMRC) via a Program (510448) grant, a PhD Scholarship (DCH) and a Practitioner Fellowship (ADK). The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770; Dai ZH, 2001, J IMMUNOL, V167, P6711, DOI 10.4049/jimmunol.167.12.6711; Deayton J, 1999, AIDS, V13, P1203, DOI 10.1097/00002030-199907090-00008; Deayton JR, 2000, AIDS, V14, P1163, DOI 10.1097/00002030-200006160-00013; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Durier N, 2013, CLIN INFECT DIS, V57, P147, DOI 10.1093/cid/cit173; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Gamadia LE, 2004, HUM IMMUNOL, V65, P486, DOI 10.1016/j.humimm.2004.02.020; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Gerna G, 2001, J ACQ IMMUN DEF SYND, V28, P320, DOI 10.1097/00126334-200112010-00003; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; Grosse V, 2002, AIDS, V16, P1075, DOI 10.1097/00002030-200205030-00017; Grosse V, 2000, IMMUNOBIOLOGY, V202, P179, DOI 10.1016/S0171-2985(00)80064-9; Guihot A, 2010, AIDS, V24, P614, DOI 10.1097/QAD.0b013e32833556f3; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; Hsieh SM, 2001, J INFECT DIS, V184, P1386, DOI 10.1086/324419; Hsu Denise C, 2012, Tuberculosis (Edinb), V92, P321, DOI 10.1016/j.tube.2012.03.008; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jacobson MA, 2001, J INFECT DIS, V183, P1399, DOI 10.1086/319854; Janossy G, 2000, BRIT J HAEMATOL, V111, P1198, DOI 10.1046/j.1365-2141.2000.02433.x; Jouan M, 2001, AIDS, V15, P23, DOI 10.1097/00002030-200101050-00006; Keane NM, 2004, HIV MED, V5, P407, DOI 10.1111/j.1468-1293.2004.00245.x; Kelleher AD, 1996, J INFECT DIS, V173, P321, DOI 10.1093/infdis/173.2.321; Keoshkerian E, 2012, J IMMUNOL METHODS, V375, P148, DOI 10.1016/j.jim.2011.10.004; Komanduri KV, 2001, J INFECT DIS, V183, P1285, DOI 10.1086/319683; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; Lederman MM, 2000, AIDS, V14, P2635, DOI 10.1097/00002030-200012010-00002; LENKEI R, 1995, CLIN IMMUNOL IMMUNOP, V77, P131, DOI 10.1006/clin.1995.1136; LI CR, 1994, BLOOD, V83, P1971, DOI 10.1182/blood.V83.7.1971.1971; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; Lilleri D, 2003, J CLIN VIROL, V26, P95, DOI 10.1016/S1386-6532(02)00044-6; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Mackall CL, 1996, J IMMUNOL, V156, P4609; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Moore RD, 1996, ANN INTERN MED, V124, P633, DOI 10.7326/0003-4819-124-7-199604010-00003; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Ozdemir E, 2002, BLOOD, V100, P3690, DOI 10.1182/blood-2002-05-1387; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PERTEL P, 1992, J ACQ IMMUN DEF SYND, V5, P1069; Pourgheysari B, 2009, BONE MARROW TRANSPL, V43, P853, DOI 10.1038/bmt.2008.403; Pourgheysari B, 2007, J VIROL, V81, P7759, DOI 10.1128/JVI.01262-06; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; REUSSER P, 1991, BLOOD, V78, P1373; Rodriguez B, 2010, CLIN IMMUNOL, V136, P400, DOI 10.1016/j.clim.2010.04.016; RUBIN RH, 1990, REV INFECT DIS, V12, pS754; Sacre K, 2012, AIDS, V26, P805, DOI 10.1097/QAD.0b013e328351f780; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sherman GG, 1999, J IMMUNOL METHODS, V222, P209, DOI 10.1016/S0022-1759(98)00172-0; Small LN, 2006, CLIN INFECT DIS, V43, P869, DOI 10.1086/507337; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Taiwo B, 2013, CURR HIV-AIDS REP, V10, P21, DOI 10.1007/s11904-012-0147-3; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Urwijitaroon Y, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P180; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Walker RE, 1998, NAT MED, V4, P852, DOI 10.1038/nm0798-852; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Weinberg A, 2006, J INFECT DIS, V193, P488, DOI 10.1086/499826; Widmann T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003634; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; Zaunders JJ, 2009, J IMMUNOL, V183, P2827, DOI 10.4049/jimmunol.0803548; Zhang R, 2004, J IMMUNOL, V172, P2678, DOI 10.4049/jimmunol.172.4.2678	79	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77479	10.1371/journal.pone.0077479	http://dx.doi.org/10.1371/journal.pone.0077479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130889	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200089
J	Jiang, SZ; Wei, HK; Song, TX; Yang, Y; Peng, J; Jiang, SW				Jiang, Shuzhong; Wei, Hongkui; Song, Tongxing; Yang, Yang; Peng, Jian; Jiang, Siwen			Transcriptome Comparison between Porcine Subcutaneous and Intramuscular Stromal Vascular Cells during Adipogenic Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; ADIPOCYTE DIFFERENTIATION; ADIPOSE; PREADIPOCYTES; STEM; IDENTIFICATION; PATHWAYS; TISSUES; TOOL	Intramuscular fat (IMF) is an important trait influencing meat quality, and preadipocyte differentiation is a key factor affecting IMF deposition. Here we compared the transcriptome profiles of porcine intramuscular and subcutaneous preadipocytes during differentiation to gain insight into specific molecular and cellular events associated with intramuscular stromal vascular cell (MSVC) differentiation. RNA-Seq was used to screen for differentially expressed genes (DEGs) during the in vitro differentiation of MSVC and subcutaneous stromal vascular cell (ASVC) on days 0, 2 and 4. A total of 985 DEGs were identified during ASVC differentiation and 1469 DEGs during MSVC differentiation. Among these DEGs, 409 genes were specifically expressed during ASVC differentiation, 893 genes were specifically expressed during MSVC differentiation, and 576 DEGs were co-expressed during ASVC and MSVC differentiation. The expression profiles of DEGs during ASVC or MSVC differentiation were determined by cluster analysis based on Short Time-series Expression Miner (STEM). Four significant STEM profiles (profiles 1, 4, 5, and 14) were determined during ASVC differentiation, and four significant STEM profiles (profiles 1, 4, 11, and 14) were determined during MSVC differentiation. Gene ontology (GO) analysis indicated that DEGs related to adipocyte differentiation were identified to be significantly enriched in both adipose and muscle profile 14. In addition, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of DEGs in adipose profile 14 and muscle profiles 11 and 14 (STEM clustered them into one cluster) showed that the PPAR signaling pathway was significantly enriched in these profiles and four signaling pathways were specifically enriched in muscle profiles 11 and 14. Furthermore, analysis of transcription factor binding sites (TFBS) in the gene set revealed two over-represented transcription factors (NR3C4 and NR3C1), which were specifically significantly enriched in the promoter regions of genes within muscle gene expression profiles 11 and 14.	[Jiang, Shuzhong; Wei, Hongkui; Song, Tongxing; Yang, Yang; Peng, Jian] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan, Peoples R China; [Jiang, Siwen] Huazhong Agr Univ, Key Lab Swine Genet & Breeding Agr Ministy, Wuhan, Peoples R China; [Jiang, Siwen] Huazhong Agr Univ, Minist Educ, Coll Anim Sci & Technol, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Peng, J (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan, Peoples R China.	pengjian@mail.hzau.edu.cn; jiangsiwen@mail.hzau.edu.cn	Wei, Hong-kui/E-8971-2015	Wei, Hongkui/0000-0001-7386-9936	National Natural Science Foundation of China [31272457]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20100146110029]; Fundamental Research Funds for the Central Universities [2011PY019, 2012MBDX010, 2013PY047]; Hubei Provincial Creative Team Project of Agricultural Science and Technology [2007-620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Provincial Creative Team Project of Agricultural Science and Technology	This work was supported by the National Natural Science Foundation of China (No. 31272457) http://www.nsfc.gov.cn/Portal0/default152.htm, Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20100146110029) http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm, Fundamental Research Funds for the Central Universities (No. 2011PY019) http://www.moe.edu.cn/, Hubei Provincial Creative Team Project of Agricultural Science and Technology (No. 2007-620) http://www.hbstd.gov.cn/, Fundamental Research Funds for the Central Universities (No. 2012MBDX010) and Fundamental Research Funds for the Central Universities (No. 2013PY047) http://www.moe.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Burton GR, 2002, GENE, V293, P21, DOI 10.1016/S0378-1119(02)00726-6; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Cui HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-213; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fujimori K, 2011, GENE, V473, P150, DOI 10.1016/j.gene.2010.12.002; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; GERBENS F, 2004, MUSCLE DEV LIVESTOCK; Ghandhi SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045410; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hausman GJ, 2005, J ANIM SCI, V83, P1010; Hausman GJ, 2004, J ANIM SCI, V82, P429; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE571, DOI 10.1152/ajpendo.00231.2010; LEE YB, 1974, J ANIM SCI, V38, P532, DOI 10.2527/jas1974.383532x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Plaisier CL, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.21; Rajesh RV, 2010, COMP BIOCHEM PHYS D, V5, P234, DOI 10.1016/j.cbd.2010.06.004; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rosen ED, 2000, GENE DEV, V14, P1293; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Samulin J, 2008, CELL BIOL INT, V32, P525, DOI 10.1016/j.cellbi.2008.01.001; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tserel L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-642; Verbeke W, 1999, MEAT SCI, V53, P77, DOI 10.1016/S0309-1740(99)00036-4; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031; Zhou X, 2007, J LIPID RES, V48, P1701, DOI 10.1194/jlr.M600525-JLR200	47	36	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77094	10.1371/journal.pone.0077094	http://dx.doi.org/10.1371/journal.pone.0077094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130839	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200056
J	Kalleda, N; Naorem, A; Manchikatla, RV				Kalleda, Natarajaswamy; Naorem, Aruna; Manchikatla, Rajam V.			Targeting Fungal Genes by Diced siRNAs: A Rapid Tool to Decipher Gene Function in Aspergillus nidulans	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; DOUBLE-STRANDED-RNA; INSERTIONAL MUTAGENESIS; MAMMALIAN-CELLS; CANCER-THERAPY; EFFICIENT TOOL; INTERFERENCE; EXPRESSION; FUMIGATUS; MECHANISMS	Background: Gene silencing triggered by chemically synthesized small interfering RNAs (siRNAs) has become a powerful tool for deciphering gene function in many eukaryotes. However, prediction and validation of a single siRNA duplex specific to a target gene is often ineffective. RNA interference (RNAi) with synthetic siRNA suffers from lower silencing efficacy, off-target effects and is cost-intensive, especially for functional genomic studies. With the explosion of fungal genomic information, there is an increasing need to analyze gene function in a rapid manner. Therefore, studies were performed in order to investigate the efficacy of gene silencing induced by RNase III-diced-siRNAs (d-siRNA) in model filamentous fungus, Aspergillus nidulans. Methodology/Principal Findings: Stable expression of heterologous reporter gene in A. nidulans eases the examination of a new RNAi-induction route. Hence, we have optimized Agrobacterium tumefaciens-mediated transformation (AMT) of A. nidulans for stable expression of sGFP gene. This study demonstrates that the reporter GFP gene stably introduced into A. nidulans can be effectively silenced by treatment of GFP-d-siRNAs. We have shown the down-regulation of two endogenous genes, AnrasA and AnrasB of A. nidulans by d-siRNAs. We have also elucidated the function of an uncharacterized Ras homolog, rasB gene, which was found to be involved in hyphal growth and development. Further, silencing potency of d-siRNA was higher as compared to synthetic siRNA duplex, targeting AnrasA. Silencing was shown to be sequence-specific, since expression profiles of other closely related Ras family genes in d-siRNA treated AnrasA and AnrasB silenced lines exhibited no change in gene expression. Conclusions/Significance: We have developed and applied a fast, specific and efficient gene silencing approach for elucidating gene function in A. nidulans using d-siRNAs. We have also optimized an efficient AMT in A. nidulans, which is useful for stable integration of transgenes.	[Kalleda, Natarajaswamy; Naorem, Aruna; Manchikatla, Rajam V.] Univ Delhi South Campus, Dept Genet, New Delhi, India	University of Delhi	Manchikatla, RV (corresponding author), Univ Delhi South Campus, Dept Genet, New Delhi, India.	rajam.mv@gmail.com		Tripp, Ralph/0000-0002-2924-9956	Department of Science and Technology (DST), New Delhi, India [SR/SO/BB-29/2008]; Indian Council of Medical Research, New Delhi	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was funded by the Department of Science and Technology (DST) (Grant No: SR/SO/BB-29/2008), New Delhi, India. NK is grateful to the Indian Council of Medical Research, New Delhi for the award of a senior research fellowship. The authors are also indebted to the Department of Science and Technology for the FIST program and the University Grants Commission for the special assistance program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRATT RW, 1965, GENETICS, V52, P233; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; dos Santos ACC, 2009, FUNGAL GENET BIOL, V46, P825, DOI 10.1016/j.fgb.2009.06.012; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Costa AMSB, 2008, J MICROBIOL METH, V75, P205, DOI 10.1016/j.mimet.2008.06.006; de Jong JF, 2006, APPL ENVIRON MICROB, V72, P1267, DOI 10.1128/AEM.72.2.1267-1269.2006; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fitzgerald A, 2004, FUNGAL GENET BIOL, V41, P963, DOI 10.1016/j.fgb.2004.06.006; Fortwendel JR, 2005, EUKARYOT CELL, V4, P1982, DOI 10.1128/EC.4.12.1982-1989.2005; Fortwendel JR, 2004, FUNGAL GENET BIOL, V41, P129, DOI 10.1016/j.fgb.2003.10.004; Gomase VS, 2008, CURR DRUG METAB, V9, P241, DOI 10.2174/138920008783884777; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond TM, 2008, EUKARYOT CELL, V7, P339, DOI 10.1128/EC.00355-07; Hammond TM, 2005, GENETICS, V169, P607, DOI 10.1534/genetics.104.035964; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Henriet SSV, 2012, J INFECT DIS, V206, P1128, DOI 10.1093/infdis/jis473; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jochl C, 2009, RNA BIOL, V6, P179; Kadotani N, 2003, MOL PLANT MICROBE IN, V16, P769, DOI 10.1094/MPMI.2003.16.9.769; Khatri M, 2007, MED MYCOL, V45, P211, DOI 10.1080/13693780601158779; Kim VN, 2003, J KOREAN MED SCI, V18, P309, DOI 10.3346/jkms.2003.18.3.309; Koller E, 2006, NUCLEIC ACIDS RES, V34, P4467, DOI 10.1093/nar/gkl589; Krappmann S, 2006, TRENDS MICROBIOL, V14, P356, DOI 10.1016/j.tim.2006.06.005; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Michielse CB, 2008, NAT PROTOC, V3, P1671, DOI 10.1038/nprot.2008.154; Morlighem JE, 2007, BIOTECHNIQUES, V42, P599, DOI 10.2144/000112444; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Osherov N, 2000, GENETICS, V155, P647; Osmani SA, 2004, FUNGAL GENET BIOL, V41, P401, DOI 10.1016/j.fgb.2003.11.009; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Phalon C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001584; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; Sambrook J., 2002, MOL CLONING LAB MANU; Schumann U., 2010, FRONT BIOL, V5, P478, DOI DOI 10.1007/S11515-010-0550-3; Semizarov D, 2004, NUCLEIC ACIDS RES, V32, P3836, DOI 10.1093/nar/gkh714; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; SOM T, 1994, MOL CELL BIOL, V14, P5333, DOI 10.1128/MCB.14.8.5333; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	55	31	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75443	10.1371/journal.pone.0075443	http://dx.doi.org/10.1371/journal.pone.0075443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130711	gold, Green Published			2022-12-27	WOS:000325814200012
J	Khattar, SK; Nayak, B; Kim, SH; Xiao, S; Samal, S; Paldurai, A; Buchholz, UJ; Collins, PL; Samal, SK				Khattar, Sunil K.; Nayak, Baibaswata; Kim, Shin-Hee; Xiao, Sa; Samal, Sweety; Paldurai, Anandan; Buchholz, Ursula J.; Collins, Peter L.; Samal, Siba K.			Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; COMPLETE GENOME SEQUENCE; PROTEIN CLEAVAGE SITE; RESPIRATORY-TRACT; FUSION PROTEIN; NEUTRALIZING ANTIBODIES; NEURAMINIDASE PROTEIN; VECTORED VACCINE; IMMUNIZATION; HEMAGGLUTININ	Avian paramyxoviruses (APMV) serotypes 1-9 are frequently isolated from domestic and wild birds worldwide. APMV-1 (also called Newcastle disease virus, NDV) is attenuated in non-human primates and is being developed as a candidate human vaccine vector. The vector potential of the other serotypes was unknown. In the present study, we evaluated nine different biologically-or recombinantly-derived APMV strains for the ability to replicate and cause disease in rhesus macaque model. Five of the viruses were: biologically-derived wild type (wt) APMV-2, -3, -5, -7 and -9. Another virus was a recombinant (r) version of wt APMV-4. The remaining three viruses were versions of wt rAPMV-2, -4 and -7 in which the F cleavage site had been modified to be multi-basic. Rhesus macaques were inoculated intranasally and intratracheally and monitored for clinical disease, virus shedding from the upper and lower respiratory tract, and seroconversion. Virus shedding was not detected for wt APMV-5. Very limited shedding was detected for wt rAPMV-4 and modified rAPMV-4, and only in a subset of animals. Shedding by the other viruses was detected in every infected animal, and usually from both the upper and lower respiratory tract. In particular, shedding over a number of days in every animal was observed for modified rAPMV-2, wt APMV-7, and modified rAPMV-7. Modification of the F protein cleavage site appeared to increase shedding by wt rAPMV-2 and marginally by wt rAPMV-4. All APMVs except wt APMV-5 induced a virus-specific serum antibody response in all infected animals. None of the animals exhibited any clinical disease signs. These results indicate that APMVs 2, 3, 4, 7, and 9 are competent to infect non-human primates, but are moderately-to-highly restricted, depending on the serotype. This suggests that they are not likely to significantly infect primates in nature, and represent promising attenuated candidates for vector development.	[Khattar, Sunil K.; Nayak, Baibaswata; Kim, Shin-Hee; Xiao, Sa; Samal, Sweety; Paldurai, Anandan; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Buchholz, Ursula J.; Collins, Peter L.] NIAID, Infect Dis Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu	SAMAL, SWEETY/GQS-6704-2022; Nayak, Baibaswata/L-6156-2016		National Institute of Allergy and Infectious Diseases (NIAID) [N01A060009]; NIAID, National Institutes of Health (NIH) Intramural Research Program; Intramural Research Program of the NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, National Institutes of Health (NIH) Intramural Research Program; Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institute of Allergy and Infectious Diseases (NIAID) contract number N01A060009 (85% support) and NIAID, National Institutes of Health (NIH) Intramural Research Program (15% support). PLC and UJB were supported by the Intramural Research Program of the NIAID, NIH. The views expressed herein do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1983, AVIAN PATHOL, V12, P469, DOI 10.1080/03079458308436192; Alexander DJ, 2003, AVIAN PARAMYXOVIRUSE; BANKOWSKI RA, 1981, AVIAN DIS, V25, P517, DOI 10.2307/1589944; Briand FX, 2013, GENOME ANNOUNC, P1; Bukreyev A, 2005, J VIROL, V79, P13275, DOI 10.1128/JVI.79.21.13275-13284.2005; Bukreyev A, 2004, LANCET, V363, P2122, DOI 10.1016/S0140-6736(04)16501-X; Bukreyev A, 2008, CURR OPIN MOL THER, V10, P46; Capua I, 2004, VET REC, V155, P156; Carnero E, 2009, J VIROL, V83, P584, DOI 10.1128/JVI.01443-08; Chang PC, 2001, J GEN VIROL, V82, P2157, DOI 10.1099/0022-1317-82-9-2157; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; DiNapoli JM, 2007, P NATL ACAD SCI USA, V104, P9788, DOI 10.1073/pnas.0703584104; DiNapoli JM, 2010, VACCINE, V29, P17, DOI 10.1016/j.vaccine.2010.10.024; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; DiNapoli JM, 2009, VACCINE, V27, P1530, DOI 10.1016/j.vaccine.2009.01.009; Huang ZH, 2004, J VIROL, V78, P10054, DOI 10.1128/JVI.78.18.10054-10063.2004; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; Khattar SK, 2011, J VIROL, V85, P10529, DOI 10.1128/JVI.05050-11; Khattar SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016776; Khattar SK, 2010, VACCINE, V28, P3159, DOI 10.1016/j.vaccine.2010.02.051; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050598; Kumar S, 2008, VIRUS RES, V137, P189, DOI 10.1016/j.virusres.2008.07.012; Kumar S, 2011, J VIROL, V85, P6521, DOI 10.1128/JVI.00367-11; KUSAGAWA S, 1993, VIROLOGY, V194, P828, DOI 10.1006/viro.1993.1325; Lamb R, 2007, PARAMYXOVIRIDAE VIRU, V5th; LIPKIND M, 1986, J GEN VIROL, V67, P427, DOI 10.1099/0022-1317-67-3-427; LIPKIND MA, 1979, VET REC, V105, P577; Martinez-Sobrido L, 2006, J VIROL, V80, P1130, DOI 10.1128/JVI.80.3.1130-1139.2006; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; MOTTET G, 1986, J VIROL, V59, P132, DOI 10.1128/JVI.59.1.132-141.1986; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; Nayak B, 2010, J VIROL, V84, P2408, DOI 10.1128/JVI.02135-09; Nayak B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006509; Nayak B, 2008, VIROL J, V5, DOI [10.1186/1743-422X-5-124, 10.1186/1743-422x-5-124]; NEROME K, 1978, J GEN VIROL, V38, P293, DOI 10.1099/0022-1317-38-2-293; Paldurai A, 2009, VIRUS RES, V142, P144, DOI 10.1016/j.virusres.2009.02.003; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rima B AD, 1995, FAMILY PARAMYXOVIRID; Saif YM, 1997, AVIAN DIS, V41, P326, DOI 10.2307/1592185; Samuel AS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-38; Samuel AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009269; Samuel AS, 2009, VIRUS RES, V142, P10, DOI 10.1016/j.virusres.2008.12.016; Subbiah M, 2008, VIRUS RES, V137, P40, DOI 10.1016/j.virusres.2008.05.012; Subbiah M, 2011, J VIROL, V85, P5394, DOI 10.1128/JVI.02696-10; TUMOVA B, 1979, RES VET SCI, V27, P135, DOI 10.1016/S0034-5288(18)32817-0; Xiao S, 2012, J VIROL, V86, P3828, DOI 10.1128/JVI.06765-11; Xiao S, 2011, VACCINE, V29, P5294, DOI 10.1016/j.vaccine.2011.05.010; Xiao S, 2010, VIRUS RES, V150, P61, DOI 10.1016/j.virusres.2010.02.015; Xiao S, 2009, VIRUS RES, V145, P80, DOI 10.1016/j.virusres.2009.06.003; YAMANE N, 1982, MICROBIOL IMMUNOL, V26, P557, DOI 10.1111/mim.1982.26.7.557	52	23	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75456	10.1371/journal.pone.0075456	http://dx.doi.org/10.1371/journal.pone.0075456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130713	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200013
J	Martinez-Bakker, ME; Sell, SK; Swanson, BJ; Kelly, BP; Tallmon, DA				Martinez-Bakker, Micaela E.; Sell, Stephanie K.; Swanson, Bradley J.; Kelly, Brendan P.; Tallmon, David A.			Combined Genetic and Telemetry Data Reveal High Rates of Gene Flow, Migration, and Long-Distance Dispersal Potential in Arctic Ringed Seals (Pusa hispida)	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; PHOCA-HISPIDA; MICROSATELLITE VARIATION; HALICHOERUS-GRYPUS; POPULATION SIZES; CLIMATE-CHANGE; LAKE SAIMAA; GREY SEALS; DIVERSITY; ALGORITHM	Ringed seals (Pusa hispida) are broadly distributed in seasonally ice covered seas, and their survival and reproductive success is intricately linked to sea ice and snow. Climatic warming is diminishing Arctic snow and sea ice and threatens to endanger ringed seals in the foreseeable future. We investigated the population structure and connectedness within and among three subspecies: Arctic (P. hispida hispida), Baltic (P. hispida botnica), and Lake Saimaa (P. hispida saimensis) ringed seals to assess their capacity to respond to rapid environmental changes. We consider (a) the geographical scale of migration, (b) use of sea ice, and (c) the amount of gene flow between subspecies. Seasonal movements and use of sea ice were determined for 27 seals tracked via satellite telemetry. Additionally, population genetic analyses were conducted using 354 seals representative of each subspecies and 11 breeding sites. Genetic analyses included sequences from two mitochondrial regions and genotypes of 9 microsatellite loci. We found that ringed seals disperse on a pan-Arctic scale and both males and females may migrate long distances during the summer months when sea ice extent is minimal. Gene flow among Arctic breeding sites and between the Arctic and the Baltic Sea subspecies was high; these two subspecies are interconnected as are breeding sites within the Arctic subspecies.	[Martinez-Bakker, Micaela E.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Martinez-Bakker, Micaela E.; Tallmon, David A.] Univ Alaska Southeast, Biol & Marine Biol Program, Juneau, AK USA; [Sell, Stephanie K.; Swanson, Bradley J.] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA; [Kelly, Brendan P.] Natl Sci Fdn, Arctic Sci Sect, Arlington, VA 22230 USA	University of Michigan System; University of Michigan; University of Alaska System; University of Alaska Southeastern; Central Michigan University; National Science Foundation (NSF)	Martinez-Bakker, ME (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	bakkerma@umich.edu	Martinez-Bakker, Micaela/J-3721-2013	Martinez-Bakker, Micaela/0000-0002-9248-9450; Swanson, Bradley/0000-0002-0360-3590	North Pacific Research Board [0515, 0631]; Cooperative Institute for Arctic Research [CIPY-23]; National Oceanic and Atmospheric Administration [NA17RJ1224]; University of Alaska; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0852111] Funding Source: National Science Foundation	North Pacific Research Board; Cooperative Institute for Arctic Research; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Alaska; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	North Pacific Research Board, Grant No. 0515, funded from May 1, 2005 - Dec 31, 2007, budget: $203,644.00, Project Title: Ice Seal movements. Website: < http://project.nprb.org/view.jsp?id = 5478c509-e849-4ccf-924b-2f8626758ab2 >. North Pacific Research Board, Grant No. 0631, funded from Sept 1, 2006 - Apr 30, 2009, budget: $223,658.00, Project Title: Population structure of ringed seals. Website: < http://project.nprb.org/view.jsp?id = de34ea6c-f2dc-4283-ae07-8a4334fb45ca >. This publication is the result in part of research sponsored by the Cooperative Institute for Arctic Research (Project CIPY-23) with funds from the National Oceanic and Atmospheric Administration under cooperative agreement NA17RJ1224 with the University of Alaska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2006, MAR ECOL PROG SER, V309, P117, DOI 10.3354/meps309117; Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; Amano M, 2002, J MAMMAL, V83, P370, DOI 10.1644/1545-1542(2002)083<0370:GVITSO>2.0.CO;2; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli Peter, 2009, V17, P42; Berta A, 2012, MAMMAL REV, V42, P207, DOI 10.1111/j.1365-2907.2011.00193.x; Crawford JA, 2012, POLAR BIOL, V35, P241, DOI 10.1007/s00300-011-1067-1; Davis CS, 2008, MOL ECOL, V17, P3078, DOI 10.1111/j.1365-294X.2008.03819.x; Davis CS, 2002, MOL ECOL NOTES, V2, P203, DOI 10.1046/j.1471-8286.2002.00187.x; *DEP COMM, 1992, FED REGISTER, V57, P60162; *DEP COMM, 2012, FED REGISTER, V77, P76706; DRUMMOND A, 2011, GENEIOUS V4 7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson SH, 2005, MAR MAMMAL SCI, V21, P121, DOI 10.1111/j.1748-7692.2005.tb01212.x; FETTERER F, 2009, SEA ICE INDEX; Freeland J., 2005, MOL ECOLOGY; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Furgal CM, 2002, POLAR RES, V21, P1, DOI 10.1111/j.1751-8369.2002.tb00063.x; GJERTZ I, 1986, Polar Research, V4, P53, DOI 10.1111/j.1751-8369.1986.tb00518.x; Gjertz I, 2000, POLAR BIOL, V23, P651, DOI 10.1007/s003000000143; Goodman SJ, 1997, ANIM GENET, V28, P310; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harding KC, 1999, AMBIO, V28, P619; Harkonen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002006; Harwood LA, 2012, ARCTIC, V65, P35; Hezel PJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052794; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Kelly BP, 2001, FINGERPRINTS OF CLIMATE CHANGE, P43; KELLY BP, 1990, CAN J ZOOL, V68, P2503, DOI 10.1139/z90-350; Kelly BP, 2010, STATUS REV RINGED SE; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; Kokko H, 1999, ANN ZOOL FENN, V36, P65; LOWRY LF, 1980, CAN J FISH AQUAT SCI, V37, P2254, DOI 10.1139/f80-270; MCLAREN IA, 1958, FISHERIES RES BOARD, V118; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Monnett C, 2006, POLAR BIOL, V29, P681, DOI 10.1007/s00300-005-0105-2; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Palo JU, 2003, CONSERV GENET, V4, P117, DOI 10.1023/A:1023303109701; Palo JU, 2001, HEREDITY, V86, P609, DOI 10.1046/j.1365-2540.2001.00859.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rozen S, 2000, Methods Mol Biol, V132, P365; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMITH TG, 1976, CAN J ZOOL, V54, P1610, DOI 10.1139/z76-188; SMITH TG, 1991, ARCTIC, V44, P124; SMITH TG, 1981, CAN J ZOOL, V59, P966, DOI 10.1139/z81-135; SMITH TG, 1975, CAN J ZOOL, V53, P1297, DOI 10.1139/z75-155; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; Swanson BJ, 2006, MOL ECOL NOTES, V6, P1006, DOI 10.1111/j.1471-8286.2006.01473.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *US FISH WILDL SER, 2008, END THREAT WILDL PLA; Valtonen M, 2012, CONSERV GENET, V13, P1231, DOI 10.1007/s10592-012-0367-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, GENETIC DATA ANAL; WRIGHT S., 1938, Science (Washington), V87, P430; 1993, FED REG, V58, P40538	59	24	24	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77125	10.1371/journal.pone.0077125	http://dx.doi.org/10.1371/journal.pone.0077125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130843	gold, Green Published			2022-12-27	WOS:000325814200060
J	da Gama, PAMD; Slama, H; Caspar, EA; Gevers, W; Cleeremans, A				da Gama, Pedro A. Magalhaes De Saldanha; Slama, Hichem; Caspar, Emilie A.; Gevers, Wim; Cleeremans, Axel			Placebo-Suggestion Modulates Conflict Resolution in the Stroop Task	PLOS ONE			English	Article							HYPNOTIC SUGGESTION; IMAGINATIVE SUGGESTIBILITY; HYPNOSIS; VARIABILITY; EXPECTANCY; MEMORY; INTERFERENCE; EXPECTATIONS; EXPERIENCE; ANALGESIA	Here, we ask whether placebo-suggestion (without any form of hypnotic induction) can modulate the resolution of cognitive conflict. Nave participants performed a Stroop Task while wearing an EEG cap described as a "brain wave" machine. In Experiment 1, participants were made to believe that the EEG cap would either enhance or decrease their color perception and performance on the Stroop task. In Experiment 2, participants were explicitly asked to imagine that their color perception and performance would be enhanced or decreased (non-hypnotic imaginative suggestion). We observed effects of placebo-suggestion on Stroop interference on accuracy: interference was decreased with positive suggestion and increased with negative suggestion compared to baseline. Intra-individual variability was also increased under negative suggestion compared to baseline. Compliance with the instruction to imagine a modulation of performance, on the other hand, did not influence accuracy and only had a negative impact on response latencies and on intra-individual variability, especially in the congruent condition of the Stroop Task. Taken together, these results demonstrate that expectations induced by a placebo-suggestion can modulate our ability to resolve cognitive conflict, either facilitating or impairing response accuracy depending on the suggestion's contents. Our results also demonstrate a dissociation between placebo-suggestion and non-hypnotic imaginative suggestion.	[da Gama, Pedro A. Magalhaes De Saldanha; Caspar, Emilie A.; Cleeremans, Axel] Univ Libre Bruxelles, Consciousness Cognit & Computat Grp CO3, Brussels, Belgium; [Slama, Hichem; Gevers, Wim] Univ Libre Bruxelles, UNESCOG Res Unit Cognit Neurosci, Brussels, Belgium; [Slama, Hichem] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Unit UR2NF, Brussels, Belgium; [Slama, Hichem] Univ Libre Bruxelles, Erasme Hosp, Dept Clin & Cognit Neuropsychol, Brussels, Belgium; [da Gama, Pedro A. Magalhaes De Saldanha; Slama, Hichem; Caspar, Emilie A.; Gevers, Wim; Cleeremans, Axel] Univ Libre Bruxelles, CRCN, Brussels, Belgium; [da Gama, Pedro A. Magalhaes De Saldanha; Slama, Hichem; Caspar, Emilie A.; Gevers, Wim; Cleeremans, Axel] Univ Libre Bruxelles, UNI, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	da Gama, PAMD (corresponding author), Univ Libre Bruxelles, Consciousness Cognit & Computat Grp CO3, Brussels, Belgium.	pmagalha@ulb.ac.be	da Gama, Pedro Magalhaes De Saldanha/AAP-8856-2021; Slama, Hichem/HGA-3213-2022; Caspar, Emilie/AAC-6322-2022	da Gama, Pedro Magalhaes De Saldanha/0000-0002-8546-4482; Slama, Hichem/0000-0003-3856-4488; Caspar, Emilie/0000-0003-1415-2032	Fundacao para a Ciencia e a Tecnologia (FCT) (Science and Technology Foundation) [SFRH / BD / 44723 / 2008]	Fundacao para a Ciencia e a Tecnologia (FCT) (Science and Technology Foundation)	This work was funded by the Fundacao para a Ciencia e a Tecnologia (FCT) (Science and Technology Foundation), Grant #SFRH / BD / 44723 / 2008. http://www.fct.pt/. A. C. is a Research Director for the National Fund for Scientific Research (FRS - FNRS Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER CN, 1977, PERS SOC PSYCHOL B, V3, P455; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Assefi SL, 2003, PSYCHOL SCI, V14, P77, DOI 10.1111/1467-9280.01422; Augustinova M, 2012, PSYCHON B REV, V19, P521, DOI 10.3758/s13423-012-0217-y; Baker S.L., 1993, CONT HYPNOSIS, V10, P117; Benedetti F, 2007, NEUROSCIENCE, V147, P260, DOI 10.1016/j.neuroscience.2007.02.020; Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3; Benedetti F, 2002, EVAL HEALTH PROF, V25, P369, DOI 10.1177/0163278702238051; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Benham G, 1998, J PERS SOC PSYCHOL, V75, P1604, DOI 10.1037/0022-3514.75.6.1604; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Braffman W, 1999, J PERS SOC PSYCHOL, V77, P578, DOI 10.1037/0022-3514.77.3.578; Braffman W., 2001, CONT HYPNOSIS, V18, P107, DOI DOI 10.1002/CH.224; Colagiuri B, 2011, PSYCHON B REV, V18, P399, DOI 10.3758/s13423-010-0041-1; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2011, CURR OPIN PSYCHIATR, V24, P149, DOI 10.1097/YCO.0b013e328343803b; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Di Blasi Z, 2003, EVAL HEALTH PROF, V26, P166, DOI 10.1177/0163278703026002003; Dienes Z., 2008, UNDERSTANDING PSYCHO; DIENES Z, 2006, HYPNOSIS CONSCIOUS S, P293; Dienes Z, 2013, CORTEX, V49, P386, DOI 10.1016/j.cortex.2012.07.009; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Eitam B, 2008, PSYCHOL SCI, V19, P261, DOI 10.1111/j.1467-9280.2008.02078.x; Elsenbruch S, 2012, Neurogastroenterol Motil, V24, P914, DOI 10.1111/j.1365-2982.2012.01950.x; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fields HL, 1997, PLACEBO EFFECT INTER, P93; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Flehmig H. C., 2007, PSYCHOL SCI, V49, P132; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Iani C, 2006, PSYCHOL SCI, V17, P721, DOI 10.1111/j.1467-9280.2006.01772.x; Iani C, 2009, CONSCIOUS COGN, V18, P856, DOI 10.1016/j.concog.2009.07.002; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Jones R.A., 1977, SELF FULFILLING PROP; Kirsch I, 1997, INT J CLIN EXP HYP, V45, P212, DOI 10.1080/00207149708416124; Kirsch I, 1997, APPL PREV PSYCHOL, V6, P69, DOI 10.1016/S0962-1849(05)80012-5; Kirsch I, 1999, AM PSYCHOL, V54, P504, DOI 10.1037/0003-066X.54.7.504; Kirsch I, 1999, INT J CLIN EXP HYP, V47, P40, DOI 10.1080/00207149908410021; Kirsch I, 2001, CURR DIR PSYCHOL SCI, V10, P57, DOI 10.1111/1467-8721.00115; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; Kirsch I., 1999, ANALES PSICOLOGIA, V15, P99; Kirsch I., 2011, CONT HYPNOSIS, V28, P107; Lifshitz M, 2013, CORTEX, V49, P463, DOI 10.1016/j.cortex.2012.08.007; MacDonald SWS, 2008, J COGNITIVE NEUROSCI, V20, P779, DOI 10.1162/jocn.2008.20502; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McClung M, 2007, J SPORT EXERCISE PSY, V29, P382, DOI 10.1123/jsep.29.3.382; Michael RB, 2012, CURR DIR PSYCHOL SCI, V21, P151, DOI 10.1177/0963721412446369; Miller FG, 2008, J ROY SOC MED, V101, P222, DOI 10.1258/jrsm.2008.070466; Milling LS, 2005, ANN BEHAV MED, V29, P116, DOI 10.1207/s15324796abm2902_6; MORSE CK, 1993, PSYCHOL AGING, V8, P156, DOI 10.1037/0882-7974.8.2.156; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; ORNE MT, 1969, RRR ROSNOW ARTIFACT, P143; Parker S, 2011, MEMORY, V19, P606, DOI 10.1080/09658211.2011.592500; PARRIS BA, HYPNOTIC SU IN PRESS; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Raz A, 2006, PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-9280.2006.01669.x; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; Raz A, 2003, CONSCIOUS COGN, V12, P332, DOI 10.1016/S1053-8100(03)00024-2; Raz A, 2002, ARCH GEN PSYCHIAT, V59, P1155, DOI 10.1001/archpsyc.59.12.1155; Raz A, 2002, ARCH GEN PSYCHIAT, V59, P85, DOI 10.1001/archpsyc.59.1.85; Raz A, 2007, AM J CLIN HYPN, V50, P29, DOI 10.1080/00029157.2007.10401595; Raz A, 2007, CONSCIOUS COGN, V16, P331, DOI 10.1016/j.concog.2006.04.004; Rosenthal R., 1968, PYGMALION CLASSROOM; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Staats P, 1998, J PAIN SYMPTOM MANAG, V15, P235, DOI 10.1016/S0885-3924(97)00363-1; Sterzer P, 2008, CURR BIOL, V18, pR697, DOI 10.1016/j.cub.2008.06.021; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Van Oorsouw K, 2007, AM J PSYCHOL, V120, P287, DOI 10.2307/20445399; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEST R, 1999, J GERONTOL B-PSYCHOL, V54, P34; WICKLESS C, 1989, J PERS SOC PSYCHOL, V57, P762, DOI 10.1037/0022-3514.57.5.762	78	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75701	10.1371/journal.pone.0075701	http://dx.doi.org/10.1371/journal.pone.0075701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130735	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900053
J	DeDeo, S				DeDeo, Simon			Collective Phenomena and Non-Finite State Computation in a Human Social System	PLOS ONE			English	Article							EVOLUTION; CONFLICT; DYNAMICS; GOSSIP	We investigate the computational structure of a paradigmatic example of distributed social interaction: that of the open-source Wikipedia community. We examine the statistical properties of its cooperative behavior, and perform model selection to determine whether this aspect of the system can be described by a finite-state process, or whether reference to an effectively unbounded resource allows for a more parsimonious description. We find strong evidence, in a majority of the most-edited pages, in favor of a collective-state model, where the probability of a "revert" action declines as the square root of the number of non-revert actions seen since the last revert. We provide evidence that the emergence of this social counter is driven by collective interaction effects, rather than properties of individual users.	[DeDeo, Simon] Santa Fe Inst, Santa Fe, NM 87501 USA; [DeDeo, Simon] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	The Santa Fe Institute; Indiana University System; Indiana University Bloomington	DeDeo, S (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	simon@santafe.edu			Santa Fe Institute Omidyar Postdoctoral Fellowship; National Science Foundation [EF-1137929]; Emergent Institutions Project	Santa Fe Institute Omidyar Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Emergent Institutions Project	The author acknowledges the support of the Santa Fe Institute Omidyar Postdoctoral Fellowship, the National Science Foundation Grant EF-1137929, "The Small Number Limit of Biological Information Processing," and the Emergent Institutions Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor J, 2001, AM J SOCIOL, V106, P1493, DOI 10.1086/321298; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; BOYD R, 1989, J THEOR BIOL, V136, P47, DOI 10.1016/S0022-5193(89)80188-2; Brandes U, 2008, INFORM VISUAL, V7, P34, DOI 10.1057/palgrave.ivs.9500171; Campbell A., 1980, AM VOTER; Chomsky N, 1969, ASPECTS THEORY SYNTA; COSLEY D, 2006, HELPING HANDS DESIGN; COTTRELL A, 1993, QUANTITATIVE FINANCE, V5, P73; CRUTCHFIELD JP, 1994, PHYSICA D, V75, P11, DOI 10.1016/0167-2789(94)90273-9; De Dreu CKW, 2003, J APPL PSYCHOL, V88, P741, DOI 10.1037/0021-9010.88.4.741; De la Higuera Colin, 2010, GRAMMATICAL INFERENC; DeCanio SJ, 1998, J ECON BEHAV ORGAN, V36, P275, DOI 10.1016/S0167-2681(98)00096-1; DeDeo S, 2011, CHAOS, V21, DOI 10.1063/1.3640747; DeDeo S, 2011, J R SOC INTERFACE, V8, P1260, DOI 10.1098/rsif.2010.0687; Dedeo S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000782; Delli Carpini M. X., 1997, WHAT AM KNOW POLITIC; Easther R, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.103533; Flack JC, 2011, CHAOS, V21, DOI 10.1063/1.3643063; GLUCKMAN M, 1963, CURR ANTHROPOL, V4, P307, DOI 10.1086/200378; GLUCKMAN M, 1968, MAN, V3, P20, DOI 10.2307/2799409; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hayek FA, 1945, AM ECON REV, V35, P519; JACKENDOFF RS, 2007, J NICOD LECT; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kittur A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P453; Kittur A, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P215; Lansing J. Stephen, 2007, PRIESTS PROGRAMMERS; Linke AM, 2012, INT INTERACT, V38, P402, DOI 10.1080/03050629.2012.696996; MACKAY DJC, 2003, INFORM THEORY INFERE, pCH28; Moore C., 2011, NATURE COMPUTATION; Mortonson MJ, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.043505; Norena J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.023505; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; POWELL BA, 2012, ARXIV12092024; POWELL BA, 2009, J COSMOLOGY ASTROPAR, V2009; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; REAGLE J, 2010, HIST FDN INFORM SCI; STOOP R, 2012, ARXIV12025913; Suchard MA, 2002, SYST BIOL, V51, P715, DOI 10.1080/10635150290102384; Suh B, 2007, IEEE CONF VIS ANAL, P163; ten Cate C, 2012, PHILOS T R SOC B, V367, P1984, DOI 10.1098/rstb.2012.0055; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Zimmerer VC, 2011, MEM COGNITION, V39, P491, DOI 10.3758/s13421-010-0039-y	44	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75818	10.1371/journal.pone.0075818	http://dx.doi.org/10.1371/journal.pone.0075818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130745	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900059
J	Reza, LW; Satyanarayna, S; Enarson, DA; Kumar, AMV; Sagili, K; Kumar, S; Prabhakar, LA; Devendrappa, NM; Pandey, A; Wilson, N; Chadha, S; Thapa, B; Sachdeva, KS; Kohli, MP				Reza, Lord Wasim; Satyanarayna, Srinath; Enarson, Donald A.; Kumar, Ajay M. V.; Sagili, Karuna; Kumar, Sujeet; Prabhakar, Levi Anand; Devendrappa, N. M.; Pandey, Ashish; Wilson, Nevin; Chadha, Sarabjit; Thapa, Badri; Sachdeva, Kuldeep Singh; Kohli, Mohan P.			LED-Fluorescence Microscopy for Diagnosis of Pulmonary Tuberculosis under Programmatic Conditions in India	PLOS ONE			English	Article							ZIEHL-NEELSEN MICROSCOPY; ACID-FAST BACILLI; SPUTUM	Background: Light-emitting diode fluorescence microscopy (LED-FM) has been shown to be more sensitive than conventional bright field microscopy using Ziehl-Neelsen (ZN) stain in detecting sputum smear positive tuberculosis in controlled laboratory conditions. In 2012, Auramine O staining based LED-FM replaced conventional ZN microscopy in 200 designated microscopy centres (DMC) of medical colleges operating in collaboration with India's Revised National Tuberculosis Control Programme. We aimed to assess the impact of introduction of LED-FM services on sputum smear positive case detection under program conditions. Methods: This was a before and after comparison study. In 15 randomly selected medical college DMCs, all presumptive TB patients who underwent sputum smear examination in the years 2011 (before LED-FM) and 2012 (after LED-FM) were compared. An additional 15 comparable DMCs that implemented conventional ZN sputum smear microscopy were also selected for comparison between 2011 and 2012. Results: The proportion of presumptive TB patients (PTP) found sputum smear positive increased by 30%- from 13.6% (3432/25159) in 2011 to 17.8% (4706/26426) in 2012 (P value < 0.01) in the sites that implemented LED-FM microscopy, whereas in DMCs where the ZN staining procedure is followed the proportion of sputum smear positive had remained unchanged (13.0% versus 12.6%; P value0.31). Conclusion: Use of LED-FM significantly increased the proportion of smear positive cases among presumptive TB patients under routine program conditions in high workload laboratories. The study provides operational evidence needed to scale-up the use of LED-FM in similar settings in India and beyond.	[Reza, Lord Wasim; Satyanarayna, Srinath; Kumar, Ajay M. V.; Sagili, Karuna; Kumar, Sujeet; Prabhakar, Levi Anand; Devendrappa, N. M.; Pandey, Ashish; Wilson, Nevin; Chadha, Sarabjit; Thapa, Badri; Kohli, Mohan P.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France; [Sachdeva, Kuldeep Singh; Kohli, Mohan P.] Minist Hlth & Family Welf, Cent TB Div, Directorate Gen Hlth Serv, New Delhi, India		Reza, LW (corresponding author), Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India.	lwreza@theunion.org		Wilson, Nevin/0000-0002-0191-8855; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Satyanarayana, Srinath/0000-0002-5420-2551	TB REACH Initiative of Stop TB Partnership (through a grant from the Canadian International Development Agency,) [T9-370-114]; American People through the United States Agency for International Development (USAID)	TB REACH Initiative of Stop TB Partnership (through a grant from the Canadian International Development Agency,); American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This project was supported by TB REACH Initiative of Stop TB Partnership (through a grant from the Canadian International Development Agency,) grant no T9-370-114. This study was a part of Operational Research course. Funding for the operational research course was made possible from by the support of the American People through the United States Agency for International Development (USAID). Funders had no role in study design, data collection, analysis or interpretation of data. The donor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The contents of this paper do not necessarily reflect the views of USAID or the United States Government or The Union.	Agarwal S, 2005, TUBERCULOSIS CONTROL, P127; Ba F, 1999, INT J TUBERC LUNG D, V3, P1101; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020175; Central TB Division Directorate of health services Ministry of Health & Family Welfare, 2005, TECHN OP GUID TUB CO; Central TB Division Directorate of health services Ministry of Health & Family Welfare, 2005, MOD LAB TECHN; Central TB Division Directorate of health services Ministry of Health & Family Welfare, 2009, DIAGN SMEAR POS PULM; Central TB Division Directorate of health services Ministry of Health & Family Welfare I, 2012, RNTCP ANN STAT REP 2; Central TB Division Directorate of health services Ministry of Health & Family Welfare I, 2005, MOD SEN TUB LAB SUP; Chaidir L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061727; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001057; Das D, 2012, INT J TUBERC LUNG D, V16, P1558, DOI 10.5588/ijtld.12.0407; Foundation for Innovative New Diagnostics, 2007, FEAS STUD PROT ILED; Gordon C, 2009, INT J TUBERC LUNG D, V13, P130; Kline E. K, 1941, J BACTERIOL, P275; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; RICHARDS OSCAR W., 1941, SCIENCE, V93, P190, DOI 10.1126/science.93.2408.190; RICHARDS OSCAR W., 1941, AMER REV TUBERC, V44, P255; Van Deun A, 2012, INT J TUBERC LUNG D, V16, P1558, DOI 10.5588/ijtld.12.0407-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, FLUOR LIGHT EM DIOD; Xia H, 2013, INT J TUBERC LUNG D, V17, P107, DOI 10.5588/ijtld.12.0184	22	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75566	10.1371/journal.pone.0075566	http://dx.doi.org/10.1371/journal.pone.0075566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130719	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900041
J	Singh, M; Singh, S; Randhawa, H; Singh, J				Singh, Manjit; Singh, Surinder; Randhawa, Harpinder; Singh, Jaswinder			Polymorphic Homoeolog of Key Gene of RdDM Pathway, ARGONAUTE4_9 class Is Associated with Pre-Harvest Sprouting in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							WHITE SPRING WHEAT; EPIGENETIC CHROMATIN MODIFIERS; SEED DORMANCY; DNA METHYLATION; ARABIDOPSIS-THALIANA; ABA SENSITIVITY; EXPRESSION; BARLEY; GERMINATION; MUTANT	Resistance to pre-harvest sprouting (PHS) is an important objective for the genetic improvement of many cereal crops, including wheat. Resistance, or susceptibility, to PHS is mainly influenced by seed dormancy, a complex trait. Reduced seed dormancy is the most important aspect of seed germination on a spike prior to harvesting, but it is influenced by various environmental factors including light, temperature and abiotic stresses. The basic genetic framework of seed dormancy depends on the antagonistic action of abscisic acid (ABA) and gibberellic acid (GA) to promote dormancy and germination. Recent studies have revealed a role for epigenetic changes, predominantly histone modifications, in controlling seed dormancy. To investigate the role of DNA methylation in seed dormancy, we explored the role of ARGONAUTE4_9 class genes in seed development and dormancy in wheat. Our results indicate that the two wheat AGO4_9 class genes i.e. AGO802 and AGO804 map to chromosomes 3S and 1S are preferentially expressed in the embryos of developing seeds. Differential expressions of AGO802-B in the embryos of PHS resistant and susceptible varieties also relates with DNA polymorphism in various wheat varieties due to an insertion of a SINE-like element into this gene. DNA methylation patterns of the embryonic tissue from six PHS resistant and susceptible varieties demonstrate a correlation with this polymorphism. These results suggest a possible role for AGO802-B in seed dormancy and PHS resistance through the modulation of DNA methylation.	[Singh, Manjit; Singh, Surinder; Singh, Jaswinder] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Randhawa, Harpinder] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	McGill University; Agriculture & Agri Food Canada	Singh, J (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	Jaswinder.Singh@mcgill.ca	Singh, Manjit/GWM-3934-2022; Randhawa, Harpinder/AAQ-7207-2021	Singh, Manjit/0000-0002-5451-3659; 	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1993, CROP SCI, V33, P453, DOI 10.2135/cropsci1993.0011183X003300030008x; Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Demetriou K, 2009, PHYSIOL PLANTARUM, V136, P358, DOI 10.1111/j.1399-3054.2009.01236.x; DePauw RM, 2009, EUPHYTICA, V168, P347, DOI 10.1007/s10681-009-9933-4; DePauw RM, 1998, CAN J PLANT SCI, V78, P617, DOI 10.4141/P97-150; DEPAUW RM, 1992, CROP SCI, V32, P838, DOI 10.2135/cropsci1992.0011183X003200030069x; Fang J, 2008, PLANT SIGNAL BEHAV, V3, P1046, DOI 10.4161/psb.3.12.6606; Faris J. D., 2002, Current Genomics, V3, P577, DOI 10.2174/1389202023350219; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; HUGHES GR, 1993, CAN J PLANT SCI, V73, P193, DOI 10.4141/cjps93-032; Humphreys DG, 2007, CAN J PLANT SCI, V87, P301, DOI 10.4141/P06-139; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Kapazoglou A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-73; Knox RE, 1995, CAN J PLANT SCI, V75, P899, DOI 10.4141/cjps95-150; Lamb-Palmer ND, 2013, MOL BIOTECHNOL, V54, P685, DOI 10.1007/s12033-012-9610-z; Lan XiuJin, 2012, African Journal of Agricultural Research, V7, P6191; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Molina-Cano JL, 1999, THEOR APPL GENET, V98, P347, DOI 10.1007/s001220051079; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Ng DWK, 2006, PLANT CELL, V18, P119, DOI 10.1105/tpc.105.037010; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Patel M, 2008, J EXP BOT, V59, P1625, DOI 10.1093/jxb/erm368; Pauw RMD, 1983, CAN J PLANT SCI, V63, P581; Peng JR, 2002, CURR OPIN PLANT BIOL, V5, P376, DOI 10.1016/S1369-5266(02)00279-0; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; Sadasivaiah RS, 2009, CAN J PLANT SCI, V89, P1099, DOI 10.4141/CJPS09010; Sadasivaiah RS, 2004, CROP SCI, V44, P696, DOI [10.2135/cropsci2004.0697, 10.2135/cropsci2004.0696]; Schramm EC, 2013, THEOR APPL GENET, V126, P791, DOI 10.1007/s00122-012-2018-0; Schramm EC, 2012, EUPHYTICA, V188, P35, DOI 10.1007/s10681-012-0669-1; Scutt CP, 2003, PLANT PHYSIOL, V132, P653, DOI 10.1104/pp.102.017798; Singh J, 2001, J CEREAL SCI, V34, P85, DOI 10.1006/jcrs.2001.0380; Singh M, 2012, EUPHYTICA, V188, P123, DOI 10.1007/s10681-012-0624-1; Singh M, 2011, PLANT CELL, V23, P443, DOI 10.1105/tpc.110.079020; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Sunkar R, 2012, ROLE MIRNAS SEED DEV, P109; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Vaillant I, 2007, PLANT CELL PHYSIOL, V48, P745, DOI 10.1093/pcp/pcm043; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zheng J, 2012, NEW PHYTOL, V193, P605, DOI 10.1111/j.1469-8137.2011.03969.x; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	49	20	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77009	10.1371/journal.pone.0077009	http://dx.doi.org/10.1371/journal.pone.0077009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130825	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900116
J	Okada, N; Shimizu, N				Okada, Naoya; Shimizu, Noriaki			Dissection of the Beta-Globin Replication-Initiation Region Reveals Specific Requirements for Replicator Elements during Gene Amplification	PLOS ONE			English	Article							EXTRACHROMOSOMAL DOUBLE MINUTES; DNA-REPLICATION; NUCLEAR-MATRIX; SEQUENCE MODULES; SITES; EXPRESSION; PLASMIDS; BEARING; PROTEIN; ORIGIN	Gene amplification plays a pivotal role in malignant transformation of human cells. A plasmid with both a mammalian replication-initiation region (IR)/origin/replicator and a nuclear matrix-attachment region (MAR) is spontaneously amplified in transfected cells by a mechanism that involves amplification at the extrachromosomal site, followed by amplification at the chromosomal arm, ultimately generating a long homogeneously staining region (HSR). Several observations suggest that replication initiation from IR sequences might mediate amplification. To test this idea, we previously dissected c-myc and DHFR IRs to identify the minimum sequence required to support amplification. In this study, we applied an improved analysis that discriminates between two amplification steps to the beta-globin RepP IR, which contains separate elements already known to be essential for initiation on the chromosome arm. The IR sequence was required at least for the extrachromosomal amplification step. In addition to the vector-encoded MAR, amplification also required an AT-rich region and a MAR-like element, consistent with the results regarding replicator activity on the chromosome. However, amplification did not require the AG-rich tract necessary for replicator activity, but instead required a novel sequence containing another AG-rich tract. The differential sequence requirement might be a consequence of extrachromosomal replication.	[Okada, Naoya; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Hiroshima University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23380203, 24658290]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (grant number 23380203) and a Grant-in-Aid for Challenging Exploratory Research (grant number 24658290), both from Japan Society for the Promotion of Science to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Altman AL, 2004, MOL CELL BIOL, V24, P4138, DOI 10.1128/MCB.24.10.4138-4150.2004; Altman AL, 2001, MOL CELL BIOL, V21, P1098, DOI 10.1128/MCB.21.4.1098-1110.2001; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; BOULIKAS T, 1993, J CELL BIOCHEM, V52, P23, DOI 10.1002/jcb.240520105; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; Demczuk A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001360; Djeliova V, 2001, NUCLEIC ACIDS RES, V29, P3181, DOI 10.1093/nar/29.15.3181; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Huang L, 2011, MOL CELL BIOL, V31, P3472, DOI 10.1128/MCB.05587-11; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Paixao S, 2004, MOL CELL BIOL, V24, P2958, DOI 10.1128/MCB.24.7.2958-2967.2004; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Soultanas P, 2011, TRANSCR-AUSTIN, V2, P140, DOI 10.4161/trns.2.3.15908; TSUTSUI K, 1993, J BIOL CHEM, V268, P12886; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; Wang LX, 2006, HUM MOL GENET, V15, P2613, DOI 10.1093/hmg/ddl187; Wang LX, 2004, MOL CELL BIOL, V24, P3373, DOI 10.1128/MCB.24.8.3373-3386.2004; Wilson RHC, 2013, GENES CELLS, V18, P17, DOI 10.1111/gtc.12010; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009	32	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77350	10.1371/journal.pone.0077350	http://dx.doi.org/10.1371/journal.pone.0077350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124615	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100172
J	Giese, M; Unternaehrer, E; Brand, S; Calabrese, P; Holsboer-Trachsler, E; Eckert, A				Giese, Maria; Unternaehrer, Eva; Brand, Serge; Calabrese, Pasquale; Holsboer-Trachsler, Edith; Eckert, Anne			The Interplay of Stress and Sleep Impacts BDNF Level	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; GENE-EXPRESSION; MESSENGER-RNA; RAT-BRAIN; SERUM; DEPRESSION; RECEPTORS; HIPPOCAMPUS; GLUCOCORTICOIDS; DISORDERS	Background: Sleep plays a pivotal role in normal biological functions. Sleep loss results in higher stress vulnerability and is often found in mental disorders. There is evidence that brain-derived neurotrophic factor (BDNF) could be a central player in this relationship. Recently, we could demonstrate that subjects suffering from current symptoms of insomnia exhibited significantly decreased serum BDNF levels compared with sleep-healthy controls. In accordance with the paradigm indicating a link between sleep and BDNF, we aimed to investigate if the stress system influences the association between sleep and BDNF. Methodology/Principal Findings: Participants with current symptoms of insomnia plus a former diagnosis of Restless Legs Syndrome (RLS) and/or Periodic Limb Movement (PLM) and sleep healthy controls were included in the study. They completed questionnaires on sleep (ISI, Insomnia Severity Index) and stress (PSS, Perceived Stress Scale) and provided a blood sample for determination of serum BDNF. We found a significant interaction between stress and insomnia with an impact on serum BDNF levels. Moreover, insomnia severity groups and score on the PSS each revealed a significant main effect on serum BDNF levels. Insomnia severity was associated with increased stress experience affecting serum BDNF levels. Of note, the association between stress and BDNF was only observed in subjects without insomnia. Using a mediation model, sleep was revealed as a mediator of the association between stress experience and serum BDNF levels. Conclusions: This is the first study to show that the interplay between stress and sleep impacts BDNF levels, suggesting an important role of this relationship in the pathogenesis of stress-associated mental disorders. Hence, we suggest sleep as a key mediator at the connection between stress and BDNF. Whether sleep is maintained or disturbed might explain why some individuals are able to handle a certain stress load while others develop a mental disorder.	[Giese, Maria; Eckert, Anne] Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland; [Unternaehrer, Eva; Brand, Serge; Calabrese, Pasquale] Univ Basel, Div Mol & Cognit Neurosci, Basel, Switzerland; [Unternaehrer, Eva] Univ Basel, Dept Clin Psychol & Epidemiol, Basel, Switzerland; [Brand, Serge; Holsboer-Trachsler, Edith] Univ Basel, Depress & Sleep Res Unit, Psychiat Univ Clin, Basel, Switzerland; [Giese, Maria; Calabrese, Pasquale; Eckert, Anne] Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Eckert, A (corresponding author), Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland.	anne.eckert@upkbs.ch	Calabrese, Pasquale/AAL-5291-2020; Brand, Serge/H-7159-2019	Brand, Serge/0000-0003-2175-2765; Unternaehrer, Eva/0000-0002-3507-1883; Eckert, Anne/0000-0002-9341-3669				American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR, Vxii; Aydemir O, 2009, TURK PSIKIYATR DERG, V20, P385; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Boulle F, 2012, MOL PSYCHIATR, V17, P584, DOI 10.1038/mp.2011.107; Brand S, 2010, INT J STRESS MANAGE, V17, P114, DOI 10.1037/a0019090; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Czubak A, 2009, PHARMACOL REP, V61, P1017, DOI 10.1016/S1734-1140(09)70163-X; Diniz BS, 2010, WORLD J BIOL PSYCHIA, V11, P550, DOI 10.3109/15622970903544620; Duman RS, 2002, EUR PSYCHIAT, V17, p306S; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Giese M, 2013, MOL PSYCHIAT; Haghighi M, 2013, J PSYCHIATR RES, V47, P908, DOI 10.1016/j.jpsychires.2013.03.006; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Janak PH, 2006, ALCOHOL CLIN EXP RES, V30, P214, DOI 10.1111/j.1530-0277.2006.00026.x; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Masi G, 2011, CNS DRUGS, V25, P913, DOI 10.2165/11595900-000000000-00000; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mori T, 2003, PRIMATES, V44, P167, DOI 10.1007/s10329-002-0015-7; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pae CU, 2012, NEUROPSYCHOBIOLOGY, V65, P1, DOI 10.1159/000327605; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Sartorius A, 2009, PHARMACOPSYCHIATRY, V42, P270, DOI 10.1055/s-0029-1224162; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; Schulte-Herbruggen O, 2006, PSYCHONEUROENDOCRINO, V31, P1266, DOI 10.1016/j.psyneuen.2006.09.008; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shimizu M, 2003, GEN COMP ENDOCR, V132, P103, DOI 10.1016/S0016-6480(03)00052-2; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Steiger A, 2007, J PSYCHIATR RES, V41, P537, DOI 10.1016/j.jpsychires.2006.04.007; Stein MB, 2008, PSYCHOSOM MED, V70, P913, DOI 10.1097/PSY.0b013e3181871405; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2003, J SLEEP RES, V12, P181, DOI 10.1046/j.1365-2869.2003.00357.x; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wolf I, 1998, EFFEKTE STRESS SOZIA; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	49	55	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76050	10.1371/journal.pone.0076050	http://dx.doi.org/10.1371/journal.pone.0076050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146812	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400032
J	Liu, JH; Mao, KZ; Liu, ZS; Wang, XM; Cui, FZ; Guo, WG; Mao, KY; Yang, SY				Liu, Jianheng; Mao, Kezheng; Liu, Zhengsheng; Wang, Xiumei; Cui, Fuzhai; Guo, Wenguang; Mao, Keya; Yang, Shuying			Injectable Biocomposites for Bone Healing in Rabbit Femoral Condyle Defects	PLOS ONE			English	Article							CALCIUM-SULFATE HEMIHYDRATE; MORPHOGENETIC PROTEINS; MINERALIZED COLLAGEN; POLYMERIC SCAFFOLDS; IN-VIVO; PHOSPHATE; RHBMP-2; REPAIR; REGENERATION; MODEL	A novel biomimetic bone scaffold was successfully prepared in this study, which was composed of calcium sulfate hemihydrate (CSH), collagen and nano-hydroxyapatite (nHAC). CSH/nHAC was prepared and observed with scanning electron microscope and rhBMP-2 was introduced into CSH/nHAC. The released protein content from the scaffold was detected using high performance liquid chromatography at predetermined time interval. In vivo bone formation capacity was investigated by means of implanting the scaffolds with rhBMP-2 or without rhBMP-2 respectively into a critical size defect model in the femoral condyle of rabbit. The releasing character of rhBMP-2 was that an initial burst release (37.5%) was observed in the first day, followed by a sustained release and reached 100% at the end of day 20. The CSH/nHAC showed a gradual decrease in degradation with the content of nHAC increase. The results of X-rays, Micro CT and histological observation indicated that more new bone was formed in rhBMP-2 group. The results implied that this new injectable bone scaffold should be very promising for bone repair and has a great potential in bone tissue engineering.	[Liu, Jianheng; Mao, Kezheng; Liu, Zhengsheng; Mao, Keya] Gen Hosp Peoples Liberat Army, Dept Orthopaed, Beijing, Peoples R China; [Wang, Xiumei; Cui, Fuzhai] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China; [Guo, Wenguang] Beijing Olymp Fine Pharmaceut Technol Co Ltd, Beijing, Peoples R China; [Yang, Shuying] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA	Tsinghua University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mao, KY (corresponding author), Gen Hosp Peoples Liberat Army, Dept Orthopaed, Beijing, Peoples R China.	maokeya@sina.com; sy47@buffalo.edu			National Nature Science Foundation of China [NO50830102]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055678] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work is supported by the National Nature Science Foundation of China, Grant NO50830102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p; Chen ZG, 2011, J BIOMED MATER RES A, V99A, P554, DOI 10.1002/jbm.a.33212; Dodde R, 2000, J CRANIOFAC SURG, V11, P346, DOI 10.1097/00001665-200011040-00013; Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U; El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1.87; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; Furlan JC, 2007, J NEUROSURG-SPINE, V7, P486, DOI 10.3171/SPI-07/09/486; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; GERHART TN, 1993, CLIN ORTHOP RELAT R, P317; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Hao B, 2002, SHENG WU YI XUE GONG, V19, P171; Hao Baoqing, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P140; Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110; Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936; Kim CS, 2005, BIOMATERIALS, V26, P2501, DOI 10.1016/j.biomaterials.2004.07.015; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19; Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002; Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439; Li JF, 2010, MAT SCI ENG C-MATER, V30, P1272, DOI 10.1016/j.msec.2010.07.011; Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035; Liu HY, 2010, TISSUE ENG PT A, V16, P2075, DOI [10.1089/ten.tea.2009.0669, 10.1089/ten.TEA.2009.0669]; Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e; Liu X, 2010, J BIOMED MATER RES B, V94B, P72, DOI 10.1002/jbm.b.31625; Liu YC, 2006, J ORTHOP RES, V24, P1454, DOI 10.1002/jor.20148; McAuliffe John A, 2003, J Hand Ther, V16, P180; Mino-Farina N, 2009, VET J, V179, P264, DOI 10.1016/j.tvjl.2007.09.011; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Ohura K, 2000, KEY ENG MAT, V192-1, P833; Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6; Parsons J R, 1988, Ann N Y Acad Sci, V523, P190, DOI 10.1111/j.1749-6632.1988.tb38512.x; Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1, DOI 10.2106/00004623-200100001-00001; Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Schlegel KA, 2006, ORAL SURG ORAL MED O, V102, P7, DOI 10.1016/j.tripleo.2005.09.011; SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4; Stevenson S, 1998, CLIN ORTHOP RELAT R, pS239; Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014; Tas AC, 2000, BIOMATERIALS, V21, P1429; Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035; Wang Y, 2008, J BIOMED MATER RES B, V86B, P29, DOI 10.1002/jbm.b.30984; Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001; YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005; Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0; Yuan ZT, 2008, CHINESE J INORG CHEM, V24, P1062; Zhang SM, 2003, J MATER SCI-MATER M, V14, P641, DOI 10.1023/A:1024083309982; Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g	58	5	9	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75668	10.1371/journal.pone.0075668	http://dx.doi.org/10.1371/journal.pone.0075668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146770	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400015
J	Schreuder, AB; Vanikova, J; Vitek, L; Havinga, R; Ahlfors, CE; Hulzebos, CV; Verkade, HJ				Schreuder, Andrea B.; Vanikova, Jana; Vitek, Libor; Havinga, Rick; Ahlfors, Charles E.; Hulzebos, Christian V.; Verkade, Henkjan J.			Optimizing Exchange Transfusion for Severe Unconjugated Hyperbilirubinemia: Studies in the Gunn Rat	PLOS ONE			English	Article							GLUCURONYL TRANSFERASE; BILIRUBIN; KERNICTERUS; ALBUMIN; MANAGEMENT; MORBIDITY; MORTALITY; FREQUENCY; THERAPY; MODEL	Background: Severe unconjugated hyperbilirubinemia carries the risk of neurotoxicity. Phototherapy (PT) and exchange transfusion (ET) are cornerstones in the treatment of unconjugated hyperbilirubinemia. Studies to improve ET efficacy have been hampered by the low application of ET in humans and by the lack of an in vivo model. The absence of an appropriate animal model has also prevented to determine the efficacy of adjunct or alternative treatment options such as albumin (Alb) administration. Aim: To establish an in vivo model for ET and to determine the most effective treatment (combination) of ET, PT and Alb administration. Methods: Gunn rats received either PT, PT+Alb, ET, ET+PT, ET+PT+Alb or sham operation (each n = 7). ET was performed via the right jugular vein in similar to 20 min. PT (18 mu W/cm(2)/nm) was started after ET or at T-0. Albumin i.p. injections (2.5 g/kg) were given after ET or before starting PT. Plasma unconjugated bilirubin (UCB), plasma free bilirubin (Bf), and brain bilirubin concentrations were determined. Results: We performed ET in 21 Gunn rats with 100% survival. At T-1, ET was profoundly more effective in decreasing both UCB -44%, p<0.01) and Bf -81%, p<0.05) than either PT or PT+Alb. After 48 h, the combination of ET+PT+Alb showed the strongest hypobilirubinemic effect (-54% compared to ET). Conclusions: We optimized ET for severe unconjugated hyperbilirubinemia in the Gunn rat model. Our data indicate that ET is the most effective treatment option, in the acute as well as the follow-up situation.	[Schreuder, Andrea B.; Havinga, Rick; Verkade, Henkjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Ctr Liver Digest & Metab Dis,Dept Pediat, Groningen, Netherlands; [Vanikova, Jana; Vitek, Libor] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague 2, Czech Republic; [Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague 2, Czech Republic; [Ahlfors, Charles E.] Stanford Univ, Sch Med, Stanford, CA USA; [Hulzebos, Christian V.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9713 AV Groningen, Netherlands	University of Groningen; Charles University Prague; Charles University Prague; Stanford University; University of Groningen	Verkade, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Ctr Liver Digest & Metab Dis,Dept Pediat, Groningen, Netherlands.	h.j.verkade@umcg.nl	Hulzebos, Christian Victor/AAY-6803-2021; Vitek, Libor/A-2645-2008; Jasprova, Jana/H-7839-2017	Hulzebos, Christian Victor/0000-0002-8159-7501; Vitek, Libor/0000-0002-5318-0151; Jasprova, Jana/0000-0002-0579-0895; Verkade, Henkjan J/0000-0002-7034-2861				AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Ahlfors CE, 2006, CLIN CHIM ACTA, V365, P78, DOI 10.1016/j.cca.2005.07.030; Ahlfors CE, 2009, J PERINATOL; Calligaris SD, 2007, PEDIATR RES, V62, P576, DOI 10.1203/PDR.0b013e3181568c94; CHAN G, 1976, J PEDIATR-US, V88, P609, DOI 10.1016/S0022-3476(76)80020-0; Cuperus FJC, 2013, J HEPATOL, V58, P134, DOI 10.1016/j.jhep.2012.08.011; Dennery PA, 2001, NEW ENGL J MED, V344, P581, DOI 10.1056/NEJM200102223440807; DIAMOND I, 1966, J CLIN INVEST, V45, P678, DOI 10.1172/JCI105383; Eguchi S, 1998, ARTIF ORGANS, V22, P847, DOI 10.1046/j.1525-1594.1998.06166.x; Gazzin S, 2012, PEDIATR RES, V71, P653, DOI 10.1038/pr.2012.23; Gourley GR, 1993, PEDIAT GASTROINTESTI, P88; HENRY CA, 1991, NUCL MED BIOL, V18, P565, DOI 10.1016/0883-2897(91)90120-A; HODGES GR, 1984, ANTIMICROB AGENTS CH, V26, P903, DOI 10.1128/AAC.26.6.903; Jackson JC, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e7; JOHNSON L, 1959, AMA J DIS CHILD, V97, P591, DOI 10.1001/archpedi.1959.02070010593009; JOHNSON L, 1961, AM J DIS CHILD, V101, P322, DOI 10.1001/archpedi.1961.04020040050007; KEENAN WJ, 1985, PEDIATRICS, V75, P417; KURANTSINMILLS J, 1987, MICROVASC RES, V34, P152, DOI 10.1016/0026-2862(87)90050-1; LAUER BA, 1982, PEDIATRICS, V70, P43; LIVADITIS A, 1974, ACTA PAEDIATR SCAND, V63, P277, DOI 10.1111/j.1651-2227.1974.tb04796.x; Maisels M J, 2001, J Perinatol, V21 Suppl 1, pS93, DOI 10.1038/sj.jp.7210642; ODELL GB, 1962, PEDIATRICS, V30, P613; OSTROW JD, 1971, J CLIN INVEST, V50, P707, DOI 10.1172/JCI106541; Patra K, 2004, J PEDIATR-US, V144, P626, DOI 10.1016/j.jpeds.2004.01.054; Raat NJ, 2005, CRIT CARE MED, V33, P39, DOI 10.1097/01.CCM.0000150655.75519.02; Steiner LA, 2007, PEDIATRICS, V120, P27, DOI 10.1542/peds.2006-2910; STREBEL L, 1971, PEDIATR RES, V5, P548, DOI 10.1203/00006450-197110000-00007; TAKEDA K, 1989, TOHOKU J EXP MED, V157, P31, DOI 10.1620/tjem.157.31; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395; Zelenka J, 2008, J CHROMATOGR B, V867, P37, DOI 10.1016/j.jchromb.2008.03.005; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	31	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77179	10.1371/journal.pone.0077179	http://dx.doi.org/10.1371/journal.pone.0077179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143211	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100046
J	Stoner, KA; Eitzer, BD				Stoner, Kimberly A.; Eitzer, Brian D.			Using a Hazard Quotient to Evaluate Pesticide Residues Detected in Pollen Trapped from Honey Bees (Apis mellifera) in Connecticut	PLOS ONE			English	Article							RISK-ASSESSMENT; SYSTEMIC INSECTICIDES; COLONY LOSSES; TOXICITY; HYMENOPTERA; EXPOSURE; APIDAE; USA	Analysis of pollen trapped from honey bees as they return to their hives provides a method of monitoring fluctuations in one route of pesticide exposure over location and time. We collected pollen from apiaries in five locations in Connecticut, including urban, rural, and mixed agricultural sites, for periods from two to five years. Pollen was analyzed for pesticide residues using a standard extraction method widely used for pesticides (QuEChERS) and liquid chromatography/mass spectrometric analysis. Sixty pesticides or metabolites were detected. Because the dose lethal to 50% of adult worker honey bees (LD50) is the only toxicity parameter available for a wide range of pesticides, and among our pesticides there were contact LD50 values ranging from 0.006 to > 1000 mu g per bee (range 166,000X), and even among insecticides LD50 values ranged from 0.006 to 59.8 mu g/bee (10,000X); therefore we propose that in studies of honey bee exposure to pesticides that concentrations be reported as Hazard Quotients as well as in standard concentrations such as parts per billion. We used both contact and oral LD50 values to calculate Pollen Hazard Quotients (PHQ = concentration in ppb divided by LD50 as mu g/bee) when both were available. In this study, pesticide Pollen Hazard Quotients ranged from over 75,000 to 0.01. The pesticides with the greatest Pollen Hazard Quotients at the maximum concentrations found in our study were (in descending order): phosmet, Imidacloprid, indoxacarb, chlorpyrifos, fipronil, thiamethoxam, azinphos-methyl, and fenthion, all with at least one Pollen Hazard Quotient (using contact or oral LD50) over 500. At the maximum rate of pollen consumption by nurse bees, a Pollen Hazard Quotient of 500 would be approximately equivalent to consuming 0.5% of the LD50 per day. We also present an example of a Nectar Hazard Quotient and the percentage of LD50 per day at the maximum nectar consumption rate.	[Stoner, Kimberly A.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; [Eitzer, Brian D.] Connecticut Agr Expt Stn, Dept Analyt Chem, New Haven, CT 06504 USA	Connecticut Agricultural Experiment Station; Connecticut Agricultural Experiment Station	Stoner, KA (corresponding author), Connecticut Agr Expt Stn, Dept Entomol, POB 1106, New Haven, CT 06504 USA.	Kimberly.Stoner@ct.gov	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Stoner, Kimberly/0000-0003-1248-7082	US Department of Agriculture Hatch Funds [CONH00384, CONH00392]; Hatch Multistate [NC1173]	US Department of Agriculture Hatch Funds(United States Department of Agriculture (USDA)); Hatch Multistate	This research was funded over a period of five years by US Department of Agriculture Hatch Funds CONH00384, CONH00392, and the Hatch Multistate project NC1173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Alix A, 2007, PEST MANAG SCI, V63, P1069, DOI 10.1002/ps.1463; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Dahlgren L, 2012, J ECON ENTOMOL, V105, P1895, DOI 10.1603/EC12175; Detroy BF, 1976, 163 AGR RES SERV; Fischer D., 2011, PEST RISK ASS POLL S; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Lehotay SJ, 2005, METH BIOTEC, V19, P239; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Nepi M, 2001, INT J PLANT SCI, V162, P353, DOI 10.1086/319581; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328	19	125	131	7	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77550	10.1371/journal.pone.0077550	http://dx.doi.org/10.1371/journal.pone.0077550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143241	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100079
J	Brand, LH; Henneges, C; Schussler, A; Kolukisaoglu, HU; Koch, G; Wallmeroth, N; Hecker, A; Thurow, K; Zell, A; Harter, K; Wanke, D				Brand, Luise H.; Henneges, Carsten; Schuessler, Axel; Kolukisaoglu, H. Uener; Koch, Grit; Wallmeroth, Niklas; Hecker, Andreas; Thurow, Kerstin; Zell, Andreas; Harter, Klaus; Wanke, Dierk			Screening for Protein-DNA Interactions by Automatable DNA-Protein Interaction ELISA	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR; BINDING MICROARRAYS; LAC-REPRESSOR; SEQUENCE SPECIFICITIES; NONRADIOACTIVE ASSAY; NUCLEIC-ACID; GATA FAMILY; ARABIDOPSIS; EFFECTOR; BZIP	DNA-binding proteins (DBPs), such as transcription factors, constitute about 10% of the protein-coding genes in eukaryotic genomes and play pivotal roles in the regulation of chromatin structure and gene expression by binding to short stretches of DNA. Despite their number and importance, only for a minor portion of DBPs the binding sequence had been disclosed. Methods that allow the de novo identification of DNA-binding motifs of known DBPs, such as protein binding microarray technology or SELEX, are not yet suited for high-throughput and automation. To close this gap, we report an automatable DNA-protein-interaction (DPI)-ELISA screen of an optimized double-stranded DNA (dsDNA) probe library that allows the high-throughput identification of hexanucleotide DNA-binding motifs. In contrast to other methods, this DPI-ELISA screen can be performed manually or with standard laboratory automation. Furthermore, output evaluation does not require extensive computational analysis to derive a binding consensus. We could show that the DPI-ELISA screen disclosed the full spectrum of binding preferences for a given DBP. As an example, AtWRKY11 was used to demonstrate that the automated DPI-ELISA screen revealed the entire range of in vitro binding preferences. In addition, protein extracts of AtbZIP63 and the DNA-binding domain of AtWRKY33 were analyzed, which led to a refinement of their known DNA-binding consensi. Finally, we performed a DPI-ELISA screen to disclose the DNA-binding consensus of a yet uncharacterized putative DBP, AtTIFY1. A palindromic TGATCA-consensus was uncovered and we could show that the GATC-core is compulsory for AtTIFY1 binding. This specific interaction between AtTIFY1 and its DNA-binding motif was confirmed by in vivo plant one-hybrid assays in protoplasts. Thus, the value and applicability of the DPI-ELISA screen for de novo binding site identification of DBPs, also under automatized conditions, is a promising approach for a deeper understanding of gene regulation in any organism of choice.	[Brand, Luise H.; Kolukisaoglu, H. Uener; Wallmeroth, Niklas; Hecker, Andreas; Harter, Klaus; Wanke, Dierk] Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany; [Henneges, Carsten; Schuessler, Axel; Zell, Andreas] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany; [Kolukisaoglu, H. Uener; Koch, Grit; Thurow, Kerstin] Ctr Life Sci Automat, Rostock, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Wanke, D (corresponding author), Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany.	dierk.wanke@uni-tuebingen.de	Wanke, Dierk/AAA-8529-2019; Kolukisaoglu, Üner/J-8831-2014; Thurow, Kerstin/AAY-4709-2020	Kolukisaoglu, Üner/0000-0002-8656-5963; 	Landesgraduiertenforderung des Landes Baden-Wurttemberg; German Science Foundation [HA2146/8-2]	Landesgraduiertenforderung des Landes Baden-Wurttemberg; German Science Foundation(German Research Foundation (DFG))	This research was supported by a scholarship of the Landesgraduiertenforderung des Landes Baden-Wurttemberg to LHB. Funding for open access charge: German Science Foundation project grant HA2146/8-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER K, 1972, NATURE, V237, P322, DOI 10.1038/237322a0; Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Benotmane AM, 1997, ANAL BIOCHEM, V250, P181, DOI 10.1006/abio.1997.2231; Berendzen KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-522; Berendzen KW, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-125; Berendzen Kenneth W., 2009, V479, P311, DOI 10.1007/978-1-59745-289-2_20; Berendzen KW, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-25; Berger Michael F., 2006, V338, P245; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Biswas D, 2004, MOL CELL BIOL, V24, P8312, DOI 10.1128/MCB.24.18.8312-8321.2004; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Brand LH, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-25; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bulyk ML, 2006, METHOD ENZYMOL, V410, P279, DOI 10.1016/S0076-6879(06)10013-0; Bulyk ML, 2007, ADV BIOCHEM ENG BIOT, V104, P65, DOI 10.1007/10_025; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chai CL, 2011, METHODS MOL BIOL, V754, P249, DOI 10.1007/978-1-61779-154-3_14; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Coats JE, 2013, NUCLEIC ACIDS RES, V41, P1372, DOI 10.1093/nar/gks1208; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Czapla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056548; Dey B, 2012, MOL CELL BIOCHEM, V365, P279, DOI 10.1007/s11010-012-1269-z; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Djordjevic M, 2010, METHODS MOL BIOL, V674, P195, DOI 10.1007/978-1-60761-854-6_12; Dong FM, 1999, J MOL BIOL, V290, P653, DOI 10.1006/jmbi.1999.2902; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Ghirlando R, 2003, J BIOL CHEM, V278, P45620, DOI 10.1074/jbc.M306410200; Godoy M, 2011, PLANT J, V66, P700, DOI 10.1111/j.1365-313X.2011.04519.x; Gross J., 2003, HDB GRAPH THEORY; GUBLER ML, 1995, BIOTECHNIQUES, V18, P1008; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Helwa R, 2010, ANAL BIOANAL CHEM, V398, P2551, DOI 10.1007/s00216-010-4096-7; HIBMA MH, 1994, NUCLEIC ACIDS RES, V22, P3806, DOI 10.1093/nar/22.18.3806; Hudson ME, 2006, BIOTECHNIQUES, V41, P673, DOI 10.2144/000112322; Jagelska E, 2002, J IMMUNOL METHODS, V267, P227, DOI 10.1016/S0022-1759(02)00182-5; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kang SG, 2010, MOL PLANT, V3, P361, DOI 10.1093/mp/ssp115; Kerschgens J, 2009, TRENDS MOL MED, V15, P352, DOI 10.1016/j.molmed.2009.06.004; Kirchler T, 2010, EUR J CELL BIOL, V89, P175, DOI 10.1016/j.ejcb.2009.11.023; Kolukisaoglu U, 2010, PLANT SCI, V178, P476, DOI 10.1016/j.plantsci.2010.03.006; Labazi M, 2009, NUCLEIC ACIDS RES, V37, P7581, DOI 10.1093/nar/gkp649; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; LEHMING N, 1988, P NATL ACAD SCI USA, V85, P7947, DOI 10.1073/pnas.85.21.7947; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Maienschein-Cline M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks771; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Massie CE, 2008, EMBO REP, V9, P337, DOI 10.1038/embor.2008.44; Matiolli CC, 2011, PLANT PHYSIOL, V157, P692, DOI 10.1104/pp.111.181743; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Merkle T, 1996, PLANT J, V10, P1177, DOI 10.1046/j.1365-313X.1996.10061177.x; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ogawa N, 2012, METHODS MOL BIOL, V786, P51, DOI 10.1007/978-1-61779-292-2_3; Opper K, SIGMA ALDRICH BIOTEC; Pazos E, 2011, CHEMBIOCHEM, V12, P1958, DOI 10.1002/cbic.201100247; Pearson Joseph C, 2013, Bioinformatics, V29, P1690, DOI 10.1093/bioinformatics/btt264; Pfreundt U, 2010, NUCLEIC ACIDS RES, V38, pD443, DOI 10.1093/nar/gkp910; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reece-Hoyes JS, 2012, METHODS, V57, P441, DOI 10.1016/j.ymeth.2012.07.027; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SARTORIUS J, 1991, J MOL BIOL, V218, P313, DOI 10.1016/0022-2836(91)90714-H; Schroder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013876; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Skiena S. S., 2008, ALGORITHM DESIGN MAN; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Sprenger-Haussels M, 2000, PLANT J, V22, P1, DOI 10.1046/j.1365-313x.2000.00687.x; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; Wanke Dierk, 2009, V479, P291, DOI 10.1007/978-1-59745-289-2_19; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yamasaki K, 2013, TRENDS PLANT SCI, V18, P267, DOI 10.1016/j.tplants.2012.09.001; Zheng YM, 2011, METHODS MOL BIOL, V754, P277, DOI 10.1007/978-1-61779-154-3_16; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	101	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75177	10.1371/journal.pone.0075177	http://dx.doi.org/10.1371/journal.pone.0075177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146751	gold, Green Published			2022-12-27	WOS:000325819400007
J	Gruszczyk, J; Olivares-Illana, V; Nourikyan, J; Fleurie, A; Bechet, E; Gueguen-Chaignon, V; Freton, C; Aumont-Nicaise, M; Morera, S; Grangeasse, C; Nessler, S				Gruszczyk, Jakub; Olivares-Illana, Vanesa; Nourikyan, Julien; Fleurie, Aurore; Bechet, Emmanuelle; Gueguen-Chaignon, Virginie; Freton, Celine; Aumont-Nicaise, Magali; Morera, Solange; Grangeasse, Christophe; Nessler, Sylvie			Comparative Analysis of the Tyr-Kinases CapB1 and CapB2 Fused to Their Cognate Modulators CapA1 and CapA2 from Staphylococcus aureus	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; ACETYL-MANNOSAMINE DEHYDROGENASE; WZC; IDENTIFICATION; BINDING; PSEUDOKINASE	A particular class of tyrosine-kinases sharing no structural similarity with eukaryotic tyrosine-kinases has been evidenced in a large array of bacterial species. These bacterial tyrosine-kinases are able to autophosphorylate on a C-terminal tyrosine-rich motif. Their autophosphorylation has been shown to play a crucial role in the biosynthesis or export of capsular polysaccharide. The analysis of the first crystal structure of the staphylococcal tyrosine kinase CapB2 associated with the activating domain of the transmembrane modulator CapA1 had brought conclusive explanation for both the autophosphorylation and activation processes. In order to explain why CapA1 activates CapB2 more efficiently than its cognate transmembrane modulator CapA2, we solved the crystal structure of CapA2B2 and compared it with the previously published structure of CapA1B2. This structural analysis did not provide the expected clues about the activation discrepancy observed between the two modulators. Staphylococcus aureus also encodes for a CapB2 homologue named CapB1 displaying more than 70% sequence similarity and being surprisingly nearly unable to autophosphorylate. We solved the crystal structure of CapA1B1 and carefully compare it with the structure of CapA1B2. The active sites of both proteins are highly conserved and the biochemical characterization of mutant proteins engineered to test the importance of small structural discrepancies identified between the two structures did not explain the inactivity of CapB1. We thus tested if CapB1 could phosphorylate other protein substrates or hydrolyze ATP. However, no activity could be detected in our in vitro assays. Taken together, these data question about the biological role of the homologous protein pairs CapA1/CapB1 and CapA2/CapB2 and we discuss about several possible interpretations.	[Gruszczyk, Jakub; Olivares-Illana, Vanesa; Gueguen-Chaignon, Virginie; Morera, Solange; Nessler, Sylvie] Ctr Natl Rech Sci CNRS, Lab Enzymol & Biochim Struct LEBS, Gif Sur Yvette, France; [Nourikyan, Julien; Fleurie, Aurore; Bechet, Emmanuelle; Gueguen-Chaignon, Virginie; Freton, Celine; Grangeasse, Christophe] Univ Claude Bernard Lyon 1 UCBL, Inst Biol & Chim Prot IBCP, Lyon, France; [Aumont-Nicaise, Magali; Nessler, Sylvie] Univ Paris Sud, CNRS, Inst Biochim & Biophys Mol & Cellulair IBBMC, Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Grangeasse, C (corresponding author), Univ Claude Bernard Lyon 1 UCBL, Inst Biol & Chim Prot IBCP, Lyon, France.	c.grangeasse@ibcp.fr; sylvie.nessler@u-psud.fr	Nessler, Sylvie/R-4296-2016; Olivares-Illana, Vanesa/AAF-9710-2021	Nessler, Sylvie/0000-0003-4973-9941; Nourikyan, Julien/0000-0001-9943-1326; Gruszczyk, Jakub/0000-0003-4536-2964; Grangeasse, Christophe/0000-0002-5484-4589; morera, solange/0000-0001-7781-0448; BECHET, Emmanuelle/0000-0001-5528-0263; Olivares-Illana, Vanesa/0000-0001-6949-5986	CNRS; University of Lyon; Association pour la Recherche sur le Cancer; Agence National de la Recherche [ANR 2010 BLAN 1303 03, ANR-07-JCJC0125-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence National de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the University of Lyon, the Association pour la Recherche sur le Cancer and the Agence National de la Recherche (ANR 2010 BLAN 1303 03 and ANR-07-JCJC0125-01) and the Association pour la Recherche sur le Cancer. V. O-I. was funded by the French research minister. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bricogne G, 2009, BUSTER VERSION 280; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins RF, 2006, J BIOL CHEM, V281, P2144, DOI 10.1074/jbc.M508078200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Gruszczyk J, 2011, J BIOL CHEM, V286, P17112, DOI 10.1074/jbc.M110.216002; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mijakovic I, 2005, J MOL MICROB BIOTECH, V9, P189, DOI 10.1159/000089647; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Soulat D, 2007, J MOL MICROB BIOTECH, V13, P45, DOI 10.1159/000103596; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75958	10.1371/journal.pone.0075958	http://dx.doi.org/10.1371/journal.pone.0075958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146800	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400031
J	Schoepf, V; Grottoli, AG; Warner, ME; Cai, WJ; Melman, TF; Hoadley, KD; Pettay, DT; Hu, XP; Li, Q; Xu, H; Wang, YC; Matsui, Y; Baumann, JH				Schoepf, Verena; Grottoli, Andrea G.; Warner, Mark E.; Cai, Wei-Jun; Melman, Todd F.; Hoadley, Kenneth D.; Pettay, D. Tye; Hu, Xinping; Li, Qian; Xu, Hui; Wang, Yongchen; Matsui, Yohei; Baumann, Justin H.			Coral Energy Reserves and Calcification in a High-CO2 World at Two Temperatures	PLOS ONE			English	Article							CO2 PARTIAL-PRESSURE; CO2-INDUCED OCEAN ACIDIFICATION; POCILLOPORA-DAMICORNIS LINNAEUS; SCLERACTINIAN CORAL; CLIMATE-CHANGE; REEF CORAL; SKELETAL GROWTH; CARBON-DIOXIDE; SEAWATER ACIDIFICATION; STYLOPHORA-PISTILLATA	Rising atmospheric CO2 concentrations threaten coral reefs globally by causing ocean acidification (OA) and warming. Yet, the combined effects of elevated pCO(2) and temperature on coral physiology and resilience remain poorly understood. While coral calcification and energy reserves are important health indicators, no studies to date have measured energy reserve pools (i.e., lipid, protein, and carbohydrate) together with calcification under OA conditions under different temperature scenarios. Four coral species, Acropora millepora, Montipora monasteriata, Pocillopora damicornis, Turbinaria reniformis, were reared under a total of six conditions for 3.5 weeks, representing three pCO(2) levels (382, 607, 741 mu atm), and two temperature regimes (26.5, 29.0 degrees C) within each pCO(2) level. After one month under experimental conditions, only A. millepora decreased calcification (-53%) in response to seawater pCO(2) expected by the end of this century, whereas the other three species maintained calcification rates even when both pCO(2) and temperature were elevated. Coral energy reserves showed mixed responses to elevated pCO(2) and temperature, and were either unaffected or displayed nonlinear responses with both the lowest and highest concentrations often observed at the mid-pCO(2) level of 607 matm. Biweekly feeding may have helped corals maintain calcification rates and energy reserves under these conditions. Temperature often modulated the response of many aspects of coral physiology to OA, and both mitigated and worsened pCO(2) effects. This demonstrates for the first time that coral energy reserves are generally not metabolized to sustain calcification under OA, which has important implications for coral health and bleaching resilience in a high-CO2 world. Overall, these findings suggest that some corals could be more resistant to simultaneously warming and acidifying oceans than previously expected.	[Schoepf, Verena; Grottoli, Andrea G.; Matsui, Yohei; Baumann, Justin H.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Warner, Mark E.; Hoadley, Kenneth D.; Pettay, D. Tye] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Cai, Wei-Jun; Hu, Xinping; Li, Qian; Xu, Hui; Wang, Yongchen] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Melman, Todd F.] Reef Syst Coral Farm, New Albany, OH USA	University System of Ohio; Ohio State University; University of Delaware; University System of Georgia; University of Georgia	Schoepf, V (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	schoepf.4@osu.edu	Warner, Mark E/J-6241-2013; Cai, Wei-Jun/C-1361-2013; Schoepf, Verena/H-5786-2014; Hu, Xinping/F-6282-2011	Cai, Wei-Jun/0000-0003-3606-8325; Schoepf, Verena/0000-0002-9467-1088; Hu, Xinping/0000-0002-0613-6545; Warner, Mark/0000-0003-1015-9413; Baumann, Justin/0000-0003-0113-0491; Hoadley, Kenneth/0000-0002-9287-181X	National Science Foundation [NSF-EF-1041124, 1040940, 1041070]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (grants NSF-EF-1041124, 1040940, 1041070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2002, LIMNOL OCEANOGR, V47, P1417, DOI 10.4319/lo.2002.47.5.1417; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Cai WJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005482; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Clausen C.D., 1971, EXPT COELENTERATE BI, P246; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, MAR BIOL, V160, P1127, DOI 10.1007/s00227-012-2165-5; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Drenkard EJ, 2013, CORAL REEFS, DOI [10.1007/s00338-00013-01021-00335, DOI 10.1007/S00338-00013-01021-00335]; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edmunds PJ, 2012, MAR BIOL, V159, P2149, DOI 10.1007/s00227-012-2001-y; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Edmunds PJ, 2011, LIMNOL OCEANOGR, V56, P2402, DOI 10.4319/lo.2011.56.6.2402; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GNAIGER E, 1984, OECOLOGIA, V62, P289, DOI 10.1007/BF00384259; Godinot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025024; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Grottoli AG, 2002, GEOCHIM COSMOCHIM AC, V66, P1955, DOI 10.1016/S0016-7037(01)00901-2; Harvey BP, 2013, ECOLOGY EVOLUTION, DOI [10.1002/ece1003.1516, DOI 10.1002/ECE1003.1516]; Herfort L, 2008, J PHYCOL, V44, P91, DOI 10.1111/j.1529-8817.2007.00445.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holcomb M, 2012, BIOGEOSCIENCES, V9, P29, DOI 10.5194/bg-9-29-2012; Houlbreque F, 2004, J EXP BIOL, V207, P1461, DOI 10.1242/jeb.00911; Houlbreque F, 2012, CORAL REEFS, V31, P101, DOI 10.1007/s00338-011-0819-2; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IPCC, 2007, CONTRIBUTION WORKING; Johannes RE, 1970, LIMNOL OCEANOGR, V21, P540; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Levas S., 2012, THESIS OHIO STATE U; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Lewis E., 1998, ORNLCDIAC105 US DEP; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; Marubini F, 2003, P ROY SOC B-BIOL SCI, V270, P179, DOI 10.1098/rspb.2002.2212; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Muehllehner N, 2008, FT LAUD FLOR 7 11 JU, P57; Muller-Parker G., 1994, Pacific Science, V48, P273; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Oku H, 2002, FISHERIES SCI, V68, P517, DOI 10.1046/j.1444-2906.2002.00456.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quinn GP, 2003, EXPT DESIGN DATA ANA; Renegar DA, 2005, MAR ECOL PROG SER, V293, P69, DOI 10.3354/meps293069; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Reynaud-Vaganay S, 2001, PALAEOGEOGR PALAEOCL, V175, P393, DOI 10.1016/S0031-0182(01)00382-0; Ries JB, 2011, GEOCHIM COSMOCHIM AC, V75, P4053, DOI 10.1016/j.gca.2011.04.025; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STAMBLER N, 1991, Pacific Science, V45, P299; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; TAKABAYASHI M, 1995, MAR BIOL, V123, P705, DOI 10.1007/BF00349113; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; Tolosa I, 2011, CORAL REEFS, V30, P763, DOI 10.1007/s00338-011-0753-3; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Trotter J, 2011, EARTH PLANET SC LETT, V303, P163, DOI 10.1016/j.epsl.2011.01.030; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wang ZHA, 2004, LIMNOL OCEANOGR, V49, P341, DOI 10.4319/lo.2004.49.2.0341; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428; Warren CR, 2008, J PLANT NUTR, V31, P1321, DOI 10.1080/01904160802135092; WEISS RF, 1985, NATURE, V314, P608, DOI 10.1038/314608a0; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Winer BJ, 1971, STAT PRINCIPLES EXPT	111	113	114	1	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75049	10.1371/journal.pone.0075049	http://dx.doi.org/10.1371/journal.pone.0075049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146747	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400005
J	Allen-Sharpley, MR; Tjia, M; Cramer, KS				Allen-Sharpley, Michelle R.; Tjia, Michelle; Cramer, Karina S.			Differential Roles for EphA and EphB Signaling in Segregation and Patterning of Central Vestibulocochlear Nerve Projections	PLOS ONE			English	Article							AXON GUIDANCE; EXPRESSION; REGENERATION; RECEPTORS; GANGLION; NEURONS; SYSTEM; GROWTH; CELLS; MORPHOGENESIS	Auditory and vestibular afferents enter the brainstem through the VIIIth cranial nerve and find targets in distinct brain regions. We previously reported that the axon guidance molecules EphA4 and EphB2 have largely complementary expression patterns in the developing avian VIIIth nerve. Here, we tested whether inhibition of Eph signaling alters central targeting of VIIIth nerve axons. We first identified the central compartments through which auditory and vestibular axons travel. We then manipulated Eph-ephrin signaling using pharmacological inhibition of Eph receptors and in ovo electroporation to misexpress EphA4 and EphB2. Anterograde labeling of auditory afferents showed that inhibition of Eph signaling did not misroute axons to non-auditory target regions. Similarly, we did not find vestibular axons within auditory projection regions. However, we found that pharmacologic inhibition of Eph receptors reduced the volume of the vestibular projection compartment. Inhibition of EphB signaling alone did not affect auditory or vestibular central projection volumes, but it significantly increased the area of the auditory sensory epithelium. Misexpression of EphA4 and EphB2 in VIIIth nerve axons resulted in a significant shift of dorsoventral spacing between the axon tracts, suggesting a cell-autonomous role for the partitioning of projection areas along this axis. Cochlear ganglion volumes did not differ among treatment groups, indicating the changes seen were not due to a gain or loss of cochlear ganglion cells. These results suggest that Eph-ephrin signaling does not specify auditory versus vestibular targets but rather contributes to formation of boundaries for patterning of inner ear projections in the hindbrain.	[Allen-Sharpley, Michelle R.; Tjia, Michelle; Cramer, Karina S.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92623 USA	University of California System; University of California Irvine	Cramer, KS (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92623 USA.	cramerk@uci.edu		Tjia, Michelle/0000-0003-1210-8775; Cramer, Karina/0000-0003-3793-4862	NIH [R01 DC010796, T32 DC010775]; DOE GAANN [P200A120165]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010796, T32DC010775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE GAANN(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by: NIH R01 DC010796, NIH T32 DC010775, DOE GAANN P200A120165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Sharpley MR, 2013, JOVE-J VIS EXP, DOI 10.3791/50305; Allen-Sharpley MR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-29; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Bianchi LM, 2002, EUR J NEUROSCI, V16, P1499, DOI 10.1046/j.1460-9568.2002.02248.x; Bianchi LM, 1999, ANAT REC, V254, P127; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Bulankina AV, 2012, PHYSIOLOGY, V27, P100, DOI 10.1152/physiol.00036.2011; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Cho J, 2009, MOL NEUROBIOL, V39, P1, DOI 10.1007/s12035-008-8047-7; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Cramer KS, 2006, DEV BIOL, V295, P76, DOI 10.1016/j.ydbio.2006.03.010; Cramer KS, 2004, DEV BIOL, V269, P26, DOI 10.1016/j.ydbio.2004.01.002; Cramer KS, 2000, J COMP NEUROL, V426, P270; Davidovics NS, 2013, JARO-J ASSOC RES OTO, V14, P233, DOI 10.1007/s10162-013-0370-7; Defourny J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2445; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Huffman KJ, 2007, DEV NEUROBIOL, V67, P1655, DOI 10.1002/dneu.20535; Jeon EJ, 2011, NEUROSCIENCE, V177, P321, DOI 10.1016/j.neuroscience.2011.01.014; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Maklad A, 2003, BRAIN RES BULL, V60, P497, DOI 10.1016/S0361-9230(03)00054-6; Merfeld DM, 2012, CURR OPIN OTOLARYNGO, V20, P386, DOI 10.1097/MOO.0b013e328357630f; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Molea D, 2003, J COMP NEUROL, V466, P577, DOI 10.1002/cne.10896; Niederlander C, 1996, DEVELOPMENT, V122, P2367; PARKS TN, 1978, J COMP NEUROL, V180, P439, DOI 10.1002/cne.901800303; Perde-Schrepler M, 2012, J OTOLARYNGOL-HEAD N, V41, P227, DOI 10.2310/7070.2012.00027; Person AL, 2004, J NEUROBIOL, V60, P28, DOI 10.1002/neu.10330; Pickles JO, 2003, HEARING RES, V178, P44, DOI 10.1016/S0378-5955(03)00029-7; Pickles JO, 1997, DEV NEUROSCI-BASEL, V19, P476, DOI 10.1159/000111245; Ren ZW, 2012, REV NEUROSCIENCE, V23, P135, DOI 10.1515/revneuro-2011-0069; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Saeger BM, 2011, DEV DYNAM, V240, P1578, DOI 10.1002/dvdy.22632; Siddiqui SA, 2005, J COMP NEUROL, V482, P309, DOI 10.1002/cne.20396; Simmons D, 2011, DEV INNER EAR EFFERE; Simmons DD, 2002, J NEUROBIOL, V53, P228, DOI 10.1002/neu.10130; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006; Thompson LA, 2012, J VESTIBUL RES-EQUIL, V22, P11, DOI 10.3233/VES-2012-0442; Torii M, 2013, CEREB CORTEX, V23, P775, DOI 10.1093/cercor/bhs066; Zhou CQ, 2011, LARYNGOSCOPE, V121, P1541, DOI 10.1002/lary.21861	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78658	10.1371/journal.pone.0078658	http://dx.doi.org/10.1371/journal.pone.0078658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130906	gold, Green Published			2022-12-27	WOS:000325814200100
J	Gillory, LA; Megison, ML; Stewart, JE; Mroczek-Musulman, E; Nabers, HC; Waters, AM; Kelly, V; Coleman, JM; Markert, JM; Gillespie, GY; Friedman, GK; Beierle, EA				Gillory, Lauren A.; Megison, Michael L.; Stewart, Jerry E.; Mroczek-Musulman, Elizabeth; Nabers, Hugh C.; Waters, Alicia M.; Kelly, Virginia; Coleman, Jennifer M.; Markert, James M.; Gillespie, G. Yancey; Friedman, Gregory K.; Beierle, Elizabeth A.			Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma	PLOS ONE			English	Article							IONIZING-RADIATION; N-MYC; CELL-LINES; BRAIN-TUMORS; STEM-CELLS; THERAPY; CANCER; REPLICATION; VIROTHERAPY; EXPRESSION	Despite intensive research efforts and therapeutic advances over the last few decades, the pediatric neural crest tumor, neuroblastoma, continues to be responsible for over 15% of pediatric cancer deaths. Novel therapeutic options are needed for this tumor. Recently, investigators have shown that mice with syngeneic murine gliomas treated with an engineered, neuroattenuated oncolytic herpes simplex virus-1 (oHSV), M002, had a significant increase in survival. M002 has deletions in both copies of the gamma,134.5 gene, enabling replication in tumor cells but precluding infection of normal neural cells. We hypothesized that M002 would also be effective in the neural crest tumor, neuroblastoma. We showed that M002 infected, replicated, and decreased survival in neuroblastoma cell lines. In addition, we showed that in murine xenografts, treatment with M002 significantly decreased tumor growth, and that this effect was augmented with the addition of ionizing radiation. Importantly, survival could be increased by subsequent doses of radiation without re-dosing of the virus. Finally, these studies showed that the primary entry protein for oHSV, CD111 was expressed by numerous neuroblastoma cell lines and was also present in human neuroblastoma specimens. We concluded that M002 effectively targeted neuroblastoma and that this oHSV may have potential for use in children with unresponsive or relapsed neuroblastoma.	[Gillory, Lauren A.; Megison, Michael L.; Stewart, Jerry E.; Nabers, Hugh C.; Waters, Alicia M.; Beierle, Elizabeth A.] Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA; [Mroczek-Musulman, Elizabeth] Childrens Alabama, Dept Pathol, Birmingham, AL USA; [Kelly, Virginia; Friedman, Gregory K.] Univ Alabama Birmingham, Div Hematol Oncol, Dept Pediat, Birmingham, AL 35294 USA; [Coleman, Jennifer M.; Markert, James M.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Beierle, EA (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA.	elizabeth.beierle@childrensal.org		Beierle, Elizabeth/0000-0002-4613-0527; Friedman, Gregory/0000-0002-6653-7420; Gillespie, George/0000-0001-6436-9542	National Cancer Institute [T32CA091078, K08CA118178, P01 CA071933]; St. Baldrick's Foundation; Kaul Pediatric Research Institute; NATIONAL CANCER INSTITUTE [P01CA071933, T32CA091078, K08CA118178] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; Kaul Pediatric Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are supported in part by grants from the National Cancer Institute, Grant Number T32CA091078 (LAG, MLM), K08CA118178 (EAB) and, P01 CA071933 (GYG, JMM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. GFK is supported by funding from St. Baldrick's Foundation(http://www.stbaldricks.org/) and Kaul Pediatric Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2007, ANN SURG ONCOL, V14, P258, DOI 10.1245/s10434-006-9127-4; Adusumilli PS, 2005, ANN THORAC SURG, V80, P409, DOI 10.1016/j.athoracsur.2005.01.048; Advani SJ, 2011, GENE THER, V18, P1098, DOI 10.1038/gt.2011.61; Advani SJ, 1998, GENE THER, V5, P160, DOI 10.1038/sj.gt.3300546; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Blank SV, 2002, HUM GENE THER, V13, P627, DOI 10.1089/10430340252837224; Brodeur G. M., 2006, PRINCIPLES PRACTICE, P933; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chung RY, 1999, J VIROL, V73, P7556, DOI 10.1128/JVI.73.9.7556-7564.1999; Chung SM, 2002, GENE THER, V9, P75, DOI 10.1038/sj.gt.3301620; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cotterill SJ, 2001, MED PEDIATR ONCOL, V36, P231, DOI 10.1002/1096-911X(20010101)36:1<231::AID-MPO1056>3.0.CO;2-U; Dai MH, 2010, BRIT J SURG, V97, P1385, DOI 10.1002/bjs.7124; Davidoff AM, 1999, J PEDIATR SURG, V34, P902, DOI 10.1016/S0022-3468(99)90395-0; EVANS AE, 1980, CANCER, V45, P1799, DOI 10.1002/cncr.1980.45.s7.1799; Friedman GK, 2012, PEDIATR RES, V71, P500, DOI 10.1038/pr.2011.58; Friedman GK, 2009, J NEURO-ONCOL, V95, P199, DOI 10.1007/s11060-009-9926-0; Friedman GK, 2009, MOL THER, V17, P1125, DOI 10.1038/mt.2009.73; Fukuhara H, 2005, CANCER RES, V65, P10663, DOI 10.1158/0008-5472.CAN-05-2534; Garcia-Castro J, 2010, CANCER GENE THER, V17, P476, DOI 10.1038/cgt.2010.4; Gil M, 2011, BRIT J CANCER, V105, P1512, DOI 10.1038/bjc.2011.429; Guffey MB, 2007, CANCER GENE THER, V14, P45, DOI 10.1038/sj.cgt.7700978; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Mahller YY, 2008, CANCER GENE THER, V15, P733, DOI 10.1038/cgt.2008.40; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Mezhir JJ, 2005, CANCER RES, V65, P9479, DOI 10.1158/0008-5472.CAN-05-1927; Moroz V, 2011, EUR J CANCER, V47, P561, DOI 10.1016/j.ejca.2010.10.022; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; Nguyen T, 2003, BIOCHEM BIOPH RES CO, V302, P462, DOI 10.1016/S0006-291X(03)00177-3; Parikh NS, 2005, PEDIATR BLOOD CANCER, V44, P469, DOI 10.1002/pbc.20268; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Pesonen S, 2010, ACTA ONCOL, V49, P120, DOI 10.3109/02841860903071369; Ramirez M, 2010, DISCOV MED, V10, P387; Redlinger RE, 2003, J PEDIATR SURG, V38, P199, DOI 10.1053/jpsu.2003.50043; SCHWEIGERER L, 1990, CANCER RES, V50, P4411; Siapati KE, 2003, BRIT J CANCER, V88, P1641, DOI 10.1038/sj.bjc.6600928; Todo T, 2001, P NATL ACAD SCI USA, V98, P6396, DOI 10.1073/pnas.101136398; Toyoda H, 2007, CANCER RES, V67, P2857, DOI 10.1158/0008-5472.CAN-06-3713; UCAR K, 1995, CANCER GENE THER, V2, P171	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77753	10.1371/journal.pone.0077753	http://dx.doi.org/10.1371/journal.pone.0077753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130898	Green Submitted, gold, Green Published			2022-12-27	WOS:000325814200094
J	Mou, HQ; Lu, J; Zhu, SF; Lin, CL; Tian, GZ; Xu, X; Zhao, WJ				Mou, Hai-Qing; Lu, Jie; Zhu, Shui-Fang; Lin, Cai-Li; Tian, Guo-Zhong; Xu, Xia; Zhao, Wen-Jun			Transcriptomic Analysis of Paulownia Infected by Paulownia Witches'-Broom Phytoplasma	PLOS ONE			English	Article							ABSCISIC-ACID; GENE-EXPRESSION; BIOSYNTHESIS; ARABIDOPSIS; PLANTS; TOOL; PROLIFERATION; PERIWINKLE; CONVERSION; GROWTH	Phytoplasmas are plant pathogenic bacteria that have no cell wall and are responsible for major crop losses throughout the world. Phytoplasma-infected plants show a variety of symptoms and the mechanisms they use to physiologically alter the host plants are of considerable interest, but poorly understood. In this study we undertook a detailed analysis of Paulownia infected by Paulownia witches'-broom (PaWB) Phytoplasma using high-throughput mRNA sequencing (RNA-Seq) and digital gene expression (DGE). RNA-Seq analysis identified 74,831 unigenes, which were subsequently used as reference sequences for DGE analysis of diseased and healthy Paulownia in field grown and tissue cultured plants. Our study revealed that dramatic changes occurred in the gene expression profile of Paulownia after PaWB Phytoplasma infection. Genes encoding key enzymes in cytokinin biosynthesis, such as isopentenyl diphosphate isomerase and isopentenyltransferase, were significantly induced in the infected Paulownia. Genes involved in cell wall biosynthesis and degradation were largely up-regulated and genes related to photosynthesis were down-regulated after PaWB Phytoplasma infection. Our systematic analysis provides comprehensive transcriptomic data about plants infected by Phytoplasma. This information will help further our understanding of the detailed interaction mechanisms between plants and Phytoplasma.	[Mou, Hai-Qing; Lu, Jie; Zhu, Shui-Fang; Xu, Xia; Zhao, Wen-Jun] Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China; [Lin, Cai-Li; Tian, Guo-Zhong] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Chinese Academy of Inspection & Quarantine; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Zhao, WJ (corresponding author), Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China.	wenjunzhao@188.com			National Science and technology support program [2012BAK11B02]	National Science and technology support program	This work was supported by the National Science and technology support program (2012BAK11B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS U, 1992, PHYTOPATHOLOGY, V82, P828, DOI 10.1094/Phyto-82-828; Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNEY SE, 1969, NEW PHYTOL, V68, P1001, DOI 10.1111/j.1469-8137.1969.tb06500.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; BRAUN EJ, 1978, PHYTOPATHOLOGY, V68, P1733, DOI 10.1094/Phyto-68-1733; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Cline M, 1997, PLANT CELL PHYSIOL, V38, P659, DOI 10.1093/oxfordjournals.pcp.a029218; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Curkovic Perica M, 2008, J APPL MICROBIOL, V105, P1826, DOI 10.1111/j.1365-2672.2008.03946.x; De Luca V, 2011, MOL BIOL REP, V38, P2993, DOI 10.1007/s11033-010-9964-x; Doi M, 1967, ANN PHYTOPATHOL SOC, V33, P259, DOI DOI 10.3186/JJPHYT0PATH.33.259; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Guthrie JN, 2001, PHYSIOL MOL PLANT P, V58, P23, DOI 10.1006/pmpp.2000.0311; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Himeno M, 2011, PLANT J, V67, P971, DOI 10.1111/j.1365-313X.2011.04650.x; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Junqueira A, 2004, PHYSIOL MOL PLANT P, V65, P181, DOI 10.1016/j.pmpp.2005.01.005; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kamada-Nobusada T, 2009, PHYTOCHEMISTRY, V70, P444, DOI 10.1016/j.phytochem.2009.02.007; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Karnchanatat A, 2007, FEMS MICROBIOL LETT, V270, P162, DOI 10.1111/j.1574-6968.2007.00662.x; KARTTE S, 1991, J PHYTOPATHOL, V131, P149, DOI 10.1111/j.1439-0434.1991.tb04740.x; KAUFMAN PB, 1974, PHYSIOL PLANTARUM, V31, P39, DOI 10.1111/j.1399-3054.1974.tb03674.x; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lepka P, 1999, PHYSIOL MOL PLANT P, V55, P59, DOI 10.1006/pmpp.1999.0202; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Luccioni LG, 2002, PLANT PHYSIOL, V128, P173, DOI 10.1104/pp.010668; Maust BE, 2003, PHYTOPATHOLOGY, V93, P976, DOI 10.1094/PHYTO.2003.93.8.976; McCoy RE, 1983, U FLORIDA AGR EXP ST, V834; MEDFORD JI, 1989, PLANT CELL, V1, P403, DOI 10.1105/tpc.1.4.403; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Namba S., 2002, Journal of General Plant Pathology, V68, P257, DOI 10.1007/PL00013086; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Roach M, 2012, PLANT J, V70, P967, DOI 10.1111/j.1365-313X.2012.04929.x; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Sanchez JP, 2001, PLANT CELL, V13, P1143, DOI 10.1105/tpc.13.5.1143; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI DOI 10.1016/S1360-1385(01)02187-2; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Tian G.Z., 1996, FOREST TREES PALMS D, P227; Weintraub PG, 2010, PHYTOPLASMAS: GENOMES, PLANT HOSTS AND VECTORS, P233, DOI 10.1079/9781845935306.0233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao Y, 2009, INT J SYST EVOL MICR, V59, P2582, DOI 10.1099/ijs.0.010249-0; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	54	54	59	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77217	10.1371/journal.pone.0077217	http://dx.doi.org/10.1371/journal.pone.0077217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130859	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200070
J	Qin, JZ; Pang, LH; Li, MQ; Xu, J; Zhou, X				Qin, Jun-Zhen; Pang, Li-Hong; Li, Min-Qing; Xu, Jing; Zhou, Xing			Risk of Chromosomal Abnormalities in Early Spontaneous Abortion after Assisted Reproductive Technology: A Meta-Analysis	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; FOLLICLE-STIMULATING-HORMONE; MATERNAL AGE; ANEUPLOIDY; IVF; OOCYTES; RATES	Background: Studies on the risk of chromosomal abnormalities in early spontaneous abortion after assisted reproductive technology (ART) are relatively controversial and insufficient. Thus, to obtain a more precise evaluation of the risk of embryonic chromosomal abnormalities in first-trimester miscarriage after ART, we performed a meta-analysis of all available case-control studies relating to the cytogenetic analysis of chromosomal abnormalities in first-trimester miscarriage after ART. Methods: Literature search in the electronic databases MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) based on the established strategy. Meta-regression, subgroup analysis, and Galbraith plots were conducted to explore the sources of heterogeneity. Results: A total of 15 studies with 1,896 cases and 1,186 controls relevant to the risk of chromosomal abnormalities in first-trimester miscarriage after ART, and 8 studies with 601 cases and 602 controls evaluating frequency of chromosome anomaly for maternal age >= 35 versus <35 were eligible for the meta-analysis. No statistical difference was found in risk of chromosomally abnormal miscarriage compared to natural conception and the different types of ART utilized, whereas the risk of fetal aneuploidy significantly increased with maternal age >= 35 (OR 2.88, 95% CI: 1.74-4.77). Conclusions: ART treatment does not present an increased risk for chromosomal abnormalities occurring in a first trimester miscarriage, but incidence of fetal aneuploidy could increase significantly with advancing maternal age.	[Qin, Jun-Zhen; Pang, Li-Hong; Li, Min-Qing] Guangxi Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanning, Peoples R China; [Xu, Jing] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Peoples R China; [Zhou, Xing] Third People Guangxi Zhuang Autonomous Reg, Dept Resp Med, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Pang, LH (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanning, Peoples R China.	panglihong@gmail.com						ANGELL RR, 1994, HUM REPROD, V9, P1199, DOI 10.1093/oxfordjournals.humrep.a138675; Battaglia DE, 1996, HUM REPROD, V11, P2217; Benadiva CA, 1996, FERTIL STERIL, V66, P248, DOI 10.1016/S0015-0282(16)58448-9; Bettio D, 2008, PLACENTA, V29, pS126, DOI 10.1016/j.placenta.2008.08.015; Bingol B, 2012, J ASSIST REPROD GEN, V29, P25, DOI 10.1007/s10815-011-9646-1; Martinez MC, 2010, FERTIL STERIL, V93, P289, DOI 10.1016/j.fertnstert.2009.07.989; Causio F, 2002, EUR J OBSTET GYN R B, V105, P44, DOI 10.1016/S0301-2115(02)00151-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BIAS METAANALYSIS; Farr SL, 2007, AM J EPIDEMIOL, V165, P1380, DOI 10.1093/aje/kwm035; Goddijn M, 2000, BEST PRACT RES CL OB, V14, P855, DOI 10.1053/beog.2000.0124; Gunby J, 2005, FERTIL STERIL, V84, P590, DOI 10.1016/j.fertnstert.2005.03.037; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD TJ, 1980, AM J HUM GENET, V32, P723; Kim JS, 2010, FIBER POLYM, V11, P153, DOI 10.1007/s12221-010-0153-2; Kornafel KL, 2007, FERTIL STERIL, V87, P1253, DOI 10.1016/j.fertnstert.2006.11.056; Kroon B, 2011, FERTIL STERIL, V95, P1827, DOI 10.1016/j.fertnstert.2010.11.065; Kushnir VA, 2009, J ASSIST REPROD GEN, V26, P93, DOI 10.1007/s10815-009-9292-z; Lathi RB, 2004, FERTIL STERIL, V81, P1270, DOI 10.1016/j.fertnstert.2003.09.065; Li G, 2013, SYST BIOL REPROD MED, V59, P227, DOI 10.3109/19396368.2012.750696; Ma S, 2006, FERTIL STERIL, V85, P236, DOI 10.1016/j.fertnstert.2005.06.041; Magli MC, 2001, MOL CELL ENDOCRINOL, V183, pS29, DOI 10.1016/S0303-7207(01)00574-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Massie JAM, 2008, FERTIL STERIL, V90, P2351, DOI 10.1016/j.fertnstert.2007.10.041; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; Nasseri A, 1999, FERTIL STERIL, V71, P715, DOI 10.1016/S0015-0282(98)00525-1; Nicolaidis P, 1998, HUM REPROD, V13, P313, DOI 10.1093/humrep/13.2.313; PLACHOT M, 1989, HUM REPROD, V4, P425, DOI 10.1093/oxfordjournals.humrep.a136921; Simon C, 1998, REPROD FERT DEVELOP, V10, P87, DOI 10.1071/R98030; Simpson J, 1987, SPONTANEOUS ABORTION, P51; Smith KE, 1996, FERTIL STERIL, V65, P35, DOI 10.1016/S0015-0282(16)58024-8; Sonntag B, 2001, HUM REPROD, V16, P1648, DOI 10.1093/humrep/16.8.1648; Tan YQ, 2004, BIOL REPROD, V70, P495, DOI 10.1095/biolreprod.103.022343; Werner M, 2012, J ASSIST REPROD GEN, V29, P817, DOI 10.1007/s10815-012-9781-3; Zhou C, 1998, J Obstet Gynaecol Res, V24, P343	35	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75953	10.1371/journal.pone.0075953	http://dx.doi.org/10.1371/journal.pone.0075953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130752	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200026
J	Sun, J; Lin, Y; Wu, J				Sun, Jin; Lin, Yi; Wu, Ji			Long Non-Coding RNA Expression Profiling of Mouse Testis during Postnatal Development	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; SPERMATOGONIAL STEM-CELLS; H19 METHYLATION IMPRINT; ANTISENSE RNA; TRANSCRIPTIONAL NOISE; MOLECULAR-MECHANISMS; ANALYSIS UNCOVERS; PARENTAL ALLELES; DNA METHYLATION; GENE-EXPRESSION	Mammalian testis development and spermatogenesis play critical roles in male fertility and continuation of a species. Previous research into the molecular mechanisms of testis development and spermatogenesis has largely focused on the role of protein-coding genes and small non-coding RNAs, such as microRNAs and piRNAs. Recently, it has become apparent that large numbers of long (>200 nt) non-coding RNAs (lncRNAs) are transcribed from mammalian genomes and that lncRNAs perform important regulatory functions in various developmental processes. However, the expression of lncRNAs and their biological functions in post-natal testis development remain unknown. In this study, we employed microarray technology to examine lncRNA expression profiles of neonatal (6-day-old) and adult (8-week-old) mouse testes. We found that 8,265 lncRNAs were expressed above background levels during post-natal testis development, of which 3,025 were differentially expressed. Candidate lncRNAs were identified for further characterization by an integrated examination of genomic context, gene ontology (GO) enrichment of their associated protein-coding genes, promoter analysis for epigenetic modification, and evolutionary conservation of elements. Many lncRNAs overlapped or were adjacent to key transcription factors and other genes involved in spermatogenesis, such as Ovol1, Ovol2, Lhx1, Sox3, Sox9, Plzf, c-Kit, Wt1, Sycp2, Prm1 and Prm2. Most differentially expressed lncRNAs exhibited epigenetic modification marks similar to protein-coding genes and tend to be expressed in a tissue-specific manner. In addition, the majority of differentially expressed lncRNAs harbored evolutionary conserved elements. Taken together, our findings represent the first systematic investigation of lncRNA expression in the mammalian testis and provide a solid foundation for further research into the molecular mechanisms of lncRNAs function in mammalian testis development and spermatogenesis.	[Sun, Jin; Wu, Ji] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Inst, Minist Educ, Shanghai 200030, Peoples R China; [Wu, Ji] Ningxia Med Univ, Minist Educ, Key Lab Fertil Preservat & Maintenance, Ningxia, Peoples R China; [Lin, Yi] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Ningxia Medical University; Shanghai Jiao Tong University	Wu, J (corresponding author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Inst, Minist Educ, Shanghai 200030, Peoples R China.	jiwu@sjtu.edu.cn			National Basic Research Program of China [2013CB967401, 2010CB945001]; National Nature Science Foundation of China [81121001]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (grant numbers 2013CB967401 and 2010CB945001; http://www.most.gov.cn) and the National Nature Science Foundation of China (grant number 81121001; http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Arun G, 2012, MOL CELL BIOL, V32, P3140, DOI 10.1128/MCB.00006-12; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Deng Y, 2005, ACTA BIOCH BIOPH SIN, V37, P159, DOI 10.1093/abbs/37.3.159; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gan HY, 2011, RNA, V17, P1191, DOI 10.1261/rna.2648411; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Guo XJ, 2010, J PROTEOME RES, V9, P1246, DOI 10.1021/pr900735k; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lee JY, 2012, MOL CELLS, V33, P111, DOI 10.1007/s10059-012-2164-x; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lee TL, 2011, SPERM CHROMATIN: BIOLOGICAL AND CLINICAL APPLICATIONS IN MALE INFERTILITY AND ASSISTED REPRODUCTION, P107, DOI 10.1007/978-1-4419-6857-9_8; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mattick JS, 2011, SEMIN CELL DEV BIOL, V22, P327, DOI 10.1016/j.semcdb.2011.05.002; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Meola N, 2012, RNA, V18, P111, DOI 10.1261/rna.029454.111; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Nie DS, 2013, MOL BIOL REP, V40, P1905, DOI 10.1007/s11033-012-2246-z; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Pang ALY, 2003, J ANDROL, V24, P899; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111; Reis EM, 2005, OMICS, V9, P2, DOI 10.1089/omi.2005.9.2; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Roberts KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029495; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt JA, 2009, BIOL REPROD, V81, P56, DOI 10.1095/biolreprod.108.075358; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Sha JH, 2002, MOL HUM REPROD, V8, P511, DOI 10.1093/molehr/8.6.511; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spiess AN, 2003, BIOL REPROD, V68, P2044, DOI 10.1095/biolreprod.102.011593; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Takeuchi A, 2003, NAT GENET, V33, P172, DOI 10.1038/ng1072; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vemuganti SA, 2007, DEV BIOL, V309, P18, DOI 10.1016/j.ydbio.2007.06.010; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	97	108	114	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75750	10.1371/journal.pone.0075750	http://dx.doi.org/10.1371/journal.pone.0075750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130740	Green Submitted, gold, Green Published			2022-12-27	WOS:000325814200021
J	Zhu, X; Zhang, DW				Zhu, Xiang; Zhang, Dianwen			Efficient Parallel Levenberg-Marquardt Model Fitting towards Real-Time Automated Parametric Imaging Microscopy	PLOS ONE			English	Article							VISUALIZATION; LOCALIZATION; SIZE	We present a fast, accurate and robust parallel Levenberg-Marquardt minimization optimizer, GPU-LMFit, which is implemented on graphics processing unit for high performance scalable parallel model fitting processing. GPU-LMFit can provide a dramatic speed-up in massive model fitting analyses to enable real-time automated pixel-wise parametric imaging microscopy. We demonstrate the performance of GPU-LMFit for the applications in superresolution localization microscopy and fluorescence lifetime imaging microscopy.	[Zhu, Xiang] China Agr Univ, Coll Informat & Elect Engn, Beijing 100094, Peoples R China; [Zhu, Xiang] China Agr Univ, Coll Econ & Management, Beijing 100094, Peoples R China; [Zhang, Dianwen] Univ Illinois, Beckman Inst Adv Sci & Technol, Imaging Technol Grp, Urbana, IL USA	China Agricultural University; China Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign	Zhang, DW (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Imaging Technol Grp, Urbana, IL USA.	zhangdw@illinois.edu	Zhang, Dianwen/M-5255-2013	Zhang, Dianwen/0000-0001-6546-3960				Albrecht S, 2009, NATURE, V461, P373, DOI 10.1038/nature08408; Apostol TM., 2012, MODULAR FUNCTIONS DI; Azuah RT, 2009, J RES NATL INST STAN, V114, P341, DOI 10.6028/jres.114.025; Bluestein KT, 2012, MAGN RESON IMAGING, V30, P19, DOI 10.1016/j.mri.2011.07.018; Busetto L, 2010, GLOBAL CHANGE BIOL, V16, P2504, DOI 10.1111/j.1365-2486.2010.02189.x; Cheong FC, 2010, OPT EXPRESS, V18, P13563, DOI 10.1364/OE.18.013563; Cheong FC, 2009, OPT EXPRESS, V17, P13071, DOI 10.1364/OE.17.013071; Fung J, 2011, OPT EXPRESS, V19, P8051, DOI 10.1364/OE.19.008051; Gourrier A, 2010, J APPL CRYSTALLOGR, V43, P1385, DOI 10.1107/S0021889810035090; Halle C, 2012, CANCER RES, V72, P5285, DOI 10.1158/0008-5472.CAN-12-1085; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; James W.D., 1997, APPL NUMERICAL LINEA; Kechkar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062918; Kirshner H, 2013, J MICROSC-OXFORD, V249, P13, DOI 10.1111/j.1365-2818.2012.03675.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laurence TA, 2010, NAT METHODS, V7, P338, DOI 10.1038/nmeth0510-338; Leray A, 2009, CYTOM PART A, V75A, P1007, DOI 10.1002/cyto.a.20802; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Markwardt CB, 2009, ASTR SOC P, V411, P251; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; More J., 1978, NUMERICAL ANAL; More J. J., 1980, ANL8074, VIII; Nguyen H, 2008, GPU GEMS; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Patterson D., 1997, COMPUTER ORG DESIGN, V2nd; Shemesh N, 2012, NMR BIOMED, V25, P236, DOI 10.1002/nbm.1737; Simpson HB, 2012, NEUROPSYCHOPHARMACOL, V37, P2684, DOI 10.1038/npp.2012.132; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Wouters FS, 2008, HFSP J, V2, P7, DOI 10.2976/1.2833600; Zhang D, 2008, THESIS U TWENTE NETH; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	33	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76665	10.1371/journal.pone.0076665	http://dx.doi.org/10.1371/journal.pone.0076665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130785	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200043
J	Mannetti, L; Brizi, A; Giacomantonio, M; Higgins, ET				Mannetti, Lucia; Brizi, Ambra; Giacomantonio, Mauro; Higgins, E. Tory			Framing Political Messages to Fit the Audience's Regulatory Orientation: How to Improve the Efficacy of the Same Message Content	PLOS ONE			English	Article							PREVENTION; PROMOTION; ASSOCIATIONS; INFORMATION; PERSUASION; PLEASURES; DECISION; IMPACT; FRAMES; PAINS	This research investigates how the impact of persuasive messages in the political domain can be improved when fit is created by subliminally priming recipients' regulatory focus (either promotion or prevention) and by linguistic framing of the message (either strategic approach framing or strategic avoidance framing). Results of two studies show that regulatory fit: a) increases the impact of a political message favoring nuclear energy on implicit attitudes of the target audience (Study 1); and b) induces a more positive evaluation of, and intentions to vote for, the political candidate who is delivering a message concerning immigration policies (Study 2).	[Mannetti, Lucia; Brizi, Ambra; Giacomantonio, Mauro] Univ Roma La Sapienza, Dept Social & Dev Psychol, I-00185 Rome, Italy; [Higgins, E. Tory] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Sapienza University Rome; Columbia University	Mannetti, L (corresponding author), Univ Roma La Sapienza, Dept Social & Dev Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	lucia.mannetti@uniroma1.it		Brizi, Ambra/0000-0001-6462-5059	Italian Ministry for Education, University and Research (MIUR) [2008H2JPTN_002]	Italian Ministry for Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The project was supported by a research grant from the Italian Ministry for Education, University and Research (MIUR) to the first author, Mannetti (2008H2JPTN_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaker JL, 2001, J CONSUM RES, V28, P33, DOI 10.1086/321946; Avnet T, 2003, J EXP SOC PSYCHOL, V39, P525, DOI 10.1016/S0022-1031(03)00027-1; Avnet T, 2006, J MARKETING RES, V4, P31; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Bizer GY, 2005, POLIT PSYCHOL, V26, P553, DOI 10.1111/j.1467-9221.2005.00431.x; Bluemke M, 2008, EUR J SOC PSYCHOL, V38, P977, DOI 10.1002/ejsp.487; Boldero JM, 2011, POLIT PSYCHOL, V32, P399, DOI 10.1111/j.1467-9221.2010.00814.x; Camacho CJ, 2003, J PERS SOC PSYCHOL, V84, P498, DOI 10.1037/0022-3514.84.3.498; Cesario J, 2004, J PERS SOC PSYCHOL, V86, P388, DOI 10.1037/0022-3514.86.3.388; de Liver Y, 2007, J EXP SOC PSYCHOL, V43, P319, DOI 10.1016/j.jesp.2006.02.012; Druckman JN, 2001, J LAW ECON ORGAN, V17, P62, DOI 10.1093/jleo/17.1.62; Evans LM, 2003, PERS SOC PSYCHOL B, V29, P313, DOI 10.1177/0146167202250090; Florack A, 2006, PSYCHOL MARKET, V23, P741, DOI 10.1002/mar.20127; Forster J, 2005, PSYCHOL SCI, V16, P631, DOI 10.1111/j.1467-9280.2005.01586.x; Freitas AL, 2002, J EXP SOC PSYCHOL, V38, P291, DOI 10.1006/jesp.2001.1504; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hayes A. F., 2012, PROCESS VERSATILE CO; Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2002, J CONSUM PSYCHOL, V12, P177, DOI 10.1207/S15327663JCP1203_01; Higgins ET, 2004, HDB SELF REGULATION, P171; Holler M, 2008, J ECON PSYCHOL, V29, P597, DOI 10.1016/j.joep.2008.01.001; Janoff-Bulman R, 2009, PSYCHOL INQ, V20, P120, DOI 10.1080/10478400903028581; Jost J. T., 2004, POLITICAL PSYCHOL KE; Katz E, 1973, JOURNALISM QUART, V48, P304; KROSNICK JA, 1993, AM POLIT SCI REV, V87, P963, DOI 10.2307/2938828; Kruglanski AW, 2006, J MARKETING RES, V43, P11, DOI 10.1509/jmkr.43.1.11; Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9; Leder Susanne, 2010, J Socio Econ, V39, P271; Lee AY, 2004, J PERS SOC PSYCHOL, V86, P205, DOI 10.1037/0022-3514.86.2.205; Lee AY, 2000, J PERS SOC PSYCHOL, V78, P1122, DOI 10.1037//0022-3514.78.6.1122; Liberman N, 1999, J PERS SOC PSYCHOL, V77, P1135, DOI 10.1037/0022-3514.77.6.1135; LOCKERBIE B, 1991, PUBLIC CHOICE, V69, P279, DOI 10.1007/BF00123865; Mannetti L, 2010, EUR J SOC PSYCHOL, V40, P206, DOI 10.1002/ejsp.726; Pham MT, 2004, J CONSUM RES, V30, P503, DOI 10.1086/380285; Price V, 1997, COMMUN RES, V24, P481, DOI 10.1177/009365097024005002; Pyszczynski T., 2003, WAKE 9 11 PSYCHOL TE; Reese S. D., 2001, WILD LIF OUR HOM PUB; Roskes M, 2013, EMOT REV, V5, P308, DOI [10.1177/1754073913477517, DOI 10.1177/1754073913477517]; Scholer AA, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P489; Shen FY, 2004, J COMMUN, V54, P123, DOI 10.1093/joc/54.1.123; Sniderman MP, 2000, OUTSIDER PREJUDICE P; Spiegel S, 2004, EUR J SOC PSYCHOL, V34, P39, DOI 10.1002/ejsp.180; Triandafyllidou A., 1999, JOURNAL FOR THE STUD, V5, P65, DOI DOI 10.1080/13504639951626; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; Weaver DH, 2007, J COMMUN, V57, P142, DOI 10.1111/j.1460-2466.2006.00333.x; Whitfield SC, 2009, RISK ANAL, V29, P425, DOI 10.1111/j.1539-6924.2008.01155.x; Wigboldus D.H.J., 2006, SINGLE TARGET UNPUB	49	9	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77040	10.1371/journal.pone.0077040	http://dx.doi.org/10.1371/journal.pone.0077040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130831	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900118
J	Mochida, K; Uehara-Yamaguchi, Y; Takahashi, F; Yoshida, T; Sakurai, T; Shinozaki, K				Mochida, Keiichi; Uehara-Yamaguchi, Yukiko; Takahashi, Fuminori; Yoshida, Takuhiro; Sakurai, Tetsuya; Shinozaki, Kazuo			Large-Scale Collection and Analysis of Full-Length cDNAs from Brachypodium distachyon and Integration with Pooideae Sequence Resources	PLOS ONE			English	Article							DATABASE RAP-DB; FOX HUNTING SYSTEM; MESSENGER-RNA; DRAFT GENOME; ARABIDOPSIS; ANNOTATION; RICE; PROJECT; STRESS; MODEL	A comprehensive collection of full-length cDNAs is essential for correct structural gene annotation and functional analyses of genes. We constructed a mixed full-length cDNA library from 21 different tissues of Brachypodium distachyon Bd21, and obtained 78,163 high quality expressed sequence tags (ESTs) from both ends of ca. 40,000 clones (including 16,079 contigs). We updated gene structure annotations of Brachypodium genes based on full-length cDNA sequences in comparison with the latest publicly available annotations. About 10,000 non-redundant gene models were supported by full-length cDNAs; ca. 6,000 showed some transcription unit modifications. We also found ca. 580 novel gene models, including 362 newly identified in Bd21. Using the updated transcription start sites, we searched a total of 580 plant cis-motifs in the -3 kb promoter regions and determined a genome-wide Brachypodium promoter architecture. Furthermore, we integrated the Brachypodium full-length cDNAs and updated gene structures with available sequence resources in wheat and barley in a web-accessible database, the RIKEN Brachypodium FL cDNA database. The database represents a "one-stop'' information resource for all genomic information in the Pooideae, facilitating functional analysis of genes in this model grass plant and seamless knowledge transfer to the Triticeae crops.	[Mochida, Keiichi; Uehara-Yamaguchi, Yukiko; Takahashi, Fuminori; Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Biomass Res Platform Team, Biomass Engn Program, Cooperat Div,Tsurumi Ku, Yokohama, Kanagawa, Japan; [Yoshida, Takuhiro; Sakurai, Tetsuya] RIKEN Ctr Sustainable Resource Sci, Integrated Genome Informat Res Unit, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Mochida, Keiichi] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 232, Japan	RIKEN; RIKEN; Yokohama City University	Mochida, K (corresponding author), RIKEN Ctr Sustainable Resource Sci, Biomass Res Platform Team, Biomass Engn Program, Cooperat Div,Tsurumi Ku, Yokohama, Kanagawa, Japan.	keiichi.mochida@riken.jp	Mochida, Keiichi/T-2866-2019; Mochida, Keiichi/N-9052-2014; Sakurai, Tetsuya/B-2690-2010; Takahashi, Fuminori/D-6200-2017	Mochida, Keiichi/0000-0003-1299-0024; Mochida, Keiichi/0000-0003-1299-0024; Sakurai, Tetsuya/0000-0003-2046-8973; Takahashi, Fuminori/0000-0001-8817-8652	strategic research project in RIKEN Biomass engineering program	strategic research project in RIKEN Biomass engineering program	This work was supported by a grant from a strategic research project in RIKEN Biomass engineering program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hayashizaki Y, 2003, COLD SPRING HARB SYM, V68, P195, DOI 10.1101/sqb.2003.68.195; Higuchi M, 2011, METHODS MOL BIOL, V678, P77, DOI 10.1007/978-1-60761-682-5_7; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kawaura K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-271; Kondou Y, 2009, PLANT J, V57, P883, DOI 10.1111/j.1365-313X.2008.03733.x; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mochida K, 2010, PLANT CELL PHYSIOL, V51, P497, DOI 10.1093/pcp/pcq027; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; Sakurai T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-66; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Taji T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-115; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Umezawa T, 2008, DNA RES, V15, P333, DOI 10.1093/dnares/dsn024; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu XH, 2011, P NATL ACAD SCI USA, V108, P12533, DOI 10.1073/pnas.1019732108; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435	41	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75265	10.1371/journal.pone.0075265	http://dx.doi.org/10.1371/journal.pone.0075265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130698	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900029
J	Radman, I; Greiss, S; Chin, JW				Radman, Inja; Greiss, Sebastian; Chin, Jason W.			Efficient and Rapid C. elegans Transgenesis by Bombardment and Hygromycin B Selection	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENETIC-CODE; ANTIBIOTIC SELECTION; TRANSFORMATION; RESISTANCE; EXPRESSION	We report a simple, cost-effective, scalable and efficient method for creating transgenic Caenorhabditis elegans that requires minimal hands-on time. The method combines biolistic bombardment with selection for transgenics that bear a hygromycin B resistance gene on agar plates supplemented with hygromycin B, taking advantage of our observation that hygromycin B is sufficient to kill wild-type C. elegans at very low concentrations. Crucially, the method provides substantial improvements in the success of bombardments for isolating transmitting strains, the isolation of multiple independent strains, and the isolation of integrated strains: 100% of bombardments in a large data set yielded transgenics; 10 or more independent strains were isolated from 84% of bombardments, and up to 28 independent strains were isolated from a single bombardment; 82% of bombardments yielded stably transmitting integrated lines with most yielding multiple integrated lines. We anticipate that the selection will be widely adopted for C. elegans transgenesis via bombardment, and that hygromycin B resistance will be adopted as a marker in other approaches for manipulating, introducing or deleting DNA in C. elegans.	[Radman, Inja; Greiss, Sebastian; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Greiss, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sgreiss@mrc-lmb.cam.ac.uk; chin@mrc-lmb.cam.ac.uk	Greiss, Sebastian/B-2395-2015	Greiss, Sebastian/0000-0001-9130-0831	UK Medical Research Council (MRC) [U105181009, UD99999908]; Louis-Jeantet Foundation Young Investigator Career Award; Herchel Smith Foundation studentship; MRC [MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Louis-Jeantet Foundation Young Investigator Career Award; Herchel Smith Foundation studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MRC; http://www.mrc.ac.uk/) (grant numbers U105181009, UD99999908) to J.W.C.; the Louis-Jeantet Foundation Young Investigator Career Award to J.W.C. (http://www.jeantet.ch/); Herchel Smith Foundation studentship to I. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; BRENNER S, 1974, GENETICS, V77, P71; Chen C, 2013, NUCL ACIDS IN PRESS; Chin JW, 2012, SCIENCE, V336, P428, DOI 10.1126/science.1221761; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Praitis V, 2001, GENETICS, V157, P1217; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Semple JI, 2012, NAT METHODS, V9, P118, DOI 10.1038/nmeth.1864; Semple JI, 2010, NAT METHODS, V7, P725, DOI 10.1038/nmeth.1495	16	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76019	10.1371/journal.pone.0076019	http://dx.doi.org/10.1371/journal.pone.0076019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130756	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900066
J	Sanchez-Puig, JM; Lorenzo, MM; Blasco, R				Sanchez-Puig, Juana M.; Lorenzo, Maria M.; Blasco, Rafael			A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles	PLOS ONE			English	Article							DEFECTIVE RETROVIRAL PARTICLES; ALLOW CYTOPLASMIC PRODUCTION; INTRON-CONTAINING GENES; IN-VIVO; CHIMERIC VECTORS; HELPER RNAS; TRANSDUCTION; SYSTEM; CELLS; GENERATION	Poxviruses and Alphaviruses constitute two promising viral vectors that have been used extensively as expression systems, or as vehicles for vaccine purposes. Poxviruses, like vaccinia virus (VV) are well-established vaccine vectors having large insertion capacity, excellent stability, and ease of administration. In turn, replicons derived from Alphaviruses like Semliki Forest virus (SFV) are potent protein expression and immunization vectors but stocks are difficult to produce and maintain. In an attempt to demonstrate the use of a Poxvirus as a means for the delivery of small vaccine vectors, we have constructed and characterized VV/SFV hybrid vectors. A SFV replicon cDNA was inserted in the VV genome and placed under the control of a VV early promoter. The replicon, transcribed from the VV genome as an early transcript, was functional, and thus capable of initiating its own replication and transcription. Further, we constructed a VV recombinant additionally expressing the SFV structural proteins under the control of a vaccinia synthetic early/late promoter. Infection with this recombinant produced concurrent transcription of the replicon and expression of SFV structural proteins, and led to the generation of replicon-containing SFV particles that were released to the medium and were able to infect additional cells. This combined VV/SFV system in a single virus allows the use of VV as a SFV delivery vehicle in vivo. The combination of two vectors, and the possibility of generating in vivo single-cycle, replicon containing alphavirus particles, may open new strategies in vaccine development or in the design of oncolytic viruses.	[Sanchez-Puig, Juana M.; Lorenzo, Maria M.; Blasco, Rafael] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Blasco, R (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain.	blasco@inia.es	Eyré, Juana Sánchez-Puig/ABF-8080-2020; Lorenzo, Maria M./ABH-4437-2020; Blasco, Rafael/B-5829-2016	Sanchez-Puig Eyre, Juana/0000-0002-3966-3499; Lorenzo, Maria M./0000-0001-7588-673X; Blasco, Rafael/0000-0002-8819-5767	European Commission [QLK2-CT2002-01867, CT2006-037536]; Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [BFU2005-05124, BIO2008-03713]; Comunidad Autonoma de Madrid [S2009/TIC-1476]	European Commission(European CommissionEuropean Commission Joint Research Centre); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was supported by contracts QLK2-CT2002-01867 and CT2006-037536 from the European Commission, and grants BFU2005-05124 and BIO2008-03713 from Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and by grant S2009/TIC-1476 from Comunidad Autonoma de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins Gregory J., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000859; Barcena J, 2000, J GEN VIROL, V81, P1073, DOI 10.1099/0022-1317-81-4-1073; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; BERGLUND P, 1993, BIO-TECHNOL, V11, P916, DOI 10.1038/nbt0893-916; Bilbao G, 1997, FASEB J, V11, P624, DOI 10.1096/fasebj.11.8.9240964; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BLASCO R, 1992, J VIROL, V66, P4170, DOI 10.1128/JVI.66.7.4170-4179.1992; Caplen NJ, 1999, GENE THER, V6, P454, DOI 10.1038/sj.gt.3300835; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Dominguez J, 1998, J IMMUNOL METHODS, V220, P115, DOI 10.1016/S0022-1759(98)00156-2; Falkner FG, 2004, CURR GENE THER, V4, P417; Feng MZ, 1997, NAT BIOTECHNOL, V15, P866, DOI 10.1038/nbt0997-866; GLAUERT AM, 1974, J CELL BIOL, V63, P717, DOI 10.1083/jcb.63.3.717; Holzer Georg W, 2003, Methods Mol Med, V76, P565; Holzer GW, 1999, VIROLOGY, V253, P107, DOI 10.1006/viro.1998.9496; Kamrud KI, 2010, J GEN VIROL, V91, P1723, DOI 10.1099/vir.0.020081-0; Kamrud KI, 2010, J VIROL, V84, P7713, DOI 10.1128/JVI.00310-10; Kohno A, 1998, GENE THER, V5, P415, DOI 10.1038/sj.gt.3300589; Konetschny C, 2003, J VIROL, V77, P7017, DOI 10.1128/JVI.77.12.7017-7025.2003; Konetschny C, 2002, J VIROL, V76, P1236, DOI 10.1128/JVI.76.3.1236-1243.2002; Li KJ, 1998, P NATL ACAD SCI USA, V95, P3650, DOI 10.1073/pnas.95.7.3650; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Liljestrom P, 1994, CURRENT POTOCOLS MOL; Lorenzo Maria M, 2004, Methods Mol Biol, V269, P15; Lorenzo MD, 1998, BIOTECHNIQUES, V24, P308, DOI 10.2144/98242rr03; Lorenzo MM, 2000, J VIROL, V74, P10535, DOI 10.1128/JVI.74.22.10535-10550.2000; Lundstrom K, 2002, CURR OPIN MOL THER, V4, P28; Lundstrom Kenneth, 2003, Expert Rev Vaccines, V2, P447; Okada T, 2004, J GENE MED, V6, P288, DOI 10.1002/jgm.490; Pan YF, 2009, J GENE MED, V11, P1030, DOI 10.1002/jgm.1390; Perdiguero B, 2006, J VIROL, V80, P8763, DOI 10.1128/JVI.00598-06; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Quetglas JI, 2010, VIRUS RES, V153, P179, DOI 10.1016/j.virusres.2010.07.027; Ramsey WJ, 1998, BIOCHEM BIOPH RES CO, V246, P912, DOI 10.1006/bbrc.1998.8726; Sanchez-Puig Juana M, 2012, Methods Mol Biol, V890, P93, DOI 10.1007/978-1-61779-876-4_5; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; USDIN TB, 1993, BIOTECHNIQUES, V14, P222; Vasilakis N, 2003, NAT BIOTECHNOL, V21, P932, DOI 10.1038/nbt845; Wahlfors JJ, 1997, HUM GENE THER, V8, P2031, DOI 10.1089/hum.1997.8.17-2031; Wahlfors JJ, 1999, HUM GENE THER, V10, P1197, DOI 10.1089/10430349950018184	41	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75574	10.1371/journal.pone.0075574	http://dx.doi.org/10.1371/journal.pone.0075574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130722	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900043
J	Santarcangelo, EL; Paoletti, G; Chiavacci, I; Palombo, C; Carli, G; Varanini, M				Santarcangelo, Enrica L.; Paoletti, Giulia; Chiavacci, Iacopo; Palombo, Carlo; Carli, Giancarlo; Varanini, Maurizio			Cognitive Modulation of Psychophysical, Respiratory and Autonomic Responses to Cold Pressor Test	PLOS ONE			English	Article							HEART-RATE; HYPNOTIC ANALGESIA; PAIN PERCEPTION; BLOOD-PRESSURE; HYPNOSIS; SUGGESTIONS; HYPNOTIZABILITY; SUGGESTIBILITY; SUSCEPTIBILITY; RELAXATION	In healthy subjects with high hypnotisability (highs) under hypnosis, subjectively effective suggestions for analgesia abolish the increases in blood pressure associated with cold pressor test (cpt) by reducing the peripheral vascular resistance. The aim of the present study was to investigate the effects of the suggestions of analgesia on the responses to cpt in healthy highs (n = 22) and in low hypnotisable participants (lows, n = 22) out of hypnosis. Cpt was administered without (CPT) and with suggestions for analgesia (CPT+AN). Psychophysical (pain intensity, pain threshold, cpt duration (time of immersion) and pain tolerance, defined as the difference between cpt duration and pain threshold), respiratory (amplitude and frequency) and autonomic variables (tonic skin conductance, mean RR interval (RR = 1/heart rate), blood pressure, skin blood flow) were studied. The suggestions for analgesia increased cpt duration and RR in both groups, but decreased pain intensity and enhanced pain threshold only in highs; in both groups they did not modulate systolic blood pressure, tonic skin conductance and skin blood flow; thus, increased parasympathetic activity appears responsible for the heart rate reduction induced by suggestions in both groups. In conclusion, our findings show that suggestions modulate pain experience differentially in highs and lows, and are partially effective also in lows. We hypothesize that the mechanisms responsible for the efficacy of suggestions in healthy lows may be involved also in their efficacy in chronic pain patients with low hypnotisability.	[Santarcangelo, Enrica L.; Paoletti, Giulia; Chiavacci, Iacopo] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Palombo, Carlo] Univ Pisa, Dept Surg, Pisa, Italy; [Carli, Giancarlo] Univ Siena, Dept Physiol, I-53100 Siena, Italy; [Varanini, Maurizio] CNR, Inst Clin Physiol, Pisa, Italy	University of Pisa; University of Pisa; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Santarcangelo, EL (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	enricals@dfb.unipi.it	Varanini, Maurizio/B-7945-2015; SANTARCANGELO, ENRICA Laura/AAM-7275-2021	Varanini, Maurizio/0000-0001-8489-3560; santarcangelo, enrica laura/0000-0003-2519-1491	Pisa University; Fondazione ARPA (Pisa)	Pisa University; Fondazione ARPA (Pisa)	The study was funded by Pisa University and Fondazione ARPA (Pisa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SL, 1991, J PERS SOC PSYCHOL, V61, P504, DOI 10.1037/0022-3514.61.3.504; BALTHAZARD CG, 1989, INT J CLIN EXP HYP, V37, P70, DOI 10.1080/00207148908410534; Carli G, 2008, ARCH ITAL BIOL, V146, P75; Carvalho C, 2008, INT J CLIN EXP HYP, V56, P295, DOI 10.1080/00207140802041850; Casiglia E, 2007, AM J CLIN HYPN, V49, P255, DOI 10.1080/00029157.2007.10524503; CHEN ACN, 1989, PAIN, V37, P143, DOI 10.1016/0304-3959(89)90126-7; de la Fuente-Fernandez R, 2009, PARKINSONISM RELAT D, V15, pS72, DOI 10.1016/S1353-8020(09)70785-0; De Pascalis V, 1999, PAIN, V83, P499, DOI 10.1016/S0304-3959(99)00157-8; De Pascalis V, 2008, PAIN, V134, P197, DOI 10.1016/j.pain.2007.09.005; DEBENEDITTIS G, 1989, INT J CLIN EXP HYP, V37, P55, DOI 10.1080/00207148908410533; DePascalis V, 1996, INT J PSYCHOPHYSIOL, V21, P163, DOI 10.1016/0167-8760(95)00050-X; DEPASCALIS V, 2000, INT J CLIN EXP HYP, V48, P15; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Fillingim Roger B, 2005, Curr Rheumatol Rep, V7, P342, DOI 10.1007/s11926-005-0018-7; GOLDSTEIN B, 1994, PEDIATR RES, V36, P358, DOI 10.1203/00006450-199409000-00016; HILGARD ER, 1975, ACTA NEUROBIOL EXP, V35, P741; Hodges GJ, 2009, APPL PHYSIOL NUTR ME, V34, P829, DOI 10.1139/H09-076; Hofbauer RK, 2001, J NEUROPHYSIOL, V86, P402, DOI 10.1152/jn.2001.86.1.402; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Jambrik Z, 2005, PAIN, V116, P181, DOI 10.1016/j.pain.2005.03.041; Jensen M, 2006, J BEHAV MED, V29, P95, DOI 10.1007/s10865-005-9031-6; Mekjavic IB, 2008, EUR J APPL PHYSIOL, V104, P193, DOI 10.1007/s00421-008-0727-5; MILLER MF, 1991, J ABNORM PSYCHOL, V100, P223, DOI 10.1037/0021-843X.100.2.223; Milling LS, 2008, CURR PAIN HEADACHE R, V12, P98, DOI 10.1007/s11916-008-0019-0; Milling LS, 2010, J CONSULT CLIN PSYCH, V78, P126, DOI 10.1037/a0017388; Milling LS, 2005, ANN BEHAV MED, V29, P116, DOI 10.1207/s15324796abm2902_6; Montgomery GH, 2000, INT J CLIN EXP HYP, V48, P138, DOI 10.1080/00207140008410045; Mourot L, 2009, PHYSIOL RES, V58, P83, DOI 10.33549/physiolres.931360; Oosterman JM, 2010, EUR J PAIN, V14, P1046, DOI 10.1016/j.ejpain.2010.04.004; Paoletti G, 2010, BRAIN RES BULL, V82, P65, DOI 10.1016/j.brainresbull.2010.03.003; Payne RA, 2006, J APPL PHYSIOL, V100, P136, DOI 10.1152/japplphysiol.00657.2005; PECKERMAN A, 1991, PSYCHOPHYSIOLOGY, V28, P485, DOI 10.1111/j.1469-8986.1991.tb01985.x; Pollatos O, 2012, PAIN, V153, P1680, DOI 10.1016/j.pain.2012.04.030; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Ray WJ, 2000, INT J CLIN EXP HYP, V48, P22, DOI 10.1080/00207140008410358; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Santarcangelo EL, 2008, INT J CLIN EXP HYP, V56, P255, DOI 10.1080/00207140802039649; Scattina E, 2012, EXP BRAIN RES, V216, P341, DOI 10.1007/s00221-011-2935-1; Sebastiani L, 2007, INT J PSYCHOPHYSIOL, V63, P125, DOI 10.1016/j.ijpsycho.2006.10.001; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Shea SA, 1996, EXP PHYSIOL, V81, P1; SPANOS NP, 1989, J ABNORM PSYCHOL, V98, P285, DOI 10.1037/0021-843X.98.3.285; TENENBAUM SJ, 1990, AM J CLIN HYPN, V33, P40, DOI 10.1080/00029157.1990.10402899; Tousignant-Laflamme Y, 2010, J PAIN, V11, P983, DOI 10.1016/j.jpain.2010.01.266; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; Weise F, 1993, Clin Auton Res, V3, P303, DOI 10.1007/BF01827331	47	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75023	10.1371/journal.pone.0075023	http://dx.doi.org/10.1371/journal.pone.0075023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130680	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900015
J	Taillebois, L; Castelin, M; Ovenden, JR; Bonillo, C; Keith, P				Taillebois, Laura; Castelin, Magalie; Ovenden, Jennifer R.; Bonillo, Celine; Keith, Philippe			Contrasting Genetic Structure among Populations of Two Amphidromous Fish Species (Sicydiinae) in the Central West Pacific	PLOS ONE			English	Article							PELAGIC LARVAL DURATION; INDO-PACIFIC; TELEOSTEI GOBIOIDEI; RANGE EXPANSION; REEF FISHES; PATTERNS; DISPERSAL; CONNECTIVITY; ISLAND; PHYLOGEOGRAPHY	Both present-day and past processes can shape connectivity of populations. Pleistocene vicariant events and dispersal have shaped the present distribution and connectivity patterns of aquatic species in the Indo-Pacific region. In particular, the processes that have shaped distribution of amphidromous goby species still remain unknown. Previous studies show that phylogeographic breaks are observed between populations in the Indian and Pacific Oceans where the shallow Sunda shelf constituted a geographical barrier to dispersal, or that the large spans of open ocean that isolate the Hawaiian or Polynesian Islands are also barriers for amphidromous species even though they have great dispersal capacity. Here we assess past and present genetic structure of populations of two amphidromous fish (gobies of the Sicydiinae) that are widely distributed in the Central West Pacific and which have similar pelagic larval durations. We analysed sections of mitochondrial COI, Cytb and nuclear Rhodospine genes in individuals sampled from different locations across their entire known range. Similar to other Sicydiinae fish, intraspecific mtDNA genetic diversity was high for all species (haplotype diversity between 0.9-0.96). Spatial analyses of genetic variation in Sicyopus zosterophorum demonstrated strong isolation across the Torres Strait, which was a geologically intermittent land barrier linking Australia to Papua New Guinea. There was a clear genetic break between the northwestern and the southwestern clusters in Si. zosterophorum (phi(ST) = 0.67502 for COI) and coalescent analyses revealed that the two populations split at 306 Kyr BP (95% HPD 79-625 Kyr BP), which is consistent with a Pleistocene separation caused by the Torres Strait barrier. However, this geographical barrier did not seem to affect Sm. fehlmanni. Historical and demographic hypotheses are raised to explain the different patterns of population structure and distribution between these species. Strategies aiming to conserve amphidromous fish should consider the presence of cryptic evolutionary lineages to prevent stock depletion.	[Taillebois, Laura; Castelin, Magalie; Keith, Philippe] UPMC, MNHN, CNRS, IRD,Milieux & Peuplements Aquat UMR 7208, Paris, France; [Taillebois, Laura] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Castelin, Magalie] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9R 5K6, Canada; [Ovenden, Jennifer R.] Univ Queensland, Mol Fisheries Lab, Brisbane, Qld, Australia; [Bonillo, Celine] Museum Natl Hist Nat, Serv Systemat Mol UMR 7138, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Charles Darwin University; Fisheries & Oceans Canada; University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN)	Taillebois, L (corresponding author), UPMC, MNHN, CNRS, IRD,Milieux & Peuplements Aquat UMR 7208, Paris, France.	laura.taillebois@cdu.edu.au	Ovenden, Jennifer/A-3717-2010	Ovenden, Jennifer/0000-0001-7538-1504	New Caledonian Government; Museum national d'Histoire naturelle of Paris; BIONEOCAL ANR; French Ichtyological Society (SFI); UMR BOREA [UMR7208]; AIMARA association	New Caledonian Government; Museum national d'Histoire naturelle of Paris; BIONEOCAL ANR(French National Research Agency (ANR)); French Ichtyological Society (SFI); UMR BOREA; AIMARA association	This study was supported by the New Caledonian Government, the Museum national d'Histoire naturelle of Paris (www.mnhn.fr/le-museum/), the BIONEOCAL ANR, the French Ichtyological Society (SFI), the UMR BOREA 7208 (www.mnhn.fr/mnhn/UMR7208/), and the AIMARA association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Brasher AM, 1996, TECHNICAL REPORT; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; BROTHERS EB, 1983, MAR BIOL, V76, P319, DOI 10.1007/BF00393035; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Chenoweth SF, 1998, P ROY SOC B-BIOL SCI, V265, P415, DOI 10.1098/rspb.1998.0310; Chubb AL, 1998, J HERED, V89, P8, DOI 10.1093/jhered/89.1.8; Cook BD, 2008, MOL ECOL, V17, P1066, DOI 10.1111/j.1365-294X.2007.03637.x; Covich AP, 2006, POL J ECOL, V54, P523; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Crandall ED, 2010, HEREDITY, V104, P563, DOI 10.1038/hdy.2009.138; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; De Bruyn M, 2007, MOL ECOL, V16, P4295, DOI 10.1111/j.1365-294X.2007.03481.x; Dettai A, 2011, DEEP-SEA RES PT II, V58, P250, DOI 10.1016/j.dsr2.2010.05.021; Dexter KG, 2010, J BIOGEOGR, V37, P2137, DOI 10.1111/j.1365-2699.2010.02362.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzsimons J. Michael, 1993, Ichthyological Exploration of Freshwaters, V4, P1; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Hantoro WS, 1997, QUATERN INT, V37, P73, DOI 10.1016/1040-6182(96)00010-9; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hasegawa T, 2009, J OCEANOGR, V65, P817, DOI 10.1007/s10872-009-0068-y; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hodges Marc H., 1998, Pacific Science, V52, P237; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Iida M, 2008, ENVIRON BIOL FISH, V83, P331, DOI 10.1007/s10641-008-9345-7; Imron, 2007, MOL ECOL, V16, P289, DOI 10.1111/j.1365-294X.2006.03141.x; Jennings JN, 1972, SOME ATTRIBUTES TORR, P29; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; Keith P, 2011, MAR BIOL, V158, P311, DOI 10.1007/s00227-010-1560-z; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Keith P., 2010, POISSONS CRUSTACES E; KINZIE RA, 1988, ENVIRON BIOL FISH, V22, P179, DOI 10.1007/BF00005380; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leis JM, 2002, ENVIRON BIOL FISH, V65, P199, DOI 10.1023/A:1020096720543; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindstrom DP, 2012, COPEIA, P293, DOI 10.1643/CI-11-027; Lord C, 2012, MAR ECOL PROG SER, V455, P269, DOI 10.3354/meps09617; Lord C, 2010, ECOL FRESHW FISH, V19, P26, DOI 10.1111/j.1600-0633.2009.00386.x; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Lukoschek V, 2007, MOL ECOL, V16, P3406, DOI 10.1111/j.1365-294X.2007.03392.x; Luton Corene D., 2005, Micronesica, V38, P1; Maeda K, 2010, PAC SCI, V64, P161, DOI 10.2984/64.2.161; Marquet G., 2003, ATLAS POISSONS CRUST; McDowall RM, 2007, FISH FISH, V8, P1, DOI 10.1111/j.1467-2979.2007.00232.x; Mirams AGK, 2011, CORAL REEFS, V30, P937, DOI 10.1007/s00338-011-0767-x; Monti D, 2009, CAN J FISH AQUAT SCI, V66, P1282, DOI 10.1139/F09-075; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; MYERS GS, 1949, COPEIA, P89; Myers MJ, 2000, FRESHWATER BIOL, V44, P535, DOI 10.1046/j.1365-2427.2000.00599.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishimoto RT, 1991, NEW DIRECTIONS RES M, P77; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaud A., 2007, TRACER VERSION 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rocha LA, 2005, MOL ECOL, V14, P3921, DOI 10.1111/j.1365-294X.2005.02698.x; Roughgarden J., 1989, P403; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Schultz JK, 2007, MAR BIOL, V151, P167, DOI 10.1007/s00227-006-0471-5; SLATKIN M, 1991, GENETICS, V129, P555; Smith GC, 2003, BIOSCIENCE, V53, P1048, DOI 10.1641/0006-3568(2003)053[1048:AEPOTB]2.0.CO;2; Taillebois L, 2011, GEN COMP ENDOCR, V173, P281, DOI 10.1016/j.ygcen.2011.06.008; Taillebois L, 2012, THESIS MUSEUM NATL H; Taillebois L, 2012, ECOL FRESHW FISH, V21, P552, DOI 10.1111/j.1600-0633.2012.00575.x; Thacker CE, 2004, CORAL REEFS, V23, P357, DOI 10.1007/s00338-004-0391-0; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Tillett BJ, 2012, CONSERV GENET, V13, P99, DOI 10.1007/s10592-011-0268-z; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; WALLACE C C, 1991, Australian Systematic Botany, V4, P199, DOI 10.1071/SB9910199; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Watanabe Shun, 2006, Coastal Marine Science, V30, P473; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Waters JM, 2000, MOL ECOL, V9, P1815, DOI 10.1046/j.1365-294x.2000.01082.x; Watson RE, 2001, CYBIUM, V25, P41; Watson Ronald E., 1999, Aqua (Graffignana), V3, P113; Watson Ronald E., 1999, Aqua (Graffignana), V3, P93; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Winters KL, 2010, MAR BIOL, V157, P1679, DOI 10.1007/s00227-010-1442-4; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	95	23	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75465	10.1371/journal.pone.0075465	http://dx.doi.org/10.1371/journal.pone.0075465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130714	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900038
J	Zou, JH; Storm, DR; Xia, ZG				Zou, Junhui; Storm, Daniel R.; Xia, Zhengui			Conditional Deletion of ERK5 MAP Kinase in the Nervous System Impairs Pheromone Information Processing and Pheromone-Evoked Behaviors	PLOS ONE			English	Article							ACCESSORY OLFACTORY-BULB; TARGETED DELETION; VOMERONASAL ORGAN; SEXUAL-BEHAVIOR; MALE-MICE; MAIN; DISCRIMINATION; NEUROGENESIS; PREFERENCE; INPUT	ERK5 MAP kinase is highly expressed in the developing nervous system but absent in most regions of the adult brain. It has been implicated in regulating the development of the main olfactory bulb and in odor discrimination. However, whether it plays an essential role in pheromone-based behavior has not been established. Here we report that conditional deletion of the Mapk7 gene which encodes ERK5 in mice in neural stem cells impairs several pheromone-mediated behaviors including aggression and mating in male mice. These deficits were not caused by a reduction in the level of testosterone, by physical immobility, by heightened fear or anxiety, or by depression. Using mouse urine as a natural pheromone-containing solution, we provide evidence that the behavior impairment was associated with defects in the detection of closely related pheromones as well as with changes in their innate preference for pheromones related to sexual and reproductive activities. We conclude that expression of ERK5 during development is critical for pheromone response and associated animal behavior in adult mice.	[Zou, Junhui; Xia, Zhengui] Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Storm, Daniel R.; Xia, Zhengui] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xia, ZG (corresponding author), Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	zxia@u.washington.edu			National Institutes of Health [R01 MH95840, R01 DC004156]; National Institute of Child Health and Human Development [P30 HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health grants (R01 MH95840 to Z X and R01 DC004156 to DRS) and facilitated by grant P30 HD02274 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum MJ, 2009, ANNU REV PHYSIOL, V71, P141, DOI 10.1146/annurev.physiol.010908.163137; BRENNAN PA, 2010, PHEROMONES MAMMALIAN; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cundiff P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005204; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Giammanco M, 2005, MED SCI MONITOR, V11, pRA136; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Jakupovic J, 2008, PHYSIOL BEHAV, V93, P467, DOI 10.1016/j.physbeh.2007.10.005; Keller M, 2006, CHEM SENSES, V31, P753, DOI 10.1093/chemse/bjl018; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; LI T, 2013, PLOS ONE; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; POWERS JB, 1975, SCIENCE, V187, P961, DOI 10.1126/science.1145182; RAISMAN G, 1972, EXP BRAIN RES, V14, P395; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Slotnick B, 2010, EUR J NEUROSCI, V31, P1108, DOI 10.1111/j.1460-9568.2010.07141.x; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Wang Z, 2007, MOL NEUROBIOL, V35, P317, DOI 10.1007/s12035-007-0014-1; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; WINANS SS, 1970, SCIENCE, V170, P330, DOI 10.1126/science.170.3955.330; WYSOCKI CJ, 1979, NEUROSCI BIOBEHAV R, V3, P301, DOI 10.1016/0149-7634(79)90015-0; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76901	10.1371/journal.pone.0076901	http://dx.doi.org/10.1371/journal.pone.0076901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130808	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900102
J	Zhou, C; Lei, H; Chen, YX; Liu, Q; Li, LC; Moorhead, JF; Varghese, Z; Ruan, XZ				Zhou, Chao; Lei, Han; Chen, Yaxi; Liu, Qing; Li, Lung-Chih; Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.			Enhanced SCAP Glycosylation by Inflammation Induces Macrophage Foam Cell Formation	PLOS ONE			English	Article							ACCELERATED ATHEROSCLEROSIS; CHOLESTEROL; MECHANISMS; RECEPTOR; INFECTION; PROLIFERATION; DYSREGULATION; EXPRESSION; RESISTANCE; SIROLIMUS	Inflammatory stress promotes foam cell formation by disrupting LDL receptor feedback regulation in macrophages. Sterol Regulatory Element Binding Proteins (SREBPs) Cleavage-Activating Protein (SCAP) glycosylation plays crucial roles in regulating LDL receptor and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCoAR) feedback regulation. The present study was to investigate if inflammatory stress disrupts LDL receptor and HMGCoAR feedback regulation by affecting SCAP glycosylation in THP-1 macrophages. Intracellular cholesterol content was assessed by Oil Red O staining and quantitative assay. The expression of molecules controlling cholesterol homeostasis was examined using real-time quantitative RT-PCR and Western blotting. The translocation of SCAP from the endoplasmic reticulum (ER) to the Golgi was detected by confocal microscopy. We demonstrated that exposure to inflammatory cytokines increased lipid accumulation in THP-1 macrophages, accompanying with an increased SCAP expression even in the presence of a high concentration of LDL. These inflammatory cytokines also prolonged the half-life of SCAP by enhancing glycosylation of SCAP due to the elevated expression of the Golgi mannosidase II. This may enhance translocation and recycling of SCAP between the ER and the Golgi, escorting more SREBP2 from the ER to the Golgi for activation by proteolytic cleavages as evidenced by an increased N-terminal of SREBP2 (active form). As a consequence, the LDL receptor and HMGCoAR expression were up-regulated. Interestingly, these effects could be blocked by inhibitors of Golgi mannosidases. Our results indicated that inflammation increased native LDL uptake and endogenous cholesterol de novo synthesis, thereby causing foam cell formation via increasing transcription and protein glycosylation of SCAP in macrophages. These data imply that inhibitors of Golgi processing enzymes might have a potential vascular-protective role in prevention of atherosclerotic foam cell formation.	[Zhou, Chao; Lei, Han; Chen, Yaxi; Ruan, Xiong Z.] Chongqing Med Univ, Ctr Lipid Res, Key Lab Metab Lipid & Glucose, Chongqing, Peoples R China; [Zhou, Chao; Lei, Han] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China; [Liu, Qing] Chongqing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Chongqing, Peoples R China; [Zhou, Chao; Li, Lung-Chih; Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.] UCL, Sch Med, Ctr Nephrol, John Moorhead Res Lab, London W1N 8AA, England; [Li, Lung-Chih] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Li, Lung-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of London; University College London; UCL Medical School; Chang Gung Memorial Hospital; Chang Gung University	Lei, H (corresponding author), Chongqing Med Univ, Ctr Lipid Res, Key Lab Metab Lipid & Glucose, Chongqing, Peoples R China.	xiaoban@cqmu.edu.cn; x.ruan@ucl.ac.uk	Ruan, Xiong Zhong/GZA-5963-2022; Moorhead, John/M-7404-2014	Ruan, Xiong Zhong/0000-0001-5199-4971; 	Major State Basic Research Development Program of China (973 Program) [2012CB517700, 2012CB517500]; National Natural Science Foundation of China [81070631, 81070317, 81030008, 81270493, 81270789, 81200567]; Moorhead Trust; Royal Free Hospital Special Trustees Grant [115]; Kidney Research UK [RP37/2008]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Moorhead Trust; Royal Free Hospital Special Trustees Grant; Kidney Research UK(Kidney Research UK (KRUK))	This study was supported by Major State Basic Research Development Program of China (973 Program, NO. 2012CB517700 & 2012CB517500), the National Natural Science Foundation of China (81070631, 81070317, and Key Program, No. 81030008,81270493, 81270789, 81200567), the Moorhead Trust, the Royal Free Hospital Special Trustees Grant-115 through Dr. Zac Varghese, and Kidney Research UK (RP37/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NHLBI MORB MORT CHAR, DOI Bethesda, MD; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Cooke CL, 2009, GASTROENTEROLOGY, V137, P1061, DOI 10.1053/j.gastro.2009.04.014; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Kreisman LSC, 2012, GLYCOBIOLOGY, V22, P1019, DOI 10.1093/glycob/cws070; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Li LC, 2013, AM J PHYSIOL-HEART C, V304, pH874, DOI 10.1152/ajpheart.00096.2012; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Linden S, 2010, HELICOBACTER, V15, P251, DOI 10.1111/j.1523-5378.2010.00765.x; Liuzzo G, 1999, J AM COLL CARDIOL, V34, P1696, DOI 10.1016/S0735-1097(99)00432-5; Ma KL, 2007, AM J PHYSIOL-HEART C, V292, pH2721, DOI 10.1152/ajpheart.01174.2006; Ma KL, 2010, AM J PHYSIOL-HEART C, V298, pH1646, DOI 10.1152/ajpheart.00492.2009; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruan XZ, 2006, ARTERIOSCL THROM VAS, V26, P1150, DOI 10.1161/01.ATV.0000217957.93135.c2; Ruan XZ, 2003, NEPHROL DIAL TRANSPL, V18, P27, DOI 10.1093/ndt/18.1.27; Ruan XZ, 2001, KIDNEY INT, V60, P1716, DOI 10.1046/j.1523-1755.2001.00025.x; Skaggs BJ, 2012, NAT REV RHEUMATOL, V8, P214, DOI 10.1038/nrrheum.2012.14; Swaminathan S, 2011, KIDNEY INT, V80, P453, DOI 10.1038/ki.2011.178; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Ye Q, 2009, INFLAMM RES, V58, P809, DOI 10.1007/s00011-009-0052-4; Yuan Y, 2011, AM J PHYSIOL-RENAL, V301, pF236, DOI 10.1152/ajprenal.00646.2010	34	16	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75650	10.1371/journal.pone.0075650	http://dx.doi.org/10.1371/journal.pone.0075650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146768	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400013
J	Deng, SF; Wang, M; Yan, ZC; Tian, Z; Chen, HR; Yang, XJ; Zhuo, YH				Deng, Shuifeng; Wang, Mei; Yan, Zhichao; Tian, Zhen; Chen, Hongrui; Yang, Xuejiao; Zhuo, Yehong			Autophagy in Retinal Ganglion Cells in a Rhesus Monkey Chronic Hypertensive Glaucoma Model	PLOS ONE			English	Article							NEURONAL AUTOPHAGY; CEREBRAL-ISCHEMIA; PRIMATE GLAUCOMA; MECHANISMS; BECLIN-1; DEATH; LC3; MACROAUTOPHAGY; DEGENERATION; ACTIVATION	Primary open angle glaucoma (POAG) is a neurodegenerative disease characterized by physiological intraocular hypertension that causes damage to the retinal ganglion cells (RGCs). In the past, RGC damage in POAG was suggested to have been attributed to RGC apoptosis. However, in the present study, we applied a model closer to human POAG through the use of a chronic hypertensive glaucoma model in rhesus monkeys to investigate whether another mode of progressive cell death, autophagy, was activated in the glaucomatous retinas. First, in the glaucomatous retinas, the levels of LC3B-II, LC3B-II/LC3B-I and Beclin 1 increased as demonstrated by Western blot analyses, whereas early or initial autophagic vacuoles (AVi) and late or degraded autophagic vacuoles (AVd) accumulated in the ganglion cell layer (GCL) and in the inner plexiform layer (IPL) as determined by transmission electron microscopy (TEM) analysis. Second, lysosome activity and autophagosome-lysosomal fusion increased in the RGCs of the glaucomatous retinas, as demonstrated by Western blotting against lysosome associated membrane protein-1 (LAMP1) and double labeling against LC3B and LAMP1. Third, apoptosis was activated in the glaucomatous eyes with increased levels of caspase-3 and cleaved caspase-3 and an increased number of TUNEL-positive RGCs. Our results suggested that autophagy was activated in RGCs in the chronic hypertensive glaucoma model of rhesus monkeys and that autophagy may have potential as a new target for intervention in glaucoma treatment.	[Deng, Shuifeng; Yan, Zhichao; Tian, Zhen; Chen, Hongrui; Yang, Xuejiao; Zhuo, Yehong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhuo, YH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn	Yang, Xuejiao/GPG-4151-2022; Yan, Zhichao/P-7671-2014	Yang, Xuejiao/0000-0002-5347-1071; Yan, Zhichao/0000-0003-1442-3015	Key Project of the Natural Science Foundation of Guangdong Province [10251008901000028]; National Natural Science Foundation of China [81270992]; Natural Science Foundation of Guangdong Province [10451008901004759, s2011010006058]	Key Project of the Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Key Project of the Natural Science Foundation of Guangdong Province (No. 10251008901000028), the National Natural Science Foundation of China (No. 81270992)), and the Natural Science Foundation of Guangdong Province (Nos. 10451008901004759 and s2011010006058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Jindal V, 2013, MOL NEUROBIOL, V48, P186, DOI 10.1007/s12035-013-8416-8; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim SH, 2008, J NEUROSCI RES, V86, P2943, DOI 10.1002/jnr.21738; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lalezary M, 2006, AM J OPHTHALMOL, V142, P576, DOI 10.1016/j.ajo.2006.05.004; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; McLeland CB, 2011, METHODS MOL BIOL, V697, P199, DOI 10.1007/978-1-60327-198-1_21; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrison JC, 2011, EXP EYE RES, V93, P156, DOI 10.1016/j.exer.2010.08.005; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; PEDERSON JE, 1984, ARCH OPHTHALMOL-CHIC, V102, P1689, DOI 10.1001/archopht.1984.01040031373030; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rasmussen CA, 2005, J GLAUCOMA, V14, P311, DOI 10.1097/01.ijg.0000169409.01635.bc; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; You Y, 2013, REV NEUROSCIENCE, V24, P301, DOI 10.1515/revneuro-2013-0003; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602	48	61	64	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77100	10.1371/journal.pone.0077100	http://dx.doi.org/10.1371/journal.pone.0077100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143204	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100039
J	Gomez-Carballa, A; Pardo-Seco, J; Fachal, L; Vega, A; Cebey, M; Martinon-Torres, N; Martinon-Torres, F; Salas, A				Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Fachal, Laura; Vega, Ana; Cebey, Miriam; Martinon-Torres, Nazareth; Martinon-Torres, Federico; Salas, Antonio			Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; VLAX ROMA; GENETIC DIVERSITY; MTDNA VARIATION; POPULATIONS; HISTORY; ASSOCIATION; HAPLOGROUPS; ADMIXTURE; ANCESTRY	In agreement with historical documentation, several genetic studies have revealed ancestral links between the European Romani and India. The entire mitochondrial DNA (mtDNA) of 27 Spanish Romani was sequenced in order to shed further light on the origins of this population. The data were analyzed together with a large published dataset (mainly hypervariable region I [HVS-I] haplotypes) of Romani (N = 1,353) and non-Romani worldwide populations (N. 150,000). Analysis of mitogenomes allowed the characterization of various Romani-specific clades. M5a1b1a1 is the most distinctive European Romani haplogroup; it is present in all Romani groups at variable frequencies (with only sporadic findings in non-Romani) and represents 18% of their mtDNA pool. Its phylogeographic features indicate that M5a1b1a1 originated 1.5 thousand years ago (kya; 95% CI: 1.3-1.8) in a proto-Romani population living in Northwest India. U3 represents the most characteristic Romani haplogroup of European/Near Eastern origin (12.4%); it appears at dissimilar frequencies across the continent (Iberia: similar to 31%; Eastern/Central Europe:,13%). All U3 mitogenomes of our Iberian Romani sample fall within a new sub-clade, U3b1c, which can be dated to 0.5 kya (95% CI: 0.3-0.7); therefore, signaling a lower bound for the founder event that followed admixture in Europe/Near East. Other minor European/Near Eastern haplogroups (e.g. H24, H88a) were also assimilated into the Romani by introgression with neighboring populations during their diaspora into Europe; yet some show a differentiation from the phylogenetically closest non-Romani counterpart. The phylogeny of Romani mitogenomes shows clear signatures of low effective population sizes and founder effects. Overall, these results are in good agreement with historical documentation, suggesting that cultural identity and relative isolation have allowed the Romani to preserve a distinctive mtDNA heritage, with some features linking them unequivocally to their ancestral Indian homeland.	[Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Grp Med Xen GMX, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Fachal, Laura; Vega, Ana; Cebey, Miriam; Martinon-Torres, Nazareth; Martinon-Torres, Federico; Salas, Antonio] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Fachal, Laura; Vega, Ana; Cebey, Miriam; Martinon-Torres, Nazareth; Martinon-Torres, Federico; Salas, Antonio] Univ Santiago de Compostela USC, Galicia, Spain; [Fachal, Laura; Vega, Ana; Martinon-Torres, Federico] IDIS, Grp Med Xen USC, Fdn Publ Galega Med Xen SERGAS, Santiago De Compostela, Galicia, Spain; [Martinon-Torres, Nazareth] Hosp Clin Univ Santiago, Dept Pediat, Pediat Emergency & Crit Care Div, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain.	antonio.salas@usc.es	Vega, Ana/R-4758-2019; Martinon-Torres, Federico/E-4982-2016; Gómez-Carballa, Alberto/I-4610-2014; Pardo-Seco, Jacobo J/G-3752-2016; Salas, Antonio/U-2029-2019; Cebey, Miriam/K-9347-2014; Salas, Antonio/E-3977-2012; Fachal, Laura/N-5560-2014	Martinon-Torres, Federico/0000-0002-9023-581X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Salas, Antonio/0000-0002-2336-702X; Cebey, Miriam/0000-0003-0599-7519; Salas, Antonio/0000-0002-2336-702X; Fachal, Laura/0000-0002-7256-9752	Ministerio de Ciencia e Innovacion [SAF2008-02971]; Plan Galego IDT; Xunta de Galicia [EM 2012/045]; Conselleria de Sanidade/Xunta de Galicia; Instituto Carlos III; Fondo de Investigacion Sanitaria [FIS, PI070069, PI1000540]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Conselleria de Sanidade/Xunta de Galicia(Xunta de Galicia); Instituto Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	The research leading to these results has received funding from the "Ministerio de Ciencia e Innovacion'' (SAF2008-02971) and from the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (A.S.) and Conselleria de Sanidade/Xunta de Galicia (RHI07/2- intensificacion actividad investigadora and 10PXIB918184PR), Instituto Carlos III (Intensificacio ' n de la actividad investigadora) and Fondo de Investigacion Sanitaria (FIS; PI070069 and PI1000540) del plan nacional de I+ D+ I and 'fondos FEDER' (F.M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt H-J, 2012, INT J LEGAL IN PRESS; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Chaix R, 2004, EUR J HUM GENET, V12, P285, DOI 10.1038/sj.ejhg.5201126; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Correa-Teiseira R, 2007, HIST CIGANOS BRASIL; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Deason ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-24; Dubut V, 2009, ANN HUM GENET, V73, P314, DOI 10.1111/j.1469-1809.2009.00519.x; Egyed B, 2007, FORENSIC SCI INT-GEN, V1, P158, DOI 10.1016/j.fsigen.2007.03.001; Fernandez O, 2008, TISSUE ANTIGENS, V71, P426, DOI 10.1111/j.1399-0039.2008.01016.x; Fraser, 1995, GYPSIES; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Iovita RP, 2004, AM ANTHROPOL, V106, P267, DOI 10.1525/aa.2004.106.2.267; Irwin J, 2007, INT J LEGAL MED, V121, P377, DOI 10.1007/s00414-006-0128-4; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Lee WC, 2003, ANN HUM GENET, V67, P618, DOI 10.1046/j.1529-8817.2003.00063.x; Liegois JP, 2007, ROMS EUROPE EDITIONS; Malyarchuk BA, 2006, ANN HUM GENET, V70, P195, DOI 10.1111/j.1529-8817.2005.00222.x; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Klaric IM, 2009, AM J PHYS ANTHROPOL, V138, P333, DOI 10.1002/ajpa.20933; Mendizabal I, 2012, CURR BIOL, V22, P2342, DOI 10.1016/j.cub.2012.10.039; Mendizabal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015988; Moorjani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058633; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Non AL, 2011, AM J PHYS ANTHROPOL, V144, P1, DOI 10.1002/ajpa.21360; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Rai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048477; Regueiro M, 2012, GENE, V504, P296, DOI 10.1016/j.gene.2012.04.093; Repiska V, 2010, MOL BIOL+, V44, P870, DOI 10.1134/S0026893310060038; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Salihovic MP, 2011, AM J PHYS ANTHROPOL, V146, P262, DOI 10.1002/ajpa.21566; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stefflova K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007842; Stevens EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002287; Thomas-Sinclair A, 1917, AM GYPSIES; Trovoada MJ, 2004, ANN HUM GENET, V68, P40, DOI 10.1046/j.1529-8817.2003.00070.x; Turner RL, 1984, POSITION ROMANI INDO; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023	55	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75397	10.1371/journal.pone.0075397	http://dx.doi.org/10.1371/journal.pone.0075397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143169	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100004
J	Mu, DL; Li, LH; Wang, DX; Li, N; Shan, GJ; Li, J; Yu, QJ; Shi, CX				Mu, Dong-Liang; Li, Li-Huan; Wang, Dong-Xin; Li, Nan; Shan, Guo-Jin; Li, Jun; Yu, Qin-Jun; Shi, Chun-Xia			High Postoperative Serum Cortisol Level Is Associated with Increased Risk of Cognitive Dysfunction Early after Coronary Artery Bypass Graft Surgery: A Prospective Cohort Study	PLOS ONE			English	Article							CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; IMPAIRMENT; STRESS; ANESTHESIA; IMPACT; BRAIN; MEN	Context: Stress response induced by surgery is proposed to play an important role in the pathogenesis of postoperative cognitive dysfunction. Objective: To investigate the association between postoperative serum cortisol level and occurrence of cognitive dysfunction early after coronary artery bypass graft surgery. Design: Prospective cohort study. Setting: Two teaching hospitals. Patients: One hundred and sixth-six adult patients who were referred to elective coronary artery bypass graft surgery from March 2008 to December 2009. Intervention: None. Main Outcome Measures: Neuropsychological tests were completed one day before and seven days after surgery. Cognitive dysfunction was defined using the same definition as used in the ISPOCD1-study. Blood samples were obtained in the first postoperative morning for measurement of serum cortisol concentration. Multivariate Logistic regression analyses were performed to assess the relationship between serum cortisol level and occurrence of postoperative cognitive dysfunction. Results: Cognitive dysfunction occurred in 39.8% (66 of 166) of patients seven days after surgery. Multivariate Logistic regression analysis showed that high serum cortisol level was significantly associated with the occurrence of postoperative cognitive dysfunction (odds ratio [OR] 2.603, 95% confidence interval [CI] 1.371-4.944, P = 0.003). Other independent predictors of early postoperative cognitive dysfunction included high preoperative New York Heart Association functional class (OR 0.402, 95% CI 0.207-0.782, P = 0.007), poor preoperative Grooved Pegboard test score of nondominant hand (OR 1.022, 95% CI 1.003-1.040, P = 0.020), use of penehyclidine as premedication (OR 2.565, 95% CI 1.109-5.933, P = 0.028), and occurrence of complications within seven days after surgery (OR 2.677, 95% CI 1.201-5.963, P = 0.016). Conclusions: High serum cortisol level in the first postoperative morning was associated with increased risk of cognitive dysfunction seven days after coronary artery bypass graft surgery.	[Mu, Dong-Liang; Wang, Dong-Xin; Li, Nan; Shan, Guo-Jin; Li, Jun] Peking Univ, Hosp 1, Dept Anesthesiol & Surg Intens Care, Beijing 100871, Peoples R China; [Li, Li-Huan; Yu, Qin-Jun; Shi, Chun-Xia] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Anesthesiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Li-Huan; Yu, Qin-Jun; Shi, Chun-Xia] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, DX (corresponding author), Peking Univ, Hosp 1, Dept Anesthesiol & Surg Intens Care, Beijing 100871, Peoples R China.	wangdongxin@vip.sina.com			Peking University First Hospital, Beijing, China	Peking University First Hospital, Beijing, China	This study was supported by a fund for scientific research from Peking University First Hospital, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Belanoff JK, 2001, J PSYCHIATR RES, V35, P127, DOI 10.1016/S0022-3956(01)00018-8; BORNSTEIN RA, 1995, ACTA NEUROL SCAND, V91, P260, DOI 10.1111/j.1600-0404.1995.tb07001.x; Bottiggi KA, 2006, AM J GERIAT PSYCHIAT, V14, P980, DOI 10.1097/01.JGP.0000224619.87681.71; Canet J, 2003, ACTA ANAESTH SCAND, V47, P1204, DOI 10.1046/j.1399-6576.2003.00238.x; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Ferrari E, 2001, EUR J ENDOCRINOL, V144, P319, DOI 10.1530/eje.0.1440319; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Ghoneim MM, 2012, EUR J ANAESTH, V29, P409, DOI 10.1097/EJA.0b013e328356bd6e; Grigore AM, 2009, ANESTH ANALG, V109, P1741, DOI 10.1213/ANE.0b013e3181c04fea; Hamad MAS, 2007, ACTA ANAESTH BELG, V58, P37; Hamad MAS, 2008, ANN THORAC SURG, V85, P488, DOI 10.1016/j.athoracsur.2007.09.010; Han XY, 2005, BIOORG MED CHEM LETT, V15, P1979, DOI 10.1016/j.bmcl.2005.02.071; Hartholt KA, 2012, Z GERONTOL GERIATR, V45, P411, DOI 10.1007/s00391-012-0326-2; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Hoda MR, 2006, ANN THORAC SURG, V82, P2179, DOI 10.1016/j.athoracsur.2006.06.087; Hogue CW, 2006, ANESTH ANALG, V102, P1602, DOI 10.1213/01.ANE.0000219591.10826.17; Hoth KF, 2008, COGN BEHAV NEUROL, V21, P65, DOI 10.1097/WNN.0b013e3181799dc8; Hudetz JA, 2012, EUR J ANAESTH, V29, P320, DOI 10.1097/EJA.0b013e328354223d; Hwang HY, 2012, ANN THORAC SURG, V94, P1157, DOI 10.1016/j.athoracsur.2012.04.118; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; JI MH, 2013, J ANESTH, DOI DOI 10.1007/S00540-013-1633-5.PUBMED:23666452; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Liu YH, 2009, ANESTH ANALG, V109, P1013, DOI 10.1213/ane.0b013e3181aed2bb; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Mu Dong-liang, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P242; Mu DL, 2010, CRIT CARE, V14, DOI 10.1186/cc9393; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2; Rasmussen LS, 1998, EUR J ANAESTH, V15, P761, DOI 10.1097/00003643-199811000-00026; Rasmussen LS, 2005, ACTA ANAESTH SCAND, V49, P1225, DOI 10.1111/j.1399-6576.2005.00791.x; RothIsigkeit AK, 1997, STEROIDS, V62, P695, DOI 10.1016/S0039-128X(97)00069-X; Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Siepe M, 2011, EUR J CARDIO-THORAC, V40, P200, DOI 10.1016/j.ejcts.2010.11.024; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P431, DOI 10.1097/00000542-200703000-00006; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Song SW, 2008, CIRC J, V72, P1966, DOI 10.1253/circj.CJ-08-0291; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x; Widmer IE, 2005, J CLIN ENDOCR METAB, V90, P4579, DOI 10.1210/jc.2005-0354; YAN M, 2006, LIN CHUANG MA ZUI XU, V22, P827	50	26	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77637	10.1371/journal.pone.0077637	http://dx.doi.org/10.1371/journal.pone.0077637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143249	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100087
J	Verhagen, LM; Incani, RN; Franco, CR; Ugarte, A; Cadenas, Y; Ruiz, CIS; Hermans, PWM; Hoek, D; Ponce, MC; de Waard, JH; Pinelli, E				Verhagen, Lilly M.; Incani, Renzo N.; Franco, Carolina R.; Ugarte, Alejandra; Cadenas, Yeneska; Sierra Ruiz, Carmen I.; Hermans, Peter W. M.; Hoek, Denise; Ponce, Maiza Campos; de Waard, Jacobus H.; Pinelli, Elena			High Malnutrition Rate in Venezuelan Yanomami Compared to Warao Amerindians and Creoles: Significant Associations WITH Intestinal Parasites and Anemia	PLOS ONE			English	Article							TRANSMITTED-HELMINTH INFECTIONS; GIARDIA-LAMBLIA INFECTION; SCHOOL-AGED CHILDREN; ORANG ASLI CHILDREN; NUTRITIONAL-STATUS; PRESCHOOL-CHILDREN; ANTHROPOMETRIC INDICATORS; ANTHELMINTIC TREATMENT; HOOKWORM INFECTION; COST-EFFECTIVENESS	Background: Children in rural areas experience the interrelated problems of poor growth, anemia and parasitic infections. We investigated the prevalence of and associations between intestinal helminth and protozoan infections, malnutrition and anemia in school-age Venezuelan children. Methods: This cross-sectional study was conducted in 390 children aged 4-16 years from three rural areas of Venezuela: the Amazon Region, Orinoco Delta and Carabobo State. Stool samples were collected for direct parasitic examinations. Anthropometric indicators of chronic (height-for-age Z score) and acute (weight-for-height and Body Mass Index (BMI)-for-age Z score in respectively children under 5 years of age and children aged 5 years and above) malnutrition were calculated. Multivariate linear and logistic regression models were built to determine factors associated with nutritional status and polyparasitism. Results: Hookworm and Strongyloides stercoralis prevalences were highest in children from the Amazon rainforest (respectively 72% and 18%) while children from the Orinoco Delta and Carabobo State showed higher rates of Ascaris lumbricoides (respectively 28% and 37%) and Trichuris trichiura (40% in both regions). The prevalence of Giardia lamblia infection was not significantly different between regions (average: 18%). Anemia prevalence was highest in the Amazon Region (24%). Hemoglobin levels were significantly decreased in children with a hookworm infection. Malnutrition was present in respectively 84%, 30% and 13% of children from the Amazon Region, Orinoco Delta and Carabobo State. In multivariate analysis including all regions, G. lamblia and helminth infections were significantly and negatively associated with respectively height-for-age and weight-for-height/BMI-for-age Z scores. Furthermore, hemoglobin levels were positively associated with the height-for-age Z score (0.11, 95% CI 0.02 - 0.20). Conclusions: In rural populations in Venezuela helminthiasis and giardiasis were associated with acute and chronic nutritional status respectively. These data highlight the need for an integrated approach to control transmission of parasites and improve the health status of rural Venezuelan children.	[Verhagen, Lilly M.; Sierra Ruiz, Carmen I.; de Waard, Jacobus H.] Cent Univ Venezuela, Inst Biomed, Lab TB, Caracas, Venezuela; [Verhagen, Lilly M.; Hermans, Peter W. M.] Radboud Univ Nijmegen Med Ctr, Lab Pediat Infect Dis, Nijmegen, Netherlands; [Incani, Renzo N.] Univ Carabobo, Fac Ciencias Salud, Dept Parasitol, Valencia, Venezuela; [Franco, Carolina R.] Hosp Ninos JM de los Rios, Dept Pediat, Caracas, Venezuela; [Ugarte, Alejandra; Cadenas, Yeneska] Cent Univ Venezuela, Escuela Bioanal, Caracas, Venezuela; [Hoek, Denise; Pinelli, Elena] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [Ponce, Maiza Campos] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands	University of Central Venezuela; Radboud University Nijmegen; University of Central Venezuela; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam	Verhagen, LM (corresponding author), Cent Univ Venezuela, Inst Biomed, Lab TB, Caracas, Venezuela.	lillyverhagen@hotmail.com	Hermans, Peter W.M./H-8042-2014; de Waard, Jacobus/AGM-8709-2022; Verhagen, Lilly M./AAG-3044-2021	Verhagen, Lilly M./0000-0002-3451-9201; Campos Ponce, Maiza/0000-0003-1700-4756; de Waard, Jacobus H./0000-0003-4118-1015	Fundacion para la Investigacion en Micobacterias (FUNDAIM), Caracas; LOCTI - Universidad de Carabobo project, Valencia, Venezuela	Fundacion para la Investigacion en Micobacterias (FUNDAIM), Caracas; LOCTI - Universidad de Carabobo project, Valencia, Venezuela	This study was supported by the Fundacion para la Investigacion en Micobacterias (FUNDAIM), Caracas, and by a LOCTI - Universidad de Carabobo project, Valencia, Venezuela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mekhlafi HMS, 2005, ASIA PAC J CLIN NUTR, V14, P188; Al-Mekhlafi MSH, 2005, T ROY SOC TROP MED H, V99, P686, DOI 10.1016/j.trstmh.2005.02.006; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Baird S, 2011, WORMS WORK LONG RUN; Basuni M, 2011, AM J TROP MED HYG, V84, P338, DOI 10.4269/ajtmh.2011.10-0499; BEAVER PC, 1953, AM J TROP MED HYG, V2, P102, DOI 10.4269/ajtmh.1953.2.102; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boatin BA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001547; Botero-Garces JH, 2009, REV INST MED TROP SP, V51, P155, DOI 10.1590/S0036-46652009000300006; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Brooker S, 2008, HEALTH POLICY PLANN, V23, P24, DOI 10.1093/heapol/czm041; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; BUNDY DAP, 1990, T ROY SOC TROP MED H, V84, P115, DOI 10.1016/0035-9203(90)90399-Y; Casapia M, 2006, INT J PARASITOL, V36, P741, DOI 10.1016/j.ijpara.2006.03.004; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; CDC, 2006, DPDX LAB ID PAR PUBL; Chhakda Tep, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P859; Coulibaly JT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-135; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Degarege A, 2013, J INFECT PUBLIC HEAL, V6, P125, DOI 10.1016/j.jiph.2012.11.008; Diniz LM, 2010, CLIN EXP IMMUNOL, V161, P142, DOI 10.1111/j.1365-2249.2010.04164.x; Duggan MB, 2010, ANN TROP PAEDIATR, V30, P1, DOI 10.1179/146532810X12637745451834; Duran C, 2010, J INFECT DEV COUNTR, V4, P417, DOI 10.3855/jidc.563; Emergency Nutrition Network, 2011, HARM TRAIN PACK RES; Farthing M, 2004, PRACTICE GUIDELINE M; Fernández de Larrea Carlos, 2002, Invest. clín, V43, P35; Fernández-Niño Julián A., 2007, Rev. salud pública, V9, P289; Francis L, 2012, INT J ENV RES PUB HE, V9, P2910, DOI 10.3390/ijerph9082910; Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013; Garcia LS, 2001, DIAGNOSTIC MED PARAS, P1; Gazzinelli A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001603; Giraldi N, 2001, Rev Soc Bras Med Trop, V34, P385, DOI 10.1590/S0037-86822001000400014; Giraldo-Gómez Jorge M, 2005, Rev. salud pública, V7, P327, DOI 10.1590/S0124-00642005000300008; Goto R, 2002, BRIT J NUTR, V88, P141, DOI 10.1079/BJN2002599; GUPTA MC, 1982, AM J CLIN NUTR, V36, P79, DOI 10.1093/ajcn/36.1.79; Hagel I, 1999, J TROP PEDIATRICS, V45, P215, DOI 10.1093/tropej/45.4.215; Hagel Isabel, 2006, Invest. clín, V47, P241; Hall A, 2007, LANCET INFECT DIS, V7, P297, DOI 10.1016/S1473-3099(07)70084-1; Halpenny CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002070; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Knopp S, 2009, T ROY SOC TROP MED H, V103, P347, DOI 10.1016/j.trstmh.2008.11.013; Leslie J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001326; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Machicado JD, 2012, T ROY SOC TROP MED H, V106, P333, DOI 10.1016/j.trstmh.2012.03.004; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mkhize-Kwitshana ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-273; Narain K, 2000, INDIAN J MED RES, V112, P140; Ndamukong K J N, 2005, East Afr Med J, V82, P559; Nematian J, 2008, ANN TROP MED PARASIT, V102, P209, DOI 10.1179/136485908X267876; Newman RD, 2001, TROP MED INT HEALTH, V6, P624, DOI 10.1046/j.1365-3156.2001.00757.x; Northrop-Clewes CA, 2001, AM J CLIN NUTR, V73, P53; Oninla SO, 2010, ANN TROP MED PARASIT, V104, P583, DOI 10.1179/136485910X12851868779786; Osazuwa F, 2011, N AM J MED SCI, V3, P30, DOI 10.4297/najms.2011.330; Phiri K, 2000, ANN TROP MED PARASIT, V94, P381, DOI 10.1080/00034983.2000.11813553; Pullan Rachel L, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-001936; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Pullan RL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000713; Quinnell RJ, 2003, INT J PARASITOL, V33, P1219, DOI 10.1016/S0020-7519(03)00175-9; Quinnell RJ, 2010, J INFECT DIS, V202, P954, DOI 10.1086/655813; Quintero K, 2012, INT HEALTH, V4, P103, DOI 10.1016/j.inhe.2012.03.002; Ramakrishna BS, 2006, POSTGRAD MED J, V82, P779, DOI 10.1136/pgmj.2006.048579; Ramsay CE, 1999, HUM GENET, V104, P269, DOI 10.1007/s004390050947; Righetti AA, 2013, J INFECT DIS, V207, P1604, DOI 10.1093/infdis/jit066; Romero-Amaro Z, 2008, KASMERA, V36, P159; Sackey ME, 2003, J TROP PEDIATRICS, V49, P17, DOI 10.1093/tropej/49.1.17; Shang Y, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-97; Siwila J, 2011, T ROY SOC TROP MED H, V105, P102, DOI 10.1016/j.trstmh.2010.10.004; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; Spencer LA, 2010, IMMUNOL CELL BIOL, V88, P250, DOI 10.1038/icb.2009.115; Tanner S, 2009, AM J HUM BIOL, V21, P651, DOI 10.1002/ajhb.20944; Tanner S, 2011, SOC SCI MED, V72, P701, DOI 10.1016/j.socscimed.2010.12.012; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; UDONSI JK, 1992, PUBLIC HEALTH, V106, P63, DOI 10.1016/S0033-3506(05)80330-0; Verhagen LM, 2012, TUBERCULOSIS, V92, P505, DOI 10.1016/j.tube.2012.07.004; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Villalba JA, 2013, AIDS, V27, P1783, DOI 10.1097/QAD.0b013e3283601bdb; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2012, ACC WORK OV GLOB IMP, P13; WHO, 2009, ANTHROPLUS PERS COMP; *WHO EXP COMM, 2002, PREV CONTR SCHIST SO; WHO Multicentre Growth Reference Study Group, 2006, CHILD GROWTH STAND M; WHO UNICEF, 2012, PROGR DRINK WAT SAN; Wiria AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057899; Wongstitwilairoong B, 2007, AM J TROP MED HYG, V76, P345, DOI 10.4269/ajtmh.2007.76.345; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT; Yori PP, 2006, AM J TROP MED HYG, V74, P97, DOI 10.4269/ajtmh.2006.74.97	92	33	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77581	10.1371/journal.pone.0077581	http://dx.doi.org/10.1371/journal.pone.0077581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143243	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100081
J	Zamzow, JP; Siebeck, UE; Eckes, MJ; Grutter, AS				Zamzow, Jill P.; Siebeck, Ulrike E.; Eckes, Maxi J.; Grutter, Alexandra S.			Ultraviolet-B Wavelengths Regulate Changes in UV Absorption of Cleaner Fish Labroides dimidiatus Mucus	PLOS ONE			English	Article							AMINO-ACIDS MAAS; GREAT-BARRIER-REEF; INDUCED DNA-DAMAGE; ABSORBING COMPOUNDS; EPIDERMAL MUCUS; SEA-URCHIN; SOLAR-RADIATION; DIET; PROTECTION; ABSORBENCY	High-energy wavelengths in the ultraviolet-B (UVB, 280-315 nm) and the UVA (315-400-nm) portion of the spectrum are harmful to terrestrial and aquatic organisms. Interestingly, UVA is also involved in the repair of UV induced damage. Organisms living in shallow coral reef environments possess UV absorbing compounds, such as mycosporine-like amino acids, to protect them from UV radiation. While it has been demonstrated that exposure to UV (280-400 nm) affects the UV absorbance of fish mucus, whether the effects of UV exposure vary between UVB and UVA wavelengths is not known. Therefore, we investigated whether the UVB, UVA, or photosynthetically active radiation (PAR, 400-700 nm) portions of the spectrum affected the UV absorbance of epithelial mucus and Fulton's body condition index of the cleaner fish Labroides dimidiatus. We also compared field-measured UV absorbance with laboratory based high-performance liquid chromatography measurements of mycosporine-like amino acid concentrations. After 1 week, we found that the UV absorbance of epithelial mucus was higher in the UVB+UVA+PAR treatment compared with the UVA+PAR and PAR only treatments; after 2 and 3 weeks, however, differences between treatments were not detected. After 3 weeks, Fulton's body condition index was lower for fish in the UVB+UVA+PAR compared with PAR and UVA+PAR treatments; furthermore, all experimentally treated fish had a lower Fulton's body condition index than did freshly caught fish. Finally, we found a decrease with depth in the UV absorbance of mucus of wild-caught fish. This study suggests that the increase in UV absorbance of fish mucus in response to increased overall UV levels is a function of the UVB portion of the spectrum. This has important implications for the ability of cleaner fish and other fishes to adjust their mucus UV protection in response to variations in environmental UV exposure.	[Zamzow, Jill P.; Eckes, Maxi J.; Grutter, Alexandra S.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Siebeck, Ulrike E.; Eckes, Maxi J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Siebeck, UE (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	u.siebeck@uq.edu.au	Grutter, Alexandra S/J-2737-2013; Siebeck, Ulrike E/J-6190-2014	Grutter, Alexandra S/0000-0003-1688-2821; Siebeck, Ulrike E/0000-0003-2024-1568	American Australian Association; University of Queensland Foundation	American Australian Association; University of Queensland Foundation(University of Queensland)	This work was supported by the American Australian Association, The University of Queensland Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED FE, 1993, CANCER RES, V53, P2249; Arbeloa EM, 2010, FOOD CHEM, V119, P586, DOI 10.1016/j.foodchem.2009.06.061; BAKER KS, 1982, LIMNOL OCEANOGR, V27, P500, DOI 10.4319/lo.1982.27.3.0500; Banaszak AT, 2009, PHOTOCH PHOTOBIO SCI, V8, P1276, DOI 10.1039/b902763g; Banaszak AT, 1998, B MAR SCI, V63, P617; Bandaranayake WM, 1999, MAR BIOL, V133, P163, DOI 10.1007/s002270050455; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Carefoot TH, 1998, MAR BIOL, V130, P389, DOI 10.1007/s002270050259; Carreto JI, 2011, MAR DRUGS, V9, P387, DOI 10.3390/md9030387; Carroll AK, 1996, MAR BIOL, V124, P561, DOI 10.1007/BF00351037; CHIOCCARA F, 1980, B SOC CHIM BELG, V89, P1101; Chong K, 2005, AQUACULTURE, V249, P469, DOI 10.1016/j.aquaculture.2005.02.045; Dong Q, 2007, J PHOTOCH PHOTOBIO B, V88, P137, DOI 10.1016/j.jphotobiol.2007.07.002; DUNLAP WC, 1989, COMP BIOCHEM PHYS B, V93, P601, DOI 10.1016/0305-0491(89)90383-0; DUNLAP WC, 1986, J EXP MAR BIOL ECOL, V104, P239, DOI 10.1016/0022-0981(86)90108-5; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; Dunlap WC, 2000, FREE RADICALS CHEM B, P200; Ebran N, 1999, COMP BIOCHEM PHYS A, V122, P181, DOI 10.1016/S1095-6433(98)10165-4; Eckes MJ, 2008, MAR ECOL PROG SER, V353, P203, DOI 10.3354/meps07210; Eckes MJ, 2009, THESIS U QUEENSLAND; Frank TM, 1996, MAR FRESHW BEHAV PHY, V27, P189, DOI 10.1080/10236249609378964; FREDERICK JE, 1989, PHOTOCHEM PHOTOBIOL, V50, P443, DOI 10.1111/j.1751-1097.1989.tb05548.x; Fulton CJ, 2001, MAR BIOL, V139, P25; Gravem SA, 2012, MAR BIOL, V159, P2839, DOI 10.1007/s00227-012-2045-z; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2004, ANIM BEHAV, V68, P583, DOI 10.1016/j.anbehav.2003.11.014; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Grutter AS, 1997, COPEIA, P346, DOI 10.2307/1447754; Jeffrey SW, 1999, MAR ECOL PROG SER, V189, P35, DOI 10.3354/meps189035; Jerlov N. G., 1976, MARINE OPTICS; KARENTZ D, 1991, MAR BIOL, V108, P157, DOI 10.1007/BF01313484; Karentz D, 1997, MAR BIOL, V129, P343, DOI 10.1007/s002270050174; Karsten U, 1998, BOT MAR, V41, P443, DOI 10.1515/botm.1998.41.1-6.443; KLIGMAN LH, 1985, J INVEST DERMATOL, V84, P272, DOI 10.1111/1523-1747.ep12265353; Krabs G, 2004, PHOTOCHEM PHOTOBIOL, V79, P515, DOI 10.1562/2003-12-14-RA.1; Kuwamura T, 2002, ETHOLOGY, V108, P443, DOI 10.1046/j.1439-0310.2002.00791.x; Lesser MP, 2001, J EXP BIOL, V204, P157; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; Markkula SE, 2006, FISH SHELLFISH IMMUN, V21, P70, DOI 10.1016/j.fsi.2005.10.007; Masiri I, 2008, INT J REMOTE SENS, V29, P4443, DOI 10.1080/01431160801930255; Mason DS, 1998, COMP BIOCHEM PHYS A, V120, P587, DOI 10.1016/S1095-6433(98)10069-7; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Oyamada C, 2008, MAR BIOTECHNOL, V10, P141, DOI 10.1007/s10126-007-9043-z; PLACK PA, 1981, BIOCHEM J, V199, P741, DOI 10.1042/bj1990741; Portwich A, 2000, PHOTOCHEM PHOTOBIOL, V71, P493, DOI 10.1562/0031-8655(2000)071<0493:ANPUPI>2.0.CO;2; RICKER W E, 1975, P382; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; Salo HM, 2000, J PHOTOCH PHOTOBIO B, V56, P154, DOI 10.1016/S1011-1344(00)00072-5; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; SHICK JM, 1992, MAR ECOL PROG SER, V90, P139, DOI 10.3354/meps090139; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Siebeck UE, 2001, VISION RES, V41, P133, DOI 10.1016/S0042-6989(00)00240-6; Subramanian S, 2008, COMP BIOCHEM PHYS B, V150, P85, DOI 10.1016/j.cbpb.2008.01.011; Sweet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041989; WESSLER E, 1957, ACTA CHEM SCAND, V11, P1240, DOI 10.3891/acta.chem.scand.11-1240; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Zamzow JP, 2006, J FISH BIOL, V69, P1583, DOI 10.1111/j.1095-8649.2006.01219.x; Zamzow JP, 2008, AM SCI, V96, P482, DOI 10.1511/2008.75.482; Zamzow JP, 2007, MAR ECOL PROG SER, V343, P263, DOI 10.3354/meps06890; Zamzow JP, 2002, ENVIRON BIOL FISH, V63, P41, DOI 10.1023/A:1013846816869; Zamzow JP, 2004, MAR BIOL, V144, P1057, DOI 10.1007/s00227-003-1286-2; Zamzow JP, 2003, MAR ECOL PROG SER, V263, P169, DOI 10.3354/meps263169	64	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78527	10.1371/journal.pone.0078527	http://dx.doi.org/10.1371/journal.pone.0078527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143264	gold, Green Submitted, Green Published			2022-12-27	WOS:000325894100103
J	Zhang, WQ; Shan, BQ; Zhang, H; Tang, WZ				Zhang, Wenqiang; Shan, Baoqing; Zhang, Hong; Tang, Wenzhong			Assessment of Preparation Methods for Organic Phosphorus Analysis in Phosphorus-Polluted Fe/Al-Rich Haihe River Sediments Using Solution P-31-NMR	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; NAOH-EDTA EXTRACTION; NMR-SPECTROSCOPY; LAKE-SEDIMENTS; SOIL-PHOSPHORUS; NEW-ZEALAND; CHINA; TRANSFORMATIONS; BIOAVAILABILITY; IDENTIFICATION	Fe/Al-rich river sediments that were highly polluted with phosphorus (P) were used in tests to determine the optimum preparation techniques for measuring organic P (Po) using solution P-31 nuclear magnetic resonance spectroscopy (P-31-NMR). The optimum pre-treatment, extraction time, sediment to solution ratio and sodium hydroxide-ethylenediamine-tetraacetic acid (NaOH-EDTA) extractant solution composition were determined. The total P and Po recovery rates were higher from freeze-and air-dried samples than from fresh samples. An extraction time of 16 h was adequate for extracting Po, and a shorter or longer extraction time led to lower recoveries of total P and Po, or led to the degradation of Po. An ideal P recovery rate and good-quality NMR spectra were obtained at a sediment: solution ratio of 1: 10, showing that this ratio is ideal for extracting Po. An extractant solution of 0.25 M NaOH and 50 mM EDTA was found to be more appropriate than either NaOH on its own, or a more concentrated NaOH-EDTA mixture for P-31-NMR analysis, as this combination minimized interference from paramagnetic ions and was appropriate for the detected range of Po concentrations. The most appropriate preparation method for Po analysis, therefore, was to extract the freeze-dried and ground sediment sample with a 0.25 M NaOH and 50 mM EDTA solution at a sediment: solution ratio of 1:10, for 16 h, by shaking. As lyophilization of the NaOH-EDTA extracts proved to be an optimal pre-concentration method for Po analysis in the river sediment, the extract was lyophilized as soon as possible, and analyzed by P-31-NMR.	[Zhang, Wenqiang; Shan, Baoqing; Zhang, Hong; Tang, Wenzhong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing, Peoples R China; [Zhang, Wenqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shan, BQ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 934, Beijing, Peoples R China.	bqshan@rcees.ac.cn	Tang, Wenzhong/AAM-6971-2020	Tang, Wenzhong/0000-0001-8347-8592	National Natural Science Foundation of China [20907067, 21107126]; National Water Pollution Control and Management Technology Major Projects of China [2012ZX07203-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Pollution Control and Management Technology Major Projects of China	This work was supported by the National Natural Science Foundation of China (Grant No. 20907067 and 21107126; http://www.nsfc.gov.cn/Portal0/default152.htm) and the National Water Pollution Control and Management Technology Major Projects of China (2012ZX07203-006; http://nwpcp.mep.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren J, 2006, LIMNOL OCEANOGR, V51, P2341, DOI 10.4319/lo.2006.51.5.2341; ASPILA KI, 1976, ANALYST, V101, P187, DOI 10.1039/an9760100187; Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; Bjorkman KM, 2003, LIMNOL OCEANOGR, V48, P1049; BOWMAN RA, 1993, SOIL SCI SOC AM J, V57, P1516, DOI 10.2136/sssaj1993.03615995005700060020x; Cade-Menun BJ, 2006, ENVIRON SCI TECHNOL, V40, P7874, DOI 10.1021/es061843e; Cade-Menun BJ, 2005, TALANTA, V66, P359, DOI 10.1016/j.talanta.2004.12.024; Cade-Menun BJ, 1996, SOIL SCI, V161, P770, DOI 10.1097/00010694-199611000-00006; Cade-Menun BJ, 2005, MAR CHEM, V97, P293, DOI 10.1016/j.marchem.2005.05.005; Cheesman AW, 2010, ENVIRON SCI TECHNOL, V44, P9265, DOI 10.1021/es102460h; Condron LM, 1996, BIOL FERT SOILS, V21, P37, DOI 10.1007/BF00335991; Ding SM, 2010, J ENVIRON QUAL, V39, P1668, DOI 10.2134/jeq2009.0396; Dong LM, 2012, ENVIRON MONIT ASSESS, V184, P5829, DOI 10.1007/s10661-012-2550-z; EMSLEY J, 1983, PHOSPHORUS SULFUR, V16, P303, DOI 10.1080/03086648308080484; Gressel N, 1996, BIOGEOCHEMISTRY, V33, P97, DOI 10.1007/BF02181034; Hill JE, 2009, J ENVIRON QUAL, V38, P130, DOI 10.2134/jeq2007.0587; Hupfer M, 2004, LIMNOL OCEANOGR, V49, P1, DOI 10.4319/lo.2004.49.1.0001; HUPFER M, 1995, LIMNOL OCEANOGR, V40, P610, DOI 10.4319/lo.1995.40.3.0610; JENSEN HS, 1992, HYDROBIOLOGIA, V235, P731, DOI 10.1007/BF00026261; Kopacek J, 2005, ENVIRON SCI TECHNOL, V39, P8784, DOI 10.1021/es050916b; Liu JY, 2009, ENVIRON POLLUT, V157, P49, DOI 10.1016/j.envpol.2008.07.031; Makarov MI, 2002, BIOL FERT SOILS, V35, P136, DOI 10.1007/s00374-002-0454-8; McDowell RW, 2009, MAR FRESHWATER RES, V60, P619, DOI 10.1071/MF08047; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [DOI 10.1016/S0003-2670(00)88444-5, 10.1016/S0003-2670(00)88444-5]; NEWMAN RH, 1980, COMMUN SOIL SCI PLAN, V11, P835, DOI 10.1080/00103628009367083; Pant HK, 1999, COMMUN SOIL SCI PLAN, V30, P757, DOI 10.1080/00103629909370244; Pernet-Coudrier B, 2012, ENVIRON SCI TECHNOL, V46, P5294, DOI 10.1021/es3004415; Qu HJ, 2010, SCI TOTAL ENVIRON, V408, P2075, DOI 10.1016/j.scitotenv.2009.12.015; Reitzel K, 2007, BIOGEOCHEMISTRY, V82, P15, DOI 10.1007/s10533-006-9049-z; Reitzel K, 2006, CAN J FISH AQUAT SCI, V63, P1686, DOI 10.1139/F06-070; Sumann M, 1998, SOIL SCI SOC AM J, V62, P1580, DOI 10.2136/sssaj1998.03615995006200060015x; Sundareshwar PV, 2001, LIMNOL OCEANOGR, V46, P1570, DOI 10.4319/lo.2001.46.6.1570; Turner BL, 2008, EUR J SOIL SCI, V59, P453, DOI 10.1111/j.1365-2389.2007.00994.x; Turner BL, 2007, ECOSYSTEMS, V10, P1166, DOI 10.1007/s10021-007-9086-z; Turner BL, 2006, ENVIRON SCI TECHNOL, V40, P727, DOI 10.1021/es0516256; Turner BL, 2005, TALANTA, V66, P294, DOI 10.1016/j.talanta.2004.11.012; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Turner BL, 2003, SOIL SCI SOC AM J, V67, P1168, DOI 10.2136/sssaj2003.1168; Turner BL, 2003, ORG GEOCHEM, V34, P1199, DOI 10.1016/S0146-6380(03)00061-5; Wang JY, 2010, ENVIRON MONIT ASSESS, V171, P309, DOI 10.1007/s10661-009-1280-3; Wang SR, 2007, CHIN AGR SCI B, V23, P355; Xu D, 2012, J SOIL SEDIMENT, V12, P909, DOI 10.1007/s11368-012-0510-4; Zhang RY, 2009, J ENVIRON QUAL, V38, P353, DOI 10.2134/jeq2007.0616; [周毅 Zhou Yi], 2002, [海洋环境科学, Marine environmental science], V21, P60	44	18	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76525	10.1371/journal.pone.0076525	http://dx.doi.org/10.1371/journal.pone.0076525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143192	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100027
J	Wagstaff, JL; Masterton, RJ; Povey, JF; Smales, CM; Howard, MJ				Wagstaff, Jane L.; Masterton, Rosalyn J.; Povey, Jane F.; Smales, C. Mark; Howard, Mark J.			H-1 NMR Spectroscopy Profiling of Metabolic Reprogramming of Chinese Hamster Ovary Cells upon a Temperature Shift during Culture	PLOS ONE			English	Article							MAMMALIAN-CELLS; ANTIBODY-PRODUCTION; COLD-SHOCK; CHO-CELLS; HYPOTHERMIA; EXPRESSION; LACTATE	We report an NMR based approach to determine the metabolic reprogramming of Chinese hamster ovary cells upon a temperature shift during culture by investigating the extracellular cell culture media and intracellular metabolome of CHOK1 and CHO-S cells during culture and in response to cold-shock and subsequent recovery from hypothermic culturing. A total of 24 components were identified for CHOK1 and 29 components identified for CHO-S cell systems including the observation that CHO-S media contains 5.6 times the level of glucose of CHOK1 media at time zero. We confirm that an NMR metabolic approach provides quantitative analysis of components such as glucose and alanine with both cell lines responding in a similar manner and comparable to previously reported data. However, analysis of lactate confirms a differentiation between CHOK1 and CHO-S and that reprogramming of metabolism in response to temperature was cell line specific. The significance of our results is presented using principal component analysis (PCA) that confirms changes in metabolite profile in response to temperature and recovery. Ultimately, our approach demonstrates the capability of NMR providing real-time analysis to detect reprogramming of metabolism upon cellular perception of cold-shock/sub-physiological temperatures. This has the potential to allow manipulation of metabolites in culture supernatant to improve growth or productivity.	[Smales, C. Mark] Univ Kent, Ctr Mol Proc, Canterbury, Kent, England; Univ Kent, Sch Biosci, Canterbury, Kent, England	University of Kent; University of Kent	Smales, CM (corresponding author), Univ Kent, Ctr Mol Proc, Canterbury, Kent, England.	c.m.smales@kent.ac.uk; m.j.howard@kent.ac.uk		Smales, Christopher Mark/0000-0002-2762-4724; Povey, Jane/0000-0003-4522-3630; Howard, Mark/0000-0002-0762-2887	University of Kent, Faculty of Sciences Strategic Development Fund; BBSRC [BB/I020055/1, BB/D009375/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009375/1, BB/I020055/1, BB/C006569/1] Funding Source: researchfish	University of Kent, Faculty of Sciences Strategic Development Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported through The University of Kent, Faculty of Sciences Strategic Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; Aranibar N, 2011, J BIOMOL NMR, V49, P195, DOI 10.1007/s10858-011-9490-8; Barba I, 2008, LIVER INT, V28, P1141, DOI 10.1111/j.1478-3231.2008.01801.x; Bradley SA, 2010, J AM CHEM SOC, V132, P9531, DOI 10.1021/ja101962c; Chong WPK, 2009, RAPID COMMUN MASS SP, V23, P3763, DOI 10.1002/rcm.4328; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dietmair S, 2012, BIOTECHNOL BIOENG, V109, P1404, DOI 10.1002/bit.24496; Li JC, 2012, BIOTECHNOL BIOENG, V109, P1173, DOI 10.1002/bit.24389; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Luo J, 2012, BIOTECHNOL BIOENG, V109, P146, DOI 10.1002/bit.23291; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; Mead EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047422; Roobol A, 2011, BIOCHEM J, V435, P499, DOI 10.1042/BJ20101303; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Sellick CA, 2011, BIOTECHNOL BIOENG, V108, P3025, DOI 10.1002/bit.23269; Sellick CA, 2009, ANAL CHEM, V81, P174, DOI 10.1021/ac8016899; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Suk Ahn W, 2012, METAB ENG; Underhill MF, 2006, MOL BIOTECHNOL, V34, P141, DOI 10.1385/MB:34:2:141; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	23	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77195	10.1371/journal.pone.0077195	http://dx.doi.org/10.1371/journal.pone.0077195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130854	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200068
J	Walker, T; Adamson, A; Jackson, DA				Walker, Thomas; Adamson, Antony; Jackson, Dean A.			BCL-3 Attenuation of TNFA Expression Involves an Incoherent Feed-Forward Loop Regulated by Chromatin Structure	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; P50; TRANSCRIPTION; RECRUITMENT; INDUCTION; MECHANISM; PROMOTER; ENCODES; BINDING	Induction of genes is rarely an isolated event; more typically occurring as part of a web of parallel interactions, or motifs, which act to refine and control gene expression. Here, we define an Incoherent Feed-forward Loop motif in which TNF alpha-induced NF-kappa B signalling activates expression of the TNFA gene itself and also controls synthesis of the negative regulator BCL-3. While sharing a common inductive signal, the two genes have distinct temporal expression profiles. Notably, while the TNFA gene promoter is primed to respond immediately to activated NF-kappa B in the nucleus, induction of BCL3 expression only occurs after a time delay of about 1h. We show that this time delay is defined by remodelling of the BCL3 gene promoter, which is required to activate gene expression, and characterise the chromatin delayed induction of BCL3 expression using mathematical models. The models show how a delay in inhibitor production effectively uncouples the rate of response to inflammatory cues from the final magnitude of inhibition. Hence, within this regulatory motif, a delayed (incoherent) feed-forward loop together with differential rates of TNFA (fast) and BCL3 (slow) mRNA turnover provide robust, pulsatile expression of TNF alpha. We propose that the structure of the BCL-3-dependent regulatory motif has a beneficial role in modulating	[Walker, Thomas; Adamson, Antony; Jackson, Dean A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Jackson, DA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	dean.jackson@manchester.ac.uk		Adamson, Antony/0000-0002-5408-0013	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [EPSRC/BBSRC]; BBSRC [BB/F00561X/1-DAJ]; BBSRC [BB/F005938/2, BB/F00561X/1, BB/F005938/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00561X/1, BB/F005938/1, BB/F005938/2] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council [EPSRC/BBSRC](UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Engineering and Physical Sciences Research Council and the Biotechnology and Biological Sciences Research Council [EPSRC/BBSRC funded University of Manchester Doctoral training Centre in Systems Biology - T.W. and BBSRC Grant BB/F00561X/1-DAJ, AA]. Funding for open access charge: Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Buetti-Dinh A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.61; Carey MF, 2009, COLD SPRING HARBOR P, V2009; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Keutgens A, 2010, MOL CELL BIOL, V30, P4006, DOI 10.1128/MCB.01600-09; Larson DR, 2011, CURR OPIN GENET DEV, V21, P591, DOI 10.1016/j.gde.2011.07.010; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Natoli G, 2012, IMMUNOL REV, V246, P183, DOI 10.1111/j.1600-065X.2012.01103.x; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Paszek P, 2010, CURR OPIN GENET DEV, V20, P670, DOI 10.1016/j.gde.2010.08.004; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77015	10.1371/journal.pone.0077015	http://dx.doi.org/10.1371/journal.pone.0077015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130828	Green Submitted, gold, Green Published			2022-12-27	WOS:000325814200050
J	de Groot, REA; Farin, HF; Macurkova, M; van Es, JH; Clevers, HC; Korswagen, HC				de Groot, Reinoud E. A.; Farin, Henner F.; Macurkova, Marie; van Es, Johan H.; Clevers, Hans C.; Korswagen, Hendrik C.			Retromer Dependent Recycling of the Wnt Secretion Factor Wls Is Dispensable for Stem Cell Maintenance in the Mammalian Intestinal Epithelium	PLOS ONE			English	Article							REQUIRES RETROMER; PROTEIN; WNTLESS; LGR5; IDENTIFICATION; COMPLEX	In C. elegans and Drosophila, retromer mediated retrograde transport of Wntless (Wls) from endosomes to the trans-Golgi network (TGN) is required for Wnt secretion. When this retrograde transport pathway is blocked, Wls is missorted to lysosomes and degraded, resulting in reduced Wnt secretion and various Wnt related phenotypes. In the mammalian intestine, Wnt signaling is essential to maintain stem cells. This prompted us to ask if retromer mediated Wls recycling is also important for Wnt signaling and stem cell maintenance in this system. To answer this question, we generated a conditional Vps35(fl) allele. As Vps35 is an essential subunit of the retromer complex, this genetic tool allowed us to inducibly interfere with retromer function in the intestinal epithelium. Using a pan-intestinal epithelial Cre line (Villin-CreERT2), we did not observe defects in crypt or villus morphology after deletion of Vps35 from the intestinal epithelium. Wnt secreted from the mesenchyme of the intestine may compensate for a reduction in epithelial Wnt secretion. To exclude the effect of the mesenchyme, we generated intestinal organoid cultures. Loss of Vps35 in intestinal organoids did not affect the overall morphology of the organoids. We were able to culture Vps35(Delta/Delta) organoids for many passages without Wnt supplementation in the growth medium. However, Wls protein levels were reduced and we observed a subtle growth defect in the Vps35(Delta/Delta) organoids. These results confirm the role of retromer in the retrograde trafficking of Wls in the intestine, but show that retromer mediated Wls recycling is not essential to maintain Wnt signaling or stem cell proliferation in the intestinal epithelium.	[de Groot, Reinoud E. A.; Farin, Henner F.; van Es, Johan H.; Clevers, Hans C.; Korswagen, Hendrik C.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [de Groot, Reinoud E. A.; Farin, Henner F.; van Es, Johan H.; Clevers, Hans C.; Korswagen, Hendrik C.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Macurkova, Marie] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Charles University Prague	Korswagen, HC (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	r.korswagen@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Macurkova, Marie/B-4424-2014; Korswagen, Hendrik/I-8782-2012; Farin, Henner/AAC-2574-2021	Farin, Henner/0000-0003-1558-5366; Macurkova, Marie/0000-0002-7082-0093; de Groot, Reinoud/0000-0002-1905-6501	Dutch Cancer Society [HUBR 2008-4114]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was funded by the Dutch Cancer Society (HUBR 2008-4114) (to HCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gasnereau I, 2011, J BIOL CHEM, V286, P43324, DOI 10.1074/jbc.M111.307231; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; RADICE G, 1991, DEVELOPMENT, V111, P801; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	31	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76971	10.1371/journal.pone.0076971	http://dx.doi.org/10.1371/journal.pone.0076971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130821	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900113
J	Lin, H; Chen, W; Ding, H				Lin, Hao; Chen, Wei; Ding, Hui			AcalPred: A Sequence-Based Tool for Discriminating between Acidic and Alkaline Enzymes	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; FEATURE-SELECTION; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; PREDICTION; OVEREXPRESSION; INFORMATION; PROPENSITY; FORM	The structure and activity of enzymes are influenced by pH value of their surroundings. Although many enzymes work well in the pH range from 6 to 8, some specific enzymes have good efficiencies only in acidic (pH, 5) or alkaline (pH. 9) solution. Studies have demonstrated that the activities of enzymes correlate with their primary sequences. It is crucial to judge enzyme adaptation to acidic or alkaline environment from its amino acid sequence in molecular mechanism clarification and the design of high efficient enzymes. In this study, we developed a sequence-based method to discriminate acidic enzymes from alkaline enzymes. The analysis of variance was used to choose the optimized discriminating features derived from g-gap dipeptide compositions. And support vector machine was utilized to establish the prediction model. In the rigorous jackknife cross-validation, the overall accuracy of 96.7% was achieved. The method can correctly predict 96.3% acidic and 97.1% alkaline enzymes. Through the comparison between the proposed method and previous methods, it is demonstrated that the proposed method is more accurate. On the basis of this proposed method, we have built an online web-server called AcalPred which can be freely accessed from the website (http://lin.uestc.edu.cn/server/AcalPred). We believe that the AcalPred will become a powerful tool to study enzyme adaptation to acidic or alkaline environment.	[Lin, Hao; Ding, Hui] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Ctr Bioinformat, Key Lab NeuroInformat,Minist Educ, Chengdu 610054, Peoples R China; [Chen, Wei] Hebei United Univ, Ctr Genom & Computat Biol, Sch Sci, Dept Phys, Tangshan, Peoples R China	University of Electronic Science & Technology of China; North China University of Science & Technology	Lin, H (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Ctr Bioinformat, Key Lab NeuroInformat,Minist Educ, Chengdu 610054, Peoples R China.	hlin@uestc.edu.cn; greatchen@heuu.edu.cn	Ding, Hui/A-8160-2016; Lin, Hao/B-2066-2012; Chen, Wei/W-8311-2019; Chen, Wei/O-6774-2017	Lin, Hao/0000-0001-6265-2862; Chen, Wei/0000-0002-6857-7696	National Natural Science Foundation of China [61202256, 61100092]; Fundamental Research Funds for the Central Universities [ZYGX2012J113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (61202256, 61100092) and the Fundamental Research Funds for the Central Universities (ZYGX2012J113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Diaz AA, 2010, BIOTECHNOL BIOENG, V105, P374, DOI 10.1002/bit.22537; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Ding H, 2013, CHEMOMETR INTELL LAB, V124, P9, DOI 10.1016/j.chemolab.2013.03.005; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Fan GL, 2013, PROCESS BIOCHEM, V48, P1048, DOI 10.1016/j.procbio.2013.05.012; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Gromiha MM, 2008, PROTEINS, V70, P1274, DOI 10.1002/prot.21616; Gromiha MM, 2005, BIOINFORMATICS, V21, P961, DOI 10.1093/bioinformatics/bti126; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Idicula-Thomas S, 2006, BIOINFORMATICS, V22, P278, DOI 10.1093/bioinformatics/bti810; Jia PL, 2008, J PROTEOME RES, V7, P1131, DOI 10.1021/pr700715c; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Ma JW, 2010, BMB REP, V43, P670, DOI [10.3858/BMBRep.2010.43.10.670, 10.5483/BMBRep.2010.43.10.670]; Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386; Nair NU, 2010, CURR ORG CHEM, V14, P1870; Nakariyakul S, 2012, AMINO ACIDS, V42, P1947, DOI 10.1007/s00726-011-0923-1; Settembre EC, 2004, ACTA CRYSTALLOGR D, V60, P1753, DOI 10.1107/S090744490401858X; Smialowski P, 2007, BIOINFORMATICS, V23, P2536, DOI 10.1093/bioinformatics/btl623; Takami H, 2000, EXTREMOPHILES, V4, P99, DOI 10.1007/s007920050143; Taylor TJ, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S5; Vapnik V., 1998, STAT LEARNING THEORY; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang D, 2011, PROTEIN PEPTIDE LETT, V18, P684, DOI 10.2174/092986611795446085; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Yin JB, 2011, CURR PROTEIN PEPT SC, V12, P580, DOI 10.2174/138920311796957702; Zhang GY, 2006, PROTEIN PEPTIDE LETT, V13, P965, DOI 10.2174/092986606778777560; Zhang Guangya, 2013, Int J Bioinform Res Appl, V9, P41, DOI 10.1504/IJBRA.2013.050744; Zhang GY, 2009, PROCESS BIOCHEM, V44, P654, DOI 10.1016/j.procbio.2009.02.007	37	68	69	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75726	10.1371/journal.pone.0075726	http://dx.doi.org/10.1371/journal.pone.0075726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130738	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900055
J	Liu, P; Chen, BJ; Altun, ZF; Gross, MJ; Shan, A; Schuman, B; Hall, DH; Wang, ZW				Liu, Ping; Chen, Bojun; Altun, Zeynep F.; Gross, Maegan J.; Shan, Alan; Schuman, Benjamin; Hall, David H.; Wang, Zhao-Wen			Six Innexins Contribute to Electrical Coupling of C. elegans Body-Wall Muscle	PLOS ONE			English	Article							GAP-JUNCTIONS; PANNEXIN 1; GENE; MUTATIONS; CONNEXIN; FAMILY; CHANNELS; RELEASE; ORGANIZATION; EXPRESSION	C. elegans body-wall muscle cells are electrically coupled through gap junctions. Previous studies suggest that UNC-9 is an important, but not the only, innexin mediating the electrical coupling. Here we analyzed junctional current (I-j) for mutants of additional innexins to identify the remaining innexin(s) important to the coupling. The results suggest that a total of six innexins contribute to the coupling, including UNC-9, INX-1, INX-10, INX-11, INX-16, and INX-18. The I-j deficiency in each mutant was rescued completely by expressing the corresponding wild-type innexin specifically in muscle, suggesting that the innexins function cell-autonomously. Comparisons of I-j between various single, double, and triple mutants suggest that the six innexins probably form two distinct populations of gap junctions with one population consisting of UNC-9 and INX-18 and the other consisting of the remaining four innexins. Consistent with their roles in muscle electrical coupling, five of the six innexins showed punctate localization at muscle intercellular junctions when expressed as GFP- or epitope-tagged proteins, and muscle expression was detected for four of them when assessed by expressing GFP under the control of innexin promoters. The results may serve as a solid foundation for further explorations of structural and functional properties of gap junctions in C. elegans body-wall muscle.	[Liu, Ping; Chen, Bojun; Gross, Maegan J.; Wang, Zhao-Wen] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06032 USA; [Altun, Zeynep F.; Hall, David H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Shan, Alan; Schuman, Benjamin] Univ Connecticut, Ctr Hlth, Undergrad Summer Res Internship Program, Farmington, CT USA	University of Connecticut; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut	Wang, ZW (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06032 USA.	zwwang@uchc.edu	Liu, Ping/B-1509-2014		National Institute of Health [5R01GM083049, 1R01MH085927]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085927] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health (5R01GM083049 and 1R01MH085927, ZWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; AVERY L, 1993, GENETICS, V133, P897; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barnes TM, 1997, J NEUROCHEM, V69, P2251; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen BJ, 2007, CURR BIOL, V17, P1334, DOI 10.1016/j.cub.2007.06.060; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Edmonds JW, 2011, DEV BIOL, V359, P47, DOI 10.1016/j.ydbio.2011.08.014; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; FERGUSON EL, 1985, GENETICS, V110, P17; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kemp BJ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm857; Kienitz MC, 2011, J BIOL CHEM, V286, P290, DOI 10.1074/jbc.M110.163477; Lehmann C, 2006, MOL BIOL CELL, V17, P1676, DOI 10.1091/mbc.E05-11-1059; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; Liu P, 2011, J BIOL CHEM, V286, P44285, DOI 10.1074/jbc.M111.292078; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OKKEMA PG, 1993, GENETICS, V135, P385; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Peters MA, 2007, CURR BIOL, V17, P1601, DOI 10.1016/j.cub.2007.08.031; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-16; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; Thompson RJ, 2008, CHANNELS, V2, P81, DOI 10.4161/chan.2.2.6003; Wang ZW, 1999, ANN NY ACAD SCI, V868, P286, DOI 10.1111/j.1749-6632.1999.tb11294.x; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Zhan HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039489	46	11	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76877	10.1371/journal.pone.0076877	http://dx.doi.org/10.1371/journal.pone.0076877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130800	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900095
J	Oettl, SK; Gerstmeier, J; Khan, SY; Wiechmann, K; Bauer, J; Atanasov, AG; Malainer, C; Awad, EM; Uhrin, P; Heiss, EH; Waltenberger, B; Remias, D; Breuss, JM; Boustie, J; Dirsch, VM; Stuppner, H; Werz, O; Rollinger, JM				Oettl, Sarah K.; Gerstmeier, Jana; Khan, Shafaat Y.; Wiechmann, Katja; Bauer, Julia; Atanasov, Atanas G.; Malainer, Clemens; Awad, Ezzat M.; Uhrin, Pavel; Heiss, Elke H.; Waltenberger, Birgit; Remias, Daniel; Breuss, Johannes M.; Boustie, Joel; Dirsch, Verena M.; Stuppner, Hermann; Werz, Oliver; Rollinger, Judith M.			Imbricaric Acid and Perlatolic Acid: Multi-Targeting Anti-Inflammatory Depsides from Cetrelia monachorum	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHASE-1; THIOGLYCOLATE PERITONITIS; INHIBITORY-ACTIVITY; KIDNEY-CELLS; 5-LIPOXYGENASE; LICHEN; DERIVATIVES; COMPONENTS; DRUGS	In vitro screening of 17 Alpine lichen species for their inhibitory activity against 5-lipoxygenase, microsomal prostaglandin E-2 synthase-1 and nuclear factor kappa B revealed Cetrelia monachorum (Zahlbr.) W.L. Culb. & C.F. Culb. As conceivable source for novel anti-inflammatory compounds. Phytochemical investigation of the ethanolic crude extract resulted in the isolation and identification of 11 constituents, belonging to depsides and derivatives of orsellinic acid, olivetolic acid and olivetol. The two depsides imbricaric acid (4) and perlatolic acid (5) approved dual inhibitory activities on microsomal prostaglandin E-2 synthase-1 (IC50 = 1.9 and 0.4 mu M, resp.) and on 5-lipoxygenase tested in a cell-based assay (IC50 = 5.3 and 1.8 mu M, resp.) and on purified enzyme (IC50 = 3.5 and 0.4 mu M, resp.). Additionally, these two main constituents quantified in the extract with 15.22% (4) and 9.10% (5) showed significant inhibition of tumor necrosis factor alpha-induced nuclear factor kappa B activation in luciferase reporter cells with IC50 values of 2.0 and 7.0 mu M, respectively. In a murine in vivo model of inflammation, 5 impaired the inflammatory, thioglycollate-induced recruitment of leukocytes to the peritoneum. The potent inhibitory effects on the three identified targets attest 4 and 5 a pronounced multi-target anti-inflammatory profile which warrants further investigation on their pharmacokinetics and in vivo efficacy.	[Oettl, Sarah K.; Waltenberger, Birgit; Remias, Daniel; Stuppner, Hermann; Rollinger, Judith M.] Leopold Franzens Univ Innsbruck, Inst Pharm Pharmacognosy, Ctr Mol Biosci Innsbruck, Innsbruck, Austria; [Gerstmeier, Jana; Wiechmann, Katja; Werz, Oliver] Univ Jena, Chair Pharmaceut Med Chem, Inst Pharm, Jena, Germany; [Khan, Shafaat Y.; Awad, Ezzat M.; Uhrin, Pavel; Breuss, Johannes M.] Med Univ Vienna, Inst Vasc Biol & Thrombosis Res, Ctr Biomol Med & Pharmacol, Vienna, Austria; [Bauer, Julia] Univ Tubingen, Dept Pharmaceut Analyt, Inst Pharmaceut, Tubingen, Germany; [Atanasov, Atanas G.; Malainer, Clemens; Heiss, Elke H.; Dirsch, Verena M.] Univ Vienna, Dept Pharmacognosy, Vienna, Austria; [Boustie, Joel] Univ Rennes 1, Inst Chem Sci Rennes, Team PNSCM, Rennes, France	University of Innsbruck; Friedrich Schiller University of Jena; Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Vienna; Universite de Rennes	Werz, O (corresponding author), Univ Jena, Chair Pharmaceut Med Chem, Inst Pharm, Jena, Germany.	Oliver.Werz@uni-jena.de; Judith.Rollinger@uibk.ac.at	Khan, Shafaat Yar/K-8006-2019; Heiss, Elke/B-6086-2015; Khan, Shafaat Yar/GRO-3887-2022; Rollinger, Judith/Q-5996-2019; Atanasov, Atanas G./C-5535-2013	Heiss, Elke/0000-0001-7618-5505; Atanasov, Atanas G./0000-0003-2545-0967; Dirsch, Verena/0000-0002-9261-5293; Uhrin, Pavel/0000-0002-9792-3420; Remias, Daniel/0000-0003-0896-435X; Rollinger, Judith/0000-0001-6581-0774; breuss, johannes/0000-0003-1312-3387	National Research Network "Drugs from Nature Targeting Inflammation" [S10703, S10704, S10713]; Austrian Science Fund (FWF)	National Research Network "Drugs from Nature Targeting Inflammation"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the National Research Network "Drugs from Nature Targeting Inflammation" (subprojects S10703, S10704, and S10713) granted by the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JQ, 2008, PHYTOTHER RES, V22, P1605, DOI 10.1002/ptr.2531; Bauer J, 2012, CHEMMEDCHEM, V7, P2077, DOI 10.1002/cmdc.201200345; Boustie J, 2011, PHYTOCHEM REV, V10, P287, DOI 10.1007/s11101-010-9201-1; Bucar F, 2004, PHYTOMEDICINE, V11, P602, DOI 10.1016/j.phymed.2004.03.004; Bugni TS, 2009, FITOTERAPIA, V80, P270, DOI 10.1016/j.fitote.2009.03.003; Einarsdottir E, 2010, PLANTA MED, V76, P969, DOI 10.1055/s-0029-1240851; Fischer L, 2003, FASEB J, V17, P949, DOI 10.1096/fj.02-0815fje; Brandao LFG, 2013, CHEM PHARM BULL, V61, P176, DOI 10.1248/cpb.c12-00739; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Huneck S, 1996, IDENTIFICATION LICHE; Ingolfsdottir K, 1997, PHYTOMEDICINE, V4, P125, DOI 10.1016/S0944-7113(97)80056-6; Ingolfsdottir K, 1996, PHYTOMEDICINE, V2, P243, DOI 10.1016/S0944-7113(96)80049-3; Johnson-Lyles DN, 2010, TOXICOL APPL PHARM, V248, P249, DOI 10.1016/j.taap.2010.08.008; Koeberle A, 2009, CURR MED CHEM, V16, P4274, DOI 10.2174/092986709789578178; Koeberle A, 2008, J MED CHEM, V51, P8068, DOI 10.1021/jm801085s; Li L., 2012, PLOS ONE, V7; Manojlovic N, 2012, PHYTOMEDICINE, V19, P1166, DOI 10.1016/j.phymed.2012.07.012; Markasz L, 2007, MOL CANCER THER, V6, P644, DOI 10.1158/1535-7163.MCT-06-0358; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Noha SM, 2011, BIOORG MED CHEM LETT, V21, P577, DOI 10.1016/j.bmcl.2010.10.051; Obermayer W, 2007, PHYTON-ANN REI BOT A, V47, P231; OKUYAMA E, 1995, PLANTA MED, V61, P113, DOI 10.1055/s-2006-958027; Radmark O, 2010, J INTERN MED, V268, P5, DOI 10.1111/j.1365-2796.2010.02246.x; Rozema E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/983023; Saadane A, 2007, AM J RESP CELL MOL, V36, P728, DOI 10.1165/rcmb.2006-0323OC; Schneider I, 2005, PHYTOTHER RES, V19, P81, DOI 10.1002/ptr.1603; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Seidman MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004316; Sokolov DN, 2012, BIOORG MED CHEM LETT, V22, P7060, DOI 10.1016/j.bmcl.2012.09.084; Stern ST, 2008, TOXICOL SCI, V106, P140, DOI 10.1093/toxsci/kfn137; Vogl S, 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/395316; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Wirth V., 1995, Flechtenflora: Bestimmung und okologische Kennzeichnung der Flechten Sudwestdeutschlands und angrenzender Gebiete: 2. Neubearbeitete und erganzte Auflage.	35	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76929	10.1371/journal.pone.0076929	http://dx.doi.org/10.1371/journal.pone.0076929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130812	Green Published, gold			2022-12-27	WOS:000325810900106
J	Paquin-Proulx, D; Santos, BAN; Carvalho, KI; Toledo-Barros, M; de Oliveira, AKB; Kokron, CM; Kalil, J; Moll, M; Kallas, EG; Sandberg, JK				Paquin-Proulx, Dominic; Santos, Bianca A. N.; Carvalho, Karina I.; Toledo-Barros, Myrthes; Barreto de Oliveira, Ana Karolina; Kokron, Cristina M.; Kalil, Jorge; Moll, Markus; Kallas, Esper G.; Sandberg, Johan K.			IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; CD1D-RESTRICTED NKT CELLS; MICROBIAL TRANSLOCATION; DENDRITIC CELLS; HIV-INFECTION; DISEASE PROGRESSION; REPLACEMENT THERAPY; MECHANISMS; EXPRESSION; FREQUENCY	Common variable immunodeficiency (CVID) is characterized by defective B cell function, impaired antibody production, and increased susceptibility to bacterial infections. Here, we addressed the hypothesis that poor antibody-mediated immune control of infections may result in substantial perturbations in the T cell compartment. Newly diagnosed CVID patients were sampled before, and 6-12 months after, initiation of intravenous immunoglobulin (IVIg) therapy. Treatment-naive CVID patients displayed suppressed CD4 T cell counts and myeloid dendritic cell (mDC) levels, as well as high levels of immune activation in CD8 T cells, CD4 T cells, and invariant natural killer T (iNKT) cells. Expression of co-stimulatory receptors CD80 and CD83 was elevated in mDCs and correlated with T cell activation. Levels of both FoxP3+ T regulatory (Treg) cells and iNKT cells were low, whereas soluble CD14 (sCD14), indicative of monocyte activation, was elevated. Importantly, immune reconstitution treatment with IVIg partially restored the CD4 T cell and mDC compartments. Treatment furthermore reduced the levels of CD8 T cell activation and mDC activation, whereas levels of Treg cells and iNKT cells remained low. Thus, primary deficiency in humoral immunity with impaired control of microbial infections is associated with significant pathological changes in cell-mediated immunity. Furthermore, therapeutic enhancement of humoral immunity with IVIg infusions alleviates several of these defects, indicating a relationship between poor antibody-mediated immune control of infections and the occurrence of abnormalities in the T cell and mDC compartments. These findings help our understanding of the immunopathogenesis of primary immunodeficiency, as well as acquired immunodeficiency caused by HIV-1 infection.	[Paquin-Proulx, Dominic; Moll, Markus; Sandberg, Johan K.] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden; [Santos, Bianca A. N.; Carvalho, Karina I.; Toledo-Barros, Myrthes; Barreto de Oliveira, Ana Karolina; Kokron, Cristina M.; Kalil, Jorge; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil	Karolinska Institutet; Karolinska University Hospital; Universidade de Sao Paulo	Sandberg, JK (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden.	johan.sandberg@ki.se	Kokron, Cristina M/D-3140-2012; KALIL, JORGE/C-8029-2012; Paquin-Proulx, Dominic/AFS-1852-2022; Carvalho, Karina IL/J-6789-2012	Kokron, Cristina M/0000-0002-9080-0305; KALIL, JORGE/0000-0001-8415-4274; Paquin-Proulx, Dominic/0000-0003-1407-3414; Carvalho, Karina IL/0000-0002-7763-8139; Kallas, Esper/0000-0003-2026-6925; Moll, Markus/0000-0003-4592-3063; Sandberg, Johan/0000-0002-6275-0750	Swedish Research Council; Swedish Cancer Foundation; Stockholm County Council; Karolinska Institutet; US National Institutes of Health [AI52731]; Canadian Institutes of Health Research; Conselho Nacional de Pesquisa (CNPq), Brazilian Ministry of Science and Technology; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the PNPD Program, Brazilian Ministry of Education; CNPq	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Conselho Nacional de Pesquisa (CNPq), Brazilian Ministry of Science and Technology(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the PNPD Program, Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by the Swedish Research Council, the Swedish Cancer Foundation, Stockholm County Council, Karolinska Institutet, and the US National Institutes of Health grant AI52731. DPP is the recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research. BANS is the recipient of a master fellowship from the Conselho Nacional de Pesquisa (CNPq), Brazilian Ministry of Science and Technology. KIC is the recipient of a postdoctoral fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the PNPD Program, Brazilian Ministry of Education. The group at the University of Sao Paulo coordinates one of the Brazilian National Institutes of Science and Technology (Instituto de Investigacao em Imunologia - iii), funded by the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 1997, J INFECT DIS, V176, P913, DOI 10.1086/516510; Ballow M, 2011, CLIN IMMUNOL, V139, P208, DOI 10.1016/j.clim.2011.02.006; Barbosa RR, 2012, CLIN EXP IMMUNOL, V169, P263, DOI 10.1111/j.1365-2249.2012.04620.x; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Carvalho KI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012652; Cunningham-Rundles C, 2010, BLOOD, V116, P7, DOI 10.1182/blood-2010-01-254417; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Gouilleux-Gruart V, 2013, CLIN EXP IMMUNOL, V171, P186, DOI 10.1111/cei.12002; Grassi F, 1999, AIDS, V13, P759, DOI 10.1097/00002030-199905070-00004; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kasztalska K, 2011, CLIN DRUG INVEST, V31, P299, DOI 10.2165/11586710-000000000-00000; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kaveri SV, 2011, CLIN EXP IMMUNOL, V164, P2, DOI 10.1111/j.1365-2249.2011.04387.x; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Klatt NR, 2012, TRENDS MICROBIOL; Leeansyah E, 2013, CURR OPIN HIV AIDS, V8, P117, DOI 10.1097/COH.0b013e32835c7134; Litzman J, 2012, CLIN EXP IMMUNOL, V170, P321, DOI 10.1111/j.1365-2249.2012.04655.x; Melo KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006269; Moll M, 2009, EUR J IMMUNOL, V39, P902, DOI 10.1002/eji.200838780; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nordoy I, 1998, CLIN EXP IMMUNOL, V114, P258; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Salzer U, 2012, ANN NY ACAD SCI, V1250, P41, DOI 10.1111/j.1749-6632.2011.06377.x; Sandberg JK, 2005, TRENDS IMMUNOL, V26, P347, DOI 10.1016/j.it.2005.05.006; Sandberg JK, 2002, J VIROL, V76, P7528, DOI 10.1128/JVI.76.15.7528-7534.2002; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; van der Vliet HJJ, 2002, J IMMUNOL, V168, P1490, DOI 10.4049/jimmunol.168.3.1490; Van Kaer L, 2012, TRENDS IMMUNOL; Vermeulen JN, 2007, AIDS RES HUM RETROV, V23, P1348, DOI 10.1089/aid.2006.0210; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599	46	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75199	10.1371/journal.pone.0075199	http://dx.doi.org/10.1371/journal.pone.0075199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130688	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900021
J	Seo, JA; Eun, CR; Cho, H; Lee, SK; Yoo, HJ; Kim, SG; Choi, KM; Baik, SH; Choi, DS; Yim, HJ; Shin, C; Kim, NH				Seo, Ji A.; Eun, Chai Ryoung; Cho, Hyunjoo; Lee, Seung Ku; Yoo, Hye Jin; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Yim, Hyung Joon; Shin, Chol; Kim, Nan Hee			Low Vitamin D Status Is Associated with Nonalcoholic Fatty Liver Disease Independent of Visceral Obesity in Korean Adults	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-19; D-RECEPTOR POLYMORPHISMS; INSULIN-RESISTANCE; 25-HYDROXYVITAMIN D; METABOLIC SYNDROME; HEPATIC STEATOSIS; SERUM 25-HYDROXYVITAMIN-D; APPARENTLY HEALTHY; D SUPPLEMENTATION; RISK-FACTORS	Objective: To investigate the association between serum 25-hydroxyvitamin D [25(OH)D] levels and nonalcoholic fatty liver disease (NAFLD) independent of visceral obesity in Koreans and to examine whether the associations differ according to the presence of diabetes or insulin resistance. Research Design and Methods: A total of 1081 adults were enrolled from a population-based cohort in Ansan city. Serum 25(OH)D concentrations were measured in all subjects. Insulin resistance was measured by homeostasis model assessment of insulin resistance (HOMA-IR). Using computed tomography, NAFLD was diagnosed if the liver attenuation index (LAI, the difference between the mean hepatic and splenic attenuation) was <5 Hounsfield Units. Results: In subjects with diabetes (n = 282), 25(OH)D levels were negatively associated with waist circumference, fasting insulin, HOMA-IR, triglyceride levels, and visceral abdominal fat, and were positively associated with LAI after adjusting for age, sex, season, exercise, and vitamin supplementation. In subjects without diabetes, only triglyceride level was negatively associated with 25(OH)D. The adjusted odds ratio (OR) for NAFLD increased sequentially across decreasing quartiles of 25(OH)D in subjects with diabetes even after adjusting for visceral fat [Q1 vs. Q4; OR for NAFLD 2.5 (95% CI: 1.0-6.2)]. In contrast, no significant difference in OR was observed in subjects without diabetes. When we classified non-diabetic subjects by HOMA-IR, an increase in the OR for NAFLD across decreasing quartiles of 25(OH)D was observed in the high HOMA-IR (>= 2.5) group [n = 207, Q1 vs. Q4; OR 3.8(1.4-10.3)], but not in the low HOMA-IR (<2.5) group [n = 592, OR 0.8 (0.3-1.9)]. Conclusions: Low vitamin D status is closely associated with NAFLD, independent of visceral obesity in subjects with diabetes or insulin resistance.	[Seo, Ji A.; Eun, Chai Ryoung; Cho, Hyunjoo; Yoo, Hye Jin; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Kim, Nan Hee] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol, Seoul 136705, South Korea; [Lee, Seung Ku; Shin, Chol] Korea Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 136705, South Korea; [Yim, Hyung Joon] Korea Univ, Coll Med, Dept Internal Med, Div Hepatol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, NH (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol, Seoul 136705, South Korea.	nhkendo@gmail.com	SEO, JI A/AAU-7968-2020; Kim, Nan Hee/T-8627-2019; Choi, Kyung Mook/C-4195-2018; Lee, SeungKu/GSN-5012-2022	SEO, JI A/0000-0002-1927-2618; Choi, Kyung Mook/0000-0001-6175-0225; Lee, SeungKu/0000-0001-5120-5557; Yoo, Hye Jin/0000-0003-0600-0266; Kim, Nan Hee/0000-0003-4378-520X; Kim, Sin Gon/0000-0002-7430-3675	Korea Centers for Disease Control and Prevention [2009-E71002-00, 2010-E71001-00]; Korea University; Korean Diabetes Association	Korea Centers for Disease Control and Prevention; Korea University; Korean Diabetes Association	This research was supported by a fund (2009-E71002-00, 2010-E71001-00) by research of Korea Centers for Disease Control and Prevention, by a Korea University grant, and by a grant (N.H.K., 2009) from the Korean Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Al-Daghri NM, 2013, J ENDOCRINOL INVEST, V36, P1, DOI 10.3275/8183; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Baik I, 2008, ARCH INTERN MED, V168, P167, DOI 10.1001/archinternmed.2007.8; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; Beydoun MA, 2010, J CLIN ENDOCR METAB, V95, P3814, DOI 10.1210/jc.2010-0410; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Breslavsky A, 2013, CLIN NUTR IN PRESS; Chacko SA, 2011, AM J CLIN NUTR, V94, P209, DOI 10.3945/ajcn.110.010272; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Choi HS, 2011, J NUTR, V141, P1524, DOI 10.3945/jn.111.139121; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Engeli S, 2003, INT J BIOCHEM CELL B, V35, P807, DOI 10.1016/S1357-2725(02)00311-4; Fabbrini E, 2010, GASTROENTEROLOGY, V139, P448, DOI 10.1053/j.gastro.2010.04.056; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fisher L, 2007, CLIN GASTROENTEROL H, V5, P513, DOI 10.1016/j.cgh.2006.10.015; Fliser D, 1997, EUR J CLIN INVEST, V27, P629, DOI 10.1046/j.1365-2362.1997.1520699.x; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gannage-Yared MH, 2003, J ENDOCRINOL INVEST, V26, P748, DOI 10.1007/BF03347358; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Lee S, 2006, J KOREAN MED SCI, V21, P695; Limanond P, 2004, RADIOLOGY, V230, P276, DOI 10.1148/radiol.2301021176; Liu E, 2009, J NUTR, V139, P329, DOI 10.3945/jn.108.093831; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Nakano T, 2011, J HEPATOL, V55, P415, DOI 10.1016/j.jhep.2010.11.028; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Park SH, 2005, CLIN SCI, V108, P553, DOI 10.1042/CS20040331; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Pickhardt PJ, 2012, EUR RADIOL, V22, P1075, DOI 10.1007/s00330-011-2349-2; Pinelli NR, 2010, DIABETES CARE, V33, P1373, DOI 10.2337/dc09-2199; Rhee EJ, 2013, ENDOCR J IN PRESS; Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Shin C, 2005, AM J RESP CRIT CARE, V171, P287, DOI 10.1164/rccm.200407-906OC; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; Vogel A, 2002, HEPATOLOGY, V35, P126, DOI 10.1053/jhep.2002.30084; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	52	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75197	10.1371/journal.pone.0075197	http://dx.doi.org/10.1371/journal.pone.0075197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130687	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900020
J	Chong, HQ; Yeow, J; Wang, I; Song, H; Jiang, RR				Chong, Huiqing; Yeow, Jianwei; Wang, Ivy; Song, Hao; Jiang, Rongrong			Improving Acetate Tolerance of Escherichia coli by Rewiring Its Global Regulator cAMP Receptor Protein (CRP)	PLOS ONE			English	Article							ACETIC-ACID TOLERANCE; TRANSCRIPTION MACHINERY; PHENOTYPIC ALTERATION; ETHANOL TOLERANCE; EXPRESSION; GROWTH; ACCUMULATION; INHIBITION; EVOLUTION; IDENTIFICATION	The presence of acetate exceeding 5 g/L is a major concern during E. coli fermentation due to its inhibitory effect on cell growth, thereby limiting high-density cell culture and recombinant protein production. Hence, engineered E. coli strains with enhanced acetate tolerance would be valuable for these bioprocesses. In this work, the acetate tolerance of E. coli was much improved by rewiring its global regulator cAMP receptor protein (CRP), which is reported to regulate 444 genes. Error-prone PCR method was employed to modify crp and the mutagenesis libraries (similar to 3x10(6)) were subjected to M9 minimal medium supplemented with 5-10 g/L sodium acetate for selection. Mutant A2 (D138Y) was isolated and its growth rate in 15 g/L sodium acetate was found to be 0.083 h(-1), much higher than that of the control (0.016 h(-1)). Real-time PCR analysis via OpenArray (R) system revealed that over 400 CRP-regulated genes were differentially expressed in A2 with or without acetate stress, including those involved in the TCA cycle, phosphotransferase system, etc. Eight genes were chosen for overexpression and the overexpression of uxaB was found to lead to E. coli acetate sensitivity.	[Chong, Huiqing; Song, Hao; Jiang, Rongrong] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Yeow, Jianwei; Wang, Ivy] Life Technol R&D, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Thermo Fisher Scientific	Jiang, RR (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	rrjiang@ntu.edu.sg	Jiang, Rongrong/G-6217-2010		Ministry of Education, Singapore [RG27/11]; Life Technologies CRC program	Ministry of Education, Singapore(Ministry of Education, Singapore); Life Technologies CRC program	This project is supported by Ministry of Education, Singapore (RG27/11) and Life Technologies CRC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; ARISTIDOU AA, 1994, BIOTECHNOL BIOENG, V44, P944, DOI 10.1002/bit.260440810; Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Basak S, 2012, PROCESS BIOCHEM, V47, P2152, DOI 10.1016/j.procbio.2012.08.006; Basak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051179; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Chen TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016228; Chong HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057628; CHOU CH, 1994, BIOTECHNOL BIOENG, V44, P952, DOI 10.1002/bit.260440811; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Geddes CC, 2011, CURR OPIN BIOTECH, V22, P312, DOI 10.1016/j.copbio.2011.04.012; Gilbert A, 2009, BIOTECHNOL BIOENG, V103, P500, DOI 10.1002/bit.22272; Gonzalez R, 2003, BIOTECHNOL PROGR, V19, P612, DOI 10.1021/bp025658q; HAN K, 1993, BIOTECHNOL BIOENG, V41, P316, DOI 10.1002/bit.260410305; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; Huang L, 2008, PROTEIN EXPRES PURIF, V61, P168, DOI 10.1016/j.pep.2008.05.016; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Liu WS, 2012, TOP CATAL, V55, P1146, DOI 10.1007/s11244-012-9893-0; LULI GW, 1990, APPL ENVIRON MICROB, V56, P1004, DOI 10.1128/AEM.56.4.1004-1011.1990; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Park KS, 2005, J BACTERIOL, V187, P5496, DOI 10.1128/JB.187.15.5496-5499.2005; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Patnaik R, 2008, BIOTECHNOL PROGR, V24, P38, DOI 10.1021/bp0701214; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Polen T, 2003, APPL ENVIRON MICROB, V69, P1759, DOI 10.1128/AEM.69.3.1759-1774.2003; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; PORTALIER RC, 1972, EUR J BIOCHEM, V30, P211, DOI 10.1111/j.1432-1033.1972.tb02089.x; REED WM, 1987, ENZYME MICROB TECH, V9, P117, DOI 10.1016/0141-0229(87)90154-2; Roe AJ, 1998, J BACTERIOL, V180, P767, DOI 10.1128/JB.180.4.767-772.1998; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Tomar A, 2003, APPL MICROBIOL BIOT, V62, P76, DOI 10.1007/s00253-003-1234-6; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Wang L, 2012, APPL MICROBIOL BIOT, V96, P1265, DOI 10.1007/s00253-012-3919-1; Wang L, 2012, APPL MICROBIOL BIOT, V94, P1233, DOI 10.1007/s00253-011-3699-z; Wang L, 2012, J MOL CATAL B-ENZYM, V76, P9, DOI 10.1016/j.molcatb.2011.11.016; Wang LA, 2011, J MOL CATAL B-ENZYM, V69, P120, DOI 10.1016/j.molcatb.2011.01.005; Wei P, 2008, BIOTECHNOL APPL BIOC, V49, P113, DOI 10.1042/BA20070072; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wong MS, 2008, METAB ENG, V10, P97, DOI 10.1016/j.ymben.2007.10.003; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166; Zhang HF, 2012, APPL MICROBIOL BIOT, V94, P1107, DOI 10.1007/s00253-012-4012-5; Zhang HF, 2012, BIOTECHNOL BIOENG, V109, P1165, DOI 10.1002/bit.24411; Zhang HF, 2010, APPL MICROBIOL BIOT, V88, P117, DOI 10.1007/s00253-010-2735-8	54	28	32	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77422	10.1371/journal.pone.0077422	http://dx.doi.org/10.1371/journal.pone.0077422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124618	gold, Green Published			2022-12-27	WOS:000325489100175
J	Pagnotta, SM; Laudanna, C; Pancione, M; Sabatino, L; Votino, C; Remo, A; Cerulo, L; Zoppoli, P; Manfrin, E; Colantuoni, V; Ceccarelli, M				Pagnotta, Stefano Maria; Laudanna, Carmelo; Pancione, Massimo; Sabatino, Lina; Votino, Carolina; Remo, Andrea; Cerulo, Luigi; Zoppoli, Pietro; Manfrin, Erminia; Colantuoni, Vittorio; Ceccarelli, Michele			Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPAR gamma and TNF alpha Signaling	PLOS ONE			English	Article							INDUCED APOPTOSIS; BETA-CATENIN; F-SPONDIN; EXPRESSION; ECTO-5'-NUCLEOTIDASE; SUPPRESSOR; CARCINOMA; CD73	We describe a novel bioinformatic and translational pathology approach, gene Signature Finder Algorithm (gSFA) to identify biomarkers associated with Colorectal Cancer (CRC) survival. Here a robust set of CRC markers is selected by an ensemble method. By using a dataset of 232 gene expression profiles, gSFA discovers 16 highly significant small gene signatures. Analysis of dichotomies generated by the signatures results in a set of 133 samples stably classified in good prognosis group and 56 samples in poor prognosis group, whereas 43 remain unreliably classified. AKAP12, DCBLD2, NT5E and SPON1 are particularly represented in the signatures and selected for validation in vivo on two independent patients cohorts comprising 140 tumor tissues and 60 matched normal tissues. Their expression and regulatory programs are investigated in vitro. We show that the coupled expression of NT5E and DCBLD2 robustly stratifies our patients in two groups (one of which with 100% survival at five years). We show that NT5E is a target of the TNF-alpha signaling in vitro; the tumor suppressor PPAR gamma acts as a novel NT5E antagonist that positively and concomitantly regulates DCBLD2 in a cancer cell context-dependent manner.	[Pagnotta, Stefano Maria; Laudanna, Carmelo; Pancione, Massimo; Sabatino, Lina; Votino, Carolina; Cerulo, Luigi; Colantuoni, Vittorio; Ceccarelli, Michele] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Cerulo, Luigi; Ceccarelli, Michele] BIOGEM Scrl, Bioinformat Lab, Ariano Irpino, Italy; [Remo, Andrea] Hosp Mater Salutis, Dept Pathol, Legnano, Italy; [Zoppoli, Pietro] Columbia Univ, Inst Canc Genet, New York, NY USA; [Manfrin, Erminia] Univ Verona, Dept Surg & Oncol, I-37100 Verona, Italy	University of Sannio; Columbia University; University of Verona	Colantuoni, V (corresponding author), Univ Sannio, Dept Sci & Technol, Benevento, Italy.	vittorio.colantuoni@unisannio.it; michele.ceccarelli@unisannio.it	manfrin, erminia/P-2645-2016; Ceccarelli, Michele/AGP-1739-2022; Zoppoli, Pietro/J-9954-2018; Remo, Andrea/Q-7746-2016; Pancione, Massimo/AAF-2109-2019	manfrin, erminia/0000-0002-5706-0018; Zoppoli, Pietro/0000-0002-7860-9655; Remo, Andrea/0000-0002-2564-2988; PAGNOTTA, Stefano Maria/0000-0002-8298-9777; Sabatino, Lina/0000-0001-5341-7430; Ceccarelli, Michele/0000-0002-4702-6617; LAUDANNA, Carmelo/0000-0002-0397-6020; PANCIONE, Massimo/0000-0003-1728-8816	Ministero dell'Universita e della Ricerca [PRIN2008-20085CH22F]; Associazione italiana per la lotta ai linfomi e leucemie	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Associazione italiana per la lotta ai linfomi e leucemie(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Ministero dell'Universita e della Ricerca under grant (PRIN2008-20085CH22F) and by Associazione italiana per la lotta ai linfomi e leucemie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Badiola I, 2012, GUT, V61, P1465, DOI 10.1136/gutjnl-2011-300810; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; Choi MC, 2004, ONCOGENE, V23, P7095, DOI 10.1038/sj.onc.1207932; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Guo XJ, 2009, J BIOL CHEM, V284, P29376, DOI 10.1074/jbc.M109.049684; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hayashi M, 2012, J SURG ONCOL, V105, P381, DOI 10.1002/jso.22135; Kim M, 2008, MOL CANCER RES, V6, P222, DOI 10.1158/1541-7786.MCR-07-0142; Liu WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024015; Liu WW, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.12.010; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Pancione M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014229; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Pancione M, 2009, HUM PATHOL, V40, P714, DOI 10.1016/j.humpath.2008.08.019; Pyle-Chenault RA, 2005, TUMOR BIOL, V26, P245, DOI 10.1159/000087379; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; Simmer F, 2012, EPIGENETICS-US, V7, P1355, DOI 10.4161/epi.22562; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Spychala J, 2004, EXP CELL RES, V296, P99, DOI 10.1016/j.yexcr.2003.11.001; Stagg J, 2012, CANCER RES, V72, P2190, DOI 10.1158/0008-5472.CAN-12-0420; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; Wang J, 2011, BIOMED ENVIRON SCI, V24, P391, DOI 10.3967/0895-3988.2011.04.010; Wu XR, 2012, J SURG ONCOL, V106, P130, DOI 10.1002/jso.23056; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068	39	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72638	10.1371/journal.pone.0072638	http://dx.doi.org/10.1371/journal.pone.0072638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	24133572	Green Published, gold, Green Submitted			2022-12-27	WOS:000323425700184
J	Girard, YK; Wang, CY; Ravi, S; Howell, MC; Mallela, J; Alibrahim, M; Green, R; Hellermann, G; Mohapatra, SS; Mohapatra, S				Girard, Yvonne K.; Wang, Chunyan; Ravi, Sowndharya; Howell, Mark C.; Mallela, Jaya; Alibrahim, Mahmoud; Green, Ryan; Hellermann, Gary; Mohapatra, Shyam S.; Mohapatra, Subhra			A 3D Fibrous Scaffold Inducing Tumoroids: A Platform for Anticancer Drug Development	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MULTICELLULAR RESISTANCE; ELECTROSPUN MATRICES; SUSTAINED DELIVERY; SPHEROID FORMATION; ALKYLATING-AGENTS; CANCER SPHEROIDS; CULTURE; MODELS; TRANSITION	The development of a suitable three dimensional (3D) culture system for anticancer drug development remains an unmet need. Despite progress, a simple, rapid, scalable and inexpensive 3D-tumor model that recapitulates in vivo tumorigenesis is lacking. Herein, we report on the development and characterization of a 3D nanofibrous scaffold produced by electrospinning a mixture of poly(lactic-co-glycolic acid) (PLGA) and a block copolymer of polylactic acid (PLA) and monomethoxypolyethylene glycol (mPEG) designated as 3P. Cancer cells cultured on the 3P scaffold formed tight irregular aggregates similar to in vivo tumors, referred to as tumoroids that depended on the topography and net charge of the scaffold. 3P scaffolds induced tumor cells to undergo the epithelial-to-mesenchymal transition (EMT) as demonstrated by up-regulation of vimentin and loss of E-cadherin expression. 3P tumoroids showed higher resistance to anticancer drugs than the same tumor cells grown as monolayers. Inhibition of ERK and PI3K signal pathways prevented EMT and reduced tumoroid formation, diameter and number. Fine needle aspirates, collected from tumor cells implanted in mice when cultured on 3P scaffolds formed tumoroids, but showed decreased sensitivity to anticancer drugs, compared to tumoroids formed by direct seeding. These results show that 3P scaffolds provide an excellent platform for producing tumoroids from tumor cell lines and from biopsies and that the platform can be used to culture patient biopsies, test for anticancer compounds and tailor a personalized cancer treatment.	[Girard, Yvonne K.; Wang, Chunyan; Ravi, Sowndharya; Howell, Mark C.; Mallela, Jaya; Green, Ryan; Mohapatra, Subhra] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA; [Girard, Yvonne K.; Wang, Chunyan; Ravi, Sowndharya; Howell, Mark C.; Mallela, Jaya; Green, Ryan; Hellermann, Gary; Mohapatra, Shyam S.; Mohapatra, Subhra] Univ S Florida, Morsani Coll Med, USF Nanomed Res Ctr, Tampa, FL USA; [Alibrahim, Mahmoud] Univ S Florida, Chem & Biomed Engn Dept, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Mohapatra, S (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.	smohapa2@health.usf.edu	Mohapatra, Shyam/C-2500-2012; Mallela, Jaya/AAJ-9875-2021; Mohapatra, Subhra/A-1381-2012; Howell, Mark/ABA-6352-2021		Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work is supported by grants from the Office of Naval Research to SM and SSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Garcia PA, 2011, NEOPLASIA, V13, P831, DOI 10.1593/neo.11612; Ballangrud AM, 1999, CLIN CANCER RES, V5, p3171S; Bongio M, 2011, Eur Cell Mater, V22, P359; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Caicedo-Carvajal Carlos E, 2011, J Tissue Eng, V2011, P362326, DOI 10.4061/2011/362326; Castaneda F, 2000, J CANCER RES CLIN, V126, P305, DOI 10.1007/s004320050348; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Davis Y, 2011, TECHNOL INNOV, V13, P51, DOI 10.3727/194982411X13003853540036; Desoize B, 1998, Bull Cancer, V85, P785; Dnace A, 2012, SCIENTIST; do Amaral JB, 2011, TISSUE ENG PART C-ME, V17, P1097, DOI 10.1089/ten.tec.2011.0260; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; ERLANSON M, 1992, CANCER CHEMOTH PHARM, V29, P343, DOI 10.1007/BF00686002; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; GEISINGER KR, 1989, CANCER-AM CANCER SOC, V63, P280, DOI 10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N; Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Guo LX, 2011, AM J PATHOL, V178, P2357, DOI 10.1016/j.ajpath.2011.01.047; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hedlund TE, 1999, PROSTATE, V41, P154; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WJ, 2010, CANCER SCI, V101, P2637, DOI 10.1111/j.1349-7006.2010.01723.x; Ivascu A, 2007, INT J ONCOL, V31, P1403; Johnson J, 2009, TISSUE ENG PART C-ME, V15, P531, DOI [10.1089/ten.tec.2008.0486, 10.1089/ten.TEC.2008.0486]; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Ma HL, 2012, MOL IMAGING, V11, P487, DOI 10.2310/7290.2012.00012; Mallela J, 2013, STEM CELLS; Masuda S., 2012, NAT REV CLIN ONCOL, V10, P79, DOI [10.1038/nrclinonc.2012.127-c1, DOI 10.1038/NRCLINONC.2012.127-C1]; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; OLIVE PL, 1991, INT J RADIAT BIOL, V60, P453, DOI 10.1080/09553009114552311; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Peart TM, 2012, CLIN EXP METASTAS, V29, P293, DOI 10.1007/s10585-011-9451-3; Piskin E, 2007, NANOMEDICINE-UK, V2, P441, DOI 10.2217/17435889.2.4.441; Prudkin L, 2009, MODERN PATHOL, V22, P668, DOI 10.1038/modpathol.2009.19; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Samavedi S, 2012, BIOMATERIALS, V33, P7727, DOI 10.1016/j.biomaterials.2012.07.008; Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la034753l; Shin JY, 2012, BIOTECHNOL LETT, V34, P795, DOI 10.1007/s10529-011-0836-9; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Song H, 2004, TISSUE ENG, V10, P1266, DOI 10.1089/1076327041887673; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; StCroix B, 1996, NAT MED, V2, P1204; Sundaramurthi D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045005; Takagi A, 2007, ANTICANCER RES, V27, P45; TEICHER BA, 1990, SCIENCE, V247, P1457, DOI 10.1126/science.2108497; Timmins NE, 2005, CELL TISSUE RES, V320, P207, DOI 10.1007/s00441-004-1064-6; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Xie JW, 2008, J BIOMED MATER RES A, V85A, P897, DOI 10.1002/jbm.a.31499; Xie JW, 2006, PHARM RES-DORDR, V23, P1817, DOI 10.1007/s11095-006-9036-z; Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042; Yamashita N, 2013, J CANCER RES CLIN, V139, P739, DOI 10.1007/s00432-013-1376-6; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Yu DG, 2012, CARBOHYD POLYM, V90, P1016, DOI 10.1016/j.carbpol.2012.06.036; Zanatta G, 2012, BRAZ J MED BIOL RES, V45, P125, DOI 10.1590/S0100-879X2011007500163; Zanatta G, 2012, J BIOMED NANOTECHNOL, V8, P211, DOI 10.1166/jbn.2012.1382; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031	77	94	101	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75345	10.1371/journal.pone.0075345	http://dx.doi.org/10.1371/journal.pone.0075345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146752	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400005
J	Cheung, SCK; Long, XH; Liu, LZ; Liu, QQ; Lan, LL; Tong, PCY; Sun, SSM				Cheung, Stanley C. K.; Long, Xiaohang; Liu, Lizhong; Liu, Qiaoquan; Lan, Linlin; Tong, Peter C. Y.; Sun, Samuel S. M.			Inhibition of Human MCF-7 Breast Cancer Cells and HT-29 Colon Cancer Cells by Rice-Produced Recombinant Human Insulin-Like Growth Binding Protein-3 (rhIGFBP-3)	PLOS ONE			English	Article							RETICULUM-RETENTION SIGNAL; SYNONYMOUS CODON CHOICE; MONOCLONAL-ANTIBODY; ENDOPLASMIC-RETICULUM; IN-VIVO; RESPECTIVE CODONS; ESCHERICHIA-COLI; TRANSGENIC RICE; RETINOIC ACID; TRANSFER-RNAS	Background: Insulin-like growth factor binding protein-3 (IGFBP-3) is a multifunctional molecule which is closely related to cell growth, apoptosis, angiogenesis, metabolism and senescence. It combines with insulin-like growth factor-I (IGF-I) to form a complex (IGF-I/IGFBP-3) that can treat growth hormone insensitivity syndrome (GHIS) and reduce insulin requirement in patients with diabetes. IGFBP-3 alone has been shown to have anti-proliferation effect on numerous cancer cells. Methodology/Principal Findings: We reported here an expression method to produce functional recombinant human IGFBP-3 (rhIGFBP-3) in transgenic rice grains. Protein sorting sequences, signal peptide and endoplasmic reticulum retention tetrapeptide (KDEL) were included in constructs for enhancing rhIGFBP-3 expression. Western blot analysis showed that only the constructs with signal peptide were successfully expressed in transgenic rice grains. Both rhIGFBP-3 proteins, with or without KDEL sorting sequence inhibited the growth of MCF-7 human breast cancer cells (65.76 +/- 1.72% vs 45.00 +/- 0.86%, p < 0.05; 50.84 +/- 1.97% vs 45.00 +/- 0.86%, p < 0.01 respectively) and HT-29 colon cancer cells (65.14 +/- 3.84% vs 18.01 +/- 13.81%, p < 0.05 and 54.7 +/- 9.44% vs 18.01 +/- 13.81%, p < 0.05 respectively) when compared with wild type rice. Conclusion/Significance: These findings demonstrated the feasibility of producing biological active rhIGFBP-3 in rice using a transgenic approach, which will definitely encourage more research on the therapeutic use of hIGFBP-3 in future.	[Cheung, Stanley C. K.; Long, Xiaohang; Sun, Samuel S. M.] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Cheung, Stanley C. K.; Liu, Lizhong; Lan, Linlin; Tong, Peter C. Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Liu, Qiaoquan] Yangzhou Univ, Coll Agr, Minist Educ, Key Lab Plant Funct Genom, Yangzhou, Jiangsu, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Yangzhou University	Sun, SSM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China.	ssun@cuhk.edu.hk	Cheung, Stanley Chun Kai/A-9302-2015		ITC ITF [1907030]; Hong Kong SAR, the Ministry of Science and Technology [2012AA10A302-7, 2011ZX08001-006]; Jiangsu Natural Science Foundation of China [BK2012010]	ITC ITF; Hong Kong SAR, the Ministry of Science and Technology; Jiangsu Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province)	This research was supported by ITC ITF support to the Partner State Key Laboratories in Hong Kong, CUHK Focused Investment Scheme (2nd phase) (Project No. 1907030) Hong Kong SAR, the Ministry of Science and Technology (Project No. 2012AA10A302-7 and 2011ZX08001-006), and the Jiangsu Natural Science Foundation of China (Project No. BK2012010). The funders conceived and designed the experiments, contributed reagents/materials/ analysis tools and made a decision to publish the manuscript.	Alami N, 2008, GROWTH HORM IGF RES, V18, P487, DOI 10.1016/j.ghir.2008.04.002; Ali O, 2003, HORM METAB RES, V35, P726; Barrieu F, 1999, PLANT PHYSIOL, V120, P961, DOI 10.1104/pp.120.4.961; Baxter RC, 2013, J CELL COMMUN SIGNAL; Brosseau C, 2013, INT J CELL BIOL, V2013, P9; Cai H, 2004, BRIT J CANCER, V91, P1364, DOI 10.1038/sj.bjc.6602124; Chang YS, 2006, CANCER BIOL THER, V5, P586, DOI 10.4161/cbt.5.6.2658; Cheung SCK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-37; Cheung SCK, 2009, TRANSGENIC RES, V18, P943, DOI 10.1007/s11248-009-9286-8; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Colston KW, 1998, J MOL ENDOCRINOL, V20, P157, DOI 10.1677/jme.0.0200157; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 1999, J ENDOCRINOL, V160, P379, DOI 10.1677/joe.0.1600379; Fischer R, 2000, TRANSGENIC RES, V9, P279, DOI 10.1023/A:1008975123362; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Forbes K, 2010, ENDOCRINOLOGY, V151, P1723, DOI 10.1210/en.2009-0896; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Greenham Trevor, 2013, Methods Mol Biol, V956, P311, DOI 10.1007/978-1-62703-194-3_22; Gucev ZS, 1996, CANCER RES, V56, P1545; Henderson AJ, 2012, ADV NUTR, V3, P643, DOI 10.3945/an.112.002303; Hood EE, 2002, CURR OPIN BIOTECH, V13, P630, DOI 10.1016/S0958-1669(02)00351-8; Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163; Huynh H, 1996, J BIOL CHEM, V271, P1016, DOI 10.1074/jbc.271.2.1016; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Jain MG, 1999, NUTR CANCER, V34, P173, DOI 10.1207/S15327914NC3402_8; Kajiura H, 2013, MOL BIOTECHNOL, V54, P784, DOI 10.1007/s12033-012-9626-4; Kannan A, 2008, J AGR FOOD CHEM, V56, P11643, DOI 10.1021/jf802558v; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Kirman I, 2004, SURGERY, V136, P205, DOI 10.1016/j.surg.2004.04.020; Ko KS, 2003, P NATL ACAD SCI USA, V100, P8013, DOI 10.1073/pnas.0832472100; Kong CKL, 2009, BIOCHEM PHARMACOL, V77, P1487, DOI 10.1016/j.bcp.2009.02.008; Larrick JW, 2001, BIOMOL ENG, V18, P87, DOI 10.1016/S1389-0344(01)00102-2; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Liu Qiao-Quan, 2005, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V31, P247; Liu Qiao-Quan, 2004, Acta Genetica Sinica, V31, P518; Liu QQ, 2003, TRANSGENIC RES, V12, P71, DOI 10.1023/A:1022148824018; Manson MM, 2003, TRENDS MOL MED, V9, P11, DOI 10.1016/S1471-4914(02)00002-3; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Nicodemus KK, 2001, CANCER CAUSE CONTROL, V12, P917, DOI 10.1023/A:1013746719385; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Schouten A, 1996, PLANT MOL BIOL, V30, P781, DOI 10.1007/BF00019011; SMIGEL K, 1992, J NATL CANCER I, V84, P80, DOI 10.1093/jnci/84.2.80; Spok A, 2008, TRENDS BIOTECHNOL, V26, P506, DOI 10.1016/j.tibtech.2008.05.007; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; Stoger E, 2000, PLANT MOL BIOL, V42, P583, DOI 10.1023/A:1006301519427; Sun WG, 2009, J NUTR BIOCHEM, V20, P276, DOI 10.1016/j.jnutbio.2008.03.003; Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x; Triguero A, 2005, PLANT BIOTECHNOL J, V3, P449, DOI 10.1111/j.1467-7652.2005.00137.x; Triguero A, 2011, PLANT BIOTECHNOL J, V9, P1120, DOI 10.1111/j.1467-7652.2011.00638.x; Verschoyle RD, 2007, BRIT J CANCER, V96, P248, DOI 10.1038/sj.bjc.6603539; WOOD WI, 1988, MOL ENDOCRINOL, V2, P1176, DOI 10.1210/mend-2-12-1176; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yang LJ, 2006, FEBS LETT, V580, P3315, DOI 10.1016/j.febslet.2006.04.092; Zimmermann EM, 2000, AM J PHYSIOL-GASTR L, V278, pG447, DOI 10.1152/ajpgi.2000.278.3.G447; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	62	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77516	10.1371/journal.pone.0077516	http://dx.doi.org/10.1371/journal.pone.0077516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143239	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100077
J	Lawton, RJ; Mata, L; de Nys, R; Paul, NA				Lawton, Rebecca J.; Mata, Leonardo; de Nys, Rocky; Paul, Nicholas A.			Algal Bioremediation of Waste Waters from Land-Based Aquaculture Using Ulva: Selecting Target Species and Strains	PLOS ONE			English	Article							MULTI-TROPHIC AQUACULTURE; DISSOLVED INORGANIC NITROGEN; TEMPERATE ATLANTIC SEAWEEDS; GREEN TIDE ALGAE; LOCAL ADAPTATION; ECOTYPIC DIFFERENTIATION; RECIPROCAL TRANSPLANTS; MOLECULAR PHYLOGENY; NUCLEAR RDNA; CHLOROPHYTA	The optimised reduction of dissolved nutrient loads in aquaculture effluents through bioremediation requires selection of appropriate algal species and strains. The objective of the current study was to identify target species and strains from the macroalgal genus Ulva for bioremediation of land-based aquaculture facilities in Eastern Australia. We surveyed land-based aquaculture facilities and natural coastal environments across three geographic locations in Eastern Australia to determine which species of Ulva occur naturally in this region and conducted growth trials at three temperature treatments on a subset of samples from each location to determine whether local strains had superior performance under local environmental conditions. DNA barcoding using the markers ITS and tufA identified six species of Ulva, with U. ohnoi being the most common blade species and U. sp. 3 the most common filamentous species. Both species occurred at multiple land-based aquaculture facilities in Townsville and Brisbane and multiple strains of each species grew well in culture. Specific growth rates of U. ohnoi and U. sp. 3 were high (over 9% and 15% day(-1) respectively) across temperature treatments. Within species, strains of U. ohnoi had higher growth in temperatures corresponding to local conditions, suggesting that strains may be locally adapted. However, across all temperature treatments Townsville strains had the highest growth rates (11.2-20.4% day(-1)) and Sydney strains had the lowest growth rates (2.5-8.3% day(-1)). We also found significant differences in growth between strains of U. ohnoi collected from the same geographic location, highlighting the potential to isolate and cultivate fast growing strains. In contrast, there was no clearly identifiable competitive strain of filamentous Ulva, with multiple species and strains having variable performance. The fast growth rates and broad geographical distribution of U. ohnoi make this an ideal species to target for bioremediation activities at land-based aquaculture facilities in Eastern Australia.	[Lawton, Rebecca J.; Mata, Leonardo; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Lawton, RJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	rebecca.lawton@jcu.edu.au	Lawton, Rebecca/A-6149-2012; Paul, Nicholas/B-6496-2009; Lawton, Rebecca/E-5711-2014; de Nys, Rocky/D-6741-2012; Mata, Leonardo/D-6733-2012	Lawton, Rebecca/0000-0001-6296-6415; de Nys, Rocky/0000-0003-3869-4928; Mata, Leonardo/0000-0002-5962-2483; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC) through the Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC) through the Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MH, 2011, AQUACULTURE, V312, P77, DOI 10.1016/j.aquaculture.2010.12.036; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Angell A, J PHYCOLOGY IN PRESS; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; Barrington K., 2009, INTEGR MARIC GLOB RE, V529, P7; Bergstrom L, 2006, J PHYCOL, V42, P36, DOI 10.1111/j.1529-8817.2006.00173.x; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Blanchette CA, 2002, MAR ECOL PROG SER, V239, P69, DOI 10.3354/meps239069; Bolton JJ, 2009, J APPL PHYCOL, V21, P575, DOI 10.1007/s10811-008-9385-6; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Chopin T, 2012, REV AQUACULT, V4, P209, DOI 10.1111/j.1753-5131.2012.01074.x; Copertino MD, 2009, J APPL PHYCOL, V21, P31, DOI 10.1007/s10811-008-9357-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DELRIO MJ, 1996, 15 INT SEAW S SPRING, V327, P61; DENNISON WC, 1986, J EXP MAR BIOL ECOL, V98, P265, DOI 10.1016/0022-0981(86)90217-0; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Fowler-Walker MJ, 2006, MAR BIOL, V148, P755, DOI 10.1007/s00227-005-0125-z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harper JT, 2001, CAH BIOL MAR, V42, P25; Hayden HS, 2004, PHYCOLOGIA, V43, P364, DOI 10.2216/i0031-8884-43-4-364.1; Hays CG, 2007, ECOLOGY, V88, P149, DOI 10.1890/0012-9658(2007)88[149:APDATI]2.0.CO;2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hiraoka M, 2004, PHYCOL RES, V52, P17, DOI 10.1111/j.1440-1835.2003.00321.x; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim JK, 2007, J APPL PHYCOL, V19, P431, DOI 10.1007/s10811-006-9150-7; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirkendale L, 2013, J PHYCOL, V49, P69, DOI 10.1111/jpy.12016; Kraft LGK, 2010, J PHYCOL, V46, P1257, DOI 10.1111/j.1529-8817.2010.00909.x; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; Msuya FE, 2006, AQUACULTURE, V254, P284, DOI 10.1016/j.aquaculture.2005.10.044; Naylor R, 2005, ANNU REV ENV RESOUR, V30, P185, DOI 10.1146/annurev.energy.30.081804.121034; Neori A, 2003, J APPL PHYCOL, V15, P543, DOI 10.1023/B:JAPH.0000004382.89142.2d; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Neori A, 1991, GROWTH RATE YIELD C, V483; Nobre AM, 2010, AQUACULTURE, V306, P116, DOI 10.1016/j.aquaculture.2010.06.002; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; O' Kelly CJ, 2004, J PHYCOL, V40, P789, DOI 10.1111/j.1529-8817.2004.03204.x; Pakker H, 1996, EUR J PHYCOL, V31, P133, DOI 10.1080/09670269600651301; Pakker H, 1996, EUR J PHYCOL, V31, P123, DOI 10.1080/09670269600651291; Paul NA, 2008, AQUACULTURE, V281, P49, DOI 10.1016/j.aquaculture.2008.05.024; Pedersen A, 2004, J EXP MAR BIOL ECOL, V312, P235, DOI 10.1016/j.jembe.2004.05.021; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Ridler N., 2007, Aquaculture Economics and Management, V11, P99, DOI 10.1080/13657300701202767; Robinson N, 2013, J APPL PHYCOL, V25, P703, DOI 10.1007/s10811-012-9950-x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Silva PHD, 2012, AQUACULT ENV INTERAC, V2, P253, DOI 10.3354/aei00043; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; SUBANDAR A, 1993, J APPL PHYCOL, V5, P455, DOI 10.1007/BF02182738; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MW, 1999, J PHYCOL, V35, P740, DOI 10.1046/j.1529-8817.1999.3540740.x; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; THOMPSON JD, 1991, NEW PHYTOL, V117, P129, DOI 10.1111/j.1469-8137.1991.tb00952.x; Troell M., 2009, FAO Fisheries and Aquaculture Technical Paper, P47; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Voskoboinikov GM, 1996, BOT MAR, V39, P341, DOI 10.1515/botm.1996.39.1-6.341; Woolcott GW, 1999, AUST SYST BOT, V12, P709, DOI 10.1071/SB97034; Yabe T, 2009, LIMNOLOGY, V10, P239, DOI 10.1007/s10201-009-0278-4; Yokoyama H, 2010, AQUACULTURE, V310, P74, DOI 10.1016/j.aquaculture.2010.10.018; Zhou Y, 2006, AQUACULTURE, V252, P264, DOI 10.1016/j.aquaculture.2005.06.046	65	90	92	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77344	10.1371/journal.pone.0077344	http://dx.doi.org/10.1371/journal.pone.0077344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143221	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000325894100058
J	Turk, EM; Das, V; Seibert, RD; Andrulis, ED				Turk, Edward M.; Das, Vaijayanti; Seibert, Ryan D.; Andrulis, Erik D.			The Mitochondrial RNA Landscape of Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST EXOSOME CORE; TRANSCRIPTION INITIATION; NUCLEOTIDE-SEQUENCE; DNA-REPLICATION; RIBOSOMAL-RNA; PROMOTER SEQUENCE; MESSENGER-RNAS; I-TASSER; 3' END; GENOME	Mitochondria are essential organelles that harbor a reduced genome, and expression of that genome requires regulated metabolism of its transcriptome by nuclear-encoded proteins. Despite extensive investigation, a comprehensive map of the yeast mitochondrial transcriptome has not been developed and all of the RNA-metabolizing proteins have not been identified, both of which are prerequisites to elucidating the basic RNA biology of mitochondria. Here, we present a mitochondrial transcriptome map of the yeast S288C reference strain. Using RNAseq and bioinformatics, we show the expression level of all transcripts, revise all promoter, origin of replication, and tRNA annotations, and demonstrate for the first time the existence of alternative splicing, mirror RNAs, and a novel RNA processing site in yeast mitochondria. The transcriptome map has revealed new aspects of mitochondrial RNA biology and we expect it will serve as a valuable resource. As a complement to the map, we present our compilation of all known yeast nuclear-encoded ribonucleases (RNases), and a screen of this dataset for those that are imported into mitochondria. We sought to identify RNases that are refractory to recovery in traditional mitochondrial screens due to an essential function or eclipsed accumulation in another cellular compartment. Using this in silico approach, the essential RNase of the nuclear and cytoplasmic exosome, Dis3p, emerges as a strong candidate. Bioinformatics and in vivo analyses show that Dis3p has a conserved and functional mitochondrial-targeting signal (MTS). A clean and marker-less chromosomal deletion of the Dis3p MTS results in a defect in the decay of intron and mirror RNAs, thus revealing a role for Dis3p in mitochondrial RNA decay.	[Turk, Edward M.; Das, Vaijayanti; Andrulis, Erik D.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Turk, Edward M.; Seibert, Ryan D.] Gilmour Acad, Dept Sci, Gates Mills, OH USA	Case Western Reserve University	Andrulis, ED (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	exa32@case.edu			National Institutes of Health [T32HD007104]; National Institutes of General Medical Sciences [R01 GM0272820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a developmental biology training grant from the National Institutes of Health (T32HD007104) to E.M.T. and the National Institutes of General Medical Sciences (R01 GM0272820) to E.D.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 1997, NATURE, V387, P5; BALDACCI G, 1982, EMBO J, V1, P987, DOI 10.1002/j.1460-2075.1982.tb01282.x; BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x; BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bernardi G, 2005, GENE, V354, P189, DOI 10.1016/j.gene.2005.03.024; Biswas TK, 1999, BIOCHEMISTRY-US, V38, P9693, DOI 10.1021/bi982804l; BISWAS TK, 1990, P NATL ACAD SCI USA, V87, P9338, DOI 10.1073/pnas.87.23.9338; Biswas TK, 1996, GENE, V170, P23, DOI 10.1016/0378-1119(95)00874-8; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; Biswas TK, 1998, GENE, V212, P305, DOI 10.1016/S0378-1119(98)00133-4; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; BORDONNE R, 1987, NUCLEIC ACIDS RES, V15, P7381; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Brachmann CB, 1998, YEAST, V14, P115; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; CHRISTIANSON T, 1983, J BIOL CHEM, V258, P4025; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CONRADWEBB H, 1990, NUCLEIC ACIDS RES, V18, P1369, DOI 10.1093/nar/18.6.1369; Daoud R, 2012, NUCLEIC ACIDS RES, V40, P1728, DOI 10.1093/nar/gkr941; Deshpande AP, 2012, BBA-GENE REGUL MECH, V1819, P930, DOI 10.1016/j.bbagrm.2012.02.003; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Ephrussi B., 1949, UNITES BIOL DOUEES C, P165; FAUGERONFONTY G, 1984, GENE, V32, P459, DOI 10.1016/0378-1119(84)90020-9; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; FOLLEY LS, 1991, GENETICS, V129, P659; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Graham AC, 2009, TRAFFIC, V10, P499, DOI 10.1111/j.1600-0854.2009.00888.x; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Graves T, 1998, NUCLEIC ACIDS RES, V26, P1309, DOI 10.1093/nar/26.5.1309; Hagemann R, 2010, MOL GENET GENOMICS, V283, P199, DOI 10.1007/s00438-010-0521-z; Hardwick SW, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120028; HENSGENS LAM, 1983, CELL, V32, P379, DOI 10.1016/0092-8674(83)90457-9; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; HOFMANN TJ, 1993, YEAST, V9, P1319, DOI 10.1002/yea.320091205; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; HUDSPETH MES, 1982, CELL, V30, P617, DOI 10.1016/0092-8674(82)90258-6; KINOSHITA N, 1991, MOL CELL BIOL, V11, P5839, DOI 10.1128/MCB.11.12.5839; Kiss DL, 2011, RNA, V17, P1, DOI 10.1261/rna.2364811; Krause K, 2004, NUCLEIC ACIDS RES, V32, P6276, DOI 10.1093/nar/gkh966; KREIKE J, 1986, CURR GENET, V11, P185, DOI 10.1007/BF00420605; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Litvinchuk AV, 2013, EUR J CELL BIOL, V92, P169, DOI 10.1016/j.ejcb.2013.02.001; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mamolen M, 2010, NUCLEIC ACIDS RES, V38, P5507, DOI 10.1093/nar/gkq295; Mamolen M, 2009, BIOCHEM BIOPH RES CO, V390, P529, DOI 10.1016/j.bbrc.2009.09.132; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MORTIMER RK, 1986, GENETICS, V113, P35; MUELLER DM, 1986, J BIOL CHEM, V261, P1816; MUELLER DM, 1986, J BIOL CHEM, V261, P1756; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P7993, DOI 10.1093/nar/10.24.7993; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P3617, DOI 10.1093/nar/10.12.3617; OSINGA KA, 1984, EMBO J, V3, P829, DOI 10.1002/j.1460-2075.1984.tb01892.x; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schaeffer D, 2010, ADV EXP MED BIOL, V702, P79, DOI 10.1007/978-1-4419-7841-7_7; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009; Szczesny RJ, 2012, BBA-GENE REGUL MECH, V1819, P1027, DOI 10.1016/j.bbagrm.2011.11.010; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; TRACY RL, 1995, CURR GENET, V28, P205, DOI 10.1007/BF00309779; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; VANOMMEN GJB, 1979, CELL, V18, P511, DOI 10.1016/0092-8674(79)90068-0; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang G, 2012, BBA-GENE REGUL MECH, V1819, P998, DOI 10.1016/j.bbagrm.2011.10.001; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLF K, 1973, MOL GEN GENET, V125, P53, DOI 10.1007/BF00292983; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZHU H, 1989, MOL CELL BIOL, V9, P1507, DOI 10.1128/MCB.9.4.1507; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	110	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78105	10.1371/journal.pone.0078105	http://dx.doi.org/10.1371/journal.pone.0078105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143261	Green Submitted, gold, Green Published			2022-12-27	WOS:000325894100100
J	Johnson, S; Chen, YJ; Phillips, R				Johnson, Stephanie; Chen, Yi-Ju; Phillips, Rob			Poly(dA:dT)-Rich DNAs Are Highly Flexible in the Context of DNA Looping	PLOS ONE			English	Article							TETHERED PARTICLE MOTION; SEQUENCE DEPENDENCE; STRUCTURAL FEATURES; PROMOTER ELEMENTS; ESCHERICHIA-COLI; REPRESSOR; TRANSCRIPTION; FLEXIBILITY; POLY(DA-DT); BINDING	Large-scale DNA deformation is ubiquitous in transcriptional regulation in prokaryotes and eukaryotes alike. Though much is known about how transcription factors and constellations of binding sites dictate where and how gene regulation will occur, less is known about the role played by the intervening DNA. In this work we explore the effect of sequence flexibility on transcription factor-mediated DNA looping, by drawing on sequences identified in nucleosome formation and ligase-mediated cyclization assays as being especially favorable for or resistant to large deformations. We examine a poly(dA:dT)-rich, nucleosome-repelling sequence that is often thought to belong to a class of highly inflexible DNAs; two strong nucleosome positioning sequences that share a set of particular sequence features common to nucleosome-preferring DNAs; and a CG-rich sequence representative of high G+C-content genomic regions that correlate with high nucleosome occupancy in vivo. To measure the flexibility of these sequences in the context of DNA looping, we combine the in vitro single-molecule tethered particle motion assay, a canonical looping protein, and a statistical mechanical model that allows us to quantitatively relate the looping probability to the looping free energy. We show that, in contrast to the case of nucleosome occupancy, G+C content does not positively correlate with looping probability, and that despite sharing sequence features that are thought to determine nucleosome affinity, the two strong nucleosome positioning sequences behave markedly dissimilarly in the context of looping. Most surprisingly, the poly(dA: dT)-rich DNA that is often characterized as highly inflexible in fact exhibits one of the highest propensities for looping that we have measured. These results argue for a need to revisit our understanding of the mechanical properties of DNA in a way that will provide a basis for understanding DNA deformation over the entire range of biologically relevant scenarios that are impacted by DNA deformability.	[Johnson, Stephanie] CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Chen, Yi-Ju] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Johnson, Stephanie] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; University of California System; University of California San Francisco	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu			National Institutes of Health [Northwestern PSOC center] [DP1 OD000217A, R01 GM085286, R01 GM085286-01S1, 1 U54 CA143869]; National Science Foundation; Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	National Institutes of Health [Northwestern PSOC center](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge the support of the National Institutes of Health (www.nih.gov, grant numbers DP1 OD000217A [Director's Pioneer Award], R01 GM085286, R01 GM085286-01S1, and 1 U54 CA143869 [Northwestern PSOC center]). SJ gratefully acknowledges the support of a graduate fellowship from the National Science Foundation (www.nsf.gov), and RP the support of the Fondation Pierre Gilles de Gennes (http://www.fondation-pgg.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Balasubramanian S, 2009, BIOPHYS J, V96, P2245, DOI 10.1016/j.bpj.2008.11.040; Bzymek M, 2001, GENETICS, V158, P527; Cheema AK, 1999, J BACTERIOL, V181, P5296, DOI 10.1128/JB.181.17.5296-5302.1999; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; Forties RA, 2009, NUCLEIC ACIDS RES, V37, P4580, DOI 10.1093/nar/gkp442; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Geggier S, 2011, NUCLEIC ACIDS RES, V39, P1419, DOI 10.1093/nar/gkq932; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; Haeusler AR, 2012, NUCLEIC ACIDS RES, V40, P4432, DOI 10.1093/nar/gks019; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HOGAN M, 1983, NATURE, V304, P752, DOI 10.1038/304752a0; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Iyer VR, 2012, TRENDS CELL BIOL, V22, P250, DOI 10.1016/j.tcb.2012.02.004; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; Johnson S, 2012, NUCLEIC ACIDS RES, V40, P7728, DOI 10.1093/nar/gks473; KUNKEL GR, 1981, NUCLEIC ACIDS RES, V9, P6869, DOI 10.1093/nar/9.24.6869; Kuznetsov SV, 2006, P NATL ACAD SCI USA, V103, P18515, DOI 10.1073/pnas.0608394103; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lilja AE, 2004, J MOL BIOL, V342, P467, DOI 10.1016/j.jmb.2004.07.057; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Manzo C, 2012, BIOPHYS J, V103, P1753, DOI 10.1016/j.bpj.2012.09.006; Mehta RA, 1999, J MOL BIOL, V294, P67, DOI 10.1006/jmbi.1999.3244; Morgan MA, 2005, BIOPHYS J, V89, P2588, DOI 10.1529/biophysj.105.067728; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; Nishida H, 2013, CURR ISSUES MOL BIOL, V15, P19; Normanno D, 2008, NUCLEIC ACIDS RES, V36, P2505, DOI 10.1093/nar/gkn071; Olson WK, 2011, CURR OPIN STRUC BIOL, V21, P348, DOI 10.1016/j.sbi.2011.03.006; Olson WK, 2004, PHILOS T R SOC A, V362, P1403, DOI 10.1098/rsta.2004.1380; PECK LJ, 1981, NATURE, V292, P375, DOI 10.1038/292375a0; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Peters JP, 2010, Q REV BIOPHYS, V43, P23, DOI 10.1017/S0033583510000077; PRUNELL A, 1982, EMBO J, V1, P173, DOI 10.1002/j.1460-2075.1982.tb01143.x; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; RHODES D, 1979, NUCLEIC ACIDS RES, V6, P1805, DOI 10.1093/nar/6.5.1805; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roychoudhury M, 2000, P NATL ACAD SCI USA, V97, P13608, DOI 10.1073/pnas.250476297; Rutkauskas D, 2009, P NATL ACAD SCI USA, V106, P16627, DOI 10.1073/pnas.0904617106; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schulz A, 2000, J MOL BIOL, V300, P709, DOI 10.1006/jmbi.2000.3921; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; SERRANO M, 1991, J MOL BIOL, V219, P403, DOI 10.1016/0022-2836(91)90182-6; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; SHRADER TE, 1990, J MOL BIOL, V216, P69, DOI 10.1016/S0022-2836(05)80061-0; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; STRAUSS F, 1981, EUR J BIOCHEM, V118, P215; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Widlund HR, 1999, J BIOL CHEM, V274, P31847, DOI 10.1074/jbc.274.45.31847; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2003, P NATL ACAD SCI USA, V100; Zhang YL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000136	77	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75799	10.1371/journal.pone.0075799	http://dx.doi.org/10.1371/journal.pone.0075799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146776	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400019
J	Mikalsen, LTG; Dhakal, HP; Bruland, OS; Naume, B; Borgen, E; Nesland, JM; Olsen, DR				Mikalsen, Lars Tore Gyland; Dhakal, Hari Prasad; Bruland, Oyvind S.; Naume, Bjorn; Borgen, Elin; Nesland, Jahn M.; Olsen, Dag Rune			The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients	PLOS ONE			English	Article							ISOLATED TUMOR-CELLS; ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW ANGIOGENESIS; TERM-FOLLOW-UP; MICROVESSEL DENSITY; CANCER-PATIENTS; PROGNOSTIC-FACTORS; CHALKLEY COUNT; IMAGE-ANALYSIS; CLINICOPATHOLOGICAL CORRELATIONS	Angiogenesis quantification, through vessel counting or area estimation in the most vascular part of the tumour, has been found to be of prognostic value across a range of carcinomas, breast cancer included. We have applied computer image analysis to quantify vascular properties pertaining to size, shape and spatial distributions in photographed fields of CD34 stained sections. Aided by a pilot (98 cases), seven parameters were selected and validated on a separate set from 293 breast cancer patients. Two new prognostic markers were identified through continuous Cox regression with endpoints Breast Cancer Specific Survival and Distant Disease Free Survival: The average size of the vessels as measured by their perimeter (p = 0.003 and 0.004, respectively), and the average complexity of the vessel shapes measured by their solidity (p = 0.004 and 0.004). The Hazard ratios for the corresponding median-dichotomized markers were 2.28 (p = 0.005) and 1.89 (p = 0.016) for the mean perimeter and 1.80 (p = 0.041) and 1.55 (p = 0.095) for the shape complexity. The markers were associated with poor histologic type, high grade, necrosis, HR negativity, inflammation, and p53 expression (vessel size only). Both markers were found to strongly influence the prognostic properties of vascular invasion (VI) and disseminated tumour cells in the bone marrow. The latter being prognostic only in cases with large vessels (p = 0.004 and 0.043) or low complexity (p = 0.018 and 0.024), but not in the small or complex vessel groups (p > 0.47). VI was significant in all groups, but showed greater hazard ratios for small and low complexity vessels (6.54-11.2) versus large and high complexity vessels (2.64-3.06). We find that not only the overall amount of produced vasculature in angiogenic hot-spots is of prognostic significance, but also the morphological appearance of the generated vessels, i.e. the size and shape of vessels in the studied hot spots.	[Mikalsen, Lars Tore Gyland] Univ Oslo, Dept Phys, Oslo, Norway; [Dhakal, Hari Prasad; Borgen, Elin; Nesland, Jahn M.] Oslo Univ Hosp HF, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Bruland, Oyvind S.; Naume, Bjorn] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Bruland, Oyvind S.; Naume, Bjorn; Nesland, Jahn M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Olsen, Dag Rune] Univ Bergen, Fac Math & Nat Sci, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen	Mikalsen, LTG (corresponding author), Univ Oslo, Dept Phys, Oslo, Norway.	l.t.g.mikalsen@fys.uio.no		Bruland, Oyvind Sverre/0000-0003-1631-3733	European Union [222741 - METOXIA]	European Union(European Commission)	The financial support from the European Union 7th Framework Programme (grant 222741 - METOXIA) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Belien JAM, 1999, J PATHOL, V189, P309; Braun S, 2005, J CLIN ONCOL, V23, P1623, DOI 10.1200/JCO.2005.10.073; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Chlenski A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-138; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dadras SS, 2005, MODERN PATHOL, V18, P1232, DOI 10.1038/modpathol.3800410; Dhakal HP, 2008, CLIN CANCER RES, V14, P2341, DOI 10.1158/1078-0432.CCR-07-4214; Dhakal HP, 2012, HISTOPATHOLOGY, V61, P350, DOI 10.1111/j.1365-2559.2012.04223.x; Dhakal HP, 2009, HISTOL HISTOPATHOL, V24, P1049, DOI 10.14670/HH-24.1049; Ebrahirnsade S, 2007, PATHOL RES PRACT, V203, P695, DOI 10.1016/j.prp.2007.05.009; Ellis IO, 2003, TUMOURS BREAST FEMAL, P9; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farinha P, 2010, HAEMATOL-HEMATOL J, V95, P2157, DOI 10.3324/haematol.2009.021766; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fox SB, 2004, APMIS, V112, P413, DOI 10.1111/j.1600-0463.2004.apm11207-0803.x; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Fox SB, 1997, JNCI-J NATL CANCER I, V89, P1044, DOI 10.1093/jnci/89.14.1044; Gasparini G, 2001, CRIT REV ONCOL HEMAT, V37, P97, DOI 10.1016/S1040-8428(00)00105-0; Hansen S, 2004, HISTOPATHOLOGY, V44, P428, DOI 10.1111/j.1365-2559.2004.01848.x; Hansen S, 2000, CLIN CANCER RES, V6, P139; Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jacquemier JD, 1998, J PATHOL, V184, P130; Kato T, 2001, BREAST CANCER RES TR, V65, P203, DOI 10.1023/A:1010668616265; Konerding MA, 1999, BRIT J CANCER, V80, P724, DOI 10.1038/sj.bjc.6690416; Korkolopoulou P, 2005, LEUKEMIA, V19, P894, DOI 10.1038/sj.leu.2403690; Korkolopoulou P, 2003, BRIT J HAEMATOL, V122, P900, DOI 10.1046/j.1365-2141.2003.04527.x; Korkolopoulou P, 2003, LEUKEMIA, V17, P89, DOI 10.1038/sj.leu.2402769; Korkolopoulou P, 2001, LEUKEMIA, V15, P1369, DOI 10.1038/sj.leu.2402220; Korkolopoulou P, 2001, VIRCHOWS ARCH, V438, P603, DOI 10.1007/s004280100400; Laitakari J, 2004, J CLIN PATHOL, V57, P394, DOI 10.1136/jcp.2002.004978; LIOTTA LA, 1976, CANCER RES, V36, P889; Luukkaa H, 2009, J ORAL PATHOL MED, V38, P695, DOI 10.1111/j.1600-0714.2009.00810.x; Luukkaa H, 2007, ACTA OTO-LARYNGOL, V127, P869, DOI 10.1080/00016480601053099; Mangia A, 2011, HISTOPATHOLOGY, V58, P1096, DOI 10.1111/j.1365-2559.2011.03842.x; McDonnell CO, 2000, EUR J SURG ONCOL, V26, P105, DOI 10.1053/ejso.1999.0753; Mikalsen LTG, 2011, ANTICANCER RES, V31, P4053; Mohammed RAA, 2011, J PATHOL, V223, P358, DOI 10.1002/path.2810; Mucci LA, 2009, J CLIN ONCOL, V27, P5627, DOI 10.1200/JCO.2008.20.8876; Naume B, 2004, CLIN CANCER RES, V10, P3091, DOI 10.1158/1078-0432.CCR-03-0373; Naume B, 2001, CLIN CANCER RES, V7, P4122; Nieto Y, 2007, BRIT J CANCER, V97, P391, DOI 10.1038/sj.bjc.6603875; Offersen BV, 2003, EUR J CANCER, V39, P881, DOI 10.1016/S0959-8049(02)00663-9; Offersen BV, 2002, ACTA ONCOL, V41, P695, DOI 10.1080/028418602321028337; Safali M, 2010, PATHOL RES PRACT, V206, P93, DOI 10.1016/j.prp.2009.10.004; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Taverna G, 2009, PATHOL RES PRACT, V205, P438, DOI 10.1016/j.prp.2008.12.019; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Weidner N, 1999, J PATHOL, V189, P297; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weidner N, 2008, METHOD ENZYMOL, V444, P305, DOI 10.1016/S0076-6879(08)02814-0; West CML, 2001, CANCER RES, V61, P2907; Weyn B, 2004, CLIN ONCOL-UK, V16, P307, DOI 10.1016/j.clon.2004.01.013; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233	64	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75954	10.1371/journal.pone.0075954	http://dx.doi.org/10.1371/journal.pone.0075954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146798	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400029
J	Bramham, K; Poli-de-Figueiredo, CE; Seed, PT; Briley, AL; Poston, L; Shennan, AH; Chappell, LC				Bramham, Kate; Poli-de-Figueiredo, Carlos E.; Seed, Paul T.; Briley, Annette L.; Poston, Lucilla; Shennan, Andrew H.; Chappell, Lucy C.			Association of Proteinuria Threshold in Pre-Eclampsia with Maternal and Perinatal Outcomes: A Nested Case Control Cohort of High Risk Women	PLOS ONE			English	Article							HYPERTENSIVE DISORDERS; PROTEIN/CREATININE RATIO; PREGNANCY; GUIDELINES; MANAGEMENT; DIAGNOSIS	Objectives: To evaluate occurrence of adverse maternal and perinatal outcomes with different thresholds of proteinuria (300-499mg and >= 500mg/24 hours) in pre-eclamptic women, comparing outcomes against women with chronic and gestational hypertension. Design: Secondary analysis of the Vitamins in Pre-Eclampsia Trial. Setting: 25 UK hospitals in ten geographical areas. Population: 946 women with pre-existing risk factors for pre-eclampsia. Methods: Women with pre-eclampsia and proteinuria 300-499mg/24h (PE300, referent group, n=60) or proteinuria >= 500 mg/24h (PE500, n= 161) were compared with two groups of non-proteinuric women with chronic hypertension (CHT, n= 615) or gestational hypertension (GH, n= 110). Main Outcome Measures: Maternal: progression to severe hypertension. Perinatal: small for gestational age (SGA) <5th centile, gestation at delivery. Results: Severe hypertension occurred more frequently in PE500 (35%) and PE300 (27%) than CHT (5.9%; P <= 0.01) and GH (10%; p <= 0.001). Gestation at delivery was earlier in PE500 (33.2w) than PE300 (37.3w; P <= 0.001), and later in CHT (38.3w; P <= 0.05) and GH (39.1w; P <= 0.001). SGA infants were more frequent in PE300 (32%) than in CHT (13.3%; P <= 0.001) and GH (16.5%; P <= 0.05). Women in PE500 were more likely to have a caesarean section than PE300 (78% vs. 48%; P= 0.001), and to receive magnesium sulphate (17% vs. 1.7%, P= 0.05). Conclusion: Women with PE300 have complication rates above those of women managed as out-patients (GH and CHT), meriting closer surveillance and confirming 300 mg/d as an appropriate threshold for determining in-patient management. Adverse perinatal outcomes are higher still in women with PE500.	[Bramham, Kate; Poli-de-Figueiredo, Carlos E.; Seed, Paul T.; Briley, Annette L.; Poston, Lucilla; Shennan, Andrew H.; Chappell, Lucy C.] Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London, England; [Bramham, Kate; Poli-de-Figueiredo, Carlos E.; Seed, Paul T.; Briley, Annette L.; Poston, Lucilla; Shennan, Andrew H.; Chappell, Lucy C.] Kings Hlth Partners, London, England; [Poli-de-Figueiredo, Carlos E.] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Rio De Janeiro, Brazil	University of London; King's College London; University of London; King's College London	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London, England.	lucy.chappell@kcl.ac.uk	Briley, Annette/N-1704-2019; Seed, Paul T/C-4435-2008; Briley, Annette/AAZ-5305-2020; Poli=de-Figueiredo, Carlos Eduardo/A-2027-2013	Seed, Paul T/0000-0001-7904-7933; Briley, Annette/0000-0002-4266-920X; Poli=de-Figueiredo, Carlos Eduardo/0000-0002-7333-8884; Bramham, Kate/0000-0002-6272-7921; Shennan, Andrew/0000-0001-5273-3132; Poston, Lucilla/0000-0003-1100-2821	Wellcome Trust; Tommy's Charity; National Institute for Health Research [DRF-2009-02-18] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Tommy's Charity; National Institute for Health Research(National Institute for Health Research (NIHR))	The original trial was funded by the Wellcome Trust (registered charity number 210183) with additional support from Tommy's Charity (registered charity number 1060508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis C, 1998, CLIN PHYSL OBSTET, P263; Bramham K, 2011, REPROD SCI, V18, P623, DOI 10.1177/1933719110395403; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Caetano ERSP, 2001, HYPERTENSION, V38, P171, DOI 10.1161/01.HYP.38.2.171; Chan P, 2005, BJOG-INT J OBSTET GY, V112, P280, DOI 10.1111/j.1471-0528.2004.00395.x; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Goodwin AA, 2005, AM J OBSTET GYNECOL, V193, P973, DOI 10.1016/j.ajog.2005.05.047; *GYN ACOOA, 2002, OBSTET GYNECOL, V33, P159; Harlow FH, 2001, HYPERTENS PREGNANCY, V20, P57, DOI 10.1081/PRG-100104172; HIGBY K, 1994, AM J OBSTET GYNECOL, V171, P984, DOI 10.1016/S0002-9378(13)90019-3; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Lindheimer MD, 2010, OBSTET GYNECOL, V115, P365, DOI 10.1097/AOG.0b013e3181cb9644; Lowe SA, 2009, AUST NZ J OBSTET GYN, V49, P242, DOI 10.1111/j.1479-828X.2009.01003.x; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; McClellan WM, 2011, J AM SOC NEPHROL, V22, P1721, DOI 10.1681/ASN.2010101085; Milne F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3129; National Institute for Clinical Excellence, 2010, HYP PREGN MAN HYP DI; NORTH R, 2007, CLASSIFICATION DIAGN; Pahwa MB, 2007, CLIN CHIM ACTA, V382, P145, DOI 10.1016/j.cca.2007.03.022; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Ramos JGL, 1999, HYPERTENS PREGNANCY, V18, P209, DOI 10.3109/10641959909016194; SIBAI BM, 1991, AM J OBSTET GYNECOL, V165, P1408; Suzuki S, 1997, NEPHROL DIAL TRANSPL, V12, P2488, DOI 10.1093/ndt/12.12.2488; Thangaratinam S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-10; Thornton CE, 2010, CLIN EXP PHARMACOL P, V37, P466, DOI 10.1111/j.1440-1681.2009.05334.x; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; Waugh J, 2005, HYPERTENS PREGNANCY, V24, P291, DOI 10.1080/10641950500281019; Waugh J, 2004, AM J OBSTET GYNECOL, V191, P1049, DOI 10.1016/j.ajog.2004.05.040	29	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76083	10.1371/journal.pone.0076083	http://dx.doi.org/10.1371/journal.pone.0076083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130760	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200030
J	Forster, A; Kerl, HU; Wenz, H; Brockmann, MA; Nolte, I; Groden, C				Foerster, Alex; Kerl, Hans Ulrich; Wenz, Holger; Brockmann, Marc A.; Noelte, Ingo; Groden, Christoph			Diffusion- and Perfusion-Weighted Imaging in Acute Lacunar Infarction: Is There a Mismatch?	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PROGRESSIVE MOTOR DEFICITS; INTRAVENOUS THROMBOLYSIS; PROGNOSIS; CLASSIFICATION; PATHOLOGY; SOFTWARE; SUBTYPES; BRAIN	Purpose: Characterization of lacunar infarction (LI) by use of multimodal MRI including diffusion-and perfusion-weighted imaging (DWI, PWI) is difficult because of the small lesion size. Only a few studies evaluated PWI in LI and the results are inconsistent. Methods: In 16 LI patients who underwent initial MRI within 6 hours after symptom onset and follow-up MRI within 1 week demographics, clinical presentation, and MRI findings were analyzed with special emphasis on DWI and PWI findings. Time to peak maps were classified as showing a normal perfusion pattern or areas of hypoperfusion which were further categorized in mismatch (PWI>DWI), inverse mismatch (PWI<DWI), and match (PWI=DWI). Quantitative perfusion maps were generated and analyzed by use of Signal Processing in NMR-Software (SPIN). Results: Of the 16 patients (mean age 65.5 +/- 12.9 years), 14 (87.5%) were male. Clinical symptoms comprised dysarthria (50%), hemiparesis (81.3%), and hemihypaesthesia (18.8%). Intravenous thrombolysis was performed in 7 (43.8%) patients. Clinical improvement was observed in 12 patients (75 %), while 2 (12.5%) patients showed a deterioration and another 2 (12.5%) a stable course. Acute ischemic lesions (mean volume of 0.46 +/- 0.29 cm(3)) were located in the thalamus (n=8, 50%), internal capsule (n=4, 25%), corona Radiata (n=3, 18.8%) and the mesencephalon (n=1, 6.3%). Circumscribed hypoperfusion (mean volume 0.61 +/- 0.48 cm(3)) was evident in 10 (62.5%) patients. Of these, 3 patients demonstrated a match, 4 an inverse mismatch, and 3 a mismatch between DWI and PWI lesion. Mean CBF and CBV ratios were 0.65 +/- 0.28 and 0.84 +/- 0.41 respectively. Growth of DWI lesions was observed in 7 (43.8%) and reversal of DWI lesions in 3 (18.8%) patients. Conclusions: MRI allows identification of different DWI and PWI patterns in LI, including growth and reversal of ischemic lesions. Consequently, it may serve for a better characterization of this stroke subtype and support treatment decisions in daily clinical practice.	[Foerster, Alex; Kerl, Hans Ulrich; Wenz, Holger; Brockmann, Marc A.; Noelte, Ingo; Groden, Christoph] Heidelberg Univ, Dept Neuroradiol, Univ Med Mannheim, Heidelberg, Germany; [Brockmann, Marc A.] Rhein Westfal TH Aachen, Univ Hosp, Dept Diagnost & Intervent Neuroradiol, D-52062 Aachen, Germany	Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital	Forster, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Univ Med Mannheim, Heidelberg, Germany.	Alex.Foerster@umm.de						ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Arnold M, 2004, STROKE, V35, P1135, DOI 10.1161/01.STR.0000125862.55804.29; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Caplan LR, 1997, NEW ENGL J MED, V337, P1309; Chalela JA, 2003, J NEUROIMAGING, V13, P152, DOI 10.1177/1051228403251260; Doege CA, 2003, AM J NEURORADIOL, V24, P1355; Fiebach JB, 2010, EUR RADIOL, V20, P2983, DOI 10.1007/s00330-010-1858-8; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Forster A, 2010, CEREBROVASC DIS, V29, P389, DOI 10.1159/000286341; Fuentes B, 2012, EUR J NEUROL, V19, P1568, DOI 10.1111/j.1468-1331.2012.03790.x; Galinovic I, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-16; Gerraty RP, 2002, STROKE, V33, P2019, DOI 10.1161/01.STR.0000020841.74704.5B; Huck S, 2012, CLIN NEURORADIOL, V22, P29, DOI 10.1007/s00062-011-0126-x; Lahoti SA, 2012, INT J STROKE; Lammie GA, 2000, BRIT MED BULL, V56, P296, DOI 10.1258/0007142001903229; Lee SJ, 2010, STROKE, V41, P2587, DOI 10.1161/STROKEAHA.110.586248; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mustanoja S, 2011, STROKE, V42, P102, DOI 10.1161/STROKEAHA.110.597534; Nakamura K, 1999, NEUROLOGY, V52, P29, DOI 10.1212/WNL.52.1.29; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Poppe AY, 2009, CEREBROVASC DIS, V28, P151, DOI 10.1159/000225908; Restrepo L, 2005, J NEUROIMAGING, V15, P254, DOI 10.1177/1051228405275199; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sacco S, 2006, NEUROLOGY, V66, P1335, DOI 10.1212/01.wnl.0000210457.89798.0e; Shobha N, 2012, INT J STROKE; Steinke W, 2002, STROKE, V33, P1510, DOI 10.1161/01.STR.0000016326.78014.FE; Tanaka Y, 2008, STROKE, V39, P205, DOI 10.1161/STROKEAHA.107.489906; Weidauer S, 2004, EUR RADIOL, V14, P1615, DOI 10.1007/s00330-004-2303-7; Weimar C, 2007, NERVENARZT, V78, P957, DOI 10.1007/s00115-007-2268-2; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687	31	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77428	10.1371/journal.pone.0077428	http://dx.doi.org/10.1371/journal.pone.0077428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130885	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200087
J	Lips, KS; Kauschke, V; Hartmann, S; Thormann, U; Ray, S; Kampschulte, M; Langheinrich, A; Schumacher, M; Gelinsky, M; Heinemann, S; Hanke, T; Kautz, AR; Schnabelrauch, M; Schnettler, R; Heiss, C; Alt, V; Kilian, O				Lips, Katrin Susanne; Kauschke, Vivien; Hartmann, Sonja; Thormann, Ulrich; Ray, Seemun; Kampschulte, Marian; Langheinrich, Alexander; Schumacher, Matthias; Gelinsky, Michael; Heinemann, Sascha; Hanke, Thomas; Kautz, Armin R.; Schnabelrauch, Matthias; Schnettler, Reinhard; Heiss, Christian; Alt, Volker; Kilian, Olaf			Podoplanin Immunopositive Lymphatic Vessels at the Implant Interface in a Rat Model of Osteoporotic Fractures	PLOS ONE			English	Article							CALCIUM-PHOSPHATE PHASES; PLATELET-AGGREGATION; EPIDERMAL-KERATINOCYTES; MECHANICAL-PROPERTIES; MEMBRANE-PROTEIN; BONE; CELLS; EXPRESSION; DIFFERENTIATION; CLONING	Insertion of bone substitution materials accelerates healing of osteoporotic fractures. Biodegradable materials are preferred for application in osteoporotic patients to avoid a second surgery for implant replacement. Degraded implant fragments are often absorbed by macrophages that are removed from the fracture side via passage through veins or lymphatic vessels. We investigated if lymphatic vessels occur in osteoporotic bone defects and whether they are regulated by the use of different materials. To address this issue osteoporosis was induced in rats using the classical method of bilateral ovariectomy and additional calcium and vitamin deficient diet. In addition, wedge-shaped defects of 3, 4, or 5 mm were generated in the distal metaphyseal area of femur via osteotomy. The 4 mm defects were subsequently used for implantation studies where bone substitution materials of calcium phosphate cement, composites of collagen and silica, and iron foams with interconnecting pores were inserted. Different materials were partly additionally functionalized by strontium or bisphosphonate whose positive effects in osteoporosis treatment are well known. The lymphatic vessels were identified by immunohistochemistry using an antibody against podoplanin. Podoplanin immunopositive lymphatic vessels were detected in the granulation tissue filling the fracture gap, surrounding the implant and growing into the iron foam through its interconnected pores. Significant more lymphatic capillaries were counted at the implant interface of composite, strontium and bisphosphonate functionalized iron foam. A significant increase was also observed in the number of lymphatics situated in the pores of strontium coated iron foam. In conclusion, our results indicate the occurrence of lymphatic vessels in osteoporotic bone. Our results show that lymphatic vessels are localized at the implant interface and in the fracture gap where they might be involved in the removal of lymphocytes, macrophages, debris and the implants degradation products. Therefore the lymphatic vessels are involved in implant integration and fracture healing.	[Lips, Katrin Susanne; Kauschke, Vivien; Hartmann, Sonja; Ray, Seemun; Schnettler, Reinhard; Kilian, Olaf] Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany; [Thormann, Ulrich; Schnettler, Reinhard; Heiss, Christian; Alt, Volker] Univ Giessen, Univ Hosp Giessen, Dept Trauma Surg Giessen, D-35390 Giessen, Germany; [Kampschulte, Marian] Univ Giessen, Dept Radiol, D-35390 Giessen, Germany; [Langheinrich, Alexander] BG Trauma Hosp, Dept Diagnost & Intervent Radiol, Frankfurt, Germany; [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Fac Med, D-01062 Dresden, Germany; [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Univ Hosp, D-01062 Dresden, Germany; [Heinemann, Sascha; Hanke, Thomas] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01062 Dresden, Germany; [Heinemann, Sascha; Hanke, Thomas] Tech Univ Dresden, Inst Mat Sci, D-01062 Dresden, Germany; [Kautz, Armin R.; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, Jena, Germany; [Kilian, Olaf] Zentralklin, Dept Orthoped & Trauma, Bad Berka, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; Justus Liebig University Giessen; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Zentralklinik Bad Berka	Lips, KS (corresponding author), Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany.	Katrin.S.Lips@chiru.med.uni-giessen.de	Schumacher, Matthias/I-1530-2013; Gelinsky, Michael/A-9680-2012	Schumacher, Matthias/0000-0001-7207-7355; Gelinsky, Michael/0000-0001-9075-5121	Deutsche Forschungsgesellschaft DFG [SFB/TRR 79]	Deutsche Forschungsgesellschaft DFG(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgesellschaft DFG (SFB/TRR 79 projects B7, T1, T2 M2, M3 and Z3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002; Alt V, 2011, ACTA BIOMATER, V7, P3773, DOI 10.1016/j.actbio.2011.06.024; Bellini C, 2012, LYMPHOLOGY, V45, P34; Boivin G., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P538; BOS I, 1990, PATHOL RES PRACT, V186, P707, DOI 10.1016/S0344-0338(11)80260-8; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Cheriyan T, 2013, ACTA BIOMATER, V9, P5751, DOI 10.1016/j.actbio.2012.11.010; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Compston J, 2010, RADIOL CLIN N AM, V48, P477, DOI 10.1016/j.rcl.2010.02.010; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Edwards J, 2008, ACTA ORTHOP, V79, P289, DOI 10.1080/17453670710015175; Edwards JR, 2008, HUM PATHOL, V39, P49, DOI 10.1016/j.humpath.2007.04.022; Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7; Ekwall AKH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3274; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; Gehlert S, 2010, LYMPHAT RES BIOL, V8, P165, DOI 10.1089/lrb.2009.0035; Goldhahn J, 2008, BONE, V43, P343, DOI 10.1016/j.bone.2008.04.017; Govindarajan P, 2013, MED SCI MONIT BASIC, V19, P76, DOI 10.12659/MSMBR.883815; Guo ML, 2010, ACTA CRYSTALLOGR E, V67, pm19; Heinemann S, 2013, ACTA BIOMATER, V9, P4878, DOI 10.1016/j.actbio.2012.10.010; Heinemann S, 2011, ACS APPL MATER INTER, V3, P4323, DOI 10.1021/am200993q; Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029; Heiss C, 2012, MED SCI MONITOR, V18, pBR199, DOI 10.12659/MSM.882895; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Kaji C, 2012, J ANAT, V220, P435, DOI 10.1111/j.1469-7580.2012.01484.x; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kashima TG, 2011, SPINE, V36, P899, DOI 10.1097/BRS.0b013e3182050284; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)80005-1; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Kilian O, 2008, BIOMATERIALS, V29, P3429, DOI 10.1016/j.biomaterials.2008.05.003; Kotani M, 2002, J NEUROSCI RES, V67, P595, DOI 10.1002/jnr.10150; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Liang P, 2005, ANTICANCER RES, V25, P2705; Matsui K, 1998, J AM SOC NEPHROL, V9, P2013; Mkonyi LE, 2012, J DENT RES, V91, P71, DOI 10.1177/0022034511424747; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; PENG Z, 1994, BONE, V15, P523, DOI 10.1016/8756-3282(94)90276-3; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Sabokbar A, 1996, ACTA ORTHOP SCAND, V67, P593, DOI 10.3109/17453679608997763; Sabokbar A, 1997, ANN RHEUM DIS, V56, P414, DOI 10.1136/ard.56.7.414; Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009; Scholl FG, 2000, LAB INVEST, V80, P1749, DOI 10.1038/labinvest.3780185; Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014; Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; Vanderbilt JN, 1998, AM J RESP CELL MOL, V19, P662, DOI 10.1165/ajrcmb.19.4.3121; WATANABE M, 1990, CANCER RES, V50, P6657; Wessel JM, 2012, INVEST OPHTH VIS SCI, V53, P3717, DOI 10.1167/iovs.12-9507; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; WRONSKI TJ, 1985, CALCIFIED TISSUE INT, V37, P324, DOI 10.1007/BF02554882; Xu YJ, 2011, ONCOL REP, V25, P599, DOI 10.3892/or.2011.1141; Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus	57	2	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77259	10.1371/journal.pone.0077259	http://dx.doi.org/10.1371/journal.pone.0077259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130867	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900131
J	Manfrino, C; Jacoby, CA; Camp, E; Frazer, TK				Manfrino, Carrie; Jacoby, Charles A.; Camp, Emma; Frazer, Thomas K.			A Positive Trajectory for Corals at Little Cayman Island	PLOS ONE			English	Article							MARINE PROTECTED AREAS; LONG-TERM DECLINE; BLEACHING EVENT; JUVENILE CORALS; CARIBBEAN CORAL; CLIMATE-CHANGE; ST-JOHN; REEF; RECOVERY; RECRUITMENT	Coral reefs are damaged by natural disturbances and local and global anthropogenic stresses. As stresses intensify, so do debates about whether reefs will recover after significant damage. True headway in this debate requires documented temporal trajectories for coral assemblages subjected to various combinations of stresses; therefore, we report relevant changes in coral assemblages at Little Cayman Island. Between 1999 and 2012, spatiotemporal patterns in cover, densities of juveniles and size structure of assemblages were documented inside and outside marine protected areas using transects, quadrats and measurements of maximum diameters. Over five years, bleaching and disease caused live cover to decrease from 26% to 14%, with full recovery seven years later. Juvenile densities varied, reaching a maximum in 2010. Both patterns were consistent within and outside protected areas. In addition, dominant coral species persisted within and outside protected areas although their size frequency distributions varied temporally and spatially. The health of the coral assemblage and the similarity of responses across levels of protection suggested that negligible anthropogenic disturbance at the local scale was a key factor underlying the observed resilience.	[Manfrino, Carrie] Kean Univ, Union, NJ USA; [Manfrino, Carrie] Cent Caribbean Marine Inst, Princeton, NJ USA; [Jacoby, Charles A.] Univ Florida, Dept Soil & Water Sci, Gainesville, FL USA; [Camp, Emma] Little Cayman Res Ctr, Cent Caribbean Marine Inst, Little Cayman, Cayman Islands, Jamaica; [Frazer, Thomas K.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Frazer, Thomas K.] Univ Florida, Sch Forest Resources & Conservat, Fisheries & Aquat Sci Program, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Manfrino, C (corresponding author), Kean Univ, Union, NJ USA.	manfrino@reefresearch.org	Camp, Emma/W-3335-2017; Jacoby, Charles A/D-5608-2013; Manfrino, Carrie/AAZ-9126-2021	Camp, Emma/0000-0003-1962-1336; Jacoby, Charles A/0000-0002-5948-3241; Manfrino, Carrie/0000-0002-3129-9629	Div Of Biological Infrastructure [1227093] Funding Source: National Science Foundation	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Anderson J. M., 2008, PERMANOVA PRIMER GUI; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Aronson RB, 2012, ECOLOGY, V93, P303, DOI 10.1890/11-1037.1; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bruckner A.W., 2002, P CAR ACR WORKSH POT; Burke L., 2011, REEFS RISK REVISITED; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Coelho VR, 2007, AQUAT CONSERV, V17, P666, DOI 10.1002/aqc.822; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; Edmunds PJ, 1998, B MAR SCI, V62, P937; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; GHIOLD J, 1990, Caribbean Journal of Science, V26, P52; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Guzman HM, 2007, MAR BIOL, V151, P401, DOI 10.1007/s00227-006-0495-x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Huntington BE, 2011, CORAL REEFS, V30, P1077, DOI 10.1007/s00338-011-0809-4; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Lang JC, 2010, AGRRA PROTOCOLS VERS, P31; McField MD, 1999, B MAR SCI, V64, P155; McGrath TA, 2003, REV BIOL TROP, V51, P67; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; van Hooidonk RJ, 2012, ESTUAR COAST SHELF S, V106, P80, DOI 10.1016/j.ecss.2012.04.021; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Villamizar E, 2008, REV BIOL TROP, V56, P255; Whelan KRT, 2007, CORAL REEFS, V26, P689, DOI 10.1007/s00338-007-0241-y; Wilkinson C, 2008, STATUS CORAL REEFS W	53	12	12	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75432	10.1371/journal.pone.0075432	http://dx.doi.org/10.1371/journal.pone.0075432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130710	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900036
J	Moreno, R; Jover, L; Diez, C; Sarda, F; Sanpera, C				Moreno, Rocio; Jover, Lluis; Diez, Carmen; Sarda, Francesc; Sanpera, Carola			Ten Years after the Prestige Oil Spill: Seabird Trophic Ecology as Indicator of Long-Term Effects on the Coastal Marine Ecosystem	PLOS ONE			English	Article							SHAGS PHALACROCORAX-ARISTOTELIS; FOOD-WEB; NATURAL VARIABILITY; CATHARACTA-SKUA; EUROPEAN SHAGS; NORTH-SEA; RECRUITMENT; FISHERIES; ATLANTIC; POSITION	Major oil spills can have long-term impacts since oil pollution does not only result in acute mortality of marine organisms, but also affects productivity levels, predator-prey dynamics, and damages habitats that support marine communities. However, despite the conservation implications of oil accidents, the monitoring and assessment of its lasting impacts still remains a difficult and daunting task. Here, we used European shags to evaluate the overall, lasting effects of the Prestige oil spill (2002) on the affected marine ecosystem. Using delta N-15 and Hg analysis, we trace temporal changes in feeding ecology potentially related to alterations of the food web due to the spill. Using climatic and oceanic data, we also investigate the influence of North Atlantic Oscillation (NAO) index, the sea surface temperature (SST) and the chlorophyll a (Chl a) on the observed changes. Analysis of delta N-15 and Hg concentrations revealed that after the Prestige oil spill, shag chicks abruptly switched their trophic level from a diet based on a high percentage of demersal-benthic fish to a higher proportion of pelagic/semi-pelagic species. There was no evidence that Chl a, SST and NAO reflected any particular changes or severity in environmental conditions for any year or season that may explain the sudden change observed in trophic level. Thus, this study highlighted an impact on the marine food web for at least three years. Our results provide the best evidence to date of the long-term consequences of the Prestige oil spill. They also show how, regardless of wider oceanographic variability, lasting impacts on predator-prey dynamics can be assessed using biochemical markers. This is particularly useful if larger scale and longer term monitoring of all trophic levels is unfeasible due to limited funding or high ecosystem complexity.	[Moreno, Rocio; Sanpera, Carola] Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain; [Jover, Lluis] Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona 7, Spain; [Diez, Carmen] Univ Vigo, Dept Ecol & Biol Anim, Fac Ciencias, Galicia, Spain; [Sarda, Francesc] ICO, Museu Zool, Barcelona, Spain; [Sarda, Francesc] CTFC, Area Biodiversitat, Solsona, Spain	University of Barcelona; University of Barcelona; Universidade de Vigo; Centre Tecnologic Forestal de Catalunya (CTFC)	Moreno, R (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain.	rocio@rociomoreno.com	Jover, Lluís/D-2192-2011; sanpera, carolina/B-5461-2013	Jover, Lluís/0000-0003-0631-1398; sanpera, carolina/0000-0002-5198-6514; Sarda-Palomera, Francesc/0000-0002-3121-9182	FPU grant ("Ministerio de Educacion y Ciencia", Spain); Spanish "Ministerio de Educacion y Ciencia" [VEM2004-08524]; Spanish "Ministerio de Ciencia e Innovacion" [CGL2008-05448-C02-C01, CGL2008-05448-C02-C02]	FPU grant ("Ministerio de Educacion y Ciencia", Spain)(German Research Foundation (DFG)); Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	R. Moreno was supported by an FPU grant ("Ministerio de Educacion y Ciencia", Spain). Funding for this work was provided by project VEM2004-08524 from the Spanish "Ministerio de Educacion y Ciencia" and CGL2008-05448-C02-C01 and CGL2008-05448-C02-C02 from the Spanish "Ministerio de Ciencia e Innovacion". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott SA, 2002, MAR ECOL PROG SER, V238, P199, DOI 10.3354/meps238199; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Azeiteiro UM, 2006, ESTUAR COAST SHELF S, V69, P554, DOI 10.1016/j.ecss.2006.05.023; Baker JM, 1999, PURE APPL CHEM, V71, P135, DOI 10.1351/pac199971010135; BARRETT RT, 1991, SARSIA, V76, P153, DOI 10.1080/00364827.1991.10413470; Barrett RT, 2002, MAR ECOL PROG SER, V230, P275, DOI 10.3354/meps230275; BARRETT RT, 1990, MAR ECOL PROG SER, V66, P205, DOI 10.3354/meps066205; Bearhop S, 2000, MAR POLLUT BULL, V40, P181, DOI 10.1016/S0025-326X(99)00205-2; Becker PH, 2002, MAR ECOL PROG SER, V243, P261, DOI 10.3354/meps243261; BOTAS JA, 1990, ESTUAR COAST SHELF S, V30, P185, DOI 10.1016/0272-7714(90)90063-W; Burnham K. P., 1998, MODEL SELECTION INFE; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Figueiras FG, 2002, HYDROBIOLOGIA, V484, P121, DOI 10.1023/A:1021309222459; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox CJ, 2000, J SEA RES, V44, P159, DOI 10.1016/S1385-1101(00)00039-3; Fraga F., 1981, COASTAL UPWELLING, P176, DOI [10.1029/co001p0176, DOI 10.1029/C0001P0176, DOI 10.1029/CO001P0176]; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Garshelis DL, 2001, J APPL ECOL, V38, P19, DOI 10.1046/j.1365-2664.2001.00563.x; Golet GH, 2002, MAR ECOL PROG SER, V241, P287, DOI 10.3354/meps241287; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P1530, DOI 10.1016/j.icesjms.2006.05.009; Guterman L, 2009, SCIENCE, V323, P1558, DOI 10.1126/science.323.5921.1558; Hebert CE, 2008, ECOLOGY, V89, P891, DOI 10.1890/07-1603.1; Hebert CE, 2006, ENVIRON SCI TECHNOL, V40, P5618, DOI 10.1021/es0520619; Hebert CE, 2006, ENVIRON SCI TECHNOL, V40, P5624, DOI 10.1021/es0520621; Hebert CE, 2009, OECOLOGIA, V160, P15, DOI 10.1007/s00442-009-1285-1; Henderson PA, 1998, J SEA RES, V40, P131, DOI 10.1016/S1385-1101(98)00020-3; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Kerr R, 2010, SCIENCE, V328, P674, DOI 10.1126/science.328.5979.674; Lens S, 1986, B I ESP OCEANOGR, V3, P5; Martinez-Abrain A, 2006, MAR ECOL PROG SER, V318, P271, DOI 10.3354/meps318271; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Michener R.H., 1994, P138; Miller AK, 2004, MAR ECOL PROG SER, V281, P207, DOI 10.3354/meps281207; Montevecchi WA, 2007, MAR ECOL PROG SER, V352, P213, DOI 10.3354/meps07075; Moore J, 2006, LONG TERM ECOLOGICAL; Moreno R, 2011, MAR ECOL PROG SER, V442, P229, DOI 10.3354/meps09420; Moreno R, 2011, ENVIRON POLLUT, V159, P2454, DOI 10.1016/j.envpol.2011.06.033; OSENBERG CW, 1994, ECOL APPL, V4, P16, DOI 10.2307/1942111; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Parker KR, 2005, ECOL APPL, V15, P2037, DOI 10.1890/04-1723; Penela-Arenaz M, 2009, ADV MAR BIOL, V56, P1, DOI [10.1016/S0065-2881(09)56001-4, DOI 10.1016/S0065-2881(09)56001-4.PUBMED:19895974]; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Punzon A, 2005, ICES COUNC M; Sanchez F, 2003, 14 IEO, P8; Sanpera C, 2008, SCI TOTAL ENVIRON, V407, P242, DOI 10.1016/j.scitotenv.2008.07.052; Serrano A, 2006, MAR POLLUT BULL, V53, P315, DOI 10.1016/j.marpolbul.2005.09.030; Sheppard C, 2006, MAR POLLUT B, V52, P238; Signa G, 2008, CONT SHELF RES, V28, P2659, DOI 10.1016/j.csr.2008.08.008; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; Thompson DR, 1998, SCI TOTAL ENVIRON, V213, P299, DOI 10.1016/S0048-9697(98)00103-X; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Varela M, 2006, MAR POLLUT BULL, V53, P272, DOI 10.1016/j.marpolbul.2005.10.005; Velando A, 2005, MAR ECOL PROG SER, V302, P263, DOI 10.3354/meps302263; Velando A, 2005, J ORNITHOL, V146, P116, DOI 10.1007/s10336-004-0068-z; Vieites DR, 2004, NATURWISSENSCHAFTEN, V91, P535, DOI 10.1007/s00114-004-0572-2; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x	61	39	40	1	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77360	10.1371/journal.pone.0077360	http://dx.doi.org/10.1371/journal.pone.0077360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130877	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900133
J	Cramer, H; Krucoff, C; Dobos, G				Cramer, Holger; Krucoff, Carol; Dobos, Gustav			Adverse Events Associated with Yoga: A Systematic Review of Published Case Reports and Case Series	PLOS ONE			English	Review							NEUROPATHY; GLAUCOMA; TEACHER; NECK	While yoga is gaining increased popularity in North America and Europe, its safety has been questioned in the lay press. The aim of this systematic review was to assess published case reports and case series on adverse events associated with yoga. Medline/Pubmed, Scopus, CAMBase, IndMed and the Cases Database were screened through February 2013; and 35 case reports and 2 case series reporting a total of 76 cases were included. Ten cases had medical preconditions, mainly glaucoma and osteopenia. Pranayama, hatha yoga, and Bikram yoga were the most common yoga practices; headstand, shoulder stand, lotus position, and forceful breathing were the most common yoga postures and breathing techniques cited. Twenty-seven adverse events (35.5%) affected the musculoskeletal system; 14 (18.4%) the nervous system; and 9 (11.8%) the eyes. Fifteen cases (19.7%) reached full recovery; 9 cases (11.3%) partial recovery; 1 case (1.3%) no recovery; and 1 case (1.3%) died. As any other physical or mental practice, yoga should be practiced carefully under the guidance of a qualified instructor. Beginners should avoid extreme practices such as headstand, lotus position and forceful breathing. Individuals with medical preconditions should work with their physician and yoga teacher to appropriately adapt postures; patients with glaucoma should avoid inversions and patients with compromised bone should avoid forceful yoga practices.	[Cramer, Holger; Dobos, Gustav] Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany; [Krucoff, Carol] Duke Univ, Duke Integrat Med, Durham, NC USA	Kliniken Essen-Mitte; University of Duisburg Essen; Duke University	Cramer, H (corresponding author), Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany.	h.cramer@kliniken-essen-mitte.de	Cramer, Holger/AAH-1794-2019	Cramer, Holger/0000-0002-3640-8046				Barnes Patricia M, 2004, Adv Data, P1; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barsky AJ, 1997, JAMA-J AM MED ASSOC, V278, P673, DOI 10.1001/jama.278.8.673; Baskaran M, 2006, OPHTHALMOLOGY, V113, P1327, DOI 10.1016/j.ophtha.2006.02.063; Bertschinger DR, 2007, BRIT J OPHTHALMOL, V91, P1413, DOI 10.1136/bjo.2007.114546; Bianchi G., 2004, J ORTHOP TRAUMATOL, V5, P188, DOI [10.1007/s10195-004-0069-y, DOI 10.1007/S10195-004-0069-Y]; Bikram Yoga College of India, 2012, BIKR YOG; Birdee GS, 2008, J GEN INTERN MED, V23, P1653, DOI 10.1007/s11606-008-0735-5; Biswas R, 2003, INT J CLIN PRACT, V57, P340; Biswas R, 2002, INT J CLIN PRACT, V56, P723; Brauer Jeremy A, 2011, Dermatol Online J, V17, P14; Broad WJ, 2012, NY TIMES; Bussing A, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/329023; Caso V, 2005, FRONT NEUROL NEUROSC, V20, P44, DOI 10.1159/000088134; Chakraborty J, 2011, BMJ CASE REPORTS; Choi Y, 2009, AM J EMERG MED, V27, P956, DOI 10.1016/j.ajem.2008.07.035; CHUSID J, 1971, J AMER MED ASSOC, V217, P827, DOI 10.1001/jama.1971.03190060065025; COHEN JA, 1995, ARCH OPHTHALMOL-CHIC, V113, P1360, DOI 10.1001/archopht.1995.01100110020011; CORRIGAN GE, 1969, J AMER MED ASSOC, V210, P1923, DOI 10.1001/jama.1969.03160360069025; Cramer H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-172; Cramer H, 2013, J ALTERN COMPLEM MED, V19, P536, DOI 10.1089/acm.2011.0885; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Cramer H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-32; Cramer H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-412; Cramer H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/863905; Cushman A, 1994, YOGA J, V118, P47; Dacci P, 2012, NEUROL SCI; Dangerfield A, 2009, BBC NEWS MAGAZI 0123; de Barros DSM, 2008, OPHTHAL SURG LAS IM, V39, P339; De Michaelis E, 2005, HIST MODERN YOGA PAT; FAHMY JA, 1973, ACTA OPHTHALMOL, V51, P80; Farooq MU, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-2; Feuerstein G., 1998, YOGA TRADITION ITS H; Fishman L., 2009, INT J YOGA THER, V19, P47, DOI [DOI 10.17761/IJYT.19.1.922087896T1H2180, 10.17761/ijyt.19.1.922087896t1h2180]; Fong K Y, 1993, Clin Exp Neurol, V30, P104; Gallardo MJ, 2006, ADV THER, V23, P921, DOI 10.1007/BF02850214; GEORGE HR, 1970, BRIT J PSYCHIAT, V117, P521, DOI 10.1192/bjp.117.540.521; Grant D, 2012, NEW YORK OBSERV 1212; HANUS SH, 1977, ARCH NEUROL-CHICAGO, V34, P574, DOI 10.1001/archneur.1977.00500210076015; Hari Yogi, 2006, HATHA YOGA PRADIPIKA; Hillsman D, 2005, CHEST, V127, P1863, DOI 10.1378/chest.127.5.1863; Hwa Charlotte, 2011, J Am Acad Dermatol, V65, pe149, DOI 10.1016/j.jaad.2011.07.027; Iyengar BellurKrishnamacharSundararaja., 1977, LIGHT YOGA; Johnson DB, 2004, CHEST, V125, P1951, DOI 10.1378/chest.125.5.1951; Kashyap AS, 2007, EMERG MED J, V24, P231, DOI 10.1136/emj.2006.036459; KENNEDY RB, 1976, AM J PSYCHIAT, V133, P1326; KHALIL PN, 2008, MMW FORTSCH MEDIZIN, V150, P39; Kim NN, 2010, J FAM PRACTICE, V59, P399; Kohanzadeh S, 2012, AM SURGEON, V78, pE361; Krucoff C, 2003, YOGA J, V120-124, P203; Kugler J, 1972, Med Klin, V67, P1195; Lamb T, 2006, YOGA STAT DEMOGRAPHI; Le Corroller T, 2012, AM J ROENTGENOL, V199, P413, DOI 10.2214/AJR.11.7440; LOVELLSMITH HD, 1985, NEW ZEAL MED J, V98, P443; Lu JS, 2007, AM J PSYCHIAT, V164, P1761, DOI 10.1176/appi.ajp.2007.07060960; Macy D, 2008, YOGA J; MARGO CE, 1992, AM J OPHTHALMOL, V113, P726, DOI 10.1016/S0002-9394(14)74810-X; MATTIO TG, 1992, NEUROLOGY, V42, P1636, DOI 10.1212/WNL.42.8.1636; McCall T, 2013, YOGA J; Meshramkar R, 2007, INT DENT J, V57, P184; Mikkonen J, 2008, INT J YOGA THER, V18, P59, DOI DOI 10.17761/IJYT.18.1.L0748P25K2558V77; NAGLER W, 1973, ARCH PHYS MED REHAB, V54, P237; Patel S C, 2008, J Orthop Surg (Hong Kong), V16, P378; Penman Stephen, 2012, Int J Yoga, V5, P92, DOI 10.4103/0973-6131.98217; Reynolds CJ, 2012, BMJ CASE REP, V2012; RICE R, 1985, AM J OPHTHALMOL, V100, P738, DOI 10.1016/0002-9394(85)90634-8; Schievink WI, 2007, HEADACHE, V47, P284, DOI 10.1111/j.1526-4610.2006.00696.x; Shah NJ, 2009, INDIAN J OPHTHALMOL, V57, P69, DOI 10.4103/0301-4738.44496; Sharma H, 2007, BRIT J SPORT MED, V41, P688, DOI 10.1136/bjsm.2007.036087; Sharma VP, 2007, INT J YOGA THERAP, V17, P75; Sinaki M, 2013, PAIN PRACT, V13, P68, DOI 10.1111/j.1533-2500.2012.00545.x; TAMARIN FM, 1988, THORAX, V43, P731, DOI 10.1136/thx.43.9.731; Vishnu-devananda S, 1988, COMPLETE ILLUSTRATED; VOGEL CM, 1991, NEUROLOGY, V41, P605, DOI 10.1212/WNL.41.4.605; Walker M, 2005, NEUROLOGIST, V11, P176, DOI 10.1097/01.nrl.0000159986.75426.d5; Yeh TS, 2011, J MED ULTRASOUND, V19, P91, DOI 10.1016/j.jmu.2011.08.004; Yochum TR, 1997, J MANIP PHYSIOL THER, V20, P56; Yorston G.A., 2001, MENTAL HLTH RELIG CU, V4, P209, DOI DOI 10.1080/713685624; Yoshikawa Y, 2013, YOGA J	79	75	75	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75515	10.1371/journal.pone.0075515	http://dx.doi.org/10.1371/journal.pone.0075515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146758	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400009
J	Takada, S; Sato, T; Ito, Y; Yamashita, S; Kato, T; Kawasumi, M; Kanai-Azuma, M; Igarashi, A; Kato, T; Tamano, M; Asahara, H				Takada, Shuji; Sato, Tempei; Ito, Yoshiaki; Yamashita, Satoshi; Kato, Tomoko; Kawasumi, Miyuri; Kanai-Azuma, Masami; Igarashi, Arisa; Kato, Tomomi; Tamano, Moe; Asahara, Hiroshi			Targeted Gene Deletion of miRNAs in Mice by TALEN System	PLOS ONE			English	Article							DNA-RECOGNITION; DISRUPTION; EFFECTORS; CLEAVAGE	Mice are among the most valuable model animal species with an enormous amount of heritage in genetic modification studies. However, targeting genes in mice is sometimes difficult, especially for small genes, such as microRNAs (miRNAs) and targeting genes in repeat sequences. Here we optimized the application of TALEN system for mice and successfully obtained gene targeting technique in mice for intergenic region and series of microRNAs. Microinjection of synthesized RNA of TALEN targeting each gene in one cell stage of embryo was carried out and injected oocytes were transferred into pseudopregnant ICR female mice, producing a high success rate of the targeted deletion of miRNA genes. In our condition, TALEN RNA without poly(A) tail worked better than that of with poly(A) tail. This mutated allele in miRNA was transmitted to the next generation, suggesting the successful germ line transmission of this targeting method. Consistent with our notion of miRNAs maturation mechanism, in homozygous mutant mice of miR-10a, the non-mutated strand of miRNAs expression was completely diminished. This method will lead us to expand and accelerate our genetic research using mice in a high throughput way.	[Takada, Shuji; Yamashita, Satoshi; Kato, Tomoko; Igarashi, Arisa; Tamano, Moe; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan; [Sato, Tempei; Ito, Yoshiaki; Kato, Tomomi; Asahara, Hiroshi] Tokyo Med & Dent Univ, Dept Syst BioMed, Grad Sch Med & Dent Sci, Tokyo, Japan; [Kawasumi, Miyuri; Kanai-Azuma, Masami] Tokyo Med & Dent Univ, Ctr Expt Anim, Tokyo, Japan; [Asahara, Hiroshi] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Asahara, Hiroshi] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Scripps Research Institute	Takada, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan.	takada-s@ncchd.go.jp; asahara.syst@tmd.ac.jp		Takada, Shuji/0000-0002-9406-4683; Igarashi, Arisa/0000-0001-7206-3105; Sato, Tempei/0000-0002-8966-3374	National Institutes of Health [AR050631]; Health and Labour Sciences Research Grants; National Center for Child Heatlth and Development; MEXT; JST, CREST; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050631, R56AR050631] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23249071] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); National Center for Child Heatlth and Development; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by National Institutes of Health AR050631, Health and Labour Sciences Research Grants, The Grant of National Center for Child Heatlth and Development, Grants-in Aid for Scientific Research (MEXT) and JST, CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940	19	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76004	10.1371/journal.pone.0076004	http://dx.doi.org/10.1371/journal.pone.0076004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146809	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400031
J	Zhang, JL; Wei, LJ; Kelly, P; Freeman, M; Jaegerson, K; Gong, JS; Xu, B; Pan, ZM; Xu, CL; Wang, CM				Zhang, Jilei; Wei, Lanjing; Kelly, Patrick; Freeman, Mark; Jaegerson, Kirsten; Gong, Jiansen; Xu, Bu; Pan, Zhiming; Xu, Chuanling; Wang, Chengming			Detection of Salmonella spp. Using a Generic and Differential FRET-PCR	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; FLORIDA ANIMAL SHELTER; ENTERICA SEROVAR TYPHI; NORMAL FECES; PARATYPHI-A; TYPHIMURIUM; FOOD; INFECTIONS; DIARRHEA	To facilitate the detection of Salmonella and to be able to rapidly and conveniently determine the species/subspecies present, we developed and tested a generic and differential FRET-PCR targeting their tetrathionate reductase response regulator gene. The differential pan-Salmonella FRET-PCR we developed successfully detected seven plasmids that contained partial sequences of S. bongori and the six S. enterica subspecies. The detection limit varied from similar to 5 copies of target gene/per PCR reaction for S. enterica enterica to similar to 200 for S. bongori. Melting curve analysis demonstrated a T-m of similar to 68 degrees C for S. enterica enterica, similar to 62.5 degrees C for S. enterica houtenae and S. enterica diarizonae, similar to 57 degrees C for S. enterica indica, and similar to 54 degrees C for S. bongori, S. enterica salamae and S. enterica arizonae. The differential pan-Salmonella FRET-PCR also detected and determined the subspecies of 4 reference strains and 47 Salmonella isolated from clinically ill birds or pigs. Finally, we found it could directly detect and differentiate Salmonella in feline (5/50 positive; 10%; one S. enterica salamae and 4 S. enterica enterica) and canine feces (15/114 positive; 13.2%; all S. enterica enterica). The differential pan-Salmonella FRET-PCR failed to react with 96 non-Salmonella bacterial strains. Our experiments show the differential pan-Salmonella FRET-PCR we developed is a rapid, sensitive and specific method to detect and differentiate Salmonella.	[Zhang, Jilei; Wei, Lanjing; Xu, Chuanling; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Zhang, Jilei; Wei, Lanjing; Gong, Jiansen; Xu, Bu; Pan, Zhiming; Xu, Chuanling; Wang, Chengming] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Kelly, Patrick; Jaegerson, Kirsten] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Freeman, Mark] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Gong, Jiansen; Xu, Bu] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China; [Pan, Zhiming] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Virginia Polytechnic Institute & State University; Chinese Academy of Agricultural Sciences; Yangzhou University	Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.	wangcm@yzu.edu.cn	Zhang, Jilei/L-8672-2019	Zhang, Jilei/0000-0002-9589-1162	Ross University School of Veterinary Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD); Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses	Ross University School of Veterinary Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD); Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses	This study was funded by the Ross University School of Veterinary Medicine, the Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD) and by Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 2012, EMERG INFECT DIS, V18, P637, DOI 10.3201/eid1804.111386; Agarwal A, 2002, MOL CELL PROBE, V16, P243, DOI 10.1006/mcpr.2002.0418; Bopp CA, 2003, MANUAL CLIN MICROBIO, P654; Chart H, 2007, J MED MICROBIOL, V56, P1161, DOI 10.1099/jmm.0.47197-0; Chaudhry R, 2005, AM J MED, V118, P799, DOI 10.1016/j.amjmed.2004.12.030; Chen S, 1997, INT J FOOD MICROBIOL, V35, P239, DOI 10.1016/S0168-1605(97)01241-5; Ellingson JLE, 2004, MOL CELL PROBE, V18, P51, DOI 10.1016/j.mcp.2003.09.007; Gado I., 2000, Acta Microbiologica et Immunologica Hungarica, V47, P445; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Giammanco GM, 2002, J CLIN MICROBIOL, V40, P3502, DOI 10.1128/JCM.40.9.3502-3505.2002; Gong JS, 2013, AVIAN PATHOL, V42, P290, DOI 10.1080/03079457.2013.788129; Hein I, 2006, J MICROBIOL METH, V66, P538, DOI 10.1016/j.mimet.2006.02.008; Josefsen MH, 2007, APPL ENVIRON MICROB, V73, P3040, DOI 10.1128/AEM.02823-06; Josefsen MH, 2011, MOLECULAR DETECTION OF HUMAN BACTERIAL PATHOGENS, P1023; Kelly PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053450; Lee K, 2009, J APPL MICROBIOL, V107, P805, DOI 10.1111/j.1365-2672.2009.04263.x; Ma Jui-Shan, 2003, Journal of Microbiology Immunology and Infection, V36, P282; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Malorny B, 2007, INT J FOOD MICROBIOL, V117, P211, DOI 10.1016/j.ijfoodmicro.2007.04.004; McCarthy N, 2009, J FOOD PROTECT, V72, P2350, DOI 10.4315/0362-028X-72.11.2350; Pedersen K, 2009, ZOONOSES PUBLIC HLTH, V56, P238, DOI 10.1111/j.1863-2378.2008.01196.x; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Sabshin SJ, 2012, JAVMA-J AM VET MED A, V241, P331, DOI 10.2460/javma.241.3.331; Tupler T, 2012, JAVMA-J AM VET MED A, V241, P338, DOI 10.2460/javma.241.3.338; Zhou LQ, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-14	25	9	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76053	10.1371/journal.pone.0076053	http://dx.doi.org/10.1371/journal.pone.0076053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146814	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400033
J	Blower, MD; Jambhekar, A; Schwarz, DS; Toombs, JA				Blower, Michael D.; Jambhekar, Ashwini; Schwarz, Dianne S.; Toombs, James A.			Combining Different mRNA Capture Methods to Analyze the Transcriptome: Analysis of the Xenopus laevis Transcriptome	PLOS ONE			English	Article							MAJOR DEVELOPMENTAL TRANSITION; TRANSLATIONAL CONTROL; REVEALS; LENGTH; EXPRESSION; OOGENESIS; LINCRNAS; REGIONS; EMBRYOS; GENOME	mRNA sequencing (mRNA-seq) is a commonly used technique to survey gene expression from organisms with fully sequenced genomes. Successful mRNA-seq requires purification of mRNA away from the much more abundant ribosomal RNA, which is typically accomplished by oligo-dT selection. However, mRNAs with short poly-A tails are captured poorly by oligo-dT based methods. We demonstrate that combining mRNA capture via oligo-dT with mRNA capture by the 5' 7-methyl guanosine cap provides a more complete view of the transcriptome and can be used to assay changes in mRNA poly-A tail length on a genome-wide scale. We also show that using mRNA-seq reads from both capture methods as input for de novo assemblers provides a more complete reconstruction of the transcriptome than either method used alone. We apply these methods of mRNA capture and de novo assembly to the transcriptome of Xenopus laevis, a well-studied frog that currently lacks a finished sequenced genome, to discover transcript sequences for thousands of mRNAs that are currently absent from public databases. The methods we describe here will be broadly applicable to many organisms and will provide insight into the transcriptomes of organisms with sequenced and unsequenced genomes.	[Blower, Michael D.; Jambhekar, Ashwini; Schwarz, Dianne S.; Toombs, James A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Blower, Michael D.; Jambhekar, Ashwini; Schwarz, Dianne S.; Toombs, James A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Blower, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	blower@molbio.mgh.harvard.edu		Jambhekar, Ashwini/0000-0003-1078-6601; Blower, Michael/0000-0002-5037-1972; Toombs, James/0000-0002-1601-5675				Bajak Edyta Z., 2008, V419, P147, DOI 10.1007/978-1-59745-033-1_10; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CABADA MO, 1977, DEV BIOL, V57, P427, DOI 10.1016/0012-1606(77)90227-5; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Desai A, 1999, METHOD CELL BIOL, V61, P385; DWORKIN MB, 1985, DEV BIOL, V112, P451, DOI 10.1016/0012-1606(85)90417-8; Gilchrist MJ, 2012, GENESIS, V50, P143, DOI 10.1002/dvg.22008; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Guigo R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s2; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Morin RD, 2006, GENOME RES, V16, P796, DOI 10.1101/gr.4871006; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; PARIS J, 1990, DEV BIOL, V140, P221, DOI 10.1016/0012-1606(90)90070-Y; Raz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019287; RICHTER JD, 1991, BIOESSAYS, V13, P179, DOI 10.1002/bies.950130406; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schoenberg DR, 2009, TRENDS BIOCHEM SCI, V34, P435, DOI 10.1016/j.tibs.2009.05.003; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; TASSAN JP, 1993, MOL CELL BIOL, V13, P2815, DOI 10.1128/MCB.13.5.2815; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9	44	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77700	10.1371/journal.pone.0077700	http://dx.doi.org/10.1371/journal.pone.0077700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143257	Green Submitted, Green Published, gold			2022-12-27	WOS:000325894100096
J	Crowe, J; Aubareda, A; McNamee, K; Przybycien, PM; Lu, X; Williams, RO; Bou-Gharios, G; Saklatvala, J; Dean, JLE				Crowe, Jonathan; Aubareda, Anna; McNamee, Kay; Przybycien, Paulina M.; Lu, Xin; Williams, Richard O.; Bou-Gharios, George; Saklatvala, Jeremy; Dean, Jonathan L. E.			Heat Shock Protein B1-Deficient Mice Display Impaired Wound Healing	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; MAPKAP KINASE-2; HUMAN HSP27; IN-VIVO; PHOSPHORYLATION; HEAT-SHOCK-PROTEIN-27; STRESS; RESISTANCE; TRISTETRAPROLIN	There is large literature describing in vitro experiments on heat shock protein (hsp)B1 but understanding of its function in vivo is limited to studies in mice overexpressing human hspB1 protein. Experiments in cells have shown that hspB1 has chaperone activity, a cytoprotective role, regulates inflammatory gene expression, and drives cell proliferation. To investigate the function of the protein in vivo we generated hspB1-deficient mice. HspB1-deficient fibroblasts display increased expression of the pro-inflammatory cytokine, interleukin-6, compared to wild-type cells, but reduced proliferation. HspB1-deficient fibroblasts exhibit reduced entry into S phase and increased expression of cyclin-dependent kinase inhibitors p27(kip1) and p21(waf1). The expression of hspB1 protein and mRNA is also controlled by the cell cycle. To investigate the physiological function of hspB1 in regulating inflammation and cell proliferation we used an excisional cutaneous wound healing model. There was a significant impairment in the rate of healing of wounds in hspB1-deficient mice, characterised by reduced re-epithelialisation and collagen deposition but also increased inflammation. HspB1 deficiency augments neutrophil infiltration in wounds, driven by increased chemokine (C-X-C motif) ligand 1 expression. This appears to be a general mechanism as similar results were obtained in the air-pouch and peritonitis models of acute inflammation.	[Aubareda, Anna; McNamee, Kay; Przybycien, Paulina M.; Williams, Richard O.; Bou-Gharios, George; Saklatvala, Jeremy; Dean, Jonathan L. E.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Crowe, Jonathan] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Lu, Xin] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Clin Med, Oxford, England	University of Oxford; Imperial College London; Ludwig Institute for Cancer Research; University of Oxford	Dean, JLE (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	jonathan.dean@kennedy.ox.ac.uk		Przybycien-Gaweda, Paulina M./0000-0002-6521-1031; Dean, Jonathan/0000-0002-0703-2756	Arthritis Research UK; Kennedy Institute of Rheumatology Trust	Arthritis Research UK(Versus Arthritis); Kennedy Institute of Rheumatology Trust	Arthritis Research UK and the Kennedy Institute of Rheumatology Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo J, 2012, INT J BIOCH CELL BIO; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Chen SWC, 2009, TRANSPLANTATION, V87, P1478, DOI 10.1097/TP.0b013e3181a3c691; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Garrido C, 1997, CANCER RES, V57, P2661; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Hayashi N, 2012, CELL DEATH DIFFER, V19, P990, DOI 10.1038/cdd.2011.184; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Huot J, 1996, CANCER RES, V56, P273; Jog NR, 2007, J IMMUNOL, V178, P2421, DOI 10.4049/jimmunol.178.4.2421; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KAUR P, 1989, FEBS LETT, V258, P269, DOI 10.1016/0014-5793(89)81671-0; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; MEHLEN P, 1995, J CELL BIOCHEM, V58, P248, DOI 10.1002/jcb.240580213; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; Sur R, 2008, J INVEST DERMATOL, V128, P1116, DOI 10.1038/sj.jid.5701157; Tessier PA, 1997, J IMMUNOL, V159, P3595; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wu Y, 2008, CELL SIGNAL	45	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77383	10.1371/journal.pone.0077383	http://dx.doi.org/10.1371/journal.pone.0077383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143227	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100064
J	Ding, GX; Feng, CC; Jiang, HW; Ding, Q; Zhang, LM; Na, R; Xu, H; Liu, J				Ding, Guanxiong; Feng, Chenchen; Jiang, Haowen; Ding, Qiang; Zhang, Limin; Na, Rong; Xu, Hua; Liu, Jun			Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; MESENCHYMAL TRANSITION; GENE-EXPRESSION; CELLS; CARCINOMA; PATHWAYS; TRANSFORMATION; STATISTICS; RESISTANCE	Though prostate cancer (PCa) has slow progression, the hormone refractory (HRCP) and metastatic entities are substantially lethal and lack effective treatments. Transcription factor Slug is critical in regulating metastases of various tumors including PCa. Here we studied targeted therapy against Slug using combination of 3 drugs targeting 3 pathways respectively converging via Slug and further regulating PCa metastasis. Using in vitro assays we confirmed that Slug up-regulation incurred inhibition of E-cadherin that was anti-metastatic, and inhibited Bim-regulated cell apoptosis in PCa. Upstream PTEN/Akt, mTOR, Erk, and AR/Hsp90 pathways were responsible for Slug up-regulation and each of these could be targeted by rapamycin, CI-1040, and 17-AAG respectively. In 4 PCa cell lines with different traits in terms of PTEN loss and androgen sensitivity we tested the efficacy of mono-and combined therapy with the drugs. We found that metastatic capacity of the cells was maximally inhibited only when all 3 drugs were combined, due to the crosstalk between the pathways. 17-AAG decreases Slug expression via blockade of HSP90-dependent AR stability. Combination of rapamycin and CI-1040 diminishes invasiveness more potently in PCa cells that are androgen insensitive and with PTEN loss. Slug inhibited Bim-mediated apoptosis that could be rescued by mTOR/Erk/HSP90 inhibitors. Using mouse models for circulating PCa DNA quantification, we found that combination of mTOR/Erk/HSP90 inhibitors reduced circulating PCa cells in vivo significantly more potently than combination of 2 or monotherapy. Conclusively, combination of mTOR/Erk/Hsp90 inhibits metastatic capacity of prostate cancer via Slug inhibition.	[Ding, Guanxiong; Feng, Chenchen; Jiang, Haowen; Ding, Qiang; Zhang, Limin; Na, Rong; Xu, Hua; Liu, Jun] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Liu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	drliujun@126.com	Xu, Hua/AAH-2453-2019; Na, Rong/AAN-8655-2021	Na, Rong/0000-0001-7470-5108; Feng, Chenchen/0000-0002-1854-356X	Fudan University [144]; National Natural Science Foundation of China [NSFC-81202002]	Fudan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by Youth Elites Scientific Funding of Fudan University (No. 144) and Youth Scientific Funding of National Natural Science Foundation of China (NSFC-81202002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; He SQ, 2013, INT J ONCOL, V42, P35, DOI 10.3892/ijo.2012.1698; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Liu J, 2010, PROSTATE, V70, P1768, DOI 10.1002/pros.21213; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Waltering KK, 2012, MOL CELL ENDOCRINOL, V360, P38, DOI 10.1016/j.mce.2011.12.019; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149	28	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77400	10.1371/journal.pone.0077400	http://dx.doi.org/10.1371/journal.pone.0077400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130883	gold, Green Submitted, Green Published			2022-12-27	WOS:000325814200086
J	Helm, F; Kammertoens, T; Lehmann, FM; Wilke, A; Bruns, H; Mautner, J; Bornkamm, GW; Gerbitz, A				Helm, Florian; Kammertoens, Thomas; Lehmann, Frank M.; Wilke, Andrea; Bruns, Heiko; Mautner, Josef; Bornkamm, Georg W.; Gerbitz, Armin			Targeting c-MYC with T-Cells	PLOS ONE			English	Article							ONCOGENE INACTIVATION; TISSUE MICROARRAYS; BURKITTS-LYMPHOMA; DENDRITIC CELLS; CANCER; ANTIGEN; IMMUNOTHERAPY; DIFFERENTIATION; MUTATIONS; TUMORS	Over-expression of the proto-oncogene c-MYC is frequently observed in a variety of tumors and is a hallmark of Burkitt's lymphoma. The fact that many tumors are oncogene-addicted to c-MYC, renders c-MYC a powerful target for anti-tumor therapy. Using a xenogenic vaccination strategy by immunizing C57BL/6 mice with human c-MYC protein or non-homologous peptides, we show that the human c-MYC protein, despite its high homology between mouse and man, contains several immunogenic epitopes presented in the context of murine H2(b) haplotype. We identified an MHC class II-restricted CD4(+) T-cell epitope and therein an MHC class I-restricted CD8(+) T-cell epitope (SSPQGSPEPL) that, after prime/boost immunization, protected up to 25% of mice against a lethal lymphoma challenge. Lymphoma-rejecting animals contained MHC multimer-binding CD8(+) cell within the peripheral blood and displayed in vivo cytolytic activity with specificity for SSPQGSPEPL. Taken together these data suggest that oncogenic c-MYC can be targeted with specific T-cells.	[Helm, Florian; Kammertoens, Thomas; Wilke, Andrea] Charite, Dept Immunol, Berlin, Germany; [Lehmann, Frank M.; Bornkamm, Georg W.] Helmholtz Ctr, Inst Clin Mol Biol & Tumor Genet, Munich, Germany; [Mautner, Josef] Tech Univ TU Munich, Dept Pediat, Munich, Germany; [Mautner, Josef] Tech Univ Munich, Clin Cooperat Grp Pediat Tumor Immunol, Munich, Germany; [Mautner, Josef] Helmholtz Ctr, Munich, Germany; [Bruns, Heiko; Gerbitz, Armin] Univ Erlangen Nurnberg, Dept Hematol, D-91054 Erlangen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg	Gerbitz, A (corresponding author), Univ Erlangen Nurnberg, Dept Hematol, D-91054 Erlangen, Germany.	armin.gerbitz@uk-erlangen.de		Lehmann, Frank Michael/0000-0002-0381-9033; Kammertoens, Thomas/0000-0003-3309-5141	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SFB TR36 (TPB4)]; Wilhelm-Sander Stiftung	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Wilhelm-Sander Stiftung	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) SFB TR36 (TPB4) and by the Wilhelm-Sander Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT T, 1994, ONCOGENE, V9, P759; Anders K, 2011, CANCER CELL, V20, P755, DOI 10.1016/j.ccr.2011.10.019; BARTH RJ, 1990, J IMMUNOL, V144, P1531; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Bubendorf L, 1999, CANCER RES, V59, P803; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gerbitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034552; Gold JS, 2003, J IMMUNOL, V170, P5188, DOI 10.4049/jimmunol.170.10.5188; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; KLEIN G, 1983, CELL, V32, P311, DOI 10.1016/0092-8674(83)90449-X; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Lehmann FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042021; Leisegang M, 2010, J CLIN INVEST, V120, P3869, DOI 10.1172/JCI43437; Li LP, 2010, NAT MED, V16, P1029, DOI 10.1038/nm.2197; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Malynn BA, 2000, GENE DEV, V14, P1390; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Schuler T, 2002, J MOL MED-JMM, V80, P533, DOI 10.1007/s00109-002-0360-4; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shanker A, 2007, J IMMUNOL, V179, P6651, DOI 10.4049/jimmunol.179.10.6651; Sodir NM, 2011, ONCOTARGET, V2, P1307; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Xue S, 2004, BLOOD CELL MOL DIS, V33, P288, DOI 10.1016/j.bcmd.2004.08.018; Yan XL, 2011, CANCER IMMUNOL IMMUN, V60, P1763, DOI 10.1007/s00262-011-1076-5; Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77375	10.1371/journal.pone.0077375	http://dx.doi.org/10.1371/journal.pone.0077375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130880	gold, Green Published			2022-12-27	WOS:000325814200084
J	Loch, D; Heidel, C; Breer, H; Strotmann, J				Loch, Diana; Heidel, Christian; Breer, Heinz; Strotmann, Joerg			Adiponectin Enhances the Responsiveness of the Olfactory System	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS NEURONS; CIRCULATING ADIPONECTIN; CALORIC RESTRICTION; ADIPOSE-TISSUE; RECEPTORS; INCREASES; INSULIN; NEUROENDOCRINE; MODULATION; EXPRESSION	The peptide hormone adiponectin is secreted by adipose tissue and the circulating concentration is reversely correlated with body fat mass; it is considered as starvation signal. The observation that mature sensory neurons of the main olfactory epithelium express the adiponectin receptor 1 has led to the concept that adiponectin may affect the responsiveness of the olfactory system. In fact, electroolfactogram recordings from olfactory epithelium incubated with exogenous adiponectin resulted in large amplitudes upon odor stimulation. To determine whether the responsiveness of the olfactory sensory neurons was enhanced, we have monitored the odorant-induced expression of the immediate early gene Egr1. It was found that in an olfactory epithelium incubated with nasally applied adiponectin the number of Egr1 positive cells was significantly higher compared to controls, suggesting that adiponectin rendered the olfactory neurons more responsive to an odorant stimulus. To analyze whether the augmented responsiveness of sensory neurons was strong enough to elicit a higher neuronal activity in the olfactory bulb, the number of activated periglomerular cells of a distinct glomerulus was determined by monitoring the stimulus-induced expression of c-fos. The studies were performed using the transgenic mOR256-17-IRES-tauGFP mice which allowed to visualize the corresponding glomerulus and to stimulate with a known ligand. The data indicate that upon exposure to 2,3-hexanedione in adiponectin-treated mice the number of activated periglomerular neurons was significantly increased compared to controls. The results of this study indicate that adiponectin increases the responsiveness of the olfactory system, probably due to a higher responsiveness of olfactory sensory neurons.	[Loch, Diana; Heidel, Christian; Breer, Heinz; Strotmann, Joerg] Univ Hohenheim, Inst Physiol, Stuttgart, Germany	University Hohenheim	Strotmann, J (corresponding author), Univ Hohenheim, Inst Physiol, Stuttgart, Germany.	strotman@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [BR712/25-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (grant #BR712/25-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Aime P, 2007, BEHAV BRAIN RES, V179, P258, DOI 10.1016/j.bbr.2007.02.012; Baly C, 2007, BRAIN RES, V1129, P130, DOI 10.1016/j.brainres.2006.10.030; Bautze V, 2012, CHEM SENSES, V37, P479, DOI 10.1093/chemse/bjr130; Caillol M, 2003, BRAIN RES, V960, P48, DOI 10.1016/S0006-8993(02)03755-1; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Ding Q, 2012, J NUTR BIOCHEM, V23, P867, DOI 10.1016/j.jnutbio.2011.04.011; Guthoff M, 2011, INT J OBESITY, V35, P873, DOI 10.1038/ijo.2010.211; Hass N, 2008, CELL TISSUE RES, V334, P187, DOI 10.1007/s00441-008-0677-6; Henry BA, 2008, J NEUROENDOCRINOL, V20, P842, DOI 10.1111/j.1365-2826.2008.1730.x; Hoyda TD, 2007, J PHYSIOL-LONDON, V585, P805, DOI 10.1113/jphysiol.2007.144519; Hoyda TD, 2010, ENDOCRINOLOGY, V151, P3154, DOI 10.1210/en.2009-1390; Hoyda TD, 2009, ENDOCRINOLOGY, V150, P832, DOI 10.1210/en.2008-1179; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Luxenhofer G, 2008, J COMP NEUROL, V509, P580, DOI 10.1002/cne.21766; Negroni J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045266; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Ricci R, 2012, VET J, V191, P292, DOI 10.1016/j.tvjl.2011.04.009; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Strotmann J, 2011, HISTOCHEM CELL BIOL, V136, P357, DOI 10.1007/s00418-011-0850-y; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; Trellakis S, 2011, REGUL PEPTIDES, V167, P112, DOI 10.1016/j.regpep.2010.12.005; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024	28	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75716	10.1371/journal.pone.0075716	http://dx.doi.org/10.1371/journal.pone.0075716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130737	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200020
J	Shi, YY; Sun, LX; Huang, ZY; Wu, XB; Zhu, YQ; Zheng, HJ; Zeng, ZJ				Shi, Yuan Yuan; Sun, Liang Xian; Huang, Zachary Y.; Wu, Xiao Bo; Zhu, Yong Qiang; Zheng, Hua Jun; Zeng, Zhi Jiang			A SNP Based High-Density Linkage Map of Apis cerana Reveals a High Recombination Rate Similar to Apis mellifera	PLOS ONE			English	Article							HONEY-BEE; DROSOPHILA-MELANOGASTER; READ ALIGNMENT; SOCIAL INSECTS; GENETIC-MAP; EVOLUTION; GENOME; MARKERS; REPRODUCTION; ELEGANS	Background: The Eastern honey bee, Apis cerana Fabricius, is distributed in southern and eastern Asia, from India and China to Korea and Japan and southeast to the Moluccas. This species is also widely kept for honey production besides Apis mellifera. Apis cerana is also a model organism for studying social behavior, caste determination, mating biology, sexual selection, and host-parasite interactions. Few resources are available for molecular research in this species, and a linkage map was never constructed. A linkage map is a prerequisite for quantitative trait loci mapping and for analyzing genome structure. We used the Chinese honey bee, Apis cerana cerana to construct the first linkage map in the Eastern honey bee. Results: F2 workers (N = 103) were genotyped for 126,990 single nucleotide polymorphisms (SNPs). After filtering low quality and those not passing the Mendel test, we obtained 3,000 SNPs, 1,535 of these were informative and used to construct a linkage map. The preliminary map contains 19 linkage groups, we then mapped the 19 linkage groups to 16 chromosomes by comparing the markers to the genome of A. mellfiera. The final map contains 16 linkage groups with a total of 1,535 markers. The total genetic distance is 3,942.7 centimorgans (cM) with the largest linkage group (180 loci) measuring 574.5 cM. Average marker interval for all markers across the 16 linkage groups is 2.6 cM. Conclusion: We constructed a high density linkage map for A. c. cerana with 1,535 markers. Because the map is based on SNP markers, it will enable easier and faster genotyping assays than randomly amplified polymorphic DNA or microsatellite based maps used in A. mellifera.	[Shi, Yuan Yuan; Wu, Xiao Bo; Zeng, Zhi Jiang] Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China; [Sun, Liang Xian] Quanzhou Normal Univ, Mol Biol & Pharmacol Key Lab Fujian Adv Educ, Quanzhou, Fujian, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Zhu, Yong Qiang; Zheng, Hua Jun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Jiangxi Agricultural University; Quanzhou Normal University; Michigan State University	Zheng, HJ (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	zhenghj@chgc.sh.cn; bees1965@sina.com	Zheng, Huajun/AAN-4973-2020; Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	Earmarked Fund for China Agriculture Research System [CARS-45-KXJ12]; Special Fund for Agro-scientific Research in the Public Interest [200903006]; National Natural Science Foundation of China [31260524]	Earmarked Fund for China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Earmarked Fund for China Agriculture Research System (No. CARS-45-KXJ12), Special Fund for Agro-scientific Research in the Public Interest (No. 200903006) and the National Natural Science Foundation of China (No. 31260524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; Albert T, 2004, J INSECT PHYSIOL, V50, P51, DOI 10.1016/j.jinsphys.2003.09.008; Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Aslam ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-647; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Cheng S L, 2001, APICULTURAL SCI CHIN, P488; *CHIN NAT COMM AN, 2011, AN GEN RES CHIN BEES; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimopoulos G, 1996, GENETICS, V143, P953; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Green P, 1990, DOCUMENTATION CRI MA; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; Hoskins RA, 2001, GENOME RES, V11, P1100, DOI 10.1101/gr.GR-1780R; HUNT GJ, 1995, GENETICS, V139, P1371; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZG, 2012, APIDOLOGIE, V43, P487, DOI 10.1007/s13592-012-0119-z; Meznar ER, 2010, J HERED, V101, pS118, DOI 10.1093/jhered/esq002; Oldroyd BP, 2001, BEHAV ECOL SOCIOBIOL, V50, P371, DOI 10.1007/s002650100376; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; PAGE RE, 1988, BEHAV ECOL SOCIOBIOL, V23, P117, DOI 10.1007/BF00299895; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Raffiudin R, 2007, MOL PHYLOGENET EVOL, V43, P543, DOI 10.1016/j.ympev.2006.10.013; RATH W, 1992, AM BEE J, V132, P329; Roethele JB, 2001, ANN ENTOMOL SOC AM, V94, P936, DOI 10.1603/0013-8746(2001)094[0936:EFBSCO]2.0.CO;2; Schmid-Hempel P, 2002, AM NAT, V160, P403, DOI 10.1086/341517; Sobel E, 1996, AM J HUM GENET, V58, P1323; Solignac M, 2004, GENETICS, V167, P253, DOI 10.1534/genetics.167.1.253; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Stolle E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-48; Tsuruda JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048276; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047954; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; WILLIAMS BD, 1992, GENETICS, V131, P609; Wu R., 2007, STAT GENETICS QUANTI; Xu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004239; XU Y, 1994, MOL QUANTITATIVE GEN; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21; Zeng ZJ, 2010, BIOL HONEY BEE; Zeng ZJ, 2009, APICULTURE	48	12	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76459	10.1371/journal.pone.0076459	http://dx.doi.org/10.1371/journal.pone.0076459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130775	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200040
J	Zanatta, AP; Zanatta, L; Goncalves, R; Zamoner, A; Silva, FRMB				Zanatta, Ana Paula; Zanatta, Leila; Goncalves, Renata; Zamoner, Ariane; Mena Barreto Silva, Fatima Regina			Rapid Responses to Reverse T-3 Hormone in Immature Rat Sertoli Cells: Calcium Uptake and Exocytosis Mediated by Integrin	PLOS ONE			English	Article							AMINO-ACID ACCUMULATION; GENOMIC-INDEPENDENT ACTION; ALVEOLAR EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; MALE REPRODUCTIVE-SYSTEM; K-ATPASE ACTIVITY; THYROID-HORMONE; PLASMA-MEMBRANE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; IODOTHYRONINE DEIODINASES	There is increasing experimental evidence of the nongenomic action of thyroid hormones mediated by receptors located in the plasma membrane or inside cells. The aim of this work was to characterize the reverse T-3 (rT(3)) action on calcium uptake and its involvement in immature rat Sertoli cell secretion. The results presented herein show that very low concentrations of rT(3) are able to increase calcium uptake after 1 min of exposure. The implication of T-type voltage-dependent calcium channels and chloride channels in the effect of rT(3) was evidenced using flunarizine and 9-anthracene, respectively. Also, the rT(3)-induced calcium uptake was blocked in the presence of the RGD peptide (an inhibitor of integrin-ligand interactions). Therefore, our findings suggest that calcium uptake stimulated by rT(3) may be mediated by integrin alpha(v)beta(3). In addition, it was demonstrated that calcium uptake stimulated by rT(3) is PKC and ERK-dependent. Furthermore, the outcomes indicate that rT(3) also stimulates cellular secretion since the cells manifested a loss of fluorescence after 4 min incubation, indicating an exocytic quinacrine release that seems to be mediated by the integrin receptor. These findings indicate that rT(3) modulates the calcium entry and cellular secretion, which might play a role in the regulation of a plethora of intracellular processes involved in male reproductive physiology.	[Zanatta, Ana Paula; Goncalves, Renata; Zamoner, Ariane; Mena Barreto Silva, Fatima Regina] Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil; [Zanatta, Leila] Univ Comunitaria Regiao Chapeco, Chapeco, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Comunitaria Regional de Chapeco	Silva, FRMB (corresponding author), Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil.	mena.barreto@ufsc.br	Zamoner, A./D-9525-2012; Silva, Fátima Regina Mena Barreto/S-7939-2019; Zanatta, Leila/C-3505-2019	Zamoner, A./0000-0003-2844-8563; Zanatta, Leila/0000-0003-0935-4190	MCT; CNPq [471594/2010-5]; CAPES/COFECUB [554/07]; FAPESC-SC [FCTP1518/000]; CAPES/PPG-Pharmacy	MCT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESC-SC; CAPES/PPG-Pharmacy	This work was supported by grants from: MCT and CNPq (no 471594/2010-5)- www.cnpq.br, CAPES/COFECUB no 554/07 - www.capes.gov.br, FAPESC-SC (no FCTP1518/000) - www.fapesc.sc.gov.br and CAPES/PPG-Pharmacy - www.pgfar.ufsc.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano B, 2008, ENDOCRINOLOGY, V149, P4209, DOI 10.1210/en.2007-1679; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bates JM, 1999, ENDOCRINOLOGY, V140, P844, DOI 10.1210/en.140.2.844; BATRA S, 1983, LIFE SCI, V32, P315, DOI 10.1016/0024-3205(83)90076-0; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Costa RR, 2011, CELL CALCIUM, V49, P191, DOI 10.1016/j.ceca.2011.02.003; Davis PJ, 2005, TRENDS ENDOCRIN MET, V16, P429, DOI 10.1016/j.tem.2005.09.007; Dentice M, 2011, J ENDOCRINOL, V209, P273, DOI 10.1530/JOE-11-0002; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; Farwell AP, 2006, ENDOCRINOLOGY, V147, P2567, DOI 10.1210/en.2005-1272; Farwell AP, 2005, CURR OPIN ENDOCRINOL, V12, P17, DOI [DOI 10.1097/01.MED.0000152036.70617.1E, 10.1097/01.med.0000152036.70617.1, DOI 10.1097/01.MED.0000152036.70617.1]; Fujisawa M, 2001, UROL RES, V29, P144, DOI 10.1007/s002400100179; GALDIERI M, 1981, J ANDROL, V2, P249; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Gorczynska-Fjalling Eleonora, 2004, Reprod Biol, V4, P219; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Iftinca M C, 2011, J Med Life, V4, P126; Jannini EA, 1999, J ENDOCRINOL INVEST, V22, P843, DOI 10.1007/BF03343656; Kavok NS, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-5; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; Lalevee N, 1997, BIOL REPROD, V56, P680, DOI 10.1095/biolreprod56.3.680; Lalevee N, 1999, J MEMBRANE BIOL, V169, P167, DOI 10.1007/s002329900528; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lee JH, 2010, ASIAN J ANDROL, V12, P807, DOI 10.1038/aja.2010.51; Lei J, 2008, AM J PHYSIOL-LUNG C, V294, pL749, DOI 10.1152/ajplung.00335.2007; Lei JX, 2003, AM J PHYSIOL-LUNG C, V285, pL762, DOI 10.1152/ajplung.00376.2002; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; Linnertz R, 2011, NEUROSCIENCE, V188, P23, DOI 10.1016/j.neuroscience.2011.04.058; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahapatra S, 2012, CELL CALCIUM, V51, P321, DOI 10.1016/j.ceca.2012.01.005; Menegaz D, 2006, MOL CELL ENDOCRINOL, V246, P128, DOI 10.1016/j.mce.2005.11.019; Menegaz D, 2010, J STEROID BIOCHEM, V74, P264; Menegaz D, 2010, INT J BIOCHEM CELL B, V42, P1046, DOI 10.1016/j.biocel.2010.03.015; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rosso A, 2012, BIOCHIMIE, V94, P146, DOI 10.1016/j.biochi.2011.10.001; Russell L. D., 1993, SERTOLI CELL; Scapin S, 2010, STEROIDS, V75, P576, DOI 10.1016/j.steroids.2009.10.013; Scapin S, 2009, AM J PHYSIOL-CELL PH, V296, pC4, DOI 10.1152/ajpcell.90604.2007; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Silva FRMB, 2001, LIFE SCI, V69, P977, DOI 10.1016/S0024-3205(01)01186-9; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Taranta A, 1997, MOL CELL ENDOCRINOL, V126, P117, DOI 10.1016/S0303-7207(96)03973-1; Tsou R, 2001, MOL CELL BIOCHEM, V224, P81, DOI 10.1023/A:1011947301849; Van der Geyten S, 2002, GEN COMP ENDOCR, V128, P65, DOI 10.1016/S0016-6480(02)00065-5; VINATIER D, 1995, EUR J OBSTET GYN R B, V59, P71, DOI 10.1016/0028-2243(94)01987-I; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Volpato KC, 2004, LIFE SCI, V74, P1277, DOI 10.1016/j.lfs.2003.08.005; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zamoner A, 2005, LIFE SCI, V77, P3321, DOI 10.1016/j.lfs.2005.05.042; Zamoner A, 2006, LIFE SCI, V80, P51, DOI 10.1016/j.lfs.2006.08.020; Zamoner A, 2008, STEROIDS, V73, P1400, DOI 10.1016/j.steroids.2008.07.002; Zamoner A, 2007, NEUROSCI RES, V57, P98, DOI 10.1016/j.neures.2006.09.012; Zamoner A, 2011, LIFE SCI, V89, P507, DOI 10.1016/j.lfs.2011.04.006; Zanatta AP, 2013, BBA-GEN SUBJECTS, V1830, P2629, DOI 10.1016/j.bbagen.2012.10.022; Zanatta L, 2012, BBA-MOL CELL RES, V1823, P1708, DOI 10.1016/j.bbamcr.2012.06.023; Zanatta L, 2011, BIOCHEMISTRY-US, V50, P10284, DOI 10.1021/bi201113n; Zanatta L, 2011, ARCH BIOCHEM BIOPHYS, V515, P46, DOI 10.1016/j.abb.2011.09.001; Zhu XG, 1998, J BIOL CHEM, V273, P27058, DOI 10.1074/jbc.273.42.27058	64	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77176	10.1371/journal.pone.0077176	http://dx.doi.org/10.1371/journal.pone.0077176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130850	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200065
J	Zhu, WN; Drewes, J; Gegenfurtner, KR				Zhu, Weina; Drewes, Jan; Gegenfurtner, Karl R.			Animal Detection in Natural Images: Effects of Color and Image Database	PLOS ONE			English	Article							HUMAN FACE PERCEPTION; RAPID VISUAL CATEGORIZATION; SACCADIC EYE-MOVEMENTS; SELECTIVE ATTENTION; PROCESSING SPEED; TIME-COURSE; RECOGNITION; POTENTIALS; CONTEXT; CORTEX	The visual system has a remarkable ability to extract categorical information from complex natural scenes. In order to elucidate the role of low-level image features for the recognition of objects in natural scenes, we recorded saccadic eye movements and event-related potentials (ERPs) in two experiments, in which human subjects had to detect animals in previously unseen natural images. We used a new natural image database (ANID) that is free of some of the potential artifacts that have plagued the widely used COREL images. Color and grayscale images picked from the ANID and COREL databases were used. In all experiments, color images induced a greater N1 EEG component at earlier time points than grayscale images. We suggest that this influence of color in animal detection may be masked by later processes when measuring reation times. The ERP results of go/nogo and forced choice tasks were similar to those reported earlier. The non-animal stimuli induced bigger N1 than animal stimuli both in the COREL and ANID databases. This result indicates ultra-fast processing of animal images is possible irrespective of the particular database. With the ANID images, the difference between color and grayscale images is more pronounced than with the COREL images. The earlier use of the COREL images might have led to an underestimation of the contribution of color. Therefore, we conclude that the ANID image database is better suited for the investigation of the processing of natural scenes than other databases commonly used.	[Zhu, Weina] Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China; [Zhu, Weina; Gegenfurtner, Karl R.] Univ Giessen, Dept Psychol, D-35390 Giessen, Germany; [Zhu, Weina] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China; [Drewes, Jan] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada	Yunnan University; Justus Liebig University Giessen; Chinese Academy of Sciences; Kunming Institute of Zoology; York University - Canada	Zhu, WN (corresponding author), Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China.	zhuweina.cn@gmail.com		Gegenfurtner, Karl/0000-0001-5390-0684	National Natural Science Foundation of China [61005087, 61263042]; Science and Technology Project of Yunnan Province, China [2009CD018]; Key Science and Technology Project of Department of Education, Yunnan Province, China [2010Z067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Yunnan Province, China; Key Science and Technology Project of Department of Education, Yunnan Province, China	This work was supported by the National Natural Science Foundation of China (61005087, 61263042), Science and Technology Project of Yunnan Province, China (2009CD018), Key Science and Technology Project of Department of Education, Yunnan Province, China (2010Z067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Bacon-Mace N, 2005, VISION RES, V45, P1459, DOI 10.1016/j.visres.2005.01.004; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Crouzet SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051471; Crouzet SM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00342; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Doherty LM, 1999, SPATIAL VISION, V12, P485, DOI 10.1163/156856899X00274; Drewes J, 2011, J VISION, V11, DOI 10.1167/11.2.20; Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; FISCHER B, 1984, EXP BRAIN RES, V57, P191; Foster DH, 2000, VISION RES, V40, P65, DOI 10.1016/S0042-6989(99)00164-9; Gaspar CM, 2009, VISION RES, V49, P3001, DOI 10.1016/j.visres.2009.09.021; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Goffaux V, 2005, VIS COGN, V12, P878, DOI 10.1080/13506280444000562; Harter M.R., 1984, VARIETIES ATTENTION, P293; HARTER MR, 1982, NEUROPSYCHOLOGIA, V20, P421, DOI 10.1016/0028-3932(82)90041-0; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Honey C, 2008, J VISION, V8, DOI 10.1167/8.12.9; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Li FF, 2005, VIS COGN, V12, P893, DOI 10.1080/13506280444000571; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Moller P, 1996, P NATL ACAD SCI USA, V93, P7421, DOI 10.1073/pnas.93.14.7421; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Pinto N., 2008, ECCV, P1; Ponce J, 2006, LECT NOTES COMPUT SC, P1; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Rieger JW, 2008, J EXP PSYCHOL HUMAN, V34, P56, DOI 10.1037/0096-1523.34.1.56; Rousselet GA, 2007, J COGNITIVE NEUROSCI, V19, P1241, DOI 10.1162/jocn.2007.19.8.1241; Tanaka JW, 1999, PERCEPT PSYCHOPHYS, V61, P1140, DOI 10.3758/BF03207619; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2006, PERCEPTION, V35, P128; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Trottier L, 2005, VISION RES, V45, P1349, DOI 10.1016/j.visres.2004.12.007; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Vogel J, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1278387.1278393; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Wichmann FA, 2002, J EXP PSYCHOL LEARN, V28, P509, DOI 10.1037//0278-7393.28.3.509; Wichmann FA, 2010, J VISION, V10, DOI 10.1167/10.4.6; WIJERS AA, 1989, BIOL PSYCHOL, V29, P213, DOI 10.1016/0301-0511(89)90021-5	52	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75816	10.1371/journal.pone.0075816	http://dx.doi.org/10.1371/journal.pone.0075816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130744	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200023
J	Beatty, WS; Kesler, DC; Webb, EB; Raedeke, AH; Naylor, LW; Humburg, DD				Beatty, William S.; Kesler, Dylan C.; Webb, Elisabeth B.; Raedeke, Andrew H.; Naylor, Luke W.; Humburg, Dale D.			Quantitative and Qualitative Approaches to Identifying Migration Chronology in a Continental Migrant	PLOS ONE			English	Article							SCAUP AYTHYA-AFFINIS; SPRING MIGRATION; MISSISSIPPI FLYWAY; DUCK ABUNDANCE; MALLARDS; CONSEQUENCES; MOVEMENT; RESERVES; ROUTES; WINTER	The degree to which extrinsic factors influence migration chronology in North American waterfowl has not been quantified, particularly for dabbling ducks. Previous studies have examined waterfowl migration using various methods, however, quantitative approaches to define avian migration chronology over broad spatio-temporal scales are limited, and the implications for using different approaches have not been assessed. We used movement data from 19 female adult mallards (Anas platyrhynchos) equipped with solar-powered global positioning system satellite transmitters to evaluate two individual level approaches for quantifying migration chronology. The first approach defined migration based on individual movements among geopolitical boundaries (state, provincial, international), whereas the second method modeled net displacement as a function of time using nonlinear models. Differences in migration chronologies identified by each of the approaches were examined with analysis of variance. The geopolitical method identified mean autumn migration midpoints at 15 November 2010 and 13 November 2011, whereas the net displacement method identified midpoints at 15 November 2010 and 14 November 2011. The mean midpoints for spring migration were 3 April 2011 and 20 March 2012 using the geopolitical method and 31 March 2011 and 22 March 2012 using the net displacement method. The duration, initiation date, midpoint, and termination date for both autumn and spring migration did not differ between the two individual level approaches. Although we did not detect differences in migration parameters between the different approaches, the net displacement metric offers broad potential to address questions in movement ecology for migrating species. Ultimately, an objective definition of migration chronology will allow researchers to obtain a comprehensive understanding of the extrinsic factors that drive migration at the individual and population levels. As a result, targeted conservation plans can be developed to support planning for habitat management and evaluation of long-term climate effects.	[Beatty, William S.; Kesler, Dylan C.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA; [Webb, Elisabeth B.] Univ Missouri, Missouri Cooperat Fisheries & Wildlife Res Unit, US Geol Survey, Dept Fisheries & Wildlife Sci, Columbia, MO USA; [Raedeke, Andrew H.] Missouri Dept Conservat, Columbia, MO USA; [Naylor, Luke W.] Arkansas Game & Fish Commiss, Little Rock, AR USA; [Humburg, Dale D.] Ducks Unlit, Memphis, TN USA	University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Beatty, WS (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA.	beattyw@missouri.edu		Beatty, William/0000-0003-0013-3113; Webb, Lisa/0000-0003-3851-6056	Missouri Department of Conservation [346, MCC-01-01-00]; USDA Natural Resources Conservation Service (NRCS) Conservation Effects Assessment Project [68-3A75-11-39]; Arkansas Game and Fish Commission; Ducks Unlimited; Missouri Department of Conservation; University of Missouri; U.S. Geological Survey; U.S. Fish and Wildlife Service; Wildlife Management Institute	Missouri Department of Conservation; USDA Natural Resources Conservation Service (NRCS) Conservation Effects Assessment Project; Arkansas Game and Fish Commission; Ducks Unlimited; Missouri Department of Conservation; University of Missouri; U.S. Geological Survey(United States Geological Survey); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	This research was funded by the Missouri Department of Conservation (Cooperative Agreement 346, Master Memorandum of Understanding MCC-01-01-00), USDA Natural Resources Conservation Service (NRCS) Conservation Effects Assessment Project (68-3A75-11-39), Arkansas Game and Fish Commission, and Ducks Unlimited. The Missouri Cooperative Fish and Wildlife Research Unit is jointly sponsored by the Missouri Department of Conservation, the University of Missouri, the U.S. Geological Survey, the U.S. Fish and Wildlife Service, and the Wildlife Management Institute. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anteau MJ, 2009, AUK, V126, P873, DOI 10.1525/auk.2009.08193; Anteau MJ, 2004, AUK, V121, P917, DOI 10.1642/0004-8038(2004)121[0917:NROLSA]2.0.CO;2; Arzel C, 2006, J ORNITHOL, V147, P167, DOI 10.1007/s10336-006-0054-8; Baar L, 2008, WATERBIRDS, V31, P394, DOI 10.1675/1524-4695-31.3.394; Bellrose F, 1980, DUCKS GEESE SWANS N; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chapman JW, 2002, ECOL ENTOMOL, V27, P641, DOI 10.1046/j.1365-2311.2002.00472.x; Chen CWS, 2011, STAT COMPUT, V21, P395, DOI 10.1007/s11222-010-9177-0; Cohn JP, 1999, BIOSCIENCE, V49, P12, DOI 10.2307/1313488; Devries JH, 2008, AUK, V125, P618, DOI 10.1525/auk.2008.07055; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Drent RJ, 2006, J ORNITHOL, V147, P122, DOI 10.1007/s10336-006-0066-4; Drilling N., 2002, BIRDS N AM, P658; Dugger BD, 1997, J FIELD ORNITHOL, V68, P331; Evrard James O., 1998, North American Bird Bander, V23, P110; Fair J., 2010, ORNITHOLOGICAL COUNC; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gelman A., 2007, DATA ANAL USING REGR; Hodgson S, 2006, FISH OCEANOGR, V15, P1, DOI 10.1111/j.1365-2419.2005.00354.x; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Klaassen M, 2006, J APPL ECOL, V43, P92, DOI 10.1111/j.1365-2664.2005.01109.x; Krementz DG, 2012, J FISH WILDL MANAG, V3, P238, DOI 10.3996/022012-JFWM-019; Krementz DG, 2011, J FISH WILDL MANAG, V2, P156, DOI 10.3996/042011-JFWM-026; Malecki RA, 2001, J WILDLIFE MANAGE, V65, P242, DOI 10.2307/3802903; Miller MR, 2005, CAN J ZOOL, V83, P1314, DOI 10.1139/Z05-125; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Murphy-Klassen HM, 2005, AUK, V122, P1130, DOI 10.1642/0004-8038(2005)122[1130:LTISAD]2.0.CO;2; North American Waterfowl Management Plan Committee, 2012, N AM WAT MAN PLAN 20; O'Neal BJ, 2012, J WILDLIFE MANAGE, V76, P285, DOI 10.1002/jwmg.283; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; R Core Team, 2012, R LANG ENV STAT COMP; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Schummer ML, 2010, J WILDLIFE MANAGE, V74, P94, DOI 10.2193/2008-524; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Turchin Peter, 1998; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunz G. A., 1984, T NE SECTION WILDLIF, V41, P219; Yamaguchi N, 2008, ZOOL SCI, V25, P875, DOI 10.2108/zsj.25.875	46	13	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75673	10.1371/journal.pone.0075673	http://dx.doi.org/10.1371/journal.pone.0075673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130732	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900051
J	Jiang, XJ; Chen, YY; Wei, HM; Sun, R; Tian, ZG				Jiang, Xiaojun; Chen, Yongyan; Wei, Haiming; Sun, Rui; Tian, Zhigang			Characterizing the Lymphopoietic Kinetics and Features of Hematopoietic Progenitors Contained in the Adult Murine Liver In Vivo	PLOS ONE			English	Article							STEM-CELLS; TRANSPLANTED LIVERS; YOLK-SAC; NK CELLS; CHIMERISM; RECIPIENT; EMBRYO; DIFFERENTIATION; POPULATION; FREQUENCY	The appearance of donor-derived lymphocytes in liver transplant patients suggests that adult livers may contain cells capable of lymphopoiesis. However, only a few published studies have addressed the lymphopoietic capacity of adult liver cells, and its kinetics and features remain unclear. Herein, we investigated the lymphopoietic capacity of adult liver mononuclear cells (MNCs) and purified liver hematopoietic progenitor cells (HPCs) in vivo. Similar to bone-marrow transplantation (BMT), transplantation of liver MNCs alone was able to rescue survival of lethally irradiated mice. In terms of kinetics, liver MNC-derived myeloid lineage cells reconstituted more slowly than those from BMT. Liver MNC-derived lymphocyte lineage cells in the blood, spleen and BM also reconstituted more slowly than BMT, but lymphocytes in the liver recovered at a similar rate. Interestingly, liver MNCs predominantly gave rise to CD3(+)CD19(-) T cells in both irradiated WT and non-irradiated lymphocyte-deficient Rag-1(-/-)Il2rg(-/-) recipients. To define the lymphopoietic potential of various cell populations within liver MNCs, we transplanted purified lineage-negative (Lin(-)) liver HPCs into recipient mice. Unlike total liver MNCs, liver HPCs reconstituted T and B cells in similar frequencies to BMT. We further determined that the predominance of T cells observed after transplanting total liver MNCs likely originated from mature T cells, as purified donor liver T cells proliferated in the recipients and gave rise to CD8(+) T cells. Thus, the capacity of donor adult liver cells to reconstitute lymphocytes in recipients derives from both HPCs and mature T cells contained in the liver MNC population.	[Jiang, Xiaojun; Chen, Yongyan; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230026, Anhui, Peoples R China; [Tian, Zhigang] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230026, Anhui, Peoples R China.	tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013		Ministry of Science & Technology of China [2013CB944902]; Natural Science Foundation of China [31021061]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science & Technology of China (973 Basic Science Project 2013CB944902) and the Natural Science Foundation of China (#31021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SI, 2008, NEW ENGL J MED, V358, P369, DOI 10.1056/NEJMoa0707255; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Bilezikci B, 2006, TRANSPL P, V38, P598, DOI 10.1016/j.transproceed.2005.12.059; COLLINS RH, 1993, NEW ENGL J MED, V328, P762, DOI 10.1056/NEJM199303183281104; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Crosbie OM, 1999, HEPATOLOGY, V29, P1193, DOI 10.1002/hep.510290402; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017; Laurenti E, 2012, ANN NY ACAD SCI, V1266, P68, DOI 10.1111/j.1749-6632.2012.06577.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Moroso V, 2011, EUR J IMMUNOL, V41, P3340, DOI 10.1002/eji.201141760; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Ng IOL, 2003, HEPATOLOGY, V38, P989, DOI 10.1053/jhep.2003.50395; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shi X, 2012, HEPATOLOGY; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; Uchida N, 2002, EXP HEMATOL, V30, P862, DOI 10.1016/S0301-472X(02)00879-2; Wang XQ, 2012, HEPATOLOGY, V56, P1557, DOI 10.1002/hep.25820	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76762	10.1371/journal.pone.0076762	http://dx.doi.org/10.1371/journal.pone.0076762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130788	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900082
J	Johnson, N; Hassdenteufel, S; Theis, M; Paton, AW; Paton, JC; Zimmermann, R; High, S				Johnson, Nicholas; Hassdenteufel, Sarah; Theis, Melanie; Paton, Adrienne W.; Paton, James C.; Zimmermann, Richard; High, Stephen			The Signal Sequence Influences Post-Translational ER Translocation at Distinct Stages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; CELL-ADHESION MOLECULE-1; PREPRO-ALPHA-FACTOR; PRESECRETORY PROTEINS; MAMMALIAN MICROSOMES; COTRANSLATIONAL TRANSLOCATION; SECRETORY PROTEINS; DOCKING PROTEIN; TRANSPORT; YEAST	The metazoan Sec61 translocon transports polypeptides into and across the membrane of the endoplasmic reticulum via two major routes, a well-established co-translational pathway and a post-translational alternative. We have used two model substrates to explore the elements of a secretory protein precursor that preferentially direct it towards a co- or post-translational pathway for ER translocation. Having first determined the capacity of precursors to enter ER derived microsomes post-translationally, we then exploited semi-permeabilized mammalian cells specifically depleted of key membrane components using siRNA to address their contribution to the membrane translocation process. These studies suggest precursor chain length is a key factor in the post-translational translocation at the mammalian ER, and identify Sec62 and Sec63 as important components acting on this route. This role for Sec62 and Sec63 is independent of the signal sequence that delivers the precursor to the ER. However, the signal sequence can influence the subsequent membrane translocation process, conferring sensitivity to a small molecule inhibitor and dictating reliance on the molecular chaperone BiP. Our data support a model where secretory protein precursors that fail to engage the signal recognition particle, for example because they are short, are delivered to the ER membrane via a distinct route that is dependent upon both Sec62 and Sec63. Although this requirement for Sec62 and Sec63 is unaffected by the specific signal sequence that delivers a precursor to the ER, this region can influence subsequent events, including both Sec61 mediated transport and the importance of BiP for membrane translocation. Taken together, our data suggest that an ER signal sequence can regulate specific aspects of Sec61 mediated membrane translocation at a stage following Sec62/Sec63 dependent ER delivery.	[Johnson, Nicholas; High, Stephen] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Hassdenteufel, Sarah; Theis, Melanie; Zimmermann, Richard] Univ Saarland, Homburg, Germany; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Adelaide, SA, Australia; [Johnson, Nicholas] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic	University of Manchester; Saarland University; University of Adelaide; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	High, S (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	stephen.high@manchester.ac.uk	Johnson, Nicholas/G-5930-2014; Hassdenteufel, Sarah/AAE-8915-2022	Hassdenteufel, Sarah/0000-0001-7243-6602; Johnson, Nicholas/0000-0002-8247-2874; High, Stephen/0000-0002-4532-8152	PhD studentship from the Biotechnology and Biological Sciences Research Council; Deutsche Forschungemeinschaft [IRTG1830]	PhD studentship from the Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungemeinschaft(German Research Foundation (DFG))	This work was supported by a PhD studentship from the Biotechnology and Biological Sciences Research Council (N. Johnson) and a grant from the Deutsche Forschungemeinschaft (IRTG1830) (S. Hassdenteufel and R. Zimmermann). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; GARCIA PD, 1988, J CELL BIOL, V106, P1043, DOI 10.1083/jcb.106.4.1043; Harant H, 2007, MOL PHARMACOL, V71, P1657, DOI 10.1124/mol.107.034249; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; High S, 1997, TRENDS CELL BIOL, V7, P206; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KLAPPA P, 1991, EMBO J, V10, P2795, DOI 10.1002/j.1460-2075.1991.tb07828.x; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; MULLER G, 1987, EMBO J, V6, P2099, DOI 10.1002/j.1460-2075.1987.tb02476.x; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ngosuwan J, 2003, J BIOL CHEM, V278, P7034, DOI 10.1074/jbc.M210544200; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHLENSTEDT G, 1987, EMBO J, V6, P699, DOI 10.1002/j.1460-2075.1987.tb04810.x; SCHLENSTEDT G, 1992, J BIOL CHEM, V267, P24328; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; ZIMMERMANN R, 1990, J BIOENERG BIOMEMBR, V22, P711; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	40	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75394	10.1371/journal.pone.0075394	http://dx.doi.org/10.1371/journal.pone.0075394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130708	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900034
J	Lu, JW; Yang, WY; Tsai, SM; Lin, YM; Chang, PH; Chen, JR; Wang, HD; Wu, JL; Jin, SLC; Yuh, CH				Lu, Jeng-Wei; Yang, Wan-Yu; Tsai, Su-Mei; Lin, Yueh-Min; Chang, Pen-Heng; Chen, Jim-Ray; Wang, Horng-Dar; Wu, Jen-Leih; Jin, Shiow-Lian Catherine; Yuh, Chiou-Hwa			Liver-Specific Expressions of HBx and src in the p53 Mutant Trigger Hepatocarcinogenesis in Zebrafish	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; X-PROTEIN; TRANSGENIC ZEBRAFISH; TUMOR PROGRESSION; TP53 MUTATIONS; FAMILY KINASES; HUMAN CANCER; MOUSE MODEL; GENE	Hepatocarcinogenesis is a multistep process that starts from fatty liver and transitions to fibrosis and, finally, into cancer. Many etiological factors, including hepatitis B virus X antigen (HBx) and p53 mutations, have been implicated in hepatocarcinogenesis. However, potential synergistic effects between these two factors and the underlying mechanisms by which they promote hepatocarcinogenesis are still unclear. In this report, we show that the synergistic action of HBx and p53 mutation triggers progressive hepatocellular carcinoma (HCC) formation via src activation in zebrafish. Liver-specific expression of HBx in wild-type zebrafish caused steatosis, fibrosis and glycogen accumulation. However, the induction of tumorigenesis by HBx was only observed in p53 mutant fish and occurred in association with the up-regulation and activation of the src tyrosine kinase pathway. Furthermore, the overexpression of src in p53 mutant zebrafish also caused hyperplasia, HCC, and sarcomatoid HCC, which were accompanied by increased levels of the signaling proteins p-erk, p-akt, myc, jnk1 and vegf. Increased expression levels of lipogenic factors and the genes involved in lipid metabolism and glycogen storage were detected during the early stages of hepatocarcinogenesis in the HBx and src transgenic zebrafish. The up-regulation of genes involved in cell cycle regulation, tumor progression and other molecular hallmarks of human liver cancer were found at later stages in both HBx and src transgenic, p53 mutant zebrafish. Together, our study demonstrates that HBx and src overexpression induced hepatocarcinogenesis in p53 mutant zebrafish. This phenomenon mimics human HCC formation and provides potential in vivo platforms for drug screening for therapies for human liver cancer.	[Lu, Jeng-Wei; Yang, Wan-Yu; Tsai, Su-Mei; Yuh, Chiou-Hwa] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Lu, Jeng-Wei; Jin, Shiow-Lian Catherine] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Changhua County, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Hou Loung Town, Miaoli County, Taiwan; [Chang, Pen-Heng] Natl Taiwan Univ, Dept Vet Med, Taipei 10764, Taiwan; [Chen, Jim-Ray] Chang Gung Mem Hosp, Dept Pathol, Keelung, Taiwan; [Chen, Jim-Ray] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; National Central University; Changhua Christian Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; Academia Sinica - Taiwan; National Tsing Hua University; National Yang Ming Chiao Tung University	Yuh, CH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan.	chyuh@nhri.org.tw	Yuh, Chiou-Hwa/E-3972-2010; Yuh, Chiou-Hwa/AAL-3531-2020; Yuh, Chiou-Hwa/AAL-2938-2020	Wang, Horng-Dar/0000-0001-9570-3611; Lu, Jeng-Wei/0000-0003-2128-2046; CHANG, PEN-HENG/0000-0002-8676-8760	NRPGM [NSC 99-3112-B-400-010]; NSC [NSC 101-2321-B-400-017, NSC 102-2321-B-400 -016]; National Health Research Institute; Liver Disease Prevention & Treatment Research Foundation, Taiwan; National Science Council (NSC) [101-2321-B-400-014]	NRPGM; NSC(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Liver Disease Prevention & Treatment Research Foundation, Taiwan; National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This research was supported by NRPGM (NSC 99-3112-B-400-010) and NSC grants (NSC 101-2321-B-400-017 and NSC 102-2321-B-400 -016) provided to CHY. Funding support from the National Health Research Institute provided to CHY is gratefully acknowledged. The fellowship to JWL and the funding support to CHY from the Liver Disease Prevention & Treatment Research Foundation, Taiwan is gratefully acknowledged. We also would like to thank the Taiwan Zebrafish Core Facility at the NTHU-NHRI site (TZeTH) for providing the fish lines and resources. The TZeTH is supported by grant 101-2321-B-400-014 from the National Science Council (NSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chan C, 2013, MOL CELL BIOL, V33, P485, DOI 10.1128/MCB.01189-12; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen J, 2007, J VIROL, V81, P6757, DOI 10.1128/JVI.00172-07; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Goessling W, 2007, NAT METHODS, V4, P551, DOI 10.1038/NMETH1059; Gouas DA, 2012, CARCINOGENESIS, V33, P1219, DOI [10.1093/carcin/bgs135, 10.1093/carcin/bgs068]; Gouas DA, 2010, CARCINOGENESIS, V31, P1475, DOI 10.1093/carcin/bgq118; Guerrieri F, 2013, SEMIN LIVER DIS, V33, P147, DOI 10.1055/s-0033-1345721; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Hobbie KR, 2012, VET PATHOL, V49, P372, DOI 10.1177/0300985811409443; HSIA CC, 1992, J NATL CANCER I, V84, P1638, DOI 10.1093/jnci/84.21.1638; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Knoll S, 2011, CELL CYCLE, V10, P3554, DOI 10.4161/cc.10.20.17856; Koo JS, 2005, INTERVIROLOGY, V48, P16, DOI 10.1159/000082090; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lara-Pezzi E, 2001, ONCOGENE, V20, P3323, DOI 10.1038/sj.onc.1204451; Lau GM, 2009, DIGEST DIS SCI, V54, P1465, DOI 10.1007/s10620-008-0519-0; Li D, 2012, LIFE SCI, V91, P440, DOI 10.1016/j.lfs.2012.08.015; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Liu W, 2012, HEPATOLOGY; Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914; Lu JW, 2013, ACTA HISTOCHEM, V115, P728, DOI 10.1016/j.acthis.2013.02.012; Lu JW, 2012, CARCINOGENESIS, V33, P209, DOI 10.1093/carcin/bgr224; Lu JW, 2011, BIRTH DEFECTS RES C, V93, P157, DOI 10.1002/bdrc.20205; Ma J, 2013, CLIN RES HEPATOL GAS; Marrero CR, 2007, ARCH MED RES, V38, P612, DOI 10.1016/j.arcmed.2006.09.004; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Muntane J, 2013, CURR CANCER DRUG TAR, V13, P300, DOI 10.2174/15680096113139990075; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Ortiz-Cuaran S, 2013, CANCER LETT, V331, P46, DOI 10.1016/j.canlet.2012.11.012; Park SS, 2004, ONCOGENE, V23, P6272, DOI 10.1038/sj.onc.1207856; Park SG, 2009, CANCER LETT, V282, P229, DOI 10.1016/j.canlet.2009.03.019; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Puisieux A, 1997, PATHOL BIOL, V45, P864; Schilling T, 2010, BIOCHEM BIOPH RES CO, V394, P817, DOI 10.1016/j.bbrc.2010.03.082; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; SEIFER M, 1991, J HEPATOL, V13, pS61, DOI 10.1016/0168-8278(91)90026-8; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Shields DJ, 2011, ONCOGENE, V30, P2123, DOI 10.1038/onc.2010.589; Soussi T, 2003, HUM MUTAT, V21, P192, DOI 10.1002/humu.10189; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P705, DOI 10.1177/019262330002800511; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thompson KJ, 2011, HPB, V13, P225, DOI 10.1111/j.1477-2574.2010.00259.x; Tsai SM, 2013, TRANSGENIC RES, V22, P301, DOI 10.1007/s11248-012-9636-9; Tseng WF, 2011, DEV BIOL, V357, P541, DOI 10.1016/j.ydbio.2011.06.040; UEDA H, 1995, INT J ONCOL, V7, P735; Wang CM, 2013, CELL CYCLE, V12, P1999, DOI 10.4161/cc.25099; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Xian LL, 2010, MOL BIOL REP, V37, P2935, DOI 10.1007/s11033-009-9855-1; Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	72	46	47	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76951	10.1371/journal.pone.0076951	http://dx.doi.org/10.1371/journal.pone.0076951			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130815	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900109
J	Lucena, JF; Alegre, F; Martinez-Urbistondo, D; Landecho, MF; Huerta, A; Garcia-Mouriz, A; Garcia, N; Quiroga, J				Lucena, Juan F.; Alegre, Felix; Martinez-Urbistondo, Diego; Landecho, Manuel F.; Huerta, Ana; Garcia-Mouriz, Alberto; Garcia, Nicolas; Quiroga, Jorge			Performance of SAPS II and SAPS 3 in Intermediate Care	PLOS ONE			English	Article							INTENSIVE-CARE; HOSPITAL MORTALITY; PROGNOSTIC MODEL; UNIT; ADMISSION; IMPACT; COST; MULTICENTER; COHORT; AREA	Objective: The efficacy and reliability of prognostic scores has been described extensively for intensive care, but their role for predicting mortality in intermediate care patients is uncertain. To provide more information in this field, we have analyzed the performance of the Simplified Acute Physiology Score (SAPS) II and SAPS 3 in a single center intermediate care unit (ImCU). Materials and Methods: Cohort study with prospectively collected data from all patients admitted to a single center ImCU in Pamplona, Spain, from April 2006 to April 2012. The SAPS II and SAPS 3 scores with respective predicted mortality rates were calculated according to standard coefficients. Discrimination was evaluated by calculating the area under receiver operating characteristic curve (AUROC) and calibration with the Hosmer-Lemeshow goodness of fit test. Standardized mortality ratios (SMR) with 95% confidence interval (95% CI) were calculated for each model. Results: The study included 607 patients. The observed in-hospital mortality was 20.1% resulting in a SMR of 0.87 (95% CI 0.73-1.04) for SAPS II and 0.56 (95% CI 0.47-0.67) for SAPS 3. Both scores showed acceptable discrimination, with an AUROC of 0.76 (95% CI 0.71-0.80) for SAPS II and 0.75 (95% CI 0.71-0.80) for SAPS 3. Calibration curves showed similar performance based on Hosmer-Lemeshow goodness of fit C-test: (X-2 = 12.9, p=0.113) for SAPS II and (X-2 = 4.07, p=0.851) for SAPS 3. Conclusions: Although both scores overpredicted mortality, SAPS II showed better discrimination for patients admitted to ImCU in terms of SMR.	[Lucena, Juan F.; Alegre, Felix; Martinez-Urbistondo, Diego; Landecho, Manuel F.; Huerta, Ana; Garcia, Nicolas; Quiroga, Jorge] Clin Univ Navarra, Dept Internal Med, Div Intermediate Care, Pamplona, Spain; [Lucena, Juan F.; Alegre, Felix; Martinez-Urbistondo, Diego; Landecho, Manuel F.; Huerta, Ana; Garcia, Nicolas; Quiroga, Jorge] Hospitalists Unit, Pamplona, Spain; [Garcia-Mouriz, Alberto] Clin Univ Navarra, Pamplona, Spain	University of Navarra; University of Navarra	Lucena, JF (corresponding author), Clin Univ Navarra, Dept Internal Med, Div Intermediate Care, Pamplona, Spain.	flucena@unav.es	Landecho, Manuel F./D-9227-2013; Garcia, Nicolas/E-4977-2015	Landecho, Manuel F./0000-0003-3234-8805; Lucena, Juan Felipe/0000-0003-4999-6753; Martinez-Urbistondo, Diego/0000-0002-0530-7349; Garcia, Nicolas/0000-0002-7804-7234				Apolone G, 1996, INTENS CARE MED, V22, P1368, DOI 10.1007/s001340050266; Auriant I, 1998, CRIT CARE MED, V26, P1368, DOI 10.1097/00003246-199808000-00023; Bertolini D, 2000, J EPIDEMIOLOGY BIOST, V5, P251; Bertolini G, 2005, RESP MED, V99, P894, DOI 10.1016/j.rmed.2004.11.014; BONE RC, 1988, CHEST, V93, P390, DOI 10.1378/chest.93.2.390; BYRICK RJ, 1993, CHEST, V104, P876, DOI 10.1378/chest.104.3.876; BYRICK RJ, 1986, CRIT CARE MED, V14, P869, DOI 10.1097/00003246-198610000-00007; DOUGLAS S, 1995, J NURS ADMIN, V25, P47, DOI 10.1097/00005110-199511000-00009; DURBIN CG, 1993, CRIT CARE MED, V21, P1547, DOI 10.1097/00003246-199310000-00025; ELPERN EH, 1991, CHEST, V99, P205, DOI 10.1378/chest.99.1.205; Lucena JF, 2012, J HOSP MED, V7, P411, DOI 10.1002/jhm.1905; FRANKLIN CM, 1988, ARCH INTERN MED, V148, P1403, DOI 10.1001/archinte.148.6.1403; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Junker C, 2002, CHEST, V121, P1253, DOI 10.1378/chest.121.4.1253; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Metnitz PGH, 1999, CRIT CARE MED, V27, P1486, DOI 10.1097/00003246-199908000-00014; Metnitz PGH, 2000, INTENS CARE MED, V26, P1466, DOI 10.1007/s001340000638; Moreno R, 1998, CRIT CARE MED, V26, P50, DOI 10.1097/00003246-199801000-00016; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nasraway SA, 1998, CRIT CARE MED, V26, P607, DOI 10.1097/00003246-199803000-00039; Poole D, 2012, INTENS CARE MED, V38, P1280, DOI 10.1007/s00134-012-2578-0; Poole D, 2009, INTENS CARE MED, V35, P1916, DOI 10.1007/s00134-009-1615-0; Reis Miranda D, 1997, ORG MANAGEMENT INTEN, V29; Soares M, 2006, INTENS CARE MED, V32, P1839, DOI 10.1007/s00134-006-0374-4; Strand K, 2009, ACTA ANAESTH SCAND, V53, P595, DOI 10.1111/j.1399-6576.2009.01948.x; Torres OH, 2006, INTENS CARE MED, V32, P1052, DOI 10.1007/s00134-006-0170-1; ZIMMERMAN JE, 1995, CHEST, V108, P490, DOI 10.1378/chest.108.2.490	29	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77229	10.1371/journal.pone.0077229	http://dx.doi.org/10.1371/journal.pone.0077229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130860	Green Published, gold			2022-12-27	WOS:000325810900128
J	Ouattara, JPN; Louwagie, J; Pigeon, O; Spanoghe, P				Ouattara, Jean Pierre Nableni; Louwagie, Johanna; Pigeon, Olivier; Spanoghe, Pieter			Comparison of the Laboratory Standard Washing Using CIPAC Washing Agent and the Domestic Washing on Three Recommended Types of Long-Lasting Insecticidal Mosquito Nets	PLOS ONE			English	Article							BED NETS; ANOPHELES-CULICIFACIES; ALPHA-CYPERMETHRIN; TREATED NETS; RESISTANCE; DELTAMETHRIN; EFFICACY; INTERCEPTOR(R); BIOEFFICACY; BEDNETS	Background: One of the best ways to prevent malaria is the use of insecticide-treated bed nets. Manufacturers pursue easier, safer and more efficient nets. Hence, many studies on the efficacy and wash resistance using World Health Organization standards have been reported. The commonly used detergent is "Savon de Marseille", because it closely resembles actually used soaps. At the 54th Collaborative International Pesticides Analytical Council (CIPAC) Technical Meeting in 2010, it was suggested to replace it by a standardized "CIPAC washing agent". The aim of this study was to investigate the difference between a laboratory hand washing simulation using the CIPAC washing agent (method-1) and a domestic washing (method-2) on different bed nets, as well as the effect of the drying process on the release of active ingredient. Methods: Interceptor (R), Permanet (R) 2.0 and Netprotect (R) nets were used in three treatments, each repeated 20 times. The first treatment included method-1 washing and indoor drying. The second treatment included method-2 washing and indoor drying. The third treatment used method-2 washing and UV-drying. The residual insecticide contents were determined using gas chromatography. Results: The washing procedure and the number of washes have a significant effect on the release of active ingredient. Statistically, the two washing methods have the same effect on removing the active ingredient from the Interceptor (R) and Permanet (R) 2.0 net, but a significantly different influence on the Netprotect (R) nets. The drying process has no significant effect on the insecticide. Conclusion: Both washing procedures affected the amount of insecticide remaining on nets independently of the impregnation technology. The active ingredient decreases with the number of washing cycles following an exponential or logarithmic model for coated nets. The laboratory hand washing simulation had more impact on the decrease of active ingredient content of the Netprotect (R) nets. All net types seemed to be effectively protected against UV-light.	[Ouattara, Jean Pierre Nableni; Spanoghe, Pieter] Univ Ghent, Lab Crop Protect Chem, Dept Crop Protect, B-9000 Ghent, Belgium; [Louwagie, Johanna] Univ Ghent, Dept Text, Zwijnaarde, Belgium; [Pigeon, Olivier] Walloon Agr Res Ctr CRA W, Agr & Nat Environm Dept, Plant Protect Prod & Biocides Physicochem & Resid, Gembloux, Belgium	Ghent University; Ghent University	Ouattara, JPN (corresponding author), Univ Ghent, Lab Crop Protect Chem, Dept Crop Protect, B-9000 Ghent, Belgium.	JeanPierreNableni.Ouattara@Ugent.be	Spanoghe, Pieter/B-9440-2015	Spanoghe, Pieter/0000-0002-8158-4401	Islamic Development Bank Merit Scholarship Program, Jeddah - Saudi Arabia	Islamic Development Bank Merit Scholarship Program, Jeddah - Saudi Arabia	The work was performed under research scholarship funded by the Islamic Development Bank Merit Scholarship Program, Jeddah - Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GUIDELINES LAB FIELD; Atieli FK, 2010, MALARIA J, V9; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; CIPAC - Collaborative International Pesticides Analytical Council, 2010, 7 JOINT CIPAC FAO WH; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; FAO, 2010, FATS FATT AC HUM NUT, P1; Faulde M, 2012, PARASITOL RES, V110, P2341, DOI 10.1007/s00436-011-2769-6; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x; Hassan V, 2010, ASIAN PAC J TROP MED, V3, P642, DOI 10.1016/S1995-7645(10)60155-1; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; ISO (International Organization for Standardization), 2007, 213482007 ISO; ISO - International Standard Organization, 2012, 63302012 ISO BSI; Jiang Y, 2009, BIOPHYS J, V96, P1151, DOI 10.1016/j.bpj.2008.10.030; Kayedi MH, 2008, T ROY SOC TROP MED H, V102, P811, DOI 10.1016/j.trstmh.2008.05.025; Kayedi MH, 2009, ANN TROP MED PARASIT, V103, P85, DOI 10.1179/136485909X385018; Kayedi MH, 2009, ACTA TROP, V111, P192, DOI 10.1016/j.actatropica.2009.04.002; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Koudou BG, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-172; Langeler C, 1996, B WORLD HEALTH ORGAN, V74, P325; Lee AJ, 2008, FIBER POLYM, V9, P101, DOI 10.1007/s12221-008-0017-1; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Liu PY, 2010, J ENVIRON SCI-CHINA, V22, P1123, DOI 10.1016/S1001-0742(09)60227-8; Mac Namara C, 2012, CHEM ENG SCI, V75, P14, DOI 10.1016/j.ces.2012.03.009; Morris SE, 2006, IND CROP PROD, V23, P9, DOI 10.1016/j.indcrop.2005.01.007; Msangi S, 2008, ACTA TROP, V107, P43, DOI 10.1016/j.actatropica.2008.03.014; Muller M, 2010, CIPAC WASH METHOD LN; NAJERA JA, 2002, MALARIA VECTOR CONTR, P1; Ouattara JPN, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-77; Pigeon O, 2011, 8 JOINT CIPAC FAO WH, P1; Pigeon O, 2011, 55 CIPAC TECHN M BEI, P1; Rafinejad J., 2008, Journal of Vector Borne Diseases, V45, P143; Rodler M, 2011, CIPAC M BEIJ, P1; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Skovmand O, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-114; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P647, DOI 10.1016/0035-9203(88)90547-0; Sreehari U, 2009, TROP MED INT HEALTH, V14, P597, DOI 10.1111/j.1365-3156.2009.02252.x; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; Vanlerberghe V, 2010, TROPICAL MED INT HLT, V15; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2007, 11 WHOPES WORK GROUP; WHO - World Health Organization, 2003, CURR STAT PROGR ISS; WHO - World Health Organization, 1993, B WORLD HEALTH ORGAN, P281; WHO - World Health Organization, VECT CONTR MAL; WHO - World Health Organization, 2001, SPEC NETT MAT REP IN; WHOPES - World Health Organization Pesticide Evaluation Scheme, 2006, REP WHOPES WORK GROU; World Health Organization, 2005, MULT STUD WOM HLTH D, P1; World Health Organization, 2008, 12 WHOPES WORK GROUP; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	51	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74824	10.1371/journal.pone.0074824	http://dx.doi.org/10.1371/journal.pone.0074824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130671	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900006
J	Poudyal, D; Cui, XL; Le, PM; Hofseth, AB; Windust, A; Nagarkatti, M; Nagarkatti, PS; Schetter, AJ; Harris, CC; Hofseth, LJ				Poudyal, Deepak; Cui, Xiangli; Le, Phuong Mai; Hofseth, Anne B.; Windust, Anthony; Nagarkatti, Mitzi; Nagarkatti, Prakash S.; Schetter, Aaron J.; Harris, Curtis C.; Hofseth, Lorne J.			A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GENE-EXPRESSION; COLORECTAL-CANCER; TUMOR INVASION; LUNG-CANCER; METASTASIS; MMP-9; MATRIX-METALLOPROTEINASE-7; GINSENOSIDE-RB2; PROLIFERATION	Metastasis of colon cancer cells increases the risk of colon cancer mortality. We have recently shown that American ginseng prevents colon cancer, and a Hexane extract of American Ginseng (HAG) has particularly potent anti-inflammatory and anticancer properties. Dysregulated microRNA (miR) expression has been observed in several disease conditions including colon cancer. Using global miR expression profiling, we observed increased miR-29b in colon cancer cells following exposure to HAG. Since miR-29b plays a role in regulating the migration of cancer cells, we hypothesized that HAG induces miR-29b expression to target matrix metalloproteinase-2 (MMP-2) thereby suppressing the migration of colon cancer cells. Results are consistent with this hypothesis. Our study supports the understanding that targeting MMP-2 by miR-29b is a mechanism by which HAG suppresses the migration of colon cancer cells.	[Poudyal, Deepak; Cui, Xiangli; Hofseth, Anne B.; Hofseth, Lorne J.] Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Cui, Xiangli] Shanxi Med Univ, Taiyuan, Shanxi, Peoples R China; [Le, Phuong Mai; Windust, Anthony] Natl Res Council Canada, Inst Natl Measurement Stand, Ottawa, ON K1A 0R6, Canada; [Nagarkatti, Mitzi; Nagarkatti, Prakash S.] Univ S Carolina, Sch Med, Columbia, SC USA; [Schetter, Aaron J.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Shanxi Medical University; National Research Council Canada; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hofseth, LJ (corresponding author), Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA.	hofseth@cop.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Nagarkatti, Mitzi/0000-0002-5977-5615	Center for CAM Research on Autoimmune and Inflammatory Diseases, NIH [1P01AT003961-01A1]; COBRE [P20RR17698-01]; NATIONAL CANCER INSTITUTE [ZIABC011492] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER	Center for CAM Research on Autoimmune and Inflammatory Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Center for CAM Research on Autoimmune and Inflammatory Diseases, NIH grant 1P01AT003961-01A1 (PN, LJH, MN), and the COBRE funded University of South Carolina Center for Colon Cancer Research, NIH grant P20RR17698-01 (Franklin Berger, Director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.175; Ara T, 1998, J PEDIATR SURG, V33, P1272, DOI 10.1016/S0022-3468(98)90167-1; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Cheng CC, 2005, CANCER CHEMOTH PHARM, V55, P531, DOI 10.1007/s00280-004-0919-6; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Cui XL, 2010, CARCINOGENESIS, V31, P1734, DOI 10.1093/carcin/bgq163; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Fujimoto J, 2001, EUR J GYNAECOL ONCOL, V22, P339; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jin Y, 2008, CARCINOGENESIS, V29, P2351, DOI 10.1093/carcin/bgn211; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung JS, 2010, BIOCHEM BIOPH RES CO, V397, P323, DOI 10.1016/j.bbrc.2010.05.117; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JY, 2002, PLANTA MED, V68, P119, DOI 10.1055/s-2002-20240; Kuo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031587; Lee SD, 2010, J MED FOOD, V13, P1, DOI 10.1089/jmf.2009.1142; Lee SD, 2009, J AM OIL CHEM SOC, V86, P1065, DOI 10.1007/s11746-009-1460-x; Liabakk NB, 1996, CANCER RES, V56, P190; Liu WK, 2000, LIFE SCI, V67, P1297, DOI 10.1016/S0024-3205(00)00720-7; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Lu MC, 2009, CELL BIOCHEM FUNCT, V27, P186, DOI 10.1002/cbf.1554; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MATSUNAGA H, 1990, CHEM PHARM BULL, V38, P3480, DOI 10.1248/cpb.38.3480; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Melo SA, 2013, NAT CELL BIOL, V15, P139, DOI 10.1038/ncb2684; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Ogawa M, 2005, HEPATO-GASTROENTEROL, V52, P875; Park MT, 1999, MOL CELLS, V9, P476; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pesta M, 2005, ANTICANCER RES, V25, P3387; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Poudyal D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/785739; Poudyal D, 2012, CANCER PREV RES, V5, P685, DOI 10.1158/1940-6207.CAPR-11-0421; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Steele Robert, 2010, Genes Cancer, V1, P381; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang CZ, 2007, PLANTA MED, V73, P669, DOI 10.1055/s-2007-981524; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041586; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yamada T, 2010, ANTICANCER RES, V30, P2693; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Ying L, 2005, CANCER RES, V65, P9132, DOI 10.1158/0008-5472.CAN-05-1358; Yoon JH, 2012, PHYTOMEDICINE, V19, P284, DOI 10.1016/j.phymed.2011.08.069; Yue Patrick Y. K., 2005, Angiogenesis, V8, P205, DOI 10.1007/s10456-005-9000-2; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	74	37	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75034	10.1371/journal.pone.0075034	http://dx.doi.org/10.1371/journal.pone.0075034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130681	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900016
J	Wilson, CB; McLaughlin, LD; Nair, A; Ebenezer, PJ; Dange, R; Francis, J				Wilson, C. Brad; McLaughlin, Leslie D.; Nair, Anand; Ebenezer, Philip J.; Dange, Rahul; Francis, Joseph			Inflammation and Oxidative Stress Are Elevated in the Brain, Blood, and Adrenal Glands during the Progression of Post-Traumatic Stress Disorder in a Predator Exposure Animal Model	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PLASMA-CORTISOL; COMBAT VETERANS; PLUS-MAZE; CYTOKINES; ANXIETY; RAT; MECHANISM; MITOCHONDRIAL; STIMULATION	This study sought to analyze specific pathophysiological mechanisms involved in the progression of post-traumatic stress disorder (PTSD) by utilizing an animal model. To examine PTSD pathophysiology, we measured damaging reactive oxygen species and inflammatory cytokines to determine if oxidative stress and inflammation in the brain, adrenal glands, and systemic circulation were upregulated in response to constant stress. Pre-clinical PTSD was induced in naive, male Sprague-Dawley rats via a predator exposure/psychosocial stress regimen. PTSD group rats were secured in Plexiglas cylinders and placed in a cage with a cat for one hour on days 1 and 11 of a 31-day stress regimen. In addition, PTSD group rats were subjected to psychosocial stress whereby their cage cohort was changed daily. This model has been shown to cause heightened anxiety, exaggerated startle response, impaired cognition, and increased cardiovascular reactivity, all of which are common symptoms seen in humans with PTSD. At the conclusion of the predator exposure/psychosocial stress regimen, the rats were euthanized and their brains were dissected to remove the hippocampus, amygdala, and pre-frontal cortex (PFC), the three areas commonly associated with PTSD development. The adrenal glands and whole blood were also collected to assess systemic oxidative stress. Analysis of the whole blood, adrenal glands, and brain regions revealed oxidative stress increased during PTSD progression. In addition, examination of pro-inflammatory cytokine (PIC) mRNA and protein demonstrated neurological inflammatory molecules were significantly upregulated in the PTSD group vs. controls. These results indicate oxidative stress and inflammation in the brain, adrenal glands, and systemic circulation may play a critical role in the development and further exacerbation of PTSD. Thus, PTSD may not be solely a neurological pathology but may progress as a systemic condition involving multiple organ systems.	[Wilson, C. Brad; Nair, Anand; Ebenezer, Philip J.; Dange, Rahul; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [McLaughlin, Leslie D.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Wilson, CB (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	jfrancis@vetmed.lsu.edu			Louisiana State University School of Veterinary Medicine corps grant	Louisiana State University School of Veterinary Medicine corps grant	This work was funded by the Louisiana State University School of Veterinary Medicine corps grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Alexopoulos G.S., 2012, J AFFECT DISORD; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Baker DG, 1999, AM J PSYCHIAT, V156, P585; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; BLANCHARD RJ, 1975, J COMP PHYSIOL PSYCH, V88, P81, DOI 10.1037/h0076213; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Cardinale JP, 2010, HYPERTENSION, V56, P437, DOI 10.1161/HYPERTENSIONAHA.110.154567; Chrousos GP, 2000, ANN NY ACAD SCI, V917, P38, DOI 10.1111/j.1749-6632.2000.tb05371.x; Dansie EJ, 2012, PSYCHOSOMATICS, V53, P250, DOI 10.1016/j.psym.2011.08.007; Diehl LA, 2012, NEUROCHEM RES, V37, P700, DOI 10.1007/s11064-011-0660-6; Dunn AJ, 2000, ANN NY ACAD SCI, V917, P608, DOI 10.1111/j.1749-6632.2000.tb05426.x; Edmondson D, 2013, PROG CARDIOVASC DIS, V55, P548, DOI 10.1016/j.pcad.2013.03.004; Elks CM, 2010, CURR HYPERTENS REP, V12, P99, DOI 10.1007/s11906-010-0096-4; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Hu SX, 1998, BIOCHEM PHARMACOL, V56, P285, DOI 10.1016/S0006-2952(98)00162-2; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; KRAHN DD, 1990, BIOL PSYCHIAT, V27, P1094, DOI 10.1016/0006-3223(90)90046-5; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Lukaschek K, 2013, J PSYCHOSOM RES, V74, P340, DOI 10.1016/j.jpsychores.2012.12.011; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; Mazjoub JA, 2006, EUROPEAN J ENDOCRINO, V155, pS71; McCann SM, 2000, ANN NY ACAD SCI, V917, P4, DOI 10.1111/j.1749-6632.2000.tb05368.x; MOKUNO K, 1994, J NEUROCHEM, V63, P612; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Pall ML, 2001, ANN NY ACAD SCI, V933, P323; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Rohleder N, 2004, BIOL PSYCHIAT, V55, P745, DOI 10.1016/j.biopsych.2003.11.018; Salgo MG, 1996, ARCH BIOCHEM BIOPHYS, V333, P482, DOI 10.1006/abbi.1996.0418; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Sondergaard HP, 2004, CLIN CHIM ACTA, V342, P93, DOI 10.1016/j.cccn.2003.12.019; Stein MB, 1997, BIOL PSYCHIAT, V42, P680, DOI 10.1016/S0006-3223(96)00489-1; SUTHERLAND SM, 1994, PSYCHIAT CLIN N AM, V17, P409; Turnbull AV, 1998, ANN NY ACAD SCI, V840, P434, DOI 10.1111/j.1749-6632.1998.tb09582.x; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; Vidovic A, 2011, PSYCHONEUROENDOCRINO, V36, P161, DOI 10.1016/j.psyneuen.2010.08.005; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007	49	127	130	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76146	10.1371/journal.pone.0076146	http://dx.doi.org/10.1371/journal.pone.0076146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130763	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900069
J	Zhong, H; Sanchez, C; Spitrzer, D; Plambeck-Suess, S; Gibbs, J; Hawkins, WG; Denardo, D; Gao, F; Pufahl, RA; Lockhart, AC; Xu, M; Linehan, D; Weber, J; Wang-Gillam, A				Zhong, Hua; Sanchez, Cesar; Spitrzer, Dirk; Plambeck-Suess, Stacy; Gibbs, Jesse; Hawkins, Williams G.; Denardo, David; Gao, Feng; Pufahl, Robert A.; Lockhart, Albert C.; Xu, Mai; Linehan, David; Weber, Jason; Wang-Gillam, Andrea			Synergistic Effects of Concurrent Blockade of PI3K and MEK Pathways in Pancreatic Cancer Preclinical Models	PLOS ONE			English	Article							PHASE-III TRIAL; AZD6244 ARRY-142886; BREAST-CANCER; INHIBITOR GDC-0941; ANTITUMOR-ACTIVITY; PLASMA-MEMBRANE; IN-VIVO; RAS; ACTIVATION; KINASE	Patients with pancreatic cancer have dismal prognoses, and novel therapies are urgently needed. Mutations of the KRAS oncogene occur frequently in pancreatic cancer and represent an attractive target. Direct targeting of the predominant KRAS pathways have been challenging and research into therapeutic strategies have been now refocused on pathways downstream of KRAS, phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK [MEK]). We hypothesized that concurrent inhibition of the PI3K and MEK pathways would result in synergistic antitumor activity, as it would circumvent the compensatory feedback loop between the two pathways. We investigated the combined effect of the PI3K inhibitor, GDC0941, and the MEK inhibitor, AZD6244, on cell viability, apoptosis and cell signaling in a panel of pancreatic cancer cell lines. An in vivo analysis was conducted on pancreatic cancer xenografts. While BxPC-3 (KRAS wild type) and MIA PaCa-2 (KRAS mutated) cell lines were sensitive to GDC0941 and AZD6244 as single agents, synergistic inhibition of tumor cell growth and induction of apoptosis were observed in both cell lines when the two drugs were combined. Interestingly, phosphorylation of the cap-dependent translational components, 4E-binding protein (p-4E-BP1) and S6 was found to be closely associated with sensitivity to GDC0941 and AZD6244. In BxPC-3 cell xenografts, survival differences were observed between the control and the AZD6244, GDC0941, and combination groups. Our study provides the rationale for concurrent targeting of the PI3K and MEK pathways, regardless of KRAS status, and suggests that phosphorylation of 4E-BP1and S6 can serve as a predictive biomarker for response to treatment.	[Zhong, Hua; Denardo, David; Pufahl, Robert A.; Lockhart, Albert C.; Xu, Mai; Weber, Jason; Wang-Gillam, Andrea] Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA; [Sanchez, Cesar] Pontificia Univ Catolica Chile, Dept Hematol Oncol, Sch Med, Santiago, Chile; [Spitrzer, Dirk; Plambeck-Suess, Stacy; Gibbs, Jesse; Hawkins, Williams G.; Linehan, David] Washington Univ, Dept Surg, St Louis, MO USA; [Hawkins, Williams G.; Gao, Feng; Lockhart, Albert C.; Linehan, David; Wang-Gillam, Andrea] Washington Univ, Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Pontificia Universidad Catolica de Chile; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Wang-Gillam, A (corresponding author), Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA.	awang@dom.wustl.edu		Sanchez Rojel, cesar/0000-0001-7512-6474; DeNardo, David/0000-0002-3655-5783; Gao, Feng/0000-0002-1425-1623; Weber, Jason/0000-0002-1069-6983	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (MCATS) [UL1TR000448];  [KL2TR000450]; NATIONAL CANCER INSTITUTE [R21CA182701, P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (MCATS); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The publication was supported by the Washington University Institute of Clinical and Translational Sciences Grant UL1TR000448 from the National Center for Advancing Translational Sciences (MCATS) and KL2TR000450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Benavente S, 2009, INT J RADIAT ONCOL, V75, P1316, DOI 10.1016/j.ijrobp.2009.01.004; Bennouna J, 2011, INVEST NEW DRUG, V29, P1021, DOI 10.1007/s10637-010-9392-8; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chang Q, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-515; Chao YK, 2012, J SURG ONCOL, V105, P288, DOI 10.1002/jso.22097; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Darb-Esfahani S, 2009, J CANCER RES CLIN, V135, P933, DOI 10.1007/s00432-008-0529-5; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hainsworth JD, 2010, J THORAC ONCOL, V5, P1630, DOI 10.1097/JTO.0b013e3181e8b3a3; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Korkolopoulou P, 2012, HISTOPATHOLOGY, V61, P293, DOI 10.1111/j.1365-2559.2012.04236.x; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Serra V, 2013, J CLIN INVEST, V123, P2551, DOI 10.1172/JCI66343; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Williams TM, 2012, MOL CANCER THER, V11, P1193, DOI 10.1158/1535-7163.MCT-12-0098; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343	37	26	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77243	10.1371/journal.pone.0077243	http://dx.doi.org/10.1371/journal.pone.0077243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130864	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900129
J	Anderson, P; Carrillo-Galvez, AB; Garcia-Perez, A; Cobo, M; Martin, F				Anderson, Per; Belen Carrillo-Galvez, Ana; Garcia-Perez, Angelica; Cobo, Marien; Martin, Francisco			CD105 (Endoglin)-Negative Murine Mesenchymal Stromal Cells Define a New Multipotent Subpopulation with Distinct Differentiation and Immunomodulatory Capacities	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; ADULT STEM-CELLS; BONE-MARROW; TGF-BETA; EXPERIMENTAL COLITIS; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; DENDRITIC CELLS; IN-VITRO; ENDOGLIN	Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a promising therapy for regenerative medicine and autoimmunity. Both mouse and human MSCs ameliorate autoimmune disease in syn-, allo-and xenogeneic settings. However, MSC preparations are heterogeneous which impairs their therapeutic efficacy and endorses variability between experiments. This heterogeneity has also been a main hurdle in translating experimental MSC data from mouse models to human patients. The objective of the present manuscript has been to further characterize murine MSCs (mMSCs) with the aim of designing more efficient and specific MSC-based therapies. We have found that mMSCs are heterogeneous for endoglin (CD105) expression and that this heterogeneity is not due to different stages of MSC differentiation. CD105 is induced on a subpopulation of mMSCs early upon in vitro culture giving rise to CD105(+) and CD105(-) MSCs. CD105(+) and CD105(-) mMSCs represent independent subpopulations that maintain their properties upon several passages. CD105 expression on CD105(+) mMSCs was affected by passage number and cell confluency while CD105(-) mMSCs remained negative. The CD105(+) and CD105(-) mMSC subpopulations had similar growth potential and expressed almost identical mMSC markers (CD29(+)CD44(+)Sca1 (+) MHC-I+ and CD45(-)CD11b(-)CD31(-)) but varied in their differentiation and immunoregulatory properties. Interestingly, CD105-mMSCs were more prone to differentiate into adipocytes and osteocytes and suppressed the proliferation of CD4(+) T cells more efficiently compared to CD105+ mMSCs. Based on these studies we propose to redefine the phenotype of mMSCs based on CD105 expression.	[Anderson, Per; Belen Carrillo-Galvez, Ana; Garcia-Perez, Angelica; Cobo, Marien; Martin, Francisco] Univ Granada, Dept Human DNA Variabil, Ctr Genom & Oncol Res, GENYO,Pfizer,Andalusian Reg Govt,PTS Granada, Granada, Spain	Pfizer; University of Granada	Anderson, P (corresponding author), Univ Granada, Dept Human DNA Variabil, Ctr Genom & Oncol Res, GENYO,Pfizer,Andalusian Reg Govt,PTS Granada, Granada, Spain.	per.anderson@genyo.es	Martin, Francisco/K-8763-2014	Martin, Francisco/0000-0003-1961-8612; Anderson, Per/0000-0002-0958-7990	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PI12/01390, PS09/00340]; Consejer a de Innovacion Ciencia y Empresa [P09-CTS-04532, PAIDI-Bio-326]; Consejer a de Salud from the Junta de Andalucia [PI0001/2009]; FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Miguel Servet Contract [CP09/00228]; Fondo Europeo de Desarollo Regional (FEDER) from the European Union); Fundacion Progreso y Salud (Consejer a de Salud - Junta de Andalucia)	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union; Consejer a de Innovacion Ciencia y Empresa(Junta de Andalucia); Consejer a de Salud from the Junta de Andalucia(Junta de Andalucia); FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Miguel Servet Contract; Fondo Europeo de Desarollo Regional (FEDER) from the European Union); Fundacion Progreso y Salud (Consejer a de Salud - Junta de Andalucia)(Junta de Andalucia)	This work has been financed by Fondo de Investigaciones Sanitarias ISCIII (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union, through the research grants No PI12/01390 (P. A) and No PS09/00340 (F. M), by the Consejer a de Innovacion Ciencia y Empresa (grants No P09-CTS-04532 and PAIDI-Bio-326) and Consejer a de Salud (grant No PI0001/2009) from the Junta de Andalucia and FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia 2007-2013 to F. M. P. A. has a Miguel Servet Contract (CP09/00228) cofinanced by the Fondo Europeo de Desarollo Regional (FEDER) from the European Union). M. C. and F. M. are funded by Fundacion Progreso y Salud (Consejer a de Salud - Junta de Andaluc a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2013, GUT, V62, P1131, DOI 10.1136/gutjnl-2012-302152; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Berg DT, 2007, J BIOL CHEM, V282, P36837, DOI 10.1074/jbc.M706909200; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Bernardo ME, 2012, ANN NY ACAD SCI, V1266, P107, DOI 10.1111/j.1749-6632.2012.06667.x; Blanco FJ, 2008, CIRC RES, V103, P1383, DOI 10.1161/CIRCRESAHA.108.176552; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chang CB, 2013, OSTEOARTHR CARTILAGE, V21, P190, DOI 10.1016/j.joca.2012.10.005; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Cobo M, 2012, CELL TRANSPLANT; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Connick P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-62; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Divya MS, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt148; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Fonsatti E, 2000, CLIN CANCER RES, V6, P2037; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Herreros MD, 2012, DIS COLON RECTUM, V55, P762, DOI 10.1097/DCR.0b013e318255364a; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishimura D, 2008, TOHOKU J EXP MED, V216, P149, DOI 10.1620/tjem.216.149; Jiang T, 2010, BIOMATERIALS, V31, P3564, DOI 10.1016/j.biomaterials.2010.01.050; Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118; KAWASHIMA I, 1991, FEBS LETT, V283, P199, DOI 10.1016/0014-5793(91)80587-S; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Levi B, 2011, J BIOL CHEM, V286, P39497, DOI 10.1074/jbc.M111.256529; Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359; Li CG, 2003, ANTICANCER RES, V23, P1189; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Perez-Gomez E, 2005, ONCOGENE, V24, P4450, DOI 10.1038/sj.onc.1208644; Perez-Simon JA, 2011, HAEMATOL-HEMATOL J, V96, P1072, DOI 10.3324/haematol.2010.038356; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Rosu-Myles M, 2010, CYTOTHERAPY, V12, P818, DOI 10.3109/14653249.2010.501785; Russell K. C., 2013, TISSUE ENG A; Salazar KD, 2009, AM J PHYSIOL-LUNG C, V297, pL1002, DOI 10.1152/ajplung.90347.2008; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Spiropoulos A, 2011, J CELL MOL MED, V15, P1983, DOI 10.1111/j.1582-4934.2010.01157.x; Sugiyama Y, 2012, INT IMMUNOL, V24, P253, DOI 10.1093/intimm/dxr126; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408; Wall ME, 2007, TISSUE ENG, V13, P1291, DOI 10.1089/ten.2006.0275; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	63	90	95	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76979	10.1371/journal.pone.0076979	http://dx.doi.org/10.1371/journal.pone.0076979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124603	Green Submitted, Green Published, gold			2022-12-27	WOS:000325489100160
J	Farkas, I; Vastagh, C; Sarvari, M; Liposits, Z				Farkas, Imre; Vastagh, Csaba; Sarvari, Miklos; Liposits, Zsolt			Ghrelin Decreases Firing Activity of Gonadotropin-Releasing Hormone (GnRH) Neurons in an Estrous Cycle and Endocannabinoid Signaling Dependent Manner	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MESSENGER-RNA EXPRESSION; GAMMA-AMINOBUTYRIC-ACID; LUTEINIZING-HORMONE; GROWTH-HORMONE; ACYLATED PEPTIDE; GABAERGIC TRANSMISSION; UNACYLATED GHRELIN; MULTIUNIT ACTIVITY; PULSE-GENERATOR	The orexigenic peptide, ghrelin is known to influence function of GnRH neurons, however, the direct effects of the hormone upon these neurons have not been explored, yet. The present study was undertaken to reveal expression of growth hormone secretagogue receptor (GHS-R) in GnRH neurons and elucidate the mechanisms of ghrelin actions upon them. Ca2+-imaging revealed a ghrelin-triggered increase of the Ca2+-content in GT1-7 neurons kept in a steroid-free medium, which was abolished by GHS-R-antagonist JMV2959 (10 mu M) suggesting direct action of ghrelin. Estradiol (1nM) eliminated the ghrelin-evoked rise of Ca2+-content, indicating the estradiol dependency of the process. Expression of GHS-R mRNA was then confirmed in GnRH-GFP neurons of transgenic mice by single cell RT-PCR. Firing rate and burst frequency of GnRH-GFP neurons were lower in metestrous than proestrous mice. Ghrelin (40nM-4 mu M) administration resulted in a decreased firing rate and burst frequency of GnRH neurons in metestrous, but not in proestrous mice. Ghrelin also decreased the firing rate of GnRH neurons in males. The ghrelin-evoked alterations of the firing parameters were prevented by JMV2959, supporting the receptor-specific actions of ghrelin on GnRH neurons. In metestrous mice, ghrelin decreased the frequency of GABAergic mPSCs in GnRH neurons. Effects of ghrelin were abolished by the cannabinoid receptor type-1 (CB1) antagonist AM251 (1 mu M) and the intracellularly applied DAG-lipase inhibitor THL (10 mu M), indicating the involvement of retrograde endocannabinoid signaling. These findings demonstrate that ghrelin exerts direct regulatory effects on GnRH neurons via GHS-R, and modulates the firing of GnRH neurons in an ovarian-cycle and endocannabinoid dependent manner.	[Farkas, Imre; Vastagh, Csaba; Sarvari, Miklos; Liposits, Zsolt] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Dept Neurosci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Farkas, I (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	farkas.imre@koki.mta.hu	Liposits, Zsolt/K-8145-2019	Liposits, Zsolt/0000-0002-3508-2750	National Science Foundation of Hungary [OTKA K100722]; National Development Agency of Hungary [NFU-BONUS-HU08/2-2011-0006]; European Community [245009]	National Science Foundation of Hungary; National Development Agency of Hungary; European Community(European Commission)	This research was supported by the National Science Foundation of Hungary (OTKA K100722) and the National Development Agency of Hungary (NFU-BONUS-HU08/2-2011-0006). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Banks WA, 2008, PEPTIDES, V29, P2061, DOI 10.1016/j.peptides.2008.07.001; Banks WA, 2012, ANN NY ACAD SCI, V1264, P13, DOI 10.1111/j.1749-6632.2012.06568.x; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bosch MA, 2013, MOL CELL ENDOCRINOL, V367, P85, DOI 10.1016/j.mce.2012.12.021; Bramley JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022721; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Castellano JM, 2010, BRAIN RES, V1364, P129, DOI 10.1016/j.brainres.2010.08.057; Chen PL, 2009, J NEUROSCI, V29, P9809, DOI 10.1523/JNEUROSCI.2509-09.2009; Christian CA, 2005, P NATL ACAD SCI USA, V102, P15682, DOI 10.1073/pnas.0504270102; Christian CA, 2007, J NEUROSCI, V27, P1913, DOI 10.1523/JNEUROSCI.4738-06.2007; Chu Z, 2012, J NEUROENDOCRINOL, V24, P1065, DOI 10.1111/j.1365-2826.2012.02313.x; Chu ZG, 2005, J NEUROSCI, V25, P5740, DOI 10.1523/JNEUROSCI.0913-05.2005; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Constantin S, 2012, ENDOCRINOLOGY, V153, P3758, DOI 10.1210/en.2012-1126; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; DeFazio RA, 2002, MOL ENDOCRINOL, V16, P2872, DOI 10.1210/me.2002-0163; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Ducret E, 2010, ENDOCRINOLOGY, V151, P2223, DOI 10.1210/en.2009-1480; Farkas I, 2010, ENDOCRINOLOGY, V151, P5818, DOI 10.1210/en.2010-0638; Fernandez-Fernandez R, 2007, REPRODUCTION, V133, P1223, DOI 10.1530/REP-06-0227; Fernandez-Fernandez R, 2005, NEUROENDOCRINOLOGY, V82, P245, DOI 10.1159/000092753; Forbes S, 2009, NEUROSCI LETT, V460, P143, DOI 10.1016/j.neulet.2009.05.060; Garcia-Galiano D, 2012, AM J PHYSIOL-ENDOC M, V303, pE1252, DOI 10.1152/ajpendo.00250.2012; Gauna C, 2004, J CLIN ENDOCR METAB, V89, P5035, DOI 10.1210/jc.2004-0363; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Glanowska KM, 2011, J NEUROPHYSIOL, V106, P3073, DOI 10.1152/jn.00046.2011; Halem HA, 2005, NEUROENDOCRINOLOGY, V81, P339, DOI 10.1159/000088796; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; Herbison AE, 2009, J PHYSIOL-LONDON, V587, P5025, DOI 10.1113/jphysiol.2009.179838; Herde MK, 2011, ENDOCRINOLOGY, V152, P3832, DOI 10.1210/en.2011-1228; Himmerich H, 2010, J PSYCHIATR PRACT, V16, P82, DOI 10.1097/01.pra.0000369969.87779.1c; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hrabovszky E, 2000, ENDOCRINOLOGY, V141, P3506, DOI 10.1210/en.141.9.3506; Hrabovszky E, 2001, ENDOCRINOLOGY, V142, P3261, DOI 10.1210/en.142.7.3261; Jasoni CL, 2007, J NEUROSCI, V27, P860, DOI 10.1523/JNEUROSCI.3579-06.2007; Jasoni CL, 2005, NEUROENDOCRINOLOGY, V82, P320, DOI 10.1159/000093155; KIMURA F, 1991, NEUROENDOCRINOLOGY, V53, P97, DOI 10.1159/000125704; Kluge M, 2007, J CLIN ENDOCR METAB, V92, P3202, DOI 10.1210/jc.2007-0593; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Lanfranco F, 2008, J CLIN ENDOCR METAB, V93, P3633, DOI 10.1210/jc.2008-0049; Lanfranco F, 2010, FRONT HORM RES, V38, P206, DOI 10.1159/000318512; Lebrethon MC, 2007, J NEUROENDOCRINOL, V19, P181, DOI 10.1111/j.1365-2826.2006.01518.x; Lee K, 2012, J NEUROENDOCRINOL, V24, P1476, DOI 10.1111/j.1365-2826.2012.02360.x; Lim CT, 2013, MOL CELL ENDOCRINOL, V365, P303, DOI 10.1016/j.mce.2012.11.007; Maletinska L, 2011, MOL CELL ENDOCRINOL, V343, P55, DOI 10.1016/j.mce.2011.06.006; MARTIN GB, 1987, EXP BRAIN RES, V67, P469; Martini AC, 2006, ENDOCRINOLOGY, V147, P2374, DOI 10.1210/en.2005-1422; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Mircea CN, 2007, J OBSTET GYNAECOL CA, V29, P887, DOI 10.1016/S1701-2163(16)32661-5; Moenter SM, 2005, ENDOCRINOLOGY, V146, P5374, DOI 10.1210/en.2005-0788; Moenter SM, 2003, FRONT NEUROENDOCRIN, V24, P79, DOI 10.1016/S0091-3022(03)00013-X; Moenter SM, 2010, BRAIN RES, V1364, P10, DOI 10.1016/j.brainres.2010.09.066; MORI Y, 1991, NEUROENDOCRINOLOGY, V53, P392, DOI 10.1159/000125746; Murakami N, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740283; Nakahara T, 2007, J PSYCHIATR RES, V41, P814, DOI 10.1016/j.jpsychires.2006.07.021; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Noel SD, 2009, MOL ENDOCRINOL, V23, P349, DOI 10.1210/me.2008-0299; Nunemaker CS, 2003, ENDOCRINOLOGY, V144, P823, DOI 10.1210/en.2002-220585; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qiu J, 2003, J NEUROSCI, V23, P9529; Qiu J, 2007, MOL PHARMACOL, V72, P885, DOI 10.1124/mol.107.038083; Repaci A, 2011, MOL CELL ENDOCRINOL, V340, P70, DOI 10.1016/j.mce.2011.02.022; Romano N, 2008, ENDOCRINOLOGY, V149, P5335, DOI 10.1210/en.2008-0424; Romano N, 2012, J NEUROENDOCRINOL, V24, P1296, DOI 10.1111/j.1365-2826.2012.02342.x; Ronnekleiv OK, 2012, J NEUROENDOCRINOL, V24, P122, DOI 10.1111/j.1365-2826.2011.02160.x; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Schmid DA, 2005, NEUROPSYCHOPHARMACOL, V30, P1187, DOI 10.1038/sj.npp.1300670; Sullivan SD, 2003, J NEUROSCI, V23, P8578; Suter KJ, 2000, ENDOCRINOLOGY, V141, P3731, DOI 10.1210/en.141.10.3731; Suter KJ, 2000, ENDOCRINOLOGY, V141, P412, DOI 10.1210/en.141.1.412; TASKER JG, 1993, J PHYSIOL-LONDON, V469, P179, DOI 10.1113/jphysiol.1993.sp019810; Tena-Sempere M, 2008, VITAM HORM, V77, P285, DOI 10.1016/S0083-6729(06)77012-1; Terasawa E, 2012, FRONT NEUROENDOCRIN, V33, P364, DOI 10.1016/j.yfrne.2012.08.001; THIERY JC, 1981, NEUROENDOCRINOLOGY, V32, P217, DOI 10.1159/000123162; Usdan Lisa S, 2008, Endocr Pract, V14, P1055; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Watanabe M, 2009, BIOL REPROD, V81, P327, DOI 10.1095/biolreprod.108.074583; Watterson KR, 2013, NEUROSIGNALS, V21, P28, DOI 10.1159/000334144; WILSON RC, 1984, NEUROENDOCRINOLOGY, V39, P256, DOI 10.1159/000123988; Yin C, 2008, J NEUROENDOCRINOL, V20, P566, DOI 10.1111/j.1365-2826.2008.01697.x; Zhang C, 2007, J NEUROSCI, V27, P10153, DOI 10.1523/JNEUROSCI.1657-07.2007; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	92	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e78178	10.1371/journal.pone.0078178	http://dx.doi.org/10.1371/journal.pone.0078178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124622	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325489100180
J	Kroezen, M; van Dijk, L; Groenewegen, PP; Francke, AL				Kroezen, Marieke; van Dijk, Liset; Groenewegen, Peter P.; Francke, Anneke L.			Knowledge Claims, Jurisdictional Control and Professional Status: The Case of Nurse Prescribing	PLOS ONE			English	Article							ANGLO-SAXON COUNTRIES; HEALTH-CARE WORKFORCE; LEGITIMACY CLAIMS; WORKPLACE; PERSPECTIVES; MEDICINES; ORDER; POWER	Over the past decades, professional boundaries in health care have come under pressure, and the expansion of prescriptive authority to include nurses touches on issues of professional domains and interprofessional competition. Knowledge claims play an important role in achieving jurisdictional control. Knowledge can take on multiple forms, ranging from indeterminate to technical (I/T ratio) and from everyday to exclusive knowledge. To investigate the interrelatedness of jurisdiction, knowledge claims and professional status, we examine which knowledge claims were made by the medical and nursing professions in the Netherlands to secure or obtain, respectively, jurisdictional control over prescribing, and which form this knowledge took. The study is based on thirteen semi-structured stakeholder interviews and an extensive document analysis. We found that the nursing profession in its knowledge claims strongly emphasized the technicality and everyday knowledge character of the prescribing task, by asserting that nurses were already prescribing medicines, albeit on an illegal basis. Their second claim focused on the indeterminate knowledge skills of nurses and stated that nurse prescribing would do justice to nurses' skills and expertise. This is a strong claim in a quest for (higher) professional status. Results showed that the medical profession initially proclaimed that prescribing should be reserved for doctors as it is a task requiring medical knowledge, i.e. indeterminate knowledge. Gradually, however, the medical profession adjusted its claims and tried to reduce nurse prescribing to a task almost exclusively based on technicality knowledge, among others by stating that nurses could prescribe in routine cases, which would generate little professional status. By investigating the form that professional knowledge claims took, this study was able to show the interconnectedness of jurisdictional control, knowledge claims and professional status. Knowledge claims are not mere rhetoric, but actively influence the everyday realities of professional status, interprofessional competition and jurisdictional division between professions.	[Kroezen, Marieke; van Dijk, Liset; Groenewegen, Peter P.; Francke, Anneke L.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Groenewegen, Peter P.] Univ Utrecht, Dept Sociol, Utrecht, Netherlands; [Groenewegen, Peter P.] Univ Utrecht, Dept Human Geog, Utrecht, Netherlands; [Francke, Anneke L.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res EMGO, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Utrecht University; Utrecht University; Vrije Universiteit Amsterdam	Kroezen, M (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.	M.Kroezen@nivel.nl		Groenewegen, Peter/0000-0003-2127-8442	Dutch Ministry of Education, Culture and Science	Dutch Ministry of Education, Culture and Science	This study was funded by a grant to NIVEL from the Dutch Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts J, 2009, HEALTH AFFAIR, V28, P404, DOI 10.1377/hlthaff.28.2.404; Abbott A., 1988, SYSTEM PROFESSIONS E; ADAMSON BJ, 1995, J ADV NURS, V21, P172, DOI 10.1046/j.1365-2648.1995.21010172.x; Allen D, 1997, SOCIOL HEALTH ILL, V19, P498; [Anonymous], 2009, REACT KNMG EV WET BI; Apesoa-Varano EC, 2011, QUAL HEALTH RES, V21, P1469, DOI 10.1177/1049732311412788; Associatie van Eerste, 2007, EADV MAGAZINE, V22, P27; Associatie van Eerste, 2006, EADV MAGAZINE, V2, P94; Ball J., 2009, IMPLEMENTING NURSE P; Bechky BA, 2003, AM J SOCIOL, V109, P720, DOI 10.1086/379527; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; BUCKLEY P, 2006, PHARM J, V277, P394; Cooper R, 2008, J AMBUL CARE MANAG, V31, P244, DOI 10.1097/01.JAC.0000324670.91153.b4; Drennan J., 2009, NATL INDEPENDENT EVA; Fisher R, 2010, INT J NURS PRACT, V16, P579, DOI 10.1111/j.1440-172X.2010.01884.x; Freidson E., 1988, PROFESSION MED STUDY; Gerrish Kate, 2003, Nurs Inq, V10, P103, DOI 10.1046/j.1440-1800.2003.00168.x; Glucksmann MA, 2009, SOCIOLOGY, V43, P878, DOI 10.1177/0038038509340727; Goundrey-Smith S., 2008, PRINCIPLES ELECT PRE, P119; Green J., 2018, QUALITATIVE METHODS, VFourth; Hendriks AC, 2011, MEDISCH CONTACT, V66, P555; Hirschkorn KA, 2006, SOCIOL HEALTH ILL, V28, P533, DOI 10.1111/j.1467-9566.2006.00506.x; Huisartsen Vereniging Landelijke, 2010, LHV BEZW TEG VOORSCH, P8; Implementatie Commissie Opleidingscontinuum en Taakherschikking, 2003, ZORG MORG FLEX SAM C; Jamous H., 1970, PROFESSIONS PROFESSI; Kaljouw M, 2010, NRC HANDELSBLAD; Kennedy J, 2002, WELOVERWOGEN DOOD; Koninklijke, 2011, NED MAATSCH BEV GEN; Koninklijke, 2006, MEDISCH CONTACT, V18, P728; Koninklijke, 2006, MEDISCH CONTACT, V18, P761; Kroezen M, 2012, INT J NURS STUD, V49, P1002, DOI 10.1016/j.ijnurstu.2012.02.002; Kroezen M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-127; Lewis R, 2001, NURSE LED PRIMARY CA; MAXQDA, 2007, VERBI SOFTW; McCann T V, 2002, J Psychiatr Ment Health Nurs, V9, P175, DOI 10.1046/j.1365-2850.2002.00454.x; Mclaughlin J, 1998, SOCIOL REV, V46, P781, DOI 10.1111/1467-954X.00140; Nancarrow SA, 2005, SOCIOL HEALTH ILL, V27, P897, DOI 10.1111/j.1467-9566.2005.00463.x; NILSSON M, 1994, LANCET, V344, P1077; Pickard S, 2009, SOCIOLOGY, V43, P250, DOI 10.1177/0038038508101164; Plonczynski D, 2003, NURSE PRESCRIBING, V1, P170; PORTER S, 1992, J ADV NURS, V17, P720, DOI 10.1111/j.1365-2648.1992.tb01970.x; Raadvoor de Volksgezondheid en Zorg, 2002, TAAKH GEZ; Reed MI, 1996, ORGAN STUD, V17, P573, DOI 10.1177/017084069601700402; Sanders T, 2008, SOCIOL HEALTH ILL, V30, P289, DOI 10.1111/j.1467-9566.2007.01052.x; Snelgrove S, 2000, J ADV NURS, V31, P661, DOI 10.1046/j.1365-2648.2000.01321.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Traynor M, 2010, SOC SCI MED, V71, P1506, DOI 10.1016/j.socscimed.2010.07.029; Van der Peet R, 2010, TIJDSCHRIFT VERPLEEG, V120, P45; Van der Peet R., 2010, TIJDSCHRIFT VERPLEEG, V120, P50; Van Meersbergen W., 2011, WORLD MED J, V57, P126; van Volksgezondheid Ministerie WeS, 2012, MEVABOA3109304 VOLKS; Verpleegkundigen Verzorgenden. Nederland, 2013, VOORSCHR VERPL JAN 2	52	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77279	10.1371/journal.pone.0077279	http://dx.doi.org/10.1371/journal.pone.0077279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124613	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100170
J	Sapoznikov, D; Elhalel, MD; Rubinger, D				Sapoznikov, Dan; Elhalel, Michal Dranitzki; Rubinger, Dvora			Heart Rate Response to Blood Pressure Variations: Sympathetic Activation versus Baroreflex Response in Patients with End-Stage Renal Disease	PLOS ONE			English	Article							FEEDFORWARD NEURAL REGULATION; SPONTANEOUS ARTERIAL-PRESSURE; NERVE ACTIVITY; TRANSPLANT PATIENTS; RATE FLUCTUATIONS; CONSCIOUS RATS; SENSITIVITY; HUMANS; HYPERTENSION; CALCINEURIN	Background: Continuous systolic blood pressure (SBP) and interbeat intervals (IBI) recordings reveal sequences of consecutive beats in which SBP and heart rate change in opposite direction, representing negative feedback baroreflex mechanisms, as well as sequences in which SBP and heart rate change in the same direction (non-baroreflex), believed to represent feedforward control mechanisms. The present study was undertaken to assess the relationship between baroreflex and non-baroreflex sequences in end stage renal insufficiency. Methodology/Principal Findings: Continuous beat-to-beat SBP and IBI monitoring was performed in patients on chronic hemodialysis (HD, n=72), in age-matched patients after renal transplantation (TX, n=41) and healthy (control) individuals (C, n=34). The proportion of baroreflex and nonbaroreflex episodes and the b coefficients (the regression line slope of SBP-IBI correlation) were determined using a newly developed 1 minute sliding window method, the classical sequence technique and the "Z" coefficient method. Analysis using the 1 minute sliding window showed an increased proportion of baroreflex episodes in controls and HD, and predominance of nonbaroreflex episodes in TX. An increased proportion of nonbaroreflex episodes in TX patients relative to HD was also revealed by the "Z" method. Baroreflex and nonbaroreflex b coefficients obtained by all methods were markedly decreased in HD. This alteration was reversed at least partly in TX. In HD, both baroreflex and nonbaroreflex b coefficients were inversely correlated to age and CRP levels; in TX, the nonbaroreflex b coefficient was influenced by the type of calcineurin inhibitor. Conclusion/Significance: Renal status affects the contribution of baroreflex and nonbaroreflex mechanisms and the strength of SBP-IBI relationship. The predominant contribution of nonbaroreflex mechanisms in TX may be suggestive of enhanced central sympathetic control. Our data may be relevant for understanding of the pathogenesis and selection of appropriate treatment of post-transplant hypertension.	[Rubinger, Dvora] Hadassah Hebrew Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel; Hadassah Hebrew Univ Med Ctr, Dept Med, Hypertens Serv, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rubinger, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel.	rdvora@hadassah.org.il						Castiglioni P, 2011, J ELECTROCARDIOL, V44, P391, DOI 10.1016/j.jelectrocard.2011.01.006; CHAPLEAU MW, 1987, CIRC RES, V61, P648, DOI 10.1161/01.RES.61.5.648; Dampney RAL, 2002, CLIN EXP PHARMACOL P, V29, P261, DOI 10.1046/j.1440-1681.2002.03640.x; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; DUCHER M, 1995, CLIN SCI, V88, P651, DOI 10.1042/cs0880651; DUCHER M, 1994, MED BIOL ENG COMPUT, V32, P649, DOI 10.1007/BF02524241; GUZZETTI S, 1988, J HYPERTENS, V6, P711, DOI 10.1097/00004872-198809000-00004; Hausberg M, 2002, CIRCULATION, V106, P1974, DOI 10.1161/01.CIR.0000034043.16664.96; Hausberg M, 2006, J HYPERTENS, V24, P957, DOI 10.1097/01.hjh.0000222767.15100.e4; Iellamo F, 1996, J HYPERTENS, V14, P1099; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Kamiya A, 2011, J PHYSIOL-LONDON, V589, P1769, DOI 10.1113/jphysiol.2011.203455; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P425, DOI 10.1097/01.ASN.0000045049.72965.B7; Klein IHHT, 2010, J HYPERTENS, V28, P1928, DOI 10.1097/HJH.0b013e32833c20eb; Kosch M, 2002, J HYPERTENS, V20, P501, DOI 10.1097/00004872-200203000-00026; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Legramante JM, 2009, AM J PHYSIOL-HEART C, V296, pH202, DOI 10.1152/ajpheart.00358.2008; Legramante JM, 1999, CIRCULATION, V99, P1760, DOI 10.1161/01.CIR.99.13.1760; Legramante JM, 2001, CIRCULATION, V103, P1250; Luft FC, 2012, NEPHROL DIAL TRANSPL, V27, P473, DOI 10.1093/ndt/gfr679; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Nollo G, 2005, AM J PHYSIOL-HEART C, V288, pH1777, DOI 10.1152/ajpheart.00594.2004; PAGANI M, 1982, CIRC RES, V50, P125, DOI 10.1161/01.RES.50.1.125; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; Penaz, 1973, P 10 INT C MED BIOL; Persson PB, 2001, J HYPERTENS, V19, P1699, DOI 10.1097/00004872-200110000-00001; Reyes-Bahamonde J, 2013, SEMIN DIALYSIS, V26, P31, DOI 10.1111/sdi.12024; Rubinger D, 2012, ASN KIDNEY WEEK; Rubinger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036943; Rubinger D, 2009, NEPHROL DIAL TRANSPL, V24, P1305, DOI 10.1093/ndt/gfn732; Schlaich MP, 2010, J HYPERTENS, V28, P1809, DOI 10.1097/HJH.0b013e32833e0e74; Silvani A, 2008, AM J PHYSIOL-REG I, V294, pR1686, DOI 10.1152/ajpregu.00756.2007; Silvani A, 2011, AUTON NEUROSCI-BASIC, V162, P66, DOI 10.1016/j.autneu.2011.04.003; Velez-Roa S, 2004, NEPHROL DIAL TRANSPL, V19, P1606, DOI 10.1093/ndt/gfh124; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; WESSELING KH, 1995, HOMEOSTASIS HLTH DIS, V36, P67; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	38	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e78338	10.1371/journal.pone.0078338	http://dx.doi.org/10.1371/journal.pone.0078338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124623	Green Published, Green Submitted, gold			2022-12-27	WOS:000325489100181
J	Biglari, V; Alfan, EB; Ahmad, RB; Hajian, N				Biglari, Vahid; Alfan, Ervina Binti; Ahmad, Rubi Binti; Hajian, Najmeh			The Ability of Analysts' Recommendations to Predict Optimistic and Pessimistic Forecasts	PLOS ONE			English	Article							VOLUNTARY DISCLOSURE; EARNINGS MANAGEMENT; COST; ASSOCIATION; ENVIRONMENT; INCENTIVES	Previous researches show that buy (growth) companies conduct income increasing earnings management in order to meet forecasts and generate positive forecast Errors (FEs). This behavior however, is not inherent in sell (non-growth) companies. Using the aforementioned background, this research hypothesizes that since sell companies are pressured to avoid income increasing earnings management, they are capable, and in fact more inclined, to pursue income decreasing Forecast Management (FM) with the purpose of generating positive FEs. Using a sample of 6553 firm-years of companies that are listed in the NYSE between the years 2005-2010, the study determines that sell companies conduct income decreasing FM to generate positive FEs. However, the frequency of positive FEs of sell companies does not exceed that of buy companies. Using the efficiency perspective, the study suggests that even though buy and sell companies have immense motivation in avoiding negative FEs, they exploit different but efficient strategies, respectively, in order to meet forecasts. Furthermore, the findings illuminated the complexities behind informative and opportunistic forecasts that falls under the efficiency versus opportunistic theories in literature.	[Biglari, Vahid; Alfan, Ervina Binti; Ahmad, Rubi Binti] Univ Malaya, Fac Business & Accountancy, Dept Accounting, Kuala Lumpur, Malaysia; [Hajian, Najmeh] Tarbiat Modares Univ, Sch Management & Econ, Dept Accounting, Tehran, Iran	Universiti Malaya; Tarbiat Modares University	Biglari, V (corresponding author), Univ Malaya, Fac Business & Accountancy, Dept Accounting, Kuala Lumpur, Malaysia.	vahidbiglari@siswa.um.edu.my	ALFAN, ERVINA/B-5334-2010; hajian, najmeh/AAE-8627-2022	ALFAN, ERVINA/0000-0001-8538-5787; 	University research Grant, University of Malaya, Malaysia [UM.TNC2/IPPP/UPGP/638/PPP]	University research Grant, University of Malaya, Malaysia	The authors gratefully acknowledge University research Grant (UM.TNC2/IPPP/UPGP/638/PPP), University of Malaya, Malaysia for support to conduct this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell J, 2003, J ACCOUNT RES, V41, P1, DOI 10.1111/1475-679X.00093; AJINKYA BB, 1984, J ACCOUNTING RES, V22, P425, DOI 10.2307/2490657; [Anonymous], 2000, REV ACCOUNT STUD, DOI DOI 10.1023/A:1009643517840; Baginski SP, 2002, ACCOUNT REV, V77, P25, DOI 10.2308/accr.2002.77.1.25; Bartov E, 2002, J ACCOUNT ECON, V33, P173, DOI 10.1016/S0165-4101(02)00045-9; Barua A, 2006, J BUS FINAN ACCOUNT, V33, P653, DOI 10.1111/j.1468-5957.2006.00017.x; Beniluz Y, 2007, MANAGEMENT EAR UNPUB; Beyer A, 2010, J ACCOUNT ECON, V50, P296, DOI 10.1016/j.jacceco.2010.10.003; Brown LD, 2005, ACCOUNT REV, V80, P423, DOI 10.2308/accr.2005.80.2.423; Burgstahler D, 1997, J ACCOUNT ECON, V24, P99, DOI 10.1016/S0165-4101(97)00017-7; Coller M, 1997, J ACCOUNTING RES, V35, P181, DOI 10.2307/2491359; Cotter J, 2006, CONTEMP ACCOUNT RES, V23, P593, DOI 10.1506/FJ4D-04UN-68T7-R8CA; Darke P, 1998, INFORM SYST J, V8, P273, DOI 10.1046/j.1365-2575.1998.00040.x; Das S, 2008, ANAL MANAGERIAL USE; DEANGELO LE, 1988, J ACCOUNT ECON, V10, P3, DOI 10.1016/0165-4101(88)90021-3; Deegan C., 2006, FINANCIAL ACCOUNTING; Degeorge F, 1999, J BUS, V72, P1, DOI 10.1086/209601; Desai HM, 2004, ACCOUNT REV, V79, P355, DOI 10.2308/accr.2004.79.2.355; DIAMOND DW, 1991, J FINANC, V46, P1325, DOI 10.2307/2328861; Downing C, 2003, WORKING PAPER; Dutta S, 2002, J ACCOUNTING RES, V40, P631, DOI 10.1111/1475-679X.00065; Fang VW, 2009, ROLE MANAGEMENT FORE; FRANKEL R, 1995, ACCOUNT REV, V70, P135; Frost CA, 1997, J ACCOUNT ECON, V23, P163, DOI 10.1016/S0165-4101(97)00006-2; Gong GJ, 2009, ACCOUNT REV, V84, P497, DOI 10.2308/accr.2009.84.2.497; Hirst DE, 2008, ACCOUNT HORIZ, V22, P315, DOI 10.2308/acch.2008.22.3.315; Hui KW, 2009, J ACCOUNT ECON, V47, P192, DOI 10.1016/j.jacceco.2009.01.001; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Kasznik R, 1999, J ACCOUNTING RES, V37, P57, DOI 10.2307/2491396; KASZNIK R, 1995, ACCOUNT REV, V70, P113; Kasznik R, 2002, J ACCOUNT RES, V40, P727, DOI 10.1111/1475-679X.00069; Kim JW, 2011, J ACCOUNT PUBLIC POL, V30, P348, DOI 10.1016/j.jaccpubpol.2011.03.001; King R., 1990, J ACCOUNT LIT, V9, P113; Lennox CS, 2006, J ACCOUNT ECON, V42, P439, DOI 10.1016/j.jacceco.2006.05.001; LEV B, 1990, J ACCOUNTING RES, V28, P49, DOI 10.2307/2491217; Li E. X. N, 2010, WORKING PAPER; Libby R, 2008, J ACCOUNT RES, V46, P173, DOI 10.1111/j.1475-679X.2007.00265.x; Matsumoto DA, 2002, ACCOUNT REV, V77, P483, DOI 10.2308/accr.2002.77.3.483; Rakow KC, 2010, ADV ACCOUNT, V26, P37, DOI 10.1016/j.adiac.2010.02.007; Riley M, 2007, ACCOUNTING INFORM AN; Rogers JL, 2005, ACCOUNT REV, V80, P1233, DOI 10.2308/accr.2005.80.4.1233; Verrecchia RE, 2001, J ACCOUNT ECON, V32, P97, DOI 10.1016/S0165-4101(01)00025-8; WATTS RL, 1978, ACCOUNT REV, V53, P112; Xin B, 2007, EARNINGS FORECAST EA; Xu WH, 2010, J ACCOUNT ECON, V49, P227, DOI 10.1016/j.jacceco.2009.11.005; Ye J., 2006, WORKING PAPER	46	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e73853	10.1371/journal.pone.0073853	http://dx.doi.org/10.1371/journal.pone.0073853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239KL	24146741	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000326022200001
J	Cai, YL; Stromme, M; Welch, K				Cai, Yanling; Stromme, Maria; Welch, Ken			Photocatalytic Antibacterial Effects Are Maintained on Resin-Based TiO2 Nanocomposites after Cessation of UV Irradiation	PLOS ONE			English	Article							NANOPARTICLES; EXPRESSION	Photocatalysis induced by TiO2 and UV light constitutes a decontamination and antibacterial strategy utilized in many applications including self-cleaning environmental surfaces, water and air treatment. The present work reveals that antibacterial effects induced by photocatalysis can be maintained even after the cessation of UV irradiation. We show that resin-based composites containing 20% TiO2 nanoparticles continue to provide a pronounced antibacterial effect against the pathogens Escherichia coli, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus mutans and Enterococcus faecalis for up to two hours post UV. For biomaterials or implant coatings, where direct UV illumination is not feasible, a prolonged antibacterial effect after the cessation of the illumination would offer new unexplored treatment possibilities.	[Cai, Yanling; Stromme, Maria; Welch, Ken] Uppsala Univ, Dept Engn Sci, Div Nanotechnol & Funct Mat, Angstrom Lab, Uppsala, Sweden	Uppsala University	Cai, YL (corresponding author), Uppsala Univ, Dept Engn Sci, Div Nanotechnol & Funct Mat, Angstrom Lab, Uppsala, Sweden.	yanling.cai@angstrom.uu.se; ken.welch@angstrom.uu.se			Carl Tryggers Foundation [CTS 08:402]; Goran Gustafsson Foundation [0969]	Carl Tryggers Foundation; Goran Gustafsson Foundation	The authors greatly acknowledge The Carl Tryggers Foundation (grant number CTS 08:402, http://www.carltryggersstiftelse.se/) and The Goran Gustafsson Foundation (grant number 0969, http://www.gustafssonsstiftelse.se/) for the financially supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahloul W, 2012, MATER CHEM PHYS, V134, P399, DOI 10.1016/j.matchemphys.2012.03.008; Beydoun D, 1999, J NANOPART RES, V1, P439, DOI 10.1023/A:1010044830871; Brioukhanov AL, 2004, BIOCHEMISTRY-MOSCOW+, V69, P949, DOI 10.1023/B:BIRY.0000043537.04115.d9; Chae YK, 2009, THIN SOLID FILMS, V517, P4260, DOI 10.1016/j.tsf.2009.02.040; Charpentier PA, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/42/425606; Chiu CW, 2011, J POLYM RES, V18, P367, DOI 10.1007/s10965-010-9426-0; Dalrymple OK, 2010, APPL CATAL B-ENVIRON, V98, P27, DOI 10.1016/j.apcatb.2010.05.001; Dunlop PSM, 2010, J PHOTOCH PHOTOBIO A, V216, P303, DOI 10.1016/j.jphotochem.2010.07.004; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Gamage J., 2010, INT J PHOTOENERGY; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Hirakawa K, 2004, FREE RADICAL RES, V38, P439, DOI 10.1080/1071576042000206487; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jensen H, 2006, J EXP NANOSCI, V1, P355, DOI 10.1080/17458080600752482; Kiwi J, 2004, J PHYS CHEM B, V108, P17675, DOI 10.1021/jp048281a; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kwak SY, 2001, ENVIRON SCI TECHNOL, V35, P2388, DOI 10.1021/es0017099; Lilja M, 2012, BIOTECHNOL LETT, V34, P2299, DOI 10.1007/s10529-012-1040-2; Lilja M, 2012, J BIOMED MATER RES B, V100B, P1078, DOI 10.1002/jbm.b.32674; Lin HX, 2008, J BIOMED MATER RES B, V87B, P425, DOI 10.1002/jbm.b.31120; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Nishimoto S, 2013, RSC ADV, V3, P671, DOI 10.1039/c2ra21260a; Patel JD, 2012, J BIOMED MATER RES A, V100A, P2863, DOI 10.1002/jbm.a.34221; Podbielska A, 2011, CENT EUR J IMMUNOL, V36, P56; Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3; Vatanpour V, 2012, DESALINATION, V292, P19, DOI 10.1016/j.desal.2012.02.006; Wang ZB, 2005, J MATER SCI, V40, P6433, DOI 10.1007/s10853-005-1713-5; Welch K, 2012, J FUNCT BIOMATER, V3, DOI 10.3390/jfb3020418; Welch K, 2010, DENT MATER, V26, P491, DOI 10.1016/j.dental.2010.01.008; Yang YN, 2007, J MEMBRANE SCI, V288, P231, DOI 10.1016/j.memsci.2006.11.019; Zhang LF, 2003, SEP PURIF TECHNOL, V31, P105, DOI 10.1016/S1383-5866(02)00157-0; Zhao J, 2003, BUILD ENVIRON, V38, P645, DOI 10.1016/S0360-1323(02)00212-3; Zhou JP, 2006, J APPL POLYM SCI, V101, P3600, DOI 10.1002/app.22650; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	36	31	31	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75929	10.1371/journal.pone.0075929	http://dx.doi.org/10.1371/journal.pone.0075929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146793	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200004
J	Lonnstedt, OM; McCormick, MI				Loennstedt, Oona M.; McCormick, Mark I.			Ultimate Predators: Lionfish Have Evolved to Circumvent Prey Risk Assessment Abilities	PLOS ONE			English	Article							INVASIVE LIONFISH; PTEROIS-VOLITANS; ECOLOGY; BEHAVIOR; PACIFIC; PATTERNS; NAIVETE; HISTORY	Invasive species cause catastrophic alterations to communities worldwide by changing the trophic balance within ecosystems. Ever since their introduction in the mid 1980's common red lionfish, Pterois volitans, are having dramatic impacts on the Caribbean ecosystem by displacing native species and disrupting food webs. Introduced lionfish capture prey at extraordinary rates, altering the composition of benthic communities. Here we demonstrate that the extraordinary success of the introduced lionfish lies in its capacity to circumvent prey risk assessment abilities as it is virtually undetectable by prey species in its native range. While experienced prey damselfish, Chromis viridis, respond with typical antipredator behaviours when exposed to a common predatory rock cod (Cephalopholis microprion) they fail to visibly react to either the scent or visual presentation of the red lionfish, and responded only to the scent (not the visual cue) of a lionfish of a different genus, Dendrochirus zebra. Experienced prey also had much higher survival when exposed to the two non-invasive predators compared to P. volitans. The cryptic nature of the red lionfish has enabled it to be destructive as a predator and a highly successful invasive species.	[Loennstedt, Oona M.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Lonnstedt, OM (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	oona.lonnstedt1@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	ARC Centre of Excellence; Australian Museum	ARC Centre of Excellence(Australian Research Council); Australian Museum	Funding support was provided by the ARC Centre of Excellence and the Australian Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2004, CHEMOECOLOGY, V14, P165, DOI 10.1007/s00049-004-0274-4; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Beukers-Stewart BD, 2004, J EXP MAR BIOL ECOL, V299, P155, DOI 10.1016/j.jembe.2003.08.015; Bosiger YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034535; CALEY MJ, 1993, MAR BIOL, V117, P33, DOI 10.1007/BF00346423; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Colin SP, 2012, P NATL ACAD SCI USA, V107, P17223; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Cure K, 2012, MAR ECOL PROG SER, V467, P181, DOI 10.3354/meps09942; Diamond J., 1986, COMMUNITY ECOL, P65; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; FISHLYN DA, 1980, BIOL BULL, V158, P34, DOI 10.2307/1540756; Green SJ, 2010, PLOS ONE, V7; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; Layman CA, 2012, MAR ECOL PROG SER, V448, P131, DOI 10.3354/meps09511; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2013, ECOL EVOL, V3, P38, DOI 10.1002/ece3.388; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Lonnstedt OM, 2011, ANIM BEHAV, V82, P213, DOI 10.1016/j.anbehav.2011.04.015; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Munoz RC, 2011, MAR ECOL PROG SER, V432, P181, DOI 10.3354/meps09154; Ortolani A, 1999, BIOL J LINN SOC, V67, P433; Ruttenberg BI, 2012, B MAR SCI, V88, P1051, DOI 10.5343/bms.2011.1108; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Sol D, 2012, SCIENCE, V337, P580, DOI 10.1126/science.1221523; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806	37	35	35	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75781	10.1371/journal.pone.0075781	http://dx.doi.org/10.1371/journal.pone.0075781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146775	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400017
J	van Marle, G; Sharkey, KA; Gill, MJ; Church, DL				van Marle, Guido; Sharkey, Keith A.; Gill, M. John; Church, Deirdre L.			Gastrointestinal Viral Load and Enteroendocrine Cell Number Are Associated with Altered Survival in HIV-1 Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; ENTEROCHROMAFFIN CELL; IMMUNE ACTIVATION; GENETIC DIVERSITY; TYPE-1 INFECTION; HIV-1 INFECTION; LYMPHOID-TISSUE; GUT; DISEASE	Human immunodeficiency virus type 1 (HIV-1) infects and destroys cells of the immune system leading to an overt immune deficiency known as HIV acquired immunodeficiency syndrome (HIV/AIDS). The gut associated lymphoid tissue is one of the major lymphoid tissues targeted by HIV-1, and is considered a reservoir for HIV-1 replication and of major importance in CD4+ T-cell depletion. In addition to immunodeficiency, HIV-1 infection also directly causes gastrointestinal (GI) dysfunction, also known as HIV enteropathy. This enteropathy can manifest itself as many pathological changes in the GI tract. The objective of this study was to determine the association of gut HIV-1 infection markers with long-term survival in a cohort of men who have sex with men (MSM) enrolled pre-HAART (Highly Active Antiretroviral Therapy). We examined survival over 15-years in a cohort of 42 HIV-infected cases: In addition to CD4+ T cell counts and HIV-1 plasma viral load, multiple gut compartment (duodenum and colon) biopsies were taken by endoscopy every 6 months during the initial 3-year period. HIV-1 was cultured from tissues and phenotyped and viral loads in the gut tissues were determined. Moreover, the tissues were subjected to an extensive assessment of enteroendocrine cell distribution and pathology. The collected data was used for survival analyses, which showed that patients with higher gut tissue viral load levels had a significantly worse survival prognosis. Moreover, lower numbers of serotonin (duodenum) and somatostatin (duodenum and colon) immunoreactive cell counts in the gut tissues of patients was associated with significant lower survival prognosis. Our study, suggested that HIV-1 pathogenesis and survival prognosis is associated with altered enteroendocrine cell numbers, which could point to a potential role for enteroendocrine function in HIV infection and pathogenesis.	[van Marle, Guido; Sharkey, Keith A.; Gill, M. John; Church, Deirdre L.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Sharkey, Keith A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [van Marle, Guido; Gill, M. John; Church, Deirdre L.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Sharkey, Keith A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Church, Deirdre L.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Church, Deirdre L.] Calgary Lab Serv, Div Microbiol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	van Marle, G (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada.	vanmarle@ucalgary.ca	Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Gill, Michael John/0000-0002-8546-8790; Sharkey, Keith/0000-0001-9560-1711; van Marle, Guido/0000-0002-5148-6229	National Health Research and Development Program (NHRDP) [6609-1782-AIDS]; Canadian Institutes of Health Research (CIHR) [CIHR-III HIV/AIDS HOP-9018]	National Health Research and Development Program (NHRDP); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Supported by: The National Health Research and Development Program (NHRDP) (Grant No. 6609-1782-AIDS, DLC-Principal Investigator) and the Canadian Institutes of Health Research (CIHR) (CIHR-III HIV/AIDS HOP-9018 GvM Principle Investigator) www.cihr-irsc.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1987, J VIROL, V61, P209, DOI 10.1128/JVI.61.1.209-213.1987; AlMulla W, 1997, J MED VIROL, V52, P31, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;31::AID-JMV6&gt;3.0.CO;2-S; Batman PA, 2007, AIDS, V21, P433, DOI 10.1097/QAD.0b013e3280142ee8; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Byakwaga Helen, 2009, J HIV Ther, V14, P57; CARLSON S, 1994, J LAB CLIN MED, V124, P652; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CHURCH DL, 1992, SCAND J INFECT DIS, V24, P567, DOI 10.3109/00365549209054642; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; Costiniuk CT, 2012, MUCOSAL IMMUNOL, V5, P596, DOI 10.1038/mi.2012.82; Deiman B, 2002, MOL BIOTECHNOL, V20, P163, DOI 10.1385/MB:20:2:163; den Bosch JV, 2009, REGUL PEPTIDES, V156, P1, DOI 10.1016/j.regpep.2009.04.003; Douek Daniel, 2007, Top HIV Med, V15, P114; Gershon MD, 2007, NEUROGASTROENT MOTIL, V19, P19, DOI 10.1111/j.1365-2982.2007.00962.x; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; GILL MJ, 1992, AIDS, V6, P553, DOI 10.1097/00002030-199206000-00005; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; GREENSON JK, 1991, ANN INTERN MED, V114, P366, DOI 10.7326/0003-4819-114-5-366; Griffith BP, 1997, J CLIN MICROBIOL, V35, P3288, DOI 10.1128/JCM.35.12.3288-3291.1997; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; HOLLINGER FB, 1992, J CLIN MICROBIOL, V30, P1787, DOI 10.1128/JCM.30.7.1787-1794.1992; JANOFF EN, 1988, GASTROENTEROL CLIN N, V17, P451; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; Kotler D P, 1995, Adv Intern Med, V40, P197; Kotler DP, 1998, SEMIN ONCOL, V25, P70; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Lane H Clifford, 2010, Top HIV Med, V18, P2; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lomax AE, 2006, AUTON NEUROSCI-BASIC, V126, P250, DOI 10.1016/j.autneu.2006.02.015; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MAY GR, 1993, DIGEST DIS SCI, V38, P1388, DOI 10.1007/BF01308593; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; Motomura Y, 2008, GUT, V57, P475, DOI 10.1136/gut.2007.129296; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SHARKEY KA, 1992, GASTROENTEROLOGY, V103, P18, DOI 10.1016/0016-5085(92)91090-Q; Spijkerman I, 1998, J INFECT DIS, V178, P397, DOI 10.1086/515627; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; SUTHERLAND LR, 1990, CAN MED ASSOC J, V143, P641; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; ULLRICH R, 1989, ANN INTERN MED, V111, P15, DOI 10.7326/0003-4819-111-1-15; ULLRICH R, 1991, IMMUNOL RES, V10, P456, DOI 10.1007/BF02919742; van Marle G, 2005, J NEUROVIROL, V11, P107, DOI 10.1080/13550280590922838; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; van Marle G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-74; Wang HQ, 2007, GUT, V56, P949, DOI 10.1136/gut.2006.103226; Yang GB, 2004, J NEUROIMMUNOL, V146, P46, DOI 10.1016/j.jneuroim.2003.10.044; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Zeitz M, 1998, ANN NY ACAD SCI, V859, P139, DOI 10.1111/j.1749-6632.1998.tb11118.x	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75967	10.1371/journal.pone.0075967	http://dx.doi.org/10.1371/journal.pone.0075967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146801	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400027
J	Gong, YX; Scott, E; Lu, R; Xu, Y; Oh, WK; Yu, Q				Gong, Yixuan; Scott, Evita; Lu, Rong; Xu, Yin; Oh, William K.; Yu, Qin			TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; PLASMA TISSUE INHIBITOR; LONG-TERM SURVIVAL; MATRIX METALLOPROTEINASES; COLORECTAL-CANCER; BREAST CARCINOMAS; CELL-SURFACE; TUMOR-GROWTH; EXPRESSION; RNA	Treatment options for late stage prostate and colon cancer are limited and there is an urgent need to develop more effective and targeted novel therapies, which starts with identification and validation of novel therapeutic targets. Recent clinical studies have demonstrated that tissue inhibitor matrix metalloproteinase-1 (TIMP-1) levels are elevated in cancer patient plasma and elevated TIMP-1 levels are associated with worse clinical outcomes. However, it is unknown whether TIMP-1 serves merely as a biomarker of cancer progression or has a functional role in promoting cancer progression and can serve as a cancer therapeutic target, which is the main objective of this study. Here, we show that stroma of human prostate and colon cancer express higher levels of TIMP-1 compared to their normal counterparts and increased expression of TIMP-1 promotes in vivo growth of both cancer types. We demonstrate for the first time that increased TIMP-1 expression stimulates accumulation of cancer associated fibroblasts (CAFs) within prostate and colon cancer tissues and that TIMP-1 enhances prostate CAF proliferation and migration in vitro and promotes ERK1/2 kinase activation in these CAF cells. Our results establish the novel promotive effects of TIMP-1 on cancer progression and on accumulation of CAFs that in turn provides a pro-tumor microenvironment. Together, these results establish the potential of TIMP-1 as a novel target for cancer therapy and the mechanism underlying the pro-tumor activity of TIMP-1.	[Scott, Evita; Lu, Rong; Xu, Yin; Yu, Qin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Dept Oncol Sci, Mt Sinai, NY USA; [Gong, Yixuan; Oh, William K.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Hematol Med Oncol, Mt Sinai, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Oh, WK (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Hematol Med Oncol, Mt Sinai, NY USA.	william.oh@mssm.edu; qin.yu@mssm.edu	Oh, William/B-9163-2012	Oh, William/0000-0001-5113-8147	United States Army Medical Research (Department of Defense) [W81XWH-10-1-0321]; NATIONAL CANCER INSTITUTE [R01CA150355, R01CA135158] Funding Source: NIH RePORTER	United States Army Medical Research (Department of Defense)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a United States Army Medical Research (Department of Defense) grant, W81XWH-10-1-0321. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldulaymi B, 2010, ONCOLOGY-BASEL, V79, P144, DOI 10.1159/000320686; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Cai J, 2012, CARCINOGENESIS, V33, P20, DOI 10.1093/carcin/bgr230; Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Corcoran NM, 2012, HISTOPATHOLOGY, V60, P216, DOI 10.1111/j.1365-2559.2011.04030.x; Courtney KD, 2012, CURR OPIN ONCOL, V24, P272, DOI 10.1097/CCO.0b013e328351059d; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; Deng XY, 2008, INT J CANCER, V122, P209, DOI 10.1002/ijc.23053; Fisher JF, 2010, METHODS MOL BIOL, V622, P471, DOI 10.1007/978-1-60327-299-5_27; Frederiksen C, 2009, ANTICANCER RES, V29, P75; Fu XY, 2008, SEMIN CELL DEV BIOL, V19, P2, DOI 10.1016/j.semcdb.2007.06.005; Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004; Gu P, 2008, NEOPLASIA, V10, P563, DOI 10.1593/neo.08208; Guedez L, 2010, LEUKEMIA RES, V34, P576, DOI 10.1016/j.leukres.2009.10.005; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Huang M, 2011, CARCINOGENESIS; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Jung YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038773; KAWAMATA H, 1995, INT J CANCER, V63, P680, DOI 10.1002/ijc.2910630513; Kawashiri S, 2009, HEAD NECK-J SCI SPEC, V31, P1346, DOI 10.1002/hed.21097; Li GY, 1999, CANCER RES, V59, P6267; Lipton A, 2008, J CLIN ONCOL, V26, P2653, DOI 10.1200/JCO.2007.15.4336; Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8; Luparello C, 1999, BREAST CANCER RES TR, V54, P235, DOI 10.1023/A:1006121129382; Marech I, 2012, INT J ONCOL, V40, P1313, DOI 10.3892/ijo.2012.1364; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; Nakopoulou L, 2002, J PATHOL, V197, P307, DOI 10.1002/path.1129; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Oh WK, 2011, CANCER-AM CANCER SOC, V117, P517, DOI 10.1002/cncr.25394; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Osanto S, 2012, THER ADV UROL, V4, P3, DOI 10.1177/1756287211432777; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Rivette AS, 2005, J EXP THER ONCOL, V5, P111; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Ross RW, 2012, LANCET ONCOL, V13, P1105, DOI 10.1016/S1470-2045(12)70263-2; Schelter F, 2011, CLIN EXP METASTAS, V28, P793, DOI 10.1007/s10585-011-9410-z; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tsao CK, 2012, CURR OPIN UROL, V22, P167, DOI 10.1097/MOU.0b013e3283523b8b; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Xu Y, 2004, J BIOL CHEM, V279, P41179, DOI 10.1074/jbc.M400292200; Yamada S, 2008, CURR PROTOC CELL BIO; Yoshikawa T, 2009, GASTRIC CANCER, V12, P31, DOI 10.1007/s10120-008-0494-3; Yoshino Y, 2008, J DERMATOL, V35, P206, DOI 10.1111/j.1346-8138.2008.00446.x; Yukawa N, 2007, ONCOLOGY-BASEL, V72, P205, DOI 10.1159/000112827; Zagouri F, 2011, CLIN CHIM ACTA, V412, P537, DOI 10.1016/j.cca.2010.11.037; Zeng ZS, 1995, CLIN CANCER RES, V1, P899; Zhang H, 2007, HEPATOB PANCREAT DIS, V6, P487; Zhang YA, 2011, CANCER LETT, V303, P47, DOI 10.1016/j.canlet.2011.01.011	56	71	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77366	10.1371/journal.pone.0077366	http://dx.doi.org/10.1371/journal.pone.0077366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143225	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100062
J	Haddad, G; Zhu, LF; Rayner, DC; Murray, AG				Haddad, George; Zhu, Lin Fu; Rayner, David C.; Murray, Allan G.			Experimental Glomerular Endothelial Injury In Vivo	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ACUTE HUMORAL REJECTION; RENAL-ALLOGRAFT REJECTION; THROMBOTIC MICROANGIOPATHY; SHIGA TOXIN; PERITUBULAR CAPILLARIES; INDUCED APOPTOSIS; MURINE MODEL; CELLS; MICE	The microvascular endothelium of the kidney glomerulus is injured in Shiga-like toxigenic bacterial infection, genetic or acquired loss of complement regulatory protein function, and allo-immune responses of solid-organ or bone marrow transplantation. Existing models of diseases with glomerular endothelial cell (EC) injury, collectively grouped as thrombotic microangiopathies, are problematic, impeding investigation of the mechanisms of microvascular defense and repair. To develop a model of glomerular endothelial injury in the mouse, we conjugated the M. oreades lectin to the cytotoxin, saporin, (LS) to selectively injure the glomerular endothelium. Injury of the microvasculature was evaluated by light, immunofluorescence, and electron microscopy, and by quantitative RT-PCR of cell-type specific transcripts. Renal function was evaluated by quantitation of serum creatinine. The toxin conjugate induced apoptosis of microvascular ECs in vitro, and subtle histologic features of thrombotic microangiopathy in vivo that were enhanced by co-injection of 50 mu g/kg LPS. Among LS/LPS-treated animals, loss of glomerular EC staining correlated with decreased expression of EC-specific transcripts, and impaired kidney function. Selective injury of the glomerular microvasculature with LS toxin conjugate and LPS elicits histologic features of thrombotic microangiopathy and acute kidney failure.	[Haddad, George; Murray, Allan G.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Zhu, Lin Fu] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Rayner, David C.] Univ Alberta, Dept Pathol & Lab Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	allan.murray@ualberta.ca	Haddad, George/AAL-5942-2021		Canadian Institutes for Health Research [MOP 53319]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this work was obtained in part from the Canadian Institutes for Health Research operating grant (MOP 53319) to AGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri L, 1997, NUCLEIC ACIDS RES, V25, P518, DOI 10.1093/nar/25.3.518; Barbieri SS, 2008, ARTERIOSCL THROM VAS, V28, P732, DOI 10.1161/ATVBAHA.107.159434; BELLONI PN, 1988, J CELL PHYSIOL, V136, P398, DOI 10.1002/jcp.1041360303; Bickerstaff A, 2008, AM J PATHOL, V173, P347, DOI 10.2353/ajpath.2008.070391; Brigotti M, 2002, FASEB J, V16, DOI 10.1096/fj.01-0521com; BURNS ER, 1982, BLOOD, V60, P1030; Chandler WL, 2002, NEW ENGL J MED, V346, P23, DOI 10.1056/NEJMoa011033; Choo JK, 1997, TRANSPLANTATION, V64, P1315, DOI 10.1097/00007890-199711150-00014; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Erwert RD, 2002, J BIOL CHEM, V277, P40567, DOI 10.1074/jbc.M206351200; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Fujii J, 2008, INFECT IMMUN, V76, P3679, DOI 10.1128/IAI.01581-07; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Gloor JM, 2007, AM J TRANSPLANT, V7, P2124, DOI 10.1111/j.1600-6143.2007.01895.x; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P1144, DOI 10.1093/ndt/gfm774; Ishii Y, 2005, KIDNEY INT, V67, P321, DOI 10.1111/j.1523-1755.2005.00085.x; JOHN HD, 1982, PATHOL RES PRACT, V173, P236, DOI 10.1016/S0344-0338(82)80087-3; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; Lajoie G, 1997, ULTRASTRUCT PATHOL, V21, P235; Laskin BL, 2011, BLOOD, V118, P1452, DOI 10.1182/blood-2011-02-321315; Li JH, 2009, AM J PATHOL, V175, P1124, DOI 10.2353/ajpath.2009.090113; Liptak P, 2005, AM J TRANSPLANT, V5, P2870, DOI 10.1111/j.1600-6143.2005.01102.x; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Magro CM, 2005, ULTRASTRUCT PATHOL, V29, P95, DOI 10.1080/019131290924108; Matsumoto M, 2004, J AM SOC NEPHROL, V15, P1574, DOI 10.1097/01.ASN.0000128047.13396.48; Matussek A, 2003, BLOOD, V102, P1323, DOI 10.1182/blood-2002-10-3301; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; Mitra D, 1998, AM J HEMATOL, V59, P279, DOI 10.1002/(SICI)1096-8652(199812)59:4<279::AID-AJH3>3.0.CO;2-J; Nozaki T, 2009, AM J TRANSPLANT, V9, P2251, DOI 10.1111/j.1600-6143.2009.02786.x; Oakes RS, 2008, PEDIATR NEPHROL, V23, P1303, DOI 10.1007/s00467-008-0799-9; Paixao-Cavalcante D, 2009, CLIN EXP IMMUNOL, V155, P339, DOI 10.1111/j.1365-2249.2008.03826.x; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Pijpers AHJM, 2001, J AM SOC NEPHROL, V12, P767, DOI 10.1681/ASN.V124767; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Sellares J, 2011, AM J TRANSPLANT, V11, P489, DOI 10.1111/j.1600-6143.2010.03415.x; SIEGLER RL, 1994, PEDIATRICS, V94, P35; Smith JD, 2011, AM J TRANSPLANT, V11, P312, DOI 10.1111/j.1600-6143.2010.03383.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547; Trpkov K, 1996, TRANSPLANTATION, V61, P1586, DOI 10.1097/00007890-199606150-00007; Warner RL, 2004, EXP MOL PATHOL, V77, P77, DOI 10.1016/j.yexmp.2004.04.003; Yamamoto K, 1997, AM J PATHOL, V151, P725	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78244	10.1371/journal.pone.0078244	http://dx.doi.org/10.1371/journal.pone.0078244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143262	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100101
J	Lieu, CH; Tran, H; Jiang, ZQ; Mao, ML; Overman, MJ; Lin, E; Eng, C; Morris, J; Ellis, L; Heymach, JV; Kopetz, S				Lieu, Christopher H.; Hai Tran; Jiang, Zhi-Qin; Mao, Muling; Overman, Michael J.; Lin, E.; Eng, Cathy; Morris, Jeffrey; Ellis, Lee; Heymach, John V.; Kopetz, Scott			The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCED ANGIOGENESIS; TUMOR-GROWTH; BEVACIZUMAB; PATHWAY; SWITCH	Background: Circulating angiogenic factors are altered in patients with mCRC receiving bevacizumab. Evaluation of alterations in levels of VEGF ligands may provide insights into possible resistance mechanisms. Methods: PlGF, VEGF-A, VEGF-C, and VEGF-D were measured from two cohorts of patients. Sequential plasma samples were obtained from a discovery cohort of 42 patients treated with chemotherapy and bevacizumab. A validation cohort included plasma samples from a cross-sectional of 403 patients prior to chemotherapy, or after progression on a regimen with or without bevacizumab. Results: In the discovery cohort, VEGF-C was increased prior to progression and at progression (+49% and +95%, respectively, p<0.01), consistent with previously reported elevations in PlGF. Levels of VEGF-D were increased (+23%) at progression (p=0.05). In the validation cohort, samples obtained from patients after progression on a regimen with bevacizumab had higher levels of PlGF and VEGF-D (+43% and +6%, p=0.02, p=0.01, respectively) compared to untreated patients, but failed to validate the increase in VEGF-C seen in the first cohort. Patients who progressed on chemotherapy with bevacizumab had significantly elevated levels of PlGF (+88%) but not VEGF-C and VEGF-D compared to patients treated with chemotherapy alone. Elevations of PlGF and VEGF-D appeared transient and returned to baseline with a half-life of 6 weeks. Conclusions: Increases in PlGF and VEGF-D were observed after progression on chemotherapy with bevacizumab. These changes appear to be reversible after discontinuing therapy. These ligands are associated with resistance to bevacizumab-containing chemotherapy in mCRC, but causation remains to be established.	[Lieu, Christopher H.] Univ Colorado, Div Med Oncol, Denver, CO 80202 USA; [Jiang, Zhi-Qin; Mao, Muling; Overman, Michael J.; Lin, E.; Eng, Cathy; Kopetz, Scott] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Hai Tran; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, Houston, TX 77030 USA; [Morris, Jeffrey] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Ellis, Lee] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Colorado System; University of Colorado Denver; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lieu, CH (corresponding author), Univ Colorado, Div Med Oncol, Denver, CO 80202 USA.	christopher.lieu@ucdenver.edu	Kopetz, Scott/AAC-1387-2019; Heymach, John/AAG-2361-2019; Jiang, Zhi-Qin/O-8999-2014	Kopetz, Scott/0000-0001-9647-3416; Heymach, John/0000-0001-9068-8942; Jiang, Zhi-Qin/0000-0002-0931-5418; Tran, Hai/0000-0003-4065-9355; Eng, Cathy/0000-0003-2335-0612	Conquer Cancer Foundation Young Investigators Award; Circadian Technologies Limited; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA130821] Funding Source: NIH RePORTER	Conquer Cancer Foundation Young Investigators Award; Circadian Technologies Limited; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Conquer Cancer Foundation Young Investigators Award (http://www.conquercancerfoundation.org/) to C. L., and a research grant from Circadian Technologies Limited (http://circadian.com.au/) to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2005, VIOPLOT VIOLIN PLOT; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bagley RG, 2011, CLIN CANCER RES, V17, P976, DOI 10.1158/1078-0432.CCR-10-2687; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bjorndahl M, 2004, CIRC RES, V94, P1443, DOI 10.1161/01.RES.0000129194.61747.bf; Broll R, 2001, EUR J SURG ONCOL, V27, P37, DOI 10.1053/ejso.2000.1052; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; GROTHEY A, 2012, J CLIN ONCOL, P30; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanrahan EO, 2010, J CLIN ONCOL, V28, P193, DOI 10.1200/JCO.2009.22.4279; Hanrahan V, 2003, J PATHOL, V200, P183, DOI 10.1002/path.1339; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hindryckx P, 2010, LAB INVEST, V90, P566, DOI 10.1038/labinvest.2010.37; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kerbel RS, 2005, CANCER CELL, V8, P269, DOI 10.1016/j.ccr.2005.09.016; KOPETZ S, 2009, J CLIN ONCOL, V2024, P8252; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Matsumoto K, 2003, ANTICANCER RES, V23, P4953; Parr C, 2005, EUR J CANCER, V41, P2819, DOI 10.1016/j.ejca.2005.07.022; Pepper MS, 1998, J CELL PHYSIOL, V177, P439, DOI 10.1002/(SICI)1097-4652(199812)177:3<439::AID-JCP7>3.0.CO;2-2; Ribatti D, 2008, ANGIOGENESIS, V11, P215, DOI 10.1007/s10456-008-9114-4; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096/fj.01-1042com; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8; Weickhardt AJ, 2011, J CLIN ONCOL, V29; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; YAO J, 2011, P NATL ACAD SCI	36	86	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77117	10.1371/journal.pone.0077117	http://dx.doi.org/10.1371/journal.pone.0077117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143206	Green Submitted, gold, Green Published			2022-12-27	WOS:000325894100041
J	Wei, YY; Wang, ZX; Chang, CY; Fan, TT; Su, L; Chen, F; Christiani, DC				Wei, Yongyue; Wang, Zhaoxi; Chang, Chiung-yu; Fan, Tianteng; Su, Li; Chen, Feng; Christiani, David C.			Global Metabolomic Profiling Reveals an Association of Metal Fume Exposure and Plasma Unsaturated Fatty Acids	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BOILERMAKER CONSTRUCTION WORKERS; WELDING FUMES; STAINLESS-STEEL; DOCOSAHEXAENOIC ACID; DUTCH INDUSTRIES; OMEGA-3-FATTY-ACIDS; RESPONSES; WELDERS; ADULTS	Background: Welding-associated air pollutants negatively affect the health of exposed workers; however, their molecular mechanisms in causing disease remain largely unclear. Few studies have systematically investigated the systemic toxic effects of welding fumes on humans. Objectives: To explore the effects of welding fumes on the plasma metabolome, and to identify biomarkers for risk assessment of welding fume exposure. Methods: The two-stage, self-controlled exploratory study included 11 boilermakers from a 2011 discovery panel and 8 boilermakers from a 2012 validation panel. Plasma samples were collected pre- and post-welding fume exposure and analyzed by chromatography/mass spectrometry. Results: Eicosapentaenoic or docosapentaenoic acid metabolic changes post-welding were significantly associated with particulate (PM2.5) exposure (p<0.05). The combined analysis by linear mixed-effects model showed that exposure was associated with a statistically significant decline in metabolite change of eicosapentaenoic acid [<(beta)over cap>(95% CI) = -0.013(-0.022 similar to-0.004); p = 0.005], docosapentaenoic acid n(3) [(beta) over cap (95% CI) = -0.010(-0.018 similar to-0.002); p = 0.017], and docosapentaenoic acid n(6) [(beta) over cap (95% CI) = -0.007(-0.013 similar to-0.001); p = 0.021]. Pathway analysis identified an association of the unsaturated fatty acid pathway with exposure (p(Study)-(2011) = 0.025; p(Study)-(2012) = 0.021; p(Combined) = 0.009). The functional network built by these fatty acids and their interactive genes contained significant enrichment of genes associated with various diseases, including neoplasms, cardiovascular diseases, and lipid metabolism disorders. Conclusions: High-dose exposure of metal welding fumes decreases unsaturated fatty acids with an exposure-response relationship. This alteration in fatty acids is a potential biological mediator and biomarker for exposure-related health disorders.	[Wei, Yongyue; Wang, Zhaoxi; Chang, Chiung-yu; Fan, Tianteng; Su, Li; Christiani, David C.] Harvard Univ, Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Chen, Feng] Nanjing Med Univ, Dept Epidemiol & Biostat, Key Lab Modern Toxicol, Minist Educ,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Nanjing Medical University	Christiani, DC (corresponding author), Harvard Univ, Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	dchris@hsph.harvard.edu	Wei, Yongyue/GYV-5660-2022	Wei, Yongyue/0000-0002-1132-1796	US NIH [ES009860, ES00002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009860, P30ES000002] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by US NIH grants ES009860 and ES00002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Antonini JM, 2005, MOL CELL BIOCHEM, V279, P17, DOI 10.1007/s11010-005-8211-6; Antonini JM, 1997, EXP LUNG RES, V23, P205, DOI 10.3109/01902149709087368; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; Cavallari JM, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-36; Chen JC, 2007, ENVIRON HEALTH PERSP, V115, P1002, DOI 10.1289/ehp.9609; Chuang CH, 2010, MUTAGENESIS, V25, P71, DOI 10.1093/mutage/gep047; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dieterle F, 2006, CHEM RES TOXICOL, V19, P1175, DOI 10.1021/tx060094b; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Geleskul Iu F, 1987, VRACHEBNOE DELO, P108; Goldstein JT, 2003, ARCH BIOCHEM BIOPHYS, V420, P185, DOI 10.1016/j.abb.2003.09.034; Hassaballa HA, 2005, OCCUP MED-OXFORD, V55, P638, DOI 10.1093/occmed/kqi141; Hauser R, 2002, CHEST, V121, P2052, DOI 10.1378/chest.121.6.2052; Hobson A, 2011, ANN OCCUP HYG, V55, P113, DOI 10.1093/annhyg/meq069; Ibfelt E, 2010, OCCUP ENVIRON MED, V67, P772, DOI 10.1136/oem.2009.051086; Jacobson TA, 2012, J CLIN LIPIDOL, V6, P5, DOI 10.1016/j.jacl.2011.10.018; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; KESKINEN H, 1980, CLIN ALLERGY, V10, P151, DOI 10.1111/j.1365-2222.1980.tb02092.x; Kim JY, 2003, ENVIRON RES, V93, P158, DOI 10.1016/S0013-9351(03)00017-3; Kuo CH, 2012, CHEM RES TOXICOL, V25, P676, DOI 10.1021/tx200465e; Mozaffarian D, 2008, CIRCULATION, V117, P1130, DOI 10.1161/CIRCULATIONAHA.107.732826; Mukherjee S, 2004, CANCER EPIDEM BIOMAR, V13, P454; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Ninio DM, 2008, BRIT J NUTR, V100, P1097, DOI 10.1017/S0007114508959225; Picard E, 1999, J NATL CANCER I, V91, P1059, DOI 10.1093/jnci/91.12.1059; Poole CD, 2013, CLIN THER, V35, P40, DOI 10.1016/j.clinthera.2012.11.008; Ringbom T, 2001, J NAT PROD, V64, P745, DOI 10.1021/np000620d; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Sauder KA, 2013, PSYCHOSOM MED, V75, P382, DOI 10.1097/PSY.0b013e318290a107; Scharrer E, 2007, INT ARCH OCC ENV HEA, V80, P265, DOI 10.1007/s00420-006-0127-2; Stewart JD, 2011, ARCH TOXICOL, V85, P3, DOI 10.1007/s00204-010-0635-4; SULOCHANA G, 1978, INDIAN J EXP BIOL, V16, P507; Szram J, 2012, EUR RESP J; 't Mannetje A, 2012, AM J EPIDEMIOL, V175, P706, DOI 10.1093/aje/kwr358; Tessier DM, 2006, TOXICOL LETT, V167, P114, DOI 10.1016/j.toxlet.2006.08.015; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tsuji M, 2003, PROSTAG LEUKOTR ESS, V68, P337, DOI 10.1016/S0952-3278(03)00025-5; VANDERWAL JF, 1985, ANN OCCUP HYG, V29, P377, DOI 10.1093/annhyg/29.3.377; VANDERWAL JF, 1986, ANN OCCUP HYG, V30, P153, DOI 10.1093/annhyg/30.2.153; Villa B, 2002, PHARMACOL RES, V45, P475, DOI 10.1006/phrs.2002.0989; von Schacky C, 2012, EVID BASED MED; Wang ZX, 2005, ENVIRON HEALTH PERSP, V113, P233, DOI 10.1289/txg.7273; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602	49	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77413	10.1371/journal.pone.0077413	http://dx.doi.org/10.1371/journal.pone.0077413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143234	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100071
J	Yarotskyy, V; Protasi, F; Dirksen, RT				Yarotskyy, Viktor; Protasi, Feliciano; Dirksen, Robert T.			Accelerated Activation of SOCE Current in Myotubes from Two Mouse Models of Anesthetic- and Heat-Induced Sudden Death	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; EXERCISE-INDUCED RHABDOMYOLYSIS; MAMMALIAN SKELETAL-MUSCLE; KNOCK-IN MOUSE; MALIGNANT HYPERTHERMIA; RYANODINE RECEPTOR; SARCOPLASMIC-RETICULUM; RETROGRADE SIGNAL; BINDING-SITES; CALCIUM STORE	Store-operated calcium entry (SOCE) channels play an important role in Ca2+ signaling. Recently, excessive SOCE was proposed to play a central role in the pathogenesis of malignant hyperthermia (MH), a pharmacogenic disorder of skeletal muscle. We tested this hypothesis by characterizing SOCE current (I-SkCRAC) magnitude, voltage dependence, and rate of activation in myotubes derived from two mouse models of anesthetic-and heat-induced sudden death: 1) type 1 ryanodine receptor (RyR1) knock-in mice (Y524S/+) and 2) calsequestrin 1 and 2 double knock-out (dCasq-null) mice. ISkCRAC voltage dependence and magnitude at -80 mV were not significantly different in myotubes derived from wild type (WT), Y524S/+ and dCasq-null mice. However, the rate of I-SkCRAC activation upon repetitive depolarization was significantly faster at room temperature in myotubes from Y524S/+ and dCasq-null mice. In addition, the maximum rate of I-SkCRAC activation in dCasq-null myotubes was also faster than WT at more physiological temperatures (35-37 degrees C). Azumolene (50 mu M), a more water-soluble analog of dantrolene that is used to reverse MH crises, failed to alter I-SkCRAC density or rate of activation. Together, these results indicate that while an increased rate of I-SkCRAC activation is a common characteristic of myotubes derived from Y524S/+ and dCasq-null mice and that the protective effects of azumolene are not due to a direct inhibition of SOCE channels.	[Yarotskyy, Viktor; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Protasi, Feliciano] Univ Gabriele dAnnunzio, Ctr Res Ageing, Chieti, Italy; [Protasi, Feliciano] Univ Gabriele dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	University of Rochester; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Dirksen, RT (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	robert_dirksen@urmc.rochester.edu			National Institutes of Health (NIH) [AR059646]; Italian Telethon Foundation [GGP08153]; NIH [AR060831]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059646, K01AR060831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon Foundation(Fondazione Telethon); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by: a research grant from the National Institutes of Health (NIH) (AR059646 to RTD), the Italian Telethon Foundation (GGP08153 to FP), and a career development K01 award from the NIH (AR060831 to VY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNET PJ, 1991, ANESTHESIOLOGY, V75, P413, DOI 10.1097/00000542-199109000-00006; Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Avila G, 2000, J GEN PHYSIOL, V115, P467, DOI 10.1085/jgp.115.4.467; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Capacchione JF, 2009, ANESTH ANALG, V109, P1065, DOI 10.1213/ane.0b013e3181a9d8d9; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Dirksen R. T, 1997, GENEREVIEWS GENETEST; Dirksen RT, 2009, J PHYSIOL-LONDON, V587, P3139, DOI 10.1113/jphysiol.2009.172148; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Edwards JN, 2010, CELL CALCIUM, V47, P458, DOI 10.1016/j.ceca.2010.04.001; FLETCHER JE, 1990, CAN J ANAESTH, V37, P695, DOI 10.1007/BF03006495; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Groom L, 2011, ANESTHESIOLOGY, V115, P938, DOI 10.1097/ALN.0b013e3182320068; HARRISON GG, 1975, BRIT J ANAESTH, V47, P62, DOI 10.1093/bja/47.1.62; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Larach MG, 2008, ANESTHESIOLOGY, V108, P603, DOI 10.1097/ALN.0b013e318167aee2; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Launikonis BS, 2003, P NATL ACAD SCI USA, V100, P2941, DOI 10.1073/pnas.0536227100; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; NELSON TE, 1981, J PHARMACOL EXP THER, V219, P107; NELSON TE, 1975, ANESTHESIOLOGY, V42, P301, DOI 10.1097/00000542-197503000-00011; Nishio Hajime, 2009, Legal Medicine, V11, P142, DOI 10.1016/j.legalmed.2008.12.004; Palnitkar SS, 1997, BIOCHEM J, V326, P847, DOI 10.1042/bj3260847; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Paolini C, 2011, J BIOMED BI IN PRESS; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; PARNESS J, 1995, J BIOL CHEM, V270, P18465, DOI 10.1074/jbc.270.31.18465; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Royer L, 2010, J GEN PHYSIOL, V136, P325, DOI 10.1085/jgp.201010454; Shin DW, 2003, J BIOL CHEM, V278, P3286, DOI 10.1074/jbc.M209045200; Szentesi P, 2001, J GEN PHYSIOL, V118, P355, DOI 10.1085/jgp.118.4.355; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Wappler F, 2010, CURR OPIN ANESTHESIO, V23, P417, DOI 10.1097/ACO.0b013e328337ffe0; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yarotskyy V, 2012, BIOPHYS J, V103, P202, DOI 10.1016/j.bpj.2012.06.001; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	49	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77633	10.1371/journal.pone.0077633	http://dx.doi.org/10.1371/journal.pone.0077633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143248	Green Submitted, gold, Green Published			2022-12-27	WOS:000325894100086
J	Yuan, Y; Wu, C; Liu, YJ; Yang, J; Huang, LQ				Yuan, Yuan; Wu, Chong; Liu, Yunjun; Yang, Jian; Huang, Luqi			The Scutellaria baicalensis R2R3-MYB Transcription Factors Modulates Flavonoid Biosynthesis by Regulating GA Metabolism in Transgenic Tobacco Plants	PLOS ONE			English	Article							PHENYLALANINE-AMMONIA-LYASE; GENE FAMILY; FUNCTIONAL-ANALYSIS; GIBBERELLIC-ACID; WALL FORMATION; ARABIDOPSIS; PROTEIN; ACCUMULATION; SEQUENCE; PURIFICATION	R2R3-MYB proteins play role in plant development, response to biotic and abiotic stress, and regulation of primary and secondary metabolism. Little is known about the R2R3-MYB proteins in Scutellaria baicalensis which is an important Chinese medical plant. In this paper, nineteen putative SbMYB genes were identified from a S. baicalensis cDNA library, and eleven R2R3-MYBs were clustered into 5 subgroups according to phylogenetic reconstruction. In the S. baicalensis leaves which were sprayed with GA(3), SbMYB2 and SbMYB7 had similar expression pattern with SbPALs, indicating that SbMYB2 and SbMYB7 might be involved in the flavonoid metabolism. Transactivation assay results showed that SbMYB2 and SbMYB7 can function as transcriptional activator. The expression of several flavonoid biosynthesis-related genes were induced or suppressed by overexpression of SbMYB2 or SbMYB7 in transgenic tobacco plants. Consistent with the change of the expression of NtDH29 and NtCHI, the contents of dicaffeoylspermidine and quercetin-3,7-O-diglucoside in SbMYB2-overexpressing or SbMYB7-overexpressing transgenic tobacco plants were decreased. The transcriptional level of NtUFGT in transgenic tobacco overexpressing SbMYB7 and the transcriptional level of NtHCT in SbMYB2-overexpressing tobacco plants were increased; however the application of GA3 inhibited the transcriptional level of these two genes. These results suggest that SbMYB2 and SbMYB7 might regulate the flavonoid biosynthesis through GA metabolism.	[Yuan, Yuan; Wu, Chong; Yang, Jian; Huang, Luqi] Chinese Acad Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100730, Peoples R China; [Liu, Yunjun] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; National Resource Center for Chinese Materia Medica, CACMS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Liu, YJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	liuyunjun@caas.cn; huangluqi@263.net			Scientific and technological research of Chinese medicine Program [06-07ZP51]; Beijing nova program [2008B82]; China Academy of Traditional Chinese Medicine [ZZ2008062]	Scientific and technological research of Chinese medicine Program; Beijing nova program(Beijing Municipal Science & Technology Commission); China Academy of Traditional Chinese Medicine	This work was supported by the Scientific and technological research of Chinese medicine Program (06-07ZP51), Beijing nova program (2008B82) and the Self-selection program of China Academy of Traditional Chinese Medicine (ZZ2008062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bailey PC, 2008, PHYTOCHEMISTRY, V69, P2417, DOI 10.1016/j.phytochem.2008.08.003; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blach-Olszewska Z, 2008, J INTERF CYTOK RES, V28, P571, DOI 10.1089/jir.2008.0125; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cook CM, 2012, PHYTOCHEMISTRY, V74, P79, DOI 10.1016/j.phytochem.2011.10.009; Craven-Bartle B, 2013, PLANT J, V74, P755, DOI 10.1111/tpj.12158; Czemmel S, 2012, PROTOPLASMA, V249, P109, DOI 10.1007/s00709-012-0380-z; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; El-kereamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052030; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HINDERER W, 1984, PLANTA, V160, P544, DOI 10.1007/BF00411143; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; HORSCH RB, 1985, COLD SPRING HARB SYM, V50, P433, DOI 10.1101/SQB.1985.050.01.054; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kumar V, 2013, MOL BIOTECHNOL, V54, P426, DOI 10.1007/s12033-012-9580-1; Lee MM, 2001, DEVELOPMENT, V128, P1539; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li DF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-109; Li XJ, 2003, PLANT SCI, V164, P549, DOI 10.1016/S0168-9452(03)00004-9; Liu RX, 2010, J BIOSCIENCES, V35, P435, DOI 10.1007/s12038-010-0049-8; Maeda K, 2005, PLANT MOL BIOL, V59, P739, DOI 10.1007/s11103-005-0910-6; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Morimoto S, 1998, J BIOL CHEM, V273, P12606, DOI 10.1074/jbc.273.20.12606; Mulder Nicola, 2007, V396, P59; Nagashima S, 2000, PHYTOCHEMISTRY, V53, P533, DOI 10.1016/S0031-9422(99)00593-2; Onkokesung N, 2012, PLANT PHYSIOL, V158, P389, DOI 10.1104/pp.111.187229; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; RUSSELL DW, 1969, PLANT PHYSIOL, V44, P1211, DOI 10.1104/pp.44.9.1211; Sasaki K, 2000, J BIOL CHEM, V275, P27466; Senthil-Kumar M, 2010, PLANT PHYSIOL BIOCH, V48, P35, DOI 10.1016/j.plaphy.2009.09.005; SHINOZAKI K, 1992, PLANT MOL BIOL, V19, P493, DOI 10.1007/BF00023398; Singh K, 2009, FUNCT INTEGR GENOMIC, V9, P125, DOI 10.1007/s10142-008-0092-9; Spitzer-Rimon B, 2012, PLANT CELL, V24, P5089, DOI 10.1105/tpc.112.105247; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Taguchi G, 1998, J PLANT BIOCHEM BIOT, V7, P79, DOI 10.1007/BF03263040; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu H, 2010, BIORESOURCE TECHNOL, V101, P9715, DOI 10.1016/j.biortech.2010.07.083; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946; Zhao CS, 2011, PLANT J, V66, P502, DOI 10.1111/j.1365-313X.2011.04508.x	55	19	28	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77275	10.1371/journal.pone.0077275	http://dx.doi.org/10.1371/journal.pone.0077275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143216	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100053
J	Tessereau, C; Buisson, M; Monnet, N; Imbert, M; Barjhoux, L; Schluth-Bolard, C; Sanlaville, D; Conseiller, E; Ceppi, M; Sinilnikova, OM; Mazoyer, S				Tessereau, Chloe; Buisson, Monique; Monnet, Nastasia; Imbert, Marine; Barjhoux, Laure; Schluth-Bolard, Caroline; Sanlaville, Damien; Conseiller, Emmanuel; Ceppi, Maurizio; Sinilnikova, Olga M.; Mazoyer, Sylvie			Direct Visualization of the Highly Polymorphic RNU2 Locus in Proximity to the BRCA1 Gene	PLOS ONE			English	Article							COPY NUMBER VARIATION; SMALL NUCLEAR-RNA; PRIMATE U2 SNRNA; HUMAN GENOME; CONCERTED EVOLUTION; CHROMOSOME 17Q21; PHYSICAL MAP; HYBRID MAP; BREAST; REGION	Although the breast cancer susceptibility gene BRCA1 is one of the most extensively characterized genetic loci, much less is known about its upstream variable number tandem repeat element, the RNU2 locus. RNU2 encodes the U2 small nuclear RNA, an essential splicing element, but this locus is missing from the human genome assembly due to the inherent difficulty in the assembly of repetitive sequences. To fill the gap between RNU2 and BRCA1, we have reconstructed the physical map of this region by re-examining genomic clone sequences of public databases, which allowed us to precisely localize the RNU2 array 124 kb telomeric to BRCA1. We measured by performing FISH analyses on combed DNA for the first time the exact number of repeats carried by each of the two alleles in 41 individuals and found a range of 6-82 copies and a level of heterozygosity of 98%. The precise localisation of the RNU2 locus in the genome reference assembly and the implementation of a new technical tool to study it will make the detailed exploration of this locus possible. This recently neglected macrosatellite could be valuable for evaluating the potential role of structural variations in disease due to its location next to a major cancer susceptibility gene.	[Tessereau, Chloe; Buisson, Monique; Monnet, Nastasia; Imbert, Marine; Barjhoux, Laure; Sinilnikova, Olga M.; Mazoyer, Sylvie] Univ Lyon 1, Ctr Berard Lyon, Genet Breast Canc Team, Canc Res Ctr Lyon,CNRS,Inserm,U1052,UMR5286, F-69365 Lyon, France; [Tessereau, Chloe; Conseiller, Emmanuel; Ceppi, Maurizio] Genom Vis, Bagneux, France; [Schluth-Bolard, Caroline; Sanlaville, Damien] Univ Lyon 1, Equipe TIGER, Hosp Civils Lyon, Serv Genet,Lab Cytogenet Constitut,Ctr Biol & Est, F-69365 Lyon, France; [Schluth-Bolard, Caroline; Sanlaville, Damien] Univ Lyon 1, Equipe TIGER, INSERM, CNRS,UMR5292,U1028, F-69365 Lyon, France; [Sinilnikova, Olga M.] Hosp Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitut Canc Frequents, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UNICANCER; Centre Leon Berard	Mazoyer, S (corresponding author), Univ Lyon 1, Ctr Berard Lyon, Genet Breast Canc Team, Canc Res Ctr Lyon,CNRS,Inserm,U1052,UMR5286, F-69365 Lyon, France.	sylvie.mazoyer@lyon.unicancer.fr	Mazoyer, Sylvie/N-7559-2017; Schluth-Bolard, Caroline/AAF-3862-2019; Sanlaville, Damien/M-4716-2014	Sanlaville, Damien/0000-0001-9939-2849; Schluth-Bolard, Caroline/0000-0002-2279-4273; Mazoyer, Sylvie/0000-0002-2135-0160	Fondation ARC pour la Recherche sur le Cancer	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by a grant from the "Fondation ARC pour la Recherche sur le Cancer" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; BAILEY AD, 1995, MOL CELL BIOL, V15, P6246; BLACK DM, 1993, AM J HUM GENET, V52, P702; Cheeseman K, 2012, HUM MUTAT, V33, P998, DOI 10.1002/humu.22060; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FLEJTER WL, 1993, GENOMICS, V17, P624, DOI 10.1006/geno.1993.1382; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; HAMMARSTROM K, 1985, EXP CELL RES, V159, P473, DOI 10.1016/S0014-4827(85)80020-3; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Jia YC, 2012, CELL, V148, P296, DOI 10.1016/j.cell.2011.11.057; Liao DQ, 1997, EMBO J, V16, P588, DOI 10.1093/emboj/16.3.588; LINDGREN V, 1985, NATURE, V314, P115, DOI 10.1038/314115a0; Liu XD, 1999, AM J HUM GENET, V64, P1427, DOI 10.1086/302358; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; Pavelitz T, 1999, EMBO J, V18, P3783, DOI 10.1093/emboj/18.13.3783; PAVELITZ T, 1995, EMBO J, V14, P169, DOI 10.1002/j.1460-2075.1995.tb06987.x; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schaap M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-143; Schluth-Bolard C, 2009, EUR J MED GENET, V52, P291, DOI 10.1016/j.ejmg.2009.05.011; Sinilnikova OM, 2006, FAM CANCER, V5, P15, DOI 10.1007/s10689-005-2571-7; Tremblay DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-632; VANARSDELL SW, 1984, MOL CELL BIOL, V4, P492, DOI 10.1128/MCB.4.3.492; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; WESTIN G, 1984, P NATL ACAD SCI-BIOL, V81, P3811, DOI 10.1073/pnas.81.12.3811; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2	36	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76054	10.1371/journal.pone.0076054	http://dx.doi.org/10.1371/journal.pone.0076054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146815	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400036
J	Tey, SK; Kennedy, GA; Cromer, D; Davenport, MP; Walker, S; Jones, LI; Crough, T; Durrant, ST; Morton, JA; Butler, JP; Misra, AK; Hill, GR; Khanna, R				Tey, Siok-Keen; Kennedy, Glen A.; Cromer, Deborah; Davenport, Miles P.; Walker, Susan; Jones, Linda I.; Crough, Tania; Durrant, Simon T.; Morton, James A.; Butler, Jason P.; Misra, Ashish K.; Hill, Geoffrey R.; Khanna, Rajiv			Clinical Assessment of Anti-Viral CD8+T Cell Immune Monitoring Using QuantiFERON-CMV (R) Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications	PLOS ONE			English	Article							CYTOMEGALOVIRUS-SPECIFIC CD4(+); MEDIATED-IMMUNITY; QUANTIFERON(R)-CMV ASSAY; RECIPIENTS; RECONSTITUTION; RESPONSES; PREDICTION; RECURRENT; THERAPY; DISEASE	The reconstitution of anti-viral cellular immunity following hematopoietic stem cell transplantation (HSCT) is crucial in preventing cytomegalovirus (CMV)-associated complications. Thus immunological monitoring has emerged as an important tool to better target pre-emptive anti-viral therapies. However, traditional laboratory-based assays are too cumbersome and complicated to implement in a clinical setting. Here we conducted a prospective study of a new whole blood assay (referred to as QuantiFERON-CMV (R)) to determine the clinical utility of measuring CMV-specific CD8+ T-cell responses as a prognostic tool. Forty-one evaluable allogeneic HSCT recipients underwent weekly immunological monitoring from day 21 post-transplant and of these 21 (51.2%) showed CMV reactivation and 29 (70.7%) developed acute graft-versus-host disease (GvHD). Patients with acute GvHD (grade >= 2) within 6 weeks of transplant showed delayed reconstitution of CMV-specific T-cell immunity (p = 0.013) and a higher risk of CMV viremia (p = 0.026). The median time to stable CMV-specific immune reconstitution was 59 days and the incidence of CMV reactivation was lower in patients who developed this than those who did not (27% versus 65%; p = 0.031). Furthermore, a failure to reconstitute CMV-specific immunity soon after the onset of CMV viraemia was associated with higher peak viral loads (5685 copies/ml versus 875 copies/ml; p = 0.002). Hence, QuantiFERON-CMV (R) testing in the week following CMV viremia can be useful in identifying HSCT recipients at risk of complicated reactivation.	[Tey, Siok-Keen; Walker, Susan; Jones, Linda I.; Crough, Tania; Khanna, Rajiv] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Herston, Qld 4006, Australia; [Tey, Siok-Keen; Walker, Susan; Jones, Linda I.; Crough, Tania; Khanna, Rajiv] Queensland Inst Med Res, Tumour Immunol Lab, Herston, Qld 4006, Australia; [Tey, Siok-Keen; Kennedy, Glen A.; Durrant, Simon T.; Morton, James A.; Butler, Jason P.; Misra, Ashish K.; Hill, Geoffrey R.] Royal Brisbane & Womens Hosp, Dept Haematol & Bone Marrow Transplantat, Herston, Qld, Australia; [Hill, Geoffrey R.] Queensland Inst Med Res, Bone Marrow Transplant Lab, Herston, Qld 4006, Australia; [Tey, Siok-Keen; Kennedy, Glen A.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Cromer, Deborah; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Kensington, NSW 2033, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; University of Queensland; University of New South Wales Sydney	Khanna, R (corresponding author), Queensland Inst Med Res, Australian Ctr Vaccine Dev, Bramston Terrace, Herston, Qld 4006, Australia.	rajiv.khanna@qimr.edu.au	Hill, Geoffrey/O-2630-2016; Tey, Siok-Keen/I-6380-2015; Khanna, Rajiv/A-7691-2008; Kennedy, Glen/AAK-1644-2021; Kennedy, Glen/F-4728-2013	Hill, Geoffrey/0000-0003-2994-0429; Tey, Siok-Keen/0000-0001-9567-382X; Khanna, Rajiv/0000-0003-2241-0353; Kennedy, Glen/0000-0002-7171-0435; Davenport, Miles/0000-0002-4751-1831; Cromer, Deborah/0000-0002-5276-5094	National Health and Medical Research Council (NHMRC), Australia; NHMRC; Leukaemia Foundation of Australia	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation of Australia	RK is supported by a Senior Principal Research Fellowship by the National Health and Medical Research Council (NH&MRC), Australia. GRH is supported by an Australia Fellowship by NH&MRC. SKT was supported by a PhD Fellowship by the Leukaemia Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avetisyan G, 2007, BONE MARROW TRANSPL, V40, P865, DOI 10.1038/sj.bmt.1705825; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Borchers S, 2011, TRANSPL INFECT DIS, V13, P222, DOI 10.1111/j.1399-3062.2011.00626.x; Cantoni N, 2010, BIOL BLOOD MARROW TR, V16, P1309, DOI 10.1016/j.bbmt.2010.03.020; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Feuchtinger T, BLOOD, V116, P4360; Fleming T, 2010, J MED VIROL, V82, P433, DOI 10.1002/jmv.21727; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Giulieri S, 2011, EXPERT REV MOL DIAGN, V11, P17, DOI [10.1586/erm.10.109, 10.1586/ERM.10.109]; Gratama JW, 2008, CYTOM PART B-CLIN CY, V74B, P211, DOI 10.1002/cyto.b.20420; Gratama JW, 2010, BLOOD, V116, P1655, DOI 10.1182/blood-2010-03-273508; Kumar D, 2009, AM J TRANSPLANT, V9, P1214, DOI 10.1111/j.1600-6143.2009.02618.x; Lamba R, 2005, BONE MARROW TRANSPL, V36, P797, DOI 10.1038/sj.bmt.1705121; Lilleri D, 2008, HAEMATOLOGICA, V93, P248, DOI 10.3324/haematol.11912; Lilleri D, 2006, BLOOD, V108, P1406, DOI 10.1182/blood-2005-11-012864; Lilleri D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041648; Lilleri D, 2009, CLIN IMMUNOL, V131, P395, DOI 10.1016/j.clim.2009.02.002; Lisboa LF, 2012, TRANSPLANTATION, V93, P195, DOI 10.1097/TP.0b013e31823c1cd4; Lochmanova A, 2010, TRANSPL P, V42, P3574, DOI 10.1016/j.transproceed.2010.07.101; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Moins-Teisserenc H, 2008, J INFECT DIS, V198, P818, DOI 10.1086/591185; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Solano C, 2011, TRANSPLANTATION, V92, pE17, DOI 10.1097/TP.0b013e318224f263; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x	25	59	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e74744	10.1371/journal.pone.0074744	http://dx.doi.org/10.1371/journal.pone.0074744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146744	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400003
J	Chiu, HW; Yeh, YL; Wang, YC; Huang, WJ; Chen, YA; Chiou, YS; Ho, SY; Lin, PP; Wang, YJ				Chiu, Hui-Wen; Yeh, Ya-Ling; Wang, Yi-Ching; Huang, Wei-Jan; Chen, Yi-An; Chiou, Yi-Shiou; Ho, Sheng-Yow; Lin, Pinpin; Wang, Ying-Jan			Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; DNA-DAMAGE; CELL-DEATH; COMBINATION TREATMENT; RADIATION RESPONSE; PANCREATIC-CANCER; ARSENIC TRIOXIDE; AUTOPHAGY; VORINOSTAT; EXPRESSION	Triple-negative breast cancer (TNBC), defined by the absence of an estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression, is associated with an early recurrence of disease and poor outcome. Furthermore, the majority of deaths in breast cancer patients are from metastases instead of from primary tumors. In this study, MCF-7 (an estrogen receptor-positive human breast cancer cell line), MDA-MB-231 (a human TNBC cell line) and 4T1 (a mouse TNBC cell line) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with suberoylanilide hydroxamic acid (SAHA, an inhibitor of histone deacetylase (HDAC)) and to determine the underlying mechanisms of these effects in vitro and in vivo. We also evaluated the ability of SAHA to inhibit the metastasis of 4T1 cells. We found that IR combined with SAHA showed increased therapeutic efficacy when compared with either treatment alone in MCF-7, MDA-MB-231 and 4T1 cells. Moreover, the combined treatment enhanced DNA damage through the inhibition of DNA repair proteins. The combined treatment was induced primarily through autophagy and ER stress. In an orthotopic breast cancer mouse model, the combination treatment showed a greater inhibition of tumor growth. In addition, SAHA inhibited the migration and invasion abilities of 4T1 cells and inhibited breast cancer cell migration by inhibiting the activity of MMP-9. In an in vivo experimental metastasis mouse model, SAHA significantly inhibited lung metastasis. SAHA not only enhances radiosensitivity but also suppresses lung metastasis in breast cancer. These novel findings suggest that SAHA alone or combined with IR could serve as a potential therapeutic strategy for breast cancer.	[Chiu, Hui-Wen; Yeh, Ya-Ling; Chen, Yi-An; Chiou, Yi-Shiou; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Huang, Wei-Jan] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Chiou, Yi-Shiou] Natl Kaohsiung Marine Univ, Dept Seafood Sci, Kaohsiung, Taiwan; [Ho, Sheng-Yow] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan	National Cheng Kung University; National Cheng Kung University; Taipei Medical University; National Kaohsiung University of Science & Technology; Chi Mei Hospital; National Health Research Institutes - Taiwan	Lin, PP (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan.	pplin@nhri.org.tw; yjwang@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019; Lin, Pinpin/B-2668-2010; Lin, PinPin/A-2006-2019	Wang, Yi-Ching/0000-0002-7694-2067; Lin, Pinpin/0000-0001-5459-907X; Lin, PinPin/0000-0001-5459-907X	National Science Council, Taiwan [NSC101-2314-B-006-050, NSC100-2325-B-400-012]; Sinlau Christian Hospital, Tainan, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Sinlau Christian Hospital, Tainan, Taiwan	This study was supported by the National Science Council, Taiwan (NSC101-2314-B-006-050 and NSC100-2325-B-400-012) and the Sinlau Christian Hospital, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Baschnagel A, 2009, MOL CANCER THER, V8, P1589, DOI 10.1158/1535-7163.MCT-09-0038; Blattmann C, 2010, INT J RADIAT ONCOL, V78, P237, DOI 10.1016/j.ijrobp.2010.03.010; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brem GJ, 2013, GYNECOL ONCOL, V128, P383, DOI 10.1016/j.ygyno.2012.10.021; Camphausen K, 2007, J CLIN ONCOL, V25, P4051, DOI 10.1200/JCO.2007.11.6202; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chinnaiyan P, 2005, INT J RADIAT ONCOL, V62, P223, DOI 10.1016/j.ijrobp.2004.12.088; Chiu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040462; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cupic DF, 2011, COLLEGIUM ANTROPOL, V35, P7; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Flatmark K, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-25; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Groselj B, 2013, BR J CANC; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; He L, 2009, FEBS LETT, V583, P903, DOI 10.1016/j.febslet.2009.02.002; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Liu YL, 2010, AUTOPHAGY, V6, P1057, DOI 10.4161/auto.6.8.13365; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Loos B, 2013, AUTOPHAGY, V9, P1270, DOI 10.4161/auto.25560; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672; Marcilla-Etxenike A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048235; McArt DG, 2010, MUTAGENESIS, V25, P299, DOI 10.1093/mutage/geq006; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moretti L, 2007, CELL CYCLE, V6, P793, DOI 10.4161/cc.6.7.4036; Mukubou H, 2010, INT J ONCOL, V37, P821, DOI 10.3892/ijo_00000732; Munshi A, 2006, MOL CANCER THER, V5, P1967, DOI 10.1158/1535-7163.MCT-06-0022; Paglin S, 2001, CANCER RES, V61, P439; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Rieber M, 2008, CANCER BIOL THER, V7, P1561, DOI 10.4161/cbt.7.10.6540; Robert C, 2012, ADV CANCER RES, V116, P87, DOI 10.1016/B978-0-12-394387-3.00003-3; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shieh JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030240; Shubassi G, 2012, CANCER RES, V72, P1332, DOI 10.1158/0008-5472.CAN-11-3172; Sun Y, 2009, POSTGRAD MED J, V85, P134, DOI 10.1136/pgmj.2008.072629; Tang FY, 2008, J NUTR BIOCHEM, V19, P287, DOI 10.1016/j.jnutbio.2007.03.003; UCKUN FM, 1991, BLOOD, V78, P2945; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Zhang F, 2009, CANCER BIOL THER, V8, P823, DOI 10.4161/cbt.8.9.8143; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455	57	58	61	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76340	10.1371/journal.pone.0076340	http://dx.doi.org/10.1371/journal.pone.0076340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130769	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200034
J	Dam, B; Dam, S; Blom, J; Liesack, W				Dam, Bomba; Dam, Somasri; Blom, Jochen; Liesack, Werner			Genome Analysis Coupled with Physiological Studies Reveals a Diverse Nitrogen Metabolism in Methylocystis sp Strain SC2	PLOS ONE			English	Article							PARTICULATE METHANE MONOOXYGENASE; METHYLOCOCCUS-CAPSULATUS BATH; 16S RIBOSOMAL-RNA; ACTIVE METHANOTROPHIC COMMUNITY; POLY-BETA-HYDROXYBUTYRATE; LANDFILL COVER SOIL; ESCHERICHIA-COLI; OXIDIZING BACTERIA; SP NOV.; OBLIGATE METHANOTROPH	Background: Methylocystis sp. strain SC2 can adapt to a wide range of methane concentrations. This is due to the presence of two isozymes of particulate methane monooxygenase exhibiting different methane oxidation kinetics. To gain insight into the underlying genetic information, its genome was sequenced and found to comprise a 3.77 Mb chromosome and two large plasmids. Principal Findings: We report important features of the strain SC2 genome. Its sequence is compared with those of seven other methanotroph genomes, comprising members of the Alphaproteobacteria, Gammaproteobacteria, and Verrucomicrobia. While the pan-genome of all eight methanotroph genomes totals 19,358 CDS, only 154 CDS are shared. The number of core genes increased with phylogenetic relatedness: 328 CDS for proteobacterial methanotrophs and 1,853 CDS for the three alphaproteobacterial Methylocystaceae members, Methylocystis sp. strain SC2 and strain Rockwell, and Methylosinus trichosporium OB3b. The comparative study was coupled with physiological experiments to verify that strain SC2 has diverse nitrogen metabolism capabilities. In correspondence to a full complement of 34 genes involved in N-2 fixation, strain SC2 was found to grow with atmospheric N-2 as the sole nitrogen source, preferably at low oxygen concentrations. Denitrification-mediated accumulation of 0.7 nmol N-30(2)/hr/mg dry weight of cells under anoxic conditions was detected by tracer analysis. N-2 production is related to the activities of plasmid-borne nitric oxide and nitrous oxide reductases. Conclusions/Perspectives: Presence of a complete denitrification pathway in strain SC2, including the plasmid-encoded nosRZDFYX operon, is unique among known methanotrophs. However, the exact ecophysiological role of this pathway still needs to be elucidated. Detoxification of toxic nitrogen compounds and energy conservation under oxygen-limiting conditions are among the possible roles. Relevant features that may stimulate further research are, for example, absence of CRISPR/Cas systems in strain SC2, high number of iron acquisition systems in strain OB3b, and large number of transposases in strain Rockwell.	[Dam, Bomba; Dam, Somasri; Liesack, Werner] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Dam, Bomba; Dam, Somasri; Liesack, Werner] Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Blom, Jochen] Univ Bielefeld, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany	Max Planck Society; Philipps University Marburg; University of Bielefeld	Liesack, W (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	liesack@mpi-marburg.mpg.de	DAM, BOMBA/AAT-6036-2020	DAM, BOMBA/0000-0003-2417-2088; Liesack, Werner/0000-0002-9533-1552	LOEWE Research Center for Synthetic Microbiology (SYNMIKRO); Alexander von Humboldt Foundation; German Federal Ministry of Education and Research [0315599A, 0315599B]	LOEWE Research Center for Synthetic Microbiology (SYNMIKRO); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was funded by the LOEWE Research Center for Synthetic Microbiology (SYNMIKRO). BD is grateful to the Alexander von Humboldt Foundation for his fellowship. JB acknowledges funding by the German Federal Ministry of Education and Research (grants 0315599A & 0315599B "GenoMik-Transfer''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Auman AJ, 2001, APPL ENVIRON MICROB, V67, P4009, DOI 10.1128/AEM.67.9.4009-4016.2001; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Baani M, 2008, P NATL ACAD SCI USA, V105, P10203, DOI 10.1073/pnas.0702643105; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; BEDARD C, 1989, MICROBIOL REV, V53, P68; Belova SE, 2011, ENV MICROBIOL REP, V3, P36, DOI 10.1111/j.1758-2229.2010.00180.x; Bergmann DJ, 1998, J BACTERIOL, V180, P6440, DOI 10.1128/JB.180.24.6440-6445.1998; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boden R, 2011, J BACTERIOL, V193, P7001, DOI 10.1128/JB.06267-11; BOWMAN JP, 1993, INT J SYST BACTERIOL, V43, P735, DOI 10.1099/00207713-43-4-735; Braker G, 2010, FEMS MICROBIOL ECOL, V73, P134, DOI 10.1111/j.1574-6941.2010.00884.x; BUURMAN ET, 1991, ARCH MICROBIOL, V155, P391; Campbell MA, 2011, FEMS MICROBIOL LETT, V322, P82, DOI 10.1111/j.1574-6968.2011.02340.x; Cebron A, 2007, FEMS MICROBIOL ECOL, V62, P12, DOI 10.1111/j.1574-6941.2007.00368.x; Chen Y, 2008, ENVIRON MICROBIOL, V10, P446, DOI 10.1111/j.1462-2920.2007.01466.x; Chen Y, 2007, ENVIRON MICROBIOL, V9, P2855, DOI 10.1111/j.1462-2920.2007.01401.x; Chen Y, 2010, J BACTERIOL, V192, P3840, DOI 10.1128/JB.00506-10; DALTON H, 1976, ARCH MICROBIOL, V109, P147, DOI 10.1007/BF00425127; Dam B, 2012, J BACTERIOL, V194, P6008, DOI 10.1128/JB.01446-12; Dam B, 2012, APPL ENVIRON MICROB, V78, P4373, DOI 10.1128/AEM.00628-12; DEBONT JAM, 1974, J GEN MICROBIOL, V83, P113, DOI 10.1099/00221287-83-1-113; Dedysh SN, 2004, MICROBIOL-SGM, V150, P1301, DOI 10.1099/mic.0.26585-0; Dedysh SN, 2003, FEMS MICROBIOL ECOL, V43, P299, DOI 10.1111/j.1574-6941.2003.tb01070.x; Dedysh SN, 2002, INT J SYST EVOL MICR, V52, P251, DOI 10.1099/00207713-52-1-251; Dedysh SN, 2007, INT J SYST EVOL MICR, V57, P472, DOI 10.1099/ijs.0.64623-0; del Cerro C, 2012, J BACTERIOL, V194, P5709, DOI 10.1128/JB.01346-12; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dunfield PF, 2002, FEMS MICROBIOL ECOL, V41, P17, DOI 10.1111/j.1574-6941.2002.tb00962.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eller G, 2001, APPL ENVIRON MICROB, V67, P2395, DOI 10.1128/AEM.67.6.2395-2403.2001; Elmore BO, 2007, FEBS LETT, V581, P911, DOI 10.1016/j.febslet.2007.01.068; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Garcia-Martinez J, 2001, NUCLEIC ACIDS RES, V29, P178, DOI 10.1093/nar/29.1.178; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Helling RB, 1998, J BACTERIOL, V180, P4571, DOI 10.1128/JB.180.17.4571-4575.1998; Hendrickson H, 2007, MOL MICROBIOL, V64, P42, DOI 10.1111/j.1365-2958.2007.05596.x; Heyer J, 2002, MICROBIOL-SGM, V148, P2831, DOI 10.1099/00221287-148-9-2831; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Horz HP, 2001, APPL ENVIRON MICROB, V67, P4177, DOI 10.1128/AEM.67.9.4177-4185.2001; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Im J, 2011, ENV MICROBIOL REP, V3, P174, DOI 10.1111/j.1758-2229.2010.00204.x; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Khadem AF, 2012, J BACTERIOL, V194, P3729, DOI 10.1128/JB.00501-12; Khadem AF, 2010, MICROBIOL-SGM, V156, P1052, DOI 10.1099/mic.0.036061-0; Kits KD, 2013, GENOME ANNOUNC, V1; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Knief C, 2003, APPL ENVIRON MICROB, V69, P6703, DOI 10.1128/AEM.69.11.6703-6714.2003; Knief C, 2006, ENVIRON MICROBIOL, V8, P321, DOI 10.1111/j.1462-2920.2005.00898.x; KOHLER T, 1989, J BACTERIOL, V171, P4326; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kolsto AB, 1997, MOL MICROBIOL, V24, P241, DOI 10.1046/j.1365-2958.1997.3501715.x; Kono N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-19; Lapidus A, 2011, J BACTERIOL, V193, P3757, DOI 10.1128/JB.00404-11; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Lindner AS, 2007, INT J SYST EVOL MICR, V57, P1891, DOI 10.1099/ijs.0.64541-0; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Matsugi J, 2004, BBA-GENE STRUCT EXPR, V1676, P23, DOI 10.1016/j.bbaexp.2003.10.003; McDonald IR, 1997, FEMS MICROBIOL LETT, V156, P205, DOI 10.1016/S0378-1097(97)00425-4; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MURRELL JC, 1983, J GEN MICROBIOL, V129, P3481; Nauer PA, 2012, BIOGEOSCIENCES, V9, P2259, DOI 10.5194/bg-9-2259-2012; Ngugi DK, 2012, ENVIRON MICROBIOL, V14, P860, DOI 10.1111/j.1462-2920.2011.02648.x; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Nyerges G, 2010, APPL ENVIRON MICROB, V76, P5648, DOI 10.1128/AEM.00747-10; Nyerges G, 2009, FEMS MICROBIOL LETT, V297, P131, DOI 10.1111/j.1574-6968.2009.01674.x; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Pieja AJ, 2011, MICROB ECOL, V62, P564, DOI 10.1007/s00248-011-9873-0; Pieja AJ, 2011, APPL ENVIRON MICROB, V77, P6012, DOI 10.1128/AEM.00509-11; Poret-Peterson AT, 2008, ISME J, V2, P1213, DOI 10.1038/ismej.2008.71; Qin L, 2005, WATER RES, V39, P1503, DOI 10.1016/j.watres.2005.01.025; Radajewski S, 2002, MICROBIOL-SGM, V148, P2331, DOI 10.1099/00221287-148-8-2331; Ren T, 2000, APPL ENVIRON MICROB, V66, P3891, DOI 10.1128/AEM.66.9.3891-3897.2000; Ricke P, 2004, APPL ENVIRON MICROB, V70, P3055, DOI 10.1128/AEM.70.5.3055-3063.2004; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; SEMRAU JD, 1995, J BACTERIOL, V177, P3071, DOI 10.1128/jb.177.11.3071-3079.1995; Sernova NV, 2008, BRIEF BIOINFORM, V9, P376, DOI 10.1093/bib/bbn031; SHONNARD DR, 1992, APPL ENVIRON MICROB, V58, P2737, DOI 10.1128/AEM.58.9.2737-2743.1992; Stein LY, 2011, BIOCHEM SOC T, V39, P1826, DOI 10.1042/BST20110712; Stein LY, 2011, J BACTERIOL, V193, P2668, DOI 10.1128/JB.00278-11; Stein LY, 2011, METHOD ENZYMOL, V486, P131, DOI [10.1016/B978-0-12-381294-0.00006-7, 10.1016/S0076-6879(11)86006-4]; Stein LY, 2010, J BACTERIOL, V192, P6497, DOI 10.1128/JB.01144-10; Steingruber SM, 2001, APPL ENVIRON MICROB, V67, P3771, DOI 10.1128/AEM.67.9.3771-3778.2001; Strobel T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-465; Sutka RL, 2003, RAPID COMMUN MASS SP, V17, P738, DOI 10.1002/RCM.968; Sutka RL, 2006, APPL ENVIRON MICROB, V72, P638, DOI 10.1128/AEM.72.1.638-644.2006; Svenning MM, 2011, J BACTERIOL, V193, P6418, DOI 10.1128/JB.05380-11; TAKEDA K, 1988, A VAN LEEUW J MICROB, V54, P521, DOI 10.1007/BF00588388; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TOUKDARIAN AE, 1984, J GEN MICROBIOL, V130, P1827; Vecherskaya M, 2009, ENV MICROBIOL REP, V1, P442, DOI 10.1111/j.1758-2229.2009.00069.x; Vuilleumier S, 2012, J BACTERIOL, V194, P551, DOI 10.1128/JB.06392-11; Waibel AE, 1999, SCIENCE, V283, P2064, DOI 10.1126/science.283.5410.2064; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P541, DOI 10.1099/ijs.0.63912-0; Weiss V, 2002, J MOL MICROB BIOTECH, V4, P229; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yoon S, 2011, METHOD ENZYMOL, P247, DOI 10.1016/B978-0-12-386905-0.00016-4; YOSHINARI T, 1976, BIOCHEM BIOPH RES CO, V69, P705, DOI 10.1016/0006-291X(76)90932-3; ZAHN JA, 1994, J BACTERIOL, V176, P5879, DOI 10.1128/jb.176.19.5879-5887.1994; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; ZHIVOTCHENKO AG, 1995, BIOPROCESS ENG, V14, P9, DOI 10.1007/s004490050177; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	119	42	45	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e74767	10.1371/journal.pone.0074767	http://dx.doi.org/10.1371/journal.pone.0074767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130670	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200002
J	Ferracci, J; Ueno, H; Numayama-Tsuruta, K; Imai, Y; Yamaguchi, T; Ishikawa, T				Ferracci, Jonathan; Ueno, Hironori; Numayama-Tsuruta, Keiko; Imai, Yohsuke; Yamaguchi, Takami; Ishikawa, Takuji			Entrapment of Ciliates at the Water-Air Interface	PLOS ONE			English	Article							BACTERIA; MODEL	The importance of water-air interfaces (WAI) on microorganism activities has been recognized by many researchers. In this paper, we report a novel phenomenon: the entrapment of ciliates Tetrahymena at the WAI. We first characterized the behavior of cells at the interface and showed that the cells' swimming velocity was considerably reduced at the WAI. To verify the possible causes of the entrapment, we investigated the effects of positive chemotaxis for oxygen, negative geotaxis and surface properties. Even though the taxes were still effective, the entrapment phenomenon was not dependent on the physiological conditions, but was instead affected by the physical properties at the interface. This knowledge is useful for a better understanding of the physiology of microorganisms at interfaces in nature and in industry.	[Ferracci, Jonathan] Tohoku Univ, Dept Engn, Sendai, Miyagi 980, Japan; [Numayama-Tsuruta, Keiko; Yamaguchi, Takami] Tohoku Univ, Dept Biomed Engn, Sendai, Miyagi 980, Japan; [Imai, Yohsuke; Ishikawa, Takuji] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Ferracci, J (corresponding author), Tohoku Univ, Dept Engn, Sendai, Miyagi 980, Japan.	jferracci@pfsl.mech.tohoku.ac.jp; ishikawa@pfsl.mech.tohoku.ac.jp	Imai, Yohsuke/D-9977-2017	Imai, Yohsuke/0000-0002-4856-3799; Numayama-Tsuruta, Keiko/0000-0001-6969-6489; Ishikawa, Takuji/0000-0002-3573-8414	NEXT program from JSPS; Grants-in-Aid for Scientific Research [24680048] Funding Source: KAKEN	NEXT program from JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the NEXT program from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berke AP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.038102; Blawzdziewicz J, 1999, PHYS FLUIDS, V11, P251, DOI 10.1063/1.869875; Crowdy D, 2011, J FLUID MECH, V681, P24, DOI 10.1017/jfm.2011.223; Drescher K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.168101; Edwards D.A., 1991, INTERFACIAL TRANSPOR; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Giacche D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056309; GLASSMAN HN, 1948, BACTERIOL REV, V12, P105, DOI 10.1128/MMBR.12.2.105-148.1948; Ishikawa T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.028102; Ishikawa T, 2006, J FLUID MECH, V568, P119, DOI 10.1017/S0022112006002631; Kristiansen TB, 1996, J CELL PHYSIOL, V169, P139, DOI 10.1002/(SICI)1097-4652(199610)169:1<139::AID-JCP14>3.0.CO;2-8; Lauga E, 2006, BIOPHYS J, V90, P400, DOI 10.1529/biophysj.105.069401; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; LEICK V, 1983, ANAL BIOCHEM, V135, P466, DOI 10.1016/0003-2697(83)90713-3; Llopis I, 2010, J NON-NEWTON FLUID, V165, P946, DOI 10.1016/j.jnnfm.2010.01.023; Marcos, 2011, P NATL ACAD SCI USA, V108, P3860, DOI 10.1073/pnas.1014576108; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; NOEVER DA, 1994, BIOPHYS J, V67, P2090, DOI 10.1016/S0006-3495(94)80692-7; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; Samanta S, 2011, CHEM ENG RES DES, V89, P2344, DOI 10.1016/j.cherd.2011.04.006; Schafer A, 1998, ENVIRON SCI TECHNOL, V32, P3704, DOI 10.1021/es980191u; Spagnolie SE, 2012, J FLUID MECH, V700, P105, DOI 10.1017/jfm.2012.101	22	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75238	10.1371/journal.pone.0075238	http://dx.doi.org/10.1371/journal.pone.0075238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130692	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200006
J	Gonsalves, L; Bicknell, B; Law, B; Webb, C; Monamy, V				Gonsalves, Leroy; Bicknell, Brian; Law, Brad; Webb, Cameron; Monamy, Vaughan			Mosquito Consumption by Insectivorous Bats: Does Size Matter?	PLOS ONE			English	Article							LONG-EARED BATS; LUCIFUGUS CHIROPTERA-VESPERTILIONIDAE; NYCTALUS-LEISLERI; ARTHROPOD PREY; BODY SIZE; ECHOLOCATION; DIET; MYOTIS; ASSEMBLAGES; AUSTRALIA	Insectivorous bats have often been touted as biological control for mosquito populations. However, mosquitoes generally represent only a small proportion of bat diet. Given the small size of mosquitoes, restrictions imposed on prey detectability by low frequency echolocation, and variable field metabolic rates (FMR), mosquitoes may not be available to or profitable for all bats. This study investigated whether consumption of mosquitoes was influenced by bat size, which is negatively correlated with echolocation frequency but positively correlated with bat FMR. To assess this, we investigated diets of five eastern Australian bat species (Vespadelus vulturnus Thomas, V. pumilus Gray, Miniopterus australis Tomes, Nyctophilus gouldi Tomes and Chalinolobus gouldii Gray) ranging in size from 4-14 g in coastal forest, using molecular analysis of fecal DNA. Abundances of potential mosquito and non-mosquito prey were concurrently measured to provide data on relative prey abundance. Aedes vigilax was locally the most abundant mosquito species, while Lepidoptera the most abundant insect order. A diverse range of prey was detected in bat feces, although members of Lepidoptera dominated, reflecting relative abundance at trap sites. Consumption of mosquitoes was restricted to V. vulturnus and V. pumilus, two smaller sized bats (4 and 4.5 g). Although mosquitoes were not commonly detected in feces of V. pumilus, they were present in feces of 55 % of V. vulturnus individuals. To meet nightly FMR requirements, Vespadelus spp. would need to consume similar to 600-660 mosquitoes on a mosquito-only diet, or similar to 160-180 similar sized moths on a moth-only diet. Lower relative profitability of mosquitoes may provide an explanation for the low level of mosquito consumption among these bats and the absence of mosquitoes in feces of larger bats. Smaller sized bats, especially V. vulturnus, are likely to be those most sensitive to reductions in mosquito abundance and should be monitored during mosquito control activities.	[Gonsalves, Leroy; Bicknell, Brian; Monamy, Vaughan] Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia; [Law, Brad] Forest Sci Ctr, Dept Primary Ind, North Parramatta, NSW, Australia; [Webb, Cameron] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Med Entomol, Westmead, NSW 2145, Australia; [Webb, Cameron] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW 2145, Australia	Australian Catholic University; University of Sydney; University of Sydney	Gonsalves, L (corresponding author), Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia.	leroy.gonsalves@acu.edu.au		Law, Bradley/0000-0002-3991-3865; Webb, Cameron/0000-0003-1029-5140	New South Wales Environmental Trust	New South Wales Environmental Trust	Funding for this research was provided by the New South Wales Environmental Trust (http://www.environment.nsw.gov.au/grants?/envtrust.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BARCLAY RMR, 1991, CAN J ZOOL, V69, P1853, DOI 10.1139/z91-256; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Bell K. M., 1989, Arbovirus research in Australia. Proceedings Fifth Symposium, August 28-September 1, 1989, Brisbane, Australia., P168; Bell SAJ, 2004, NATURAL VEGETATION G, V2; BELWOOD JJ, 1976, CAN J ZOOL, V54, P1674, DOI 10.1139/z76-194; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Bradshaw PA, 1996, BC MIN FOR RES PROGR, V23, P199; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; BUCHLER ER, 1976, AM NAT, V110, P619, DOI 10.1086/283094; Churchill S., 2009, AUSTR BATS; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; GERELL R, 1993, BIOL CONSERV, V65, P153, DOI 10.1016/0006-3207(93)90444-6; Gonsalves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064081; Gonsalves L, 2013, WILDLIFE RES, V40, P10, DOI 10.1071/WR12148; GRANT JDA, 1991, AUST J ZOOL, V39, P45, DOI 10.1071/ZO9910045; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; JONES G, 1995, J ZOOL, V237, P303, DOI 10.1111/j.1469-7998.1995.tb02764.x; Jones G, 1999, J EXP BIOL, V202, P3359; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; KALKO EKV, 1995, ANIM BEHAV, V50, P861, DOI 10.1016/0003-3472(95)80090-5; Kokkinn MJ, 2009, MED VET ENTOMOL, V23, P85, DOI 10.1111/j.1365-2915.2008.00787.x; Kunz T.H., 1988, P191; Lloyd A, 2006, BIOL CONSERV, V129, P207, DOI 10.1016/j.biocon.2005.10.035; LOWMAN MD, 1982, AUST J ECOL, V7, P353, DOI 10.1111/j.1442-9993.1982.tb01310.x; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; Mehl B., 1988, ANIMAL SONAR PROCESS, P435, DOI DOI 10.1007/978-1-4684-7493-0_43; ONEILL MG, 1989, AUST J ECOL, V14, P19; Pavey CR, 2001, BIOTROPICA, V33, P670, DOI 10.1646/0006-3606(2001)033[0670:DBOTFB]2.0.CO;2; Payne R, 2006, MICROBAT SMALL MAMMA; POOLE EARL L., 1932, JOUR MAMMALOGY, V13, P365; RABINOWITZ AR, 1982, ACTA THERIOL, V27, P283, DOI 10.4098/AT.arch.82-25; Reinhold L, 2001, KEY BAT CALLS S E; Reiskind MH, 2009, J MED ENTOMOL, V46, P1037, DOI 10.1603/033.046.0510; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Russell RC, 1998, INT J PARASITOL, V28, P955, DOI 10.1016/S0020-7519(98)00053-8; RUSSELL RC, 1996, COLOUR PHOTO ATLAS M; Russell TL, 2008, AUST J ENTOMOL, V47, P232, DOI 10.1111/j.1440-6055.2008.00642.x; Rydell J., 1990, Bats (Austin), V8, P8; Rydell J, 1989, ECOGRAPHY, V12, P16, DOI [10.1111/j.1600-0587.1989.tb00817.x, DOI 10.1111/J.1600-0587.1989.TB00817.X]; Shiel CB, 1998, J ZOOL, V246, P417, DOI 10.1111/j.1469-7998.1998.tb00173.x; Speakman JR, 2003, BAT ECOLOGY, P430; SUTHERLAND RM, 2000, THESIS U OXFORD OXFO; TIDEMANN CR, 1978, AUST WILDLIFE RES, V5, P355, DOI 10.1071/WR9780355; Tuttle M.D., 2005, AM NEIGHBORHOOD BATS AM NEIGHBORHOOD BATS; VESTJENS WJM, 1977, AUST WILDLIFE RES, V4, P25; WATERS DA, 1995, BEHAV ECOL SOCIOBIOL, V37, P321, DOI 10.1007/BF00174136; Webb CE, 2011, ANN REPORT MOSQUITO, P2010; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	53	36	38	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77183	10.1371/journal.pone.0077183	http://dx.doi.org/10.1371/journal.pone.0077183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130851	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200066
J	Gu, Y; Wei, JF; Yang, J; Huang, JJ; Yang, XD; Zhu, XP				Gu, Yuan; Wei, Junfei; Yang, Jing; Huang, Jingjing; Yang, Xiaodi; Zhu, Xinping			Protective Immunity against Trichinella spiralis Infection Induced by a Multi-Epitope Vaccine in a Murine Model	PLOS ONE			English	Article							PARAMYOSIN; ANTIGEN; MICE; CELL; IDENTIFICATION; TRICHINOSIS; ANTIBODIES; RESPONSES; MIMOTOPE; NEMATODE	Trichinellosis is one of the most important food-borne parasitic zoonoses throughout the world. Because infected pigs are the major source of human infections, and China is becoming the largest international producer of pork, the development of a transmission-blocking vaccine to prevent swine from being infected is urgently needed for trichinellosis control in China. Our previous studies have demonstrated that specific Trichinella spiralis paramyosin (Ts-Pmy) and Ts-87 antigen could provide protective immunity against T. spiralis infection in immunized mice. Certain protective epitopes of Ts-Pmy and Ts-87 antigen have been identified. To identify more Ts-Pmy protective epitopes, a new monoclonal antibody, termed 8F12, was produced against the N-terminus of Ts-Pmy. This antibody elicited significant protective immunity in mice against T. spiralis infection by passive transfer and was subsequently used to screen a random phage display peptide library to identify recognized epitopes. Seven distinct positive phage clones were identified and their displayed peptides were sequenced. Synthesized epitope peptides conjugated to keyhole limpet hemocyanin were used to immunize mice, four of which exhibited larval reduction (from 18.7% to 26.3%, respectively) in vaccinated mice in comparison to the KLH control. To increase more effective protection, the epitope 8F7 that was found to induce the highest protection in this study was combined with two other previously identified epitopes (YX1 from Ts-Pmy and M7 from Ts-87) to formulate a multi-epitope vaccine. Mice immunized with this multi-epitope vaccine experienced a 35.0% reduction in muscle larvae burden after being challenged with T. spiralis larvae. This protection is significantly higher than that induced by individual-epitope peptides and is associated with high levels of subclasses IgG and IgG1. These results showed that a multi-epitope vaccine induced better protective immunity than an individual epitope and provided a feasible approach for developing a safer and more effective vaccine against trichinellosis.	[Gu, Yuan; Wei, Junfei; Yang, Jing; Huang, Jingjing; Yang, Xiaodi; Zhu, Xinping] Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China	Capital Medical University	Zhu, XP (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China.	zhuxping@ccmu.edu.cn			National Natural Science Foundation of China [81171598, 81201312]; National Science and Technology Major Project [2012ZX10004220-012]; PhD Programs Foundation of the Municipal Education Commission of Beijing [20111002503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; PhD Programs Foundation of the Municipal Education Commission of Beijing	This work was supported by grants from the National Natural Science Foundation of China (81171598, 81201312), the National Science and Technology Major Project (2012ZX10004220-012), and the PhD Programs Foundation of the Municipal Education Commission of Beijing (20111002503). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anders RF, 2011, TRENDS PARASITOL, V27, P330, DOI 10.1016/j.pt.2011.04.003; Arnon R, 2000, IMMUNOLOGY, V101, P555, DOI 10.1046/j.1365-2567.2000.00139.x; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Boireau P, 1997, PARASITOLOGY, V115, P641, DOI 10.1017/S0031182097001716; CAPRON A, 1994, TROP GEOGR MED, V46, P242; Casey JL, 2004, INFECT IMMUN, V72, P1126, DOI 10.1128/IAI.72.2.1126-1134.2004; Chen XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049913; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Cui J, 2011, VET J, V190, P323, DOI 10.1016/j.tvjl.2010.12.025; Dea-Ayuela MA, 2006, VACCINE, V24, P2772, DOI 10.1016/j.vaccine.2006.01.006; Deville S, 2005, VET PARASITOL, V132, P75, DOI 10.1016/j.vetpar.2005.05.029; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Dupouy-Camet J, 2007, FAO WHO OIE GUIDELIN, P37; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fischer NO, 2010, BIOCONJUGATE CHEM, V21, P1018, DOI 10.1021/bc100083d; Fodey TL, 2008, VET IMMUNOL IMMUNOP, V122, P25, DOI 10.1016/j.vetimm.2007.10.016; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; Gobert GN, 2005, PARASITOL INT, V54, P101, DOI 10.1016/j.parint.2005.02.004; Goding JW, 1996, MONOCLONAL ANTIBODIE, P141; Goldstein G, 2012, HUM VACC IMMUNOTHER, V8, P479, DOI 10.4161/hv.19184; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; GRENCIS RK, 1991, IMMUNOLOGY, V74, P329; Gu Y, 2008, EXP PARASITOL, V118, P66, DOI 10.1016/j.exppara.2007.06.014; HELLING F, 1994, CANCER RES, V54, P197; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Kaba SA, 2008, CLIN VACCINE IMMUNOL, V15, P1674, DOI 10.1128/CVI.00164-08; Kang SA, 2012, VET PARASITOL, V186, P319, DOI 10.1016/j.vetpar.2011.12.002; Kurdova-Mintcheva R, 2009, VET PARASITOL, V159, P316, DOI 10.1016/j.vetpar.2008.10.070; LI BW, 1993, J IMMUNOL, V150, P1881; Li Qiang, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P101; Li Y, 2013, RES VET SCI, V94, P490, DOI 10.1016/j.rvsc.2012.10.013; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; Meloen RH, 2000, J MOL RECOGNIT, V13, P352, DOI 10.1002/1099-1352(200011/12)13:6<352::AID-JMR509>3.0.CO;2-C; Oscherwitz J, 2009, INFECT IMMUN, V77, P3380, DOI 10.1128/IAI.00358-09; Paul S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-212; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Ramirez BL, 1996, PARASITE IMMUNOL, V18, P49, DOI 10.1046/j.1365-3024.1996.d01-4.x; Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sharma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056996; Skwarczynski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046870; Solis CF, 2005, INFECT IMMUN, V73, P1895, DOI 10.1128/IAI.73.3.1895-1897.2005; STEWARD MW, 1995, J VIROL, V69, P7668, DOI 10.1128/JVI.69.12.7668-7673.1995; Wang FJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-204; Wang SH, 2009, ACTA TROP, V110, P46, DOI 10.1016/j.actatropica.2009.01.003; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072; Xue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049842; Yang J, 2008, BIOCHEM BIOPH RES CO, V365, P528, DOI 10.1016/j.bbrc.2007.11.012; Yang J, 2010, EXP PARASITOL, V124, P403, DOI 10.1016/j.exppara.2009.12.010; Yang Y, 2003, J CAPITAL U MED SCI, V24, P108, DOI DOI 10.3969/J.ISSN.1006-7795.2003.02.005; Yang Ya-ping, 2002, Chinese Journal of Parasitology and Parasitic Diseases, V20, P270; Yang YP, 2013, VET PARASITOL, V194, P207, DOI 10.1016/j.vetpar.2013.01.057; Yang YP, 2010, VACCINE, V28, P2735, DOI 10.1016/j.vaccine.2010.01.026; Zhang ZF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001225	58	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77238	10.1371/journal.pone.0077238	http://dx.doi.org/10.1371/journal.pone.0077238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130862	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200072
J	Jain, D; Siede, W				Jain, Dilip; Siede, Wolfram			Rad5 Template Switch Pathway of DNA Damage Tolerance Determines Synergism between Cisplatin and NSC109268 in Saccharomyces cerevisiae	PLOS ONE			English	Article							ANTICANCER DRUG CISPLATIN; REPLICATION FORK; HOMOLOGOUS RECOMBINATION; PROTEASOME INHIBITORS; MOLECULAR-MECHANISMS; APOPTOSIS INDUCERS; TRANSPORTER CTR1; HUMAN CANCER; CELL-LINES; RESISTANCE	The success of cisplatin (CP) based therapy is often hindered by acquisition of CP resistance. We isolated NSC109268 as a compound altering cellular sensitivity to DNA damaging agents. Previous investigation revealed an enhancement of CP sensitivity by NSC109268 in wild-type Saccharomyces cerevisiae and CP-sensitive and - resistant cancer cell lines that correlated with a slower S phase traversal. Here, we extended these studies to determine the target pathway(s) of NSC109268 in mediating CP sensitization, using yeast as a model. We reasoned that mutants defective in the relevant target of NSC109268 should be hypersensitive to CP and the sensitization effect by NSC109268 should be absent or strongly reduced. A survey of various yeast deletion mutants converged on the Rad5 pathway of DNA damage tolerance by template switching as the likely target pathway of NSC109268 in mediating cellular sensitization to CP. Additionally, cell cycle delays following CP treatment were not synergistically influenced by NSC109268 in the CP hypersensitive rad5 Delta mutant. The involvement of the known inhibitory activities of NSC109268 on 20S proteasome and phosphatases 2C alpha and 2A was tested. In the CP hypersensitive ptc2 Delta ptc3 Delta pph3 Delta yeast strain, deficient for 2C and 2A-type phosphatases, cellular sensitization to CP by NSC109268 was greatly reduced. It is therefore suggested that NSC109268 affects CP sensitivity by inhibiting the activity of unknown protein(s) whose dephosphorylation is required for the template switch pathway.	[Jain, Dilip; Siede, Wolfram] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Siede, W (corresponding author), Santa Fe Biolabs LLC 808, PMB 313, Ft Worth, TX USA.	wolfram@santafebiolabs.com			Developmental Therapeutics Branch of the National Cancer Institute [NSC109268]; Joe and Jessie Crump Fund for Medical Education	Developmental Therapeutics Branch of the National Cancer Institute; Joe and Jessie Crump Fund for Medical Education	NSC109268 was initially provided by the Developmental Therapeutics Branch of the National Cancer Institute. These studies were supported by a grant from the Joe and Jessie Crump Fund for Medical Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Amberg DC., 2005, METHODS YEAST GENETI; ANDREWS PA, 1988, CANCER RES, V48, P68; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Chabner B. A., 1996, CANC CHEMOTHERAPY BI; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chatterjee B, 2013, COLD SPRING IN PRESS; Cho S, 2011, J CANCER RES CLIN, V137, P629, DOI 10.1007/s00432-010-0925-5; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Daniel KG, 2007, FRONT BIOSCI-LANDMRK, V12, P135, DOI 10.2741/2054; Daniel KG, 2004, BIOCHEM PHARMACOL, V67, P1139, DOI 10.1016/j.bcp.2003.10.031; Davis AP, 2001, GENETICS, V159, P515; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Fortuna M, 2001, CURRENT PROTOC CYTOM, V11, P13; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furuta T, 2002, CANCER RES, V62, P4899; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gong J, 2011, INTERNET J MICROBIOL, V9, P2; Grossmann KF, 2001, MUTAT RES-DNA REPAIR, V487, P73, DOI 10.1016/S0921-8777(01)00106-9; Haynes R.H., 1981, MOL BIOL YEAST SACCH, P371; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; JACKEL M, 1991, CANCER CHEMOTH PHARM, V27, P464, DOI 10.1007/BF00685161; Jain D, 2010, CANCER CHEMOTH PHARM, V66, P945, DOI 10.1007/s00280-010-1246-8; Johnson SW, 1997, CANCER RES, V57, P850; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim JA, 2011, MOL CELL BIOL, V31, P507, DOI 10.1128/MCB.01168-10; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Liaw H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021424; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; MAMENTA EL, 1994, CANCER RES, V54, P3500; Mieczkowski P, 2000, CURR GENET, V38, P53, DOI 10.1007/s002940000136; Minca EC, 2011, NUCLEIC ACIDS RES, V39, P2610, DOI 10.1093/nar/gkq1215; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; OCONNELL D, 2007, INT J PHARM MED, V21, P339; Perego P, 1998, MOL PHARMACOL, V54, P213, DOI 10.1124/mol.54.1.213; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Samimi G, 2004, MOL PHARMACOL, V66, P25, DOI 10.1124/mol.66.1.25; Shankar Eswar, 2010, J Mol Signal, V5, P4, DOI 10.1186/1750-2187-5-4; SHERMAN SE, 1985, SCIENCE, V230, P412, DOI 10.1126/science.4048939; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Simon JA, 2000, CANCER RES, V60, P328; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; van Waardenburg RCA, 2004, MOL CANCER THER, V3, P393; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wu F, 2004, CANCER RES, V64, P8029, DOI 10.1158/0008-5472.CAN-03-3942; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zhang H, 2003, MUTAT RES-FUND MOL M, V527, P37, DOI 10.1016/S0027-5107(03)00074-5; ZIMMERMANN FK, 1975, MUTAT RES, V28, P381, DOI 10.1016/0165-1218(75)90141-X	61	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77666	10.1371/journal.pone.0077666	http://dx.doi.org/10.1371/journal.pone.0077666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130896	gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200093
J	Kinoshita, SM; Kogure, A; Taguchi, S; Nolan, GP				Kinoshita, Shigemi M.; Kogure, Amane; Taguchi, Shizuka; Nolan, Garry P.			Snapin, Positive Regulator of Stimulation- Induced Ca2+ Release through RyR, Is Necessary for HIV-1 Replication in T Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CALCIUM-RELEASE; ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; ACTIVATION; PROTEIN; LYMPHOCYTES; MECHANISMS; EXPRESSION; RECEPTORS	To identify critical host factors necessary for human immunodeficiency virus 1 (HIV-1) replication, large libraries of short-peptide-aptamers were expressed retrovirally. The target of one inhibitor peptide, Pep80, identified in this screen was determined to be Snapin, a protein associated with the soluble N-ethyl maleimide sensitive factor adaptor protein receptor (SNARE) complex that is critical for calcium-dependent exocytosis during neurotransmission. Pep80 inhibited Ca2+ release from intracellular stores and blocked downstream signaling by direct interruption of the association between Snapin and an intracellular calcium release channel, the ryanodine receptor (RyR). NFAT signaling was preferentially abolished by Pep80. Expression of Snapin overcame Pep80-mediated inhibition of Ca2+/NFAT signaling and HIV-1 replication. Furthermore, Snapin induced HIV-1 replication in primary CD4+ T cells. Thus, through its interaction with RyR, Snapin is a critical regulator of Ca2+ signaling and T cell activation. Use of the genetically selected intracellular aptamer inhibitors allowed us to define unique mechanisms important to HIV-1 replication and T cell biology.	[Kinoshita, Shigemi M.; Kogure, Amane] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Kinoshita, Shigemi M.; Taguchi, Shizuka] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Suita, Osaka, Japan; [Nolan, Garry P.] Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA; [Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Jefferson University; Osaka University; Stanford University; Stanford University	Kinoshita, SM (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	shigemi.kinoshita@jefferson.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	National Institute of Health [AI56920]; Sankyo Foundation of Life Science; Chugai-Roche Pharmaceutical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, R01AI056920] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sankyo Foundation of Life Science; Chugai-Roche Pharmaceutical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was supported by National Institute of Health grant AI56920, Sankyo Foundation of Life Science, and Chugai-Roche Pharmaceutical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Brini M, 2004, BIOCHEM BIOPH RES CO, V322, P1245, DOI 10.1016/j.bbrc.2004.08.029; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Inesi G, 2005, J BIOENERG BIOMEMBR, V37, P365, DOI 10.1007/s10863-005-9472-1; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kinoshita SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041725; Kinoshita SM, 2008, P NATL ACAD SCI USA, V105, P15022, DOI 10.1073/pnas.0807269105; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Ogawa Y, 2008, BIOCHEM BIOPH RES CO, V369, P208, DOI 10.1016/j.bbrc.2007.11.139; Shirokova N, 2008, METHODS, V46, P183, DOI 10.1016/j.ymeth.2008.09.017; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Suzuki F, 2007, J BIOL CHEM, V282, P29563, DOI 10.1074/jbc.M702063200; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Wang SC, 2009, NEUROSIGNALS, V17, P169, DOI 10.1159/000200076; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502; Zissimopoulos S, 2006, J CELL SCI, V119, P2386, DOI 10.1242/jcs.02936	40	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75297	10.1371/journal.pone.0075297	http://dx.doi.org/10.1371/journal.pone.0075297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130701	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200009
J	Musekiwa, A; Muchiri, E; Manda, SOM; Mwambi, HG				Musekiwa, Alfred; Muchiri, Evans; Manda, Samuel O. M.; Mwambi, Henry G.			Pregnancy Incidence and Risk Factors among Women Participating in Vaginal Microbicide Trials for HIV Prevention: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CONTRACEPTIVE USE; DOUBLE-BLIND; INFECTION; GEL; ACQUISITION; TRANSMISSION; EFFICACY	Introduction: Pregnancy is contraindicated in vaginal microbicide trials for the prevention of HIV infection in women due to the unknown maternal and fetal safety of the microbicides. Women who become pregnant are taken off the microbicide during pregnancy period but this result in reduction of the power of the trials. Strategies to reduce the pregnancy rates require an understanding of the incidence and associated risk factors of pregnancy in microbicide trials. This systematic review estimates the overall incidence rate of pregnancy in microbicide trials and describes the associated risk factors. Methods: A comprehensive literature search was carried out to identify eligible studies from electronic databases and other sources. Two review authors independently selected studies and extracted relevant data from included studies. Meta-analysis of incidence rates of pregnancy was carried out and risk factors of pregnancy were reported narratively. Results: Fifteen studies reporting data from 10 microbicide trials (N= 27,384 participants) were included. A total of 4,107 participants (15.0%) fell pregnant and a meta-analysis of incidence rates of pregnancy from 8 microbicide trials (N= 25,551) yielded an overall incidence rate of 23.37 (95% CI: 17.78 to 28.96) pregnancies per 100 woman-years. However, significant heterogeneity was detected. Hormonal injectable, intra-uterine device (IUD) or implants or sterilization, older age, more years of education and condom use were associated with lower pregnancy. On the other hand, living with a man, history of pregnancy, self and partner desire for future baby, oral contraceptive use, increased number of unprotected sexual acts and inconsistent use of condoms were associated with higher pregnancy. Conclusions: The incidence rate of pregnancy in microbicide trials is high and strategies for its reduction are urgently required in order to improve the sample size and power of these trials.	[Musekiwa, Alfred; Manda, Samuel O. M.; Mwambi, Henry G.] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa; [Musekiwa, Alfred; Muchiri, Evans] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa; [Manda, Samuel O. M.] South African Med Res Council, Biostat Unit, Pretoria, South Africa	University of Kwazulu Natal; University of Witwatersrand; South African Medical Research Council	Musekiwa, A (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa.	Alfred.Musekiwa@gmail.com	Muchiri, Evans/AAH-4642-2020	Musekiwa, Alfred/0000-0001-5880-3680; Manda, Samuel/0000-0002-9672-3312	Royal Netherlands Embassy in South Africa [17956]	Royal Netherlands Embassy in South Africa	The manuscript was partly supported by Royal Netherlands Embassy in South Africa (Activity 17956).	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; CHIRENJE ZM, 2010, MTN 003 PROTOCOL 2 0; *FACTS CONS, 2013, WORK TOG PREV HIV FA; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Halpern V, 2011, CONTRACEPTION, V83, P436, DOI 10.1016/j.contraception.2010.08.018; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Horsted F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001275; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Obiero J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-289; Odutola A, 2012, SEX TRANSM INFECT, V88, P436, DOI 10.1136/sextrans-2011-050412; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Ramjee G, 2012, B WORLD HEALTH ORGAN, V90, P748, DOI 10.2471/BLT.12.105700; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Richardson BA, 2001, SEX TRANSM DIS, V28, P394, DOI 10.1097/00007435-200107000-00006; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Schreiber CA, 2011, CONTRACEPTION, V83, P74, DOI 10.1016/j.contraception.2010.06.012; Shelton JD, 2011, SCIENCE, V334, P1645, DOI 10.1126/science.1212353; Sibeko S, 2012, BEST PRACT RES CL OB, V26, P473, DOI 10.1016/j.bpobgyn.2012.01.005; Sibeko S, 2011, OBSTET GYNECOL, V118, P895, DOI 10.1097/AOG.0b013e31822be512; SIEGFRIED N, 2009, COCHRANE DB SYST REV, P3362; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; World Health Organization, 2011, GLOB SUMM HIV AIDS E	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77014	10.1371/journal.pone.0077014	http://dx.doi.org/10.1371/journal.pone.0077014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130827	Green Published, gold, Green Submitted			2022-12-27	WOS:000325814200049
J	Deng, XD; Tian, YX; Niu, QH; Xu, XE; Shi, H; Zhang, HB; Liang, LM; Zhang, KQ; Huang, XW				Deng, Xidan; Tian, Yunxia; Niu, Qiuhong; Xu, Xiao'e; Shi, Hui; Zhang, Hanbo; Liang, Lianming; Zhang, Keqin; Huang, Xiaowei			The ComP-ComA Quorum System Is Essential For "Trojan horse" Like Pathogenesis in Bacillus nematocida	PLOS ONE			English	Article							TO-CELL COMMUNICATION; VIRULENCE REGULATION; GENOME ANALYSIS; SENSING SYSTEM; CEREUS GROUP; GENE; SUBTILIS; DEGU; PLCR; CONSERVATION	Bacillus nematocida B16 has been shown to use "Trojan horse" mechanism in pathogenesis that has characteristics of "social" behavior. The ComP-ComA system, a conserved quorum sensing system in the genus Bacillus, functions in many physiological processes including competence development, lipopeptide antibiotic surfactin production, degradative enzyme production and even some unknown functions. Here we investigated the requirement of ComP-ComA system in B. nematocida B16 for its pathogenicity against nematodes. The Delta comP mutant displayed deficiencies in attracting and killing nematodes, due to the absence of attractive signal molecules and the decreased expressions of virulence factors, respectively. Contrarily, a complemented comP mutant at least partially resumed its pathogenicity. Our data from transcriptional analysis further confirmed that this signaling system directly or indirectly regulated the expressions of two major virulence proteases in the infection of B. nematocida B16. Bioinformatics analyses from comparative genomics also suggested that the potential target genes of transcription factor ComA were involved in the processes such as the synthesis of attractants, production of extracellular degradative enzymes and sortase, secondary metabolites biosynthesis, regulation of transcription factors, mobility, as well as transporters, most of which were different from a saprophytic relative B. subtilis 168. Therefore, our investigation firstly revealed that the participation and necessity of ComP-ComA signaling system in bacterial pathogenesis.	[Deng, Xidan; Tian, Yunxia; Xu, Xiao'e; Shi, Hui; Zhang, Hanbo; Liang, Lianming; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Yunnan, Peoples R China; [Deng, Xidan; Tian, Yunxia; Xu, Xiao'e; Shi, Hui; Zhang, Hanbo; Liang, Lianming; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Yunnan, Peoples R China; [Deng, Xidan] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Niu, Qiuhong] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Henan, Peoples R China	Yunnan University; Yunnan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Nanyang Normal College	Zhang, KQ (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Yunnan, Peoples R China.	kqzhang@ynu.edu.cn; xwhuang@ynu.edu.cn	zhang, ke/AAH-8217-2019; Liang, Lian-Ming/AAL-3861-2021		National Basic Research Program of China [2013CB127500, 2011AA10A203]; National Natural Science Foundation Program of China [30970065, U1036602]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation Program of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province, China	This work is supported by the National Basic Research Program of China (grant no. 2013CB127500 and no. 2011AA10A203), the National Natural Science Foundation Program of China (grant no. 30970065 and no. U1036602), the Department of Science and Technology of Yunnan Province, China (grant No. 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I, 2005, FEMS MICROBIOL LETT, V250, P175, DOI 10.1016/j.femsle.2005.07.008; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Chan WC, 2004, J MED CHEM, V47, P4633, DOI 10.1021/jm0400754; Chen XH, 2009, J BIOTECHNOL, V140, P27, DOI 10.1016/j.jbiotec.2008.10.011; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; GARZA AG, 1995, P NATL ACAD SCI USA, V92, P1970, DOI 10.1073/pnas.92.6.1970; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Huang XW, 2005, SYST APPL MICROBIOL, V28, P323, DOI 10.1016/j.syapm.2005.01.008; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; MSADEK T, 1991, J BACTERIOL, V173, P2366, DOI 10.1128/JB.173.7.2366-2377.1991; Mylonakis E, 2002, INFECT IMMUN, V70, P4678, DOI 10.1128/IAI.70.8.4678-4681.2002; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Rahmati S, 2002, MOL MICROBIOL, V43, P677, DOI 10.1046/j.1365-2958.2002.02773.x; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Slamti L, 2004, J BACTERIOL, V186, P3531, DOI 10.1128/JB.186.11.3531-3538.2004; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; Tortosa P, 1999, CURR OPIN MICROBIOL, V2, P588, DOI 10.1016/S1369-5274(99)00026-0; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224; Vollenbroich D, 1997, APPL ENVIRON MICROB, V63, P44, DOI 10.1128/AEM.63.1.44-49.1997; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Withers H, 2001, CURR OPIN MICROBIOL, V4, P186, DOI 10.1016/S1369-5274(00)00187-9	39	5	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76920	10.1371/journal.pone.0076920	http://dx.doi.org/10.1371/journal.pone.0076920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130811	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900105
J	dos Santos, CG; Silva, AL; Souza, FL; Lanfredi, AJC; Di Mascio, P; Nascimento, OR; Rodrigues, T; Nantes, IL				dos Santos, Carolina G.; Silva, Andre L.; Souza, Flavio L.; Lanfredi, Alexandre J. C.; Di Mascio, Paolo; Nascimento, Otaciro R.; Rodrigues, Tiago; Nantes, Iseli L.			UV-Light Effects on Cytochrome C Modulated by the Aggregation State of Phenothiazines	PLOS ONE			English	Article							SPIN-STATE; SINGLET OXYGEN; HEME IRON; MITOCHONDRIAL; MECHANISMS; RELEASE; PHOTOSENSITIZERS; INTERFACES; ABILITY	The present study shows the factors that modulate the photodamage promoted by phenothiazines. Cytochrome c was irradiated with UV light for 120 min, over a pH range from 4.0 to 8.0, in the absence and in the presence of different concentrations of thioridazine (TR) and fluphenazine (FP). In the absence of phenothiazines, the maximal rate of a Soret band blue shift (nm/min) from 409 to 406 nm was obtained at pH 4.0 (0.028 nm/min). The presence of phenothiazines at the concentration range 10-25 mu mol/L amplified and accelerated a cytochrome c blue shift (409 to 405 nm, at a rate = 0.041 nm/min). Above 25 mu mol/L, crescent concentrations of phenothiazines contributed to cytochrome c protection with (maximal at 2500 mu mol/L). Scanning electronic microscopy revealed the formation of nanostructures. The pH also influenced the effect of low phenothiazine concentrations on cytochrome c. Thus, the predominance of phenothiazine-promoted cytochrome c damage or protection depends on a balance of the following factors: the yield of photo-generated drug cation radicals, which is favored by acidic pH; the stability of the cation radicals, which is favored by the drug aggregation; and the cytochrome c structure, modulated by the pH.	[dos Santos, Carolina G.; Silva, Andre L.; Souza, Flavio L.; Rodrigues, Tiago; Nantes, Iseli L.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, NanoBioMAv, Santo Andre, SP, Brazil; [dos Santos, Carolina G.] Univ Mogi das Cruzes UMC, Mogi Das Cruzes, SP, Brazil; [Lanfredi, Alexandre J. C.] Univ Fed ABC, Ctr Engn & Ciencias Sociais Aplicadas, Santo Andre, SP, Brazil; [Di Mascio, Paolo] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Nascimento, Otaciro R.] Univ Sao Paulo USP Sao Carlos, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, Sao Carlos, SP, Brazil	Universidade Federal do ABC (UFABC); Universidade de Mogi das Cruzes; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Nantes, IL (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, NanoBioMAv, Santo Andre, SP, Brazil.	ilnantes@gmail.com	Souza, Flavio Leandro/C-3128-2012; Santos, Carolina G dos/A-7032-2018; Rodrigues, Tiago/AAG-1121-2020; Lanfredi, Alexandre JC/C-5721-2013; Di Mascio, Paolo/D-1264-2014; Rodrigues, Tiago/B-8459-2012; Nantes, Iseli Lourenço/B-9517-2012	Souza, Flavio Leandro/0000-0003-2036-9123; Santos, Carolina G dos/0000-0003-0684-2463; Rodrigues, Tiago/0000-0003-1277-0224; Di Mascio, Paolo/0000-0003-4125-8350; Rodrigues, Tiago/0000-0003-1277-0224; Nantes, Iseli Lourenço/0000-0003-1434-3154; de Castro Lanfredi, Alexandre Jose/0000-0002-8530-8826	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa da UMC (FAEP-UMC); NanoBioMed Brazil Network (CAPES); Guggenheim Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa da UMC (FAEP-UMC); NanoBioMed Brazil Network (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Guggenheim Foundation	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa da UMC (FAEP-UMC), NanoBioMed Brazil Network (CAPES) and the Guggenheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron JJ, 2009, TOP HETEROCYCL CHEM, V16, P153, DOI 10.1007/7081_2008_125; Abu-Abdoun II, 1997, EUR POLYM J, V33, P1671, DOI 10.1016/S0014-3057(97)00044-X; ALKAITIS SA, 1975, J AM CHEM SOC, V97, P5723, DOI 10.1021/ja00853a015; Amaral L, 2001, INT J ANTIMICROB AG, V18, P411, DOI 10.1016/S0924-8579(01)00432-0; Babul J, 1972, BIOCHEMISTRY-US, V11, P7; Borges MBD, 2010, FREE RADICAL RES, V44, P1054, DOI 10.3109/10715762.2010.498826; CILENTO G, 1995, FREE RADICAL BIO MED, V19, P103, DOI 10.1016/0891-5849(95)00002-F; Cruz TS, 2010, BIOCHEM PHARMACOL, V80, P1284, DOI 10.1016/j.bcp.2010.06.052; Dasgupta A, 2008, TOP HETEROCYCL CHEM, V15, P67, DOI 10.1007/7081_2007_108; dos Santos CG, 2010, FREE RADICAL BIO MED, V49, pS180, DOI 10.1016/j.freeradbiomed.2010.10.513; EberleinKonig B, 1997, DERMATOLOGY, V194, P131, DOI 10.1159/000246080; Elisei F, 2002, PHOTOCHEM PHOTOBIOL, V75, P11, DOI 10.1562/0031-8655(2002)075<0011:ESPAIV>2.0.CO;2; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; FORD JM, 1989, MOL PHARMACOL, V35, P105; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gomurashvili Z, 2001, J POLYM SCI POL CHEM, V39, P1187, DOI 10.1002/pola.1096; Guo QX, 1996, J PHOTOCH PHOTOBIO A, V93, P27, DOI 10.1016/1010-6030(95)04148-6; Hendrich AB, 2003, MOL MEMBR BIOL, V20, P53, DOI 10.1080/0968768031000045815; KAMEN MD, 1973, P NATL ACAD SCI USA, V70, P1851, DOI 10.1073/pnas.70.6.1851; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOCHEVAR IE, 1981, J INVEST DERMATOL, V77, P59, DOI 10.1111/1523-1747.ep12479244; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Michalak K, 2006, CURR DRUG TARGETS, V7, P1095, DOI 10.2174/138945006778226570; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Nantes IL, 2000, FREE RADICAL BIO MED, V28, P786, DOI 10.1016/S0891-5849(00)00170-2; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; Ordway D, 2002, INT J ANTIMICROB AG, V20, P34, DOI 10.1016/S0924-8579(02)00110-3; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; RAMOS GR, 1986, MIKROCHIM ACTA, V1, P115; Rinaldi TA, 2004, FREE RADICAL BIO MED, V36, P802, DOI 10.1016/j.freeradbiomed.2003.12.002; Rodrigues T., 2005, Revista de Ciencias Farmaceuticas Basica e Aplicada, V26, P19; Rodrigues T, 2007, J BIOL CHEM, V282, P25577, DOI 10.1074/jbc.M700009200; Rodrigues T, 2006, J PHYS CHEM B, V110, P12257, DOI 10.1021/jp0605404; Severino D, 2003, PHOTOCHEM PHOTOBIOL, V77, P459, DOI 10.1562/0031-8655(2003)077<0459:IONCIO>2.0.CO;2; Sharonov GV, 2005, APOPTOSIS, V10, P797, DOI 10.1007/s10495-005-0366-9; Simon M, 2013, J BIOL INORG CHEM, V18, P27, DOI 10.1007/s00775-012-0946-4; Sudeshna G, 2010, EUR J PHARMACOL, V648, P6, DOI 10.1016/j.ejphar.2010.08.045; Suto D, 2005, BIOCHEM J, V392, P399, DOI 10.1042/BJ20050580; Viola G, 2003, CHEM RES TOXICOL, V16, P644, DOI 10.1021/tx025680t; Wainwright M, 1999, DYES PIGMENTS, V42, P45, DOI 10.1016/S0143-7208(99)00008-X; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	43	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76857	10.1371/journal.pone.0076857	http://dx.doi.org/10.1371/journal.pone.0076857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130798	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900093
J	Gazi, NN; Tamang, R; Singh, VK; Ferdous, A; Pathak, AK; Singh, M; Anugula, S; Veeraiah, P; Kadarkaraisamy, S; Yadav, BK; Reddy, AG; Rani, DS; Qadri, SS; Singh, L; Chaubey, G; Thangaraj, K				Gazi, Nurun Nahar; Tamang, Rakesh; Singh, Vipin Kumar; Ferdous, Ahmed; Pathak, Ajai Kumar; Singh, Mugdha; Anugula, Sharath; Veeraiah, Pandichelvam; Kadarkaraisamy, Subburaj; Yadav, Brijesh Kumar; Reddy, Alla G.; Rani, Deepa Selvi; Qadri, Syed Saleheen; Singh, Lalji; Chaubey, Gyaneshwer; Thangaraj, Kumarasamy			Genetic Structure of Tibeto-Burman Populations of Bangladesh: Evaluating the Gene Flow along the Sides of Bay-of-Bengal	PLOS ONE			English	Article							SOUTH-ASIA; Y-CHROMOSOMES; COMMON; INDIA; RESOLUTION; HISTORY; TREE	Human settlement and migrations along sides of Bay-of-Bengal have played a vital role in shaping the genetic landscape of Bangladesh, Eastern India and Southeast Asia. Bangladesh and Northeast India form the vital land bridge between the South and Southeast Asia. To reconstruct the population history of this region and to see whether this diverse region geographically acted as a corridor or barrier for human interaction between South Asia and Southeast Asia, we, for the first time analyzed high resolution uniparental (mtDNA and Y chromosome) and biparental autosomal genetic markers among aboriginal Bangladesh tribes currently speaking Tibeto-Burman language. All the three studied populations; Chakma, Marma and Tripura from Bangladesh showed strikingly high homogeneity among themselves and strong affinities to Northeast Indian Tibeto-Burman groups. However, they show substantially higher molecular diversity than Northeast Indian populations. Unlike Austroasiatic (Munda) speakers of India, we observed equal role of both males and females in shaping the Tibeto-Burman expansion in Southern Asia. Moreover, it is noteworthy that in admixture proportion, TB populations of Bangladesh carry substantially higher mainland Indian ancestry component than Northeast Indian Tibeto-Burmans. Largely similar expansion ages of two major paternal haplogroups (O2a and O3a3c), suggested that they arose before the differentiation of any language group and approximately at the same time. Contrary to the scenario proposed for colonization of Northeast India as male founder effect that occurred within the past 4,000 years, we suggest a significantly deep colonization of this region. Overall, our extensive analysis revealed that the population history of South Asian Tibeto-Burman speakers is more complex than it was suggested before.	[Gazi, Nurun Nahar; Ferdous, Ahmed; Qadri, Syed Saleheen] Univ Dhaka, Ctr Adv Res Phys Chem Biol & Pharmaceut Sci, Dhaka 1000, Bangladesh; [Tamang, Rakesh; Singh, Vipin Kumar; Singh, Mugdha; Anugula, Sharath; Veeraiah, Pandichelvam; Kadarkaraisamy, Subburaj; Yadav, Brijesh Kumar; Reddy, Alla G.; Rani, Deepa Selvi; Singh, Lalji; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Pathak, Ajai Kumar] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Pathak, Ajai Kumar; Chaubey, Gyaneshwer] Estonian Bioctr, Tartu, Estonia; [Singh, Lalji] Genome Fdn, Hyderabad, Andhra Pradesh, India; [Singh, Lalji] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India	University of Dhaka; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Tartu; Estonian Biocentre; Banaras Hindu University (BHU)	Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	thangs@ccmb.res.in	Veeraiah, Pandichelvam/AAS-4134-2020; Pathak, Ajai/S-2032-2017; Chaubey, Gyaneshwer/AAC-6409-2019; Anugula, Sharath/AAI-2443-2019; Chaubey, Gyaneshwer/H-2753-2012; ANUGULA, SHARATH/N-8362-2015	Veeraiah, Pandichelvam/0000-0002-9149-7483; Pathak, Ajai/0000-0003-2088-3616; Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaubey, Gyaneshwer/0000-0003-2899-3852; Thangaraj, Kumarasamy/0000-0002-0075-0106; Singh, Mugdha/0000-0003-3536-5539	Council of Scientific and Industrial Research, Government of India [GENESIS: BSC0121]; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India; Centre of Excellence of the Estonian Biocentre; European Social Fund's Doctoral Studies and Internationationalisation Programme DoRa	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Centre of Excellence of the Estonian Biocentre; European Social Fund's Doctoral Studies and Internationationalisation Programme DoRa	K.T. was supported by the Council of Scientific and Industrial Research (GENESIS: BSC0121), Government of India. L.S. was supported by a Bose Fellowship from the Department of Science and Technology, Government of India and Bhatnagar fellowship from the Council of Scientific and Industrial Research, Government of India. G.C. was supported by the Centre of Excellence of the Estonian Biocentre and A.K.P. was supported by European Social Fund's Doctoral Studies and Internationationalisation Programme DoRa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Blench R., 2008, LINGUISTICS ARCHAEOL, P159; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Maloney C, 1984, TRIBAL CULTURES BANG, P5; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sharma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032546; Tambets K, 2003, MCDONALD I ARCHAEOLO, P449; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	30	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75064	10.1371/journal.pone.0075064	http://dx.doi.org/10.1371/journal.pone.0075064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130682	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900017
J	Marongiu, L; Donini, M; Toffali, L; Zenaro, E; Dusi, S				Marongiu, Laura; Donini, Marta; Toffali, Lara; Zenaro, Elena; Dusi, Stefano			ESAT-6 and HspX Improve the Effectiveness of BCG to Induce Human Dendritic Cells-Dependent Th1 and NK Cells Activation	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; BACILLUS-CALMETTE-GUERIN; ANTIMYCOBACTERIAL T-CELL; SECRETED ANTIGEN ESAT-6; IFN-GAMMA; DC-SIGN; VACCINE; RESPONSES; IMMUNITY; INNATE	The limited efficacy of the BCG vaccine against tuberculosis is partly due to the missing expression of immunogenic proteins. We analyzed whether the addition to BCG of ESAT-6 and HspX, two Mycobacterium tuberculosis (Mtb) antigens, could enhance its capacity to activate human dendritic cells (DCs). BCG showed a weak ability to induce DC maturation, cytokine release, and CD4(+) lymphocytes and NK cells activation. The addition of ESAT-6 or HspX alone to BCG-stimulated DC did not improve these processes, whereas their simultaneous addition enhanced BCG-dependent DC maturation and cytokine release, as well as the ability of BCG-treated DCs to stimulate IFN-gamma release and CD69 expression by CD4(+) lymphocytes and NK cells. Addition of TLR2-blocking antibody decreased IL-12 release by BCG-stimulated DCs incubated with ESAT-6 and HspX, as well as IFN-gamma secretion by CD4+ lymphocytes co-cultured with these cells. Moreover, HspX and ESAT-6 improved the capacity of BCG-treated DCs to induce the expression of memory phenotype marker CD45RO in naive CD4(+) T cells. Our results indicate that ESAT-6 and HspX cooperation enables BCG-treated human DCs to induce T lymphocyte and NK cell-mediated immune responses through TLR2-dependent IL-12 secretion. Therefore ESAT-6 and HspX represent good candidates for improving the effectiveness of BCG vaccination.	[Marongiu, Laura; Donini, Marta; Toffali, Lara; Zenaro, Elena; Dusi, Stefano] Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, I-37100 Verona, Italy	University of Verona	Dusi, S (corresponding author), Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, I-37100 Verona, Italy.	stefano.dusi@univr.it		Zenaro, Elena/0000-0003-3928-6272; Donini, Marta/0000-0003-3101-0183	Fondazione Cariverona (Bando)	Fondazione Cariverona (Bando)(Fondazione Cariverona)	This work was supported by grants from Fondazione Cariverona (Bando 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Andoniou CE, 2008, EUR J IMMUNOL, V38, P2938, DOI 10.1002/eji.200838882; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2010, EUR J IMMUNOL, V40, P3312, DOI 10.1002/eji.201041145; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brewer TF, 2000, CLIN INFECT DIS, V31, pS64, DOI 10.1086/314072; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Ize B, 2006, SCIENCE, V313, P1583, DOI 10.1126/science.1132537; Jacobs B, 2008, HORM METAB RES, V40, P99, DOI 10.1055/s-2007-1022561; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kong CU, 2011, VACCINE, V29, P1374, DOI 10.1016/j.vaccine.2010.12.070; Li Q, 2011, SCAND J IMMUNOL, V73, P568, DOI 10.1111/j.1365-3083.2011.02531.x; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Mariotti S, 2004, INFECT IMMUN, V72, P4385, DOI 10.1128/IAI.72.8.4385-4392.2004; Marras F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/152430; Mihret A, 2012, VIRULENCE, V3, P654, DOI 10.4161/viru.22586; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pala P, 2000, J IMMUNOL METHODS, V243, P107, DOI 10.1016/S0022-1759(00)00230-1; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Presky DH, 1998, J IMMUNOL, V160, P2174; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Siddiqui KF, 2011, CRIT REV MICROBIOL, V37, P349, DOI 10.3109/1040841X.2011.606425; Taylor JL, 2012, IMMUNOL CELL BIOL; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Wang XS, 2009, J IMMUNOL, V182, P3668, DOI 10.4049/jimmunol.0803579; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Xu J, 2008, VACCINE, V26, P4519, DOI 10.1016/j.vaccine.2008.06.044; Zenaro E, 2009, J LEUKOCYTE BIOL, V86, P1393, DOI 10.1189/jlb.0409242; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	55	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75684	10.1371/journal.pone.0075684	http://dx.doi.org/10.1371/journal.pone.0075684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130733	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900052
J	Meyer, JB; Cartier, LE; Pinto-Figueroa, EA; Krzemnicki, MS; Hanni, HA; McDonald, BA				Meyer, Joana B.; Cartier, Laurent E.; Pinto-Figueroa, Eric A.; Krzemnicki, Michael S.; Haenni, Henry A.; McDonald, Bruce A.			DNA Fingerprinting of Pearls to Determine Their Origins	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NACREOUS LAYER; PINCTADA-MARGARITIFERA; CULTURED PEARLS; NATURAL PEARLS; RIBOSOMAL DNA; OYSTER; EXTRACTION; BIVALVIA; PROTEINS	We report the first successful extraction of oyster DNA from a pearl and use it to identify the source oyster species for the three major pearl-producing oyster species Pinctada margaritifera, P. maxima and P. radiata. Both mitochondrial and nuclear gene fragments could be PCR-amplified and sequenced. A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay in the internal transcribed spacer (ITS) region was developed and used to identify 18 pearls of unknown origin. A micro-drilling technique was developed to obtain small amounts of DNA while maintaining the commercial value of the pearls. This DNA fingerprinting method could be used to document the source of historic pearls and will provide more transparency for traders and consumers within the pearl industry.	[Meyer, Joana B.; McDonald, Bruce A.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Meyer, Joana B.; Cartier, Laurent E.; Krzemnicki, Michael S.] Swiss Gemmol Inst SSEF, Basel, Switzerland; [Cartier, Laurent E.] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Pinto-Figueroa, Eric A.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Haenni, Henry A.] GemExpert, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Lausanne	Meyer, JB (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.	joana.meyer82@gmail.com; gemlab@ssef.ch	McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172; Krzemnicki, Michael/0000-0003-3757-8781	Swiss Gemmological Institute (SSEF)	Swiss Gemmological Institute (SSEF)	This study was supported by the Swiss Gemmological Institute (SSEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud Sophie, 2000, Conservation Genetics, V1, P299, DOI 10.1023/A:1011575722481; Arnaud-Haond S, 2007, MAR BIOTECHNOL, V9, P113, DOI 10.1007/s10126-006-6033-5; Arnaud-Haond S, 2003, J EVOLUTION BIOL, V16, P388, DOI 10.1046/j.1420-9101.2003.00549.x; Bari H, 2010, PEARLS; Barton HA, 2006, J MICROBIOL METH, V66, P21, DOI 10.1016/j.mimet.2005.10.005; Bowen RL, 1951, MIDDLE E J, V5, P161; Carter Robert, 2005, J ECON SOC HIST ORIE, V48, P139, DOI [10.1163/1568520054127149, DOI 10.1163/1568520054127149]; Cartier LE, 2012, GEMS GEMOL, V48, P108, DOI 10.5741/GEMS.48.2.108; Charpentier V, 2012, ARAB ARCHAEOL EPIGR, V23, P1, DOI 10.1111/j.1600-0471.2011.00351.x; Checa AG, 2006, P R SOC B, V273, P1329, DOI 10.1098/rspb.2005.3460; Chu KH, 2001, MAR BIOTECHNOL, V3, P355, DOI 10.1007/s10126001-0014-5; Comps M, 2000, AQUAT LIVING RESOUR, V13, P49, DOI 10.1016/S0990-7440(00)00134-0; Cuif JP, 1996, AQUAT LIVING RESOUR, V9, P187, DOI 10.1051/alr:1996022; Cunha RL, 2011, MAR BIOTECHNOL, V13, P181, DOI 10.1007/s10126-010-9278-y; Doherty S, 2007, AQUAT BIOL, V1, P161, DOI 10.3354/ab00020; Domard J, 1962, COMM PAC SUD C TECH, V1, P13; Donkin Robin A., 1998, PRICE PEARLS PEARL F; Elen S, 2002, G G, V38, P66, DOI [DOI 10.5741/GEMS.38.1.66, 10.5741/GEMS.38.1.66]; Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x; Forsman ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015021; Geist J, 2008, J MOLLUS STUD, V74, P337, DOI 10.1093/mollus/eyn025; Goebel M., 1989, GEMS GEMOL, V25, P130, DOI [DOI 10.5741/GEMS.25.3.130, 10.5741/GEMS.25.3.130]; Guthrie JN, 2000, J MICROBIOL METH, V43, P73, DOI 10.1016/S0167-7012(00)00207-4; Gwak WS, 2011, AQUACULT INT, V19, P585, DOI 10.1007/s10499-010-9385-9; Hanni HA, 2010, J GEMMOL, V32, P31; Hanni HA, 2007, J GEMMOL, V30, P357; He MX, 2005, MAR BIOTECHNOL, V7, P40, DOI 10.1007/s10126-004-0003-6; Karampelas S, 2011, GEMS GEMOL, V47, P31, DOI 10.5741/GEMS.47.1.31; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Krzemnicki MS, 2010, GEMS GEMOL, V46, P128, DOI 10.5741/GEMS.46.2.128; Krzemnicki MS, 2013, RADIOCARBON IN PRESS; Krzemnicki MS, 2010, KESHI CULTURED PEARL; Kunz GF, 1908, BOOK PEARL HIST ART, DOI [10.1184/OCLC/00838185, DOI 10.1184/0CLC/00838185]; Landman Neil H., 2001, PEARLS NATURAL HIST; Lind CE, 2012, BIOL J LINN SOC, V107, P632, DOI 10.1111/j.1095-8312.2012.01960.x; Liping L., 2001, J GEMMOL, V27, P449, DOI [DOI 10.15506/JOG.2001.278.449, 10.15506/JoG.2001.27.8.449]; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Loreille OM, 2007, FORENSIC SCI INT-GEN, V1, P191, DOI 10.1016/j.fsigen.2007.02.006; Macpherson C., 2000, PACIFIC STUDIES, V23, P33; Marie B, 2012, AMINO ACIDS, V42, P2009, DOI 10.1007/s00726-011-0932-0; MARTINSON HG, 1973, BIOCHEMISTRY-US, V12, P2737, DOI 10.1021/bi00738a029; Masaoka T, 2005, FISH GENET BREED SCI, V35, P49, DOI [10.1111/j.1444-2906.2005.01035.x, DOI 10.1111/J.1444-2906.2005.01035.X]; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; MIYOSHI T, 1987, JPN J APPL PHYS 1, V26, P1069, DOI 10.1143/JJAP.26.1069; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Safar A, 2012, PEARLS TREATED IMITA; Scarratt K, 2012, GEMS GEMOL, V48, P236, DOI 10.5741/GEMS.48.4.236; Shor R, 2007, GEMS GEMOL, V43, P200, DOI 10.5741/GEMS.43.3.200; SIMKISS K, 1980, ENDEAVOUR, V4, P32, DOI 10.1016/0160-9327(80)90107-6; Sims NA., 1992, BIOL CULTURE PEARL O; Southgate P, 2008, PEARL OYSTER, pVII; Strack Elisabeth, 2006, PEARLS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor J, 2008, PEARL OYSTER, P273, DOI 10.1016/B978-0-444-52976-3.00008-5; Temkin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-342; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Yang SC, 2011, AFR J BIOTECHNOL, V10, P19203, DOI 10.5897/AJB11.2780; Yu DH, 2006, FISHERIES SCI, V72, P1183, DOI 10.1111/j.1444-2906.2006.01275.x; Yu DH, 2006, BIOCHEM SYST ECOL, V34, P240, DOI 10.1016/j.bse.2005.09.004	63	13	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75606	10.1371/journal.pone.0075606	http://dx.doi.org/10.1371/journal.pone.0075606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130725	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900045
J	Muenzel, D; Kabus, S; Gramer, B; Leber, V; Vembar, M; Schmitt, H; Wildgruber, M; Fingerle, AA; Rummeny, EJ; Huber, A; Noel, PB				Muenzel, Daniela; Kabus, Sven; Gramer, Bettina; Leber, Vivian; Vembar, Mani; Schmitt, Holger; Wildgruber, Moritz; Fingerle, Alexander A.; Rummeny, Ernst J.; Huber, Armin; Noel, Peter B.			Dynamic CT Perfusion Imaging of the Myocardium: A Technical Note on Improvement of Image Quality	PLOS ONE			English	Article							ENHANCED MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; DIAGNOSTIC PERFORMANCE; COMPUTED-TOMOGRAPHY; ANGIOGRAPHY; STRESS; ACCURACY; STENOSIS; MR	Objective: To improve image and diagnostic quality in dynamic CT myocardial perfusion imaging (MPI) by using motion compensation and a spatio-temporal filter. Methods: Dynamic CT MPI was performed using a 256-slice multidetector computed tomography scanner (MDCT). Data from two different patients-with and without myocardial perfusion defects-were evaluated to illustrate potential improvements for MPI (institutional review board approved). Three datasets for each patient were generated: (i) original data (ii) motion compensated data and (iii) motion compensated data with spatio-temporal filtering performed. In addition to the visual assessment of the tomographic slices, noise and contrast-to-noise-ratio (CNR) were measured for all data. Perfusion analysis was performed using time-density curves with regions-of-interest (ROI) placed in normal and hypoperfused myocardium. Precision in definition of normal and hypoperfused areas was determined in corresponding coloured perfusion maps. Results: The use of motion compensation followed by spatio-temporal filtering resulted in better alignment of the cardiac volumes over time leading to a more consistent perfusion quantification and improved detection of the extend of perfusion defects. Additionally image noise was reduced by 78.5%, with CNR improvements by a factor of 4.7. The average effective radiation dose estimate was 7.1 +/- 1.1 mSv. Conclusion: The use of motion compensation and spatio-temporal smoothing will result in improved quantification of dynamic CT MPI using a latest generation CT scanner.	[Muenzel, Daniela; Gramer, Bettina; Leber, Vivian; Wildgruber, Moritz; Fingerle, Alexander A.; Rummeny, Ernst J.; Huber, Armin; Noel, Peter B.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-80290 Munich, Germany; [Kabus, Sven; Schmitt, Holger] Philips Res Labs, Digital Imaging Dept, Hamburg, Germany; [Vembar, Mani] Philips Healthcare, CT Clin Sci, Cleveland, OH USA	Technical University of Munich; Philips; Philips Research; Philips; Philips Healthcare	Muenzel, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-80290 Munich, Germany.	muenzel@tum.de		Noel, Peter/0000-0002-9671-6171; Pfeiffer, Daniela/0000-0003-2002-8337	German Federal Ministry of Education and Research Grant [02NUK008C]	German Federal Ministry of Education and Research Grant	This work is partly supported by a German Federal Ministry of Education and Research Grant (02NUK008C). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg F, 2011, RADIOLOGY, V260, P689, DOI 10.1148/radiol.11110638; Bastarrika G, 2010, INVEST RADIOL, V45, P306, DOI 10.1097/RLI.0b013e3181dfa2f2; Beek AM, 2003, J AM COLL CARDIOL, V42, P895, DOI 10.1016/S0735-1097(03)00835-0; Beller GA, 2010, J NUCL CARDIOL, V17, P1, DOI 10.1007/s12350-009-9189-3; Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chao SP, 2010, EUR HEART J, V31, P1916, DOI 10.1093/eurheartj/ehq072; Cody D, 2008, MANAGEMENT RAD DOSE; Cury RC, 2006, RADIOLOGY, V240, P39, DOI 10.1148/radiol.2401051161; Cury RC, 2010, AM J CARDIOL, V106, P310, DOI 10.1016/j.amjcard.2010.03.025; de Graaf FR, 2010, EUR HEART J, V31, P1908, DOI 10.1093/eurheartj/ehp571; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Gebker R, 2008, RADIOLOGY, V247, P57, DOI 10.1148/radiol.2471070596; Gerber BL, 2012, J AM COLL CARDIOL, V59, P825, DOI 10.1016/j.jacc.2011.09.073; Hirai N, 2008, RADIOLOGY, V248, P424, DOI 10.1148/radiol.2482071804; Isola AA, 2011, PHYS MED BIOL, V56, P5925, DOI 10.1088/0031-9155/56/18/010; Kabus S., 2010, FAST ELASTIC IMAGE R, P81; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Modersitzki J., 2004, NUMER MATH SCI COMP; Muenzel D, 2011, EUR RADIOL, V21, P2277, DOI 10.1007/s00330-011-2185-4; Muenzel D, 2012, EUR J RADIOL, V81, P1562, DOI 10.1016/j.ejrad.2011.04.027; Rocha JA, 2010, RADIOLOGY, V254, P410, DOI 10.1148/radiol.09091014; Scheffel H, 2008, HEART, V94, P1132, DOI 10.1136/hrt.2008.149971; Schwitter J, 2001, CIRCULATION, V103, P2230; So A, 2012, EUR RADIOL, V22, P39, DOI 10.1007/s00330-011-2260-x; Thilo C, 2009, EUR RADIOL, V19, P845, DOI 10.1007/s00330-008-1214-4	26	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75263	10.1371/journal.pone.0075263	http://dx.doi.org/10.1371/journal.pone.0075263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130697	gold, Green Submitted, Green Published			2022-12-27	WOS:000325810900028
J	Yang, LY; Jia, XB; Li, NW; Chen, C; Liu, Y; Wang, HJ				Yang, LingYun; Jia, XiBiao; Li, NingWei; Chen, Cen; Liu, Yi; Wang, HongJing			Comprehensive Clinic-Pathological Characteristics of Cervical Cancer in Southwestern China and the Clinical Significance of Histological Type and Lymph Node Metastases in Young Patients	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; HUMAN-PAPILLOMAVIRUS; UNITED-STATES; CARCINOMA; WOMEN; AGE; CHEMORADIATION; ADENOCARCINOMA; MORTALITY; NEOPLASIA	Objective: To analyze the clinic-pathological characteristics of women with cervical cancers in southwestern China and discuss the features and prognosis of young patients. Methods: A retrospective study was performed, which consisted of 1,543 patients diagnosed with cervical cancer and underwent treatment at West China Second University Hospital between November 2005 and December 2010. Among them, 154 young patients with surgical procedures between November 2005 and December 2008 were selected for a 5-year follow-up and prognostic analysis. Results: The proportion of advanced FIGO stage in patients aged over 35 years was higher than in patients aged 35 years or younger (55.1% vs 38.8%, P<0.001), and strong correlation was found between FIGO stages and the postoperative pathological risk factors (P<0.05). 312 patients (20.2%) were under 35 years old in the last 5 years. The proportion of cervical adenocarcinoma remained high in young patients (13.6%), and young women with adenocarcinoma had a higher rate of LN metastases, comparing with those with squamous cell carcinoma (42.9% vs 15.8%, P = 0.004). Young patients with adenocarcinoma had shorter progression-free survival than those who had squamous cell carcinoma (P = 0.024). Patients aged 35 years or younger with positive postoperative pathological risk factors had shorter progression-free survival, comparing with those with negative factors (P<0.01). Conclusion: Patients over 35 years were preliminarily diagnosed as advanced FIGO stage and they were more likely to have deep stromal invasion, LVSI, LN metastases, parametrial and surgical margin involvement. Regarding to young patients, cervical adenocarcinoma increased the risk of LN metastases and positive postoperative pathological risk factors could apparently worsen the prognosis. Histological type and LN metastases were independent prognostic factors for young patients in southwestern China. We re-emphasize the importance of health education and regular smear screening for elder women, and more attention should be paid to young patients with adenocarcinoma or LN metastases.	[Yang, LingYun; Jia, XiBiao; Li, NingWei; Chen, Cen; Liu, Yi; Wang, HongJing] Sichuan Univ, Dept Gynecol & Obstet, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China	Sichuan University	Wang, HJ (corresponding author), Sichuan Univ, Dept Gynecol & Obstet, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China.	whjscdx@163.com						Adamopoulou M, 2009, ANTICANCER RES, V29, P3401; Barnholtz-Sloan J, 2009, CANCER CAUSE CONTROL, V20, P1129, DOI 10.1007/s10552-009-9317-z; Bulk S, 2003, BRIT J CANCER, V89, P834, DOI 10.1038/sj.bjc.6601157; Cao ZY, 2010, CHINA OBSTETRICS GYN; CARMICHAEL JA, 1986, AM J OBSTET GYNECOL, V154, P264, DOI 10.1016/0002-9378(86)90652-6; CLARK MA, 1991, AM J CLIN ONCOL-CANC, V14, P352, DOI 10.1097/00000421-199108000-00016; Delaloye JF, 1996, EUR J OBSTET GYN R B, V64, P201, DOI 10.1016/0301-2115(95)02290-2; ELLIOTT PM, 1989, BRIT MED J, V298, P288, DOI 10.1136/bmj.298.6669.288; Frega A, 2003, CANCER LETT, V196, P127, DOI 10.1016/S0304-3835(03)00218-0; Gold MA, 2008, CANCER, V112, P1954, DOI 10.1002/cncr.23400; Grisaru D, 2001, CANCER, V92, P2999, DOI 10.1002/1097-0142(20011215)92:12<2999::AID-CNCR10145>3.0.CO;2-1; Ho CM, 2004, GYNECOL ONCOL, V93, P458, DOI 10.1016/j.ygyno.2004.01.026; Hoque ME, 2013, J CANCER RES THER, V9, P25, DOI 10.4103/0973-1482.110350; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JUNOR EJ, 1989, BRIT J OBSTET GYNAEC, V96, P522, DOI 10.1111/j.1471-0528.1989.tb03250.x; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KODAMA S, 1991, CANCER, V68, P2481, DOI 10.1002/1097-0142(19911201)68:11<2481::AID-CNCR2820681127>3.0.CO;2-K; Lau HY, 2009, INT J GYNECOL OBSTET, V107, P220, DOI 10.1016/j.ijgo.2009.07.029; [刘兰芳 LIU Lanfang], 2008, [中国癌症杂志, China Oncology], V18, P298; Marchiole P, 2005, GYNECOL ONCOL, V97, P727, DOI 10.1016/j.ygyno.2005.01.004; Masumoto N, 2004, GYNECOL ONCOL, V94, P509, DOI 10.1016/j.ygyno.2004.05.011; McMullin JM, 2005, ETHNIC HEALTH, V10, P3, DOI 10.1080/1355785052000323001; MEANWELL CA, 1988, BRIT MED J, V296, P386, DOI 10.1136/bmj.296.6619.386; Moore DH, 2008, CANCER, V112, P1874, DOI 10.1002/cncr.23386; Moscicki Anna-Barbara, 2010, Adolesc Med State Art Rev, V21, P347; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; PIVER MS, 1974, OBSTET GYNECOL, V44, P265; Robertson D., 1993, European Journal of Gynaecological Oncology, V14, P283; RUTLEDGE FN, 1992, GYNECOL ONCOL, V44, P123, DOI 10.1016/0090-8258(92)90027-G; Sasieni P, 2009, INT J CANCER, V125, P525, DOI 10.1002/ijc.24410; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; Shi JF, 2008, VACCINE, V26, pM53, DOI 10.1016/j.vaccine.2008.05.009; SPANOS WJ, 1989, GYNECOL ONCOL, V35, P66, DOI 10.1016/0090-8258(89)90013-9; Touboul C, 2010, ONCOLOGIST, V15, P405, DOI 10.1634/theoncologist.2009-0295; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Vinh-Hung V, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-164; Wang SS, 2010, CANCER-AM CANCER SOC, V116, P949, DOI 10.1002/cncr.24843	39	9	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75849	10.1371/journal.pone.0075849	http://dx.doi.org/10.1371/journal.pone.0075849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130747	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900060
J	Pooja, S; Francis, A; Rajender, S; Tamang, R; Rajkumar, R; Saini, KS; Megu, K; Goel, MM; Surekha, D; Rao, DR; Rao, L; Ramachandra, L; Kumar, S; Kumar, S; Vishnupriya, S; Satyamoorthy, K; Negi, MPS; Thangaraj, K; Konwar, R				Pooja, Singh; Francis, Amirtharaj; Rajender, Singh; Tamang, Rakesh; Rajkumar, Raja; Saini, Karan Singh; Megu, Kaling; Goel, Madhu Mati; Surekha, Daminani; Rao, Digumarthi Raghunatha; Rao, Lakshmi; Ramachandra, Lingadakai; Kumar, Sandeep; Kumar, Surender; Vishnupriya, Satti; Satyamoorthy, Kapaettu; Negi, Mahendra Pal Singh; Thangaraj, Kumarasamy; Konwar, Rituraj			Strong Impact of TGF-beta 1 Gene Polymorphisms on Breast Cancer Risk in Indian Women: A Case-Control and Population-Based Study	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; TUMOR-SUPPRESSOR; THERAPEUTIC TARGET; SIGNALING PATHWAY; METASTASIS; INHIBITION; SURVIVAL; ROLES; CELLS	Introduction: TGF-beta 1 is a multi-functional cytokine that plays an important role in breast carcinogenesis. Critical role of TGF-beta 1 signaling in breast cancer progression is well documented. Some TGF-beta 1 polymorphisms influence its expression; however, their impact on breast cancer risk is not clear. Methods: We analyzed 1222 samples in a candidate gene-based genetic association study on two distantly located and ethnically divergent case-control groups of Indian women, followed by a population-based genetic epidemiology study analyzing these polymorphisms in other Indian populations. The c.29C>T (Pro10Leu, rs1982073 or rs1800470) and c.74G>C (Arg25Pro, rs1800471) polymorphisms in the TGF-beta 1 gene were analyzed using direct DNA sequencing, and peripheral level of TGF-beta 1 were measured by ELISA. Results: c.29C>T substitution increased breast cancer risk, irrespective of ethnicity and menopausal status. On the other hand, c.74G>C substitution reduced breast cancer risk significantly in the north Indian group (p=0.0005) and only in the pre-menopausal women. The protective effect of c.74G>C polymorphism may be ethnicity-specific, as no association was seen in south Indian group. The polymorphic status of c.29C>T was comparable among Indo-Europeans, Dravidians, and Tibeto-Burmans. Interestingly, we found that Tibeto-Burmans lack polymorphism at c.74G>C locus as true for the Chinese populations. However, the Brahmins of Nepal (Indo-Europeans) showed polymorphism in 2.08% of alleles. Mean TGF-beta 1 was significantly elevated in patients in comparison to controls (p<0.001). Conclusion: c.29C>T and c.74G>C polymorphisms in the TGF-beta 1 gene significantly affect breast cancer risk, which correlates with elevated TGF-beta 1 level in the patients. The c.29C>T locus is polymorphic across ethnically different populations, but c.74G>C locus is monomorphic in Tibeto-Burmans and polymorphic in other Indian populations.	[Pooja, Singh; Rajender, Singh; Saini, Karan Singh; Konwar, Rituraj] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Pooja, Singh; Goel, Madhu Mati] King Georges Med Univ, Dept Pathol, Lucknow, Uttar Pradesh, India; [Francis, Amirtharaj; Tamang, Rakesh; Rajkumar, Raja; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Tamang, Rakesh; Surekha, Daminani; Vishnupriya, Satti] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Megu, Kaling; Kumar, Sandeep; Kumar, Surender] King Georges Med Univ, Dept Surg, Lucknow, Uttar Pradesh, India; [Rao, Digumarthi Raghunatha] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Rao, Lakshmi] Manipal Univ, Kasturba Med Coll, Dept Pathol, Manipal, Karnataka, India; [Ramachandra, Lingadakai] Manipal Univ, Kasturba Med Coll, Dept Surg, Manipal, Karnataka, India; [Kumar, Sandeep] All India Inst Med Sci, Bhopal, India; [Satyamoorthy, Kapaettu] Manipal Univ, Manipal Life Sci Ctr, Manipal, Karnataka, India; [Negi, Mahendra Pal Singh] CSIR Cent Drug Res Inst, Biometr & Stat Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Osmania University; King George's Medical University; Nizam's Institute of Medical Sciences; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; All India Institute of Medical Sciences (AIIMS) Bhopal; Manipal Academy of Higher Education (MAHE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Thangaraj, K (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	thangs@ccmb.res.in; r_konwar@cdri.res.in	Kumar, Sandeep/AAG-6866-2021; kumar, sandeep/GMX-3097-2022; KUMAR, SANDEEP/GZA-7182-2022; Konwar, Rituraj/B-2272-2010; Satyamoorthy, Kapaettu/H-3254-2015; Singh, Rajender/ABE-3512-2020	Konwar, Rituraj/0000-0002-3740-8363; Amirtharaj, Francis/0000-0001-6862-2875; Satyamoorthy, Kapaettu/0000-0002-2368-5490; Rajender, Singh/0000-0002-4592-6566; Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Council of Medical Research (ICMR) [5/13/12/2007-NCDIII]; SRF from ICMR [3/2/2/72/2011-NCD-III]; CSIR-CDRI from MOH &FW, Govt. of India [GAP0001]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); SRF from ICMR; CSIR-CDRI from MOH &FW, Govt. of India	This work was supported by the ad-hoc extramural project of the Indian Council of Medical Research (ICMR) through Grant Number 5/13/12/2007-NCDIII). In addition, this research was also supported by SRF project (No 3/2/2/72/2011-NCD-III) from ICMR and CSIR-CDRI Reproductive Health Research Programme (GAP0001) from MOH &FW, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Beisner J, 2006, CANCER RES, V66, P7554, DOI 10.1158/0008-5472.CAN-06-0634; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biswas S, 2006, CLIN CANCER RES, V12, P4142, DOI 10.1158/1078-0432.CCR-06-0952; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Colleran G, 2010, BREAST CANCER RES TR, V119, P437, DOI 10.1007/s10549-009-0395-0; Cox DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-175; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Dunning AM, 2003, CANCER RES, V63, P2610; FUJII D, 1986, SOMAT CELL MOLEC GEN, V12, P281, DOI 10.1007/BF01570787; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Gu DY, 2010, BREAST CANCER RES TR, V123, P857, DOI 10.1007/s10549-010-0766-6; Gupta S., 2009, Indian Journal of Cancer, V46, P303, DOI 10.4103/0019-509X.55550; Huang YS, 2010, BREAST CANCER RES TR, V123, P863, DOI 10.1007/s10549-010-0796-0; Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin QR, 2004, INT J CANCER, V112, P94, DOI 10.1002/ijc.20370; Joshi NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021866; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kao JY, 2003, J IMMUNOL, V170, P3806, DOI 10.4049/jimmunol.170.7.3806; Kelly RJ, 2010, J IMMUNOTOXICOL, V7, P15, DOI 10.3109/15476910903389920; Ma XY, 2010, BREAST CANCER RES TR, V124, P453, DOI 10.1007/s10549-010-0843-x; MacCallum J, 1996, BRIT J CANCER, V74, P474, DOI 10.1038/bjc.1996.385; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Mu L, 2008, BRIT J CANCER, V99, P1357, DOI 10.1038/sj.bjc.6604689; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pinkas J, 2006, BIOCHEM PHARMACOL, V72, P523, DOI 10.1016/j.bcp.2006.03.004; Pooja S, 2012, CYTOKINE, V60, P122, DOI 10.1016/j.cyto.2012.06.241; Qi XW, 2010, BREAST CANCER RES TR, V122, P273, DOI 10.1007/s10549-010-0847-6; Qiu LX, 2010, BREAST CANCER RES TR, V123, P563, DOI 10.1007/s10549-010-0781-7; Rajkumar T, 2008, BREAST CANCER RES TR, V112, P81, DOI 10.1007/s10549-007-9821-3; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reiss M, 1999, MICROBES INFECT, V1, P1327, DOI 10.1016/S1286-4579(99)00251-8; Saha A, 2004, EUR J IMMUNOGENET, V31, P37, DOI 10.1111/j.1365-2370.2004.00442.x; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Seoane J, 2008, CLIN TRANSL ONCOL, V10, P14, DOI 10.1007/s12094-008-0148-2; Shin AS, 2005, CANCER EPIDEM BIOMAR, V14, P1567, DOI 10.1158/1055-9965.EPI-05-0078; Shu XO, 2004, CANCER RES, V64, P836, DOI 10.1158/0008-5472.CAN-03-3492; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; TGF{&beta} Blockade as Anticancer Therapy, 2008, AACR ED BOOK, P71; Tomita S, 1999, BREAST CANCER RES TR, V53, P33, DOI 10.1023/A:1006167210269; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watanabe Y, 2002, J HUM GENET, V47, P478, DOI 10.1007/s100380200069; Welm AL, 2008, CELL, V133, P27, DOI 10.1016/j.cell.2008.03.012; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zheng Wei, 2009, V472, P265, DOI 10.1007/978-1-60327-492-0_11	57	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75979	10.1371/journal.pone.0075979	http://dx.doi.org/10.1371/journal.pone.0075979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146803	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200006
J	Wang, GH; Mao, WB; Byler, R; Patel, K; Henegar, C; Alexeev, A; Sulchek, T				Wang, Gonghao; Mao, Wenbin; Byler, Rebecca; Patel, Krishna; Henegar, Caitlin; Alexeev, Alexander; Sulchek, Todd			Stiffness Dependent Separation of Cells in a Microfluidic Device	PLOS ONE			English	Article							CONTINUOUS-FLOW; CANCER-PATIENTS; CYTOCHALASIN-D; SINGLE CELLS; WHOLE-BLOOD; DEFORMABILITY; CHIP; DIELECTROPHORESIS; FLUID; MICROCAPSULES	Abnormal cell mechanical stiffness can point to the development of various diseases including cancers and infections. We report a new microfluidic technique for continuous cell separation utilizing variation in cell stiffness. We use a microfluidic channel decorated by periodic diagonal ridges that compress the flowing cells in rapid succession. The compression in combination with secondary flows in the ridged microfluidic channel translates each cell perpendicular to the channel axis in proportion to its stiffness. We demonstrate the physical principle of the cell sorting mechanism and show that our microfluidic approach can be effectively used to separate a variety of cell types which are similar in size but of different stiffnesses, spanning a range from 210 Pa to 23 kPa. Atomic force microscopy is used to directly measure the stiffness of the separated cells and we found that the trajectories in the microchannel correlated to stiffness. We have demonstrated that the current processing throughput is 250 cells per second. This microfluidic separation technique opens new ways for conducting rapid and low-cost cell analysis and disease diagnostics through biophysical markers.	[Wang, Gonghao; Mao, Wenbin; Henegar, Caitlin; Alexeev, Alexander; Sulchek, Todd] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Byler, Rebecca; Patel, Krishna; Sulchek, Todd] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Sulchek, Todd] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sulchek, T (corresponding author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	todd.sulchek@me.gatech.edu	Mao, Wenbin/J-4546-2014; Alexeev, Alexander/B-1322-2011	Mao, Wenbin/0000-0002-8582-0205; Alexeev, Alexander/0000-0002-8285-0003	National Science Foundation [CBET-0932510]; TI:GER program at Scheller College of Business at Georgia Institute of Technology; Georgia Tech; Petit Fellowship	National Science Foundation(National Science Foundation (NSF)); TI:GER program at Scheller College of Business at Georgia Institute of Technology; Georgia Tech; Petit Fellowship	The authors thank National Science Foundation (project number CBET-0932510) and TI:GER program at Scheller College of Business at Georgia Institute of Technology for financial support of this project. The authors also thank the President's Undergraduate Research Award (PURA) program at Georgia Tech for providing funding to CH and the Petit Fellowship for support to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148103; Alexeev A, 2005, MACROMOLECULES, V38, P10244, DOI 10.1021/ma0516135; Alexeev A, 2007, LANGMUIR, V23, P983, DOI 10.1021/la062914q; Arata JP, 2009, SOFT MATTER, V5, P2721, DOI 10.1039/b908213a; Beech JP, 2012, LAB CHIP, V12, P1048, DOI 10.1039/c2lc21083e; Bouzidi M, 2001, PHYS FLUIDS, V13, P3452, DOI 10.1063/1.1399290; Buxton GA, 2001, MODEL SIMUL MATER SC, V9, P485, DOI 10.1088/0965-0393/9/6/302; Choi S, 2007, LAB CHIP, V7, P1532, DOI 10.1039/b705203k; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Didar TF, 2010, LAB CHIP, V10, P3043, DOI [10.1039/c0lc00130a, 10.1039/c01c00130a]; Doh I, 2005, SENSOR ACTUAT A-PHYS, V121, P59, DOI 10.1016/j.sna.2005.01.030; Ekpenyong AE, 2012, PLOS ONE, V7; Fedosov DA, 2010, COMPUT METHOD APPL M, V199, P1937, DOI 10.1016/j.cma.2010.02.001; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Han KH, 2006, LAB CHIP, V6, P265, DOI 10.1039/b514539b; Hou HW, 2010, LAB CHIP, V10, P2605, DOI 10.1039/c003873c; Hur SC, 2011, LAB CHIP, V11, P912, DOI [10.1039/c0lc00595a, 10.1039/c01c00595a]; Kilimnik A, 2011, PHYS FLUIDS, V23; Kim U, 2008, ANAL CHEM, V80, P8656, DOI 10.1021/ac8015938; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Ladd AJC, 1997, PHYS REV E, V55, P3271, DOI 10.1103/PhysRevE.55.3271; Ladd AJC, 2001, J STAT PHYS, V104, P1191, DOI 10.1023/A:1010414013942; Lee WG, 2007, LAB CHIP, V7, P516, DOI 10.1039/b614912j; Lenshof A, 2009, ANAL CHEM, V81, P6030, DOI 10.1021/ac9013572; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Lincoln B, 2004, CYTOM PART A, V59A, P203, DOI 10.1002/cyto.a.20050; Mao WB, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3590264; Mao XL, 2012, LAB CHIP, V12, P4006, DOI 10.1039/c2lc90100e; MILLS GB, 1990, J CLIN INVEST, V86, P851, DOI 10.1172/JCI114784; Mohamed H, 2009, J CHROMATOGR A, V1216, P8289, DOI 10.1016/j.chroma.2009.05.036; Moreno-Flores S, 2010, NANOTECHNOLOGY, P21; Moreno-Flores S, 2010, J BIOMECH, V43, P349, DOI 10.1016/j.jbiomech.2009.07.037; Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a; Perroud TD, 2008, ANAL CHEM, V80, P6365, DOI 10.1021/ac8007779; Petersson F, 2007, ANAL CHEM, V79, P5117, DOI 10.1021/ac070444e; Pommer MS, 2008, ELECTROPHORESIS, V29, P1213, DOI 10.1002/elps.200700607; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Rosenbluth MJ, 2008, LAB CHIP, V8, P1062, DOI 10.1039/b802931h; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Schulze C, 2009, CELL MOTIL CYTOSKEL, V66, P193, DOI 10.1002/cm.20341; Shi JJ, 2009, LAB CHIP, V9, P3354, DOI 10.1039/b915113c; Succi S, 2001, LATTICE BOLTZMANN EQ, P290; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Vahey MD, 2008, ANAL CHEM, V80, P3135, DOI 10.1021/ac7020568; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang MM, 2005, NAT BIOTECHNOL, V23, P83, DOI 10.1038/nbt1050; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Xu WW, 2012, PLOS ONE, P7; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189; Zhu GD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2753150	55	69	71	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75901	10.1371/journal.pone.0075901	http://dx.doi.org/10.1371/journal.pone.0075901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146787	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400022
J	Clotuche, G; Navajas, M; Mailleux, AC; Hance, T				Clotuche, Gwendoline; Navajas, Maria; Mailleux, Anne-Catherine; Hance, Thierry			Reaching the Ball or Missing the Flight? Collective Dispersal in the Two-Spotted Spider Mite Tetranychus urticae	PLOS ONE			English	Article							AERIAL-DISPERSAL; COCKROACH AGGREGATION; EVOLUTION; BEHAVIOR; ACARI; DISCRIMINATION; CONSEQUENCES; RECOGNITION	The two-spotted spider mite is a worldwide phytophagous pest displaying a peculiar dispersal. At high density, when plants are exhausted, individuals gather at the plant apex to form a collective silk-ball. This structure can be dispersed by wind or phoresy. Individuals initiating the ball are enclosed in the centre and have a high risk to die. For the first time, the ultimate and proximate mechanisms leading to this group dispersal are examined. To explore if a particular mite genotype was involved in the ball formation, plants were infested with individuals of different genetic background. After the silk-ball formation, the mites in the ball and those remaining on the plant were collected and genotyped. The balls were harvested after 4h and 24h to determine the role of timing between the formation and dispersal on the mortality of mites. Mites do not segregate according to their degree of relatedness, stage, or sex. Mites parallel humans using public transportation: they climb up in the ball whatever their genetic background. Silk-balls composed of unrelated individuals may help avoiding inbreeding when colonizing a new plant. Our results also emphasize the importance of an adequate timing for efficient dispersal between the time spent between ball formation and dispersal.	[Clotuche, Gwendoline; Mailleux, Anne-Catherine; Hance, Thierry] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium; [Navajas, Maria] UMR CBGP INRA IRD Cirad Montpellier SupAgro, INRA, Montferrier Sur Lez, France	Universite Catholique Louvain; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Clotuche, G (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium.	gwendoline.clotuche@gmail.com	NAVAJAS, Maria/AAM-2294-2020	NAVAJAS, Maria/0000-0002-0702-4238	Belgian Fund "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)"; Fund for Fundamental and Collective Research (FRFC)	Belgian Fund "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)"(Fonds de la Recherche Scientifique - FNRS); Fund for Fundamental and Collective Research (FRFC)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian Fund "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)" and by the Fund for Fundamental and Collective Research (FRFC, convention 2.4622.06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; Bergman CM, 2000, OECOLOGIA, V123, P364, DOI 10.1007/s004420051023; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; BRANDENBURG RL, 1982, ENTOMOL EXP APPL, V32, P269, DOI 10.1111/j.1570-7458.1982.tb03217.x; Clotuche G, 2009, MICROSC RES TECHNIQ, V72, P659, DOI 10.1002/jemt.20712; CLOTUCHE G, 2011, THESIS LOUVAIN LA NE; Clotuche G, 2012, CR BIOL, V335, P535, DOI 10.1016/j.crvi.2012.07.001; Clotuche G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018854; Costa J., 2006, OTHER INSECT SOC; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HUSSEY N. W., 1963, ENTOMOL EXP APPL, V6, P207, DOI 10.1007/BF00300527; Ims Rolf A., 2001, P203; Kennedy G.G., 1985, P233; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Le Goff G., 2011, THESIS LOUVAIN LA NE; Le Goff G, 2009, CR BIOL, V332, P927, DOI 10.1016/j.crvi.2009.06.002; LI JB, 1993, ENTOMOL EXP APPL, V68, P79, DOI 10.1007/BF02380584; Mailleux AC, 2008, INSECT SOC, V55, P355, DOI 10.1007/s00040-008-1011-8; Mailleux AC, 2006, J EXP BIOL, V209, P4224, DOI 10.1242/jeb.02461; Navajas M, 2002, INSECT MOL BIOL, V11, P157, DOI 10.1046/j.1365-2583.2002.00320.x; Nichols J., 2001, DISPERSAL; Osakabe M, 2008, EXP APPL ACAROL, V44, P165, DOI 10.1007/s10493-008-9141-2; Page RE, 1997, ENDEAVOUR, V21, P114, DOI 10.1016/S0160-9327(97)80220-7; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; PRALAVORIO M, 1989, ENTOMOPHAGA, V34, P129, DOI 10.1007/BF02372596; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rivault C, 1998, ANIM BEHAV, V55, P177, DOI 10.1006/anbe.1997.0628; ROBSON SK, 1998, INFORM PROCESSING SO, P239; Roeder C, 1996, J EVOLUTION BIOL, V9, P143, DOI 10.1046/j.1420-9101.1996.9020143.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITO Y, 1983, ACAROLOGIA, V24, P377; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sherwin WB, 2000, CONSERV BIOL SER, V4, P9; Singer TL, 1998, AM ZOOL, V38, P394; SMITLEY DR, 1985, ANN ENTOMOL SOC AM, V78, P609, DOI 10.1093/aesa/78.5.609; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Tien NSH, 2011, EXP APPL ACAROL, V54, P119, DOI 10.1007/s10493-011-9431-y; TREHERNE JE, 1981, ANIM BEHAV, V29, P911, DOI 10.1016/S0003-3472(81)80028-0; Turchin Peter, 1998; Uesugi R, 2007, MOL ECOL NOTES, V7, P290, DOI 10.1111/j.1471-8286.2006.01583.x; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; WRANGHAM RW, 1979, SOC SCI INFORM, V18, P335; Yano S, 2004, EXP APPL ACAROL, V32, P243, DOI 10.1023/B:APPA.0000023241.73640.e4	50	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77573	10.1371/journal.pone.0077573	http://dx.doi.org/10.1371/journal.pone.0077573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143242	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100080
J	Francis, O; Han, FJ; Adams, JC				Francis, Ore; Han, Fujun; Adams, Josephine C.			Molecular Phylogeny of a RING E3 Ubiquitin Ligase, Conserved in Eukaryotic Cells and Dominated by Homologous Components, the Muskelin/RanBPM/CTLH Complex	PLOS ONE			English	Article							SCAFFOLDING PROTEIN RANBPM; N-TERMINAL DOMAIN; GID COMPLEX; DROSOPHILA-MELANOGASTER; CATABOLITE DEGRADATION; GENOME-WIDE; MUSKELIN; SEQUENCE; FRUCTOSE-1,6-BISPHOSPHATASE; EVOLUTION	Ubiquitination is an essential post-translational modification that regulates signalling and protein turnover in eukaryotic cells. Specificity of ubiquitination is driven by ubiquitin E3 ligases, many of which remain poorly understood. One such is the mammalian muskelin/RanBP9/CTLH complex that includes eight proteins, five of which (RanBP9/RanBPM, TWA1, MAEA, Rmnd5 and muskelin), share striking similarities of domain architecture and have been implicated in regulation of cell organisation. In budding yeast, the homologous GID complex acts to down-regulate gluconeogenesis. In both complexes, Rmnd5/GID2 corresponds to a RING ubiquitin ligase. To better understand this E3 ligase system, we conducted molecular phylogenetic and sequence analyses of the related components. TWA1, Rmnd5, MAEA and WDR26 are conserved throughout all eukaryotic supergroups, albeit WDR26 was not identified in Rhizaria. RanBPM is absent from Excavates and from some sub-lineages. Armc8 and c17orf39 were represented across unikonts but in bikonts were identified only in Viridiplantae and in O. trifallax within alveolates. Muskelin is present only in Opisthokonts. Phylogenetic and sequence analyses of the shared LisH and CTLH domains of RanBPM, TWA1, MAEA and Rmnd5 revealed closer relationships and profiles of conserved residues between, respectively, Rmnd5 and MAEA, and RanBPM and TWA1. Rmnd5 and MAEA are also related by the presence of conserved, variant RING domains. Examination of how N- or C-terminal domain deletions alter the sub-cellular localisation of each protein in mammalian cells identified distinct contributions of the LisH domains to protein localisation or folding/stability. In conclusion, all components except muskelin are inferred to have been present in the last eukaryotic common ancestor. Diversification of this ligase complex in different eukaryotic lineages may result from the apparently fast evolution of RanBPM, differing requirements for WDR26, Armc8 or c17orf39, and the origin of muskelin in opisthokonts as a RanBPM-binding protein.	[Francis, Ore; Han, Fujun; Adams, Josephine C.] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol	Adams, JC (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	jo.adams@bristol.ac.uk	Adams, Josephine C/B-1121-2009	Adams, Josephine C/0000-0002-2225-4947; Francis, Ore/0000-0003-2678-917X	BBSRC; Wellcome Trust [090300]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	Financial support of BBSRC (OF is supported by a BBSRC Doctoral Training grant) and the Wellcome Trust (090300 to JCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams JC, 2002, GENE, V297, P69, DOI 10.1016/S0378-1119(02)00887-9; Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Bala S, 2006, BIOCHEM BIOPH RES CO, V342, P1040, DOI 10.1016/j.bbrc.2006.02.060; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Burger A, 2006, NEOPLASIA, V8, P689, DOI 10.1593/neo.06469; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Hosono K, 2010, GENOMICS, V96, P102, DOI 10.1016/j.ygeno.2010.05.003; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Keeling PJ, 2007, SCIENCE, V317, P1875, DOI 10.1126/science.1149593; Kim MH, 2004, STRUCTURE, V12, P987, DOI 10.1016/j.str.2004.03.024; Kim YE, 2005, BIOCHEM BIOPH RES CO, V330, P746, DOI 10.1016/j.bbrc.2005.03.052; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Koonin EV, 2010, CELL, V140, P606, DOI 10.1016/j.cell.2010.02.022; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MARCUS F, 1987, ARCH BIOL MED EXP, V20, P371; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; PETERS R, 1984, EMBO J, V3, P1831, DOI 10.1002/j.1460-2075.1984.tb02055.x; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Prag S, 2004, BIOCHEM J, V381, P547, DOI 10.1042/BJ20040253; Puverel S, 2011, DEVELOPMENT, V138, P2511, DOI 10.1242/dev.062505; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rogozin IB, 2009, GENOME BIOL EVOL, V1, P99, DOI 10.1093/gbe/evp011; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Soni S, 2008, BLOOD CELL MOL DIS, V41, P141, DOI 10.1016/j.bcmd.2008.03.008; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Suresh B, 2010, J BIOL CHEM, V285, P35340, DOI 10.1074/jbc.M110.156836; Suzuki T, 2008, BIOCHEM J, V411, P581, DOI 10.1042/BJ20071312; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Tillmann H, 2002, GENE, V291, P57, DOI 10.1016/S0378-1119(02)00627-3; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Tomastikova E, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-83; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yuan SL, 2012, PLANT PHYSIOL, V160, P106, DOI 10.1104/pp.112.199000; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	70	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75217	10.1371/journal.pone.0075217	http://dx.doi.org/10.1371/journal.pone.0075217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143168	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100003
J	Bansal, D; Yadav, AK; Kumar, V; Minz, M; Sakhuja, V; Jha, V				Bansal, Dinesh; Yadav, Ashok K.; Kumar, Vinod; Minz, Mukut; Sakhuja, Vinay; Jha, Vivekanand			Deferred Pre-Emptive Switch from Calcineurin Inhibitor to Sirolimus Leads to Improvement in GFR and Expansion of T Regulatory Cell Population: A Randomized, Controlled Trial	PLOS ONE			English	Article							KIDNEY-TRANSPLANT RECIPIENTS; RENAL-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; DE-NOVO; EARLY CONVERSION; CYCLOSPORINE; EFFICACY; RAPAMYCIN; THERAPY; SAFETY	Background: Measures to prevent chronic calcineurin inhibitor (CNI) toxicity have included limiting exposure by switching to sirolimus (SIR). SIR may favorably influence T regulator cell (T-reg) population. This randomized controlled trial compares the effect of switching from CNI to SIR on glomerular filtration rate (GFR) and T-reg frequency. Methods: In this prospective open label randomized trial, primary living donor kidney transplant recipients on CNI-based immunosuppression were randomized to continue CNI or switched to sirolimus 2 months after surgery; 29 were randomized to receive CNI and 31 to SIR. All patients received mycophenolate mofetil and steroids. The main outcome parameter was estimated GFR (eGFR) at 180 days. T-reg population was estimated by flowcytometry. Results: Baseline characteristics in the two groups were similar. Forty-eight patients completed the trial. At six months, patients in the SIR group had significantly higher eGFR as compared to those in the CNI group (88.94 +/- 11.78 vs 80.59 +/- 16.51 mL/min, p = 0.038). Patients on SIR had a 12 mL/min gain of eGFR of at the end of six months. Patients in the SIR group showed significant increase in T-reg population at 30 days, which persisted till day 180. There was no difference in the adverse events in terms of number of acute rejection episodes, death, infections, proteinuria, lipid profile, blood pressure control and hematological parameters between the two groups. Four patients taking SIR developed enthesitis. No patient left the study or switched treatment because of adverse event. Conclusions: A deferred pre-emptive switch over from CNI to SIR safely improves renal function and T-reg population at 6 months in living donor kidney transplant recipients. Registered in Clinical Trials Registry of India (CTRI/2011/091/000034)	[Bansal, Dinesh; Yadav, Ashok K.; Kumar, Vinod; Sakhuja, Vinay; Jha, Vivekanand] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India; [Minz, Mukut] Postgrad Inst Med Educ & Res, Dept Renal Transplant Surg, Chandigarh 160012, India; [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Dept Regenerat & Translat Med, Chandigarh 160012, India; [Jha, Vivekanand] George Inst Int Hlth, Hyderabad, Andhra Pradesh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Jha, V (corresponding author), Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India.	vjha@pginephro.org	, vinod/AAP-8318-2021	, vinod/0000-0002-1082-8050; Yadav, Ashok Kumar/0000-0003-0155-928X; Jha, Vivekanand/0000-0002-8015-9470	Biocon Nephrology, Bangalore, India	Biocon Nephrology, Bangalore, India	The study was funded by Biocon Nephrology, Bangalore, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom DD, 2008, AM J TRANSPLANT, V8, P793, DOI 10.1111/j.1600-6143.2007.02134.x; Budde K, 2012, AM J TRANSPLANT, V12, P1528, DOI 10.1111/j.1600-6143.2012.03994.x; Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Buchler M, 2007, AM J TRANSPLANT, V7, P2522, DOI 10.1111/j.1600-6143.2007.01976.x; Carroll RP, 2013, NEPHROL DIAL TRANSPL, V28, P462, DOI 10.1093/ndt/gfs474; Chen JF, 2010, CHINESE MED J-PEKING, V123, P942, DOI 10.3760/cma.j.issn.0366-6999.2010.07.032; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Guba M, 2012, TRANSPL INT, V25, P416, DOI 10.1111/j.1432-2277.2012.01432.x; Guba M, 2010, TRANSPLANTATION, V90, P175, DOI 10.1097/TP.0b013e3181e11798; Kang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x; Korczak-Kowalska G, 2007, TRANSPL P, V39, P2721, DOI 10.1016/j.transproceed.2007.09.015; Larson TS, 2006, AM J TRANSPLANT, V6, P514, DOI 10.1111/j.1600-6143.2005.01177.x; Lebranchu Y, 2011, AM J TRANSPLANT, V11, P1665, DOI 10.1111/j.1600-6143.2011.03637.x; Lebranchu Y, 2009, AM J TRANSPLANT, V9, P1115, DOI 10.1111/j.1600-6143.2009.02615.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P2058, DOI 10.1111/j.1600-6143.2004.00624.x; Mourad G, 1998, TRANSPLANTATION, V65, P661, DOI 10.1097/00007890-199803150-00010; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Noris M, 2007, J AM SOC NEPHROL, V18, P1007, DOI 10.1681/ASN.2006101143; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Segundo DS, 2006, TRANSPLANTATION, V82, P550, DOI 10.1097/01.tp.0000229473.95202.50; SINCLAIR NR, 1986, NEW ENGL J MED, V314, P1219; Tsaur I, 2011, KIDNEY INT, V79, P1005, DOI 10.1038/ki.2010.533; Valente JF, 2003, AM J TRANSPLANT, V3, P1128, DOI 10.1034/j.1600-6143.2003.00185.x; Weir MR, 2011, KIDNEY INT, V79, P897, DOI 10.1038/ki.2010.492; Weir MR, 2004, AM J NEPHROL, V24, P379, DOI 10.1159/000079390; Wimmer CD, 2007, KIDNEY INT, V71, P1271, DOI 10.1038/sj.ki.5002154	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75591	10.1371/journal.pone.0075591	http://dx.doi.org/10.1371/journal.pone.0075591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146762	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400012
J	He, C; Convertino, M; Feng, ZK; Zhang, SY				He, Cheng; Convertino, Matteo; Feng, Zhongke; Zhang, Siyu			Using LiDAR Data to Measure the 3D Green Biomass of Beijing Urban Forest in China	PLOS ONE			English	Article							BROAD-LEAVED FOREST; SPATIAL-PATTERNS; CLIMATE-CHANGE; CARBON STOCKS; TREE; BIODIVERSITY; ECOSYSTEMS; DENSITY; EAST; RAIN	The purpose of the paper is to find a new approach to measure 3D green biomass of urban forest and to testify its precision. In this study, the 3D green biomass could be acquired on basis of a remote sensing inversion model in which each standing wood was first scanned by Terrestrial Laser Scanner to catch its point cloud data, then the point cloud picture was opened in a digital mapping data acquisition system to get the elevation in an independent coordinate, and at last the individual volume captured was associated with the remote sensing image in SPOT5(System Probatoired'Observation dela Tarre) by means of such tools as SPSS (Statistical Product and Service Solutions), GIS (Geographic Information System), RS (Remote Sensing) and spatial analysis software (FARO SCENE and Geomagic studio11). The results showed that the 3D green biomass of Beijing urban forest was 399.1295 million m(3), of which coniferous was 28.7871 million m(3) and broad-leaf was 370.3424 million m(3). The accuracy of 3D green biomass was over 85%, comparison with the values from 235 field sample data in a typical sampling way. This suggested that the precision done by the 3D forest green biomass based on the image in SPOT5 could meet requirements. This represents an improvement over the conventional method because it not only provides a basis to evalue indices of Beijing urban greenings, but also introduces a new technique to assess 3D green biomass in other cities.	[He, Cheng; Zhang, Siyu] Nanjing Forest Police Coll, Nanjing, Jiangsu, Peoples R China; [Convertino, Matteo] Univ Minnesota Twin Cities, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Convertino, Matteo] Univ Minnesota Twin Cities, Inst Environm, Minneapolis, MN USA; [Feng, Zhongke] Beijing Forestry Univ, Coll Forestry, Inst GIS RS&GPS, Beijing, Peoples R China	Nanjing Forest Police College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Beijing Forestry University	Zhang, SY (corresponding author), Nanjing Forest Police Coll, Nanjing, Jiangsu, Peoples R China.	siyu85878817@163.com	Convertino, Matteo/ABD-5828-2021; Convertino, Matteo/J-1365-2016	Convertino, Matteo/0000-0001-7003-7587; feng, zhong ke/0000-0002-1444-7976	state forestry administration project "948" [2013-4-65]; National Project "863" [2009AA12Z327, 2008AA121305-4]; Beijing Natural Science Foundation [09D0297]; National Natural Science Foundations of China [30872038, 30671696]	state forestry administration project "948"; National Project "863"; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the state forestry administration project "948" (2013-4-65); National Project "863" (2009AA12Z327, 2008AA121305-4); Beijing Natural Science Foundation (09D0297); National Natural Science Foundations of China (30872038, 30671696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baraloto C, 2011, GLOBAL CHANGE BIOL, V17, P2677, DOI 10.1111/j.1365-2486.2011.02432.x; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Caspersen JP, 2001, ECOL RES, V16, P895, DOI 10.1046/j.1440-1703.2001.00455.x; Chen B, 2009, GUTIANSHAN FOREST DY; Chen Fang, 2006, Yingyong Shengtai Xuebao, V17, P592; Chen Q., 1993, CHIN J PLANT ECOL, V17, P38; Chen W, 2000, J FUJIAN FORESTRY TE, V27, P31; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Du G, 1987, J ZHEJIANG FORESTRY, V7, P5; Du YJ, 2012, ACTA OECOL, V39, P87, DOI 10.1016/j.actao.2012.01.006; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; [胡正华 Hu Zhenghua], 2008, [生态环境, Ecology and Environment], V17, P1961; Imai N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008267; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; KIRA T, 1991, ECOL RES, V6, P185, DOI 10.1007/BF02347161; Kral K, 2010, FOREST ECOL MANAG, V260, P2196, DOI 10.1016/j.foreco.2010.09.020; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Lv ME, 2000, CHINESE LANDSCAPE AR, V16, P41; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Man XingXing, 2011, Biodiversity Science, V19, P197, DOI 10.3724/SP.J.1003.2011.09220; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; McEwan RW, 2011, FOREST ECOL MANAG, V262, P1817, DOI 10.1016/j.foreco.2011.07.028; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paoli GD, 2008, OECOLOGIA, V155, P287, DOI 10.1007/s00442-007-0906-9; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Ruiz-Jaen MC, 2011, NEW PHYTOL, V189, P978, DOI 10.1111/j.1469-8137.2010.03501.x; Running SW, 2008, SCIENCE, V321, P652, DOI 10.1126/science.1159607; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020778; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Tateno R, 2003, ECOL RES, V18, P559, DOI 10.1046/j.1440-1703.2003.00578.x; Tong QX., 1997, J REMOTE SENSING, V2, P111; VANSCHAIK CP, 1985, BIOTROPICA, V17, P196, DOI 10.2307/2388217; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; Yamada T, 2007, J ECOL, V95, P332, DOI 10.1111/j.1365-2745.2006.01209.x; Yang TH, 2010, SCI CHINA LIFE SCI, V53, P811, DOI 10.1007/s11427-010-4021-5; Yu MingJian, 2001, Journal of Zhejiang University (Agriculture and Life Sciences), V27, P375; Zhang J, 2007, FOREST ECOL MANAG, V245, P64, DOI 10.1016/j.foreco.2007.03.042; Zhang L., 2010, THESIS CHINESE ACAD; Zhong Z, 1987, J SW CHINA NORMAL U, V3, P109; Zhou J.H., 1995, J REMOTE SENS, V3, P162	53	22	23	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75920	10.1371/journal.pone.0075920	http://dx.doi.org/10.1371/journal.pone.0075920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146792	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400026
J	Kang, SY; McGree, J; Mengersen, K				Kang, Su Yun; McGree, James; Mengersen, Kerrie			The Impact of Spatial Scales and Spatial Smoothing on the Outcome of Bayesian Spatial Model	PLOS ONE			English	Article							NESTED LAPLACE APPROXIMATIONS; COUNT DATA; REGRESSION; COMPUTATION; INLA	Discretization of a geographical region is quite common in spatial analysis. There have been few studies into the impact of different geographical scales on the outcome of spatial models for different spatial patterns. This study aims to investigate the impact of spatial scales and spatial smoothing on the outcomes of modelling spatial point-based data. Given a spatial point-based dataset (such as occurrence of a disease), we study the geographical variation of residual disease risk using regular grid cells. The individual disease risk is modelled using a logistic model with the inclusion of spatially unstructured and/or spatially structured random effects. Three spatial smoothness priors for the spatially structured component are employed in modelling, namely an intrinsic Gaussian Markov random field, a second-order random walk on a lattice, and a Gaussian field with Matern correlation function. We investigate how changes in grid cell size affect model outcomes under different spatial structures and different smoothness priors for the spatial component. A realistic example (the Humberside data) is analyzed and a simulation study is described. Bayesian computation is carried out using an integrated nested Laplace approximation. The results suggest that the performance and predictive capacity of the spatial models improve as the grid cell size decreases for certain spatial structures. It also appears that different spatial smoothness priors should be applied for different patterns of point data.	[Kang, Su Yun; McGree, James; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Kang, Su Yun; McGree, James; Mengersen, Kerrie] Cooperat Res Ctr Spatial Informat, Melbourne, Vic, Australia	Queensland University of Technology (QUT)	Kang, SY (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	s7.kang@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	McGree, James/0000-0003-2997-8929; Mengersen, Kerrie/0000-0001-8625-9168; Kang, Su Yun/0000-0003-4648-9844	Cooperative Research Centre for Spatial Information; Australian Commonwealth's Cooperative Research Centres Programme	Cooperative Research Centre for Spatial Information(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Commonwealth's Cooperative Research Centres Programme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The work has been supported by the Cooperative Research Centre for Spatial Information, whose activities are funded by the Australian Commonwealth's Cooperative Research Centres Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkin M., 2010, STAT INFERENCE INTEG; [Anonymous], 2000, SPATIAL EPIDEMIOLOGY; Baddeley A, 2010, ELECTRON J STAT, V4, P1151, DOI 10.1214/10-EJS581; Banerjee S., 2004, HIERARCHICAL MODELIN; BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Biggeri A, 2006, STAT METHODS MED RES, V15, P337, DOI 10.1191/0962280206sm455oa; Bivand R., 2020, SPDEP SPATIAL DEPEND; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Clayton DG, 1992, GEOGRAPHICAL ENV EPI; CRESSIE N, 1989, J AM STAT ASSOC, V84, P393, DOI 10.2307/2289922; CUZICK J, 1990, J ROY STAT SOC B MET, V52, P73; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; HANDCOCK MS, 1993, TECHNOMETRICS, V35, P403, DOI 10.2307/1270273; Held L, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P91, DOI 10.1007/978-3-7908-2413-1_6; Hossain MM, 2009, COMPUT STAT DATA AN, V53, P2831, DOI 10.1016/j.csda.2008.05.017; Illian JB, 2012, ANN APPL STAT, V6, P1499, DOI 10.1214/11-AOAS530; Illian JB, 2012, J ENV STAT, V3, P1; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001; Li Y, 2012, J R STAT SOC C-APPL, V61, P99, DOI 10.1111/j.1467-9876.2011.01004.x; Meliker JR, 2011, SPAT SPATIO-TEMPORAL, V2, P1, DOI 10.1016/j.sste.2010.10.001; Minasny B, 2005, GEODERMA, V128, P192, DOI 10.1016/j.geoderma.2005.04.003; Mollie A., 1996, MARKOV CHAIN MONTE C, P359; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Openshaw S., 1979, STAT APPL SPATIAL SC, V21, P127; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Roos M, 2011, BAYESIAN ANAL, V6, P259, DOI 10.1214/11-BA609; Rue H., 2005, GAUSSIAN MARKOV RAND, V104; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Rytkonen Mika J, 2004, Int J Circumpolar Health, V63, P9; Sauleau EA, 2010, ARXIV10063764; Schrodle B, 2011, COMPUTATION STAT, V26, P241, DOI 10.1007/s00180-010-0208-2; Schrodle B, 2011, J R STAT SOC C-APPL, V60, P261, DOI 10.1111/j.1467-9876.2010.00740.x; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; Simpson D, 2011, ARXIV11052982; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stein M.L., 1999, INTERPOLATION SPATIA; Tango T, 2000, STAT MED, V19, P191, DOI 10.1002/(SICI)1097-0258(20000130)19:2<191::AID-SIM281>3.0.CO;2-Q; TERZOPOULOS D, 1988, IEEE T PATTERN ANAL, V10, P417, DOI 10.1109/34.3908; VANHATALO J, 2007, J MACHINE LEARNING R, V1, P73; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Willgert KJE, 2011, GEOSPATIAL HEALTH, V5, P227, DOI 10.4081/gh.2011.175	46	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75957	10.1371/journal.pone.0075957	http://dx.doi.org/10.1371/journal.pone.0075957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146799	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400030
J	Lobysheva, II; Biller, P; Gallez, B; Beauloye, C; Balligand, JL				Lobysheva, Irina I.; Biller, Pauline; Gallez, Bernard; Beauloye, Christophe; Balligand, Jean-Luc			Nitrosylated Hemoglobin Levels in Human Venous Erythrocytes Correlate with Vascular Endothelial Function Measured by Digital Reactive Hyperemia	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITRIC-OXIDE; IN-VIVO; NO; DYSFUNCTION; TRANSPORT	Impaired nitric oxide (NO)-dependent endothelial function is associated with the development of cardiovascular diseases. We hypothesized that erythrocyte levels of nitrosylated hemoglobin (HbNO-heme) may reflect vascular endothelial function in vivo. We developed a modified subtraction method using Electron Paramagnetic Resonance (EPR) spectroscopy to identify the 5-coordinate alpha-HbNO (HbNO) concentration in human erythrocytes and examined its correlation with endothelial function assessed by peripheral arterial tonometry (PAT). Changes in digital pulse amplitude were measured by PAT during reactive hyperemia following brachial arterial occlusion in a group of healthy volunteers (50 subjects). Erythrocyte HbNO levels were measured at baseline and at the peak of hyperemia. We digitally subtracted an individual model EPR signal of erythrocyte free radicals from the whole EPR spectrum to unmask and quantitate the HbNO EPR signals. Results: Mean erythrocyte HbNO concentration at baseline was 219+/212 nmol/L (n = 50). HbNO levels and reactive hyperemia (RH) indexes were higher in female (free of contraceptive pills) than male subjects. We observed a dynamic increase of HbNO levels in erythrocytes isolated at 1-2 min of post-occlusion hyperemia (120+/28% of basal levels); post-occlusion HbNO levels were correlated with basal levels. Both basal and post-occlusion HbNO levels were significantly correlated with reactive hyperemia (RH) indexes (r = 0.58; P, 0.0001 for basal HbNO). Conclusion: The study demonstrates quantitative measurements of 5-coordinate a-HbNO in human venous erythrocytes, its dynamic physiologic regulation and correlation with endothelial function measured by tonometry during hyperemia. This opens the way to further understanding of in vivo determinants of NO bioavailability in human circulation.	[Lobysheva, Irina I.; Biller, Pauline; Balligand, Jean-Luc] UCL, Pole Pharmacol & Therapeut FATH, IREC, Brussels, Belgium; [Gallez, Bernard] UCL, Louvain Drug Res Inst, Biomed Magnet Resonance Unit, Brussels, Belgium; [Beauloye, Christophe] Catholic Univ Louvain, Clin Univ St Luc, Pole Cardiovasc Res CARD, B-1200 Brussels, Belgium; [Beauloye, Christophe] Catholic Univ Louvain, Clin Univ St Luc, Dept Internal Med, B-1200 Brussels, Belgium; [Beauloye, Christophe] Catholic Univ Louvain, Clin Univ St Luc, Dept Cardiovasc Dis, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Lobysheva, II (corresponding author), UCL, Pole Pharmacol & Therapeut FATH, IREC, Brussels, Belgium.	Irina.lobysheva@uclouvain.be; jl.balligand@uclouvain.be	Balligand, Jean-Luc J/D-7543-2012	Lobysheva, Irina/0000-0002-4290-3625; BALLIGAND, Jean-Luc/0000-0002-0522-4156	Federation Wallonie Bruxelles [ARC11-16/035]; Region Wallonne; Fonds Special de Recherche-UCL; Fondation Roger Havaux	Federation Wallonie Bruxelles; Region Wallonne; Fonds Special de Recherche-UCL; Fondation Roger Havaux	This work was supported by grant ARC11-16/035 of the Federation Wallonie Bruxelles (to JLB), a PPP "NOHEMIE" from the Region Wallonne (to JLB), the Fonds Special de Recherche-UCL and Fondation Roger Havaux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Carr A, 1999, FASEB J, V13, P1007, DOI 10.1096/fasebj.13.9.1007; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Fink Bruno, 2006, Pharmacol Rep, V58 Suppl, P8; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; Glover RE, 1999, MOL PHARMACOL, V55, P1006, DOI 10.1124/mol.55.6.1006; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Han TH, 2005, BBA-GEN SUBJECTS, V1723, P135, DOI 10.1016/j.bbagen.2005.01.013; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; Henry Y, 1997, NITRIC OXIDE RES CHE, P61; Hogg N, 2010, FREE RADICAL BIO MED, V49, P122, DOI 10.1016/j.freeradbiomed.2010.03.009; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Kirima K, 2003, AM J PHYSIOL-HEART C, V285, pH589, DOI 10.1152/ajpheart.01010.2002; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Kleschyov AL, 2007, J CHROMATOGR B, V851, P12, DOI 10.1016/j.jchromb.2006.10.006; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; MAXWELL JC, 1976, BIOCHEMISTRY-US, V15, P388, DOI 10.1021/bi00647a023; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Napoli C, 2009, ARCH PHARM RES, V32, P1103, DOI 10.1007/s12272-009-1801-1; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Paniagua OA, 2001, CIRCULATION, V103, P1752, DOI 10.1161/01.CIR.103.13.1752; Paolini M, 1999, LIFE SCI, V64, pPL273, DOI 10.1016/S0024-3205(99)00167-8; Piknova B, 2005, J BIOL CHEM, V280, P40583, DOI 10.1074/jbc.M506292200; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Siervo M, 2011, FREE RADICAL BIO MED, V51, P795, DOI 10.1016/j.freeradbiomed.2011.05.032; SUNDE RA, 1980, NUTR REV, V38, P265, DOI 10.1111/j.1753-4887.1980.tb05957.x; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wood KC, 2013, ARTERIOSCLE IN PRESS	35	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76457	10.1371/journal.pone.0076457	http://dx.doi.org/10.1371/journal.pone.0076457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130774	Green Submitted, Green Published, gold			2022-12-27	WOS:000325814200039
J	Shaik, R; Ramakrishna, W				Shaik, Rafi; Ramakrishna, Wusirika			Genes and Co-Expression Modules Common to Drought and Bacterial Stress Responses in Arabidopsis and Rice	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; TRANSCRIPTION FACTOR; BINDING-PROTEINS; SALICYLIC-ACID; JASMONATE; NETWORKS; BIOSYNTHESIS; DATABASE; PLANTS; IDENTIFICATION	Plants are simultaneously exposed to multiple stresses resulting in enormous changes in the molecular landscape within the cell. Identification and characterization of the synergistic and antagonistic components of stress response mechanisms contributing to the cross talk between stresses is of high priority to explore and enhance multiple stress responses. To this end, we performed meta-analysis of drought (abiotic), bacterial (biotic) stress response in rice and Arabidopsis by analyzing a total of 386 microarray samples belonging to 20 microarray studies and identified approximately 3100 and 900 DEGs in rice and Arabidopsis, respectively. About 38.5% (1214) and 28.7% (272) DEGs were common to drought and bacterial stresses in rice and Arabidopsis, respectively. A majority of these common DEGs showed conserved expression status in both stresses. Gene ontology enrichment analysis clearly demarcated the response and regulation of various plant hormones and related biological processes. Fatty acid metabolism and biosynthesis of alkaloids were upregulated and, nitrogen metabolism and photosynthesis was downregulated in both stress conditions. WRKY transcription family genes were highly enriched in all upregulated gene sets while 'CO-like' TF family showed inverse relationship of expression between drought and bacterial stresses. Weighted gene co-expression network analysis divided DEG sets into multiple modules that show high co-expression and identified stress specific hub genes with high connectivity. Detection of consensus modules based on DEGs common to drought and bacterial stress revealed 9 and 4 modules in rice and Arabidopsis, respectively, with conserved and reversed co-expression patterns.	[Shaik, Rafi; Ramakrishna, Wusirika] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Michigan Technological University	Ramakrishna, W (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.	wusirika@mtu.edu	Wusirika, Ramakrishna/O-9116-2019; Ramakrishna, Wusirika/M-6646-2017	Ramakrishna, Wusirika/0000-0002-8571-5827				Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brossa R, 2011, J PLANT GROWTH REGUL, V30, P322, DOI 10.1007/s00344-011-9194-z; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Cui XF, 2012, MOL PLANT, V5, P959, DOI 10.1093/mp/sss090; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Demmig-Adams B, 2013, NEW PHYTOL, V197, P720, DOI 10.1111/nph.12100; DOWNS GS, 2013, PLANT PHYSL; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; DUAN L, 2013, PLANT CELL; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; GHANEKAR R, 2008, INT J PLANTS GENOMIC, V2008; Godfray HCJ, 2011, P NATL ACAD SCI USA, V108, P19845, DOI 10.1073/pnas.1118568109; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Hamada K, 2011, PLANT CELL PHYSIOL, V52, P220, DOI 10.1093/pcp/pcq195; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hayden CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-32; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jorgensen RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00191; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kim CY, 2008, NEW PHYTOL, V180, P57, DOI 10.1111/j.1469-8137.2008.02557.x; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meier S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-24; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Muench DG, 2012, WIRES RNA, V3, P178, DOI 10.1002/wrna.1104; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pantin F, 2013, NEW PHYTOL, V197, P65, DOI 10.1111/nph.12013; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Reynolds MP, 2012, J EXP BOT, V63, P1, DOI 10.1093/jxb/err241; Rodrigo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040526; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1214, DOI 10.1093/nar/gks1122; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shu LB, 2011, PROTEOMICS, V11, P4122, DOI 10.1002/pmic.201000485; Song XQ, 2013, MOL PLANT, V6, P768, DOI 10.1093/mp/sst025; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; TOHGE T, 2013, CRIT REV BIOCH MOL B; Tsai YC, 2012, PLANT PHYSIOL, V158, P1666, DOI 10.1104/pp.111.192765; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tzin V, 2010, MOL PLANT, V3, P956, DOI 10.1093/mp/ssq048; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; *WASDE, 2012, US DROUGHT 2012 FARM; Weston DJ, 2011, PLANT CELL ENVIRON, V34, P1488, DOI 10.1111/j.1365-3040.2011.02347.x; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhang JH, 2013, MOL BIOL REP, V40, P2633, DOI 10.1007/s11033-012-2350-0; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	95	71	76	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77261	10.1371/journal.pone.0077261	http://dx.doi.org/10.1371/journal.pone.0077261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130868	gold, Green Submitted, Green Published			2022-12-27	WOS:000325814200075
J	Bobes, MA; Castellanos, AL; Quinones, I; Garcia, L; Valdes-Sosa, M				Bobes, Maria A.; Lage Castellanos, Agustin; Quinones, Ileana; Garcia, Lorna; Valdes-Sosa, Mitchell			Timing and Tuning for Familiarity of Cortical Responses to Faces	PLOS ONE			English	Article							NEURAL SYSTEMS; FUNCTIONAL NEUROANATOMY; RECOGNITION; PERCEPTION; CORTEX; FMRI; REPRESENTATION; INFORMATION; KNOWLEDGE; BRAIN	Different kinds of known faces activate brain areas to dissimilar degrees. However, the tuning to type of knowledge, and the temporal course of activation, of each area have not been well characterized. Here we measured, with functional magnetic resonance imaging, brain activity elicited by unfamiliar, visually familiar, and personally-familiar faces. We assessed response amplitude and duration using flexible hemodynamic response functions, as well as the tuning to face type, of regions within the face processing system. Core face processing areas (occipital and fusiform face areas) responded to all types of faces with only small differences in amplitude and duration. In contrast, most areas of the extended face processing system (medial orbito-frontal, anterior and posterior cingulate) had weak responses to unfamiliar and visually-familiar faces, but were highly tuned and exhibited prolonged responses to personally-familiar faces. This indicates that the neural processing of different types of familiar faces not only differs in degree, but is probably mediated by qualitatively distinct mechanisms.	[Bobes, Maria A.; Lage Castellanos, Agustin; Valdes-Sosa, Mitchell] Cuban Neurosci Ctr, Cognit Neurosci Dept, Havana, Cuba; [Quinones, Ileana; Garcia, Lorna] Basque Ctr Cognit Brain & Language BCBL, Donostia San Sebastian, Spain		Bobes, MA (corresponding author), Cuban Neurosci Ctr, Cognit Neurosci Dept, Havana, Cuba.	antonieta@cneuro.edu.cu	Penton, Lorna Garcia/I-3269-2015; Garcia-Penton, Lorna/I-7662-2018; Quiñones, Ileana/I-1574-2015	Penton, Lorna Garcia/0000-0001-9296-9318; Garcia-Penton, Lorna/0000-0001-9296-9318; Quiñones, Ileana/0000-0002-0288-364X; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Bobes, Maria Antonieta/0000-0003-0024-3881				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bobes MA, 2007, BIOL PSYCHOL, V75, P146, DOI 10.1016/j.biopsycho.2007.01.006; BODAMER A, 1947, ARCH PSYCHIAT NERVEN, V179, P6; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Cato MA, 2004, J COGNITIVE NEUROSCI, V16, P167, DOI 10.1162/089892904322984481; Chatterjee A, 2009, NEUROPSYCHOLOGY, V23, P135, DOI 10.1037/a0014430; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Critchley HD, 2000, J NEUROSCI, V20, P3033; Ellis HD, 2001, TRENDS COGN SCI, V5, P149, DOI 10.1016/S1364-6613(00)01620-X; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Gorno-Tempini ML, 2001, BRAIN, V124, P2087, DOI 10.1093/brain/124.10.2087; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Lashkari D, 2010, NEUROIMAGE, V50, P1085, DOI 10.1016/j.neuroimage.2009.12.106; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Natu V, 2011, BRIT J PSYCHOL, V102, P726, DOI 10.1111/j.2044-8295.2011.02053.x; Quiroga RQ, 2008, P NATL ACAD SCI USA, V105, P3599, DOI 10.1073/pnas.0707043105; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Schwartz CE, 2003, BIOL PSYCHIAT, V53, P854, DOI 10.1016/S0006-3223(02)01906-6; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Todorov A, 2007, NEUROPSYCHOLOGIA, V45, P163, DOI 10.1016/j.neuropsychologia.2006.04.018; TRANEL D, 1995, J COGNITIVE NEUROSCI, V7, P425, DOI 10.1162/jocn.1995.7.4.425; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; Tsukiura T, 2010, J COGNITIVE NEUROSCI, V22, P2226, DOI 10.1162/jocn.2009.21349; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valdes-Sosa M, 2011, NEUROIMAGE, V57, P1162, DOI 10.1016/j.neuroimage.2011.04.057; vies-Thompson J, 2009, NEUROPSYCHOLOGIA, V47, P1627; Waugh CE, 2010, NEUROIMAGE, V49, P1699, DOI 10.1016/j.neuroimage.2009.10.006	40	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76100	10.1371/journal.pone.0076100	http://dx.doi.org/10.1371/journal.pone.0076100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130761	Green Submitted, gold, Green Published			2022-12-27	WOS:000325810900068
J	Davis, JT; Mengersen, K; Abram, NK; Ancrenaz, M; Wells, JA; Meijaard, E				Davis, Jacqueline T.; Mengersen, Kerrie; Abram, Nicola K.; Ancrenaz, Marc; Wells, Jessie A.; Meijaard, Erik			It's Not Just Conflict That Motivates Killing of Orangutans	PLOS ONE			English	Article							PRIMATES; FORESTS; CONSERVATION; WILDLIFE; SUMATRA	We investigated why orangutans are being killed in Kalimantan, Indonesia, and the role of conflict in these killings. Based on an analysis of interview data from over 5,000 respondents in over 450 villages, we also assessed the socio-ecological factors associated with conflict and non-conflict killings. Most respondents never kill orangutans. Those who reported having personally killed an orangutan primarily did so for non-conflict reasons; for example, 56% of these respondents said that the reason they had killed an orangutan was to eat it. Of the conflict-related reasons for killing, the most common reasons orangutans were killed was fear of orangutans or in self-defence. A similar pattern was evident among reports of orangutan killing by other people in the villages. Regression analyses indicated that religion and the percentage of intact forest around villages were the strongest socio-ecological predictors of whether orangutans were killed for conflict or non-conflict related reasons. Our data indicate that between 44,170 and 66,570 orangutans were killed in Kalimantan within the respondents' active hunting lifetimes: between 12,690 and 29,024 for conflict reasons (95% CI) and between 26,361 and 41,688 for non-conflict reasons (95% CI). These findings confirm that habitat protection alone will not ensure the survival of orangutans in Indonesian Borneo, and that effective reduction of orangutan killings is urgently needed.	[Davis, Jacqueline T.; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Abram, Nicola K.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc] HUTAN Kinabatangan Orang Utan Conservat Programme, Sandakan, Sabah, Malaysia; [Abram, Nicola K.; Ancrenaz, Marc; Meijaard, Erik] People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia; [Wells, Jessie A.; Meijaard, Erik] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia	Queensland University of Technology (QUT); University of Kent; People & Nature Consulting International; University of Queensland; Australian National University	Meijaard, E (corresponding author), People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia.	emeijaard@gmail.com	Mengersen, Kerrie/AHC-4096-2022; Wells, Jessie A/F-7318-2010; Meijaard, Erik/A-2687-2016; Abram, Nicola/K-2060-2014	Wells, Jessie A/0000-0002-3555-5108; Meijaard, Erik/0000-0001-8685-3685; Mengersen, Kerrie/0000-0001-8625-9168; Abram, Nicola/0000-0003-1886-7297; Davis, Jac/0000-0001-6700-5648	The Adopt-an-Acre program; United States Agency for International Development (USAID)	The Adopt-an-Acre program; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The Adopt-an-Acre program and the United States Agency for International Development (USAID) provided funding and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; [Anonymous], 2011, JAKARTA POST; Ave J., 1986, PEOPLE WEEPING FORES; BODMER RE, 1994, BIOL CONSERV, V67, P29, DOI 10.1016/0006-3207(94)90005-1; Bowen-Jones E, 1999, ORYX, V33, P233, DOI 10.1046/j.1365-3008.1999.00066.x; Caldecott J. O., 1988, HUNTING WILDLIFE MAN; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Davies L, 2011, OBSERVER; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2000, CONSERV BIOL, V14, P1602, DOI [10.1111/j.1523-1739.2000.99067.x, 10.1046/j.1523-1739.2000.99067.x]; Fisher RJ, 2000, PSYCHOL MARKET, V17, P105, DOI 10.1002/(SICI)1520-6793(200002)17:2<105::AID-MAR3>3.0.CO;2-9; Gates J. F., 2006, AUSTR J ECOLOGY, V21, P1; Gonzalez-Kirchner J.P., 1998, Human Evolution, V13, P15, DOI 10.1007/BF02439364; Harrison T., 2000, B INDOPACIFIC PREHIS, V20, P133; Hicks Thurston C., 2010, African Primates, V7, P1; Holbrook AL, 2003, PUBLIC OPIN QUART, V67, P79, DOI 10.1086/346010; Marshall Andrew J., 2009, P311; Meijaard E, PLOS ONE IN PRESS; Meijaard E, 2012, ANN NY ACAD SCI, V1249, P29, DOI 10.1111/j.1749-6632.2011.06288.x; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2011, BIOTROPICA, V43, P524, DOI 10.1111/j.1744-7429.2011.00802.x; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Mitchell AH, 1968, SEL P 10 C INT PRIM, P249; Mitlermeier R.A., 1987, Monographs in Primatology, V9, P109; Mittermeier, 2012, PRIMATES PERIL WORLD; Nijman V., 2005, HANGING BALANCE ASSE; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Piper PJ, 2009, INT J OSTEOARCHAEOL, V19, P551, DOI 10.1002/oa.1046; Presser S, 1998, AM SOCIOL REV, V63, P137, DOI 10.2307/2657486; Puri RK, 1997, THESIS U HAWAII INDO; Rijksen HD, 1999, OUR VANISHING RELATI; Sharma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049429; Sheil D, 2010, BIOTROPICA, V42, P566, DOI 10.1111/j.1744-7429.2010.00687.x; Singleton I., 2004, ORANGUTAN POPULATION; Soehartono T., 2007, STRATEGI RENCANA AKS; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Wadley RL, 1997, HUM ECOL, V25, P243, DOI 10.1023/A:1021926206649; Wich SA, 2012, BIOL CONSERV, V146, P163, DOI 10.1016/j.biocon.2011.12.006; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049142; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wilkie DS, 1998, ORYX, V32, P131, DOI 10.1017/S0030605300029872	47	39	41	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75373	10.1371/journal.pone.0075373	http://dx.doi.org/10.1371/journal.pone.0075373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130707	Green Submitted, gold, Green Published			2022-12-27	WOS:000325810900033
J	de Oliveira, RR; Martins, CS; Rocha, YR; Braga, ABR; Mattos, RM; Hecht, F; Brito, GAC; Nasciutti, LE				de Oliveira, Rodrigo R.; Martins, Conceicao S.; Rocha, Yuri R.; Braga, Allysson B. R.; Mattos, Romulo M.; Hecht, Fabio; Brito, Gerly A. C.; Nasciutti, Luiz E.			Experimental Diabetes Induces Structural, Inflammatory and Vascular Changes of Achilles Tendons	PLOS ONE			English	Article							POWER DOPPLER ULTRASONOGRAPHY; VIVO TENDINOPATHY MODEL; PATELLAR TENDINOSIS; MAST-CELL; MELLITUS; NEOVASCULARIZATION; RATS; FOOT; ANGIOGENESIS; ACTIVATION	This study aims to demonstrate how the state of chronic hyperglycemia from experimental Diabetes Mellitus can influence the homeostatic imbalance of tendons and, consequently, lead to the characteristics of tendinopathy. Twenty animals were randomly divided into two experimental groups: control group, consisting of healthy rats and diabetic group constituted by rats induced to Diabetes Mellitus I. After twenty-four days of the induction of Diabetes type I, the Achilles tendon were removed for morphological evaluation, cellularity, number and cross-sectional area of blood vessel, immunohistochemistry for Collagen type I, VEGF and NF-kappa B nuclear localization sequence (NLS) and nitrate and nitrite level. The Achilles tendon thickness (mu m/100g) of diabetic animals was significantly increased and, similarly, an increase was observed in the density of fibrocytes and mast cells in the tendons of the diabetic group. The average number of blood vessels per field, in peritendinous tissue, was statistically higher in the diabetic group 3.39 (2.98) vessels/field when compared to the control group 0.89 (1.68) vessels/field p = 0.001 and in the intratendinous region, it was observed that blood vessels were extremely rare in the control group 0.035 (0.18) vessels/field and were often present in the tendons of the diabetic group 0.89 (0.99) vessels/field. The immunohistochemistry analysis identified higher density of type 1 collagen and increased expression of VEGF as well as increased immunostaining for NF kappa B p50 NLS in the nucleus in Achilles tendon of the diabetic group when compared to the control group. Higher levels of nitrite/nitrate were observed in the experimental group induced to diabetes. We conclude that experimental DM induces notable structural, inflammatory and vascular changes in the Achilles tendon which are compatible with the process of chronic tendinopathy.	[de Oliveira, Rodrigo R.] Univ Fed Ceara, Fac Med, Dept Phys Therapy, Fortaleza, Ceara, Brazil; [Martins, Conceicao S.; Rocha, Yuri R.; Braga, Allysson B. R.; Brito, Gerly A. C.] Univ Fed Ceara, Fac Med, Dept Morphol, Fortaleza, Ceara, Brazil; [Mattos, Romulo M.; Nasciutti, Luiz E.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Hecht, Fabio] Univ Fed Rio de Janeiro, Dept Endocrinol, Rio De Janeiro, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	de Oliveira, RR (corresponding author), Univ Fed Ceara, Fac Med, Dept Phys Therapy, Fortaleza, Ceara, Brazil.	rodrigo@ufc.br	de Castro Brito, Gerly Anne/C-8597-2013; Brito, Gerly/AHB-3965-2022; de Oliveira, Rodrigo Ribeiro/N-9892-2013; Hecht, Fabio/R-9004-2017	de Castro Brito, Gerly Anne/0000-0002-8214-4379; Brito, Gerly/0000-0002-8214-4379; de Oliveira, Rodrigo Ribeiro/0000-0002-5810-3737; Hecht, Fabio/0000-0001-9110-2587; Martins, Conceicao/0000-0001-8710-1856	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477692/2011-7]; CAPES [23038044935/2009-12]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The financial support provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Universal no 477692/2011-7) and fellowship from the CAPES for Inter-institutional Doctorate Program in Morphological Sciences - Federal University of Ceara - UFC/Federal University of Rio de Janeiro - UFRJ - Brazil (No23038044935/2009-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2012, INT J IMMUNOPATH PH, V25, P757, DOI 10.1177/039463201202500322; Akturk M, 2007, EXP CLIN ENDOCR DIAB, V115, P92, DOI 10.1055/s-2007-955097; Akturk M, 2002, DIABETES CARE, V25, P408, DOI 10.2337/diacare.25.2.408; Alfredson H, 2005, KNEE SURG SPORT TR A, V13, P74, DOI 10.1007/s00167-004-0549-x; Alfredson H, 2003, KNEE SURG SPORT TR A, V11, P334, DOI 10.1007/s00167-003-0391-6; Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Batista F, 2008, FOOT ANKLE INT, V29, P498, DOI 10.3113/FAI.2008.0498; Berglund ME, 2010, J HAND SURG-AM, V35A, P1842, DOI 10.1016/j.jhsa.2010.06.031; Bolton NRM, 2005, CLIN BIOMECH, V20, P540; Chbinou N, 2004, AM J PHYSIOL-REG I, V286, pR952, DOI 10.1152/ajpregu.00536.2003; Cook JL, 2004, J ORTHOP RES, V22, P334, DOI 10.1016/j.orthres.2003.08.005; Cook JL, 2004, CLIN J SPORT MED, V14, P296, DOI 10.1097/00042752-200409000-00008; Dall'Ago P, 2002, BRAZ J MED BIOL RES, V35, P843, DOI 10.1590/S0100-879X2002000700013; de Oliveira RR, 2011, DIABETIC MED, V28, P886, DOI 10.1111/j.1464-5491.2010.03197.x; de Oliveira RR, 2012, J DIABETES COMPLICAT, V26, P163, DOI 10.1016/j.jdiacomp.2012.03.017; de Oliveira RR, 2011, ANN BIOMED ENG, V39, P1528, DOI 10.1007/s10439-011-0247-z; de Oliveira RR, 2011, ANN BIOMED ENG; de Vos RJ, 2007, AM J SPORT MED, V35, P1696, DOI 10.1177/0363546507303116; DiDomenico LA, 2008, J FOOT ANKLE SURG, V47, P463, DOI 10.1053/j.jfas.2008.05.007; Fox AJS, 2011, J ORTHOPAEDIC RES; Giacomozzi C, 2005, CLIN BIOMECH, V20, P532, DOI 10.1016/j.clinbiomech.2005.01.011; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Karsten K, 2008, J ORTHOPAEDIC SURG R, V3; Knoblock K, 2007, J ORTHOP SPORT PHYS, V37, P269, DOI 10.2519/jospt.2007.2296; Kubota S, 2011, INVESTIGATIVE OPHTHA; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Maffulli N, 2002, J BONE JOINT SURG BR, V84B, P1, DOI 10.1302/0301-620X.84B1.12792; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; Nakama LH, 2005, J ORTHOP RES, V23, P1199, DOI 10.1016/j.orthres.2005.03.006; Papanas N, 2009, EXP CLIN ENDOCR DIAB, V117, P645, DOI 10.1055/s-0029-1224121; Peers KHE, 2003, INT ORTHOP, V27, P180, DOI 10.1007/s00264-002-0426-5; Ramirez LC, 1998, J DIABETES COMPLICAT, V12, P337, DOI 10.1016/S1056-8727(98)00024-5; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Scott A, 2008, BRIT J SPORT MED, V42, P753, DOI 10.1136/bjsm.2007.040212; Scott A, 2008, SCAND J MED SCI SPOR, V18, P427, DOI 10.1111/j.1600-0838.2007.00735.x; Scott A, 2008, CLIN ORTHOP RELAT R, V466, P1598, DOI 10.1007/s11999-008-0272-x; Stein V, 2000, ACTA ORTHOP SCAND, V71, P60, DOI 10.1080/00016470052943919; Szomor ZL, 2006, J ORTHOP RES, V24, P80, DOI 10.1002/jor.20009; Tang JB, 2004, PLAST RECONSTR SURG, V113, P1703, DOI 10.1097/01.PRS.0000117365.48381.42; Unlu Z, 2003, J RHEUMATOL, V30, P352; Walsh DA, 2001, ARTHRITIS RES, V3, P147, DOI 10.1186/ar292; WOO SLY, 2007, TENDINOPATHY ATHLETE; Zanetti M, 2003, RADIOLOGY, V227, P556, DOI 10.1148/radiol.2272012069	46	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74942	10.1371/journal.pone.0074942	http://dx.doi.org/10.1371/journal.pone.0074942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130676	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900011
J	Han, S; Tie, XX; Meng, LX; Wang, YJ; Wu, AH				Han, Sheng; Tie, Xinxin; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua			PMA and Ionomycin Induce Glioblastoma Cell Death: Activation-Induced Cell-Death-Like Phenomena Occur in Glioma Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; T-CELLS; EXPRESSION; NFAT; APOPTOSIS; PATHWAY; FAS; RADIOTHERAPY; TEMOZOLOMIDE; ASTROCYTES	Phorbol myristate acetate (PMA) and ionomycin (Io) can induce T cell activation and proliferation. Furthermore, they stimulate activation-induced cell death (AICD) in mature lymphocytes via Fas/Fas ligand (FasL) up-regulation. In this study, we explored the influence of PMA/Io treatment on glioblastoma cells, and found that AICD-like phenomena may also occur in glioma. Using the MTT assay and cell counting, we demonstrated that treatment of PMA/Io significantly inhibited the proliferation of glioma cell lines, U87 and U251. TUNEL assays and transmission electron microscopy revealed that PMA/Io markedly induced U87 and U251 cell apoptosis. Propidium iodide staining and flow cytometry showed that treatment with PMA/Io resulted in an arrestment of cell cycle and an increase in cell death. Using real-time PCR and western blot, we found that PMA/Io up-regulated the expression of Fas and FasL at both mRNA and protein level, which confirmed that PMA/Io induced glioma cell death. Specific knockdown of NFAT1 expression by small hairpin RNA greatly reduced the PMA/Io induced cell death and apoptosis by inhibition of FasL expression. Microarray analysis showed that the expression of NFAT1 significantly correlated with the expression of Fas. The coexistence of Fas with NFAT1 in vivo provides the background for AICD-like phenomena to occur in glioma. These findings demonstrate that PMA/Io can induce glioblastoma cell death through the NFAT1-Fas/FasL pathway. Glioma-related AICD-like phenomena may provide a novel avenue for glioma treatment.	[Han, Sheng; Tie, Xinxin; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua] China Med Univ, Dept Neurosurg, Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University	Wu, AH (corresponding author), China Med Univ, Dept Neurosurg, Hosp 1, Shenyang, Liaoning, Peoples R China.	cmuwuanhua1@yahoo.com			National High Technology Research and Development Program of China (863) [2012AA02A508]; National Natural Science Foundation of China [81172409]; Science and Technology Department of Liaoning Province [2011225034]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National High Technology Research and Development Program of China (863) (No. 2012AA02A508), National Natural Science Foundation of China (No. 81172409) and Science and Technology Department of Liaoning Province (No. 2011225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Austin JW, 2008, J NEUROTRAUM, V25, P411, DOI 10.1089/neu.2007.0436; Bloch O, 2013, CLIN CANCER RES, V19, P3165, DOI 10.1158/1078-0432.CCR-12-3314; Catala-Rabasa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028591; Pedrosa AMD, 2010, J IMMUNOL, V184, P3487, DOI 10.4049/jimmunol.0902961; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Faget DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047868; Gopinath S, 2009, CELL MOL LIFE SCI, V66, P3967, DOI 10.1007/s00018-009-0157-5; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Greeneltch KM, 2005, J IMMUNOL, V175, P4999, DOI 10.4049/jimmunol.175.8.4999; Hamad A R, 2001, Int Rev Immunol, V20, P535, DOI 10.3109/08830180109045577; Hughes MA, 2005, INT J RADIAT ONCOL, V62, P1423, DOI 10.1016/j.ijrobp.2004.12.085; Ju S T, 1999, Int Rev Immunol, V18, P485, DOI 10.3109/08830189909088495; Konig A, 2010, PANCREATOLOGY, V10, P416, DOI 10.1159/000315035; Kwon D, 2001, J NEUROIMMUNOL, V113, P1, DOI 10.1016/S0165-5728(00)00321-0; Ladjemi MZ, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00158; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Lo CA, 2011, INT J ONCOL, V39, P1353; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Meehan AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060144; Mueller K, 2013, NUCLEIC ACIDS RES, V41, P2138, DOI 10.1093/nar/gks1349; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Pan Q, 2012, CELL BIOCHEM BIOPHYS, V62, P185, DOI 10.1007/s12013-011-9280-7; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; Ramalho-Carvalho J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058206; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Robbs BK, 2013, BBA-MOL CELL RES, V1833, P2016, DOI 10.1016/j.bbamcr.2013.04.003; Roth P, 2013, BRAIN, V136, P564, DOI 10.1093/brain/aws351; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Stankov K, 2012, J BUON, V17, P369; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tie XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066008; van der Most Robbert G, 2005, Discov Med, V5, P265; VANDUUREN BL, 1978, CANCER RES, V38, P865; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; Wingett D, 1996, J IMMUNOL, V156, P549; Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO;2-R; Wu AH, 2010, CELL ONCOL, V32, P313, DOI 10.3233/CLO-2010-0524; Yahata T, 1999, EUR J IMMUNOL, V29, P727, DOI 10.1002/(SICI)1521-4141(199903)29:03<727::AID-IMMU727>3.0.CO;2-0; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P279, DOI 10.1093/neuonc/nos306; Zhang YY, 2008, J IMMUNOL, V181, P190, DOI 10.4049/jimmunol.181.1.190	47	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76717	10.1371/journal.pone.0076717	http://dx.doi.org/10.1371/journal.pone.0076717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130787	Green Submitted, Green Published, gold			2022-12-27	WOS:000325810900081
J	Nalbandian, A; Nguyen, C; Katheria, V; Llewellyn, KJ; Badadani, M; Caiozzo, V; Kimonis, VE				Nalbandian, Angele; Nguyen, Christopher; Katheria, Veeral; Llewellyn, Katrina J.; Badadani, Mallikarjun; Caiozzo, Vincent; Kimonis, Virginia E.			Exercise Training Reverses Skeletal Muscle Atrophy in an Experimental Model of VCP Disease	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; MUSCULAR-DYSTROPHY; BONE; MUTATIONS; GENE; MICE; REVEALS	Background: The therapeutic effects of exercise resistance and endurance training in the alleviation of muscle hypertrophy/atrophy should be considered in the management of patients with advanced neuromuscular diseases. Patients with progressive neuromuscular diseases often experience muscle weakness, which negatively impact independence and quality of life levels. Mutations in the valosin containing protein (VCP) gene lead to Inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD) and more recently affect 2% of amyotrophic lateral sclerosis (ALS)-diagnosed cases. Methods/Principle Findings: The present investigation was undertaken to examine the effects of uphill and downhill exercise training on muscle histopathology and the autophagy cascade in an experimental VCP mouse model carrying the R155H mutation. Progressive uphill exercise in VCPR155H/+ mice revealed significant improvement in muscle strength and performance by grip strength and Rotarod analyses when compared to the sedentary mice. In contrast, mice exercised to run downhill did not show any significant improvement. Histologically, the uphill exercised VCPR155H/+ mice displayed an improvement in muscle atrophy, and decreased expression levels of ubiquitin, P62/SQSTM1, LC3I/II, and TDP-43 autophagy markers, suggesting an alleviation of disease-induced myopathy phenotypes. There was also an improvement in the Paget-like phenotype. Conclusions: Collectively, our data highlights that uphill exercise training in VCPR155H/+ mice did not have any detrimental value to the function of muscle, and may offer effective therapeutic options for patients with VCP-associated diseases.	[Nalbandian, Angele; Nguyen, Christopher; Katheria, Veeral; Llewellyn, Katrina J.; Badadani, Mallikarjun; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Orthoped, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kimonis, VE (corresponding author), Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA.	vkimonis@uci.edu			Muscular Dystrophy Association (MDA) [175682]	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	Funding for this study was provided by the Muscular Dystrophy Association (MDA) 175682 to VEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badadani M, 2010, PLOS ONE, V5; Benatar M, 2013, NEUROLOGY, V80, P1874, DOI 10.1212/WNL.0b013e3182929fc3; Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009; Biondi O, 2012, J PHYSIOL-LONDON, V590, P5907, DOI 10.1113/jphysiol.2012.238196; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; DUPONTVERSTEEGDEN EE, 1994, J APPL PHYSIOL, V77, P1736, DOI 10.1152/jappl.1994.77.4.1736; Fanganiello RD, 2011, BRAZ J MED BIOL RES, V44, P374, DOI 10.1590/S0100-879X2011007500028; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Joya JE, 2004, HUM MOL GENET, V13, P2633, DOI 10.1093/hmg/ddh285; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Kim JS, 2005, J APPL PHYSIOL, V98, P334, DOI 10.1152/japplphysiol.00172.2003; Kimonis V, 2012, NEW VISTAS UNDERSTAN; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2008, BIOCH BIOPHYS ACTA; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002; Lim JH, 2004, MUSCLE NERVE, V30, P456, DOI 10.1002/mus.20139; Lima LO, 2013, J PHYSIOTHER, V59, P7, DOI 10.1016/S1836-9553(13)70141-3; Mallinson JE, 2013, NUTRITION, V29, P22, DOI 10.1016/j.nut.2012.04.012; Mangner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052274; Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676; Mortensen B, 2013, AM J PHYSL ENDOCRINO; Mortensen SP, 2013, HYPERTENSION, V61, P1126, DOI 10.1161/HYPERTENSIONAHA.111.00328; Nalbandian A, 2012, MUSCLE NERVE; Nalbandian A, 2011, J MOL NEUROSCI; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nalbandian A, 2012, CTS-CLIN TRANSL SCI, V5, P226, DOI 10.1111/j.1752-8062.2012.00407.x; Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Siciliano G, 2012, NEUROMUSCULAR DISORD, V22, pS172, DOI 10.1016/j.nmd.2012.10.005; Spina S, 2008, FASEB J, V22, P584; Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189; Sveen ML, 2013, MUSCLE NERVE, V47, P163, DOI 10.1002/mus.23491; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Viassolo V, 2008, CLIN GENET; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008	46	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76187	10.1371/journal.pone.0076187	http://dx.doi.org/10.1371/journal.pone.0076187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130765	Green Published, gold			2022-12-27	WOS:000325810900071
J	Upadrasta, A; O'Sullivan, L; O'Sullivan, O; Sexton, N; Lawlor, PG; Hill, C; Fitzgerald, GF; Stanton, C; Ross, RP				Upadrasta, Aditya; O'Sullivan, Lisa; O'Sullivan, Orla; Sexton, Noel; Lawlor, Peadar G.; Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul			The Effect of Dietary Supplementation with Spent Cider Yeast on the Swine Distal Gut Microbiome	PLOS ONE			English	Article							PORCINE GASTROINTESTINAL-TRACT; WEANLING PIGS; NUTRIENT DIGESTIBILITY; HIGH-THROUGHPUT; LIVE YEAST; SP NOV.; PERFORMANCE; SALMONELLA; BACTERIA; CULTURE	Background: There is an increasing need for alternatives to antibiotics for promoting animal health, given the increasing problems associated with antibiotic resistance. In this regard, we evaluated spent cider yeast as a potential probiotic for modifying the gut microbiota in weanling pigs using pyrosequencing of 16S rRNA gene libraries. Methodology and Principal Findings: Piglets aged 24-26 days were assigned to one of two study groups; control (n = 12) and treatment (n = 12). The control animals were fed with a basal diet and the treatment animals were fed with basal diet in combination with cider yeast supplement (500 ml cider yeast containing similar to 7.6 log CFU/ml) for 21 days. Faecal samples were collected for 16s rRNA gene compositional analysis. 16S rRNA compositional sequencing analysis of the faecal samples collected from day 0 and day 21 revealed marked differences in microbial diversity at both the phylum and genus levels between the control and treatment groups. This analysis confirmed that levels of Salmonella and Escherichia were significantly decreased in the treatment group, compared with the control (P<0.001). This data suggest a positive influence of dietary supplementation with live cider yeast on the microbial diversity of the pig distal gut. Conclusions/Significance: The effect of dietary cider yeast on porcine gut microbial communities was characterized for the first time using 16S rRNA gene compositional sequencing. Dietary cider yeast can potentially alter the gut microbiota, however such changes depend on their endogenous microbiota that causes a divergence in relative response to that given diet.	[Upadrasta, Aditya; O'Sullivan, Lisa; O'Sullivan, Orla; Stanton, Catherine; Ross, R. Paul] TEAGASC, Food Res Programme, Fermoy, Cork, Ireland; [Lawlor, Peadar G.] TEAGASC, Pig Prod Dev Unit, Moorepk Res Ctr, Fermoy, Cork, Ireland; [Upadrasta, Aditya; Hill, Colin; Fitzgerald, Gerald F.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Upadrasta, Aditya; O'Sullivan, Lisa; O'Sullivan, Orla; Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Sexton, Noel] Food Ingredients Co, Cybercolors Ltd, Cork, Ireland	Teagasc; Teagasc; University College Cork; University College Cork	Ross, RP (corresponding author), TEAGASC, Food Res Programme, Moorepk, Fermoy, Cork, Ireland.	paul.ross@teagasc.ie	Upadrasta, Aditya/B-2977-2008; Ross, Paul/A-7584-2015; Hill, Colin/A-5611-2012; O'Sullivan, Orla/ABE-5980-2020; Stanton, Catherine/A-9549-2015	Upadrasta, Aditya/0000-0002-7788-9894; Ross, Paul/0000-0003-4876-8839; Hill, Colin/0000-0002-8527-1445; O'Sullivan, Orla/0000-0002-4332-1109; Stanton, Catherine/0000-0002-6724-7011	Enterprise Ireland, under the Commercialisation Fund [CFTD/05/117]; Irish Government under the National Development Plan; European Research and Development Fund; Science Foundation Ireland (SFI)	Enterprise Ireland, under the Commercialisation Fund; Irish Government under the National Development Plan; European Research and Development Fund; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was funded by Enterprise Ireland, under the Commercialisation Fund (Contract No: CFTD/05/117), the Irish Government under the National Development Plan, 2000-2006, the European Research and Development Fund and Science Foundation Ireland (SFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benus RFJ, 2010, BRIT J NUTR, V104, P693, DOI 10.1017/S0007114510001030; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casey PG, 2007, APPL ENVIRON MICROB, V73, P1858, DOI 10.1128/AEM.01840-06; Casey PG, 2004, LETT APPL MICROBIOL, V39, P431, DOI 10.1111/j.1472-765X.2004.01603.x; Cavitte JC, 2001, PRESENT FUTURE CONTR, P46; Chapman JD, 1988, PROBIOTICS ACIDIFIER, P219; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO/WHO, 2001, FAO WHO EV HLTH NUTR; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gardiner GE, 2004, APPL ENVIRON MICROB, V70, P1895, DOI 10.1128/AEM.70.4.1895-1906.2004; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GIONGO A, 2010, ISME J; Giongo A, 2010, DIVERSITY-BASEL, V2, P1015, DOI DOI 10.3390/d2071015; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Jabari L, 2012, INT J SYST EVOL MICR, V62, P2522, DOI 10.1099/ijs.0.032508-0; Kogan G, 2007, LIVEST SCI, V109, P161, DOI 10.1016/j.livsci.2007.01.134; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li JY, 2006, ARCH ANIM NUTR, V60, P277, DOI 10.1080/17450390600785343; Line JE, 1998, POULTRY SCI, V77, P405, DOI 10.1093/ps/77.3.405; Martin FP, 2008, MOL SYSTEMS BIOL, P4; Martins FS, 2007, J MED MICROBIOL, V56, P352, DOI 10.1099/jmm.0.46525-0; Mathew AG, 1998, J ANIM SCI, V76, P2138; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Oli MW, 1998, DIGEST DIS SCI, V43, P138, DOI 10.1023/A:1018892524790; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PEARSON V, 1978, J ANIM SCI, V47, P488, DOI 10.2527/jas1978.472488x; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rambaut A, 2009, FIG TREE V1 3 1; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rozeboom DW, 2005, J ANIM SCI, V83, P2637; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sokol H, 2008, P NATL ACAD SCI; Spring P, 1998, MANNANOLIGOSACCHARID, P553; Stein H, 2007, FEEDING PIGS IMMUNE, P61801; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; Van der Peet-Schwering CMC, 2007, J ANIM SCI; van Heugten E, 2003, J ANIM SCI, V81, P1004; VEUM TL, 1973, J ANIM SCI, V37, P67, DOI 10.2527/jas1973.37167x; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; White LA, 2002, J ANIM SCI, V80, P2619; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	49	29	35	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75714	10.1371/journal.pone.0075714	http://dx.doi.org/10.1371/journal.pone.0075714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130736	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900054
J	Lourhmati, A; Buniatian, GH; Paul, C; Verleysdonk, S; Buecheler, R; Buadze, M; Proksch, B; Schwab, M; Gleiter, CH; Danielyan, L				Lourhmati, Ali; Buniatian, Gayane H.; Paul, Christina; Verleysdonk, Stephan; Buecheler, Reinhild; Buadze, Marine; Proksch, Barbara; Schwab, Matthias; Gleiter, Christoph H.; Danielyan, Lusine			Age-Dependent Astroglial Vulnerability to Hypoxia and Glutamate: The Role for Erythropoietin	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; SYNTHETASE ACTIVITY; RAT HIPPOCAMPAL; IN-VITRO; ASTROCYTES; METALLOTHIONEIN; EXPRESSION; RECEPTOR; INJURY	Extracellular accumulation of toxic concentrations of glutamate (Glu) is a hallmark of many neurodegenerative diseases, often accompanied by hypoxia and impaired metabolism of this neuromediator. To address the question whether the multifunctional neuroprotective action of erythropoietin (EPO) extends to the regulation of extracellular Glu-level and is age-related, young and culture-aged rat astroglial primary cells (APC) were simultaneously treated with 1mM Glu and/or human recombinant EPO under normoxic and hypoxic conditions (NC and HC). EPO increased the Glu uptake by astrocytes under both NC and especially upon HC in culture-aged APC (by 60%). Moreover, treatment with EPO up-regulated the activity of glutamine synthetase (GS), the expression of glutamate-aspartate transporter (GLAST) and the level of EPO mRNA. EPO alleviated the Glu- and hypoxia-induced LDH release from astrocytes. These protective EPO effects were concentration-dependent and they were strongly intensified with age in culture. More than a 4-fold increase in apoptosis and a 2-fold decrease in GS enzyme activity was observed in APC transfected with EPO receptor (EPOR)-siRNA. Our in vivo data show decreased expression of EPO and a strong increase of EPOR in brain homogenates of APP/PS1 mice and their wild type controls during aging. Comparison of APP/PS1 and age-matched WT control mice revealed a stronger expression of EPOR but a weaker one of EPO in the Alzheimer's disease (AD) model mice. Here we show for the first time the direct correlation between the extent of differentiation (age) of astrocytes and the efficacy of EPO in balancing extracellular glutamate clearance and metabolism in an in-vitro model of hypoxia and Glu-induced astroglial injury. The clinical relevance of EPO and EPOR as markers of brain cells vulnerability during aging and neurodegeneration is evidenced by remarkable changes in their expression levels in a transgenic model of AD and their WT controls.	[Lourhmati, Ali; Buniatian, Gayane H.; Paul, Christina; Buecheler, Reinhild; Buadze, Marine; Proksch, Barbara; Schwab, Matthias; Gleiter, Christoph H.; Danielyan, Lusine] Univ Hosp Tuebingen, Inst Clin & Expt Pharmacol & Toxicol, Dept Clin Pharmacol, Tubingen, Germany; [Buniatian, Gayane H.] Natl Acad Sci, H Buniatyan Inst Biochem, Yerevan, Armenia; [Verleysdonk, Stephan] German Univ Cairo, Cairo, Egypt; [Schwab, Matthias] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Institute of Biochemistry after H. Buniatyan - NAS RA; National Academy of Sciences of Armenia; Egyptian Knowledge Bank (EKB); German University in Cairo; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Buniatian, GH (corresponding author), Univ Hosp Tuebingen, Inst Clin & Expt Pharmacol & Toxicol, Dept Clin Pharmacol, Tubingen, Germany.	buniatian@web.de; lusine.danielyan@med.uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020	Danielyan, Lusine/0000-0003-4130-8477; Buadze, Marine/0000-0002-4175-0065	University of Tubingen [F124410]	University of Tubingen	This work was supported by University of Tubingen Fortune Grant F124410 (to LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mageed AB, 2003, EXP BIOL MED, V228, P1033, DOI 10.1177/153537020322800908; Albrecht J, 2007, FRONT BIOSCI-LANDMRK, V12, P332, DOI 10.2741/2067; Almeida A, 1998, BRAIN RES, V790, P209, DOI 10.1016/S0006-8993(98)00064-X; Arabpoor Zohreh, 2012, Adv Biomed Res, V1, P50, DOI 10.4103/2277-9175.100157; Assaraf MI, 2007, J NEUROPATH EXP NEUR, V66, P389, DOI 10.1097/nen.0b013e3180517b28; Brettschneider J, 2006, NEUROSCI LETT, V404, P347, DOI 10.1016/j.neulet.2006.06.011; Buniatian GH, 2002, ANAT RECORD, V267, P296, DOI 10.1002/ar.10115; Buniatian GH, 2001, NEUROCHEM INT, V38, P373, DOI 10.1016/S0197-0186(00)00116-9; Byts N, 2009, EXPT TRANSLATIONAL S, V21, P1; Castegna A, 2011, NEUROSCIENCE, V185, P97, DOI 10.1016/j.neuroscience.2011.04.041; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Danielyan L, 2005, EUR J CELL BIOL, V84, P567, DOI 10.1016/j.ejcb.2004.12.030; Danielyan L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004416; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; IQBAL K, 1970, BIOCHEM J, V119, P145, DOI 10.1042/bj1190145; Juul S, 2002, ACTA PAEDIATR, V91, P36, DOI 10.1080/080352502320764184; Kannurpatti SS, 2004, NEUROCHEM INT, V44, P361, DOI 10.1016/S0197-0186(03)00164-5; Kobayashi S, 2001, J NEUROCHEM, V76, P1935, DOI 10.1046/j.1471-4159.2001.00214.x; Kumar R, 2010, KOREAN J PHYSIOL PHA, V14, P345, DOI 10.4196/kjpp.2010.14.5.345; Lehmann C, 2009, BRAIN RES, V1297, P1, DOI 10.1016/j.brainres.2009.08.070; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Mawatari C, 1996, NEUROSCIENCE, V73, P201, DOI 10.1016/0306-4522(96)00025-5; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V2, P4; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Ndubuizu OI, 2009, AM J PHYSIOL-REG I, V297, pR158, DOI 10.1152/ajpregu.90829.2008; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Parfenova H, 2006, AM J PHYSIOL-CELL PH, V290, pC1399, DOI 10.1152/ajpcell.00386.2005; Parihar MS, 2007, J NEUROSCI RES, V85, P1018, DOI 10.1002/jnr.21218; Rabie T, 2011, INT J DEV NEUROSCI, V29, P655, DOI 10.1016/j.ijdevneu.2011.06.003; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Santos SS, 2011, NEUROCHEM INT, V58, P665, DOI 10.1016/j.neuint.2011.02.005; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; SHER PK, 1990, GLIA, V3, P350, DOI 10.1002/glia.440030506; Takeda A, 2010, INT J ALZHEIMERS DIS, V2011; THOLEY G, 1991, NEUROCHEM RES, V16, P423, DOI 10.1007/BF00965561; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wakida K, 2007, NEUROSCIENCE, V148, P105, DOI 10.1016/j.neuroscience.2007.04.063; Wang V., 2010, FRONT AGING NEUROSCI, V30, P2; YU ACH, 1989, J CEREBR BLOOD F MET, V9, P20, DOI 10.1038/jcbfm.1989.3; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	52	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77182	10.1371/journal.pone.0077182	http://dx.doi.org/10.1371/journal.pone.0077182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124607	gold, Green Submitted, Green Published			2022-12-27	WOS:000325489100164
J	Lu, HY; Liu, Y; Dahiya, K; Qian, HZ; Fan, WS; Zhang, L; Ma, JT; Ruan, YH; Shao, YM; Vermund, SH; Yin, L				Lu, Hongyan; Liu, Yu; Dahiya, Kapil; Qian, Han-Zhu; Fan, Wensheng; Zhang, Li; Ma, Juntao; Ruan, Yuhua; Shao, Yiming; Vermund, Sten H.; Yin, Lu			Effectiveness of HIV Risk Reduction Interventions among Men who have Sex with Men in China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PREVENTION INTERVENTIONS; DEVELOPING-COUNTRIES; BEHAVIORS; PREVALENCE; INFECTION; HIV/AIDS; TRANSMISSION; EFFICACY; PROVINCE; TRIALS	Objective: To evaluate the effect of risk reduction interventions on HIV knowledge, attitudes and behaviors among men who have sex with men (MSM) in China. Methods: We performed a systematic review and meta-analysis of HIV risk reduction intervention studies among Chinese MSM. The summary difference of standardized mean differences (SMD) between both study arms or between pre- and post-intervention assessments were defined as the effect size (ES); ES was calculated using standard meta-analysis in random effects models. Results: Thirty-four eligible studies were included in the analysis, including two randomized clinical trials (RCT), six quasi-experimental studies, six pre-and-post intervention studies, and twenty serial cross-sectional intervention studies. These studies showed an increase in consistent condom use with any male sexual partners (mean ES, 0.46; 95% confidence interval [CI], 0.35-0.56), with regular sexual partners (mean ES, 0.41; 95% CI, 0.18-0.63), and casual sexual partners (mean ES, 0.52; 95% CI, 0.24-0.79). The analysis of ten studies that measured the impact on uptake of HIV testing also showed a positive result (mean ES, 0.55; 95% CI, 0.38-0.71). The risk reduction interventions also improved HIV/AIDS-related knowledge (mean ES, 0.77; 95% CI, 0.60-0.94) and attitudes (mean ES, 1.35; 95% CI, 0.91-1.79), but did not reduce prevalence of HIV (mean ES, 0.23; 95% CI, 0.02-0.45) and syphilis infections (mean ES, -0.01; 95% CI, -0.19-0.17). There was significant heterogeneity among these studies. Conclusions: On aggregate, HIV risk reduction interventions were effective in reducing risky behaviors and improving knowledge and attitudes among Chinese MSM, but were not associated with a change in the prevalence of HIV and syphilis. Future studies should use incidence as definitive study outcome.	[Lu, Hongyan; Zhang, Li] Beijing Ctr Dis Prevent & Control, Inst AIDS STD Prevent & Control, Beijing, Peoples R China; [Liu, Yu; Qian, Han-Zhu; Vermund, Sten H.; Yin, Lu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Dahiya, Kapil; Fan, Wensheng] Western Kentucky Univ, Coll Hlth & Human Serv, Dept Publ Hlth, Bowling Green, KY 42101 USA; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Ma, Juntao] Chinese Peoples Liberat Army, Med Lib, Beijing, Peoples R China; [Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control & Prevent China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Ruan, Yuhua; Shao, Yiming] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Vanderbilt University; Western Kentucky University; Vanderbilt University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Vanderbilt University	Yin, L (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	lu.yin@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Yin, Lu/0000-0001-9596-3325	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI09462, R34AI091446]; Ministry of Science and Technology of China [2012ZX10001-002]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2012SKLID103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R34AI091446] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory for Infectious Disease Develop Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI09462 and R34AI091446. This research was also partially supported by grants from the Ministry of Science and Technology of China (2012ZX10001-002) and Chinese State Key Laboratory for Infectious Disease Develop Grant (2012SKLID103). The content is solely the responsibility of the authors and does not necessarily represent the official views of these funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Blais M, 2006, CULT HEALTH SEX, V8, P31, DOI 10.1080/13691050500391232; Cao NX, 2009, CHIN J AIDS STD, V15, P497; Chow EPF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048025; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cox DR., 1970, ANAL BINARY DATA; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Davis KC, 2011, J HEALTH COMMUN, V16, P1024, DOI 10.1080/10810730.2011.571342; DEEKS J, 2002, SYSTEMATIC REV HLTH, P285; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding XianBin, 2010, Journal of Tropical Medicine (Guangzhou), V10, P323; Duan YW, 2013, AIDS EDUC PREV, V25, P38, DOI 10.1521/aeap.2013.25.1.38; Feng Lian-Gui, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P18; Gao MY, 2007, AIDS CARE, V19, P799, DOI 10.1080/09540120601114832; Gao Y, 2005, XIAN DAI YU FANG YI, V32, P1512; Gerbi GB, 2011, J SUBST USE, V16, P464, DOI 10.3109/14659891.2010.495820; Gerbi GB, 2009, J SUBST USE, V14, P90, DOI 10.1080/14659890802624261; Guo W, 2013, CHINESE MED J-PEKING, V126, P1257, DOI 10.3760/cma.j.issn.0366-6999.20121721; Hao C, 2012, AIDS BEHAV, V16, P1138, DOI 10.1007/s10461-012-0141-1; He J, 2010, SHI JIE GAN RAN ZA Z, V10, P32; Huang ZH, 2013, AIDS RES HUM RETROV, V29, P441, DOI [10.1089/aid.2012.0151, 10.1089/AID.2012.0151]; International HIV/AIDS Alliance Asia and Eastern Europe team, 2004, VOL COUNS TEST EM AP; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Lau JTF, 2008, AIDS CARE, V20, P820, DOI 10.1080/09540120701694048; Li JianJun, 2011, Chinese Preventive Medicine, V12, P666; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Liu F, 2008, PRACT PREV MED, V15, P1055; Ma GL, 2010, CHIN J DIS CONTROL P, V14, P726; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Meng XJ, 2013, SEX HEALTH, V10, P211, DOI 10.1071/SH12093; Meng XY, 2010, PREV MED TRIB, V16, P334; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Nong QX, 2010, J PREV MED INF, V26, P200; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Qu L, 2011, CHIN J INFECT DIS, V29; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; Slavin S, 2004, HEALTH RISK SOC, V6, P39, DOI 10.1080/1369857042000193057; Song Dan, 2005, China Tropical Medicine, V5, P877; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Tan Jing-guang, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P732; van den Boom W, 2012, AIDS CARE, V24, P167, DOI 10.1080/09540121.2011.603285; Vidal-Alaball J, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004655.pub2, 10.1002/14651858.CD004775.pub2]; Wang FX, 2011, PREV MED TRIB, V17, p[518, 524]; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Wang L, 2011, CHIN PRIM HLTH CARE, V25, P94; Wang M, 2009, J PUB HLTH PREV MED, V20, P43; Wang S, 2005, ZHONG GUO XING BING, V59, P109; Wang Y, 2009, PRACT PREV MED, V16, P654; Wang Y, 2008, J PRE MED INFO, V24, P962; Wang YiNa, 2011, Modern Preventive Medicine, V38, P2526; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; Wolitski RJ, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000167356.94664.59; Wu GF, 2011, ANHUI J PREV MED, V17, P86; Wu Z, 2013, CLIN INFECT DIS; Xiu CZ, 2009, PREV MED, V15, P103; Xiu CZ, 2009, PREV MED TRIB, V15, P97; Xu J, 2009, CHIN J HLTH ED, V25, P736; Xu J, 2006, CHIN J AIDS STD, V12, P231; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050873; Yu JP, 2012, HEALTH SOC CARE COMM, V20, P561, DOI 10.1111/j.1365-2524.2011.01054.x; Zeng Gang, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P977; Zhang Hong-bo, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P970; Zhang Z, 2010, YU FANG YI XUE QING, V26, P784; Zheng LJ, 2012, SEX TRANSM DIS, V39, P886, DOI 10.1097/OLQ.0b013e31826ae85e; Zhu Jun-li, 2008, Zhonghua Yufang Yixue Zazhi, V42, P895	69	30	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72747	10.1371/journal.pone.0072747	http://dx.doi.org/10.1371/journal.pone.0072747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24137497	Green Submitted, gold, Green Published			2022-12-27	WOS:000323880200037
J	Santa-Ana-Tellez, Y; Mantel-Teeuwisse, AK; Dreser, A; Leufkens, HGM; Wirtz, VJ				Santa-Ana-Tellez, Yared; Mantel-Teeuwisse, Aukje K.; Dreser, Anahi; Leufkens, Hubert G. M.; Wirtz, Veronika J.			Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico	PLOS ONE			English	Article							RESISTANCE	Background: In Latin American countries over-the-counter (OTC) dispensing of antibiotics is common. In 2010, both Mexico and Brazil implemented policies to enforce existing laws of restricting consumption of antibiotics only to patients presenting a prescription. The objective of the present study is therefore to evaluate the impact of OTC restrictions (2010) on antibiotics consumption in Brazil and Mexico. Methods and Findings: Retail quarterly sales data in kilograms of oral and injectable antibiotics between January 2007 and June 2012 for Brazil and Mexico were obtained from IMS Health. The unit of analysis for antibiotics consumption was the defined daily dose per 1,000 inhabitants per day (DDD/TID) according to the WHO ATC classification system. Interrupted time series analysis was conducted using antihypertensives as reference group to account for changes occurring independently of the OTC restrictions directed at antibiotics. To reduce the effect of (a) seasonality and (b) autocorrelation, dummy variables and Prais-Winsten regression were used respectively. Between 2007 and 2012 total antibiotic usage increased in Brazil (from 5.7 to 8.5 DDD/TID, +49.3%) and decreased in Mexico (10.5 to 7.5 DDD/TID, -29.2%). Interrupted time series analysis showed a change in level of consumption of -1.35 DDD/TID (p<0.01) for Brazil and -1.17 DDD/TID (p<0.00) for Mexico. In Brazil the penicillins, sulfonamides and macrolides consumption had a decrease in level after the intervention of 0.64 DDD/TID (p = 0.02), 0.41 (p = 0.02) and 0.47 (p = 0.01) respectively. While in Mexico it was found that only penicillins and sulfonamides had significant changes in level of 20.86 DDD/TID (p<0.00) and -0.17 DDD/TID (p = 0.07). Conclusions: Despite different overall usage patterns of antibiotics in Brazil and Mexico, the effect of the OTC restrictions on antibiotics usage was similar. In Brazil the trend of increased usage of antibiotics was tempered after the OTC restrictions; in Mexico the trend of decreased usage was boosted.	[Santa-Ana-Tellez, Yared; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G. M.] UIPS, WHO Collaborating Ctr Pharmaceut Policy & Regulat, Utrecht, Netherlands; [Dreser, Anahi; Wirtz, Veronika J.] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Wirtz, Veronika J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA	Utrecht University; Instituto Nacional de Salud Publica; Boston University	Wirtz, VJ (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	vwirtz@bu.edu	Wirtz, Veornika/AAG-9712-2019; Dreser, Anahí/AAS-5886-2021; Mantel-Teeuwisse, Aukje/I-8902-2016; Dreser, Anahi/A-8317-2013	Dreser, Anahí/0000-0001-9019-2330; Dreser, Anahi/0000-0001-9019-2330; Wirtz, Veronika J./0000-0002-0863-8768; Santa-Ana-Tellez, Yared/0000-0003-3086-446X	CONACYT (National Council of Science and Technology Mexico)	CONACYT (National Council of Science and Technology Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Yared Santa-Ana-Tellez received funding from CONACYT (National Council of Science and Technology Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVISA, 2012, SIST GER PROD CONTR; ANVISA, 2013, DEF NOV DAT CONTR EL; Bavestrello L, 2002, REV MED CHILE, V130, P1265; CHIPMAN JS, 1979, ECONOMETRICA, V47, P115, DOI 10.2307/1912350; Diario Oficial de la Federacino, 2010, AC QUE SE SET LIN QU; Diekema DJ, 2000, EMERG INFECT DIS, V6, P552, DOI 10.3201/eid0605.000519; Dreser A, 2008, SALUD PUBLICA MEXICO, V50, pS480, DOI 10.1590/S0036-36342008001000009; Dreser A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1051; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Health IMS, 2008, PHARM MARK; IMS Health, 2006, PHARM SHAK UP; Luis BF, 2011, REV CHIL INFECTOL, V28, P107, DOI /S0716-10182011000200001; Pan American Health Organization, 2004, LEG ANT AM LAT; Pan American Health Organization, 1999, PREV CONTR ANT RES; Pan American Health Organization (n.d.), PAN AM HLTH ORG DAT; StataCorp, 2011, STAT STAT SOFTW REL, P173; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wirtz VJ, 2013, TROP MED INT HEALTH, V18, P665, DOI 10.1111/tmi.12096; Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009; World Health Organization Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health, 2012, ATC DDD IND	21	77	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75550	10.1371/journal.pone.0075550	http://dx.doi.org/10.1371/journal.pone.0075550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146761	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400010
J	Boonyanugomol, W; Chomvarin, C; Hahnvajanawong, C; Sripa, B; Kaparakis-Liaskos, M; Ferrero, RL				Boonyanugomol, Wongwarut; Chomvarin, Chariya; Hahnvajanawong, Chariya; Sripa, Banchob; Kaparakis-Liaskos, Maria; Ferrero, Richard L.			Helicobacter pylori cag Pathogenicity Island (cagPAI) Involved in Bacterial Internalization and IL-8 Induced Responses via NOD1-and MyD88-Dependent Mechanisms in Human Biliary Epithelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; KAPPA-B; IV SECRETION; EXPRESSION; PEPTIDOGLYCAN; INDUCTION; ACTIVATION; INTEGRINS; ADHERENCE; INVASION	Helicobacter pylori infection has been proposed to be associated with various diseases of the hepatobiliary tract, including cancer of the bile duct epithelial cells (cholangiocarcinoma, CCA). The ability of H. pylori bacteria to cause pathogenic effects in these cells has, however, yet to be investigated. Given that the cag pathogenicity island (cagPAI) is required for H. pylori pathogenesis in gastric epithelial cells, we investigated wild-type and cag mutant strains for their ability to adhere, be internalized and induce pro-inflammatory responses in two bile duct epithelial cell lines derived from cases of CCA. The findings from these experiments were compared to results obtained with the well-characterized AGS gastric cancer cell line. We showed that the cagPAI encodes factors involved in H. pylori internalization in CCA cells, but not for adhesion to these cells. Consistent with previous studies in hepatocytes, actin polymerization and alpha 5 beta 1 integrin may be involved in H. pylori internalization in CCA cells. As for AGS cells, we observed significantly reduced levels of NF-kappa B activation and IL-8 production in CCA cells stimulated with either cagA, cagL or cagPAI bacteria, when compared with wild-type bacteria. Importantly, these IL-8 responses could be inhibited via either pre-treatment of cells with antibodies to alpha 5 beta 1 integrins, or via siRNA-mediated knockdown of the innate immune signaling molecules, nucleotide oligomerization domain 1 (NOD1) and myeloid differentiation response gene 88 (MyD88). Taken together, the data demonstrate that the cagPAI is critical for H. pylori pathogenesis in bile duct cells, thus providing a potential causal link for H. pylori in biliary tract disease.	[Boonyanugomol, Wongwarut; Chomvarin, Chariya; Hahnvajanawong, Chariya] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Sripa, Banchob] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Boonyanugomol, Wongwarut; Chomvarin, Chariya; Hahnvajanawong, Chariya; Sripa, Banchob] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Kaparakis-Liaskos, Maria; Ferrero, Richard L.] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia	Khon Kaen University; Khon Kaen University; Khon Kaen University; Monash University	Chomvarin, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	chariya@kku.ac.th	Kaparakis-Liaskos, Maria/R-9321-2019; Ferrero, Richard/U-1332-2017	Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Sripa, Banchob/0000-0001-8899-5919; Ferrero, Richard/0000-0001-6817-6211	Commission on Higher Education of Thailand; Faculty of Medicine, Khon Kaen University	Commission on Higher Education of Thailand(Office of Higher Education Commission (OHEC)); Faculty of Medicine, Khon Kaen University	This work was supported by the Commission on Higher Education of Thailand for grant support under the program Strategic Scholarships for Frontier Research Network under the Joint Ph.D. Program for Thai Doctoral degrees, and some parts of this work was supported by Faculty of Medicine, Khon Kaen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LAH, 1999, J LEUKOCYTE BIOL, V66, P753, DOI 10.1002/jlb.66.5.753; Allison CC, 2010, FUTURE MICROBIOL, V5, P1233, DOI 10.2217/FMB.10.84; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Birkness KA, 1996, ANN NY ACAD SCI, V797, P293, DOI 10.1111/j.1749-6632.1996.tb52983.x; Boonyanugomol W, 2012, HPB, V14, P754, DOI 10.1111/j.1477-2574.2012.00533.x; Boonyanugomol W, 2012, DIGEST DIS SCI, V57, P2615, DOI 10.1007/s10620-012-2216-2; Boonyanugomol W, 2012, HPB, V14, P177, DOI 10.1111/j.1477-2574.2011.00423.x; Boonyanugomol W, 2011, DIGEST DIS SCI, V56, P1682, DOI 10.1007/s10620-010-1512-y; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Cho SO, 2006, ANN NY ACAD SCI, V1090, P298, DOI 10.1196/annals.1378.032; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; CRABTREE JE, 1995, J CLIN PATHOL, V48, P967, DOI 10.1136/jcp.48.10.967; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; Gorrell RJ, 2012, CELL MICROBIOL, DOI 10.1111/cmi.12055; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Grubman A, 2010, CELL MICROBIOL, V12, P626, DOI 10.1111/j.1462-5822.2009.01421.x; Hahnvajanawong C, 2012, BIOL PHARM BULL, V35, P1914, DOI 10.1248/bpb.b12-00118; Hirata Y, 2006, J IMMUNOL, V176, P3796, DOI 10.4049/jimmunol.176.6.3796; Huang Y, 2004, J CLIN PATHOL, V57, P1273, DOI 10.1136/jcp.2004.018556; Hutton ML, 2010, INFECT IMMUN, V78, P4523, DOI 10.1128/IAI.00439-10; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ito K, 2008, DIGEST DIS SCI, V53, P2541, DOI 10.1007/s10620-007-0164-z; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Leelawat Kawin, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P881; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Namwat N, 2008, CHEMOTHERAPY, V54, P343, DOI 10.1159/000151541; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 1995, LAB INVEST, V73, P760; Pellicano R, 2008, LANCET INFECT DIS, V8, P254, DOI 10.1016/S1473-3099(08)70066-5; Petersen AM, 2001, FEMS IMMUNOL MED MIC, V30, P103, DOI 10.1016/S0928-8244(00)00246-7; Petersen AM, 2000, FEMS IMMUNOL MED MIC, V29, P59, DOI 10.1016/S0928-8244(00)00189-9; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sharma SA, 1998, J IMMUNOL, V160, P2401; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392, DOI 10.3748/wjg.v11.i22.3392; Su B, 1999, GASTROENTEROLOGY, V117, P595, DOI 10.1016/S0016-5085(99)70452-X; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tepsiri N, 2005, WORLD J GASTROENTERO, V11, P2748, DOI 10.3748/wjg.v11.i18.2748; Tiwari SK, 2006, WORLD J GASTROENTERO, V12, P2181, DOI 10.3748/wjg.v12.i14.2181; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/476482; Yamaoka Y, 2004, GASTROENTEROLOGY, V126, P1030, DOI 10.1053/j.gastro.2003.12.048; Zhang Y, 2005, WORLD J GASTROENTERO, V11, P3485, DOI 10.3748/wjg.v11.i22.3485	53	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77358	10.1371/journal.pone.0077358	http://dx.doi.org/10.1371/journal.pone.0077358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143223	gold, Green Submitted, Green Published			2022-12-27	WOS:000325894100060
J	Chi, XL; Zeng, XC; Hao, WB; Li, M; Li, W; Huang, XH; Wang, SH; Luo, SH				Chi, Xuelin; Zeng, Xiancheng; Hao, Wenbo; Li, Ming; Li, Wei; Huang, Xiaohong; Wang, Shihua; Luo, Shuhong			Heterogeneity among Orf Virus Isolates from Goats in Fujian Province, Southern China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; IDENTIFICATION; SHEEP; INFECTION; LAMBS; ANTIBODIES; OUTBREAK; LESIONS	Orf virus is a parapoxvirus that causes recurring contagious ecthyma or orf disease in goat, sheep and other wild and domestic ruminants. Infected animals show signs of pustular lesions on the mouth and muzzle and develop scabs over the lesions. Although the infection is usually cleared within 1-2 months, delayed growth and associated secondary infections could still impact the herds. Orf virus can also infect humans, causing lesions similar to the animals in pathological histology. Prior infection of orf virus apparently offers little protective immunity against future infections. Several gene products of orf virus have been identified as responsible for immunomodulatory functions. In our recent study of orf virus isolates from an area along the Minjiang River in northern Fujian Province, we found a high heterogeneity among isolates from 10 farms within a 120-kilometer distance. Only two isolates from locations within 1 km to each other had same viral genes. There is no correlation between the geographical distance between the corresponding collection sites and the phylogenetic distance in ORFV011 or ORV059 genes for any two isolates. This finding suggests that there are diverse populations of orf virus present in the environment. This may in part contribute to the phenomenon of recurring outbreaks and heighten the need for better surveillance.	[Chi, Xuelin; Zeng, Xiancheng; Wang, Shihua; Luo, Shuhong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Chi, Xuelin; Zeng, Xiancheng; Huang, Xiaohong] Fujian Agr & Forestry Univ, Univ Key Lab Integrated Chinese Tradit & Western, Coll Anim Sci, Fuzhou, Peoples R China; [Hao, Wenbo; Li, Ming; Li, Wei; Luo, Shuhong] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Southern Medical University - China	Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China.	1094324057@qq.com; sluo815@gmail.com			National Natural Science Foundation of China (NSFC) [31070138, 31170147]; Special Funds for Colleges and Universities Talents by Guangdong Province; Scientific Research Foundation of Introducing Talents of Southern Medical University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Funds for Colleges and Universities Talents by Guangdong Province; Scientific Research Foundation of Introducing Talents of Southern Medical University	The study was supported by the grant (No. 31070138 and No. 31170147) from the National Natural Science Foundation of China (NSFC) and Special Funds for Colleges and Universities Talents by Guangdong Province (2011) and Scientific Research Foundation of Introducing Talents of Southern Medical University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billinis C., 2012, VIROL J, V19, P9; Bora DP, 2012, VIRUS GENES, V45, P98, DOI 10.1007/s11262-012-0740-y; CHAHIDI N, 1993, BRIT J PLAST SURG, V46, P532, DOI 10.1016/0007-1226(93)90231-Y; Chan KW, 2007, VIRUS GENES, V35, P705, DOI 10.1007/s11262-007-0144-6; de Oliveira CHS, 2012, VECTOR-BORNE ZOONOT, V12, P336, DOI 10.1089/vbz.2011.0725; Guibal F, 1996, EUR J DERMATOL, V6, P41; Haig DM, 2002, VIRUS RES, V88, P3, DOI 10.1016/S0168-1702(02)00117-X; Haig DM, 1998, VET RES, V29, P311; Hosamani M, 2006, VET MICROBIOL, V116, P317, DOI 10.1016/j.vetmic.2006.04.028; HOUSAWI FMT, 1992, J COMP PATHOL, V106, P153, DOI 10.1016/0021-9975(92)90044-U; Hu G, 2005, TURK J VET ANIM SCI, V29, P95; Li H, 2012, VIRUS GENES, V44, P429, DOI 10.1007/s11262-011-0710-9; Li W, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-229; Mavrogianni VS, 2006, VET RES, V37, P89, DOI 10.1051/vetres:2005042; McElroy MC, 2007, VET J, V174, P663, DOI 10.1016/j.tvjl.2006.10.024; MCKEEVER DJ, 1987, VET MICROBIOL, V15, P229, DOI 10.1016/0378-1135(87)90077-0; MEYNINK SE, 1987, VET REC, V121, P594; ROBINSON AJ, 1983, NEW ZEAL VET J, V31, P161, DOI 10.1080/00480169.1983.35008; SULLIVAN JT, 1994, VIROLOGY, V202, P968, DOI 10.1006/viro.1994.1420; Uzel M, 2005, EPIDEMIOL INFECT, V133, P653, DOI 10.1017/S0950268805003778; Zhao K, 2010, VET MICROBIOL, V142, P408, DOI 10.1016/j.vetmic.2009.10.006	21	13	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e66958	10.1371/journal.pone.0066958	http://dx.doi.org/10.1371/journal.pone.0066958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143166	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100001
J	Zhao, L; Hu, YL; Lin, GG; Gao, YC; Fang, YT; Zeng, DH				Zhao, Lei; Hu, Ya-Lin; Lin, Gui-Gang; Gao, Yong-chao; Fang, Yun-Ting; Zeng, De-Hui			Mixing Effects of Understory Plant Litter on Decomposition and Nutrient Release of Tree Litter in Two Plantations in Northeast China	PLOS ONE			English	Article							LEAF-LITTER; DECAY-RATES; NITROGEN; PINE; DYNAMICS; FORESTS; LIGNIN; BIODIVERSITY; COMMUNITIES; VEGETATION	Understory vegetation plays a crucial role in carbon and nutrient cycling in forest ecosystems; however, it is not clear how understory species affect tree litter decomposition and nutrient dynamics. In this study, we examined the impacts of understory litter on the decomposition and nutrient release of tree litter both in a pine (Pinus sylvestris var. mongolica) and a poplar (Populus x xiaozhuanica) plantation in Northeast China. Leaf litter of tree species, and senesced aboveground materials from two dominant understory species, Artemisia scoparia and Setaria viridis in the pine stand and Elymus villifer and A. sieversiana in the poplar stand, were collected. Mass loss and N and P fluxes of single-species litter and three-species mixtures in each of the two forests were quantified. Data from single-species litterbags were used to generate predicted mass loss and N and P fluxes for the mixed-species litterbags. In the mixture from the pine stand, the observed mass loss and N release did not differ from the predicted value, whereas the observed P release was greater than the predicted value. However, the presence of understory litter decelerated the mass loss and did not affect N and P releases from the pine litter. In the poplar stand, litter mixture presented a positive non-additive effect on litter mass loss and P release, but an addition effect on N release. The presence of understory species accelerated only N release of poplar litter. Moreover, the responses of mass loss and N and P releases of understory litter in the mixtures varied with species in both pine and poplar plantations. Our results suggest that the effects of understory species on tree litter decomposition vary with tree species, and also highlight the importance of understory species in litter decomposition and nutrient cycles in forest ecosystems.	[Zhao, Lei; Hu, Ya-Lin; Lin, Gui-Gang; Gao, Yong-chao; Fang, Yun-Ting; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China; [Zhao, Lei; Lin, Gui-Gang; Gao, Yong-chao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Lei; Hu, Ya-Lin; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, Daqinggou Ecol Stn, Shenyang 110016, Liaoning, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Zeng, DH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China.	zengdh@iae.ac.cn	Fang, Yunting/G-4456-2012	Fang, Yunting/0000-0001-7531-546X; Lin, Guigang/0000-0003-4473-2708	National Basic Research Program of China [2012CB416902]; National Natural Science Foundation of China [31270668]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB416902) and the National Natural Science Foundation of China (31270668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Ball BA, 2008, J ECOL, V96, P303, DOI 10.1111/j.1365-2745.2007.01346.x; Ball BA, 2009, ECOSYSTEMS, V12, P87, DOI 10.1007/s10021-008-9208-2; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; BLAIR JM, 1988, SOIL BIOL BIOCHEM, V20, P693, DOI 10.1016/0038-0717(88)90154-X; Bonanomi G, 2010, PLANT SOIL, V331, P481, DOI 10.1007/s11104-009-0269-6; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chastain RA, 2006, FOREST ECOL MANAG, V231, P63, DOI 10.1016/j.foreco.2006.04.040; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; FYLES JW, 1993, CAN J FOREST RES, V23, P358, DOI 10.1139/x93-052; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gartner TB, 2006, SOIL BIOL BIOCHEM, V38, P2307, DOI 10.1016/j.soilbio.2006.02.014; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Girisha GK, 2003, FOREST ECOL MANAG, V179, P169, DOI 10.1016/S0378-1127(02)00518-2; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Laganiere J, 2009, APPL SOIL ECOL, V41, P19, DOI 10.1016/j.apsoil.2008.08.005; Li W, 2009, ECOL RES, V24, P761, DOI 10.1007/s11284-008-0546-5; Liu P, 2007, BIOL FERT SOILS, V44, P211, DOI 10.1007/s00374-007-0195-9; Mao R, 2012, GEODERMA, V170, P112, DOI 10.1016/j.geoderma.2011.11.008; McLaren JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023702; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Muller Robert N., 2003, P15; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Polyakova O, 2007, FOREST ECOL MANAG, V253, P11, DOI 10.1016/j.foreco.2007.06.049; PRESCOTT CE, 1993, CAN J FOREST RES, V23, P1576, DOI 10.1139/x93-198; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Strickland MS, 2009, FUNCT ECOL, V23, P627, DOI 10.1111/j.1365-2435.2008.01515.x; Sundarapandian SM, 1999, FOREST ECOL MANAG, V123, P231, DOI 10.1016/S0378-1127(99)00062-6; Swan CM, 2009, ECOLOGY, V90, P1650, DOI 10.1890/08-0329.1; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Vance ED, 2001, SOIL BIOL BIOCHEM, V33, P173, DOI 10.1016/S0038-0717(00)00127-9; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2006, SOIL BIOL BIOCHEM, V35, P827; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057; Zeng DH, 2009, PLANT SOIL, V317, P121, DOI 10.1007/s11104-008-9793-z	49	17	23	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76334	10.1371/journal.pone.0076334	http://dx.doi.org/10.1371/journal.pone.0076334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143184	Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100019
J	Coghill, LM; Hulsey, CD; Chaves-Campos, J; de Leon, FJG; Johnson, SG				Coghill, Lyndon M.; Hulsey, C. Darrin; Chaves-Campos, Johel; Garcia de Leon, Francisco J.; Johnson, Steven G.			Phylogeography and Conservation Genetics of a Distinct Lineage of Sunfish in the Cuatro Cienegas Valley of Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; BLACK BASSES; ACTINOPTERYGII; BIOGEOGRAPHY; EVOLUTION; INFERENCE; MODELS; SNAIL; FLOW	The valley of Cuatro Cienegas, an aquatic oasis located in the Mexican Chihuahuan Desert, exhibits the highest level of endemism in North America and is a Mexican National Protected Area. However, little is known about the evolutionary distinctiveness of several vertebrate species present in the Cuatro Cienegas valley. We conducted a phylogeographic study using mitochondrial haplotypes from the centrarchid fish Lepomis megalotis to determine if the populations found within the valley were evolutionarily distinct from populations outside the valley. We also examined if there was evidence of unique haplotypes of this sunfish within the valley. Genetic divergence of L. megalotis suggests populations within the valley are evolutionarily unique when compared to L. megalotis outside the valley. Significant mitochondrial sequence divergence was also discovered between L. megalotis populations on either side of the Sierra de San Marcos that bisects the valley. Our results reinforce previous studies that suggest the organisms occupying aquatic habitats not only within Cuatro Cienegas but also in each of the two lobes of the valley generally deserve independent consideration during management decisions.	[Coghill, Lyndon M.; Chaves-Campos, Johel; Johnson, Steven G.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Hulsey, C. Darrin] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Garcia de Leon, Francisco J.] Ctr Invest Biol Noroeste, Lab Genet Conservac, La Paz, Baja California, Mexico	University of Louisiana System; University of New Orleans; University of Tennessee System; University of Tennessee Knoxville; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Coghill, LM (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	lcoghill@uno.edu	León, Francisco García-De/AAH-9391-2019; Chaves-Campos, Johel/AAF-9147-2020	León, Francisco García-De/0000-0003-2323-2560; Chaves-Campos, Johel/0000-0001-8026-7626; Hulsey, C. Darrin/0000-0002-9653-6728	University of Tennessee, Knoxville; The University of New Orleans; Northwestern Center of Biological Research for Mexico (CIBNOR)	University of Tennessee, Knoxville; The University of New Orleans; Northwestern Center of Biological Research for Mexico (CIBNOR)	Support was provided to C. D. Hulsey by the University of Tennessee, Knoxville and S. G. Johnson, L. M. Coghill and Johel Chaves-Campos were supported by The University of New Orleans. Northwestern Center of Biological Research for Mexico (CIBNOR) provided support to F. J. Garcia de Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Biomatters, 2010, GENEIOUS; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Carson EW, 2006, MOL ECOL, V15, P667, DOI 10.1111/j.1365-294X.2005.02763.x; Castiglia PJ, 2006, GEOLOGY, V34, P113, DOI 10.1130/G22036.1; Chaves-Campos J, 2011, CONSERV GENET, V12, P557, DOI 10.1007/s10592-010-0163-z; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Guia APO, 2007, ECOL RES, V22, P604, DOI 10.1007/s11284-006-0059-z; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; du Toit JT, 2010, ANIM CONSERV, V13, P229, DOI 10.1111/j.1469-1795.2010.00355.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fluxus-Engineering, 2012, NETWORK; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hawkins JP, 2000, ANIM CONSERV, V3, P81, DOI 10.1111/j.1469-1795.2000.tb00089.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HENDRICKSON DA, 2008, ARIDLAND SPRINGS N A; Howeth JG, 2008, MOL ECOL, V17, P4209, DOI 10.1111/j.1365-294X.2008.03904.x; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; Hulsey CD, 2006, J FISH BIOL, V68, P1399, DOI 10.1111/j.0022-1112.2006.01021.x; Husemann M, 2012, BIOL J LINN SOC, V107, P867, DOI 10.1111/j.1095-8312.2012.01973.x; Johnson SG, 2005, MOL ECOL, V14, P2299, DOI 10.1111/j.1365-294X.2005.02580.x; Johnson SG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-50; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Lee DS, 1980, ATLAS N AM FRESHWATE; McGaugh SE, 2012, CONSERV GENET, V13, P1561, DOI 10.1007/s10592-012-0403-5; Miller RR, 2006, FRESHWATER FISHES ME; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Near TJ, 2003, EVOLUTION, V57, P1610; Near TJ, 2004, MOL PHYLOGENET EVOL, V32, P344, DOI 10.1016/j.ympev.2003.12.010; Rafinesque CS, 1820, W REV MISCELLANEOUS, P49; Rambaut A, 2013, TRACER VERSION 1 6; Rodriguez-Martinez R, 2004, DIVERSIDAD GENETICA; Sinclair EA, 2011, ANIM CONSERV, V14, P87, DOI 10.1111/j.1469-1795.2010.00395.x; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Strecker U, 2004, MOL PHYLOGENET EVOL, V33, P469, DOI 10.1016/j.ympev.2004.07.001; Suchard MA, 2005, BIOMETRICS, V61, P665, DOI 10.1111/j.1541-0420.2005.00352.x; Vignieri SN, 2006, ANIM CONSERV, V9, P237, DOI 10.1111/j.1469-1795.2006.00038.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wesner JS, 2012, ANIM CONSERV, V15, P445, DOI 10.1111/j.1469-1795.2012.00538.x	47	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77013	10.1371/journal.pone.0077013	http://dx.doi.org/10.1371/journal.pone.0077013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130826	Green Published, gold			2022-12-27	WOS:000325814200048
J	Gonin, J; Carlotti, A; Dietrich, C; Audebourg, A; Radenen-Bussiere, B; Caignard, A; Avril, MF; Vacher-Lavenu, MC; Larousserie, F; Devergne, O				Gonin, Julie; Carlotti, Agnes; Dietrich, Celine; Audebourg, Anne; Radenen-Bussiere, Brigitte; Caignard, Anne; Avril, Marie-Francoise; Vacher-Lavenu, Marie-Cecile; Larousserie, Frederique; Devergne, Odile			Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; COMPLETE REGRESSION; IL-17 PRODUCTION; INDUCED GENE-3; INTERLEUKIN-27; ANTITUMOR; CYTOKINE; INFLAMMATION; INDUCTION; ANTIBODY	Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immunosuppressive functions depending on the context. In various murine tumor models including melanoma models, ectopic expression of IL-27 has been shown to play an anti-tumoral role and to favor tumor regression. In this study, we investigated whether IL-27 might play a role in the development of melanoma in humans. We analyzed the in situ expression of IL-27 in melanocytic lesions (n=82) representative of different stages of tumor progression. IL-27 expression was not observed in nevus (n=8) nor in in situ melanoma (n=9), but was detected in 28/46 (61%) cases of invasive cutaneous melanoma, notably in advanced stages (19/23 cases of stages 3 and 4). In most cases, the main source of IL-27 was tumor cells. Of note, when IL-27 was detected in primary cutaneous melanomas, its expression was maintained in metastatic lesions. These in situ data suggested that the immunosuppressive functions of IL-27 may dominate in human melanoma. Consistent with this hypothesis, we found that IL-27 could induce suppressive molecules such as PD-L1, and to a lesser extent IL-10, in melanoma cells, and that the in situ expression of IL-27 in melanoma correlated with those of PD-L1 and IL-10.	[Gonin, Julie; Dietrich, Celine; Larousserie, Frederique; Devergne, Odile] Univ Paris 05, CNRS, Unite Mixte Rech 8147, Sorbonne Paris Cite, Paris, France; [Gonin, Julie; Carlotti, Agnes; Audebourg, Anne; Radenen-Bussiere, Brigitte; Vacher-Lavenu, Marie-Cecile; Larousserie, Frederique] Hop Cochin, Assistance Publ Hop Paris, Serv Anat Pathol, F-75674 Paris, France; [Gonin, Julie; Carlotti, Agnes; Audebourg, Anne; Radenen-Bussiere, Brigitte; Vacher-Lavenu, Marie-Cecile; Larousserie, Frederique] Hop Cochin, Assistance Publ Hop Paris, Univ Paris Descartes, F-75674 Paris, France; [Caignard, Anne] Univ Paris 05, CNRS, Inst Cochin, INSERM,U1016,Unite Mixte Rech 8104, Paris, France; [Avril, Marie-Francoise] Hop Cochin, Assistance Publ Hop Paris, Serv Dermatol, F-75674 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Devergne, O (corresponding author), Univ Paris 05, CNRS, Unite Mixte Rech 8147, Sorbonne Paris Cite, Paris, France.	odile.devergne@inserm.fr	Devergne, Odile/M-6633-2017; Caignard, Anne/F-8159-2013	Caignard, Anne/0000-0001-9923-6045; Devergne, Odile/0000-0002-2838-7564	CNRS; Universite Paris Descartes; Ligue Contre le Cancer (Comite de Paris); Academie Nationale de Medecine	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Ligue Contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer); Academie Nationale de Medecine	This work was supported by institutional funds from the CNRS and Universite Paris Descartes, and by a grant from the Ligue Contre le Cancer (Comite de Paris). JG was supported by a fellowship from the Academie Nationale de Medecine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Coulomb-L'Hermine A, 2007, PLACENTA, V28, P1133, DOI 10.1016/j.placenta.2007.06.004; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Dummer W, 1996, INT J CANCER, V66, P607, DOI 10.1002/(SICI)1097-0215(19960529)66:5<607::AID-IJC4>3.3.CO;2-B; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fregni G, 2011, CLIN CANCER RES, V17, P2628, DOI 10.1158/1078-0432.CCR-10-2084; Gadiot J, 2011, CANCER-AM CANCER SOC, V117, P2192, DOI 10.1002/cncr.25747; Gonin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024617; Guleria I, 2007, J IMMUNOL, V178, P3345, DOI 10.4049/jimmunol.178.6.3345; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Itakura E, 2011, MODERN PATHOL, V24, P801, DOI 10.1038/modpathol.2011.5; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Larousserie F, 2006, J PATHOL, V209, P360, DOI 10.1002/path.1995; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; Larousserie F, 2004, J PATHOL, V202, P164, DOI 10.1002/path.1508; Matsui M, 2004, J VIROL, V78, P9093, DOI 10.1128/JVI.78.17.9093-9104.2004; Mohr P, 2009, ANN ONCOL, V20, P14, DOI 10.1093/annonc/mdp256; Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686; Morishima N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/605483; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nagai H, 2010, IMMUNOTHERAPY-UK, V2, P697, DOI 10.2217/IMT.10.46; Niedobitek G, 2002, J PATHOL, V198, P310, DOI 10.1002/path.1217; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Schneider R, 2011, EUR J IMMUNOL, V41, P47, DOI 10.1002/eji.201040804; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Tanida S, 2011, CYTOKINE, V55, P237, DOI 10.1016/j.cyto.2011.04.020; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371	46	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75694	10.1371/journal.pone.0075694	http://dx.doi.org/10.1371/journal.pone.0075694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130734	Green Published, Green Submitted, gold			2022-12-27	WOS:000325814200019
J	Wang, L; Pan, JS; Wang, TL; Song, M; Chen, WT				Wang, Li; Pan, Jinsong; Wang, Tingle; Song, Meng; Chen, Wantao			Pathological Cyclic Strain-Induced Apoptosis in Human Periodontal Ligament Cells through the RhoGDI alpha/Caspase-3/PARP Pathway	PLOS ONE			English	Article							MECHANICAL FORCES; TOOTH MOVEMENT; SHEAR-STRESS; STRETCH; INHIBITOR; CASPASE; DEATH; EXPRESSION; CULTURE; TISSUES	Aim: Human periodontal ligament (PDL) cells incur changes in morphology and express proteins in response to cyclic strain. However, it is not clear whether cyclic strain, especially excessive cyclic strain, induces PDL cell apoptosis and if so, what mechanism(s) are responsible. The aim of the present study was to elucidate the molecular mechanisms by which pathological levels of cyclic strain induce human PDL cell apoptosis. Materials and Methods: Human PDL cells were obtained from healthy premolar tissue. After three to five passages in culture, the cells were subjected to 20% cyclic strain at a frequency of 0.1 Hz for 6 or 24 h using an FX-5000T system. Morphological changes of the cells were assessed by inverted phase-contrast microscopy, and apoptosis was detected by fluorescein isothiocyanate (FITC)-conjugated annexin V and propidium iodide staining followed by flow cytometry. Protein expression was evaluated by Western blot analysis. Results: The number of apoptotic human PDL cells increased in a time-dependent manner in response to pathological cyclic strain. The stretched cells were oriented parallel to each another with their long axes perpendicular to the strain force vector. Cleaved caspase-3 and poly-ADP-ribose polymerase (PARP) protein levels increased in response to pathological cyclic strain over time, while Rho GDP dissociation inhibitor alpha (RhoGDI alpha) decreased. Furthermore, knock-down of RhoGDIa by targeted siRNA transfection increased stretch-induced apoptosis and upregulated cleaved caspase-3 and PARP protein levels. Inhibition of caspase-3 prevented stretch-induced apoptosis, but did not change RhoGDIa protein levels. Conclusion: The overall results suggest that pathological-level cyclic strain not only influenced morphology but also induced apoptosis in human PDL cells through the RhoGDI alpha/caspase-3/PARP pathway. Our findings provide novel insight into the mechanism of apoptosis induced by pathological cyclic strain in human PDL cells.	[Wang, Li; Pan, Jinsong; Song, Meng] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Stomatol, Shanghai 200030, Peoples R China; [Pan, Jinsong; Chen, Wantao] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China; [Pan, Jinsong; Chen, Wantao] Shanghai Res Inst Stomatol, Shanghai, Peoples R China; [Wang, Tingle] Cent Hosp Minhang Dist, Dept Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Song, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Stomatol, Shanghai 200030, Peoples R China.	smgjzh160@sohu.com; chenwantao2002@hotmail.com			National Natural Science Foundation of China [11172177, 30973343]; Shanghai Science and Technology Committee [11DZ2291800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research was supported by grants from the National Natural Science Foundation of China (No. 11172177 and 30973343) and projects of the Shanghai Science and Technology Committee (Grant No. 11DZ2291800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD LF, 1972, J DENT RES, V51, P953, DOI 10.1177/00220345720510043801; BRUNETTE DM, 1976, ARCH ORAL BIOL, V21, P393, DOI 10.1016/0003-9969(76)90001-7; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Chiba M, 2004, CELL BIOCHEM FUNCT, V22, P249, DOI 10.1002/cbf.1097; Fukui T, 2003, EUR J ORTHODONT, V25, P167, DOI 10.1093/ejo/25.2.167; Hao Y, 2009, ARCH ORAL BIOL, V54, P864, DOI 10.1016/j.archoralbio.2009.05.012; Hatai T, 2001, ORAL DIS, V7, P287, DOI 10.1034/j.1601-0825.2001.00663.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Howard PS, 1998, J PERIODONTAL RES, V33, P500; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Liu JQ, 2010, INT J BIOCHEM CELL B, V42, P2004, DOI 10.1016/j.biocel.2010.08.013; Liu JQ, 2009, J CELL BIOCHEM, V107, P834, DOI 10.1002/jcb.22182; LOCKSHIN RICHARD A., 1965, J INSECT PHYSIOL, V11, P123, DOI 10.1016/0022-1910(65)90099-5; MAJNO G, 1995, AM J PATHOL, V146, P3; Morioka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026384; NARAYANAN AS, 1983, COLLAGEN REL RES, V3, P33; Pan Jin-song, 2010, Zhonghua Kou Qiang Yi Xue Za Zhi, V45, P80; Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414, DOI 10.1177/10454411010120050401; Pini M, 2004, J BIOMECH, V37, P111, DOI 10.1016/S0021-9290(03)00234-3; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Reitan F., 1994, ORTHODONTICS CURRENT, V2, P96; Rennier Keith, 2013, BMC Res Notes, V6, P10, DOI 10.1186/1756-0500-6-10; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wei Z, 2008, NEUROPHARMACOLOGY, V54, P721, DOI 10.1016/j.neuropharm.2007.12.006; Xu C, 2011, J PERIODONTAL RES, V46, P742, DOI 10.1111/j.1600-0765.2011.01397.x; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yamaguchi M, 2005, ARCH IMMUNOL THER EX, V53, P388; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	34	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75973	10.1371/journal.pone.0075973	http://dx.doi.org/10.1371/journal.pone.0075973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130754	gold, Green Submitted, Green Published			2022-12-27	WOS:000325814200027
J	Lambie, EJ; Tieu, PJ; Lebedeva, N; Church, DL; Conradt, B				Lambie, Eric J.; Tieu, Pamela J.; Lebedeva, Nadja; Church, Diane L.; Conradt, Barbara			CATP-6, a C. elegans Ortholog of ATP13A2 PARK9, Positively Regulates GEM-1, an SLC16A Transporter	PLOS ONE			English	Article							P-TYPE ATPASE; CAENORHABDITIS-ELEGANS; ALPHA-SYNUCLEIN; GENE; PARKINSONISM; SUPERFAMILY; HOMEOSTASIS; EXPRESSION; MUTATIONS; TOXICITY	In previous work, we found that gain-of-function mutations that hyperactivate GEM-1 (an SLC16A transporter protein) can bypass the requirement for GON-2 (a TRPM channel protein) during the initiation of gonadogenesis in C. elegans. Consequently, we proposed that GEM-1 might function as part of a Mg2+ uptake pathway that functions in parallel to GON-2. In this study, we report that CATP-6, a C. elegans ortholog of the P5B ATPase, ATP13A2 (PARK9), is necessary for gem-1 gain-of-function mutations to suppress the effects of gon-2 inactivation. One possible explanation for this observation is that GEM-1 serves to activate CATP-6, which then functions as a Mg2+ transporter. However, we found that overexpression of GEM-1 can alleviate the requirement for CATP-6 activity, suggesting that CATP-6 probably acts as a non-essential upstream positive regulator of GEM-1. Our results are consistent with the notion that P5B ATPases govern intracellular levels of Mg2+ and/or Mn2+ by regulating the trafficking of transporters and other proteins associated with the plasma membrane.	[Lambie, Eric J.; Lebedeva, Nadja; Conradt, Barbara] Univ Munich, Dept Cell & Dev Biol, Munich, Planegg Martins, Germany; [Tieu, Pamela J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Church, Diane L.] Dartmouth Hitchcock Med Ctr, Parkinsons Ctr, Lebanon, NH 03766 USA; [Conradt, Barbara] Univ Munich, CIPS M Ctr Integrated Prot Sci, Munich, Germany	University of Munich; Dartmouth College; Dartmouth College; University of Munich	Lambie, EJ (corresponding author), Univ Munich, Dept Cell & Dev Biol, Munich, Planegg Martins, Germany.	lambie@bio.lmu.du	Conradt, Barbara/K-2665-2014; Lambie, Eric/K-5657-2014	Lambie, Eric/0000-0002-7371-128X; Conradt, Barbara/0000-0002-3731-4308	NIH [GM076651, GM069950, GM49785]; Center for Integrated Protein Science; Ludwig-Maximilians-University, Munich; Dartmouth Women in Science Project; Dartmouth Presidential Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076651, R01GM069950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrated Protein Science; Ludwig-Maximilians-University, Munich; Dartmouth Women in Science Project; Dartmouth Presidential Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants: GM076651, GM069950, GM49785. Center for Integrated Protein Science and Ludwig-Maximilians-University, Munich. Dartmouth Women in Science Project. Dartmouth Presidential Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BRENNER S, 1974, GENETICS, V77, P71; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; Chan H, 2010, J MOL MICROB BIOTECH, V19, P5, DOI 10.1159/000319588; Covy JP, 2012, J NEUROSCI RES, V90, P2306, DOI 10.1002/jnr.23112; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Habtemichael N, 2002, GENE, V283, P271, DOI 10.1016/S0378-1119(01)00881-2; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Heinick A, 2010, FASEB J, V24, P206, DOI 10.1096/fj.09-135889; HODGKIN J, 1989, GENETICS, V123, P301; Jakubowski J, 1999, GENETICS, V153, P743; Kemp BJ, 2009, GENETICS, V181, P581, DOI 10.1534/genetics.108.094870; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Patchornik G, 2002, BIOCHEMISTRY-US, V41, P11740, DOI 10.1021/bi026334d; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Sun AY, 1997, GENETICS, V147, P1077; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Usenovic M, 2012, AUTOPHAGY, V8, P987, DOI 10.4161/auto.20256; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0	35	9	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77202	10.1371/journal.pone.0077202	http://dx.doi.org/10.1371/journal.pone.0077202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130856	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900126
J	Mowry, EM; Carey, RF; Blasco, MR; Pelletier, J; Duquette, P; Villoslada, P; Malikova, I; Roger, E; Kinkel, RP; McDonald, J; Bacchetti, P; Waubant, E				Mowry, Ellen M.; Carey, Robert F.; Blasco, Maria R.; Pelletier, Jean; Duquette, Pierre; Villoslada, Pablo; Malikova, Irina; Roger, Elaine; Kinkel, R. Phillip; McDonald, Jamie; Bacchetti, Peter; Waubant, Emmanuelle			Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; GENOME-WIDE ASSOCIATION; 1ST DEMYELINATING EVENT; CONTROLLED-TRIAL; OPTIC NEURITIS; LOCI; RISK; REPLICATION; DISABILITY; ALLELES	Objective: Patients with early multiple sclerosis (MS) have stereotyped attack severity and recovery. We sought to determine if polymorphisms in MS susceptibility genes are associated with these attack features or with the risk of a second attack. Methods: 503 white subjects evaluated within a year of MS onset were included in the study. The severity of and recovery from the first two attacks were determined based on published definitions. Seventeen MS susceptibility genes were genotyped at the UCSF MS Genetics laboratory. Each polymorphism was evaluated in multivariate ordinal models, adjusted for the other polymorphisms, for its association with attack severity and recovery. We also assessed if these polymorphisms were associated with increased risk of a second attack. Results: The MPHOSPH9 polymorphism was associated with greater attack severity (odds ratios [OR] = 1.47, 95% CI [1.11, 1.94], p = 0.008), while the RGS1 and TNFRSF1A polymorphisms tended to be associated with reduced attack severity. The CD6 polymorphism tended to be associated with increased odds of worse attack recovery (OR = 1.25, 95% CI [0.93, 1.68], p = 0.13). In those who were HLA-DRB1-negative, the EVI5 polymorphism was associated with attacks of less severity; in HLA-DRB1 positive patients, EVI5 was associated with attacks of greater severity and worse recovery. The IL7R, TNFRSF1A, and GPC5 polymorphisms tended to be associated with having a second event within a year. Conclusions: Some MS susceptibility polymorphisms may be associated with attack severity, recovery, or frequency. Further characterization of these genes may lead to a better understanding of MS pathogenesis and to a more individualized treatment approach.	[Mowry, Ellen M.] Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA; [Carey, Robert F.; McDonald, Jamie; Waubant, Emmanuelle] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA; [Blasco, Maria R.] Hosp Univ Puerta de Hierro, Dept Neurol, Madrid, Spain; [Pelletier, Jean; Malikova, Irina] Aix Marseille Univ, CHU Timone, Ctr Resonance Magnet Biol & Med, Pole Neurosci Clin,Serv Neurol, Marseille, France; [Duquette, Pierre; Roger, Elaine] Ctr Hosp Univ Montreal, Multiple Sclerosis Clin, Montreal, PQ, Canada; [Villoslada, Pablo] August Pi Sunyer Hosp Clin, Inst Biomed Res, Ctr Neuroimmunol, Barcelona, Spain; [Kinkel, R. Phillip] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Johns Hopkins University; University of California System; University of California San Francisco; Hospital Puerta de Hierro-Majadahonda; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montreal; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Francisco	Mowry, EM (corresponding author), Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA.	emowry1@jhmi.edu	Villoslada, Pablo/AAF-9547-2019	Mowry, Ellen/0000-0003-0623-5188; Villoslada, Pablo/0000-0002-8735-6119; Blasco Quilez, Maria Rosario/0000-0003-2719-4629	National Multiple Sclerosis Society research grant [RG-3692A]	National Multiple Sclerosis Society research grant	This study was supported by a National Multiple Sclerosis Society research grant (www.nmss.org; RG-3692A; PI E. Waubant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; CONFAVREUX C, 1994, ANN NEUROL, V36, pS136, DOI 10.1002/ana.410360733; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Dennison L, 2009, CLIN PSYCHOL REV, V29, P141, DOI 10.1016/j.cpr.2008.12.001; Esposito F, 2010, GENES IMMUN, V11, P397, DOI 10.1038/gene.2010.28; Habek M, 2010, EXPERT REV MOL DIAGN, V10, P857, DOI 10.1586/ERM.10.77; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hobart J, 2004, MULT SCLER J, V10, P41, DOI 10.1191/1352458504ms983oa; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Hoppenbrouwers IA, 2009, J HUM GENET, V54, P676, DOI 10.1038/jhg.2009.96; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81; Kalincik T, 2013, GENES IMMUN, V14, P244, DOI 10.1038/gene.2013.17; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Marcus JF, 2010, MULT SCLER J, V16, P1004; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Mowry EM, 2009, NEUROLOGY, V72, P602, DOI 10.1212/01.wnl.0000342458.39625.91; Mowry EM, 2009, J NEUROL, V256, P1061, DOI 10.1007/s00415-009-5063-0; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sharrack B, 1999, BRAIN, V122, P141, DOI 10.1093/brain/122.1.141; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Tran T, 2010, INT J CELL BIOL, V2010; Waldron-Perrine B, 2009, CLIN NEUROPSYCHOL, V23, P462, DOI 10.1080/13854040802279683; Waubant E, 2012, NEUROLOGY, V78, P1171, DOI 10.1212/WNL.0b013e31824f7fdd	31	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75416	10.1371/journal.pone.0075416	http://dx.doi.org/10.1371/journal.pone.0075416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130709	gold, Green Published, Green Submitted			2022-12-27	WOS:000325810900035
J	Sayeed, A; Fedele, C; Trerotola, M; Ganguly, KK; Languino, LR				Sayeed, Aejaz; Fedele, Carmine; Trerotola, Marco; Ganguly, Kirat K.; Languino, Lucia R.			IGF-IR Promotes Prostate Cancer Growth by Stabilizing alpha(5)beta(1) Integrin Protein Levels	PLOS ONE			English	Article							LYSOSOMAL DEGRADATION; BETA(1C) INTEGRIN; RECEPTOR IGF1R; CELL-ADHESION; CROSS-TALK; E-CADHERIN; EXPRESSION; UBIQUITINATION; FIBRONECTIN; MIGRATION	Dynamic crosstalk between growth factor receptors, cell adhesion molecules and extracellular matrix is essential for cancer cell migration and invasion. Integrins are transmembrane receptors that bind extracellular matrix proteins and enable cell adhesion and cytoskeletal organization. They also mediate signal transduction to regulate cell proliferation and survival. The type 1 insulin-like growth factor receptor (IGF-IR) mediates tumor cell growth, adhesion and inhibition of apoptosis in several types of cancer. We have previously demonstrated that beta(1) integrins regulate anchorage-independent growth of prostate cancer (PrCa) cells by regulating IGF-IR expression and androgen receptor-mediated transcriptional functions. Furthermore, we have recently reported that IGF-IR regulates the expression of beta(1) integrins in PrCa cells. We have dissected the mechanism through which IGF-IR regulates beta(1) integrin expression in PrCa. Here we report that IGF-IR is crucial for PrCa cell growth and that beta(1) integrins contribute to the regulation of proliferation by IGF-IR. We demonstrate that beta(1) integrin regulation by IGF-IR does not occur at the mRNA level. Exogenous expression of a CD4 - beta(1) integrin cytoplasmic domain chimera does not interfere with such regulation and fails to stabilize beta(1) integrin expression in the absence of IGF-IR. This appears to be due to the lack of interaction between the beta(1) cytoplasmic domain and IGF-IR. We demonstrate that IGF-IR stabilizes the beta(1) subunit by protecting it from proteasomal degradation. The alpha(5) subunit, one of the binding partners of beta(1), is also downregulated along with beta(1) upon IGF-IR knockdown while no change is observed in the expression of the alpha(2), alpha(3), alpha(4), alpha(6) and alpha(7) subunits. Our results reveal a crucial mechanistic role for the alpha(5)beta(1) integrin, downstream of IGF-IR, in regulating cancer growth.	[Sayeed, Aejaz; Fedele, Carmine; Trerotola, Marco; Ganguly, Kirat K.; Languino, Lucia R.] Thomas Jefferson Univ, Dept Canc Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA	Jefferson University	Languino, LR (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA.	lucia.languino@jefferson.edu	Trerotola, Marco/J-9015-2016	Trerotola, Marco/0000-0003-1855-7002; Languino, Lucia/0000-0001-9011-7031	NIH [R01 CA-89720, CA-109874, P01 CA-140043]; American Cancer Society [(ACS)-IRG-08-060-04]; Pennsylvania Department of Health; Commonwealth University Research Enhancement Program grant; Pennsylvania Department of Health (H.R.); NATIONAL CANCER INSTITUTE [R01CA089720, P01CA140043, R01CA109874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Pennsylvania Department of Health; Commonwealth University Research Enhancement Program grant; Pennsylvania Department of Health (H.R.); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Contract grant sponsor: NIH; Contract grant number: R01 CA-89720 and CA-109874 (to LRL), P01 CA-140043 (to LRL); American Cancer Society (ACS)-IRG-08-060-04 (to AS); Contract grant sponsor: Pennsylvania Department of Health. This project is also funded, in part, under a Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health (H.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Arnaldez FI, 2012, HEMATOL ONCOL CLIN N, V26, P527, DOI 10.1016/j.hoc.2012.01.004; BASERGA R, 1995, CANCER RES, V55, P249; Beattie J, 2010, J CELL PHYSIOL, V224, P605, DOI 10.1002/jcp.22183; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Cheng BX, 2011, MOL CELL NEUROSCI, V47, P181, DOI 10.1016/j.mcn.2011.04.002; Damsky C, 2002, ANN NY ACAD SCI, V961, P154, DOI 10.1111/j.1749-6632.2002.tb03069.x; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Fornaro M, 1999, J CLIN INVEST, V103, P321, DOI 10.1172/JCI4585; FORNARO M, 1995, J BIOL CHEM, V270, P24666, DOI 10.1074/jbc.270.42.24666; Fornaro M, 1998, AM J PATHOL, V153, P1079, DOI 10.1016/S0002-9440(10)65652-0; Fornaro M, 1997, MATRIX BIOL, V16, P185, DOI 10.1016/S0945-053X(97)90007-X; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Goel H, 2013, J CELL PHYSL; Goel HL, 2010, J CELL PHYSIOL, V224, P210, DOI 10.1002/jcp.22116; Goel HL, 2005, CANCER RES, V65, P6692, DOI 10.1158/0008-5472.CAN-04-4315; Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guvakova MA, 1997, EXP CELL RES, V231, P149, DOI 10.1006/excr.1996.3457; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Huang P, 2012, CANCER RES, V72, P1428, DOI 10.1158/0008-5472.CAN-11-2621; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; KNOX JD, 1994, AM J PATHOL, V145, P167; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Liu J, 2011, MOL CELL BIOL, V31, P3366, DOI 10.1128/MCB.01403-10; Liu WG, 2008, CARCINOGENESIS, V29, P1096, DOI 10.1093/carcin/bgn026; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; Marelli MM, 2006, INT J ONCOL, V28, P723; McKenzie JA, 2013, CARCINOGENESIS; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Morozevich GE, 2012, AGING-US, V4, P368, DOI 10.18632/aging.100457; Murant SJ, 1997, EUR J CANCER, V33, P263, DOI 10.1016/S0959-8049(96)00418-2; Ohyagi-Hara C, 2013, AM J PATHOL, V182, P1876, DOI 10.1016/j.ajpath.2013.01.039; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Quaranta V, 1997, KIDNEY INT, V51, P1441, DOI 10.1038/ki.1997.197; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Salani B, 2009, BIOCHEM BIOPH RES CO, V380, P489, DOI 10.1016/j.bbrc.2009.01.102; Sayeed A, 2012, J CELL PHYSIOL, V227, P751, DOI 10.1002/jcp.22784; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Tai YT, 2003, CANCER RES, V63, P5850; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wu CM, 2011, J CELL PHYSIOL, V226, P3270, DOI 10.1002/jcp.22688; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258	55	25	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76513	10.1371/journal.pone.0076513	http://dx.doi.org/10.1371/journal.pone.0076513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130778	Green Published, Green Submitted, gold			2022-12-27	WOS:000325810900074
J	Shin, DW; Suh, B; Chun, S; Cho, J; Yoo, SH; Kim, SJ; Oh, B; Cho, B				Shin, Dong Wook; Suh, Beomseok; Chun, Sohyun; Cho, Juhee; Yoo, Sang Ho; Kim, Seok Joong; Oh, Bumjo; Cho, Belong			The Prevalence of and Factors Associated with the Use of Smoking Cessation Medication in Korea: Trend between 2005-2011	PLOS ONE			English	Article							NICOTINE REPLACEMENT THERAPY; REAL-WORLD; EX-SMOKERS; IMPACT; VARENICLINE; EFFICACY; RISK; AIDS	Background: In Korea, nicotine replacement therapy (NRT) has been widely used in government-led, public health center-based smoking cessation services since 2004 and varenicline has become available from 2007 but without reimbursement. In this study which used a series of nationwide cross-sectional surveys in Korea performed from 2005 to 2011, we examined the prevalence of smoking cessation medication use and factors associated with it. Methods: We analyzed data from the third to fifth waves of Korean National Health and Nutrition Examination Survey (2005-2011). Prevalence of each smoking cessation method use was calculated for each year, and its secular trend was tested by multivariate logistic regression. Results: Among smokers who made quit attempt during the previous year, 15.7% had used smoking cessation medications, 15.3% had used NRT, and 0.7% had used prescription medication. There was a significant increasing trend for NRT use (P < 0.001) during the study period, but use of prescription medication did not show any increase over time (P = 0.654) Education on smoking prevention and cessation was associated with smoking cessation medications use (OR 2.08, 95% CI 1.58-2.75). Conclusions: While the use of NRT has increased over years through government-sponsored smoking cessation programs, use of prescription drugs remained very low and flat probably due to lack of reimbursement. Education of smokers about effective smoking cessation methods and change in reimbursement policy are suggested to stimulate evidence-based smoking cessation practice.	[Shin, Dong Wook; Suh, Beomseok; Chun, Sohyun; Oh, Bumjo; Cho, Belong] Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea; [Shin, Dong Wook; Oh, Bumjo] Seoul Natl Univ Hosp, Ctr Hlth Promot & Optimal Aging, Seoul 110744, South Korea; [Shin, Dong Wook; Oh, Bumjo; Cho, Belong] Seoul Natl Univ Canc Hosp, Canc Survivorship Clin, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Yoo, Sang Ho] Hallym Univ Hosp, Dept Family Med, Pyongchon, South Korea; [Kim, Seok Joong] Natl Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Hallym University; National Medical Center - Korea	Cho, B (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea.	belong@snu.ac.kr	Oh, Bumjo/GWN-2776-2022; Cho, Belong/GLU-3443-2022; Yoo, Sang-Ho/AAI-4446-2020; Cho, Juhee/ABD-2280-2021	Cho, Belong/0000-0001-9558-689X; 	Pfizer	Pfizer(Pfizer)	DWS has received a research grant for his investigator-initiated study from Pfizer. The other authors have no relevant conflict of interest to declare in relation to this work. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Bansal MA, 2004, NICOTINE TOB RES, V6, P303, DOI 10.1080/14622200412331320707; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; Chen M S Jr, 2001, Asian Am Pac Isl J Health, V9, P61; Cummings KM, 2005, ANNU REV PUBL HEALTH, V26, P583, DOI 10.1146/annurev.publhealth.26.021304.144501; Cummings KM, 2004, NICOTINE TOB RES, V6, P333, DOI 10.1080/14622200412331320734; Etter JF, 2001, CLIN PHARMACOL THER, V69, P175, DOI 10.1067/mcp.2001.113722; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Fong Timothy W, 2007, Psychiatry (Edgmont), V4, P51; Fu SS, 2005, AM J HEALTH PROMOT, V20, P108, DOI 10.4278/0890-1171-20.2.108; Hammond D, 2004, ADDICTION, V99, P1042, DOI 10.1111/j.1360-0443.2004.00754.x; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Hung WT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-592; International Agency for Research on Cancer, 2008, IARC HDB CANC PREV T, V12; Kim CH, 2009, KOREAN J FAM MED, V30, P857, DOI 10.4082/kjfm.2009.30.11.857; Korea Health Promotion Foundation, 2011, INTR 2011 PUBL HLTH; Kotz D, 2009, ADDICTION, V104, P1403, DOI 10.1111/j.1360-0443.2009.02639.x; Miller N, 2005, LANCET, V365, P1849, DOI 10.1016/S0140-6736(05)66615-9; Moore TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027016; Oh JK, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050110; Pierce JP, 2002, JAMA-J AM MED ASSOC, V288, P1260, DOI 10.1001/jama.288.10.1260; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Shiffman S, 2003, TOB CONTROL, V12, P310, DOI 10.1136/tc.12.3.310; Shiffman S, 2002, ADDICTION, V97, P505, DOI 10.1046/j.1360-0443.2002.00141.x; Shiffman S, 2008, ADDICTION, V103, P1371, DOI 10.1111/j.1360-0443.2008.02268.x; Shiffman S, 2008, DRUG ALCOHOL DEPEN, V93, P121, DOI 10.1016/j.drugalcdep.2007.09.005; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Shiffman S, 2010, AM J PREV MED, V38, pS382, DOI 10.1016/j.amepre.2009.12.004; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; West R, 2007, THORAX, V62, P998, DOI 10.1136/thx.2007.078758; Willemsen MC, 2006, ADDICTION, V101, P441, DOI 10.1111/j.1360-0443.2006.01349.x; World Health Organization, 1998, GUID CONTR MON TOB E; World Health Organization, 2019, WHO REPORT GLOBAL TO	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74904	10.1371/journal.pone.0074904	http://dx.doi.org/10.1371/journal.pone.0074904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130674	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900009
J	Wortham, BW; Eppert, BL; Flury, JL; Garcia, SM; Borchers, MT				Wortham, Brian W.; Eppert, Bryan L.; Flury, Jennifer L.; Garcia, Sara Morgado; Borchers, Michael T.			TLR and NKG2D Signaling Pathways Mediate CS-Induced Pulmonary Pathologies	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NATURAL-KILLER-CELLS; CIGARETTE-SMOKE; MOUSE MODEL; EPITHELIAL-CELLS; INNATE IMMUNE; LUNG; ACTIVATION; STIMULATION; LIGANDS	Long-term exposure to cigarette smoke (CS) can have deleterious effects on lung epithelial cells including cell death and the initiation of inflammatory responses. CS-induced cell injury can elaborate cell surface signals and cellular byproducts that stimulate immune system surveillance. Our previous work has shown that the expression of ligands for the cytotoxic lymphocyte activating receptor NKG2D is enhanced in patients with COPD and that the induction of these ligands in a mouse model can replicate COPD pathologies. Here, we extend these findings to demonstrate a role for the NKG2D receptor in CS-induced pathophysiology and provide evidence linking nucleic acid-sensing endosomal toll-like receptor (TLR) signaling to COPD pathology through NKG2D activation. Specifically, we show that mice deficient in NKG2D exhibit attenuated pulmonary inflammation and airspace enlargement in a model of CS-induced emphysema. Additionally, we show that CS exposure induces the release of free nucleic acids in the bronchoalveolar lavage and that direct exposure of mouse lung epithelial cells to cigarette smoke extract similarly induces functional nucleic acids as assessed by TLR3, 7, and 9 reporter cell lines. We demonstrate that exposure of mouse lung epithelial cells to TLR ligands stimulates the surface expression of RAET1, a ligand for NKG2D, and that mice deficient in TLR3/7/9 receptor signaling do not exhibit CS-induced NK cell hyperresponsiveness and airspace enlargement. The findings indicate that CS-induced airway injury stimulates TLR signaling by endogenous nucleic acids leading to elevated NKG2D ligand expression. Activation of these pathways plays a major role in the altered NK cell function, pulmonary inflammation and remodeling related to long-term CS exposure.	[Wortham, Brian W.; Eppert, Bryan L.; Flury, Jennifer L.; Garcia, Sara Morgado; Borchers, Michael T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Borchers, MT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45221 USA.	BORCHEMT@UCMAIL.UC.EDU			National Institutes of Health [R01 ES015036, T32 ES016646]; University of Cincinnati Center for Environmental Genetics [P30 ES006096]; Flight Attendant Medical Research Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES015036, T32ES016646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Center for Environmental Genetics; Flight Attendant Medical Research Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health research Grants R01 ES015036 (to M.T.B.), T32 ES016646 (to B.W.W.), the University of Cincinnati Center for Environmental Genetics P30 ES006096, a Flight Attendant Medical Research Institute grant (to M.T.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Eppert BL, 2013, J IMMUNOL, V190, P1331, DOI 10.4049/jimmunol.1202442; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hue S, 2003, J IMMUNOL, V171, P1909, DOI 10.4049/jimmunol.171.4.1909; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Lyerla TA, 2003, AM J PHYSIOL-LUNG C, V285, pL643, DOI 10.1152/ajplung.00024.2003; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Murray LA, 2008, AM J RESP CRIT CARE, V178, P1227, DOI 10.1164/rccm.200807-1020OC; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Pauwels R, 2001, EUR RESPIR J, V18, P901, DOI 10.1183/09031936.01.0027401; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Schrambach S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000518; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Vayssier M, 1998, AM J PHYSIOL-LUNG C, V275, pL771, DOI 10.1152/ajplung.1998.275.4.L771; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104	40	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e78735	10.1371/journal.pone.0078735	http://dx.doi.org/10.1371/journal.pone.0078735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130907	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900146
J	Xu, Q; Chen, ZY; Cheng, X; Xu, L; Jin, H				Xu, Qi; Chen, Zhongying; Cheng, Xing; Xu, Lucy; Jin, Hong			Evaluation of Live Attenuated H7N3 and H7N7 Vaccine Viruses for Their Receptor Binding Preferences, Immunogenicity in Ferrets and Cross Reactivity to the Novel H7N9 Virus	PLOS ONE			English	Article							INFLUENZA-A VIRUS; HEMAGGLUTININ; SPECIFICITY; H2; REPLICATION; PROTECTION; ANTIBODY; MICE; AMINO-ACID-226; PATHOGENICITY	Live attenuated influenza vaccine (LAIV) candidates of the H7 subtype, A/Netherlands/219/03 (H7N7, NL03 ca) and A/chicken/British Columbia/CN-6/2004 (H7N3, BC04 ca), were evaluated for their receptor binding specificity and immunogenicity in ferrets. The BC04 ca virus exhibited alpha 2,3-SA and alpha 2,6-SA dual receptor binding preference while the NL03 ca virus preferentially bound to alpha 2,3-SA. Substitution of the Q226 and G228 (Q-G) by the L226 and S228 (L-S) residues in the HA improved binding to alpha 2,6-SA for NL03 ca. The vaccine viruses with L-S retained the attenuation phenotype. NL03 L-S ca replicated more efficiently than the original NL03 ca virus in the upper respiratory tract of ferrets, and induced higher levels of humoral and cellular immune responses. Prior vaccination with seasonal LAIV reduced H7-specific antibody responses, but did not reduce the H7N7 vaccine mediated protection against a heterologous H7N3 BC04 wt virus infection in ferrets. In addition, the H7N3 and H7N7 vaccine immunized ferret sera cross reacted with the newly emerged H7N9 virus. These data, in combination with the safety data from previously conducted Phase 1 studies, suggest that these vaccines may have a role in responding to the threat posed by the H7N9 virus.	[Xu, Qi; Chen, Zhongying; Cheng, Xing; Xu, Lucy; Jin, Hong] MedImmune LLC, Mountain View, CA USA	AstraZeneca; Medimmune	Jin, H (corresponding author), MedImmune LLC, Mountain View, CA USA.	jinh@medimmune.com		Xu, Lucy/0000-0001-6765-463X				Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Ayora-Talavera G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007836; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chen GL, 2010, J VIROL, V84, P7695, DOI 10.1128/JVI.00511-10; Chen ZY, 2012, J VIROL, V86, P2780, DOI 10.1128/JVI.06219-11; Chen ZY, 2010, VACCINE, V28, P4079, DOI 10.1016/j.vaccine.2010.03.078; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Cheng X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004436; Cherukuri A, 2012, VACCINE, V30, P237, DOI 10.1016/j.vaccine.2011.11.001; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Joseph T, 2008, VIROLOGY, V378, P123, DOI 10.1016/j.virol.2008.05.021; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Min JY, 2010, J VIROL, V84, P11950, DOI 10.1128/JVI.01305-10; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Wu H, 2013, N ENGL J MED; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081	35	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76884	10.1371/journal.pone.0076884	http://dx.doi.org/10.1371/journal.pone.0076884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130801	Green Published, gold, Green Submitted			2022-12-27	WOS:000325810900096
J	Seo, YJ; Pritzl, CJ; Vijayan, M; Bomb, K; McClain, ME; Alexander, S; Hahm, B				Seo, Young-Jin; Pritzl, Curtis J.; Vijayan, Madhuvanthi; Bomb, Kavita; McClain, Mariah E.; Alexander, Stephen; Hahm, Bumsuk			Sphingosine Kinase 1 Serves as a Pro-Viral Factor by Regulating Viral RNA Synthesis and Nuclear Export of Viral Ribonucleoprotein Complex upon Influenza Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; RAN-BINDING PROTEIN-3; MATRIX PROTEIN; A VIRUSES; ACTIVATION; INHIBITION; PROPAGATION; 1-PHOSPHATE; INDUCTION; TARGET	Influenza continues to pose a threat to humans by causing significant morbidity and mortality. Thus, it is imperative to investigate mechanisms by which influenza virus manipulates the function of host factors and cellular signal pathways. In this study, we demonstrate that influenza virus increases the expression and activation of sphingosine kinase (SK) 1, which in turn regulates diverse cellular signaling pathways. Inhibition of SK suppressed virus-induced NF-kappa B activation and markedly reduced the synthesis of viral RNAs and proteins. Further, SK blockade interfered with activation of Ran-binding protein 3 (RanBP3), a cofactor of chromosome region maintenance 1 (CRM1), to inhibit CRM1-mediated nuclear export of the influenza viral ribonucleoprotein complex. In support of this observation, SK inhibition altered the phosphorylation of ERK, p90RSK, and AKT, which is the upstream signal of RanBP3/CRM1 activation. Collectively, these results indicate that SK is a key pro-viral factor regulating multiple cellular signal pathways triggered by influenza virus infection.	[Seo, Young-Jin; Pritzl, Curtis J.; Vijayan, Madhuvanthi; Bomb, Kavita; McClain, Mariah E.; Hahm, Bumsuk] Univ Missouri, Dept Surg & Mol Microbiol, Columbia, MO 65211 USA; [Seo, Young-Jin; Pritzl, Curtis J.; Vijayan, Madhuvanthi; Bomb, Kavita; McClain, Mariah E.; Hahm, Bumsuk] Univ Missouri, Dept Immunol, Columbia, MO USA; [Alexander, Stephen] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Hahm, B (corresponding author), Univ Missouri, Dept Surg & Mol Microbiol, Columbia, MO 65211 USA.	hahmb@health.missouri.edu	Vijayan, Madhuvanthi/U-3524-2019		NIH/NIAID [R01AI091797, R21AI088363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091797, R21AI088363] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grants R01AI091797 and R21AI088363 (B.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P497; Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Carr JM, 2013, REV MED VIROL, V23, P73, DOI 10.1002/rmv.1718; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Eierhoff T, 2009, BIOL CHEM, V390, P509, DOI 10.1515/BC.2009.053; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; French KJ, 2003, CANCER RES, V63, P5962; Gandy KAO, 2013, BBA-MOL CELL BIOL L, V1831, P157, DOI 10.1016/j.bbalip.2012.07.002; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Gault CR, 2011, CRIT REV BIOCHEM MOL, V46, P342, DOI 10.3109/10409238.2011.597737; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Ludwig S, 2004, FEBS LETT, V561, P37, DOI 10.1016/S0014-5793(04)00108-5; Machesky NJ, 2008, J BIOL CHEM, V283, P26148, DOI 10.1074/jbc.M710181200; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Monick MM, 2004, AM J RESP CELL MOL, V30, P844, DOI 10.1165/rcmb.2003-0424OC; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pchejetski D, 2011, IMMUNOL CELL BIOL, V89, P268, DOI 10.1038/icb.2010.91; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Pleschka Stephan, 2009, P109, DOI 10.1142/9789812833808_0005; Predicala R, 2013, J GEN VIROL; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Root CN, 2000, J GEN VIROL, V81, P2697, DOI 10.1099/0022-1317-81-11-2697; Seo YJ, 2011, CYTOKINE GROWTH F R, V22, P55, DOI 10.1016/j.cytogfr.2010.12.001; Seo YJ, 2010, ADV APPL MICROBIOL, V73, P83, DOI 10.1016/S0065-2164(10)73004-5; Seo YJ, 2010, J VIROL, V84, P8124, DOI 10.1128/JVI.00510-10; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Voisset C, 2008, CELL MICROBIOL, V10, P606, DOI 10.1111/j.1462-5822.2007.01070.x; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Watanabe K, 2001, VIRUS RES, V77, P31, DOI 10.1016/S0168-1702(01)00263-5; Watanabe K, 2008, DRUG DISCOV THER, V2, P77; Wati S, 2011, J GEN VIROL, V92, P807, DOI 10.1099/vir.0.028159-0; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yamane D, 2009, J BIOL CHEM, V284, P13648, DOI 10.1074/jbc.M807498200; Yatomi Y, 1996, BIOCHEMISTRY-US, V35, P626, DOI 10.1021/bi9515533; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024	70	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e75005	10.1371/journal.pone.0075005	http://dx.doi.org/10.1371/journal.pone.0075005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24137500	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200104
J	Wang, FM; Xu, X; Zou, B; Guo, ZH; Li, ZA; Zhu, WX				Wang, Faming; Xu, Xin; Zou, Bi; Guo, Zhihua; Li, Zhian; Zhu, Weixing			Biomass Accumulation and Carbon Sequestration in Four Different Aged Casuarina equisetifolia Coastal Shelterbelt Plantations in South China	PLOS ONE			English	Article							FINE-ROOT BIOMASS; SOIL CARBON; SECONDARY FORESTS; STAND DEVELOPMENT; DRY TROPICS; NITROGEN; DYNAMICS; CHRONOSEQUENCE; EUCALYPTUS; FIXATION	Thousands of kilometers of shelterbelt plantations of Casuarina equisetifolia have been planted to protect the southeast coastline of China. These plantations also play an important role in the regional carbon (C) cycling. In this study, we examined plant biomass increment and C accumulation in four different aged C. equisetifolia plantations in sandy beaches in South China. The C accumulated in the C. equisetifolia plant biomass increased markedly with stand age. The annual rate of C accumulation in the C. equisetifolia plant biomass during 0-3, 3-6, 6-13 and 13-18 years stage was 2.9, 8.2, 4.2 and 1.0 Mg C ha(-1) yr(-1), respectively. Soil organic C (SOC) at the top 1 m soil layer in these plantations was 17.74, 5.14, 6.93, and 11.87 Mg C ha(-1), respectively, with SOC density decreasing with increasing soil depth. Total C storage in the plantation ecosystem averaged 26.57, 38.50, 69.78, and 79.79 Mg C ha(-1) in the 3, 6, 13 and 18-yrs plantation, with most of the C accumulated in the aboveground biomass rather than in the belowground root biomass and soil organic C. Though our results suggest that C. equisetifolia plantations have the characteristics of fast growth, high biomass accumulation, and the potential of high C sequestration despite planting in poor soil conditions, the interactive effects of soil condition, natural disturbance, and human policies on the ecosystem health of the plantation need to be further studied to fully realize the ecological and social benefits of the C equisetifolia shelterbelt forests in South China.	[Wang, Faming; Xu, Xin; Zou, Bi; Li, Zhian; Zhu, Weixing] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Guo, Zhihua] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Zhu, Weixing] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Forestry; Institute of Wetland Research, CAF; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Li, ZA (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	lizan@scbg.ac.cn; wxzhu@binghamton.edu	Wang, Faming/J-9342-2014	Wang, Faming/0000-0002-7543-6779; Zhu, Weixing/0000-0002-4274-6973	National Basic Research Program of China [2011CB403200]; NSFC [U1131001]; Natural Science Foundation of China [31300419]; Chinese Academy of Sciences [KSCX2-EW-J-28, XDA05070307]; National Science and Technology Pillar program [2009BAD2B0604]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Pillar program	This work was funded by National Basic Research Program of China (2011CB403200), NSFC-Guangdong Joint Project (U1131001), Natural Science Foundation of China (31300419), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-28), the "Strategic Priority Research Program - Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (XDA05070307) and the key projects in the National Science and Technology Pillar program (2009BAD2B0604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Borja I, 2008, TREE PHYSIOL, V28, P773, DOI 10.1093/treephys/28.5.773; Campo J, 2001, BIOGEOCHEMISTRY, V53, P161, DOI 10.1023/A:1010663516029; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; Clements F.E., 1916, PLANT SUCCESSION ANA; Davis MR, 2003, FOREST ECOL MANAG, V177, P313, DOI 10.1016/S0378-1127(02)00333-X; El-Lankany M, 1990, ADV CASUARINA RES UT; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fonseca W, 2011, FOREST ECOL MANAG, V262, P1400, DOI 10.1016/j.foreco.2011.06.036; GAUTHIER D, 1985, SOIL BIOL BIOCHEM, V17, P375, DOI 10.1016/0038-0717(85)90076-8; Goulden ML, 2011, GLOBAL CHANGE BIOL, V17, P855, DOI 10.1111/j.1365-2486.2010.02274.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hardman CJ, 2012, ORYX, V46, P204, DOI 10.1017/S0030605311000251; Harmand JM, 2004, FOREST ECOL MANAG, V188, P249, DOI 10.1016/j.foreco.2003.07.026; HARRISON AF, 1995, FORESTRY, V68, P335, DOI 10.1093/forestry/68.4.335; Hong YuanCheng, 2010, Journal of Zhejiang Forestry Science and Technology, V30, P66; Hughes RF, 1999, ECOLOGY, V80, P1892; Johnston MH, 1996, FOREST ECOL MANAG, V83, P17, DOI 10.1016/0378-1127(96)03704-8; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Usuga JCL, 2010, FOREST ECOL MANAG, V260, P1906, DOI 10.1016/j.foreco.2010.08.040; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; Mascarenhas A, 2008, J ENVIRON MANAGE, V89, P24, DOI 10.1016/j.jenvman.2007.01.053; Mather A, 2003, LAND USE POLICY, V20, P195, DOI 10.1016/S0264-8377(03)00003-6; Miao S.Y., 1998, GUIHAIA, V18, P16; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Muthukumar T, 2010, NEW FOREST, V40, P101, DOI 10.1007/s11056-009-9186-z; Parrotta JA, 1996, CAN J FOREST RES, V26, P1684, DOI 10.1139/x26-190; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Rokityanskiy D, 2007, TECHNOL FORECAST SOC, V74, P1057, DOI 10.1016/j.techfore.2006.05.022; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; Schedlbauer JL, 2008, FOREST ECOL MANAG, V255, P1326, DOI 10.1016/j.foreco.2007.10.039; Schlamadinger B, 1996, BIOMASS BIOENERG, V10, P275, DOI 10.1016/0961-9534(95)00113-1; Srivastava AK, 1995, BIOMASS BIOENERG, V9, P465, DOI 10.1016/0961-9534(95)00048-8; State Forestry Administration (SFA), 2009, CHIN FOR STAT YB 200; TROUVE C, 1994, SOIL BIOL BIOCHEM, V26, P287, DOI 10.1016/0038-0717(94)90169-4; WILDE SERGIUS A., 1964, SOIL SCI, V97, P276, DOI 10.1097/00010694-196404000-00009; WILLIAMSLINERA G, 1983, BIOTROPICA, V15, P275, DOI 10.2307/2387652; [杨昆 YANG Kun], 2006, [生态环境, Ecology and Environment], V15, P84; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; Zhang H.L., 1996, CHINESE ECOSYSTEM RE, P1; Zhong C., 2003, CHINA FOREST SCI TEC, V17, P3, DOI DOI 10.3969/J.ISSN.1000-8101.2003.02.001; Zhong CL, 2010, SYMBIOSIS, V50, P107, DOI 10.1007/s13199-009-0039-5; Zoysa M. de, 2008, Small-scale Forestry, V7, P17, DOI 10.1007/s11842-008-9038-2	46	18	20	8	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77449	10.1371/journal.pone.0077449	http://dx.doi.org/10.1371/journal.pone.0077449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143236	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100073
J	Shi, JR; Jiang, BB; Qiu, YL; Guan, J; Jain, M; Cao, X; Bauer, M; Su, LH; Burkly, LC; Leone, TC; Kelly, DP; Liao, RL				Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Su, Lihe; Burkly, Linda C.; Leone, Teresa C.; Kelly, Daniel P.; Liao, Ronglih			PGC1 alpha Plays a Critical Role in TWEAK-Induced Cardiac Dysfunction	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MULTIFUNCTIONAL CYTOKINE; PGC-1 COACTIVATORS; WEAK INDUCER; RECEPTOR; PGC-1-ALPHA; METABOLISM; APOPTOSIS; BINDS; FN14	Background: Inflammatory cytokines play an important role in the pathogenesis of heart failure. We have recently found the cytokine TWEAK (tumor necrosis factor (TNF)-like weak inducer of apoptosis), a member of the TNF superfamily, to be increased in patients with cardiomyopathy and result in the development of heart failure when overexpressed in mice. The molecular mechanisms underlying TWEAK-induced cardiac pathology, however, remain unknown. Methodology and Critical Finding: Using mouse models of elevated circulating TWEAK levels, established through intravenous injection of adenovirus expressing TWEAK or recombinant TWEAK protein, we find that TWEAK induces a progressive dilated cardiomyopathy with impaired contractile function in mice. Moreover, TWEAK treatment is associated with decreased expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC1 alpha) and genes required for mitochondrial oxidative phosphorylation, which precede the onset of cardiac dysfunction. TWEAK-induced downregulation of PGC1 alpha requires expression of its cell surface receptor, fibroblast growth factor-inducible 14 (Fn14). We further find that TWEAK downregulates PGC1 alpha gene expression via the TNF receptor-associated factor 2 (TRAF2) and NFkB signaling pathways. Maintaining PGC1 alpha levels through adenoviral-mediated gene expression is sufficient to protect against TWEAK-induced cardiomyocyte dysfunction. Conclusion: Collectively, our data suggest that TWEAK induces cardiac dysfunction via downregulation of PGC1 alpha, through FN14-TRAF2-NF kappa B-dependent signaling. Selective targeting of the FN14-TRAF2-NF kappa B-dependent signaling pathway or augmenting PGC1 alpha levels may serve as novel therapeutic strategies for cardiomyopathy and heart failure.	[Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Liao, Ronglih] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA; [Su, Lihe] Biogen Idec Inc, Dept Prot Biochem, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Immunol, Cambridge, MA USA; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orlando, FL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Biogen; Biogen; Sanford Burnham Prebys Medical Discovery Institute	Liao, RL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA.	rliao@rics.bwh.harvard.edu	Qiu, Yiling/C-7138-2013; Kelly, Daniel/ABG-2056-2021	Liao, Ronglih/0000-0002-9598-9020; Bai, Chunxue/0000-0001-5798-3130	National Institute of Health [HL099073, HL086967, HL093147, R01HL058493, R01HL101189, R01DK045416, K08 HL107451]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101189, R01HL058493, R01HL086967, K08HL107451, R01HL099073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institute of Health research grants HL099073 HL086967 and HL093147 (R.L.), R01HL058493, R01HL101189, and R01DK045416 (D.P.K.) grants. M.J. is the recipient of NIH mentored award (K08 HL107451). J.S. and M.B. were supported by a postdoctoral fellowship from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kumar A, 2012, CURR OPIN CLIN NUTR, V15, P233, DOI 10.1097/MCO.0b013e328351c3fc; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liao Ronglih, 2007, V139, P251; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schilling J, 2011, J MOL CELL CARDIOL, V51, P578, DOI 10.1016/j.yjmcc.2010.09.021; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Weinberg JM, 2011, KIDNEY INT, V79, P151, DOI 10.1038/ki.2010.435; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yepes M, 2006, DRUG NEWS PERSPECT, V19, P589, DOI 10.1358/dnp.2006.19.10.1068005	35	43	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54054	10.1371/journal.pone.0054054	http://dx.doi.org/10.1371/journal.pone.0054054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342071	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700080
J	Luo, JD; Lu, ZH; Lu, XJ; Chen, L; Cao, JP; Zhang, SY; Ling, Y; Zhou, XF				Luo, Judong; Lu, Zhonghua; Lu, Xujing; Chen, Ling; Cao, Jianping; Zhang, Shuyu; Ling, Yang; Zhou, Xifa			OTUD5 Regulates p53 Stability by Deubiquitinating p53	PLOS ONE			English	Article							HAUSP; MDM2; PATHWAY; DESTABILIZATION; STRESS; P300	Background: The p53 tumour suppressor protein is a transcription factor that prevents oncogenic progression by activating the expression of apoptosis and cell-cycle arrest genes in stressed cells. The stability of p53 is tightly regulated by ubiquitin-dependent degradation, driven mainly by its negative regulators ubiquitin ligase MDM2. Principal Findings: In this study, we have identified OTUD5 as a DUB that interacts with and deubiquitinates p53. OTUD5 forms a direct complex with p53 and controls level of ubiquitination. The function of OTUD5 is required to allow the rapid activation of p53-dependent transcription and a p53-dependent apoptosis in response to DNA damage stress. Conclusions: As a novel deubiquitinating enzyme for p53, OTUD5 is required for the stabilization and the activation of a p53 response.	[Luo, Judong; Lu, Zhonghua; Lu, Xujing; Chen, Ling; Ling, Yang; Zhou, Xifa] Soochow Univ, Changzhou Tumor Hosp, Dept Radiotherapy, Changzhou, Peoples R China; [Luo, Judong; Cao, Jianping; Zhang, Shuyu] Soochow Univ, Sch Radiat Med & Protect, Suzhou, Peoples R China; [Luo, Judong; Cao, Jianping; Zhang, Shuyu] Soochow Univ, Jiangsu Prov Key Lab Radiat Med & Protect, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Ling, Y (corresponding author), Soochow Univ, Changzhou Tumor Hosp, Dept Radiotherapy, Changzhou, Peoples R China.	medilyn2001@yahoo.com.cn; 756035311@qq.com			National Natural Science Foundation of China [81102078, 81172597]; Natural Science Foundation of Jiangsu Province [BK2009102]; Innovative Project of Jiangsu Province [BL2012046]; Changzhou Social Development [CE20125026]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Innovative Project of Jiangsu Province; Changzhou Social Development; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work is supported by the National Natural Science Foundation of China (81102078 and 81172597), Natural Science Foundation of Jiangsu Province (BK2009102), Innovative Project of Jiangsu Province (BL2012046), Changzhou Social Development (CE20125026) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; COX RF, 1984, AM J HOSP PHARM, V41, P2410, DOI 10.1093/ajhp/41.11.2410; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Miao L, 2010, ONCOGENE, V29, P711, DOI 10.1038/onc.2009.372; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	27	65	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77682	10.1371/journal.pone.0077682	http://dx.doi.org/10.1371/journal.pone.0077682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143256	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100095
J	Maire, V; Baldeyron, C; Richardson, M; Tesson, B; Vincent-Salomon, A; Gravier, E; Marty-Prouvost, B; De Koning, L; Rigaill, G; Dumont, A; Gentien, D; Barillot, E; Roman-Roman, S; Depil, S; Cruzalegui, F; Pierre, A; Tucker, GC; Dubois, T				Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.; Dubois, Thierry			TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer	PLOS ONE			English	Article							P53-DEPENDENT POSTMITOTIC CHECKPOINT; SPINDLE-ASSEMBLY CHECKPOINT; GENE-EXPRESSION PATTERNS; BASAL-LIKE CARCINOMAS; MOLECULAR PORTRAITS; MITOTIC CHECKPOINT; KINASE INHIBITORS; DNA-DAMAGE; MPS1; CELLS	Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical behavior. No targeted therapy is currently available for the treatment of patients with TNBC. In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human TNBC biopsies and whose silencing in TNBC cell lines causes cell death. A cohort including human BC biopsies obtained at Institut Curie as well as normal tissues has been analyzed at a gene-expression level. The data revealed that the human protein kinase monopolar spindle 1 (hMPS1), also known as TTK and involved in mitotic checkpoint, is specifically overexpressed in TNBC, compared to the other BC subgroups and healthy tissues. We confirmed by immunohistochemistry and reverse phase protein array that TNBC expressed higher levels of TTK protein compared to the other BC subgroups. We then determined the biological effects of TTK depletion by RNA interference, through analyses of tumorigenic capacity and cell viability in different human TNBC cell lines. We found that RNAi-mediated depletion of TTK in various TNBC cell lines severely compromised their viability and their ability to form colonies in an anchorage-independent manner. Moreover, we observed that TTK silencing led to an increase in H2AX phosphorylation, activation of caspases 3/7, sub-G1 cell population accumulation and high annexin V staining, as well as to a decrease in G1 phase cell population and an increased aneuploidy. Altogether, these data indicate that TTK depletion in TNBC cells induces apoptosis. These results point out TTK as a protein kinase overexpressed in TNBC that may represent an attractive therapeutic target specifically for this poor prognosis associated subgroup of breast cancer.	[Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Dubois, Thierry] Inst Curie, Res Ctr, Paris, France; [Maire, Virginie; Baldeyron, Celine; Tesson, Bruno; Marty-Prouvost, Berengere; Rigaill, Guillem; Dumont, Aurelie; Roman-Roman, Sergio; Dubois, Thierry] Dept Translat Res, Breast Canc Biol Grp, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] INSERM, U900, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [De Koning, Leanne] RPPA Platform, Dept Translat Res, Paris, France; [Rigaill, Guillem] AgroParisTech, INRA, UMR 518, MIA, Paris, France; [Gentien, David] Dept Translat Res, Platform Mol Biol Facil, Paris, France; [Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.] Inst Rech SERVIER, Oncol Res & Dev Unit, Croissy Sur Seine, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Servier; Institut de Recherches Internationales Servier	Dubois, T (corresponding author), Inst Curie, Res Ctr, Paris, France.	thierry.dubois@curie.fr	Gentien, David/O-9356-2019; Roman-Roman, Sergio/K-9993-2014; Baldeyron, Céline/F-6990-2019; Gentien, David/L-7757-2017; Soussana, Jean-Francois/P-2094-2016; Gross, Nicolas/I-2368-2016; Dubois, Thierry/D-2852-2017; Wright, Ian/G-4979-2012	Roman-Roman, Sergio/0000-0001-6459-2613; Baldeyron, Céline/0000-0003-2311-1523; Gentien, David/0000-0001-8317-5188; Soussana, Jean-Francois/0000-0002-1932-6583; Gross, Nicolas/0000-0001-9730-3240; Dubois, Thierry/0000-0003-4739-6164; Wright, Ian/0000-0001-8338-9143; Rigaill, Guillem/0000-0002-7176-7511; Maire, Vincent/0000-0002-3245-2568; BARILLOT, Emmanuel/0000-0003-2724-2002; Martin, Raphael/0000-0001-8778-7915	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa); Canceropole Ile de France	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France)	This work was supported by Institut de Recherches Servier and Institut Curie. GR is supported by a grant of Institut National du Cancer (INCa) and LDK by a grant from Canceropole Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Azoulay S, 2005, MODERN PATHOL, V18, P1623, DOI 10.1038/modpathol.3800483; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Fadare O, 2008, NAT CLIN PRACT ONCOL, V5, P149, DOI 10.1038/ncponc1038; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kilpinen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015068; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; Mizukami Y, 2008, CANCER SCI, V99, P1448, DOI 10.1111/j.1349-7006.2008.00844.x; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; RIGAILL G, 2010, ARXIV10040887V1, P40887; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440; Thykjaer T, 2001, CANCER RES, V61, P2492; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; VALENTIN MD, 2012, BREAST CANC RES TREA; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Wang YC, 2010, ORAL ONCOL, V46, P255, DOI 10.1016/j.oraloncology.2010.01.003; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zafrani B, 2000, HISTOPATHOLOGY, V37, P536, DOI 10.1046/j.1365-2559.2000.01006.x	71	118	120	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63712	10.1371/journal.pone.0063712	http://dx.doi.org/10.1371/journal.pone.0063712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	24130879	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400027
J	Zhang, DY; Ali, Z; Wang, CB; Xu, L; Yi, JX; Xu, ZL; Liu, XQ; He, XL; Huang, YH; Khan, IA; Trethowan, RM; Ma, HX				Zhang, Da Yong; Ali, Zulfiqar; Wang, Chang Biao; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Khan, Iqrar Ahmad; Trethowan, Richard M.; Ma, Hong Xiang			Genome-Wide Sequence Characterization and Expression Analysis of Major Intrinsic Proteins in Soybean (Glycine max L.)	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; PLANT AQUAPORINS; PLASMA-MEMBRANE; WATER TRANSPORT; GENE FAMILY; ARABIDOPSIS; IDENTIFICATION; CHANNELS; NODULIN; SELECTIVITY	Water is essential for all living organisms. Aquaporin proteins are the major facilitator of water transport activity through cell membranes of plants including soybean. These proteins are diverse in plants and belong to a large major intrinsic (MIP) protein family. In higher plants, MIPs are classified into five subfamilies including plasma membrane intrinsic proteins (PIP), tonoplast intrinsic proteins (TIP), NOD26-like intrinsic proteins (NIP), small basic intrinsic proteins (SIP), and the recently discovered X intrinsic proteins (XIP). This paper reports genome wide assembly of soybean MIPs, their functional prediction and expression analysis. Using a bioinformatic homology search, 66 GmMIPs were identified in the soybean genome. Phylogenetic analysis of amino acid sequences of GmMIPs divided the large and highly similar multi-gene family into 5 subfamilies: GmPIPs, GmTIPs, GmNIPs, GmSIPs and GmXIPs. GmPIPs consisted of 22 genes and GmTIPs 23, which showed high sequence similarity within subfamilies. GmNIPs contained 13 and GmSIPs 6 members which were diverse. In addition, we also identified a two member GmXIP, a distinct 5th subfamily. GmMIPs were further classified into twelve subgroups based on substrate selectivity filter analysis. Expression analyses were performed for a selected set of GmMIPs using semi-quantitative reverse transcription (semi-RT-qPCR) and qPCR. Our results suggested that many GmMIPs have high sequence similarity but diverse roles as evidenced by analysis of sequences and their expression. It can be speculated that GmMIPs contains true aquaporins, glyceroporins, aquaglyceroporins and mixed transport facilitators.	[Zhang, Da Yong; Ali, Zulfiqar; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Ma, Hong Xiang] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Ali, Zulfiqar] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Wang, Chang Biao] Shanxi Agr Sci, Cotton Res Inst, Yuncheng, Peoples R China; [Xu, Zhao Long] Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China; [Khan, Iqrar Ahmad] Univ Agr Faisalabad, Coll Agr & Appl Biol, Faisalabad, Pakistan; [Trethowan, Richard M.] Univ Sydney, Plant Breeding Inst, Sydney, NSW 2006, Australia	Jiangsu Academy of Agricultural Sciences; University of Agriculture Faisalabad; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University; University of Agriculture Faisalabad; University of Sydney	Ali, Z (corresponding author), Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China.	zulfiqarpbg@hotmail.com; hxma@jaas.ac.cn	Ali, Zulfiqar/AAF-2663-2019; Wang, Changbiao/S-8473-2019; Ali, Zulfiqar/AAF-4171-2021; Trethowan, Richard/ADZ-7680-2022	Ali, Zulfiqar/0000-0003-1228-3338; Zhang, Dan-Dan/0000-0002-1498-6718; Trethowan, Richard/0000-0003-0105-875X	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China [31101166, 30971798]; Jiangsu Natural Science Foundation, China [BK2010474]; Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu [CX(12)5132, CX(12)1005-2]; Jiangsu Key Laboratory for Bioresources of Saline Soils [JKLBS2012002]; Project in the National Science & Technology Pillar Program [2011BAD35B06-4-3]	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation, China(Natural Science Foundation of Jiangsu Province); Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu; Jiangsu Key Laboratory for Bioresources of Saline Soils; Project in the National Science & Technology Pillar Program	ZA is thankful for financial assistance from Jiangsu and Punjab sister provinces of China and Pakistan for his visit at Jiangsu Academy of Agricultural Sciences, Nanjing, People's Republic of China. This study was sponsored by National Science Foundation of China (31101166, 30971798); the Jiangsu Natural Science Foundation, China (BK2010474); the Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu (CX(12)5132, CX(12) 1005-2); Jiangsu Key Laboratory for Bioresources of Saline Soils (JKLBS2012002) and the Project in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2011BAD35B06-4-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Barkla BJ, 1999, TRENDS PLANT SCI, V4, P86, DOI 10.1016/S1360-1385(99)01388-6; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 1998, PLANT PHYSIOL, V117, P1143, DOI 10.1104/pp.117.4.1143; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; DENKER BM, 1988, J BIOL CHEM, V263, P15634; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Guenther JF, 2000, PLANTA, V210, P741, DOI 10.1007/s004250050675; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; Maurel C, 2002, INT REV CYTOL, V215, P105; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	44	116	128	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56312	10.1371/journal.pone.0056312	http://dx.doi.org/10.1371/journal.pone.0056312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437113	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200059
J	Liu, XQ; Zhou, CL; Li, YJ; Ji, Y; Xu, GP; Wang, XT; Yan, JL				Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong			SDF-1 Promotes Endochondral Bone Repair during Fracture Healing at the Traumatic Brain Injury Condition	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEAD-INJURY; ENHANCED OSTEOGENESIS; IN-VITRO; MYOCARDIAL-INFARCTION; MARROW; GROWTH; MIGRATION; MODEL; RATS	Purposes: The objective of this study was to investigate the role of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, on bone healing and whether SDF-1 contributes to accelerating bone repair in traumatic brain injury (TBI)/fracture model. Materials and Methods: Real-time polymerase chain reaction and immunohistochemical analysis were used to detect the expression of SDF-1 during the repair of femoral bone in TBI/fracture model. The TBI/fracture model was treated with anti-SDF-1 neutralizing antibody or AMD3100, an antagonist for CXCR4, and evaluated by histomorphometry. In vitro and in vivo migration assays were used to evaluate the functional effect of SDF-1 on primary mesenchymal stem cells. Results: The expression of SDF1 and CXCR4 messenger RNA was increased during the bone healing in TBI/fracture model but was less increased in fracture only model. High expression of SDF-1 protein was observed in the surrounding tissue of the damaged bone. Treated with anti-SDF-1 antibody or AMD3100 could inhibit new bone formation. SDF-1 increased mesenchymal stem cell chemotaxis in vitro in a dose-dependent manner. The in vivo migration study demonstrated that mesenchymal stem cells recruited by SDF-1 participate in endochondral bone repair. Conclusion: The SDF-1/CXCR4 axis plays a crucial role in the accelerating fracture healing under the condition of TBI and contributes to endochondral bone repair.	[Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China	Harbin Medical University	Yan, JL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China.	yanjlhyd@hotmail.com		John, Ciny/0000-0003-3688-0751; Liu, Geoffrey/0000-0002-2603-7296	National Natural Science Foundation of China [100334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (100334) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Guo ZK, 2006, STEM CELLS, V24, P992, DOI 10.1634/stemcells.2005-0224; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Khare G N, 1995, Indian J Med Sci, V49, P281; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Liu XQ, 2012, BIOTECHNOL LETT, V34, P387, DOI 10.1007/s10529-011-0757-7; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mori T, 2004, MOL CANCER THER, V3, P29; Otfinowski Janusz, 1993, Patologia Polska, V44, P133; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; SPENCER RF, 1990, S AFR J SURG, V28, P51; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Tiyapatanaputi P, 2004, J ORTHOP RES, V22, P1254, DOI 10.1016/j.orthres.2004.03.017; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013	35	100	110	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54077	10.1371/journal.pone.0054077	http://dx.doi.org/10.1371/journal.pone.0054077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	24130878	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100041
J	Wang, CJ; Song, XD; Li, YJ; Han, F; Gao, SY; Wang, XZ; Xie, SY; Lv, CJ				Wang, Congjie; Song, Xiaodong; Li, Youjie; Han, Fang; Gao, Shuyan; Wang, Xiaozhi; Xie, Shuyang; Lv, Changjun			Low-Dose Paclitaxel Ameliorates Pulmonary Fibrosis by Suppressing TGF-beta 1/Smad3 Pathway via miR-140 Upregulation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MONOCLONAL-ANTIBODY; CELLS; SMAD3; INHIBITION; MODEL; FIBROBLASTS; TISSUE	Abnormal TGF-beta 1/Smad3 activation plays an important role in the pathogenesis of pulmonary fibrosis, which can be prevented by paclitaxel (PTX). This study aimed to investigate an antifibrotic effect of the low-dose PTX (10 to 50 nM in vitro, and 0.6 mg/kg in vivo). PTX treatment resulted in phenotype reversion of epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AECs) with increase of miR-140. PTX resulted in an amelioration of bleomycin (BLM)-induced pulmonary fibrosis in rats with reduction of the wet lung weight to body weight ratios and the collagen deposition. Our results further demonstrated that PTX inhibited the effect of TGF-beta 1 on regulating the expression of Smad3 and phosphorylated Smad3 (p-Smad3), and restored the levels of E-cadherin, vimentin and alpha-SMA. Moreover, lower miR-140 levels were found in idiopathic pulmonary fibrosis (IPF) patients, TGF-beta 1-treated AECs and BLM-instilled rat lungs. Through decreasing Smad3/p-Smad3 expression and upregulating miR-140, PTX treatment could significantly reverse the EMT of AECs and prevent pulmonary fibrosis of rats. The action of PTX to ameliorate TGF-beta 1-induced EMT was promoted by miR-140, which increased E-cadherin levels and reduced the expression of vimentin, Smad3 and p-Smad3. Collectively, our results demonstrate that low-dose PTX prevents pulmonary fibrosis by suppressing the TGF-beta 1/Smad3 pathway via upregulating miR-140.	[Wang, Congjie; Han, Fang; Gao, Shuyan; Lv, Changjun] Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China; [Song, Xiaodong] Binzhou Med Univ, Med Res Ctr, Yantai, Peoples R China; [Li, Youjie; Gao, Shuyan; Xie, Shuyang] Binzhou Med Univ, Key Lab Tumor Mol Biol, Dept Biochem & Mol Biol, Yantai, Peoples R China; [Wang, Xiaozhi] Binzhou Med Univ, Affiliated Hosp, Dept Resp Med, Binzhou, Peoples R China	Binzhou Medical University; Binzhou Medical University; Binzhou Medical University; Binzhou Medical University	Lv, CJ (corresponding author), Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China.	shuyangxie@yahoo.com.cn	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [81273957]; Taishan Scholar Project; Important Project of Science and Technology of Shandong Province [2010GWZ20254, 2011GHY11501];  [NCET-10-0919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project; Important Project of Science and Technology of Shandong Province; 	This work was supported by the National Natural Science Foundation of China (Grant No. 81273957), NCET-10-0919, "Taishan Scholar Project" and Important Project of Science and Technology of Shandong Province (Grant No. 2010GWZ20254, 2011GHY11501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; ALLEN EM, 1977, J IMMUNOL, V119, P343; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BRAHN E, 1994, ARTHRITIS RHEUM, V37, P839, DOI 10.1002/art.1780370611; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi HS, 2007, J SURG RES, V141, P183, DOI 10.1016/j.jss.2006.12.558; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hay ED, 1995, ACTA ANAT, V154, P8; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; JULESELYSEE K, 1990, CLIN CHEST MED, V11, P1; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Liu SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047482; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MCDONALD JA, 1986, J CLIN INVEST, V78, P1237, DOI 10.1172/JCI112707; Mitsuhashi H, 1996, AM J RESP CRIT CARE, V153, P369, DOI 10.1164/ajrccm.153.1.8542145; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Sato N, 2000, AM J RESP CRIT CARE, V161, P1681, DOI 10.1164/ajrccm.161.5.9907104; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sharma SK, 1996, AM J RESP CRIT CARE, V154, P193, DOI 10.1164/ajrccm.154.1.8680680; Silva CIS, 2007, J THORAC IMAG, V22, P221, DOI 10.1097/01.rti.0000213588.52343.13; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THRALL RS, 1979, AM J PATHOL, V95, P117; Tran PL, 1997, J CLIN INVEST, V99, P608, DOI 10.1172/JCI119203; Uhal Bruce D., 1998, American Journal of Physiology, V275, pL1192; Vanderburg CR, 1996, ACTA ANAT, V157, P87; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059; Zhou J, 2010, WORLD J GASTROENTERO, V16, P3330, DOI 10.3748/wjg.v16.i26.3330; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	68	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70725	10.1371/journal.pone.0070725	http://dx.doi.org/10.1371/journal.pone.0070725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967091	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000012
J	Wang, C; Tian, LL; Li, S; Li, HB; Zhou, Y; Wang, H; Yang, QZ; Ma, LJ; Shang, DJ				Wang, Che; Tian, Li-Li; Li, Song; Li, Hui-Bing; Zhou, Yang; Wang, He; Yang, Qing-Zhu; Ma, Li-Jie; Shang, De-Jing			Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CHINESE BROWN FROG; SYSTEMIC INOCULATION; RANA-CHENSINENSIS; TUMOR-GROWTH; APOPTOSIS; DEATH; LINES; PHOSPHATIDYLSERINE; MITOCHONDRIA	Temporin-1CEa is an antimicrobial peptide isolated from the skin secretions of the Chinese brown frog (Rana chensinensis). We have previously reported the rapid and broad-spectrum anticancer activity of temporin-1CEa in vitro. However, the detailed mechanisms for temporin-1CEa-induced cancer cell death are still weakly understood. In the present study, the mechanisms of temporin-1CEa-induced rapid cytotoxicity on two human breast cancer cell lines, MDA-MB-231 and MCF-7, were investigated. The MTT assay and the LDH leakage assay indicated that one-hour of incubation with temporin-1CEa led to cytotoxicity in a dose-dependent manner. The morphological observation using electronic microscopes suggested that one-hour exposure of temporin-1CEa resulted in profound morphological changes in both MDA-MB-231 and MCF-7 cells. The membrane-disrupting property of temporin-1CEa was further characterized by induction of cell-surface exposure of phosphatidylserine, elevation of plasma membrane permeability and rapid depolarization of transmembrane potential. Moreover, temporin-1CEa evoked intracellular calcium ion and reactive oxygen species (ROS) elevations as well as collapse of mitochondrial membrane potential (Delta phi m). In summary, the present study indicates that temporin-1CEa triggers rapid cell death in breast cancer cells. This rapid cytotoxic activity might be mediated by both membrane destruction and intracellular calcium mechanism.	[Wang, Che; Tian, Li-Li; Wang, He; Yang, Qing-Zhu; Shang, De-Jing] Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China; [Wang, Che; Li, Hui-Bing; Zhou, Yang; Ma, Li-Jie] Liaoning Normal Univ, Dept Pharm, Sch Chem & Chem Engn, Dalian, Peoples R China; [Li, Song] Dalian Univ Technol, Lab Biophys & Pharmacol, Sch Phys & Optoelect Engn, Dalian, Peoples R China; [Shang, De-Jing] Liaoning Normal Univ, Fac Life Sci, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University; Dalian University of Technology; Liaoning Normal University	Shang, DJ (corresponding author), Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China.	dejingshang@yahoo.com	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [30970352, 81202448, 31272314]; Scientific Research Fund of Liaoning Provincial Education Department [L2012382]; Program for Liaoning Innovative Research Team in University [LT2012019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Liaoning Provincial Education Department; Program for Liaoning Innovative Research Team in University	This work was supported by the National Natural Science Foundation of China (30970352, 81202448 and 31272314), the Scientific Research Fund of Liaoning Provincial Education Department (L2012382), and the Program for Liaoning Innovative Research Team in University (LT2012019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Chan SC, 1998, ANTICANCER RES, V18, P4467; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dennis J W, 1991, Semin Cancer Biol, V2, P411; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lin VCL, 2003, AM J PATHOL, V162, P1781, DOI 10.1016/S0002-9440(10)64313-1; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Segura C, 2007, BIOCHEM BIOPH RES CO, V353, P908, DOI 10.1016/j.bbrc.2006.12.113; Shang DJ, 2009, ZOOL SCI, V26, P220, DOI 10.2108/zsj.26.220; Steinstraesser L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018321; Sureda FX, 1997, CYTOMETRY, V28, P74, DOI 10.1002/(SICI)1097-0320(19970501)28:1<74::AID-CYTO9>3.0.CO;2-H; Tan JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022836; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; UTSUGI T, 1991, CANCER RES, V51, P3062; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang C, 2012, BIOCHIMIE, V94, P434, DOI 10.1016/j.biochi.2011.08.011; Yoon WH, 1996, BIOCHEM BIOPH RES CO, V222, P694, DOI 10.1006/bbrc.1996.0806	36	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60462	10.1371/journal.pone.0060462	http://dx.doi.org/10.1371/journal.pone.0060462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23967091	gold, Green Published			2022-12-27	WOS:000319109800052
